Citrus Sinensis ID: 045835

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-
Protein Sequence
TFEGDGQIGGGAATFHLQDDTNWGFSSTGDFADDNDDQNTRYTATSDSSGLSELYINARIAPLSLTYFGYCLDNGNYTLSLHFAEIQFSNGITFHSLGRRLFDIYIQDNLVERNFDIKAEASGVLKPVARSYNVTVTNHIIEIRFHWAGKGTTALPKRGIYGPLVSAISLNDPKLKPGKKKVVPIVVGVVAGLSLIILVVSILGWRYYLRTKRHKETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV
Secondary Structure (PSIPRED)
ccccccccccccEEEEEcccccEEEEccccccccccccccEEEEcccccccHHHHHHcccccccccccccccccccEEEEEEEEEEEEcccccccccccEEEEEEEEcEEEccccccccccccccccccEEEEEEEEccEEEEEEEccccccccccccccccccccccccccccccccccEEccEEEEHHHHHHHHHHHHHHHHHHHHHHcccHHHHHHHcccccccccccHHHHHHHHcccccccccccccccccEEEEEccccEEEEEEccccccccHHHHHHHHHHHHHcccccccEEEEEEEcccEEEEEEEEcccccccccccccccccccccHHHHHHHHHHHHHHHHHHcccccccEEEccccccccccccccccccccccccccccccccEEEEEEEEEcccccHHHHccccccEEcccEEEEEEEEEEEccccccccccccccccccHHHHHHHHHHcccccEEccccccccccHHHHHHHHHHHHcccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccEEEEcccccEEEEcccccccccccccEEEEccccccccHHHHHccccccccEEEEEEEcccccEEEEEEEEEEEEcccccHHHcccEEEEEEEEccEEEccccHHHHcccccEEEEEEEEEEEcccEEEEEEEEccccccccccccccccEEEEEEEccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccHHHHHHHcccccccccEcHHHHHHHHccccHHccccccccccEEEEEcccccEEEEEEcccccccccHHHHHHHHHHHHHHcccHEEEEEEEcccccEEEEEEEcccccHHHHHccccccccccccHHHHHHHHHHHHHHHHHHHccHcccEcccccHHHEEEcccccEEEccHHHcEEcccccEEcccccccccccccHHHHHHcEEcHHHHHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHHHHHcccccEEEcccccccccHHHHHHHHHHHHHHcccccccccccccc
Coil and Loop (DISEMBL)
tfegdgqigggaatfhlqddtnwgfsstgdfaddnddqntrytatsdssglselyinariaplsltyfgycldngnytlSLHFAEiqfsngitfhslGRRLFDIYIQDNLVERNFDIKAeasgvlkpvarsynVTVTNHIIEIRfhwagkgttalpkrgiygplvsaislndpklkpgkkkvvPIVVGVVAGLSLIILVVSILGWRYYLRTKRHKetafmkesdlQTISFTLKQIKAATNNfdsakkigeggfgpvykgqladgTIIAVKQLSSKSRQGNREFLNEIAMISClqhpnlvkihgccvegDQLLLVYEYMENNSLACALFGrenceleldwptRQKICLGIARGLAFLHEESRFKIVHRDIKATNVlldrdlnpkisdfglakldegdkthistriagtigymapeYALWGYLtykadvysFGIVALEIVsgknnmsyapalefDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLctnaspslrptmsev
Flexible Loop (DISEMBL)
tfegdgqigggAATFHLQDDTNWGFSSTGDFADDNDDQNTRYTatsdssglseLYINARIAPLSLTYFGYCLDNGNYTLSLHFAEIQFSNGITFHSLGRRLFDIYIQDNLVERNFDIKAEasgvlkpvarsYNVTVTNHIIEIRFHWAGKGTTALPKRGIYGPLVSAIslndpklkpgkkKVVPIVVGVVAGLSLIILVVSILGWRYYLRTKRHKetafmkesdlqTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKatnvlldrdlnpkISDFglakldegdkthistriagtigyMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVsllctnaspslrptmsev
Low Complexity Region (SEG)
TFEGDGQIGGGAATFHLQDDTNWGFSSTGDFADDNDDQNTRYTATSDSSGLSELYINARIAPLSLTYFGYCLDNGNYTLSLHFAEIQFSNGITFHSLGRRLFDIYIQDNLVERNFDIKAEASGVLKPVARSYNVTVTNHIIEIRFHWAGKGTTALPKRGIYGPLVSAISLNDpklkpgkkkvvpivvgvvaglsliilvvsilgWRYYLRTKRHKETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV
Disordered region (IsUnstruct)
*************TFHLQDDTNWGF*************************LSELYINARIAPLSLTYFGYCLDNGNYTLSLHFAEIQFSNGITFHSLGRRLFDIYIQDNLVERNFDIKAEASGVLKPVARSYNVTVTNHIIEIRFHWAGKGTTALPKRGIYGPLVSAISLNDPKLKPGKKKVVPIVVGVVAGLSLIILVVSILGWRYYLRTKRHKETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQL********REFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGS*********MIKVSLLC**************
Disordered Region (DISOPRED)
TFEGDG*IGGGAATFHLQDDTNWGFSSTGDFADDNDDQNTRYTATSDSSGLSELYINARIAPLSLTYFGYCLDNGNYTLSLHFAEIQFSNGITFHSLGRRLFDIYIQDNLVERNFDIKAEASGVLKPVARSYNVTVTNHIIEIRFHWAGKGTTALPKRGIYGPLVS******************IVVGVVAGLSLIILVVSILGWRYY********************SFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLS******NREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSY*PALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMS**
Disordered Region (DISEMBL)
TFEGDGQIGGGAATFHLQDDTNWGFSSTGDFADDNDDQNTRYTATSDSSGLSELYINARIAPLSLTYFGYCLDNGNYTLSLHFAEIQFSNGITFHSLGRRLFDIYIQDNLVERNFDIKAEASGVLKPVARSYNVTVTNHIIEIRFHWAGKGTTALPKRGIYGPLVSAISLNDPKLKPGKKKVVPIVVGVVAGLSLIILVVSILGWRYYLRTKRHKETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPS********
Disordered Region (DISPRO)
******QIGGGAATFHLQDDTNWGFSSTGDFADDNDDQNTRYTATSDSSGLSELYINARIAPLSLTYFGYCLDNGNYTLSLHFAEIQFSNGITFHSLGRRLFDIYIQDNLVERNFDIKAEASGVLKPVARSYNVTVTNHIIEIRFHWAGKGTTALPKRGIYGPLVSAISLNDPKLKPGKKKVVPIVVGVVAGLSLIILVVSILGWRYYLRTKRHKETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNAS**********
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
TFEGDGQIGGGAATFHLQDDTNWGFSSTGDFADDNDDQNTRYTATSDSSGLSELYINARIAPLSLTYFGYCLDNGNYTLSLHFAEIQFSNGITFHSLGRRLFDIYIQDNLVERNFDIKAEASGVLKPVARSYNVTVTNHIIEIRFHWAGKGTTALPKRGIYGPLVSAISLNDPKLKPGKKKVVPIVVGVVAGLSLIILVVSILGWRYYLRTKRHKETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	511	2.2.26 [Sep-21-2011]
Q9FXF2	1021	Probable LRR receptor-lik	yes	no	0.988	0.494	0.583	1e-174
C0LGE0	1014	Probable LRR receptor-lik	no	no	0.982	0.495	0.592	1e-171
Q9ASQ6	1019	Probable LRR receptor-lik	no	no	0.947	0.474	0.586	1e-165
C0LGG8	1038	Probable LRR receptor-lik	no	no	0.964	0.474	0.596	1e-164
C0LGG9	1035	Probable LRR receptor-lik	no	no	0.966	0.477	0.598	1e-163
C0LGN2	1020	Probable leucine-rich rep	no	no	0.947	0.474	0.577	1e-160
C0LGG7	953	Probable LRR receptor-lik	no	no	0.949	0.508	0.576	1e-159
C0LGH3	1033	Probable LRR receptor-lik	no	no	0.962	0.476	0.480	1e-130
C0LGH2	1032	Probable LRR receptor-lik	no	no	0.962	0.476	0.472	1e-128
Q9ZP16	667	Cysteine-rich receptor-li	no	no	0.659	0.505	0.435	1e-77

>sp|Q9FXF2|RKF1_ARATH Probable LRR receptor-like serine/threonine-protein kinase RFK1 OS=Arabidopsis thaliana GN=RKF1 PE=1 SV=1

 Score =  610 bits (1573), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 301/516 (58%), Positives = 387/516 (75%), Gaps = 11/516 (2%)

Query: 2   FEGDGQIGGGAATFHLQDDTNWGFSSTGDFADDNDDQNTRYTATSDSSGLSELYINARIA 61
           +EGDG + GGAA + L+ D NWGFSSTGDF DDN+ QNTR+T    +S  S+LY +ARIA
Sbjct: 438 YEGDGNVEGGAAKYFLKPDANWGFSSTGDFMDDNNFQNTRFTMFVPASNQSDLYKSARIA 497

Query: 62  PLSLTYFGYCLDNGNYTLSLHFAEIQFSNGITFHSLGRRLFDIYIQDNLVERNFDIKAEA 121
           P+SLTYF  CL+NGNYT++L FAEI+F+N   ++ LGRRLFDIYIQ+ LV ++F+I  EA
Sbjct: 498 PVSLTYFHACLENGNYTINLDFAEIRFTNDENYNRLGRRLFDIYIQEKLVAKDFNIMDEA 557

Query: 122 SGVLKPVARSYNVTVTNHIIEIRFHWAGKGTTALPKRGIYGPLVSAISLNDPKLKPGKKK 181
            G   P+ +     VTNH + IR  WAGKGTT +P RG+YGP++SAIS+     KP ++ 
Sbjct: 558 KGAQTPIIKPLTAYVTNHFLTIRLSWAGKGTTRIPTRGVYGPIISAISIVSDS-KPCERP 616

Query: 182 VVPIVVG--VVAGLSLIILVVSILGWRYYL----RTKRHKETAFMKESDLQTISFTLKQI 235
              +  G  +  G+    L++ ILG+ +      R  R ++  +  E +L + +FTL+QI
Sbjct: 617 KTGMSPGAYIAIGIGAPCLIIFILGFLWICGCLPRCGRQRKDPY--EEELPSGTFTLRQI 674

Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQH 295
           K AT++F+   KIGEGGFG V+KG LADG ++AVKQLSSKSRQGNREFLNEI  ISCLQH
Sbjct: 675 KFATDDFNPTNKIGEGGFGAVFKGVLADGRVVAVKQLSSKSRQGNREFLNEIGAISCLQH 734

Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           PNLVK+HG CVE  QLLL YEYMENNSL+ ALF  ++ ++ +DWPTR KIC GIA+GLAF
Sbjct: 735 PNLVKLHGFCVERAQLLLAYEYMENNSLSSALFSPKHKQIPMDWPTRFKICCGIAKGLAF 794

Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEY 415
           LHEES  K VHRDIKATN+LLD+DL PKISDFGLA+LDE +KTHIST++AGTIGYMAPEY
Sbjct: 795 LHEESPLKFVHRDIKATNILLDKDLTPKISDFGLARLDEEEKTHISTKVAGTIGYMAPEY 854

Query: 416 ALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD 475
           ALWGYLT+KADVYSFG++ LEIV+G  N ++  A   D  CLL++A    + G L+++VD
Sbjct: 855 ALWGYLTFKADVYSFGVLVLEIVAGITNSNFMGA--GDSVCLLEFANECVESGHLMQVVD 912

Query: 476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           ERL  +  ++EAE +IKV+L+C++ASP+ RP MSEV
Sbjct: 913 ERLRPEVDRKEAEAVIKVALVCSSASPTDRPLMSEV 948

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGE0|Y1765_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07650 OS=Arabidopsis thaliana GN=At1g07650 PE=1 SV=1

 Score =  602 bits (1552), Expect = e-171,   Method: Compositional matrix adjust.
 Identities = 311/525 (59%), Positives = 396/525 (75%), Gaps = 23/525 (4%)

Query: 1   TFEGDGQIGGGAATFHLQDDTNWGFSSTGDFADDNDD------QNTRYTATSDSSGLSEL 54
           T++ D +   GA+ + L  +  W  SSTG+F D++DD      QNT   + + SS    L
Sbjct: 431 TYQADDE-PKGASMYVLGANKRWALSSTGNFMDNDDDADEYTVQNTSRLSVNASSPSFGL 489

Query: 55  YINARIAPLSLTYFGYCLDNGNYTLSLHFAEIQFSNGITFHSLGRRLFDIYIQDNLVERN 114
           Y  AR++PLSLTY+G CL NGNYT++LHFAEI F++  T +SLG+RLFDIY+QD LV +N
Sbjct: 490 YRTARVSPLSLTYYGICLGNGNYTVNLHFAEIIFTDDNTLYSLGKRLFDIYVQDQLVIKN 549

Query: 115 FDIKAEASGVLKPVARSYNVTVTNHIIEIRFHWAGKGTTALPKRGIYGPLVSAISLNDPK 174
           F+I+  A G  KP+ +S+ V VT+H ++I   WAGKGTT +P RG+YGP++SAIS+ +P 
Sbjct: 550 FNIQEAARGSGKPIIKSFLVNVTDHTLKIGLRWAGKGTTGIPIRGVYGPMISAISV-EPN 608

Query: 175 LKPG---KKKVVPIVVGV-VAGLSLIILVVSILGWRYYLRTKRHKETAFMKES---DLQT 227
            KP      K + + VGV VA  +L++ ++  + W+     KR  +    KE    DLQT
Sbjct: 609 FKPPVYYDTKDIILKVGVPVAAATLLLFIIVGVFWK-----KRRDKNDIDKELRGLDLQT 663

Query: 228 ISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEI 287
            +FTL+QIKAAT+NFD  +KIGEGGFG VYKG+L++G +IAVKQLS+KSRQGNREF+NEI
Sbjct: 664 GTFTLRQIKAATDNFDVTRKIGEGGFGSVYKGELSEGKLIAVKQLSAKSRQGNREFVNEI 723

Query: 288 AMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGR-ENCELELDWPTRQKIC 346
            MIS LQHPNLVK++GCCVEG+QL+LVYEY+ENN L+ ALFG+ E+  L+LDW TR+KI 
Sbjct: 724 GMISALQHPNLVKLYGCCVEGNQLILVYEYLENNCLSRALFGKDESSRLKLDWSTRKKIF 783

Query: 347 LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG 406
           LGIA+GL FLHEESR KIVHRDIKA+NVLLD+DLN KISDFGLAKL++   THISTRIAG
Sbjct: 784 LGIAKGLTFLHEESRIKIVHRDIKASNVLLDKDLNAKISDFGLAKLNDDGNTHISTRIAG 843

Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQ 466
           TIGYMAPEYA+ GYLT KADVYSFG+VALEIVSGK+N ++ P  +F    LLDWA  LQ+
Sbjct: 844 TIGYMAPEYAMRGYLTEKADVYSFGVVALEIVSGKSNTNFRPTEDF--VYLLDWAYVLQE 901

Query: 467 DGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
            G L+ELVD  L S Y +EEA  M+ V+L+CTNASP+LRPTMS+V
Sbjct: 902 RGSLLELVDPTLASDYSEEEAMLMLNVALMCTNASPTLRPTMSQV 946

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ASQ6|Y1972_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g29720 OS=Arabidopsis thaliana GN=RFK1 PE=2 SV=3

 Score =  582 bits (1500), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 291/496 (58%), Positives = 364/496 (73%), Gaps = 12/496 (2%)

Query: 23  WGFSSTGDFADDNDDQNTRYTAT--SDSSGLSELYINARIAPLSLTYFGYCLDNGNYTLS 80
           WG S+TGDF DDN D +  YT+T  + S    +LY  AR + LSL Y+ +CL+NGNY + 
Sbjct: 446 WGVSNTGDFTDDNSDHDEYYTSTNLTLSGDYPDLYKTARRSALSLVYYAFCLENGNYNVK 505

Query: 81  LHFAEIQFSNGITFHSLGRRLFDIYIQDNLVERNFDIKAEASGVLKPVARSYNVTVTNHI 140
           LHF EIQFS+   +  LGRR+FD+Y+Q  L  R+F+I  EA+G +KPV +  N TVTNH+
Sbjct: 506 LHFMEIQFSDKEVYSRLGRRIFDVYVQGKLFLRDFNINKEANGNMKPVIKEINATVTNHM 565

Query: 141 IEIRFHWAGKGTTALPKRGIYGPLVSAISL---NDPKLKPGKKK---VVPIVVGVVAGLS 194
           +EIR +WAGKGTT +PKRG YGPL+SAISL    +P     K K     P+++G    L 
Sbjct: 566 LEIRLYWAGKGTTLIPKRGNYGPLISAISLCHSQEPLCGVEKTKHHIKYPLILGASGALV 625

Query: 195 LIILVVSILGWRYYLRTKRHKETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFG 254
            I+L+   +  R   R   ++    ++   LQT+ F+ +Q++ ATNNFD A K+GEGGFG
Sbjct: 626 TIVLLAVGIYARGIYRRDNNRRERDLRAQGLQTVCFSWRQLQTATNNFDQANKLGEGGFG 685

Query: 255 PVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLV 314
            V+KG+L+DGTIIAVKQLSSKS QGNREF+NEI MIS L HPNLVK++GCCVE DQLLLV
Sbjct: 686 SVFKGELSDGTIIAVKQLSSKSSQGNREFVNEIGMISGLNHPNLVKLYGCCVERDQLLLV 745

Query: 315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNV 374
           YEYMENNSLA ALFG+ +  L+LDW  RQKIC+GIARGL FLH+ S  ++VHRDIK TNV
Sbjct: 746 YEYMENNSLALALFGQNS--LKLDWAARQKICVGIARGLEFLHDGSAMRMVHRDIKTTNV 803

Query: 375 LLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVA 434
           LLD DLN KISDFGLA+L E + THIST++AGTIGYMAPEYALWG LT KADVYSFG+VA
Sbjct: 804 LLDTDLNAKISDFGLARLHEAEHTHISTKVAGTIGYMAPEYALWGQLTEKADVYSFGVVA 863

Query: 435 LEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVS 494
           +EIVSGK+N         D   L++WA  LQQ G ++E+VD  L  ++ + EA RMIKV+
Sbjct: 864 MEIVSGKSNTKQQG--NADSVSLINWALTLQQTGDILEIVDRMLEGEFNRSEAVRMIKVA 921

Query: 495 LLCTNASPSLRPTMSE 510
           L+CTN+SPSLRPTMSE
Sbjct: 922 LVCTNSSPSLRPTMSE 937

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGG8|Y5343_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53430 OS=Arabidopsis thaliana GN=At1g53430 PE=1 SV=1

 Score =  580 bits (1494), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 305/511 (59%), Positives = 363/511 (71%), Gaps = 18/511 (3%)

Query: 11  GAATFHLQDDTNWGFSSTGDFADDNDD---QNTRYTATSDSSGLSELYINARIAPLSLTY 67
           G +TF    +  WG+SS+G +    D       R+   + S+   E Y  AR++P SL Y
Sbjct: 434 GQSTFSSVSE-RWGYSSSGVWLGKEDAGYLATDRFNLINGST--PEYYKTARLSPQSLKY 490

Query: 68  FGYCLDNGNYTLSLHFAEIQFSNGITFHSLGRRLFDIYIQDNLVERNFDIKAEASGVLKP 127
           +G CL  G+Y L LHFAEI FSN  TF+SLGRR+FDIY+Q NL+ER+F+I   A GV KP
Sbjct: 491 YGLCLRRGSYKLQLHFAEIMFSNDQTFNSLGRRIFDIYVQGNLLERDFNIAERAGGVGKP 550

Query: 128 VARSYN-VTVTNHIIEIRFHWAGKGTTALPKRGIYGPLVSAISLNDPKLKPGKKKVVPIV 186
             R  + V V    +EI   W GKGT  +P RG+YGPL+SAI++  P  K    K  P+ 
Sbjct: 551 FIRQIDGVQVNGSTLEIHLQWTGKGTNVIPTRGVYGPLISAITIT-PNFKVDTGK--PLS 607

Query: 187 VGVVAGLSLI------ILVVSILGWRYYLRTKRHKETAFMKESDLQTISFTLKQIKAATN 240
            G VAG+ +       +LV+ IL    YL  K   E   ++  DLQT SFTLKQIK ATN
Sbjct: 608 NGAVAGIVIAACAVFGLLVLVILRLTGYLGGKEVDENEELRGLDLQTGSFTLKQIKRATN 667

Query: 241 NFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
           NFD   KIGEGGFGPVYKG LADG  IAVKQLSSKS+QGNREF+ EI MIS LQHPNLVK
Sbjct: 668 NFDPENKIGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIGMISALQHPNLVK 727

Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
           ++GCC+EG +LLLVYEY+ENNSLA ALFG E   L LDW TR KIC+GIA+GLA+LHEES
Sbjct: 728 LYGCCIEGKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKICIGIAKGLAYLHEES 787

Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGY 420
           R KIVHRDIKATNVLLD  LN KISDFGLAKL++ + THISTRIAGTIGYMAPEYA+ GY
Sbjct: 788 RLKIVHRDIKATNVLLDLSLNAKISDFGLAKLNDDENTHISTRIAGTIGYMAPEYAMRGY 847

Query: 421 LTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGS 480
           LT KADVYSFG+V LEIVSGK+N +Y P  EF    LLDWA  LQ+ G L+ELVD  LG+
Sbjct: 848 LTDKADVYSFGVVCLEIVSGKSNTNYRPKEEF--VYLLDWAYVLQEQGSLLELVDPDLGT 905

Query: 481 KYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
            + K+EA RM+ ++LLCTN SP+LRP MS V
Sbjct: 906 SFSKKEAMRMLNIALLCTNPSPTLRPPMSSV 936

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGG9|Y5344_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53440 OS=Arabidopsis thaliana GN=At1g53440 PE=1 SV=2

 Score =  573 bits (1478), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 305/510 (59%), Positives = 362/510 (70%), Gaps = 16/510 (3%)

Query: 11  GAATFHLQDDTNWGFSSTGDFADDNDDQNTRYTATSD--SSGLSELYINARIAPLSLTYF 68
           GA+TF    +  WG+SS+G +   ND      T T +  +    E Y  AR+A  SL Y+
Sbjct: 432 GASTFSSVSE-RWGYSSSGAWLG-NDGATYLATDTFNLINESTPEYYKTARLASQSLKYY 489

Query: 69  GYCLDNGNYTLSLHFAEIQFSNGITFHSLGRRLFDIYIQDNLVERNFDIKAEASGVLKPV 128
           G C+  G+Y + L+FAEI FSN  T+ SLGRRLFDIY+Q  L+ER+F+I   A GV KP 
Sbjct: 490 GLCMRRGSYKVQLYFAEIMFSNDQTYSSLGRRLFDIYVQGILLERDFNIAQRAGGVGKPF 549

Query: 129 ARSYN-VTVTNHIIEIRFHWAGKGTTALPKRGIYGPLVSAISLNDPKLKPGKKKVVPIVV 187
            R  + V V    +EI   W GKGT  +P RG+YGPL+SAI++  P  K    K  P+  
Sbjct: 550 LRQVDEVQVNGSTLEIHLKWTGKGTNVIPTRGVYGPLISAITVT-PNFKVDTGK--PLSN 606

Query: 188 GVVAGLSLI------ILVVSILGWRYYLRTKRHKETAFMKESDLQTISFTLKQIKAATNN 241
           GVVAG+ +       +LV+ IL    YL  K   E   ++  DLQT SFTLKQIK ATNN
Sbjct: 607 GVVAGIVIAACVAFGLLVLVILRLTGYLGGKEVDENEELRGLDLQTGSFTLKQIKRATNN 666

Query: 242 FDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKI 301
           FD   KIGEGGFGPVYKG LADG  IAVKQLSSKS+QGNREF+ EI MIS LQHPNLVK+
Sbjct: 667 FDPENKIGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIGMISALQHPNLVKL 726

Query: 302 HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESR 361
           +GCC+EG +LLLVYEY+ENNSLA ALFG E   L LDW TR K+C+GIA+GLA+LHEESR
Sbjct: 727 YGCCIEGKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKVCIGIAKGLAYLHEESR 786

Query: 362 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYL 421
            KIVHRDIKATNVLLD  LN KISDFGLAKLDE + THISTRIAGTIGYMAPEYA+ GYL
Sbjct: 787 LKIVHRDIKATNVLLDLSLNAKISDFGLAKLDEEENTHISTRIAGTIGYMAPEYAMRGYL 846

Query: 422 TYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSK 481
           T KADVYSFG+V LEIVSGK+N +Y P  EF    LLDWA  LQ+ G L+ELVD  LG+ 
Sbjct: 847 TDKADVYSFGVVCLEIVSGKSNTNYRPKEEF--IYLLDWAYVLQEQGSLLELVDPDLGTS 904

Query: 482 YKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           + K+EA RM+ ++LLCTN SP+LRP MS V
Sbjct: 905 FSKKEAMRMLNIALLCTNPSPTLRPPMSSV 934

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGN2|Y3148_ARATH Probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840 OS=Arabidopsis thaliana GN=LRR-RLK PE=1 SV=1

 Score =  565 bits (1457), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 293/507 (57%), Positives = 363/507 (71%), Gaps = 23/507 (4%)

Query: 23  WGFSSTGDFADDNDDQNTRYTATSDSSGLS--------ELYINARIAPLSLTYFGYCLDN 74
           W  S+TG+F DD D  N   +  S+SS L          LY  AR++ +SLTY   CL  
Sbjct: 438 WVSSNTGNFLDD-DRTNNGKSKWSNSSELKITNSSIDFRLYTQARLSAISLTYQALCLGK 496

Query: 75  GNYTLSLHFAEIQFSNGITFHSLGRRLFDIYIQDNLVERNFDIKAEASGVLKPVARSYNV 134
           GNYT++LHFAEI F+    + +LGRR FDIY+Q     ++F+I  EA GV K V + + V
Sbjct: 497 GNYTVNLHFAEIMFNEKNMYSNLGRRYFDIYVQGKREVKDFNIVDEAKGVGKAVVKKFPV 556

Query: 135 TVTNHIIEIRFHWAGKGTTALPKRGIYGPLVSAISLNDPKLKPGKKKVVPIVVG------ 188
            VTN  +EIR  WAGKGT A+P RG+YGPL+SA+S+ DP   P K+       G      
Sbjct: 557 MVTNGKLEIRLQWAGKGTQAIPVRGVYGPLISAVSV-DPDFIPPKEPGTGTGGGSSVGTV 615

Query: 189 ----VVAGLSLIILVVSILGWRYYLRTKRHKETAFMKESDLQTISFTLKQIKAATNNFDS 244
               + + + L++L+  IL WR  LR K   E  F K  D Q  SF+L+QIK AT+NFD 
Sbjct: 616 VGSVIASTVFLVLLIGGILWWRGCLRPKSQMEKDF-KNLDFQISSFSLRQIKVATDNFDP 674

Query: 245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
           A KIGEGGFGPV+KG + DGT+IAVKQLS+KS+QGNREFLNEIAMIS LQHP+LVK++GC
Sbjct: 675 ANKIGEGGFGPVHKGIMTDGTVIAVKQLSAKSKQGNREFLNEIAMISALQHPHLVKLYGC 734

Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
           CVEGDQLLLVYEY+ENNSLA ALFG +  ++ L+WP RQKIC+GIARGLA+LHEESR KI
Sbjct: 735 CVEGDQLLLVYEYLENNSLARALFGPQETQIPLNWPMRQKICVGIARGLAYLHEESRLKI 794

Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYK 424
           VHRDIKATNVLLD++LNPKISDFGLAKLDE + THISTR+AGT GYMAPEYA+ G+LT K
Sbjct: 795 VHRDIKATNVLLDKELNPKISDFGLAKLDEEENTHISTRVAGTYGYMAPEYAMRGHLTDK 854

Query: 425 ADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKK 484
           ADVYSFG+VALEIV GK+N S     + D   LLDW   L++   L+E+VD RLG+ Y K
Sbjct: 855 ADVYSFGVVALEIVHGKSNTSSRS--KADTFYLLDWVHVLREQNTLLEVVDPRLGTDYNK 912

Query: 485 EEAERMIKVSLLCTNASPSLRPTMSEV 511
           +EA  MI++ +LCT+ +P  RP+MS V
Sbjct: 913 QEALMMIQIGMLCTSPAPGDRPSMSTV 939

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGG7|Y1534_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53420 OS=Arabidopsis thaliana GN=At1g53420 PE=2 SV=2

 Score =  560 bits (1444), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 286/496 (57%), Positives = 361/496 (72%), Gaps = 11/496 (2%)

Query: 23  WGFSSTGDFADDNDDQNTRYTATSDSSGLSE----LYINARIAPLSLTYFGYCLDNGNYT 78
           W  ++ G F DD      R T  S+SS L+     LY  ARI+ +SLTY+  CL+NGNY 
Sbjct: 400 WFSNNVGVFVDDKHVPE-RVTIESNSSELNVVDFGLYTQARISAISLTYYALCLENGNYN 458

Query: 79  LSLHFAEIQFSNGITFHSLGRRLFDIYIQDNLVERNFDIKAEASGVLKPVARSYNVTVTN 138
           ++LHFAEI F+    + SLGRR FDIYIQ  L  ++F+I  EA  V   V +++ V + +
Sbjct: 459 VNLHFAEIMFNGNNNYQSLGRRFFDIYIQRKLEVKDFNIAKEAKDVGNVVIKTFPVEIKD 518

Query: 139 HIIEIRFHWAGKGTTALPKRGIYGPLVSAISLN---DPKLKPGKKKVVPIVVGVVAGLSL 195
             +EIR +WAG+GTT +PK  +YGPL+SAIS++   +P  + G        + V+  + +
Sbjct: 519 GKLEIRLYWAGRGTTVIPKERVYGPLISAISVDSSVNPSPRNGMSTGTLHTLVVILSIFI 578

Query: 196 IILVVSILGWRYYLRTKRHKETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGP 255
           + LV   L  + YLR+K   E  F K  +L   SF+L+QIK ATNNFDSA +IGEGGFGP
Sbjct: 579 VFLVFGTLWKKGYLRSKSQMEKDF-KSLELMIASFSLRQIKIATNNFDSANRIGEGGFGP 637

Query: 256 VYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY 315
           VYKG+L DGTIIAVKQLS+ S+QGNREFLNEI MIS L HPNLVK++GCCVEG QLLLVY
Sbjct: 638 VYKGKLFDGTIIAVKQLSTGSKQGNREFLNEIGMISALHHPNLVKLYGCCVEGGQLLLVY 697

Query: 316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVL 375
           E++ENNSLA ALFG +  +L LDWPTR+KIC+G+ARGLA+LHEESR KIVHRDIKATNVL
Sbjct: 698 EFVENNSLARALFGPQETQLRLDWPTRRKICIGVARGLAYLHEESRLKIVHRDIKATNVL 757

Query: 376 LDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVAL 435
           LD+ LNPKISDFGLAKLDE D THISTRIAGT GYMAPEYA+ G+LT KADVYSFGIVAL
Sbjct: 758 LDKQLNPKISDFGLAKLDEEDSTHISTRIAGTFGYMAPEYAMRGHLTDKADVYSFGIVAL 817

Query: 436 EIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSL 495
           EIV G++N       + +   L+DW   L++   L+ELVD RLGS+Y +EEA  MI++++
Sbjct: 818 EIVHGRSNK--IERSKNNTFYLIDWVEVLREKNNLLELVDPRLGSEYNREEAMTMIQIAI 875

Query: 496 LCTNASPSLRPTMSEV 511
           +CT++ P  RP+MSEV
Sbjct: 876 MCTSSEPCERPSMSEV 891

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2

 Score =  465 bits (1197), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 248/516 (48%), Positives = 340/516 (65%), Gaps = 24/516 (4%)

Query: 11  GAATFHLQDDTNWGFSSTGDFADDNDDQNTRYTATSDSSGL----SELYINARIAPLSLT 66
           G A+F +     W  SS G FA  +   N  Y +TS S  +    SEL+ +AR++  SL 
Sbjct: 451 GPASFVVSAGQRWAASSVGLFAGSS---NNIYISTSQSQFVNTLDSELFQSARLSASSLR 507

Query: 67  YFGYCLDNGNYTLSLHFAEIQF--SNGITFHSLGRRLFDIYIQDNLVERNFDIKAEAS-G 123
           Y+G  L+NG YT++L FAEIQ   S   T+  LGRR FDIY+Q  LVE++FD++  A   
Sbjct: 508 YYGLGLENGGYTVTLQFAEIQILGSTSNTWRGLGRRRFDIYVQGRLVEKDFDVRRTAGDS 567

Query: 124 VLKPVARSYNVTVTNHIIEIRFHWAGKGTTALPKRGIYGPLVSAISLNDPKLKPG----- 178
            ++ V R Y   V+ + +EI   WAGKGT  +P +G YGPL+SA+    P   P      
Sbjct: 568 TVRAVQREYKANVSQNHLEIHLFWAGKGTCCIPIQGAYGPLISAVGAT-PDFTPTVGNRP 626

Query: 179 ---KKKVVPIVVGVVAGLSLIILVVSILGWRYYLRTKRHKETAFMKESDLQTISFTLKQI 235
               K +   +VGV+ G+ L+ ++  ++ +    R KR+ +   +   D++  +FT  ++
Sbjct: 627 PSKGKSMTGTIVGVIVGVGLLSIISGVVIFIIRKRRKRYTDDEEILSMDVKPYTFTYSEL 686

Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQH 295
           K+AT +FD + K+GEGGFGPVYKG+L DG  +AVK LS  SRQG  +F+ EI  IS +QH
Sbjct: 687 KSATQDFDPSNKLGEGGFGPVYKGKLNDGREVAVKLLSVGSRQGKGQFVAEIVAISAVQH 746

Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
            NLVK++GCC EG+  LLVYEY+ N SL  ALFG +   L LDW TR +ICLG+ARGL +
Sbjct: 747 RNLVKLYGCCYEGEHRLLVYEYLPNGSLDQALFGEKT--LHLDWSTRYEICLGVARGLVY 804

Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEY 415
           LHEE+R +IVHRD+KA+N+LLD  L PK+SDFGLAKL +  KTHISTR+AGTIGY+APEY
Sbjct: 805 LHEEARLRIVHRDVKASNILLDSKLVPKVSDFGLAKLYDDKKTHISTRVAGTIGYLAPEY 864

Query: 416 ALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD 475
           A+ G+LT K DVY+FG+VALE+VSG+ N      LE +   LL+WA +L + G+ VEL+D
Sbjct: 865 AMRGHLTEKTDVYAFGVVALELVSGRPNSD--ENLEDEKRYLLEWAWNLHEKGREVELID 922

Query: 476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
            +L +++  EE +RMI ++LLCT  S +LRP MS V
Sbjct: 923 HQL-TEFNMEEGKRMIGIALLCTQTSHALRPPMSRV 957

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2

 Score =  458 bits (1179), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 244/516 (47%), Positives = 337/516 (65%), Gaps = 24/516 (4%)

Query: 11  GAATFHLQDDTNWGFSSTGDFADDNDDQNTRYTATSDSSGL----SELYINARIAPLSLT 66
           G A+F +     W  SS G FA  +   N  Y ATS S  +    SEL+ +AR++  S+ 
Sbjct: 452 GPASFFVSAGQRWAASSVGLFAGSS---NNIYIATSQSQFVNTLDSELFQSARLSASSVR 508

Query: 67  YFGYCLDNGNYTLSLHFAEIQF--SNGITFHSLGRRLFDIYIQDNLVERNFDIKAEAS-G 123
           Y+G  L+NG YT++L FAEIQ   S   T+  LGRR FDIY+Q  LVE++FD++  A   
Sbjct: 509 YYGLGLENGGYTVTLQFAEIQILGSTSTTWKGLGRRRFDIYVQGRLVEKDFDVRRTAGDS 568

Query: 124 VLKPVARSYNVTVTNHIIEIRFHWAGKGTTALPKRGIYGPLVSAISLNDPKLKPGKKKVV 183
            ++ V R Y   V+ + +E+   WAGKGT  +P +G YGPL+SA+S   P   P      
Sbjct: 569 TVRAVQRVYKANVSENHLEVHLFWAGKGTCCIPIQGAYGPLISAVSAT-PDFTPTVANKP 627

Query: 184 P--------IVVGVVAGLSLIILVVSILGWRYYLRTKRHKETAFMKESDLQTISFTLKQI 235
           P         +VGV+ G+ L+ ++  ++ +    R KR+ +   +   D++   FT  ++
Sbjct: 628 PSKGKNRTGTIVGVIVGVGLLSILAGVVMFTIRKRRKRYTDDEELLGMDVKPYIFTYSEL 687

Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQH 295
           K+AT +FD + K+GEGGFGPVYKG L DG ++AVK LS  SRQG  +F+ EI  IS + H
Sbjct: 688 KSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEIVAISSVLH 747

Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
            NLVK++GCC EG+  +LVYEY+ N SL  ALFG +   L LDW TR +ICLG+ARGL +
Sbjct: 748 RNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFGDKT--LHLDWSTRYEICLGVARGLVY 805

Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEY 415
           LHEE+  +IVHRD+KA+N+LLD  L P+ISDFGLAKL +  KTHISTR+AGTIGY+APEY
Sbjct: 806 LHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVAGTIGYLAPEY 865

Query: 416 ALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD 475
           A+ G+LT K DVY+FG+VALE+VSG+ N      LE +   LL+WA +L +  + +EL+D
Sbjct: 866 AMRGHLTEKTDVYAFGVVALELVSGRPNSD--ENLEEEKKYLLEWAWNLHEKSRDIELID 923

Query: 476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           ++L + +  EEA+RMI ++LLCT  S +LRP MS V
Sbjct: 924 DKL-TDFNMEEAKRMIGIALLCTQTSHALRPPMSRV 958

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZP16|CRK11_ARATH Cysteine-rich receptor-like protein kinase 11 OS=Arabidopsis thaliana GN=CRK11 PE=2 SV=2

 Score =  290 bits (743), Expect = 1e-77,   Method: Compositional matrix adjust.
 Identities = 152/349 (43%), Positives = 225/349 (64%), Gaps = 12/349 (3%)

Query: 171 NDPKLKPGKKKVVPIVVGVVAGLSLIILVVSILGWRYYLRTKRHKETAFMKESDLQT--- 227
           ++P     K     +VV +     + IL++ +LG+  + R K ++ T    ESD+ T   
Sbjct: 276 DNPTNNDSKGISAGVVVAITVPTVIAILILLVLGFVLFRRRKSYQRTKTESESDISTTDS 335

Query: 228 ISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEI 287
           + +  K I+AATN F ++ K+GEGGFG VYKG+L++GT +AVK+LS KS QG REF NE 
Sbjct: 336 LVYDFKTIEAATNKFSTSNKLGEGGFGAVYKGKLSNGTDVAVKRLSKKSGQGTREFRNEA 395

Query: 288 AMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL 347
            +++ LQH NLV++ G C+E ++ +L+YE++ N SL   LF  E  + +LDW  R KI  
Sbjct: 396 VLVTKLQHRNLVRLLGFCLEREEQILIYEFVHNKSLDYFLFDPEK-QSQLDWTRRYKIIG 454

Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIST-RIAG 406
           GIARG+ +LH++SR KI+HRD+KA+N+LLD D+NPKI+DFGLA +   ++T  +T RIAG
Sbjct: 455 GIARGILYLHQDSRLKIIHRDLKASNILLDADMNPKIADFGLATIFGVEQTQGNTNRIAG 514

Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTC----LLDWAC 462
           T  YM+PEYA+ G  + K+D+YSFG++ LEI+SGK N   +   + D T     L+ +A 
Sbjct: 515 TYAYMSPEYAMHGQYSMKSDIYSFGVLVLEIISGKKN---SGVYQMDETSTAGNLVTYAS 571

Query: 463 HLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
            L ++   +ELVD   G  Y+  E  R I ++LLC   +P  RP +S +
Sbjct: 572 RLWRNKSPLELVDPTFGRNYQSNEVTRCIHIALLCVQENPEDRPMLSTI 620

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	511
297740560	1001	unnamed protein product [Vitis vinifera]	0.988	0.504	0.692	0.0
359483540	1066	PREDICTED: probable LRR receptor-like se	0.988	0.473	0.693	0.0
297740557	839	unnamed protein product [Vitis vinifera]	0.990	0.603	0.691	0.0
255562540	2046	kinase, putative [Ricinus communis] gi|2	0.988	0.246	0.691	0.0
224079009	1030	predicted protein [Populus trichocarpa]	0.986	0.489	0.668	0.0
224116760	1024	predicted protein [Populus trichocarpa]	0.988	0.493	0.680	0.0
147838007	667	hypothetical protein VITISV_025000 [Viti	0.966	0.740	0.669	0.0
224078996	942	predicted protein [Populus trichocarpa]	0.988	0.536	0.657	0.0
449520451	987	PREDICTED: LOW QUALITY PROTEIN: probable	0.984	0.509	0.650	0.0
449459314	1019	PREDICTED: probable LRR receptor-like se	0.984	0.493	0.650	0.0

>gi|297740560|emb|CBI30742.3| unnamed protein product [Vitis vinifera]

 Score =  734 bits (1895), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 356/514 (69%), Positives = 421/514 (81%), Gaps = 9/514 (1%)

Query: 2   FEGDGQIGGGAATFHLQDDTNWGFSSTGDFADDNDDQNTRYTATSDSSGLSELYINARIA 61
           +EGD ++ GG A +    ++ WG SSTGDF DDN+DQN RY  T  S  +S +Y  AR++
Sbjct: 102 YEGDAEVEGGTAKYFRSKNSYWGLSSTGDFMDDNNDQNMRYIETLSSGNISGVYTTARLS 161

Query: 62  PLSLTYFGYCLDNGNYTLSLHFAEIQFSNGITFHSLGRRLFDIYIQDNLVERNFDIKAEA 121
           PLSLTYFGYCL+NG+YTL LHFAEI F+N  T+ SLG+RLFDIYIQ+ LV ++F+I+ EA
Sbjct: 162 PLSLTYFGYCLENGDYTLQLHFAEIYFTNDKTYDSLGKRLFDIYIQEQLVHKDFNIEDEA 221

Query: 122 SGVLKPVARSYNVTVTNHIIEIRFHWAGKGTTALPKRGIYGPLVSAISLNDPKLKP---- 177
            G  KPV + +N +VTN+++EIRF+WAGKGTT +P RG+YGPL+SAIS++ P  K     
Sbjct: 222 RGARKPVMKQFNTSVTNNVLEIRFYWAGKGTTRIPSRGVYGPLISAISVH-PNFKSCSSS 280

Query: 178 GKKKVVPIVVGVVAGLSLIILVVSILGWRYYLRTKRHKETAFMKESDLQTISFTLKQIKA 237
           GKK +   ++G V GL +I+L++  L W+  LR ++ +E    +  DLQT SFTLKQIK 
Sbjct: 281 GKKGMTAYIIGGVVGLCIILLILGFLQWKGCLRGRKREEKD-PEGLDLQTSSFTLKQIKN 339

Query: 238 ATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPN 297
           ATNNFDSA KIGEGGFGPV+KG L+DGT +AVKQLSS SRQGNREFLNEI MISCLQHPN
Sbjct: 340 ATNNFDSANKIGEGGFGPVFKGLLSDGTTVAVKQLSSGSRQGNREFLNEIGMISCLQHPN 399

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH 357
           LV++HGCCVEGDQLLLVYEYMENNSLA ALFG EN +L LDWPTR KIC+GIA+GLAFLH
Sbjct: 400 LVELHGCCVEGDQLLLVYEYMENNSLARALFGPENSQLILDWPTRLKICIGIAKGLAFLH 459

Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYAL 417
           EESR KIVHRDIKATNVLLDRDLNPKISDFGLA+LD+G K+HISTRIAGTIGYMAPEYAL
Sbjct: 460 EESRLKIVHRDIKATNVLLDRDLNPKISDFGLARLDDGGKSHISTRIAGTIGYMAPEYAL 519

Query: 418 WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER 477
            GYLTYKADVYSFGIV LEIVSGKNN  Y P+    C CLLDWACHLQQ GKL+ELVDE 
Sbjct: 520 RGYLTYKADVYSFGIVVLEIVSGKNN-DYMPS--NSCFCLLDWACHLQQSGKLLELVDEA 576

Query: 478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           LGS+ ++EEAE M+K+++LCTNASPSLRPTMSEV
Sbjct: 577 LGSEVREEEAEMMVKMAILCTNASPSLRPTMSEV 610

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483540|ref|XP_002264878.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase RFK1-like [Vitis vinifera]

 Score =  728 bits (1879), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 357/515 (69%), Positives = 415/515 (80%), Gaps = 10/515 (1%)

Query: 1   TFEGDGQIGGGAATFHLQ-DDTNWGFSSTGDFADDNDDQNTRYTATSDSSGLSELYINAR 59
           T+EGD       A ++L  D+ NWGFSS+GDF DDN++ N  Y  TS S     LY  AR
Sbjct: 430 TYEGDTARDNSDAKYYLSADNNNWGFSSSGDFMDDNNELNKDYIITSKSQISETLYNTAR 489

Query: 60  IAPLSLTYFGYCLDNGNYTLSLHFAEIQFSNGITFHSLGRRLFDIYIQDNLVERNFDIKA 119
           I+PLSLTYF YCL NG+Y++ LHFAEI+F+N  T+ SLG+R+FDIY QD LV+++F+I+ 
Sbjct: 490 ISPLSLTYFRYCLQNGSYSVRLHFAEIEFTNDSTYGSLGKRMFDIYAQDELVKKDFNIED 549

Query: 120 EASGVLKPVARSYNVTVTNHIIEIRFHWAGKGTTALPKRGIYGPLVSAISLNDPKLKP-- 177
            A G LKP    +N TVTN+++EIRF++AG+GTT +P+RG+YGPL+SAIS+ DP   P  
Sbjct: 550 HAKGALKPYTLPFNATVTNNVLEIRFYFAGRGTTRIPQRGVYGPLISAISV-DPNFTPPS 608

Query: 178 --GKKKVVPIVVGVVAGLSLIILVVSILGWRYYLRTKRHKETAFMKESDLQTISFTLKQI 235
             GK K  PI++GVVA   LI L + I  WR  LRTK  +E  F    D+   SFTLKQI
Sbjct: 609 EGGKTKTAPIIIGVVAA-CLICLALGIFWWRVNLRTKNGREKDF-GGLDVHIGSFTLKQI 666

Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQH 295
           KAATNNFDS  +IGEGGFGPVYKG L DGT IAVKQLSSKS QGNREFLNEI MISCLQH
Sbjct: 667 KAATNNFDSLNQIGEGGFGPVYKGLLPDGTAIAVKQLSSKSTQGNREFLNEIGMISCLQH 726

Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           PNLVK+HGCC+EG+QLLLVYEYMENNSLA AL G ENC+L+LDWPTRQKIC+GIARGLAF
Sbjct: 727 PNLVKLHGCCIEGNQLLLVYEYMENNSLARALLGPENCQLKLDWPTRQKICVGIARGLAF 786

Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEY 415
           LHEESR KIVHRDIK TNVLLD DLNPKISDFGLAKL E +KTHISTR+AGTIGYMAPEY
Sbjct: 787 LHEESRLKIVHRDIKGTNVLLDGDLNPKISDFGLAKLHEEEKTHISTRVAGTIGYMAPEY 846

Query: 416 ALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD 475
           ALWGYLTYKADVYSFG+VALEIVSGK+NMSY P  + DC CLLDWAC LQQ G ++ELVD
Sbjct: 847 ALWGYLTYKADVYSFGVVALEIVSGKHNMSYQP--KNDCACLLDWACSLQQSGDIMELVD 904

Query: 476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSE 510
           ++LGS++ K+EAERMIKV+LLCTNASPSLRP MSE
Sbjct: 905 QKLGSEFNKKEAERMIKVALLCTNASPSLRPNMSE 939

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297740557|emb|CBI30739.3| unnamed protein product [Vitis vinifera]

 Score =  728 bits (1878), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 357/516 (69%), Positives = 415/516 (80%), Gaps = 10/516 (1%)

Query: 1   TFEGDGQIGGGAATFHLQ-DDTNWGFSSTGDFADDNDDQNTRYTATSDSSGLSELYINAR 59
           T+EGD       A ++L  D+ NWGFSS+GDF DDN++ N  Y  TS S     LY  AR
Sbjct: 141 TYEGDTARDNSDAKYYLSADNNNWGFSSSGDFMDDNNELNKDYIITSKSQISETLYNTAR 200

Query: 60  IAPLSLTYFGYCLDNGNYTLSLHFAEIQFSNGITFHSLGRRLFDIYIQDNLVERNFDIKA 119
           I+PLSLTYF YCL NG+Y++ LHFAEI+F+N  T+ SLG+R+FDIY QD LV+++F+I+ 
Sbjct: 201 ISPLSLTYFRYCLQNGSYSVRLHFAEIEFTNDSTYGSLGKRMFDIYAQDELVKKDFNIED 260

Query: 120 EASGVLKPVARSYNVTVTNHIIEIRFHWAGKGTTALPKRGIYGPLVSAISLNDPKLKP-- 177
            A G LKP    +N TVTN+++EIRF++AG+GTT +P+RG+YGPL+SAIS+ DP   P  
Sbjct: 261 HAKGALKPYTLPFNATVTNNVLEIRFYFAGRGTTRIPQRGVYGPLISAISV-DPNFTPPS 319

Query: 178 --GKKKVVPIVVGVVAGLSLIILVVSILGWRYYLRTKRHKETAFMKESDLQTISFTLKQI 235
             GK K  PI++GVVA   LI L + I  WR  LRTK  +E  F    D+   SFTLKQI
Sbjct: 320 EGGKTKTAPIIIGVVAAC-LICLALGIFWWRVNLRTKNGREKDF-GGLDVHIGSFTLKQI 377

Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQH 295
           KAATNNFDS  +IGEGGFGPVYKG L DGT IAVKQLSSKS QGNREFLNEI MISCLQH
Sbjct: 378 KAATNNFDSLNQIGEGGFGPVYKGLLPDGTAIAVKQLSSKSTQGNREFLNEIGMISCLQH 437

Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           PNLVK+HGCC+EG+QLLLVYEYMENNSLA AL G ENC+L+LDWPTRQKIC+GIARGLAF
Sbjct: 438 PNLVKLHGCCIEGNQLLLVYEYMENNSLARALLGPENCQLKLDWPTRQKICVGIARGLAF 497

Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEY 415
           LHEESR KIVHRDIK TNVLLD DLNPKISDFGLAKL E +KTHISTR+AGTIGYMAPEY
Sbjct: 498 LHEESRLKIVHRDIKGTNVLLDGDLNPKISDFGLAKLHEEEKTHISTRVAGTIGYMAPEY 557

Query: 416 ALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD 475
           ALWGYLTYKADVYSFG+VALEIVSGK+NMSY P  + DC CLLDWAC LQQ G ++ELVD
Sbjct: 558 ALWGYLTYKADVYSFGVVALEIVSGKHNMSYQP--KNDCACLLDWACSLQQSGDIMELVD 615

Query: 476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           ++LGS++ K+EAERMIKV+LLCTNASPSLRP MSE 
Sbjct: 616 QKLGSEFNKKEAERMIKVALLCTNASPSLRPNMSEA 651

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255562540|ref|XP_002522276.1| kinase, putative [Ricinus communis] gi|223538529|gb|EEF40134.1| kinase, putative [Ricinus communis]

 Score =  718 bits (1854), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 357/516 (69%), Positives = 420/516 (81%), Gaps = 11/516 (2%)

Query: 1   TFEGDGQIGGGAATFHLQDDTNWGFSSTGDFADDNDDQNTRYTATSDSSGLSE-LYINAR 59
           T+EGDG +GGGA+TF+   +  WGFSSTGDF DD+D  N  Y A S SS +S  LY  AR
Sbjct: 412 TYEGDGDVGGGASTFY-PSNNGWGFSSTGDFMDDDDFLNEAYIAESPSSLISNGLYRTAR 470

Query: 60  IAPLSLTYFGYCLDNGNYTLSLHFAEIQFSNGITFHSLGRRLFDIYIQDNLVERNFDIKA 119
           IAPLSLTY+  CL +GNYT+SLHFAEIQF+N  T++SLGRRLF+IYIQ+++VE+NF+I  
Sbjct: 471 IAPLSLTYYRQCLIDGNYTVSLHFAEIQFTNDSTYNSLGRRLFNIYIQNDMVEQNFNIAD 530

Query: 120 EASGVLKPVARSYNVTVTNHIIEIRFHWAGKGTTALPKRGIYGPLVSAISLNDPKLKP-- 177
           EA+GV   + + YN TVTN+I+EIR  WAGKGTT +P  G+YGPL+SAIS+ DP  KP  
Sbjct: 531 EANGVATLIKKMYNATVTNNILEIRLSWAGKGTTRIPDSGVYGPLISAISI-DPHFKPPS 589

Query: 178 --GKKKVVPIVVGVVAGLSLIILVVSILGWRYYLRTKRHKETAFMKESDLQTISFTLKQI 235
             G  K+ PI+VGV+ G  LIIL + ++ W+ Y R K  ++  F +  ++QT+SFTLKQI
Sbjct: 590 GGGNTKIAPIIVGVL-GSCLIILALGLIVWKRYFRAKNGRQKDF-EGLEIQTVSFTLKQI 647

Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQH 295
           K ATNNF  A KIGEGGFGPVYKG LAD T+IAVKQLSSKS QGNREFLNEI +ISC+QH
Sbjct: 648 KTATNNFAPANKIGEGGFGPVYKGLLADNTVIAVKQLSSKSNQGNREFLNEIGVISCMQH 707

Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           PNLVK+HGCC+EG+QLLLVYEYMENNSLA  L G E+  L+LDW TRQ+IC+GIA+GLA+
Sbjct: 708 PNLVKLHGCCIEGNQLLLVYEYMENNSLAHTLLGPEDRCLKLDWQTRQRICVGIAKGLAY 767

Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEY 415
           LHEES  KIVHRDIKATNVLLD+ LNPKISDFGLAKLD  +KTHISTR+AGTIGYMAPEY
Sbjct: 768 LHEESTLKIVHRDIKATNVLLDKHLNPKISDFGLAKLDSEEKTHISTRVAGTIGYMAPEY 827

Query: 416 ALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD 475
           ALWGYLTYKAD+YSFGIVALEIVSGK+NMS  P   F   CLLDWACHLQQ GKL+ELVD
Sbjct: 828 ALWGYLTYKADIYSFGIVALEIVSGKHNMSRGPESNFG--CLLDWACHLQQGGKLMELVD 885

Query: 476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           E+LGS++KK EAERMIKV+LLCTN S SLRP MSEV
Sbjct: 886 EKLGSEFKKVEAERMIKVALLCTNGSASLRPIMSEV 921

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224079009|ref|XP_002305716.1| predicted protein [Populus trichocarpa] gi|222848680|gb|EEE86227.1| predicted protein [Populus trichocarpa]

 Score =  700 bits (1806), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 345/516 (66%), Positives = 421/516 (81%), Gaps = 12/516 (2%)

Query: 1   TFEGDGQIGGGAATFHLQDDTNWGFSSTGDFADDNDDQNTRYTATSDSSGLSELYINARI 60
           T+EGD     GAA F+  +D  WG SSTGDF DDND QN  Y     S  ++ELY  AR+
Sbjct: 406 TYEGDAAASSGAAIFYRSED-EWGISSTGDFMDDNDFQNRAYIENMPSLNINELYQTARV 464

Query: 61  APLSLTYFGYCLDNGNYTLSLHFAEIQFSNGITFHSLGRRLFDIYIQDNLVERNFDIKAE 120
           +P+SLTY+  CL+NGNYT+SLHFAEI+F N  T++SLGRRLFD+YIQ+NLVE++F+I+ E
Sbjct: 465 SPISLTYYHRCLENGNYTVSLHFAEIRFKNDNTYNSLGRRLFDVYIQNNLVEKDFNIEVE 524

Query: 121 ASGVLKPVARSYNVTVTNHIIEIRFHWAGKGTTALPKRGIYGPLVSAISLNDPKLKP--- 177
           A+GV KPV + +N TVTN+I++I  +WAGKGTT +P  G+YGPL+SAIS+  P  KP   
Sbjct: 525 AAGVAKPVTKIHNATVTNNILDIHLYWAGKGTTRIPVSGVYGPLISAISVY-PNFKPRFS 583

Query: 178 --GKKKVVPIVVGVVAGLSLIILVVSILGWRYYLRTKRHKETAFMKESDLQTISFTLKQI 235
             GK K VPI++GVV G  L+   ++I  W+ Y R ++ ++   ++  ++QT+SFTLKQI
Sbjct: 584 GGGKTKTVPIILGVV-GFCLVFSALAIFWWKCYFRVQKKRQKG-LEGIEIQTVSFTLKQI 641

Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQH 295
           KAAT NF+ A KIGEGGFGPVYKG L DGT+IAVKQLSSKS QGNREFLNEI +ISC+QH
Sbjct: 642 KAATGNFNPANKIGEGGFGPVYKGLLPDGTVIAVKQLSSKSSQGNREFLNEIGVISCMQH 701

Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           P+LVK+HGCC+EGDQLLLVYEYMENNSL+ ALFG EN +L LDW TRQKIC+GIA+GL+F
Sbjct: 702 PHLVKLHGCCIEGDQLLLVYEYMENNSLSRALFGPEN-QLHLDWKTRQKICIGIAKGLSF 760

Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEY 415
           LHEESR KIVHRDIK TNVLLD+DLNPKISDFGLAKLDE +KT+ISTR+AGT+GYMAPEY
Sbjct: 761 LHEESRLKIVHRDIKVTNVLLDKDLNPKISDFGLAKLDEREKTYISTRVAGTVGYMAPEY 820

Query: 416 ALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD 475
           ALWG LTYKADVYSFGIVALEIVSGK+N S  P  +F  +CLLDWACHL+Q+G L+E+VD
Sbjct: 821 ALWGRLTYKADVYSFGIVALEIVSGKHNKSCGPDDQF--SCLLDWACHLEQNGNLIEIVD 878

Query: 476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           ++LGS++ K EAER+IKV+LLC NASPSLRP MSEV
Sbjct: 879 QKLGSEFNKVEAERLIKVALLCANASPSLRPIMSEV 914

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224116760|ref|XP_002317385.1| predicted protein [Populus trichocarpa] gi|222860450|gb|EEE97997.1| predicted protein [Populus trichocarpa]

 Score =  697 bits (1799), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 351/516 (68%), Positives = 416/516 (80%), Gaps = 11/516 (2%)

Query: 1   TFEGDGQIGGGAATFHLQDDTNWGFSSTGDFADDNDDQNTRYTATSDSSGLSELYINARI 60
           T+EGD  + GGA  F+ Q    WG SSTGDF DDND QN  YT    S  ++ELY  ARI
Sbjct: 414 TYEGDAAVSGGAGLFY-QSADEWGLSSTGDFMDDNDFQNRAYTENVPSLNINELYQTARI 472

Query: 61  APLSLTYFGYCLDNGNYTLSLHFAEIQFSNGITFHSLGRRLFDIYIQDNLVERNFDIKAE 120
           +P+SLTY+  CL+NGNYT+SLHFAEI+F+N  TF+SLGRRLFDIYIQ+NLVE++F+I+ +
Sbjct: 473 SPISLTYYRRCLENGNYTVSLHFAEIRFTNDNTFNSLGRRLFDIYIQNNLVEKDFNIEVQ 532

Query: 121 ASGVLKPVARSYNVTVTNHIIEIRFHWAGKGTTALPKRGIYGPLVSAISLNDPKLKP--- 177
           A+GV KPV   +N  VTN+I+EIR  WAGKGT  +P  G+YGPL+SAIS+ DP  KP   
Sbjct: 533 AAGVAKPVTEIHNAIVTNNILEIRLFWAGKGTRRIPVSGVYGPLISAISV-DPNFKPRFS 591

Query: 178 --GKKKVVPIVVGVVAGLSLIILVVSILGWRYYLRTKRHKETAFMKESDLQTISFTLKQI 235
              K K VPI+VGVV G  LI  V++I  WR   R  + +    ++  ++QT+SFTLKQI
Sbjct: 592 REEKTKTVPIIVGVVVGFCLIFSVLAIFWWRCCFRINKKRRKG-LEGIEIQTVSFTLKQI 650

Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQH 295
           KAAT+NFD A KIGEGGFGPVYKG L DGT+IAVKQLSSKS QGNREFLNEI +ISC+QH
Sbjct: 651 KAATDNFDPANKIGEGGFGPVYKGLLPDGTVIAVKQLSSKSSQGNREFLNEIGVISCMQH 710

Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           P+LVK+HGCC+EGDQLLLVYEYMENNSL+ ALFG E+ +L LDW TRQKIC+GIA+GLAF
Sbjct: 711 PHLVKLHGCCIEGDQLLLVYEYMENNSLSRALFGPEH-QLHLDWKTRQKICVGIAKGLAF 769

Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEY 415
           LHEESR KIVHRDIK TNVLLD+DLNPKISDFGLAKLDE +KT ISTR+AGT+GYMAPEY
Sbjct: 770 LHEESRLKIVHRDIKVTNVLLDKDLNPKISDFGLAKLDEREKTFISTRVAGTVGYMAPEY 829

Query: 416 ALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD 475
           ALWG LTYKADVYSFGIVALEIVSGK NMS  P  ++  +CLLDWACHL+++G L+ELVD
Sbjct: 830 ALWGRLTYKADVYSFGIVALEIVSGKYNMSCGPENQY--SCLLDWACHLERNGNLIELVD 887

Query: 476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
            +LGS++ K EA+RMIKV+LLC NASP LRP MSEV
Sbjct: 888 RKLGSEFNKVEAQRMIKVALLCANASPLLRPIMSEV 923

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147838007|emb|CAN73789.1| hypothetical protein VITISV_025000 [Vitis vinifera]

 Score =  693 bits (1789), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 345/515 (66%), Positives = 400/515 (77%), Gaps = 21/515 (4%)

Query: 1   TFEGDGQIGGGAATFHLQDDTNWGFSSTGDFADDNDDQNTRYTATSDSSGLSELYINARI 60
           T+EGD       A ++L  D NWGFSS+GDF DDN + N  Y  TS S     LY NARI
Sbjct: 44  TYEGDTARDNSDAKYYLSADNNWGFSSSGDFMDDNKELNKDYIITSKSQISETLYNNARI 103

Query: 61  APLSLTYFGYCLDNGNYTLSLHFAEIQFSNGITFHSLGRRLFDIYIQDNLVERNFDIKAE 120
           +PLSLTYF YCL NG+Y++ LHFAEI+F+N  T+ SLG+R+FDIY QD LV+++F+I+  
Sbjct: 104 SPLSLTYFRYCLQNGSYSVRLHFAEIEFTNDSTYGSLGKRMFDIYAQDELVKKDFNIEDH 163

Query: 121 ASGVLKPVARSYNVTVTNHIIEIRFHWAGKGTTALPKRGIYGPLVSAISLNDPKLKP--- 177
           A G LKP    +N TVTN+++EIRF++AG+GTT +P+RG+YGPL+SAIS+ DP   P   
Sbjct: 164 AKGALKPYTLPFNATVTNNVLEIRFYFAGRGTTRIPQRGVYGPLISAISV-DPNFTPPSE 222

Query: 178 -GKKKVVPIVVGVVAGLSLIILVVSILGWRYYLRTKRHKETAFMKESDLQTISFTLKQIK 236
            GK K  PI++GVVA   LI L + I  WR  LRTK  +E  F    D+   SFTLKQIK
Sbjct: 223 GGKTKTAPIIIGVVAAC-LICLALGIFWWRGNLRTKNGREKDF-GGLDVHIGSFTLKQIK 280

Query: 237 AATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHP 296
           AATNNFDS  +IGEGGFGPVYKG L DGT IAVKQLSSKS QGNREFLNEI MISCLQHP
Sbjct: 281 AATNNFDSINQIGEGGFGPVYKGLLPDGTAIAVKQLSSKSTQGNREFLNEIGMISCLQHP 340

Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFL 356
           NLVK+ GCC+EG+QLLLVYEYMENNSL  AL G            +QKIC+GIARGLAFL
Sbjct: 341 NLVKLRGCCIEGNQLLLVYEYMENNSLTRALLG------------KQKICVGIARGLAFL 388

Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYA 416
           HEESR KIVHRDIK TNVLLD DLNPKISDFGLAKL E +KTHISTR+AGTIGYMAPEYA
Sbjct: 389 HEESRLKIVHRDIKGTNVLLDGDLNPKISDFGLAKLHEEEKTHISTRVAGTIGYMAPEYA 448

Query: 417 LWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDE 476
           LWGYLTYKADVYSFG+VALEIVSGK+N SY P  + DC CLLDWAC LQQ G ++ELVD+
Sbjct: 449 LWGYLTYKADVYSFGVVALEIVSGKHNXSYXP--KNDCACLLDWACXLQQSGDIMELVDQ 506

Query: 477 RLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           +LGS++ K+EAERMIKV+LLCTNASPSLRP MSE 
Sbjct: 507 KLGSEFNKKEAERMIKVALLCTNASPSLRPNMSEA 541

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224078996|ref|XP_002305711.1| predicted protein [Populus trichocarpa] gi|222848675|gb|EEE86222.1| predicted protein [Populus trichocarpa]

 Score =  681 bits (1756), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 341/519 (65%), Positives = 410/519 (78%), Gaps = 14/519 (2%)

Query: 1   TFEGDGQIGGGAATFHLQDDTNWGFSSTGDFADDNDDQNTRYTATSDSSGLSELYINARI 60
           ++EGDGQ  GGAA + + + + WGFSS+GDF DDND QNTRYT +  SS L ELY  ARI
Sbjct: 355 SYEGDGQEEGGAAKYFVNEQSFWGFSSSGDFMDDNDYQNTRYTVSMQSSTLPELYSTARI 414

Query: 61  APLSLTYFGYCLDNGNYTLSLHFAEIQFSNGITFHSLGRRLFDIYIQDNLVERNFDIKAE 120
           +P+SLTYF YCL+NGNYT++LHFAEIQF+N +T+ SLGRR+FDIY+Q       F+I+ +
Sbjct: 415 SPISLTYFHYCLENGNYTVNLHFAEIQFTNDLTYKSLGRRIFDIYVQVCSYTNKFNIEDQ 474

Query: 121 ASGVLKPVARS-YNVTVTNHIIEIRFHWAGKGTTALPKRGIYGPLVSAISLNDPKLKP-- 177
                KP+ +   NV+VTN+++EIRF++AGKGTT  P RG+YGP++S IS+    LKP  
Sbjct: 475 VGSAEKPLVKQVLNVSVTNNMLEIRFYFAGKGTTRTPDRGVYGPIISGISVFS-DLKPCS 533

Query: 178 -GKKKVVPIVVGVVAGLS-LIILVVSILGWRYYLRTK--RHKETAFMKESDLQTISFTLK 233
            GKKK     V      S LI +++ IL W+ YL  K  R K+   +   +    +F+LK
Sbjct: 534 SGKKKGTVYAVAGAVVASCLIAIILGILWWKDYLPGKWCRKKDAEGL---NFPNGTFSLK 590

Query: 234 QIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCL 293
           QI+AAT++FD + KIGEGGFGPVYKGQL DGT+IAVKQLSSKSRQGNREFLNE+ +ISCL
Sbjct: 591 QIRAATDDFDPSNKIGEGGFGPVYKGQLPDGTVIAVKQLSSKSRQGNREFLNEMGIISCL 650

Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGR--ENCELELDWPTRQKICLGIAR 351
           QHPNLVK+HGCC+E DQLLLVYEYMENNSLA ALFG   E  +  LDWP+R KIC+GIAR
Sbjct: 651 QHPNLVKLHGCCIESDQLLLVYEYMENNSLARALFGECHEINQPNLDWPSRLKICIGIAR 710

Query: 352 GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYM 411
           GLAFLHEESRFKIVHRDIKATNVLLD DLN KISDFGLA+LDE +K+HISTR+AGTIGYM
Sbjct: 711 GLAFLHEESRFKIVHRDIKATNVLLDGDLNAKISDFGLARLDEEEKSHISTRVAGTIGYM 770

Query: 412 APEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLV 471
           APEYALWGYLTYKADVYSFG+VALEIVSGKNN +Y P+ + +C CLLDWACHLQQ G  +
Sbjct: 771 APEYALWGYLTYKADVYSFGVVALEIVSGKNNNNYMPS-DNNCVCLLDWACHLQQSGSFM 829

Query: 472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSE 510
           ELVDE L S+   +EAE M+KV+LLCTNASP+LRPTMSE
Sbjct: 830 ELVDETLKSEVNMKEAEIMVKVALLCTNASPTLRPTMSE 868

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449520451|ref|XP_004167247.1| PREDICTED: LOW QUALITY PROTEIN: probable LRR receptor-like serine/threonine-protein kinase RFK1-like, partial [Cucumis sativus]

 Score =  674 bits (1740), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 341/524 (65%), Positives = 410/524 (78%), Gaps = 21/524 (4%)

Query: 2   FEGDGQIGGGAATFHLQDDTNWGFSSTGDFADDNDDQNTRYTATSDSSGLSELYINARIA 61
           + GD  I GG A F++  D+ WG SSTGDF DD D QNTRYT +  SS LSELY  AR +
Sbjct: 395 YNGDADIEGGTAKFYIDQDSYWGLSSTGDFMDDFDHQNTRYTLSLSSSNLSELYSTARRS 454

Query: 62  PLSLTYFGYCLDNGNYTLSLHFAEIQFSNGITFHSLGRRLFDIYIQDNLVERNFDIKAEA 121
           P++LTYF  CL+NGNY+++LHFAE+QF+N  T+ SLGRR FDIYIQD LV  NFDI  +A
Sbjct: 455 PITLTYFHRCLENGNYSVTLHFAELQFTNDKTYKSLGRRKFDIYIQDRLVLENFDIDEKA 514

Query: 122 SGVLKPVARSYN-VTVTNHIIEIRFHWAGKGTTALPKRGIYGPLVSAISL-NDPKLKP-- 177
            G  KP    +  ++V NH++EIRF+WAGKGTT +P+RG+YGPL+SAIS+ +D K  P  
Sbjct: 515 GGAQKPTEMQFAYISVFNHVLEIRFYWAGKGTTRIPERGVYGPLISAISVYSDLKYCPIR 574

Query: 178 --GKKKVVPIVVGVVAGLSLI--ILVVSILGWRYYLRTKRHKETAFMKESDLQTISFTLK 233
              KKK V +VVG+  GL  +  I++V +L W+  L+  R  +     E  +QT  FTLK
Sbjct: 575 ESSKKKTVALVVGITVGLLCLATIIIVGLLWWKGSLKVIRRSKGGTGIE--VQTGIFTLK 632

Query: 234 QIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCL 293
           QIKAATN+FDS  KIGEGGFGPVYKGQL DGTI+A+KQLSSKSRQGNREFLNEI MISCL
Sbjct: 633 QIKAATNHFDSCNKIGEGGFGPVYKGQLVDGTIVAIKQLSSKSRQGNREFLNEIGMISCL 692

Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
           QHPNLVK+HGCC+EGDQLLLVYEY+ENNSLA ALFG   C L LDWPTR +IC+GIA+GL
Sbjct: 693 QHPNLVKLHGCCIEGDQLLLVYEYLENNSLARALFG---CRLNLDWPTRLRICIGIAKGL 749

Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTI----- 408
           A+LHEES  KIVHRDIKATNVLLD +LNPKISDFGLAKL++ +KTHI+TR+AGT+     
Sbjct: 750 AYLHEESSLKIVHRDIKATNVLLDGELNPKISDFGLAKLNDEEKTHITTRVAGTMYVIVL 809

Query: 409 -GYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD 467
            GYMAPEYALWGYLTYKADVYSFG+VALEI+ G++N  Y P+    C CLLDWACHLQQ 
Sbjct: 810 SGYMAPEYALWGYLTYKADVYSFGVVALEIIGGRSNNDYVPSET--CVCLLDWACHLQQF 867

Query: 468 GKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           G ++ELVDE+L S+   +EAE M+K++LLCTNASPS+RP MSEV
Sbjct: 868 GNVMELVDEKLKSEIDMKEAENMVKIALLCTNASPSVRPAMSEV 911

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449459314|ref|XP_004147391.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase RFK1-like [Cucumis sativus]

 Score =  674 bits (1740), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 341/524 (65%), Positives = 410/524 (78%), Gaps = 21/524 (4%)

Query: 2   FEGDGQIGGGAATFHLQDDTNWGFSSTGDFADDNDDQNTRYTATSDSSGLSELYINARIA 61
           + GD  I GG A F++  D+ WG SSTGDF DD D QNTRYT +  SS LSELY  AR +
Sbjct: 427 YNGDADIEGGTAKFYIDQDSYWGLSSTGDFMDDFDHQNTRYTLSLSSSNLSELYSTARRS 486

Query: 62  PLSLTYFGYCLDNGNYTLSLHFAEIQFSNGITFHSLGRRLFDIYIQDNLVERNFDIKAEA 121
           P++LTYF  CL+NGNY+++LHFAE+QF+N  T+ SLGRR FDIYIQD LV  NFDI  +A
Sbjct: 487 PITLTYFHRCLENGNYSVTLHFAELQFTNDKTYKSLGRRKFDIYIQDRLVLENFDIDEKA 546

Query: 122 SGVLKPVARSYN-VTVTNHIIEIRFHWAGKGTTALPKRGIYGPLVSAISL-NDPKLKP-- 177
            G  KP    +  ++V NH++EIRF+WAGKGTT +P+RG+YGPL+SAIS+ +D K  P  
Sbjct: 547 GGAQKPTEMQFAYISVFNHVLEIRFYWAGKGTTRIPERGVYGPLISAISVYSDLKYCPIR 606

Query: 178 --GKKKVVPIVVGVVAGLSLI--ILVVSILGWRYYLRTKRHKETAFMKESDLQTISFTLK 233
              KKK V +VVG+  GL  +  I++V +L W+  L+  R  +     E  +QT  FTLK
Sbjct: 607 ESSKKKTVALVVGITVGLLCLATIIIVGLLWWKGSLKVIRRSKGGTGIE--VQTGIFTLK 664

Query: 234 QIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCL 293
           QIKAATN+FDS  KIGEGGFGPVYKGQL DGTI+A+KQLSSKSRQGNREFLNEI MISCL
Sbjct: 665 QIKAATNHFDSCNKIGEGGFGPVYKGQLVDGTIVAIKQLSSKSRQGNREFLNEIGMISCL 724

Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
           QHPNLVK+HGCC+EGDQLLLVYEY+ENNSLA ALFG   C L LDWPTR +IC+GIA+GL
Sbjct: 725 QHPNLVKLHGCCIEGDQLLLVYEYLENNSLARALFG---CRLNLDWPTRLRICIGIAKGL 781

Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTI----- 408
           A+LHEES  KIVHRDIKATNVLLD +LNPKISDFGLAKL++ +KTHI+TR+AGT+     
Sbjct: 782 AYLHEESSLKIVHRDIKATNVLLDGELNPKISDFGLAKLNDEEKTHITTRVAGTMYVIVL 841

Query: 409 -GYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD 467
            GYMAPEYALWGYLTYKADVYSFG+VALEI+ G++N  Y P+    C CLLDWACHLQQ 
Sbjct: 842 SGYMAPEYALWGYLTYKADVYSFGVVALEIIGGRSNNDYVPSET--CVCLLDWACHLQQF 899

Query: 468 GKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           G ++ELVDE+L S+   +EAE M+K++LLCTNASPS+RP MSEV
Sbjct: 900 GNVMELVDEKLKSEIDMKEAENMVKIALLCTNASPSVRPAMSEV 943

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	511
TAIR|locus:2203847	1021	RKF1 "receptor-like kinase in	0.563	0.282	0.665	7e-156
TAIR|locus:2203718	1035	AT1G53440 [Arabidopsis thalian	0.590	0.291	0.713	2.6e-145
TAIR|locus:2019317	969	AT1G29730 [Arabidopsis thalian	0.577	0.304	0.670	1.1e-144
TAIR|locus:2019367	1078	AT1G29740 [Arabidopsis thalian	0.547	0.259	0.685	5.5e-143
TAIR|locus:2009630	953	AT1G53420 [Arabidopsis thalian	0.949	0.508	0.566	1.9e-140
TAIR|locus:2205250	1032	AT1G56130 [Arabidopsis thalian	0.581	0.287	0.546	2e-115
TAIR|locus:2205260	1047	AT1G56120 [Arabidopsis thalian	0.581	0.283	0.552	4.2e-115
TAIR|locus:2017923	390	AT1G16670 [Arabidopsis thalian	0.579	0.758	0.516	2.1e-77
TAIR|locus:2095334	393	AT3G09010 [Arabidopsis thalian	0.545	0.709	0.531	1.5e-76
TAIR|locus:2121691	667	CRK11 "cysteine-rich RLK (RECE	0.590	0.452	0.464	8.9e-70

TAIR|locus:2203847 RKF1 "receptor-like kinase in flowers 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1004 (358.5 bits), Expect = 7.0e-156, Sum P(2) = 7.0e-156
 Identities = 193/290 (66%), Positives = 238/290 (82%)

Query:   222 ESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNR 281
             E +L + +FTL+QIK AT++F+   KIGEGGFG V+KG LADG ++AVKQLSSKSRQGNR
Sbjct:   661 EEELPSGTFTLRQIKFATDDFNPTNKIGEGGFGAVFKGVLADGRVVAVKQLSSKSRQGNR 720

Query:   282 EFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPT 341
             EFLNEI  ISCLQHPNLVK+HG CVE  QLLL YEYMENNSL+ ALF  ++ ++ +DWPT
Sbjct:   721 EFLNEIGAISCLQHPNLVKLHGFCVERAQLLLAYEYMENNSLSSALFSPKHKQIPMDWPT 780

Query:   342 RQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS 401
             R KIC GIA+GLAFLHEES  K VHRDIKATN+LLD+DL PKISDFGLA+LDE +KTHIS
Sbjct:   781 RFKICCGIAKGLAFLHEESPLKFVHRDIKATNILLDKDLTPKISDFGLARLDEEEKTHIS 840

Query:   402 TRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWA 461
             T++AGTIGYMAPEYALWGYLT+KADVYSFG++ LEIV+G  N ++  A   D  CLL++A
Sbjct:   841 TKVAGTIGYMAPEYALWGYLTFKADVYSFGVLVLEIVAGITNSNFMGA--GDSVCLLEFA 898

Query:   462 CHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                 + G L+++VDERL  +  ++EAE +IKV+L+C++ASP+ RP MSEV
Sbjct:   899 NECVESGHLMQVVDERLRPEVDRKEAEAVIKVALVCSSASPTDRPLMSEV 948

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006857 "oligopeptide transport" evidence=RCA

GO:0004702 "receptor signaling protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2203718 AT1G53440 [Arabidopsis thaliana (taxid:3702)]

 Score = 1093 (389.8 bits), Expect = 2.6e-145, Sum P(2) = 2.6e-145
 Identities = 217/304 (71%), Positives = 244/304 (80%)

Query:   208 YLRTKRHKETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTII 267
             YL  K   E   ++  DLQT SFTLKQIK ATNNFD   KIGEGGFGPVYKG LADG  I
Sbjct:   633 YLGGKEVDENEELRGLDLQTGSFTLKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTI 692

Query:   268 AVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL 327
             AVKQLSSKS+QGNREF+ EI MIS LQHPNLVK++GCC+EG +LLLVYEY+ENNSLA AL
Sbjct:   693 AVKQLSSKSKQGNREFVTEIGMISALQHPNLVKLYGCCIEGKELLLVYEYLENNSLARAL 752

Query:   328 FGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF 387
             FG E   L LDW TR K+C+GIA+GLA+LHEESR KIVHRDIKATNVLLD  LN KISDF
Sbjct:   753 FGTEKQRLHLDWSTRNKVCIGIAKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDF 812

Query:   388 GLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYA 447
             GLAKLDE + THISTRIAGTIGYMAPEYA+ GYLT KADVYSFG+V LEIVSGK+N +Y 
Sbjct:   813 GLAKLDEEENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYR 872

Query:   448 PALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPT 507
             P  EF    LLDWA  LQ+ G L+ELVD  LG+ + K+EA RM+ ++LLCTN SP+LRP 
Sbjct:   873 PKEEF--IYLLDWAYVLQEQGSLLELVDPDLGTSFSKKEAMRMLNIALLCTNPSPTLRPP 930

Query:   508 MSEV 511
             MS V
Sbjct:   931 MSSV 934

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019317 AT1G29730 [Arabidopsis thaliana (taxid:3702)]

 Score = 1023 (365.2 bits), Expect = 1.1e-144, Sum P(2) = 1.1e-144
 Identities = 199/297 (67%), Positives = 242/297 (81%)

Query:   215 KETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSS 274
             K+ + +K  DL+T SF+L+Q+K ATN+FD   KIGEGGFG VYKG+L DGT+IAVK+LSS
Sbjct:   613 KKISKLKGPDLRTGSFSLRQLKVATNDFDPLNKIGEGGFGSVYKGRLPDGTLIAVKKLSS 672

Query:   275 KSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCE 334
             KS QGN+EF+NEI MI+CLQHPNLVK++GCCVE +QLLLVYEY+ENN L+ ALF   +C 
Sbjct:   673 KSHQGNKEFVNEIGMIACLQHPNLVKLYGCCVEKNQLLLVYEYLENNCLSDALFAGRSC- 731

Query:   335 LELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 394
             L+L+W TR KICLGIARGLAFLHE+S  KI+HRDIK TNVLLD+DLN KISDFGLA+L E
Sbjct:   732 LKLEWGTRHKICLGIARGLAFLHEDSAVKIIHRDIKGTNVLLDKDLNSKISDFGLARLHE 791

Query:   395 GDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDC 454
              +++HI+TR+AGTIGYMAPEYA+ G+LT KADVYSFG+VA+EIVSGK+N  Y P  E  C
Sbjct:   792 DNQSHITTRVAGTIGYMAPEYAMRGHLTEKADVYSFGVVAMEIVSGKSNAKYTPDDEC-C 850

Query:   455 TCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
               LLDWA  LQ+ G + E++D RL   +   EAERMIKVSLLC N S +LRP MS+V
Sbjct:   851 VGLLDWAFVLQKKGDIAEILDPRLEGMFDVMEAERMIKVSLLCANKSSTLRPNMSQV 907

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019367 AT1G29740 [Arabidopsis thaliana (taxid:3702)]

 Score = 998 (356.4 bits), Expect = 5.5e-143, Sum P(2) = 5.5e-143
 Identities = 194/283 (68%), Positives = 235/283 (83%)

Query:   229 SFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIA 288
             SF+L+Q+K AT++F+   KIGEGGFG VYKG+L +GT+IAVK+LSSKS QGN+EF+NEI 
Sbjct:   664 SFSLRQLKVATDDFNPLNKIGEGGFGSVYKGRLPNGTLIAVKKLSSKSCQGNKEFINEIG 723

Query:   289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLG 348
             +I+CLQHPNLVK++GCCVE  QLLLVYEY+ENN LA ALFGR    L+LDW TR KICLG
Sbjct:   724 IIACLQHPNLVKLYGCCVEKTQLLLVYEYLENNCLADALFGRSG--LKLDWRTRHKICLG 781

Query:   349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTI 408
             IARGLAFLHE+S  KI+HRDIK TN+LLD+DLN KISDFGLA+L E D++HI+TR+AGTI
Sbjct:   782 IARGLAFLHEDSAVKIIHRDIKGTNILLDKDLNSKISDFGLARLHEDDQSHITTRVAGTI 841

Query:   409 GYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDG 468
             GYMAPEYA+ G+LT KADVYSFG+VA+EIVSGK+N +Y P  E  C  LLDWA  LQ+ G
Sbjct:   842 GYMAPEYAMRGHLTEKADVYSFGVVAMEIVSGKSNANYTPDNEC-CVGLLDWAFVLQKKG 900

Query:   469 KLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                E++D +L   +   EAERMIKVSLLC++ SP+LRPTMSEV
Sbjct:   901 AFDEILDPKLEGVFDVMEAERMIKVSLLCSSKSPTLRPTMSEV 943

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2009630 AT1G53420 [Arabidopsis thaliana (taxid:3702)]

 Score = 1374 (488.7 bits), Expect = 1.9e-140, P = 1.9e-140
 Identities = 281/496 (56%), Positives = 349/496 (70%)

Query:    23 WGFSSTGDFADDNDDQNTRYTATSDSSGLSE----LYINARIAPLSLTYFGYCLDNGNYT 78
             W  ++ G F DD      R T  S+SS L+     LY  ARI+ +SLTY+  CL+NGNY 
Sbjct:   400 WFSNNVGVFVDDKHVPE-RVTIESNSSELNVVDFGLYTQARISAISLTYYALCLENGNYN 458

Query:    79 LSLHFAEIQFSNGITFHSLGRRLFDIYIQDNLVERNFDIKAEASGVLKPVARSYNVTVTN 138
             ++LHFAEI F+    + SLGRR FDIYIQ  L  ++F+I  EA  V   V +++ V + +
Sbjct:   459 VNLHFAEIMFNGNNNYQSLGRRFFDIYIQRKLEVKDFNIAKEAKDVGNVVIKTFPVEIKD 518

Query:   139 HIIEIRFHWAGKGTTALPKRGIYGPLVSAISLNDXXXXX--XXXXXXXXXXXXXXXXXXX 196
               +EIR +WAG+GTT +PK  +YGPL+SAIS++                           
Sbjct:   519 GKLEIRLYWAGRGTTVIPKERVYGPLISAISVDSSVNPSPRNGMSTGTLHTLVVILSIFI 578

Query:   197 XXXXXXXXWRY-YLRTKRHKETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGP 255
                     W+  YLR+K   E  F K  +L   SF+L+QIK ATNNFDSA +IGEGGFGP
Sbjct:   579 VFLVFGTLWKKGYLRSKSQMEKDF-KSLELMIASFSLRQIKIATNNFDSANRIGEGGFGP 637

Query:   256 VYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY 315
             VYKG+L DGTIIAVKQLS+ S+QGNREFLNEI MIS L HPNLVK++GCCVEG QLLLVY
Sbjct:   638 VYKGKLFDGTIIAVKQLSTGSKQGNREFLNEIGMISALHHPNLVKLYGCCVEGGQLLLVY 697

Query:   316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVL 375
             E++ENNSLA ALFG +  +L LDWPTR+KIC+G+ARGLA+LHEESR KIVHRDIKATNVL
Sbjct:   698 EFVENNSLARALFGPQETQLRLDWPTRRKICIGVARGLAYLHEESRLKIVHRDIKATNVL 757

Query:   376 LDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVAL 435
             LD+ LNPKISDFGLAKLDE D THISTRIAGT GYMAPEYA+ G+LT KADVYSFGIVAL
Sbjct:   758 LDKQLNPKISDFGLAKLDEEDSTHISTRIAGTFGYMAPEYAMRGHLTDKADVYSFGIVAL 817

Query:   436 EIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSL 495
             EIV G++N       + +   L+DW   L++   L+ELVD RLGS+Y +EEA  MI++++
Sbjct:   818 EIVHGRSNK--IERSKNNTFYLIDWVEVLREKNNLLELVDPRLGSEYNREEAMTMIQIAI 875

Query:   496 LCTNASPSLRPTMSEV 511
             +CT++ P  RP+MSEV
Sbjct:   876 MCTSSEPCERPSMSEV 891

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2205250 AT1G56130 [Arabidopsis thaliana (taxid:3702)]

 Score = 834 (298.6 bits), Expect = 2.0e-115, Sum P(2) = 2.0e-115
 Identities = 165/302 (54%), Positives = 220/302 (72%)

Query:   210 RTKRHKETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAV 269
             R KR+ +   +   D++   FT  ++K+AT +FD + K+GEGGFGPVYKG L DG ++AV
Sbjct:   662 RRKRYTDDEELLGMDVKPYIFTYSELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAV 721

Query:   270 KQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFG 329
             K LS  SRQG  +F+ EI  IS + H NLVK++GCC EG+  +LVYEY+ N SL  ALFG
Sbjct:   722 KLLSVGSRQGKGQFVAEIVAISSVLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFG 781

Query:   330 RENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL 389
              +   L LDW TR +ICLG+ARGL +LHEE+  +IVHRD+KA+N+LLD  L P+ISDFGL
Sbjct:   782 DKT--LHLDWSTRYEICLGVARGLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGL 839

Query:   390 AKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPA 449
             AKL +  KTHISTR+AGTIGY+APEYA+ G+LT K DVY+FG+VALE+VSG+ N      
Sbjct:   840 AKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGVVALELVSGRPNSD--EN 897

Query:   450 LEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMS 509
             LE +   LL+WA +L +  + +EL+D++L + +  EEA+RMI ++LLCT  S +LRP MS
Sbjct:   898 LEEEKKYLLEWAWNLHEKSRDIELIDDKL-TDFNMEEAKRMIGIALLCTQTSHALRPPMS 956

Query:   510 EV 511
              V
Sbjct:   957 RV 958

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=ISS

TAIR|locus:2205260 AT1G56120 [Arabidopsis thaliana (taxid:3702)]

 Score = 835 (299.0 bits), Expect = 4.2e-115, Sum P(2) = 4.2e-115
 Identities = 167/302 (55%), Positives = 219/302 (72%)

Query:   210 RTKRHKETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAV 269
             R K + +   +   D++  +FT  ++K AT +FD + K+GEGGFG VYKG L DG  +AV
Sbjct:   678 RRKPYTDDEEILSMDVKPYTFTYSELKNATQDFDLSNKLGEGGFGAVYKGNLNDGREVAV 737

Query:   270 KQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFG 329
             KQLS  SRQG  +F+ EI  IS + H NLVK++GCC EGD  LLVYEY+ N SL  ALFG
Sbjct:   738 KQLSIGSRQGKGQFVAEIIAISSVLHRNLVKLYGCCFEGDHRLLVYEYLPNGSLDQALFG 797

Query:   330 RENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL 389
              ++  L LDW TR +ICLG+ARGL +LHEE+  +I+HRD+KA+N+LLD +L PK+SDFGL
Sbjct:   798 DKS--LHLDWSTRYEICLGVARGLVYLHEEASVRIIHRDVKASNILLDSELVPKVSDFGL 855

Query:   390 AKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPA 449
             AKL +  KTHISTR+AGTIGY+APEYA+ G+LT K DVY+FG+VALE+VSG+ N      
Sbjct:   856 AKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGVVALELVSGRKNSD--EN 913

Query:   450 LEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMS 509
             LE     LL+WA +L +  + VEL+D+ L S+Y  EE +RMI ++LLCT +S +LRP MS
Sbjct:   914 LEEGKKYLLEWAWNLHEKNRDVELIDDEL-SEYNMEEVKRMIGIALLCTQSSYALRPPMS 972

Query:   510 EV 511
              V
Sbjct:   973 RV 974

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2017923 AT1G16670 [Arabidopsis thaliana (taxid:3702)]

 Score = 779 (279.3 bits), Expect = 2.1e-77, P = 2.1e-77
 Identities = 157/304 (51%), Positives = 214/304 (70%)

Query:   214 HKETAFMKESDLQTIS----FTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAV 269
             H+  A   + ++  I     +  ++I+ AT++F +  KIGEGGFG VYKG L DG + A+
Sbjct:     9 HRREATEVDGEIAAIDNVKIYKYREIRQATDDFSAENKIGEGGFGSVYKGCLKDGKLAAI 68

Query:   270 KQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALF- 328
             K LS++SRQG +EFL EI +IS +QH NLVK++GCCVEG+  +LVY ++ENNSL   L  
Sbjct:    69 KVLSAESRQGVKEFLTEINVISEIQHENLVKLYGCCVEGNHRILVYNFLENNSLDKTLLA 128

Query:   329 -GRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF 387
              G     ++ DW +R  IC+G+A+GLAFLHEE R  I+HRDIKA+N+LLD+ L+PKISDF
Sbjct:   129 GGYTRSGIQFDWSSRANICVGVAKGLAFLHEEVRPHIIHRDIKASNILLDKYLSPKISDF 188

Query:   388 GLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYA 447
             GLA+L   + TH+STR+AGTIGY+APEYA+ G LT KAD+YSFG++ +EIVSG++N +  
Sbjct:   189 GLARLMPPNMTHVSTRVAGTIGYLAPEYAVRGQLTRKADIYSFGVLLMEIVSGRSNKNTR 248

Query:   448 PALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPT 507
                E+    LL+ A  L +  +LV+LVD  L   +  EEA R +K+ LLCT  SP LRP+
Sbjct:   249 LPTEYQY--LLERAWELYERNELVDLVDSGLNGVFDAEEACRYLKIGLLCTQDSPKLRPS 306

Query:   508 MSEV 511
             MS V
Sbjct:   307 MSTV 310

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

TAIR|locus:2095334 AT3G09010 [Arabidopsis thaliana (taxid:3702)]

 Score = 771 (276.5 bits), Expect = 1.5e-76, P = 1.5e-76
 Identities = 150/282 (53%), Positives = 200/282 (70%)

Query:   230 FTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAM 289
             F+   +++AT++F    +IG GG+G V+KG L DGT +AVK LS++S+QG REFL EI +
Sbjct:    34 FSYNSLRSATDSFHPTNRIGGGGYGVVFKGVLRDGTQVAVKSLSAESKQGTREFLTEINL 93

Query:   290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGI 349
             IS + HPNLVK+ GCC+EG+  +LVYEY+ENNSLA  L G  +  + LDW  R  IC+G 
Sbjct:    94 ISNIHHPNLVKLIGCCIEGNNRILVYEYLENNSLASVLLGSRSRYVPLDWSKRAAICVGT 153

Query:   350 ARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIG 409
             A GLAFLHEE    +VHRDIKA+N+LLD + +PKI DFGLAKL   + TH+STR+AGT+G
Sbjct:   154 ASGLAFLHEEVEPHVVHRDIKASNILLDSNFSPKIGDFGLAKLFPDNVTHVSTRVAGTVG 213

Query:   410 YMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGK 469
             Y+APEYAL G LT KADVYSFGI+ LE++SG  N S   A   +   L++W   L+++ +
Sbjct:   214 YLAPEYALLGQLTKKADVYSFGILVLEVISG--NSSTRAAFGDEYMVLVEWVWKLREERR 271

Query:   470 LVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
             L+E VD  L +K+  +E  R IKV+L CT A+   RP M +V
Sbjct:   272 LLECVDPEL-TKFPADEVTRFIKVALFCTQAAAQKRPNMKQV 312

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

TAIR|locus:2121691 CRK11 "cysteine-rich RLK (RECEPTOR-like protein kinase) 11" [Arabidopsis thaliana (taxid:3702)]

 Score = 707 (253.9 bits), Expect = 8.9e-70, P = 8.9e-70
 Identities = 144/310 (46%), Positives = 208/310 (67%)

Query:   208 YLRTKRHKETAFMKESDLQT---ISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADG 264
             + R K ++ T    ESD+ T   + +  K I+AATN F ++ K+GEGGFG VYKG+L++G
Sbjct:   313 FRRRKSYQRTKTESESDISTTDSLVYDFKTIEAATNKFSTSNKLGEGGFGAVYKGKLSNG 372

Query:   265 TIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLA 324
             T +AVK+LS KS QG REF NE  +++ LQH NLV++ G C+E ++ +L+YE++ N SL 
Sbjct:   373 TDVAVKRLSKKSGQGTREFRNEAVLVTKLQHRNLVRLLGFCLEREEQILIYEFVHNKSLD 432

Query:   325 CALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKI 384
               LF  E  + +LDW  R KI  GIARG+ +LH++SR KI+HRD+KA+N+LLD D+NPKI
Sbjct:   433 YFLFDPEK-QSQLDWTRRYKIIGGIARGILYLHQDSRLKIIHRDLKASNILLDADMNPKI 491

Query:   385 SDFGLAKLDEGDKTHIST-RIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNN 443
             +DFGLA +   ++T  +T RIAGT  YM+PEYA+ G  + K+D+YSFG++ LEI+SGK N
Sbjct:   492 ADFGLATIFGVEQTQGNTNRIAGTYAYMSPEYAMHGQYSMKSDIYSFGVLVLEIISGKKN 551

Query:   444 MSYAPALEFDCTC--LLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNAS 501
              S    ++   T   L+ +A  L ++   +ELVD   G  Y+  E  R I ++LLC   +
Sbjct:   552 -SGVYQMDETSTAGNLVTYASRLWRNKSPLELVDPTFGRNYQSNEVTRCIHIALLCVQEN 610

Query:   502 PSLRPTMSEV 511
             P  RP +S +
Sbjct:   611 PEDRPMLSTI 620

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006979 "response to oxidative stress" evidence=IEP;RCA

GO:0009816 "defense response to bacterium, incompatible interaction" evidence=IEP

GO:0016020 "membrane" evidence=ISS

GO:0009611 "response to wounding" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00035809001 SubName- Full=Chromosome chr10 scaffold_81, whole genome shotgun sequence; (966 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	511
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-53
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-50
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-49
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-49
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-49
pfam11721	164	pfam11721, Malectin, Di-glucose binding within end	8e-49
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-48
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-47
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	8e-45
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-44
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	9e-37
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-35
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	9e-35
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-34
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-34
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-32
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-32
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	8e-31
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-30
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-30
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-30
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-29
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-29
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-29
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	5e-29
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	6e-29
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-28
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-28
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-28
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-28
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	7e-28
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-27
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-27
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-27
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-27
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	7e-27
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	9e-27
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-26
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-26
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-26
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-25
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-25
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-25
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-25
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-25
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-25
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-25
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-25
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-25
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	5e-25
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-25
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	7e-25
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	7e-25
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-24
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-24
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-24
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	5e-24
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	6e-24
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-24
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-23
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-23
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-23
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-23
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-23
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-23
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-23
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-23
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-23
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-23
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	6e-23
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-23
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-23
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	6e-23
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	9e-23
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-22
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-22
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-22
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-22
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-22
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-22
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	7e-22
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	9e-22
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	9e-22
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-21
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-21
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-21
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-21
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-21
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-21
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-21
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-21
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-21
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-21
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-21
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-21
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	6e-21
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	7e-21
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	8e-21
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-20
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-20
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-20
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-20
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-20
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-20
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-20
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	6e-20
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-20
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	9e-20
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-19
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-19
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-19
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-19
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-19
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-19
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-19
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-19
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-19
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	5e-19
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	5e-19
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	6e-19
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	6e-19
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-19
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	7e-19
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	7e-19
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-18
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-18
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-18
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-18
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-18
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-18
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-18
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	5e-18
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	6e-18
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	7e-18
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	7e-18
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-18
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	8e-18
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-17
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-17
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-17
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-17
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-17
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-17
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-17
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-17
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-17
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	7e-17
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	7e-17
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	7e-17
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	8e-17
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-16
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-16
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-16
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-16
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-16
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-16
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-16
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-16
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-16
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	6e-16
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	7e-16
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	8e-16
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	8e-16
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	9e-16
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-15
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-15
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-15
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-15
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-15
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-15
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-15
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-15
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	6e-15
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-15
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	7e-15
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	9e-15
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-14
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-14
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-14
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-14
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-14
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-14
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-14
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-14
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-14
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-14
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-14
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-14
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-14
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-14
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-14
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-14
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	6e-14
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	7e-14
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	8e-14
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	8e-14
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	9e-14
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-13
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-13
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-13
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-13
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-13
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-13
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-13
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	5e-13
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	6e-13
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	6e-13
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-12
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-12
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-12
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-12
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-12
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-12
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-12
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-12
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-12
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	6e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	6e-12
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	7e-12
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	8e-12
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-11
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-11
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-11
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-11
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-11
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-11
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-11
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	5e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	6e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	6e-11
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	7e-11
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	7e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	9e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-10
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-10
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-10
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-10
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-10
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-10
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-10
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-10
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-10
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-10
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-10
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	7e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-09
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-09
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-09
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	6e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	6e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	6e-09
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	7e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	7e-08
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-07
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-07
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	4e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-07
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	9e-07
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-06
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	6e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-05
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	2e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	3e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	3e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-05
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	8e-05
pfam12819	335	pfam12819, Malectin_like, Carbohydrate-binding pro	8e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	4e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	7e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.001
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	0.002
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	0.003
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.003

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  180 bits (458), Expect = 1e-53
 Identities = 72/194 (37%), Positives = 104/194 (53%), Gaps = 11/194 (5%)

Query: 248 IGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNRE-FLNEIAMISCLQHPNLVKIHGCC 305
           +GEGGFG VY  +    G  +A+K +  +      E  L EI ++  L HPN+VK++G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
            + + L LV EY E  SL   L   +  E +L      +I L I  GL +LH      I+
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLL---KENEGKLSEDEILRILLQILEGLEYLHSN---GII 114

Query: 366 HRDIKATNVLLD-RDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYAL-WGYLTY 423
           HRD+K  N+LLD  +   K++DFGL+KL       +   I GT  YMAPE  L  GY + 
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKL-LTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173

Query: 424 KADVYSFGIVALEI 437
           K+D++S G++  E+
Sbjct: 174 KSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  172 bits (439), Expect = 2e-50
 Identities = 76/200 (38%), Positives = 106/200 (53%), Gaps = 12/200 (6%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSR--QGNREFLNEIAMISCLQHPNLVKIH 302
           +K+G G FG VYK +    G I+AVK L  +S   + ++    EI ++  L HPN+V++ 
Sbjct: 5   RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64

Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRF 362
               + D L LV EY E   L      R      L     +KI L I RGL +LH     
Sbjct: 65  DAFEDKDHLYLVMEYCEGGDL-FDYLSRGGP---LSEDEAKKIALQILRGLEYLHSNG-- 118

Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWG-YL 421
            I+HRD+K  N+LLD +   KI+DFGLAK      + ++T   GT  YMAPE  L G   
Sbjct: 119 -IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEVLLGGNGY 176

Query: 422 TYKADVYSFGIVALEIVSGK 441
             K DV+S G++  E+++GK
Sbjct: 177 GPKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  170 bits (433), Expect = 1e-49
 Identities = 93/278 (33%), Positives = 125/278 (44%), Gaps = 40/278 (14%)

Query: 246 KKIGEGGFGPVYKGQLADG-----TIIAVKQL-SSKSRQGNREFLNEIAMISCLQHPNLV 299
           KK+GEG FG VYKG L          +AVK L    S Q   EFL E  ++  L HPN+V
Sbjct: 5   KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64

Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
           K+ G C E + L++V EYM    L   L  R+N   EL         L IARG+ +L  +
Sbjct: 65  KLLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARGMEYLESK 122

Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGD-KTHISTRIAGTIGYMAPEYAL 417
                +HRD+ A N L+  +L  KISDFGL++ L + D       ++   I +MAPE   
Sbjct: 123 ---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLK 177

Query: 418 WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER 477
            G  T K+DV+SFG++  EI +                            G     V E 
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTL---------------------GEEPYPGMSNAEVLEY 216

Query: 478 LGSKYK----KEEAERMIKVSLLCTNASPSLRPTMSEV 511
           L   Y+          + K+ L C    P  RPT SE+
Sbjct: 217 LKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSEL 254

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  170 bits (434), Expect = 1e-49
 Identities = 94/283 (33%), Positives = 131/283 (46%), Gaps = 43/283 (15%)

Query: 246 KKIGEGGFGPVYKGQLADG----TIIAVKQL-SSKSRQGNREFLNEIAMISCLQHPNLVK 300
           KK+GEG FG VYKG+L       T +AVK L    S +  ++FL E  ++  L HPN+V+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 301 IHGCCVEGDQLLLVYEYMENNSL-----ACALFGRENCELELDWPTRQKICLGIARGLAF 355
           + G C E + L LV EYME   L               +  L         + IA+G+ +
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPE 414
           L  +   K VHRD+ A N L+  DL  KISDFGL++ + + D     T     I +MAPE
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177

Query: 415 YALWGYLTYKADVYSFGIVALEIVS-GK---NNMSYAPALEFDCTCLLDWACHLQQDGKL 470
               G  T K+DV+SFG++  EI + G      +S    LE           +L++  +L
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLE-----------YLRKGYRL 226

Query: 471 V--ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
              E   + L         E M    L C    P  RPT SE+
Sbjct: 227 PKPEYCPDEL--------YELM----LSCWQLDPEDRPTFSEL 257

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  169 bits (430), Expect = 4e-49
 Identities = 92/277 (33%), Positives = 124/277 (44%), Gaps = 39/277 (14%)

Query: 246 KKIGEGGFGPVYKGQL-----ADGTIIAVKQL-SSKSRQGNREFLNEIAMISCLQHPNLV 299
           KK+GEG FG VYKG+L          +AVK L    S Q   EFL E  ++  L HPN+V
Sbjct: 5   KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVV 64

Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
           K+ G C E + L +V EYME   L   L        +L         L IARG+ +L  +
Sbjct: 65  KLLGVCTEEEPLYIVMEYMEGGDLLSYL---RKNRPKLSLSDLLSFALQIARGMEYLESK 121

Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWG 419
                +HRD+ A N L+  +L  KISDFGL++    D  +        I +MAPE    G
Sbjct: 122 ---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEG 178

Query: 420 YLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERL 478
             T K+DV+SFG++  EI + G+    Y                     G   E V E L
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLGE--QPY--------------------PGMSNEEVLEYL 216

Query: 479 GSKYK----KEEAERMIKVSLLCTNASPSLRPTMSEV 511
            + Y+          +  + L C    P  RPT SE+
Sbjct: 217 KNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSEL 253

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|221187 pfam11721, Malectin, Di-glucose binding within endoplasmic reticulum

 Score =  165 bits (419), Expect = 8e-49
 Identities = 74/170 (43%), Positives = 96/170 (56%), Gaps = 26/170 (15%)

Query: 1   TFEGDGQIGGGAATFHLQDDTNWGFSSTGDFADDNDDQNTRYTATSDSSGLSELYINARI 60
           T+E D    GG+A +++ D TN   S  G       D               ELY   R 
Sbjct: 19  TYEADTYFTGGSADYYVSD-TNGSSSIAG-----TTDP--------------ELYQTERY 58

Query: 61  APLSLTYFGYCLDNGNYTLSLHFAEIQFSNGITFHSLGRRLFDIYIQDNLVERNFDIKAE 120
           +P S +Y+  CL+NGNYT+ LHFAEI F        LGRR+FD+Y+Q  LV ++FDI AE
Sbjct: 59  SPSSFSYYIPCLENGNYTVILHFAEIYFGE----DGLGRRVFDVYVQGKLVLKDFDIVAE 114

Query: 121 ASGVLKPVARSY-NVTVTNHIIEIRFHWAGKGTTALPKRGIYG-PLVSAI 168
           A G  K   + Y  VTVT+  +EI F+WAGKGT  +P RG+YG P +SAI
Sbjct: 115 AGGKGKTAHKEYIPVTVTDGTLEIHFYWAGKGTLLIPFRGVYGNPKISAI 164

Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan. Length = 164

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  168 bits (427), Expect = 1e-48
 Identities = 82/268 (30%), Positives = 125/268 (46%), Gaps = 26/268 (9%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNRE-FLNEIAMISCLQHPNLVKIHG 303
           +K+GEG FG VY  +    G ++A+K +  K  + +RE  L EI ++  L+HPN+V+++ 
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFK 363
              + D+L LV EY E   L   L  ++   L  D    +     I   L +LH +    
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDE--ARFYLRQILSALEYLHSK---G 117

Query: 364 IVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTY 423
           IVHRD+K  N+LLD D + K++DFGLA+        ++T + GT  YMAPE  L      
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQ-LDPGEKLTTFV-GTPEYMAPEVLLGKGYGK 175

Query: 424 KADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYK 483
             D++S G++  E+++G       P   F     L          K      E       
Sbjct: 176 AVDIWSLGVILYELLTG-----KPP---FPGDDQLLELFKKIGKPKPPFPPPE----WDI 223

Query: 484 KEEAERMIKVSLLCTNASPSLRPTMSEV 511
             EA+ +I+  LL  +  P  R T  E 
Sbjct: 224 SPEAKDLIR-KLLVKD--PEKRLTAEEA 248

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  163 bits (416), Expect = 5e-47
 Identities = 75/202 (37%), Positives = 109/202 (53%), Gaps = 13/202 (6%)

Query: 246 KKIGEGGFGPVYKGQL-----ADGTIIAVKQLSSKSRQGNR-EFLNEIAMISCLQHPNLV 299
           KK+GEG FG VYKG L        T +AVK L   + +  R EFL E +++  L HPN+V
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
           ++ G C +G+ L +V EYM    L    F R++   +L      ++ L IA+G+ +L  +
Sbjct: 65  RLLGVCTQGEPLYIVTEYMPGGDL--LDFLRKH-GEKLTLKDLLQMALQIAKGMEYLESK 121

Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT-IGYMAPEYALW 418
                VHRD+ A N L+  +L  KISDFGL++    D  +         I +MAPE    
Sbjct: 122 ---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKD 178

Query: 419 GYLTYKADVYSFGIVALEIVSG 440
           G  T K+DV+SFG++  EI + 
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  158 bits (401), Expect = 8e-45
 Identities = 74/204 (36%), Positives = 105/204 (51%), Gaps = 17/204 (8%)

Query: 246 KKIGEGGFGPVYKGQLAD-GTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQHPNLVKIH 302
           + +G G FG VY     D G ++AVK   LS  S +       EI ++S LQHPN+V+ +
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 303 GCCV--EGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICLGIARGLAFLHE 358
           G     E + L +  EY+   SL+  L  FG+   E  +   TRQ     I  GLA+LH 
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP-EPVIRKYTRQ-----ILEGLAYLHS 119

Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPEYAL 417
                IVHRDIK  N+L+D D   K++DFG AK L + +    +  + GT  +MAPE   
Sbjct: 120 N---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176

Query: 418 WGYLTYKADVYSFGIVALEIVSGK 441
                  AD++S G   +E+ +GK
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  156 bits (396), Expect = 3e-44
 Identities = 73/210 (34%), Positives = 112/210 (53%), Gaps = 9/210 (4%)

Query: 242 FDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
           F+  +KIG+GGFG VYK      G  +A+K +  +S++   + +NEI ++   +HPN+VK
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
            +G  ++ D+L +V E+    SL   L   ++    L       +C  + +GL +LH   
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKDLL---KSTNQTLTESQIAYVCKELLKGLEYLHSN- 117

Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGY 420
              I+HRDIKA N+LL  D   K+ DFGL+   +   T     + GT  +MAPE      
Sbjct: 118 --GIIHRDIKAANILLTSDGEVKLIDFGLSA--QLSDTKARNTMVGTPYWMAPEVINGKP 173

Query: 421 LTYKADVYSFGIVALEIVSGKNNMSYAPAL 450
             YKAD++S GI A+E+  GK   S  P +
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPYSELPPM 203

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  136 bits (344), Expect = 9e-37
 Identities = 70/201 (34%), Positives = 107/201 (53%), Gaps = 17/201 (8%)

Query: 247 KIGEGGFGPVYKG-QLADGTIIAVKQLS--SKSRQGNREFLNEIAMISCLQHPNLVKIHG 303
            IG G FG VYKG  L  G  +A+KQ+S      +  +  + EI ++  L+HPN+VK  G
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 304 CCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICLGIARGLAFLHEESR 361
                D L ++ EY EN SL   +  FG    E  +     Q     + +GLA+LHE+  
Sbjct: 67  SIETSDSLYIILEYAENGSLRQIIKKFGPFP-ESLVAVYVYQ-----VLQGLAYLHEQ-- 118

Query: 362 FKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHISTRIAGTIGYMAPEYALWGY 420
             ++HRDIKA N+L  +D   K++DFG+A KL++  K      + GT  +MAPE      
Sbjct: 119 -GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSG 175

Query: 421 LTYKADVYSFGIVALEIVSGK 441
            +  +D++S G   +E+++G 
Sbjct: 176 ASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  132 bits (333), Expect = 3e-35
 Identities = 75/199 (37%), Positives = 108/199 (54%), Gaps = 16/199 (8%)

Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGN---REFLNEIAMISCLQHPNLVKIH 302
           +K+G G FG V+ G     T +AVK L    + G      FL E  ++  L+H  LV+++
Sbjct: 12  RKLGAGQFGEVWMGTWNGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLVQLY 67

Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRF 362
             C E + + +V EYM   SL   L   E  +L L  P    +   IA G+A+L  ESR 
Sbjct: 68  AVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL--PQLVDMAAQIAEGMAYL--ESR- 122

Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK--THISTRIAGTIGYMAPEYALWGY 420
             +HRD+ A N+L+  +L  KI+DFGLA+L E D+       +    I + APE A +G 
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFP--IKWTAPEAANYGR 180

Query: 421 LTYKADVYSFGIVALEIVS 439
            T K+DV+SFGI+  EIV+
Sbjct: 181 FTIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  130 bits (329), Expect = 9e-35
 Identities = 85/269 (31%), Positives = 125/269 (46%), Gaps = 38/269 (14%)

Query: 248 IGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVE 307
           IG+G FG V  G    G  +AVK L   S      FL E ++++ L+HPNLV++ G  ++
Sbjct: 14  IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 308 GDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHR 367
           G+ L +V EYM   SL   L  R    + L    +    L +  G+ +L E+     VHR
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLRSRGRAVITLA--QQLGFALDVCEGMEYLEEK---NFVHR 126

Query: 368 DIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADV 427
           D+ A NVL+  DL  K+SDFGLAK  E  +   S ++   + + APE       + K+DV
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLP--VKWTAPEALREKKFSTKSDV 182

Query: 428 YSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEE 486
           +SFGI+  EI S G+      P                     L ++V   +   Y+ E 
Sbjct: 183 WSFGILLWEIYSFGRVPYPRIP---------------------LKDVVP-HVEKGYRMEA 220

Query: 487 AE----RMIKVSLLCTNASPSLRPTMSEV 511
            E     + KV   C    P+ RPT  ++
Sbjct: 221 PEGCPPEVYKVMKDCWELDPAKRPTFKQL 249

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  130 bits (330), Expect = 1e-34
 Identities = 65/206 (31%), Positives = 110/206 (53%), Gaps = 15/206 (7%)

Query: 239 TNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQH 295
              + + +KIGEG  G VYK    A G  +A+K+  L  ++++     +NEI ++   +H
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI---INEILIMKDCKH 74

Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           PN+V  +   + GD+L +V EYM+  SL   +       + ++ P    +C  + +GL +
Sbjct: 75  PNIVDYYDSYLVGDELWVVMEYMDGGSLTDII---TQNFVRMNEPQIAYVCREVLQGLEY 131

Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL-AKLDEGDKTHISTRIAGTIGYMAPE 414
           LH      ++HRDIK+ N+LL +D + K++DFG  A+L +      S  + GT  +MAPE
Sbjct: 132 LH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPE 186

Query: 415 YALWGYLTYKADVYSFGIVALEIVSG 440
                    K D++S GI+ +E+  G
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  128 bits (325), Expect = 5e-34
 Identities = 82/278 (29%), Positives = 135/278 (48%), Gaps = 43/278 (15%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLS-SKSRQGNREF-LNEIAMISCLQHPNLVKIH 302
           K+IG+G FG VY  +  +DG +  +K++  S   +  RE  LNE+ ++  L HPN++K +
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 303 GCCVEGDQLLLVYEYMENNSLA-----CALFGRENCELE-LDWPTRQKICLGIARGLAFL 356
               E  +L +V EY +   L+         G+   E + LDW    ++CL     L +L
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV--QLCLA----LKYL 119

Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYA 416
           H     KI+HRDIK  N+ L  +   K+ DFG++K+         T + GT  Y++PE  
Sbjct: 120 HSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPE-- 173

Query: 417 LW---GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVEL 473
           L     Y  YK+D++S G V  E+ + K          F+   LL+ A       K+++ 
Sbjct: 174 LCQNKPY-NYKSDIWSLGCVLYELCTLK------HP--FEGENLLELAL------KILKG 218

Query: 474 VDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
               + S+Y   E   ++  SLL     P  RP+++++
Sbjct: 219 QYPPIPSQYSS-ELRNLVS-SLL--QKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  124 bits (313), Expect = 3e-32
 Identities = 72/220 (32%), Positives = 111/220 (50%), Gaps = 36/220 (16%)

Query: 248 IGEGGFGPVYKGQLA------DGTIIAVKQLS-SKSRQGNREFLNEIAMISCLQHPNLVK 300
           +GEG FG V+ G+        D  ++AVK L  + S    ++F  E  +++  QH N+VK
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 301 IHGCCVEGDQLLLVYEYMENNSL----------ACALFGRENCELELDWPTRQKICLGIA 350
            +G C EGD  ++V+EYME+  L          A  L   ++   EL      +I + IA
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIST----RIAG 406
            G+ +L  +  F  VHRD+   N L+  DL  KI DFG+++        + T    R+ G
Sbjct: 133 SGMVYLASQ-HF--VHRDLATRNCLVGYDLVVKIGDFGMSR-------DVYTTDYYRVGG 182

Query: 407 T----IGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GK 441
                I +M PE  ++   T ++DV+SFG+V  EI + GK
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  123 bits (310), Expect = 5e-32
 Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 12/202 (5%)

Query: 242 FDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
           FD  +K+GEG +G VYK      G ++A+K +  +     +E + EI+++     P +VK
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62

Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
            +G   +   L +V EY    S++  +   +     L       I     +GL +LH   
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIM---KITNKTLTEEEIAAILYQTLKGLEYLH--- 116

Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYAL-WG 419
             K +HRDIKA N+LL+ +   K++DFG++          +T I GT  +MAPE     G
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQEIG 175

Query: 420 YLTYKADVYSFGIVALEIVSGK 441
           Y   KAD++S GI A+E+  GK
Sbjct: 176 Y-NNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  120 bits (302), Expect = 8e-31
 Identities = 70/206 (33%), Positives = 101/206 (49%), Gaps = 18/206 (8%)

Query: 246 KKIGEGGFGPVYKG-QLADGTIIAVKQLS-SKSRQGN-REFLNEIAMISCLQHPNLVKIH 302
            KIG G FG VY    L  G ++AVK++    +     +E  +E+ ++  L+HPNLVK +
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 303 GCCVEGDQLLLVYEYMENNSLACAL-FGRENCELELDWPTRQKICLGIARGLAFLHEESR 361
           G  V  +++ +  EY    +L   L  GR   E  +   T Q     +  GLA+LH    
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQ-----LLEGLAYLHSH-- 118

Query: 362 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIG---YMAPEYALW 418
             IVHRDIK  N+ LD +   K+ DFG A   + + T +   +    G   YMAPE    
Sbjct: 119 -GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177

Query: 419 GYLTYK---ADVYSFGIVALEIVSGK 441
           G        AD++S G V LE+ +GK
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGK 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  118 bits (297), Expect = 4e-30
 Identities = 69/201 (34%), Positives = 109/201 (54%), Gaps = 14/201 (6%)

Query: 246 KKIGEGGFGPVYKGQLA----DGTIIAVKQLSSKSRQGNR-EFLNEIAMISCLQHPNLVK 300
           K IG G FG V +G+L         +A+K L + S    R +FL E +++    HPN+++
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
           + G   +   ++++ EYMEN SL    F REN + +        +  GIA G+ +L   S
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDK--FLREN-DGKFTVGQLVGMLRGIASGMKYL---S 123

Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIG--YMAPEYALW 418
               VHRD+ A N+L++ +L  K+SDFGL++  E  +   +T+  G I   + APE   +
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK-GGKIPIRWTAPEAIAY 182

Query: 419 GYLTYKADVYSFGIVALEIVS 439
              T  +DV+SFGIV  E++S
Sbjct: 183 RKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  118 bits (298), Expect = 4e-30
 Identities = 81/288 (28%), Positives = 131/288 (45%), Gaps = 50/288 (17%)

Query: 246 KKIGEGGFGPVYKGQLAD------GTIIAVKQLSSKSRQGNR-EFLNEIAMISCLQHPNL 298
           +++G+G FG VY+G           T +A+K ++  +    R EFLNE +++      ++
Sbjct: 12  RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHV 71

Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGR----ENCELELDWPTRQKI---CLGIAR 351
           V++ G    G   L+V E M    L   L  R    EN    L  PT QK       IA 
Sbjct: 72  VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPG-LGPPTLQKFIQMAAEIAD 130

Query: 352 GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGY 410
           G+A+L  +   K VHRD+ A N ++  DL  KI DFG+ + + E D      +    + +
Sbjct: 131 GMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187

Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVS-------GKNNMSYAPALEFDCTCLLDWACH 463
           MAPE    G  T K+DV+SFG+V  E+ +       G +N      L+F           
Sbjct: 188 MAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLKFVI--------- 235

Query: 464 LQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
              DG  ++L          +   ++++++  +C   +P +RPT  E+
Sbjct: 236 ---DGGHLDL---------PENCPDKLLELMRMCWQYNPKMRPTFLEI 271

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  117 bits (296), Expect = 5e-30
 Identities = 89/272 (32%), Positives = 130/272 (47%), Gaps = 27/272 (9%)

Query: 247 KIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFL-NEIAMISCLQHPNLVKIHGC 304
            IG G    VY    L +   +A+K++  +  Q + + L  E+  +S   HPN+VK +  
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67

Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
            V GD+L LV  Y+   SL   +         LD      +   + +GL +LH   +   
Sbjct: 68  FVVGDELWLVMPYLSGGSLL-DIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ--- 123

Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAK--LDEGDKTHIS-TRIAGTIGYMAPE--YALWG 419
           +HRDIKA N+LL  D + KI+DFG++    D GD+T        GT  +MAPE    + G
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG 183

Query: 420 YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD-GKLVELVDERL 478
           Y  +KAD++SFGI A+E+ +G    S  P ++     +L     LQ D   L    D + 
Sbjct: 184 Y-DFKADIWSFGITAIELATGAAPYSKYPPMK---VLMLT----LQNDPPSLETGADYKK 235

Query: 479 GSKYKKEEAERMIKVSLLCTNASPSLRPTMSE 510
            SK  ++    MI    LC    PS RPT  E
Sbjct: 236 YSKSFRK----MIS---LCLQKDPSKRPTAEE 260

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  115 bits (290), Expect = 3e-29
 Identities = 64/194 (32%), Positives = 106/194 (54%), Gaps = 6/194 (3%)

Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           +K+G G FG V++G   + T +AVK L   +     +FL E  ++  L+HP L++++  C
Sbjct: 12  RKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVC 70

Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
              + + +V E M+  SL   L G     L+L  P    +   +A G+A+L  ++    +
Sbjct: 71  TLEEPIYIVTELMKYGSLLEYLQGGAGRALKL--PQLIDMAAQVASGMAYLEAQN---YI 125

Query: 366 HRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKA 425
           HRD+ A NVL+  +   K++DFGLA++ + D           I + APE AL+   + K+
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185

Query: 426 DVYSFGIVALEIVS 439
           DV+SFGI+  EIV+
Sbjct: 186 DVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  115 bits (289), Expect = 3e-29
 Identities = 72/207 (34%), Positives = 111/207 (53%), Gaps = 15/207 (7%)

Query: 241 NFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQHPN 297
           +F+   KIG+G FG V+K  + AD  + A+KQ  LS  +R+   E ++E  +++ L    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACAL---FGRENCELELDWPTRQKICLGIARGLA 354
           +++ +   ++  +L +V EY EN  L   L    GR   E +  W    +  + I  GLA
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPE-DQVW----RFFIQILLGLA 115

Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPE 414
            LH +   KI+HRDIK+ N+ LD   N KI D G+AKL   D T+ +  I GT  Y++PE
Sbjct: 116 HLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKL-LSDNTNFANTIVGTPYYLSPE 171

Query: 415 YALWGYLTYKADVYSFGIVALEIVSGK 441
                    K+DV++ G+V  E  +GK
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  115 bits (290), Expect = 5e-29
 Identities = 84/279 (30%), Positives = 136/279 (48%), Gaps = 25/279 (8%)

Query: 246 KKIGEGGFGPVYKGQ---LADGT--IIAVKQLS-SKSRQGNREFLNEIAMISCLQHPNLV 299
           K++GEG FG V   +   L D T   +AVK L+ S   Q   +F  EI ++  L H N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 300 KIHGCCVE--GDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH 357
           K  G C +  G  L L+ EY+ + SL   L    +   +++          I +G+ +L 
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLG 126

Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT--IGYMAPEY 415
            +   + +HRD+ A N+L++ +   KISDFGLAK+   DK +   +  G   I + APE 
Sbjct: 127 SQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC 183

Query: 416 ALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD 475
                 +  +DV+SFG+   E+ +   + S +P  EF    ++  A       +L+EL+ 
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFT-YGDPSQSPPAEF--LRMIGIAQGQMIVTRLLELLK 240

Query: 476 --ERLGSKYK-KEEAERMIKVSLLCTNASPSLRPTMSEV 511
             ERL       +E   ++K   LC  A P  RP+ +++
Sbjct: 241 EGERLPRPPSCPDEVYDLMK---LCWEAEPQDRPSFADL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  117 bits (294), Expect = 5e-29
 Identities = 73/214 (34%), Positives = 105/214 (49%), Gaps = 19/214 (8%)

Query: 241 NFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSK---SRQGNREFLNEI-AMISCLQHP 296
           ++   +K+GEG FG VY  +  D  ++A+K L+ K     +    FL EI  + S    P
Sbjct: 1   SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFL 356
           N+VK++    +   L LV EY++  SL   L  +   +  L       I   I   L +L
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLE-DLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 357 HEESRFKIVHRDIKATNVLLDRDLN-PKISDFGLAKLDEGDKTHISTR-----IAGTIGY 410
           H +    I+HRDIK  N+LLDRD    K+ DFGLAKL     +  S         GT GY
Sbjct: 118 HSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174

Query: 411 MAPEYAL---WGYLTYKADVYSFGIVALEIVSGK 441
           MAPE  L     Y +  +D++S GI   E+++G 
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208

Length = 384

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  114 bits (288), Expect = 6e-29
 Identities = 77/284 (27%), Positives = 123/284 (43%), Gaps = 45/284 (15%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNR-EFLNEI-AMISCLQHP 296
           ++ +  K +G+G  G VYK +    G I A+K++     +  R + L E+  + SC + P
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-ESP 59

Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQ--KICLGIARGLA 354
            +VK +G   +  ++ +V EYM+  SLA  L            P      I   I +GL 
Sbjct: 60  YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGK------IPEPVLAYIARQILKGLD 113

Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIA------GTI 408
           +LH +    I+HRDIK +N+L++     KI+DFG++K        +   +       GT+
Sbjct: 114 YLHTKR--HIIHRDIKPSNLLINSKGEVKIADFGISK-------VLENTLDQCNTFVGTV 164

Query: 409 GYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQ-- 466
            YM+PE       +Y AD++S G+  LE   GK    + P  +        +   +Q   
Sbjct: 165 TYMSPERIQGESYSYAADIWSLGLTLLECALGKF--PFLPPGQ------PSFFELMQAIC 216

Query: 467 DGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSE 510
           DG    L  E         E    I     C    P  RP+ +E
Sbjct: 217 DGPPPSLPAEE-----FSPEFRDFIS---ACLQKDPKKRPSAAE 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  114 bits (286), Expect = 1e-28
 Identities = 73/208 (35%), Positives = 103/208 (49%), Gaps = 30/208 (14%)

Query: 248 IGEGGFGPVYKG-QLADGTIIAVKQLS-----SKSRQGNREFLNEIAMISCLQHPNLVKI 301
           +G G FG VY+G  L DG   AVK++S        ++  ++   EIA++S LQHPN+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 302 HGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWP-----TRQKICLGIARGLA 354
            G   E D L +  E +   SLA  L  +G          P     TRQ     I  GL 
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYG------SFPEPVIRLYTRQ-----ILLGLE 116

Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPE 414
           +LH+      VHRDIK  N+L+D +   K++DFG+AK         S +  G+  +MAPE
Sbjct: 117 YLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK--GSPYWMAPE 171

Query: 415 YAL-WGYLTYKADVYSFGIVALEIVSGK 441
                G     AD++S G   LE+ +GK
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  114 bits (286), Expect = 1e-28
 Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 8/199 (4%)

Query: 242 FDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKI 301
           F   +K+G G FG V++G   +   +A+K L S      ++F  E+  +  L+H +L+ +
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 302 HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESR 361
              C  G+ + ++ E ME  SL   L   E     L   +   +   +A G+A+L E+  
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQ-- 123

Query: 362 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD-KTHISTRIAGTIGYMAPEYALWGY 420
              +HRD+ A N+L+  DL  K++DFGLA+L + D       +I     + APE A  G 
Sbjct: 124 -NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP--YKWTAPEAASHGT 180

Query: 421 LTYKADVYSFGIVALEIVS 439
            + K+DV+SFGI+  E+ +
Sbjct: 181 FSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  113 bits (284), Expect = 2e-28
 Identities = 71/197 (36%), Positives = 108/197 (54%), Gaps = 13/197 (6%)

Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNRE---FLNEIAMISCLQHPNLVKIH 302
           KK+G G FG V+ G     T +A+K L    +QG+     FL E  ++  LQHP LV+++
Sbjct: 12  KKLGAGQFGEVWMGYYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQHPRLVRLY 67

Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRF 362
              V  + + ++ EYMEN SL   L   E  +L +       +   IA G+AF+  ++  
Sbjct: 68  AV-VTQEPIYIITEYMENGSLVDFLKTPEGIKLTI--NKLIDMAAQIAEGMAFIERKN-- 122

Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLT 422
             +HRD++A N+L+   L  KI+DFGLA+L E ++          I + APE   +G  T
Sbjct: 123 -YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 181

Query: 423 YKADVYSFGIVALEIVS 439
            K+DV+SFGI+  EIV+
Sbjct: 182 IKSDVWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  114 bits (286), Expect = 2e-28
 Identities = 70/207 (33%), Positives = 113/207 (54%), Gaps = 26/207 (12%)

Query: 246 KKIGEGGFGPVYKG---QLADGTII--AVKQL-SSKSRQGNREFLNEIAMISCLQHPNLV 299
           K +G G FG VYKG      +   I  A+K L    S + N+E L+E  +++ + HP++V
Sbjct: 13  KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72

Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACAL-FGREN-----CELELDWPTRQKICLGIARGL 353
           ++ G C+   Q+ L+ + M    L C L + R +      +  L+W      C+ IA+G+
Sbjct: 73  RLLGICL-SSQVQLITQLMP---LGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGM 122

Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT-IGYMA 412
           ++L EE R  +VHRD+ A NVL+    + KI+DFGLAKL + D+           I +MA
Sbjct: 123 SYL-EEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMA 179

Query: 413 PEYALWGYLTYKADVYSFGIVALEIVS 439
            E  L    T+K+DV+S+G+   E+++
Sbjct: 180 LESILHRIYTHKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  111 bits (279), Expect = 7e-28
 Identities = 71/213 (33%), Positives = 108/213 (50%), Gaps = 12/213 (5%)

Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNRE-FLNEIAMISCLQHPNLVKIHGC 304
           +KIG+G FG VYKG L   T +AVK   S      +  FL E  ++    HPN+VK+ G 
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60

Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
           CV+   + +V E +   SL   L  ++N    L      ++ L  A G+ +L  ES+   
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLRKKKN---RLTVKKLLQMSLDAAAGMEYL--ESK-NC 114

Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT-IGYMAPEYALWGYLTY 423
           +HRD+ A N L+  +   KISDFG+++ +EG    +S  +    I + APE   +G  T 
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174

Query: 424 KADVYSFGIVALEIVSGKN----NMSYAPALEF 452
           ++DV+S+GI+  E  S  +     MS     E 
Sbjct: 175 ESDVWSYGILLWETFSLGDTPYPGMSNQQTRER 207

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  111 bits (279), Expect = 2e-27
 Identities = 66/208 (31%), Positives = 114/208 (54%), Gaps = 22/208 (10%)

Query: 241 NFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNREFL-NEIAMISCLQHPNL 298
             D+  KIGEG  G V      + G  +AVK++  + +Q  RE L NE+ ++   QHPN+
Sbjct: 20  YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHPNI 78

Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
           V+++   + GD+L +V E++E  +L   +         ++      +CL + + L+FLH 
Sbjct: 79  VEMYSSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLAVLKALSFLHA 133

Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGL-AKLDEGDKTHISTR--IAGTIGYMAPEY 415
           +    ++HRDIK+ ++LL  D   K+SDFG  A++ +     +  R  + GT  +MAPE 
Sbjct: 134 Q---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK----EVPRRKSLVGTPYWMAPE- 185

Query: 416 ALWGYLTY--KADVYSFGIVALEIVSGK 441
            +   L Y  + D++S GI+ +E+V G+
Sbjct: 186 -VISRLPYGTEVDIWSLGIMVIEMVDGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  111 bits (278), Expect = 2e-27
 Identities = 70/214 (32%), Positives = 107/214 (50%), Gaps = 23/214 (10%)

Query: 246 KKIGEGGFGPVYKGQL------ADGTIIAVKQLSSK-SRQGNREFLNEIAMISCLQHPNL 298
           +++GEG FG VYKG+L         T +A+K L      +  +EF  E  ++S LQHPN+
Sbjct: 11  EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNI 70

Query: 299 VKIHGCCVEGDQLLLVYEYMENNSL------------ACALFGRENCELELDWPTRQKIC 346
           V + G C +     +++EY+ +  L              A  G E  +  LD      I 
Sbjct: 71  VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130

Query: 347 LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD-EGDKTHISTRIA 405
           + IA G+ +L   S    VHRD+ A N L+   L  KISDFGL++     D   + ++  
Sbjct: 131 IQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSL 187

Query: 406 GTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
             + +M PE  L+G  T ++D++SFG+V  EI S
Sbjct: 188 LPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  110 bits (278), Expect = 2e-27
 Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 19/202 (9%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLN-EIAMISCLQHPNLVKIHG 303
           + IG+G FG VYK        ++A+K +  +  +   E +  EI  +S  + P + K +G
Sbjct: 7   ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYG 66

Query: 304 CCVEGDQLLLVYEYMENNSLACAL-FGRENCELELDWPTRQKICLGIARGLAFLHEESRF 362
             ++G +L ++ EY    S    L  G+      LD      I   +  GL +LHEE   
Sbjct: 67  SFLKGSKLWIIMEYCGGGSCLDLLKPGK------LDETYIAFILREVLLGLEYLHEE--- 117

Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR---IAGTIGYMAPEYALWG 419
             +HRDIKA N+LL  + + K++DFG++    G  T   ++     GT  +MAPE     
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVS----GQLTSTMSKRNTFVGTPFWMAPEVIKQS 173

Query: 420 YLTYKADVYSFGIVALEIVSGK 441
               KAD++S GI A+E+  G+
Sbjct: 174 GYDEKADIWSLGITAIELAKGE 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  110 bits (278), Expect = 2e-27
 Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 26/207 (12%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQG--NREFLNEIAMISCLQHPNLVKIH 302
            KIGEG +G VYK +    G I+A+K++  +       +  L EI ++  L HPN++K+ 
Sbjct: 5   GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64

Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC---LGIARGLAFLHEE 359
                   L LV+E+M+ +     L       L         I      + +GLAF H  
Sbjct: 65  DVFRHKGDLYLVFEFMDTD--LYKLIKDRQRGLPES-----LIKSYLYQLLQGLAFCH-- 115

Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK---TH-ISTRIAGTIGYMAPEY 415
               I+HRD+K  N+L++ +   K++DFGLA+         TH + TR      Y APE 
Sbjct: 116 -SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW-----YRAPEL 169

Query: 416 ALW-GYLTYKADVYSFGIVALEIVSGK 441
            L     +   D++S G +  E++S +
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  109 bits (275), Expect = 7e-27
 Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 13/199 (6%)

Query: 247 KIGEGGFGPVYK-GQLADGTIIAVKQLSSKSRQGN--REFLNEIAMISCLQHPNLVKIHG 303
           +IGEG  G V+K      G  +A+K+++ +  +G    + L EI  +   QHP +VK+  
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFK 363
               G   +LV EYM +  L+  L    + E  L     +     + +G+A++H      
Sbjct: 67  VFPHGSGFVLVMEYMPS-DLSEVL---RDEERPLPEAQVKSYMRMLLKGVAYMHAN---G 119

Query: 364 IVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTY 423
           I+HRD+K  N+L+  D   KI+DFGLA+L   ++  + +    T  Y APE  L+G   Y
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPEL-LYGARKY 178

Query: 424 KA--DVYSFGIVALEIVSG 440
               D+++ G +  E+++G
Sbjct: 179 DPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  109 bits (273), Expect = 9e-27
 Identities = 66/236 (27%), Positives = 106/236 (44%), Gaps = 49/236 (20%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSK-SRQGNREFLNEIAMISC 292
           NN +  + IG+G FG V++ +          T++AVK L  + S     +F  E A+++ 
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64

Query: 293 LQHPNLVKIHGCCVEGDQLLLVYEYME--------------------NNSLACALFGREN 332
             HPN+VK+ G C  G  + L++EYM                     +++ +    G   
Sbjct: 65  FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124

Query: 333 CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-- 390
             L      +  I   +A G+A+L E    K VHRD+   N L+  ++  KI+DFGL+  
Sbjct: 125 LPLSC--TEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 179

Query: 391 -------KLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
                  K  E D        A  I +M PE   +   T ++DV+++G+V  EI S
Sbjct: 180 IYSADYYKASEND--------AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  107 bits (269), Expect = 3e-26
 Identities = 66/211 (31%), Positives = 105/211 (49%), Gaps = 21/211 (9%)

Query: 247 KIGEGGFGPVYKGQLA------DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
           ++GEG FG V+  +        D  ++AVK L   S    ++F  E  +++ LQH ++V+
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 301 IHGCCVEGDQLLLVYEYMENNSL----------ACALFGRENCEL-ELDWPTRQKICLGI 349
            +G C EG  LL+V+EYM +  L          A  L G E+    +L       I   I
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 350 ARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTI 408
           A G+ +L   +    VHRD+   N L+ + L  KI DFG+++ +   D   +  R    I
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188

Query: 409 GYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
            +M PE  L+   T ++D++SFG+V  EI +
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  106 bits (267), Expect = 4e-26
 Identities = 69/209 (33%), Positives = 118/209 (56%), Gaps = 19/209 (9%)

Query: 241 NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQHPN 297
           +F   KK+G+G +G VYK + L+D    A+K+  L S S++   + +NEI +++ + HPN
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH 357
           ++      ++G++L +V EY     L+ A+  R+     +      +I + + RGL  LH
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD--KTHISTRIAGTIGYMAPEY 415
           E+   KI+HRD+K+ N+LL  +   KI D G++K+ + +  KT I     GT  YMAPE 
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI-----GTPHYMAPE- 171

Query: 416 ALWG---YLTYKADVYSFGIVALEIVSGK 441
            +W    Y +YK+D++S G +  E+ +  
Sbjct: 172 -VWKGRPY-SYKSDIWSLGCLLYEMATFA 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score =  107 bits (268), Expect = 5e-26
 Identities = 69/220 (31%), Positives = 108/220 (49%), Gaps = 30/220 (13%)

Query: 246 KKIGEGGFGPVYKGQLADG----------------TIIAVKQLSSKSRQGNR-EFLNEIA 288
           +K+GEG FG V+  + A+G                 ++AVK L +   +  R +FL EI 
Sbjct: 11  EKLGEGQFGEVHLCE-AEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK 69

Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRE--------NCELELDWP 340
           ++S L++PN++++ G CV  D L ++ EYMEN  L   L  RE        N    +   
Sbjct: 70  IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129

Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTH 399
               + + IA G+ +L   +    VHRD+   N L+      KI+DFG+++ L  GD   
Sbjct: 130 NLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYR 186

Query: 400 ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
           I  R    I +MA E  L G  T  +DV++FG+   E+ +
Sbjct: 187 IQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  105 bits (264), Expect = 1e-25
 Identities = 66/194 (34%), Positives = 104/194 (53%), Gaps = 6/194 (3%)

Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           KK+G G FG V+ G   + T +AVK L   +    + FL E  ++  LQH  LV+++   
Sbjct: 12  KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVV 70

Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
            + + + ++ EYM   SL   L   E  ++ L  P        IA G+A++  ++    +
Sbjct: 71  TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIERKN---YI 125

Query: 366 HRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKA 425
           HRD++A NVL+   L  KI+DFGLA++ E ++          I + APE   +G  T K+
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185

Query: 426 DVYSFGIVALEIVS 439
           DV+SFGI+  EIV+
Sbjct: 186 DVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  105 bits (264), Expect = 1e-25
 Identities = 73/210 (34%), Positives = 109/210 (51%), Gaps = 22/210 (10%)

Query: 248 IGEGGFGPVYKGQLA-DGTIIAVKQL-----SSKSRQGNREFLN----EIAMISCLQHPN 297
           IG G FG VY G  A  G ++AVKQ+     S+ S+   R  L+    EIA++  LQH N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH 357
           +V+  G  ++ D L +  EY+   S+A  L    N     +    +     I +GL +LH
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALL----NNYGAFEETLVRNFVRQILKGLNYLH 123

Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIA-----GTIGYMA 412
                 I+HRDIK  N+L+D     KISDFG++K  E +     T  A     G++ +MA
Sbjct: 124 NR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180

Query: 413 PEYALWGYLTYKADVYSFGIVALEIVSGKN 442
           PE       T KAD++S G + +E+++GK+
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKH 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  105 bits (264), Expect = 1e-25
 Identities = 67/203 (33%), Positives = 101/203 (49%), Gaps = 19/203 (9%)

Query: 246 KKIGEGGFGPVYKG--QLADGTII--AVKQLS-SKSRQGNREFLNEIAMISCLQHPNLVK 300
           K++G G FG V KG   +  G  +  AVK L       G +EFL E ++++ L HP +V+
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENC-ELEL-DWPTRQKICLGIARGLAFLHE 358
           + G C +G+ L+LV E      L   L  R      +L +   +      +A G+A+L E
Sbjct: 61  LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYL-E 112

Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT--IGYMAPEYA 416
              F  VHRD+ A NVLL      KISDFG+++       +     AG   + + APE  
Sbjct: 113 SKHF--VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170

Query: 417 LWGYLTYKADVYSFGIVALEIVS 439
            +G  + K+DV+S+G+   E  S
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  105 bits (264), Expect = 1e-25
 Identities = 67/218 (30%), Positives = 110/218 (50%), Gaps = 31/218 (14%)

Query: 242 FDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
           ++  ++IG G +G VYK + +A G ++A+K +  +          EI+M+   +HPN+V 
Sbjct: 5   YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64

Query: 301 IHGCCVEGDQLLLVYEYMENNSLA---CALFGRENCELELDWPTRQKICLGIARGLAFLH 357
             G  +  D+L +V EY    SL        G  + EL++ +  R+ +     +GLA+LH
Sbjct: 65  YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLS-ELQIAYVCRETL-----KGLAYLH 118

Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIA------GTIGYM 411
           E      +HRDIK  N+LL  D + K++DFG++         ++  IA      GT  +M
Sbjct: 119 E---TGKIHRDIKGANILLTEDGDVKLADFGVS-------AQLTATIAKRKSFIGTPYWM 168

Query: 412 APEYAL----WGYLTYKADVYSFGIVALEIVSGKNNMS 445
           APE A      GY   K D+++ GI A+E+   +  M 
Sbjct: 169 APEVAAVERKGGY-DGKCDIWALGITAIELAELQPPMF 205

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  105 bits (262), Expect = 2e-25
 Identities = 67/193 (34%), Positives = 103/193 (53%), Gaps = 7/193 (3%)

Query: 247 KIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCV 306
           K+G+G FG V+ G     T +A+K L   +      FL E  ++  L+H  LV+++    
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 307 EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVH 366
           E + + +V EYM   SL   L G     L L  P    +   IA G+A++    R   VH
Sbjct: 72  E-EPIYIVTEYMSKGSLLDFLKGEMGKYLRL--PQLVDMAAQIASGMAYVE---RMNYVH 125

Query: 367 RDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKAD 426
           RD++A N+L+  +L  K++DFGLA+L E ++          I + APE AL+G  T K+D
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 427 VYSFGIVALEIVS 439
           V+SFGI+  E+ +
Sbjct: 186 VWSFGILLTELTT 198

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  105 bits (264), Expect = 2e-25
 Identities = 65/203 (32%), Positives = 106/203 (52%), Gaps = 18/203 (8%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREF----LNEIAMISCLQHPNLVK 300
           +K+GEG +G VYK +    G I+A+K++  +            L EI+++  L+HPN+VK
Sbjct: 5   EKLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHPNIVK 62

Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
           +        +L LV+EY + + L   L   +     L     + I   + RGLA+ H  S
Sbjct: 63  LLDVIHTERKLYLVFEYCDMD-LKKYL---DKRPGPLSPNLIKSIMYQLLRGLAYCH--S 116

Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGY 420
             +I+HRD+K  N+L++RD   K++DFGLA+         +  +  T+ Y APE  L G 
Sbjct: 117 H-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPE-ILLGS 173

Query: 421 LTY--KADVYSFGIVALEIVSGK 441
             Y    D++S G +  E+++GK
Sbjct: 174 KHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  104 bits (262), Expect = 2e-25
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 17/203 (8%)

Query: 246 KKIGEGGFGPVYKGQL--ADGTII--AVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVK 300
           KK+G+G FG V +G+   + G +I  AVK L S        +FL E A++  L H NL++
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60

Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
           ++G  V    L++V E     SL   L  R++        T     + IA G+ +L E  
Sbjct: 61  LYGV-VLTHPLMMVTELAPLGSLLDRL--RKDALGHFLISTLCDYAVQIANGMRYL-ESK 116

Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHIST---RIAGTIGYMAPEYA 416
           RF  +HRD+ A N+LL  D   KI DFGL + L + +  ++     ++     + APE  
Sbjct: 117 RF--IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP--FAWCAPESL 172

Query: 417 LWGYLTYKADVYSFGIVALEIVS 439
                ++ +DV+ FG+   E+ +
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  104 bits (263), Expect = 3e-25
 Identities = 58/210 (27%), Positives = 106/210 (50%), Gaps = 19/210 (9%)

Query: 242 FDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKS-RQG-NREFLNEIAMISCLQHPNL 298
           ++   +IGEG +G VYK +    G ++A+K++  ++ ++G     + EI ++  L+HPN+
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60

Query: 299 VKIHGCCVEGDQ--LLLVYEYMEN--NSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           V++        +  + +V+EYM++    L       ++ E++      +     +  GL 
Sbjct: 61  VRLKEIVTSKGKGSIYMVFEYMDHDLTGLL------DSPEVKFTESQIKCYMKQLLEGLQ 114

Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPE 414
           +LH      I+HRDIK +N+L++ D   K++DFGLA+      +   T    T+ Y  PE
Sbjct: 115 YLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPE 171

Query: 415 YALWGYLTYKA--DVYSFGIVALEIVSGKN 442
             L G   Y    D++S G +  E+  GK 
Sbjct: 172 L-LLGATRYGPEVDMWSVGCILAELFLGKP 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score =  104 bits (261), Expect = 3e-25
 Identities = 65/210 (30%), Positives = 104/210 (49%), Gaps = 19/210 (9%)

Query: 246 KKIGEGGFGPVYKGQL------ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
           +++GEG FG V+  +        D  ++AVK L   S    ++F  E  +++ LQH ++V
Sbjct: 11  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 70

Query: 300 KIHGCCVEGDQLLLVYEYMENNSLA---------CALFGRENCELELDWPTRQKICLGIA 350
           K +G CVEGD L++V+EYM++  L            L    N   EL       I   IA
Sbjct: 71  KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130

Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIG 409
            G+ +L  +     VHRD+   N L+  +L  KI DFG+++ +   D   +       I 
Sbjct: 131 AGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187

Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVS 439
           +M PE  ++   T ++DV+S G+V  EI +
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  103 bits (259), Expect = 5e-25
 Identities = 68/194 (35%), Positives = 104/194 (53%), Gaps = 7/194 (3%)

Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           KK+G G FG V+ G     T +AVK L   +      FL E  ++  L+H  LV+++   
Sbjct: 12  KKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVV 70

Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
            E + + +V EYM   SL   L   E   L+L  P    +   +A G+A++    R   +
Sbjct: 71  SE-EPIYIVTEYMSKGSLLDFLKDGEGRALKL--PNLVDMAAQVAAGMAYIE---RMNYI 124

Query: 366 HRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKA 425
           HRD+++ N+L+   L  KI+DFGLA+L E ++          I + APE AL+G  T K+
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 426 DVYSFGIVALEIVS 439
           DV+SFGI+  E+V+
Sbjct: 185 DVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  103 bits (258), Expect = 5e-25
 Identities = 58/198 (29%), Positives = 104/198 (52%), Gaps = 13/198 (6%)

Query: 245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQG---NREFLNEIAMISCLQHPNLVKI 301
            ++IG G FG V+ G   +   +A+K +    R+G     +F+ E  ++  L HP LV++
Sbjct: 9   VQEIGSGQFGLVWLGYWLEKRKVAIKTI----REGAMSEEDFIEEAQVMMKLSHPKLVQL 64

Query: 302 HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESR 361
           +G C E   + LV+E+ME+  L+  L  +     +    T   +CL +  G+A+L   + 
Sbjct: 65  YGVCTERSPICLVFEFMEHGCLSDYLRAQRG---KFSQETLLGMCLDVCEGMAYLESSN- 120

Query: 362 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYL 421
             ++HRD+ A N L+  +   K+SDFG+ +    D+   ST     + + +PE   +   
Sbjct: 121 --VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKY 178

Query: 422 TYKADVYSFGIVALEIVS 439
           + K+DV+SFG++  E+ S
Sbjct: 179 SSKSDVWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  103 bits (259), Expect = 7e-25
 Identities = 67/204 (32%), Positives = 114/204 (55%), Gaps = 21/204 (10%)

Query: 248 IGEGGFGPVYKGQLA----DGTIIAVKQLSSK-SRQGNREFLNEIAMISCLQHPNLVKIH 302
           IG G FG V +G+L         +A+K L S  + +  R+FL+E +++    HPN++ + 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL--GIARGLAFLHEES 360
           G   +   ++++ E+MEN +L    F R+N   +  +   Q + +  GIA G+ +L E +
Sbjct: 72  GVVTKSRPVMIITEFMENGALDS--FLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEMN 126

Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKL---DEGDKTHISTRIAGTIG--YMAPEY 415
               VHRD+ A N+L++ +L  K+SDFGL++    D  D T+ S+ + G I   + APE 
Sbjct: 127 ---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS-LGGKIPIRWTAPEA 182

Query: 416 ALWGYLTYKADVYSFGIVALEIVS 439
             +   T  +DV+S+GIV  E++S
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  103 bits (258), Expect = 7e-25
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 13/198 (6%)

Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           K++G G FG V+ G+      +A+K +   +     +F+ E  ++  L HPNLV+++G C
Sbjct: 10  KELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVC 68

Query: 306 VEGDQLLLVYEYMENNSLACALF---GRENCELELDWPTRQKICLGIARGLAFLHEESRF 362
            +   + +V EYM N  L   L    G+   E  LD      +C  +   + +L E + F
Sbjct: 69  TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLD------MCSDVCEAMEYL-ESNGF 121

Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLT 422
             +HRD+ A N L+  D   K+SDFGLA+    D+   S      + +  PE   +   +
Sbjct: 122 --IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179

Query: 423 YKADVYSFGIVALEIVSG 440
            K+DV+SFG++  E+ S 
Sbjct: 180 SKSDVWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  101 bits (255), Expect = 2e-24
 Identities = 62/199 (31%), Positives = 96/199 (48%), Gaps = 14/199 (7%)

Query: 248 IGEGGFGPVYKGQ-LADGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHG 303
           +G+G FG V   +    G + A+K L  K    R+     L E  ++S + HP +VK+H 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLG-IARGLAFLHEESRF 362
                ++L LV EY     L  +   +E    E     R +     I   L +LH     
Sbjct: 61  AFQTEEKLYLVLEYAPGGELF-SHLSKEGRFSE----ERARFYAAEIVLALEYLHSL--- 112

Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLT 422
            I++RD+K  N+LLD D + K++DFGLAK    + +  +T   GT  Y+APE  L     
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGKGYG 171

Query: 423 YKADVYSFGIVALEIVSGK 441
              D +S G++  E+++GK
Sbjct: 172 KAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  101 bits (254), Expect = 2e-24
 Identities = 78/273 (28%), Positives = 129/273 (47%), Gaps = 38/273 (13%)

Query: 247 KIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           K+G G +G VY+G        +AVK L   + +   EFL E A++  ++HPNLV++ G C
Sbjct: 13  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 71

Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
                  ++ E+M   +L   L  RE    E++      +   I+  + +L  E +   +
Sbjct: 72  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYL--EKK-NFI 126

Query: 366 HRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT---IGYMAPEYALWGYLT 422
           HRD+ A N L+  +   K++DFGL++L  GD     T  AG    I + APE   +   +
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAYNKFS 183

Query: 423 YKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKY 482
            K+DV++FG++  EI +    MS  P ++            L Q       V E L   Y
Sbjct: 184 IKSDVWAFGVLLWEIAT--YGMSPYPGID------------LSQ-------VYELLEKGY 222

Query: 483 KKEEAE----RMIKVSLLCTNASPSLRPTMSEV 511
           + E  E    ++ ++   C   +PS RP+ +E+
Sbjct: 223 RMERPEGCPPKVYELMRACWQWNPSDRPSFAEI 255

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  102 bits (256), Expect = 3e-24
 Identities = 59/230 (25%), Positives = 101/230 (43%), Gaps = 39/230 (16%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNRE-----FLNEIAMISCL 293
           ++F   K IGEG F  V   +        A+K L    RQ  +E        E  +++ L
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDK--RQLIKEKKVKYVKIEKEVLTRL 58

Query: 294 -QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICLGIA 350
             HP ++K++    + + L  V EY  N  L   +  +G       LD    +     I 
Sbjct: 59  NGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS------LDEKCTRFYAAEIL 112

Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIA----- 405
             L +LH +    I+HRD+K  N+LLD+D++ KI+DFG AK+ + + +  S +       
Sbjct: 113 LALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169

Query: 406 --------------GTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
                         GT  Y++PE          +D+++ G +  ++++GK
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  101 bits (253), Expect = 5e-24
 Identities = 69/222 (31%), Positives = 102/222 (45%), Gaps = 28/222 (12%)

Query: 238 ATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCL-QH 295
            T  F+  + IGEG +G VYK +    G ++A+K +     +   E   E  ++     H
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNH 62

Query: 296 PNLVKIHGC------CVEGDQLLLVYEYMENNS---LACALFGRENCELELDWPTRQKIC 346
           PN+   +G           DQL LV E     S   L   L  +    L+ +W     I 
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK-RLKEEWIAY--IL 119

Query: 347 LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL-AKLD-EGDKTHISTRI 404
               RGLA+LHE    K++HRDIK  N+LL ++   K+ DFG+ A+LD    + +     
Sbjct: 120 RETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-- 174

Query: 405 AGTIGYMAPE-----YALWGYLTYKADVYSFGIVALEIVSGK 441
            GT  +MAPE              ++DV+S GI A+E+  GK
Sbjct: 175 -GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  100 bits (252), Expect = 6e-24
 Identities = 66/213 (30%), Positives = 106/213 (49%), Gaps = 23/213 (10%)

Query: 248 IGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCLQH---PNLVKIH 302
           IG G +G VY+G  +  G ++A+K ++  +   +  +   E+A++S L+    PN+ K +
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIAR----GLAFLHE 358
           G  ++G +L ++ EY E  S+           L    P  +K    I R     L ++H+
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSVR---------TLMKAGPIAEKYISVIIREVLVALKYIHK 119

Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALW 418
                ++HRDIKA N+L+    N K+ DFG+A L   + +  ST   GT  +MAPE    
Sbjct: 120 VG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPEVITE 175

Query: 419 G-YLTYKADVYSFGIVALEIVSGKNNMSYAPAL 450
           G Y   KAD++S GI   E+ +G    S   A 
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPPYSDVDAF 208

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  100 bits (250), Expect = 6e-24
 Identities = 66/193 (34%), Positives = 103/193 (53%), Gaps = 7/193 (3%)

Query: 247 KIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCV 306
           K+G+G FG V+ G     T +A+K L   +      FL E  ++  L+H  LV ++    
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-PEAFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 307 EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVH 366
           E + + +V E+M   SL    F +E     L  P    +   IA G+A++    R   +H
Sbjct: 72  E-EPIYIVTEFMGKGSLLD--FLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIH 125

Query: 367 RDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKAD 426
           RD++A N+L+  +L  KI+DFGLA+L E ++          I + APE AL+G  T K+D
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 427 VYSFGIVALEIVS 439
           V+SFGI+  E+V+
Sbjct: 186 VWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  100 bits (250), Expect = 1e-23
 Identities = 72/210 (34%), Positives = 103/210 (49%), Gaps = 22/210 (10%)

Query: 248 IGEGGFGPVYKGQLAD------GTI-IAVKQLSSKSR-QGNREFLNEIAMISCLQHPNLV 299
           +G G FG VY+G   D      G I +AVK L   +  Q  +EFL E  ++S   HPN+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELE---LDWPTRQKICLGIARGLAFL 356
           K+ G C+  +   ++ E ME   L   L            L       ICL +A+G  +L
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 357 HEESRFKIVHRDIKATNVLL-----DRDLNPKISDFGLAKLDEGDKTHISTRIAGTIG-- 409
            E+  F  +HRD+ A N L+     D D   KI DFGLA+ D     +      G +   
Sbjct: 123 -EQMHF--IHRDLAARNCLVSEKGYDADRVVKIGDFGLAR-DIYKSDYYRKEGEGLLPVR 178

Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVS 439
           +MAPE  L G  T ++DV+SFG++  EI++
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 99.7 bits (248), Expect = 1e-23
 Identities = 67/194 (34%), Positives = 101/194 (52%), Gaps = 7/194 (3%)

Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           KK+G G FG V+       T +AVK +   S      FL E  ++  LQH  LVK+H   
Sbjct: 12  KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV- 69

Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
           V  + + ++ E+M   SL   L   E  +  L  P        IA G+AF+ + +    +
Sbjct: 70  VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YI 124

Query: 366 HRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKA 425
           HRD++A N+L+   L  KI+DFGLA++ E ++          I + APE   +G  T K+
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 184

Query: 426 DVYSFGIVALEIVS 439
           DV+SFGI+ +EIV+
Sbjct: 185 DVWSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 99.7 bits (248), Expect = 1e-23
 Identities = 65/203 (32%), Positives = 110/203 (54%), Gaps = 17/203 (8%)

Query: 246 KKIGEGGFGPVYKGQLA----DGTIIAVKQLSSKSRQGNR-EFLNEIAMISCLQHPNLVK 300
           K IG G FG V++G L         +A+K L     +  R +FL+E +++    H N+++
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70

Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL--GIARGLAFLHE 358
           + G   +    +++ EYMEN +L    + R++   + ++ + Q + +  GIA G+ +L  
Sbjct: 71  LEGVVTKFKPAMIITEYMENGALD--KYLRDH---DGEFSSYQLVGMLRGIAAGMKYL-- 123

Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIG--YMAPEYA 416
            S    VHRD+ A N+L++ +L  K+SDFGL+++ E D     T   G I   + APE  
Sbjct: 124 -SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAI 182

Query: 417 LWGYLTYKADVYSFGIVALEIVS 439
            +   T  +DV+SFGIV  E++S
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  100 bits (250), Expect = 2e-23
 Identities = 65/218 (29%), Positives = 106/218 (48%), Gaps = 30/218 (13%)

Query: 246 KKIGEGGFGPVYKGQLAD------GTIIAVKQL-SSKSRQGNREFLNEIAMISCL-QHPN 297
           K +GEG FG V K +          + +AVK L    + +   + ++E+ M+  + +H N
Sbjct: 18  KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACALFGR----ENCELELDWPTRQKI-------- 345
           ++ + G C +   L +V EY  + +L   L  R    E    +   P  + +        
Sbjct: 78  IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137

Query: 346 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK----LDEGDKTHIS 401
              +ARG+ FL   S+ K +HRD+ A NVL+  D   KI+DFGLA+    +D   KT   
Sbjct: 138 AYQVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT--- 191

Query: 402 TRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
           T     + +MAPE       T+++DV+SFG++  EI +
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 99.5 bits (248), Expect = 2e-23
 Identities = 66/202 (32%), Positives = 102/202 (50%), Gaps = 17/202 (8%)

Query: 248 IGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCV 306
           +G+G +G VY  + L+    IA+K++  +  +  +    EIA+ S L+H N+V+  G   
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 307 EGDQLLLVYEYMENNSLACALFGR----ENCELELDWPTRQKICLGIARGLAFLHEESRF 362
           E     +  E +   SL+  L  +    ++ E  + + T+Q     I  GL +LH+    
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ-----ILEGLKYLHDN--- 127

Query: 363 KIVHRDIKATNVLLDRDLNP-KISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYL 421
           +IVHRDIK  NVL++      KISDFG +K   G      T   GT+ YMAPE    G  
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-FTGTLQYMAPEVIDKGPR 186

Query: 422 TY--KADVYSFGIVALEIVSGK 441
            Y   AD++S G   +E+ +GK
Sbjct: 187 GYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 99.4 bits (248), Expect = 2e-23
 Identities = 82/287 (28%), Positives = 120/287 (41%), Gaps = 48/287 (16%)

Query: 246 KKIGEGGFGPVYKGQLA--DGTI----IAVKQL-SSKSRQGNREFLNEIAMISCLQHPNL 298
           + +G G FG VY+G     DG      +AVK L  S S Q   +FL E  ++S   H N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQ------KICLGIARG 352
           V++ G   E     ++ E M    L    F RE      + P+             +A+G
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKS--FLRE-NRPRPERPSSLTMKDLLFCARDVAKG 128

Query: 353 LAFLHEESRFKIVHRDIKATNVLL-----DRDLNPKISDFGLAK-LDEGDKTHISTRIAG 406
             +L EE+ F  +HRDI A N LL      R    KI+DFG+A+ +          R   
Sbjct: 129 CKYL-EENHF--IHRDIAARNCLLTCKGPGRVA--KIADFGMARDIYRASYYRKGGRAML 183

Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQ 466
            I +M PE  L G  T K DV+SFG++  EI S    + Y P           +     Q
Sbjct: 184 PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS----LGYMP-----------YPGRTNQ 228

Query: 467 DGKLVELVDE--RLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           +  ++E V    RL     K     + ++   C   +P  RP  + +
Sbjct: 229 E--VMEFVTGGGRLD--PPKGCPGPVYRIMTDCWQHTPEDRPNFATI 271

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 99.7 bits (248), Expect = 3e-23
 Identities = 69/222 (31%), Positives = 109/222 (49%), Gaps = 31/222 (13%)

Query: 246 KKIGEGGFGPVYKGQ------LADGTIIAVKQLSSKSRQGN-REFLNEIAMISCLQHPNL 298
           K +GEG FG V K         A  T +AVK L   +     R+ L+E  ++  + HP++
Sbjct: 6   KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65

Query: 299 VKIHGCCVEGDQLLLVYEYMENNSL----------ACALFGRENCELE--LDWPTRQKIC 346
           +K++G C +   LLL+ EY +  SL            +  G +       LD P  + + 
Sbjct: 66  IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125

Query: 347 LG--------IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDK 397
           +G        I+RG+ +L E    K+VHRD+ A NVL+      KISDFGL++ + E D 
Sbjct: 126 MGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182

Query: 398 THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
               ++    + +MA E       T ++DV+SFG++  EIV+
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 99.4 bits (247), Expect = 3e-23
 Identities = 67/212 (31%), Positives = 111/212 (52%), Gaps = 10/212 (4%)

Query: 231 TLKQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNREFLNEIAM 289
           T+  I      +   +KIG+G  G V+    +A G  +A+KQ++ + +      +NEI +
Sbjct: 10  TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILV 69

Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGI 349
           +  L++PN+V      + GD+L +V EY+   SL   +   E C   +D      +C   
Sbjct: 70  MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV--TETC---MDEAQIAAVCREC 124

Query: 350 ARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIG 409
            + L FLH     +++HRDIK+ NVLL  D + K++DFG       +++  ST + GT  
Sbjct: 125 LQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPY 180

Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           +MAPE         K D++S GI+A+E+V G+
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 99.2 bits (247), Expect = 3e-23
 Identities = 83/272 (30%), Positives = 129/272 (47%), Gaps = 21/272 (7%)

Query: 246 KKIGEGGFGPV--YKGQLA-DGT--IIAVKQLSSKSRQGNRE-FLNEIAMISCLQHPNLV 299
           + +GEG FG V  Y    A DGT  ++AVK L  +  Q N   +  EI ++  L H N+V
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 300 KIHGCCVE-GDQ-LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH 357
           K  GCC E G + L L+ EY+   SL   L  +    L       Q+IC     G+A+LH
Sbjct: 70  KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQIC----EGMAYLH 124

Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTH-ISTRIAGTIGYMAPEY 415
            +     +HRD+ A NVLLD D   KI DFGLAK + EG + + +       + + A E 
Sbjct: 125 SQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVEC 181

Query: 416 ALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD 475
                 +Y +DV+SFG+   E+++   +   +P  +F+   ++          +L+EL++
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLT-HCDSKQSPPKKFE--EMIGPKQGQMTVVRLIELLE 238

Query: 476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPT 507
             +     K   + +  +   C       RPT
Sbjct: 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPT 270

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 99.2 bits (247), Expect = 4e-23
 Identities = 65/197 (32%), Positives = 106/197 (53%), Gaps = 10/197 (5%)

Query: 246 KKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
           +KIG+G  G VY    +A G  +A+KQ++ + +      +NEI ++   +HPN+V     
Sbjct: 25  EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84

Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
            + GD+L +V EY+   SL   +   E C   +D      +C    + L FLH     ++
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVV--TETC---MDEGQIAAVCRECLQALEFLHSN---QV 136

Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYK 424
           +HRDIK+ N+LL  D + K++DFG       +++  ST + GT  +MAPE         K
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 195

Query: 425 ADVYSFGIVALEIVSGK 441
            D++S GI+A+E+V G+
Sbjct: 196 VDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 98.9 bits (246), Expect = 6e-23
 Identities = 68/228 (29%), Positives = 110/228 (48%), Gaps = 37/228 (16%)

Query: 246 KKIGEGGFGPVYKGQLAD-----------------GTIIAVKQLSSKSRQGNR-EFLNEI 287
           +K+GEG FG V+  ++ +                   ++AVK L   + +  R +FL E+
Sbjct: 11  EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEV 70

Query: 288 AMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL---------------FGREN 332
            ++S L+ PN++++ G CV+ D L ++ EYMEN  L   L                   +
Sbjct: 71  KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAH 130

Query: 333 CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK- 391
           C   + + +   + L IA G+ +L   S    VHRD+   N L+  +L  KI+DFG+++ 
Sbjct: 131 CLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRN 187

Query: 392 LDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
           L  GD   I  R    I +MA E  L G  T  +DV++FG+   EI+ 
Sbjct: 188 LYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 98.0 bits (244), Expect = 6e-23
 Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 30/218 (13%)

Query: 241 NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLS----SKSRQGN--REFLNEIAMISCL 293
            +   +++G G F   Y+ + +  GT++AVKQ++    + S Q         EI +++ L
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FG--RENCELELDWPTRQKICLGI 349
            HP+++++ G   E     L  E+M   S++  L  +G  +E   +             +
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVII--------NYTEQL 112

Query: 350 ARGLAFLHEESRFKIVHRDIKATNVLLD---RDLNPKISDFGLAKLDEGDKT---HISTR 403
            RGL++LHE    +I+HRD+K  N+L+D   + L  +I+DFG A       T       +
Sbjct: 113 LRGLSYLHEN---QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQGQ 167

Query: 404 IAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           + GTI +MAPE           DV+S G V +E+ + K
Sbjct: 168 LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 98.0 bits (244), Expect = 6e-23
 Identities = 68/203 (33%), Positives = 110/203 (54%), Gaps = 17/203 (8%)

Query: 246 KKIGEGGFGPVYKGQLA----DGTIIAVKQLSSK-SRQGNREFLNEIAMISCLQHPNLVK 300
           K IG G FG V  G+L         +A+K L +  + +  R+FL+E +++    HPN++ 
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL--GIARGLAFLHE 358
           + G   +   +++V EYMEN SL    F R++   +  +   Q + +  GIA G+ +L  
Sbjct: 70  LEGVVTKSKPVMIVTEYMENGSLDA--FLRKH---DGQFTVIQLVGMLRGIASGMKYL-- 122

Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIG--YMAPEYA 416
            S    VHRD+ A N+L++ +L  K+SDFGL+++ E D     T   G I   + APE  
Sbjct: 123 -SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 181

Query: 417 LWGYLTYKADVYSFGIVALEIVS 439
            +   T  +DV+S+GIV  E++S
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 97.9 bits (244), Expect = 6e-23
 Identities = 66/211 (31%), Positives = 106/211 (50%), Gaps = 27/211 (12%)

Query: 248 IGEGGFGPVYKGQLAD-GTIIAVKQLS---------SKSRQGNREFLN-EIAMISCLQHP 296
           IG+G +G VY       G ++AVKQ+             ++   + L  EI  +  L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICLGIARGLA 354
           N+V+  G     + L +  EY+   S+   L  +GR   +L + + T Q     +  GLA
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL-VRFFTEQ-----VLEGLA 122

Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS-TRIAGTIGYMAP 413
           +LH +    I+HRD+KA N+L+D D   KISDFG++K  +    +     + G++ +MAP
Sbjct: 123 YLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179

Query: 414 EY---ALWGYLTYKADVYSFGIVALEIVSGK 441
           E       GY + K D++S G V LE+ +G+
Sbjct: 180 EVIHSYSQGY-SAKVDIWSLGCVVLEMFAGR 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 98.2 bits (244), Expect = 9e-23
 Identities = 67/230 (29%), Positives = 113/230 (49%), Gaps = 24/230 (10%)

Query: 246 KKIGEGGFGPVYKGQ------LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
           +++GEG FG V+  +        D  ++AVK L   +    ++F  E  +++ LQH ++V
Sbjct: 11  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70

Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICLG--------- 348
           K +G C +GD L++V+EYM++  L   L   G +   L    P + K  LG         
Sbjct: 71  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130

Query: 349 -IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAG 406
            IA G+ +L  +     VHRD+   N L+  +L  KI DFG+++ +   D   +      
Sbjct: 131 QIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187

Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNN-MSYAPALEFDC 454
            I +M PE  ++   T ++DV+SFG++  EI + GK      +     +C
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 97.5 bits (242), Expect = 1e-22
 Identities = 64/197 (32%), Positives = 106/197 (53%), Gaps = 10/197 (5%)

Query: 246 KKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
           +KIG+G  G VY    +A G  +A+KQ++ + +      +NEI ++   ++PN+V     
Sbjct: 25  EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84

Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
            + GD+L +V EY+   SL   +   E C   +D      +C    + L FLH     ++
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVV--TETC---MDEGQIAAVCRECLQALDFLHSN---QV 136

Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYK 424
           +HRDIK+ N+LL  D + K++DFG       +++  ST + GT  +MAPE         K
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 195

Query: 425 ADVYSFGIVALEIVSGK 441
            D++S GI+A+E+V G+
Sbjct: 196 VDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 96.7 bits (241), Expect = 2e-22
 Identities = 63/198 (31%), Positives = 104/198 (52%), Gaps = 17/198 (8%)

Query: 248 IGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCV 306
           +G+G FG VYK Q  + G   A K +  +S +   +F+ EI ++S  +HPN+V ++    
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 307 EGDQLLLVYEYMENNSLACALFGRENCELE--LDWPTRQKICLGIARGLAFLHEESRFKI 364
             ++L ++ E+ +  +L   +      ELE  L  P  + +C  +   L FLH     K+
Sbjct: 73  YENKLWILIEFCDGGALDSIML-----ELERGLTEPQIRYVCRQMLEALNFLHSH---KV 124

Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLT-- 422
           +HRD+KA N+LL  D + K++DFG++  ++       T I GT  +MAPE          
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDN 183

Query: 423 ---YKADVYSFGIVALEI 437
              YKAD++S GI  +E+
Sbjct: 184 PYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 96.9 bits (241), Expect = 2e-22
 Identities = 66/220 (30%), Positives = 107/220 (48%), Gaps = 29/220 (13%)

Query: 246 KKIGEGGFGPVY----KGQLA-------------DGTIIAVKQLSSKSRQGNR-EFLNEI 287
           +K+GEG FG V+    +G                   ++AVK L   + +  R +FL EI
Sbjct: 11  EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEI 70

Query: 288 AMISCLQHPNLVKIHGCCVEGDQLLLVYEYMEN---NSLACALFGRENCELE----LDWP 340
            ++S L+ PN++++   C+  D L ++ EYMEN   N        +E  E      + + 
Sbjct: 71  KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130

Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTH 399
           T   +   IA G+ +L   S    VHRD+   N L+ ++   KI+DFG+++ L  GD   
Sbjct: 131 TLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYR 187

Query: 400 ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
           I  R    I +M+ E  L G  T  +DV++FG+   EI++
Sbjct: 188 IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 95.8 bits (239), Expect = 3e-22
 Identities = 56/207 (27%), Positives = 101/207 (48%), Gaps = 16/207 (7%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVK--QLSSKSRQGNREFLNEIAMISCLQHP 296
           ++ +   ++G G  G V K      G I+AVK  +L        ++ L E+ ++     P
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-AIQKQILRELDILHKCNSP 59

Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFL 356
            +V  +G       + +  EYM+  SL   L   +  +  +      KI + + +GL +L
Sbjct: 60  YIVGFYGAFYNNGDISICMEYMDGGSLDKIL---KEVQGRIPERILGKIAVAVLKGLTYL 116

Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEGDKTHISTRIAGTIGYMAPE 414
           HE  + KI+HRD+K +N+L++     K+ DFG++   ++   KT       GT  YMAPE
Sbjct: 117 HE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF-----VGTSSYMAPE 169

Query: 415 YALWGYLTYKADVYSFGIVALEIVSGK 441
                  + K+D++S G+  +E+ +G+
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 97.6 bits (243), Expect = 3e-22
 Identities = 67/213 (31%), Positives = 100/213 (46%), Gaps = 33/213 (15%)

Query: 243 DSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGN------REFLNEIAMISCLQH 295
           +   +IG G  G VYK      G + A+K +      GN      R+   EI ++  + H
Sbjct: 77  ERVNRIGSGAGGTVYKVIHRPTGRLYALKVI-----YGNHEDTVRRQICREIEILRDVNH 131

Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           PN+VK H       ++ ++ E+M+  SL          E  L    RQ     I  G+A+
Sbjct: 132 PNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT---HIADEQFLADVARQ-----ILSGIAY 183

Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL--DEGDKTHISTRIAGTIGYMAP 413
           LH   R  IVHRDIK +N+L++   N KI+DFG++++     D  + S    GTI YM+P
Sbjct: 184 LH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV---GTIAYMSP 237

Query: 414 E-----YALWGYLTYKADVYSFGIVALEIVSGK 441
           E          Y  Y  D++S G+  LE   G+
Sbjct: 238 ERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 96.2 bits (239), Expect = 3e-22
 Identities = 64/204 (31%), Positives = 107/204 (52%), Gaps = 20/204 (9%)

Query: 246 KKIGEGGFGPVYKG-QLADGTII----AVKQLSSKS-RQGNREFLNEIAMISCLQHPNLV 299
           K +G G FG V+KG  + +G  I    A+K +  +S RQ  +E  + +  +  L H  +V
Sbjct: 13  KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72

Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACALFGRE---NCELELDWPTRQKICLGIARGLAFL 356
           ++ G C  G  L LV +     SL   +       + +  L+W      C+ IA+G+ +L
Sbjct: 73  RLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYYL 125

Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPEY 415
            E    ++VHR++ A N+LL  D   +I+DFG+A  L   DK +  +     I +MA E 
Sbjct: 126 EEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182

Query: 416 ALWGYLTYKADVYSFGIVALEIVS 439
            L+G  T+++DV+S+G+   E++S
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 94.9 bits (236), Expect = 7e-22
 Identities = 76/287 (26%), Positives = 125/287 (43%), Gaps = 54/287 (18%)

Query: 248 IGEGGFGPVYKGQLADG--TIIAVKQLS---------SKSRQGN-REFLNEIAMI-SCLQ 294
           +G G FG VYK +  +    ++A+K+++          + R  +  + ++E+ +I   L+
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFG-----RENCELELDWPTRQKICLGI 349
           HPN+V+ +   +E D+L +V + +E   L    F      ++    E  W    ++ L  
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLG-EHFNSLKEKKQRFTEERIWNIFVQMVLA- 125

Query: 350 ARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIG 409
              L +LH+E R  IVHRD+   N++L  D    I+DFGLAK  +  ++ + T + GTI 
Sbjct: 126 ---LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKL-TSVVGTIL 178

Query: 410 YMAPEYALWGYLTYKADVYSFG-----IVALEIVSGKNNMSYAPALEFDCTCLLDWACHL 464
           Y  PE         KADV++FG     +  L+      NM                   L
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-------------------L 219

Query: 465 QQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
               K+VE V E L      E+   +I     C       RP + +V
Sbjct: 220 SLATKIVEAVYEPLPEGMYSEDVTDVITS---CLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 95.5 bits (237), Expect = 9e-22
 Identities = 65/204 (31%), Positives = 115/204 (56%), Gaps = 20/204 (9%)

Query: 246 KKIGEGGFGPVYKG-QLADGTII----AVKQLSSKS-RQGNREFLNEIAMISCLQHPNLV 299
           K +G G FG VYKG  + +G  +    A+K L+  +  + N EF++E  +++ + HP+LV
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACALFGREN---CELELDWPTRQKICLGIARGLAFL 356
           ++ G C+    + LV + M +  L   +   ++    +L L+W      C+ IA+G+ +L
Sbjct: 73  RLLGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYL 125

Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT-IGYMAPEY 415
            E    ++VHRD+ A NVL+    + KI+DFGLA+L EGD+   +       I +MA E 
Sbjct: 126 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182

Query: 416 ALWGYLTYKADVYSFGIVALEIVS 439
             +   T+++DV+S+G+   E+++
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 94.5 bits (235), Expect = 9e-22
 Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 19/212 (8%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQ-----LSSKSRQGNREFLNEIAMISCL 293
            N+   K +G+G FG VY     D G  +AVKQ      S ++++       EI ++  L
Sbjct: 2   TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61

Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLA--CALFGRENCELELDWPTRQKICLGIAR 351
           QH  +V+ +GC  + + L +  EYM   S+      +G     +   + TRQ     I  
Sbjct: 62  QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKY-TRQ-----ILE 115

Query: 352 GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS--TRIAGTIG 409
           G+ +LH      IVHRDIK  N+L D   N K+ DFG +K  +   +  +    + GT  
Sbjct: 116 GVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPY 172

Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           +M+PE         KADV+S G   +E+++ K
Sbjct: 173 WMSPEVISGEGYGRKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 95.1 bits (236), Expect = 1e-21
 Identities = 64/214 (29%), Positives = 114/214 (53%), Gaps = 16/214 (7%)

Query: 242 FDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
            D+  KIGEG  G V    + + G ++AVK++  + +Q      NE+ ++   QH N+V+
Sbjct: 22  LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81

Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
           ++   + GD+L +V E++E  +L   +      E ++       +CL + + L+ LH + 
Sbjct: 82  MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLKALSVLHAQG 136

Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGL-AKLDEGDKTHISTRIAGTIGYMAPEYALWG 419
              ++HRDIK+ ++LL  D   K+SDFG  A++ +  +      + GT  +MAPE  L  
Sbjct: 137 ---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKSLVGTPYWMAPE--LIS 189

Query: 420 YLTY--KADVYSFGIVALEIVSGKNNMSYAPALE 451
            L Y  + D++S GI+ +E+V G+      P L+
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK 223

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 94.5 bits (236), Expect = 1e-21
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 36/212 (16%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREF--------LNEIAMISCLQ-H 295
           K++G+G FG VY  +    G ++A+K++        ++F        L E+  +  L  H
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEH 57

Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFG--RENCELELDWPTRQKICLGIARGL 353
           PN+VK+     E D+L  V+EYME N     L+   ++           + I   I +GL
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYMEGN-----LYQLMKDRKGKPFSESVIRSIIYQILQGL 112

Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH---ISTRIAGTIGY 410
           A +H+   F   HRD+K  N+L+      KI+DFGLA+       +   +STR      Y
Sbjct: 113 AHIHKHGFF---HRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-----WY 164

Query: 411 MAPEYALW-GYLTYKADVYSFGIVALEIVSGK 441
            APE  L     +   D+++ G +  E+ + +
Sbjct: 165 RAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 94.4 bits (235), Expect = 1e-21
 Identities = 84/282 (29%), Positives = 134/282 (47%), Gaps = 31/282 (10%)

Query: 246 KKIGEGGFGPVYKGQ---LADGT--IIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
           +++G+G FG V   +   L D T  ++AVK+L   + +  R+F  EI ++  LQH N+VK
Sbjct: 10  QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 301 IHGCCVEGDQ--LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
             G C    +  L LV EY+   SL   L   +     LD          I +G+ +L  
Sbjct: 70  YKGVCYSAGRRNLRLVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICKGMEYLGS 126

Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT--IGYMAPEYA 416
           + R+  VHRD+   N+L++ +   KI DFGL K+   DK +   R  G   I + APE  
Sbjct: 127 K-RY--VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183

Query: 417 LWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDE 476
                +  +DV+SFG+V  E+ +  ++ S +P  EF     +    + +Q   +V  + E
Sbjct: 184 TESKFSVASDVWSFGVVLYELFT-YSDKSCSPPAEF-----MRMMGNDKQGQMIVYHLIE 237

Query: 477 RLGSKYK-------KEEAERMIKVSLLCTNASPSLRPTMSEV 511
            L +  +         E   ++K    C N  PS RP+ SE+
Sbjct: 238 LLKNNGRLPAPPGCPAEIYAIMK---ECWNNDPSQRPSFSEL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 94.9 bits (236), Expect = 1e-21
 Identities = 69/212 (32%), Positives = 102/212 (48%), Gaps = 20/212 (9%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQLADGTI-------IAVKQLSSKSRQGNREFL-NEIAMIS 291
           NN    K +G G FG V +   A G         +AVK L   +    RE L +E+ ++S
Sbjct: 35  NNLSFGKTLGAGAFGKVVEAT-AYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMS 93

Query: 292 CL-QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
            L  H N+V + G C  G  +L++ EY     L   L  R   E  L           +A
Sbjct: 94  HLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL--RRKRESFLTLEDLLSFSYQVA 151

Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI---STRIAGT 407
           +G+AFL  ++    +HRD+ A NVLL      KI DFGLA+    D  ++   + R+   
Sbjct: 152 KGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLP-- 206

Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
           + +MAPE       T+++DV+S+GI+  EI S
Sbjct: 207 VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 93.5 bits (232), Expect = 2e-21
 Identities = 63/194 (32%), Positives = 105/194 (54%), Gaps = 13/194 (6%)

Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           + IGEG FG V +G+   G  +AVK +  K     + FL E A+++ L H NLV++ G  
Sbjct: 12  EIIGEGEFGAVLQGEYT-GQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGVI 68

Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
           +  + L +V E M   +L   L  R    + +      +  L +A G+ +L  ES+ K+V
Sbjct: 69  LH-NGLYIVMELMSKGNLVNFLRTRGRALVSV--IQLLQFSLDVAEGMEYL--ESK-KLV 122

Query: 366 HRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKA 425
           HRD+ A N+L+  D   K+SDFGLA++  G     ++++   + + APE       + K+
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLP--VKWTAPEALKHKKFSSKS 178

Query: 426 DVYSFGIVALEIVS 439
           DV+S+G++  E+ S
Sbjct: 179 DVWSYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 61/198 (30%), Positives = 92/198 (46%), Gaps = 13/198 (6%)

Query: 248 IGEGGFGPVYKGQLAD-GTIIAVKQLSSK---SRQGNREFLNEIAMISCLQHPNLVKIHG 303
           IG+G FG V   Q  D   + A+K ++ +    +   R  LNE  ++  L HP LV +  
Sbjct: 8   IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67

Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFK 363
              + + + LV + +    L   L  +     E     +  IC  I   L +LH +    
Sbjct: 68  SFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQ---VKFWIC-EIVLALEYLHSK---G 120

Query: 364 IVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTY 423
           I+HRDIK  N+LLD   +  I+DF +A     D   ++T  +GT GYMAPE       + 
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCRQGYSV 178

Query: 424 KADVYSFGIVALEIVSGK 441
             D +S G+ A E + GK
Sbjct: 179 AVDWWSLGVTAYECLRGK 196

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 94.0 bits (233), Expect = 2e-21
 Identities = 61/197 (30%), Positives = 105/197 (53%), Gaps = 10/197 (5%)

Query: 246 KKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
           +KIG+G  G VY    +A G  +A++Q++ + +      +NEI ++   ++PN+V     
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
            + GD+L +V EY+   SL   +   E C   +D      +C    + L FLH     ++
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV--TETC---MDEGQIAAVCRECLQALEFLHSN---QV 137

Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYK 424
           +HRDIK+ N+LL  D + K++DFG       +++  S  + GT  +MAPE         K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS-TMVGTPYWMAPEVVTRKAYGPK 196

Query: 425 ADVYSFGIVALEIVSGK 441
            D++S GI+A+E++ G+
Sbjct: 197 VDIWSLGIMAIEMIEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 93.3 bits (232), Expect = 3e-21
 Identities = 65/202 (32%), Positives = 93/202 (46%), Gaps = 19/202 (9%)

Query: 248 IGEGGFGPVYKGQLAD-GTIIAVKQLSSK---SRQGNREFLNEIAMISCLQHPNLVKIHG 303
           +G+GGFG V   Q+   G + A K+L  K    R+G +  LNE  ++  +    +V +  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENC---ELELDWPTRQKICLGIARGLAFLHEES 360
                D L LV   M    L   ++        E    +   Q IC     GL  LH+  
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIIC-----GLEHLHQR- 114

Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHISTRIAGTIGYMAPEYALWG 419
             +IV+RD+K  NVLLD   N +ISD GLA +L  G K       AGT GYMAPE     
Sbjct: 115 --RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR---AGTPGYMAPEVLQGE 169

Query: 420 YLTYKADVYSFGIVALEIVSGK 441
              +  D ++ G    E+++G+
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 93.5 bits (233), Expect = 3e-21
 Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 27/213 (12%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREF----LNEIAMISCLQ 294
           N ++    +GEG +G V K +  A G I+A+K+   K  + + +     L E+ ++  L+
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF--KESEDDEDVKKTALREVKVLRQLR 58

Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELE-----LDWPTRQKICLGI 349
           H N+V +        +L LV+EY+E   L           LE     L     +     +
Sbjct: 59  HENIVNLKEAFRRKGRLYLVFEYVERTLLE---------LLEASPGGLPPDAVRSYIWQL 109

Query: 350 ARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIG 409
            + +A+ H      I+HRDIK  N+L+      K+ DFG A+          T    T  
Sbjct: 110 LQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRW 166

Query: 410 YMAPEYALWGYLTY--KADVYSFGIVALEIVSG 440
           Y APE  L G   Y    DV++ G +  E++ G
Sbjct: 167 YRAPEL-LVGDTNYGKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 93.3 bits (232), Expect = 3e-21
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 22/212 (10%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQG-NREFLNEIAMISCLQHPN 297
                  ++GEG  G V K +L   G I A+K +++       ++ L E+ +    + P 
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 298 LVKIHGCCVE--GDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA----R 351
           +VK +G  ++     + +  EY E  SL  +++ +     +      +K+   IA    +
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLD-SIYKKV---KKRGGRIGEKVLGKIAESVLK 116

Query: 352 GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEGDKTHISTRIAGTIG 409
           GL++LH     KI+HRDIK +N+LL R    K+ DFG++   ++    T       GT  
Sbjct: 117 GLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTSF 168

Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           YMAPE       +  +DV+S G+  LE+   +
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 92.9 bits (231), Expect = 3e-21
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 14/206 (6%)

Query: 239 TNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ------LSSKSRQGNREFLNEIAMIS 291
             NF   KKIG+G F  VYK   L DG ++A+K+      + +K+RQ   + L EI ++ 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ---DCLKEIDLLK 57

Query: 292 CLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIAR 351
            L HPN++K     +E ++L +V E  +   L+  +   +  +  +   T  K  + +  
Sbjct: 58  QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117

Query: 352 GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYM 411
            L  +H +   +I+HRDIK  NV +      K+ D GL +     KT  +  + GT  YM
Sbjct: 118 ALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLVGTPYYM 173

Query: 412 APEYALWGYLTYKADVYSFGIVALEI 437
           +PE        +K+D++S G +  E+
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 93.0 bits (231), Expect = 4e-21
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 18/209 (8%)

Query: 246 KKIGEGGFGPVYKGQLA--DGTI--IAVK--QLSSKSRQGNREFLNEIAMISCLQHPNLV 299
           K +GEG FG V +GQL+  DG+   +AVK  +L   +     EFL+E A +    HPN++
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64

Query: 300 KIHGCCVEGDQL------LLVYEYMENNSLACALFGRENCELELDWPTRQ--KICLGIAR 351
           K+ G C E   L      +++  +M++  L   L       L    P +   K  + IA 
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124

Query: 352 GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT-IGY 410
           G+ +L   S    +HRD+ A N +L  D+   ++DFGL+K       +   RIA   + +
Sbjct: 125 GMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181

Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVS 439
           +A E       T K+DV++FG+   EI +
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 92.5 bits (230), Expect = 5e-21
 Identities = 61/205 (29%), Positives = 112/205 (54%), Gaps = 11/205 (5%)

Query: 241 NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGN-REFLNEIAMISCLQHPNL 298
           NF   +K+GEG +  VYKG+    G I+A+K++   + +G     + EI+++  L+H N+
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
           V++H      ++L+LV+EYM+ +             L+ +  T +     + +G+AF HE
Sbjct: 61  VRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPN--TVKSFTYQLLKGIAFCHE 118

Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALW 418
               +++HRD+K  N+L+++    K++DFGLA+         S  +  T+ Y AP+  L 
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPD-VLL 173

Query: 419 GYLTYKA--DVYSFGIVALEIVSGK 441
           G  TY    D++S G +  E+++G+
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 91.9 bits (228), Expect = 6e-21
 Identities = 72/273 (26%), Positives = 130/273 (47%), Gaps = 38/273 (13%)

Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           K++G G FG V  G+      +A+K +   S   + EF+ E  ++  L H  LV+++G C
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMKLSHEKLVQLYGVC 68

Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKI---CLGIARGLAFLHEESRF 362
            +   + +V EYM N  L   L  RE+           ++   C  +  G+A+L  ES+ 
Sbjct: 69  TKQRPIYIVTEYMSNGCLLNYL--REH----GKRFQPSQLLEMCKDVCEGMAYL--ESK- 119

Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEGDKTHISTRIAGTIGYMAPEYALWGY 420
           + +HRD+ A N L+D     K+SDFGL++  LD+   + + ++    + +  PE  L+  
Sbjct: 120 QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFP--VRWSPPEVLLYSK 177

Query: 421 LTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLG 479
            + K+DV++FG++  E+ S GK      P   F+ +  ++    + Q  +L         
Sbjct: 178 FSSKSDVWAFGVLMWEVYSLGK-----MPYERFNNSETVE---KVSQGLRL--------- 220

Query: 480 SKYKKEEA-ERMIKVSLLCTNASPSLRPTMSEV 511
             Y+   A E++  +   C +     RPT  ++
Sbjct: 221 --YRPHLASEKVYAIMYSCWHEKAEERPTFQQL 251

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 92.9 bits (231), Expect = 7e-21
 Identities = 71/220 (32%), Positives = 109/220 (49%), Gaps = 24/220 (10%)

Query: 242 FDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGN---REFLNEIAMISCLQHPN 297
           F   ++IG G FG VY  + +    ++A+K++S   +Q N   ++ + E+  +  L+HPN
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 298 LVKIHGCCVEGDQLLLVYEY-MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFL 356
            ++  GC +      LV EY + + S    +  +   E+E+       IC G  +GLA+L
Sbjct: 77  TIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEI-----AAICHGALQGLAYL 131

Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYA 416
           H   R   +HRDIKA N+LL      K++DFG A L     + +     GT  +MAPE  
Sbjct: 132 HSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVI 183

Query: 417 LW---GYLTYKADVYSFGIVALEIVSGKN---NMSYAPAL 450
           L    G    K DV+S GI  +E+   K    NM+   AL
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 92.8 bits (231), Expect = 8e-21
 Identities = 70/209 (33%), Positives = 109/209 (52%), Gaps = 18/209 (8%)

Query: 241 NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLS-SKSRQG-NREFLNEIAMISCLQHPN 297
            F+   +IGEG +G VY+ +    G I+A+K++     R G     L EI ++  L+HPN
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67

Query: 298 LVKIHGCCVEGDQL---LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           +V++    V G  L    LV EY E + LA  L   +N          + + L + RGL 
Sbjct: 68  IVELKEV-VVGKHLDSIFLVMEYCEQD-LASLL---DNMPTPFSESQVKCLMLQLLRGLQ 122

Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPE 414
           +LHE   F I+HRD+K +N+LL      KI+DFGLA+        ++ ++  T+ Y APE
Sbjct: 123 YLHE--NF-IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPE 178

Query: 415 YALWGYLTYKA--DVYSFGIVALEIVSGK 441
             L G  TY    D+++ G +  E+++ K
Sbjct: 179 L-LLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 91.0 bits (226), Expect = 1e-20
 Identities = 71/278 (25%), Positives = 129/278 (46%), Gaps = 35/278 (12%)

Query: 241 NFDSAKKIGEGGFGP--VYKGQLADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQHP 296
           ++   + +G+G FG   +Y+ +  D +++  K+  L+  S +  R+ LNEI ++S LQHP
Sbjct: 1   HYIPIRVLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59

Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELE---LDWPTRQKICLGIARGL 353
           N++  +   ++ + LL+  EY    +L   +  ++    E   + W   Q     I   +
Sbjct: 60  NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQ-----IVSAV 114

Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAP 413
           +++H+     I+HRDIK  N+ L +    K+ DFG++K+   + +   T + GT  YM+P
Sbjct: 115 SYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSP 170

Query: 414 EYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVEL 473
           E        +K+D+++ G V  E+++ K          FD T  L+    + Q      +
Sbjct: 171 ELCQGVKYNFKSDIWALGCVLYELLTLKRT--------FDATNPLNLVVKIVQGNYTPVV 222

Query: 474 VDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                 S Y  E    +I +        P  RPT  EV
Sbjct: 223 ------SVYSSE----LISLVHSLLQQDPEKRPTADEV 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 91.5 bits (228), Expect = 1e-20
 Identities = 68/201 (33%), Positives = 107/201 (53%), Gaps = 24/201 (11%)

Query: 248 IGEGGFGPVYKGQ-LADGTIIAVKQLS-SKSRQGNREF-LNEIAMISCLQ---HPNLVKI 301
           IGEG +G VYK + L  G  +A+K++    S +G     L EIA++  L+   HPN+V++
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66

Query: 302 ----HGCCVEGD-QLLLVYEYMENNSLACALFGRENC-ELELDWPTRQKICLGIARGLAF 355
               HG   + + +L LV+E+++ + LA  L     C +  L   T + +   + RG+ F
Sbjct: 67  LDVCHGPRTDRELKLTLVFEHVDQD-LATYL---SKCPKPGLPPETIKDLMRQLLRGVDF 122

Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS-TRIAGTIGYMAPE 414
           LH     +IVHRD+K  N+L+  D   KI+DFGLA++       ++ T +  T+ Y APE
Sbjct: 123 LHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS---FEMALTSVVVTLWYRAPE 176

Query: 415 YALWGYLTYKADVYSFG-IVA 434
             L        D++S G I A
Sbjct: 177 VLLQSSYATPVDMWSVGCIFA 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 91.3 bits (227), Expect = 2e-20
 Identities = 67/223 (30%), Positives = 104/223 (46%), Gaps = 35/223 (15%)

Query: 246 KKIGEGGFGPVY------------KGQLADG-----TIIAVKQL----SSKSRQGNREFL 284
           +K+GEG FG V+            K    +       ++AVK L    S  +R+   +FL
Sbjct: 11  EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE---DFL 67

Query: 285 NEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRE-------NCELEL 337
            E+ ++S L  PN+ ++ G C     L ++ EYMEN  L   L                L
Sbjct: 68  KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127

Query: 338 DWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGD 396
            + T   +   IA G+ +L  ES    VHRD+   N L+ ++   KI+DFG+++ L   D
Sbjct: 128 SFSTLLYMATQIASGMRYL--ESL-NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184

Query: 397 KTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
              +  R    I +MA E  L G  T K+DV++FG+   EI++
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 91.5 bits (228), Expect = 2e-20
 Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 22/199 (11%)

Query: 241 NFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQG-----NREFLNEIAMISCLQ 294
            ++  KK+GEG +  VYK      G I+A+K++    R+      N   L EI ++  L+
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQK-ICLGIARGL 353
           HPN++ +         + LV+E+ME + L   +   ++  L    P   K   L   RGL
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFMETD-LE-KVIKDKSIVLT---PADIKSYMLMTLRGL 115

Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAP 413
            +LH  S + I+HRD+K  N+L+  D   K++DFGLA+        ++ ++  T  Y AP
Sbjct: 116 EYLH--SNW-ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAP 171

Query: 414 EYALWGYLTYKADVYSFGI 432
           E      L + A  Y  G+
Sbjct: 172 E------LLFGARHYGVGV 184

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 90.9 bits (225), Expect = 3e-20
 Identities = 63/201 (31%), Positives = 105/201 (52%), Gaps = 21/201 (10%)

Query: 247 KIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           ++G+G FG VYK +  + G + A K + +KS +   +++ EI +++   HP +VK+ G  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDW----PTRQKICLGIARGLAFLHEESR 361
               +L ++ E+    ++   +       LELD     P  Q IC  +   L +LH    
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIM-------LELDRGLTEPQIQVICRQMLEALQYLHSM-- 129

Query: 362 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYL 421
            KI+HRD+KA NVLL  D + K++DFG++  +        + I GT  +MAPE  +   +
Sbjct: 130 -KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYWMAPEVVMCETM 187

Query: 422 T-----YKADVYSFGIVALEI 437
                 YKAD++S GI  +E+
Sbjct: 188 KDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 90.1 bits (223), Expect = 3e-20
 Identities = 62/193 (32%), Positives = 100/193 (51%), Gaps = 7/193 (3%)

Query: 248 IGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNR-EFLNEIAMISCLQHPNLVKIHGCCV 306
           +G+G FG V+KG L D T +AVK       Q  + +FL+E  ++    HPN+VK+ G C 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 307 EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVH 366
           +   + +V E +        L  +++   EL      K  L  A G+A+L  ES+   +H
Sbjct: 63  QRQPIYIVMELVPGGDFLSFLRKKKD---ELKTKQLVKFALDAAAGMAYL--ESK-NCIH 116

Query: 367 RDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKAD 426
           RD+ A N L+  +   KISDFG+++ ++      S      I + APE   +G  + ++D
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176

Query: 427 VYSFGIVALEIVS 439
           V+S+GI+  E  S
Sbjct: 177 VWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 90.4 bits (224), Expect = 3e-20
 Identities = 74/286 (25%), Positives = 128/286 (44%), Gaps = 40/286 (13%)

Query: 246 KKIGEGGFGPVYKGQL-----ADGTIIAVKQLSS-KSRQGNREFLNEIAMISCLQHPNLV 299
           +++GE  FG +YKG L         ++A+K L    + Q   EF  E ++++ L HPN+V
Sbjct: 11  EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70

Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACALFGRE-----NCELELDWPTRQK--------IC 346
            + G   +   + +++EY+    L   L  R       C  + D   +          I 
Sbjct: 71  CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130

Query: 347 LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIA 405
           + IA G+ +L   S F  VH+D+ A N+L+   L+ KISD GL++ +   D   +  +  
Sbjct: 131 IQIAAGMEYL--SSHF-FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 406 GTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQ 465
             I +M PE  ++G  +  +D++SFG+V  EI S        P   F             
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS----FGLQPYYGF------------- 230

Query: 466 QDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
            + +++E+V +R      ++   RM  +   C    PS RP   ++
Sbjct: 231 SNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 89.1 bits (221), Expect = 6e-20
 Identities = 72/276 (26%), Positives = 130/276 (47%), Gaps = 44/276 (15%)

Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQG---NREFLNEIAMISCLQHPNLVKIH 302
           K++G G FG V+ G+      +A+K +     +G     +F+ E  ++  L HP LV+++
Sbjct: 10  KELGSGQFGVVHLGKWRAQIKVAIKAI----NEGAMSEEDFIEEAKVMMKLSHPKLVQLY 65

Query: 303 GCCVEGDQLLLVYEYMENNSLACAL---FGRENCELELDWPTRQKICLGIARGLAFLHEE 359
           G C +   L +V E+MEN  L   L    G+ + ++ L       +C  +  G+ +L E 
Sbjct: 66  GVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLL------SMCQDVCEGMEYL-ER 118

Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWG 419
           + F  +HRD+ A N L+      K+SDFG+ +    D+   S+     + +  PE   + 
Sbjct: 119 NSF--IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFS 176

Query: 420 YLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDE-- 476
             + K+DV+SFG++  E+ + GK  M +     ++                +VE++    
Sbjct: 177 KYSSKSDVWSFGVLMWEVFTEGK--MPFEKKSNYE----------------VVEMISRGF 218

Query: 477 RLGSKYKKEEAERMI-KVSLLCTNASPSLRPTMSEV 511
           RL   Y+ + A   + +V   C +  P  RPT +E+
Sbjct: 219 RL---YRPKLASMTVYEVMYSCWHEKPEGRPTFAEL 251

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 93.4 bits (232), Expect = 6e-20
 Identities = 91/337 (27%), Positives = 156/337 (46%), Gaps = 37/337 (10%)

Query: 189 VVAGLSLIILVVSILGWRY-YLRTKRHKETAFMKESD--LQTISFTLKQIKAAT-NNFDS 244
            +       LV++++ + + ++R + + E   ++  D   +   F  K  K+ T N+  S
Sbjct: 631 YITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILS 690

Query: 245 AKK----IGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
           + K    I  G  G  YKG+ + +G    VK++       N    +EIA +  LQHPN+V
Sbjct: 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEI----NDVNSIPSSEIADMGKLQHPNIV 746

Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
           K+ G C       L++EY+E  +L+  L         L W  R+KI +GIA+ L FLH  
Sbjct: 747 KLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCR 799

Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWG 419
               +V  ++    +++D    P +    L  L   D     +       Y+APE     
Sbjct: 800 CSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS-----AYVAPETRETK 853

Query: 420 YLTYKADVYSFGIVALEIVSGKNNMSYAPA-LEFDCT-CLLDWACHLQQDGKLVELVDER 477
            +T K+D+Y FG++ +E+++GK+     PA  EF     +++WA +   D  L   +D  
Sbjct: 854 DITEKSDIYGFGLILIELLTGKS-----PADAEFGVHGSIVEWARYCYSDCHLDMWIDPS 908

Query: 478 LG---SKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           +    S  + E  E M  ++L CT   P+ RP  ++V
Sbjct: 909 IRGDVSVNQNEIVEVM-NLALHCTATDPTARPCANDV 944

Length = 968

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 89.3 bits (221), Expect = 9e-20
 Identities = 62/213 (29%), Positives = 107/213 (50%), Gaps = 14/213 (6%)

Query: 242 FDSAKKIGEGGFGPV-YKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
            DS  KIGEG  G V    +   G  +AVK++  + +Q      NE+ ++    H N+V 
Sbjct: 24  LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVD 83

Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
           ++   + GD+L +V E++E  +L   +      E ++       +CL + R L++LH + 
Sbjct: 84  MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLSVLRALSYLHNQG 138

Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGY 420
              ++HRDIK+ ++LL  D   K+SDFG        +      + GT  +MAPE  +   
Sbjct: 139 ---VIHRDIKSDSILLTSDGRIKLSDFGFCA-QVSKEVPKRKSLVGTPYWMAPE--VISR 192

Query: 421 LTY--KADVYSFGIVALEIVSGKNNMSYAPALE 451
           L Y  + D++S GI+ +E++ G+      P L+
Sbjct: 193 LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ 225

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 89.7 bits (222), Expect = 1e-19
 Identities = 66/211 (31%), Positives = 115/211 (54%), Gaps = 26/211 (12%)

Query: 242 FDSAKKIGEGGFGPVYKG-QLADGTII----AVKQL-SSKSRQGNREFLNEIAMISCLQH 295
           F   K +G G FG VYKG  + +G  +    A+K+L  + S + N+E L+E  +++ + +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACAL-FGRENCE-----LELDWPTRQKICLGI 349
           P++ ++ G C+    + L+ + M      C L + RE+ +       L+W      C+ I
Sbjct: 69  PHVCRLLGICLT-STVQLITQLM---PFGCLLDYVREHKDNIGSQYLLNW------CVQI 118

Query: 350 ARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD-KTHISTRIAGTI 408
           A+G+ +L E    ++VHRD+ A NVL+    + KI+DFGLAKL   D K + +      I
Sbjct: 119 AKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPI 175

Query: 409 GYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
            +MA E  L    T+++DV+S+G+   E+++
Sbjct: 176 KWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 88.5 bits (219), Expect = 1e-19
 Identities = 72/279 (25%), Positives = 126/279 (45%), Gaps = 31/279 (11%)

Query: 241 NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ------LSSKSRQGNREFLNEIAMISCL 293
           NF   KKIG G F  VY+   L DG  +A+K+      + +K+R    + + EI ++  L
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARA---DCIKEIDLLKQL 59

Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
            HPN++K +   +E ++L +V E  +   L+  +   +  +  +   T  K  + +   L
Sbjct: 60  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119

Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAP 413
             +H     +++HRDIK  NV +      K+ D GL +     KT  +  + GT  YM+P
Sbjct: 120 EHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLVGTPYYMSP 175

Query: 414 EYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVEL 473
           E        +K+D++S G +  E+ + ++   Y   +     C            K +E 
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNLYSLC------------KKIEQ 222

Query: 474 VD-ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
            D   L S +  EE  +++    +C N  P  RP ++ V
Sbjct: 223 CDYPPLPSDHYSEELRQLVN---MCINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 88.0 bits (218), Expect = 2e-19
 Identities = 63/216 (29%), Positives = 106/216 (49%), Gaps = 22/216 (10%)

Query: 248 IGEGGFGPVYKGQLADGTIIAVKQL---SSKSRQGNREFLN---EIAMISCLQHPNLVKI 301
           +G+G +G VY G    G +IAVKQ+   +S      +E+     E+ ++  L+H N+V+ 
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 302 HGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICLGIARGLAFLHEE 359
            G C++ + + +  E++   S++  L  FG    E      T+Q     I  G+A+LH  
Sbjct: 68  LGTCLDDNTISIFMEFVPGGSISSILNRFG-PLPEPVFCKYTKQ-----ILDGVAYLHNN 121

Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL-----DEGDKTHISTRIAGTIGYMAPE 414
               +VHRDIK  NV+L  +   K+ DFG A+        G  +++   + GT  +MAPE
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178

Query: 415 YALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPAL 450
                    K+D++S G    E+ +GK  ++    L
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL 214

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 88.2 bits (218), Expect = 2e-19
 Identities = 61/199 (30%), Positives = 103/199 (51%), Gaps = 17/199 (8%)

Query: 247 KIGEGGFGPVYKGQLADGTIIAV-KQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           ++G+G FG VYK Q  +  ++A  K + +KS +   +++ EI +++   HPN+VK+    
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELE--LDWPTRQKICLGIARGLAFLHEESRFK 363
              + L ++ E+    ++   +      ELE  L  P  + +C      L +LHE    K
Sbjct: 72  YYENNLWILIEFCAGGAVDAVML-----ELERPLTEPQIRVVCKQTLEALNYLHEN---K 123

Query: 364 IVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGY--- 420
           I+HRD+KA N+L   D + K++DFG++  +        + I GT  +MAPE  +      
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKD 182

Query: 421 --LTYKADVYSFGIVALEI 437
               YKADV+S GI  +E+
Sbjct: 183 RPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 67/227 (29%), Positives = 106/227 (46%), Gaps = 37/227 (16%)

Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAM-- 289
           ++  A  N+ ++  +IG G  G VYK +    G ++AVKQ+    R GN+E    I M  
Sbjct: 8   QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMR---RTGNKEENKRILMDL 64

Query: 290 -ISCLQH--PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTR--QK 344
            +    H  P +VK +G  +    + +  E M   +    L  R    +    P     K
Sbjct: 65  DVVLKSHDCPYIVKCYGYFITDSDVFICMELMS--TCLDKLLKRIQGPI----PEDILGK 118

Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI 404
           + + I + L +L E+    ++HRD+K +N+LLD   N K+ DFG++      K    TR 
Sbjct: 119 MTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRS 174

Query: 405 AGTIGYMAPE----------YALWGYLTYKADVYSFGIVALEIVSGK 441
           AG   YMAPE          Y +      +ADV+S GI  +E+ +G+
Sbjct: 175 AGCAAYMAPERIDPPDPNPKYDI------RADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 87.5 bits (217), Expect = 3e-19
 Identities = 61/199 (30%), Positives = 97/199 (48%), Gaps = 12/199 (6%)

Query: 246 KKIGEGGFGPVYKG----QLADGTIIAVKQLSSKSRQGNRE-FLNEIAMISCLQHPNLVK 300
           + IGEG FG VY+G       +   +AVK   + +    RE FL E  ++    HP++VK
Sbjct: 12  RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71

Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
           + G   E + + +V E      L   L   +     LD  +       ++  LA+L  ES
Sbjct: 72  LIGVITE-NPVWIVMELAPLGELRSYLQVNKY---SLDLASLILYSYQLSTALAYL--ES 125

Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGY 420
           + + VHRDI A NVL+      K+ DFGL++  E +  + +++    I +MAPE   +  
Sbjct: 126 K-RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRR 184

Query: 421 LTYKADVYSFGIVALEIVS 439
            T  +DV+ FG+   EI+ 
Sbjct: 185 FTSASDVWMFGVCMWEILM 203

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 87.5 bits (217), Expect = 3e-19
 Identities = 71/285 (24%), Positives = 117/285 (41%), Gaps = 49/285 (17%)

Query: 248 IGEGGFGPVYKGQL------ADGTIIAVKQLSSKSRQG-NREFLNEIAMISCLQHPNLVK 300
           +G G FG V+  +          T++ VK L     +    EF  E+ M   L H N+V+
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWP---TRQK--ICLGIARGLAF 355
           + G C E +   ++ EY +   L   L   ++ + +L  P   T+QK  +C  IA G+  
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132

Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEY 415
           L   S  + VHRD+ A N L+      K+S   L+K     + +        + ++APE 
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEA 189

Query: 416 ALWGYLTYKADVYSFGIVALEIVS-------GKNNMSYAPALEFDCTCLLDWACHLQQDG 468
                 + K+DV+SFG++  E+ +       G ++      L               Q G
Sbjct: 190 VQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL---------------QAG 234

Query: 469 KLVELVDERLGSKYKKEEA--ERMIKVSLLCTNASPSLRPTMSEV 511
           KL          +    E    R+ K+   C   +P  RP+ SE+
Sbjct: 235 KL----------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSEL 269

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 87.8 bits (217), Expect = 4e-19
 Identities = 67/220 (30%), Positives = 107/220 (48%), Gaps = 24/220 (10%)

Query: 242 FDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGN---REFLNEIAMISCLQHPN 297
           F   ++IG G FG VY  +      ++A+K++S   +Q N   ++ + E+  +  ++HPN
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 298 LVKIHGCCVEGDQLLLVYEY-MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFL 356
            ++  GC +      LV EY + + S    +  +   E+E+       I  G  +GLA+L
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI-----AAITHGALQGLAYL 141

Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYA 416
           H  +   ++HRDIKA N+LL      K++DFG A +        +    GT  +MAPE  
Sbjct: 142 HSHN---MIHRDIKAGNILLTEPGQVKLADFGSASI-----ASPANSFVGTPYWMAPEVI 193

Query: 417 LW---GYLTYKADVYSFGIVALEIVSGKN---NMSYAPAL 450
           L    G    K DV+S GI  +E+   K    NM+   AL
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 233

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 87.8 bits (217), Expect = 4e-19
 Identities = 66/220 (30%), Positives = 108/220 (49%), Gaps = 24/220 (10%)

Query: 242 FDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGN---REFLNEIAMISCLQHPN 297
           F   ++IG G FG VY  + + +  ++A+K++S   +Q N   ++ + E+  +  L+HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 298 LVKIHGCCVEGDQLLLVYEY-MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFL 356
            ++  GC +      LV EY + + S    +  +   E+E+       +  G  +GLA+L
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI-----AAVTHGALQGLAYL 131

Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYA 416
           H  +   ++HRD+KA N+LL      K+ DFG A +        +    GT  +MAPE  
Sbjct: 132 HSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASI-----MAPANXFVGTPYWMAPEVI 183

Query: 417 LW---GYLTYKADVYSFGIVALEIVSGKN---NMSYAPAL 450
           L    G    K DV+S GI  +E+   K    NM+   AL
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 86.4 bits (214), Expect = 5e-19
 Identities = 75/280 (26%), Positives = 124/280 (44%), Gaps = 39/280 (13%)

Query: 241 NFDSAKKIGEGGFGPVY------KGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ 294
            ++  + +G G FG V+        +L     I V+Q++   R       NE  ++  L 
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLA---AQNECQVLKLLS 57

Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HPN+++ +   +E   L++V EY    +LA  +  R N  L+ D      I     + L 
Sbjct: 58  HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDED-----TILHFFVQILL 112

Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNP-KISDFGLAKLDEGDKTHISTRIAGTIGYMAP 413
            LH      I+HRD+K  N+LLD+     KI DFG++K+    K+   T + GT  Y++P
Sbjct: 113 ALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI-LSSKSKAYT-VVGTPCYISP 170

Query: 414 EYALWGYLTYKADVYSFGIVALEIVSGKNNMSYA--PALEFDCTCLLDWACHLQQDGKLV 471
           E         K+D+++ G V  E+ S K     A  PAL                  K++
Sbjct: 171 ELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVL----------------KIM 214

Query: 472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                 +  +Y  +   R + +S+L  N  PS RP +S++
Sbjct: 215 SGTFAPISDRYSPD--LRQLILSML--NLDPSKRPQLSQI 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 86.4 bits (214), Expect = 5e-19
 Identities = 84/278 (30%), Positives = 127/278 (45%), Gaps = 42/278 (15%)

Query: 248 IGEGGFGPVYKGQLADG----TIIAVKQLSSKSRQGNRE-FLNEIAMISCLQHPNLVKIH 302
           IG+G FG VY G L D        AVK L+  +     E FL E  ++    HPN++ + 
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 303 GCCVEGDQL-LLVYEYMENNSLACALFGRENCELELDWPTRQKIC---LGIARGLAFLHE 358
           G C+  +   L+V  YM++  L      R     E   PT + +    L +A+G+ +L  
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDL------RNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS 116

Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LD-EGDKTHISTRIAGTIGYMAPEY 415
           +   K VHRD+ A N +LD     K++DFGLA+   D E    H  T     + +MA E 
Sbjct: 117 K---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173

Query: 416 ALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD 475
                 T K+DV+SFG++  E+++ +    Y     FD T  L     LQ          
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVDSFDITVYL-----LQ---------- 217

Query: 476 ERLGSKYKKEE--AERMIKVSLLCTNASPSLRPTMSEV 511
              G +  + E   + + +V L C +  P +RPT SE+
Sbjct: 218 ---GRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSEL 252

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 86.2 bits (213), Expect = 6e-19
 Identities = 70/193 (36%), Positives = 99/193 (51%), Gaps = 13/193 (6%)

Query: 248 IGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVE 307
           IG+G FG V  G    G  +AVK +  K+    + FL E ++++ L+H NLV++ G  VE
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 308 GD-QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVH 366
               L +V EYM   SL   L  R    L  D     K  L +   + +L E + F  VH
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD--CLLKFSLDVCEAMEYL-EANNF--VH 125

Query: 367 RDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKAD 426
           RD+ A NVL+  D   K+SDFGL K  E   T  + ++   + + APE       + K+D
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTKSD 181

Query: 427 VYSFGIVALEIVS 439
           V+SFGI+  EI S
Sbjct: 182 VWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 86.1 bits (214), Expect = 6e-19
 Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 16/207 (7%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLS-SKSRQGNREFL-NEIAMISCLQHPNLVKIH 302
           + IG+G FG V K +  +DG I+  K++      +  ++ L +E+ ++  L+HPN+V+ +
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 303 GCCV--EGDQLLLVYEYMENNSLACAL--FGRENCELELD--WPTRQKICLGIARGLAFL 356
              +      L +V EY E   LA  +    +E   +E +  W    ++ L +       
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE----C 121

Query: 357 H--EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPE 414
           H   +    ++HRD+K  N+ LD + N K+ DFGLAK+   D +   T   GT  YM+PE
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT-YVGTPYYMSPE 180

Query: 415 YALWGYLTYKADVYSFGIVALEIVSGK 441
                    K+D++S G +  E+ +  
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 87.0 bits (215), Expect = 6e-19
 Identities = 55/203 (27%), Positives = 102/203 (50%), Gaps = 14/203 (6%)

Query: 242 FDSAKKIGEGGFGPV-YKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
            ++  KIGEG  G V    +   G  +AVK +  + +Q      NE+ ++   QH N+V+
Sbjct: 23  LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVE 82

Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
           ++   + G++L ++ E+++  +L   +      +  L+      +C  + + L +LH + 
Sbjct: 83  MYKSYLVGEELWVLMEFLQGGALTDIV-----SQTRLNEEQIATVCESVLQALCYLHSQG 137

Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR--IAGTIGYMAPEYALW 418
              ++HRDIK+ ++LL  D   K+SDFG       D   +  R  + GT  +MAPE    
Sbjct: 138 ---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD---VPKRKSLVGTPYWMAPEVISR 191

Query: 419 GYLTYKADVYSFGIVALEIVSGK 441
                + D++S GI+ +E+V G+
Sbjct: 192 TPYGTEVDIWSLGIMVIEMVDGE 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 87.0 bits (216), Expect = 7e-19
 Identities = 70/229 (30%), Positives = 108/229 (47%), Gaps = 35/229 (15%)

Query: 238 ATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQ-LSSKSRQGNREF----LNEIAMIS 291
              +++   K+GEG FG VYK  Q+  G ++A+K+ L    + G   F    L EI ++ 
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILK 62

Query: 292 CLQHPNLVKIHGCCVE-----GDQLLLVY---EYMENNSLACALFGRENCELELDWPTRQ 343
            L+HPN+V +    VE       +   VY    YM+++ L+  L   EN  ++L     +
Sbjct: 63  KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHD-LSGLL---ENPSVKLTESQIK 118

Query: 344 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK------ 397
              L +  G+ +LHE     I+HRDIKA N+L+D     KI+DFGLA+  +G        
Sbjct: 119 CYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175

Query: 398 ----THISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
               T   T +  T  Y  PE  L     T   D++  G V  E+ + +
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 86.3 bits (213), Expect = 7e-19
 Identities = 65/202 (32%), Positives = 106/202 (52%), Gaps = 11/202 (5%)

Query: 242 FDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNREFLN-EIAMISCLQHPNLV 299
           F   ++IG+G FG VYKG       ++A+K +  +  +   E +  EI ++S    P + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
           + +G  ++G +L ++ EY+   S   AL   +   LE  +     I   I +GL +LH E
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGS---ALDLLKPGPLEETYIA--TILREILKGLDYLHSE 120

Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWG 419
            +   +HRDIKA NVLL    + K++DFG+A      +   +T + GT  +MAPE     
Sbjct: 121 RK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQS 176

Query: 420 YLTYKADVYSFGIVALEIVSGK 441
              +KAD++S GI A+E+  G+
Sbjct: 177 AYDFKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 86.6 bits (214), Expect = 1e-18
 Identities = 70/220 (31%), Positives = 108/220 (49%), Gaps = 24/220 (10%)

Query: 242 FDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGN---REFLNEIAMISCLQHPN 297
           F    +IG G FG VY    +    ++AVK++S   +Q N   ++ + E+  +  L+HPN
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 298 LVKIHGCCVEGDQLLLVYEY-MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFL 356
            ++  GC ++     LV EY + + S    +  +   E+E+       I  G  +GLA+L
Sbjct: 83  TIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEI-----AAITHGALQGLAYL 137

Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYA 416
           H  +   ++HRDIKA N+LL      K++DFG A      K+  +    GT  +MAPE  
Sbjct: 138 HSHN---MIHRDIKAGNILLTEPGQVKLADFGSAS-----KSSPANSFVGTPYWMAPEVI 189

Query: 417 LW---GYLTYKADVYSFGIVALEIVSGKN---NMSYAPAL 450
           L    G    K DV+S GI  +E+   K    NM+   AL
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 229

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 44/154 (28%), Positives = 83/154 (53%), Gaps = 10/154 (6%)

Query: 241 NFDSAKKIGEGGFGPVYKGQLAD-GTIIAVK--QLSSKSRQGNREFLNEIAMISCLQHPN 297
            ++  +KIGEG +G V+K +  +   I+A+K  +L           L EI ++  L+H N
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH 357
           +V+++       +L LV+EY + + L       ++C  ++D    +     + +GLAF H
Sbjct: 61  IVRLYDVLHSDKKLTLVFEYCDQD-LKKYF---DSCNGDIDPEIVKSFMFQLLKGLAFCH 116

Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 391
                 ++HRD+K  N+L++++   K++DFGLA+
Sbjct: 117 SH---NVLHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 85.1 bits (210), Expect = 2e-18
 Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 17/205 (8%)

Query: 242 FDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNREFLN-EIAMISCLQHPNLV 299
           F   ++IG+G FG V+KG       ++A+K +  +  +   E +  EI ++S    P + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
           K +G  ++G +L ++ EY+   S    L      E ++    ++     I +GL +LH E
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKE-----ILKGLDYLHSE 120

Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR---IAGTIGYMAPEYA 416
              K +HRDIKA NVLL    + K++DFG+A    G  T    +     GT  +MAPE  
Sbjct: 121 ---KKIHRDIKAANVLLSEQGDVKLADFGVA----GQLTDTQIKRNTFVGTPFWMAPEVI 173

Query: 417 LWGYLTYKADVYSFGIVALEIVSGK 441
                  KAD++S GI A+E+  G+
Sbjct: 174 QQSAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 84.6 bits (209), Expect = 2e-18
 Identities = 77/282 (27%), Positives = 121/282 (42%), Gaps = 35/282 (12%)

Query: 246 KKIGEGGFGPVYKGQLADGTIIA---VKQL-SSKSRQGNREFLNEIAMISCLQHPNLVKI 301
            +IG G FG V  G+   G   A   VK+L +S +      FL E+     L HPN+++ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 302 HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWP---TRQKICLGIARGLAFLHE 358
            G C+E    LLV E+     L   L  R N  +          Q++   +A GL +LH 
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYL--RSNRGMVAQMAQKDVLQRMACEVASGLLWLH- 117

Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIST--RIAGTIGYMAPEYA 416
             +   +H D+   N  L  DL+ KI D+GLA L++  + +  T    A  + ++APE  
Sbjct: 118 --QADFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELV 174

Query: 417 -------LWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGK 469
                  L    T K++++S G+   E+ +  +     P  +     +L      Q    
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQ----PYPDLSDEQVLKQVVREQD--- 227

Query: 470 LVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
            ++L   +L  KY    ++R  +V   C    P  RPT  EV
Sbjct: 228 -IKLPKPQLDLKY----SDRWYEVMQFCW-LDPETRPTAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 84.3 bits (209), Expect = 3e-18
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 32/208 (15%)

Query: 247 KIGEGGFGPVYKGQLAD-GTIIAVKQL--SSKSRQGNREFLNEIAMISCLQHPNLVKIHG 303
           KIGEG +G V+K +  + G I+A+K+   S       +  L EI M+  L+HPNLV +  
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67

Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENCELE-----LDWPTRQKICLGIARGLAFLHE 358
                 +L LV+EY ++  L          ELE     +     +KI     + + F H+
Sbjct: 68  VFRRKRKLHLVFEYCDHTVLN---------ELEKNPRGVPEHLIKKIIWQTLQAVNFCHK 118

Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL---DEGDKT-HISTRIAGTIGYMAPE 414
                 +HRD+K  N+L+ +    K+ DFG A++      D T +++TR      Y APE
Sbjct: 119 H---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPE 170

Query: 415 YALWGYLTYKA--DVYSFGIVALEIVSG 440
             L G   Y    DV++ G V  E+++G
Sbjct: 171 L-LVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 84.5 bits (209), Expect = 4e-18
 Identities = 61/205 (29%), Positives = 107/205 (52%), Gaps = 11/205 (5%)

Query: 241 NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQHPN 297
           NF   +KIGEG +G VYK +    G ++A+K+  L +++       + EI+++  L HPN
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH 357
           +VK+       ++L LV+E++ +  L   +       + L  P  +     + +GLAF H
Sbjct: 61  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPL--PLIKSYLFQLLQGLAFCH 117

Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYAL 417
                +++HRD+K  N+L++ +   K++DFGLA+   G      T    T+ Y APE  L
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARA-FGVPVRTYTHEVVTLWYRAPEILL 173

Query: 418 WG-YLTYKADVYSFGIVALEIVSGK 441
              Y +   D++S G +  E+V+ +
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 83.9 bits (207), Expect = 5e-18
 Identities = 67/207 (32%), Positives = 112/207 (54%), Gaps = 26/207 (12%)

Query: 246 KKIGEGGFGPVYKG-QLADGTII----AVKQL-SSKSRQGNREFLNEIAMISCLQHPNLV 299
           K +G G FG VYKG  + DG  +    A+K L  + S + N+E L+E  +++ +  P + 
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72

Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACAL-FGREN-----CELELDWPTRQKICLGIARGL 353
           ++ G C+    + LV + M      C L + REN      +  L+W      C+ IA+G+
Sbjct: 73  RLLGICLT-STVQLVTQLM---PYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGM 122

Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT-IGYMA 412
           ++L E    ++VHRD+ A NVL+    + KI+DFGLA+L + D+T          I +MA
Sbjct: 123 SYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMA 179

Query: 413 PEYALWGYLTYKADVYSFGIVALEIVS 439
            E  L    T+++DV+S+G+   E+++
Sbjct: 180 LESILHRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 84.0 bits (208), Expect = 5e-18
 Identities = 80/270 (29%), Positives = 124/270 (45%), Gaps = 33/270 (12%)

Query: 248 IGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNRE---FLNEI-AMISCLQHPNLVKIH 302
           IG G FG V K      GTI+AVK++ S      +E    L ++  ++     P +VK +
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTV--DEKEQKRLLMDLDVVMRSSDCPYIVKFY 69

Query: 303 GCCV-EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESR 361
           G    EGD  + + E M+ +      +  E  +  +      KI +   + L +L EE  
Sbjct: 70  GALFREGDCWICM-ELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE-- 126

Query: 362 FKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHISTRIAGTIGYMAPE----YA 416
            KI+HRD+K +N+LLDR+ N K+ DFG++ +L +   +   TR AG   YMAPE     A
Sbjct: 127 LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD---SIAKTRDAGCRPYMAPERIDPSA 183

Query: 417 LWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDE 476
             GY   ++DV+S GI   E+ +GK    Y             W     Q  ++V+    
Sbjct: 184 RDGY-DVRSDVWSLGITLYEVATGK--FPYP-----------KWNSVFDQLTQVVKGDPP 229

Query: 477 RLGSKYKKEEAERMIKVSLLCTNASPSLRP 506
            L +  ++E +   +    LC     S RP
Sbjct: 230 ILSNSEEREFSPSFVNFINLCLIKDESKRP 259

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 83.9 bits (207), Expect = 6e-18
 Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 23/214 (10%)

Query: 246 KKIGEGGFGPVYKGQLADGT------IIAVKQLSSKSRQGNRE-FLNEIAMISCLQHPNL 298
           +++GE  FG VYKG L           +A+K L  K+    RE F +E  M S LQHPN+
Sbjct: 11  EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNI 70

Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGR------------ENCELELDWPTRQKIC 346
           V + G   +   L +++ Y  ++ L   L  R            +  +  L+      I 
Sbjct: 71  VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130

Query: 347 LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIA 405
             IA G+ FL   S   +VH+D+   NVL+   LN KISD GL + +   D   +     
Sbjct: 131 TQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSL 187

Query: 406 GTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
             I +M+PE  ++G  +  +D++S+G+V  E+ S
Sbjct: 188 LPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 83.8 bits (208), Expect = 7e-18
 Identities = 66/211 (31%), Positives = 110/211 (52%), Gaps = 22/211 (10%)

Query: 241 NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLS-SKSRQGNREF----LNEIAMISCLQ 294
            ++   +I EG +G VY+ +    G I+A+K+L   K ++G   F    L EI ++  LQ
Sbjct: 6   EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG---FPITSLREINILLKLQ 62

Query: 295 HPNLVKIHGCCV--EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARG 352
           HPN+V +    V    D++ +V EY+E++ L   +   E  +        + + L +  G
Sbjct: 63  HPNIVTVKEVVVGSNLDKIYMVMEYVEHD-LKSLM---ETMKQPFLQSEVKCLMLQLLSG 118

Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMA 412
           +A LH+     I+HRD+K +N+LL+     KI DFGLA+ + G      T++  T+ Y A
Sbjct: 119 VAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAR-EYGSPLKPYTQLVVTLWYRA 174

Query: 413 PEYALWGYLTY--KADVYSFGIVALEIVSGK 441
           PE  L G   Y    D++S G +  E+++ K
Sbjct: 175 PEL-LLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 83.5 bits (206), Expect = 7e-18
 Identities = 62/209 (29%), Positives = 109/209 (52%), Gaps = 17/209 (8%)

Query: 245 AKKIGEGGFGPVYKGQL-ADGTI--IAVK--QLSSKSRQGNREFLNEIAMISCLQHPNLV 299
            K +GEG FG V +GQL  D +I  +AVK  +++  +R    +FL+E   +    HPN++
Sbjct: 4   GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVM 63

Query: 300 KIHGCCVEGDQL------LLVYEYMENNSL-ACALFGR-ENCELELDWPTRQKICLGIAR 351
           ++ G C++  +       +++  +M++  L +  L+ R  +C   L      K    IA 
Sbjct: 64  RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123

Query: 352 GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT-IGY 410
           G+ +L  +S    +HRD+ A N +L+ ++N  ++DFGL+K       +   RIA   + +
Sbjct: 124 GMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180

Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVS 439
           +A E       T K+DV+SFG+   EI +
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIAT 209

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 83.1 bits (206), Expect = 7e-18
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 28/209 (13%)

Query: 248 IGEGGFGPVY---KGQLADGTIIAVKQLSSKSRQGNREF---LNEIAMISCLQHPNLVKI 301
           I +G +G V+   K    D  I A+K +         +    L E  ++S  Q P +VK+
Sbjct: 1   ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 302 HGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICLG-IARGLAFLHE 358
           +        L LV EY+    LA  L   G     L+ D     +I +  I   L +LH 
Sbjct: 59  YYSFQGKKNLYLVMEYLPGGDLASLLENVG----SLDEDV---ARIYIAEIVLALEYLH- 110

Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-------LDEGDKTHISTRIAGTIGYM 411
                I+HRD+K  N+L+D + + K++DFGL+K       ++  D      RI GT  Y+
Sbjct: 111 --SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168

Query: 412 APEYALWGYLTYKADVYSFGIVALEIVSG 440
           APE  L    +   D +S G +  E + G
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 83.5 bits (206), Expect = 8e-18
 Identities = 71/222 (31%), Positives = 106/222 (47%), Gaps = 19/222 (8%)

Query: 232 LKQIKAATNNFDSAKKIGEGGFGPVYK-GQLADGTIIAVKQLSSKSRQGNREFLNEIAMI 290
           L+ +   T+ ++  + IG+G +G VYK     DG++ AVK L       + E   E  ++
Sbjct: 14  LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDP-ISDVDEEIEAEYNIL 72

Query: 291 SCL-QHPNLVKIHGCCVEGD-----QLLLVYEYMENNSLACALFGRENCELELDWPTRQK 344
             L  HPN+VK +G   + D     QL LV E     S+   + G   C   LD      
Sbjct: 73  QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY 132

Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI 404
           I  G   GL  LH     +I+HRD+K  N+LL  +   K+ DFG++      +   +T +
Sbjct: 133 ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV 189

Query: 405 AGTIGYMAPEYAL----WGYLTYKA--DVYSFGIVALEIVSG 440
            GT  +MAPE       + Y +Y A  DV+S GI A+E+  G
Sbjct: 190 -GTPFWMAPEVIACEQQYDY-SYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 83.2 bits (205), Expect = 1e-17
 Identities = 80/278 (28%), Positives = 124/278 (44%), Gaps = 41/278 (14%)

Query: 242 FDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNREFLN-EIAMISCLQHPNLV 299
           F   +KIG+G FG V+KG       ++A+K +  +  +   E +  EI ++S    P + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELE---LDWPTRQKICLGIARGLAFL 356
           K +G  ++  +L ++ EY+   S A  L       LE   LD      I   I +GL +L
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGS-ALDL-------LEPGPLDETQIATILREILKGLDYL 117

Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR---IAGTIGYMAP 413
           H E +   +HRDIKA NVLL      K++DFG+A    G  T    +     GT  +MAP
Sbjct: 118 HSEKK---IHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRNTFVGTPFWMAP 170

Query: 414 EYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVEL 473
           E         KAD++S GI A+E+  G+      P  E                 K++ L
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKGE-----PPHSEL-------------HPMKVLFL 212

Query: 474 VDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           + +      +   ++ + +    C N  PS RPT  E+
Sbjct: 213 IPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKEL 250

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 82.3 bits (203), Expect = 2e-17
 Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 11/197 (5%)

Query: 248 IGEGGFGPVYKGQLA----DGTIIAVKQL-SSKSRQGNREFLNEIAMISCLQHPNLVKIH 302
           +G G FG + +G L         +A+  L +  S +  R FL E   +    H N+V++ 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRF 362
           G    G+ +++V EYM N +L   L   E    +L       +  G+A G+ +L E    
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDSFLRKHEG---QLVAGQLMGMLPGLASGMKYLSE---M 126

Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLT 422
             VH+ + A  VL++ DL  KIS F   + D+ +  + +      + + APE   + + +
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFS 186

Query: 423 YKADVYSFGIVALEIVS 439
             +DV+SFGIV  E++S
Sbjct: 187 SASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 69/215 (32%), Positives = 99/215 (46%), Gaps = 36/215 (16%)

Query: 247 KIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSR---QGNREFLNEI-AMISCLQHPNLVKI 301
           KIGEG F  V K Q    G   A+K +    +   Q N   L EI A+     HPN++++
Sbjct: 6   KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN--LREIQALRRLSPHPNILRL 63

Query: 302 HGCCVE--GDQLLLVYEYMENNSLACALFGRENC--ELELDWPTRQKICLGIARGLAFLH 357
                +    +L LV+E M+ N L   + GR+    E  +     Q     + + L  +H
Sbjct: 64  IEVLFDRKTGRLALVFELMDMN-LYELIKGRKRPLPEKRVKSYMYQ-----LLKSLDHMH 117

Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEGDKT-HISTRIAGTIGYMAPE 414
              R  I HRDIK  N+L+  D+  K++DFG  +    +   T +ISTR      Y APE
Sbjct: 118 ---RNGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPYTEYISTR-----WYRAPE 168

Query: 415 YALW-GYLTYKADVYSFGIVALEIVS------GKN 442
             L  GY   K D+++ G V  EI+S      G N
Sbjct: 169 CLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN 203

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 69/215 (32%), Positives = 103/215 (47%), Gaps = 26/215 (12%)

Query: 242 FDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCL-QHPNLV 299
           F+  + +G G +G VYKG+ +  G + A+K +     +   E   EI M+     H N+ 
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIA 76

Query: 300 KIHGCCVE------GDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
             +G  ++       DQL LV E+    S+   +   +   L+ DW     IC  I RGL
Sbjct: 77  TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGL 134

Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL-AKLDEGDKTHISTR--IAGTIGY 410
           A LH     K++HRDIK  NVLL  +   K+ DFG+ A+LD      +  R    GT  +
Sbjct: 135 AHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT----VGRRNTFIGTPYW 187

Query: 411 MAPEYALW-----GYLTYKADVYSFGIVALEIVSG 440
           MAPE             Y++D++S GI A+E+  G
Sbjct: 188 MAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 81.5 bits (201), Expect = 2e-17
 Identities = 58/214 (27%), Positives = 104/214 (48%), Gaps = 26/214 (12%)

Query: 241 NFDSAKKIGEGGFGPVYKGQLADGTI---------IAVKQLSSKSRQGNREFLNEIAMIS 291
            ++  KKIGEG FG +Y   LA             I + ++  K ++ ++    E+ +++
Sbjct: 1   RYEIIKKIGEGSFGKIY---LAKAKSDSEHCVIKEIDLTKMPVKEKEASK---KEVILLA 54

Query: 292 CLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC--LGI 349
            ++HPN+V       E  +L +V EY +       L  R N +  + +   Q +   + I
Sbjct: 55  KMKHPNIVTFFASFQENGRLFIVMEYCDGGD----LMKRINRQRGVLFSEDQILSWFVQI 110

Query: 350 ARGLAFLHEESRFKIVHRDIKATNVLLDRD-LNPKISDFGLAKLDEGDKTHISTRIAGTI 408
           + GL  +H+    KI+HRDIK+ N+ L ++ +  K+ DFG+A+    D   ++    GT 
Sbjct: 111 SLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQ-LNDSMELAYTCVGTP 166

Query: 409 GYMAPEYALWGYLTYKADVYSFGIVALEIVSGKN 442
            Y++PE         K D++S G V  E+ + K+
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKH 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 81.2 bits (200), Expect = 4e-17
 Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 19/210 (9%)

Query: 245 AKKIGEGGFGPVYKGQLADGTI-------IAVKQLSSKSRQGNR-EFLNEIAMISCLQHP 296
           ++++G+G FG VY+G +A G +       +A+K ++  +    R EFLNE +++      
Sbjct: 11  SRELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 69

Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSLAC---ALFGRENCELELDWPTRQKICL---GIA 350
           ++V++ G   +G   L++ E M    L     +L            P+ +K+      IA
Sbjct: 70  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129

Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIG 409
            G+A+L+     K VHRD+ A N ++  D   KI DFG+ + + E D      +    + 
Sbjct: 130 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVS 439
           +M+PE    G  T  +DV+SFG+V  EI +
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 81.2 bits (201), Expect = 4e-17
 Identities = 63/213 (29%), Positives = 107/213 (50%), Gaps = 29/213 (13%)

Query: 242 FDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQHPNL 298
           +   +KIGEG +G VYK +    G I+A+K+  L ++        + EI+++  L HPN+
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60

Query: 299 VKIHGCCVEGDQLLLVYE--------YMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           V++       ++L LV+E        YM+++               LD P  +     + 
Sbjct: 61  VRLLDVVHSENKLYLVFEFLDLDLKKYMDSSP-----------LTGLDPPLIKSYLYQLL 109

Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
           +G+A+ H  S  +++HRD+K  N+L+DR+   K++DFGLA+   G      T    T+ Y
Sbjct: 110 QGIAYCH--SH-RVLHRDLKPQNLLIDREGALKLADFGLARA-FGVPVRTYTHEVVTLWY 165

Query: 411 MAPEYALWGYLTYKA--DVYSFGIVALEIVSGK 441
            APE  L G   Y    D++S G +  E+V+ +
Sbjct: 166 RAPE-ILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 80.9 bits (199), Expect = 4e-17
 Identities = 66/213 (30%), Positives = 102/213 (47%), Gaps = 22/213 (10%)

Query: 242 FDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCL-QHPNLV 299
           F+  + +G G +G VYKG+ +  G + A+K +     +   E   EI M+     H N+ 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIA 66

Query: 300 KIHGCCVE------GDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
             +G  ++       DQL LV E+    S+   +   +   L+ +W     IC  I RGL
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGL 124

Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL-AKLDEGDKTHISTRIAGTIGYMA 412
           + LH+    K++HRDIK  NVLL  +   K+ DFG+ A+LD            GT  +MA
Sbjct: 125 SHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR--TVGRRNTFIGTPYWMA 179

Query: 413 PEYALW-----GYLTYKADVYSFGIVALEIVSG 440
           PE             +K+D++S GI A+E+  G
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 81.2 bits (200), Expect = 5e-17
 Identities = 65/212 (30%), Positives = 108/212 (50%), Gaps = 28/212 (13%)

Query: 248 IGEGGFGPVYKGQLA-DGTII--AVKQLSS-KSRQGNREFLNEIAMISCL-QHPNLVKIH 302
           IGEG FG V +  +  DG  +  A+K L    S   +R+F  E+ ++  L  HPN++ + 
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELD------------WPTRQ--KICLG 348
           G C     L +  EY    +L    F R++  LE D              ++Q  +    
Sbjct: 70  GACENRGYLYIAIEYAPYGNLLD--FLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG-T 407
           +A G+ +L E+   + +HRD+ A NVL+  +L  KI+DFGL++   G++ ++   +    
Sbjct: 128 VATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLP 181

Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
           + +MA E   +   T K+DV+SFG++  EIVS
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 80.8 bits (199), Expect = 7e-17
 Identities = 80/284 (28%), Positives = 129/284 (45%), Gaps = 42/284 (14%)

Query: 246 KKIGEGGFGPVYKGQLAD------GTIIAVKQLS-SKSRQGNREFLNEIAMISCLQHPNL 298
           +++G+G FG VY+G   D       T +AVK ++ S S +   EFLNE +++      ++
Sbjct: 12  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 71

Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFG-RENCELELDWPT---RQKICLG--IARG 352
           V++ G   +G   L+V E M +  L   L   R   E     P    ++ I +   IA G
Sbjct: 72  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131

Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYM 411
           +A+L+ +   K VHRD+ A N ++  D   KI DFG+ + + E D      +    + +M
Sbjct: 132 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188

Query: 412 APEYALWGYLTYKADVYSFGIVALEIVS----GKNNMSYAPALEFDCTCLLDWACHLQQD 467
           APE    G  T  +D++SFG+V  EI S        +S    L+F              D
Sbjct: 189 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMD 236

Query: 468 GKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           G  ++  D            ER+  +  +C   +P +RPT  E+
Sbjct: 237 GGYLDQPDNC---------PERVTDLMRMCWQFNPKMRPTFLEI 271

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 79.9 bits (197), Expect = 7e-17
 Identities = 63/203 (31%), Positives = 103/203 (50%), Gaps = 15/203 (7%)

Query: 246 KKIGEGGFG-PVYKGQLADGTIIAVKQ-----LSSKSRQGNREFLNEIAMISCLQHPNLV 299
           KKIGEG FG  +      DG    +K+     +S K R+ +R+   E+A++S ++HPN+V
Sbjct: 6   KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRK---EVAVLSNMKHPNIV 62

Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
           +      E   L +V +Y E   L    + + N +  + +P  Q +   +   LA  H  
Sbjct: 63  QYQESFEENGNLYIVMDYCEGGDL----YKKINAQRGVLFPEDQILDWFVQICLALKHVH 118

Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWG 419
            R KI+HRDIK+ N+ L +D   K+ DFG+A++         T I GT  Y++PE     
Sbjct: 119 DR-KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICENR 176

Query: 420 YLTYKADVYSFGIVALEIVSGKN 442
               K+D+++ G V  E+ + K+
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLKH 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 80.1 bits (197), Expect = 7e-17
 Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 15/200 (7%)

Query: 246 KKIGEGGFGPVYKGQL-ADGTIIAVKQL-SSKSRQGNREFLNEIAMISCLQHPNLVKIHG 303
           ++IG G FG V+ G+L AD T +AVK    +       +FL E  ++    HPN+V++ G
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFK 363
            C +   + +V E ++       L         L      ++    A G+ +L  ES+  
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFL---RTEGPRLKVKELIQMVENAAAGMEYL--ESKHC 115

Query: 364 IVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT----IGYMAPEYALWG 419
           I HRD+ A N L+      KISDFG+++ +E D  + ST   G     + + APE   +G
Sbjct: 116 I-HRDLAARNCLVTEKNVLKISDFGMSR-EEEDGVYAST--GGMKQIPVKWTAPEALNYG 171

Query: 420 YLTYKADVYSFGIVALEIVS 439
             + ++DV+SFGI+  E  S
Sbjct: 172 RYSSESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 80.5 bits (199), Expect = 8e-17
 Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 14/206 (6%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQL--SSKSRQGNREFLNEIAMISCLQHP 296
             +++   +GEG +G V K +  + G I+A+K+   S   +   +  + EI M+  L+H 
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60

Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFL 356
           NLV +        +L LV+E++++  L       E     LD    +K    I RG+ F 
Sbjct: 61  NLVNLIEVFRRKKRLYLVFEFVDHTVLD----DLEKYPNGLDESRVRKYLFQILRGIEFC 116

Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYA 416
           H  +   I+HRDIK  N+L+ +    K+ DFG A+        + T    T  Y APE  
Sbjct: 117 HSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYTDYVATRWYRAPEL- 171

Query: 417 LWGYLTY-KA-DVYSFGIVALEIVSG 440
           L G   Y +A D+++ G +  E+++G
Sbjct: 172 LVGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 79/286 (27%), Positives = 126/286 (44%), Gaps = 58/286 (20%)

Query: 248 IGEGGFGPVYKGQ-LADGTIIAVKQL-SSKSRQGNREFLNE--IAMIS--CLQHPNLVKI 301
           +G G +G V K + +  GTI+AVK++ ++ + Q  +  L +  I+M S  C   P  V  
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDC---PYTVTF 65

Query: 302 HGCCV-EGDQLLLVYEYMENNSLACALFGRENCELELDWPTR--QKICLGIARGLAFLHE 358
           +G    EGD    V+  ME    +   F ++  +  L  P     KI + I + L +LH 
Sbjct: 66  YGALFREGD----VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121

Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFG--------LAKLDEGDKTHISTRIAGTIGY 410
             +  ++HRD+K +NVL++R+   K+ DFG        +AK          T  AG   Y
Sbjct: 122 --KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK----------TIDAGCKPY 169

Query: 411 MAPE-----YALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQ 465
           MAPE         GY   K+DV+S GI  +E+ +G+    Y             W    Q
Sbjct: 170 MAPERINPELNQKGY-DVKSDVWSLGITMIELATGR--FPYD-----------SWKTPFQ 215

Query: 466 QDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           Q  ++VE    +L ++    E +  +     C   +   RP   E+
Sbjct: 216 QLKQVVEEPSPQLPAEKFSPEFQDFVNK---CLKKNYKERPNYPEL 258

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 79.2 bits (195), Expect = 1e-16
 Identities = 63/199 (31%), Positives = 104/199 (52%), Gaps = 13/199 (6%)

Query: 247 KIGEGGFGPVYKG--QLADGTI-IAVKQLSSKSRQGNR-EFLNEIAMISCLQHPNLVKIH 302
           ++G G FG V KG  ++    I +A+K L +++ +  R E + E  ++  L +P +V++ 
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRF 362
           G C E + L+LV E      L   L G+++   E+      ++   ++ G+ +L E   F
Sbjct: 62  GVC-EAEALMLVMEMASGGPLNKFLSGKKD---EITVSNVVELMHQVSMGMKYL-EGKNF 116

Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT--IGYMAPEYALWGY 420
             VHRD+ A NVLL      KISDFGL+K    D ++   R AG   + + APE   +  
Sbjct: 117 --VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174

Query: 421 LTYKADVYSFGIVALEIVS 439
            + ++DV+S+GI   E  S
Sbjct: 175 FSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 79.2 bits (195), Expect = 2e-16
 Identities = 67/208 (32%), Positives = 98/208 (47%), Gaps = 17/208 (8%)

Query: 242 FDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK---SRQGNREFLNEIAMISCLQHPN 297
           F   + +G+GGFG V   Q+ A G + A K+L  K    R+G    LNE  ++  +    
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACALF--GRENCELELDWPTRQKICLGIARGLAF 355
           +V +       D L LV   M    L   ++  G    E E       +I  G    L  
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG----LED 117

Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHISTRIAGTIGYMAPE 414
           LH E+    V+RD+K  N+LLD   + +ISD GLA K+ EG+   I  R+ GT+GYMAPE
Sbjct: 118 LHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYMAPE 171

Query: 415 YALWGYLTYKADVYSFGIVALEIVSGKN 442
                  T   D +  G +  E++ G++
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMIEGQS 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 79.0 bits (194), Expect = 2e-16
 Identities = 62/212 (29%), Positives = 109/212 (51%), Gaps = 28/212 (13%)

Query: 248 IGEGGFGPVYKGQLA-DGTII--AVKQLSS-KSRQGNREFLNEIAMISCL-QHPNLVKIH 302
           IGEG FG V K ++  DG  +  A+K++    S+  +R+F  E+ ++  L  HPN++ + 
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELD------------WPTRQ--KICLG 348
           G C     L L  EY  + +L    F R++  LE D              ++Q       
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLD--FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG-T 407
           +ARG+ +L ++   + +HRD+ A N+L+  +   KI+DFGL++   G + ++   +    
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 174

Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
           + +MA E   +   T  +DV+S+G++  EIVS
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 26/218 (11%)

Query: 245 AKKIGEGGFGPVY--------KGQLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCL-Q 294
            K +GEG FG V         K +  +   +AVK L   + + +  + ++E+ M+  + +
Sbjct: 20  GKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 79

Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDW-----PTRQ------ 343
           H N++ + G C +   L ++ EY    +L   L  R    +E  +     P  Q      
Sbjct: 80  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139

Query: 344 -KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHIS 401
                 +ARG+ +L  +   K +HRD+ A NVL+  +   KI+DFGLA+ ++  D    +
Sbjct: 140 VSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196

Query: 402 TRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
           T     + +MAPE       T+++DV+SFG++  EI +
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 79.5 bits (196), Expect = 2e-16
 Identities = 64/211 (30%), Positives = 104/211 (49%), Gaps = 24/211 (11%)

Query: 242 FDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQHPNL 298
           ++  +KIGEG +G VYK +       IA+K+  L  +        + EI+++  +QH N+
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63

Query: 299 VKIHGCCVEGDQLLLVYEYME----NNSLACALFGRENCELELDWPTRQKICL-GIARGL 353
           V++        +L LV+EY++     +  +   F +         P   K  L  I RG+
Sbjct: 64  VRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKN--------PRLIKTYLYQILRGI 115

Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNP-KISDFGLAKLDEGDKTHISTRIAGTIGYMA 412
           A+ H     +++HRD+K  N+L+DR  N  K++DFGLA+   G      T    T+ Y A
Sbjct: 116 AYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARA-FGIPVRTFTHEVVTLWYRA 171

Query: 413 PEYALWGYLTYKA--DVYSFGIVALEIVSGK 441
           PE  L G   Y    D++S G +  E+V+ K
Sbjct: 172 PEILL-GSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 78.8 bits (194), Expect = 3e-16
 Identities = 66/217 (30%), Positives = 111/217 (51%), Gaps = 17/217 (7%)

Query: 246 KKIGEGGFGPV----YKGQLAD-GTIIAVKQLSSKSRQGNREFL-NEIAMISCLQHPNLV 299
           + +GEG FG V    Y  +  + G  +AVK L  +S   +   L  EI ++  L H N+V
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69

Query: 300 KIHGCCVE--GDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH 357
           K  G C E  G+ + L+ E++ + SL   L   +N   +++   + K  + I +G+ +L 
Sbjct: 70  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKN---KINLKQQLKYAVQICKGMDYLG 126

Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR--IAGTIGYMAPEY 415
             SR + VHRD+ A NVL++ +   KI DFGL K  E DK + + +  +   + + APE 
Sbjct: 127 --SR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183

Query: 416 ALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEF 452
            +       +DV+SFG+   E+++   +   +P   F
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT-YCDSESSPMTLF 219

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 61/200 (30%), Positives = 104/200 (52%), Gaps = 15/200 (7%)

Query: 246 KKIGEGGFGPVY----KGQLADGTIIAVKQLSSKSRQGNR--EFLNEIAMISCLQHPNLV 299
           +++G+G FG VY    K  +A+  +  +K++       N   +   E  ++S L HP +V
Sbjct: 6   QRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65

Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
           K H   +E D   ++ EY E   L C L   ++    L      +  + +  G+ ++H+ 
Sbjct: 66  KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125

Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYAL-- 417
              +I+HRD+KA N+ L  +L  KI DFG+++L  G    ++T   GT  YM+PE AL  
Sbjct: 126 ---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMG-SCDLATTFTGTPYYMSPE-ALKH 179

Query: 418 WGYLTYKADVYSFGIVALEI 437
            GY + K+D++S G +  E+
Sbjct: 180 QGYDS-KSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 78.5 bits (193), Expect = 5e-16
 Identities = 67/223 (30%), Positives = 106/223 (47%), Gaps = 36/223 (16%)

Query: 245 AKKIGEGGFGPVYKGQLADG---------TIIAVKQLSSKSRQGN-REFLNEIAMISCL- 293
            K +GEG FG V   + A G         T +AVK L S + + +  + ++E+ M+  + 
Sbjct: 23  GKPLGEGCFGQVVMAE-AIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 81

Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDW-----PTRQ----- 343
           +H N++ + G C +   L ++ EY    +L   L  R    +E  +     P  Q     
Sbjct: 82  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141

Query: 344 --KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS 401
                  +ARG+ +L  +   K +HRD+ A NVL+  D   KI+DFGLA+    D  HI 
Sbjct: 142 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHID 194

Query: 402 TRIAGTIG-----YMAPEYALWGYLTYKADVYSFGIVALEIVS 439
                T G     +MAPE       T+++DV+SFG++  EI +
Sbjct: 195 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 77.8 bits (191), Expect = 6e-16
 Identities = 75/255 (29%), Positives = 112/255 (43%), Gaps = 42/255 (16%)

Query: 242 FDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK---SRQGNREFLNEIAMISCLQHPN 297
           F   + +G+GGFG V   Q+ A G + A K+L  K    R+G    LNE  ++  +    
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH 357
           +V +       D L LV   M    L   ++     E   +          I  GL  LH
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIY--HMGEAGFEEGRAVFYAAEICCGLEDLH 119

Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYAL 417
           +E   +IV+RD+K  N+LLD   + +ISD GLA      +T I  R+ GT+GYMAPE   
Sbjct: 120 QE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVK 174

Query: 418 WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER 477
               T+  D ++ G +  E+++G+     +P                QQ  K        
Sbjct: 175 NERYTFSPDWWALGCLLYEMIAGQ-----SP---------------FQQRKK-------- 206

Query: 478 LGSKYKKEEAERMIK 492
              K K+EE ER++K
Sbjct: 207 ---KIKREEVERLVK 218

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 77.6 bits (191), Expect = 7e-16
 Identities = 67/207 (32%), Positives = 99/207 (47%), Gaps = 17/207 (8%)

Query: 242 FDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK---SRQGNREFLNEIAMISCLQHPN 297
           F   + +G+GGFG V   Q+ A G + A K+L  K    R+G    LNE  ++  +    
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACALF--GRENCELELDWPTRQKICLGIARGLAF 355
           +V +       D L LV   M    L   ++  G    + E       +I  G    L  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCG----LED 117

Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHISTRIAGTIGYMAPE 414
           LH E   +IV+RD+K  N+LLD   + +ISD GLA ++ EG+   I  R+ GT+GYMAPE
Sbjct: 118 LHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYMAPE 171

Query: 415 YALWGYLTYKADVYSFGIVALEIVSGK 441
                  T+  D +  G +  E++ GK
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 77.5 bits (191), Expect = 8e-16
 Identities = 64/208 (30%), Positives = 106/208 (50%), Gaps = 16/208 (7%)

Query: 241 NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQHPN 297
           ++   +KIGEG +G VYKG+    G I+A+K+  L S+        + EI+++  LQHPN
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 298 LVKIHGCCVEGDQLLLVYEY--MENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           +V +    ++  +L L++E+  M+      +L   +  + EL      +I  GI     F
Sbjct: 61  IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGI----LF 116

Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEY 415
            H     +++HRD+K  N+L+D     K++DFGLA+   G    + T    T+ Y APE 
Sbjct: 117 CH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARA-FGIPVRVYTHEVVTLWYRAPE- 171

Query: 416 ALWGYLTYKA--DVYSFGIVALEIVSGK 441
            L G   Y    D++S G +  E+ + K
Sbjct: 172 VLLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 78.1 bits (192), Expect = 8e-16
 Identities = 64/225 (28%), Positives = 106/225 (47%), Gaps = 40/225 (17%)

Query: 245 AKKIGEGGFGPVY--------KGQLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCL-Q 294
            K +GEG FG V         K +      +AVK L   +   +  + ++E+ M+  + +
Sbjct: 17  GKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK 76

Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGR---------ENCELELDWPTRQKI 345
           H N++ + G C +   L ++ EY    +L   L  R         + C+L    P  Q  
Sbjct: 77  HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL----PEEQLT 132

Query: 346 C-------LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK----LDE 394
                     +ARG+ +L  +   K +HRD+ A NVL+  D   KI+DFGLA+    +D 
Sbjct: 133 FKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDY 189

Query: 395 GDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
             KT  + R+   + +MAPE       T+++DV+SFG++  EI +
Sbjct: 190 YKKT-TNGRLP--VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 77.1 bits (190), Expect = 9e-16
 Identities = 73/268 (27%), Positives = 128/268 (47%), Gaps = 25/268 (9%)

Query: 246 KKIGEGGFGPVYK-GQLADGTIIAVKQLSSKSRQGNR-EFLNEIAMISCLQHPNLVKIHG 303
             +G G  G V K   +  GT++A K +   ++   R + L E+ ++   + P +V  +G
Sbjct: 11  SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYG 70

Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFK 363
             +  + + +  E+M+  SL      ++   + ++     KI + +  GL +L+   R  
Sbjct: 71  AFLNENNICMCMEFMDCGSLDRIY--KKGGPIPVE--ILGKIAVAVVEGLTYLYNVHR-- 124

Query: 364 IVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH-ISTRIAGTIGYMAPEYALWGYLT 422
           I+HRDIK +N+L++     K+ DFG++    G+  + I+    GT  YM+PE    G  T
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPERIQGGKYT 180

Query: 423 YKADVYSFGIVALEIVSGKNNMSYAPAL---EFDCTCLLDWACHLQQDGKLVELVDERLG 479
            K+DV+S GI  +E+  GK   +++      + D   +LD    LQQ   +V+    RL 
Sbjct: 181 VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL---LQQ---IVQEPPPRLP 234

Query: 480 SKYKKEEAERMIKVSLLCTNASPSLRPT 507
           S    E+    +   LL     P+ RPT
Sbjct: 235 SSDFPEDLRDFVDACLL---KDPTERPT 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 76.4 bits (188), Expect = 1e-15
 Identities = 60/200 (30%), Positives = 91/200 (45%), Gaps = 17/200 (8%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIA----MISCLQHPNLVK 300
           K I +G FG VY  +  + G   A+K L         +  N  A    M+   + P + K
Sbjct: 2   KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61

Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
           ++      D L LV EY+  N   CA   +    L  DW  +Q I   +  G+  LH+  
Sbjct: 62  LYYSFQSKDYLYLVMEYL--NGGDCASLIKTLGGLPEDW-AKQYIA-EVVLGVEDLHQRG 117

Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGY 420
              I+HRDIK  N+L+D+  + K++DFGL++         + +  GT  Y+APE  L   
Sbjct: 118 ---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL-----ENKKFVGTPDYLAPETILGVG 169

Query: 421 LTYKADVYSFGIVALEIVSG 440
               +D +S G V  E + G
Sbjct: 170 DDKMSDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 76.1 bits (188), Expect = 2e-15
 Identities = 55/200 (27%), Positives = 89/200 (44%), Gaps = 17/200 (8%)

Query: 248 IGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNRE---FLNEIAMISCLQHPNLVKIHG 303
           +G GGFG V   ++       A+K +  +      +     +E  ++    HP +VK++ 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFK 363
              +   + ++ EY     L   L  R       D  T +     +     +LH      
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGL----FDEYTARFYIACVVLAFEYLHNRG--- 113

Query: 364 IVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPEYALW-GYL 421
           I++RD+K  N+LLD +   K+ DFG AK L  G KT       GT  Y+APE  L  GY 
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEIILNKGY- 169

Query: 422 TYKADVYSFGIVALEIVSGK 441
            +  D +S GI+  E+++G+
Sbjct: 170 DFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 50/193 (25%), Positives = 87/193 (45%), Gaps = 29/193 (15%)

Query: 242 FDSAKKIGEGGFGPVYKGQL---ADGTIIAVKQLSSKSRQG---NREFLNEIAMISCLQH 295
           ++    IG G +G VYK +     DG   A+K+      Q    ++    EIA++  L+H
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 296 PNLVKIHGCCVE-GDQLL-LVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
            N+V +    +E  D+ + L+++Y E++      F R+   + +     + +   I  G+
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121

Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNP----KISDFGLAK--------LDEGDKTHIS 401
            +LH      ++HRD+K  N+L+  +       KI D GLA+        L + D   + 
Sbjct: 122 HYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV- 177

Query: 402 TRIAGTIGYMAPE 414
                TI Y APE
Sbjct: 178 -----TIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 76.3 bits (188), Expect = 3e-15
 Identities = 60/196 (30%), Positives = 96/196 (48%), Gaps = 29/196 (14%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNRE--F----LNEIAMISC 292
           + ++   KIG+G FG V+K +      I+A+K    K    N +  F    L EI ++  
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALK----KVLMENEKEGFPITALREIKILQL 67

Query: 293 LQHPNLVK-IHGCCVEGDQ-------LLLVYEYMENNSLACALFGRENCELELDWPTRQK 344
           L+H N+V  I  C  +            LV+E+ E++ LA  L    N  ++      +K
Sbjct: 68  LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHD-LAGLL---SNKNVKFTLSEIKK 123

Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK---LDEGDKTHIS 401
           +   +  GL ++H   R KI+HRD+KA N+L+ +D   K++DFGLA+   L +  K +  
Sbjct: 124 VMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180

Query: 402 TRIAGTIGYMAPEYAL 417
           T    T+ Y  PE  L
Sbjct: 181 TNRVVTLWYRPPELLL 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 75.4 bits (185), Expect = 3e-15
 Identities = 64/205 (31%), Positives = 96/205 (46%), Gaps = 16/205 (7%)

Query: 246 KKIGEGGFGPVYKGQLADG---TIIAVKQL-SSKSRQGNREFLNEIAMISCLQHPNLVKI 301
           K+IG G FG V  G++  G     + VK+L  S S Q   +FL E      LQH NL++ 
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60

Query: 302 HGCCVEGDQLLLVYEYMENNSLACALFGRENCE-LELDWPTRQKICLGIARGLAFLHEES 360
            G C E    LLV E+     L   L      E +  D  T Q++   IA GL  LH   
Sbjct: 61  LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--- 117

Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI-STRIAGTIGYMAPEYA--L 417
           +   +H D+   N LL  DL  KI D+GL+     +  ++   ++   + ++APE    +
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177

Query: 418 WGYL-----TYKADVYSFGIVALEI 437
            G L     T +++V+S G+   E+
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 75.9 bits (186), Expect = 4e-15
 Identities = 57/206 (27%), Positives = 109/206 (52%), Gaps = 15/206 (7%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNR-EFLNEIAMISCLQHPN 297
           ++++  +K+GEG +  VYKG+   +G ++A+K +  +  +G     + E +++  L+H N
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL-GIARGLAFL 356
           +V +H      + L LV+EY+  +   C    +    L    P   K+ L  + RGL+++
Sbjct: 65  IVLLHDIIHTKETLTLVFEYVHTD--LCQYMDKHPGGLH---PENVKLFLFQLLRGLSYI 119

Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYA 416
           H+  R+ I+HRD+K  N+L+      K++DFGLA+  +   +H  +    T+ Y  P+  
Sbjct: 120 HQ--RY-ILHRDLKPQNLLISDTGELKLADFGLARA-KSVPSHTYSNEVVTLWYRPPD-V 174

Query: 417 LWGYLTYKA--DVYSFGIVALEIVSG 440
           L G   Y    D++  G + +E++ G
Sbjct: 175 LLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 75.8 bits (186), Expect = 4e-15
 Identities = 63/212 (29%), Positives = 110/212 (51%), Gaps = 28/212 (13%)

Query: 248 IGEGGFGPVYKGQL-ADGTII--AVKQLSS-KSRQGNREFLNEIAMISCL-QHPNLVKIH 302
           IGEG FG V K ++  DG  +  A+K++    S+  +R+F  E+ ++  L  HPN++ + 
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELD------------WPTRQKICLG-- 348
           G C     L L  EY  + +L    F R++  LE D              ++Q +     
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLD--FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132

Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG-T 407
           +ARG+ +L   S+ + +HRD+ A N+L+  +   KI+DFGL++   G + ++   +    
Sbjct: 133 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 186

Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
           + +MA E   +   T  +DV+S+G++  EIVS
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 75.8 bits (186), Expect = 5e-15
 Identities = 65/220 (29%), Positives = 109/220 (49%), Gaps = 32/220 (14%)

Query: 246 KKIGEGGFGPVYKG-------QLADGTI-IAVKQLSSKSRQGN-REFLNEIAMISCL-QH 295
           K +GEG FG V +           D T+ +AVK L   +   +  + ++E+ ++  + +H
Sbjct: 18  KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77

Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGR------------ENCELELDWPTRQ 343
            N++ + G C +   L ++ EY    +L   L  R            +  E +L +    
Sbjct: 78  KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137

Query: 344 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK----LDEGDKTH 399
                +ARG+ +L  ESR + +HRD+ A NVL+  D   KI+DFGLA+    +D   KT 
Sbjct: 138 SCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194

Query: 400 ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
            + R+   + +MAPE       T+++DV+SFGI+  EI +
Sbjct: 195 -NGRLP--VKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 75.4 bits (185), Expect = 6e-15
 Identities = 60/204 (29%), Positives = 93/204 (45%), Gaps = 17/204 (8%)

Query: 246 KKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMIS------CLQHPNL 298
           K +G+G FG V+  +L       A+K L       + +   E  M+         +HP L
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDV--ECTMVEKRVLSLAWEHPFL 58

Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
             ++      + L  V EY+    L   +F  ++C  + D P        I  GL FLH 
Sbjct: 59  THLYCTFQTKENLFFVMEYLNGGDL---MFHIQSCH-KFDLPRATFYAAEIICGLQFLHS 114

Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALW 418
           +    IV+RD+K  N+LLD D + KI+DFG+ K +        T   GT  Y+APE  L 
Sbjct: 115 KG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIAPEILLG 170

Query: 419 GYLTYKADVYSFGIVALEIVSGKN 442
                  D +SFG++  E++ G++
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQS 194

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 75.0 bits (184), Expect = 6e-15
 Identities = 59/212 (27%), Positives = 107/212 (50%), Gaps = 21/212 (9%)

Query: 238 ATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQG-NREFLNEIAMISCLQH 295
           A  ++ + +K+GEG +  VYKG    +G ++A+K +S K+ +G     + E +++  L+H
Sbjct: 3   AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62

Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALF----GRENCELELDWPTRQKICLGIAR 351
            N+V +H      + L  V+EYM  + LA  +     G     + L           + R
Sbjct: 63  ANIVLLHDIIHTKETLTFVFEYMHTD-LAQYMIQHPGGLHPYNVRL-------FMFQLLR 114

Query: 352 GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYM 411
           GLA++H +    I+HRD+K  N+L+      K++DFGLA+         S+ +  T+ Y 
Sbjct: 115 GLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYR 170

Query: 412 APEYALWGYLTYKA--DVYSFGIVALEIVSGK 441
            P+  L G   Y +  D++  G + +E++ G+
Sbjct: 171 PPD-VLLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 74.2 bits (182), Expect = 7e-15
 Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 15/201 (7%)

Query: 246 KKIGEGGFGPVYKG---QLADGTIIAVKQLSSKSRQG--NREFLNEIAMISCLQHPNLVK 300
            ++G G FG V KG          +AVK L + +       E L E  ++  L +P +V+
Sbjct: 1   GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60

Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
           + G C E +  +LV E  E   L   L   ++   +       ++   ++ G+ +L EE+
Sbjct: 61  MIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEK----NITELVHQVSMGMKYL-EET 114

Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT--IGYMAPEYALW 418
            F  VHRD+ A NVLL      KISDFGL+K    D+ +   +  G   + + APE   +
Sbjct: 115 NF--VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172

Query: 419 GYLTYKADVYSFGIVALEIVS 439
              + K+DV+SFG++  E  S
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 74.8 bits (184), Expect = 9e-15
 Identities = 64/201 (31%), Positives = 93/201 (46%), Gaps = 15/201 (7%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIA----MISCLQHPNLVK 300
           K IG+G FG V   +  ADG   AVK L  K+    +E  + +A    ++  ++HP LV 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
           +H      D+L  V +Y+    L   L  RE    E   P  +     IA  L +LH   
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHL-QRERSFPE---PRARFYAAEIASALGYLHS-- 114

Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD-EGDKTHISTRIAGTIGYMAPEYALWG 419
              I++RD+K  N+LLD   +  ++DFGL K   E  KT  ++   GT  Y+APE     
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRKQ 171

Query: 420 YLTYKADVYSFGIVALEIVSG 440
                 D +  G V  E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 75/279 (26%), Positives = 124/279 (44%), Gaps = 41/279 (14%)

Query: 247 KIGEGGFGPVYKG-QLADGTIIAVKQL-----SSKSRQGNREFLNEIAMISCLQHPNLVK 300
           ++G+G +G VYK      G  +A+K++      SK  Q     + E+ ++     P +V 
Sbjct: 8   ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQ----IIMELDILHKAVSPYIVD 63

Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
            +G       + +  EYM+  SL   L+        +     ++I   + +GL FL EE 
Sbjct: 64  FYGAFFIEGAVYMCMEYMDAGSLD-KLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE- 121

Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD--KTHISTRIAGTIGYMAPEY--- 415
              I+HRD+K TNVL++ +   K+ DFG++        KT+I     G   YMAPE    
Sbjct: 122 -HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERIKS 175

Query: 416 -ALWGYLTY--KADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVE 472
                  TY  ++DV+S G+  LE+  G+    Y P           +A    Q   +V+
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGR--YPYPPET---------YANIFAQLSAIVD 224

Query: 473 LVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                L S Y  ++A+  +     C N  P+ RPT +++
Sbjct: 225 GDPPTLPSGY-SDDAQDFVA---KCLNKIPNRRPTYAQL 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 73.8 bits (181), Expect = 1e-14
 Identities = 63/201 (31%), Positives = 94/201 (46%), Gaps = 17/201 (8%)

Query: 248 IGEGGFGPVYKGQLAD-GTIIAVKQLSSK---SRQGNREFLNEIAMISCLQHPNLVKIHG 303
           +G+GGFG V   Q+ + G + A K+L  K    + G +  L E  ++  +  P +V +  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENCELELD---WPTRQKICLGIARGLAFLHEES 360
                  L LV   M    L   ++      LE++     + Q     I  G+  LH   
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQ-----ITCGILHLHS-- 113

Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGY 420
              IV+RD+K  NVLLD   N ++SD GLA   +  KT   T+ AGT GYMAPE      
Sbjct: 114 -MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEP 170

Query: 421 LTYKADVYSFGIVALEIVSGK 441
            +Y  D ++ G    E+V+G+
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 74.1 bits (183), Expect = 1e-14
 Identities = 67/211 (31%), Positives = 100/211 (47%), Gaps = 27/211 (12%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSS----KSRQGNREFLNEIAMISCLQ 294
           ++F+  K +G G FG V   +    G   A+K LS     K +Q     LNE  ++  ++
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIR 59

Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTR---QKICLGIAR 351
           HP LV ++G   +   L LV EY+    L   L  R++         R    ++ L    
Sbjct: 60  HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL--RKSGRFPEPV-ARFYAAQVVLA--- 113

Query: 352 GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGY 410
            L +LH      IV+RD+K  N+LLD D   KI+DFG AK +     T     + GT  Y
Sbjct: 114 -LEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT-----LCGTPEY 164

Query: 411 MAPEYAL-WGYLTYKADVYSFGIVALEIVSG 440
           +APE  L  GY     D ++ GI+  E+++G
Sbjct: 165 LAPEIILSKGY-GKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 37/213 (17%)

Query: 246 KKIGEGGFGPV----YKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ------- 294
           K +G+G FG V     KG      + AVK L        ++ + +   + C         
Sbjct: 1   KVLGKGSFGKVLLAELKGT---DELYAVKVL-------KKDVILQDDDVECTMTEKRVLA 50

Query: 295 ----HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
               HP L ++H C    D+L  V EY+    L   +F  +      D P  +     I 
Sbjct: 51  LAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDL---MFHIQRSG-RFDEPRARFYAAEIV 106

Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEGDKTHISTRIAGTI 408
            GL FLHE     I++RD+K  NVLLD + + KI+DFG+ K  +  G  T   +   GT 
Sbjct: 107 LGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCGTP 160

Query: 409 GYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
            Y+APE   +       D ++ G++  E+++G+
Sbjct: 161 DYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 73.7 bits (181), Expect = 1e-14
 Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 18/203 (8%)

Query: 248 IGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIH---- 302
           +G+GGFG V   Q+ A G + A K+L+ K  +  + +  E AM+   +   L K+H    
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGY--EGAMV---EKRILAKVHSRFI 55

Query: 303 ---GCCVEGD-QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
                  +    L LV   M    L   ++  +        P        I  GL  LH+
Sbjct: 56  VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ 115

Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALW 418
               +I++RD+K  NVLLD D N +ISD GLA ++  D    +   AGT G+MAPE    
Sbjct: 116 R---RIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKTKGYAGTPGFMAPELLQG 171

Query: 419 GYLTYKADVYSFGIVALEIVSGK 441
               +  D ++ G+   E+++ +
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 14/206 (6%)

Query: 241 NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ------LSSKSRQGNREFLNEIAMISCL 293
           NF   KKIG G F  VY+   L D   +A+K+      + +K+RQ   + + EI ++  L
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ---DCVKEIDLLKQL 59

Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
            HPN++K     +E ++L +V E  +   L+  +   +  +  +   T  K  + +   +
Sbjct: 60  NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119

Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAP 413
             +H  SR +++HRDIK  NV +      K+ D GL +     KT  +  + GT  YM+P
Sbjct: 120 EHMH--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLVGTPYYMSP 175

Query: 414 EYALWGYLTYKADVYSFGIVALEIVS 439
           E        +K+D++S G +  E+ +
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAA 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 13/206 (6%)

Query: 242 FDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK---SRQGNREFLNEIAMISCLQHPN 297
           F   + +G+GGFG V   Q+ A G + A K+L  K    R+G    LNE  ++  +    
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH 357
           +V +       D L LV   M    L   ++   N   +      Q+     A     L 
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFD-----EQRAIFYAAELCCGLE 116

Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHISTRIAGTIGYMAPEYA 416
           +  R +IV+RD+K  N+LLD   + +ISD GLA ++ EG+   +  R+ GT+GYMAPE  
Sbjct: 117 DLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYMAPEVI 173

Query: 417 LWGYLTYKADVYSFGIVALEIVSGKN 442
                T+  D +  G +  E++ G++
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQS 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 73.1 bits (179), Expect = 3e-14
 Identities = 54/199 (27%), Positives = 102/199 (51%), Gaps = 13/199 (6%)

Query: 247 KIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNR-EFLNEIAMISCLQHPNLVKIHGC 304
           K+GEG +  V+KG+      ++A+K++  +  +G     + E++++  L+H N+V +H  
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71

Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
                 L LV+EY++++ L   L   +NC   +     +     + RGL++ H+    KI
Sbjct: 72  IHTERCLTLVFEYLDSD-LKQYL---DNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KI 124

Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYK 424
           +HRD+K  N+L++     K++DFGLA+         S  +  T+ Y  P+  L G   Y 
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPD-VLLGSTEYS 182

Query: 425 A--DVYSFGIVALEIVSGK 441
              D++  G +  E+ +G+
Sbjct: 183 TPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 73.7 bits (182), Expect = 3e-14
 Identities = 57/222 (25%), Positives = 92/222 (41%), Gaps = 49/222 (22%)

Query: 246 KKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNREF---------LNEIAMISCLQH 295
           K IG G +G V        G  +A+K++       +  F         L EI ++  L+H
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRHLRH 58

Query: 296 PNLVKIHGCCVEGDQ-----LLLVYEYMENNSLACALFGRENCELELDWPTRQKICL--- 347
            N++ +              + +V E ME + L   +         L   T   I     
Sbjct: 59  ENIIGLLDILRPPSPEDFNDVYIVTELMETD-LHKVI----KSPQPL---TDDHIQYFLY 110

Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS------ 401
            I RGL +LH      ++HRD+K +N+L++ + + KI DFGLA+  + D+          
Sbjct: 111 QILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYV 167

Query: 402 -TRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
            TR      Y APE  L     T   D++S G +  E+++ K
Sbjct: 168 VTRW-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 72.6 bits (178), Expect = 3e-14
 Identities = 46/148 (31%), Positives = 71/148 (47%), Gaps = 7/148 (4%)

Query: 246 KKIGEGGFGPVYKGQLADGTIIA---VKQL-SSKSRQGNREFLNEIAMISCLQHPNLVKI 301
           ++IG G FG V   ++   T +A   VK+L ++ S +   EFL +      LQHPN+++ 
Sbjct: 1   QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60

Query: 302 HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESR 361
            G CVE    LLV+EY E   L   L   +           Q++   IA G+  +H   +
Sbjct: 61  LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---K 117

Query: 362 FKIVHRDIKATNVLLDRDLNPKISDFGL 389
              +H D+   N  L  DL  K+ D+G+
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGI 145

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 72.4 bits (177), Expect = 4e-14
 Identities = 57/209 (27%), Positives = 103/209 (49%), Gaps = 28/209 (13%)

Query: 241 NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
           +F+  ++IG G +G VYK + +  G + A+K +  +  +       EI M+   +H N+V
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69

Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACALFGREN--CELELDWPTRQKICLGIARGLAFLH 357
              G  +  D+L +  E+    SL   ++       E ++ + +R+ +     +GL +LH
Sbjct: 70  AYFGSYLRRDKLWICMEFCGGGSLQ-DIYHVTGPLSESQIAYVSRETL-----QGLYYLH 123

Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIA------GTIGYM 411
            + +   +HRDIK  N+LL  + + K++DFG++         I+  IA      GT  +M
Sbjct: 124 SKGK---MHRDIKGANILLTDNGHVKLADFGVS-------AQITATIAKRKSFIGTPYWM 173

Query: 412 APEYALW---GYLTYKADVYSFGIVALEI 437
           APE A     G      D+++ GI A+E+
Sbjct: 174 APEVAAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 72.4 bits (177), Expect = 4e-14
 Identities = 71/217 (32%), Positives = 109/217 (50%), Gaps = 29/217 (13%)

Query: 241 NFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQL--SSKSRQGNREFLN----EIAMISCL 293
           N+   K +G G FG VY    AD G  +AVKQ+     S++ ++E +N    EI ++  L
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKE-VNALECEIQLLKNL 61

Query: 294 QHPNLVKIHGCCVEGDQ--LLLVYEYMENNSLACAL--FG--RENCELELDWPTRQKICL 347
           +H  +V+ +GC  + ++  L +  EYM   S+   L  +G   EN        TRQ    
Sbjct: 62  RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRY---TRQ---- 114

Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG---DKTHISTRI 404
            I +G+++LH      IVHRDIK  N+L D   N K+ DFG +K  +      T I + +
Sbjct: 115 -ILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-V 169

Query: 405 AGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
            GT  +M+PE         KADV+S     +E+++ K
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 72.5 bits (178), Expect = 4e-14
 Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 36/220 (16%)

Query: 241 NFDSAKKIGEGGFGPVY----KGQLADGTIIAVKQL----------SSKSRQGNREFLNE 286
           NF+  + +G G +G V+     G    G + A+K L          +++  +  R+ L  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 287 IAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC 346
           +      + P LV +H       +L L+ +Y+    L   L+ RE+           ++ 
Sbjct: 61  VR-----RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-----EVRVY 110

Query: 347 LG-IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL---DEGDKTHIST 402
           +  I   L  LH+     I++RDIK  N+LLD + +  ++DFGL+K    +E ++ +   
Sbjct: 111 IAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY--- 164

Query: 403 RIAGTIGYMAPEYALWGYLTY-KA-DVYSFGIVALEIVSG 440
              GTI YMAPE    G   + KA D +S G++  E+++G
Sbjct: 165 SFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 72.3 bits (177), Expect = 4e-14
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 22/211 (10%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREF----LNEIAMISCLQ 294
           N F+    +GEG +G V K +  +   I+A+K+   K  + N E     L E+ M+  L+
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF--KDSEENEEVKETTLRELKMLRTLK 58

Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPT---RQKICLGIAR 351
             N+V++        +L LV+EY+E N L          EL  + P     +K+   I +
Sbjct: 59  QENIVELKEAFRRRGKLYLVFEYVEKNML----------ELLEEMPNGVPPEKVRSYIYQ 108

Query: 352 GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGY 410
            +  +H   +  IVHRDIK  N+L+  +   K+ DFG A+ L EG   + +  +A T  Y
Sbjct: 109 LIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVA-TRWY 167

Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
            +PE  L        D++S G +  E+  G+
Sbjct: 168 RSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 72.7 bits (178), Expect = 4e-14
 Identities = 55/201 (27%), Positives = 103/201 (51%), Gaps = 15/201 (7%)

Query: 246 KKIGEGGFGPVYKG--QLADGTIIAVKQLSSKSRQGNR-EFLNEIAMISCLQHPNLVKIH 302
           +K+GEG +  V+KG  +L +  ++A+K++  +  +G     + E++++  L+H N+V +H
Sbjct: 12  EKLGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70

Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRF 362
                   L LV+EY++ +         ++C   +     +     I RGLA+ H   R 
Sbjct: 71  DIVHTDKSLTLVFEYLDKDLKQYM----DDCGNIMSMHNVKIFLYQILRGLAYCH---RR 123

Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLT 422
           K++HRD+K  N+L++     K++DFGLA+         S  +  T+ Y  P+  L G   
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPD-VLLGSSE 181

Query: 423 Y--KADVYSFGIVALEIVSGK 441
           Y  + D++  G +  E+ SG+
Sbjct: 182 YSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 71.5 bits (175), Expect = 6e-14
 Identities = 62/203 (30%), Positives = 97/203 (47%), Gaps = 14/203 (6%)

Query: 246 KKIGEGGFGPV-YKGQLADGTIIAVKQLSSK--SRQGNREFLNEIAMISCLQHPNLVKIH 302
           + +G+G +G V       DG    +K+L+ +  SR+  +    E  ++S L+HPN+V   
Sbjct: 6   RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65

Query: 303 GCCVEGD-QLLLVYEYMENNSLACALFGRENCELELDWPTRQKI--CLGIARGLAFLHEE 359
                 D  L +V  + E   L   L  ++   L    P  Q +   + IA  L +LHE+
Sbjct: 66  ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLL----PENQVVEWFVQIAMALQYLHEK 121

Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWG 419
               I+HRD+K  NV L R    K+ D G+A++ E      ST I GT  YM+PE     
Sbjct: 122 ---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPELFSNK 177

Query: 420 YLTYKADVYSFGIVALEIVSGKN 442
              YK+DV++ G    E+ + K+
Sbjct: 178 PYNYKSDVWALGCCVYEMATLKH 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 74.4 bits (183), Expect = 6e-14
 Identities = 61/231 (26%), Positives = 97/231 (41%), Gaps = 41/231 (17%)

Query: 242 FDSAKKIGEGGFGPVYKG-QLADGTIIAVKQ----LSSKSRQGNREFLNEIAMISCLQHP 296
           +D  + IG+GG G VY          +A+K+    LS       R FL E  + + L HP
Sbjct: 4   YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKR-FLREAKIAADLIHP 62

Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL---ELDWPTR--------QKI 345
            +V ++  C +GD +     Y+E  +L   L      E    EL   T          KI
Sbjct: 63  GIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122

Query: 346 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH------ 399
           C  I     ++H  S+  ++HRD+K  N+LL       I D+G A   + ++        
Sbjct: 123 CATIE----YVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV 175

Query: 400 -----------ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
                      I  +I GT  YMAPE  L    +   D+Y+ G++  ++++
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 71.8 bits (176), Expect = 7e-14
 Identities = 64/278 (23%), Positives = 117/278 (42%), Gaps = 50/278 (17%)

Query: 248 IGEGGFGPVYKG-QLADGTIIAVKQLS-SKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           +G G  G VYK   L    I+AVK +    + +  ++ ++E+ ++     P ++  +G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
              +++ +  E+M+  SL   ++ +      +      +I + + +GL +L      KI+
Sbjct: 69  FVENRISICTEFMDGGSLD--VYRK------IPEHVLGRIAVAVVKGLTYLWS---LKIL 117

Query: 366 HRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIA----GTIGYMAPEYALWGYL 421
           HRD+K +N+L++     K+ DFG++       T +   IA    GT  YMAPE       
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVS-------TQLVNSIAKTYVGTNAYMAPERISGEQY 170

Query: 422 TYKADVYSFGIVALEIVSG--------KNNMSYAPALEFDCTCLLDWACHLQQDGKLVEL 473
              +DV+S GI  +E+  G        KN  S  P L+    C++D    +   G+    
Sbjct: 171 GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP-LQL-LQCIVDEDPPVLPVGQF--- 225

Query: 474 VDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                        +E+ +     C    P  RP    +
Sbjct: 226 -------------SEKFVHFITQCMRKQPKERPAPENL 250

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 71.3 bits (174), Expect = 8e-14
 Identities = 68/213 (31%), Positives = 106/213 (49%), Gaps = 21/213 (9%)

Query: 241 NFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLS--SKSRQGNREFLN---EIAMISCLQ 294
           N+   K +G+G FG VY     D G  +A KQ+    +S + ++E      EI ++  LQ
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 295 HPNLVKIHGCCVE-GDQLLLVY-EYMENNSLACAL--FGRENCELELDWPTRQKICLGIA 350
           H  +V+ +GC  +  ++ L ++ EYM   S+   L  +G     +   + TRQ     I 
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKY-TRQ-----IL 116

Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTR-IAGTI 408
            G+++LH      IVHRDIK  N+L D   N K+ DFG +K L     +    R + GT 
Sbjct: 117 EGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTP 173

Query: 409 GYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
            +M+PE         KADV+S G   +E+++ K
Sbjct: 174 YWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 72.1 bits (177), Expect = 8e-14
 Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 30/209 (14%)

Query: 246 KKIGEGGFGPVY---KGQLAD-GTIIAVKQL---SSKSRQGNREFLNEIAMISCLQHPNL 298
           K +G+G FG V+   K    D G + A+K L   + K R   R    E  +++ + HP +
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFI 60

Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACAL-----FGRENCELELDWPTRQKICLGIARGL 353
           VK+H       +L L+ +++    L   L     F  E+ +  L           +A  L
Sbjct: 61  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL---------AELALAL 111

Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEGDKTHISTRIAGTIGYM 411
             LH      I++RD+K  N+LLD + + K++DFGL+K  +D   K +      GT+ YM
Sbjct: 112 DHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYM 165

Query: 412 APEYALWGYLTYKADVYSFGIVALEIVSG 440
           APE       T  AD +SFG++  E+++G
Sbjct: 166 APEVVNRRGHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 71.6 bits (175), Expect = 9e-14
 Identities = 56/200 (28%), Positives = 104/200 (52%), Gaps = 15/200 (7%)

Query: 247 KIGEGGFGPVYKG--QLADGTIIAVKQLSSKSRQGNR-EFLNEIAMISCLQHPNLVKIHG 303
           K+GEG +  VYKG  +L D  ++A+K++  +  +G     + E++++  L+H N+V +H 
Sbjct: 13  KLGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFK 363
                  L LV+EY++ + L   L   ++C   ++    +     + RGL + H   R K
Sbjct: 72  IIHTEKSLTLVFEYLDKD-LKQYL---DDCGNSINMHNVKLFLFQLLRGLNYCH---RRK 124

Query: 364 IVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTY 423
           ++HRD+K  N+L++     K++DFGLA+         S  +  T+ Y  P+  L G   Y
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILL-GSTDY 182

Query: 424 --KADVYSFGIVALEIVSGK 441
             + D++  G +  E+ +G+
Sbjct: 183 STQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 71.4 bits (175), Expect = 1e-13
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 27/218 (12%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQH- 295
           + ++  +KIGEG +G VYK +    G ++A+K+  L           L EI+++  L   
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 296 PNLVKIHGCCVEG-------DQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLG 348
             +V++    VE          L LV+EY++++               L   T +     
Sbjct: 61  IYIVRL--LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118

Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP-KISDFGLAK---LDEGDKTHISTRI 404
           + +G+A  H+     ++HRD+K  N+L+D+     KI+D GL +   +     TH    I
Sbjct: 119 LLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH---EI 172

Query: 405 AGTIGYMAPEYALWGYLTYKA--DVYSFGIVALEIVSG 440
             T+ Y APE  L G   Y    D++S G +  E+   
Sbjct: 173 V-TLWYRAPE-VLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 39/226 (17%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLS----SKSRQGNREF----------LNEIAMI 290
             +GEG +G V K      G I+A+K++     S     +R+           L E+ ++
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 291 SCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           + ++H N++ +    VEGD + LV + M ++ L   +    + ++ L     + I L I 
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIMASD-LKKVV----DRKIRLTESQVKCILLQIL 129

Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-------------KLDEGDK 397
            GL  LH+      +HRD+   N+ ++     KI+DFGLA             K +   +
Sbjct: 130 NGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186

Query: 398 THISTRIAGTIGYMAPEYALWGYLTY--KADVYSFGIVALEIVSGK 441
               T    T+ Y APE  L G   Y    D++S G +  E+++GK
Sbjct: 187 REEMTSKVVTLWYRAPEL-LMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 55/208 (26%), Positives = 104/208 (50%), Gaps = 20/208 (9%)

Query: 242 FDSAKKIGEGGFGPVYKGQ-LADG-TIIAVKQLSSKSRQGNREF--LNEIAMISCLQ--- 294
           ++   +IGEG +G V+K + L +G   +A+K++  ++ +       + E+A++  L+   
Sbjct: 3   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62

Query: 295 HPNLVKIHGCCV-----EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGI 349
           HPN+V++   C         +L LV+E+++ +      +  +  E  +   T + +   +
Sbjct: 63  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD---LTTYLDKVPEPGVPTETIKDMMFQL 119

Query: 350 ARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIG 409
            RGL FLH     ++VHRD+K  N+L+      K++DFGLA++         T +  T+ 
Sbjct: 120 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLW 174

Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEI 437
           Y APE  L        D++S G +  E+
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 20/208 (9%)

Query: 248 IGEGGFGPVYKG---QLADG-----TIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
           +G+G F  ++KG   ++ D      T + +K L    R  +  F    +M+S L H +LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF-LHE 358
             +G CV GD+ ++V EY++  SL   L   +N  + + W       L +A+ LA+ LH 
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNL-INISWK------LEVAKQLAWALHF 115

Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL-DEGDKTHISTR--IAGTIGYMAPE- 414
                + H ++ A NVLL R+ + K  +    KL D G    +  +  +   I ++ PE 
Sbjct: 116 LEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPEC 175

Query: 415 YALWGYLTYKADVYSFGIVALEIVSGKN 442
                 L+  AD +SFG    EI SG +
Sbjct: 176 IENPQNLSLAADKWSFGTTLWEIFSGGD 203

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 63/212 (29%), Positives = 107/212 (50%), Gaps = 32/212 (15%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFL--NEIAMISCLQHP 296
           ++++  +++G G +G VYK + L  G + AVK +  K   G+   L   EI M+   +H 
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKII--KLEPGDDFSLIQQEIFMVKECKHC 66

Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSLACALFGREN--CELELDWPTRQKICLGIARGLA 354
           N+V   G  +  ++L +  EY    SL   ++       EL++ +  R+ +     +GLA
Sbjct: 67  NIVAYFGSYLSREKLWICMEYCGGGSLQ-DIYHVTGPLSELQIAYVCRETL-----QGLA 120

Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIA------GTI 408
           +LH + +   +HRDIK  N+LL  + + K++DFG+A         I+  IA      GT 
Sbjct: 121 YLHSKGK---MHRDIKGANILLTDNGDVKLADFGVA-------AKITATIAKRKSFIGTP 170

Query: 409 GYMAPEYALW---GYLTYKADVYSFGIVALEI 437
            +MAPE A     G      D+++ GI A+E+
Sbjct: 171 YWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 57/206 (27%), Positives = 102/206 (49%), Gaps = 23/206 (11%)

Query: 250 EGGFGPVYKGQLADGT--------IIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKI 301
           EG FG ++ G L D          +  VK  +S+  Q     L E  ++  L H N++ I
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEI-QVTL-LLQESCLLYGLSHQNILPI 73

Query: 302 HGCCVE-GDQLLLVYEYMENNSLACALFGRENCELELDWP----TRQKICLG--IARGLA 354
              C+E G+   ++Y YM   +L   LF ++    E + P    T+Q + +   IA G++
Sbjct: 74  LHVCIEDGEPPFVLYPYMNWGNLK--LFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131

Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAP 413
           +LH   +  ++H+DI A N ++D +L  KI+D  L++ L   D   +       + +MA 
Sbjct: 132 YLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMAL 188

Query: 414 EYALWGYLTYKADVYSFGIVALEIVS 439
           E  +    +  +DV+SFG++  E+++
Sbjct: 189 ESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 58/210 (27%), Positives = 102/210 (48%), Gaps = 22/210 (10%)

Query: 239 TNNFDSAKKIGEGGFGPV--YKGQLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQ 294
           TN +   + +G G FG V   + QL  G  +A+K++     +    +    E+ ++  L+
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR 67

Query: 295 HPNLVKIHGCCVEG-DQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
           H N++ +    +   + +  V E +  + L   L  R      L+    Q     I RGL
Sbjct: 68  HENIISLSDIFISPLEDIYFVTELLGTD-LHRLLTSRP-----LEKQFIQYFLYQILRGL 121

Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-HISTRIAGTIGYMA 412
            ++H      +VHRD+K +N+L++ + + KI DFGLA++ +   T ++STR      Y A
Sbjct: 122 KYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRA 173

Query: 413 PEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           PE  L W     + D++S G +  E++ GK
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 70.4 bits (172), Expect = 3e-13
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 15/201 (7%)

Query: 246 KKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIA----MISCLQHPNLVK 300
           K IG+G FG V   +  +DG+  AVK L  K+    +E  + +A    ++  L+HP LV 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
           +H      ++L  V +Y+    L   L  RE C LE   P  +     +A  + +LH  +
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHL-QRERCFLE---PRARFYAAEVASAIGYLHSLN 116

Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG-DKTHISTRIAGTIGYMAPEYALWG 419
              I++RD+K  N+LLD   +  ++DFGL K  EG +    ++   GT  Y+APE     
Sbjct: 117 ---IIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKE 171

Query: 420 YLTYKADVYSFGIVALEIVSG 440
                 D +  G V  E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 69.4 bits (170), Expect = 5e-13
 Identities = 65/220 (29%), Positives = 105/220 (47%), Gaps = 33/220 (15%)

Query: 242 FDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGN-RE-----FLNEIAMISCLQ 294
           FD   +IGEG +G VYK +  D G ++A+K    K R  N +E      + EI ++  L 
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALK----KVRLDNEKEGFPITAIREIKILRQLN 64

Query: 295 HPNLVKIHGCCVEGDQLL----------LVYEYMENNSLACALFG-RENCELELDWPTRQ 343
           H N+V +     +    L          LV+EYM+++     L G  E+  +       +
Sbjct: 65  HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHD-----LMGLLESGLVHFSEDHIK 119

Query: 344 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR 403
                +  GL + H+++    +HRDIK +N+LL+     K++DFGLA+L   +++   T 
Sbjct: 120 SFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTN 176

Query: 404 IAGTIGYMAPEYALWGYLTY--KADVYSFGIVALEIVSGK 441
              T+ Y  PE  L G   Y    DV+S G +  E+ + K
Sbjct: 177 KVITLWYRPPELLL-GEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 69.4 bits (170), Expect = 6e-13
 Identities = 56/180 (31%), Positives = 88/180 (48%), Gaps = 22/180 (12%)

Query: 246 KKIGEGGFGPVYKGQLADGT----IIAVKQLSS----KSRQGNREFLNEIAMISCLQHPN 297
           K +G+GG+G V++ +   G     I A+K L      ++++       E  ++  ++HP 
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLG-IARGLAFL 356
           +V +      G +L L+ EY+    L   L  RE   +E          L  I+  L  L
Sbjct: 62  IVDLIYAFQTGGKLYLILEYLSGGELFMHL-EREGIFME----DTACFYLSEISLALEHL 116

Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEGDKTHISTRIAGTIGYMAPE 414
           H++    I++RD+K  N+LLD   + K++DFGL K  + EG  TH      GTI YMAPE
Sbjct: 117 HQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEYMAPE 170

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 69.7 bits (170), Expect = 6e-13
 Identities = 63/200 (31%), Positives = 93/200 (46%), Gaps = 13/200 (6%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKS---RQGNREFLNEI-AMISCLQHPNLVK 300
           K IG+G FG V   +  A+    AVK L  K+   ++  +  ++E   ++  ++HP LV 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
           +H      D+L  V +Y+    L   L  RE C LE   P  +     IA  L +LH   
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHL-QRERCFLE---PRARFYAAEIASALGYLHS-- 114

Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGY 420
              IV+RD+K  N+LLD   +  ++DFGL K +       ST   GT  Y+APE      
Sbjct: 115 -LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTPEYLAPEVLHKQP 172

Query: 421 LTYKADVYSFGIVALEIVSG 440
                D +  G V  E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 68.0 bits (166), Expect = 1e-12
 Identities = 69/207 (33%), Positives = 96/207 (46%), Gaps = 30/207 (14%)

Query: 248 IGEGGFGPVYKGQLAD-GTIIAVKQLSSKS---RQGNREFLNEIAMISCLQH---PNLVK 300
           IG GGFG VY  + AD G + A+K L  K    +QG    LNE  M+S +     P +V 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 301 IHGCCVEGDQLLLVYEYMENNSLACAL-----FGRENCELELDWPTRQKICLGIARGLAF 355
           +       D+L  + + M    L   L     F     E E+ +   + I       L  
Sbjct: 62  MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS----EAEMRFYAAEII-------LGL 110

Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEY 415
            H  +RF +V+RD+K  N+LLD   + +ISD GLA      K H S    GT GYMAPE 
Sbjct: 111 EHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEV 166

Query: 416 ALWGYLTY--KADVYSFGIVALEIVSG 440
              G + Y   AD +S G +  +++ G
Sbjct: 167 LQKG-VAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 68.9 bits (169), Expect = 1e-12
 Identities = 64/211 (30%), Positives = 88/211 (41%), Gaps = 38/211 (18%)

Query: 248 IGEGGFGPV----YKGQ--------LADGTIIA---VKQLSSKSRQGNREFLNEIAMISC 292
           +G G FG V    YK          L  G IIA   V+ L  + R      + E A  + 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKR------IFETA--NS 58

Query: 293 LQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIAR- 351
            +HP LV +  C    D +  V EY     L           +  D  +  +     A  
Sbjct: 59  ERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMM--------HIHTDVFSEPRAVFYAACV 110

Query: 352 --GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIG 409
             GL +LHE    KIV+RD+K  N+LLD +   KI+DFGL K   G     ST   GT  
Sbjct: 111 VLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-FCGTPE 166

Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           ++APE       T   D +  G++  E++ G
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 68.0 bits (166), Expect = 1e-12
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 18/213 (8%)

Query: 242 FDSAKKIGEGGFGPVYKGQLA--DGTI--IAVKQLSSK--SRQGNREFLNEIAMISCLQH 295
           F   + +G+G FG V + QL   DG+   +AVK L +   S     EFL E A +    H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 296 PNLVKIHGCCVEGDQL------LLVYEYMENNSLACALFGRENCELELDWP--TRQKICL 347
           PN++K+ G  +           +++  +M++  L   L      E     P  T  +  +
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHISTRIAG 406
            IA G+ +L   S    +HRD+ A N +L+ ++   ++DFGL+ K+  GD          
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
            + ++A E       T  +DV++FG+   EI++
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 52/206 (25%), Positives = 104/206 (50%), Gaps = 15/206 (7%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNR-EFLNEIAMISCLQHPN 297
           ++F+   ++G G  G V K Q    G I+A K +  + +   R + + E+ ++     P 
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH 357
           +V  +G      ++ +  E+M+  SL   L   +    E+      K+ + + RGLA+L 
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEI----LGKVSIAVLRGLAYLR 120

Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEGDKTHISTRIAGTIGYMAPEY 415
           E  + +I+HRD+K +N+L++     K+ DFG++   +D      ++    GT  YM+PE 
Sbjct: 121 E--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPER 173

Query: 416 ALWGYLTYKADVYSFGIVALEIVSGK 441
               + + ++D++S G+  +E+  G+
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 68.4 bits (167), Expect = 1e-12
 Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 19/205 (9%)

Query: 246 KKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMIS------CLQHPNL 298
           K +G+G FG V   +L   G   AVK L       + +   E  M+         ++P L
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDV--ECTMVEKRVLALAWENPFL 58

Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL-ELDWPTRQKICLGIARGLAFLH 357
             ++      + L  V E++    L   +  +   +L    +   + +C     GL FLH
Sbjct: 59  THLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC-----GLQFLH 113

Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYAL 417
            +    I++RD+K  NV+LDRD + KI+DFG+ K +       ST   GT  Y+APE   
Sbjct: 114 SKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQ 169

Query: 418 WGYLTYKADVYSFGIVALEIVSGKN 442
               T+  D +SFG++  E++ G++
Sbjct: 170 GLKYTFSVDWWSFGVLLYEMLIGQS 194

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 68.0 bits (166), Expect = 2e-12
 Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 21/202 (10%)

Query: 248 IGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREF---LNEIAMIS-CLQHPNLVKIH 302
           +G+G FG V   +L   G + AVK L       + +    + E  ++S    HP L +++
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRF 362
            C    D+L  V E++    L   +F  +      D    +     I   L FLH++   
Sbjct: 63  CCFQTPDRLFFVMEFVNGGDL---MFHIQKSR-RFDEARARFYAAEITSALMFLHDKG-- 116

Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR-IAGTIGYMAPEY---ALW 418
            I++RD+K  NVLLD + + K++DFG+ K  EG     +T    GT  Y+APE     L+
Sbjct: 117 -IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEMLY 173

Query: 419 GYLTYKADVYSFGIVALEIVSG 440
           G      D ++ G++  E++ G
Sbjct: 174 GPSV---DWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 28/216 (12%)

Query: 241 NFDSAKKIGEGGFGPV--------------YKGQLADGTIIAVKQLSSKSRQGNREFLNE 286
           NF+  K +G G +G V              Y  ++     I  K  +++  +  R+ L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 287 IAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC 346
           I      Q P LV +H       +L L+ +Y+    L   L  RE           Q++ 
Sbjct: 61  IR-----QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERF-------KEQEVQ 108

Query: 347 LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG 406
           +     +  L    +  I++RDIK  N+LLD + +  ++DFGL+K    D+   +    G
Sbjct: 109 IYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCG 168

Query: 407 TIGYMAPEYALWGYLTY-KA-DVYSFGIVALEIVSG 440
           TI YMAP+    G   + KA D +S G++  E+++G
Sbjct: 169 TIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 47/150 (31%), Positives = 75/150 (50%), Gaps = 12/150 (8%)

Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           +P LV +H C     +L LV EY+    L   +  +     E       +IC+     L 
Sbjct: 55  NPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA----LN 110

Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEGDKTHISTRIAGTIGYMA 412
           FLHE     I++RD+K  NVLLD D + K++D+G+ K  L  GD T   +   GT  Y+A
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIA 164

Query: 413 PEYALWGYLTYKADVYSFGIVALEIVSGKN 442
           PE        +  D ++ G++  E+++G++
Sbjct: 165 PEILRGEEYGFSVDWWALGVLMFEMMAGRS 194

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 21/212 (9%)

Query: 242 FDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREF--LNEIAMISCLQ---H 295
           ++   +IG G +G VYK +    G  +A+K +  ++ +       + E+A++  L+   H
Sbjct: 2   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61

Query: 296 PNLVKIHGCCVEG--DQ---LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           PN+V++   C     D+   + LV+E+++ + L   L       L  +  T + +     
Sbjct: 62  PNIVRLMDVCATSRTDRETKVTLVFEHVDQD-LRTYLDKVPPPGLPAE--TIKDLMRQFL 118

Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS-TRIAGTIG 409
           RGL FLH      IVHRD+K  N+L+      K++DFGLA++       ++ T +  T+ 
Sbjct: 119 RGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYS---CQMALTPVVVTLW 172

Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           Y APE  L        D++S G +  E+   K
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 69/226 (30%), Positives = 110/226 (48%), Gaps = 28/226 (12%)

Query: 241 NFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQL--SSKSRQGNRE---FLNEIAMISCLQ 294
           N+   K +G+G FG VY    AD G  +AVKQ+    +S + ++E      EI ++  L 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 295 HPNLVKIHGCCVEGDQ--LLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICLGIA 350
           H  +V+ +GC  +  +  L +  E+M   S+   L  +G     +   + TRQ     I 
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKY-TRQ-----IL 116

Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG---DKTHISTRIAGT 407
            G+++LH      IVHRDIK  N+L D   N K+ DFG +K  +      T + + + GT
Sbjct: 117 EGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGT 172

Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFD 453
             +M+PE         KAD++S G   +E+++ K      P  EF+
Sbjct: 173 PYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK-----PPWAEFE 213

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 66.6 bits (162), Expect = 4e-12
 Identities = 67/206 (32%), Positives = 93/206 (45%), Gaps = 28/206 (13%)

Query: 248 IGEGGFGPVYKGQLAD-GTIIAVKQLSSKS---RQGNREFLNEIAMISCLQH---PNLVK 300
           IG GGFG VY  + AD G + A+K L  K    +QG    LNE  M+S +     P +V 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 301 IHGCCVEGDQLLLVYEYMENNSLACAL-----FGRENCELELDWPTRQKICLGIARGLAF 355
           +       D+L  + + M    L   L     F  +            +I LG+      
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-----YATEIILGLE----- 111

Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEY 415
            H  +RF +V+RD+K  N+LLD   + +ISD GLA      K H S    GT GYMAPE 
Sbjct: 112 -HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEV 166

Query: 416 ALWGY-LTYKADVYSFGIVALEIVSG 440
              G      AD +S G +  +++ G
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 66.6 bits (163), Expect = 5e-12
 Identities = 62/291 (21%), Positives = 111/291 (38%), Gaps = 43/291 (14%)

Query: 251 GGFGPVYKGQLADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEG 308
                + K +    T++AVK+  L S S++  +    EI     LQHPN++      +  
Sbjct: 13  LMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD 71

Query: 309 DQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRD 368
            +L +V   M   S  C    + +    L       I   +   L ++H +     +HR 
Sbjct: 72  SELYVVSPLMAYGS--CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRS 126

Query: 369 IKATNVLLDRDLNPKISDFGLA-KLDEGDK----THISTR-IAGTIGYMAPEY---ALWG 419
           +KA+++LL  D    +S    +  + +  K     H   +     + +++PE     L G
Sbjct: 127 VKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQG 186

Query: 420 YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCT------------CLLDWACHLQQD 467
           Y   K+D+YS GI A E+ +G     + P  +   T            CLLD + +   +
Sbjct: 187 Y-NEKSDIYSVGITACELANG-----HVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240

Query: 468 GKLVELVDERLGS--------KYKKEEAERMIKVSLLCTNASPSLRPTMSE 510
             + +                 Y +  +E   +   LC    P  RP+ S+
Sbjct: 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQ 291

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 65.8 bits (160), Expect = 6e-12
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 34/212 (16%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQL----SSKSRQGNREFLNEIAMISCLQHPNLVK 300
           + +GEG FG     Q +      A+K++    SS + + +R+   E  +++ ++HPN+V 
Sbjct: 6   RVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK---EAVLLAKMKHPNIVA 62

Query: 301 IHGCCVEGD-QLLLVYEYMENNSLA-------CALFGRENCELELDWPTRQKICLGIARG 352
                 E D  L +V EY +   L          LF  +     L W    ++CLG+   
Sbjct: 63  FKES-FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI---LQWFV--QMCLGVQH- 115

Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMA 412
              +HE+   +++HRDIK+ N+ L ++   K+ DFG A+L      +  T + GT  Y+ 
Sbjct: 116 ---IHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVP 168

Query: 413 PEYALWGYLTY--KADVYSFGIVALEIVSGKN 442
           PE  +W  + Y  K+D++S G +  E+ + K+
Sbjct: 169 PE--IWENMPYNNKSDIWSLGCILYELCTLKH 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 68.3 bits (167), Expect = 6e-12
 Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 20/194 (10%)

Query: 267 IAVKQLSSKSRQGNRE---FLNEIAMISCLQHPNLVKIHGCCVEGDQLLL-VYEYMENNS 322
           +A+K L + + +   +   F  E A+ + L HPN+V +         LL  V+EY+   +
Sbjct: 6   VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRT 65

Query: 323 LACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD-RDLN 381
           L   L      +  L      ++ L +   LA  H +    IVHRD+K  N+++    + 
Sbjct: 66  LREVL----AADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVR 118

Query: 382 P--KISDFGLAKL----DEGDKTHIS--TRIAGTIGYMAPEYALWGYLTYKADVYSFGIV 433
           P  K+ DFG+  L     + D   ++  T + GT  Y APE      +T  +D+Y++G++
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178

Query: 434 ALEIVSGKNNMSYA 447
            LE ++G+  +  A
Sbjct: 179 FLECLTGQRVVQGA 192

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 66.7 bits (163), Expect = 7e-12
 Identities = 36/95 (37%), Positives = 55/95 (57%), Gaps = 6/95 (6%)

Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTI 408
           I RGL +LH      I+HRDIK  N+L++ +   KI DFGLA+++E D++   T+   T 
Sbjct: 112 ILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168

Query: 409 GYMAPEYALWG--YLTYKADVYSFGIVALEIVSGK 441
            Y APE  L G  + T   D++S G +  E++  +
Sbjct: 169 YYRAPEI-LMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 66.0 bits (161), Expect = 8e-12
 Identities = 65/216 (30%), Positives = 98/216 (45%), Gaps = 24/216 (11%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQL----ADGTIIAVKQLSSKSRQGNRE----FLNEIAMIS 291
            +FD    +G G FG V   Q+    A G I A+K +  KS    +E    F  E  ++S
Sbjct: 1   KDFDVKSLVGRGHFGEV---QVVREKATGDIYAMKVMK-KSVLLAQETVSFFEEERDILS 56

Query: 292 CLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIAR 351
               P + ++     + D L LV EY     L  +L  R   + + D          +A 
Sbjct: 57  ISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDL-LSLLNRYEDQFDEDM-----AQFYLAE 110

Query: 352 GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYM 411
            +  +H   +   VHRDIK  NVL+DR  + K++DFG A     +K   S    GT  Y+
Sbjct: 111 LVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYI 170

Query: 412 APEY--ALWGYL--TY--KADVYSFGIVALEIVSGK 441
           APE    + G    TY  + D +S G++A E++ G+
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 67/214 (31%), Positives = 100/214 (46%), Gaps = 17/214 (7%)

Query: 239 TNNFDSAKKIGEGGFGPVYK-GQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ-HP 296
           ++ ++  + IG+G +G V+K     +G+  AVK L       + E   E  ++  L  HP
Sbjct: 17  SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDP-IHDIDEEIEAEYNILKALSDHP 75

Query: 297 NLVKIHGC-----CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIAR 351
           N+VK +G         GDQL LV E     S+   + G       ++ P    I      
Sbjct: 76  NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM 135

Query: 352 GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYM 411
           GL  LH     K +HRD+K  N+LL  +   K+ DFG++      +   +T + GT  +M
Sbjct: 136 GLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWM 191

Query: 412 APEY-ALWGYL--TYKA--DVYSFGIVALEIVSG 440
           APE  A    L  TY A  DV+S GI A+E+  G
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 36/94 (38%), Positives = 55/94 (58%), Gaps = 4/94 (4%)

Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTI 408
           I  GL FLH++    I++RD+K  NVLLD+D + KI+DFG+ K +   +   ST   GT 
Sbjct: 105 IICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTP 160

Query: 409 GYMAPEYALWGYLTYKADVYSFGIVALEIVSGKN 442
            Y+APE           D +SFG++  E++ G++
Sbjct: 161 DYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQS 194

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 18/232 (7%)

Query: 215 KETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTI--IAVKQL 272
           K     K+ D  +     ++ K    +F+  + +G G FG V      +     +A+K+ 
Sbjct: 5   KNLQLHKKKDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRF 64

Query: 273 SS----KSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALF 328
                 K +Q +  F +E  +++ + HP  V ++G   +   L LV E++         F
Sbjct: 65  EKSKIIKQKQVDHVF-SERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFT--F 121

Query: 329 GRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFG 388
            R N     D       C   A+ +          IV+RD+K  N+LLD+D   K++DFG
Sbjct: 122 LRRNKRFPNDVG-----CFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFG 176

Query: 389 LAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            AK+ +   T   T + GT  Y+APE  L       AD ++ GI   EI+ G
Sbjct: 177 FAKVVD---TRTYT-LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 60/201 (29%), Positives = 91/201 (45%), Gaps = 15/201 (7%)

Query: 246 KKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK---SRQGNREFLNEI-AMISCLQHPNLVK 300
           K IG+G FG V   +   DG   AVK L  K   +R+  +  + E   ++  ++HP LV 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
           +H      ++L  V +++    L    F     E     P  +     IA  L +LH   
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGEL----FFHLQRERSFPEPRARFYAAEIASALGYLHS-- 114

Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG-DKTHISTRIAGTIGYMAPEYALWG 419
              IV+RD+K  N+LLD   +  ++DFGL K  EG  ++  +T   GT  Y+APE     
Sbjct: 115 -INIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQ 171

Query: 420 YLTYKADVYSFGIVALEIVSG 440
                 D +  G V  E++ G
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 65.3 bits (160), Expect = 2e-11
 Identities = 66/221 (29%), Positives = 114/221 (51%), Gaps = 40/221 (18%)

Query: 242 FDSAKKIGEGGFGPVYKGQLAD---GTIIAVK------QLSSKSRQGNRE--FLNEIAMI 290
           ++  +K+G+G +G V+K    D     ++A+K      + ++ +++  RE  FL E+   
Sbjct: 9   YEILQKLGKGAYGIVWKA--IDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG-- 64

Query: 291 SCLQHPNLVK---IHGCCVEGDQ-LLLVYEYMENNSLACALFGRENCELELDWPTRQKIC 346
               HPN+VK   +     E D+ + LV+EYME +  A     R N   ++    ++ I 
Sbjct: 65  ---DHPNIVKLLNVIK--AENDKDIYLVFEYMETDLHAVI---RANILEDVH---KRYIM 113

Query: 347 LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK----LDEGDKTHIST 402
             + + L ++H  S   ++HRD+K +N+LL+ D   K++DFGLA+    L+E  +  + T
Sbjct: 114 YQLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLT 170

Query: 403 RIAGTIGYMAPEYALWGYLTY-KA-DVYSFGIVALEIVSGK 441
               T  Y APE  L G   Y K  D++S G +  E++ GK
Sbjct: 171 DYVATRWYRAPE-ILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 65.1 bits (158), Expect = 2e-11
 Identities = 64/279 (22%), Positives = 124/279 (44%), Gaps = 26/279 (9%)

Query: 240 NNFDSAKKIGEGGFGPVYK-GQLADGTIIAVKQLSSKSRQGNR-EFLNEIAMISCLQHPN 297
           ++F+   ++G G  G V+K      G I+A K +  + +   R + + E+ ++     P 
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH 357
           +V  +G      ++ +  E+M+  SL   L        ++      K+ + + +GL +L 
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLR 120

Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEGDKTHISTRIAGTIGYMAPEY 415
           E  + KI+HRD+K +N+L++     K+ DFG++   +D      ++    GT  YM+PE 
Sbjct: 121 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPER 173

Query: 416 ALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD 475
               + + ++D++S G+  +E+  G+  +    A E +    L + C ++ D    E   
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE----LMFGCPVEGDPAESETSP 229

Query: 476 E-----RLGSKYKKEEAERMIKVSLL--CTNASPSLRPT 507
                 R  S Y  +    M    LL    N  P   P+
Sbjct: 230 RPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPS 268

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 64.3 bits (156), Expect = 4e-11
 Identities = 51/166 (30%), Positives = 81/166 (48%), Gaps = 24/166 (14%)

Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG-T 407
           +A+G+ FL   SR K +HRD+ A N+LL  +   KI DFGLA+    D  ++    A   
Sbjct: 188 VAKGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD 467
           + +MAPE       T ++DV+SFG++  EI S     S  P ++ D     ++   L++ 
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPGVKID----EEFCRRLKE- 297

Query: 468 GKLVELVDERLGSKYKKEE--AERMIKVSLLCTNASPSLRPTMSEV 511
                      G++ +  +     M +  L C +  PS RPT SE+
Sbjct: 298 -----------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL 332

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 64.2 bits (156), Expect = 4e-11
 Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 26/211 (12%)

Query: 242 FDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHPN- 297
           + S K++G G +G V        G  +A+K+LS   +S    +    E+ ++  +QH N 
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76

Query: 298 --LVKIHGCCVEGDQL---LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARG 352
             L+ +    V GD+     LV  YM+ +     + G    E ++ +   Q +C     G
Sbjct: 77  IGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPLSEDKVQYLVYQMLC-----G 129

Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-HISTRIAGTIGYM 411
           L ++H      I+HRD+K  N+ ++ D   KI DFGLA+  + + T ++ TR      Y 
Sbjct: 130 LKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYR 181

Query: 412 APEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           APE  L W +     D++S G +  E+++GK
Sbjct: 182 APEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 45/150 (30%), Positives = 76/150 (50%), Gaps = 12/150 (8%)

Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HP LV +H C     +L  V EY+    L   +F  +  + +L     +     I+  L 
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQR-QRKLPEEHARFYSAEISLALN 110

Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEGDKTHISTRIAGTIGYMA 412
           +LHE     I++RD+K  NVLLD + + K++D+G+ K  L  GD T   +   GT  Y+A
Sbjct: 111 YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIA 164

Query: 413 PEYALWGYLTYKADVYSFGIVALEIVSGKN 442
           PE        +  D ++ G++  E+++G++
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRS 194

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 63.6 bits (155), Expect = 5e-11
 Identities = 46/150 (30%), Positives = 72/150 (48%), Gaps = 16/150 (10%)

Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICLGIARGL 353
           P L ++H C    D+L  V EY+    L   +   G+         P        IA GL
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK------FKEPHAVFYAAEIAIGL 114

Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEGDKTHISTRIAGTIGYM 411
            FLH +    I++RD+K  NV+LD + + KI+DFG+ K  +  G  T       GT  Y+
Sbjct: 115 FFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT---FCGTPDYI 168

Query: 412 APEYALWGYLTYKADVYSFGIVALEIVSGK 441
           APE   +       D ++FG++  E+++G+
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 62.8 bits (153), Expect = 6e-11
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 25/210 (11%)

Query: 241 NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKS----RQGNREFLNEIAMISCLQH 295
           + +  K +G G FG V+  +        A+K ++       +Q  +   NE  ++  + H
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQ-EQHVHNEKRVLKEVSH 60

Query: 296 PNLVKIHGCCVEGDQ--LLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICLGIAR 351
           P ++++     E DQ  L ++ EY+    L   L   GR +    L + +       I  
Sbjct: 61  PFIIRLF--WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE------IVC 112

Query: 352 GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYM 411
            L +LH +    IV+RD+K  N+LLD++ + K++DFG AK    D+T     + GT  Y+
Sbjct: 113 ALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK-KLRDRTWT---LCGTPEYL 165

Query: 412 APEYALWGYLTYKADVYSFGIVALEIVSGK 441
           APE           D ++ GI+  E++ G 
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVGY 195

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 63.1 bits (153), Expect = 6e-11
 Identities = 47/148 (31%), Positives = 72/148 (48%), Gaps = 12/148 (8%)

Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICLGIARGL 353
           P L ++H C    D+L  V EY+    L   +   GR         P        IA GL
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR------FKEPHAVFYAAEIAIGL 114

Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAP 413
            FLH +    I++RD+K  NV+LD + + KI+DFG+ K +  D     T   GT  Y+AP
Sbjct: 115 FFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT-FCGTPDYIAP 170

Query: 414 EYALWGYLTYKADVYSFGIVALEIVSGK 441
           E   +       D ++FG++  E+++G+
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 63.4 bits (154), Expect = 7e-11
 Identities = 61/205 (29%), Positives = 88/205 (42%), Gaps = 24/205 (11%)

Query: 248 IGEGGFGPVYKGQLAD-GTIIAVKQLSSK---------SRQGNREFLNEIAMISCLQHPN 297
           IG+G FG VY+ +  D   I A+K LS K            G R  L    +      P 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDES---PF 57

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH 357
           +V +         L LV +YM    L   L      + E  +    +    IA  +  L 
Sbjct: 58  IVGLKFSFQTDSDLYLVTDYMSGGELFWHL------QKEGRFS-EDRAKFYIAELVLALE 110

Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYAL 417
              ++ IV+RD+K  N+LLD   +  + DFGL+K +  D    +T   GT  Y+APE  L
Sbjct: 111 HLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT-FCGTTEYLAPEVLL 169

Query: 418 --WGYLTYKADVYSFGIVALEIVSG 440
              GY T   D +S G++  E+  G
Sbjct: 170 DEKGY-TKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 62.5 bits (152), Expect = 7e-11
 Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 43/218 (19%)

Query: 248 IGEGGFGPVYKGQL---ADGTI--------IAVKQLSSKSRQGNREFLNEIAMISCLQHP 296
           +G+G F  +YKG L   +D  I        + +K L S  R  +  F    +++S L H 
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHK 61

Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSLACALFGREN-----CELELDWPTRQKICLGIAR 351
           +LVK++G CV  D+ ++V EY++   L   L   +N      +L++           +A 
Sbjct: 62  HLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAK--------QLAS 112

Query: 352 GLAFLHEESRFKIVHRDIKATNVLLDR-DLNP------KISDFGLAKLDEGDKTHISTRI 404
            L +L ++   K+VH ++   N+L+ R  LN       K+SD G+  +    +     RI
Sbjct: 113 ALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP-ITVLSREERVERI 168

Query: 405 AGTIGYMAPEY--ALWGYLTYKADVYSFGIVALEIVSG 440
                ++APE        LT  AD +SFG   LEI S 
Sbjct: 169 P----WIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 63.1 bits (154), Expect = 9e-11
 Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 45/215 (20%)

Query: 248 IGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLN---------EIAMISCLQHPN 297
           +G G +G V        G  +A+K+LS       R F +         E+ ++  + H N
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLS-------RPFQSAIHAKRTYRELRLLKHMDHEN 75

Query: 298 LVKIHGCCVEG------DQLLLVYEYME---NNSLACALFGRENCELELDWPTRQKICLG 348
           ++ +               + LV   M    NN + C     ++          Q +   
Sbjct: 76  VIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHI---------QFLVYQ 126

Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-HISTRIAGT 407
           I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +++TR    
Sbjct: 127 ILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR---- 179

Query: 408 IGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
             Y APE  L W +     D++S G +  E+++GK
Sbjct: 180 -WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 29/216 (13%)

Query: 241 NFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQ--GNREFLNEIAMISCLQHPN 297
            + +   IGEG +G V        G  +A+K++S    Q    R  L EI ++   +H N
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT-LREIKILRRFKHEN 64

Query: 298 LVKIHGCCVEGD-----QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL---GI 349
           ++ I              + +V E ME +     L   ++        +   I      I
Sbjct: 65  IIGILDIIRPPSFESFNDVYIVQELMETD--LYKLIKTQHL-------SNDHIQYFLYQI 115

Query: 350 ARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD--EGDKTHISTRIAGT 407
            RGL ++H  +   ++HRD+K +N+LL+ + + KI DFGLA++   E D T   T    T
Sbjct: 116 LRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT 172

Query: 408 IGYMAPEYAL--WGYLTYKADVYSFGIVALEIVSGK 441
             Y APE  L   GY T   D++S G +  E++S +
Sbjct: 173 RWYRAPEIMLNSKGY-TKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 26/167 (15%)

Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI---STRIA 405
           +ARG+ FL   SR K +HRD+ A N+LL  +   KI DFGLA+    D  ++     R+ 
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 406 GTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQ 465
             + +MAPE       T ++DV+SFG++  EI S     S  P ++ D     +  C   
Sbjct: 239 --LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS--LGASPYPGVQID-----EEFCRRL 289

Query: 466 QDGKLVELVDERLGS-KYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           ++G        R+ + +Y   E   +  + L C + +P  RPT SE+
Sbjct: 290 KEGT-------RMRAPEYATPE---IYSIMLDCWHNNPEDRPTFSEL 326

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 12/150 (8%)

Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HP LV +H C     +L  V E++    L   +  +     E       +I L     L 
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA----LN 110

Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEGDKTHISTRIAGTIGYMA 412
           FLHE     I++RD+K  NVLLD + + K++D+G+ K  +  GD T  ST   GT  Y+A
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT--ST-FCGTPNYIA 164

Query: 413 PEYALWGYLTYKADVYSFGIVALEIVSGKN 442
           PE        +  D ++ G++  E+++G++
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRS 194

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 41/166 (24%), Positives = 70/166 (42%), Gaps = 29/166 (17%)

Query: 284 LNEIAMISCLQHPNLVKIHGCCVEGDQLLLV--------YEYMENNSLACALFGRENCEL 335
           L E  ++  + HP+++++    V G    +V        Y Y+   S             
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRS------RP----- 153

Query: 336 ELDWPTRQKICL--GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 393
               P  Q + +   I  GL +LH +   +I+HRD+K  N+ ++      I D G A+  
Sbjct: 154 ---LPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFP 207

Query: 394 EGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
                 +   +AGT+   APE         KAD++S GIV  E+++
Sbjct: 208 VVAPAFLG--LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 45/149 (30%), Positives = 73/149 (48%), Gaps = 14/149 (9%)

Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICLGIARGL 353
           P L ++H C    D+L  V EY+    L   +   G+         P        I+ GL
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK------FKEPQAVFYAAEISVGL 114

Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR-IAGTIGYMA 412
            FLH      I++RD+K  NV+LD + + KI+DFG+ K  E     ++TR   GT  Y+A
Sbjct: 115 FFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIA 169

Query: 413 PEYALWGYLTYKADVYSFGIVALEIVSGK 441
           PE   +       D +++G++  E+++G+
Sbjct: 170 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 61.9 bits (151), Expect = 2e-10
 Identities = 60/243 (24%), Positives = 94/243 (38%), Gaps = 59/243 (24%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQLA----DGTIIAVKQLSSKS---RQGN-------REFLN 285
           ++F+  K IG G FG V    L      G + A+K L  KS   ++         R+ L 
Sbjct: 1   DDFEVIKVIGRGAFGEV---WLVRDKDTGQVYAMKVL-RKSDMIKRNQIAHVRAERDILA 56

Query: 286 EIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKI 345
           +         P +VK++    + + L LV EYM    L   L  R++     +   R   
Sbjct: 57  DAD------SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLI-RKDV-FPEET-AR--- 104

Query: 346 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-------------- 391
              IA  +  L    +   +HRDIK  N+L+D D + K++DFGL K              
Sbjct: 105 -FYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLND 163

Query: 392 --------------LDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEI 437
                          D   +   +    GT  Y+APE         + D +S G++  E+
Sbjct: 164 SHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEM 223

Query: 438 VSG 440
           + G
Sbjct: 224 LYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 62.2 bits (151), Expect = 2e-10
 Identities = 39/125 (31%), Positives = 64/125 (51%), Gaps = 13/125 (10%)

Query: 326 ALFGRENCELELDWPTRQ----KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN 381
           +   ++  + E  WP       +    +A+G+ FL  ++    +HRD+ A NVLL     
Sbjct: 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRV 250

Query: 382 PKISDFGLAKLDEGDKTHI---STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIV 438
            KI DFGLA+    D  ++   + R+   + +MAPE       T ++DV+S+GI+  EI 
Sbjct: 251 AKICDFGLARDIMNDSNYVVKGNARLP--VKWMAPESIFDCVYTVQSDVWSYGILLWEIF 308

Query: 439 S-GKN 442
           S GK+
Sbjct: 309 SLGKS 313

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 44/148 (29%), Positives = 82/148 (55%), Gaps = 11/148 (7%)

Query: 247 KIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNR-EFLNEIAMISCLQHPNLVKIHGC 304
           K+GEG +  VYKG+    G ++A+K++  +  +G     + E +++  L+H N+V +H  
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71

Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL-GIARGLAFLHEESRFK 363
                 L LV+EY++ + L   +   ++C   L      ++ L  + RGLA+ H+    +
Sbjct: 72  IHTKKTLTLVFEYLDTD-LKQYM---DDCGGGLS-MHNVRLFLFQLLRGLAYCHQR---R 123

Query: 364 IVHRDIKATNVLLDRDLNPKISDFGLAK 391
           ++HRD+K  N+L+      K++DFGLA+
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 33/206 (16%)

Query: 267 IAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIH--------------GCCVEGDQLL 312
           +AVK++     Q  +  L EI +I  L H N+VK++              G   E + + 
Sbjct: 33  VAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVY 92

Query: 313 LVYEYMEN---NSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDI 369
           +V EYME    N L       E+  L             + RGL ++H  +   ++HRD+
Sbjct: 93  IVQEYMETDLANVLEQGPLSEEHARL---------FMYQLLRGLKYIHSAN---VLHRDL 140

Query: 370 KATNVLLD-RDLNPKISDFGLAKLDEGDKTHISTRIAGTIG--YMAPEYALW-GYLTYKA 425
           K  NV ++  DL  KI DFGLA++ +   +H      G +   Y +P   L     T   
Sbjct: 141 KPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAI 200

Query: 426 DVYSFGIVALEIVSGKNNMSYAPALE 451
           D+++ G +  E+++GK   + A  LE
Sbjct: 201 DMWAAGCIFAEMLTGKPLFAGAHELE 226

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 52/166 (31%), Positives = 79/166 (47%), Gaps = 24/166 (14%)

Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI---STRIA 405
           +ARG+ FL   SR K +HRD+ A N+LL  +   KI DFGLA+    D  ++   S R+ 
Sbjct: 183 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 406 GTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQ 465
             + +MAPE       T ++DV+SFG++  EI S     S  P ++ +     +  C   
Sbjct: 240 --LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS--LGASPYPGVQIN-----EEFCQRL 290

Query: 466 QDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           +DG  +   +          E  R++   L C    P  RPT S +
Sbjct: 291 KDGTRMRAPE------NATPEIYRIM---LACWQGDPKERPTFSAL 327

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 61.3 bits (149), Expect = 3e-10
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 19/207 (9%)

Query: 241 NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNR-EFLNEIAMISCLQHPNL 298
           +F+   ++G G  G V K      G I+A K +  + +   R + + E+ ++     P +
Sbjct: 2   DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYI 61

Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICLGIARGLAFL 356
           V  +G      ++ +  E+M+  SL   L   GR      +      KI + + RGL +L
Sbjct: 62  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR------IPENILGKISIAVLRGLTYL 115

Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEGDKTHISTRIAGTIGYMAPE 414
            E+   KI+HRD+K +N+L++     K+ DFG++   +D    + + TR      YM+PE
Sbjct: 116 REK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSPE 168

Query: 415 YALWGYLTYKADVYSFGIVALEIVSGK 441
                + T ++D++S G+  +E+  G+
Sbjct: 169 RLQGTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 61.5 bits (149), Expect = 3e-10
 Identities = 65/217 (29%), Positives = 104/217 (47%), Gaps = 31/217 (14%)

Query: 241 NFDSAKKIGEGGFGPVYKGQLADG----TIIAVKQLS-------SKSRQGNREFLNEIAM 289
           NF+  K +G G +G V+  +   G     + A+K L        +K+ +  R   N +  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGREN-CELELDWPTRQKICLG 348
           +   Q P LV +H       +L L+ +Y+    +   L+ R+N  E E+      +   G
Sbjct: 61  VR--QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEV------RFYSG 112

Query: 349 -IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK---LDEGDKTHISTRI 404
            I   L  LH   +  IV+RDIK  N+LLD + +  ++DFGL+K    +E ++T+     
Sbjct: 113 EIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY---SF 166

Query: 405 AGTIGYMAPEYALWGYLTYKA-DVYSFGIVALEIVSG 440
            GTI YMAPE         KA D +S GI+  E+++G
Sbjct: 167 CGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 35/210 (16%)

Query: 248 IGEGGFGPV---YKGQLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHPNLVKI- 301
           +G G +G V   Y  +L     +AVK+LS   +S    R    E+ ++  ++H N++ + 
Sbjct: 23  VGSGAYGSVCSAYDTRLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80

Query: 302 -----HGCCVEGDQLLLVYEYME---NNSLACALFGRENCELELDWPTRQKICLGIARGL 353
                       +++ LV   M    NN + C     E+          Q +   + RGL
Sbjct: 81  DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHV---------QFLIYQLLRGL 131

Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-HISTRIAGTIGYMA 412
            ++H      I+HRD+K +NV ++ D   +I DFGLA+  + + T +++TR      Y A
Sbjct: 132 KYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRA 183

Query: 413 PEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           PE  L W +     D++S G +  E++ GK
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 61.2 bits (148), Expect = 4e-10
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 21/208 (10%)

Query: 242 FDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHPNL 298
           +   K IG G  G V        G  +AVK+LS   +++   +    E+ ++ C+ H N+
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82

Query: 299 VKI------HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARG 352
           + +           E   + LV E M+ N   C +       +ELD      +   +  G
Sbjct: 83  ISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVI-----HMELDHERMSYLLYQMLCG 135

Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMA 412
           +  LH      I+HRD+K +N+++  D   KI DFGLA+        + T    T  Y A
Sbjct: 136 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRA 190

Query: 413 PEYALWGYLTYKADVYSFGIVALEIVSG 440
           PE  L        D++S G +  E+V G
Sbjct: 191 PEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 60.6 bits (147), Expect = 5e-10
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 25/207 (12%)

Query: 246 KKIGEGGFGPVYKGQLADGT--IIAVKQLSSKSRQGNREFLNEIAMIS------CLQHPN 297
           K +G+G FG V   +L  GT  + A+K L       + +   +  M          +HP 
Sbjct: 1   KVLGKGSFGKVMLAEL-KGTDEVYAIKVLKKDVILQDDDV--DCTMTEKRILALAAKHPF 57

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH 357
           L  +H C    D+L  V EY+    L   +F  +    + D P  +     +   L FLH
Sbjct: 58  LTALHCCFQTKDRLFFVMEYVNGGDL---MFQIQRSR-KFDEPRSRFYAAEVTLALMFLH 113

Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG-DKTHISTRIAGTIGYMAPEYA 416
              R  +++RD+K  N+LLD + + K++DFG+ K  EG      +T   GT  Y+APE  
Sbjct: 114 ---RHGVIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPE-- 166

Query: 417 LWGYLTYKADV--YSFGIVALEIVSGK 441
           +   L Y   V  ++ G++  E+++G+
Sbjct: 167 ILQELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 60.8 bits (147), Expect = 5e-10
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)

Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 10  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 69

Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 70  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 122

Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 123 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 177

Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 178 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 60.1 bits (146), Expect = 7e-10
 Identities = 52/225 (23%), Positives = 90/225 (40%), Gaps = 55/225 (24%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSK---SRQGNREFLNEIAMISCLQH 295
            +F    ++G+GG+G V+  +  D G I+A+K++           R  L E  +++  + 
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60

Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL-- 353
             LVK            L+Y + ++  L  A+               + +  G  R L  
Sbjct: 61  EWLVK------------LLYAFQDDEYLYLAM---------------EYVPGGDFRTLLN 93

Query: 354 --AFLHEES-RFKI---------------VHRDIKATNVLLDRDLNPKISDFGLAKLDEG 395
               L E+  RF +               +HRD+K  N L+D   + K++DFGL+K    
Sbjct: 94  NLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSK---- 149

Query: 396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
                +  + G+  YMAPE        +  D +S G +  E + G
Sbjct: 150 GIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 59.7 bits (144), Expect = 1e-09
 Identities = 62/201 (30%), Positives = 89/201 (44%), Gaps = 14/201 (6%)

Query: 246 KKIGEGGFGPV-YKGQLADGTIIAVKQLSSKSRQGNREF---LNEIAMISCLQHPNLVKI 301
           K +G+G FG V    + A G   A+K L  +      E    L E  ++   +HP L  +
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 302 HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLG-IARGLAFLHEES 360
                  D+L  V EY+    L   L  RE    E     R +     I   L +LH   
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGELFFHL-SRERVFSE----DRTRFYGAEIVSALDYLHSG- 114

Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGY 420
             KIV+RD+K  N++LD+D + KI+DFGL K    D   + T   GT  Y+APE      
Sbjct: 115 --KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLEDND 171

Query: 421 LTYKADVYSFGIVALEIVSGK 441
                D +  G+V  E++ G+
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 32/212 (15%)

Query: 248 IGEGGFGPVYKG-QLADGTIIAVKQ-------LSSKSRQGNREFLNEIAMISCLQHPNLV 299
           IG+G +G V        G  +A+K+       +S  +R      L EI ++  L+HP++V
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATR-----ILREIKLLRLLRHPDIV 62

Query: 300 KIHGCCVEGDQ-----LLLVYEYMENNSLACALFGRENCELELDWPTRQKICL-GIARGL 353
           +I    +   +     + +V+E ME++ L   +  + N +L    P   +  L  + R L
Sbjct: 63  EIKHIMLPPSRREFKDIYVVFELMESD-LHQVI--KANDDLT---PEHHQFFLYQLLRAL 116

Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEGDKTHISTRIAGTIGYM 411
            ++H  + F   HRD+K  N+L + D   KI DFGLA+   ++       T    T  Y 
Sbjct: 117 KYIHTANVF---HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173

Query: 412 APEY--ALWGYLTYKADVYSFGIVALEIVSGK 441
           APE   + +   T   D++S G +  E+++GK
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 52/188 (27%), Positives = 84/188 (44%), Gaps = 32/188 (17%)

Query: 331 ENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 390
           E  EL LD          +A+G++FL  ++    +HRD+ A N+LL      KI DFGLA
Sbjct: 205 EEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLA 261

Query: 391 KLDEGDKTHI---STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYA 447
           +    D  ++   + R+   + +MAPE       T+++DV+S+GI+  EI S  +  S  
Sbjct: 262 RDIRNDSNYVVKGNARLP--VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGS--SPY 317

Query: 448 PALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAE----RMIKVSLLCTNASPS 503
           P +                D K  +++ E     Y+    E     M  +   C +A P 
Sbjct: 318 PGMPV--------------DSKFYKMIKE----GYRMLSPECAPSEMYDIMKSCWDADPL 359

Query: 504 LRPTMSEV 511
            RPT  ++
Sbjct: 360 KRPTFKQI 367

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 59.3 bits (144), Expect = 1e-09
 Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 36/214 (16%)

Query: 246 KKIGEGGFGPVYKGQLAD-GTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHPNLVKIH 302
           K IG G +G V   + ++    +A+K++++   +R   +  L EI ++  L H N++ I 
Sbjct: 11  KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIK 70

Query: 303 GCC--VEGDQ---LLLVYEYME---------NNSLACALFGRENCELELDWPTRQKICLG 348
                   +    + +VYE M+         + +L+      ++C         Q     
Sbjct: 71  DIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLS-----DDHC---------QYFLYQ 116

Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTI 408
           + RGL ++H  +   ++HRD+K +N+LL+ + + KI DFGLA+    +K    T    T 
Sbjct: 117 LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVVTR 172

Query: 409 GYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
            Y APE  L     T   DV+S G +  E++  K
Sbjct: 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 62/232 (26%), Positives = 104/232 (44%), Gaps = 27/232 (11%)

Query: 232 LKQIKAATNNFDSAKKIGEGGFGPVYKGQL----ADGTIIAVKQLSS---KSRQGNREFL 284
           +++++    ++D  K IG G FG V   QL    +   + A+K LS      R  +  F 
Sbjct: 35  IRKLQMKAEDYDVVKVIGRGAFGEV---QLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFW 91

Query: 285 NEIAMISCLQHPNLVKIHGCCVEGDQ-LLLVYEYMENNSLACALFGRENCELELDWPTRQ 343
            E  +++    P +V++  C  + D+ L +V EYM    L   +    N ++   W    
Sbjct: 92  EERDIMAFANSPWVVQLF-CAFQDDKYLYMVMEYMPGGDLVNLM---SNYDVPEKWAK-- 145

Query: 344 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHIST 402
                 A  +  L       ++HRD+K  N+LLD+  + K++DFG   K+DE       T
Sbjct: 146 ---FYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDT 202

Query: 403 RIAGTIGYMAPEYALW----GYLTYKADVYSFGIVALEIVSGKNNMSYAPAL 450
            + GT  Y++PE        GY   + D +S G+   E++ G     YA +L
Sbjct: 203 AV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF-YADSL 252

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 25/211 (11%)

Query: 242 FDSAKKIGEGGFGPV---YKGQLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHP 296
           + + K IG G  G V   Y   L     +A+K+LS   +++   +    E+ ++ C+ H 
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 297 NLVKI------HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           N++ +           E   + LV E M+ N   C +      ++ELD      +   + 
Sbjct: 77  NIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVI-----QMELDHERMSYLLYQML 129

Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
            G+  LH      I+HRD+K +N+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 130 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 184

Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
            APE  L        D++S G +  E+V  K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 57/221 (25%), Positives = 96/221 (43%), Gaps = 24/221 (10%)

Query: 232 LKQIKAATNNFDSAKKIGEGGFGPVYKGQL----ADGTIIAVKQLSS---KSRQGNREFL 284
           + +++    +FD  K IG G FG V   QL    +   + A+K LS      R  +  F 
Sbjct: 35  ITKLRMKAEDFDVIKVIGRGAFGEV---QLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFW 91

Query: 285 NEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQK 344
            E  +++      +V++H    +   L +V EYM    L   +    N ++   W   + 
Sbjct: 92  EERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM---SNYDIPEKWA--RF 146

Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHISTR 403
               +   L  +H       +HRD+K  N+LLD+  + K++DFG   K+D        T 
Sbjct: 147 YTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA 203

Query: 404 IAGTIGYMAPEYALW----GYLTYKADVYSFGIVALEIVSG 440
           + GT  Y++PE        GY   + D +S G+   E++ G
Sbjct: 204 V-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 61/201 (30%), Positives = 86/201 (42%), Gaps = 14/201 (6%)

Query: 246 KKIGEGGFGPV-YKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ---HPNLVKI 301
           K +G+G FG V    + A G   A+K L  +      E  + +     LQ   HP L  +
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 302 HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLG-IARGLAFLHEES 360
                  D+L  V EY     L   L  RE    E     R +     I   L +LH   
Sbjct: 61  KYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTE----ERARFYGAEIVSALEYLHSRD 115

Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGY 420
              +V+RDIK  N++LD+D + KI+DFGL K    D   + T   GT  Y+APE      
Sbjct: 116 ---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDND 171

Query: 421 LTYKADVYSFGIVALEIVSGK 441
                D +  G+V  E++ G+
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 57.7 bits (139), Expect = 6e-09
 Identities = 44/186 (23%), Positives = 76/186 (40%), Gaps = 27/186 (14%)

Query: 277 RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELE 336
           R G      E  ++  + HP+++++ G           + Y   N   C +  R   +L 
Sbjct: 127 RGGT---ATEAHILRAINHPSIIQLKG----------TFTY---NKFTCLILPRYKTDLY 170

Query: 337 LDWPTRQKICL--------GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFG 388
                ++ I +         + R + +LHE     I+HRDIKA N+ ++   +  + DFG
Sbjct: 171 CYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFG 227

Query: 389 LAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAP 448
            A        +     AGTI   APE           D++S GIV  E+ +  +++    
Sbjct: 228 AACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKD 287

Query: 449 ALEFDC 454
            L+ DC
Sbjct: 288 GLDGDC 293

Length = 391

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 57.3 bits (138), Expect = 6e-09
 Identities = 61/201 (30%), Positives = 88/201 (43%), Gaps = 13/201 (6%)

Query: 246 KKIGEGGFGPV-YKGQLADGTIIAVKQLSSKSRQGNREF---LNEIAMISCLQHPNLVKI 301
           K +G+G FG V    + A G   A+K L  +      E    L E  ++   +HP L  +
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 302 HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLG-IARGLAFLHEES 360
                  D+L  V EY     L   L  RE    E     R +     I   L +LH E 
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSE----DRARFYGAEIVSALDYLHSEK 115

Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGY 420
              +V+RD+K  N++LD+D + KI+DFGL K    D   + T   GT  Y+APE      
Sbjct: 116 --NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDND 172

Query: 421 LTYKADVYSFGIVALEIVSGK 441
                D +  G+V  E++ G+
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 57.3 bits (138), Expect = 6e-09
 Identities = 55/227 (24%), Positives = 103/227 (45%), Gaps = 28/227 (12%)

Query: 226 QTISFTLKQIKAATNNFDSAKKIGEGGFGPV-YKGQLADGTIIAVKQLSS--KSRQGNRE 282
           Q ++ T+ ++      +   K++G G +G V        G  +A+K+L    +S    + 
Sbjct: 4   QEVNKTIWEVPDR---YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKR 60

Query: 283 FLNEIAMISCLQHPNLVKIHGCCVEGDQL------LLVYEYMENNSLACALFGRENCELE 336
              E+ ++  ++H N++ +         L       LV  +M  +       G+     +
Sbjct: 61  AYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTD------LGKLMKHEK 114

Query: 337 LDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD 396
           L     Q +   + +GL ++H      I+HRD+K  N+ ++ D   KI DFGLA+  + +
Sbjct: 115 LSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSE 171

Query: 397 KT-HISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
            T ++ TR      Y APE  L W + T   D++S G +  E+++GK
Sbjct: 172 MTGYVVTR-----WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 57.4 bits (138), Expect = 7e-09
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 25/211 (11%)

Query: 242 FDSAKKIGEGGFGPV---YKGQLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHP 296
           + + K IG G  G V   Y   L     +A+K+LS   +++   +    E+ ++ C+ H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83

Query: 297 NLVKI------HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           N++ +           E   + +V E M+ N   C +      ++ELD      +   + 
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVI-----QMELDHERMSYLLYQML 136

Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
            G+  LH      I+HRD+K +N+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 137 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 191

Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
            APE  L        D++S G +  E++ G 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 59/200 (29%), Positives = 86/200 (43%), Gaps = 12/200 (6%)

Query: 246 KKIGEGGFGPV-YKGQLADGTIIAVKQLSSKSRQGNREF---LNEIAMISCLQHPNLVKI 301
           K +G+G FG V    + A G   A+K L  +      E    L E  ++   +HP L  +
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60

Query: 302 HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESR 361
                  D+L  V EY     L   L  RE    E      +     I   L +LH    
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSE---DRARFYGAEIVSALGYLHSC-- 114

Query: 362 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYL 421
             +V+RD+K  N++LD+D + KI+DFGL K    D   + T   GT  Y+APE       
Sbjct: 115 -DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDY 172

Query: 422 TYKADVYSFGIVALEIVSGK 441
               D +  G+V  E++ G+
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 48/205 (23%), Positives = 91/205 (44%), Gaps = 23/205 (11%)

Query: 247 KIGEGGFGPVYKG-QLADGTIIAVKQLSSKSR--QGNREFLNEIAMISCLQHPNLVKIHG 303
            IG G +G V        G  +A+K++          +  L E+ ++   +H N++ I  
Sbjct: 12  NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRD 71

Query: 304 CCV----EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
                  +   + +V + ME++ L   +   +    E      +     + RGL ++H  
Sbjct: 72  ILRPPGADFKDVYVVMDLMESD-LHHIIHSDQPLTEEH----IRYFLYQLLRGLKYIHSA 126

Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL----DEGDKTHISTRIAGTIGYMAPE- 414
               ++HRD+K +N+L++ D   +I DFG+A+         K  ++  +A T  Y APE 
Sbjct: 127 ---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA-TRWYRAPEL 182

Query: 415 -YALWGYLTYKADVYSFGIVALEIV 438
             +L  Y T   D++S G +  E++
Sbjct: 183 LLSLPEY-TTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 37/95 (38%), Positives = 53/95 (55%), Gaps = 10/95 (10%)

Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT- 407
           +ARG+ FL  ++    VHRD+ A NVLL +    KI DFGLA+    D  ++S    G+ 
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK---GST 299

Query: 408 ---IGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
              + +MAPE       T  +DV+S+GI+  EI S
Sbjct: 300 FLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 16/199 (8%)

Query: 248 IGEGGFGPVYKGQLADGTII----AVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHG 303
           IG+G FG V + +  D   I     +++    SR      L E  +++ +  P +V +  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENC--ELELDWPTRQKICLGIARGLAFLHEESR 361
                ++L LV  ++    L   L  RE         + T + +C      L  LH+   
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHL-QREGRFDLSRARFYTAELLC-----ALENLHK--- 111

Query: 362 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYL 421
           F +++RD+K  N+LLD   +  + DFGL KL+  D    +T   GT  Y+APE  L    
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLAPELLLGHGY 170

Query: 422 TYKADVYSFGIVALEIVSG 440
           T   D ++ G++  E+++G
Sbjct: 171 TKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 54.1 bits (130), Expect = 7e-08
 Identities = 34/92 (36%), Positives = 47/92 (51%), Gaps = 6/92 (6%)

Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHISTRIAG 406
            +   LA+LH      I+HRD+K  N+ LD   N  + DFG A KLD    T      +G
Sbjct: 193 RLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSG 249

Query: 407 TIGYMAPEY-ALWGYLTYKADVYSFGIVALEI 437
           T+   +PE  AL  Y   K D++S G+V  E+
Sbjct: 250 TLETNSPELLALDPYCA-KTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 20/214 (9%)

Query: 241 NFDSAKKIGEGGFGPVYKGQLA---DGTIIAVKQLS---SKSRQGNREFLNEIAMISCLQ 294
            ++  K++G+G +G V   + A   +   +A+K+++   SK     R  L E+ ++   +
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRA-LRELKLLRHFR 59

Query: 295 -HPNLVKIHGC-CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARG 352
            H N+  ++    V       +Y Y E   +   L         L     Q     I  G
Sbjct: 60  GHKNITCLYDMDIVFPGNFNELYLYEE--LMEADLHQIIRSGQPLTDAHFQSFIYQILCG 117

Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK---LDEGDKTHISTRIAGTIG 409
           L ++H  +   ++HRD+K  N+L++ D   KI DFGLA+    + G+     T    T  
Sbjct: 118 LKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRW 174

Query: 410 YMAPEYALWGYLTY-KA-DVYSFGIVALEIVSGK 441
           Y APE  L  + +Y KA DV+S G +  E++  K
Sbjct: 175 YRAPEIML-SFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 52/268 (19%), Positives = 103/268 (38%), Gaps = 43/268 (16%)

Query: 256 VYKGQLADGTII--AVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHG----CCVEGD 309
           +YKG   +  +I    K+     +       NEI  +  +   N++KI+G       +  
Sbjct: 36  IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95

Query: 310 QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDI 369
           +L L+ EY     L   L    + E +L + T+  + +   +GL  L+        ++++
Sbjct: 96  RLSLILEYCTRGYLREVL----DKEKDLSFKTKLDMAIDCCKGLYNLY--KYTNKPYKNL 149

Query: 370 KATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYAL--WGYLTYKADV 427
            + + L+  +   KI   GL K+     +    +    + Y + +     +   T K D+
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKI----LSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDI 205

Query: 428 YSFGIVALEIVSGK---NNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKK 484
           YS G+V  EI +GK    N++                       ++ +L+  +  S    
Sbjct: 206 YSLGVVLWEIFTGKIPFENLTTK---------------------EIYDLIINKNNSLKLP 244

Query: 485 EEAERMIK-VSLLCTNASPSLRPTMSEV 511
            +    IK +   CT+     RP + E+
Sbjct: 245 LDCPLEIKCIVEACTSHDSIKRPNIKEI 272

Length = 283

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 23/212 (10%)

Query: 247 KIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQG---NREFLNEIAMISCLQHPNLVKIHG 303
           K+G G +G VYK +  DG     K+ + K  +G   +     EIA++  L+HPN++ +  
Sbjct: 8   KVGRGTYGHVYKAKRKDGK--DEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQK 65

Query: 304 CCVEGD--QLLLVYEYMENNSLACALFGRENCE----LELDWPTRQKICLGIARGLAFLH 357
             +     ++ L+++Y E++      F R +      ++L     + +   I  G+ +LH
Sbjct: 66  VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125

Query: 358 EESRFKIVHRDIKATNVLLDRDLNP-----KISDFGLAKLDEGDKTHIS--TRIAGTIGY 410
                 ++HRD+K  N+L+  +  P     KI+D G A+L       ++    +  T  Y
Sbjct: 126 ANW---VLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 411 MAPEYALWG-YLTYKADVYSFGIVALEIVSGK 441
            APE  L   + T   D+++ G +  E+++ +
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 58/219 (26%), Positives = 91/219 (41%), Gaps = 49/219 (22%)

Query: 246 KKIGEGGFGPVYKGQLADGTI----IAVKQLSSKSRQGNREFLN---------EIAMISC 292
           K IG G  G V     A  T+    +A+K+LS       R F N         E+ ++  
Sbjct: 22  KPIGSGAQGIVC---AAYDTVTGQNVAIKKLS-------RPFQNVTHAKRAYRELVLMKL 71

Query: 293 LQHPNLVKIHGCCV------EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC 346
           + H N++ +           E   + LV E M+ N   C +   +     + +   Q +C
Sbjct: 72  VNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMDLDHERMSYLLYQMLC 129

Query: 347 LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT---HISTR 403
                G+  LH      I+HRD+K +N+++  D   KI DFGLA+          ++ TR
Sbjct: 130 -----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 181

Query: 404 IAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
                 Y APE  L  GY     D++S G +  E++ G 
Sbjct: 182 Y-----YRAPEVILGMGY-KENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 36/95 (37%), Positives = 51/95 (53%), Gaps = 10/95 (10%)

Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT- 407
           +A G+ FL  ++    VHRD+ A NVL+      KI DFGLA+    D  +IS    G+ 
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISK---GST 301

Query: 408 ---IGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
              + +MAPE       T  +DV+SFGI+  EI +
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 51.4 bits (123), Expect = 4e-07
 Identities = 49/181 (27%), Positives = 86/181 (47%), Gaps = 23/181 (12%)

Query: 267 IAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACA 326
           + +K L    R     F    +++S + H +L  +HG CV G + ++V E++E+  L   
Sbjct: 47  VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVC 106

Query: 327 LFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR-----DLN 381
           L  +E   + + W  +  +   +A  L++L +++   +VH ++ A N+LL R       +
Sbjct: 107 L-RKEKGRVPVAW--KITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTS 160

Query: 382 P--KISDFG--LAKLDEGDKTHISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALE 436
           P  K+SD G     L   ++          I ++APE    G  L+  AD +SFG   LE
Sbjct: 161 PFIKLSDPGVSFTALSREERVE-------RIPWIAPECVPGGNSLSTAADKWSFGTTLLE 213

Query: 437 I 437
           I
Sbjct: 214 I 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 51.6 bits (123), Expect = 4e-07
 Identities = 52/212 (24%), Positives = 99/212 (46%), Gaps = 23/212 (10%)

Query: 247 KIGEGGFGPVYKGQLADG---TIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHG 303
           K+G G +G VYK +  DG      A+KQ+       +     EIA++  L+HPN++ +  
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQK 65

Query: 304 CCVE--GDQLLLVYEYMENNSLACALFGRENCE----LELDWPTRQKICLGIARGLAFLH 357
             +     ++ L+++Y E++      F R +      ++L     + +   I  G+ +LH
Sbjct: 66  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125

Query: 358 EESRFKIVHRDIKATNVLLDRDLNP-----KISDFGLAKLDEGDKTHIS--TRIAGTIGY 410
                 ++HRD+K  N+L+  +  P     KI+D G A+L       ++    +  T  Y
Sbjct: 126 ANW---VLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 411 MAPEYALWG-YLTYKADVYSFGIVALEIVSGK 441
            APE  L   + T   D+++ G +  E+++ +
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 50.7 bits (121), Expect = 9e-07
 Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 39/200 (19%)

Query: 264 GTIIAVK--QLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENN 321
           GT++ V+   L + + +  +   NE+ +    +HPN++        G  L ++  +M   
Sbjct: 25  GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA-- 82

Query: 322 SLACALFGRENCELELDWPTRQ------KICLGIARGLAFLHEESRFKIVHRDIKATNVL 375
                 +G  N  L+  +P          I  G  RGL +LH+      +HR+IKA+++L
Sbjct: 83  ------YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHIL 133

Query: 376 LDRDLNPKISDFGLAKL----DEGDKTHI-------STRIAGTIGYMAPEYA---LWGYL 421
           +  D    +S  GL+ L      G K  +       ST +   + +++PE     L+GY 
Sbjct: 134 ISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSV---LPWLSPELLRQDLYGY- 187

Query: 422 TYKADVYSFGIVALEIVSGK 441
             K+D+YS GI A E+ +G+
Sbjct: 188 NVKSDIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 50/205 (24%), Positives = 91/205 (44%), Gaps = 17/205 (8%)

Query: 241 NFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSS----KSRQGNREFLNEIAMISCLQH 295
           +F+  + +G G FG V   +    G   A+K L      K +Q  +    E +++  L H
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQ-VQHVAQEKSILMELSH 77

Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           P +V +     + +++  + E++    L   L  R+      D    +     +     +
Sbjct: 78  PFIVNMMCSFQDENRVYFLLEFVVGGELFTHL--RKAGRFPND--VAKFYHAELVLAFEY 133

Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEY 415
           LH +    I++RD+K  N+LLD   + K++DFG AK    D+T     + GT  Y+APE 
Sbjct: 134 LHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK-KVPDRTFT---LCGTPEYLAPEV 186

Query: 416 ALWGYLTYKADVYSFGIVALEIVSG 440
                     D ++ G++  E ++G
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 51.0 bits (122), Expect = 1e-06
 Identities = 34/97 (35%), Positives = 54/97 (55%), Gaps = 16/97 (16%)

Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL------DEGDKTHISTRIAG 406
           LA  H  S+  ++HRDIK+ N+LL  +   K+ DFG +K+      D+  +T       G
Sbjct: 154 LAVHHVHSK-HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT-----FCG 207

Query: 407 TIGYMAPEYALWGYLTY--KADVYSFGIVALEIVSGK 441
           T  Y+APE  +W    Y  KAD++S G++  E+++ K
Sbjct: 208 TPYYVAPE--IWRRKPYSKKADMFSLGVLLYELLTLK 242

Length = 496

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 61/231 (26%), Positives = 95/231 (41%), Gaps = 38/231 (16%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMI-----SCLQ 294
           ++F+  K IG G FG V           AV ++    R    + LN+  M+     +C +
Sbjct: 1   DDFEIIKVIGRGAFGEV-----------AVVKMKHTERIYAMKILNKWEMLKRAETACFR 49

Query: 295 HPNLVKIHGCCV----------EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQK 344
               V ++G C           + + L LV +Y     L   L   E+  L  D      
Sbjct: 50  EERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFED-RLPEDMAR--- 105

Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI 404
               IA  +  +H   +   VHRDIK  NVLLD + + +++DFG       D T  S+  
Sbjct: 106 --FYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA 163

Query: 405 AGTIGYMAPEYAL-----WGYLTYKADVYSFGIVALEIVSGKNNMSYAPAL 450
            GT  Y++PE         G    + D +S G+   E++ G+    YA +L
Sbjct: 164 VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF-YAESL 213

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 31/209 (14%)

Query: 248 IGEGGFGPVYKGQLADGT-IIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKI----H 302
           IG G FG VY+    D +  +A+K++    +  NRE L    ++  L H N++ +    +
Sbjct: 74  IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLNHINIIFLKDYYY 129

Query: 303 GCCVEGDQ----LLLVYEYM-ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH 357
             C + ++    L +V E++ +        + R N  L L     +     + R LA++H
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPL--FLVKLYSYQLCRALAYIH 187

Query: 358 EESRFKIVHRDIKATNVLLD-RDLNPKISDFGLAK-LDEGDK--THISTRIAGTIGYMAP 413
             S+F I HRD+K  N+L+D      K+ DFG AK L  G +  ++I +R      Y AP
Sbjct: 188 --SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-----YRAP 239

Query: 414 EYALWGYLTYKA--DVYSFGIVALEIVSG 440
           E  L G   Y    D++S G +  E++ G
Sbjct: 240 ELML-GATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 48.6 bits (116), Expect = 3e-06
 Identities = 55/228 (24%), Positives = 103/228 (45%), Gaps = 43/228 (18%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQLADG-TIIAVKQLSSKS---RQGNREFLNEIAMISCLQH 295
            +F++ K I  G +G VY  +  +     A+K+++ ++   R   ++   E  +++  ++
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60

Query: 296 PNLVKIHGCCVEGDQ-LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIAR--- 351
           P +V +  C  E  + L +V EY+E     CA   +    L +D          +AR   
Sbjct: 61  PFVVSMF-CSFETKRHLCMVMEYVEGGD--CATLLKNIGALPVD----------MARMYF 107

Query: 352 -----GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--------------L 392
                 L +LH    + IVHRD+K  N+L+    + K++DFGL+K              +
Sbjct: 108 AETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHI 164

Query: 393 DEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           ++  +  +  ++ GT  Y+APE  L        D ++ GI+  E + G
Sbjct: 165 EKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 48.9 bits (117), Expect = 3e-06
 Identities = 69/259 (26%), Positives = 102/259 (39%), Gaps = 82/259 (31%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFL----NEIAMISCLQ 294
           ++F+S K IG G FG V   Q  D G I A+K+L  KS    +E +     E  +++   
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLR-KSEMLEKEQVAHVRAERDILAEAD 59

Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           +P +VK++    + + L L+ EY+    +   L  ++                       
Sbjct: 60  NPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKD----------------------T 97

Query: 355 FLHEESRFKI---------------VHRDIKATNVLLDRDLNPKISDFGL---------- 389
           F  EE+RF I               +HRDIK  N+LLD   + K+SDFGL          
Sbjct: 98  FTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157

Query: 390 ------------AKLDEGDKTHISTRIA---------------GTIGYMAPEYALW-GYL 421
                         LD   K   S R A               GT  Y+APE  L  GY 
Sbjct: 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY- 216

Query: 422 TYKADVYSFGIVALEIVSG 440
             + D +S G++  E++ G
Sbjct: 217 NKECDWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 49.1 bits (117), Expect = 4e-06
 Identities = 41/159 (25%), Positives = 75/159 (47%), Gaps = 17/159 (10%)

Query: 242 FDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAM----ISCLQHP 296
           F   K I  G FG VY G+   +  + AVK +  K+   N+  ++++      ++  + P
Sbjct: 6   FVIVKPISRGAFGKVYLGRKKNNSKLYAVK-VVKKADMINKNMVHQVQAERDALALSKSP 64

Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSLAC--ALFGRENCELELDWPTRQKICLGIARGLA 354
            +V ++      + + LV EY+    +     ++G        D     K    +A  L 
Sbjct: 65  FIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY------FDEEMAVKYISEVALALD 118

Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 393
           +LH   R  I+HRD+K  N+L+  + + K++DFGL+K+ 
Sbjct: 119 YLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 48.3 bits (115), Expect = 6e-06
 Identities = 43/156 (27%), Positives = 72/156 (46%), Gaps = 13/156 (8%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLN----EIAMISCLQ 294
            +F + K IG+G FG V   Q    G I A+K L  KS    ++ L     E  +++   
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLL-KSEMFKKDQLAHVKAERDVLAESD 59

Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
            P +V ++    +   L L+ E++    L   L   +    ++   TR      +A  + 
Sbjct: 60  SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV---TR----FYMAECVL 112

Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 390
            +    +   +HRDIK  N+L+DR  + K+SDFGL+
Sbjct: 113 AIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 54/228 (23%), Positives = 98/228 (42%), Gaps = 19/228 (8%)

Query: 232 LKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSK----SRQGNREFLNEI 287
           ++ ++    +++  K IG G FG V   +      +   +L SK     R  +  F  E 
Sbjct: 35  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94

Query: 288 AMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL 347
            +++    P +V++     +   L +V EYM    L   +    N ++   W   +    
Sbjct: 95  DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWA--RFYTA 149

Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHISTRIAG 406
            +   L  +H       +HRD+K  N+LLD+  + K++DFG   K+++       T + G
Sbjct: 150 EVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-G 205

Query: 407 TIGYMAPEYALW----GYLTYKADVYSFGIVALEIVSGKNNMSYAPAL 450
           T  Y++PE        GY   + D +S G+   E++ G     YA +L
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF-YADSL 252

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 8/158 (5%)

Query: 285 NEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQK 344
           +E+  ++   H  +VK        D+LLL+ EY     L   +  R    L         
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173

Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTR 403
           +   I   L  +H  SR K++HRD+K+ N+ L      K+ DFG +K   +     +++ 
Sbjct: 174 LFYQIVLALDEVH--SR-KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230

Query: 404 IAGTIGYMAPEYALWGYLTY--KADVYSFGIVALEIVS 439
             GT  Y+APE  LW    Y  KAD++S G++  E+++
Sbjct: 231 FCGTPYYLAPE--LWERKRYSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 47.0 bits (111), Expect = 2e-05
 Identities = 41/164 (25%), Positives = 72/164 (43%), Gaps = 21/164 (12%)

Query: 285 NEIAMISCLQHPNLVKIHGCCVEGDQLLLV--------YEYMENNSLACALFGRENCELE 336
           NEI  +  L H N++KI           ++        Y +M + +           +  
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWK-------DRP 264

Query: 337 LDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD 396
           L   TR  I   +   + ++H++   K++HRDIK  N+ L+ D    + DFG A   E +
Sbjct: 265 LLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKE 320

Query: 397 KTHISTRIAGTIGYMAPE-YALWGYLTYKADVYSFGIVALEIVS 439
           +        GT+   +PE  A  GY     D++S G++ L+++S
Sbjct: 321 REAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 50/196 (25%), Positives = 85/196 (43%), Gaps = 34/196 (17%)

Query: 286 EIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNS---LACALFGRENCELELDWPTR 342
           E+ +     HPN+V      +  ++L +V  +M   S   L C  F     EL + +   
Sbjct: 49  ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAY--- 105

Query: 343 QKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF--GLAKLDEGDKTHI 400
             I  G+ + L ++H       VHR +KA+++L+  D    +S     L+ ++ G +  +
Sbjct: 106 --ILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160

Query: 401 -------STRIAGTIGYMAPEYA---LWGYLTYKADVYSFGIVALEIVSGKNNMSYAPA- 449
                  S ++   + +++PE     L GY   K+D+YS GI A E+ +G       PA 
Sbjct: 161 VHDFPKYSVKV---LPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPAT 216

Query: 450 ------LEFDCTCLLD 459
                 L     CLLD
Sbjct: 217 QMLLEKLNGTVPCLLD 232

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 44.3 bits (105), Expect = 3e-05
 Identities = 34/153 (22%), Positives = 59/153 (38%), Gaps = 16/153 (10%)

Query: 243 DSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCL-QHPNLV-K 300
            S K +  G    VY     D   + +K   S+ +  +RE   E+A++  L +    V K
Sbjct: 1   SSIKLLKGGLTNRVYLLGTKDEDYV-LKINPSREKGADRE--REVAILQLLARKGLPVPK 57

Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
           +           L+ E++E  +L            E+    ++ I   +A  LA LH+  
Sbjct: 58  VLASGESDGWSYLLMEWIEGETLD-----------EVSEEEKEDIAEQLAELLAKLHQLP 106

Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 393
              + H D+   N+L+D      I D+  A   
Sbjct: 107 LLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 46/176 (26%), Positives = 84/176 (47%), Gaps = 13/176 (7%)

Query: 267 IAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACA 326
           + +K L    R  +  F    +M+  + H ++V ++G CV   + ++V E++E   L   
Sbjct: 35  VILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL--D 92

Query: 327 LFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD-LNPKIS 385
           LF     ++ L  P + K+   +A  L++L ++    +VH ++   N+LL R+ ++ +  
Sbjct: 93  LFMHRKSDV-LTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECG 148

Query: 386 DFGLAKL-DEGDKTHISTR--IAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEI 437
            F   KL D G    + +R      I ++APE       L+  AD +SFG    EI
Sbjct: 149 PF--IKLSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 46.0 bits (109), Expect = 4e-05
 Identities = 30/83 (36%), Positives = 41/83 (49%), Gaps = 4/83 (4%)

Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK-THISTRIAGTIGYMAP 413
           ++H E    I+HRDIK  NVL++   +  + DFG A    G   T     IAGT+   AP
Sbjct: 275 YIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAP 331

Query: 414 EYALWGYLTYKADVYSFGIVALE 436
           E       T   D++S G+V  E
Sbjct: 332 EVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 45.6 bits (108), Expect = 6e-05
 Identities = 28/89 (31%), Positives = 44/89 (49%), Gaps = 8/89 (8%)

Query: 70  YCLD---NGNYTLSLHFAEIQFSNGITFHSLGRRLFDIYIQDNLVERNFDIKAEASGVLK 126
           Y +D   N NY++ LHFAEI   N IT  + G+R+FD+ I  +   ++ DI   +     
Sbjct: 270 YTMDVDPNRNYSVWLHFAEID--NSIT--AEGKRVFDVLINGDTAFKDVDIVKMSGERYT 325

Query: 127 PVARSYNVTVTNHIIEIRFHWAGKGTTAL 155
            +  +  V V+   + I      KGT A+
Sbjct: 326 ALVLNKTVAVSGRTLTIVLQ-PKKGTHAI 353

Length = 623

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 44.6 bits (105), Expect = 8e-05
 Identities = 57/244 (23%), Positives = 95/244 (38%), Gaps = 55/244 (22%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNL 298
           ++F+S K IG G FG V   Q  D G I A+K L    R+ +     ++A I   +   L
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKIL----RKADMLEKEQVAHIRA-ERDIL 55

Query: 299 VKIHGCCV--------EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           V+  G  V        +   L L+ E++    +   L  +       D  + +     IA
Sbjct: 56  VEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK-------DTLSEEATQFYIA 108

Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL--------------------- 389
             +  +    +   +HRDIK  N+LLD   + K+SDFGL                     
Sbjct: 109 ETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPP 168

Query: 390 -------------AKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALE 436
                        A+  + ++  ++    GT  Y+APE  +        D +S G++  E
Sbjct: 169 SDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228

Query: 437 IVSG 440
           ++ G
Sbjct: 229 MLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER

 Score = 44.3 bits (105), Expect = 8e-05
 Identities = 36/163 (22%), Positives = 54/163 (33%), Gaps = 33/163 (20%)

Query: 19  DDTNWGFSSTGDFADDNDDQNTRYTATSDSSGLSE-----LYINARI-----APLSLTYF 68
           DD           +      +T  +    S+         +   A       APL+ T+ 
Sbjct: 188 DDVYDRIWEPFFSSPGWSQISTSLSVDISSNNAPYIPPSAVLQTAVTPTNASAPLNFTWD 247

Query: 69  GYCLDNGN--YTLSLHFAEIQFSNGITFHSLGRRLFDIYIQDNLVERNFDIKAEASGVLK 126
              L + N  Y + LHFAEIQ        SL  R FDIYI    V  +   K        
Sbjct: 248 ---LVDPNFEYYVYLHFAEIQ--------SLETREFDIYINGKTVYGDVSPK-YLGTDTG 295

Query: 127 PVARSYNVTVT-NHIIEIRFHWAGKGTTALPKRGIYGPLVSAI 168
            +   + V V+   ++ I        T          PL++A+
Sbjct: 296 ALYLDFPVNVSGGGLLNISLVPTSGST--------LPPLLNAL 330

Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 59/228 (25%), Positives = 99/228 (43%), Gaps = 32/228 (14%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNL 298
           ++F+  K IG G FG V   ++ + G + A+K L       N+  + + A  +C +    
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKIL-------NKWEMLKRAETACFREERD 53

Query: 299 VKIHGCC----------VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLG 348
           V ++G             + + L LV +Y     L   L  +    L  D          
Sbjct: 54  VLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDL-LTLLSKFEDRLPEDMAR-----FY 107

Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFG-LAKLDEGDKTHISTRIAGT 407
           +A  +  +    +   VHRDIK  NVLLD++ + +++DFG   +L   D T  S    GT
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA-DGTVQSNVAVGT 166

Query: 408 IGYMAPEY--AL---WGYLTYKADVYSFGIVALEIVSGKNNMSYAPAL 450
             Y++PE   A+    G    + D +S G+   E++ G+    YA +L
Sbjct: 167 PDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF-YAESL 213

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 57/239 (23%), Positives = 95/239 (39%), Gaps = 47/239 (19%)

Query: 241 NFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEI-AMISCLQHPN- 297
           +F+S K IG G FG V   Q  D G + A+K L  K+    +E +  I A    L   + 
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILR-KADMLEKEQVGHIRAERDILVEADS 60

Query: 298 --LVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
             +VK+     +   L L+ E++    +   L  +       D  T ++    IA  +  
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK-------DTLTEEETQFYIAETVLA 113

Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL-------------------------- 389
           +    +   +HRDIK  N+LLD   + K+SDFGL                          
Sbjct: 114 IDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTF 173

Query: 390 --------AKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
                   A+  + ++  ++    GT  Y+APE  +        D +S G++  E++ G
Sbjct: 174 QNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 42.9 bits (101), Expect = 3e-04
 Identities = 28/86 (32%), Positives = 45/86 (52%), Gaps = 8/86 (9%)

Query: 240 NNFDSAKKIGEGGFGPVYK------GQLADGTIIAVKQLSSKSRQGNREFL-NEIAMISC 292
           +N    K +G G FG V +      G+  +   +AVK L + +    RE L +E+ ++S 
Sbjct: 38  DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97

Query: 293 L-QHPNLVKIHGCCVEGDQLLLVYEY 317
           L QH N+V + G C  G  +L++ EY
Sbjct: 98  LGQHKNIVNLLGACTHGGPVLVITEY 123

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 43.2 bits (101), Expect = 3e-04
 Identities = 61/239 (25%), Positives = 110/239 (46%), Gaps = 48/239 (20%)

Query: 240 NNFDSAKKIGEGGFGPVY------KGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCL 293
           N ++  KKIG G FG V+        +      I+ + L  + +    + + E+ ++  L
Sbjct: 13  NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKS---QLVIEVNVMREL 69

Query: 294 QHPNLVK-IHGCCVEGDQ-LLLVYEYMENNSLA-----C-ALFGRENCELELDWPTRQKI 345
           +H N+V+ I     + +Q L ++ E+ +   L+     C  +FG+      +D  TRQ  
Sbjct: 70  KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDI-TRQ-- 126

Query: 346 CLGIARGLAFLHE----ESRFKIVHRDIKATNVLLD-------------RDLN----PKI 384
              +   LA+ H      +  +++HRD+K  N+ L               +LN     KI
Sbjct: 127 ---LLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKI 183

Query: 385 SDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTY--KADVYSFGIVALEIVSGK 441
            DFGL+K + G ++ ++    GT  Y +PE  L    +Y  K+D+++ G +  E+ SGK
Sbjct: 184 GDFGLSK-NIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240

Length = 1021

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 42.9 bits (101), Expect = 4e-04
 Identities = 48/176 (27%), Positives = 70/176 (39%), Gaps = 31/176 (17%)

Query: 241 NFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSK--SRQGNRE-FLNEIAMISC----- 292
           +F   KK+GEG FG VYK  L +       +   K  +  G  E ++NE    +C     
Sbjct: 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCA 192

Query: 293 -LQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRE---NCELEL-----DWP--- 340
              +  L  +     + D+  LV+ Y   ++LA  +  +E   N E  L     D P   
Sbjct: 193 DFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGL 250

Query: 341 TRQKICLG-----IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP-KISDFGLA 390
            R+   +      I   L  LH      IVHRD+K  N++        KI D G A
Sbjct: 251 ERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAA 303

Length = 566

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 41.8 bits (99), Expect = 4e-04
 Identities = 40/154 (25%), Positives = 69/154 (44%), Gaps = 25/154 (16%)

Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           +PN +K++         +L+ +Y+++  L    F     E +L     +KI   +   L 
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDL----FDLLKKEGKLSEAEVKKIIRQLVEALN 123

Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNP-KISDFGLAKLDEGDKTHISTRIAGTIGYMAP 413
            LH   +  I+H DIK  NVL DR  +   + D+GL K+  G  +       GT+ Y +P
Sbjct: 124 DLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI-IGTPSCYD----GTLDYFSP 175

Query: 414 E------YALWGYLTYKADVYSFGIVALEIVSGK 441
           E      Y          D ++ G++  E+++GK
Sbjct: 176 EKIKGHNYD------VSFDWWAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 41.6 bits (97), Expect = 7e-04
 Identities = 56/220 (25%), Positives = 94/220 (42%), Gaps = 18/220 (8%)

Query: 241 NFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNRE----FLNEIAMISCLQHP 296
           +F+  K IG G FG V   +L +   +   ++ +K     R     F  E  ++    + 
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFL 356
            +  +H    + + L LV +Y     L   L   E+  L  D          +A  +  +
Sbjct: 62  WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFED-RLPEDMAR-----FYLAEMVIAI 115

Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFG-LAKLDEGDKTHISTRIAGTIGYMAPEY 415
               +   VHRDIK  N+L+D + + +++DFG   KL E D T  S+   GT  Y++PE 
Sbjct: 116 DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME-DGTVQSSVAVGTPDYISPEI 174

Query: 416 ALW-----GYLTYKADVYSFGIVALEIVSGKNNMSYAPAL 450
                   G    + D +S G+   E++ G+    YA +L
Sbjct: 175 LQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF-YAESL 213

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 40.9 bits (96), Expect = 0.001
 Identities = 30/119 (25%), Positives = 47/119 (39%), Gaps = 42/119 (35%)

Query: 365 VHRDIKATNVLLDRDLNPKISDFGLA---------------------------KLDEGDK 397
           +HRDIK  N+L+DRD + K++DFGL                            +  E D+
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 398 THIST---------------RIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
             +                  + GT  Y+APE  L    T   D +S G++  E++ G+
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 40.0 bits (94), Expect = 0.002
 Identities = 44/164 (26%), Positives = 67/164 (40%), Gaps = 27/164 (16%)

Query: 242 FDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPN 297
           F   K +G+G  G V+  +L   G + A+K L  K    R   +  L E  +++ L HP 
Sbjct: 3   FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF 62

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACALFGR-ENCELELDWPTRQKICLGIAR----- 351
           L  ++        L LV +Y     L   L  +   C           +   +AR     
Sbjct: 63  LPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKC-----------LSEEVARFYAAE 111

Query: 352 ---GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL 392
               L +LH      IV+RD+K  N+LL    +  +SDF L+K 
Sbjct: 112 VLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQ 152

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 39.1 bits (91), Expect = 0.003
 Identities = 40/158 (25%), Positives = 61/158 (38%), Gaps = 19/158 (12%)

Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELEL--DWPTRQKICLGIARGL 353
           PN+V +H   V  D + LV ++ E   L   +    N   E    W     + L      
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA---- 100

Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFG--LAKLDEGDKTHISTRIAGTIGYM 411
             LH E    IV RD+   N+LLD   + +++ F       D  D   +         Y 
Sbjct: 101 --LHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YC 149

Query: 412 APEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPA 449
           APE       T   D +S G +  E+++GK  +   P+
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPS 187

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 39.6 bits (92), Expect = 0.003
 Identities = 53/250 (21%), Positives = 90/250 (36%), Gaps = 57/250 (22%)

Query: 242 FDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPN 297
           F   K +G G FG V   +  D   + A+K L  K    R        E  +++   +  
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH 357
           +V+++    + D L  V +Y+    +   L       + +           IA     + 
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLL-------IRMGIFPEDLARFYIAELTCAVE 115

Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK----------LDEGD----------- 396
              +   +HRDIK  N+L+DRD + K++DFGL               GD           
Sbjct: 116 SVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSN 175

Query: 397 ----------------------KTH---ISTRIAGTIGYMAPEYALWGYLTYKADVYSFG 431
                                 + H   ++  + GT  Y+APE  L    T   D +S G
Sbjct: 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235

Query: 432 IVALEIVSGK 441
           ++  E++ G+
Sbjct: 236 VILYEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	511
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.98
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.98
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.93
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.92
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.92
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.91
PRK09188	365	serine/threonine protein kinase; Provisional	99.91
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.88
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.88
PF11721	174	Malectin: Di-glucose binding within endoplasmic re	99.87
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.85
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.85
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.84
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.84
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.84
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.84
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.83
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.81
PRK10345	210	hypothetical protein; Provisional	99.79
PRK12274	218	serine/threonine protein kinase; Provisional	99.79
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.78
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.76
PRK14879	211	serine/threonine protein kinase; Provisional	99.75
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.73
smart00090	237	RIO RIO-like kinase.	99.73
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.73
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.72
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.7
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.7
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.7
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.64
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.62
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.58
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.58
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.54
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.46
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.46
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.31
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.31
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.28
KOG1243	690	consensus Protein kinase [General function predict	99.22
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.15
PLN03150	623	hypothetical protein; Provisional	99.12
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.1
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.05
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.99
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.96
KOG3087	229	consensus Serine/threonine protein kinase [General	98.94
PF12819	347	Malectin_like: Carbohydrate-binding protein of the	98.83
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.81
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.8
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.78
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.52
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.51
COG4248	637	Uncharacterized protein with protein kinase and he	98.5
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.47
PRK09902	216	hypothetical protein; Provisional	98.47
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.29
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.29
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.21
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.17
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.09
PF01636	239	APH: Phosphotransferase enzyme family This family	98.07
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.03
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.02
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.91
PLN02876	822	acyl-CoA dehydrogenase	97.9
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.89
PRK10593	297	hypothetical protein; Provisional	97.76
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.65
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.55
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.51
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.47
KOG3593	355	consensus Predicted receptor-like serine/threonine	97.45
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.38
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.34
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.32
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.23
PLN03150	623	hypothetical protein; Provisional	97.13
PRK05231	319	homoserine kinase; Provisional	97.08
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.03
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.02
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.73
PLN02236	344	choline kinase	96.37
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.3
PF12819	347	Malectin_like: Carbohydrate-binding protein of the	96.28
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.1
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.05
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.95
KOG1093	725	consensus Predicted protein kinase (contains TBC a	95.82
PLN02756	418	S-methyl-5-thioribose kinase	95.76
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.69
COG2334	331	Putative homoserine kinase type II (protein kinase	95.68
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	95.51
PRK11768	325	serine/threonine protein kinase; Provisional	94.88
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	94.58
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	94.57
PRK06148	1013	hypothetical protein; Provisional	94.57
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	94.52
KOG2270	520	consensus Serine/threonine protein kinase involved	94.41

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-61  Score=485.34  Aligned_cols=281  Identities=53%  Similarity=0.872  Sum_probs=251.1

Q ss_pred             ccccccHHHHHHHhcCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEE
Q 045835          226 QTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC  305 (511)
Q Consensus       226 ~~~~~~~~~l~~~~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~  305 (511)
                      ....|+++++..||++|...++||+|+||.||+|.+.+|+.||||++.....+..++|.+|++++++++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            45679999999999999999999999999999999999999999988765443256799999999999999999999999


Q ss_pred             EeCC-EEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEE
Q 045835          306 VEGD-QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKI  384 (511)
Q Consensus       306 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl  384 (511)
                      .+.+ +.+||||||++|+|.++|+.....  .++|.+|++||.++|+||+|||+...++||||||||+|||||+++++||
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl  218 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL  218 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence            9998 599999999999999999886543  7899999999999999999999998889999999999999999999999


Q ss_pred             eecCCcccCCC-CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHh
Q 045835          385 SDFGLAKLDEG-DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACH  463 (511)
Q Consensus       385 ~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~  463 (511)
                      +|||+|+..+. .... .+...||.+|+|||++..+..++|+|||||||+|+||+||+.|.+...  ......+.+|++.
T Consensus       219 sDFGLa~~~~~~~~~~-~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~--~~~~~~l~~w~~~  295 (361)
T KOG1187|consen  219 SDFGLAKLGPEGDTSV-STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR--PRGELSLVEWAKP  295 (361)
T ss_pred             cCccCcccCCccccce-eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC--CcccccHHHHHHH
Confidence            99999987664 3222 221179999999999999999999999999999999999999887544  2344459999999


Q ss_pred             hhccCchhHhhhhhhC-CCCCH-HHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          464 LQQDGKLVELVDERLG-SKYKK-EEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       464 ~~~~~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...++++.+++|+.+. ..++. +++.++.+++.+|++.+|++||+|.||
T Consensus       296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~V  345 (361)
T KOG1187|consen  296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQV  345 (361)
T ss_pred             HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHH
Confidence            9999999999999987 66665 789999999999999999999999875

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4e-49  Score=396.18  Aligned_cols=246  Identities=35%  Similarity=0.537  Sum_probs=206.3

Q ss_pred             ccCceeccCceeEEeccccCCcEEEEEEecccCccc--hHHHHHHHHHHhcCCCCCceeEEEEEEeCC-EEEEEEEecCC
Q 045835          244 SAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQG--NREFLNEIAMISCLQHPNLVKIHGCCVEGD-QLLLVYEYMEN  320 (511)
Q Consensus       244 ~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey~~~  320 (511)
                      ..+.||+|+||+||+|.+.....||||++.......  .++|.+|+.+|++++|||||+++|+|.+.. .+++|||||++
T Consensus        45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~  124 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG  124 (362)
T ss_pred             hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence            445699999999999999755559999998653222  568999999999999999999999999987 79999999999


Q ss_pred             CCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCC-CeEEeecCCcccCCCCCce
Q 045835          321 NSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL-NPKISDFGLAKLDEGDKTH  399 (511)
Q Consensus       321 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~-~~kl~DfGla~~~~~~~~~  399 (511)
                      |+|.++|+..  .+..+++..+++++.+||+||.|||+++.  ||||||||+||||+.++ ++||+|||+++...... .
T Consensus       125 GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~  199 (362)
T KOG0192|consen  125 GSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-T  199 (362)
T ss_pred             CcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-c
Confidence            9999999874  23579999999999999999999999863  99999999999999998 99999999998654332 2


Q ss_pred             eecccccCCCcccccccc--cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          400 ISTRIAGTIGYMAPEYAL--WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       400 ~~~~~~gt~~y~aPE~~~--~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                      ..+...||..|||||++.  ...++.|+|||||||+||||+||+.||......        .         -...++...
T Consensus       200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~--------~---------~~~~v~~~~  262 (362)
T KOG0192|consen  200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV--------Q---------VASAVVVGG  262 (362)
T ss_pred             cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH--------H---------HHHHHHhcC
Confidence            233368999999999999  669999999999999999999999999754310        0         112333344


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .+..++..+...+..++.+||+.+|..||++.|+
T Consensus       263 ~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei  296 (362)
T KOG0192|consen  263 LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEI  296 (362)
T ss_pred             CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHH
Confidence            5556666688889999999999999999999764

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-49  Score=396.47  Aligned_cols=245  Identities=31%  Similarity=0.498  Sum_probs=216.0

Q ss_pred             CcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCCC
Q 045835          242 FDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENN  321 (511)
Q Consensus       242 f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g  321 (511)
                      +...+.||+|-||.||.|.++....||+|.++.. ....++|.+|+++|++|+|+|||+|+|+|..+..++||||||+.|
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            4467899999999999999988789999999875 334468999999999999999999999999988999999999999


Q ss_pred             CHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCceee
Q 045835          322 SLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS  401 (511)
Q Consensus       322 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~~  401 (511)
                      +|.++|..+.  +..+...+.+.++.|||+||+||++++   +|||||.++||||+++..+||+|||||+...++.....
T Consensus       287 sLl~yLr~~~--~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~  361 (468)
T KOG0197|consen  287 SLLDYLRTRE--GGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS  361 (468)
T ss_pred             cHHHHhhhcC--CCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeec
Confidence            9999997632  346889999999999999999999986   99999999999999999999999999996665555555


Q ss_pred             cccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCC
Q 045835          402 TRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGS  480 (511)
Q Consensus       402 ~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  480 (511)
                      ....-+..|.|||.+..+.++.|||||||||+||||+| |+.|+....                  ..++.+.+++..+-
T Consensus       362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms------------------n~ev~~~le~GyRl  423 (468)
T KOG0197|consen  362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS------------------NEEVLELLERGYRL  423 (468)
T ss_pred             CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC------------------HHHHHHHHhccCcC
Confidence            55556889999999999999999999999999999999 888876433                  23556777777777


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCcCC
Q 045835          481 KYKKEEAERMIKVSLLCTNASPSLRPTMSE  510 (511)
Q Consensus       481 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e  510 (511)
                      ..|..++..+.+|+..||+.+|++|||+..
T Consensus       424 p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~  453 (468)
T KOG0197|consen  424 PRPEGCPDEVYELMKSCWHEDPEDRPTFET  453 (468)
T ss_pred             CCCCCCCHHHHHHHHHHhhCCcccCCCHHH
Confidence            888899999999999999999999999863

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.1e-47  Score=402.57  Aligned_cols=252  Identities=32%  Similarity=0.524  Sum_probs=213.8

Q ss_pred             hcCCcccCceeccCceeEEecccc------CCcEEEEEEecccCcc-chHHHHHHHHHHhcCCCCCceeEEEEEEeCCEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSKSRQ-GNREFLNEIAMISCLQHPNLVKIHGCCVEGDQL  311 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~  311 (511)
                      +.+....+.||+|.||.||+|+..      +...||||.++..... ..++|.+|+++|..++|||||+|+|+|.+++.+
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            345566789999999999999753      3467999999877554 778999999999999999999999999999999


Q ss_pred             EEEEEecCCCCHhHHHhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCC
Q 045835          312 LLVYEYMENNSLACALFGREN----------CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN  381 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~  381 (511)
                      ++|+|||..|+|.++|..+..          .+.+|+..+.+.||.|||.||.||-++.   ++||||..+|+||.++..
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence            999999999999999965321          1334889999999999999999999886   999999999999999999


Q ss_pred             eEEeecCCccc-CCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhh
Q 045835          382 PKISDFGLAKL-DEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLD  459 (511)
Q Consensus       382 ~kl~DfGla~~-~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~  459 (511)
                      +||+||||+|- +..+......+..-+++|||||.++.+++|++||||||||||||++| |+.|+....           
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS-----------  710 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS-----------  710 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc-----------
Confidence            99999999984 33344444434456789999999999999999999999999999999 899886433           


Q ss_pred             hhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          460 WACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       460 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                             +.++.+.+..+..-+.|.+++.++.+|+..||+.+|++||+++||
T Consensus       711 -------n~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  711 -------NQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             -------hHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence                   223444444443367888999999999999999999999999885

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=8e-47  Score=362.99  Aligned_cols=247  Identities=29%  Similarity=0.434  Sum_probs=204.7

Q ss_pred             cccCceeccCceeEEecccc-CCcEEEEEEeccc-CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCC-EEEEEEEecC
Q 045835          243 DSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK-SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGD-QLLLVYEYME  319 (511)
Q Consensus       243 ~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey~~  319 (511)
                      +..+.||+|..|+|||+.++ +++.+|+|++... .....+++.+|+++++..+||+||+++|.|.... ...++||||+
T Consensus        82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD  161 (364)
T KOG0581|consen   82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD  161 (364)
T ss_pred             hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence            34689999999999999875 6889999999644 3455678999999999999999999999999988 5999999999


Q ss_pred             CCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCce
Q 045835          320 NNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH  399 (511)
Q Consensus       320 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~  399 (511)
                      +|||++++...    ..++++...+|+.++++||.|||+..  +||||||||+|||++..|.+||||||.++...+.   
T Consensus       162 gGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---  232 (364)
T KOG0581|consen  162 GGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---  232 (364)
T ss_pred             CCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence            99999999654    24899999999999999999999742  5999999999999999999999999999876544   


Q ss_pred             eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhC
Q 045835          400 ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLG  479 (511)
Q Consensus       400 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  479 (511)
                      .....+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+.....      ....|..      -+..+++.. .
T Consensus       233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~------~~~~~~~------Ll~~Iv~~p-p  299 (364)
T KOG0581|consen  233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP------PYLDIFE------LLCAIVDEP-P  299 (364)
T ss_pred             hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC------CCCCHHH------HHHHHhcCC-C
Confidence            44557899999999999999999999999999999999999999974311      1111211      112233311 1


Q ss_pred             CCCCHH-HHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          480 SKYKKE-EAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       480 ~~~~~~-~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...|.+ .+.++..++..||++||.+|||+.|+
T Consensus       300 P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qL  332 (364)
T KOG0581|consen  300 PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQL  332 (364)
T ss_pred             CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHH
Confidence            233443 77889999999999999999998764

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-45  Score=357.41  Aligned_cols=198  Identities=32%  Similarity=0.559  Sum_probs=179.4

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEeccc--CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK--SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      .+|...+.||+|.|+.||+|++. ++..||||.+...  .+...+....|+.+|+.++|||||+|++++..++.++||||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            57888899999999999999865 5789999999876  45555678899999999999999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCC------CCeEEeecCCc
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD------LNPKISDFGLA  390 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~------~~~kl~DfGla  390 (511)
                      ||.+|+|.++++.++    .+++.+...++.|+|.||++||+++   ||||||||.||||+..      -.+||+|||+|
T Consensus        90 yC~gGDLs~yi~~~~----~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   90 YCNGGDLSDYIRRRG----RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             eCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            999999999998765    4999999999999999999999987   9999999999999875      45899999999


Q ss_pred             ccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 045835          391 KLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSY  446 (511)
Q Consensus       391 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~  446 (511)
                      +.+....  .....+|++-|||||+++.++|+-|+|+||.|+|||++++|+.||..
T Consensus       163 R~L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a  216 (429)
T KOG0595|consen  163 RFLQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA  216 (429)
T ss_pred             hhCCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence            9876433  34557999999999999999999999999999999999999999973

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-46  Score=385.04  Aligned_cols=247  Identities=28%  Similarity=0.474  Sum_probs=213.3

Q ss_pred             CCcccCceeccCceeEEeccccC----CcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLAD----GTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~~----g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ...+.++||.|.||.|++|+++-    ...||||.++... .....+|+.|..+|.+.+||||++|.|+.......++|+
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            34677899999999999998752    3579999998653 455678999999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      |||+||+|+.+|..+.   .++.+.+..-++.+||.||+||-+.+   ++||||.++||||+.+..+|++||||++...+
T Consensus       710 EyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             hhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence            9999999999997654   35999999999999999999999876   99999999999999999999999999998766


Q ss_pred             CCceeeccc--ccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhH
Q 045835          396 DKTHISTRI--AGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVE  472 (511)
Q Consensus       396 ~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  472 (511)
                      +.....+..  .-+.+|.|||.+...++|.+||||||||||||+++ |..|+=...                  +.++.+
T Consensus       784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS------------------NQdVIk  845 (996)
T KOG0196|consen  784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS------------------NQDVIK  845 (996)
T ss_pred             CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc------------------hHHHHH
Confidence            553322222  23679999999999999999999999999999887 888874222                  335566


Q ss_pred             hhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          473 LVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       473 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      -++...+...|.+++..|.+|++.||++|-.+||.+.+|
T Consensus       846 aIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qi  884 (996)
T KOG0196|consen  846 AIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQI  884 (996)
T ss_pred             HHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHH
Confidence            677777778889999999999999999999999998764

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-45  Score=370.63  Aligned_cols=243  Identities=28%  Similarity=0.437  Sum_probs=208.2

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEeccc---CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK---SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ..|...+.||+|||..||.++. ..|+.||+|++...   .....+...+||++.+.|+|||||+++++|++.+..|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5688999999999999999986 78999999999764   2344567889999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      |+|++++|..++..+    .+++++....+..||+.||.|||+++   |+|||||..|++|+++.++||+|||||.....
T Consensus        98 ELC~~~sL~el~Krr----k~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRR----KPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             EecCCccHHHHHHhc----CCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecC
Confidence            999999999999743    36999999999999999999999987   99999999999999999999999999987664


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      +... ....+||+.|+|||++.....+..+||||+|||||-||.|++||...                     .+.+..+
T Consensus       171 ~~Er-k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk---------------------~vkety~  228 (592)
T KOG0575|consen  171 DGER-KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK---------------------TVKETYN  228 (592)
T ss_pred             cccc-cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc---------------------hHHHHHH
Confidence            4322 34579999999999999999999999999999999999999999732                     1222222


Q ss_pred             hhhC--CCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          476 ERLG--SKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       476 ~~l~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..-.  -..|...+....+|+.++|+++|.+|||+++|
T Consensus       229 ~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~v  266 (592)
T KOG0575|consen  229 KIKLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEV  266 (592)
T ss_pred             HHHhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHH
Confidence            2211  12344566678899999999999999999875

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-45  Score=354.73  Aligned_cols=247  Identities=28%  Similarity=0.410  Sum_probs=200.9

Q ss_pred             hcCCcccCceeccCceeEEecc-ccCCcEEEEEEecccCcc-------chHHHHHHHHHHhcCCCCCceeEEEEEEeCCE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQ-------GNREFLNEIAMISCLQHPNLVKIHGCCVEGDQ  310 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~~~-------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~  310 (511)
                      .+.|.+.+.||+|+||.|-+|. .++|+.||||+++.....       ......+|+++|++|+|||||++.+++...+.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            3567788999999999999995 567999999999754211       12235799999999999999999999999999


Q ss_pred             EEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCC---CCeEEeec
Q 045835          311 LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD---LNPKISDF  387 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~---~~~kl~Df  387 (511)
                      .|+|||||++|.|.+.+-.+.    .+.+.....++.|++.|+.|||+.|   |+||||||+|||+..+   ..+||+||
T Consensus       251 ~YmVlE~v~GGeLfd~vv~nk----~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVANK----YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             eEEEEEEecCccHHHHHHhcc----ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence            999999999999999997654    3777778889999999999999998   9999999999999766   67999999


Q ss_pred             CCcccCCCCCceeecccccCCCcccccccccCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhh
Q 045835          388 GLAKLDEGDKTHISTRIAGTIGYMAPEYALWGY---LTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHL  464 (511)
Q Consensus       388 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~  464 (511)
                      |+|+...  ........+||+.|.|||++.+..   +..+.|+||+|||||-+|||.+||+..-.               
T Consensus       324 GlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~---------------  386 (475)
T KOG0615|consen  324 GLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT---------------  386 (475)
T ss_pred             chhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC---------------
Confidence            9999765  344556789999999999998663   34588999999999999999999974321               


Q ss_pred             hccCchhHhhhh-hh--CCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          465 QQDGKLVELVDE-RL--GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       465 ~~~~~~~~~~d~-~l--~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                        ...+.+.+-. +.  ......+..++..+|+.+||..||++|||+.|+
T Consensus       387 --~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~ea  434 (475)
T KOG0615|consen  387 --DPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEA  434 (475)
T ss_pred             --CccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHH
Confidence              1112222222 22  122334567889999999999999999998763

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.4e-46  Score=341.63  Aligned_cols=247  Identities=26%  Similarity=0.426  Sum_probs=205.9

Q ss_pred             cCCcccCceeccCceeEEecc-ccCCcEEEEEEeccc--CccchHHHHHHHHHHhcCCCCCceeEEE-EEEeCCE-EEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSK--SRQGNREFLNEIAMISCLQHPNLVKIHG-CCVEGDQ-LLLV  314 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~-~~~g~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g-~~~~~~~-~~lV  314 (511)
                      .+|.+.++||+|.||.|||+. +.+|..||.|.+.-.  +.+..+....|+.+|++|+|||||++++ -+.+.++ +.+|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            357788999999999999995 678999999998733  3455678899999999999999999999 4445555 8999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-CCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES-RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~-~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      ||||..|+|...+..-+..+..+++++.++++.|+++||..+|+.- +..|+||||||.||+|+.+|.+||+||||++++
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            9999999999999776666677999999999999999999999942 123999999999999999999999999999987


Q ss_pred             CCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHh
Q 045835          394 EGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVEL  473 (511)
Q Consensus       394 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  473 (511)
                      .+... .....+||+.||+||.+....|+.||||||+||++|||..-++||....        +.+             +
T Consensus       179 ~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n--------~~~-------------L  236 (375)
T KOG0591|consen  179 SSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN--------LLS-------------L  236 (375)
T ss_pred             cchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc--------HHH-------------H
Confidence            76443 3455789999999999999999999999999999999999999997431        211             1


Q ss_pred             hhhhhCCC---CC-HHHHHHHHHHHHHcCCCCCCCCCCc
Q 045835          474 VDERLGSK---YK-KEEAERMIKVSLLCTNASPSLRPTM  508 (511)
Q Consensus       474 ~d~~l~~~---~~-~~~~~~l~~l~~~Cl~~~p~~RPs~  508 (511)
                      -...-+.+   +| ...+.++.+|+..|+..||+.||+.
T Consensus       237 ~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  237 CKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             HHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence            11111122   33 4568889999999999999999984

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-44  Score=341.94  Aligned_cols=239  Identities=28%  Similarity=0.387  Sum_probs=201.0

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  314 (511)
                      .++|+++++||+|+||.||.++. ++++.+|+|+++...   ....+...+|..+|.+++||.||+++-.+++.+.++||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            46799999999999999999975 468999999997652   33456678999999999999999999999999999999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      +||+.||.|..+|.+..    .+++....-.+..|+.||.|||+.+   ||||||||+|||||.+|+++|+||||++...
T Consensus       104 ld~~~GGeLf~hL~~eg----~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~  176 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREG----RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL  176 (357)
T ss_pred             EeccCCccHHHHHHhcC----CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence            99999999999996543    4889989999999999999999997   9999999999999999999999999999544


Q ss_pred             CCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          395 GDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       395 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      .... .+...+||+.|||||++.+..++..+|.||+|+++|||++|.+||....        .             .++.
T Consensus       177 ~~~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~--------~-------------~~~~  234 (357)
T KOG0598|consen  177 KDGD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED--------V-------------KKMY  234 (357)
T ss_pred             cCCC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc--------H-------------HHHH
Confidence            3322 2344799999999999999999999999999999999999999997432        1             2222


Q ss_pred             hhhhC---CCCCHHHHHHHHHHHHHcCCCCCCCCC
Q 045835          475 DERLG---SKYKKEEAERMIKVSLLCTNASPSLRP  506 (511)
Q Consensus       475 d~~l~---~~~~~~~~~~l~~l~~~Cl~~~p~~RP  506 (511)
                      +..+.   ...+.-...+..+++.+.|..+|++|-
T Consensus       235 ~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  235 DKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             HHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence            22221   122223556788899999999999996

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-43  Score=354.46  Aligned_cols=253  Identities=30%  Similarity=0.485  Sum_probs=208.0

Q ss_pred             cCCcccCceeccCceeEEeccccCCcEEEEEEecccCc-cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSR-QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      ....+.++||+|-||.|..+....+..||||+++.... ....+|..|+++|.+++|||||+|+|+|..++.+++|+|||
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            44567789999999999999998889999999997654 44589999999999999999999999999999999999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcc-cCCCCC
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDK  397 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~-~~~~~~  397 (511)
                      ++|+|..+|..+...  .+.-....+||.|||.||+||.+..   ++||||.++|+|+|.++++||+|||+++ ++..+.
T Consensus       618 EnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y  692 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY  692 (807)
T ss_pred             hcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCc
Confidence            999999999876432  1455667789999999999999875   9999999999999999999999999999 445555


Q ss_pred             ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHH--hCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          398 THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIV--SGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ell--tG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      .++..+.+-+++|||||.+..+++|.++|||+||+++||++  |...||+....     .+..         ++..++++
T Consensus       693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~-----e~vv---------en~~~~~~  758 (807)
T KOG1094|consen  693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD-----EQVV---------ENAGEFFR  758 (807)
T ss_pred             eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH-----HHHH---------HhhhhhcC
Confidence            66666667789999999999999999999999999999975  57778763321     1111         12223333


Q ss_pred             hh---hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          476 ER---LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       476 ~~---l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..   .....|.-++..+.+++++||+.+.++|||+++|
T Consensus       759 ~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~l  797 (807)
T KOG1094|consen  759 DQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQL  797 (807)
T ss_pred             CCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHH
Confidence            21   1123355677889999999999999999999764

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.3e-43  Score=345.65  Aligned_cols=259  Identities=27%  Similarity=0.418  Sum_probs=202.2

Q ss_pred             cCCcccCceeccCceeEEecc-ccCCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeC--CEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEG--DQLLLV  314 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV  314 (511)
                      +.|+.+++||+|+||.||+|+ +.+|+.||+|+++...  ........+||.+|++|+||||++|.+...+.  ..+|||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            457778999999999999996 5689999999998654  33445668999999999999999999998876  689999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      +|||+. +|.-++...   ...++..++..++.|++.||+|+|+.+   |.|||||.+|||||.+|.+||+|||||+++.
T Consensus       197 FeYMdh-DL~GLl~~p---~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSP---GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             Eecccc-hhhhhhcCC---CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence            999987 787777543   457999999999999999999999997   9999999999999999999999999999877


Q ss_pred             CCCceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCccccc------ccc--hhhhhHhhh
Q 045835          395 GDKTHISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFD------CTC--LLDWACHLQ  465 (511)
Q Consensus       395 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~------~~~--l~~~~~~~~  465 (511)
                      .......+..+-|..|.|||.+++. .|+.+.|+||.||||.||++|++.+.....++.-      +..  -.-|..  .
T Consensus       270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~--~  347 (560)
T KOG0600|consen  270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPV--S  347 (560)
T ss_pred             CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccc--c
Confidence            6665556667789999999999876 8999999999999999999999988744322110      000  001210  0


Q ss_pred             ccCchhHhhhhhhCCCCC-------HHHHHHHHHHHHHcCCCCCCCCCCcCC
Q 045835          466 QDGKLVELVDERLGSKYK-------KEEAERMIKVSLLCTNASPSLRPTMSE  510 (511)
Q Consensus       466 ~~~~~~~~~d~~l~~~~~-------~~~~~~l~~l~~~Cl~~~p~~RPs~~e  510 (511)
                      +-. ....+.+  ...+.       .......++|+..+|..||.+|.|+.+
T Consensus       348 kLP-~~~~~kp--~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~  396 (560)
T KOG0600|consen  348 KLP-HATIFKP--QQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASS  396 (560)
T ss_pred             cCC-cccccCC--CCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHH
Confidence            000 0011111  01111       122456788999999999999999865

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.7e-43  Score=327.50  Aligned_cols=259  Identities=22%  Similarity=0.312  Sum_probs=199.7

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      +.|+.+.++|+|+||.|||++.+ +|+.||||++....  +...+-.++|+.+|++++|+|+|.|+.+|.....++||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            45788899999999999999876 59999999997543  3344557899999999999999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      ||+.- +.+-|....   ..++.....+++.|+++|+.|+|+++   +|||||||+||||+.++.+||||||+|+.... 
T Consensus        82 ~~dhT-vL~eLe~~p---~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-  153 (396)
T KOG0593|consen   82 YCDHT-VLHELERYP---NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-  153 (396)
T ss_pred             ecchH-HHHHHHhcc---CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence            99874 444443332   34888899999999999999999986   99999999999999999999999999997663 


Q ss_pred             CceeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhc-cCchhHhh
Q 045835          397 KTHISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQ-DGKLVELV  474 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~-~~~~~~~~  474 (511)
                      .....+..+.|.+|+|||.+.+ -+|...+||||.||++.||++|.+-|....+.+    .|.--...+-. ..+..+++
T Consensus       154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiD----QLy~I~ktLG~L~prhq~iF  229 (396)
T KOG0593|consen  154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDID----QLYLIRKTLGNLIPRHQSIF  229 (396)
T ss_pred             CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHH----HHHHHHHHHcccCHHHHHHh
Confidence            3344566788999999999987 589999999999999999999999887544221    11111000000 01112222


Q ss_pred             hhh----------hC-----CCCCHHHHHHHHHHHHHcCCCCCCCCCCcCC
Q 045835          475 DER----------LG-----SKYKKEEAERMIKVSLLCTNASPSLRPTMSE  510 (511)
Q Consensus       475 d~~----------l~-----~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e  510 (511)
                      ...          ..     +.--+..+.-+++++..||+.||++|++-+|
T Consensus       230 ~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~q  280 (396)
T KOG0593|consen  230 SSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQ  280 (396)
T ss_pred             ccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHH
Confidence            211          00     0011223456899999999999999998765

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-42  Score=339.01  Aligned_cols=250  Identities=30%  Similarity=0.428  Sum_probs=200.9

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCC--EEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGD--QLLLVYE  316 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~E  316 (511)
                      .++...+.||+|+||+||++... +|...|||.+........+.+.+|+.+|++++|||||+.+|......  .+.+.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            34667889999999999999865 48999999997654333567899999999999999999999855444  6899999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcC-CCCeEEeecCCcccCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR-DLNPKISDFGLAKLDEG  395 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~-~~~~kl~DfGla~~~~~  395 (511)
                      |+++|+|.+++.+...   .|+++...+...||++||+|||+++   |+||||||+||||+. ++.+||+|||+++....
T Consensus        97 y~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             ccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            9999999999976542   5999999999999999999999987   999999999999999 79999999999986553


Q ss_pred             --CCceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhH
Q 045835          396 --DKTHISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVE  472 (511)
Q Consensus       396 --~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  472 (511)
                        ..........||+.|||||++..+ ....++|||||||++.||+||++|+...       ....++..         .
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-------~~~~~~~~---------~  234 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-------FEEAEALL---------L  234 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-------cchHHHHH---------H
Confidence              222223346899999999999964 3445999999999999999999998732       01111211         1


Q ss_pred             hhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          473 LVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       473 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +........+|...+.+..+++.+|+..+|++|||+.++
T Consensus       235 ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eL  273 (313)
T KOG0198|consen  235 IGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEEL  273 (313)
T ss_pred             HhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHH
Confidence            111111225566677788999999999999999999764

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=377.52  Aligned_cols=251  Identities=30%  Similarity=0.495  Sum_probs=206.5

Q ss_pred             hcCCcccCceeccCceeEEeccccC--Cc----EEEEEEeccc-CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLAD--GT----IIAVKQLSSK-SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQL  311 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~~--g~----~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~  311 (511)
                      ..+.+..+.||+|.||.||+|...+  |.    .||||.++.. +.+...+|++|..+|++++|||||+++|+|.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            3456677899999999999998653  33    4899999765 456667899999999999999999999999999999


Q ss_pred             EEEEEecCCCCHhHHHhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecC
Q 045835          312 LLVYEYMENNSLACALFGREN---CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFG  388 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfG  388 (511)
                      ++++|||++|+|..+|...+.   ....|+....+.++.|||+|+.||++++   +|||||.++|+||+....+||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence            999999999999999976521   2346889999999999999999999986   9999999999999999999999999


Q ss_pred             Ccc-cCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhc
Q 045835          389 LAK-LDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQ  466 (511)
Q Consensus       389 la~-~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~  466 (511)
                      ||+ ....+.........-+.+|||||.+..+.++.|+|||||||+|||++| |..||.....                 
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n-----------------  910 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-----------------  910 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch-----------------
Confidence            999 333333332222234578999999999999999999999999999999 8888864321                 


Q ss_pred             cCchhH-hhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          467 DGKLVE-LVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       467 ~~~~~~-~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                       -++.. ++... +-+.|..+++++.+|+..||+.+|++||++..|
T Consensus       911 -~~v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i  954 (1025)
T KOG1095|consen  911 -FEVLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTI  954 (1025)
T ss_pred             -HHHHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHH
Confidence             11222 11222 446678889999999999999999999998653

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=5.8e-42  Score=347.25  Aligned_cols=253  Identities=25%  Similarity=0.430  Sum_probs=196.3

Q ss_pred             hcCCcccCceeccCceeEEeccc------cCCcEEEEEEecccCc-cchHHHHHHHHHHhcC-CCCCceeEEEEEEeC-C
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL------ADGTIIAVKQLSSKSR-QGNREFLNEIAMISCL-QHPNLVKIHGCCVEG-D  309 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~------~~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~  309 (511)
                      .++|++.++||+|+||.||+|..      .+++.||||++..... .....+.+|+.+++.+ +||||++++++|... .
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            46789999999999999999963      2356899999975432 3345789999999999 899999999998764 4


Q ss_pred             EEEEEEEecCCCCHhHHHhcCCC---------------------------------------------------------
Q 045835          310 QLLLVYEYMENNSLACALFGREN---------------------------------------------------------  332 (511)
Q Consensus       310 ~~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------  332 (511)
                      ..++||||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            68899999999999999864321                                                         


Q ss_pred             -CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCcee-ecccccCCCc
Q 045835          333 -CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI-STRIAGTIGY  410 (511)
Q Consensus       333 -~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y  410 (511)
                       ....+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......... .....++..|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence             0234788899999999999999999986   9999999999999999999999999998543322211 1223456789


Q ss_pred             ccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHH
Q 045835          411 MAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAER  489 (511)
Q Consensus       411 ~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  489 (511)
                      +|||++.+..++.++|||||||++|||++ |+.||......    .   ..... ...+         .....+...+..
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~----~---~~~~~-~~~~---------~~~~~~~~~~~~  305 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN----E---EFCQR-LKDG---------TRMRAPENATPE  305 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc----H---HHHHH-HhcC---------CCCCCCCCCCHH
Confidence            99999999999999999999999999997 99998642210    0   01000 1111         111123344567


Q ss_pred             HHHHHHHcCCCCCCCCCCcCCC
Q 045835          490 MIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       490 l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +.+++.+||+.+|++|||+.||
T Consensus       306 l~~li~~cl~~dp~~RPs~~el  327 (338)
T cd05102         306 IYRIMLACWQGDPKERPTFSAL  327 (338)
T ss_pred             HHHHHHHHccCChhhCcCHHHH
Confidence            8999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-42  Score=352.62  Aligned_cols=245  Identities=32%  Similarity=0.512  Sum_probs=199.9

Q ss_pred             CcccCceeccCceeEEeccccC--C--cE-EEEEEeccc---CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEE
Q 045835          242 FDSAKKIGEGGFGPVYKGQLAD--G--TI-IAVKQLSSK---SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       242 f~~~~~lG~G~fG~Vy~g~~~~--g--~~-vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  313 (511)
                      ....++||+|.||.||+|++..  +  .. ||||..+..   ......+|++|..+|++++|||||+++|++.....+++
T Consensus       159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~i  238 (474)
T KOG0194|consen  159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLML  238 (474)
T ss_pred             ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEE
Confidence            3455899999999999998643  2  23 899999853   35566799999999999999999999999999999999


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      |||+|.||+|.++|.....   .++..++.+++.++|+||+|||+++   +|||||.++|+|++.++.+||+||||++..
T Consensus       239 vmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~  312 (474)
T KOG0194|consen  239 VMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAG  312 (474)
T ss_pred             EEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCC
Confidence            9999999999999976542   5999999999999999999999986   999999999999999999999999999864


Q ss_pred             CCCCceeec-ccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchh
Q 045835          394 EGDKTHIST-RIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLV  471 (511)
Q Consensus       394 ~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  471 (511)
                      ..  ..... ...-+..|+|||.+..+.++.++|||||||++||+++ |..|+.....     .....            
T Consensus       313 ~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~-----~~v~~------------  373 (474)
T KOG0194|consen  313 SQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN-----YEVKA------------  373 (474)
T ss_pred             cc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH-----HHHHH------------
Confidence            31  11111 1235679999999999999999999999999999999 7888864321     11111            


Q ss_pred             HhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       472 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .++-...+...+...+..+..++.+||..+|++||||.+|
T Consensus       374 kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i  413 (474)
T KOG0194|consen  374 KIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTI  413 (474)
T ss_pred             HHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHH
Confidence            1212233344455667778889999999999999999864

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4e-41  Score=332.73  Aligned_cols=240  Identities=20%  Similarity=0.279  Sum_probs=193.2

Q ss_pred             ccCceeccCceeEEeccccCCcEEEEEEecccCccc---hHHHHHHHHHHhcCCCCCceeEEEEEEe----CCEEEEEEE
Q 045835          244 SAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQG---NREFLNEIAMISCLQHPNLVKIHGCCVE----GDQLLLVYE  316 (511)
Q Consensus       244 ~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~E  316 (511)
                      ....||+|++|.||+|.+ +|+.||||+++......   .+.|.+|+.+|++++||||++++|++.+    ....++|||
T Consensus        24 ~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         24 TSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             CCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence            346899999999999988 68899999997653332   4667899999999999999999999977    357899999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      |+++|+|.+++...    ..++|....+++.+++.||.|||+..  .++||||||+|||+++++.+||+|||+++.....
T Consensus       103 y~~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~  176 (283)
T PHA02988        103 YCTRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP  176 (283)
T ss_pred             eCCCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence            99999999999654    25899999999999999999999742  2779999999999999999999999999865432


Q ss_pred             CceeecccccCCCccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          397 KTHISTRIAGTIGYMAPEYALW--GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      .    ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||.....     ..+..            .++
T Consensus       177 ~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-----~~~~~------------~i~  235 (283)
T PHA02988        177 P----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-----KEIYD------------LII  235 (283)
T ss_pred             c----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-----HHHHH------------HHH
Confidence            1    12357889999999876  6899999999999999999999999963321     11111            111


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ....+...+...+..+.+++.+||+.+|++|||+.||
T Consensus       236 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~el  272 (283)
T PHA02988        236 NKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEI  272 (283)
T ss_pred             hcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHH
Confidence            1111222333456679999999999999999999875

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-42  Score=344.16  Aligned_cols=246  Identities=29%  Similarity=0.456  Sum_probs=208.2

Q ss_pred             cCCcccCceeccCceeEEecc-ccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      ..|....+||+|..|.||.+. ..+++.||||++........+-.++|+.+|+..+|+|||.+++.+..++++|+|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            457788899999999999995 5578899999998776666667799999999999999999999999999999999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      ++|+|.+.+...     .+++.++..||.++++||+|||.++   |+|||||++|||++.++.+||+|||++........
T Consensus       353 ~ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~  424 (550)
T KOG0578|consen  353 EGGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS  424 (550)
T ss_pred             CCCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence            999999998543     3899999999999999999999997   99999999999999999999999999986655443


Q ss_pred             eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhh-h
Q 045835          399 HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDE-R  477 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~-~  477 (511)
                      . ....+||+.|||||++....|.+|.||||||++++||+-|++||-.....       ..          +.-+.+. .
T Consensus       425 K-R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl-------rA----------lyLIa~ng~  486 (550)
T KOG0578|consen  425 K-RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-------RA----------LYLIATNGT  486 (550)
T ss_pred             c-cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH-------HH----------HHHHhhcCC
Confidence            2 34578999999999999999999999999999999999999999642211       11          1111111 1


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +....+...+..+.+++.+||+.|+++||++.|+
T Consensus       487 P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eL  520 (550)
T KOG0578|consen  487 PKLKNPEKLSPELKDFLDRCLVVDVEQRASAKEL  520 (550)
T ss_pred             CCcCCccccCHHHHHHHHHHhhcchhcCCCHHHH
Confidence            2223455667789999999999999999999874

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-42  Score=341.52  Aligned_cols=261  Identities=26%  Similarity=0.391  Sum_probs=202.0

Q ss_pred             hcCCcccCceeccCceeEEecc-ccCCcEEEEEEecccCccchHHH--HHHHHHHhcCC-CCCceeEEEEEEeCC-EEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREF--LNEIAMISCLQ-HPNLVKIHGCCVEGD-QLLL  313 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~~~~~~~~--~~Ei~~l~~l~-H~niv~l~g~~~~~~-~~~l  313 (511)
                      .++|...++||.|+||.||+|+ ...|..||||+++.+-.. .++.  ++|++.|++|+ ||||++|.+++.+.+ .+++
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            4678899999999999999997 456889999999865433 2333  68999999998 999999999999988 9999


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      |||||+. +|.+++.++   ...+++..+..|+.||++||+|+|.+|   +.|||+||+|||+..+..+||+||||||..
T Consensus        88 VfE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   88 VFEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             eHHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence            9999986 899999776   357999999999999999999999998   999999999999999999999999999966


Q ss_pred             CCCCceeecccccCCCcccccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccC----
Q 045835          394 EGDKTHISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDG----  468 (511)
Q Consensus       394 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~----  468 (511)
                      .....  .+..+.|..|+|||++. .+.|+.+.||||+|||++|+.+-++.|......+.- -.+.+......+..    
T Consensus       161 ~SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi-~KIc~VLGtP~~~~~~eg  237 (538)
T KOG0661|consen  161 RSKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQI-YKICEVLGTPDKDSWPEG  237 (538)
T ss_pred             ccCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHH-HHHHHHhCCCccccchhH
Confidence            54433  35568899999999886 458999999999999999999999988754422110 00000000000000    


Q ss_pred             -chhHhhhhhhC-------CCCCHHHHHHHHHHHHHcCCCCCCCCCCcCC
Q 045835          469 -KLVELVDERLG-------SKYKKEEAERMIKVSLLCTNASPSLRPTMSE  510 (511)
Q Consensus       469 -~~~~~~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e  510 (511)
                       ++...+.-.+.       ...-+..+.+.++|+.+|++.||.+|||+.|
T Consensus       238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~  287 (538)
T KOG0661|consen  238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQ  287 (538)
T ss_pred             HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHH
Confidence             01111111110       0111236788999999999999999999876

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-41  Score=328.76  Aligned_cols=259  Identities=27%  Similarity=0.412  Sum_probs=204.4

Q ss_pred             hcCCcccCceeccCceeEEecc-ccCCcEEEEEEecccCcc-chHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQ-GNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      .+.|++.+.||.|..++||+|+ .+.++.||||++.....+ ....+.+|+..|+.++||||++.+..|..+..+|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            4678999999999999999996 567899999999865433 34788999999999999999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      ||.+||+.+++...-.  ..+++..+..|+.++++||.|||.+|   .||||||+.||||+++|.+||+|||.+-.+...
T Consensus       105 fMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             hhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence            9999999999976432  34899999999999999999999997   999999999999999999999999987633222


Q ss_pred             Ccee--e-cccccCCCcccccccccC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchh
Q 045835          397 KTHI--S-TRIAGTIGYMAPEYALWG--YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLV  471 (511)
Q Consensus       397 ~~~~--~-~~~~gt~~y~aPE~~~~~--~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  471 (511)
                      ....  . ...+||+.|||||+++..  .|+.|+||||||+..+||.+|..||...+++..-       ...+....  .
T Consensus       180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL-------l~tLqn~p--p  250 (516)
T KOG0582|consen  180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL-------LLTLQNDP--P  250 (516)
T ss_pred             CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH-------HHHhcCCC--C
Confidence            1111  1 456899999999996543  7999999999999999999999999865533210       00111110  0


Q ss_pred             HhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       472 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...-..+..+-.......+.+++..||+.||++|||++++
T Consensus       251 ~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskL  290 (516)
T KOG0582|consen  251 TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKL  290 (516)
T ss_pred             CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHH
Confidence            0000111111122334578999999999999999998764

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-42  Score=348.66  Aligned_cols=257  Identities=29%  Similarity=0.477  Sum_probs=202.0

Q ss_pred             HHHHHHHhcCCcccCceeccCceeEEeccccCCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 045835          232 LKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGD  309 (511)
Q Consensus       232 ~~~l~~~~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~  309 (511)
                      .++.....+.+.+...||+|.||+||+|++.+  .||||++....  ....+.|.+|+..+++-+|.||+=+.|||....
T Consensus       384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             ccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            34555555667788999999999999999863  49999998653  345678999999999999999999999999876


Q ss_pred             EEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCC
Q 045835          310 QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL  389 (511)
Q Consensus       310 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGl  389 (511)
                      . .+|+.+|++.+|..+|+-.+   ..++..+.+.|+.|||+||.|||.++   |||||||+.||+|.+++.+||+||||
T Consensus       462 ~-AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGL  534 (678)
T KOG0193|consen  462 L-AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGL  534 (678)
T ss_pred             e-eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccc
Confidence            6 99999999999999998665   46899999999999999999999986   99999999999999999999999999


Q ss_pred             cccCCCC-CceeecccccCCCcccccccccC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhh
Q 045835          390 AKLDEGD-KTHISTRIAGTIGYMAPEYALWG---YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQ  465 (511)
Q Consensus       390 a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~  465 (511)
                      +.....- ........-|...|||||+++..   +|++.+||||||+|+|||+||..||..... +.    + -|   .+
T Consensus       535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~-dq----I-if---mV  605 (678)
T KOG0193|consen  535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR-DQ----I-IF---MV  605 (678)
T ss_pred             eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh-hh----e-EE---Ee
Confidence            9642211 11111223477899999998744   799999999999999999999999973221 00    0 00   00


Q ss_pred             ccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          466 QDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       466 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..|.+    .+.+ .....++..+|.+|+..||..++++||.+.+|
T Consensus       606 GrG~l----~pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~i  646 (678)
T KOG0193|consen  606 GRGYL----MPDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQL  646 (678)
T ss_pred             ccccc----Cccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHH
Confidence            11110    0100 12334667789999999999999999998754

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=5.6e-41  Score=328.43  Aligned_cols=249  Identities=25%  Similarity=0.397  Sum_probs=198.6

Q ss_pred             hcCCcccCceeccCceeEEecccc----CCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA----DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~----~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  313 (511)
                      .++|++.+.||+|+||.||+|.+.    .+..||+|.++... ......|.+|+.++++++||||++++|++..++..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            356888999999999999999753    35689999997653 2334578999999999999999999999999999999


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      ||||+++|+|.+++....   ..+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.+|++|||.+...
T Consensus        84 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          84 VTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             EEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            999999999999996532   35899999999999999999999886   999999999999999999999999988653


Q ss_pred             CCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhH
Q 045835          394 EGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVE  472 (511)
Q Consensus       394 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  472 (511)
                      ............++..|+|||.+.+..++.++|||||||++||+++ |+.||.....     ..+...            
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~-----~~~~~~------------  220 (266)
T cd05064         158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-----QDVIKA------------  220 (266)
T ss_pred             cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH-----HHHHHH------------
Confidence            3222111122335678999999999999999999999999999875 9999863221     111111            


Q ss_pred             hhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          473 LVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       473 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                       +........+...+..+.+++.+||+.+|++||++.||
T Consensus       221 -~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i  258 (266)
T cd05064         221 -VEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQI  258 (266)
T ss_pred             -HHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHH
Confidence             11111122344456679999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.6e-40  Score=379.56  Aligned_cols=253  Identities=28%  Similarity=0.479  Sum_probs=209.8

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      ...|...+.||+|+||.||+|+. .++..||||++......    ...|++.+++++|||||+++|+|.+.+..++||||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            34677888999999999999986 57899999998643322    23568899999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +++|+|.++++       .++|..+.+++.|+|+||+|||..+.++|+||||||+||+++.++.+++. ||........ 
T Consensus       765 ~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-  835 (968)
T PLN00113        765 IEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-  835 (968)
T ss_pred             CCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-
Confidence            99999999994       28899999999999999999997766679999999999999999988876 6665433221 


Q ss_pred             ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          398 THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                          ....+|..|+|||++.+..++.++|||||||++|||+||+.|+....   .....+.+|+...........++|+.
T Consensus       836 ----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  908 (968)
T PLN00113        836 ----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF---GVHGSIVEWARYCYSDCHLDMWIDPS  908 (968)
T ss_pred             ----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc---CCCCcHHHHHHHhcCccchhheeCcc
Confidence                12357899999999999999999999999999999999999985322   22345778877666666667777776


Q ss_pred             hCC--CCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGS--KYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~--~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +..  ..+.++..++.+++.+||+.+|++||||.||
T Consensus       909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~ev  944 (968)
T PLN00113        909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDV  944 (968)
T ss_pred             ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHH
Confidence            643  3456777889999999999999999999875

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=9.2e-41  Score=333.37  Aligned_cols=258  Identities=27%  Similarity=0.446  Sum_probs=197.0

Q ss_pred             cCCcccCceeccCceeEEeccccC-----------------CcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLAD-----------------GTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKI  301 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~-----------------g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l  301 (511)
                      ++|.+.++||+|+||.||++...+                 +..||+|.+.... .....+|.+|+.++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            568888999999999999996432                 3469999987643 3344579999999999999999999


Q ss_pred             EEEEEeCCEEEEEEEecCCCCHhHHHhcCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEE
Q 045835          302 HGCCVEGDQLLLVYEYMENNSLACALFGREN---------------CELELDWPTRQKICLGIARGLAFLHEESRFKIVH  366 (511)
Q Consensus       302 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH  366 (511)
                      ++++.+.+..++||||+++|+|.+++.....               ....++|....+++.|++.||+|||+.+   |+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence            9999999999999999999999999854321               1234788999999999999999999986   999


Q ss_pred             ccCCCCCeEEcCCCCeEEeecCCcccCCCCCc-eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhC--CCC
Q 045835          367 RDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG--KNN  443 (511)
Q Consensus       367 ~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG--~~p  443 (511)
                      |||||+|||+++++.+||+|||+++....... .......++..|+|||++..+.++.++||||||+++|||+++  ..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999985433222 222334567889999999988999999999999999999874  455


Q ss_pred             CCCCCcccccccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          444 MSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       444 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +....     .......+........      .......++.++..+.+++.+||+.+|++|||+.||
T Consensus       242 ~~~~~-----~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i  298 (304)
T cd05096         242 YGELT-----DEQVIENAGEFFRDQG------RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDI  298 (304)
T ss_pred             CCcCC-----HHHHHHHHHHHhhhcc------ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHH
Confidence            54221     1111122111111000      000011123345678999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.8e-40  Score=328.25  Aligned_cols=246  Identities=26%  Similarity=0.357  Sum_probs=197.5

Q ss_pred             CCcccCceeccCceeEEeccc-cCCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      .|+..+.||+|+||.||++.. .+++.||+|.+....   ......+.+|+.++++++|+|++++.+++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            377889999999999999975 578999999986432   2333467899999999999999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      |+++|+|.+++....  ...+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++......
T Consensus        81 ~~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05631          81 IMNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG  155 (285)
T ss_pred             ecCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence            999999998886432  235899999999999999999999986   999999999999999999999999999865432


Q ss_pred             CceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhh
Q 045835          397 KTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDE  476 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  476 (511)
                      ..  .....||..|+|||++.+..++.++|||||||++|||++|+.||.......     ..+         .+...+ .
T Consensus       156 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-----~~~---------~~~~~~-~  218 (285)
T cd05631         156 ET--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV-----KRE---------EVDRRV-K  218 (285)
T ss_pred             Ce--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch-----hHH---------HHHHHh-h
Confidence            22  233568999999999999999999999999999999999999997432100     000         000000 0


Q ss_pred             hhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCc
Q 045835          477 RLGSKYKKEEAERMIKVSLLCTNASPSLRPTM  508 (511)
Q Consensus       477 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  508 (511)
                      .....++...+..+.+|+.+||+.+|++||+.
T Consensus       219 ~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~  250 (285)
T cd05631         219 EDQEEYSEKFSEDAKSICRMLLTKNPKERLGC  250 (285)
T ss_pred             cccccCCccCCHHHHHHHHHHhhcCHHHhcCC
Confidence            11122334456678999999999999999984

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-40  Score=335.91  Aligned_cols=247  Identities=23%  Similarity=0.365  Sum_probs=202.3

Q ss_pred             HhcCCcccCceeccCceeEEeccc-cCCcEEEEEEeccc----Cc-cchHHHHHHHHHHhcCC-CCCceeEEEEEEeCCE
Q 045835          238 ATNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK----SR-QGNREFLNEIAMISCLQ-HPNLVKIHGCCVEGDQ  310 (511)
Q Consensus       238 ~~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~----~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~  310 (511)
                      ..++|...+.||+|+||.|+.|.. .++..||+|++...    .. .....+.+|+.+++.++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            356899999999999999999964 46899999977653    11 23445668999999999 9999999999999999


Q ss_pred             EEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCC-CCeEEeecCC
Q 045835          311 LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD-LNPKISDFGL  389 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~-~~~kl~DfGl  389 (511)
                      +++||||+.+|+|.+++...    ..+.+....+++.|++.|++|||+.+   |+||||||+|||+|.+ +++||+|||+
T Consensus        95 ~~ivmEy~~gGdL~~~i~~~----g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVNK----GRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             EEEEEEecCCccHHHHHHHc----CCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence            99999999999999999763    35888999999999999999999997   9999999999999999 9999999999


Q ss_pred             cccCCCCCceeecccccCCCcccccccccCC-CC-cchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhcc
Q 045835          390 AKLDEGDKTHISTRIAGTIGYMAPEYALWGY-LT-YKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD  467 (511)
Q Consensus       390 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~  467 (511)
                      +.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||....        ....       
T Consensus       168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~--------~~~l-------  231 (370)
T KOG0583|consen  168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN--------VPNL-------  231 (370)
T ss_pred             ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc--------HHHH-------
Confidence            99774 2223345578999999999999866 65 78999999999999999999997421        1111       


Q ss_pred             CchhHhhhhhhCCCCCHHH-HHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          468 GKLVELVDERLGSKYKKEE-AERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       468 ~~~~~~~d~~l~~~~~~~~-~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                         ...+... .-.+|... +.++..|+.+|+..+|.+|+|+.||
T Consensus       232 ---~~ki~~~-~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i  272 (370)
T KOG0583|consen  232 ---YRKIRKG-EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEI  272 (370)
T ss_pred             ---HHHHhcC-CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence               1111110 11233333 7789999999999999999998774

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.1e-41  Score=329.16  Aligned_cols=245  Identities=33%  Similarity=0.526  Sum_probs=190.8

Q ss_pred             ccCceeccCceeEEecccc-----CCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          244 SAKKIGEGGFGPVYKGQLA-----DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       244 ~~~~lG~G~fG~Vy~g~~~-----~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      ..+.||+|.||.||+|.+.     .+..|+||.++... ......|.+|+..+++++||||++++|+|...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999876     25689999996543 33467899999999999999999999999988889999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC-
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD-  396 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~-  396 (511)
                      +++|+|.++|....  ...+++..+.+|+.||++||+|||+.+   ++|+||+++||++++++.+||+|||++...... 
T Consensus        83 ~~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   83 CPGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             -TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             cccccccccccccc--ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence            99999999998762  245899999999999999999999986   999999999999999999999999999865322 


Q ss_pred             CceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          397 KTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      .............|+|||.+....++.++||||||+++|||++ |+.|+....        ..++          .+.+.
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~--------~~~~----------~~~~~  219 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD--------NEEI----------IEKLK  219 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC--------HHHH----------HHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc--------cccc----------ccccc
Confidence            2222333456778999999999999999999999999999999 678775321        1111          11112


Q ss_pred             hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       476 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .......+..+...+.+++.+||+.+|++||||.||
T Consensus       220 ~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i  255 (259)
T PF07714_consen  220 QGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEI  255 (259)
T ss_dssp             TTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHH
T ss_pred             ccccceeccchhHHHHHHHHHHcCCChhhCcCHHHH
Confidence            222223344456779999999999999999999864

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=327.58  Aligned_cols=257  Identities=31%  Similarity=0.439  Sum_probs=192.6

Q ss_pred             cCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHh--cCCCCCceeEEEEEEeCC----EEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMIS--CLQHPNLVKIHGCCVEGD----QLLL  313 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~--~l~H~niv~l~g~~~~~~----~~~l  313 (511)
                      ......++||+|+||.||||.+. ++.||||++....   .+.|.+|-.+.+  .++|+||+++++.-..+.    +++|
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc-CceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            34556789999999999999995 5899999997644   457888877766  568999999999876655    8999


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCCeEEccCCCCCeEEcCCCCeEEeec
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE------SRFKIVHRDIKATNVLLDRDLNPKISDF  387 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~------~~~~iiH~Dlk~~NILld~~~~~kl~Df  387 (511)
                      |+||.++|+|.++|..+     .++|....+|+..+++||+|||+.      .+++|+|||||++||||.+|+++.|+||
T Consensus       286 Vt~fh~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF  360 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF  360 (534)
T ss_pred             EeeeccCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence            99999999999999765     489999999999999999999986      3678999999999999999999999999


Q ss_pred             CCcccCCCCCc-eeecccccCCCcccccccccC-CCC-----cchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhh
Q 045835          388 GLAKLDEGDKT-HISTRIAGTIGYMAPEYALWG-YLT-----YKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDW  460 (511)
Q Consensus       388 Gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~-----~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~  460 (511)
                      |||..+..... ......+||.+|||||++.+. .+.     .+.||||+|.|||||++.-..+...+ .+.   ....+
T Consensus       361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~-vp~---Yqlpf  436 (534)
T KOG3653|consen  361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGP-VPE---YQLPF  436 (534)
T ss_pred             ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCC-CCc---ccCch
Confidence            99986553322 222346899999999998654 232     36899999999999999654432111 000   00111


Q ss_pred             hHhhhcc---CchhHh-hhhhhCCCCCHH-----HHHHHHHHHHHcCCCCCCCCCCcC
Q 045835          461 ACHLQQD---GKLVEL-VDERLGSKYKKE-----EAERMIKVSLLCTNASPSLRPTMS  509 (511)
Q Consensus       461 ~~~~~~~---~~~~~~-~d~~l~~~~~~~-----~~~~l~~l~~~Cl~~~p~~RPs~~  509 (511)
                      -..+-..   +++.++ +..+.+..++..     .+..+.+.+..||+.||+-|-|+.
T Consensus       437 e~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  437 EAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             hHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence            1111111   122222 223334444432     366789999999999999998863

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.2e-40  Score=342.35  Aligned_cols=253  Identities=28%  Similarity=0.450  Sum_probs=197.7

Q ss_pred             hcCCcccCceeccCceeEEeccc------cCCcEEEEEEecccC-ccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL------ADGTIIAVKQLSSKS-RQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQ  310 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~------~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~  310 (511)
                      .++|+..++||+|+||.||+|+.      .++..||||+++... ....+.+.+|+.+++.+ +||||++++++|.+++.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45788999999999999999853      235689999997543 23345688999999999 89999999999999999


Q ss_pred             EEEEEEecCCCCHhHHHhcCCC----------------------------------------------------------
Q 045835          311 LLLVYEYMENNSLACALFGREN----------------------------------------------------------  332 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~----------------------------------------------------------  332 (511)
                      .++||||+++|+|.+++.....                                                          
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999999864321                                                          


Q ss_pred             -------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCce
Q 045835          333 -------------CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH  399 (511)
Q Consensus       333 -------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~  399 (511)
                                   ....++|..+.+++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                         0124789999999999999999999986   999999999999999999999999999855432221


Q ss_pred             -eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          400 -ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       400 -~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                       ......++..|+|||.+.+..++.++|||||||++|||++ |..||......    ..+             .+.+...
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~----~~~-------------~~~~~~~  333 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD----SKF-------------YKMIKEG  333 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch----HHH-------------HHHHHhC
Confidence             1112335668999999999999999999999999999998 88887532210    011             1111211


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....+...+.++.+++.+||+.+|++|||+.||
T Consensus       334 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei  367 (375)
T cd05104         334 YRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQI  367 (375)
T ss_pred             ccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence            1111222234578999999999999999999875

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.4e-40  Score=321.75  Aligned_cols=247  Identities=26%  Similarity=0.439  Sum_probs=198.5

Q ss_pred             cCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecC
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYME  319 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~  319 (511)
                      +.|+..+.||+|+||.||++...++..+|+|.+... ......+.+|+.++++++||||++++++|.+.+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            457888999999999999999888888999988643 2334678999999999999999999999999999999999999


Q ss_pred             CCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCce
Q 045835          320 NNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH  399 (511)
Q Consensus       320 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~  399 (511)
                      +|+|.+++....   ..++|..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++........
T Consensus        83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05114          83 NGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT  156 (256)
T ss_pred             CCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence            999999986533   24899999999999999999999886   999999999999999999999999999854433222


Q ss_pred             eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhh
Q 045835          400 ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERL  478 (511)
Q Consensus       400 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  478 (511)
                      ......++..|+|||.+....++.++||||||+++|||++ |+.||....     .......   ..+.          .
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~-----~~~~~~~---i~~~----------~  218 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS-----NYEVVEM---ISRG----------F  218 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH---HHCC----------C
Confidence            2222345668999999988889999999999999999999 888886322     1111111   1110          0


Q ss_pred             CCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          479 GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       479 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ....+...+..+.+++.+||+.+|++|||+.||
T Consensus       219 ~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l  251 (256)
T cd05114         219 RLYRPKLASMTVYEVMYSCWHEKPEGRPTFAEL  251 (256)
T ss_pred             CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHH
Confidence            011122234578999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-42  Score=342.29  Aligned_cols=234  Identities=27%  Similarity=0.437  Sum_probs=196.2

Q ss_pred             ccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCCCCH
Q 045835          244 SAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSL  323 (511)
Q Consensus       244 ~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL  323 (511)
                      .++-||+|+.|.||+|++. ++.||||+++.-       -..+|+-|++|+||||+.+.|+|.....+++|||||..|.|
T Consensus       128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL  199 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL  199 (904)
T ss_pred             hhhhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence            4688999999999999996 577999998642       23588999999999999999999999999999999999999


Q ss_pred             hHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCceeecc
Q 045835          324 ACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR  403 (511)
Q Consensus       324 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~  403 (511)
                      ...|....    .+.-.....+..+||.||.|||.+.   |||||||+-||||..+..+||+|||-++......+.  ..
T Consensus       200 ~~VLka~~----~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STk--MS  270 (904)
T KOG4721|consen  200 YEVLKAGR----PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTK--MS  270 (904)
T ss_pred             HHHHhccC----ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhhhh--hh
Confidence            99997654    4777788899999999999999985   999999999999999999999999999865543322  23


Q ss_pred             cccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCCCCC
Q 045835          404 IAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYK  483 (511)
Q Consensus       404 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  483 (511)
                      .+||..|||||++...+.++|+|||||||||||||||.-||.......      .-|           .+=...|....|
T Consensus       271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA------IIw-----------GVGsNsL~LpvP  333 (904)
T KOG4721|consen  271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA------IIW-----------GVGSNSLHLPVP  333 (904)
T ss_pred             hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe------eEE-----------eccCCcccccCc
Confidence            689999999999999999999999999999999999999996322110      001           111123334567


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          484 KEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       484 ~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..+++-+.-|+..||+..|..|||++++
T Consensus       334 stcP~GfklL~Kqcw~sKpRNRPSFrqi  361 (904)
T KOG4721|consen  334 STCPDGFKLLLKQCWNSKPRNRPSFRQI  361 (904)
T ss_pred             ccCchHHHHHHHHHHhcCCCCCccHHHH
Confidence            7788889999999999999999999764

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.5e-40  Score=305.31  Aligned_cols=260  Identities=24%  Similarity=0.349  Sum_probs=201.6

Q ss_pred             cCCcccCceeccCceeEEecc-ccCCcEEEEEEecccCc--cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSR--QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      .+|...++||+|.||.||+|+ ..+|+.||||+++....  ......++|++.|+.++|+||+.|++++...+.+.+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            357778999999999999996 55799999999986532  234578999999999999999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      ||+. +|+..+....   ..++-.+...++.++++||+|||++.   |.||||||.|+|+++++.+||+|||||+.+...
T Consensus        82 fm~t-dLe~vIkd~~---i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKN---IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             eccc-cHHHHhcccc---cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            9986 8998886543   46888999999999999999999997   999999999999999999999999999987654


Q ss_pred             CceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccc--------cchhhhhHhhhcc
Q 045835          397 KTHISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDC--------TCLLDWACHLQQD  467 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~--------~~l~~~~~~~~~~  467 (511)
                      ... .+..+-|..|+|||.+.+. .|+...||||.|||+.||+-|.+-|....+.+.-.        ....+|-.    -
T Consensus       155 ~~~-~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~----~  229 (318)
T KOG0659|consen  155 NRI-QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPE----M  229 (318)
T ss_pred             Ccc-cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcc----c
Confidence            433 2333679999999988765 79999999999999999999987766433221100        00011110    0


Q ss_pred             CchhHhhhhh-----hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          468 GKLVELVDER-----LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       468 ~~~~~~~d~~-----l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..+.+.++-.     .....-+.+..+.++|+..++..||.+|+|++|.
T Consensus       230 ~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qa  278 (318)
T KOG0659|consen  230 TSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQA  278 (318)
T ss_pred             cccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHH
Confidence            0111111111     0111223445677999999999999999998763

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=341.62  Aligned_cols=255  Identities=25%  Similarity=0.427  Sum_probs=216.4

Q ss_pred             HHHHHHhcCCcccCceeccCceeEEeccccC-CcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEE
Q 045835          233 KQIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQL  311 (511)
Q Consensus       233 ~~l~~~~~~f~~~~~lG~G~fG~Vy~g~~~~-g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~  311 (511)
                      ++.+....+....++||-|.||.||.|.++. ...||||.++... ...++|+.|..+|+.++|||+|+|+|+|..+..+
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            4444444556677899999999999998764 5789999998653 3457999999999999999999999999999999


Q ss_pred             EEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcc
Q 045835          312 LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK  391 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~  391 (511)
                      |+|+|||..|+|.++|..-.  +..++--..+.++.||+.||+||..++   +|||||.++|+|+.++..+||+||||++
T Consensus       339 YIiTEfM~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsR  413 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSR  413 (1157)
T ss_pred             EEEEecccCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhh
Confidence            99999999999999996533  234566678899999999999999876   9999999999999999999999999999


Q ss_pred             cCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCch
Q 045835          392 LDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKL  470 (511)
Q Consensus       392 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  470 (511)
                      ++..+.........-++.|.|||.+....++.|+|||+|||+|||+.| |..|+....                  ..++
T Consensus       414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------------------lSqV  475 (1157)
T KOG4278|consen  414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------------------LSQV  475 (1157)
T ss_pred             hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------------------HHHH
Confidence            988776544444445789999999999999999999999999999998 777765211                  2245


Q ss_pred             hHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          471 VELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       471 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .+++....+-+-|+.|+.++.+|+..||+.+|.+||++.|+
T Consensus       476 Y~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaei  516 (1157)
T KOG4278|consen  476 YGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEI  516 (1157)
T ss_pred             HHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence            66677777777888999999999999999999999999874

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.6e-40  Score=322.34  Aligned_cols=249  Identities=29%  Similarity=0.436  Sum_probs=201.0

Q ss_pred             hcCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      .++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++.+.+..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            35788999999999999999998888899999986533 23568899999999999999999999999999999999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      ++++|.+++....  ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++........
T Consensus        84 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          84 AKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             CCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            9999999986543  235889999999999999999999886   99999999999999999999999999986544332


Q ss_pred             eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          399 HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                      .......++..|+|||++....++.++|||||||++|||+| |+.||....     ......+..             ..
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~-----~~~~~~~~~-------------~~  220 (261)
T cd05072         159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS-----NSDVMSALQ-------------RG  220 (261)
T ss_pred             eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC-----HHHHHHHHH-------------cC
Confidence            22223345678999999988889999999999999999998 999885321     111111110             00


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .........+..+.+++.+|++.+|++||++.+|
T Consensus       221 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i  254 (261)
T cd05072         221 YRMPRMENCPDELYDIMKTCWKEKAEERPTFDYL  254 (261)
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHH
Confidence            1111122344578999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.7e-40  Score=340.99  Aligned_cols=253  Identities=28%  Similarity=0.450  Sum_probs=197.4

Q ss_pred             hcCCcccCceeccCceeEEeccc------cCCcEEEEEEecccCc-cchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL------ADGTIIAVKQLSSKSR-QGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQ  310 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~------~~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~  310 (511)
                      .++|++.+.||+|+||.||+++.      .++..||||+++.... .....+.+|+.+++.+ +|+||++++++|...+.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            45788999999999999999863      2345799999975432 2345688999999999 89999999999999999


Q ss_pred             EEEEEEecCCCCHhHHHhcCCC----------------------------------------------------------
Q 045835          311 LLLVYEYMENNSLACALFGREN----------------------------------------------------------  332 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~----------------------------------------------------------  332 (511)
                      .++||||+++|+|.+++.....                                                          
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            9999999999999999854210                                                          


Q ss_pred             --------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCce-eecc
Q 045835          333 --------CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH-ISTR  403 (511)
Q Consensus       333 --------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~-~~~~  403 (511)
                              ....+++....+++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++........ ....
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                    1124788999999999999999999986   999999999999999999999999999754332221 1122


Q ss_pred             cccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCCCC
Q 045835          404 IAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKY  482 (511)
Q Consensus       404 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  482 (511)
                      ..++..|+|||++....++.++|||||||++|||++ |+.||.....                 .....+.+........
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~-----------------~~~~~~~~~~~~~~~~  336 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV-----------------NSKFYKMVKRGYQMSR  336 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc-----------------cHHHHHHHHcccCccC
Confidence            335678999999998899999999999999999997 9999863211                 0011112221111222


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          483 KKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       483 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +...+..+.+++.+||+.+|++|||+.||
T Consensus       337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l  365 (374)
T cd05106         337 PDFAPPEIYSIMKMCWNLEPTERPTFSQI  365 (374)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            22234678999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=6.4e-41  Score=334.56  Aligned_cols=241  Identities=27%  Similarity=0.412  Sum_probs=207.4

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      ++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+..  ....+...+|+++++.++|||||.++++++...++++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57888899999999999999754 67899999987543  3345678999999999999999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      |+.+ +|..+|....    .++++....|+.+++.||.|||+..   |+|||+||.|||++..+.+|++|||+|+.+.. 
T Consensus        82 ~a~g-~L~~il~~d~----~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-  152 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG----KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST-  152 (808)
T ss_pred             hhhh-hHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc-
Confidence            9987 9999996654    4999999999999999999999986   99999999999999999999999999997664 


Q ss_pred             CceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhh
Q 045835          397 KTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDE  476 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  476 (511)
                      ++.+-+.+.||+.|||||...++.|+..+|.||+||++||+.+|++||...                     .+.+++..
T Consensus       153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~---------------------si~~Lv~~  211 (808)
T KOG0597|consen  153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR---------------------SITQLVKS  211 (808)
T ss_pred             CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH---------------------HHHHHHHH
Confidence            556677789999999999999999999999999999999999999999622                     12233333


Q ss_pred             hhCC--CCCHHHHHHHHHHHHHcCCCCCCCCCCcCC
Q 045835          477 RLGS--KYKKEEAERMIKVSLLCTNASPSLRPTMSE  510 (511)
Q Consensus       477 ~l~~--~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e  510 (511)
                      .+..  ..|......+..++...|.+||..|.|..+
T Consensus       212 I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~  247 (808)
T KOG0597|consen  212 ILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTD  247 (808)
T ss_pred             HhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHH
Confidence            2222  235567788999999999999999998654

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=7.9e-40  Score=330.82  Aligned_cols=199  Identities=25%  Similarity=0.407  Sum_probs=174.5

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      .++|+..+.||+|+||.||+++.. ++..+|+|.+.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            367999999999999999999764 68889999987543 2334678999999999999999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      |+++++|.+++....    .+++..+..++.|++.||.|||+.+  .|+||||||+|||++.++.+||+|||++......
T Consensus        84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          84 HMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence            999999999986543    4889999999999999999999853  4999999999999999999999999999754332


Q ss_pred             CceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 045835          397 KTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSY  446 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~  446 (511)
                      .   .....|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       158 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~  204 (331)
T cd06649         158 M---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP  204 (331)
T ss_pred             c---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            1   2234689999999999988999999999999999999999999964

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=331.49  Aligned_cols=248  Identities=25%  Similarity=0.358  Sum_probs=204.8

Q ss_pred             HhcCCcccCceeccCceeEEecc-ccCCcEEEEEEecccC---ccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEEE
Q 045835          238 ATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKS---RQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQLL  312 (511)
Q Consensus       238 ~~~~f~~~~~lG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~  312 (511)
                      ..++|...+.||+|+|++|++|+ ...++.+|||++...-   .....-...|-.+|.+| .||.|++|+-.|.+...+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            34678999999999999999997 4568999999986541   22233456788889999 8999999999999999999


Q ss_pred             EEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCccc
Q 045835          313 LVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       313 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~  392 (511)
                      +|+||+++|+|.+++...+    .|++......+.+|+.||+|||+.|   ||||||||+|||||+|+++||+|||-|+.
T Consensus       151 FvLe~A~nGdll~~i~K~G----sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKKYG----SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             EEEEecCCCcHHHHHHHhC----cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence            9999999999999997654    4899999999999999999999997   99999999999999999999999999997


Q ss_pred             CCCCCce----------ee--cccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhh
Q 045835          393 DEGDKTH----------IS--TRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDW  460 (511)
Q Consensus       393 ~~~~~~~----------~~--~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~  460 (511)
                      +......          .+  ...+||..|.+||++..+..++.+|+|+|||+||.|+.|++||.....          |
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne----------y  293 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE----------Y  293 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH----------H
Confidence            6432111          11  347899999999999999999999999999999999999999974331          1


Q ss_pred             hHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          461 ACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       461 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .       ...++++  +.-++++...+...+|+.+.|..||.+|+|..+|
T Consensus       294 l-------iFqkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qI  335 (604)
T KOG0592|consen  294 L-------IFQKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQI  335 (604)
T ss_pred             H-------HHHHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHH
Confidence            0       0112222  2234555556788999999999999999998764

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.3e-40  Score=319.29  Aligned_cols=249  Identities=29%  Similarity=0.481  Sum_probs=201.2

Q ss_pred             hcCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      .++|+..+.||+|+||.||+|...+++.||+|.++... ...+++.+|+.++++++|||++++++++...+..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            45688899999999999999988778889999987543 33567899999999999999999999999999999999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      ++++|.+++....  ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.......
T Consensus        84 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          84 KYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             cCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            9999999996543  235899999999999999999999986   99999999999999999999999999986543221


Q ss_pred             eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          399 HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                      ........+..|+|||++....++.++||||||++++||++ |+.|+.....     .             .+...++..
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~-------------~~~~~~~~~  220 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-----A-------------EVLQQVDQG  220 (261)
T ss_pred             cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH-----H-------------HHHHHHHcC
Confidence            11111223457999999998899999999999999999999 8888853210     0             011111111


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....+...+..+.+++.+|++.+|++||++.+|
T Consensus       221 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l  254 (261)
T cd05068         221 YRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETL  254 (261)
T ss_pred             CCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            1122333456789999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.2e-40  Score=347.87  Aligned_cols=250  Identities=19%  Similarity=0.252  Sum_probs=201.6

Q ss_pred             CCcccCceeccCceeEEecccc-C-CcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA-D-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~-~-g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      .|.+.+.||+|+||.||++... + +..||+|.+..........+.+|+.+++.++||||++++++|..++..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            3888999999999999999643 3 6788899876555454567788999999999999999999999999999999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      ++|+|.+++.........+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999988654333456889999999999999999999986   99999999999999999999999999986543221


Q ss_pred             -eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          399 -HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       399 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....        .+..         ..+....
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--------~~~~---------~~~~~~~  287 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ--------REIM---------QQVLYGK  287 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHH---------HHHHhCC
Confidence             223345699999999999999999999999999999999999999863221        0100         1111111


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      . ...+...+..+.+++.+||+.+|++||++.++
T Consensus       288 ~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~  320 (478)
T PTZ00267        288 Y-DPFPCPVSSGMKALLDPLLSKNPALRPTTQQL  320 (478)
T ss_pred             C-CCCCccCCHHHHHHHHHHhccChhhCcCHHHH
Confidence            1 11233445678999999999999999998763

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=5.9e-40  Score=323.70  Aligned_cols=251  Identities=30%  Similarity=0.518  Sum_probs=201.3

Q ss_pred             cCCcccCceeccCceeEEeccccC------CcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLAD------GTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLL  312 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~------g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  312 (511)
                      ++|+..+.||+|+||.||+|....      ...||+|.+.... ......|.+|+.++++++||||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            367889999999999999997532      2579999987543 233457899999999999999999999999999999


Q ss_pred             EEEEecCCCCHhHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCC
Q 045835          313 LVYEYMENNSLACALFGREN------------CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL  380 (511)
Q Consensus       313 lV~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~  380 (511)
                      ++|||+++++|.+++.....            ....+++...+.++.|++.||+|||+.+   ++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            99999999999999965321            1135889999999999999999999986   99999999999999999


Q ss_pred             CeEEeecCCcccCCCCC-ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchh
Q 045835          381 NPKISDFGLAKLDEGDK-THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLL  458 (511)
Q Consensus       381 ~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~  458 (511)
                      .+||+|||+++...... ........++..|+|||.+....++.++|||||||++|||++ |+.||.....     .   
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~-----~---  233 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-----Q---  233 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH-----H---
Confidence            99999999997543222 122233456788999999998899999999999999999998 9998863221     1   


Q ss_pred             hhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          459 DWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       459 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                                ++.+.+........+...+.++.+|+.+||+.+|.+||++.||
T Consensus       234 ----------~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i  276 (283)
T cd05048         234 ----------EVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDI  276 (283)
T ss_pred             ----------HHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence                      1122222222223445567789999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=8.4e-40  Score=323.39  Aligned_cols=264  Identities=21%  Similarity=0.281  Sum_probs=198.5

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      ++|++.+.||+|+||.||+++.. +++.||+|++....  ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46889999999999999999865 57899999987542  2334578899999999999999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      |++++++..+...    ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....
T Consensus        81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  153 (287)
T cd07848          81 YVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEG  153 (287)
T ss_pred             cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence            9999877655432    135889999999999999999999886   999999999999999999999999999865433


Q ss_pred             CceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchh--------hhhHhhhccC
Q 045835          397 KTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLL--------DWACHLQQDG  468 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~--------~~~~~~~~~~  468 (511)
                      .........|+..|+|||++.+..++.++|||||||++|||++|+.||......+. .....        .+........
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07848         154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ-LFTIQKVLGPLPAEQMKLFYSNP  232 (287)
T ss_pred             ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhCCCCHHHHHhhhccc
Confidence            22222345689999999999988899999999999999999999999964321110 00000        0000000010


Q ss_pred             chhHhhhhhhCC------CCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          469 KLVELVDERLGS------KYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       469 ~~~~~~d~~l~~------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .......+....      ......+..+.+++.+||+.+|++|||++|+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~  281 (287)
T cd07848         233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQC  281 (287)
T ss_pred             hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHH
Confidence            000000000000      0111234568999999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-40  Score=327.20  Aligned_cols=238  Identities=21%  Similarity=0.271  Sum_probs=195.7

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|+..+.||+|+||.||++... +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46888999999999999999764 68899999986432   233456889999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++|+|.+++....    .+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          81 EYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            9999999999986543    4889999999999999999999987   99999999999999999999999999986543


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      ..    ....|++.|+|||.+.+..++.++|||||||++|||++|+.||.....        ....         ..+..
T Consensus       154 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--------~~~~---------~~i~~  212 (291)
T cd05612         154 RT----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP--------FGIY---------EKILA  212 (291)
T ss_pred             Cc----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHH---------HHHHh
Confidence            21    234689999999999988899999999999999999999999863221        0110         11111


Q ss_pred             hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCC
Q 045835          476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPT  507 (511)
Q Consensus       476 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs  507 (511)
                      ..  ..++......+.+++.+||+.||.+||+
T Consensus       213 ~~--~~~~~~~~~~~~~li~~~l~~dp~~R~~  242 (291)
T cd05612         213 GK--LEFPRHLDLYAKDLIKKLLVVDRTRRLG  242 (291)
T ss_pred             CC--cCCCccCCHHHHHHHHHHcCCCHHHccC
Confidence            11  1233334567899999999999999996

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-40  Score=306.12  Aligned_cols=234  Identities=25%  Similarity=0.368  Sum_probs=198.3

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccCc---cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR---QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      .+|+..+.||.|+||.|..++.+ +|..+|+|+++...-   ...+...+|..+|+.+.||.++++++.|.+.+.++|||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            46888999999999999999865 588999999976532   23345679999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++|.|.++|+..+    +++++...-.+.+|+.||+|||+.+   |++|||||+|||||.+|.+||+|||+|+....
T Consensus       124 eyv~GGElFS~Lrk~~----rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~  196 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSG----RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG  196 (355)
T ss_pred             eccCCccHHHHHHhcC----CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence            9999999999996543    5999999999999999999999987   99999999999999999999999999997654


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      .    ....+||+.|+|||.+....+..++|.|||||++|||+.|.+||....+                     .++.+
T Consensus       197 r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---------------------~~iY~  251 (355)
T KOG0616|consen  197 R----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---------------------IQIYE  251 (355)
T ss_pred             c----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---------------------HHHHH
Confidence            3    3357999999999999999999999999999999999999999974331                     22222


Q ss_pred             hhhCC--CCCHHHHHHHHHHHHHcCCCCCCCC
Q 045835          476 ERLGS--KYKKEEAERMIKVSLLCTNASPSLR  505 (511)
Q Consensus       476 ~~l~~--~~~~~~~~~l~~l~~~Cl~~~p~~R  505 (511)
                      ..+..  .+|.-...++.+|+...++.|-.+|
T Consensus       252 KI~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  252 KILEGKVKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             HHHhCcccCCcccCHHHHHHHHHHHhhhhHhh
Confidence            22211  3455556677788888888888777

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4.7e-40  Score=320.35  Aligned_cols=250  Identities=28%  Similarity=0.462  Sum_probs=206.1

Q ss_pred             HhcCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          238 ATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       238 ~~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      +..+|+..++||+|+||.||+|...++..+|+|.+..........+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            44678899999999999999999888899999999876655567889999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +++++|.+++....  ...+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||++.......
T Consensus        84 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          84 MEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             cccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            99999999997543  245899999999999999999999986   9999999999999999999999999998654332


Q ss_pred             ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhh
Q 045835          398 THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDE  476 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  476 (511)
                      .. .....++..|+|||.+....++.++||||||++++||++ |+.|+.....     .             ...+.+..
T Consensus       159 ~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~-----~-------------~~~~~~~~  219 (261)
T cd05148         159 YL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN-----H-------------EVYDQITA  219 (261)
T ss_pred             cc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH-----H-------------HHHHHHHh
Confidence            21 123345678999999988899999999999999999998 8888863220     0             11111112


Q ss_pred             hhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          477 RLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       477 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ......+...+..+.+++.+||+.+|++|||+.++
T Consensus       220 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l  254 (261)
T cd05148         220 GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKAL  254 (261)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence            22223344556778999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.1e-39  Score=317.43  Aligned_cols=247  Identities=26%  Similarity=0.421  Sum_probs=198.2

Q ss_pred             cCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecC
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYME  319 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~  319 (511)
                      ++|+..+.||+|+||.||+|...++..+|+|.+.... ....+|.+|+.++++++||||++++++|.+.+..+++|||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            3577889999999999999988777789999987543 334678999999999999999999999999889999999999


Q ss_pred             CCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCce
Q 045835          320 NNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH  399 (511)
Q Consensus       320 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~  399 (511)
                      +|+|.+++....   ..+++..+++++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++........
T Consensus        83 ~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05113          83 NGCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT  156 (256)
T ss_pred             CCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence            999999986532   25899999999999999999999986   999999999999999999999999999865433222


Q ss_pred             eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhh
Q 045835          400 ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERL  478 (511)
Q Consensus       400 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  478 (511)
                      ......++..|+|||.+....++.++|||||||++|||++ |+.|+.....     ......            + ....
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-----~~~~~~------------~-~~~~  218 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-----SETVEK------------V-SQGL  218 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH-----HHHHHH------------H-hcCC
Confidence            2222345678999999988889999999999999999999 9988863221     001111            0 0111


Q ss_pred             CCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          479 GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       479 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ....+......+.+++.+||+.+|.+||++.+|
T Consensus       219 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l  251 (256)
T cd05113         219 RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQL  251 (256)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence            111122335678999999999999999999764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-40  Score=332.95  Aligned_cols=250  Identities=22%  Similarity=0.310  Sum_probs=199.5

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|++.+.||+|+||.||+|+.. +++.||||+++...   ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            46889999999999999999865 58899999997542   233456889999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++|+|.+++....    .+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 e~~~g~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG----VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            9999999999996432    4889999999999999999999987   99999999999999999999999999985433


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                          ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+..|..          .+.
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~----------~~~  218 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-TWENLKYWKE----------TLQ  218 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH-HHHHHHhccc----------ccc
Confidence                2234568999999999999899999999999999999999999996432100 0000111100          000


Q ss_pred             hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       476 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...........+..+.+++.+||+.+|.+||++.||
T Consensus       219 ~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~l  254 (333)
T cd05600         219 RPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDI  254 (333)
T ss_pred             CCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHH
Confidence            000000012345678899999999999999998764

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.2e-39  Score=320.95  Aligned_cols=251  Identities=27%  Similarity=0.469  Sum_probs=200.9

Q ss_pred             cCCcccCceeccCceeEEeccccC------CcEEEEEEecccCcc-chHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLAD------GTIIAVKQLSSKSRQ-GNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLL  312 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~------g~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  312 (511)
                      ++|.+.+.||+|+||.||+|...+      +..||||.++..... ..+.+.+|+++++.++|+|++++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            468888999999999999997532      478999999765443 4568999999999999999999999999999999


Q ss_pred             EEEEecCCCCHhHHHhcCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCe
Q 045835          313 LVYEYMENNSLACALFGRE----------NCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP  382 (511)
Q Consensus       313 lV~Ey~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~  382 (511)
                      +||||+++++|.+++....          .....+++.....++.|++.||+|||+.+   ++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence            9999999999999997542          12345789999999999999999999986   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCc-eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhh
Q 045835          383 KISDFGLAKLDEGDKT-HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDW  460 (511)
Q Consensus       383 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~  460 (511)
                      ||+|||+++....... .......++..|+|||++....++.++|||||||++|||++ |+.||.....     ......
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~-----~~~~~~  236 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN-----EEVIEC  236 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Confidence            9999999975432221 12223345778999999999999999999999999999998 9998853221     111111


Q ss_pred             hHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          461 ACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       461 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                                   +........+...+..+.+++.+||+.+|++||++.||
T Consensus       237 -------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ei  274 (280)
T cd05049         237 -------------ITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDI  274 (280)
T ss_pred             -------------HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence                         11111112233445678999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.4e-39  Score=317.76  Aligned_cols=248  Identities=26%  Similarity=0.444  Sum_probs=199.6

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      ..|...++||+|+||.||+|... .++.||+|.+... .....++.+|+.++++++||||++++++|...+..+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            35778899999999999999754 5788999998753 334567899999999999999999999999999999999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      ++++|.+++....  ...+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++.......
T Consensus        85 ~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          85 TYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             CCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            9999999986533  235899999999999999999999886   99999999999999999999999999986544322


Q ss_pred             eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          399 HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                      .......++..|+|||.+.+..++.++|||||||++|||++ |..|+....        ..+.          .+.+...
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~--------~~~~----------~~~~~~~  221 (263)
T cd05052         160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--------LSQV----------YELLEKG  221 (263)
T ss_pred             eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC--------HHHH----------HHHHHCC
Confidence            22222234668999999998899999999999999999998 888875321        1111          1111111


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....+...+..+.+++.+||+.+|++|||+.||
T Consensus       222 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l  255 (263)
T cd05052         222 YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEI  255 (263)
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence            2223334455679999999999999999999874

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1e-39  Score=327.71  Aligned_cols=247  Identities=27%  Similarity=0.449  Sum_probs=195.4

Q ss_pred             cCCcccCceeccCceeEEecccc-CCc----EEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGT----IIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~----~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  313 (511)
                      .+|+..+.||+|+||.||+|++. ++.    .||+|.++... ....+++.+|+.+++.++||||++++|+|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46889999999999999999753 333    48999987543 34456789999999999999999999999864 5779


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      ++||+++|+|.+++....   ..+++...+.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        86 v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          86 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             eeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence            999999999999996543   35889999999999999999999986   999999999999999999999999999865


Q ss_pred             CCCCceee-cccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchh
Q 045835          394 EGDKTHIS-TRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLV  471 (511)
Q Consensus       394 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  471 (511)
                      ........ ....++..|+|||++....++.++|||||||++|||++ |+.|+.....        .+.          .
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~--------~~~----------~  221 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SEI----------S  221 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--------HHH----------H
Confidence            44332211 12234678999999999999999999999999999998 9998863221        111          1


Q ss_pred             HhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       472 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +++........+..+..++.+++.+||+.+|.+||++.+|
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l  261 (316)
T cd05108         222 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFREL  261 (316)
T ss_pred             HHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            1111111111223345678999999999999999999864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=9e-40  Score=329.27  Aligned_cols=235  Identities=25%  Similarity=0.321  Sum_probs=190.6

Q ss_pred             CceeccCceeEEeccc-cCCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCCC
Q 045835          246 KKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENN  321 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g  321 (511)
                      +.||+|+||.||+++. .+|+.||+|+++...   ......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999975 468899999997532   233456788999999999999999999999999999999999999


Q ss_pred             CHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCceee
Q 045835          322 SLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS  401 (511)
Q Consensus       322 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~~  401 (511)
                      +|.+++....    .+++.....++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....... ..
T Consensus        81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~  152 (323)
T cd05571          81 ELFFHLSRER----VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TM  152 (323)
T ss_pred             cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-cc
Confidence            9999986532    5899999999999999999999987   99999999999999999999999999975322211 12


Q ss_pred             cccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCCC
Q 045835          402 TRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSK  481 (511)
Q Consensus       402 ~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  481 (511)
                      ....||+.|+|||.+.+..++.++|||||||++|||++|+.||....     ...+...            +...  ...
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~-----~~~~~~~------------~~~~--~~~  213 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HEKLFEL------------ILME--EIR  213 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC-----HHHHHHH------------HHcC--CCC
Confidence            33568999999999999999999999999999999999999986321     0111111            0000  112


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCC
Q 045835          482 YKKEEAERMIKVSLLCTNASPSLRPT  507 (511)
Q Consensus       482 ~~~~~~~~l~~l~~~Cl~~~p~~RPs  507 (511)
                      ++......+.+++.+||+.||++||+
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~  239 (323)
T cd05571         214 FPRTLSPEAKSLLAGLLKKDPKQRLG  239 (323)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCC
Confidence            33445567899999999999999993

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.8e-39  Score=321.58  Aligned_cols=252  Identities=29%  Similarity=0.498  Sum_probs=199.7

Q ss_pred             hcCCcccCceeccCceeEEeccc------cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL------ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLL  312 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~------~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  312 (511)
                      ..+|.+.+.||+|+||.||++..      .++..+|+|.+..........+.+|+.++++++||||++++++|...+..+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            35788999999999999999964      234568999987665555678999999999999999999999999999999


Q ss_pred             EEEEecCCCCHhHHHhcCC---------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeE
Q 045835          313 LVYEYMENNSLACALFGRE---------NCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPK  383 (511)
Q Consensus       313 lV~Ey~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~k  383 (511)
                      +||||+++++|.+++....         .....+++..++.++.|++.||+|||+.+   ++||||||+|||+++++.+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence            9999999999999986432         12235899999999999999999999986   99999999999999999999


Q ss_pred             EeecCCcccCCCCCc-eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhh
Q 045835          384 ISDFGLAKLDEGDKT-HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWA  461 (511)
Q Consensus       384 l~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~  461 (511)
                      |+|||+++....... .......++..|+|||.+.+..++.++|||||||+++||++ |+.|+.....     ...... 
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~-----~~~~~~-  234 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-----NEVIEC-  234 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHH-
Confidence            999999985433221 12223345778999999998899999999999999999998 8888753221     001110 


Q ss_pred             HhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          462 CHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       462 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                         ...+.         ....+...+..+.+++.+||+.+|.+|||+.||
T Consensus       235 ---i~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v  272 (288)
T cd05093         235 ---ITQGR---------VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEI  272 (288)
T ss_pred             ---HHcCC---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence               01111         011122234568999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-39  Score=315.97  Aligned_cols=247  Identities=27%  Similarity=0.430  Sum_probs=198.0

Q ss_pred             cCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecC
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYME  319 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~  319 (511)
                      .+|++.+.||+|+||.||++...++..+|+|.+.... .....|.+|+.++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            3477889999999999999988777789999986432 234578899999999999999999999999999999999999


Q ss_pred             CCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCce
Q 045835          320 NNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH  399 (511)
Q Consensus       320 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~  399 (511)
                      +++|.+++....   ..+++.....++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++........
T Consensus        83 ~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~  156 (256)
T cd05059          83 NGCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT  156 (256)
T ss_pred             CCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence            999999986543   25899999999999999999999987   999999999999999999999999999865432222


Q ss_pred             eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhh
Q 045835          400 ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERL  478 (511)
Q Consensus       400 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  478 (511)
                      ......++..|+|||.+....++.++||||||+++|||++ |+.|+.....     ...             .+.+....
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~-------------~~~~~~~~  218 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN-----SEV-------------VESVSAGY  218 (256)
T ss_pred             ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH-----HHH-------------HHHHHcCC
Confidence            1222234557999999998899999999999999999999 7888863221     001             01111111


Q ss_pred             CCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          479 GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       479 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ....+...+..+.+++.+||+.+|++|||+.||
T Consensus       219 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~  251 (256)
T cd05059         219 RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKL  251 (256)
T ss_pred             cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence            112233356679999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.1e-39  Score=329.38  Aligned_cols=238  Identities=21%  Similarity=0.306  Sum_probs=195.8

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|++.+.||+|+||.||+|+.. +++.||+|.+....   ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            56888999999999999999865 58899999986532   233457889999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++|+|.+++....    .+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        98 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG----RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             cCCCCChHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            9999999999986543    4788899999999999999999986   99999999999999999999999999986543


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      ..    ....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....        .+..         ..+..
T Consensus       171 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~---------~~i~~  229 (329)
T PTZ00263        171 RT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--------FRIY---------EKILA  229 (329)
T ss_pred             Cc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--------HHHH---------HHHhc
Confidence            22    234689999999999999999999999999999999999999863221        0000         01111


Q ss_pred             hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCC
Q 045835          476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPT  507 (511)
Q Consensus       476 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs  507 (511)
                      ..+  .++......+.+++.+||+.||.+||+
T Consensus       230 ~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~  259 (329)
T PTZ00263        230 GRL--KFPNWFDGRARDLVKGLLQTDHTKRLG  259 (329)
T ss_pred             CCc--CCCCCCCHHHHHHHHHHhhcCHHHcCC
Confidence            111  122233456889999999999999997

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3.2e-39  Score=326.65  Aligned_cols=199  Identities=24%  Similarity=0.409  Sum_probs=173.3

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      .++|++.++||+|+||.||++... ++..+|+|.+.... ......+.+|+.++++++||||++++++|.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            468999999999999999999765 67889999887543 2334578999999999999999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      |+++|+|.+++....    .+++.....++.+++.||.|||+.+  +++||||||+|||+++++.+||+|||++......
T Consensus        84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~  157 (333)
T cd06650          84 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (333)
T ss_pred             cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence            999999999996532    4788999999999999999999753  4999999999999999999999999999754322


Q ss_pred             CceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 045835          397 KTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSY  446 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~  446 (511)
                      .   .....|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       158 ~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         158 M---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             c---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            1   1234688999999999988999999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-39  Score=325.34  Aligned_cols=234  Identities=23%  Similarity=0.320  Sum_probs=190.9

Q ss_pred             eeccCceeEEecccc-CCcEEEEEEeccc---CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCCCCH
Q 045835          248 IGEGGFGPVYKGQLA-DGTIIAVKQLSSK---SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSL  323 (511)
Q Consensus       248 lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL  323 (511)
                      ||+|+||.||+++.. +++.||+|++...   .......+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999754 5789999998643   233445678999999999999999999999999999999999999999


Q ss_pred             hHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCceeecc
Q 045835          324 ACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR  403 (511)
Q Consensus       324 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~  403 (511)
                      .+++....    .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....... ....
T Consensus        81 ~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~  152 (312)
T cd05585          81 FHHLQREG----RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNT  152 (312)
T ss_pred             HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-cccc
Confidence            99986532    4899999999999999999999986   99999999999999999999999999985432221 2234


Q ss_pred             cccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCCCCC
Q 045835          404 IAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYK  483 (511)
Q Consensus       404 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  483 (511)
                      ..||+.|+|||.+.+..++.++|||||||+++||++|+.||....        .......         +...  ...++
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~--------~~~~~~~---------~~~~--~~~~~  213 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN--------VNEMYRK---------ILQE--PLRFP  213 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC--------HHHHHHH---------HHcC--CCCCC
Confidence            578999999999999999999999999999999999999986321        1111111         1111  11233


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCc
Q 045835          484 KEEAERMIKVSLLCTNASPSLRPTM  508 (511)
Q Consensus       484 ~~~~~~l~~l~~~Cl~~~p~~RPs~  508 (511)
                      ......+.+++.+||+.+|++||++
T Consensus       214 ~~~~~~~~~li~~~L~~dp~~R~~~  238 (312)
T cd05585         214 DGFDRDAKDLLIGLLSRDPTRRLGY  238 (312)
T ss_pred             CcCCHHHHHHHHHHcCCCHHHcCCC
Confidence            3445678899999999999999875

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-39  Score=316.27  Aligned_cols=249  Identities=29%  Similarity=0.438  Sum_probs=199.3

Q ss_pred             hcCCcccCceeccCceeEEeccccC----CcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLAD----GTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~~----g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  313 (511)
                      .++|+..+.||+|+||.||+|....    ...||||.++... .....+|.+|+.++++++||||+++++++.+.+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            3578899999999999999997642    4579999987543 3344678999999999999999999999999999999


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      +|||+++++|.+++....   ..+++..+.+++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+++..
T Consensus        83 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~  156 (266)
T cd05033          83 ITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRL  156 (266)
T ss_pred             EEEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcc
Confidence            999999999999986543   25899999999999999999999976   999999999999999999999999999876


Q ss_pred             CCCCc-eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchh
Q 045835          394 EGDKT-HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLV  471 (511)
Q Consensus       394 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  471 (511)
                      ..... .......++..|+|||.+....++.++||||||++++||++ |+.|+....     ...+...           
T Consensus       157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~-----~~~~~~~-----------  220 (266)
T cd05033         157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS-----NQDVIKA-----------  220 (266)
T ss_pred             cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH-----------
Confidence            42222 12222345678999999998899999999999999999998 988875321     1111111           


Q ss_pred             HhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       472 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                        +........+...+..+.+++.+|++.+|++||++.||
T Consensus       221 --~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei  258 (266)
T cd05033         221 --VEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQI  258 (266)
T ss_pred             --HHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence              11111112233445678999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.8e-39  Score=319.52  Aligned_cols=253  Identities=24%  Similarity=0.391  Sum_probs=197.9

Q ss_pred             HhcCCcccCceeccCceeEEecccc------CCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCE
Q 045835          238 ATNNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQ  310 (511)
Q Consensus       238 ~~~~f~~~~~lG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~  310 (511)
                      .+++|+..+.||+|+||.||+|...      .+..||||++.... .....++.+|+.+++.++||||+++++++.++..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4678999999999999999998642      35679999986432 2334578899999999999999999999999999


Q ss_pred             EEEEEEecCCCCHhHHHhcCCCC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEE
Q 045835          311 LLLVYEYMENNSLACALFGRENC------ELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKI  384 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl  384 (511)
                      .++||||+++++|.+++......      ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence            99999999999999998653211      234688999999999999999999986   999999999999999999999


Q ss_pred             eecCCcccCCCCCce-eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhH
Q 045835          385 SDFGLAKLDEGDKTH-ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWAC  462 (511)
Q Consensus       385 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~  462 (511)
                      +|||+++........ ......++..|+|||++..+.++.++|||||||+++||++ |+.|+.....     ....... 
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-----~~~~~~~-  234 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-----EQVLRFV-  234 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHH-
Confidence            999999754332221 1122345778999999998899999999999999999999 6888753221     1111110 


Q ss_pred             hhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          463 HLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       463 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                                 .... ....+...+..+.+++.+|++.+|++|||+.|+
T Consensus       235 -----------~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~  271 (277)
T cd05062         235 -----------MEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI  271 (277)
T ss_pred             -----------HcCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence                       0110 112233345678999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.7e-39  Score=320.78  Aligned_cols=251  Identities=27%  Similarity=0.468  Sum_probs=200.1

Q ss_pred             cCCcccCceeccCceeEEecccc------CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  313 (511)
                      .+|...+.||+|+||.||+|+..      ++..+++|.+........+.+.+|+.++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45778899999999999999632      345689999876655555679999999999999999999999999999999


Q ss_pred             EEEecCCCCHhHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCC
Q 045835          314 VYEYMENNSLACALFGREN------------CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN  381 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~  381 (511)
                      ||||+++++|.+++.....            ....++|..++.++.|++.||+|||+.+   |+||||||+|||++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            9999999999999965421            1235899999999999999999999987   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCc-eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhh
Q 045835          382 PKISDFGLAKLDEGDKT-HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLD  459 (511)
Q Consensus       382 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~  459 (511)
                      +||+|||+++....... .......++..|+|||++....++.++||||||+++|||+| |+.|+.....     ....+
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-----~~~~~  236 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-----TEVIE  236 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHH
Confidence            99999999975433221 12233456788999999998999999999999999999999 9998753221     00111


Q ss_pred             hhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          460 WACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       460 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                                   .+........+...+..+.+++.+||+.+|++|||+.+|
T Consensus       237 -------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v  275 (291)
T cd05094         237 -------------CITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEI  275 (291)
T ss_pred             -------------HHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHH
Confidence                         111111111223345678999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.1e-39  Score=334.86  Aligned_cols=253  Identities=26%  Similarity=0.391  Sum_probs=197.8

Q ss_pred             hcCCcccCceeccCceeEEecccc------CCcEEEEEEecccCc-cchHHHHHHHHHHhcCC-CCCceeEEEEEEeCCE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSKSR-QGNREFLNEIAMISCLQ-HPNLVKIHGCCVEGDQ  310 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~  310 (511)
                      .++|.+.++||+|+||.||+|+..      .+..||||+++.... ...+.+.+|+.+++++. ||||++++++|.+.+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            467888999999999999999742      234699999975433 33457899999999996 9999999999999999


Q ss_pred             EEEEEEecCCCCHhHHHhcCCC----------------------------------------------------------
Q 045835          311 LLLVYEYMENNSLACALFGREN----------------------------------------------------------  332 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~----------------------------------------------------------  332 (511)
                      .++||||+++|+|.++|.....                                                          
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            9999999999999998864210                                                          


Q ss_pred             ----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcC
Q 045835          333 ----------------------------------CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR  378 (511)
Q Consensus       333 ----------------------------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~  378 (511)
                                                        ....+++..+..++.|++.||+|||+.+   |+||||||+|||+++
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence                                              0124788899999999999999999986   999999999999999


Q ss_pred             CCCeEEeecCCcccCCCCCce-eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccc
Q 045835          379 DLNPKISDFGLAKLDEGDKTH-ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTC  456 (511)
Q Consensus       379 ~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~  456 (511)
                      ++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.|+.....   +   
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~---~---  346 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV---D---  346 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch---h---
Confidence            999999999999854332221 1122346788999999998899999999999999999997 8888753210   0   


Q ss_pred             hhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          457 LLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       457 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                                 ......+........+......+.+++.+||+.+|++|||+.+|
T Consensus       347 -----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l  390 (400)
T cd05105         347 -----------STFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHL  390 (400)
T ss_pred             -----------HHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHH
Confidence                       00011111111122233455678999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-40  Score=314.57  Aligned_cols=260  Identities=21%  Similarity=0.314  Sum_probs=214.7

Q ss_pred             cHHHHHHHhcCCcccCceeccCceeEEecccc------CCcEEEEEEecccCcc-chHHHHHHHHHHhcCCCCCceeEEE
Q 045835          231 TLKQIKAATNNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSKSRQ-GNREFLNEIAMISCLQHPNLVKIHG  303 (511)
Q Consensus       231 ~~~~l~~~~~~f~~~~~lG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g  303 (511)
                      +..++.....++....++.+|+||.||+|.+.      +.+.|.||.++....+ ....++.|..++..+.|||+.++.+
T Consensus       275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            45566667788999999999999999999543      4456788988765443 3456889999999999999999999


Q ss_pred             EEEe-CCEEEEEEEecCCCCHhHHHhc----CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcC
Q 045835          304 CCVE-GDQLLLVYEYMENNSLACALFG----RENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR  378 (511)
Q Consensus       304 ~~~~-~~~~~lV~Ey~~~gsL~~~l~~----~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~  378 (511)
                      +|.+ ....+++|.++..|+|..+|..    ..+..+.++-.+...++.|++.|++|||.++   +||.||.++|++||+
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD  431 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence            9976 4578999999999999999972    1233445777788899999999999999987   999999999999999


Q ss_pred             CCCeEEeecCCcc-cCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccc
Q 045835          379 DLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTC  456 (511)
Q Consensus       379 ~~~~kl~DfGla~-~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~  456 (511)
                      ...+||+|-.|++ +++.+..+.......+..||+||.+....++.++|||||||+||||+| |+.|+....+       
T Consensus       432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP-------  504 (563)
T KOG1024|consen  432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP-------  504 (563)
T ss_pred             heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH-------
Confidence            9999999999998 566666777777778899999999999999999999999999999998 8888863321       


Q ss_pred             hhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          457 LLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       457 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                                 .++...+....+...|-+++.++..++.-||...|++||+++++
T Consensus       505 -----------fEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Ql  548 (563)
T KOG1024|consen  505 -----------FEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQL  548 (563)
T ss_pred             -----------HHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHH
Confidence                       12233333444445567888999999999999999999998764

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-39  Score=331.90  Aligned_cols=242  Identities=25%  Similarity=0.403  Sum_probs=205.5

Q ss_pred             HhcCCcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEEE
Q 045835          238 ATNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQLL  312 (511)
Q Consensus       238 ~~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~  312 (511)
                      .-++|...++||+|.||+|+++.++ +++.+|||.+++..   ....+..+.|..++... +||.|++|+.++...++++
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            3468999999999999999999865 57899999998763   44456678888888776 5999999999999999999


Q ss_pred             EEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCccc
Q 045835          313 LVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       313 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~  392 (511)
                      +||||+.+|++..+.+.     ..+++....-++..|+.||+|||+++   ||+||||.+|||||.+|.+||+||||++.
T Consensus       446 fvmey~~Ggdm~~~~~~-----~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe  517 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHIHT-----DVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE  517 (694)
T ss_pred             EEEEecCCCcEEEEEec-----ccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence            99999999995444322     35999999999999999999999997   99999999999999999999999999995


Q ss_pred             CCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhH
Q 045835          393 DEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVE  472 (511)
Q Consensus       393 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  472 (511)
                      ...... .....+||+.|||||++.+..|+..+|.|||||+|||||.|..||...                     +..+
T Consensus       518 ~m~~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd---------------------dEee  575 (694)
T KOG0694|consen  518 GMGQGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD---------------------DEEE  575 (694)
T ss_pred             cCCCCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC---------------------CHHH
Confidence            432222 345689999999999999999999999999999999999999999732                     2245


Q ss_pred             hhhhhhCC--CCCHHHHHHHHHHHHHcCCCCCCCCCCcC
Q 045835          473 LVDERLGS--KYKKEEAERMIKVSLLCTNASPSLRPTMS  509 (511)
Q Consensus       473 ~~d~~l~~--~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~  509 (511)
                      ++|..+..  .+|...+.+.+.++.+.+..+|++|--+.
T Consensus       576 ~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~  614 (694)
T KOG0694|consen  576 VFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSG  614 (694)
T ss_pred             HHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCCC
Confidence            66665543  35677788899999999999999998763

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=319.31  Aligned_cols=250  Identities=28%  Similarity=0.406  Sum_probs=198.5

Q ss_pred             HhcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCc--------------cchHHHHHHHHHHhcCCCCCceeEE
Q 045835          238 ATNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSR--------------QGNREFLNEIAMISCLQHPNLVKIH  302 (511)
Q Consensus       238 ~~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~--------------~~~~~~~~Ei~~l~~l~H~niv~l~  302 (511)
                      .-|+|++.+.||+|.||.|-+|+. .+++.||||++.....              ...+...+||.+|++++|||||+|+
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            347899999999999999999974 4789999999965421              1124688999999999999999999


Q ss_pred             EEEEe--CCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCC
Q 045835          303 GCCVE--GDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL  380 (511)
Q Consensus       303 g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~  380 (511)
                      .+..+  .+.+|||+|||..|.+...-    .....++..+.++++.++..||+|||.++   ||||||||+|+||++++
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence            99876  45899999999999875321    11223899999999999999999999997   99999999999999999


Q ss_pred             CeEEeecCCcccCCCCC----ceeecccccCCCcccccccccC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccc
Q 045835          381 NPKISDFGLAKLDEGDK----THISTRIAGTIGYMAPEYALWG----YLTYKADVYSFGIVALEIVSGKNNMSYAPALEF  452 (511)
Q Consensus       381 ~~kl~DfGla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~  452 (511)
                      ++||+|||.+.......    ...-.+.+||+.|+|||...++    ..+.+.||||+||+||.|+.|+.||-.....  
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~--  325 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL--  325 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH--
Confidence            99999999998663221    1122346899999999988764    3567889999999999999999999632210  


Q ss_pred             cccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          453 DCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       453 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                                     .-..+|+...+...-.++..+++.+|++++|++||+.|.++.||
T Consensus       326 ---------------~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~i  369 (576)
T KOG0585|consen  326 ---------------ELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDI  369 (576)
T ss_pred             ---------------HHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhh
Confidence                           01123444444333344678889999999999999999998875

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.4e-39  Score=313.57  Aligned_cols=247  Identities=30%  Similarity=0.476  Sum_probs=198.2

Q ss_pred             cCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecC
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYME  319 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~  319 (511)
                      ++|++.++||+|+||.||++...++..+|+|.++.... ..+.+.+|+.++++++|+|++++++++. ....+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            46788999999999999999888888899999875433 3467999999999999999999999885 456889999999


Q ss_pred             CCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCce
Q 045835          320 NNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH  399 (511)
Q Consensus       320 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~  399 (511)
                      +++|.+++....  ...+++.++..++.+++.||+|||+.+   ++||||||+||++++++.++|+|||++.........
T Consensus        84 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05070          84 KGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence            999999986532  235899999999999999999999986   999999999999999999999999999865433222


Q ss_pred             eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhh
Q 045835          400 ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERL  478 (511)
Q Consensus       400 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  478 (511)
                      ......++..|+|||.+....++.++||||||++++||++ |+.||....     .....+             .+....
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-----~~~~~~-------------~~~~~~  220 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN-----NREVLE-------------QVERGY  220 (260)
T ss_pred             cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH-------------HHHcCC
Confidence            2222335668999999988899999999999999999999 888885321     111111             111111


Q ss_pred             CCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          479 GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       479 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ....+...+..+.+++.+|++.+|++|||+.++
T Consensus       221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l  253 (260)
T cd05070         221 RMPCPQDCPISLHELMLQCWKKDPEERPTFEYL  253 (260)
T ss_pred             CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHH
Confidence            222334456679999999999999999999764

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.8e-39  Score=344.37  Aligned_cols=255  Identities=20%  Similarity=0.296  Sum_probs=202.7

Q ss_pred             HHHhcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCC---
Q 045835          236 KAATNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGD---  309 (511)
Q Consensus       236 ~~~~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~---  309 (511)
                      ....++|.+.+.||+|+||.||+++. .+++.||||++....  ......+.+|+..+..++|+|++++...+...+   
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            33457899999999999999999974 578999999986542  334456889999999999999999988775432   


Q ss_pred             -----EEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEE
Q 045835          310 -----QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKI  384 (511)
Q Consensus       310 -----~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl  384 (511)
                           .+++||||+++|+|.+++..+......+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence                 368999999999999999765444456899999999999999999999986   999999999999999999999


Q ss_pred             eecCCcccCCCCC-ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHh
Q 045835          385 SDFGLAKLDEGDK-THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACH  463 (511)
Q Consensus       385 ~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~  463 (511)
                      +|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....        ..+....
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~--------~~~~~~~  256 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN--------MEEVMHK  256 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC--------HHHHHHH
Confidence            9999998654321 222334579999999999999999999999999999999999999986321        1111111


Q ss_pred             hhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          464 LQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       464 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                               +... .....+......+.+++.+||+.+|++||++.+|
T Consensus       257 ---------~~~~-~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~el  294 (496)
T PTZ00283        257 ---------TLAG-RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKL  294 (496)
T ss_pred             ---------HhcC-CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHH
Confidence                     1110 1112334455679999999999999999998764

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.9e-39  Score=329.01  Aligned_cols=237  Identities=23%  Similarity=0.302  Sum_probs=193.6

Q ss_pred             cCCcccCceeccCceeEEeccccC--CcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLAD--GTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~--g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  314 (511)
                      ++|++.+.||+|+||.||+|....  +..||+|++....   ......+.+|+.+++.++||||+++++++.+++..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            568899999999999999997543  3689999986432   23345688999999999999999999999999999999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      |||+++|+|.+++....    .+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       110 ~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            99999999999996543    4889999999999999999999987   9999999999999999999999999998654


Q ss_pred             CCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          395 GDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       395 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      ...    ....||+.|+|||++.+..++.++|||||||++|||++|+.||......       ..+          ..+.
T Consensus       183 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~----------~~i~  241 (340)
T PTZ00426        183 TRT----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-------LIY----------QKIL  241 (340)
T ss_pred             CCc----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-------HHH----------HHHh
Confidence            321    2356899999999999888999999999999999999999999643210       000          0111


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRP  506 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP  506 (511)
                      ...  ..++......+.+++.+|++.+|++|+
T Consensus       242 ~~~--~~~p~~~~~~~~~li~~~l~~dp~~R~  271 (340)
T PTZ00426        242 EGI--IYFPKFLDNNCKHLMKKLLSHDLTKRY  271 (340)
T ss_pred             cCC--CCCCCCCCHHHHHHHHHHcccCHHHcC
Confidence            111  112333345678999999999999996

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.5e-39  Score=331.37  Aligned_cols=192  Identities=22%  Similarity=0.318  Sum_probs=167.1

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      ++|++.+.||+|+||.||++.. .+++.||+|....      ..+.+|+.++++++||||+++++++......++|+|++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            5799999999999999999975 4688999997532      35678999999999999999999999999999999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      . ++|..++....    .+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus       166 ~-~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~  237 (391)
T PHA03212        166 K-TDLYCYLAAKR----NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA  237 (391)
T ss_pred             C-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence            5 68888875432    4889999999999999999999986   99999999999999999999999999975433222


Q ss_pred             eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 045835          399 HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMS  445 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~  445 (511)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.|+.
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~  284 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF  284 (391)
T ss_pred             cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence            22334579999999999999899999999999999999999998864

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.1e-39  Score=325.31  Aligned_cols=235  Identities=25%  Similarity=0.317  Sum_probs=189.6

Q ss_pred             CceeccCceeEEeccc-cCCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCCC
Q 045835          246 KKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENN  321 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g  321 (511)
                      +.||+|+||.||+++. .+|..||+|+++...   ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999975 468999999997542   233456778999999999999999999999999999999999999


Q ss_pred             CHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCceee
Q 045835          322 SLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS  401 (511)
Q Consensus       322 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~~  401 (511)
                      +|..++....    .+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....... ..
T Consensus        81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~  152 (323)
T cd05595          81 ELFFHLSRER----VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TM  152 (323)
T ss_pred             cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-cc
Confidence            9998885432    5899999999999999999999986   99999999999999999999999999875322221 12


Q ss_pred             cccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCCC
Q 045835          402 TRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSK  481 (511)
Q Consensus       402 ~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  481 (511)
                      ....||..|+|||++.+..++.++|||||||++|||++|+.||.....     ..+.            ..+....  ..
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-----~~~~------------~~~~~~~--~~  213 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLF------------ELILMEE--IR  213 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH-----HHHH------------HHHhcCC--CC
Confidence            235689999999999999999999999999999999999999863221     0000            0111111  11


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCC
Q 045835          482 YKKEEAERMIKVSLLCTNASPSLRPT  507 (511)
Q Consensus       482 ~~~~~~~~l~~l~~~Cl~~~p~~RPs  507 (511)
                      ++......+.+++.+||+.+|++||+
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~  239 (323)
T cd05595         214 FPRTLSPEAKSLLAGLLKKDPKQRLG  239 (323)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHhCC
Confidence            23344567889999999999999983

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.4e-39  Score=317.73  Aligned_cols=251  Identities=28%  Similarity=0.482  Sum_probs=197.9

Q ss_pred             cCCcccCceeccCceeEEeccc-----cCCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-----ADGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-----~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  313 (511)
                      +.|++.+.||+|+||.||+|..     .++..||+|.+.... .+....+.+|+.+++.++||||+++++++..++..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4577889999999999999973     246789999997533 3334678899999999999999999999999999999


Q ss_pred             EEEecCCCCHhHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCC
Q 045835          314 VYEYMENNSLACALFGREN-------------CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL  380 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~  380 (511)
                      ||||+++++|.+++.....             ....+++.+...++.|++.||+|||+.+   ++||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            9999999999999853221             1234789999999999999999999986   99999999999999999


Q ss_pred             CeEEeecCCcccCCCCC-ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchh
Q 045835          381 NPKISDFGLAKLDEGDK-THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLL  458 (511)
Q Consensus       381 ~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~  458 (511)
                      .+||+|||+++...... ........++..|+|||++.+..++.++||||||++++||++ |..||.....         
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---------  232 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---------  232 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---------
Confidence            99999999997543222 112222345678999999988889999999999999999998 8888753210         


Q ss_pred             hhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          459 DWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       459 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                               ..+.+.++.......+......+.+++.+|++.+|++||++.+|
T Consensus       233 ---------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i  276 (283)
T cd05090         233 ---------QEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDI  276 (283)
T ss_pred             ---------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHH
Confidence                     01112222211122333445678999999999999999999764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2e-39  Score=321.17  Aligned_cols=259  Identities=25%  Similarity=0.396  Sum_probs=191.5

Q ss_pred             cCCcccCceeccCceeEEeccc--cCCcEEEEEEecccC--ccchHHHHHHHHHHhcC---CCCCceeEEEEEEe-----
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL--ADGTIIAVKQLSSKS--RQGNREFLNEIAMISCL---QHPNLVKIHGCCVE-----  307 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~--~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~-----  307 (511)
                      ++|++.+.||+|+||.||+|+.  .+++.||+|+++...  ......+.+|+.+++.+   +||||++++++|..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            3688899999999999999975  246889999987543  22234566777777665   69999999999863     


Q ss_pred             CCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeec
Q 045835          308 GDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF  387 (511)
Q Consensus       308 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~Df  387 (511)
                      ....++||||+. ++|.+++....  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccc
Confidence            346899999997 58988886533  235899999999999999999999986   999999999999999999999999


Q ss_pred             CCcccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhc-
Q 045835          388 GLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQ-  466 (511)
Q Consensus       388 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~-  466 (511)
                      |+++.....  .......||..|+|||.+....++.++|||||||++|||++|++||......+     .......... 
T Consensus       155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-----~~~~i~~~~~~  227 (290)
T cd07862         155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-----QLGKILDVIGL  227 (290)
T ss_pred             cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-----HHHHHHHHhCC
Confidence            999865432  12234568999999999988899999999999999999999999997433111     1111100000 


Q ss_pred             --cCchh-------HhhhhhhCC---CCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          467 --DGKLV-------ELVDERLGS---KYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       467 --~~~~~-------~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                        .....       ....+....   ...++....+.+++.+||+.+|++|||+.|+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~  284 (290)
T cd07862         228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA  284 (290)
T ss_pred             CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHH
Confidence              00000       000000000   0111234567899999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=6.5e-39  Score=310.26  Aligned_cols=242  Identities=29%  Similarity=0.441  Sum_probs=194.2

Q ss_pred             CceeccCceeEEeccccCCcEEEEEEecccCc-cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCCCCHh
Q 045835          246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSR-QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLA  324 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~  324 (511)
                      ++||+|+||.||+|...++..+|+|.++.... .....+.+|+.+++.++||||++++++|...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            46899999999999988889999999875533 23346889999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCceeeccc
Q 045835          325 CALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI  404 (511)
Q Consensus       325 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~  404 (511)
                      +++....   ..+++..+..++.+++.||.|||+.+   ++||||||+||++++++.+||+|||++..............
T Consensus        81 ~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (250)
T cd05085          81 SFLRKKK---DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK  154 (250)
T ss_pred             HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence            9986432   35889999999999999999999886   99999999999999999999999999975433222111222


Q ss_pred             ccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCCCCC
Q 045835          405 AGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYK  483 (511)
Q Consensus       405 ~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  483 (511)
                      .++..|+|||++....++.++||||||+++||+++ |..||.....     ...             ...+........+
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~-----~~~-------------~~~~~~~~~~~~~  216 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN-----QQA-------------REQVEKGYRMSCP  216 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH-----HHH-------------HHHHHcCCCCCCC
Confidence            34667999999998899999999999999999998 8988853211     000             0111111112223


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          484 KEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       484 ~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...+..+.+++.+|++.+|++||++.||
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l  244 (250)
T cd05085         217 QKCPDDVYKVMQRCWDYKPENRPKFSEL  244 (250)
T ss_pred             CCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence            3455789999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.7e-39  Score=325.48  Aligned_cols=235  Identities=26%  Similarity=0.309  Sum_probs=190.0

Q ss_pred             CceeccCceeEEeccc-cCCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCCC
Q 045835          246 KKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENN  321 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g  321 (511)
                      +.||+|+||.||+++. .+++.||+|++....   ......+.+|+.+++.++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999975 468999999997542   233457889999999999999999999999999999999999999


Q ss_pred             CHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCceee
Q 045835          322 SLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS  401 (511)
Q Consensus       322 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~~  401 (511)
                      +|..++....    .+++.....++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....... ..
T Consensus        81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~  152 (328)
T cd05593          81 ELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TM  152 (328)
T ss_pred             CHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccc-cc
Confidence            9998886432    5899999999999999999999986   99999999999999999999999999975332221 12


Q ss_pred             cccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCCC
Q 045835          402 TRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSK  481 (511)
Q Consensus       402 ~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  481 (511)
                      ....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....     .   ...          +.+.. ....
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-----~---~~~----------~~~~~-~~~~  213 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----E---KLF----------ELILM-EDIK  213 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-----H---HHH----------HHhcc-CCcc
Confidence            335689999999999988999999999999999999999999863221     0   000          00000 0012


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCC
Q 045835          482 YKKEEAERMIKVSLLCTNASPSLRPT  507 (511)
Q Consensus       482 ~~~~~~~~l~~l~~~Cl~~~p~~RPs  507 (511)
                      ++......+.+++.+||+.+|++||+
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~  239 (328)
T cd05593         214 FPRTLSADAKSLLSGLLIKDPNKRLG  239 (328)
T ss_pred             CCCCCCHHHHHHHHHHcCCCHHHcCC
Confidence            23344567889999999999999983

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=5.8e-39  Score=312.76  Aligned_cols=248  Identities=31%  Similarity=0.488  Sum_probs=199.5

Q ss_pred             hcCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      .++|++.++||+|+||.||+|...+++.||+|.+.... .....+.+|+.++++++|+|++++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            35688899999999999999998888999999987543 33467899999999999999999999864 46789999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      ++++|.+++....  ...+++.++..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++........
T Consensus        83 ~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          83 ENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence            9999999986543  245899999999999999999999886   99999999999999999999999999986553322


Q ss_pred             eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          399 HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                      .......++..|+|||++....++.++||||||++++||++ |+.||.....     ..+             .+.+...
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~-------------~~~~~~~  219 (260)
T cd05067         158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN-----PEV-------------IQNLERG  219 (260)
T ss_pred             ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh-----HHH-------------HHHHHcC
Confidence            22223345778999999998899999999999999999999 9999863221     001             1111111


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....+...+.++.+++.+|++.+|++|||++++
T Consensus       220 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l  253 (260)
T cd05067         220 YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYL  253 (260)
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence            1122233345679999999999999999998764

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.2e-39  Score=316.66  Aligned_cols=259  Identities=28%  Similarity=0.409  Sum_probs=199.0

Q ss_pred             CcccCceeccCceeEEecc-----ccCCcEEEEEEecccCc-cchHHHHHHHHHHhcCCCCCceeEEEEEEeC--CEEEE
Q 045835          242 FDSAKKIGEGGFGPVYKGQ-----LADGTIIAVKQLSSKSR-QGNREFLNEIAMISCLQHPNLVKIHGCCVEG--DQLLL  313 (511)
Q Consensus       242 f~~~~~lG~G~fG~Vy~g~-----~~~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l  313 (511)
                      |+..+.||+|+||.||++.     ..++..||+|.++.... .....|.+|+.++++++||||++++++|...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            3788999999999998754     23578899999875432 3456788999999999999999999998764  46889


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      +|||+++++|.+++...     .+++..+..++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||+++..
T Consensus        86 v~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          86 IMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             EecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccccc
Confidence            99999999999998543     4899999999999999999999986   999999999999999999999999999865


Q ss_pred             CCCCce--eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchh
Q 045835          394 EGDKTH--ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLV  471 (511)
Q Consensus       394 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  471 (511)
                      ......  ......++..|+|||.+....++.++||||||++++||+||+.|+......   ...+..+.........+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~  234 (283)
T cd05080         158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK---FEEMIGPKQGQMTVVRLI  234 (283)
T ss_pred             CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch---hhhhhcccccccchhhhh
Confidence            432211  112223566799999998888999999999999999999999997643211   011111111111112233


Q ss_pred             HhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       472 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +.++.......+...+..+.+++.+||+.+|++|||+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i  274 (283)
T cd05080         235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSL  274 (283)
T ss_pred             hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHH
Confidence            3333333333344556789999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=8.1e-39  Score=316.95  Aligned_cols=262  Identities=19%  Similarity=0.318  Sum_probs=195.6

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      ++|...++||+|+||.||+|... ++..||+|.++... ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46888999999999999999754 68899999987543 23345678999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +++ +|.+++....   ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        85 ~~~-~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~  157 (288)
T cd07871          85 LDS-DLKQYLDNCG---NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT  157 (288)
T ss_pred             CCc-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence            985 8988885432   34788999999999999999999986   9999999999999999999999999997543222


Q ss_pred             ceeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccch---------hhhhHhhhcc
Q 045835          398 THISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCL---------LDWACHLQQD  467 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l---------~~~~~~~~~~  467 (511)
                      .. .....++..|+|||.+.+ ..++.++||||+||++|||+||+.||......+. ....         ..|. .....
T Consensus       158 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~  234 (288)
T cd07871         158 KT-YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE-LHLIFRLLGTPTEETWP-GITSN  234 (288)
T ss_pred             cc-ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHHhh-ccccc
Confidence            11 223467899999998875 4689999999999999999999999864321100 0000         0000 00000


Q ss_pred             CchhHhhhhhhCCC----CCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          468 GKLVELVDERLGSK----YKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       468 ~~~~~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ........+.....    .......++.+++.+||+.+|.+|||+.|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~  282 (288)
T cd07871         235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAA  282 (288)
T ss_pred             hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHH
Confidence            11111111111000    011224567899999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=9.9e-39  Score=315.03  Aligned_cols=244  Identities=24%  Similarity=0.352  Sum_probs=193.3

Q ss_pred             eeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCCCCH
Q 045835          248 IGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSL  323 (511)
Q Consensus       248 lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL  323 (511)
                      ||+|+||.||++... +++.+|+|.+....   ......+..|+.+++.++|+||+++.+++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999754 68899999986432   22335678899999999999999999999999999999999999999


Q ss_pred             hHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCceeecc
Q 045835          324 ACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR  403 (511)
Q Consensus       324 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~  403 (511)
                      ..++.........+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......... ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence            9888654333456899999999999999999999986   999999999999999999999999999755432221 223


Q ss_pred             cccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCCCCC
Q 045835          404 IAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYK  483 (511)
Q Consensus       404 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  483 (511)
                      ..||..|+|||.+.+..++.++|||||||++|||++|+.||.......    ......         ..+...  ....+
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~----~~~~~~---------~~~~~~--~~~~~  221 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV----ENKELK---------QRILND--SVTYP  221 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch----hHHHHH---------Hhhccc--CCCCc
Confidence            468999999999999999999999999999999999999986322100    000000         011111  11233


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCcCC
Q 045835          484 KEEAERMIKVSLLCTNASPSLRPTMSE  510 (511)
Q Consensus       484 ~~~~~~l~~l~~~Cl~~~p~~RPs~~e  510 (511)
                      ...+..+.+++.+||+.+|++||++++
T Consensus       222 ~~~~~~~~~li~~~l~~~P~~R~~~~~  248 (280)
T cd05608         222 DKFSPASKSFCEALLAKDPEKRLGFRD  248 (280)
T ss_pred             ccCCHHHHHHHHHHhcCCHHHhcCCCC
Confidence            445667899999999999999996543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=5.2e-39  Score=324.55  Aligned_cols=245  Identities=22%  Similarity=0.329  Sum_probs=192.1

Q ss_pred             CceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEEEEEEEecCC
Q 045835          246 KKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQLLLVYEYMEN  320 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~  320 (511)
                      +.||+|+||.||+++.. +++.+|+|+++...   ......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999854 57899999997542   23334577888888776 899999999999999999999999999


Q ss_pred             CCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCcee
Q 045835          321 NSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI  400 (511)
Q Consensus       321 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~  400 (511)
                      |+|..++...    ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....... .
T Consensus        81 ~~L~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~  152 (329)
T cd05618          81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-T  152 (329)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-c
Confidence            9999888543    25899999999999999999999986   99999999999999999999999999975322211 1


Q ss_pred             ecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCC
Q 045835          401 STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGS  480 (511)
Q Consensus       401 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  480 (511)
                      .....||..|+|||++.+..++.++|||||||++|||++|+.||...............+......        ..  ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~--------~~--~~  222 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL--------EK--QI  222 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh--------cC--CC
Confidence            233568999999999999999999999999999999999999996322111111111122211111        11  11


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCc
Q 045835          481 KYKKEEAERMIKVSLLCTNASPSLRPTM  508 (511)
Q Consensus       481 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  508 (511)
                      .++......+.+++.+||+.+|++||+.
T Consensus       223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         223 RIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            2344455678899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=8.3e-39  Score=312.33  Aligned_cols=248  Identities=29%  Similarity=0.464  Sum_probs=197.3

Q ss_pred             hcCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      .++|.+.++||+|+||.||+|+..+...||+|.++... .....|.+|+.++++++||||+++++++. .+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence            35688999999999999999987776789999987532 33467899999999999999999999875 45689999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      ++|+|.+++....  ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++.......
T Consensus        83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          83 SKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             CCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            9999999996532  235789999999999999999999986   99999999999999999999999999986543332


Q ss_pred             eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          399 HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                      .......++..|+|||+..+..++.++||||||++++||++ |+.||.....     .   +          +.+.+...
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~-----~---~----------~~~~~~~~  219 (262)
T cd05071         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----R---E----------VLDQVERG  219 (262)
T ss_pred             ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh-----H---H----------HHHHHhcC
Confidence            22223346678999999988899999999999999999999 7877753210     0   0          00111111


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....+.+.+..+.+++.+|++.+|++||++.++
T Consensus       220 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~  253 (262)
T cd05071         220 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYL  253 (262)
T ss_pred             CCCCCccccCHHHHHHHHHHccCCcccCCCHHHH
Confidence            1112234556778999999999999999999764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.8e-39  Score=325.88  Aligned_cols=246  Identities=23%  Similarity=0.318  Sum_probs=193.8

Q ss_pred             CCcccCceeccCceeEEeccc----cCCcEEEEEEecccC----ccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQL----ADGTIIAVKQLSSKS----RQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQL  311 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~----~~g~~vAvK~~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~  311 (511)
                      +|++.+.||+|+||.||+++.    .+++.||+|++....    ......+..|+.+++.+ +|+||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            478889999999999999864    357899999986432    22335678899999999 599999999999999999


Q ss_pred             EEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcc
Q 045835          312 LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK  391 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~  391 (511)
                      ++||||+++|+|.+++..+.    .+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD----NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            99999999999999986543    4889999999999999999999986   9999999999999999999999999998


Q ss_pred             cCCCCCceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCch
Q 045835          392 LDEGDKTHISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKL  470 (511)
Q Consensus       392 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  470 (511)
                      ..............||..|+|||.+.+. .++.++|||||||++|||++|+.||......    .........       
T Consensus       154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~~~~~~~-------  222 (332)
T cd05614         154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER----NTQSEVSRR-------  222 (332)
T ss_pred             cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC----CCHHHHHHH-------
Confidence            5433332223345789999999998765 4789999999999999999999998632210    000011000       


Q ss_pred             hHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCc
Q 045835          471 VELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTM  508 (511)
Q Consensus       471 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  508 (511)
                        +..  .....+......+.+++.+||+.+|++||++
T Consensus       223 --~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~  256 (332)
T cd05614         223 --ILK--CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGA  256 (332)
T ss_pred             --Hhc--CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCC
Confidence              000  1112233345568899999999999999954

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.5e-39  Score=317.10  Aligned_cols=257  Identities=29%  Similarity=0.450  Sum_probs=198.4

Q ss_pred             cCCcccCceeccCceeEEeccc-----cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeC--CEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-----ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEG--DQLL  312 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-----~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~  312 (511)
                      ++|++.+.||+|+||.||++..     .++..||+|.+........+.+.+|+.++++++|||++++.+++...  ...+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4688899999999999999864     25789999999876665667899999999999999999999988643  4689


Q ss_pred             EEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCccc
Q 045835          313 LVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       313 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~  392 (511)
                      +|+||+++++|.+++....   ..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++.
T Consensus        84 lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             EEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence            9999999999999986432   35899999999999999999999986   99999999999999999999999999986


Q ss_pred             CCCCCce--eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhcc---
Q 045835          393 DEGDKTH--ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD---  467 (511)
Q Consensus       393 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~---  467 (511)
                      .......  ......++..|+|||++.+..++.++|||||||+++||++|..+......         .+.......   
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---------~~~~~~~~~~~~  228 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA---------EFMRMMGNDKQG  228 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch---------hhhhhccccccc
Confidence            5433221  11122334569999999888999999999999999999998876543221         000000000   


Q ss_pred             ----CchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          468 ----GKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       468 ----~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                          ..+.+.+........+...+..+.+++.+||+.+|++|||+.||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei  276 (284)
T cd05081         229 QMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSEL  276 (284)
T ss_pred             ccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence                01112222222222233445679999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.5e-38  Score=317.27  Aligned_cols=200  Identities=25%  Similarity=0.432  Sum_probs=169.4

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCc-cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR-QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      .++|++.++||+|+||.||+|+.. +++.||||++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            467999999999999999999865 688999999875432 233467899999999999999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      |+. ++|.+++....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++.....
T Consensus        84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          84 YVH-TDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP  156 (303)
T ss_pred             CCC-cCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence            996 57777775432   34888999999999999999999987   999999999999999999999999999754322


Q ss_pred             CceeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 045835          397 KTHISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSY  446 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~  446 (511)
                      .. ......+|..|+|||.+.+ ..++.++|||||||+++||++|+.||..
T Consensus       157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  206 (303)
T cd07869         157 SH-TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG  206 (303)
T ss_pred             Cc-cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            21 1223467899999998865 4688999999999999999999999974

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.2e-39  Score=328.40  Aligned_cols=244  Identities=27%  Similarity=0.426  Sum_probs=190.3

Q ss_pred             CCcccCceeccCceeEEecccc-CCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      +|+..++||+|+||.||+|+.. +++.||||++.... ......+.+|+++++.++|+||+++++++.+.+..++||||+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            4556789999999999999754 68999999986543 233467899999999999999999999999999999999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      ++|+|.+..        ...+.....++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.......
T Consensus       155 ~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        155 DGGSLEGTH--------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             CCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence            999986432        2566778899999999999999986   99999999999999999999999999986543221


Q ss_pred             eeecccccCCCccccccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHh
Q 045835          399 HISTRIAGTIGYMAPEYALW-----GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVEL  473 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  473 (511)
                       ......||..|+|||.+..     ...+.++|||||||++|||++|+.||.....        .+|.....       .
T Consensus       224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~--------~~~~~~~~-------~  287 (353)
T PLN00034        224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ--------GDWASLMC-------A  287 (353)
T ss_pred             -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--------ccHHHHHH-------H
Confidence             1223468999999998743     2345689999999999999999999863221        11211100       0


Q ss_pred             hhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          474 VDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       474 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +........+.....++.+++.+||+.+|++|||+.||
T Consensus       288 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~el  325 (353)
T PLN00034        288 ICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQL  325 (353)
T ss_pred             HhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHH
Confidence            00011122233455678999999999999999999874

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=9.1e-39  Score=322.09  Aligned_cols=241  Identities=25%  Similarity=0.380  Sum_probs=190.7

Q ss_pred             CcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHH---hcCCCCCceeEEEEEEeCCEEEEE
Q 045835          242 FDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMI---SCLQHPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       242 f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l---~~l~H~niv~l~g~~~~~~~~~lV  314 (511)
                      |++.+.||+|+||.||++... +++.||||+++...   ....+.+.+|+.++   +.++||||+++++++.+++..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567889999999999999754 68899999997532   22234566665554   577899999999999999999999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      |||+++++|..++..     ..+++.....++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus        81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05589          81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGM  152 (324)
T ss_pred             EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence            999999999888753     24899999999999999999999986   9999999999999999999999999987432


Q ss_pred             CCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          395 GDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       395 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      .... ......|+..|+|||.+.+..++.++|||||||++|||++|+.||.....        .+...         .+.
T Consensus       153 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~--------~~~~~---------~i~  214 (324)
T cd05589         153 GFGD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE--------EEVFD---------SIV  214 (324)
T ss_pred             CCCC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH--------HHHHH---------HHH
Confidence            2211 12335689999999999999999999999999999999999999864321        01110         111


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSE  510 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e  510 (511)
                      ...  ..++......+.+++.+||+.+|.+||++.+
T Consensus       215 ~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~  248 (324)
T cd05589         215 NDE--VRYPRFLSREAISIMRRLLRRNPERRLGSGE  248 (324)
T ss_pred             hCC--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            111  1123334567889999999999999997543

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=8.8e-39  Score=315.17  Aligned_cols=247  Identities=28%  Similarity=0.409  Sum_probs=192.5

Q ss_pred             cCCcccCceeccCceeEEecccc-CCc----EEEEEEecccCc-cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGT----IIAVKQLSSKSR-QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~----~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  313 (511)
                      +.|+..+.||+|+||.||+|... +++    .+++|.+..... ....++..|+..+++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            45778899999999999999753 344    478888754332 334577888889999999999999999864 56788


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      ++||+++|+|.+++....   ..++|.....++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||+++..
T Consensus        86 i~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHR---DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLL  159 (279)
T ss_pred             EEEeCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceec
Confidence            999999999999996533   35899999999999999999999986   999999999999999999999999999865


Q ss_pred             CCCCc-eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchh
Q 045835          394 EGDKT-HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLV  471 (511)
Q Consensus       394 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  471 (511)
                      ..... .......++..|+|||.+..+.++.++|||||||++|||++ |+.|+.....     ...             .
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----~~~-------------~  221 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-----HEV-------------P  221 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----HHH-------------H
Confidence            33221 22233456778999999998899999999999999999998 9988863221     111             1


Q ss_pred             HhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       472 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +++........+..+...+.+++.+|+..+|++|||+.||
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el  261 (279)
T cd05111         222 DLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKEL  261 (279)
T ss_pred             HHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence            1122111111122234567889999999999999999874

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.9e-39  Score=324.89  Aligned_cols=258  Identities=24%  Similarity=0.371  Sum_probs=192.5

Q ss_pred             CCcccCceeccCceeEEeccc-cCCcEEEEEEeccc--CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCC-----EEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK--SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGD-----QLL  312 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~  312 (511)
                      +|++.++||+|+||.||+|+. .++..||||++...  .......+.+|+.+++.++||||+++++++...+     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            477889999999999999975 46899999998743  2233456889999999999999999999986432     589


Q ss_pred             EEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCccc
Q 045835          313 LVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       313 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~  392 (511)
                      +||||+. ++|.+++....    .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 lv~e~~~-~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          81 VVFELME-SDLHQVIKAND----DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc----cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccc
Confidence            9999996 68888885432    4899999999999999999999987   99999999999999999999999999985


Q ss_pred             CCCCCc--eeecccccCCCccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhh----
Q 045835          393 DEGDKT--HISTRIAGTIGYMAPEYALW--GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHL----  464 (511)
Q Consensus       393 ~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~----  464 (511)
                      ......  .......||..|+|||++.+  ..++.++|||||||+++||++|+.||......     .........    
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~-----~~~~~~~~~~~~~  227 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV-----HQLDLITDLLGTP  227 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH-----HHHHHHHHHhCCC
Confidence            432211  11234568999999998865  67899999999999999999999998643210     011110000    


Q ss_pred             -------hccCchhHhhhhhh---CCCCC---HHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          465 -------QQDGKLVELVDERL---GSKYK---KEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       465 -------~~~~~~~~~~d~~l---~~~~~---~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                             .......+.+....   .....   +.....+.+++.+||+.+|++|||+.||
T Consensus       228 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~  287 (338)
T cd07859         228 SPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEA  287 (338)
T ss_pred             CHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHH
Confidence                   00111111111100   00000   1123567899999999999999999875

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=8e-39  Score=317.11  Aligned_cols=250  Identities=30%  Similarity=0.460  Sum_probs=197.2

Q ss_pred             CCcccCceeccCceeEEecccc------CCcEEEEEEecccCc-cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSKSR-QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  313 (511)
                      +|.+.+.||+|+||.||+|...      ....+++|.+..... .....+.+|+.+++.++||||+++++.|...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4778899999999999999642      235789998875432 334578899999999999999999999999999999


Q ss_pred             EEEecCCCCHhHHHhcCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCC
Q 045835          314 VYEYMENNSLACALFGREN--------------------CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATN  373 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~N  373 (511)
                      ++||+.+++|.+++.....                    ....+++..++.++.|++.||+|||+.+   ++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            9999999999999864211                    1235889999999999999999999886   9999999999


Q ss_pred             eEEcCCCCeEEeecCCcccCCCCCcee-ecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCccc
Q 045835          374 VLLDRDLNPKISDFGLAKLDEGDKTHI-STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALE  451 (511)
Q Consensus       374 ILld~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~  451 (511)
                      ||+++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||++++||++ |+.|+....   
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---  234 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA---  234 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC---
Confidence            999999999999999998543322211 122345678999999988899999999999999999999 998885322   


Q ss_pred             ccccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          452 FDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       452 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                        ..             .+.+.+........+......+.+++.+|++.+|++||++.||
T Consensus       235 --~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i  279 (290)
T cd05045         235 --PE-------------RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI  279 (290)
T ss_pred             --HH-------------HHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence              01             1112222222222334455679999999999999999999874

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2e-39  Score=332.80  Aligned_cols=249  Identities=21%  Similarity=0.315  Sum_probs=197.5

Q ss_pred             HhcCCcccCceeccCceeEEecccc-CCcEEEEEEeccc---CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEE
Q 045835          238 ATNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK---SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       238 ~~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  313 (511)
                      ..++|+..++||+|+||.||+++.. +++.||+|++...   .......+.+|+.+++.++||||+++++++.+++..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3567999999999999999999754 6889999998643   22333457899999999999999999999999999999


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      ||||+++|+|.+++...     .++......++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       121 v~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~  192 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (370)
T ss_pred             EEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence            99999999999988543     3778888899999999999999986   999999999999999999999999999865


Q ss_pred             CCCCceeecccccCCCcccccccccC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCc
Q 045835          394 EGDKTHISTRIAGTIGYMAPEYALWG----YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGK  469 (511)
Q Consensus       394 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  469 (511)
                      ............||+.|+|||.+...    .++.++|||||||++|||++|+.||.....        ..         .
T Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~---------~  255 (370)
T cd05596         193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VG---------T  255 (370)
T ss_pred             cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH--------HH---------H
Confidence            43322222345799999999988653    478999999999999999999999963221        00         0


Q ss_pred             hhHhhhhhhCCCCCH--HHHHHHHHHHHHcCCCCCCC--CCCcCCC
Q 045835          470 LVELVDERLGSKYKK--EEAERMIKVSLLCTNASPSL--RPTMSEV  511 (511)
Q Consensus       470 ~~~~~d~~l~~~~~~--~~~~~l~~l~~~Cl~~~p~~--RPs~~eV  511 (511)
                      ..++++......++.  ..+..+.+++.+||+.+|++  |||+.|+
T Consensus       256 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~el  301 (370)
T cd05596         256 YSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEI  301 (370)
T ss_pred             HHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHH
Confidence            111221111111121  34567889999999999987  9998764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-40  Score=329.69  Aligned_cols=247  Identities=29%  Similarity=0.464  Sum_probs=208.6

Q ss_pred             cCCcccCceeccCceeEEeccccC---Cc--EEEEEEeccc-CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLAD---GT--IIAVKQLSSK-SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~---g~--~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  313 (511)
                      +.....++||+|-||.||+|.+.+   |.  .||||..+.. .....+.|+.|..+|++++||||++|+|+|.+ ...++
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi  467 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI  467 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence            344556789999999999997532   33  5899998864 45567789999999999999999999999986 56899


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      |||.++-|.|..+|..+.   ..|+..+....|.||+.||+|||+..   .+||||..+|||+.+...+||+||||++..
T Consensus       468 vmEL~~~GELr~yLq~nk---~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~  541 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQNK---DSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYL  541 (974)
T ss_pred             EEecccchhHHHHHHhcc---ccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhc
Confidence            999999999999997654   36888899999999999999999985   999999999999999999999999999988


Q ss_pred             CCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhH
Q 045835          394 EGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVE  472 (511)
Q Consensus       394 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  472 (511)
                      ..+.....+...-++.|||||.+....++.++|||.|||.+||+++ |..||..-.                  +.++..
T Consensus       542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk------------------NsDVI~  603 (974)
T KOG4257|consen  542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK------------------NSDVIG  603 (974)
T ss_pred             cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc------------------ccceEE
Confidence            8777666666667889999999999999999999999999999877 999986432                  222222


Q ss_pred             hhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          473 LVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       473 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .+...-+..+|+.|+..+..|+.+||..+|.+||++.|+
T Consensus       604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei  642 (974)
T KOG4257|consen  604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEI  642 (974)
T ss_pred             EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHH
Confidence            333333456788889999999999999999999998764

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-39  Score=331.52  Aligned_cols=247  Identities=25%  Similarity=0.319  Sum_probs=198.8

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|.+.+.||+|+||.||+++.. +++.||||+++...   ......+.+|+.++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46889999999999999999864 68999999997532   234457889999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++++|.+++...    ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence            999999999999654    35889999999999999999999986   99999999999999999999999999985543


Q ss_pred             CC----------------------------ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 045835          396 DK----------------------------THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYA  447 (511)
Q Consensus       396 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~  447 (511)
                      ..                            ........||..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~  233 (350)
T cd05573         154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD  233 (350)
T ss_pred             cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence            22                            11223356899999999999999999999999999999999999999643


Q ss_pred             CcccccccchhhhhHhhhccCchhHhhh--hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCC-cCCC
Q 045835          448 PALEFDCTCLLDWACHLQQDGKLVELVD--ERLGSKYKKEEAERMIKVSLLCTNASPSLRPT-MSEV  511 (511)
Q Consensus       448 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d--~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-~~eV  511 (511)
                      ...        ...         ..+..  ..+........+..+.+++.+|++ +|.+||+ +.|+
T Consensus       234 ~~~--------~~~---------~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~l  282 (350)
T cd05573         234 TLQ--------ETY---------NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEI  282 (350)
T ss_pred             CHH--------HHH---------HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHH
Confidence            210        000         11111  111111111135678899999997 9999999 7653

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.2e-38  Score=309.20  Aligned_cols=247  Identities=27%  Similarity=0.396  Sum_probs=201.0

Q ss_pred             CCcccCceeccCceeEEecccc-CCcEEEEEEeccc--CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK--SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      +|...+.||+|+||.||++... +++.|++|.+...  .......+.+|+.+++.++|||++++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4677899999999999999764 6889999998643  234456789999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +++++|.+++....  ...+++.....++.+++.||.|||+.+   ++|+||||+||++++++.+||+|||+++......
T Consensus        81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence            99999999997542  245889999999999999999999886   9999999999999999999999999998654332


Q ss_pred             ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          398 THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                      .. .....|+..|+|||+..+..++.++||||||++++||++|+.||.....     .....            .+.. .
T Consensus       156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~------------~~~~-~  216 (256)
T cd08529         156 NF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-----GALIL------------KIIR-G  216 (256)
T ss_pred             ch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----HHHHH------------HHHc-C
Confidence            22 2234678899999999999999999999999999999999999863321     00111            0111 1


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....+......+.+++.+||+.+|++||++.||
T Consensus       217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l  250 (256)
T cd08529         217 VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQL  250 (256)
T ss_pred             CCCCCccccCHHHHHHHHHHccCCcccCcCHHHH
Confidence            1122333455679999999999999999999874

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.1e-38  Score=310.49  Aligned_cols=239  Identities=27%  Similarity=0.409  Sum_probs=190.3

Q ss_pred             ceeccCceeEEeccc---cCCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCCC
Q 045835          247 KIGEGGFGPVYKGQL---ADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENN  321 (511)
Q Consensus       247 ~lG~G~fG~Vy~g~~---~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g  321 (511)
                      .||+|+||.||+|.+   .++..+|+|+++...  ....+++.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            689999999999964   357889999986543  234467899999999999999999999986 45678999999999


Q ss_pred             CHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCceee
Q 045835          322 SLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS  401 (511)
Q Consensus       322 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~~  401 (511)
                      +|.+++....    .+++.....++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++..........
T Consensus        81 ~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          81 PLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            9999986432    4889999999999999999999986   99999999999999999999999999986543322211


Q ss_pred             --cccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhh
Q 045835          402 --TRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERL  478 (511)
Q Consensus       402 --~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  478 (511)
                        ....++..|+|||.+....++.++|||||||++|||++ |+.||.....     .   ++          .+.+....
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~---~~----------~~~i~~~~  215 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-----N---EV----------TQMIESGE  215 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----H---HH----------HHHHHCCC
Confidence              12234578999999988889999999999999999998 9999863221     1   11          11122222


Q ss_pred             CCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          479 GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       479 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ....+...+.++.+++.+||+.+|++||++.+|
T Consensus       216 ~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i  248 (257)
T cd05116         216 RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVV  248 (257)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHH
Confidence            223344456678999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=7.8e-39  Score=315.05  Aligned_cols=253  Identities=27%  Similarity=0.373  Sum_probs=199.3

Q ss_pred             HhcCCcccCceeccCceeEEeccccC------CcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCE
Q 045835          238 ATNNFDSAKKIGEGGFGPVYKGQLAD------GTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQ  310 (511)
Q Consensus       238 ~~~~f~~~~~lG~G~fG~Vy~g~~~~------g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~  310 (511)
                      ++++|.+.+.||+|+||.||+|...+      +..||+|.+.... ......|.+|+.+++.++|+||+++++++.+.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            35679999999999999999997643      5678999886443 3334578999999999999999999999999999


Q ss_pred             EEEEEEecCCCCHhHHHhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCC---CeEE
Q 045835          311 LLLVYEYMENNSLACALFGREN---CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL---NPKI  384 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~---~~kl  384 (511)
                      .++||||+++++|.+++.....   ....++|..+.+++.||+.||+|||+.+   ++||||||+||+++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence            9999999999999999865431   1235899999999999999999999986   99999999999998764   5999


Q ss_pred             eecCCcccCCCCCcee-ecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhH
Q 045835          385 SDFGLAKLDEGDKTHI-STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWAC  462 (511)
Q Consensus       385 ~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~  462 (511)
                      +|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||.....     .       
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~-----~-------  228 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-----Q-------  228 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----H-------
Confidence            9999998653222111 112233567999999998999999999999999999997 9888863221     0       


Q ss_pred             hhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          463 HLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       463 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                            .+.+.+........+...+..+.+++.+|++.+|++|||+.+|
T Consensus       229 ------~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~v  271 (277)
T cd05036         229 ------EVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATI  271 (277)
T ss_pred             ------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence                  1112222222223344455678999999999999999999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=6.7e-39  Score=324.75  Aligned_cols=253  Identities=26%  Similarity=0.418  Sum_probs=196.0

Q ss_pred             hcCCcccCceeccCceeEEecccc------CCcEEEEEEecccCc-cchHHHHHHHHHHhcC-CCCCceeEEEEEEeC-C
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSKSR-QGNREFLNEIAMISCL-QHPNLVKIHGCCVEG-D  309 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~  309 (511)
                      .++|++.+.||+|+||.||+|...      +++.||+|+++.... .....+..|+.++.++ +|+||++++++|... .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            357889999999999999999632      247899999875432 2335678899999999 899999999988754 5


Q ss_pred             EEEEEEEecCCCCHhHHHhcCCCC--------------------------------------------------------
Q 045835          310 QLLLVYEYMENNSLACALFGRENC--------------------------------------------------------  333 (511)
Q Consensus       310 ~~~lV~Ey~~~gsL~~~l~~~~~~--------------------------------------------------------  333 (511)
                      ..++++||+++++|.+++......                                                        
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            688999999999999998643210                                                        


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCcee-ecccccCCCcc
Q 045835          334 -ELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI-STRIAGTIGYM  411 (511)
Q Consensus       334 -~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~  411 (511)
                       ...++|..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++......... .....++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence             125899999999999999999999886   9999999999999999999999999998653322211 12234567899


Q ss_pred             cccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHH
Q 045835          412 APEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERM  490 (511)
Q Consensus       412 aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l  490 (511)
                      |||++.+..++.++|||||||+++||++ |+.||......    ..+             .+.+........+.....++
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~----~~~-------------~~~~~~~~~~~~~~~~~~~~  305 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID----EEF-------------CRRLKEGTRMRAPEYATPEI  305 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc----HHH-------------HHHHhccCCCCCCccCCHHH
Confidence            9999999999999999999999999998 99988632110    001             11111111112233445678


Q ss_pred             HHHHHHcCCCCCCCCCCcCCC
Q 045835          491 IKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       491 ~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .+++.+||+.+|++||++.||
T Consensus       306 ~~l~~~cl~~~p~~RPs~~el  326 (337)
T cd05054         306 YSIMLDCWHNNPEDRPTFSEL  326 (337)
T ss_pred             HHHHHHHccCChhhCcCHHHH
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-40  Score=323.97  Aligned_cols=246  Identities=27%  Similarity=0.415  Sum_probs=203.0

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      ..|...+.||+|.||.||+|.. ..++.||+|++.... .....+...|+.+|++.+++||.+.+|.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            3467778999999999999974 468899999998653 34456788999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      |.+|++.+.|....    .+++....-|+.++..||.|||.++   .+|||||+.|||+..++.+||+|||++.......
T Consensus        93 ~~gGsv~~lL~~~~----~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~  165 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGN----ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV  165 (467)
T ss_pred             hcCcchhhhhccCC----CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh
Confidence            99999999986443    3467777778899999999999986   9999999999999999999999999998766544


Q ss_pred             ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          398 THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                      ... ...+||+-|||||++....|+.|+||||||++.+||.+|.+|+....++                  +..-++-..
T Consensus       166 ~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm------------------rvlflIpk~  226 (467)
T KOG0201|consen  166 KRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM------------------RVLFLIPKS  226 (467)
T ss_pred             hcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc------------------eEEEeccCC
Confidence            433 5578999999999999889999999999999999999999998743221                  111111111


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      -...........+.+++..||+.+|+.|||+.++
T Consensus       227 ~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~L  260 (467)
T KOG0201|consen  227 APPRLDGDFSPPFKEFVEACLDKNPEFRPSAKEL  260 (467)
T ss_pred             CCCccccccCHHHHHHHHHHhhcCcccCcCHHHH
Confidence            1222223556679999999999999999999864

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-38  Score=309.95  Aligned_cols=248  Identities=27%  Similarity=0.356  Sum_probs=199.4

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCc-----cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSR-----QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~-----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  313 (511)
                      ++|+..+.||+|++|.||++.. .+++.+|+|.+.....     .....+.+|+.++++++||||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5789999999999999999975 4688999999864321     123468899999999999999999999999999999


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      |+||+++++|.+++....    .+++.....++.|++.||+|||+.+   ++||||+|+||++++++.++|+|||+++..
T Consensus        82 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~  154 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL  154 (263)
T ss_pred             EEEECCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            999999999999986543    4788999999999999999999986   999999999999999999999999999754


Q ss_pred             CCCCceee--cccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchh
Q 045835          394 EGDKTHIS--TRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLV  471 (511)
Q Consensus       394 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  471 (511)
                      ........  ....++..|+|||.+.+..++.++||||||+++|||++|+.||.......     .            ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~------------~~  217 (263)
T cd06625         155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA-----A------------IF  217 (263)
T ss_pred             cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH-----H------------HH
Confidence            33211111  23457889999999999899999999999999999999999986322100     0            01


Q ss_pred             HhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       472 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...........+......+.+++.+||+.+|.+|||+.||
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l  257 (263)
T cd06625         218 KIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEEL  257 (263)
T ss_pred             HHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            1111111223344456678999999999999999999764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1e-38  Score=309.36  Aligned_cols=242  Identities=26%  Similarity=0.423  Sum_probs=192.4

Q ss_pred             CceeccCceeEEecccc-CCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCCCCH
Q 045835          246 KKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSL  323 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL  323 (511)
                      +.||+|+||.||+|+.. +++.+|+|.+.... ......+.+|++++++++||||++++++|......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46999999999999864 68899999876443 33446789999999999999999999999999999999999999999


Q ss_pred             hHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCcee-ec
Q 045835          324 ACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI-ST  402 (511)
Q Consensus       324 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~-~~  402 (511)
                      .+++....   ..+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.......... ..
T Consensus        81 ~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          81 LTFLRTEG---PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence            99986432   35889999999999999999999886   9999999999999999999999999997543221111 01


Q ss_pred             ccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCCC
Q 045835          403 RIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSK  481 (511)
Q Consensus       403 ~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  481 (511)
                      ....+..|+|||.+..+.++.++||||||+++|||++ |..|+.....     .             .....+.......
T Consensus       155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~-----~-------------~~~~~~~~~~~~~  216 (252)
T cd05084         155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN-----Q-------------QTREAIEQGVRLP  216 (252)
T ss_pred             CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH-----H-------------HHHHHHHcCCCCC
Confidence            1123457999999998899999999999999999998 8887753211     0             1111111222223


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          482 YKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       482 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .+...+..+.+++.+|++.+|++|||+.||
T Consensus       217 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~  246 (252)
T cd05084         217 CPELCPDAVYRLMERCWEYDPGQRPSFSTV  246 (252)
T ss_pred             CcccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            344456678999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=8.7e-39  Score=322.91  Aligned_cols=245  Identities=22%  Similarity=0.331  Sum_probs=192.4

Q ss_pred             CceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEEEEEEEecCC
Q 045835          246 KKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQLLLVYEYMEN  320 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~  320 (511)
                      +.||+|+||.||+++.. +++.||+|+++...   ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999754 68899999997532   23345678899999888 799999999999999999999999999


Q ss_pred             CCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCcee
Q 045835          321 NSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI  400 (511)
Q Consensus       321 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~  400 (511)
                      |+|.+++...    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....... .
T Consensus        81 g~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-~  152 (329)
T cd05588          81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-T  152 (329)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCC-c
Confidence            9999888543    25899999999999999999999987   99999999999999999999999999974222111 1


Q ss_pred             ecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCC
Q 045835          401 STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGS  480 (511)
Q Consensus       401 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  480 (511)
                      .....||..|+|||++.+..++.++|||||||++|||++|+.||..............++.....        ....  .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--------~~~~--~  222 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI--------LEKQ--I  222 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH--------HcCC--C
Confidence            23357899999999999999999999999999999999999999643211111111112221111        1111  1


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCc
Q 045835          481 KYKKEEAERMIKVSLLCTNASPSLRPTM  508 (511)
Q Consensus       481 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  508 (511)
                      ..+...+..+.+++.+||+.+|.+||+.
T Consensus       223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~  250 (329)
T cd05588         223 RIPRSLSVKASSVLKGFLNKDPKERLGC  250 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            2233445678999999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.2e-39  Score=322.68  Aligned_cols=236  Identities=24%  Similarity=0.351  Sum_probs=189.8

Q ss_pred             cCceeccCceeEEeccc----cCCcEEEEEEecccC----ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          245 AKKIGEGGFGPVYKGQL----ADGTIIAVKQLSSKS----RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       245 ~~~lG~G~fG~Vy~g~~----~~g~~vAvK~~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      +++||+|+||.||+++.    .+++.||||+++...    ......+.+|+.+++.++||||+++++++..++..++|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            36899999999999964    357899999987432    2233467889999999999999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      |+++++|.+++....    .+.+.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  153 (323)
T cd05584          81 YLSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE  153 (323)
T ss_pred             CCCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence            999999999986543    4788888999999999999999986   999999999999999999999999999743222


Q ss_pred             CceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhh
Q 045835          397 KTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDE  476 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  476 (511)
                      .. ......||..|+|||++.+..++.++|||||||++|||++|+.||.....        ...         ...+...
T Consensus       154 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~--------~~~---------~~~~~~~  215 (323)
T cd05584         154 GT-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR--------KKT---------IDKILKG  215 (323)
T ss_pred             CC-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH--------HHH---------HHHHHcC
Confidence            21 22335689999999999988899999999999999999999999963221        011         1111111


Q ss_pred             hhCCCCCHHHHHHHHHHHHHcCCCCCCCCCC
Q 045835          477 RLGSKYKKEEAERMIKVSLLCTNASPSLRPT  507 (511)
Q Consensus       477 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs  507 (511)
                      .  ...+......+.+++.+||+.+|++||+
T Consensus       216 ~--~~~~~~~~~~~~~li~~~l~~~p~~R~~  244 (323)
T cd05584         216 K--LNLPPYLTPEARDLLKKLLKRNPSSRLG  244 (323)
T ss_pred             C--CCCCCCCCHHHHHHHHHHcccCHhHcCC
Confidence            1  1223344567899999999999999993

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.6e-38  Score=310.70  Aligned_cols=253  Identities=23%  Similarity=0.373  Sum_probs=201.4

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|++.+.||+|+||.||+|+.. +++.||||.+....   ......+.+|+.+++.++|||++++++++.+.+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57889999999999999999754 68899999876432   233456889999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++++|.+++.........+++.....++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            999999999988654333345888999999999999999999986   99999999999999999999999999986543


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      .... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+....      .....+......         
T Consensus       159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~------~~~~~~~~~~~~---------  222 (267)
T cd08228         159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLFSLCQKIEQ---------  222 (267)
T ss_pred             hhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc------ccHHHHHHHHhc---------
Confidence            2221 123457889999999998889999999999999999999999985321      111111111100         


Q ss_pred             hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       476 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..............+.+++.+||+.+|++||++.||
T Consensus       223 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~v  258 (267)
T cd08228         223 CDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYV  258 (267)
T ss_pred             CCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHH
Confidence            011111223455779999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=5.6e-39  Score=316.84  Aligned_cols=250  Identities=29%  Similarity=0.439  Sum_probs=196.4

Q ss_pred             CCcccCceeccCceeEEecccc------CCcEEEEEEecccCcc-chHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSKSRQ-GNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  313 (511)
                      .|.+.+.||+|+||.||+|...      ++..||+|+++..... ....+.+|+.+++.++||||+++++++.+.+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            4667889999999999999753      2468999999755432 23568899999999999999999999999999999


Q ss_pred             EEEecCCCCHhHHHhcCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCC
Q 045835          314 VYEYMENNSLACALFGRE------------NCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN  381 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~  381 (511)
                      ++||+.+++|.+++....            .....+++..+..++.|++.||+|||+.+   |+||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence            999999999999985321            11234788999999999999999999986   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCc-eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhh
Q 045835          382 PKISDFGLAKLDEGDKT-HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLD  459 (511)
Q Consensus       382 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~  459 (511)
                      +||+|||+++....... .......+++.|+|||.+..+.++.++|||||||++|||++ |..|+....        ..+
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------~~~  234 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--------NQD  234 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC--------HHH
Confidence            99999999985433221 11223345778999999988899999999999999999998 777775321        111


Q ss_pred             hhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          460 WACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       460 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +.          +.+........+.+.+..+.+++..||+.+|++||++.||
T Consensus       235 ~~----------~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i  276 (283)
T cd05091         235 VI----------EMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDI  276 (283)
T ss_pred             HH----------HHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHH
Confidence            11          1111111122344556678999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3e-38  Score=311.09  Aligned_cols=242  Identities=28%  Similarity=0.367  Sum_probs=190.2

Q ss_pred             eeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCCCCH
Q 045835          248 IGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSL  323 (511)
Q Consensus       248 lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL  323 (511)
                      ||+|+||.||+++.. +|+.+|+|.+....   ......+..|++++++++||||+++.+++.++...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999754 68999999986432   12234556799999999999999999999999999999999999999


Q ss_pred             hHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCceeecc
Q 045835          324 ACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR  403 (511)
Q Consensus       324 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~  403 (511)
                      .+++....  ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++........  ...
T Consensus        81 ~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~  153 (277)
T cd05607          81 KYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQ  153 (277)
T ss_pred             HHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eec
Confidence            98886433  235889999999999999999999986   99999999999999999999999999986543322  233


Q ss_pred             cccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCCCCC
Q 045835          404 IAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYK  483 (511)
Q Consensus       404 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  483 (511)
                      ..|+..|+|||++.+..++.++|||||||++|||++|+.||.....    .........         ..+...... ..
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~----~~~~~~~~~---------~~~~~~~~~-~~  219 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE----KVAKEELKR---------RTLEDEVKF-EH  219 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcc----hhhHHHHHH---------Hhhcccccc-cc
Confidence            4689999999999988899999999999999999999999863221    000001100         011111100 01


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCcCC
Q 045835          484 KEEAERMIKVSLLCTNASPSLRPTMSE  510 (511)
Q Consensus       484 ~~~~~~l~~l~~~Cl~~~p~~RPs~~e  510 (511)
                      .....++.+++.+||+.+|++||++.|
T Consensus       220 ~~~~~~~~~li~~~L~~~P~~R~~~~~  246 (277)
T cd05607         220 QNFTEESKDICRLFLAKKPEDRLGSRE  246 (277)
T ss_pred             ccCCHHHHHHHHHHhccCHhhCCCCcc
Confidence            133556899999999999999999965

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=8.2e-39  Score=315.16  Aligned_cols=253  Identities=23%  Similarity=0.362  Sum_probs=200.2

Q ss_pred             HhcCCcccCceeccCceeEEeccccC-----CcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEe-CCE
Q 045835          238 ATNNFDSAKKIGEGGFGPVYKGQLAD-----GTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVE-GDQ  310 (511)
Q Consensus       238 ~~~~f~~~~~lG~G~fG~Vy~g~~~~-----g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~  310 (511)
                      ..++|.+.+.||+|+||.||+|...+     +..|++|++.... ......+.+|+.++++++|||++++++++.. +..
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            35688899999999999999998655     6889999987543 2334568899999999999999999999876 467


Q ss_pred             EEEEEEecCCCCHhHHHhcCCCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEee
Q 045835          311 LLLVYEYMENNSLACALFGRENC----ELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISD  386 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~D  386 (511)
                      .++++||+++++|.+++......    ...+++.++..++.|++.||+|||+.+   ++||||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence            89999999999999998654322    146899999999999999999999886   99999999999999999999999


Q ss_pred             cCCcccCCCCCce-eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhh
Q 045835          387 FGLAKLDEGDKTH-ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHL  464 (511)
Q Consensus       387 fGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~  464 (511)
                      ||+++........ ......++..|+|||++....++.++||||||+++||+++ |+.||.....     ..+..+..  
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~--  233 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-----FEMAAYLK--  233 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-----HHHHHHHH--
Confidence            9999855433222 2233456778999999988889999999999999999999 9999863221     11111111  


Q ss_pred             hccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          465 QQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       465 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                                 .......+...+..+.+++.+||+.+|++|||+.||
T Consensus       234 -----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~  269 (280)
T cd05043         234 -----------DGYRLAQPINCPDELFAVMACCWALDPEERPSFSQL  269 (280)
T ss_pred             -----------cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence                       111111122334578999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=5e-39  Score=318.81  Aligned_cols=255  Identities=28%  Similarity=0.436  Sum_probs=201.5

Q ss_pred             HHHhcCCcccCceeccCceeEEecccc------CCcEEEEEEeccc-CccchHHHHHHHHHHhcC-CCCCceeEEEEEEe
Q 045835          236 KAATNNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSK-SRQGNREFLNEIAMISCL-QHPNLVKIHGCCVE  307 (511)
Q Consensus       236 ~~~~~~f~~~~~lG~G~fG~Vy~g~~~------~g~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~  307 (511)
                      ....++|+..+.||+|+||.||++...      ....+|+|.+... ......++.+|+.++.++ +|+||++++++|..
T Consensus         8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   87 (293)
T cd05053           8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ   87 (293)
T ss_pred             ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence            344567889999999999999999753      2367999998753 223345688999999999 89999999999999


Q ss_pred             CCEEEEEEEecCCCCHhHHHhcCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeE
Q 045835          308 GDQLLLVYEYMENNSLACALFGRE------------NCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVL  375 (511)
Q Consensus       308 ~~~~~lV~Ey~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NIL  375 (511)
                      ++..+++|||+++|+|..++....            .....+++..+++++.|++.||+|||+.+   |+||||||+||+
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil  164 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVL  164 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEE
Confidence            999999999999999999986432            22346899999999999999999999886   999999999999


Q ss_pred             EcCCCCeEEeecCCcccCCCCCce-eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCccccc
Q 045835          376 LDRDLNPKISDFGLAKLDEGDKTH-ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFD  453 (511)
Q Consensus       376 ld~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~  453 (511)
                      ++.++.+||+|||+++........ ......++..|+|||.+....++.++|||||||++|||++ |..|+......   
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---  241 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE---  241 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH---
Confidence            999999999999999865433221 1122235678999999988899999999999999999998 88887532210   


Q ss_pred             ccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          454 CTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       454 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                                     .+.+.+........+......+.+++.+|++.+|++|||+.||
T Consensus       242 ---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ei  284 (293)
T cd05053         242 ---------------ELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQL  284 (293)
T ss_pred             ---------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHH
Confidence                           1111222222223344456679999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.3e-38  Score=314.03  Aligned_cols=251  Identities=27%  Similarity=0.447  Sum_probs=199.2

Q ss_pred             cCCcccCceeccCceeEEeccc------cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL------ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~------~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  313 (511)
                      +++...++||+|+||.||++..      .++..+|+|.+..........+.+|+.+++.++|+||+++++++.+.+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            5677889999999999999853      2356899999887666666789999999999999999999999999999999


Q ss_pred             EEEecCCCCHhHHHhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCe
Q 045835          314 VYEYMENNSLACALFGREN-----------CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP  382 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~  382 (511)
                      ++||+++++|.+++.....           ....+++..++.++.|++.||+|||+.+   ++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence            9999999999999875431           1135889999999999999999999886   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCc-eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhh
Q 045835          383 KISDFGLAKLDEGDKT-HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDW  460 (511)
Q Consensus       383 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~  460 (511)
                      ||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||......     ..   
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----~~---  233 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT-----EA---  233 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH-----HH---
Confidence            9999999975433221 11222345678999999998999999999999999999998 88887532210     00   


Q ss_pred             hHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          461 ACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       461 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                                .+.+........+...+..+.+++.+||+.+|.+||++.||
T Consensus       234 ----------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l  274 (280)
T cd05092         234 ----------IECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI  274 (280)
T ss_pred             ----------HHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence                      11111111112223344568899999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.2e-38  Score=308.75  Aligned_cols=247  Identities=30%  Similarity=0.457  Sum_probs=196.8

Q ss_pred             cCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecC
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYME  319 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~  319 (511)
                      ++|.+.++||+|+||.||++...++..+|+|.+.... ...+.+.+|+.++++++|+|++++++++. .+..+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            4578889999999999999988777789999886543 33467899999999999999999999875 456889999999


Q ss_pred             CCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCce
Q 045835          320 NNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH  399 (511)
Q Consensus       320 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~  399 (511)
                      +++|.+++....  ...+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||+++........
T Consensus        84 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          84 KGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence            999999996543  235889999999999999999999886   999999999999999999999999999865432222


Q ss_pred             eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhh
Q 045835          400 ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERL  478 (511)
Q Consensus       400 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  478 (511)
                      ......++..|+|||......++.++||||||+++|||++ |+.|+.....     .....+             +....
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~~-------------~~~~~  220 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN-----REVLEQ-------------VERGY  220 (260)
T ss_pred             ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHH-------------HHcCC
Confidence            2222345678999999988899999999999999999999 8888863221     011111             11111


Q ss_pred             CCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          479 GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       479 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ....+...+..+.+++.+||+.+|++||++.+|
T Consensus       221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i  253 (260)
T cd05069         221 RMPCPQGCPESLHELMKLCWKKDPDERPTFEYI  253 (260)
T ss_pred             CCCCCcccCHHHHHHHHHHccCCcccCcCHHHH
Confidence            112334456779999999999999999999764

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-38  Score=309.72  Aligned_cols=249  Identities=32%  Similarity=0.500  Sum_probs=201.2

Q ss_pred             hcCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      .++|.+.++||+|+||.||++...++..+|||.+.... ....++.+|+.++++++|+|++++++++......++||||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            46788999999999999999988778889999987543 34567999999999999999999999999889999999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      ++++|.+++....  ...+++..+..++.+++.||+|||+.+   ++|+||||+||++++++.+||+|||+++.......
T Consensus        84 ~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          84 SKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             CCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            9999999996543  235899999999999999999999986   99999999999999999999999999986543222


Q ss_pred             eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          399 HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                      .......++..|+|||.+.+..++.++||||||++++||++ |+.||.....     .....             .+...
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-----~~~~~-------------~~~~~  220 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-----REVLE-------------QVERG  220 (261)
T ss_pred             hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHH-------------HHHcC
Confidence            21122234568999999998899999999999999999999 9998853210     00111             11111


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....+...+..+.+++.+|++.+|++||++.++
T Consensus       221 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l  254 (261)
T cd05034         221 YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYL  254 (261)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence            1112233345678999999999999999999764

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-39  Score=294.37  Aligned_cols=245  Identities=24%  Similarity=0.365  Sum_probs=205.4

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|++.+.||+|.||.||.|+.+ ++..||+|++....   .+..+++.+|+++-+.|+||||+++++++.+....||++
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil  101 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL  101 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence            56899999999999999999854 57899999986542   345578999999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||...|+|...|.....  ..+++.....+..|+|.||.|+|...   +|||||||+|+|++.++..||+|||.+...+.
T Consensus       102 Eya~~gel~k~L~~~~~--~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~  176 (281)
T KOG0580|consen  102 EYAPRGELYKDLQEGRM--KRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS  176 (281)
T ss_pred             EecCCchHHHHHHhccc--ccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence            99999999999985543  35888888999999999999999875   99999999999999999999999999986543


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      ..   ....+||..|++||...+...+.+.|+|++|++.+|++.|.+||....     .            .+...++..
T Consensus       177 ~k---R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-----~------------~etYkrI~k  236 (281)
T KOG0580|consen  177 NK---RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-----H------------SETYKRIRK  236 (281)
T ss_pred             CC---ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-----h------------HHHHHHHHH
Confidence            22   234789999999999999999999999999999999999999997322     0            001111111


Q ss_pred             hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       476 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                        ....+|........+++.+|+..+|.+|.+..||
T Consensus       237 --~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v  270 (281)
T KOG0580|consen  237 --VDLKFPSTISGGAADLISRLLVKNPIERLALTEV  270 (281)
T ss_pred             --ccccCCcccChhHHHHHHHHhccCccccccHHHH
Confidence              1223455566778999999999999999988764

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-38  Score=311.50  Aligned_cols=249  Identities=27%  Similarity=0.414  Sum_probs=194.6

Q ss_pred             CcccCceeccCceeEEeccccC----CcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCE-----
Q 045835          242 FDSAKKIGEGGFGPVYKGQLAD----GTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQ-----  310 (511)
Q Consensus       242 f~~~~~lG~G~fG~Vy~g~~~~----g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-----  310 (511)
                      |.+.+.||+|+||.||+|....    +..||+|+++...  ......+.+|+..++.++|||++++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999997642    3679999987542  2334578999999999999999999999876554     


Q ss_pred             -EEEEEEecCCCCHhHHHhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeec
Q 045835          311 -LLLVYEYMENNSLACALFGRE--NCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF  387 (511)
Q Consensus       311 -~~lV~Ey~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~Df  387 (511)
                       .++++||+++|+|..++....  .....+++.....++.|++.||+|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             799999999999999986532  22346899999999999999999999986   999999999999999999999999


Q ss_pred             CCcccCCCCCcee-ecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhh
Q 045835          388 GLAKLDEGDKTHI-STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQ  465 (511)
Q Consensus       388 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~  465 (511)
                      |+++......... .....++..|+|||.+....++.++|||||||+++||++ |..|+....     ...+.++.    
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~-----~~~~~~~~----  228 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE-----NHEIYDYL----  228 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHH----
Confidence            9998654332211 112234678999999988899999999999999999999 888875322     11111111    


Q ss_pred             ccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          466 QDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       466 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                               ........+......+.+++.+||+.+|++|||+.||
T Consensus       229 ---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~  265 (273)
T cd05035         229 ---------RHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKL  265 (273)
T ss_pred             ---------HcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence                     1111122334456689999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=4.5e-39  Score=329.94  Aligned_cols=254  Identities=20%  Similarity=0.322  Sum_probs=197.6

Q ss_pred             HHHHHHhcCCcccCceeccCceeEEecccc-CCcEEEEEEeccc---CccchHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 045835          233 KQIKAATNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK---SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEG  308 (511)
Q Consensus       233 ~~l~~~~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~  308 (511)
                      .++....++|+..+.||+|+||.||+++.. +++.+|+|.+...   .......+.+|+.+++.++||||+++++++.++
T Consensus        36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (370)
T cd05621          36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD  115 (370)
T ss_pred             HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            344445678999999999999999999864 5789999998642   222345678999999999999999999999999


Q ss_pred             CEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecC
Q 045835          309 DQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFG  388 (511)
Q Consensus       309 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfG  388 (511)
                      +..++||||+++|+|.+++...     .+++.....++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG  187 (370)
T cd05621         116 KYLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFG  187 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecc
Confidence            9999999999999999998543     3788899999999999999999986   9999999999999999999999999


Q ss_pred             CcccCCCCCceeecccccCCCcccccccccC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhh
Q 045835          389 LAKLDEGDKTHISTRIAGTIGYMAPEYALWG----YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHL  464 (511)
Q Consensus       389 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~  464 (511)
                      +++..............||+.|+|||.+...    .++.++|||||||++|||++|+.||.....        ..     
T Consensus       188 ~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~--------~~-----  254 (370)
T cd05621         188 TCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL--------VG-----  254 (370)
T ss_pred             cceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH--------HH-----
Confidence            9986543322222345799999999998754    378999999999999999999999963321        00     


Q ss_pred             hccCchhHhhhhhhCCCCCH--HHHHHHHHHHHHcCCCCCCC--CCCcCCC
Q 045835          465 QQDGKLVELVDERLGSKYKK--EEAERMIKVSLLCTNASPSL--RPTMSEV  511 (511)
Q Consensus       465 ~~~~~~~~~~d~~l~~~~~~--~~~~~l~~l~~~Cl~~~p~~--RPs~~eV  511 (511)
                          ....+++......++.  ..+..+.+++..|++..+.+  ||++.|+
T Consensus       255 ----~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~  301 (370)
T cd05621         255 ----TYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEI  301 (370)
T ss_pred             ----HHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHH
Confidence                1122222211111222  23556788888899755543  7887653

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=7.7e-39  Score=329.85  Aligned_cols=199  Identities=25%  Similarity=0.340  Sum_probs=171.1

Q ss_pred             CCcccCceeccCceeEEeccc-cCCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      .|+..+.||+|+||.||+|+. .+++.||||++....   ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            588899999999999999975 468899999997532   2334568899999999999999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      |+++|+|.+++....    .+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~  154 (381)
T cd05626          82 YIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT  154 (381)
T ss_pred             cCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence            999999999986543    4888899999999999999999986   999999999999999999999999997532110


Q ss_pred             C----------------------------------------------ceeecccccCCCcccccccccCCCCcchhHHHH
Q 045835          397 K----------------------------------------------THISTRIAGTIGYMAPEYALWGYLTYKADVYSF  430 (511)
Q Consensus       397 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~  430 (511)
                      .                                              ........||..|+|||.+.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (381)
T cd05626         155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV  234 (381)
T ss_pred             cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence            0                                              001123469999999999998889999999999


Q ss_pred             HHHHHHHHhCCCCCCC
Q 045835          431 GIVALEIVSGKNNMSY  446 (511)
Q Consensus       431 Gvvl~elltG~~p~~~  446 (511)
                      ||++|||++|+.||..
T Consensus       235 G~il~elltG~~Pf~~  250 (381)
T cd05626         235 GVILFEMLVGQPPFLA  250 (381)
T ss_pred             hhHHHHHHhCCCCCcC
Confidence            9999999999999964

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.2e-39  Score=327.33  Aligned_cols=250  Identities=24%  Similarity=0.284  Sum_probs=198.4

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|++.+.||+|+||.||+++.. +++.||+|+++...   ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46889999999999999999754 68899999997542   234456889999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++|+|.+++....   ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  154 (330)
T cd05601          81 EYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTA  154 (330)
T ss_pred             CCCCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence            9999999999996542   35899999999999999999999986   99999999999999999999999999986554


Q ss_pred             CCceeecccccCCCcccccccc------cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCc
Q 045835          396 DKTHISTRIAGTIGYMAPEYAL------WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGK  469 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  469 (511)
                      ..........||..|+|||++.      ...++.++|||||||++|||++|+.||.....        ............
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--------~~~~~~i~~~~~  226 (330)
T cd05601         155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS--------AKTYNNIMNFQR  226 (330)
T ss_pred             CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH--------HHHHHHHHcCCC
Confidence            4333334457899999999986      45678999999999999999999999963321        011111111000


Q ss_pred             hhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          470 LVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       470 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                             .+........+..+.+++..|++ +|++|||+.++
T Consensus       227 -------~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l  260 (330)
T cd05601         227 -------FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGL  260 (330)
T ss_pred             -------ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHH
Confidence                   00001111235568889999998 99999998764

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-38  Score=314.10  Aligned_cols=246  Identities=28%  Similarity=0.365  Sum_probs=197.1

Q ss_pred             CCcccCceeccCceeEEeccc-cCCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      +|+..++||+|+||.||++.. .+++.||+|++....   ......+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            477889999999999999975 468899999986532   2223457889999999999999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      |+++|+|.+++....  ...+++.....++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          81 LMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             ccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            999999998886432  235899999999999999999999986   999999999999999999999999999865432


Q ss_pred             CceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhh
Q 045835          397 KTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDE  476 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  476 (511)
                      ...  ....|+..|+|||++.+..++.++|||||||++|||++|+.||......     .....         +...+..
T Consensus       156 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-----~~~~~---------~~~~~~~  219 (285)
T cd05605         156 ETI--RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-----VKREE---------VERRVKE  219 (285)
T ss_pred             Ccc--ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-----hHHHH---------HHHHhhh
Confidence            221  2346899999999999889999999999999999999999999742210     00000         1111111


Q ss_pred             hhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCc
Q 045835          477 RLGSKYKKEEAERMIKVSLLCTNASPSLRPTM  508 (511)
Q Consensus       477 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  508 (511)
                       ....++...+..+.+++.+||+.||++||++
T Consensus       220 -~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~  250 (285)
T cd05605         220 -DQEEYSEKFSEAARSICRQLLTKDPGFRLGC  250 (285)
T ss_pred             -cccccCcccCHHHHHHHHHHccCCHHHhcCC
Confidence             1122344556678999999999999999943

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.5e-38  Score=319.32  Aligned_cols=237  Identities=24%  Similarity=0.361  Sum_probs=188.0

Q ss_pred             CceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhc-CCCCCceeEEEEEEeCCEEEEEEEecCC
Q 045835          246 KKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISC-LQHPNLVKIHGCCVEGDQLLLVYEYMEN  320 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~~~~~~lV~Ey~~~  320 (511)
                      +.||+|+||.||+|+.. +++.||+|.++...   ......+..|..++.. .+||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999864 57889999987532   2233455667777664 4899999999999999999999999999


Q ss_pred             CCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCcee
Q 045835          321 NSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI  400 (511)
Q Consensus       321 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~  400 (511)
                      |+|..++....    .+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...... ..
T Consensus        81 g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~  152 (316)
T cd05592          81 GDLMFHIQSSG----RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK  152 (316)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence            99999886532    4888999999999999999999986   9999999999999999999999999998543222 22


Q ss_pred             ecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCC
Q 045835          401 STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGS  480 (511)
Q Consensus       401 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  480 (511)
                      .....||..|+|||.+.+..++.++|||||||++|||++|+.||.....     .   +...         .+..  ...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-----~---~~~~---------~i~~--~~~  213 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-----D---ELFD---------SILN--DRP  213 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-----H---HHHH---------HHHc--CCC
Confidence            2345689999999999988999999999999999999999999863221     0   0000         0110  011


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCcC
Q 045835          481 KYKKEEAERMIKVSLLCTNASPSLRPTMS  509 (511)
Q Consensus       481 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~  509 (511)
                      .++......+.+++.+||+.+|++||++.
T Consensus       214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~  242 (316)
T cd05592         214 HFPRWISKEAKDCLSKLFERDPTKRLGVD  242 (316)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHHHcCCCh
Confidence            22333455688999999999999999874

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=310.97  Aligned_cols=248  Identities=30%  Similarity=0.396  Sum_probs=190.2

Q ss_pred             hcCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHh--cCCCCCceeEEEEEEeCC----EEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMIS--CLQHPNLVKIHGCCVEGD----QLL  312 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~--~l~H~niv~l~g~~~~~~----~~~  312 (511)
                      .+...+.+.||+|.||.||+|.+. |+.||||++.....   +++.+|.++.+  .|+|+||+.+++.-..++    +++
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw  285 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW  285 (513)
T ss_pred             hheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence            356778899999999999999996 77899999975433   57778888776  459999999998865433    789


Q ss_pred             EEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEEccCCCCCeEEcCCCCeEEeec
Q 045835          313 LVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE-----SRFKIVHRDIKATNVLLDRDLNPKISDF  387 (511)
Q Consensus       313 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-----~~~~iiH~Dlk~~NILld~~~~~kl~Df  387 (511)
                      ||++|.++|||.|+|...     .++-...++++..+|.||++||.+     |+|.|.|||||+.||||.+++.+.|+|+
T Consensus       286 LvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL  360 (513)
T KOG2052|consen  286 LVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  360 (513)
T ss_pred             EeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence            999999999999999653     488999999999999999999975     7889999999999999999999999999


Q ss_pred             CCcccCCCCCce---eecccccCCCcccccccccCC------CCcchhHHHHHHHHHHHHhC----------CCCCCCCC
Q 045835          388 GLAKLDEGDKTH---ISTRIAGTIGYMAPEYALWGY------LTYKADVYSFGIVALEIVSG----------KNNMSYAP  448 (511)
Q Consensus       388 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~DV~S~Gvvl~elltG----------~~p~~~~~  448 (511)
                      |||.........   .....+||.+|||||++...-      .-..+||||||+|+||+...          +.||.   
T Consensus       361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy---  437 (513)
T KOG2052|consen  361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY---  437 (513)
T ss_pred             eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc---
Confidence            999865544322   133468999999999886431      12368999999999998652          23332   


Q ss_pred             cccccccchhhhhHhhhccCchhHhh-hhhhCCCCC-----HHHHHHHHHHHHHcCCCCCCCCCCc
Q 045835          449 ALEFDCTCLLDWACHLQQDGKLVELV-DERLGSKYK-----KEEAERMIKVSLLCTNASPSLRPTM  508 (511)
Q Consensus       449 ~~~~~~~~l~~~~~~~~~~~~~~~~~-d~~l~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~  508 (511)
                                +|+..-..-+++.+++ ..++++.+|     .+.+..|.+++..||..+|.-|-|+
T Consensus       438 ----------d~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltA  493 (513)
T KOG2052|consen  438 ----------DVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTA  493 (513)
T ss_pred             ----------cCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHH
Confidence                      2211111111222221 233444333     3568889999999999999999875

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-39  Score=329.63  Aligned_cols=243  Identities=22%  Similarity=0.288  Sum_probs=192.3

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|+..+.||+|+||.||+++.. +++.||||++....   ......+.+|+.++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47889999999999999999754 68899999997532   233456788999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++|+|.+++....    .+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 E~~~~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  153 (364)
T cd05599          81 EYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK  153 (364)
T ss_pred             CCCCCcHHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence            9999999999986543    4899999999999999999999987   99999999999999999999999999874322


Q ss_pred             CCce-------------------------------------eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHH
Q 045835          396 DKTH-------------------------------------ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIV  438 (511)
Q Consensus       396 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ell  438 (511)
                      ....                                     ......||+.|+|||++....++.++|||||||+++||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~  233 (364)
T cd05599         154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML  233 (364)
T ss_pred             cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence            1100                                     011246899999999999999999999999999999999


Q ss_pred             hCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhh--hhCCCCCHHHHHHHHHHHHHcCCCCCCCCCC
Q 045835          439 SGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDE--RLGSKYKKEEAERMIKVSLLCTNASPSLRPT  507 (511)
Q Consensus       439 tG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~--~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs  507 (511)
                      +|+.||......     ...            ..+++.  .+...........+.+++.+|+. +|.+|++
T Consensus       234 ~G~~Pf~~~~~~-----~~~------------~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~  286 (364)
T cd05599         234 VGYPPFCSDNPQ-----ETY------------RKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLG  286 (364)
T ss_pred             cCCCCCCCCCHH-----HHH------------HHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCC
Confidence            999999643210     000            011110  00000011224567788888986 9999998

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=9.3e-39  Score=319.20  Aligned_cols=248  Identities=22%  Similarity=0.308  Sum_probs=200.4

Q ss_pred             HHhcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEE
Q 045835          237 AATNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLL  312 (511)
Q Consensus       237 ~~~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  312 (511)
                      ...++|+++..||+|+||.||.++. .+|..+|+|+++...   .......+.|-.+|...++|.||+|+-.|.+.+.+|
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY  217 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY  217 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence            3457899999999999999999975 469999999998653   344567889999999999999999999999999999


Q ss_pred             EEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCccc
Q 045835          313 LVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       313 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~  392 (511)
                      |||||++||++..+|....    .|++......+.+++.|+.-||+.|   +|||||||+|+|||..|++||+||||+.-
T Consensus       218 LiMEylPGGD~mTLL~~~~----~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~g  290 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLLMRKD----TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTG  290 (550)
T ss_pred             EEEEecCCccHHHHHHhcC----cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccch
Confidence            9999999999999996654    5888889999999999999999997   99999999999999999999999999842


Q ss_pred             CCC-----------------------CCc----ee-------------------ecccccCCCcccccccccCCCCcchh
Q 045835          393 DEG-----------------------DKT----HI-------------------STRIAGTIGYMAPEYALWGYLTYKAD  426 (511)
Q Consensus       393 ~~~-----------------------~~~----~~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~D  426 (511)
                      ...                       +..    ..                   ....+||+.|||||++.+..|+..+|
T Consensus       291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD  370 (550)
T KOG0605|consen  291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD  370 (550)
T ss_pred             hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence            100                       000    00                   01257999999999999999999999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCC
Q 045835          427 VYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRP  506 (511)
Q Consensus       427 V~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP  506 (511)
                      .||+|||+||||.|-+||....+ ......+..|...+....              ......+..+|+.+|+. ||++|-
T Consensus       371 wWSLG~ImyEmLvGyPPF~s~tp-~~T~rkI~nwr~~l~fP~--------------~~~~s~eA~DLI~rll~-d~~~RL  434 (550)
T KOG0605|consen  371 WWSLGCIMYEMLVGYPPFCSETP-QETYRKIVNWRETLKFPE--------------EVDLSDEAKDLITRLLC-DPENRL  434 (550)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhhhccCCC--------------cCcccHHHHHHHHHHhc-CHHHhc
Confidence            99999999999999999974432 222334445543322211              11223667888999998 999986


Q ss_pred             C
Q 045835          507 T  507 (511)
Q Consensus       507 s  507 (511)
                      -
T Consensus       435 G  435 (550)
T KOG0605|consen  435 G  435 (550)
T ss_pred             C
Confidence            4

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1e-38  Score=301.47  Aligned_cols=258  Identities=27%  Similarity=0.365  Sum_probs=197.2

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCc-cc-hHHHHHHHHHHhcCCCCCceeEEEEEEe--CCEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSR-QG-NREFLNEIAMISCLQHPNLVKIHGCCVE--GDQLLLV  314 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~-~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV  314 (511)
                      ++|+.+++|++|+||.||+|+. ++++.||+|+++.... .+ --.-++||.+|.+.+|||||.+..+...  -+..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            4578899999999999999975 4689999999986532 11 2345899999999999999999998774  3579999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      ||||+. +|..++....   .++...+...+..|+++|++|||...   |+|||||++|+|+...|.+||+|||||+.+.
T Consensus       156 Me~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             HHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence            999987 8999886543   46888999999999999999999987   9999999999999999999999999999776


Q ss_pred             CCCceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccC--c--
Q 045835          395 GDKTHISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDG--K--  469 (511)
Q Consensus       395 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~--~--  469 (511)
                      ... ...+..+-|..|+|||.+.+. .|++..|+||+|||+.||+++++.|......+     ..+-+..+..-.  .  
T Consensus       229 sp~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d-----Ql~~If~llGtPte~iw  302 (419)
T KOG0663|consen  229 SPL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID-----QLDKIFKLLGTPSEAIW  302 (419)
T ss_pred             CCc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH-----HHHHHHHHhCCCccccC
Confidence            543 234567789999999998866 79999999999999999999999887433211     111111110000  0  


Q ss_pred             ----hhHhh---------hhhhCCCCCHH-HHHHHHHHHHHcCCCCCCCCCCcCC
Q 045835          470 ----LVELV---------DERLGSKYKKE-EAERMIKVSLLCTNASPSLRPTMSE  510 (511)
Q Consensus       470 ----~~~~~---------d~~l~~~~~~~-~~~~l~~l~~~Cl~~~p~~RPs~~e  510 (511)
                          ....+         -..++..++.. ..+.-.+|+...+..||.+|.|++|
T Consensus       303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~  357 (419)
T KOG0663|consen  303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAED  357 (419)
T ss_pred             CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHH
Confidence                00000         00111112111 3356678889999999999999875

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.4e-38  Score=308.25  Aligned_cols=240  Identities=26%  Similarity=0.397  Sum_probs=190.1

Q ss_pred             ceeccCceeEEecccc---CCcEEEEEEecccCc-cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCCCC
Q 045835          247 KIGEGGFGPVYKGQLA---DGTIIAVKQLSSKSR-QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNS  322 (511)
Q Consensus       247 ~lG~G~fG~Vy~g~~~---~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs  322 (511)
                      .||+|+||.||+|.+.   .+..||+|++..... ...+.+.+|+.++++++||||++++++|. .+..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999653   355799999876533 33457899999999999999999999986 457899999999999


Q ss_pred             HhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCceee-
Q 045835          323 LACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS-  401 (511)
Q Consensus       323 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~~-  401 (511)
                      |.+++....   ..+++..+++++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||+++.......... 
T Consensus        81 L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          81 LNKFLSGKK---DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             HHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            999986432   35899999999999999999999986   99999999999999999999999999985443322111 


Q ss_pred             -cccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhC
Q 045835          402 -TRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLG  479 (511)
Q Consensus       402 -~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  479 (511)
                       ....++..|+|||.+....++.++|||||||++||+++ |+.||.....        .++          ...+.....
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~----------~~~~~~~~~  216 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG--------PEV----------MSFIEQGKR  216 (257)
T ss_pred             cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH--------HHH----------HHHHHCCCC
Confidence             11233578999999988889999999999999999996 9999863321        011          111122222


Q ss_pred             CCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          480 SKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       480 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...+..+..++.+++.+||+.+|++||++.+|
T Consensus       217 ~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i  248 (257)
T cd05115         217 LDCPAECPPEMYALMKDCWIYKWEDRPNFAKV  248 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            23344556788999999999999999999764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4.3e-38  Score=307.27  Aligned_cols=252  Identities=26%  Similarity=0.393  Sum_probs=203.2

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEeccc---CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK---SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|+..+.||+|+||.||+|... +|+.||+|.++..   .......+.+|++++++++|+|++++++++.+.+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57889999999999999999865 7899999988642   2233567899999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++++|.+++.........+++.++..++.+++.||.|||+.+   ++||||+|+||+++.++.++|+|||+++....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999998654444456899999999999999999999986   99999999999999999999999999976543


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      .... .....++..|+|||.+.+..++.++|||||||++|||++|+.|+....      ..+.+....          +.
T Consensus       159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~----------~~  221 (267)
T cd08224         159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLYSLCKK----------IE  221 (267)
T ss_pred             CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC------ccHHHHHhh----------hh
Confidence            2221 123457889999999988889999999999999999999999985321      111111111          11


Q ss_pred             hhhCCCCCH-HHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          476 ERLGSKYKK-EEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       476 ~~l~~~~~~-~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .......+. .....+.+++.+||+.+|++|||+.+|
T Consensus       222 ~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~i  258 (267)
T cd08224         222 KCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYV  258 (267)
T ss_pred             cCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHH
Confidence            111112222 455678999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-40  Score=297.77  Aligned_cols=257  Identities=24%  Similarity=0.301  Sum_probs=206.6

Q ss_pred             hcCCcccCceeccCceeEEecc-ccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCC-----EEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGD-----QLL  312 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~  312 (511)
                      .++|.+.++||+|||.-||.++ +.++..+|+|++...+.+..+..++|++.-++++|||++++++++..+.     +.+
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            4679999999999999999997 6778999999999888778888999999999999999999999876543     589


Q ss_pred             EEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCccc
Q 045835          313 LVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       313 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~  392 (511)
                      ++++|...|||.+.+......+..+++.+.+.|+.++++||++||+.. ++++||||||.|||+.+++.++|.|||.+..
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~  178 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQ  178 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccc
Confidence            999999999999999876665667999999999999999999999985 5899999999999999999999999999975


Q ss_pred             CCCCCce--------eecccccCCCcccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhh
Q 045835          393 DEGDKTH--------ISTRIAGTIGYMAPEYAL---WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWA  461 (511)
Q Consensus       393 ~~~~~~~--------~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~  461 (511)
                      .+-.-..        .-.....|..|+|||.+.   +...++++|||||||+||+|+.|..||+..-. ..+  ++.   
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~Gg--Sla---  252 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGG--SLA---  252 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCC--eEE---
Confidence            4321100        001234688999999875   55789999999999999999999999973221 000  000   


Q ss_pred             HhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          462 CHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       462 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                               ..+..+.+...-....++.+.+++.+|++.||.+||++.|+
T Consensus       253 ---------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~l  293 (302)
T KOG2345|consen  253 ---------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPEL  293 (302)
T ss_pred             ---------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHH
Confidence                     01111122111122367889999999999999999998764

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.8e-38  Score=315.84  Aligned_cols=249  Identities=27%  Similarity=0.427  Sum_probs=194.9

Q ss_pred             cCCcccCceeccCceeEEeccccC-Cc--EEEEEEeccc-CccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLAD-GT--IIAVKQLSSK-SRQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~-g~--~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV  314 (511)
                      ++|++.+.||+|+||.||+|...+ +.  .+++|.++.. .....+.+.+|+.+++++ +||||+++++++.+.+..+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            568889999999999999997653 32  4788888743 333456789999999999 799999999999999999999


Q ss_pred             EEecCCCCHhHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCe
Q 045835          315 YEYMENNSLACALFGREN------------CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP  382 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~  382 (511)
                      +||+++++|.+++.....            ....+++..+..++.|++.||+|||+.+   ++||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            999999999999965321            1135889999999999999999999986   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhh
Q 045835          383 KISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWA  461 (511)
Q Consensus       383 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~  461 (511)
                      ||+|||++........  ......+..|+|||++....++.++|||||||+++||++ |+.||.....     .   +. 
T Consensus       159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-----~---~~-  227 (297)
T cd05089         159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-----A---EL-  227 (297)
T ss_pred             EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----H---HH-
Confidence            9999999874321111  111123557999999998899999999999999999998 9999863221     0   11 


Q ss_pred             HhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          462 CHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       462 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                               .+.+........+......+.+++.+||+.+|.+|||+.+|
T Consensus       228 ---------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i  268 (297)
T cd05089         228 ---------YEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQI  268 (297)
T ss_pred             ---------HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence                     11111112222333445678999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.6e-38  Score=328.19  Aligned_cols=253  Identities=26%  Similarity=0.412  Sum_probs=198.8

Q ss_pred             hcCCcccCceeccCceeEEecccc------CCcEEEEEEecccCc-cchHHHHHHHHHHhcCC-CCCceeEEEEEEeCCE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSKSR-QGNREFLNEIAMISCLQ-HPNLVKIHGCCVEGDQ  310 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~  310 (511)
                      .++|.+.++||+|+||.||+|++.      .+..||||+++.... ...+.+.+|+.+|.++. ||||++++++|...+.
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~  115 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP  115 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence            456778899999999999999753      346799999975432 22357889999999997 9999999999999999


Q ss_pred             EEEEEEecCCCCHhHHHhcCCC----------------------------------------------------------
Q 045835          311 LLLVYEYMENNSLACALFGREN----------------------------------------------------------  332 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~----------------------------------------------------------  332 (511)
                      .++|+||+++|+|.++++....                                                          
T Consensus       116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (401)
T cd05107         116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM  195 (401)
T ss_pred             cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence            9999999999999999965321                                                          


Q ss_pred             ------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEE
Q 045835          333 ------------------------------------CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL  376 (511)
Q Consensus       333 ------------------------------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILl  376 (511)
                                                          ....++|.....++.|++.||+|||+.+   ++||||||+|||+
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl  272 (401)
T cd05107         196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI  272 (401)
T ss_pred             hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence                                                1124788889999999999999999876   9999999999999


Q ss_pred             cCCCCeEEeecCCcccCCCCCce-eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccc
Q 045835          377 DRDLNPKISDFGLAKLDEGDKTH-ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDC  454 (511)
Q Consensus       377 d~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~  454 (511)
                      ++++.+||+|||+++........ ......++..|+|||.+....++.++|||||||+++||++ |+.|+......    
T Consensus       273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~----  348 (401)
T cd05107         273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN----  348 (401)
T ss_pred             eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch----
Confidence            99999999999999854322211 1122356788999999998889999999999999999998 88887532210    


Q ss_pred             cchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          455 TCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       455 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                          +         ...+.+....+...+......+.+++.+||+.+|.+||+++||
T Consensus       349 ----~---------~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~el  392 (401)
T cd05107         349 ----E---------QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQL  392 (401)
T ss_pred             ----H---------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence                0         0111122222222333455679999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.8e-38  Score=309.78  Aligned_cols=249  Identities=26%  Similarity=0.430  Sum_probs=191.2

Q ss_pred             CcccCceeccCceeEEeccccC-Cc--EEEEEEeccc--CccchHHHHHHHHHHhcCCCCCceeEEEEEEeC------CE
Q 045835          242 FDSAKKIGEGGFGPVYKGQLAD-GT--IIAVKQLSSK--SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEG------DQ  310 (511)
Q Consensus       242 f~~~~~lG~G~fG~Vy~g~~~~-g~--~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~  310 (511)
                      |.+.++||+|+||.||+|...+ +.  .+|+|.++..  .......+.+|+.+++.++||||++++++|...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3467899999999999998654 32  5899988654  233456788999999999999999999998642      24


Q ss_pred             EEEEEEecCCCCHhHHHhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecC
Q 045835          311 LLLVYEYMENNSLACALFGRE--NCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFG  388 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfG  388 (511)
                      .++++||+++|+|.+++....  .....+++.....++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence            689999999999999874322  22345899999999999999999999986   9999999999999999999999999


Q ss_pred             CcccCCCCCcee-ecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhc
Q 045835          389 LAKLDEGDKTHI-STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQ  466 (511)
Q Consensus       389 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~  466 (511)
                      +++......... .....++..|+|||+.....++.++||||||+++|||++ |+.||.....     ..+.+   . ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~~~~~---~-~~  228 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-----SEIYD---Y-LR  228 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHH---H-HH
Confidence            998654332211 122345678999999999999999999999999999999 7888753211     11111   1 11


Q ss_pred             cCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          467 DGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       467 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .+.         ....+......+.+++.+||+.+|++|||+.||
T Consensus       229 ~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l  264 (272)
T cd05075         229 QGN---------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETL  264 (272)
T ss_pred             cCC---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence            111         011222345568999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-38  Score=313.28  Aligned_cols=252  Identities=26%  Similarity=0.405  Sum_probs=199.5

Q ss_pred             hcCCcccCceeccCceeEEecccc------CCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQL  311 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~  311 (511)
                      .++|.+.+.||+|+||.||+|...      .+..||+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            457888999999999999999753      24689999986543 23345788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHhHHHhcCCCC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEe
Q 045835          312 LLVYEYMENNSLACALFGRENC------ELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKIS  385 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~  385 (511)
                      ++||||+++|+|.+++......      ...++|..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence            9999999999999999654321      224789999999999999999999886   9999999999999999999999


Q ss_pred             ecCCcccCCCCCc-eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHh
Q 045835          386 DFGLAKLDEGDKT-HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACH  463 (511)
Q Consensus       386 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~  463 (511)
                      |||+++....... .......++..|+|||.+..+.++.++|||||||++|||+| |+.|+....     ......+   
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-----~~~~~~~---  233 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS-----NEEVLKF---  233 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC-----HHHHHHH---
Confidence            9999975433221 12223346788999999988899999999999999999998 888875321     1111111   


Q ss_pred             hhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          464 LQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       464 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                                +........+...+..+.+++.+||+.+|++|||+.||
T Consensus       234 ----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l  271 (277)
T cd05032         234 ----------VIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEI  271 (277)
T ss_pred             ----------HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence                      11111112233346689999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.9e-39  Score=322.07  Aligned_cols=238  Identities=23%  Similarity=0.323  Sum_probs=192.3

Q ss_pred             CceeccCceeEEeccc----cCCcEEEEEEecccCc--cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecC
Q 045835          246 KKIGEGGFGPVYKGQL----ADGTIIAVKQLSSKSR--QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYME  319 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~----~~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~  319 (511)
                      +.||+|+||.||+++.    .+|+.+|+|++.....  .....+.+|+.++++++||||+++++++.+++..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            6799999999999863    3578999999975322  233457789999999999999999999999999999999999


Q ss_pred             CCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCce
Q 045835          320 NNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH  399 (511)
Q Consensus       320 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~  399 (511)
                      +|+|.+++...    ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....... 
T Consensus        82 ~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-  153 (318)
T cd05582          82 GGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-  153 (318)
T ss_pred             CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence            99999998543    24899999999999999999999986   99999999999999999999999999985433222 


Q ss_pred             eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhC
Q 045835          400 ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLG  479 (511)
Q Consensus       400 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  479 (511)
                      ......|+..|+|||.+....++.++|||||||++|||++|+.||.....     ....            ..+....  
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-----~~~~------------~~i~~~~--  214 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-----KETM------------TMILKAK--  214 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-----HHHH------------HHHHcCC--
Confidence            12335789999999999988899999999999999999999999863221     0010            0111111  


Q ss_pred             CCCCHHHHHHHHHHHHHcCCCCCCCCCCcCC
Q 045835          480 SKYKKEEAERMIKVSLLCTNASPSLRPTMSE  510 (511)
Q Consensus       480 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e  510 (511)
                      ...+......+.+++.+||+.+|++||++.+
T Consensus       215 ~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         215 LGMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            1223334567889999999999999999765

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.8e-38  Score=317.95  Aligned_cols=237  Identities=24%  Similarity=0.392  Sum_probs=189.9

Q ss_pred             CceeccCceeEEecccc-CCcEEEEEEeccc---CccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEEEEEEEecCC
Q 045835          246 KKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK---SRQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQLLLVYEYMEN  320 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~  320 (511)
                      +.||+|+||.||+++.. +++.||||++...   .......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999864 5889999998743   223345677888888876 699999999999999999999999999


Q ss_pred             CCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCcee
Q 045835          321 NSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI  400 (511)
Q Consensus       321 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~  400 (511)
                      |+|.+++....    .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....... .
T Consensus        81 g~L~~~i~~~~----~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~  152 (320)
T cd05590          81 GDLMFHIQKSR----RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-T  152 (320)
T ss_pred             chHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-c
Confidence            99999886543    4889999999999999999999986   99999999999999999999999999875322211 2


Q ss_pred             ecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCC
Q 045835          401 STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGS  480 (511)
Q Consensus       401 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  480 (511)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....     ..+..   .         +....  .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~~~---~---------i~~~~--~  213 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-----DDLFE---A---------ILNDE--V  213 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHHHH---H---------HhcCC--C
Confidence            2335689999999999988999999999999999999999999963221     01111   1         11100  1


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCcC
Q 045835          481 KYKKEEAERMIKVSLLCTNASPSLRPTMS  509 (511)
Q Consensus       481 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~  509 (511)
                      ..+......+.+++.+||+.+|++||++.
T Consensus       214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~~  242 (320)
T cd05590         214 VYPTWLSQDAVDILKAFMTKNPTMRLGSL  242 (320)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence            12223455788999999999999999973

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.5e-38  Score=317.78  Aligned_cols=241  Identities=24%  Similarity=0.384  Sum_probs=193.1

Q ss_pred             CCcccCceeccCceeEEecccc-CCcEEEEEEeccc---CccchHHHHHHHHHHhcCCCC-CceeEEEEEEeCCEEEEEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK---SRQGNREFLNEIAMISCLQHP-NLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~-niv~l~g~~~~~~~~~lV~  315 (511)
                      +|++.+.||+|+||.||+|+.. +++.||||++...   .....+.+..|..++..++|+ +|+++++++.+.+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788899999999999999754 5788999998753   223445678899999999765 5888999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++|+|.+++....    .+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05587          81 EYVNGGDLMYHIQQVG----KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIF  153 (324)
T ss_pred             cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence            9999999999886442    4889999999999999999999986   99999999999999999999999999874322


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      ... ......||..|+|||++.+..++.++|||||||++|||+||+.||.....     ..+..            .+..
T Consensus       154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-----~~~~~------------~i~~  215 (324)
T cd05587         154 GGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-----DELFQ------------SIME  215 (324)
T ss_pred             CCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHH------------HHHc
Confidence            111 12235689999999999999999999999999999999999999963221     11111            1111


Q ss_pred             hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCc
Q 045835          476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTM  508 (511)
Q Consensus       476 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  508 (511)
                      .  ...++......+.+++.+||+.+|++||+.
T Consensus       216 ~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         216 H--NVSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             C--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            1  112233445678899999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.1e-38  Score=309.06  Aligned_cols=256  Identities=26%  Similarity=0.334  Sum_probs=201.7

Q ss_pred             HHHHhcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEE
Q 045835          235 IKAATNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       235 l~~~~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  313 (511)
                      ++.+++++.....||+|+||.||+|... ++..||+|.+........+.+.+|+.++++++|+||+++++++..++..++
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            4556778888889999999999999754 678899999887666666789999999999999999999999999999999


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcC-CCCeEEeecCCccc
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR-DLNPKISDFGLAKL  392 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~-~~~~kl~DfGla~~  392 (511)
                      |+||+++++|.+++..... ....++..+..++.|++.||+|||+.+   |+||||||+||+++. ++.+||+|||++..
T Consensus        83 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~  158 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKR  158 (268)
T ss_pred             EEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence            9999999999999975421 112378888999999999999999886   999999999999986 67899999999975


Q ss_pred             CCCCCceeecccccCCCcccccccccC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCch
Q 045835          393 DEGDKTHISTRIAGTIGYMAPEYALWG--YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKL  470 (511)
Q Consensus       393 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  470 (511)
                      ...... ......++..|+|||++...  .++.++||||||+++|||++|+.|+.....     .....|...       
T Consensus       159 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~-----~~~~~~~~~-------  225 (268)
T cd06624         159 LAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE-----PQAAMFKVG-------  225 (268)
T ss_pred             cccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC-----hhhhHhhhh-------
Confidence            433222 12234578899999998664  378999999999999999999999853211     001111000       


Q ss_pred             hHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          471 VELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       471 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                          -.......+......+.+++.+||+.+|++|||+.||
T Consensus       226 ----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l  262 (268)
T cd06624         226 ----MFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDL  262 (268)
T ss_pred             ----hhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHH
Confidence                0011122344455678999999999999999999874

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.1e-38  Score=318.09  Aligned_cols=241  Identities=24%  Similarity=0.393  Sum_probs=193.5

Q ss_pred             CCcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEEEEEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      +|+..+.||+|+||.||+|+.. +++.||||.++...   ......+..|..++..+ +|++|+++.+++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4778899999999999999754 57899999987542   22334567788888777 5899999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++|+|.+.+....    .+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++....
T Consensus        81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~  153 (323)
T cd05616          81 EYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMW  153 (323)
T ss_pred             cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence            9999999998886543    4889999999999999999999986   99999999999999999999999999975332


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      ... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.....     ..+..            .+..
T Consensus       154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-----~~~~~------------~i~~  215 (323)
T cd05616         154 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELFQ------------SIME  215 (323)
T ss_pred             CCC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH-----HHHHH------------HHHh
Confidence            221 12345689999999999999999999999999999999999999963221     11111            1111


Q ss_pred             hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCc
Q 045835          476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTM  508 (511)
Q Consensus       476 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  508 (511)
                      ..  ..++.....++.+++.+|++.+|++|++.
T Consensus       216 ~~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         216 HN--VAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             CC--CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence            11  12334455678999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.4e-38  Score=315.97  Aligned_cols=237  Identities=26%  Similarity=0.372  Sum_probs=188.9

Q ss_pred             CceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhc-CCCCCceeEEEEEEeCCEEEEEEEecCC
Q 045835          246 KKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISC-LQHPNLVKIHGCCVEGDQLLLVYEYMEN  320 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~~~~~~lV~Ey~~~  320 (511)
                      +.||+|+||.||+|+.. +++.||||+++...   ......+..|..+++. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999865 57899999997542   2333456678888875 4999999999999999999999999999


Q ss_pred             CCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCcee
Q 045835          321 NSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI  400 (511)
Q Consensus       321 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~  400 (511)
                      |+|.+++...    ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....... .
T Consensus        81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  152 (316)
T cd05619          81 GDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-K  152 (316)
T ss_pred             CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-c
Confidence            9999998643    24889999999999999999999986   99999999999999999999999999974322211 1


Q ss_pred             ecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCC
Q 045835          401 STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGS  480 (511)
Q Consensus       401 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  480 (511)
                      .....||..|+|||++.+..++.++|||||||++|||++|+.||.....     ..+...             +.. ...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----~~~~~~-------------i~~-~~~  213 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-----EELFQS-------------IRM-DNP  213 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-----HHHHHH-------------HHh-CCC
Confidence            2235689999999999988999999999999999999999999863221     111111             000 001


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCcC
Q 045835          481 KYKKEEAERMIKVSLLCTNASPSLRPTMS  509 (511)
Q Consensus       481 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~  509 (511)
                      .++......+.+++.+||+.+|++||++.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~  242 (316)
T cd05619         214 CYPRWLTREAKDILVKLFVREPERRLGVK  242 (316)
T ss_pred             CCCccCCHHHHHHHHHHhccCHhhcCCCh
Confidence            12233455688999999999999999986

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.8e-38  Score=309.20  Aligned_cols=249  Identities=27%  Similarity=0.447  Sum_probs=197.3

Q ss_pred             hcCCcccCceeccCceeEEecccc-CC---cEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DG---TIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g---~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  313 (511)
                      .++|+..+.||+|+||.||+|+.. ++   ..+|+|.++... ....+.+.+|+.++++++|||++++.+++.+.+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            457888999999999999999864 23   379999987543 3334678999999999999999999999999999999


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      ||||+++++|.+++....   ..+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus        84 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          84 ITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVL  157 (268)
T ss_pred             EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceec
Confidence            999999999999986532   35899999999999999999999986   999999999999999999999999999855


Q ss_pred             CCCCceee--cccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCch
Q 045835          394 EGDKTHIS--TRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKL  470 (511)
Q Consensus       394 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  470 (511)
                      ........  .....+..|+|||++....++.++|||||||++|||++ |+.||....     .   .++....      
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~-----~---~~~~~~i------  223 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS-----N---HEVMKAI------  223 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC-----H---HHHHHHH------
Confidence            43222111  11223457999999998889999999999999999998 999985321     0   1111111      


Q ss_pred             hHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          471 VELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       471 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                          ........+.+....+.+++.+|++.+|++||+|.+|
T Consensus       224 ----~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i  260 (268)
T cd05063         224 ----NDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDI  260 (268)
T ss_pred             ----hcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence                1111112223445678999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.9e-38  Score=324.80  Aligned_cols=200  Identities=25%  Similarity=0.348  Sum_probs=172.7

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|+..+.||+|+||.||++... +++.||||+++...   ......+.+|+.++.+++|+||+++++++.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47889999999999999999754 58899999997532   223356788999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++|+|.+++....    .+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~  153 (363)
T cd05628          81 EFLPGGDMMTLLMKKD----TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK  153 (363)
T ss_pred             cCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence            9999999999996542    5899999999999999999999986   99999999999999999999999999875321


Q ss_pred             CCc----------------------------------eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCC
Q 045835          396 DKT----------------------------------HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK  441 (511)
Q Consensus       396 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~  441 (511)
                      ...                                  .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~  233 (363)
T cd05628         154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (363)
T ss_pred             cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence            100                                  0012347999999999999999999999999999999999999


Q ss_pred             CCCCC
Q 045835          442 NNMSY  446 (511)
Q Consensus       442 ~p~~~  446 (511)
                      .||..
T Consensus       234 ~Pf~~  238 (363)
T cd05628         234 PPFCS  238 (363)
T ss_pred             CCCCC
Confidence            99963

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3e-38  Score=306.73  Aligned_cols=247  Identities=26%  Similarity=0.464  Sum_probs=197.4

Q ss_pred             cCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecC
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYME  319 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~  319 (511)
                      ..|+..+.||+|+||.||++...++..+|+|.+.... .....|.+|++++++++|||++++++++......++|+||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            3577889999999999999987778889999886432 234578999999999999999999999999999999999999


Q ss_pred             CCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCce
Q 045835          320 NNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH  399 (511)
Q Consensus       320 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~  399 (511)
                      +++|.+++....   ..+++..+..++.+++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++........
T Consensus        83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  156 (256)
T cd05112          83 HGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT  156 (256)
T ss_pred             CCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence            999999986533   24789999999999999999999986   999999999999999999999999999754433222


Q ss_pred             eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhh
Q 045835          400 ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERL  478 (511)
Q Consensus       400 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  478 (511)
                      ......++.+|+|||.+.++.++.++||||||+++|||++ |+.|+.....        ........          ...
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~----------~~~  218 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN--------SEVVETIN----------AGF  218 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH--------HHHHHHHh----------CCC
Confidence            2222335678999999998899999999999999999998 8988863221        11111110          001


Q ss_pred             CCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          479 GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       479 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ....+...+..+.+++.+||+.+|++|||+.||
T Consensus       219 ~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~  251 (256)
T cd05112         219 RLYKPRLASQSVYELMQHCWKERPEDRPSFSLL  251 (256)
T ss_pred             CCCCCCCCCHHHHHHHHHHcccChhhCCCHHHH
Confidence            111122234679999999999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-38  Score=314.60  Aligned_cols=258  Identities=26%  Similarity=0.418  Sum_probs=195.0

Q ss_pred             cCCcccCceeccCceeEEeccccC---------------CcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLAD---------------GTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHG  303 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~---------------g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g  303 (511)
                      ++|++.++||+|+||.||++...+               ...||+|.++... ......|.+|++++++++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578899999999999999986532               2358999987542 333457899999999999999999999


Q ss_pred             EEEeCCEEEEEEEecCCCCHhHHHhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeE
Q 045835          304 CCVEGDQLLLVYEYMENNSLACALFGREN--------CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVL  375 (511)
Q Consensus       304 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NIL  375 (511)
                      ++...+..++||||+++++|.+++.....        ....+++..++.++.|++.||+|||+.+   ++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence            99999999999999999999999864321        1124789999999999999999999986   999999999999


Q ss_pred             EcCCCCeEEeecCCcccCCCCCc-eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCcccc
Q 045835          376 LDRDLNPKISDFGLAKLDEGDKT-HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS--GKNNMSYAPALEF  452 (511)
Q Consensus       376 ld~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt--G~~p~~~~~~~~~  452 (511)
                      +++++.+||+|||++........ .......++..|+|||.+..+.++.++|||||||+++||++  |..||.....   
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~---  238 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD---  238 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh---
Confidence            99999999999999975433221 11222345678999999998899999999999999999998  4555542211   


Q ss_pred             cccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          453 DCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       453 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                        .............      .........+...+..+.+++.+|++.+|++||||.+|
T Consensus       239 --~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i  289 (295)
T cd05097         239 --EQVIENTGEFFRN------QGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKI  289 (295)
T ss_pred             --HHHHHHHHHhhhh------ccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence              1111111000000      00000011122234679999999999999999999875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2e-38  Score=325.71  Aligned_cols=258  Identities=23%  Similarity=0.335  Sum_probs=194.4

Q ss_pred             CCcccCceeccCceeEEeccc-cCCcEEEEEEeccc--CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCC-----EEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK--SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGD-----QLL  312 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~  312 (511)
                      +|++.++||+|+||.||++.. .+++.||||++...  .....+.+.+|+.+++.++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478899999999999999975 47899999998643  2233457889999999999999999999998776     789


Q ss_pred             EEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCccc
Q 045835          313 LVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       313 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~  392 (511)
                      +|+||+. ++|.+.+...    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 lv~e~~~-~~l~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~  152 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP----QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARV  152 (372)
T ss_pred             EEeeccc-cCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceee
Confidence            9999997 5777777433    35899999999999999999999986   99999999999999999999999999986


Q ss_pred             CCCCCceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCch-
Q 045835          393 DEGDKTHISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKL-  470 (511)
Q Consensus       393 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~-  470 (511)
                      .............++..|+|||.+.+. .++.++|||||||+++||++|+.||.......     ...-.......... 
T Consensus       153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~i~~~~g~~~~~  227 (372)
T cd07853         153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-----QLDLITDLLGTPSLE  227 (372)
T ss_pred             cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-----HHHHHHHHcCCCCHH
Confidence            543332223334678899999998764 57999999999999999999999996432110     00100000000000 


Q ss_pred             ---------hHhhhhhh-CC-------CCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          471 ---------VELVDERL-GS-------KYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       471 ---------~~~~d~~l-~~-------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                               ...+.... ..       .........+.+++.+||+.||++|||+.|+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~  285 (372)
T cd07853         228 AMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADA  285 (372)
T ss_pred             HHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHH
Confidence                     00000000 00       1112234578899999999999999998764

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.5e-38  Score=314.68  Aligned_cols=251  Identities=29%  Similarity=0.458  Sum_probs=198.4

Q ss_pred             hcCCcccCceeccCceeEEeccc------cCCcEEEEEEecccC-ccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL------ADGTIIAVKQLSSKS-RQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQ  310 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~------~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~  310 (511)
                      .++|...+.||+|+||.||++..      ..+..||||.++... ....+.+.+|+.+++++ +||||++++++|...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            35788999999999999999863      134579999987543 23345789999999999 79999999999999999


Q ss_pred             EEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCc
Q 045835          311 LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA  390 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla  390 (511)
                      .+++|||+++|+|.+++.....  ..+++.+...++.+++.||+|||+.+   ++|+||||+|||++.++.+||+|||++
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence            9999999999999999865332  23899999999999999999999986   999999999999999999999999999


Q ss_pred             ccCCCCCce-eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccC
Q 045835          391 KLDEGDKTH-ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDG  468 (511)
Q Consensus       391 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~  468 (511)
                      +........ ......++..|+|||.+....++.++|||||||++|||++ |+.|+......    .             
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~----~-------------  251 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD----S-------------  251 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch----H-------------
Confidence            855433221 1222345678999999998899999999999999999998 99887632210    0             


Q ss_pred             chhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          469 KLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       469 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...+.++.......+......+.+++.+|++.+|++|||+.||
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~el  294 (302)
T cd05055         252 KFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQI  294 (302)
T ss_pred             HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence            0111122111112222334678999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=9.4e-39  Score=322.12  Aligned_cols=234  Identities=25%  Similarity=0.318  Sum_probs=188.1

Q ss_pred             CceeccCceeEEeccc-cCCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCCC
Q 045835          246 KKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENN  321 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g  321 (511)
                      +.||+|+||.||++.. .++..||+|.+....   ......+.+|+.+++.++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999974 468899999997532   233456788999999999999999999999999999999999999


Q ss_pred             CHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCcee
Q 045835          322 SLACALFGRENCELELDWPTRQKICLGIARGLAFLHE-ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI  400 (511)
Q Consensus       322 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~  400 (511)
                      +|..++....    .+++.....++.|++.||+|||+ .+   |+||||||+|||++.++.+||+|||+++........ 
T Consensus        81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-  152 (325)
T cd05594          81 ELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-  152 (325)
T ss_pred             cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc-
Confidence            9998885432    58999999999999999999997 45   999999999999999999999999998753322221 


Q ss_pred             ecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCC
Q 045835          401 STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGS  480 (511)
Q Consensus       401 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  480 (511)
                      .....||..|+|||++.+..++.++|||||||++|||++|+.||.....     ..+             .+.+... ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-----~~~-------------~~~i~~~-~~  213 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKL-------------FELILME-EI  213 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-----HHH-------------HHHHhcC-CC
Confidence            2234689999999999999999999999999999999999999863221     001             0111000 01


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCC
Q 045835          481 KYKKEEAERMIKVSLLCTNASPSLRP  506 (511)
Q Consensus       481 ~~~~~~~~~l~~l~~~Cl~~~p~~RP  506 (511)
                      .++......+.+++.+||+.+|++||
T Consensus       214 ~~p~~~~~~~~~li~~~L~~dP~~R~  239 (325)
T cd05594         214 RFPRTLSPEAKSLLSGLLKKDPKQRL  239 (325)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHHhC
Confidence            12333455688999999999999997

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-38  Score=305.91  Aligned_cols=244  Identities=32%  Similarity=0.502  Sum_probs=199.3

Q ss_pred             hcCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      .++|+..+.||+|+||.||+|... |+.||+|.+..... ..+++.+|+.+++.++|+|++++++++.+.+..++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            356888999999999999999864 78899999976544 4568999999999999999999999999999999999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      ++++|.+++.....  ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.......
T Consensus        83 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~  157 (256)
T cd05039          83 AKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD  157 (256)
T ss_pred             CCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence            99999999865432  35899999999999999999999986   99999999999999999999999999986532211


Q ss_pred             eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          399 HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                          ....+..|+|||++..+.++.++||||||++++||++ |+.|+.....     ..+             .+.+...
T Consensus       158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~-------------~~~~~~~  215 (256)
T cd05039         158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDV-------------VPHVEKG  215 (256)
T ss_pred             ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH-----HHH-------------HHHHhcC
Confidence                2234668999999998899999999999999999997 9988853221     111             1111111


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....+...+..+.+++.+||+.+|++|||+.||
T Consensus       216 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l  249 (256)
T cd05039         216 YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQL  249 (256)
T ss_pred             CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHH
Confidence            1122233345678999999999999999999874

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.8e-38  Score=319.53  Aligned_cols=236  Identities=23%  Similarity=0.386  Sum_probs=188.4

Q ss_pred             CceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEEEEEEEecCC
Q 045835          246 KKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQLLLVYEYMEN  320 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~  320 (511)
                      ++||+|+||.||+|+.. +++.||+|++....   ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999764 57899999987532   23345677888888866 899999999999999999999999999


Q ss_pred             CCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCcee
Q 045835          321 NSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI  400 (511)
Q Consensus       321 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~  400 (511)
                      |+|...+....    .+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....... .
T Consensus        81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~  152 (321)
T cd05591          81 GDLMFQIQRSR----KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-T  152 (321)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc-c
Confidence            99998886433    4889999999999999999999987   99999999999999999999999999975332221 1


Q ss_pred             ecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCC
Q 045835          401 STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGS  480 (511)
Q Consensus       401 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  480 (511)
                      .....||..|+|||++.+..++.++|||||||++|||++|+.||.....     ..+..            .+....  .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~-----~~~~~------------~i~~~~--~  213 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-----DDLFE------------SILHDD--V  213 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH-----HHHHH------------HHHcCC--C
Confidence            2335689999999999988999999999999999999999999964321     11111            111110  0


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCc
Q 045835          481 KYKKEEAERMIKVSLLCTNASPSLRPTM  508 (511)
Q Consensus       481 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  508 (511)
                      ..+......+.+++.+||+.+|++||+.
T Consensus       214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~  241 (321)
T cd05591         214 LYPVWLSKEAVSILKAFMTKNPNKRLGC  241 (321)
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            1222234578899999999999999943

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3e-38  Score=308.70  Aligned_cols=253  Identities=24%  Similarity=0.380  Sum_probs=201.3

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|++.+.||+|+||.||++.. .++..+|||.+....   .....++.+|+.+++.++||||+++++++.+++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4678889999999999999984 578999999876432   233457889999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++++|.+++.........+++.....++.+++.||+|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999998653333456899999999999999999999986   99999999999999999999999999876543


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      .... .....++..|+|||++....++.++||||||+++|||++|..|+.....      ....+....         ..
T Consensus       159 ~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~---------~~  222 (267)
T cd08229         159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKI---------EQ  222 (267)
T ss_pred             CCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc------hHHHHhhhh---------hc
Confidence            2221 2234688899999999888899999999999999999999999853210      011111100         00


Q ss_pred             hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       476 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .......+......+.+++.+||+.+|++||||.+|
T Consensus       223 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i  258 (267)
T cd08229         223 CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYV  258 (267)
T ss_pred             CCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHH
Confidence            011111122355679999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3.5e-38  Score=308.33  Aligned_cols=251  Identities=25%  Similarity=0.369  Sum_probs=197.3

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      .++|++.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++||||+++++++..++..++|+||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            35789999999999999999985 56889999999765555556788999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +++++|.+++...    ..+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++.......
T Consensus        88 ~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          88 CGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             CCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence            9999999998643    24889999999999999999999886   9999999999999999999999999998553221


Q ss_pred             ceeecccccCCCcccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          398 THISTRIAGTIGYMAPEYAL---WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      .. .....++..|+|||.+.   ...++.++|||||||+++||++|+.|+........    ...+     ...   ...
T Consensus       161 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~----~~~~-----~~~---~~~  227 (267)
T cd06646         161 AK-RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA----LFLM-----SKS---NFQ  227 (267)
T ss_pred             cc-cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh----heee-----ecC---CCC
Confidence            11 12245788999999874   34578899999999999999999999853221100    0000     000   000


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .+...  .....+..+.+++.+||+.+|++|||+.+|
T Consensus       228 ~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i  262 (267)
T cd06646         228 PPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERL  262 (267)
T ss_pred             CCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHH
Confidence            01110  012234678999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.4e-38  Score=310.29  Aligned_cols=251  Identities=27%  Similarity=0.407  Sum_probs=196.5

Q ss_pred             HHhcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcC-CCCCceeEEEEEEeC------
Q 045835          237 AATNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCL-QHPNLVKIHGCCVEG------  308 (511)
Q Consensus       237 ~~~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~------  308 (511)
                      .+++.|+..+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.+++++ +|+|++++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            45678999999999999999999754 57899999986543 3446788999999998 799999999998763      


Q ss_pred             CEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecC
Q 045835          309 DQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFG  388 (511)
Q Consensus       309 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfG  388 (511)
                      ...+++|||+++++|.+++....  ...+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.+||+|||
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg  156 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG  156 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCC
Confidence            46899999999999999987533  235889999999999999999999986   9999999999999999999999999


Q ss_pred             CcccCCCCCceeecccccCCCcccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHh
Q 045835          389 LAKLDEGDKTHISTRIAGTIGYMAPEYAL-----WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACH  463 (511)
Q Consensus       389 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~  463 (511)
                      +++....... ......|+..|+|||++.     ...++.++|||||||++|||++|+.|+.....       ...... 
T Consensus       157 ~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~-------~~~~~~-  227 (272)
T cd06637         157 VSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-------MRALFL-  227 (272)
T ss_pred             Cceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH-------HHHHHH-
Confidence            9986433222 123356889999999886     34678899999999999999999999853211       001100 


Q ss_pred             hhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          464 LQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       464 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                               +.........+...+..+.+++.+||+.+|.+|||+.||
T Consensus       228 ---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i  266 (272)
T cd06637         228 ---------IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQL  266 (272)
T ss_pred             ---------HhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHH
Confidence                     000000111112334568999999999999999999874

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-38  Score=324.00  Aligned_cols=241  Identities=25%  Similarity=0.365  Sum_probs=204.6

Q ss_pred             CCcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      -|++.+.||.|+-|.|-.|++. +|+.+|||++....   ......+.+|+.+|+.|.|||+++|++++.+..++|+|.|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            3678899999999999999864 79999999997652   2233467899999999999999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      |+++|-|.++|..++    ++.+....+.+.||+.|+.|+|..+   |+||||||+|+|||...++||+|||+|-+-..+
T Consensus        93 yv~gGELFdylv~kG----~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g  165 (786)
T KOG0588|consen   93 YVPGGELFDYLVRKG----PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG  165 (786)
T ss_pred             ecCCchhHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence            999999999997654    5899999999999999999999886   999999999999999999999999999875544


Q ss_pred             CceeecccccCCCcccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          397 KTHISTRIAGTIGYMAPEYALWGYL-TYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      .  .-...+|++.|.|||++++.+| ..++||||.||||+-||||+.||+.                     +++..++.
T Consensus       166 k--lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD---------------------dNir~LLl  222 (786)
T KOG0588|consen  166 K--LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD---------------------DNIRVLLL  222 (786)
T ss_pred             c--cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC---------------------ccHHHHHH
Confidence            3  2344689999999999998865 6799999999999999999999972                     22333333


Q ss_pred             hhhCC--CCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          476 ERLGS--KYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       476 ~~l~~--~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...++  +.|...+.+..+|+.+|+..||+.|.|+.||
T Consensus       223 KV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI  260 (786)
T KOG0588|consen  223 KVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEI  260 (786)
T ss_pred             HHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHH
Confidence            33222  3455667788999999999999999999875

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3e-38  Score=315.71  Aligned_cols=252  Identities=28%  Similarity=0.428  Sum_probs=197.9

Q ss_pred             hcCCcccCceeccCceeEEecccc--------CCcEEEEEEecccC-ccchHHHHHHHHHHhcC-CCCCceeEEEEEEeC
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA--------DGTIIAVKQLSSKS-RQGNREFLNEIAMISCL-QHPNLVKIHGCCVEG  308 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~--------~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~  308 (511)
                      .++|.+.+.||+|+||.||+++..        +...+|+|.++... .....++.+|+.+++.+ +||||++++++|...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            356889999999999999998642        23579999997542 23345788999999999 799999999999999


Q ss_pred             CEEEEEEEecCCCCHhHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEE
Q 045835          309 DQLLLVYEYMENNSLACALFGREN------------CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL  376 (511)
Q Consensus       309 ~~~~lV~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILl  376 (511)
                      +..++||||+++|+|.+++.....            ....++|.++++++.|++.||+|||+.+   ++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence            999999999999999999975432            1235899999999999999999999886   9999999999999


Q ss_pred             cCCCCeEEeecCCcccCCCCCcee-ecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccc
Q 045835          377 DRDLNPKISDFGLAKLDEGDKTHI-STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDC  454 (511)
Q Consensus       377 d~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~  454 (511)
                      +.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |+.|+...+      
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~------  247 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------  247 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC------
Confidence            999999999999997543321111 111224568999999998889999999999999999998 888875322      


Q ss_pred             cchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          455 TCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       455 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                        ..+          +.+.+......+.+......+.+++.+|++.+|++||||.||
T Consensus       248 --~~~----------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ev  292 (307)
T cd05098         248 --VEE----------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL  292 (307)
T ss_pred             --HHH----------HHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHH
Confidence              111          111111122223344456688899999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.5e-38  Score=317.70  Aligned_cols=237  Identities=24%  Similarity=0.346  Sum_probs=188.0

Q ss_pred             CceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHH-HHhcCCCCCceeEEEEEEeCCEEEEEEEecCC
Q 045835          246 KKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIA-MISCLQHPNLVKIHGCCVEGDQLLLVYEYMEN  320 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~  320 (511)
                      +.||+|+||.||+|+.. +|+.||+|++....   ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999864 68999999986532   222334555554 56789999999999999999999999999999


Q ss_pred             CCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCcee
Q 045835          321 NSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI  400 (511)
Q Consensus       321 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~  400 (511)
                      |+|..++...    ..+++.....++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....... .
T Consensus        81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~  152 (323)
T cd05575          81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-T  152 (323)
T ss_pred             CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-c
Confidence            9999988643    25889999999999999999999987   99999999999999999999999999975322211 2


Q ss_pred             ecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCC
Q 045835          401 STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGS  480 (511)
Q Consensus       401 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  480 (511)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....        .+...         .+....  .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--------~~~~~---------~i~~~~--~  213 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT--------AEMYD---------NILNKP--L  213 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH--------HHHHH---------HHHcCC--C
Confidence            2345689999999999999999999999999999999999999863221        11111         111111  1


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCcC
Q 045835          481 KYKKEEAERMIKVSLLCTNASPSLRPTMS  509 (511)
Q Consensus       481 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~  509 (511)
                      ..++.....+.+++.+||+.+|++||++.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         214 RLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            12223456789999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=6.2e-38  Score=311.89  Aligned_cols=247  Identities=25%  Similarity=0.401  Sum_probs=200.3

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      .+|+..+.||+|+||.||+|.. .++..||+|.+..........+.+|+.+++.++|+|++++++++..+...++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            5788899999999999999974 468899999998665555677899999999999999999999999999999999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      ++++|.+++...     .+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++........
T Consensus       100 ~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~  171 (296)
T cd06654         100 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (296)
T ss_pred             CCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence            999999998532     3789999999999999999999986   99999999999999999999999999875432221


Q ss_pred             eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhh
Q 045835          399 HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERL  478 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  478 (511)
                      . .....++..|+|||.+.+..++.++|||||||+++||++|+.||.....        ..+......        +...
T Consensus       172 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~--------~~~~~~~~~--------~~~~  234 (296)
T cd06654         172 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--------LRALYLIAT--------NGTP  234 (296)
T ss_pred             c-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH--------HHhHHHHhc--------CCCC
Confidence            1 1234688899999999988899999999999999999999999863221        011000000        0101


Q ss_pred             CCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          479 GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       479 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ....+......+.+++.+||+.+|++|||+.||
T Consensus       235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ei  267 (296)
T cd06654         235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL  267 (296)
T ss_pred             CCCCccccCHHHHHHHHHHCcCCcccCcCHHHH
Confidence            111233445678899999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=5.8e-38  Score=309.26  Aligned_cols=248  Identities=22%  Similarity=0.346  Sum_probs=194.7

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEeccc-CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK-SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      ++|+..++||+|+||.||+|.. .+++.||+|.+... ......++.+|+.++++++|||++++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3577889999999999999974 46889999998654 233446789999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +++++|..+.        .+++.....++.|++.||+|||+.+   |+|+||||+|||++.++.+||+|||++.......
T Consensus        81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~  149 (279)
T cd06619          81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI  149 (279)
T ss_pred             CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence            9999986542        3678889999999999999999986   9999999999999999999999999997543221


Q ss_pred             ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          398 THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                         .....|+..|+|||++....++.++||||||+++|||++|+.||.......... ....+.         ..+.++.
T Consensus       150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~---------~~~~~~~  216 (279)
T cd06619         150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-MPLQLL---------QCIVDED  216 (279)
T ss_pred             ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-chHHHH---------HHHhccC
Confidence               223468899999999998899999999999999999999999986422111000 000110         1111111


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...........++.+++.+|++.+|++||++.||
T Consensus       217 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~ei  250 (279)
T cd06619         217 PPVLPVGQFSEKFVHFITQCMRKQPKERPAPENL  250 (279)
T ss_pred             CCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHH
Confidence            1111112234568899999999999999999874

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.4e-38  Score=330.46  Aligned_cols=258  Identities=21%  Similarity=0.264  Sum_probs=189.8

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeC--------C
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEG--------D  309 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--------~  309 (511)
                      .++|...++||+|+||.||+|... +++.||||++....    ....+|+.+|+.++||||+++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            467999999999999999999754 68899999885432    2345799999999999999999886532        2


Q ss_pred             EEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCC-CeEEeecC
Q 045835          310 QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL-NPKISDFG  388 (511)
Q Consensus       310 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~-~~kl~DfG  388 (511)
                      .+++||||+++ +|.+++.........+++.....++.|++.||+|||+.+   |+||||||+|||++.++ .+||+|||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence            46799999985 677766543333446899999999999999999999987   99999999999999765 79999999


Q ss_pred             CcccCCCCCceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhcc
Q 045835          389 LAKLDEGDKTHISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD  467 (511)
Q Consensus       389 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~  467 (511)
                      +++........  ....||+.|+|||++.+. .++.++|||||||++|||++|++||......    ..+..... ....
T Consensus       217 la~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~----~~~~~i~~-~~~~  289 (440)
T PTZ00036        217 SAKNLLAGQRS--VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV----DQLVRIIQ-VLGT  289 (440)
T ss_pred             cchhccCCCCc--ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHH-HhCC
Confidence            99865433222  234679999999988754 6899999999999999999999999743211    11111110 0000


Q ss_pred             CchhH--hhh-------------hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          468 GKLVE--LVD-------------ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       468 ~~~~~--~~d-------------~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....  ...             ..+...++...+.++.+|+.+||+.+|.+|||+.|+
T Consensus       290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~  348 (440)
T PTZ00036        290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEA  348 (440)
T ss_pred             CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence            00000  000             011111222334678999999999999999998763

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.7e-38  Score=312.18  Aligned_cols=259  Identities=27%  Similarity=0.425  Sum_probs=199.2

Q ss_pred             hcCCcccCceeccCceeEEeccccC-----------------CcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCcee
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLAD-----------------GTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVK  300 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~~-----------------g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~  300 (511)
                      .++|++.+.||+|+||.||++...+                 +..||+|.+.... .....++.+|+.++++++|||+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4578899999999999999986532                 2468999987543 334567899999999999999999


Q ss_pred             EEEEEEeCCEEEEEEEecCCCCHhHHHhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCC
Q 045835          301 IHGCCVEGDQLLLVYEYMENNSLACALFGREN-------CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATN  373 (511)
Q Consensus       301 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~N  373 (511)
                      ++++|..++..++++||+++++|.+++.....       ....+++..++.++.|++.||+|||+.+   ++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            99999999999999999999999999965431       1235899999999999999999999986   9999999999


Q ss_pred             eEEcCCCCeEEeecCCcccCCCCCc-eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCcc
Q 045835          374 VLLDRDLNPKISDFGLAKLDEGDKT-HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS--GKNNMSYAPAL  450 (511)
Q Consensus       374 ILld~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt--G~~p~~~~~~~  450 (511)
                      |+++.++.++|+|||+++....... .......++..|+|||++....++.++|||||||++|||++  |..|+....  
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~--  238 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT--  238 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence            9999999999999999975433221 22233456778999999998899999999999999999998  566664221  


Q ss_pred             cccccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          451 EFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       451 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                         ................      .......+...+.++.+++.+||+.+|++|||+.||
T Consensus       239 ---~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el  290 (296)
T cd05051         239 ---DQQVIENAGHFFRDDG------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI  290 (296)
T ss_pred             ---hHHHHHHHHhcccccc------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHH
Confidence               1111111111111110      011111222344679999999999999999999875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=4.4e-38  Score=309.93  Aligned_cols=247  Identities=28%  Similarity=0.442  Sum_probs=194.9

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCc----EEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGT----IIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~----~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  313 (511)
                      ++|+..++||+|+||.||+|+. .++.    .||+|.+.... .....++.+|+.+++.++||||++++++|.. ...++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence            5688899999999999999974 3444    48999987543 3345678899999999999999999999975 45779


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      ++||+++|+|.+++....   ..+++...+.++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||+++..
T Consensus        86 ~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          86 VTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             EEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence            999999999999986532   35899999999999999999999986   999999999999999999999999999865


Q ss_pred             CCCCcee-ecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchh
Q 045835          394 EGDKTHI-STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLV  471 (511)
Q Consensus       394 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  471 (511)
                      ....... .....++..|+|||...+..++.++|||||||++|||++ |+.|+....     ...+..            
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~~------------  222 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP-----AREIPD------------  222 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH------------
Confidence            4332221 112234678999999998899999999999999999998 888886322     111111            


Q ss_pred             HhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       472 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                       .+........+...+..+.+++.+||+.+|++||++.|+
T Consensus       223 -~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l  261 (279)
T cd05109         223 -LLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFREL  261 (279)
T ss_pred             -HHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence             111111112233445678999999999999999999764

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.9e-38  Score=325.60  Aligned_cols=253  Identities=20%  Similarity=0.303  Sum_probs=196.7

Q ss_pred             HHHHHHHhcCCcccCceeccCceeEEecccc-CCcEEEEEEeccc---CccchHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 045835          232 LKQIKAATNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK---SRQGNREFLNEIAMISCLQHPNLVKIHGCCVE  307 (511)
Q Consensus       232 ~~~l~~~~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~  307 (511)
                      +.++....++|++.+.||+|+||.||+++.. +++.+|+|.+...   .......+.+|+.+++.++||||+++++++.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            4455556689999999999999999999765 5789999998642   22233457889999999999999999999999


Q ss_pred             CCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeec
Q 045835          308 GDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF  387 (511)
Q Consensus       308 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~Df  387 (511)
                      ++..++||||+++|+|.+++...     .++......++.|++.||+|||+.+   |+||||||+|||++.++.+||+||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~Df  186 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF  186 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeC
Confidence            99999999999999999998543     3788888899999999999999987   999999999999999999999999


Q ss_pred             CCcccCCCCCceeecccccCCCcccccccccC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHh
Q 045835          388 GLAKLDEGDKTHISTRIAGTIGYMAPEYALWG----YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACH  463 (511)
Q Consensus       388 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~  463 (511)
                      |+++..............||+.|+|||++...    .++.++|||||||++|||++|+.||.....        ....  
T Consensus       187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~--  256 (371)
T cd05622         187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTY--  256 (371)
T ss_pred             CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH--------HHHH--
Confidence            99986543332223345799999999998754    378999999999999999999999964321        1111  


Q ss_pred             hhccCchhHhhhhh--hCCCCCHHHHHHHHHHHHHcCCCCCCC---CCCcCC
Q 045835          464 LQQDGKLVELVDER--LGSKYKKEEAERMIKVSLLCTNASPSL---RPTMSE  510 (511)
Q Consensus       464 ~~~~~~~~~~~d~~--l~~~~~~~~~~~l~~l~~~Cl~~~p~~---RPs~~e  510 (511)
                             ..++...  +........+..+.+++.+|++ +|..   ||++.|
T Consensus       257 -------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~-~~~~r~~r~~~~e  300 (371)
T cd05622         257 -------SKIMNHKNSLTFPDDNDISKEAKNLICAFLT-DREVRLGRNGVEE  300 (371)
T ss_pred             -------HHHHcCCCcccCCCcCCCCHHHHHHHHHHcC-ChhhhcCCCCHHH
Confidence                   1111110  1111112345668889999998 4444   566654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=5.6e-38  Score=312.04  Aligned_cols=259  Identities=26%  Similarity=0.431  Sum_probs=196.5

Q ss_pred             hcCCcccCceeccCceeEEecccc-----------------CCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCcee
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-----------------DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVK  300 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-----------------~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~  300 (511)
                      .++|++.++||+|+||.||++...                 ++..+|+|.++... ......+.+|+.+++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            356899999999999999998532                 23468999987543 334467899999999999999999


Q ss_pred             EEEEEEeCCEEEEEEEecCCCCHhHHHhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCC
Q 045835          301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENC-------ELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATN  373 (511)
Q Consensus       301 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~N  373 (511)
                      +++++...+..++||||+++++|.+++......       ...+++.+...++.|++.||+|||+.+   ++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence            999999999999999999999999998754321       134788999999999999999999986   9999999999


Q ss_pred             eEEcCCCCeEEeecCCcccCCCCCce-eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCcc
Q 045835          374 VLLDRDLNPKISDFGLAKLDEGDKTH-ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS--GKNNMSYAPAL  450 (511)
Q Consensus       374 ILld~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt--G~~p~~~~~~~  450 (511)
                      ||+++++.++|+|||+++........ ......++..|+|||....+.++.++|||||||++|||++  |..|+..... 
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~-  239 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD-  239 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh-
Confidence            99999999999999999854332211 1122334678999999888899999999999999999998  6677653221 


Q ss_pred             cccccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          451 EFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       451 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                          ..............      ........+..++..+.+++.+||+.+|++||++.||
T Consensus       240 ----~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i  290 (296)
T cd05095         240 ----EQVIENTGEFFRDQ------GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEI  290 (296)
T ss_pred             ----HHHHHHHHHHHhhc------cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence                00111000000000      0000011122344678999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4.8e-38  Score=315.70  Aligned_cols=237  Identities=25%  Similarity=0.366  Sum_probs=188.5

Q ss_pred             CceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhc-CCCCCceeEEEEEEeCCEEEEEEEecCC
Q 045835          246 KKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISC-LQHPNLVKIHGCCVEGDQLLLVYEYMEN  320 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~~~~~~lV~Ey~~~  320 (511)
                      +.||+|+||.||+|+.. +|+.||+|.++...   ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999865 58899999997532   2233456778777765 4899999999999999999999999999


Q ss_pred             CCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCcee
Q 045835          321 NSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI  400 (511)
Q Consensus       321 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~  400 (511)
                      |+|..++...    ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....... .
T Consensus        81 g~L~~~i~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  152 (316)
T cd05620          81 GDLMFHIQDK----GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-R  152 (316)
T ss_pred             CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-c
Confidence            9999988653    24889999999999999999999986   99999999999999999999999999874322111 1


Q ss_pred             ecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCC
Q 045835          401 STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGS  480 (511)
Q Consensus       401 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  480 (511)
                      .....||..|+|||++.+..++.++|||||||++|||++|+.||.....     ..+.+             .+... ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-----~~~~~-------------~~~~~-~~  213 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-----DELFE-------------SIRVD-TP  213 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHH-------------HHHhC-CC
Confidence            2345689999999999999999999999999999999999999963221     11111             00000 11


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCcC
Q 045835          481 KYKKEEAERMIKVSLLCTNASPSLRPTMS  509 (511)
Q Consensus       481 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~  509 (511)
                      ..+.....++.+++.+||+.+|++||++.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~dP~~R~~~~  242 (316)
T cd05620         214 HYPRWITKESKDILEKLFERDPTRRLGVV  242 (316)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHHHcCCCh
Confidence            22223455788999999999999999974

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.2e-38  Score=311.73  Aligned_cols=253  Identities=26%  Similarity=0.414  Sum_probs=195.9

Q ss_pred             HhcCCcccCceeccCceeEEecccc------CCcEEEEEEecccCc-cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCE
Q 045835          238 ATNNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSKSR-QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQ  310 (511)
Q Consensus       238 ~~~~f~~~~~lG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~  310 (511)
                      .+++|++.+.||+|+||.||+|...      .+..||+|.+..... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4578999999999999999998643      245799998864432 233468899999999999999999999999999


Q ss_pred             EEEEEEecCCCCHhHHHhcCCC------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEE
Q 045835          311 LLLVYEYMENNSLACALFGREN------CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKI  384 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl  384 (511)
                      .++||||+++|+|.+++.....      ....+++....+++.|++.||+|||+.+   |+||||||+|||+++++.+||
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence            9999999999999999965321      1234677888999999999999999886   999999999999999999999


Q ss_pred             eecCCcccCCCCCce-eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhH
Q 045835          385 SDFGLAKLDEGDKTH-ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWAC  462 (511)
Q Consensus       385 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~  462 (511)
                      +|||+++........ ......++..|+|||.+.++.++.++|||||||+++||++ |+.|+....     .......  
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~-----~~~~~~~--  233 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS-----NEQVLKF--  233 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHH--
Confidence            999999854332211 1122234678999999998899999999999999999999 677775221     0011111  


Q ss_pred             hhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          463 HLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       463 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                                +.+... ...+......+.+++.+|++.+|++|||+.|+
T Consensus       234 ----------~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l  271 (288)
T cd05061         234 ----------VMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEI  271 (288)
T ss_pred             ----------HHcCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence                      111111 11223345679999999999999999999764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.2e-37  Score=308.00  Aligned_cols=247  Identities=26%  Similarity=0.342  Sum_probs=195.8

Q ss_pred             CcccCceeccCceeEEeccc-cCCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          242 FDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       242 f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      |+..+.||+|+||.||++.. .+++.+|+|.+....   ......+.+|+.+++.++|+|++++.+++..++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            66778899999999999975 468899999986542   22234578899999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +++++|.+++....  ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++.......
T Consensus        82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          82 MNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             ccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence            99999998886533  235899999999999999999999986   9999999999999999999999999997543322


Q ss_pred             ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          398 THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                      .  .....|+..|+|||++.+..++.++|+|||||+++||++|+.||.......    ....+..         .+... 
T Consensus       157 ~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~----~~~~~~~---------~~~~~-  220 (285)
T cd05632         157 S--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV----KREEVDR---------RVLET-  220 (285)
T ss_pred             c--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHH---------hhhcc-
Confidence            2  123468999999999998899999999999999999999999986432100    0000000         00000 


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSE  510 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e  510 (511)
                       ...++......+.+++.+|++.+|++||++.|
T Consensus       221 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~  252 (285)
T cd05632         221 -EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQE  252 (285)
T ss_pred             -ccccCccCCHHHHHHHHHHccCCHhHcCCCcc
Confidence             11223344556889999999999999999653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.2e-37  Score=311.56  Aligned_cols=258  Identities=23%  Similarity=0.334  Sum_probs=198.3

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      ++|++.+.||+|+||.||++... ++..+|+|.+.... ......+.+|++++++++||||++++++|.+++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46889999999999999999754 57889999887542 23345688999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +++++|.+++...    ..+++.....++.|++.||.|||+..  +++||||||+|||++.++.+||+|||++.......
T Consensus        81 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (308)
T cd06615          81 MDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  154 (308)
T ss_pred             cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence            9999999999654    34889999999999999999999742  49999999999999999999999999987543221


Q ss_pred             ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhh------------
Q 045835          398 THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQ------------  465 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~------------  465 (511)
                         .....++..|+|||.+.+..++.++||||||++++||++|+.|+......     .+..+.....            
T Consensus       155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~  226 (308)
T cd06615         155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK-----ELEAMFGRPVSEGEAKESHRPV  226 (308)
T ss_pred             ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh-----hHHHhhcCccccccccCCcccc
Confidence               22346889999999998888999999999999999999999998532210     0100000000            


Q ss_pred             --------ccCchhHhhhhhhCC---CCC-HHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          466 --------QDGKLVELVDERLGS---KYK-KEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       466 --------~~~~~~~~~d~~l~~---~~~-~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                              ......++.+.....   ..+ ......+.+++.+||+.+|++|||+.||
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~l  284 (308)
T cd06615         227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKEL  284 (308)
T ss_pred             cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHH
Confidence                    000011111111111   111 1234568999999999999999999875

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=5.6e-38  Score=315.52  Aligned_cols=236  Identities=26%  Similarity=0.420  Sum_probs=190.0

Q ss_pred             CceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEEEEEEEecCC
Q 045835          246 KKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQLLLVYEYMEN  320 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~  320 (511)
                      +.||+|+||.||+++.. +++.||||+++...   ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999765 57899999997532   23345677888888877 799999999999999999999999999


Q ss_pred             CCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCcee
Q 045835          321 NSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI  400 (511)
Q Consensus       321 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~  400 (511)
                      |+|..++....    .+++.....++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++....... .
T Consensus        81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~  152 (318)
T cd05570          81 GDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-T  152 (318)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-c
Confidence            99998886432    5899999999999999999999986   99999999999999999999999999974322221 1


Q ss_pred             ecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCC
Q 045835          401 STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGS  480 (511)
Q Consensus       401 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  480 (511)
                      .....|+..|+|||++.+..++.++|||||||++|||++|+.||.....     ..+..            .+...  ..
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-----~~~~~------------~i~~~--~~  213 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-----DELFQ------------SILED--EV  213 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-----HHHHH------------HHHcC--CC
Confidence            2234689999999999999999999999999999999999999863221     11111            01111  11


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCc
Q 045835          481 KYKKEEAERMIKVSLLCTNASPSLRPTM  508 (511)
Q Consensus       481 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  508 (511)
                      .++......+.+++.+||+.+|++|||+
T Consensus       214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~  241 (318)
T cd05570         214 RYPRWLSKEAKSILKSFLTKNPEKRLGC  241 (318)
T ss_pred             CCCCcCCHHHHHHHHHHccCCHHHcCCC
Confidence            2233445678999999999999999998

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=5.7e-38  Score=305.85  Aligned_cols=248  Identities=29%  Similarity=0.462  Sum_probs=198.3

Q ss_pred             hcCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      .++|+..++||+|+||.||++...++..+|+|.+.... ...+.+.+|+.++++++|+|++++.+++.+ ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            35788899999999999999987777889999887532 234678999999999999999999999887 7789999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      ++++|.+++....  ...+++..+..++.+++.||+|||+.+   ++|+||||+||+++.++.+||+|||++........
T Consensus        83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  157 (260)
T cd05073          83 AKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  157 (260)
T ss_pred             CCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence            9999999996543  235889999999999999999999886   99999999999999999999999999976543322


Q ss_pred             eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          399 HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                      .......++..|+|||++..+.++.++|+|||||+++|+++ |+.||....     ...+..+.             ...
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~-----~~~~~~~~-------------~~~  219 (260)
T cd05073         158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-----NPEVIRAL-------------ERG  219 (260)
T ss_pred             ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHH-------------hCC
Confidence            22222345678999999998889999999999999999999 898886321     11111111             111


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....+...+..+.+++.+|++.+|++||++.+|
T Consensus       220 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l  253 (260)
T cd05073         220 YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYI  253 (260)
T ss_pred             CCCCCcccCCHHHHHHHHHHcccCcccCcCHHHH
Confidence            1112223445678999999999999999998764

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=6.1e-38  Score=306.90  Aligned_cols=248  Identities=28%  Similarity=0.438  Sum_probs=196.6

Q ss_pred             cCCcccCceeccCceeEEecccc----CCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA----DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~----~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  314 (511)
                      .+|++.+.||+|+||.||+|...    .+..+|+|.++... ......+.+|+.++++++||||+++++++.+++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            56888999999999999999753    23479999987543 23345789999999999999999999999999999999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      |||+++++|.+++....   ..+++.+...++.|++.||+|||+.+   ++||||||+|||++.++.++|+|||+++...
T Consensus        84 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          84 TEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            99999999999996542   35899999999999999999999986   9999999999999999999999999998654


Q ss_pred             CCCceeec--ccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchh
Q 045835          395 GDKTHIST--RIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLV  471 (511)
Q Consensus       395 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  471 (511)
                      ........  ...++..|+|||++.+..++.++||||||++++|+++ |+.||.....     ........         
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~-----~~~~~~~~---------  223 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-----QDVIKAIE---------  223 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH-----HHHHHHHh---------
Confidence            43322221  1223567999999998899999999999999999887 9998863221     11111110         


Q ss_pred             HhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       472 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                         + ......+...+..+.+++.+|++.+|.+||+|.+|
T Consensus       224 ---~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i  259 (267)
T cd05066         224 ---E-GYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQI  259 (267)
T ss_pred             ---C-CCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHH
Confidence               0 01111222345678999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=8.4e-38  Score=314.92  Aligned_cols=242  Identities=24%  Similarity=0.385  Sum_probs=193.4

Q ss_pred             CCcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcCC-CCCceeEEEEEEeCCEEEEEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQ-HPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~  315 (511)
                      +|+..+.||+|+||.||++... +++.||+|++....   ....+.+..|..++..+. |++|+++.+++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4677899999999999999754 68899999987532   233456778888888885 577888999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++|+|.+++....    .+++.....++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++....
T Consensus        81 Ey~~~g~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~  153 (323)
T cd05615          81 EYVNGGDLMYHIQQVG----KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV  153 (323)
T ss_pred             cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence            9999999999886432    4899999999999999999999986   99999999999999999999999999975332


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      ... ......||..|+|||++.+..++.++|||||||++|||++|+.||.....     ..+.            ..+..
T Consensus       154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-----~~~~------------~~i~~  215 (323)
T cd05615         154 DGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-----DELF------------QSIME  215 (323)
T ss_pred             CCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-----HHHH------------HHHHh
Confidence            221 12335689999999999988999999999999999999999999864321     0011            11111


Q ss_pred             hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcC
Q 045835          476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMS  509 (511)
Q Consensus       476 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~  509 (511)
                      ..  ..++...+..+.+++.+||+.+|.+|++..
T Consensus       216 ~~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~~  247 (323)
T cd05615         216 HN--VSYPKSLSKEAVSICKGLMTKHPSKRLGCG  247 (323)
T ss_pred             CC--CCCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence            11  123334456788999999999999999853

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.9e-38  Score=327.04  Aligned_cols=199  Identities=24%  Similarity=0.346  Sum_probs=170.6

Q ss_pred             CCcccCceeccCceeEEeccc-cCCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      +|+..++||+|+||.||+|+. .+++.+|+|++....   ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            588899999999999999975 468899999987532   2334568899999999999999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      |+++|+|.+++....    .+++.....++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~  154 (382)
T cd05625          82 YIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (382)
T ss_pred             CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence            999999999986542    4788888999999999999999986   999999999999999999999999997532100


Q ss_pred             C----------------------------------------------ceeecccccCCCcccccccccCCCCcchhHHHH
Q 045835          397 K----------------------------------------------THISTRIAGTIGYMAPEYALWGYLTYKADVYSF  430 (511)
Q Consensus       397 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~  430 (511)
                      .                                              ........||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (382)
T cd05625         155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  234 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence            0                                              001123468999999999999899999999999


Q ss_pred             HHHHHHHHhCCCCCCC
Q 045835          431 GIVALEIVSGKNNMSY  446 (511)
Q Consensus       431 Gvvl~elltG~~p~~~  446 (511)
                      ||++|||++|+.||..
T Consensus       235 Gvil~elltG~~Pf~~  250 (382)
T cd05625         235 GVILYEMLVGQPPFLA  250 (382)
T ss_pred             hHHHHHHHhCCCCCCC
Confidence            9999999999999964

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5.2e-38  Score=313.48  Aligned_cols=252  Identities=26%  Similarity=0.416  Sum_probs=198.1

Q ss_pred             hcCCcccCceeccCceeEEeccc--------cCCcEEEEEEecccC-ccchHHHHHHHHHHhcC-CCCCceeEEEEEEeC
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL--------ADGTIIAVKQLSSKS-RQGNREFLNEIAMISCL-QHPNLVKIHGCCVEG  308 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~--------~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~  308 (511)
                      .++|.+.+.||+|+||.||+++.        .++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            45688889999999999999863        134579999987542 33456789999999999 899999999999999


Q ss_pred             CEEEEEEEecCCCCHhHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEE
Q 045835          309 DQLLLVYEYMENNSLACALFGREN------------CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL  376 (511)
Q Consensus       309 ~~~~lV~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILl  376 (511)
                      ...++||||+++|+|.+++.....            ....++|.++..++.|++.||+|||+.+   ++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence            999999999999999999975421            1235789999999999999999999986   9999999999999


Q ss_pred             cCCCCeEEeecCCcccCCCCCcee-ecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccc
Q 045835          377 DRDLNPKISDFGLAKLDEGDKTHI-STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDC  454 (511)
Q Consensus       377 d~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~  454 (511)
                      ++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+....      
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------  244 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------  244 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC------
Confidence            999999999999998654322221 122345678999999988889999999999999999998 777765321      


Q ss_pred             cchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          455 TCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       455 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                        ..++..          .+........+...+..+.+++.+||+.+|++|||+.||
T Consensus       245 --~~~~~~----------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~  289 (304)
T cd05101         245 --VEELFK----------LLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQL  289 (304)
T ss_pred             --HHHHHH----------HHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHH
Confidence              111111          111111112233456678999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=5.7e-38  Score=304.93  Aligned_cols=243  Identities=28%  Similarity=0.425  Sum_probs=193.9

Q ss_pred             CceeccCceeEEeccccC--C--cEEEEEEecccCc-cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCC
Q 045835          246 KKIGEGGFGPVYKGQLAD--G--TIIAVKQLSSKSR-QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMEN  320 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~~--g--~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~  320 (511)
                      ++||+|++|.||+|...+  +  ..||+|.+..... ...+.+.+|+.++++++||||+++++++.+ ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999997643  3  3689999987655 556789999999999999999999999988 889999999999


Q ss_pred             CCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCce-
Q 045835          321 NSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH-  399 (511)
Q Consensus       321 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~-  399 (511)
                      ++|.+++.....  ..++|.....++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++........ 
T Consensus        80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            999999976432  45899999999999999999999986   999999999999999999999999999865432211 


Q ss_pred             -eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          400 -ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       400 -~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                       ......++..|+|||++....++.++|||||||+++||++ |+.|+.....     ......   ...         ..
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~~---~~~---------~~  217 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG-----SQILKK---IDK---------EG  217 (257)
T ss_pred             ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHH---HHh---------cC
Confidence             1123456789999999998899999999999999999999 9999853211     001111   000         00


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....+...+..+.+++.+|++.+|++|||+.||
T Consensus       218 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~  251 (257)
T cd05040         218 ERLERPEACPQDIYNVMLQCWAHNPADRPTFAAL  251 (257)
T ss_pred             CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHH
Confidence            1111222345678999999999999999999874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.6e-38  Score=304.35  Aligned_cols=240  Identities=30%  Similarity=0.471  Sum_probs=190.0

Q ss_pred             CceeccCceeEEecccc--C--CcEEEEEEecccCc-cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCC
Q 045835          246 KKIGEGGFGPVYKGQLA--D--GTIIAVKQLSSKSR-QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMEN  320 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~--~--g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~  320 (511)
                      ++||+|+||.||+|...  +  +..+|+|.+..... ....++.+|+.+++.++|+|++++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            47999999999999643  2  26899999875543 24567899999999999999999999876 4568999999999


Q ss_pred             CCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCcee
Q 045835          321 NSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI  400 (511)
Q Consensus       321 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~  400 (511)
                      |+|.+++....    .+++..+..++.|++.||+|||+.+   ++|+||||+|||++.++.+||+|||+++.........
T Consensus        80 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          80 GPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             CcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            99999997543    5899999999999999999999886   9999999999999999999999999998654333221


Q ss_pred             ec--ccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          401 ST--RIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       401 ~~--~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                      ..  ...++..|+|||.+....++.++||||||+++|||++ |+.||....     ...+..+.             ...
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~-----~~~~~~~~-------------~~~  214 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK-----GAEVIAML-------------ESG  214 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC-----HHHHHHHH-------------HcC
Confidence            11  1223467999999998899999999999999999998 999986322     11111211             111


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....+...+..+.+++.+||+.+|++||++.+|
T Consensus       215 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l  248 (257)
T cd05060         215 ERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSEL  248 (257)
T ss_pred             CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence            1112333445678999999999999999999874

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.8e-38  Score=302.89  Aligned_cols=262  Identities=24%  Similarity=0.325  Sum_probs=197.2

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCc--cchHHHHHHHHHHhcCCCCC-ceeEEEEEEeCC-----
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSR--QGNREFLNEIAMISCLQHPN-LVKIHGCCVEGD-----  309 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~-----  309 (511)
                      ...|+..++||+|+||.||+|+. .+|+.||+|+++....  .......+|+.+|+.++|+| ||+|.+++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            34566778899999999999974 4789999999986544  23456789999999999999 999999999877     


Q ss_pred             -EEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecC
Q 045835          310 -QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFG  388 (511)
Q Consensus       310 -~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfG  388 (511)
                       .+++|+||++. +|..++.........++...+..++.||++||+|||+++   |+||||||.||||++++.+||+|||
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence             88999999976 899988665432234666889999999999999999997   9999999999999999999999999


Q ss_pred             CcccCCCCCceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhcc
Q 045835          389 LAKLDEGDKTHISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD  467 (511)
Q Consensus       389 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~  467 (511)
                      +|+...-.... .++.++|..|.|||++.+. .|+...||||+||++.||+++++-|......     +...-+......
T Consensus       166 lAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~-----~ql~~If~~lGt  239 (323)
T KOG0594|consen  166 LARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI-----DQLFRIFRLLGT  239 (323)
T ss_pred             hHHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH-----HHHHHHHHHcCC
Confidence            99965432222 3456789999999999887 8999999999999999999999888644321     111111111100


Q ss_pred             C------chhHhhhhh--hCC-----CCCH---HHHHHHHHHHHHcCCCCCCCCCCcCC
Q 045835          468 G------KLVELVDER--LGS-----KYKK---EEAERMIKVSLLCTNASPSLRPTMSE  510 (511)
Q Consensus       468 ~------~~~~~~d~~--l~~-----~~~~---~~~~~l~~l~~~Cl~~~p~~RPs~~e  510 (511)
                      .      .+..+.+-.  ...     ....   .......+++.+||+.+|.+|.|+..
T Consensus       240 P~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~  298 (323)
T KOG0594|consen  240 PNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKG  298 (323)
T ss_pred             CCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHH
Confidence            0      000000100  000     0001   11146789999999999999999754

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.3e-39  Score=319.77  Aligned_cols=245  Identities=25%  Similarity=0.390  Sum_probs=208.8

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCE-EEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQ-LLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-~~lV~  315 (511)
                      ++|..++++|+|+||.++..+.+ +++.+++|.+....  ....+...+|+.++++++|||||...+.+.+++. .++||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57888999999999999999754 57789999987542  3334477899999999999999999999999888 89999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      +|++||++.+.+...+  ..-+++++...++.|++.|+.|||+..   |.|||||+.||++..+..+||+|||+|+.+..
T Consensus        84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            9999999999997654  356899999999999999999999775   99999999999999999999999999998776


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      .... .....||+.||.||.+.+.+|..|+|||||||++|||++-+++|....                     +..++.
T Consensus       159 ~~~~-a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~---------------------m~~Li~  216 (426)
T KOG0589|consen  159 EDSL-ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN---------------------MSELIL  216 (426)
T ss_pred             chhh-hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc---------------------hHHHHH
Confidence            5422 344789999999999999999999999999999999999999986322                     222222


Q ss_pred             hhh---CCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          476 ERL---GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       476 ~~l---~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...   ....+...+.++..++..|++.+|..||++.++
T Consensus       217 ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~L  255 (426)
T KOG0589|consen  217 KINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALEL  255 (426)
T ss_pred             HHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHH
Confidence            222   234566778899999999999999999998764

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.1e-37  Score=314.74  Aligned_cols=244  Identities=23%  Similarity=0.341  Sum_probs=191.9

Q ss_pred             CceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEEEEEEEecCC
Q 045835          246 KKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQLLLVYEYMEN  320 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~  320 (511)
                      +.||+|+||.||+++.. +++.||+|+++...   ......+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999754 57899999997542   23345678899999888 699999999999999999999999999


Q ss_pred             CCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCcee
Q 045835          321 NSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI  400 (511)
Q Consensus       321 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~  400 (511)
                      |+|..++....    .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....... .
T Consensus        81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~  152 (327)
T cd05617          81 GDLMFHMQRQR----KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-T  152 (327)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-c
Confidence            99998885432    4899999999999999999999986   99999999999999999999999999974322111 1


Q ss_pred             ecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCC
Q 045835          401 STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGS  480 (511)
Q Consensus       401 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  480 (511)
                      .....||..|+|||++.+..++.++|||||||++|||++|+.||.......  .....++.....        ...  ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~--~~~~~~~~~~~~--------~~~--~~  220 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNP--DMNTEDYLFQVI--------LEK--PI  220 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCc--ccccHHHHHHHH--------HhC--CC
Confidence            233568999999999999999999999999999999999999996422110  011111111111        111  11


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCcC
Q 045835          481 KYKKEEAERMIKVSLLCTNASPSLRPTMS  509 (511)
Q Consensus       481 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~  509 (511)
                      ..+...+..+.+++.+||+.+|++||++.
T Consensus       221 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         221 RIPRFLSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence            23334456788999999999999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=5.3e-38  Score=310.81  Aligned_cols=252  Identities=29%  Similarity=0.476  Sum_probs=197.9

Q ss_pred             hcCCcccCceeccCceeEEecccc------CCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQL  311 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~  311 (511)
                      .++|+..+.||+|+||.||++...      ++..||+|.+.... .....++.+|+.++++++|||+++++++|.+++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467999999999999999999753      46789999987543 33446789999999999999999999999999999


Q ss_pred             EEEEEecCCCCHhHHHhcCC------------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCC
Q 045835          312 LLVYEYMENNSLACALFGRE------------------NCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATN  373 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~------------------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~N  373 (511)
                      ++|+||+++|+|.+++....                  .....+++..++.++.|++.||+|||+.+   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            99999999999999996431                  11235788999999999999999999986   9999999999


Q ss_pred             eEEcCCCCeEEeecCCcccCCCCCc-eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCccc
Q 045835          374 VLLDRDLNPKISDFGLAKLDEGDKT-HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALE  451 (511)
Q Consensus       374 ILld~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~  451 (511)
                      |++++++.+||+|||+++....... ........+..|+|||.+.+..++.++|||||||++|||++ |..|+....   
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~---  237 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA---  237 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC---
Confidence            9999999999999999875432211 11122334667999999998899999999999999999998 877774221   


Q ss_pred             ccccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          452 FDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       452 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                           ..++.... ..++        . ...+...+.++.+++.+||+.+|++|||+.||
T Consensus       238 -----~~~~~~~~-~~~~--------~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el  282 (288)
T cd05050         238 -----HEEVIYYV-RDGN--------V-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASI  282 (288)
T ss_pred             -----HHHHHHHH-hcCC--------C-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence                 01111111 1111        1 11223345679999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1e-37  Score=302.93  Aligned_cols=245  Identities=35%  Similarity=0.529  Sum_probs=198.2

Q ss_pred             CceeccCceeEEeccccC----CcEEEEEEecccCcc-chHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCC
Q 045835          246 KKIGEGGFGPVYKGQLAD----GTIIAVKQLSSKSRQ-GNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMEN  320 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~~----g~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~  320 (511)
                      +.||+|+||.||++....    +..|++|.++..... ....+.+|+..++.++|+|++++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            479999999999998653    788999999865443 357889999999999999999999999999999999999999


Q ss_pred             CCHhHHHhcCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          321 NSLACALFGRENC-----ELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       321 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ++|.+++......     ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999765211     246899999999999999999999986   99999999999999999999999999986544


Q ss_pred             CCc-eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHh
Q 045835          396 DKT-HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVEL  473 (511)
Q Consensus       396 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  473 (511)
                      ... .......++..|+|||.+....++.++||||+|++++||++ |+.|+.....     ..+.+.             
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~-------------  219 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-----EEVLEY-------------  219 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH-------------
Confidence            321 12233457889999999988899999999999999999999 5888864321     111111             


Q ss_pred             hhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          474 VDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       474 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +........+...+.++.+++.+||+.+|++|||+.|+
T Consensus       220 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l  257 (262)
T cd00192         220 LRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSEL  257 (262)
T ss_pred             HHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHH
Confidence            11111122334446789999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=4.6e-38  Score=317.10  Aligned_cols=237  Identities=25%  Similarity=0.340  Sum_probs=187.7

Q ss_pred             CceeccCceeEEeccc-cCCcEEEEEEecccC---ccchHHHHHHHH-HHhcCCCCCceeEEEEEEeCCEEEEEEEecCC
Q 045835          246 KKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS---RQGNREFLNEIA-MISCLQHPNLVKIHGCCVEGDQLLLVYEYMEN  320 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~  320 (511)
                      +.||+|+||.||+++. .+|+.+|+|++....   ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999975 468999999986532   223345556655 56789999999999999999999999999999


Q ss_pred             CCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCcee
Q 045835          321 NSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI  400 (511)
Q Consensus       321 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~  400 (511)
                      |+|..++...    ..+++.....++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++....... .
T Consensus        81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~  152 (325)
T cd05604          81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-T  152 (325)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-C
Confidence            9999888543    25889999999999999999999987   99999999999999999999999999975322111 1


Q ss_pred             ecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCC
Q 045835          401 STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGS  480 (511)
Q Consensus       401 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  480 (511)
                      .....||..|+|||.+.+..++.++|||||||++|||++|+.||.....        .+...         .+....+  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--------~~~~~---------~~~~~~~--  213 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV--------AEMYD---------NILHKPL--  213 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH--------HHHHH---------HHHcCCc--
Confidence            2345689999999999999999999999999999999999999863221        01100         1111111  


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCcC
Q 045835          481 KYKKEEAERMIKVSLLCTNASPSLRPTMS  509 (511)
Q Consensus       481 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~  509 (511)
                      ..++.....+.+++.+|++.+|.+||++.
T Consensus       214 ~~~~~~~~~~~~ll~~ll~~~p~~R~~~~  242 (325)
T cd05604         214 VLRPGASLTAWSILEELLEKDRQRRLGAK  242 (325)
T ss_pred             cCCCCCCHHHHHHHHHHhccCHHhcCCCC
Confidence            11223455688999999999999999986

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-38  Score=326.51  Aligned_cols=200  Identities=25%  Similarity=0.352  Sum_probs=171.0

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|.+.++||+|+||.||++.. .+++.||||++....   ......+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            4688899999999999999974 468899999986432   233456788999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++|+|.+++....    .+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 E~~~gg~L~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~  153 (377)
T cd05629          81 EFLPGGDLMTMLIKYD----TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK  153 (377)
T ss_pred             eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence            9999999999986532    4888899999999999999999987   99999999999999999999999999963211


Q ss_pred             CCc------------e----------------------------------eecccccCCCcccccccccCCCCcchhHHH
Q 045835          396 DKT------------H----------------------------------ISTRIAGTIGYMAPEYALWGYLTYKADVYS  429 (511)
Q Consensus       396 ~~~------------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S  429 (511)
                      ...            .                                  ......||+.|+|||++.+..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  233 (377)
T cd05629         154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS  233 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence            000            0                                  001246899999999999989999999999


Q ss_pred             HHHHHHHHHhCCCCCCC
Q 045835          430 FGIVALEIVSGKNNMSY  446 (511)
Q Consensus       430 ~Gvvl~elltG~~p~~~  446 (511)
                      |||++|||++|+.||..
T Consensus       234 lGvil~elltG~~Pf~~  250 (377)
T cd05629         234 LGAIMFECLIGWPPFCS  250 (377)
T ss_pred             cchhhhhhhcCCCCCCC
Confidence            99999999999999964

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.1e-37  Score=304.47  Aligned_cols=235  Identities=23%  Similarity=0.354  Sum_probs=184.3

Q ss_pred             CceeccCceeEEeccccC-------------CcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEE
Q 045835          246 KKIGEGGFGPVYKGQLAD-------------GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLL  312 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~~-------------g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  312 (511)
                      +.||+|+||.||+|+..+             ...|++|.+..........|.+|+.+++.++||||++++++|......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999997532             2258999887665555567889999999999999999999999999999


Q ss_pred             EEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCC-------eEEe
Q 045835          313 LVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN-------PKIS  385 (511)
Q Consensus       313 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~-------~kl~  385 (511)
                      +||||+++|+|..++....   ..+++..+.+++.||+.||+|||+.+   |+||||||+|||++.++.       +|++
T Consensus        81 lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~  154 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLS  154 (262)
T ss_pred             EEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeC
Confidence            9999999999998886432   35899999999999999999999986   999999999999987664       8999


Q ss_pred             ecCCcccCCCCCceeecccccCCCcccccccc-cCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCcccccccchhhhhHh
Q 045835          386 DFGLAKLDEGDKTHISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIV-SGKNNMSYAPALEFDCTCLLDWACH  463 (511)
Q Consensus       386 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DV~S~Gvvl~ell-tG~~p~~~~~~~~~~~~~l~~~~~~  463 (511)
                      |||++.......     ...++..|+|||++. ...++.++|||||||++|||+ +|+.|+.....        .+.   
T Consensus       155 d~g~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~---  218 (262)
T cd05077         155 DPGIPITVLSRQ-----ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL--------AEK---  218 (262)
T ss_pred             CCCCCccccCcc-----cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch--------hHH---
Confidence            999987543221     235778899999887 467899999999999999998 57777653210        000   


Q ss_pred             hhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          464 LQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       464 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                             .........  ........+.+++.+||+.+|.+||++.||
T Consensus       219 -------~~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~i  257 (262)
T cd05077         219 -------ERFYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAI  257 (262)
T ss_pred             -------HHHHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHH
Confidence                   000011010  111123568899999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4.1e-38  Score=314.26  Aligned_cols=250  Identities=26%  Similarity=0.423  Sum_probs=193.9

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCc--EEEEEEeccc-CccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGT--IIAVKQLSSK-SRQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~--~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l  313 (511)
                      .++|++.+.||+|+||.||+|... ++.  .+|+|.++.. .......+.+|+.++.++ +||||+++++++.+++..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            357888999999999999999754 444  4678777643 233456788999999999 89999999999999999999


Q ss_pred             EEEecCCCCHhHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCC
Q 045835          314 VYEYMENNSLACALFGREN------------CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN  381 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~  381 (511)
                      |+||+++++|.+++.....            ....+++.+++.++.|++.||+|||+.+   ++||||||+|||+++++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence            9999999999999965421            1235789999999999999999999886   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhh
Q 045835          382 PKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDW  460 (511)
Q Consensus       382 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~  460 (511)
                      +||+|||+++......  ......++..|+|||++....++.++|||||||+++||+| |..||.....     ..... 
T Consensus       163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~~~~~-  234 (303)
T cd05088         163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----AELYE-  234 (303)
T ss_pred             EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh-----HHHHH-
Confidence            9999999996422111  1111224567999999988889999999999999999998 9998853221     00111 


Q ss_pred             hHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          461 ACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       461 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                                  .+........+......+.+++.+||+.+|++||++.++
T Consensus       235 ------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i  273 (303)
T cd05088         235 ------------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI  273 (303)
T ss_pred             ------------HHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence                        111111111222344578999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1e-37  Score=302.61  Aligned_cols=247  Identities=26%  Similarity=0.392  Sum_probs=200.6

Q ss_pred             cCCcccCceeccCceeEEeccccC-CcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~-g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      ++|+..+.||+|+||.||+|...+ +..+++|.+.....  .+++.+|++++++++|||++++++++.+....++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            578899999999999999998764 78999999875433  578999999999999999999999999999999999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      ++++|.+++....   ..+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (256)
T cd06612          81 GAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA  154 (256)
T ss_pred             CCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence            9999999985432   35899999999999999999999986   99999999999999999999999999986543321


Q ss_pred             eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhh
Q 045835          399 HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERL  478 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  478 (511)
                       ......++..|+|||++.+..++.++||||||++++||++|+.|+.......       ...  ....       ....
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~-------~~~--~~~~-------~~~~  217 (256)
T cd06612         155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR-------AIF--MIPN-------KPPP  217 (256)
T ss_pred             -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh-------hhh--hhcc-------CCCC
Confidence             1223457889999999988899999999999999999999999986432110       000  0000       0000


Q ss_pred             CCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          479 GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       479 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ....+......+.+++.+||+.+|++|||+.||
T Consensus       218 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~i  250 (256)
T cd06612         218 TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQL  250 (256)
T ss_pred             CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHH
Confidence            111223344678999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=5.5e-38  Score=307.45  Aligned_cols=247  Identities=27%  Similarity=0.467  Sum_probs=195.0

Q ss_pred             CCcccCceeccCceeEEeccccC-C---cEEEEEEeccc-CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLAD-G---TIIAVKQLSSK-SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~~-g---~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      .|++.+.||+|+||.||+|.... +   ..||||.+... ......+|..|+.++++++||||+++.+++.++...++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            46788999999999999997642 3   36999998754 3334568999999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++++|.+++....   ..+++.+++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++....
T Consensus        85 e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          85 EFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             ecCCCCcHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence            9999999999986532   35899999999999999999999986   99999999999999999999999999975543


Q ss_pred             CCcee--ecccc--cCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCch
Q 045835          396 DKTHI--STRIA--GTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKL  470 (511)
Q Consensus       396 ~~~~~--~~~~~--gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  470 (511)
                      .....  .....  .+..|+|||++....++.++|||||||+++||++ |+.||....     ......++.        
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~-----~~~~~~~i~--------  225 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-----NQDVINAIE--------  225 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC-----HHHHHHHHH--------
Confidence            22111  11111  2457999999998999999999999999999986 998885321     111112211        


Q ss_pred             hHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          471 VELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       471 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                           .......+.+.+..+.+++.+||+.+|++||++.+|
T Consensus       226 -----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i  261 (269)
T cd05065         226 -----QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQI  261 (269)
T ss_pred             -----cCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence                 111112233445678999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-37  Score=301.37  Aligned_cols=242  Identities=31%  Similarity=0.485  Sum_probs=194.8

Q ss_pred             CceeccCceeEEeccccCCcEEEEEEecccCcc-chHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCCCCHh
Q 045835          246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQ-GNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLA  324 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~  324 (511)
                      ++||+|+||.||++...+++.||+|.+...... ....+.+|+.++++++|+||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            479999999999998777899999998765433 4567899999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCceee-cc
Q 045835          325 CALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS-TR  403 (511)
Q Consensus       325 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~~-~~  403 (511)
                      +++....   ..+++.....++.+++.||+|||+.+   ++||||||+||+++.++.+||+|||+++.......... ..
T Consensus        81 ~~l~~~~---~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (251)
T cd05041          81 TFLRKKK---NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL  154 (251)
T ss_pred             HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence            9986532   25789999999999999999999886   99999999999999999999999999986543222211 11


Q ss_pred             cccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCCCC
Q 045835          404 IAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKY  482 (511)
Q Consensus       404 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  482 (511)
                      ...+..|+|||.+.++.++.++||||||++++||+| |..|+.....     .             ...+.+........
T Consensus       155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~-----~-------------~~~~~~~~~~~~~~  216 (251)
T cd05041         155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN-----Q-------------QTRERIESGYRMPA  216 (251)
T ss_pred             CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH-----H-------------HHHHHHhcCCCCCC
Confidence            233567999999988899999999999999999999 7887753221     0             01111111112223


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          483 KKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       483 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +...+..+.+++.+|++.+|++|||+.||
T Consensus       217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~el  245 (251)
T cd05041         217 PQLCPEEIYRLMLQCWAYDPENRPSFSEI  245 (251)
T ss_pred             CccCCHHHHHHHHHHhccChhhCcCHHHH
Confidence            34455689999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.9e-38  Score=326.38  Aligned_cols=201  Identities=24%  Similarity=0.349  Sum_probs=171.2

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|++.+.||+|+||.||+++.. +++.||||.+....   ......+.+|+.+++.++|+||+++++.+.+++.+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36889999999999999999754 58899999986432   223456789999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++|+|.+++....    .+++.....++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        81 E~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~  153 (376)
T cd05598          81 DYIPGGDMMSLLIRLG----IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (376)
T ss_pred             eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence            9999999999996542    4788888999999999999999986   99999999999999999999999999752210


Q ss_pred             C------------------------------------------CceeecccccCCCcccccccccCCCCcchhHHHHHHH
Q 045835          396 D------------------------------------------KTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIV  433 (511)
Q Consensus       396 ~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvv  433 (511)
                      .                                          .........||+.|+|||++.+..++.++|||||||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  233 (376)
T cd05598         154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  233 (376)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence            0                                          0000123469999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCC
Q 045835          434 ALEIVSGKNNMSYA  447 (511)
Q Consensus       434 l~elltG~~p~~~~  447 (511)
                      +|||++|+.||...
T Consensus       234 lyell~G~~Pf~~~  247 (376)
T cd05598         234 LYEMLVGQPPFLAD  247 (376)
T ss_pred             eeehhhCCCCCCCC
Confidence            99999999999643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-37  Score=305.75  Aligned_cols=243  Identities=27%  Similarity=0.447  Sum_probs=188.6

Q ss_pred             CceeccCceeEEeccccC-Cc--EEEEEEeccc-CccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEEEEEEEecCC
Q 045835          246 KKIGEGGFGPVYKGQLAD-GT--IIAVKQLSSK-SRQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQLLLVYEYMEN  320 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~~-g~--~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~  320 (511)
                      +.||+|+||.||+|...+ +.  .+++|.++.. .......+.+|+.+++++ +||||++++++|...+..+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            468999999999998653 43  4688888743 234456788999999999 899999999999999999999999999


Q ss_pred             CCHhHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecC
Q 045835          321 NSLACALFGREN------------CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFG  388 (511)
Q Consensus       321 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfG  388 (511)
                      |+|.+++.....            ....+++.++..++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            999999865321            1234789999999999999999999886   9999999999999999999999999


Q ss_pred             CcccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhcc
Q 045835          389 LAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQD  467 (511)
Q Consensus       389 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~  467 (511)
                      ++........  ......+..|+|||++....++.++|||||||+++||++ |+.||....     ..   +.       
T Consensus       158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~-----~~---~~-------  220 (270)
T cd05047         158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----CA---EL-------  220 (270)
T ss_pred             Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC-----HH---HH-------
Confidence            9863221111  111223567999999988899999999999999999997 999885321     00   11       


Q ss_pred             CchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          468 GKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       468 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                         .+.+......+.+......+.+++.+|++.+|.+|||+.|+
T Consensus       221 ---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  261 (270)
T cd05047         221 ---YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI  261 (270)
T ss_pred             ---HHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHH
Confidence               11111111112223344578999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=9.6e-38  Score=307.06  Aligned_cols=234  Identities=23%  Similarity=0.383  Sum_probs=182.8

Q ss_pred             ceeccCceeEEeccccC-------------------------CcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeE
Q 045835          247 KIGEGGFGPVYKGQLAD-------------------------GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKI  301 (511)
Q Consensus       247 ~lG~G~fG~Vy~g~~~~-------------------------g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l  301 (511)
                      +||+|+||.||+|.+..                         ...||+|.+.........+|.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997421                         13589999876555555678899999999999999999


Q ss_pred             EEEEEeCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCC-
Q 045835          302 HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL-  380 (511)
Q Consensus       302 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~-  380 (511)
                      +++|.+....++||||+++|+|..++....   ..+++..+..++.|+++||+|||+.+   |+||||||+|||+++.+ 
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK---GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL  155 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCc
Confidence            999999999999999999999999886432   35889999999999999999999886   99999999999997643 


Q ss_pred             ------CeEEeecCCcccCCCCCceeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHH-hCCCCCCCCCcccc
Q 045835          381 ------NPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIV-SGKNNMSYAPALEF  452 (511)
Q Consensus       381 ------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~ell-tG~~p~~~~~~~~~  452 (511)
                            .+|++|||++.......     ...++..|+|||.+.+ ..++.++|||||||++|||+ +|+.|+.....   
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~~~-----~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---  227 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALSRE-----ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP---  227 (274)
T ss_pred             ccCccceeeecCCcccccccccc-----ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh---
Confidence                  37999999986432211     1246788999998875 56899999999999999995 68888853221   


Q ss_pred             cccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          453 DCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       453 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                        .....             ..+...  ..+......+.+++.+||+.+|++|||+.+|
T Consensus       228 --~~~~~-------------~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i  269 (274)
T cd05076         228 --SEKER-------------FYEKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTI  269 (274)
T ss_pred             --HHHHH-------------HHHhcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHH
Confidence              00111             111111  1111223468899999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.1e-37  Score=302.60  Aligned_cols=247  Identities=20%  Similarity=0.295  Sum_probs=198.8

Q ss_pred             CCcccCceeccCceeEEecccc-CCcEEEEEEeccc-CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK-SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      +|++.+.||+|+||.||++... ++..+|+|.++.. .....+.+.+|+.+++.++|+|++++++++.+++..+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4778899999999999999754 6889999998643 2334567889999999999999999999999999999999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      ++++|.+++....  ...+++.....++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++........
T Consensus        81 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  155 (255)
T cd08219          81 DGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA  155 (255)
T ss_pred             CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence            9999999886432  234788999999999999999999986   99999999999999999999999999976543222


Q ss_pred             eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhh
Q 045835          399 HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERL  478 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  478 (511)
                       ......++..|+|||++.+..++.++||||||+++++|++|+.||....        ......... .         ..
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~--------~~~~~~~~~-~---------~~  216 (255)
T cd08219         156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS--------WKNLILKVC-Q---------GS  216 (255)
T ss_pred             -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC--------HHHHHHHHh-c---------CC
Confidence             1223568889999999988889999999999999999999999986321        111111110 0         01


Q ss_pred             CCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          479 GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       479 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ....+......+.+++.+||+.+|++|||+.||
T Consensus       217 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i  249 (255)
T cd08219         217 YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTI  249 (255)
T ss_pred             CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHH
Confidence            112233445678899999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-38  Score=334.08  Aligned_cols=248  Identities=23%  Similarity=0.292  Sum_probs=203.0

Q ss_pred             cCCcccCceeccCceeEEeccccCC-cEEEEEEecccCccchHHHHHHHHHHhcCC-CCCceeEEEEE-Ee------CCE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLADG-TIIAVKQLSSKSRQGNREFLNEIAMISCLQ-HPNLVKIHGCC-VE------GDQ  310 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~g-~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~-~~------~~~  310 (511)
                      .+.++.+.|.+|||+.||.+....+ ..+|+|++-..+....+.+.+|+++|++|+ |+|||.+++.. ..      .-+
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            3456788999999999999987665 999999998878888889999999999997 99999999932 21      136


Q ss_pred             EEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCc
Q 045835          311 LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA  390 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla  390 (511)
                      .+|.||||++|+|-+++..+..  ..|++..+++|+.++++|+++||.. +++|||||||-+||||+.++..||||||.+
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence            8999999999999999976543  3499999999999999999999998 589999999999999999999999999999


Q ss_pred             ccCCCCC-ce-----eec--ccccCCCccccccc---ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhh
Q 045835          391 KLDEGDK-TH-----IST--RIAGTIGYMAPEYA---LWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLD  459 (511)
Q Consensus       391 ~~~~~~~-~~-----~~~--~~~gt~~y~aPE~~---~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~  459 (511)
                      .-..... ..     +..  ...-|+.|+|||.+   .+..+++|+|||||||+||-|+....||+...           
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg-----------  262 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG-----------  262 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-----------
Confidence            6321111 00     000  12358899999976   46689999999999999999999999997432           


Q ss_pred             hhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          460 WACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       460 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                                ...|++........+.....|.+|+..||+.+|.+||++-+|
T Consensus       263 ----------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv  304 (738)
T KOG1989|consen  263 ----------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQV  304 (738)
T ss_pred             ----------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHH
Confidence                      123444444434446889999999999999999999998654

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.1e-37  Score=302.95  Aligned_cols=242  Identities=30%  Similarity=0.431  Sum_probs=193.8

Q ss_pred             cCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEE-eCCEEEEEEEec
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCV-EGDQLLLVYEYM  318 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~-~~~~~~lV~Ey~  318 (511)
                      ++|.+.+.||+|+||.||++... |..+|+|.++...  ..+.+.+|+.++++++|+|++++++++. +++..++++||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            46888899999999999999764 7789999986432  3457899999999999999999999865 456789999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      ++++|.+++.....  ..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++...... 
T Consensus        83 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  156 (256)
T cd05082          83 AKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  156 (256)
T ss_pred             CCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence            99999999865432  34889999999999999999999986   9999999999999999999999999997543222 


Q ss_pred             eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          399 HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                         ....++..|+|||++....++.++|||||||++|||++ |+.|+....        +.+.....          ...
T Consensus       157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~--------~~~~~~~~----------~~~  215 (256)
T cd05082         157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVPRV----------EKG  215 (256)
T ss_pred             ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHH----------hcC
Confidence               12234668999999998899999999999999999998 888875321        11111111          111


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....+...+..+.+++.+|++.+|++|||+.++
T Consensus       216 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l  249 (256)
T cd05082         216 YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQL  249 (256)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence            1122233445678999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=305.20  Aligned_cols=245  Identities=28%  Similarity=0.410  Sum_probs=199.3

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      ++|+..+.||.|+||.||+|+.. +++.||+|.+.... ......+.+|+.+++.++|+|++++.+++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36788899999999999999754 68899999987543 33446788999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +++++|.+++...     .+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+++......
T Consensus        81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  152 (274)
T cd06609          81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM  152 (274)
T ss_pred             eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence            9999999998543     5899999999999999999999986   9999999999999999999999999998654332


Q ss_pred             ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          398 THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                      .. .....++..|+|||++.+..++.++||||||+++|||+||+.|+......        ...          ..+...
T Consensus       153 ~~-~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--------~~~----------~~~~~~  213 (274)
T cd06609         153 SK-RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--------RVL----------FLIPKN  213 (274)
T ss_pred             cc-cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH--------HHH----------HHhhhc
Confidence            21 22346788999999999888999999999999999999999998632210        010          001111


Q ss_pred             hCCCCCHH-HHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSKYKKE-EAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~~~~~-~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....+.. ....+.+++.+||+.+|++|||+++|
T Consensus       214 ~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~i  248 (274)
T cd06609         214 NPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKEL  248 (274)
T ss_pred             CCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHH
Confidence            11111112 45578899999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-39  Score=334.60  Aligned_cols=245  Identities=31%  Similarity=0.461  Sum_probs=207.1

Q ss_pred             CcccCceeccCceeEEecc-ccCCc----EEEEEEeccc-CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          242 FDSAKKIGEGGFGPVYKGQ-LADGT----IIAVKQLSSK-SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       242 f~~~~~lG~G~fG~Vy~g~-~~~g~----~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      .+..++||+|.||+||+|. .++|+    +||+|++... ..+...++++|+..|.+++|||+++|+|+|.... +.||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            3456899999999999996 44544    6899998754 4556789999999999999999999999998765 88999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      +||+.|+|.++++.++.   .+--+..+.++.|||+||.|||++.   ++||||.++||||.+-..+||+|||++++...
T Consensus       777 q~mP~G~LlDyvr~hr~---~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHRD---NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAP  850 (1177)
T ss_pred             HhcccchHHHHHHHhhc---cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence            99999999999977543   5778899999999999999999885   99999999999999999999999999998766


Q ss_pred             CCceeecc-cccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHh
Q 045835          396 DKTHISTR-IAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVEL  473 (511)
Q Consensus       396 ~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  473 (511)
                      +....... ..-.+.|||-|.+....++.++|||||||.+||++| |..|+...+.                  .++.++
T Consensus       851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~------------------~eI~dl  912 (1177)
T KOG1025|consen  851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA------------------EEIPDL  912 (1177)
T ss_pred             ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH------------------HHhhHH
Confidence            55443332 334678999999999999999999999999999998 8888875431                  234455


Q ss_pred             hhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          474 VDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       474 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +....+...|+.+..++..++.+||..|+..||+++++
T Consensus       913 le~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel  950 (1177)
T KOG1025|consen  913 LEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKEL  950 (1177)
T ss_pred             HhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHH
Confidence            55555566788899999999999999999999998763

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.4e-37  Score=304.54  Aligned_cols=250  Identities=26%  Similarity=0.425  Sum_probs=196.2

Q ss_pred             CCcccCceeccCceeEEeccccC--CcEEEEEEecccC----------ccchHHHHHHHHHHhc-CCCCCceeEEEEEEe
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLAD--GTIIAVKQLSSKS----------RQGNREFLNEIAMISC-LQHPNLVKIHGCCVE  307 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~~--g~~vAvK~~~~~~----------~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~  307 (511)
                      +|+..+.||+|+||.||+|....  ++.+|+|.+....          .....++.+|+.++.+ ++|||++++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788999999999999998654  6789999886332          1223457788888865 799999999999999


Q ss_pred             CCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeec
Q 045835          308 GDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF  387 (511)
Q Consensus       308 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~Df  387 (511)
                      .+..+++|||+++++|.+++.........+++..+++++.|++.||.|||+..  +++|+||+|+||+++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999999988543333446899999999999999999999632  4999999999999999999999999


Q ss_pred             CCcccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhcc
Q 045835          388 GLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD  467 (511)
Q Consensus       388 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~  467 (511)
                      |++.......  ......++..|+|||.+.+..++.++||||||+++|||++|+.|+....        ......     
T Consensus       159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~--------~~~~~~-----  223 (269)
T cd08528         159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN--------MLSLAT-----  223 (269)
T ss_pred             cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC--------HHHHHH-----
Confidence            9998654432  2234568889999999998889999999999999999999999986322        111111     


Q ss_pred             CchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          468 GKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       468 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                          .+.+..............+.+++.+||+.+|++||++.||
T Consensus       224 ----~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~  263 (269)
T cd08528         224 ----KIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQV  263 (269)
T ss_pred             ----HHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHH
Confidence                1111111111111234578899999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.6e-37  Score=303.43  Aligned_cols=247  Identities=26%  Similarity=0.403  Sum_probs=197.8

Q ss_pred             CCcccCceeccCceeEEeccccCCcEEEEEEecccCc------cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSR------QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  314 (511)
                      +|...+.||+|+||.||+|...+++.+|+|.+.....      .....+.+|+.+++.++|+||+++.++|.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            3677899999999999999877889999999864321      2234688999999999999999999999999999999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      +||+++++|.+++....    .+++.....++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  153 (265)
T cd06631          81 MEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLA  153 (265)
T ss_pred             EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence            99999999999996532    4789999999999999999999886   9999999999999999999999999997542


Q ss_pred             CC-----CceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCc
Q 045835          395 GD-----KTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGK  469 (511)
Q Consensus       395 ~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  469 (511)
                      ..     .........++..|+|||++.+..++.++||||||++++||++|+.||......       ...         
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-------~~~---------  217 (265)
T cd06631         154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL-------AAM---------  217 (265)
T ss_pred             hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH-------HHH---------
Confidence            11     111122346888999999999888999999999999999999999998632210       000         


Q ss_pred             hhHhhhh-hhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          470 LVELVDE-RLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       470 ~~~~~d~-~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                       ..+... ......+......+.+++.+||+.+|++||++.||
T Consensus       218 -~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~  259 (265)
T cd06631         218 -FYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQL  259 (265)
T ss_pred             -HHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHH
Confidence             000000 01112233445678999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.7e-38  Score=309.11  Aligned_cols=256  Identities=27%  Similarity=0.412  Sum_probs=196.8

Q ss_pred             cCCcccCceeccCceeEEeccc-----cCCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeC--CEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-----ADGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEG--DQL  311 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-----~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~  311 (511)
                      +.|++.+.||+|+||.||+++.     .++..||+|.++... ......+.+|+.++++++|||++++.+++.+.  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4578899999999999999863     357889999987543 33346789999999999999999999999875  568


Q ss_pred             EEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcc
Q 045835          312 LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK  391 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~  391 (511)
                      ++||||+++++|.+++....   ..++|..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             EEEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccc
Confidence            99999999999999985432   25899999999999999999999986   9999999999999999999999999998


Q ss_pred             cCCCCCc--eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccc-------cccchhhhhH
Q 045835          392 LDEGDKT--HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEF-------DCTCLLDWAC  462 (511)
Q Consensus       392 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~-------~~~~l~~~~~  462 (511)
                      .......  .......++..|+|||++.+..++.++||||||++++||++++.|.........       .......+  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  235 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL--  235 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH--
Confidence            6543222  112234567789999999888899999999999999999998776432110000       00000011  


Q ss_pred             hhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          463 HLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       463 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                              .+.+........+...+..+.+++.+|++.+|++|||+.||
T Consensus       236 --------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i  276 (284)
T cd05079         236 --------VRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNL  276 (284)
T ss_pred             --------HHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHH
Confidence                    11111111122233456789999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.2e-37  Score=314.07  Aligned_cols=238  Identities=24%  Similarity=0.336  Sum_probs=187.1

Q ss_pred             CceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHH-HHHhcCCCCCceeEEEEEEeCCEEEEEEEecCC
Q 045835          246 KKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEI-AMISCLQHPNLVKIHGCCVEGDQLLLVYEYMEN  320 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei-~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~  320 (511)
                      +.||+|+||.||+++.. +++.||+|++....   ......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999754 57889999986432   12223444444 456889999999999999999999999999999


Q ss_pred             CCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCcee
Q 045835          321 NSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI  400 (511)
Q Consensus       321 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~  400 (511)
                      |+|.+++....    .+.+.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....... .
T Consensus        81 ~~L~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~  152 (325)
T cd05602          81 GELFYHLQRER----CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-T  152 (325)
T ss_pred             CcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-C
Confidence            99999986532    4778888899999999999999987   99999999999999999999999999975322211 1


Q ss_pred             ecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCC
Q 045835          401 STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGS  480 (511)
Q Consensus       401 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  480 (511)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....        .+..         ..+....  .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~---------~~i~~~~--~  213 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--------AEMY---------DNILNKP--L  213 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH--------HHHH---------HHHHhCC--c
Confidence            2345689999999999999999999999999999999999999963221        0110         0111111  1


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCcCC
Q 045835          481 KYKKEEAERMIKVSLLCTNASPSLRPTMSE  510 (511)
Q Consensus       481 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e  510 (511)
                      ..++.....+.+++.+|++.+|.+||++.+
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~  243 (325)
T cd05602         214 QLKPNITNSARHLLEGLLQKDRTKRLGAKD  243 (325)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence            122334567889999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.1e-37  Score=305.49  Aligned_cols=247  Identities=26%  Similarity=0.378  Sum_probs=195.3

Q ss_pred             cCCcccCceeccCceeEEeccccC----CcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLAD----GTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~----g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  314 (511)
                      ++|.+.+.||+|+||.||+|...+    ...||||...... ....+.+.+|+.++++++|||+++++++|.+ +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            457888999999999999997543    2468999887654 3445678999999999999999999999875 457899


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      |||+++++|.+++....   ..+++..+..++.+++.||+|||+.+   ++||||||+||+++.++.+||+|||+++...
T Consensus        85 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          85 MELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             EEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence            99999999999996532   35899999999999999999999886   9999999999999999999999999998655


Q ss_pred             CCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHh
Q 045835          395 GDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVEL  473 (511)
Q Consensus       395 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  473 (511)
                      ...........++..|+|||.+....++.++||||||++++||++ |+.||.....     .....+..    .      
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-----~~~~~~~~----~------  223 (270)
T cd05056         159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN-----NDVIGRIE----N------  223 (270)
T ss_pred             cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHH----c------
Confidence            443222222334568999999988889999999999999999986 9999863321     11111110    0      


Q ss_pred             hhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          474 VDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       474 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                         ......+...+..+.+++.+|+..+|++|||+.|+
T Consensus       224 ---~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~  258 (270)
T cd05056         224 ---GERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTEL  258 (270)
T ss_pred             ---CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence               00112233445679999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.3e-37  Score=312.24  Aligned_cols=252  Identities=27%  Similarity=0.423  Sum_probs=196.1

Q ss_pred             hcCCcccCceeccCceeEEecccc--------CCcEEEEEEecccC-ccchHHHHHHHHHHhcC-CCCCceeEEEEEEeC
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA--------DGTIIAVKQLSSKS-RQGNREFLNEIAMISCL-QHPNLVKIHGCCVEG  308 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~--------~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~  308 (511)
                      .++|.+.++||+|+||.||+++..        ....+|+|.++... .....++.+|+.+++++ +||||++++++|.+.
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            356888999999999999998631        24578999987542 23345788999999999 699999999999999


Q ss_pred             CEEEEEEEecCCCCHhHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEE
Q 045835          309 DQLLLVYEYMENNSLACALFGREN------------CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL  376 (511)
Q Consensus       309 ~~~~lV~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILl  376 (511)
                      ...+++|||+++|+|.+++.....            ....++|.+..+++.|++.||+|||+.+   ++||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence            999999999999999999965321            1235899999999999999999999986   9999999999999


Q ss_pred             cCCCCeEEeecCCcccCCCCCce-eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccc
Q 045835          377 DRDLNPKISDFGLAKLDEGDKTH-ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDC  454 (511)
Q Consensus       377 d~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~  454 (511)
                      +.++.+||+|||+++........ ......++..|+|||.+....++.++|||||||++|||++ |+.||.....     
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~-----  242 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV-----  242 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH-----
Confidence            99999999999999855432211 1111234467999999998899999999999999999999 8888753221     


Q ss_pred             cchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          455 TCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       455 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..+.             +.+........+.....++.+++.+||+.+|++|||+.||
T Consensus       243 ~~~~-------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l  286 (314)
T cd05099         243 EELF-------------KLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQL  286 (314)
T ss_pred             HHHH-------------HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence            0011             1111111112233445678899999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.3e-37  Score=313.25  Aligned_cols=237  Identities=23%  Similarity=0.330  Sum_probs=187.3

Q ss_pred             CceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHH-HHhcCCCCCceeEEEEEEeCCEEEEEEEecCC
Q 045835          246 KKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIA-MISCLQHPNLVKIHGCCVEGDQLLLVYEYMEN  320 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~  320 (511)
                      ++||+|+||.||+++.. +++.||+|++....   ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999864 68899999986432   122334555554 67889999999999999999999999999999


Q ss_pred             CCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCcee
Q 045835          321 NSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI  400 (511)
Q Consensus       321 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~  400 (511)
                      |+|..++...    ..+++.....++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....... .
T Consensus        81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~  152 (321)
T cd05603          81 GELFFHLQRE----RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-T  152 (321)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-c
Confidence            9999888543    24788888999999999999999986   99999999999999999999999999875322211 2


Q ss_pred             ecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCC
Q 045835          401 STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGS  480 (511)
Q Consensus       401 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  480 (511)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||....        ......         .+...  ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~---------~i~~~--~~  213 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------VSQMYD---------NILHK--PL  213 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC--------HHHHHH---------HHhcC--CC
Confidence            234568999999999998899999999999999999999999986321        001100         11111  11


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCcC
Q 045835          481 KYKKEEAERMIKVSLLCTNASPSLRPTMS  509 (511)
Q Consensus       481 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~  509 (511)
                      ..+......+.+++.+||+.+|.+||+..
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            23334456789999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.7e-37  Score=306.14  Aligned_cols=246  Identities=25%  Similarity=0.408  Sum_probs=196.0

Q ss_pred             CcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCC
Q 045835          242 FDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMEN  320 (511)
Q Consensus       242 f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~  320 (511)
                      |++.+.||+|+||.||+|... ++..+++|.+..........+.+|+++++.++|||++++++++..++..++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            567889999999999999865 4778899998766555567889999999999999999999999999999999999999


Q ss_pred             CCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCcee
Q 045835          321 NSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI  400 (511)
Q Consensus       321 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~  400 (511)
                      ++|..++....   ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++........ .
T Consensus        87 ~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~  159 (282)
T cd06643          87 GAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R  159 (282)
T ss_pred             CcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc-c
Confidence            99998876432   35899999999999999999999986   99999999999999999999999999975432221 1


Q ss_pred             ecccccCCCcccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          401 STRIAGTIGYMAPEYAL-----WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       401 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      .....++..|+|||++.     ...++.++|||||||++|||++|++|+.....        .+-.         ..+..
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--------~~~~---------~~~~~  222 (282)
T cd06643         160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP--------MRVL---------LKIAK  222 (282)
T ss_pred             cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH--------HHHH---------HHHhh
Confidence            22346889999999874     34578899999999999999999999863221        0000         00100


Q ss_pred             h-hhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          476 E-RLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       476 ~-~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      . ......+......+.+++.+||+.+|.+||++.+|
T Consensus       223 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i  259 (282)
T cd06643         223 SEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQL  259 (282)
T ss_pred             cCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHH
Confidence            0 00011223345678999999999999999999764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.7e-37  Score=301.88  Aligned_cols=246  Identities=30%  Similarity=0.457  Sum_probs=196.9

Q ss_pred             CCcccCceeccCceeEEecccc-CCcEEEEEEecccCcc---------chHHHHHHHHHHhcCCCCCceeEEEEEEeCCE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQ---------GNREFLNEIAMISCLQHPNLVKIHGCCVEGDQ  310 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~---------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~  310 (511)
                      +|.+...||+|+||.||+|... +++.+|+|.+......         ....+.+|+.++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            3667789999999999999753 5789999988654322         12467899999999999999999999999999


Q ss_pred             EEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCc
Q 045835          311 LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA  390 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla  390 (511)
                      .++++||+++++|.+++....    .+++.....++.|++.||+|||+.+   ++||||+|+||++++++.+||+|||++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~  153 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG----AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGIS  153 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCC
Confidence            999999999999999996542    4888999999999999999999886   999999999999999999999999999


Q ss_pred             ccCCCCCce-----eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhh
Q 045835          391 KLDEGDKTH-----ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQ  465 (511)
Q Consensus       391 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~  465 (511)
                      +........     ......|+..|+|||.+....++.++||||||++++||++|+.||......        .      
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~------  219 (267)
T cd06628         154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--------Q------  219 (267)
T ss_pred             cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--------H------
Confidence            865422111     111235788999999999888999999999999999999999998632210        0      


Q ss_pred             ccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          466 QDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       466 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                         ...++.. ......+......+.+++.+||+.+|++||++.||
T Consensus       220 ---~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i  261 (267)
T cd06628         220 ---AIFKIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAEL  261 (267)
T ss_pred             ---HHHHHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHH
Confidence               0011111 11223334456778999999999999999999764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.2e-37  Score=316.45  Aligned_cols=253  Identities=26%  Similarity=0.410  Sum_probs=193.1

Q ss_pred             hcCCcccCceeccCceeEEeccc------cCCcEEEEEEecccCc-cchHHHHHHHHHHhcC-CCCCceeEEEEEEeC-C
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL------ADGTIIAVKQLSSKSR-QGNREFLNEIAMISCL-QHPNLVKIHGCCVEG-D  309 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~------~~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~  309 (511)
                      .++|++.+.||+|+||.||+|..      .+++.||||+++.... .....+.+|+.++.++ +||||++++++|... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            35788999999999999999952      3567899999975432 2345688999999999 689999999988754 4


Q ss_pred             EEEEEEEecCCCCHhHHHhcCCC---------------------------------------------------------
Q 045835          310 QLLLVYEYMENNSLACALFGREN---------------------------------------------------------  332 (511)
Q Consensus       310 ~~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------  332 (511)
                      ..+++|||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            67899999999999999864321                                                         


Q ss_pred             ------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCce-eecccc
Q 045835          333 ------CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH-ISTRIA  405 (511)
Q Consensus       333 ------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~-~~~~~~  405 (511)
                            ....++|..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++........ ......
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                  0124788899999999999999999986   999999999999999999999999999754322211 111233


Q ss_pred             cCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCCCCCH
Q 045835          406 GTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKK  484 (511)
Q Consensus       406 gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  484 (511)
                      ++..|+|||.+....++.++||||||+++|||++ |..|+......    .   .          ....+........+.
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~---~----------~~~~~~~~~~~~~~~  305 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----E---E----------FCRRLKEGTRMRAPD  305 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc----H---H----------HHHHHhccCCCCCCC
Confidence            5678999999988899999999999999999997 88887532110    0   0          011111111111122


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          485 EEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       485 ~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ....++.+++.+||+.+|++|||+.||
T Consensus       306 ~~~~~~~~~~~~cl~~~p~~Rps~~ei  332 (343)
T cd05103         306 YTTPEMYQTMLDCWHGEPSQRPTFSEL  332 (343)
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            233568999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.6e-37  Score=306.81  Aligned_cols=254  Identities=24%  Similarity=0.375  Sum_probs=199.7

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      ++|++.+.||+|+||.||++.. .+++.+|+|++.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            5678889999999999999975 468899999886543 33456789999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +++++|.+++....    .+++.....++.+++.||.|||+..  +++||||||+||++++++.++|+|||++.......
T Consensus        85 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~  158 (284)
T cd06620          85 MDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI  158 (284)
T ss_pred             CCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence            99999999885432    4899999999999999999999742  39999999999999999999999999987543221


Q ss_pred             ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccccc---ccchhhhhHhhhccCchhHhh
Q 045835          398 THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFD---CTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~---~~~l~~~~~~~~~~~~~~~~~  474 (511)
                         .....|+..|+|||++.+..++.++|||||||+++||++|+.||.........   ...+.++.         ..++
T Consensus       159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~  226 (284)
T cd06620         159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLL---------QQIV  226 (284)
T ss_pred             ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHH---------HHHh
Confidence               12346889999999998889999999999999999999999999743321100   00011111         1111


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ............+..+.+++.+|++.+|++|||+.||
T Consensus       227 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~  263 (284)
T cd06620         227 QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQL  263 (284)
T ss_pred             hccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHH
Confidence            1111111112245678999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.8e-37  Score=306.89  Aligned_cols=244  Identities=27%  Similarity=0.368  Sum_probs=194.2

Q ss_pred             CcccCceeccCceeEEecccc-CCcEEEEEEecccCc---cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          242 FDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR---QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       242 f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      |+..+.||+|+||.||++... +++.+|+|.+.....   .....+.+|+.++++++|+|++++.+.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            677889999999999999754 688999999865422   2234577899999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +++++|.+++.....  ..+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++.......
T Consensus        82 ~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          82 MNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             cCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            999999998864332  35889999999999999999999886   9999999999999999999999999997654322


Q ss_pred             ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          398 THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                      ..  ....|+..|+|||.+.+..++.++|||||||++|||++|+.||.......    .. +         ....+.+. 
T Consensus       157 ~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~----~~-~---------~~~~~~~~-  219 (285)
T cd05630         157 TI--KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI----KR-E---------EVERLVKE-  219 (285)
T ss_pred             cc--cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc----hH-H---------HHHhhhhh-
Confidence            21  23468999999999998899999999999999999999999996422100    00 0         00111111 


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPT  507 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs  507 (511)
                      .....+......+.+++.+||+.+|++|||
T Consensus       220 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s  249 (285)
T cd05630         220 VQEEYSEKFSPDARSLCKMLLCKDPKERLG  249 (285)
T ss_pred             hhhhcCccCCHHHHHHHHHHhhcCHHHccC
Confidence            011122334456889999999999999999

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2e-37  Score=308.29  Aligned_cols=247  Identities=26%  Similarity=0.413  Sum_probs=200.2

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      .+|+..+.||.|+||.||+|.. .+++.||+|.+..........+.+|+.+++.++|||++++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            4688999999999999999974 578999999997665555678899999999999999999999999999999999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      ++++|.+++...     .+++.++..++.+++.||+|||+.+   ++||||||+||+++.++.+||+|||++........
T Consensus        99 ~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~  170 (296)
T cd06655          99 AGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS  170 (296)
T ss_pred             CCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence            999999988532     4899999999999999999999986   99999999999999999999999999875433222


Q ss_pred             eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhh
Q 045835          399 HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERL  478 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  478 (511)
                      . .....++..|+|||.+.+..++.++|||||||++|||++|+.||......        .........        ...
T Consensus       171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~--------~~~~~~~~~--------~~~  233 (296)
T cd06655         171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--------RALYLIATN--------GTP  233 (296)
T ss_pred             c-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhc--------CCc
Confidence            1 22346788999999999888999999999999999999999998643210        000000000        000


Q ss_pred             CCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          479 GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       479 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ....+......+.+++.+||+.+|++|||+.+|
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~i  266 (296)
T cd06655         234 ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKEL  266 (296)
T ss_pred             ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHH
Confidence            011222344568899999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=8.5e-38  Score=307.55  Aligned_cols=244  Identities=29%  Similarity=0.446  Sum_probs=196.4

Q ss_pred             CCcccCceeccCceeEEecccc-CCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      .|+..+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            3566788999999999999754 57889999987443 334457889999999999999999999999999999999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      ++++|.+++..     ..+++.....++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++........
T Consensus        85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence            99999998853     24889999999999999999999886   99999999999999999999999999976543221


Q ss_pred             eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhh
Q 045835          399 HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERL  478 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  478 (511)
                       ......++..|+|||++.+..++.++|||||||+++||++|+.|+......     ...             ..+....
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----~~~-------------~~~~~~~  217 (277)
T cd06642         157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM-----RVL-------------FLIPKNS  217 (277)
T ss_pred             -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh-----hHH-------------hhhhcCC
Confidence             112245788999999999889999999999999999999999998632210     000             0111111


Q ss_pred             CCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          479 GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       479 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ....+...+..+.+++.+||+.+|++||+|.||
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i  250 (277)
T cd06642         218 PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKEL  250 (277)
T ss_pred             CCCCCcccCHHHHHHHHHHccCCcccCcCHHHH
Confidence            112233445678999999999999999999875

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3.9e-37  Score=302.96  Aligned_cols=245  Identities=29%  Similarity=0.435  Sum_probs=199.9

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      ..|+..+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++|||++++++++.+++..++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            34777889999999999999754 58899999987543 34456788999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +++++|.+++...     .+++.....++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06640          84 LGGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence            9999999988532     4788899999999999999999886   9999999999999999999999999997654322


Q ss_pred             ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          398 THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                      . ......++..|+|||++.+..++.++|||||||+++||++|+.|+......        .          ....+...
T Consensus       156 ~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--------~----------~~~~~~~~  216 (277)
T cd06640         156 I-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM--------R----------VLFLIPKN  216 (277)
T ss_pred             c-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH--------h----------HhhhhhcC
Confidence            2 122345788999999998888999999999999999999999998632210        0          01111111


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....+......+.+++.+||+.+|++||++.||
T Consensus       217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i  250 (277)
T cd06640         217 NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKEL  250 (277)
T ss_pred             CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHH
Confidence            1223445567789999999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.5e-37  Score=299.24  Aligned_cols=247  Identities=24%  Similarity=0.408  Sum_probs=200.2

Q ss_pred             CCcccCceeccCceeEEeccc-cCCcEEEEEEeccc--CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          241 NFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK--SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      +|+..+.||+|+||.||.++. .+++.+++|.+...  ......++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            578889999999999998864 46889999998654  234456789999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +++++|.+++....  ...+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            99999999996543  245899999999999999999999886   9999999999999999999999999998654433


Q ss_pred             ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          398 THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                      . ......++..|+|||.+.+..++.++||||||++++||++|+.|+....        ..+...         ++....
T Consensus       156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--------~~~~~~---------~~~~~~  217 (256)
T cd08221         156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN--------PLNLVV---------KIVQGN  217 (256)
T ss_pred             c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC--------HHHHHH---------HHHcCC
Confidence            2 2233568899999999988889999999999999999999999885321        111111         111111


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      . ...+......+.+++.+||+.+|++||++.|+
T Consensus       218 ~-~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~l  250 (256)
T cd08221         218 Y-TPVVSVYSSELISLVHSLLQQDPEKRPTADEV  250 (256)
T ss_pred             C-CCCccccCHHHHHHHHHHcccCcccCCCHHHH
Confidence            1 11223445678999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.3e-37  Score=307.96  Aligned_cols=248  Identities=26%  Similarity=0.405  Sum_probs=200.8

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      .++|...+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|+|++++++++..++..++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            36789999999999999999974 47899999999766555566788999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +++++|.+++...     .+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++.......
T Consensus        98 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~  169 (297)
T cd06656          98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (297)
T ss_pred             cCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence            9999999998532     4788999999999999999999986   9999999999999999999999999997543322


Q ss_pred             ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          398 THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                      .. .....++..|+|||.+.+..++.++|||||||++++|++|+.||........    +..    ...        ...
T Consensus       170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~----~~~----~~~--------~~~  232 (297)
T cd06656         170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA----LYL----IAT--------NGT  232 (297)
T ss_pred             cC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh----eee----ecc--------CCC
Confidence            21 2234678899999999988899999999999999999999999963321100    000    000        000


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....+......+.+++.+||+.+|++||++.||
T Consensus       233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  266 (297)
T cd06656         233 PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKEL  266 (297)
T ss_pred             CCCCCccccCHHHHHHHHHHccCChhhCcCHHHH
Confidence            0111223344568899999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.1e-37  Score=304.95  Aligned_cols=245  Identities=30%  Similarity=0.462  Sum_probs=192.1

Q ss_pred             CceeccCceeEEeccccC-------CcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          246 KKIGEGGFGPVYKGQLAD-------GTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~~-------g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      +.||+|+||.||+|+..+       +..+|+|.+.... ......+.+|+.+++.++||||++++++|...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            468999999999997542       2578999886543 23456789999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCC-----CeEEeecCC
Q 045835          318 MENNSLACALFGREN---CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL-----NPKISDFGL  389 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~-----~~kl~DfGl  389 (511)
                      +++++|.+++.....   ....+++.+++.++.|++.||+|||+.+   ++|+||||+||+++.+.     .+||+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            999999999975322   1234789999999999999999999886   99999999999999887     899999999


Q ss_pred             cccCCCCCc-eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhcc
Q 045835          390 AKLDEGDKT-HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQD  467 (511)
Q Consensus       390 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~  467 (511)
                      ++....... .......++..|+|||++.++.++.++|||||||++|||+| |+.|+.....     ....         
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~-----~~~~---------  223 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-----QEVL---------  223 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH-----HHHH---------
Confidence            975432211 11122345678999999999999999999999999999998 9988863221     0111         


Q ss_pred             CchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          468 GKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       468 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                          ..++.......+...+..+.+++.+||+.+|++||++.+|
T Consensus       224 ----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i  263 (269)
T cd05044         224 ----QHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRI  263 (269)
T ss_pred             ----HHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHH
Confidence                1111111112233456678999999999999999999874

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.3e-37  Score=311.41  Aligned_cols=263  Identities=20%  Similarity=0.314  Sum_probs=194.3

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      ++|...++||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56888999999999999999754 57889999987543 23334678999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +++ +|.+++....   ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        86 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          86 LDK-DLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             CCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence            985 7887775432   34788999999999999999999986   9999999999999999999999999997543322


Q ss_pred             ceeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCccccccc-------c-hhhhhHhhhccC
Q 045835          398 THISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCT-------C-LLDWACHLQQDG  468 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~-------~-l~~~~~~~~~~~  468 (511)
                      .. .....++..|+|||.+.+ ..++.++|||||||+++||+||+.||......+....       . ...|.. .....
T Consensus       159 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  236 (309)
T cd07872         159 KT-YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPG-ISSND  236 (309)
T ss_pred             cc-cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh-hcchh
Confidence            11 123457889999998865 4689999999999999999999999964321100000       0 000100 00000


Q ss_pred             chhHhhhhhhCC----CCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          469 KLVELVDERLGS----KYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       469 ~~~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....-.+....    ........++.+++.+||+.+|.+|||+.|+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~  283 (309)
T cd07872         237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEA  283 (309)
T ss_pred             hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHH
Confidence            000000000000    0011234567899999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.9e-37  Score=301.88  Aligned_cols=247  Identities=27%  Similarity=0.356  Sum_probs=192.3

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC-----ccchHHHHHHHHHHhcCCCCCceeEEEEEEe--CCEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS-----RQGNREFLNEIAMISCLQHPNLVKIHGCCVE--GDQL  311 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~  311 (511)
                      .+|...+.||+|+||.||++.. .++..||+|++....     .+....+.+|+.++++++||||+++++++.+  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            5788999999999999999975 458899999886432     1223467889999999999999999999875  3578


Q ss_pred             EEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcc
Q 045835          312 LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK  391 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~  391 (511)
                      ++++||+++++|.+++....    .+++...+.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~  154 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK  154 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence            89999999999999986532    4789999999999999999999886   9999999999999999999999999997


Q ss_pred             cCCCCCc--eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCc
Q 045835          392 LDEGDKT--HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGK  469 (511)
Q Consensus       392 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  469 (511)
                      .......  .......++..|+|||++.+..++.++|||||||++|||++|+.||.....        ....        
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~--------~~~~--------  218 (266)
T cd06651         155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA--------MAAI--------  218 (266)
T ss_pred             ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch--------HHHH--------
Confidence            5432111  111234578899999999988899999999999999999999999863211        0000        


Q ss_pred             hhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          470 LVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       470 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                       ............+......+.+++ +|+..+|++||++.||
T Consensus       219 -~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~ei  258 (266)
T cd06651         219 -FKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEEL  258 (266)
T ss_pred             -HHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHH
Confidence             111111111223333444556665 6888999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.6e-38  Score=305.01  Aligned_cols=255  Identities=27%  Similarity=0.344  Sum_probs=191.3

Q ss_pred             CCcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCC-----EEEEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGD-----QLLLV  314 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~lV  314 (511)
                      .|...+++|.|+||.||+|.+. ++..||||+.....+-    --+|+.+|+.++|||||+|+-++....     ...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            4667789999999999999865 4689999998765442    236999999999999999999887532     34589


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCC-CCeEEeecCCcccC
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD-LNPKISDFGLAKLD  393 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~-~~~kl~DfGla~~~  393 (511)
                      ||||+. +|.+.+......+..++.....-+..||.+||+|||+.+   |+||||||.|+|+|.+ +.+||||||.|+..
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999987 898888753333345677777888999999999999976   9999999999999987 89999999999977


Q ss_pred             CCCCceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhH
Q 045835          394 EGDKTHISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVE  472 (511)
Q Consensus       394 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  472 (511)
                      ..+...++.  ..|.-|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.....    ...|..-+..+ .-....+
T Consensus       177 ~~~epniSY--icSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~----~dQL~eIik~l-G~Pt~e~  249 (364)
T KOG0658|consen  177 VKGEPNISY--ICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS----VDQLVEIIKVL-GTPTRED  249 (364)
T ss_pred             ccCCCceeE--EEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH----HHHHHHHHHHh-CCCCHHH
Confidence            655554443  457789999998866 799999999999999999999998874321    12222221111 1111111


Q ss_pred             ----------hhhhhhCC-----CCCHHHHHHHHHHHHHcCCCCCCCCCCcCC
Q 045835          473 ----------LVDERLGS-----KYKKEEAERMIKVSLLCTNASPSLRPTMSE  510 (511)
Q Consensus       473 ----------~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e  510 (511)
                                .-.+.+..     -.......+.++++.++++.+|.+|.+..|
T Consensus       250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~  302 (364)
T KOG0658|consen  250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALE  302 (364)
T ss_pred             HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHH
Confidence                      11111111     122344567899999999999999998765

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.4e-37  Score=305.42  Aligned_cols=252  Identities=25%  Similarity=0.381  Sum_probs=197.7

Q ss_pred             cCCcccCceeccCceeEEecccc------CCcEEEEEEecccCcc-chHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSKSRQ-GNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLL  312 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  312 (511)
                      ++|+..+.||+|+||.||+|+..      +...|++|.+...... ....+.+|+.++++++|+||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            57889999999999999999753      3467999988754433 4567999999999999999999999999989999


Q ss_pred             EEEEecCCCCHhHHHhcCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeec
Q 045835          313 LVYEYMENNSLACALFGRENC-----ELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF  387 (511)
Q Consensus       313 lV~Ey~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~Df  387 (511)
                      +||||+++|+|.+++......     ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999999754321     125899999999999999999999986   999999999999999999999999


Q ss_pred             CCcccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhc
Q 045835          388 GLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQ  466 (511)
Q Consensus       388 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~  466 (511)
                      |+++..............++..|+|||.+.+...+.++||||||++++||++ |..||.....     .......    .
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-----~~~~~~~----~  232 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-----EEVLNRL----Q  232 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-----HHHHHHH----H
Confidence            9987543322222223356778999999988889999999999999999999 7777752210     1111110    0


Q ss_pred             cCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          467 DGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       467 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .        .......+...+..+.+++.+||+.+|++|||+.|+
T Consensus       233 ~--------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~  269 (275)
T cd05046         233 A--------GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSEL  269 (275)
T ss_pred             c--------CCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence            0        011111122344578999999999999999998764

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-37  Score=298.81  Aligned_cols=252  Identities=27%  Similarity=0.417  Sum_probs=201.7

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      .++|+..+.||+|+||.||++... +++.+++|.+........+.+.+|+.++++++|||++++++++.+++..+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            357889999999999999999754 5788999999876555667899999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +++++|.+++....   ..+++.....++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        82 ~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  155 (262)
T cd06613          82 CGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI  155 (262)
T ss_pred             CCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence            99999999886532   35889999999999999999999986   9999999999999999999999999997644322


Q ss_pred             ceeecccccCCCcccccccccC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          398 THISTRIAGTIGYMAPEYALWG---YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      . ......++..|+|||.+...   .++.++||||||++++||++|+.|+.......    ...    .... .   +..
T Consensus       156 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~----~~~----~~~~-~---~~~  222 (262)
T cd06613         156 A-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR----ALF----LISK-S---NFP  222 (262)
T ss_pred             h-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH----HHH----HHHh-c---cCC
Confidence            1 12234678889999998776   88999999999999999999999986322100    000    0000 0   000


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .+.  .......+..+.+++.+||+.+|.+|||+.||
T Consensus       223 ~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i  257 (262)
T cd06613         223 PPK--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKL  257 (262)
T ss_pred             Ccc--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHH
Confidence            000  11223445679999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.9e-37  Score=299.61  Aligned_cols=245  Identities=31%  Similarity=0.445  Sum_probs=197.9

Q ss_pred             CCcccCceeccCceeEEecccc-CCcEEEEEEecccC-----ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS-----RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  314 (511)
                      +|+..+.||+|+||.||+|... +++.|++|.+....     ....+.+.+|+.+++.++|+|++++++++.+....+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            3667789999999999999865 78999999986543     22446789999999999999999999999999999999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      +||+++++|.+++....    .+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~  153 (258)
T cd06632          81 LELVPGGSLAKLLKKYG----SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVV  153 (258)
T ss_pred             EEecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            99999999999986432    4889999999999999999999986   9999999999999999999999999998654


Q ss_pred             CCCceeecccccCCCcccccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHh
Q 045835          395 GDKTHISTRIAGTIGYMAPEYALWGY-LTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVEL  473 (511)
Q Consensus       395 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  473 (511)
                      ...  ......++..|+|||.+.... ++.++|+||||++++||++|+.||.....        ......         +
T Consensus       154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~--------~~~~~~---------~  214 (258)
T cd06632         154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG--------VAAVFK---------I  214 (258)
T ss_pred             ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH--------HHHHHH---------H
Confidence            332  123346888999999988776 89999999999999999999999863221        011111         1


Q ss_pred             hhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          474 VDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       474 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .........+......+.+++.+||+.+|++||++.|+
T Consensus       215 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~  252 (258)
T cd06632         215 GRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAEL  252 (258)
T ss_pred             HhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHH
Confidence            01001112333445678899999999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2e-37  Score=302.94  Aligned_cols=251  Identities=24%  Similarity=0.379  Sum_probs=197.0

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      .++|...+.||+|+||.||+|+. .+++.||+|.++.........+.+|+.+++.++||||+++++++...+..++|+||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            35788889999999999999975 46889999998766555556788999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +++++|.+++....    .+++.+...++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++.......
T Consensus        88 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06645          88 CGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI  160 (267)
T ss_pred             cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence            99999999886433    4889999999999999999999986   9999999999999999999999999987543221


Q ss_pred             ceeecccccCCCcccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          398 THISTRIAGTIGYMAPEYAL---WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      . ......|+..|+|||++.   ...++.++|||||||++|||++|+.|+.......    .+  +  ..... .   ..
T Consensus       161 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~----~~--~--~~~~~-~---~~  227 (267)
T cd06645         161 A-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR----AL--F--LMTKS-N---FQ  227 (267)
T ss_pred             c-ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh----hH--H--hhhcc-C---CC
Confidence            1 122346889999999874   4568899999999999999999999985322100    00  0  00000 0   00


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .+....  .......+.+++.+|++.+|++|||+.+|
T Consensus       228 ~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~l  262 (267)
T cd06645         228 PPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKL  262 (267)
T ss_pred             CCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHH
Confidence            000000  01223468899999999999999999764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.3e-37  Score=322.60  Aligned_cols=193  Identities=24%  Similarity=0.304  Sum_probs=166.0

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      .+|.+.+.||+|+||.||++... .++.||||....      ..+.+|+.+|++++|+|||++++++..+...++|||++
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~  242 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY  242 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence            46889999999999999999865 478899996432      34678999999999999999999999999999999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      . ++|.+++....   ..++|..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus       243 ~-~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        243 R-SDLYTYLGARL---RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             C-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            5 68888875432   25899999999999999999999986   99999999999999999999999999986543221


Q ss_pred             -eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 045835          399 -HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMS  445 (511)
Q Consensus       399 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~  445 (511)
                       .......||..|+|||++.+..++.++|||||||+||||++|..++-
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf  363 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF  363 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence             12234579999999999999999999999999999999999887653

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.6e-37  Score=307.04  Aligned_cols=259  Identities=25%  Similarity=0.336  Sum_probs=190.2

Q ss_pred             CCcccCceeccCceeEEecccc-CCcEEEEEEecccCc--cchHHHHHHHHHHhcC---CCCCceeEEEEEEe-----CC
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR--QGNREFLNEIAMISCL---QHPNLVKIHGCCVE-----GD  309 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~-----~~  309 (511)
                      +|++.+.||+|+||.||+|+.. +++.||+|.++....  .....+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788899999999999999754 688999999875422  2234566777777655   79999999999865     34


Q ss_pred             EEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCC
Q 045835          310 QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL  389 (511)
Q Consensus       310 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGl  389 (511)
                      ..+++|||+.+ +|.+++....  ...+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||+
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCc
Confidence            57999999985 8888886432  234899999999999999999999987   99999999999999999999999999


Q ss_pred             cccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhc--c
Q 045835          390 AKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQ--D  467 (511)
Q Consensus       390 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~--~  467 (511)
                      ++......  ......+|..|+|||++.+..++.++|||||||+++||++|++||.......    .+.........  .
T Consensus       155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~----~~~~~~~~~~~~~~  228 (288)
T cd07863         155 ARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD----QLGKIFDLIGLPPE  228 (288)
T ss_pred             cccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH----HHHHHHHHhCCCCh
Confidence            98654322  1233467899999999998899999999999999999999999986432110    01000000000  0


Q ss_pred             Cchh---H----hhhhhh---CCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          468 GKLV---E----LVDERL---GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       468 ~~~~---~----~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ....   .    ...+..   .....++....+.+++.+||+.||++|||+.|+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~  282 (288)
T cd07863         229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRA  282 (288)
T ss_pred             hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHH
Confidence            0000   0    000000   001112334568899999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.7e-37  Score=305.45  Aligned_cols=248  Identities=25%  Similarity=0.404  Sum_probs=197.7

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      ++|++.++||+|+||.||+|+.. ++..+++|.+........+.+.+|+.+++.++|||++++++++..+...++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56889999999999999999865 48899999998766666678899999999999999999999999999999999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      ++++|..++....   ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++........
T Consensus        92 ~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~  165 (292)
T cd06644          92 PGGAVDAIMLELD---RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ  165 (292)
T ss_pred             CCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence            9999988875432   25899999999999999999999986   99999999999999999999999999875332211


Q ss_pred             eeecccccCCCcccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHh
Q 045835          399 HISTRIAGTIGYMAPEYAL-----WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVEL  473 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  473 (511)
                       ......++..|+|||++.     ...++.++|||||||++|||++|+.|+.....        .....         ++
T Consensus       166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--------~~~~~---------~~  227 (292)
T cd06644         166 -RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLL---------KI  227 (292)
T ss_pred             -ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--------HHHHH---------HH
Confidence             112345788999999885     34578899999999999999999998853210        00000         11


Q ss_pred             hhhhh-CCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          474 VDERL-GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       474 ~d~~l-~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..... ....+.....++.+++.+||+.+|++||++.||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i  266 (292)
T cd06644         228 AKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQL  266 (292)
T ss_pred             hcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHH
Confidence            10000 011123345578899999999999999998774

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.8e-37  Score=306.03  Aligned_cols=261  Identities=27%  Similarity=0.389  Sum_probs=202.3

Q ss_pred             ccHHHHHHHhcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcC-CCCCceeEEEEEEe
Q 045835          230 FTLKQIKAATNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCL-QHPNLVKIHGCCVE  307 (511)
Q Consensus       230 ~~~~~l~~~~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~  307 (511)
                      +++.++..++++|...+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|+.++.++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            45566777789999999999999999999975 468899999986532 2345678899999999 89999999999975


Q ss_pred             C-----CEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCe
Q 045835          308 G-----DQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP  382 (511)
Q Consensus       308 ~-----~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~  382 (511)
                      .     ...++|+||+++++|.+++.........+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence            4     3589999999999999988653333346899999999999999999999886   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCceeecccccCCCcccccccccC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccch
Q 045835          383 KISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWG-----YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCL  457 (511)
Q Consensus       383 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l  457 (511)
                      ||+|||++......... .....|+..|+|||.+...     .++.++|||||||++|||++|+.|+......    ..+
T Consensus       168 kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~----~~~  242 (291)
T cd06639         168 KLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV----KTL  242 (291)
T ss_pred             EEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH----HHH
Confidence            99999999854432211 2234678899999987643     3689999999999999999999998632210    001


Q ss_pred             hhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          458 LDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       458 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..+.     .....     .  ...+.+....+.+++.+|++.+|++||++.|+
T Consensus       243 ~~~~-----~~~~~-----~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i  284 (291)
T cd06639         243 FKIP-----RNPPP-----T--LLHPEKWCRSFNHFISQCLIKDFEARPSVTHL  284 (291)
T ss_pred             HHHh-----cCCCC-----C--CCcccccCHHHHHHHHHHhhcChhhCcCHHHH
Confidence            1110     00000     0  01122344578999999999999999999874

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.3e-37  Score=307.52  Aligned_cols=261  Identities=25%  Similarity=0.357  Sum_probs=201.0

Q ss_pred             ccHHHHHHHhcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcC-CCCCceeEEEEEE-
Q 045835          230 FTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCL-QHPNLVKIHGCCV-  306 (511)
Q Consensus       230 ~~~~~l~~~~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~-  306 (511)
                      +.++.+..+.++|++.+.||+|+||.||++... +++.+|+|.+.... ....++.+|+.+++.+ +|||++++++++. 
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            445667778899999999999999999999754 57899999886432 2235688899999999 6999999999985 


Q ss_pred             ----eCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCe
Q 045835          307 ----EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP  382 (511)
Q Consensus       307 ----~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~  382 (511)
                          .++..++||||+++++|.+++.........+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence                345789999999999999988654333346889999999999999999999986   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCceeecccccCCCcccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccch
Q 045835          383 KISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYAL-----WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCL  457 (511)
Q Consensus       383 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l  457 (511)
                      ||+|||+++....... ......|+..|+|||++.     ...++.++|||||||++|||++|+.|+.......    .+
T Consensus       164 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~----~~  238 (286)
T cd06638         164 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR----AL  238 (286)
T ss_pred             EEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH----HH
Confidence            9999999986543221 122346899999999875     3457889999999999999999999986322100    00


Q ss_pred             hhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          458 LDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       458 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...    . ...     .+.  ...+......+.+++.+||+.+|++|||+.||
T Consensus       239 ~~~----~-~~~-----~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~el  280 (286)
T cd06638         239 FKI----P-RNP-----PPT--LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDL  280 (286)
T ss_pred             hhc----c-ccC-----CCc--ccCCCCcCHHHHHHHHHHccCCcccCCCHHHH
Confidence            000    0 000     000  00111234568999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.8e-38  Score=304.42  Aligned_cols=243  Identities=23%  Similarity=0.358  Sum_probs=201.7

Q ss_pred             cCCcccCceeccCceeEEecc-ccCCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      .+|++.+.||+|+||.|-++. ...|+.||||.++...   .+..-.+.+|+++|+.|+||||+.++.+|+..+.+.+||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            468888999999999999996 4679999999997653   444456789999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||..+|.|.+++..+.    .|++.....++.||..|+.|+|.+.   ++|||||.+|||||.++++||+||||+.++..
T Consensus       133 EYaS~GeLYDYiSer~----~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  133 EYASGGELYDYISERG----SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EecCCccHHHHHHHhc----cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            9999999999997654    5999999999999999999999886   99999999999999999999999999988765


Q ss_pred             CCceeecccccCCCcccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYL-TYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      .+  .-+..+|++.|.+||.+.+.+| .+..|-|||||+||-|+.|..||+...        ....++.         +-
T Consensus       206 ~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D--------hk~lvrQ---------Is  266 (668)
T KOG0611|consen  206 KK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD--------HKRLVRQ---------IS  266 (668)
T ss_pred             cc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch--------HHHHHHH---------hh
Confidence            43  3355799999999999988765 688999999999999999999997432        1111111         11


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ....+   .++.+....-|+.+||..+|++|.|+.||
T Consensus       267 ~GaYr---EP~~PSdA~gLIRwmLmVNP~RRATieDi  300 (668)
T KOG0611|consen  267 RGAYR---EPETPSDASGLIRWMLMVNPERRATIEDI  300 (668)
T ss_pred             ccccc---CCCCCchHHHHHHHHHhcCcccchhHHHH
Confidence            11111   12233456678899999999999998875

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=314.16  Aligned_cols=201  Identities=26%  Similarity=0.341  Sum_probs=171.9

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEeccc---CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK---SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|++.+.||+|+||.||+++.. +++.||+|++...   .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46889999999999999999854 5889999998642   2223456889999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++|+|.+++....   ..+++.....++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          81 DYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             ecCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            9999999999986432   35889999999999999999999987   99999999999999999999999999975443


Q ss_pred             CCceeecccccCCCccccccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 045835          396 DKTHISTRIAGTIGYMAPEYALW-----GYLTYKADVYSFGIVALEIVSGKNNMSY  446 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~S~Gvvl~elltG~~p~~~  446 (511)
                      ..........||+.|+|||++..     ..++.++|||||||++|||++|+.||..
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  210 (331)
T cd05597         155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence            33322333468999999999863     4678899999999999999999999863

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4.2e-37  Score=298.68  Aligned_cols=247  Identities=24%  Similarity=0.367  Sum_probs=197.8

Q ss_pred             CCcccCceeccCceeEEecccc-CCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEe-CCEEEEEEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVE-GDQLLLVYE  316 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~E  316 (511)
                      +|++.+.||+|++|.||++... +++.+|+|.+....  ....+.+.+|+.++++++|+|++++.+.+.. ....+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788899999999999999754 57889999986542  2344578899999999999999999998764 446789999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      |+++++|.+++....  ...+++.++..++.+++.||+|||+.+   ++||||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          81 FCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             ccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence            999999999986532  235899999999999999999999987   999999999999999999999999999865432


Q ss_pred             CceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhh
Q 045835          397 KTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDE  476 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  476 (511)
                      .. ......++..|+|||.+.+..++.++||||||++++||++|+.||....        ...+....         ...
T Consensus       156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~--------~~~~~~~~---------~~~  217 (257)
T cd08223         156 CD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD--------MNSLVYRI---------IEG  217 (257)
T ss_pred             CC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHH---------Hhc
Confidence            22 2233467889999999999999999999999999999999999886321        11111111         111


Q ss_pred             hhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          477 RLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       477 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                       .....+......+.+++.+|++.+|++|||+.|+
T Consensus       218 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~  251 (257)
T cd08223         218 -KLPPMPKDYSPELGELIATMLSKRPEKRPSVKSI  251 (257)
T ss_pred             -CCCCCccccCHHHHHHHHHHhccCcccCCCHHHH
Confidence             1112334455679999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-38  Score=322.60  Aligned_cols=245  Identities=25%  Similarity=0.372  Sum_probs=204.8

Q ss_pred             cccCceeccCceeEEecccc--CCc--EEEEEEecccCcc-chHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          243 DSAKKIGEGGFGPVYKGQLA--DGT--IIAVKQLSSKSRQ-GNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       243 ~~~~~lG~G~fG~Vy~g~~~--~g~--~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      ...++||+|.||.|++|.+.  +|+  .||||.++..... ...+|++|+.+|.+|+|||+++|+|+..+ ..+.+|+|.
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL  191 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL  191 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence            35689999999999999764  454  5899999876543 66799999999999999999999999987 778999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      ++.|||.+-|+.  ..+..|-.......|.|||.||.||.++.   +|||||.++|+||-..-.+||+||||.+.+....
T Consensus       192 aplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  192 APLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             cccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            999999999976  22346777888899999999999999986   9999999999999999999999999999654432


Q ss_pred             -cee-ecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          398 -THI-STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       398 -~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                       .+. .....-.+.|.|||.+....++.++|||+|||++|||+| |+.|+..-..                  -.+.+.+
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g------------------~qIL~~i  328 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG------------------IQILKNI  328 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH------------------HHHHHhc
Confidence             222 223345778999999999999999999999999999999 6777753321                  1345566


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      |.+-+..-+..++++++++++.||..+|++|||++.|
T Consensus       329 D~~erLpRPk~csedIY~imk~cWah~paDRptFsai  365 (1039)
T KOG0199|consen  329 DAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAI  365 (1039)
T ss_pred             cccccCCCCCCChHHHHHHHHHhccCCccccccHHHH
Confidence            6655556678899999999999999999999998753

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.7e-37  Score=305.84  Aligned_cols=260  Identities=28%  Similarity=0.415  Sum_probs=200.6

Q ss_pred             cCCcccCceeccCceeEEecccc-----CCcEEEEEEecccCcc-chHHHHHHHHHHhcCCCCCceeEEEEEEe--CCEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-----DGTIIAVKQLSSKSRQ-GNREFLNEIAMISCLQHPNLVKIHGCCVE--GDQL  311 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-----~g~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~  311 (511)
                      +.|...+.||+|+||.||++++.     ++..+|||.+...... ....|.+|+++++.++||||+++++++..  +...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            35677899999999999999753     3678999999765443 45689999999999999999999999987  5678


Q ss_pred             EEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcc
Q 045835          312 LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK  391 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~  391 (511)
                      +++|||+++++|.+++....   ..+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++.
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~  157 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK  157 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccc
Confidence            99999999999999996543   25899999999999999999999986   9999999999999999999999999998


Q ss_pred             cCCCCCc--eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhh---hc
Q 045835          392 LDEGDKT--HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHL---QQ  466 (511)
Q Consensus       392 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~---~~  466 (511)
                      .......  .......++..|+|||.+....++.++||||||++++||+||+.|+.......      ..++...   ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~------~~~~~~~~~~~~  231 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF------LRMIGIAQGQMI  231 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchh------cccccccccccc
Confidence            6553221  11112345567999999988899999999999999999999999875432111      0000000   00


Q ss_pred             cCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          467 DGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       467 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...+.+.+........+..+..++.+++.+||+.+|++||||.||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei  276 (284)
T cd05038         232 VTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADL  276 (284)
T ss_pred             HHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHH
Confidence            011122222222222233445779999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.1e-37  Score=303.06  Aligned_cols=248  Identities=32%  Similarity=0.470  Sum_probs=195.4

Q ss_pred             CcccCceeccCceeEEecccc-CCcEEEEEEecccCccch--HHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          242 FDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGN--REFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       242 f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~--~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      |+..+.||+|+||.||+++.. +++.+|+|.+........  ....+|+.++++++||||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            567789999999999999865 567899999987644322  23456999999999999999999999999999999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      ++++|.+++...    ..+++..+..++.|+++||++||+.+   ++|+||||+||++++++.++|+|||++..... ..
T Consensus        81 ~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQKN----KPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NN  152 (260)
T ss_dssp             TTEBHHHHHHHH----SSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS-TT
T ss_pred             cccccccccccc----cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-cc
Confidence            999999999722    35899999999999999999999986   99999999999999999999999999975422 22


Q ss_pred             eeecccccCCCcccccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          399 HISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                      .......++..|+|||.+. ....+.++||||+|+++++|++|+.|+......  +   ....         ..+...+.
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~--~---~~~~---------~~~~~~~~  218 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD--D---QLEI---------IEKILKRP  218 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH--H---HHHH---------HHHHHHTH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccch--h---hhhh---------hhhccccc
Confidence            2334457899999999998 889999999999999999999999998743100  0   0000         01111100


Q ss_pred             hCCC--CCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSK--YKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~--~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +...  ........+.+++.+||+.+|++|||+.++
T Consensus       219 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l  254 (260)
T PF00069_consen  219 LPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEEL  254 (260)
T ss_dssp             HHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHH
T ss_pred             ccccccccchhHHHHHHHHHHHccCChhHCcCHHHH
Confidence            0000  000112689999999999999999999764

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.6e-37  Score=299.79  Aligned_cols=252  Identities=25%  Similarity=0.365  Sum_probs=201.2

Q ss_pred             CCcccCceeccCceeEEeccc-cCCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEe--CCEEEEEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVE--GDQLLLVY  315 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~  315 (511)
                      +|+..+.||.|+||.||++.. .++..+|+|.+....  ....+.+.+|+.++++++|||++++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            477889999999999999974 467899999986432  3334568899999999999999999998864  45689999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES--RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~--~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      ||+++++|.+++.........+++...+.++.+++.||+|||..+  ..+++|+||||+||+++.++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999999765444457899999999999999999999332  335999999999999999999999999999865


Q ss_pred             CCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHh
Q 045835          394 EGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVEL  473 (511)
Q Consensus       394 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  473 (511)
                      ...... .....++..|+|||.+....++.++||||||+++++|++|+.|+....     ...+.             +.
T Consensus       161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~-------------~~  221 (265)
T cd08217         161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-----QLQLA-------------SK  221 (265)
T ss_pred             cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-----HHHHH-------------HH
Confidence            543321 223468899999999998889999999999999999999999986322     11111             11


Q ss_pred             hhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          474 VDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       474 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +........+...+..+.+++.+|++.+|++||++.||
T Consensus       222 ~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~i  259 (265)
T cd08217         222 IKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEEL  259 (265)
T ss_pred             HhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHH
Confidence            11111223444556789999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=4.3e-37  Score=298.23  Aligned_cols=247  Identities=35%  Similarity=0.525  Sum_probs=197.7

Q ss_pred             CcccCceeccCceeEEeccccC-----CcEEEEEEecccCcc-chHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          242 FDSAKKIGEGGFGPVYKGQLAD-----GTIIAVKQLSSKSRQ-GNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       242 f~~~~~lG~G~fG~Vy~g~~~~-----g~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      |.+.+.||+|+||.||+++..+     +..||+|.+...... ....+..|+.+++.++|+|++++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567899999999999997653     378999999765433 5568899999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++++|.+++.....  ..+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||+++....
T Consensus        81 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       81 EYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             eccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccc
Confidence            99999999999965432  12899999999999999999999986   99999999999999999999999999986554


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      ..........++..|+|||.+....++.++||||+|++++||++ |+.|+....     ...+...             +
T Consensus       156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~-----~~~~~~~-------------~  217 (258)
T smart00219      156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS-----NEEVLEY-------------L  217 (258)
T ss_pred             ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHH-------------H
Confidence            42222222336789999999988889999999999999999998 777775321     1111111             1


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ........+...+.++.+++.+|++.+|++|||+.|+
T Consensus       218 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l  254 (258)
T smart00219      218 KKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSEL  254 (258)
T ss_pred             hcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHH
Confidence            1111112233356679999999999999999999874

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.4e-37  Score=314.45  Aligned_cols=201  Identities=25%  Similarity=0.323  Sum_probs=171.7

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEeccc---CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK---SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|++.++||+|+||.||+++.. +++.+|+|.+...   .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46888999999999999999865 4778999998642   1223345788999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++|+|.+++....   ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 ey~~~g~L~~~l~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          81 DYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             eccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            9999999999996532   25889999999999999999999986   99999999999999999999999999975433


Q ss_pred             CCceeecccccCCCcccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 045835          396 DKTHISTRIAGTIGYMAPEYAL-----WGYLTYKADVYSFGIVALEIVSGKNNMSY  446 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gvvl~elltG~~p~~~  446 (511)
                      ..........||+.|+|||++.     ...++.++|||||||++|||++|+.||..
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~  210 (332)
T cd05623         155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA  210 (332)
T ss_pred             CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence            3333333457999999999886     34688999999999999999999999963

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.1e-37  Score=315.15  Aligned_cols=201  Identities=26%  Similarity=0.323  Sum_probs=172.6

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEeccc---CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK---SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|.+.+.||+|+||.||+++.. +++.||+|.+...   .......+.+|..++..++|+||+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47889999999999999999754 5788999998642   1223345788999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++|+|.+++....   ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 Ey~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  154 (331)
T cd05624          81 DYYVGGDLLTLLSKFE---DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ  154 (331)
T ss_pred             eCCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence            9999999999996532   25889999999999999999999986   99999999999999999999999999986544


Q ss_pred             CCceeecccccCCCccccccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 045835          396 DKTHISTRIAGTIGYMAPEYALW-----GYLTYKADVYSFGIVALEIVSGKNNMSY  446 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~S~Gvvl~elltG~~p~~~  446 (511)
                      ..........||..|+|||++.+     +.++.++|||||||++|||++|+.||..
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~  210 (331)
T cd05624         155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence            33332334568999999998875     5678999999999999999999999963

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.6e-37  Score=300.21  Aligned_cols=242  Identities=28%  Similarity=0.401  Sum_probs=184.4

Q ss_pred             CceeccCceeEEecccc----CCcEEEEEEeccc-CccchHHHHHHHHHHhcCCCCCceeEEEEEEe-CCEEEEEEEecC
Q 045835          246 KKIGEGGFGPVYKGQLA----DGTIIAVKQLSSK-SRQGNREFLNEIAMISCLQHPNLVKIHGCCVE-GDQLLLVYEYME  319 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~----~g~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~Ey~~  319 (511)
                      +.||+|+||.||+|...    +...||+|.+... .......+.+|+.+++.++|||+++++++|.. ++..++++||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999753    2457999998643 23345678899999999999999999998864 556789999999


Q ss_pred             CCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCce
Q 045835          320 NNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH  399 (511)
Q Consensus       320 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~  399 (511)
                      +|+|.+++....   ..+++..+..++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||+++........
T Consensus        81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          81 HGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            999999996532   24678888999999999999999886   999999999999999999999999999754322111


Q ss_pred             ---eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          400 ---ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK-NNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       400 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~-~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                         ......++..|+|||.+....++.++|||||||++|||++|+ +|+....     ...+...   ...         
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-----~~~~~~~---~~~---------  217 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-----SFDITVY---LLQ---------  217 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH---Hhc---------
Confidence               111234577899999998889999999999999999999964 4443211     1111111   100         


Q ss_pred             hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       476 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                       ......+...+..+.+++.+||+.+|++||++.||
T Consensus       218 -~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i  252 (262)
T cd05058         218 -GRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSEL  252 (262)
T ss_pred             -CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence             00111122234578999999999999999999875

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.5e-37  Score=305.07  Aligned_cols=265  Identities=24%  Similarity=0.316  Sum_probs=194.2

Q ss_pred             CCcccCceeccCceeEEecccc-CCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      +|+..+.||+|+||.||+|+.. ++..||+|+++...  ......+.+|+.+++.++|||++++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4778899999999999999864 68899999986432  22345788999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      ++ ++|.+++..... ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            97 688888754322 245899999999999999999999986   9999999999999999999999999997543221


Q ss_pred             ceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhH---hhhc-cCchhH
Q 045835          398 THISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWAC---HLQQ-DGKLVE  472 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~---~~~~-~~~~~~  472 (511)
                       .......++..|+|||.+.+. .++.++|||||||+++||+||+.||............+..+..   .... ...+..
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence             112233568899999988654 5789999999999999999999998643211100000000000   0000 000000


Q ss_pred             ---hhhhhhC---CCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          473 ---LVDERLG---SKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       473 ---~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                         .+.....   .........++.+++.+||+.+|++|||+.||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~l  279 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKA  279 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHH
Confidence               0000000   00011234567899999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=4.6e-37  Score=314.15  Aligned_cols=196  Identities=28%  Similarity=0.395  Sum_probs=166.1

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEeccc--CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCC------
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK--SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGD------  309 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------  309 (511)
                      .++|...+.||+|+||.||++.. .+|..||||++...  .......+.+|+.+++.++||||+++++++....      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            47899999999999999999975 46889999998643  2334457889999999999999999999986543      


Q ss_pred             EEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCC
Q 045835          310 QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL  389 (511)
Q Consensus       310 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGl  389 (511)
                      ..++||||+++ +|...+..      .+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       100 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence            57999999976 56555532      3788889999999999999999987   99999999999999999999999999


Q ss_pred             cccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 045835          390 AKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSY  446 (511)
Q Consensus       390 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~  446 (511)
                      ++......  ......||..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       170 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~  224 (359)
T cd07876         170 ARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG  224 (359)
T ss_pred             ccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence            97543221  22335689999999999999999999999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.1e-37  Score=318.96  Aligned_cols=200  Identities=26%  Similarity=0.363  Sum_probs=172.4

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|+..+.||+|+||.||+++.. +++.||+|+++...   ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999754 68899999997432   233456788999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++|+|.+++....    .+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~  153 (360)
T cd05627          81 EFLPGGDMMTLLMKKD----TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK  153 (360)
T ss_pred             eCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence            9999999999986543    4889999999999999999999987   99999999999999999999999999874321


Q ss_pred             CC----------------------------------ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCC
Q 045835          396 DK----------------------------------THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK  441 (511)
Q Consensus       396 ~~----------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~  441 (511)
                      ..                                  ........||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~  233 (360)
T cd05627         154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (360)
T ss_pred             ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence            10                                  00012346899999999999999999999999999999999999


Q ss_pred             CCCCC
Q 045835          442 NNMSY  446 (511)
Q Consensus       442 ~p~~~  446 (511)
                      .||..
T Consensus       234 ~Pf~~  238 (360)
T cd05627         234 PPFCS  238 (360)
T ss_pred             CCCCC
Confidence            99964

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=4.2e-37  Score=298.64  Aligned_cols=247  Identities=23%  Similarity=0.364  Sum_probs=199.3

Q ss_pred             CCcccCceeccCceeEEeccc-cCCcEEEEEEeccc--CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          241 NFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK--SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      +|+..+.||+|+||.||++.. .+++.+|+|.+...  ......++.+|+.++++++||||+++.+++.+.+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            478889999999999999974 46889999998643  233345789999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +++++|.+++....  ...+++...+.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          81 CEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            99999999886432  235789999999999999999999986   9999999999999999999999999998654322


Q ss_pred             ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          398 THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                      .. .....|+..|+|||+..+...+.++|||||||+++||++|+.|+....        ..+...         +++...
T Consensus       156 ~~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--------~~~~~~---------~~~~~~  217 (256)
T cd08218         156 EL-ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN--------MKNLVL---------KIIRGS  217 (256)
T ss_pred             hh-hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC--------HHHHHH---------HHhcCC
Confidence            11 223457889999999998899999999999999999999999985321        111111         111110


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                       ....+......+.+++.+||+.+|++||+|.||
T Consensus       218 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~v  250 (256)
T cd08218         218 -YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSI  250 (256)
T ss_pred             -CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHH
Confidence             112233456679999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=5.3e-37  Score=299.03  Aligned_cols=247  Identities=31%  Similarity=0.461  Sum_probs=197.9

Q ss_pred             CCcccCceeccCceeEEecccc-CCcEEEEEEecccCcc--chHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQ--GNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      +|+..+.||+|+||.||+|... +++.|++|.++.....  ..+.+.+|+.+++.++|+||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4778899999999999999754 6889999998765432  557889999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +++++|.+++....    .+++..+..++.+++.||+|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          81 CSGGTLEELLEHGR----ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             CCCCcHHHHHhhcC----CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence            99999999986532    4788999999999999999999987   9999999999999999999999999998654433


Q ss_pred             ceeec---ccccCCCcccccccccCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchh
Q 045835          398 THIST---RIAGTIGYMAPEYALWGY---LTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLV  471 (511)
Q Consensus       398 ~~~~~---~~~gt~~y~aPE~~~~~~---~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  471 (511)
                      .....   ...++..|+|||++....   .+.++||||||++++||++|+.||.....         .|.......    
T Consensus       154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~---------~~~~~~~~~----  220 (264)
T cd06626         154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN---------EFQIMFHVG----  220 (264)
T ss_pred             CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc---------hHHHHHHHh----
Confidence            22211   245788999999988766   89999999999999999999999863210         111000000    


Q ss_pred             HhhhhhhCCCCCH--HHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          472 ELVDERLGSKYKK--EEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       472 ~~~d~~l~~~~~~--~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                          .......+.  .....+.+++.+||+.+|++|||+.|+
T Consensus       221 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i  258 (264)
T cd06626         221 ----AGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASEL  258 (264)
T ss_pred             ----cCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHH
Confidence                000111122  225667899999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4e-37  Score=301.48  Aligned_cols=249  Identities=29%  Similarity=0.413  Sum_probs=187.0

Q ss_pred             CceeccCceeEEeccccC---CcEEEEEEecccCc-cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCCC
Q 045835          246 KKIGEGGFGPVYKGQLAD---GTIIAVKQLSSKSR-QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENN  321 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~~---g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g  321 (511)
                      +.||+|+||.||+|...+   +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            468999999999997543   45799999875432 33357889999999999999999999999999999999999999


Q ss_pred             CHhHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCcee
Q 045835          322 SLACALFGREN-CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI  400 (511)
Q Consensus       322 sL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~  400 (511)
                      +|.+++..... ....+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99999975432 2234678888899999999999999986   9999999999999999999999999997543322211


Q ss_pred             -ecccccCCCcccccccccC-------CCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchh
Q 045835          401 -STRIAGTIGYMAPEYALWG-------YLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLV  471 (511)
Q Consensus       401 -~~~~~gt~~y~aPE~~~~~-------~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  471 (511)
                       .....++..|+|||++...       .++.++||||||+++|||++ |+.||.....     .......    ..+...
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~-----~~~~~~~----~~~~~~  228 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD-----EQVLTYT----VREQQL  228 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh-----HHHHHHH----hhcccC
Confidence             2234567889999988632       35789999999999999996 9999864321     1111110    001111


Q ss_pred             HhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       472 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .+.++.+    .......+.+++..|+ .+|++|||+.||
T Consensus       229 ~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l  263 (269)
T cd05087         229 KLPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEV  263 (269)
T ss_pred             CCCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHH
Confidence            1111111    1123345788899998 589999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=5e-37  Score=335.60  Aligned_cols=250  Identities=22%  Similarity=0.316  Sum_probs=194.9

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|++.++||+|+||.||+|... +++.||+|+++...   ....+.|.+|+.++++++||||+++++++.+++..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57889999999999999999754 58899999997542   223457899999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecC
Q 045835          316 EYMENNSLACALFGREN-------CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFG  388 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfG  388 (511)
                      ||+++|+|.+++.....       ....+++...++++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            99999999999864211       1234677888999999999999999986   9999999999999999999999999


Q ss_pred             CcccCCCCC-----------------ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccc
Q 045835          389 LAKLDEGDK-----------------THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALE  451 (511)
Q Consensus       389 la~~~~~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~  451 (511)
                      +++......                 ........||+.|+|||++.+..++.++|||||||+++||+||+.||...... 
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~-  237 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR-  237 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh-
Confidence            998552110                 00112246899999999999999999999999999999999999998632110 


Q ss_pred             ccccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCc
Q 045835          452 FDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTM  508 (511)
Q Consensus       452 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  508 (511)
                          ... +      .   ..+.++... ....+.+..+.+++.+|++.+|++||+.
T Consensus       238 ----ki~-~------~---~~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss  279 (932)
T PRK13184        238 ----KIS-Y------R---DVILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSS  279 (932)
T ss_pred             ----hhh-h------h---hhccChhhc-cccccCCHHHHHHHHHHccCChhhCcCH
Confidence                000 0      0   000111000 0012334568899999999999999864

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=7.7e-37  Score=301.63  Aligned_cols=260  Identities=24%  Similarity=0.327  Sum_probs=196.5

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      ++|+..+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|+.++++++|||++++++++...+..++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888999999999999999865 58899999986432  2334568899999999999999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      |+++++|..++...    ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          81 YCDHTVLNELEKNP----RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             ccCccHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            99999888876432    24899999999999999999999986   999999999999999999999999999865433


Q ss_pred             CceeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhcc-CchhHhh
Q 045835          397 KTHISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD-GKLVELV  474 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~  474 (511)
                      .. ......++..|+|||.+.+ ..++.++||||||++++||++|+.||......+    .+.......... ....++.
T Consensus       154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07847         154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD----QLYLIRKTLGDLIPRHQQIF  228 (286)
T ss_pred             cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCChHHhhhc
Confidence            21 1123457788999999875 468899999999999999999999986433111    011110000000 0000000


Q ss_pred             ----------hhhhCCCCC-----HHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          475 ----------DERLGSKYK-----KEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       475 ----------d~~l~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                                .+......+     ......+.+++.+||+.+|++|||+.|+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ei  280 (286)
T cd07847         229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEEL  280 (286)
T ss_pred             ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHH
Confidence                      000000000     1224678899999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.1e-37  Score=311.33  Aligned_cols=198  Identities=19%  Similarity=0.270  Sum_probs=164.0

Q ss_pred             ccCceecc--CceeEEeccc-cCCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          244 SAKKIGEG--GFGPVYKGQL-ADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       244 ~~~~lG~G--~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      +.++||+|  +|++||++.. .+|+.||+|++....  ......+.+|+.+++.++||||++++++|..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            46789999  7899999975 478999999997542  223346778999999999999999999999999999999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      ++|+|.+++..+..  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.++++||+.+........
T Consensus        82 ~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          82 AYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             CCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            99999999865422  24899999999999999999999986   99999999999999999999999987543221110


Q ss_pred             ------eeecccccCCCccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 045835          399 ------HISTRIAGTIGYMAPEYALW--GYLTYKADVYSFGIVALEIVSGKNNMSY  446 (511)
Q Consensus       399 ------~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~Gvvl~elltG~~p~~~  446 (511)
                            .......++..|+|||++..  ..++.++|||||||+++||++|+.||..
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  212 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  212 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence                  00112346778999999876  4689999999999999999999999964

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.9e-37  Score=298.80  Aligned_cols=241  Identities=27%  Similarity=0.447  Sum_probs=193.2

Q ss_pred             cCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecC
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYME  319 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~  319 (511)
                      ++|++.+.||+|+||.||++.. +++.||+|.++...  ....+.+|+.++++++|||++++++++... ..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4578889999999999999975 57789999986532  345789999999999999999999998764 5789999999


Q ss_pred             CCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCce
Q 045835          320 NNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH  399 (511)
Q Consensus       320 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~  399 (511)
                      +++|.+++....  ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......  
T Consensus        82 ~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--  154 (254)
T cd05083          82 KGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--  154 (254)
T ss_pred             CCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC--
Confidence            999999996543  235889999999999999999999876   9999999999999999999999999997543221  


Q ss_pred             eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhh
Q 045835          400 ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERL  478 (511)
Q Consensus       400 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  478 (511)
                        .....+..|+|||.+.++.++.++||||||++++||++ |+.||....        ..++          .+.+....
T Consensus       155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------~~~~----------~~~~~~~~  214 (254)
T cd05083         155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS--------LKEV----------KECVEKGY  214 (254)
T ss_pred             --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC--------HHHH----------HHHHhCCC
Confidence              11234567999999988899999999999999999998 898886322        1111          11111111


Q ss_pred             CCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          479 GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       479 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ....+...+..+.+++.+||+.+|++||++.+|
T Consensus       215 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l  247 (254)
T cd05083         215 RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKL  247 (254)
T ss_pred             CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            222233445678999999999999999999874

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-37  Score=302.65  Aligned_cols=247  Identities=29%  Similarity=0.478  Sum_probs=194.9

Q ss_pred             cCCcccCceeccCceeEEecccc-CCc----EEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGT----IIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~----~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  313 (511)
                      .+|+..+.||+|+||.||+|... +|.    .+|+|.+.... .....++.+|+.++++++|||+++++++|.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            46788899999999999999754 232    58999887553 3344678899999999999999999999987 78899


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      |+||+++|+|.+++....   ..+++.....++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++..
T Consensus        86 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHK---DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             EEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence            999999999999996543   24899999999999999999999976   999999999999999999999999999865


Q ss_pred             CCCCceee-cccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchh
Q 045835          394 EGDKTHIS-TRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLV  471 (511)
Q Consensus       394 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  471 (511)
                      ........ ....++..|+|||.+....++.++|+||||++++|+++ |+.|+.....        .++.          
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~----------  221 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--------VEIP----------  221 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--------HHHH----------
Confidence            43322211 11223568999999988899999999999999999999 9999863221        1111          


Q ss_pred             HhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       472 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +.+........+..+...+.+++.+||..+|.+||++.++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l  261 (279)
T cd05057         222 DLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKEL  261 (279)
T ss_pred             HHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence            1111111112223344578899999999999999998764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-37  Score=303.01  Aligned_cols=250  Identities=26%  Similarity=0.419  Sum_probs=199.8

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      .++|++.+.||+|+||.||++... ++..+|+|.++.........|.+|++++++++|||++++++.+..+...++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            467889999999999999999864 6889999999866655667899999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +++++|.+++....   ..+++.....++.|++.||+|||+.+   |+|+||||+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (280)
T cd06611          84 CDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL  157 (280)
T ss_pred             cCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence            99999999986532   35899999999999999999999987   9999999999999999999999999987543322


Q ss_pred             ceeecccccCCCcccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhH
Q 045835          398 THISTRIAGTIGYMAPEYAL-----WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVE  472 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  472 (511)
                      . ......++..|+|||.+.     ...++.++||||||+++|||++|+.|+.....        .+....... .    
T Consensus       158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~-~----  223 (280)
T cd06611         158 Q-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP--------MRVLLKILK-S----  223 (280)
T ss_pred             c-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH--------HHHHHHHhc-C----
Confidence            1 122346888999999875     34577899999999999999999999863221        000000000 0    


Q ss_pred             hhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          473 LVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       473 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                         .......+......+.+++.+||+.+|.+||++.+|
T Consensus       224 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  259 (280)
T cd06611         224 ---EPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAEL  259 (280)
T ss_pred             ---CCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHH
Confidence               000111223345678899999999999999999764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.4e-37  Score=301.88  Aligned_cols=259  Identities=26%  Similarity=0.360  Sum_probs=199.5

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccCc-cchHHHHHHHHHHhcCCCCCceeEEEEEEeC--CEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR-QGNREFLNEIAMISCLQHPNLVKIHGCCVEG--DQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~  315 (511)
                      ++|+..+.||.|++|.||++... +++.+|+|.+..... .....+.+|++++++++||||++++++|.+.  +..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            46888899999999999999864 578999999875432 3456789999999999999999999998754  4789999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++++|.+++.........+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            999999999987643333446889999999999999999999986   99999999999999999999999999875432


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      ...   ....++..|+|||.+.+..++.++||||||+++|||++|+.|+............+..+...    .....+.+
T Consensus       158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~  230 (287)
T cd06621         158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNPELKD  230 (287)
T ss_pred             ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCchhhcc
Confidence            211   23457888999999998899999999999999999999999987432111111112222111    00011100


Q ss_pred             hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       476 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      . .  .........+.+++.+||+.+|++|||+.||
T Consensus       231 ~-~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ei  263 (287)
T cd06621         231 E-P--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDM  263 (287)
T ss_pred             C-C--CCCCchHHHHHHHHHHHcCCCcccCCCHHHH
Confidence            0 0  0011235678999999999999999999874

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5e-37  Score=313.58  Aligned_cols=192  Identities=24%  Similarity=0.331  Sum_probs=164.0

Q ss_pred             HhcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          238 ATNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       238 ~~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      ...+|++.+.||+|+||.||+|+.. ++..||+|.....      ....|+.++++++||||+++++++......++|+|
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            3467999999999999999999865 4678999975432      23569999999999999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      ++. ++|.+++....   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       138 ~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  210 (357)
T PHA03209        138 HYS-SDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA  210 (357)
T ss_pred             ccC-CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence            995 58888875432   35899999999999999999999986   999999999999999999999999999753322


Q ss_pred             CceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 045835          397 KTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNM  444 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~  444 (511)
                      ..  .....||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus       211 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        211 PA--FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             cc--cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            11  22356899999999999999999999999999999999966554

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.1e-37  Score=307.92  Aligned_cols=247  Identities=28%  Similarity=0.476  Sum_probs=192.4

Q ss_pred             cCCcccCceeccCceeEEecccc-CCc----EEEEEEecccCc-cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGT----IIAVKQLSSKSR-QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~----~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  313 (511)
                      ++|+..+.||+|+||.||+|... ++.    .||+|.+..... ....++.+|+.+++.++||||++++|+|... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            46778899999999999999753 343    578998865432 3334788999999999999999999999754 4678


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      ++||+++|+|.+++....   ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++..
T Consensus        86 v~e~~~~g~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHK---DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             eehhcCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence            999999999999986542   25889999999999999999999986   999999999999999999999999999865


Q ss_pred             CCCCce-eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchh
Q 045835          394 EGDKTH-ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLV  471 (511)
Q Consensus       394 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  471 (511)
                      ...... ......++..|+|||++.+..++.++||||||+++|||++ |+.|+....     .....++           
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~-----~~~~~~~-----------  223 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP-----TREIPDL-----------  223 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHH-----------
Confidence            432221 1122345678999999998899999999999999999997 888885321     0111111           


Q ss_pred             HhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       472 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                        +........+..+...+.+++..||..+|++||++.||
T Consensus       224 --~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l  261 (303)
T cd05110         224 --LEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKEL  261 (303)
T ss_pred             --HHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence              11111111122344578999999999999999999874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.6e-37  Score=302.50  Aligned_cols=235  Identities=26%  Similarity=0.400  Sum_probs=185.2

Q ss_pred             CceeccCceeEEeccccC--------CcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          246 KKIGEGGFGPVYKGQLAD--------GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~~--------g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      +.||+|+||.||+|....        ...+|+|.+........+.+.+|+.+++.++|||++++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999997532        234888888765555566889999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCC--------eEEeecCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN--------PKISDFGL  389 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~--------~kl~DfGl  389 (511)
                      +++|+|.+++....   ..+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.        ++++|||+
T Consensus        81 ~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~  154 (258)
T cd05078          81 VKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI  154 (258)
T ss_pred             CCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccc
Confidence            99999999996543   25889999999999999999999986   999999999999987765        59999999


Q ss_pred             cccCCCCCceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCC-CCCCCCCcccccccchhhhhHhhhcc
Q 045835          390 AKLDEGDKTHISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGK-NNMSYAPALEFDCTCLLDWACHLQQD  467 (511)
Q Consensus       390 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~-~p~~~~~~~~~~~~~l~~~~~~~~~~  467 (511)
                      +......     ....++..|+|||++.+. .++.++||||||+++|||++|. .|+.....        ...       
T Consensus       155 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~--------~~~-------  214 (258)
T cd05078         155 SITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS--------QKK-------  214 (258)
T ss_pred             ccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH--------HHH-------
Confidence            8754321     223578889999999864 5899999999999999999995 44432110        000       


Q ss_pred             CchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          468 GKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       468 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                         ..+...  ....+.....++.+++.+||+.+|++|||+.||
T Consensus       215 ---~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  253 (258)
T cd05078         215 ---LQFYED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAI  253 (258)
T ss_pred             ---HHHHHc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHH
Confidence               011111  112233334578999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.1e-37  Score=312.19  Aligned_cols=251  Identities=27%  Similarity=0.416  Sum_probs=196.2

Q ss_pred             cCCcccCceeccCceeEEecccc--------CCcEEEEEEecccC-ccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCC
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA--------DGTIIAVKQLSSKS-RQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGD  309 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~--------~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~  309 (511)
                      .+|.+.+.||+|+||.||++...        .+..||+|.++... ....+++.+|+.+++++ +||||++++++|...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            46888999999999999999631        12368999887532 33456789999999999 8999999999999999


Q ss_pred             EEEEEEEecCCCCHhHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEc
Q 045835          310 QLLLVYEYMENNSLACALFGREN------------CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD  377 (511)
Q Consensus       310 ~~~lV~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld  377 (511)
                      ..++++||+++|+|.+++.....            ....++|.++..++.|++.||+|||+.+   ++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence            99999999999999999865321            2235889999999999999999999986   99999999999999


Q ss_pred             CCCCeEEeecCCcccCCCCCcee-ecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCccccccc
Q 045835          378 RDLNPKISDFGLAKLDEGDKTHI-STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCT  455 (511)
Q Consensus       378 ~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~  455 (511)
                      .++.+||+|||+++......... .....++..|+|||.+....++.++||||||+++|||++ |+.|+....       
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-------  241 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-------  241 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-------
Confidence            99999999999998544322111 112234567999999999999999999999999999998 888775322       


Q ss_pred             chhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          456 CLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       456 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                       ..++..          .+........+......+.+++.+|++.+|++|||+.||
T Consensus       242 -~~~~~~----------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~el  286 (334)
T cd05100         242 -VEELFK----------LLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQL  286 (334)
T ss_pred             -HHHHHH----------HHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHH
Confidence             111111          111111122233445678999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=4.7e-37  Score=313.52  Aligned_cols=197  Identities=27%  Similarity=0.369  Sum_probs=166.4

Q ss_pred             HhcCCcccCceeccCceeEEecccc-CCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeC------
Q 045835          238 ATNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEG------  308 (511)
Q Consensus       238 ~~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------  308 (511)
                      ..++|...+.||+|+||.||++... .++.||||++....  ......+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            3478999999999999999999753 58899999987542  23345678999999999999999999998643      


Q ss_pred             CEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecC
Q 045835          309 DQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFG  388 (511)
Q Consensus       309 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfG  388 (511)
                      ...++||||+++ +|.+.+..      .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence            357999999975 56666532      3788899999999999999999987   9999999999999999999999999


Q ss_pred             CcccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 045835          389 LAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSY  446 (511)
Q Consensus       389 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~  446 (511)
                      +++......  ......||..|+|||.+.+..++.++|||||||+++||++|+.||..
T Consensus       165 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  220 (355)
T cd07874         165 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG  220 (355)
T ss_pred             ccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            998543221  22335689999999999988999999999999999999999999964

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4.9e-37  Score=302.75  Aligned_cols=250  Identities=25%  Similarity=0.386  Sum_probs=192.5

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC-ccchHHHHHHHHH-HhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS-RQGNREFLNEIAM-ISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      ++|++.+.||+|+||.||+++.. +|+.||+|+++... ......+..|+.. ++.++|||++++++++...+..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46888999999999999999764 68999999987542 2333456666665 667799999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      |++ |+|.+++.........+++...+.++.|++.||+|||++.  +++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            997 6888887654333456899999999999999999999862  3999999999999999999999999999865332


Q ss_pred             CceeecccccCCCccccccccc----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhH
Q 045835          397 KTHISTRIAGTIGYMAPEYALW----GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVE  472 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  472 (511)
                      .  ..+...++..|+|||.+..    ..++.++|+||||+++|||++|+.|+.....   .   ..          .+..
T Consensus       158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~---~~----------~~~~  219 (283)
T cd06617         158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT---P---FQ----------QLKQ  219 (283)
T ss_pred             c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc---C---HH----------HHHH
Confidence            1  1223467889999998764    4568899999999999999999999853210   0   00          0111


Q ss_pred             hhhhhhCCCCC-HHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          473 LVDERLGSKYK-KEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       473 ~~d~~l~~~~~-~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .+.. .....+ ...+..+.+++.+||+.+|++||++.||
T Consensus       220 ~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~i  258 (283)
T cd06617         220 VVEE-PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPEL  258 (283)
T ss_pred             HHhc-CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHH
Confidence            1111 111111 1235678999999999999999999764

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=298.53  Aligned_cols=264  Identities=23%  Similarity=0.309  Sum_probs=196.7

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecc--cCccchHHHHHHHHHHhcCCCCCceeEEEEEEe-----CCE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHPNLVKIHGCCVE-----GDQ  310 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-----~~~  310 (511)
                      ...|...+.||+|.||.|.++.. .+|+.||||++..  ......+.-.+|+++|+.++|+||+.+.+....     -+.
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            34566678999999999999964 4689999999973  344455678899999999999999999999865     357


Q ss_pred             EEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCc
Q 045835          311 LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA  390 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla  390 (511)
                      .++|+|+|+. +|...++...    .|+.....-+..|+++||+|+|+.+   |+||||||+|+|++.+...||+|||||
T Consensus       101 vYiV~elMet-DL~~iik~~~----~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA  172 (359)
T KOG0660|consen  101 VYLVFELMET-DLHQIIKSQQ----DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA  172 (359)
T ss_pred             eEEehhHHhh-HHHHHHHcCc----cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence            8999999954 7888886543    4889999999999999999999987   999999999999999999999999999


Q ss_pred             ccCCCC-CceeecccccCCCcccccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccc------cchhhhhH
Q 045835          391 KLDEGD-KTHISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDC------TCLLDWAC  462 (511)
Q Consensus       391 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~------~~l~~~~~  462 (511)
                      +..... .....+..+.|..|.|||.+. ...|+...||||.|||+.||++|++-|........-.      ....+...
T Consensus       173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l  252 (359)
T KOG0660|consen  173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL  252 (359)
T ss_pred             eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence            976432 122235567899999999876 4589999999999999999999999887433211000      00000011


Q ss_pred             hhhccCchhHhhhhhhC-CCCC-----HHHHHHHHHHHHHcCCCCCCCCCCcCC
Q 045835          463 HLQQDGKLVELVDERLG-SKYK-----KEEAERMIKVSLLCTNASPSLRPTMSE  510 (511)
Q Consensus       463 ~~~~~~~~~~~~d~~l~-~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~e  510 (511)
                      .....+.....+..... ...+     +......++|+.+||..||.+|+|+.|
T Consensus       253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~e  306 (359)
T KOG0660|consen  253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEE  306 (359)
T ss_pred             HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHH
Confidence            11111112222221110 0001     133456789999999999999999875

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.1e-36  Score=297.46  Aligned_cols=247  Identities=26%  Similarity=0.329  Sum_probs=194.3

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC-----ccchHHHHHHHHHHhcCCCCCceeEEEEEEeC--CEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS-----RQGNREFLNEIAMISCLQHPNLVKIHGCCVEG--DQL  311 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~  311 (511)
                      ++|++.++||+|+||.||+|... ++..||||.+....     ......+.+|+.++++++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57889999999999999999754 58899999886322     12235678899999999999999999998763  467


Q ss_pred             EEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcc
Q 045835          312 LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK  391 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~  391 (511)
                      +++|||+++++|.+++....    .+++....+++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||+++
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~  154 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASK  154 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccc
Confidence            89999999999999986442    3788889999999999999999986   9999999999999999999999999997


Q ss_pred             cCCCCCc--eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCc
Q 045835          392 LDEGDKT--HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGK  469 (511)
Q Consensus       392 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  469 (511)
                      .......  .......++..|+|||.+.+..++.++|||||||++|||++|+.|+.....       ...          
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-------~~~----------  217 (265)
T cd06652         155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA-------MAA----------  217 (265)
T ss_pred             ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch-------HHH----------
Confidence            5432111  111234588899999999888899999999999999999999999863211       000          


Q ss_pred             hhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          470 LVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       470 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..++.........+......+.+++.+|+. +|++||+++||
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~i  258 (265)
T cd06652         218 IFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADEL  258 (265)
T ss_pred             HHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHH
Confidence            011111111223445556678889999995 89999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.2e-36  Score=303.48  Aligned_cols=197  Identities=25%  Similarity=0.393  Sum_probs=160.1

Q ss_pred             cCceeccCceeEEecccc---CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEe--CCEEEEEEEecC
Q 045835          245 AKKIGEGGFGPVYKGQLA---DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVE--GDQLLLVYEYME  319 (511)
Q Consensus       245 ~~~lG~G~fG~Vy~g~~~---~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey~~  319 (511)
                      .++||+|+||.||+|+..   +++.+|+|.+....  ....+.+|+.++++++||||+++++++..  ....++++||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999754   46789999986532  23467899999999999999999999864  456889999986


Q ss_pred             CCCHhHHHhcCC-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEE----cCCCCeEEeecCCc
Q 045835          320 NNSLACALFGRE-----NCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL----DRDLNPKISDFGLA  390 (511)
Q Consensus       320 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILl----d~~~~~kl~DfGla  390 (511)
                      + +|.+++....     .....+++.....++.|++.||+|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            5 7877764321     11235889999999999999999999987   9999999999999    45678999999999


Q ss_pred             ccCCCCCce--eecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 045835          391 KLDEGDKTH--ISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYA  447 (511)
Q Consensus       391 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~  447 (511)
                      +........  ......||+.|+|||++.+. .++.++||||+||+++||++|++||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            865432211  12345689999999998764 6899999999999999999999999643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.2e-37  Score=304.52  Aligned_cols=261  Identities=23%  Similarity=0.356  Sum_probs=196.9

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccCc--cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR--QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      ++|+..++||+|+||.||+|... +++.||+|++.....  .....+.+|+++++.++||||+++++++..++..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888999999999999999865 588999999864322  234568899999999999999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      |+++++|..+....    ..++|..++.++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07846          81 FVDHTVLDDLEKYP----NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  153 (286)
T ss_pred             cCCccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence            99999998876433    24899999999999999999999986   999999999999999999999999999865433


Q ss_pred             CceeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          397 KTHISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      . .......++..|+|||++.+ ..++.++||||||++++||++|++|+......+ ....+..+...+.  ....+..+
T Consensus       154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~  229 (286)
T cd07846         154 G-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID-QLYHIIKCLGNLI--PRHQEIFQ  229 (286)
T ss_pred             c-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH-HHHHHHHHhCCCc--hhhHHHhc
Confidence            2 22233457889999998875 457889999999999999999998886332110 0000011000000  00000100


Q ss_pred             ------hhhCCC---------CCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          476 ------ERLGSK---------YKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       476 ------~~l~~~---------~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                            ......         ..+..+..+.+++.+||+.+|++||++.||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i  280 (286)
T cd07846         230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQL  280 (286)
T ss_pred             cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHH
Confidence                  000000         011335679999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-37  Score=306.10  Aligned_cols=246  Identities=23%  Similarity=0.279  Sum_probs=197.4

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccCc---cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR---QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|+..+.||+|+||.||++... +++.+|+|.+.....   ...+.+.+|+++++.++|+||+++++++.+....++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888999999999999999765 488999999975432   24456889999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+.+++|.+++....  ...+++.....++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          81 DYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             EecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            9999999999986432  245899999999999999999999986   99999999999999999999999999875422


Q ss_pred             CCce----------------------------eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 045835          396 DKTH----------------------------ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYA  447 (511)
Q Consensus       396 ~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~  447 (511)
                      ....                            ......|+..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            1110                            011235788999999999888999999999999999999999998633


Q ss_pred             CcccccccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCC
Q 045835          448 PALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPT  507 (511)
Q Consensus       448 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs  507 (511)
                      ...                 ....++.+..............+.+++.+||+.+|++|||
T Consensus       236 ~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s  278 (316)
T cd05574         236 NRD-----------------ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLG  278 (316)
T ss_pred             chH-----------------HHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCC
Confidence            210                 0111222222111111224678999999999999999999

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.8e-37  Score=302.45  Aligned_cols=251  Identities=25%  Similarity=0.402  Sum_probs=198.3

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEeccc-CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK-SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      ++|++.+.||+|+||.||++... ++..+|+|.++.. .......+.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            35788999999999999999865 6889999988754 233346789999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +++++|..++..... ...+++..+..++.+++.||.|||+..  +++|+||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          81 MDAGSLDKLYAGGVA-TEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             cCCCCHHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            999999998865321 235899999999999999999999742  49999999999999999999999999997543221


Q ss_pred             ceeecccccCCCcccccccccC------CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchh
Q 045835          398 THISTRIAGTIGYMAPEYALWG------YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLV  471 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  471 (511)
                         .....++..|+|||.+.+.      .++.++|||||||++|||++|+.||.....        ..+..      .+.
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--------~~~~~------~~~  220 (286)
T cd06622         158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY--------ANIFA------QLS  220 (286)
T ss_pred             ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch--------hhHHH------HHH
Confidence               2234578899999988544      358899999999999999999999853210        00000      011


Q ss_pred             HhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       472 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .+.+. .....+.+...++.+++.+||+.+|++||++.++
T Consensus       221 ~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l  259 (286)
T cd06622         221 AIVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQL  259 (286)
T ss_pred             HHhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHH
Confidence            11111 1123445567788999999999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=9.2e-37  Score=296.48  Aligned_cols=233  Identities=27%  Similarity=0.436  Sum_probs=183.9

Q ss_pred             CceeccCceeEEeccccCCc-----------EEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEE
Q 045835          246 KKIGEGGFGPVYKGQLADGT-----------IIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~~g~-----------~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  314 (511)
                      +.||+|+||.||+|...+..           .+++|.+...... ...|.+|+.++++++|||+++++++|.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46899999999999875432           5788887654433 6789999999999999999999999988 778999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCC-------CeEEeec
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL-------NPKISDF  387 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~-------~~kl~Df  387 (511)
                      +||+++|+|.+++.....   .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++       .+||+||
T Consensus        79 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df  152 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDP  152 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCC
Confidence            999999999999965432   5889999999999999999999886   99999999999999888       7999999


Q ss_pred             CCcccCCCCCceeecccccCCCcccccccccC--CCCcchhHHHHHHHHHHHHhC-CCCCCCCCcccccccchhhhhHhh
Q 045835          388 GLAKLDEGDKTHISTRIAGTIGYMAPEYALWG--YLTYKADVYSFGIVALEIVSG-KNNMSYAPALEFDCTCLLDWACHL  464 (511)
Q Consensus       388 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DV~S~Gvvl~elltG-~~p~~~~~~~~~~~~~l~~~~~~~  464 (511)
                      |++......     ....++..|+|||++...  .++.++||||||+++|||++| ..|+.....        ..+....
T Consensus       153 g~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~--------~~~~~~~  219 (259)
T cd05037         153 GIPITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS--------SEKERFY  219 (259)
T ss_pred             Ccccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc--------hhHHHHH
Confidence            999854331     123466789999998876  789999999999999999994 666543210        0111000


Q ss_pred             hccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          465 QQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       465 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .         ...   ..+......+.+++.+||+.+|++|||+.||
T Consensus       220 ~---------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i  254 (259)
T cd05037         220 Q---------DQH---RLPMPDCAELANLINQCWTYDPTKRPSFRAI  254 (259)
T ss_pred             h---------cCC---CCCCCCchHHHHHHHHHhccChhhCCCHHHH
Confidence            0         000   0111112678999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=5.8e-37  Score=300.21  Aligned_cols=249  Identities=26%  Similarity=0.393  Sum_probs=184.5

Q ss_pred             CceeccCceeEEeccccC---CcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCCC
Q 045835          246 KKIGEGGFGPVYKGQLAD---GTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENN  321 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~~---g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g  321 (511)
                      +.||+|+||.||+|...+   ...+|+|.+.... ......|.+|+..++.++||||+++++.|.+....++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            368999999999996543   3468888876443 233457889999999999999999999999999999999999999


Q ss_pred             CHhHHHhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCcee
Q 045835          322 SLACALFGRENC-ELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI  400 (511)
Q Consensus       322 sL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~  400 (511)
                      +|.+++...... ....++.....++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            999999764321 233568888999999999999999986   9999999999999999999999999987533222111


Q ss_pred             -ecccccCCCccccccccc-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchh
Q 045835          401 -STRIAGTIGYMAPEYALW-------GYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLV  471 (511)
Q Consensus       401 -~~~~~gt~~y~aPE~~~~-------~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  471 (511)
                       .....++..|+|||++..       ..++.++|||||||++|||++ |+.|+......     ....   ..... ...
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-----~~~~---~~~~~-~~~  228 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-----QVLK---QVVRE-QDI  228 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-----HHHH---HHhhc-cCc
Confidence             122345678999998743       357889999999999999999 77777532210     0000   00000 001


Q ss_pred             HhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       472 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .+.++    ..+......+.+++..|+ .+|++|||+.||
T Consensus       229 ~~~~~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v  263 (269)
T cd05042         229 KLPKP----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEV  263 (269)
T ss_pred             cCCCC----cccccCCHHHHHHHHHHh-cCcccccCHHHH
Confidence            11111    122334456777888898 599999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1e-36  Score=298.85  Aligned_cols=251  Identities=27%  Similarity=0.382  Sum_probs=194.4

Q ss_pred             CCcccCceeccCceeEEeccc-cCCcEEEEEEecccCc----------cchHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 045835          241 NFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSR----------QGNREFLNEIAMISCLQHPNLVKIHGCCVEGD  309 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~----------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~  309 (511)
                      +|...+.||+|+||.||+|.. .+++.+|+|.++....          ...+.+.+|+.+++.++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            466788999999999999974 4688999998863211          01235788999999999999999999999999


Q ss_pred             EEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCC
Q 045835          310 QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL  389 (511)
Q Consensus       310 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGl  389 (511)
                      ..++||||+++++|.+++...    ..+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~  154 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGI  154 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccc
Confidence            999999999999999998654    25889999999999999999999986   99999999999999999999999999


Q ss_pred             cccCCCCCce-eecccccCCCcccccccccCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhc
Q 045835          390 AKLDEGDKTH-ISTRIAGTIGYMAPEYALWGY--LTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQ  466 (511)
Q Consensus       390 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~  466 (511)
                      ++........ ......++..|+|||.+....  ++.++||||||++++|+++|+.|+.....       .... .....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-------~~~~-~~~~~  226 (272)
T cd06629         155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-------IAAM-FKLGN  226 (272)
T ss_pred             cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-------HHHH-HHhhc
Confidence            9864432211 122346788999999987654  88999999999999999999999853221       0000 00000


Q ss_pred             cCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          467 DGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       467 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .. .    ..........+....+.+++.+||+.+|++|||+.||
T Consensus       227 ~~-~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  266 (272)
T cd06629         227 KR-S----APPIPPDVSMNLSPVALDFLNACFTINPDNRPTAREL  266 (272)
T ss_pred             cc-c----CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHH
Confidence            00 0    0001111222345678999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6.5e-37  Score=336.02  Aligned_cols=254  Identities=22%  Similarity=0.333  Sum_probs=195.6

Q ss_pred             HhcCCcccCceeccCceeEEecccc-CCcEEEEEEeccc--CccchHHHHHHHHHHhcCCCCCceeEEEEEEe--CCEEE
Q 045835          238 ATNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK--SRQGNREFLNEIAMISCLQHPNLVKIHGCCVE--GDQLL  312 (511)
Q Consensus       238 ~~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~  312 (511)
                      ..++|.+.++||+|+||.||++... ++..+|+|.+...  .......|..|+.++++|+|||||++++++.+  ...++
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            3468999999999999999999754 5778999998643  22334578899999999999999999998865  35689


Q ss_pred             EEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC----CCeEEccCCCCCeEEcCC---------
Q 045835          313 LVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESR----FKIVHRDIKATNVLLDRD---------  379 (511)
Q Consensus       313 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~----~~iiH~Dlk~~NILld~~---------  379 (511)
                      +||||+++|+|.++|.........+++..++.|+.||+.||+|||+.+.    .+|+||||||+||||+.+         
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            9999999999999997543333468999999999999999999998542    359999999999999642         


Q ss_pred             --------CCeEEeecCCcccCCCCCceeecccccCCCccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 045835          380 --------LNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALW--GYLTYKADVYSFGIVALEIVSGKNNMSYAPA  449 (511)
Q Consensus       380 --------~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~  449 (511)
                              ..+||+|||++.......  ......||+.|+|||++..  ..++.++|||||||+||||+||+.||.....
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~  248 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN  248 (1021)
T ss_pred             cccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence                    348999999998653322  1233568999999999864  4588999999999999999999999863221


Q ss_pred             ccccccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          450 LEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       450 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                             .......+...        +.+   .....+..+.+|+..||+.+|.+||++.|+
T Consensus       249 -------~~qli~~lk~~--------p~l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~Ql  292 (1021)
T PTZ00266        249 -------FSQLISELKRG--------PDL---PIKGKSKELNILIKNLLNLSAKERPSALQC  292 (1021)
T ss_pred             -------HHHHHHHHhcC--------CCC---CcCCCCHHHHHHHHHHhcCChhHCcCHHHH
Confidence                   11111111100        001   011234578899999999999999998764

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-37  Score=300.62  Aligned_cols=253  Identities=27%  Similarity=0.410  Sum_probs=198.6

Q ss_pred             HHhcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCC-----
Q 045835          237 AATNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGD-----  309 (511)
Q Consensus       237 ~~~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~-----  309 (511)
                      .++++|++.+.||+|+||.||+|... +++.+++|.+..... ....+.+|+.+++++ +|+|++++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            35689999999999999999999864 578899999875443 346789999999999 7999999999997644     


Q ss_pred             -EEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecC
Q 045835          310 -QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFG  388 (511)
Q Consensus       310 -~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfG  388 (511)
                       ..++||||+++++|.+++.........+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence             489999999999999998654333456899999999999999999999986   9999999999999999999999999


Q ss_pred             CcccCCCCCceeecccccCCCccccccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHh
Q 045835          389 LAKLDEGDKTHISTRIAGTIGYMAPEYALW-----GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACH  463 (511)
Q Consensus       389 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~  463 (511)
                      ++......... .....++..|+|||.+..     ..++.++|||||||+++||++|+.||......    ..+      
T Consensus       159 ~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~------  227 (275)
T cd06608         159 VSAQLDSTLGR-RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM----RAL------  227 (275)
T ss_pred             cceecccchhh-hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH----HHH------
Confidence            99754332221 223457889999998753     35778999999999999999999998632110    000      


Q ss_pred             hhccCchhHhhhh-hhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          464 LQQDGKLVELVDE-RLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       464 ~~~~~~~~~~~d~-~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                             .++... ......+......+.+++.+||+.+|++|||+.||
T Consensus       228 -------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~l  269 (275)
T cd06608         228 -------FKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEEL  269 (275)
T ss_pred             -------HHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHH
Confidence                   111111 00111122355678999999999999999999874

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=8.1e-37  Score=304.46  Aligned_cols=263  Identities=19%  Similarity=0.309  Sum_probs=194.4

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      ++|...+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            46888999999999999999754 57899999987443 33345678999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      ++ ++|.+++....   ..+++.....++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||++.......
T Consensus        86 ~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          86 LD-KDLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT  158 (301)
T ss_pred             cc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence            97 58888886432   35789999999999999999999986   9999999999999999999999999997543222


Q ss_pred             ceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccc--------cchhhhhHhhhccC
Q 045835          398 THISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDC--------TCLLDWACHLQQDG  468 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~--------~~l~~~~~~~~~~~  468 (511)
                      .. .....++..|+|||.+.+. .++.++|||||||+++||++|+.||......+...        .....|.. .....
T Consensus       159 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  236 (301)
T cd07873         159 KT-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPG-ILSNE  236 (301)
T ss_pred             Cc-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchh-hhccc
Confidence            11 1223568899999988654 57889999999999999999999986432110000        00000100 00000


Q ss_pred             chhHhhhhhhCCC----CCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          469 KLVELVDERLGSK----YKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       469 ~~~~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....-.+.....    ........+.+++.+|++.+|.+|||+.||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~ei  283 (301)
T cd07873         237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEA  283 (301)
T ss_pred             cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence            0000000000000    011234567899999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-37  Score=303.51  Aligned_cols=264  Identities=22%  Similarity=0.339  Sum_probs=199.0

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      ++|+..+.||+|+||.||+|... +++.||+|.++...  ......+.+|++++++++|+||+++++++..++..+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            46888999999999999999865 57899999987532  3344678999999999999999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      |++++.+..+....    ..+++.....++.+++.||+|||+.+   ++|+||+|+||++++++.+||+|||++......
T Consensus        81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          81 YVERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            99987776655332    24889999999999999999999986   999999999999999999999999999865544


Q ss_pred             CceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhh--------hhHhhhcc
Q 045835          397 KTHISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLD--------WACHLQQD  467 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~--------~~~~~~~~  467 (511)
                      .........++..|+|||++... .++.++||||||+++|||++|+.|+......+.. ..+..        +.......
T Consensus       154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07833         154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQL-YLIQKCLGPLPPSHQELFSSN  232 (288)
T ss_pred             ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCHHHhhhcccC
Confidence            33223345678899999999888 8899999999999999999999988643211000 00000        00000000


Q ss_pred             Cch-----hHhhhh-hhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          468 GKL-----VELVDE-RLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       468 ~~~-----~~~~d~-~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...     .+..++ .....++...+.++.+++.+||+.+|++|||+++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  282 (288)
T cd07833         233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDEL  282 (288)
T ss_pred             ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHH
Confidence            000     000000 00001122236779999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.4e-36  Score=311.20  Aligned_cols=196  Identities=26%  Similarity=0.373  Sum_probs=166.4

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeC------C
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEG------D  309 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~  309 (511)
                      .++|...+.||+|+||.||++... .++.||||++....  ......+.+|+.+++.++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            468999999999999999999743 57889999987532  23345788999999999999999999987543      3


Q ss_pred             EEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCC
Q 045835          310 QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL  389 (511)
Q Consensus       310 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGl  389 (511)
                      ..++||||+++ +|.+.+..      .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       103 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence            57999999975 67666632      3788999999999999999999986   99999999999999999999999999


Q ss_pred             cccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 045835          390 AKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSY  446 (511)
Q Consensus       390 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~  446 (511)
                      ++......  ......+|..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       173 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  227 (364)
T cd07875         173 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG  227 (364)
T ss_pred             ccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence            98543321  12334689999999999999999999999999999999999999964

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=8.4e-37  Score=299.17  Aligned_cols=249  Identities=26%  Similarity=0.391  Sum_probs=184.4

Q ss_pred             CceeccCceeEEeccccCC---cEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCCC
Q 045835          246 KKIGEGGFGPVYKGQLADG---TIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENN  321 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~~g---~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g  321 (511)
                      +.||+|+||.||+|...++   ..+++|.+.... ......|.+|+.+++.++||||++++++|.+....++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3699999999999975433   346677765433 334568999999999999999999999999999999999999999


Q ss_pred             CHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC-cee
Q 045835          322 SLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK-THI  400 (511)
Q Consensus       322 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~-~~~  400 (511)
                      +|.+++.........+++.....++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||++....... ...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            999999764333334677788899999999999999886   9999999999999999999999999986422111 111


Q ss_pred             ecccccCCCccccccccc-------CCCCcchhHHHHHHHHHHHHhC-CCCCCCCCcccccccchhhhhHhhhccCchhH
Q 045835          401 STRIAGTIGYMAPEYALW-------GYLTYKADVYSFGIVALEIVSG-KNNMSYAPALEFDCTCLLDWACHLQQDGKLVE  472 (511)
Q Consensus       401 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DV~S~Gvvl~elltG-~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  472 (511)
                      .....++..|+|||++..       ..++.++|||||||++|||+++ ..|+.....        .+...... .+....
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~~~~~~-~~~~~~  228 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--------REVLNHVI-KDQQVK  228 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHH-hhcccc
Confidence            223467889999998743       2457899999999999999974 666642211        11111111 111122


Q ss_pred             hhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          473 LVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       473 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +.++.+..    .....+.+++..|| .+|++||++.||
T Consensus       229 ~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i  262 (268)
T cd05086         229 LFKPQLEL----PYSERWYEVLQFCW-LSPEKRATAEEV  262 (268)
T ss_pred             cCCCccCC----CCcHHHHHHHHHHh-hCcccCCCHHHH
Confidence            23332222    23456788888999 579999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.9e-36  Score=298.79  Aligned_cols=259  Identities=24%  Similarity=0.321  Sum_probs=197.5

Q ss_pred             CCcccCceeccCceeEEecccc-CCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      +|++.+.||+|+||.||+|... +|+.||+|++....  ......+.+|+.++++++|||++++++++..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4778899999999999999854 68999999987543  33346789999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      + +++|.+++....   ..+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++.......
T Consensus        81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            9 999999986543   35899999999999999999999986   9999999999999999999999999998654433


Q ss_pred             ceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccC--------
Q 045835          398 THISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDG--------  468 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~--------  468 (511)
                      ........++..|+|||.+.+. .++.++||||+|++++||++|++++......     ....+........        
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07832         154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-----EQLAIVFRTLGTPNEETWPGL  228 (286)
T ss_pred             CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-----HHHHHHHHHcCCCChHHHhhc
Confidence            2222334688899999988654 5689999999999999999998777532210     0111111100000        


Q ss_pred             ----chhHhhhhhhC----CCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          469 ----KLVELVDERLG----SKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       469 ----~~~~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                          +...+..+...    ....++....+.+++.+|++.+|++|||++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~  279 (286)
T cd07832         229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEA  279 (286)
T ss_pred             cCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHH
Confidence                00000000000    00111234788999999999999999999864

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.5e-36  Score=294.38  Aligned_cols=246  Identities=26%  Similarity=0.402  Sum_probs=197.5

Q ss_pred             CCcccCceeccCceeEEeccc-cCCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          241 NFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      +|+..+.||+|+||.||++.. .+++.+|+|.+....  ......+.+|+.++++++|||++++++.+..++..++|+||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            578889999999999999875 367889999986542  33456789999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCC-CCeEEeecCCcccCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD-LNPKISDFGLAKLDEGD  396 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~-~~~kl~DfGla~~~~~~  396 (511)
                      +++++|.+++....  ...+++..+.+++.+++.||+|||+.+   ++|+||+|+||+++++ ..+||+|||++......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            99999999996543  235889999999999999999999986   9999999999999865 46899999999865432


Q ss_pred             CceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhh
Q 045835          397 KTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDE  476 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  476 (511)
                      ..  .....++..|+|||.+....++.++||||||+++++|++|+.|+....        ....+..         +...
T Consensus       156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~--------~~~~~~~---------~~~~  216 (256)
T cd08220         156 SK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN--------LPALVLK---------IMSG  216 (256)
T ss_pred             cc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc--------hHHHHHH---------HHhc
Confidence            21  223467889999999998889999999999999999999999985322        1111111         1111


Q ss_pred             hhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          477 RLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       477 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                       .....+......+.+++.+||+.+|++|||+.|+
T Consensus       217 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l  250 (256)
T cd08220         217 -TFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQI  250 (256)
T ss_pred             -CCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHH
Confidence             1112233345678999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.2e-36  Score=297.30  Aligned_cols=250  Identities=26%  Similarity=0.419  Sum_probs=198.9

Q ss_pred             CCcccCceeccCceeEEeccc-cCCcEEEEEEecccCc------cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSR------QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  313 (511)
                      +|+..+.||+|+||.||++.. .+++.+|+|.+.....      .....+.+|+.++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999974 5688999999864321      124578899999999999999999999999999999


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCC-CeEEeecCCccc
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL-NPKISDFGLAKL  392 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~-~~kl~DfGla~~  392 (511)
                      |+||+++++|.+++....    .+++.....++.|++.||+|||+.+   ++|+||+|+||+++.++ .+||+|||++..
T Consensus        81 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~  153 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAAR  153 (268)
T ss_pred             EEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence            999999999999986532    5889999999999999999999986   99999999999998776 599999999976


Q ss_pred             CCCCCc---eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCc
Q 045835          393 DEGDKT---HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGK  469 (511)
Q Consensus       393 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  469 (511)
                      ......   .......++..|+|||.+....++.++||||+|++++||++|+.|+.....     .......        
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~--------  220 (268)
T cd06630         154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH-----SNHLALI--------  220 (268)
T ss_pred             cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-----cchHHHH--------
Confidence            543211   111234578899999999888899999999999999999999999863221     0011110        


Q ss_pred             hhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          470 LVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       470 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                       .+..........+......+.+++.+|++.+|++||++.|+
T Consensus       221 -~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~l  261 (268)
T cd06630         221 -FKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSREL  261 (268)
T ss_pred             -HHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHH
Confidence             11111111233445566789999999999999999999764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.3e-36  Score=297.41  Aligned_cols=244  Identities=30%  Similarity=0.429  Sum_probs=196.7

Q ss_pred             CCcccCceeccCceeEEeccc-cCCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          241 NFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      -|+..+.||+|+||.||+|.. .++..+|+|.+.... ......+.+|+.++++++||||+++++++.+++..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            367788999999999999975 468899999886433 233457889999999999999999999999999999999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      ++++|.+++...     .+++.....++.+++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        85 ~~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06641          85 GGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence            999999988532     4889999999999999999999986   99999999999999999999999999975543221


Q ss_pred             eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhh
Q 045835          399 HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERL  478 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  478 (511)
                      . .....++..|+|||.+....++.++|||||||+++||++|+.|+.....        ..+.          ..+....
T Consensus       157 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--------~~~~----------~~~~~~~  217 (277)
T cd06641         157 K-RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP--------MKVL----------FLIPKNN  217 (277)
T ss_pred             h-hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch--------HHHH----------HHHhcCC
Confidence            1 2234578899999999888899999999999999999999999863211        0111          0111111


Q ss_pred             CCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          479 GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       479 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ....+......+.+++.+||+.+|.+||++.|+
T Consensus       218 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~  250 (277)
T cd06641         218 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKEL  250 (277)
T ss_pred             CCCCCcccCHHHHHHHHHHccCChhhCcCHHHH
Confidence            122233445678899999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.9e-36  Score=295.01  Aligned_cols=249  Identities=28%  Similarity=0.440  Sum_probs=203.2

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccCc-cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR-QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      ++|+..+.||+|++|.||+++.. +++.|+||++..... .....+.+|+..+++++|+|++++++++...+..++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            46888999999999999999865 489999999876543 4457899999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE-ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      +++++|.+++...    ..+++..+..++.|+++||+|||+ .+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~  153 (264)
T cd06623          81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENT  153 (264)
T ss_pred             cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence            9999999999654    358999999999999999999999 76   999999999999999999999999999865433


Q ss_pred             CceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhh
Q 045835          397 KTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDE  476 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  476 (511)
                      ... .....++..|+|||.+....++.++||||||+++|||++|+.|+.....  .....+..            .+...
T Consensus       154 ~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~------------~~~~~  218 (264)
T cd06623         154 LDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSFFELMQ------------AICDG  218 (264)
T ss_pred             CCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCHHHHHH------------HHhcC
Confidence            222 1234578899999999988999999999999999999999999864321  01001111            11111


Q ss_pred             hhCCCCCHH-HHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          477 RLGSKYKKE-EAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       477 ~l~~~~~~~-~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                       .....+.. .+..+.+++.+|++.+|++|||+.|+
T Consensus       219 -~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l  253 (264)
T cd06623         219 -PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAEL  253 (264)
T ss_pred             -CCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence             11122333 56789999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.2e-36  Score=302.30  Aligned_cols=243  Identities=29%  Similarity=0.455  Sum_probs=192.7

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccCc---cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR---QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      +.|+..+.||+|+||.||+|... +++.||+|.+.....   ...+++.+|+.+++.++|||++++.++|.+.+..++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45888899999999999999764 688999999864332   23356889999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+. |+|.+++....   ..+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||++.....
T Consensus        95 e~~~-g~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          95 EYCL-GSASDILEVHK---KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HhhC-CCHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            9997 57777664332   35899999999999999999999886   99999999999999999999999999976543


Q ss_pred             CCceeecccccCCCcccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhH
Q 045835          396 DKTHISTRIAGTIGYMAPEYAL---WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVE  472 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  472 (511)
                      ..     ...++..|+|||.+.   .+.++.++||||||+++|||+||+.|+.....        ......         
T Consensus       168 ~~-----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~--------~~~~~~---------  225 (307)
T cd06607         168 AN-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYH---------  225 (307)
T ss_pred             CC-----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH--------HHHHHH---------
Confidence            22     235788899999874   45688999999999999999999999853221        000000         


Q ss_pred             hhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          473 LVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       473 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +.........+......+.+++.+||+.+|++||++.+|
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i  264 (307)
T cd06607         226 IAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEEL  264 (307)
T ss_pred             HhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHH
Confidence            000001111123345678999999999999999999875

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=7.7e-37  Score=301.44  Aligned_cols=258  Identities=27%  Similarity=0.414  Sum_probs=200.6

Q ss_pred             ccHHHHHHHhcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcC-CCCCceeEEEEEEe
Q 045835          230 FTLKQIKAATNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCL-QHPNLVKIHGCCVE  307 (511)
Q Consensus       230 ~~~~~l~~~~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~  307 (511)
                      .++.++..+.+.|+..+.||+|+||.||+|.. .+++.+|+|.+.... ....++..|+.+++++ +|+|++++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            35666667788999999999999999999975 467899999986543 2335688899999998 79999999999863


Q ss_pred             ------CCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCC
Q 045835          308 ------GDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN  381 (511)
Q Consensus       308 ------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~  381 (511)
                            .+..+++|||+++|+|.+++.....  ..+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~  159 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAE  159 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCC
Confidence                  4578999999999999999865432  34788889999999999999999986   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCceeecccccCCCcccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccc
Q 045835          382 PKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYAL-----WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTC  456 (511)
Q Consensus       382 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~  456 (511)
                      ++|+|||++........ ......|+..|+|||.+.     ...++.++|||||||++|||++|+.||.......     
T Consensus       160 ~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~-----  233 (282)
T cd06636         160 VKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR-----  233 (282)
T ss_pred             EEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh-----
Confidence            99999999875432211 112346888999999876     3467889999999999999999999985322100     


Q ss_pred             hhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          457 LLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       457 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                                  ....+.............+..+.+++.+||+.+|.+||++.||
T Consensus       234 ------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~el  276 (282)
T cd06636         234 ------------ALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQL  276 (282)
T ss_pred             ------------hhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHH
Confidence                        0001111111111122345679999999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=5e-37  Score=304.81  Aligned_cols=247  Identities=27%  Similarity=0.424  Sum_probs=196.1

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      +.|.....||+|+||.||++... ++..||||.+..........+.+|+..++.++|+|++++++.+..++..++||||+
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~  101 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL  101 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence            34455678999999999999754 68899999987655555667899999999999999999999999999999999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      ++++|.+++...     .+++.....++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++........
T Consensus       102 ~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~  173 (292)
T cd06658         102 EGGALTDIVTHT-----RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP  173 (292)
T ss_pred             CCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence            999999988432     4889999999999999999999986   99999999999999999999999999975432221


Q ss_pred             eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhh
Q 045835          399 HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERL  478 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  478 (511)
                      . .....|+..|+|||.+....++.++||||||++++||++|+.|+......     ...   ..      ....+.+.+
T Consensus       174 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-----~~~---~~------~~~~~~~~~  238 (292)
T cd06658         174 K-RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL-----QAM---RR------IRDNLPPRV  238 (292)
T ss_pred             c-CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHH---HH------HHhcCCCcc
Confidence            1 12345788999999998888999999999999999999999998632210     000   00      000111111


Q ss_pred             CCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          479 GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       479 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .  ........+.+++.+|++.+|++|||+.||
T Consensus       239 ~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~i  269 (292)
T cd06658         239 K--DSHKVSSVLRGFLDLMLVREPSQRATAQEL  269 (292)
T ss_pred             c--cccccCHHHHHHHHHHccCChhHCcCHHHH
Confidence            1  111234568889999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.1e-36  Score=295.15  Aligned_cols=254  Identities=30%  Similarity=0.433  Sum_probs=201.0

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      ++|++.+.||.|+||.||+|... ++..+|+|++.... ......+.+|+++++.++|+|++++++.+..++..++|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47889999999999999999754 67889999986432 33556789999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +++++|.+++..... ...+++.....++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            999999999965432 235899999999999999999999886   9999999999999999999999999997554332


Q ss_pred             ce---eecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHh
Q 045835          398 TH---ISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVEL  473 (511)
Q Consensus       398 ~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  473 (511)
                      ..   ......|+..|+|||++... ..+.++|||||||+++||++|+.|+.......    .+....    ..      
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~----~~~~~~----~~------  222 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK----VLMLTL----QN------  222 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh----hHHHHh----cC------
Confidence            21   22334688999999998877 78999999999999999999999986432110    011110    00      


Q ss_pred             hhhhhCCCC-CHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          474 VDERLGSKY-KKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       474 ~d~~l~~~~-~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..+.+.... ....+..+.+++.+||+.+|++|||+.||
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l  261 (267)
T cd06610         223 DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEEL  261 (267)
T ss_pred             CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHH
Confidence            001111111 12345678999999999999999999874

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.3e-36  Score=296.62  Aligned_cols=250  Identities=24%  Similarity=0.384  Sum_probs=199.7

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      ++|+..+.||+|+||.||++... +++.+|+|.+.... .....++.+|++++++++||||+++++++...+..++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            35778899999999999999865 68899999987653 34456789999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE-ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      +++++|.+++....   ..+++....+++.|++.||+|||+ .+   ++|+||||+||++++++.++|+|||++......
T Consensus        81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~  154 (265)
T cd06605          81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS  154 (265)
T ss_pred             cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence            99999999986542   358889999999999999999998 65   999999999999999999999999998754322


Q ss_pred             CceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhh
Q 045835          397 KTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDE  476 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  476 (511)
                      ...   ...++..|+|||++.+..++.++||||||+++++|++|+.|+......   .....+...         .+...
T Consensus       155 ~~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~---------~~~~~  219 (265)
T cd06605         155 LAK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP---PDGIFELLQ---------YIVNE  219 (265)
T ss_pred             Hhh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc---cccHHHHHH---------HHhcC
Confidence            211   156788999999999889999999999999999999999998643210   011111111         11111


Q ss_pred             hhCCCCCHH-HHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          477 RLGSKYKKE-EAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       477 ~l~~~~~~~-~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      . ....+.. ....+.+++.+||..+|++|||+.|+
T Consensus       220 ~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l  254 (265)
T cd06605         220 P-PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKEL  254 (265)
T ss_pred             C-CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHH
Confidence            1 1112222 55678999999999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-36  Score=314.71  Aligned_cols=259  Identities=18%  Similarity=0.207  Sum_probs=194.0

Q ss_pred             hcCCcccCceeccCceeEEecccc---CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA---DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~---~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ..+|.+.+.||+|+||.||++...   .+..||+|.+...     ..+.+|+.++++++||||+++++++......+++|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            357999999999999999998643   3578999988643     24568999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      |++. ++|.+++...    ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       166 e~~~-~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        166 PKYK-CDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA  237 (392)
T ss_pred             hhcC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence            9996 5788887332    35899999999999999999999986   99999999999999999999999999975443


Q ss_pred             CCc-eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhc-------c
Q 045835          396 DKT-HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQ-------D  467 (511)
Q Consensus       396 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~-------~  467 (511)
                      ... .......||..|+|||++....++.++|||||||++|||++|+.||....... ....+..-...+..       .
T Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~l~~i~~~~~~~~~~~~~~  316 (392)
T PHA03207        238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS-SSSQLRSIIRCMQVHPLEFPQN  316 (392)
T ss_pred             ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC-cHHHHHHHHHHhccCccccCCc
Confidence            222 22234578999999999999999999999999999999999999986432111 11111111110000       0


Q ss_pred             --CchhHhh---hhhhCCCCC-------HHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          468 --GKLVELV---DERLGSKYK-------KEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       468 --~~~~~~~---d~~l~~~~~-------~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                        ..+.+.+   ....+..+.       .....++.+++.+||..+|++|||+.|+
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~  372 (392)
T PHA03207        317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDI  372 (392)
T ss_pred             cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHH
Confidence              0000000   000111111       1123567889999999999999999874

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=5.6e-36  Score=300.35  Aligned_cols=196  Identities=25%  Similarity=0.401  Sum_probs=159.2

Q ss_pred             cCceeccCceeEEecccc---CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEe--CCEEEEEEEecC
Q 045835          245 AKKIGEGGFGPVYKGQLA---DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVE--GDQLLLVYEYME  319 (511)
Q Consensus       245 ~~~lG~G~fG~Vy~g~~~---~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey~~  319 (511)
                      ..+||+|+||.||+|+..   ++..||+|.+....  ....+.+|+.++++++||||+++++++..  +...++|+||+.
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            368999999999999854   35789999986542  23467899999999999999999999864  457899999987


Q ss_pred             CCCHhHHHhcCC-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEE----cCCCCeEEeecCCc
Q 045835          320 NNSLACALFGRE-----NCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL----DRDLNPKISDFGLA  390 (511)
Q Consensus       320 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILl----d~~~~~kl~DfGla  390 (511)
                      + +|.+++....     .....+++..+..++.|++.||+|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 6766664221     12235889999999999999999999986   9999999999999    56678999999999


Q ss_pred             ccCCCCCce--eecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 045835          391 KLDEGDKTH--ISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSY  446 (511)
Q Consensus       391 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~  446 (511)
                      +........  ......+|..|+|||.+.+. .++.++|||||||++|||+||++||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            865432211  12235689999999998764 589999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-36  Score=296.76  Aligned_cols=245  Identities=27%  Similarity=0.457  Sum_probs=195.1

Q ss_pred             CCcccCceeccCceeEEeccc-cCCcEEEEEEecccC-ccchHHHHHHHHHHhcCC---CCCceeEEEEEEeCCEEEEEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQ---HPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~  315 (511)
                      .|+..+.||+|+||.||+|.. .+++.+|+|.+.... .....++.+|+.++++++   |||++++++++.++...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            577889999999999999985 568899999987542 334467889999999986   999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++++|.+++...     .+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917          82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence            999999999988542     5889999999999999999999986   99999999999999999999999999986544


Q ss_pred             CCceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      .... .....|+..|+|||.+.++ .++.++|||||||++|||++|+.|+.....        ..+.... ...     .
T Consensus       154 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~--------~~~~~~~-~~~-----~  218 (277)
T cd06917         154 NSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA--------FRAMMLI-PKS-----K  218 (277)
T ss_pred             Cccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh--------hhhhhcc-ccC-----C
Confidence            3322 2234688899999988754 578999999999999999999999863221        1111000 000     0


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .+.+..   .....++.+++.+||+.+|++||++.|+
T Consensus       219 ~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~i  252 (277)
T cd06917         219 PPRLED---NGYSKLLREFVAACLDEEPKERLSAEEL  252 (277)
T ss_pred             CCCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence            011111   1144578899999999999999998764

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-37  Score=310.46  Aligned_cols=236  Identities=26%  Similarity=0.324  Sum_probs=182.0

Q ss_pred             eeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcC---CCCCceeEEEEEEeCCEEEEEEEecCC
Q 045835          248 IGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCL---QHPNLVKIHGCCVEGDQLLLVYEYMEN  320 (511)
Q Consensus       248 lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~~~lV~Ey~~~  320 (511)
                      ||+|+||.||+|+.. +++.||||++....   ......+..|..++...   +||||+++++++.+.+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999754 58899999986432   12223455666776655   699999999999999999999999999


Q ss_pred             CCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCcee
Q 045835          321 NSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI  400 (511)
Q Consensus       321 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~  400 (511)
                      |+|.+++...    ..+++.....++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....... .
T Consensus        81 g~L~~~l~~~----~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~  152 (330)
T cd05586          81 GELFWHLQKE----GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-T  152 (330)
T ss_pred             ChHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-C
Confidence            9999888643    24889999999999999999999987   99999999999999999999999999975322221 1


Q ss_pred             ecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhC
Q 045835          401 STRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLG  479 (511)
Q Consensus       401 ~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  479 (511)
                      .....||..|+|||.+.+. .++.++|||||||++|||++|+.||.....        .+...... .+.      ..+.
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~--------~~~~~~i~-~~~------~~~~  217 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT--------QQMYRNIA-FGK------VRFP  217 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH--------HHHHHHHH-cCC------CCCC
Confidence            2345689999999998765 589999999999999999999999863210        01100000 000      0010


Q ss_pred             CCCCHHHHHHHHHHHHHcCCCCCCCCCCcC
Q 045835          480 SKYKKEEAERMIKVSLLCTNASPSLRPTMS  509 (511)
Q Consensus       480 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~  509 (511)
                         .......+.+++.+||+.+|++||+..
T Consensus       218 ---~~~~~~~~~~li~~~L~~~P~~R~~~~  244 (330)
T cd05586         218 ---KNVLSDEGRQFVKGLLNRNPQHRLGAH  244 (330)
T ss_pred             ---CccCCHHHHHHHHHHcCCCHHHCCCCC
Confidence               112345678999999999999999643

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.9e-36  Score=296.87  Aligned_cols=249  Identities=23%  Similarity=0.396  Sum_probs=191.3

Q ss_pred             CcccCceeccCceeEEecccc----CCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCC------
Q 045835          242 FDSAKKIGEGGFGPVYKGQLA----DGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGD------  309 (511)
Q Consensus       242 f~~~~~lG~G~fG~Vy~g~~~----~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------  309 (511)
                      |.+.+.||+|+||.||+|...    ++..||||++....  ....+++.+|+.+++.++|||++++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567789999999999999753    36789999987542  334567889999999999999999999987542      


Q ss_pred             EEEEEEEecCCCCHhHHHhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeec
Q 045835          310 QLLLVYEYMENNSLACALFGRE--NCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF  387 (511)
Q Consensus       310 ~~~lV~Ey~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~Df  387 (511)
                      ..++++||+.+|+|.+++....  .....+++...++++.|++.||+|||+.+   |+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            2478899999999998875322  12235789999999999999999999986   999999999999999999999999


Q ss_pred             CCcccCCCCCce-eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhh
Q 045835          388 GLAKLDEGDKTH-ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQ  465 (511)
Q Consensus       388 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~  465 (511)
                      |+++........ ......++..|++||.+....++.++||||||+++|||++ |+.|+....     ...+..+..   
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~-----~~~~~~~~~---  229 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE-----NSEIYNYLI---  229 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC-----HHHHHHHHH---
Confidence            999865332211 1122345678999999998889999999999999999999 888875322     111111111   


Q ss_pred             ccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          466 QDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       466 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...          ....+......+.+++.+|++.+|++|||+.||
T Consensus       230 ~~~----------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~  265 (273)
T cd05074         230 KGN----------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHL  265 (273)
T ss_pred             cCC----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            000          011122345679999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-36  Score=307.13  Aligned_cols=196  Identities=26%  Similarity=0.390  Sum_probs=166.1

Q ss_pred             HhcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeC------
Q 045835          238 ATNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEG------  308 (511)
Q Consensus       238 ~~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------  308 (511)
                      ..++|...+.||+|+||.||+|.. .++..||||++....  ......+.+|+.+++.++||||+++++++...      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            357899999999999999999974 467899999987532  22345677999999999999999999987643      


Q ss_pred             CEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecC
Q 045835          309 DQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFG  388 (511)
Q Consensus       309 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfG  388 (511)
                      ...++++|++ +++|.+++..     ..+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence            3578999988 7789887743     24899999999999999999999987   9999999999999999999999999


Q ss_pred             CcccCCCCCceeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 045835          389 LAKLDEGDKTHISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSY  446 (511)
Q Consensus       389 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~  446 (511)
                      +++......    ....||..|+|||++.+ ..++.++|||||||+++||++|+.||..
T Consensus       164 ~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  218 (343)
T cd07878         164 LARQADDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG  218 (343)
T ss_pred             cceecCCCc----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            998654321    23468999999999876 5789999999999999999999999864

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.1e-36  Score=303.10  Aligned_cols=245  Identities=25%  Similarity=0.395  Sum_probs=195.2

Q ss_pred             CcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCC
Q 045835          242 FDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMEN  320 (511)
Q Consensus       242 f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~  320 (511)
                      |+....||+|+||.||++... +++.||+|.+..........+.+|+.+++.++|||++++++++..++..++|+||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            444568999999999999754 6889999999765555566788999999999999999999999999999999999999


Q ss_pred             CCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCcee
Q 045835          321 NSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI  400 (511)
Q Consensus       321 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~  400 (511)
                      ++|.+++..     ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++......... 
T Consensus       103 ~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~-  173 (297)
T cd06659         103 GALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-  173 (297)
T ss_pred             CCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccccc-
Confidence            999988743     24889999999999999999999986   999999999999999999999999999754432211 


Q ss_pred             ecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCC
Q 045835          401 STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGS  480 (511)
Q Consensus       401 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  480 (511)
                      .....++..|+|||++.+..++.++|||||||+++||++|+.||......     .....   .. ...     .+.  .
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~~~~---~~-~~~-----~~~--~  237 (297)
T cd06659         174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV-----QAMKR---LR-DSP-----PPK--L  237 (297)
T ss_pred             ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHH---Hh-ccC-----CCC--c
Confidence            22346889999999999888999999999999999999999998632210     00000   00 000     000  0


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          481 KYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       481 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .........+.+++.+||+.+|++||++.||
T Consensus       238 ~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~l  268 (297)
T cd06659         238 KNAHKISPVLRDFLERMLTREPQERATAQEL  268 (297)
T ss_pred             cccCCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence            0111234568899999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=4.1e-36  Score=300.02  Aligned_cols=247  Identities=21%  Similarity=0.293  Sum_probs=193.7

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|+..+.||+|+||.||++... .++.||+|.+....   ......+.+|+.+++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46888999999999999999754 57899999987543   223456889999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++++|.+++....    .+++.....++.+++.||+|||+.+   ++||||||+||+++.++.+||+|||+++....
T Consensus        81 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~  153 (305)
T cd05609          81 EYVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM  153 (305)
T ss_pred             ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence            9999999999996542    4889999999999999999999986   99999999999999999999999999874211


Q ss_pred             CC--------------ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhh
Q 045835          396 DK--------------THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWA  461 (511)
Q Consensus       396 ~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~  461 (511)
                      ..              ........++..|+|||.+....++.++|+||||+++|||++|+.||.....        .++.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~--------~~~~  225 (305)
T cd05609         154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP--------EELF  225 (305)
T ss_pred             CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHH
Confidence            00              0011123578899999999888999999999999999999999999853210        1111


Q ss_pred             HhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcC
Q 045835          462 CHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMS  509 (511)
Q Consensus       462 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~  509 (511)
                      ......    ....+    ......+..+.+++.+||+.+|++||++.
T Consensus       226 ~~~~~~----~~~~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~  265 (305)
T cd05609         226 GQVISD----DIEWP----EGDEALPADAQDLISRLLRQNPLERLGTG  265 (305)
T ss_pred             HHHHhc----ccCCC----CccccCCHHHHHHHHHHhccChhhccCcc
Confidence            110000    00001    01112345689999999999999999954

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.7e-36  Score=299.71  Aligned_cols=247  Identities=27%  Similarity=0.413  Sum_probs=199.4

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      ++|+..+.||+|+||.||++.. .++..||+|.+........+.+.+|+.++++++|||+++++++|...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            6788999999999999999974 467889999987655555677899999999999999999999999999999999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      ++++|.+++...     .+++..+..++.+++.||.|||+.+   ++|+||||+||+++.++.+||+|||++........
T Consensus        99 ~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          99 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             CCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            999999998542     3789999999999999999999986   99999999999999999999999999875443222


Q ss_pred             eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhh
Q 045835          399 HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERL  478 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  478 (511)
                      . .....++..|+|||.+....++.++||||||+++||+++|+.||........    +..    ...        .+..
T Consensus       171 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~----~~~----~~~--------~~~~  233 (293)
T cd06647         171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA----LYL----IAT--------NGTP  233 (293)
T ss_pred             c-cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh----eee----hhc--------CCCC
Confidence            1 1224578899999999888899999999999999999999999964321100    000    000        0000


Q ss_pred             CCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          479 GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       479 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ....+......+.+++.+||+.+|++||++.++
T Consensus       234 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~i  266 (293)
T cd06647         234 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKEL  266 (293)
T ss_pred             CCCCccccCHHHHHHHHHHccCChhhCcCHHHH
Confidence            111122344568899999999999999999764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.6e-36  Score=319.22  Aligned_cols=201  Identities=23%  Similarity=0.303  Sum_probs=163.5

Q ss_pred             HHHHHhcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCCC------CCceeEEEEEE
Q 045835          234 QIKAATNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQH------PNLVKIHGCCV  306 (511)
Q Consensus       234 ~l~~~~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H------~niv~l~g~~~  306 (511)
                      ++...+++|++.++||+|+||.||+|... .++.||||+++... ....++..|+.+++.++|      .+++++++++.
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            34445688999999999999999999754 57889999996432 223455667777776654      45899999887


Q ss_pred             eC-CEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEEccCCCCCeEEcCCC----
Q 045835          307 EG-DQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE-SRFKIVHRDIKATNVLLDRDL----  380 (511)
Q Consensus       307 ~~-~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~iiH~Dlk~~NILld~~~----  380 (511)
                      .. ...++|||++ +++|.+++....    .+++..+..++.||+.||+|||++ +   |+||||||+|||++.++    
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~  273 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMKHG----PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVD  273 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccc
Confidence            64 4788999988 678888886542    589999999999999999999974 5   99999999999998765    


Q ss_pred             ------------CeEEeecCCcccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 045835          381 ------------NPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYA  447 (511)
Q Consensus       381 ------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~  447 (511)
                                  .+||+|||++.....    ......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~  348 (467)
T PTZ00284        274 PVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH  348 (467)
T ss_pred             cccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                        499999998864322    123457899999999999999999999999999999999999999743

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.7e-36  Score=297.28  Aligned_cols=250  Identities=28%  Similarity=0.473  Sum_probs=202.1

Q ss_pred             HHhcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          237 AATNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       237 ~~~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ..+++|+..+.||+|+||.||+|... ++..+++|++..... ....+.+|+++++.++|+|++++++++...+..++++
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            35677888999999999999999876 688999999976544 4567899999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++++|.+++....   ..+++..+..++.+++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        95 e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  168 (286)
T cd06614          95 EYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTK  168 (286)
T ss_pred             eccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence            9999999999997643   35899999999999999999999976   99999999999999999999999999875433


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      ... ......++..|+|||.+.+..++.++|||||||++|||++|+.|+......     ....            .+..
T Consensus       169 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-----~~~~------------~~~~  230 (286)
T cd06614         169 EKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-----RALF------------LITT  230 (286)
T ss_pred             chh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-----HHHH------------HHHh
Confidence            221 112335788999999998888999999999999999999999998632211     0000            0001


Q ss_pred             hhh-CCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          476 ERL-GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       476 ~~l-~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ... ....+......+.+++.+|++.+|.+|||+.+|
T Consensus       231 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i  267 (286)
T cd06614         231 KGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEEL  267 (286)
T ss_pred             cCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHH
Confidence            000 011112245678999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-37  Score=314.01  Aligned_cols=242  Identities=29%  Similarity=0.403  Sum_probs=200.9

Q ss_pred             ceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCCCCHhH
Q 045835          247 KIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLAC  325 (511)
Q Consensus       247 ~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~  325 (511)
                      +||+|+||+||.|+.. +...+|||-+.....+..+-+.+|+.+-+.|+|.|||+.+|.|.++..+-+.||.++||||.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            7999999999999855 456799999988777777778899999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcC-CCCeEEeecCCcccCCCCCceeec
Q 045835          326 ALFGRENCELEL--DWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR-DLNPKISDFGLAKLDEGDKTHIST  402 (511)
Q Consensus       326 ~l~~~~~~~~~l--~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~-~~~~kl~DfGla~~~~~~~~~~~~  402 (511)
                      +|...-   .++  .+.+.-....||++||.|||+..   |+|||||-.|||++. .|.+||+|||-++....-.. ...
T Consensus       662 LLrskW---GPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~TE  734 (1226)
T KOG4279|consen  662 LLRSKW---GPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-CTE  734 (1226)
T ss_pred             HHHhcc---CCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCc-ccc
Confidence            996543   244  67788888999999999999986   999999999999964 68999999999986654333 334


Q ss_pred             ccccCCCcccccccccC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCC
Q 045835          403 RIAGTIGYMAPEYALWG--YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGS  480 (511)
Q Consensus       403 ~~~gt~~y~aPE~~~~~--~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  480 (511)
                      ..-||..|||||++..+  .|..++|||||||.+.||.|||+||......     .-           .+.++=--..-.
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp-----qA-----------AMFkVGmyKvHP  798 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP-----QA-----------AMFKVGMYKVHP  798 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh-----hH-----------hhhhhcceecCC
Confidence            46799999999999876  5899999999999999999999999733210     00           011111112335


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          481 KYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       481 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ++|.+.+.+...++++|+.++|.+||+++++
T Consensus       799 ~iPeelsaeak~FilrcFepd~~~R~sA~~L  829 (1226)
T KOG4279|consen  799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDL  829 (1226)
T ss_pred             CCcHHHHHHHHHHHHHHcCCCcccCccHHHh
Confidence            6788889999999999999999999999864

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=8.9e-37  Score=301.15  Aligned_cols=259  Identities=22%  Similarity=0.306  Sum_probs=192.9

Q ss_pred             CCcccCceeccCceeEEecccc-CCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      +|+..+.||+|+||.||+|+.. +|+.+|+|+++...  ......+.+|+.++++++|||++++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4778899999999999999764 68899999986532  22335678899999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      ++ ++|.+++....   ..+++.....++.||++||.|||+.+   ++||||||+||+++.++.+||+|||+++......
T Consensus        81 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          81 CD-QDLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence            97 47877775432   35899999999999999999999986   9999999999999999999999999998543322


Q ss_pred             ceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccC------ch
Q 045835          398 THISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDG------KL  470 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~------~~  470 (511)
                      .. .....++..|+|||.+.+. .++.++|||||||+++||+||+.|+.......    .............      .+
T Consensus       154 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd07839         154 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD----DQLKRIFRLLGTPTEESWPGV  228 (284)
T ss_pred             CC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH----HHHHHHHHHhCCCChHHhHHh
Confidence            21 1234578899999988765 47899999999999999999998864322111    0101000000000      00


Q ss_pred             hHhhhhhh----C-----CCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          471 VELVDERL----G-----SKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       471 ~~~~d~~l----~-----~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .++.+...    .     ....+..+..+.+++.+||+.+|.+|||+.|+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~i  278 (284)
T cd07839         229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEA  278 (284)
T ss_pred             hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHH
Confidence            00000000    0     01112235678899999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-36  Score=304.42  Aligned_cols=246  Identities=24%  Similarity=0.346  Sum_probs=206.0

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCcc---chHHHHHHHHHHhcCC-CCCceeEEEEEEeCCEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQ---GNREFLNEIAMISCLQ-HPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~---~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~l  313 (511)
                      ...|++.+.||+|.||.||+++.+ +|+.+|+|.+......   ....+.+|+.+|+++. |||||.+.+.+++.+..++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            456888899999999999999865 4999999999765433   3458899999999998 9999999999999999999


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCC----CCeEEeecCC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD----LNPKISDFGL  389 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~----~~~kl~DfGl  389 (511)
                      |||++.+|.|.+.+...     .+++.....++.|++.+++|||+.+   |+||||||+|+|+...    +.+|++|||+
T Consensus       114 vmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            99999999999999765     2889999999999999999999987   9999999999999644    4799999999


Q ss_pred             cccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCc
Q 045835          390 AKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGK  469 (511)
Q Consensus       390 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  469 (511)
                      +.....  .......+||+.|+|||.+....++..+||||+||++|.|++|.+||......                 +.
T Consensus       186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~-----------------~~  246 (382)
T KOG0032|consen  186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF-----------------EI  246 (382)
T ss_pred             ceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh-----------------HH
Confidence            997765  33445678999999999999999999999999999999999999999743211                 01


Q ss_pred             hhHhhhh--hhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          470 LVELVDE--RLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       470 ~~~~~d~--~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...+...  ....+.....+....+++..|+..||..|+|+.++
T Consensus       247 ~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~  290 (382)
T KOG0032|consen  247 FLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQA  290 (382)
T ss_pred             HHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHH
Confidence            1122222  22333445567889999999999999999998753

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3.3e-36  Score=299.34  Aligned_cols=262  Identities=24%  Similarity=0.322  Sum_probs=195.0

Q ss_pred             CCcccCceeccCceeEEecccc-CCcEEEEEEecccCcc-----chHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQ-----GNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~-----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  314 (511)
                      +|+..+.||+|+||.||+|... +++.||||.+......     ....+..|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4778899999999999999754 6889999999755322     334577899999999999999999999999999999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      |||+ +++|.+++....   ..+++..+..++.|+++||+|||+.+   ++|+||||+||+++.++.+||+|||+++...
T Consensus        81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  153 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG  153 (298)
T ss_pred             Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence            9999 899999986533   35899999999999999999999987   9999999999999999999999999998654


Q ss_pred             CCCceeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHh-----hhccC
Q 045835          395 GDKTHISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACH-----LQQDG  468 (511)
Q Consensus       395 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~-----~~~~~  468 (511)
                      ..... .....++..|+|||.+.+ ..++.++|||||||+++||++|.+++........ ..........     .....
T Consensus       154 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  231 (298)
T cd07841         154 SPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ-LGKIFEALGTPTEENWPGVT  231 (298)
T ss_pred             CCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH-HHHHHHHcCCCchhhhhhcc
Confidence            33221 122346778999998854 4678999999999999999999877753221110 0000000000     00000


Q ss_pred             chhHhhhhhhCCC-----CCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          469 KLVELVDERLGSK-----YKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       469 ~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .+...........     ........+.+++.+||+.+|++|||+.||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~  279 (298)
T cd07841         232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQA  279 (298)
T ss_pred             cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHH
Confidence            0000000000011     112335678999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=6e-36  Score=295.95  Aligned_cols=246  Identities=28%  Similarity=0.446  Sum_probs=197.0

Q ss_pred             CCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecC
Q 045835          241 NFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYME  319 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~  319 (511)
                      .|...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++|||++++++++...+..++++||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            455568999999999999974 4688999999876555555678899999999999999999999999999999999999


Q ss_pred             CCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCce
Q 045835          320 NNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH  399 (511)
Q Consensus       320 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~  399 (511)
                      +++|.+++..     ..+++..+..++.|++.||+|||+.+   ++||||+|+||+++.++.++|+|||++.........
T Consensus       100 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~  171 (285)
T cd06648         100 GGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR  171 (285)
T ss_pred             CCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcc
Confidence            9999999865     24889999999999999999999986   999999999999999999999999998754332211


Q ss_pred             eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhC
Q 045835          400 ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLG  479 (511)
Q Consensus       400 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  479 (511)
                       .....|+..|+|||.+.+..++.++|||||||+++||++|+.|+....        ...........      ..+.. 
T Consensus       172 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~--------~~~~~~~~~~~------~~~~~-  235 (285)
T cd06648         172 -RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP--------PLQAMKRIRDN------LPPKL-  235 (285)
T ss_pred             -cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC--------HHHHHHHHHhc------CCCCC-
Confidence             123458889999999988889999999999999999999999985321        11111111100      00011 


Q ss_pred             CCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          480 SKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       480 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                       ..+......+.+++.+||+.+|++|||+.|+
T Consensus       236 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i  266 (285)
T cd06648         236 -KNLHKVSPRLRSFLDRMLVRDPAQRATAAEL  266 (285)
T ss_pred             -cccccCCHHHHHHHHHHcccChhhCcCHHHH
Confidence             1112244679999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.4e-36  Score=298.30  Aligned_cols=238  Identities=26%  Similarity=0.359  Sum_probs=195.4

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|...+.||+|+||.||++... +++.+|+|.+....   ......+.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46888999999999999999754 58899999986432   223456889999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++++|.+++...    ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||+++....
T Consensus        81 e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  153 (290)
T cd05580          81 EYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG  153 (290)
T ss_pred             ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence            999999999998654    25889999999999999999999986   99999999999999999999999999986544


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      .    .....+++.|+|||.+.....+.++||||||++++||++|+.|+.....     ...            ...+..
T Consensus       154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~------------~~~~~~  212 (290)
T cd05580         154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-----IQI------------YEKILE  212 (290)
T ss_pred             C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-----HHH------------HHHHhc
Confidence            3    2234688999999999888899999999999999999999999863220     000            011111


Q ss_pred             hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCC
Q 045835          476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPT  507 (511)
Q Consensus       476 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs  507 (511)
                      .  ....+......+.+++.+||+.+|.+||+
T Consensus       213 ~--~~~~~~~~~~~l~~li~~~l~~~p~~R~~  242 (290)
T cd05580         213 G--KVRFPSFFSPDAKDLIRNLLQVDLTKRLG  242 (290)
T ss_pred             C--CccCCccCCHHHHHHHHHHccCCHHHccC
Confidence            1  11223334567889999999999999993

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-36  Score=300.10  Aligned_cols=203  Identities=25%  Similarity=0.363  Sum_probs=168.2

Q ss_pred             CCcccCceeccCceeEEecccc---CCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeC--CEEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA---DGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEG--DQLL  312 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~---~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~  312 (511)
                      .|++.++||+|+||.||+|...   ++..||+|.+....   ......+.+|+.+++.++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4778899999999999999864   47899999998633   34446778999999999999999999999988  7899


Q ss_pred             EEEEecCCCCHhHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcC----CCCeEEeec
Q 045835          313 LVYEYMENNSLACALFGREN-CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR----DLNPKISDF  387 (511)
Q Consensus       313 lV~Ey~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~----~~~~kl~Df  387 (511)
                      +||||+++ +|.+++..... ....+++.....++.|++.||+|||+.+   |+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999985 66666643322 2236889999999999999999999986   999999999999999    899999999


Q ss_pred             CCcccCCCCCc--eeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 045835          388 GLAKLDEGDKT--HISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYA  447 (511)
Q Consensus       388 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~  447 (511)
                      |+++.......  .......++..|+|||.+.+. .++.++|||||||+++||++|+.||...
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~  219 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR  219 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence            99986543222  112234678899999988764 5889999999999999999999998744

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.4e-36  Score=292.91  Aligned_cols=247  Identities=27%  Similarity=0.413  Sum_probs=202.3

Q ss_pred             CCcccCceeccCceeEEeccc-cCCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          241 NFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      +|++.+.||+|+||.||+++. .++..+|+|.+....  .....++.+|+.+++.++|+||+++.+++.+....++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            477889999999999999964 467899999987542  23345788999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +++++|.+++.........+++.....++.+++.||+|||+.+   ++|+||+|+||++++++.+||+|||+++..... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999998764433456899999999999999999999986   999999999999999999999999999866543 


Q ss_pred             ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          398 THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                        ......++..|+|||.+.+..++.++|+||||++++||++|+.|+.....     ..+             ...+...
T Consensus       157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~-------------~~~~~~~  216 (256)
T cd08530         157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-----QDL-------------RYKVQRG  216 (256)
T ss_pred             --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHH-------------HHHHhcC
Confidence              12234578899999999988999999999999999999999999863321     001             1111111


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....+......+.+++.+|++.+|++|||+.||
T Consensus       217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~  250 (256)
T cd08530         217 KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKI  250 (256)
T ss_pred             CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHH
Confidence            1223334566779999999999999999999764

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=8.6e-36  Score=287.35  Aligned_cols=245  Identities=32%  Similarity=0.517  Sum_probs=200.0

Q ss_pred             CCcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecC
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYME  319 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~  319 (511)
                      .|+..+.||+|++|.||++... ++..+++|++..........+.+|+.++++++|+|++++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            3677889999999999999865 688999999977655556789999999999999999999999999999999999999


Q ss_pred             CCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCce
Q 045835          320 NNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH  399 (511)
Q Consensus       320 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~  399 (511)
                      +++|.+++....   ..+++..+..++.+++.||+|||+.+   ++||||+|+||++++++.++|+|||.+........ 
T Consensus        81 ~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  153 (253)
T cd05122          81 GGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-  153 (253)
T ss_pred             CCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence            999999986542   35899999999999999999999976   99999999999999999999999999986544321 


Q ss_pred             eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhC
Q 045835          400 ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLG  479 (511)
Q Consensus       400 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  479 (511)
                       .....++..|+|||.+.....+.++||||||+++++|++|+.|+.....        .......          .....
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~----------~~~~~  214 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP--------MKALFKI----------ATNGP  214 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch--------HHHHHHH----------HhcCC
Confidence             2334678899999999888899999999999999999999999863210        0000000          00001


Q ss_pred             CCCC--HHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          480 SKYK--KEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       480 ~~~~--~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...+  ......+.+++.+||+.+|++|||+.||
T Consensus       215 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~  248 (253)
T cd05122         215 PGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQL  248 (253)
T ss_pred             CCcCcccccCHHHHHHHHHHccCChhhCCCHHHH
Confidence            1111  1125678999999999999999999874

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-36  Score=298.14  Aligned_cols=199  Identities=25%  Similarity=0.432  Sum_probs=167.9

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccCc-cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR-QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      ++|+..+.||+|+||.||+|... +++.||+|.+..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57888999999999999999764 688999999875432 2234577899999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +.+ +|.+++....   ..+++.....++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++......
T Consensus        85 ~~~-~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  157 (291)
T cd07844          85 LDT-DLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS  157 (291)
T ss_pred             CCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence            985 8998886543   25889999999999999999999986   9999999999999999999999999987432211


Q ss_pred             ceeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 045835          398 THISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSY  446 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~  446 (511)
                      . ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       158 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~  206 (291)
T cd07844         158 K-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPG  206 (291)
T ss_pred             c-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            1 1122346788999998875 4688999999999999999999999863

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=7.2e-36  Score=289.25  Aligned_cols=249  Identities=24%  Similarity=0.414  Sum_probs=203.3

Q ss_pred             CCcccCceeccCceeEEecccc-CCcEEEEEEecccCc--cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR--QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      +|+..+.||+|+||.||++... ++..+++|++.....  .....+.+|+++++.++|+|++++.+.+..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4778899999999999999764 588999999976533  4556788999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +++++|.+++.........+++..+..++.+++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            9999999999765433356999999999999999999999986   9999999999999999999999999998654432


Q ss_pred             ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          398 THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                       .......|+..|+|||......++.++||||+|+++++|++|+.|+....        ..+....         +... 
T Consensus       158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--------~~~~~~~---------~~~~-  218 (258)
T cd08215         158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN--------LLELALK---------ILKG-  218 (258)
T ss_pred             -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc--------HHHHHHH---------HhcC-
Confidence             22233467889999999988889999999999999999999999986322        1111111         1111 


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....+......+.+++.+||+.+|++|||+.||
T Consensus       219 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l  252 (258)
T cd08215         219 QYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQI  252 (258)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            1112233445678999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-36  Score=295.94  Aligned_cols=258  Identities=25%  Similarity=0.398  Sum_probs=194.4

Q ss_pred             CcccCceeccCceeEEecccc-CCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeC--CEEEEEEE
Q 045835          242 FDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEG--DQLLLVYE  316 (511)
Q Consensus       242 f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~E  316 (511)
                      |++.+.||+|+||.||+|+.. +++.+|+|++....  ......+.+|+.++++++|+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567889999999999999765 58899999998653  33345788999999999999999999999988  89999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      |+++ +|.+++....   ..+++..++.++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++......
T Consensus        81 ~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          81 YMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             cccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            9985 8888885432   35899999999999999999999986   999999999999999999999999999865443


Q ss_pred             CceeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchh---------hhhH----
Q 045835          397 KTHISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLL---------DWAC----  462 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~---------~~~~----  462 (511)
                      .........++..|+|||.+.+ ..++.++||||||++++||++|+.|+....... ....+.         .|..    
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07840         154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE-QLEKIFELCGSPTDENWPGVSKL  232 (287)
T ss_pred             CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCchhhccccccc
Confidence            3222233456788999998764 467899999999999999999999986332100 000000         0000    


Q ss_pred             ----hhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          463 ----HLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       463 ----~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                          ...........+...    +...++..+.+++.+||+.+|.+||++.+|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~  281 (287)
T cd07840         233 PWFENLKPKKPYKRRLREF----FKHLIDPSALDLLDKLLTLDPKKRISADQA  281 (287)
T ss_pred             hhhhhccccccchhHHHHH----hcccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence                000000000011110    111125678999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.8e-36  Score=298.24  Aligned_cols=264  Identities=25%  Similarity=0.353  Sum_probs=196.0

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccCc--cchHHHHHHHHHHhcCCCCCceeEEEEEEeC--CEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR--QGNREFLNEIAMISCLQHPNLVKIHGCCVEG--DQLLLV  314 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV  314 (511)
                      ++|+..+.||+|+||.||+|... +++.+|+|.++....  .....+.+|+.++++++||||+++++++...  +..++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46888999999999999999865 588999999975432  2234567899999999999999999999877  889999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      |||+.+ +|.+++....   ..+++.....++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++...
T Consensus        85 ~e~~~~-~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          85 MEYVEH-DLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             ehhcCc-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            999974 8988886543   25899999999999999999999986   9999999999999999999999999998654


Q ss_pred             CCCceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCccccccc--------chhhhhHh--
Q 045835          395 GDKTHISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCT--------CLLDWACH--  463 (511)
Q Consensus       395 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~--------~l~~~~~~--  463 (511)
                      ..... .....++..|+|||.+.+. .++.++|+||||++++||++|+.||...........        ....|...  
T Consensus       158 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         158 SPLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             CCccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence            43211 1223568889999988754 468999999999999999999999864332110000        00001000  


Q ss_pred             h--hccCchhHhhhhhhCCCCCHH-HHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          464 L--QQDGKLVELVDERLGSKYKKE-EAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       464 ~--~~~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +  .............+...++.. ....+.+++.+||+.+|++|||+.||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~el  287 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDA  287 (293)
T ss_pred             cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHH
Confidence            0  000000011111111222222 35668899999999999999999874

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.9e-36  Score=292.61  Aligned_cols=247  Identities=23%  Similarity=0.386  Sum_probs=198.0

Q ss_pred             CCcccCceeccCceeEEecccc-CCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      +|+..+.||+|+||.||+|... +|..+|+|.+....  ......+.+|+.+++.++|+|++++++++...+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4778899999999999999865 57889999986532  23345788999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCC-CeEEeecCCcccCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL-NPKISDFGLAKLDEGD  396 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~-~~kl~DfGla~~~~~~  396 (511)
                      +++++|.+++....  ...+++..+..++.|++.||+|||+.+   ++|+||||+||++++++ .+||+|||.+......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          81 CDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            99999999986533  235799999999999999999999986   99999999999999886 4699999999765432


Q ss_pred             CceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhh
Q 045835          397 KTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDE  476 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  476 (511)
                      .. ......|+..|+|||+.....++.++||||||++++||++|+.|+....        ..++....         ...
T Consensus       156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~---------~~~  217 (257)
T cd08225         156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN--------LHQLVLKI---------CQG  217 (257)
T ss_pred             cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHH---------hcc
Confidence            22 2223458889999999988889999999999999999999999985321        12222211         111


Q ss_pred             hhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          477 RLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       477 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .. ..........+.+++.+|++.+|++|||+.||
T Consensus       218 ~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l  251 (257)
T cd08225         218 YF-APISPNFSRDLRSLISQLFKVSPRDRPSITSI  251 (257)
T ss_pred             cC-CCCCCCCCHHHHHHHHHHhccChhhCcCHHHH
Confidence            11 11222344578999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.1e-35  Score=298.60  Aligned_cols=242  Identities=29%  Similarity=0.447  Sum_probs=191.1

Q ss_pred             CCcccCceeccCceeEEeccc-cCCcEEEEEEecccCc---cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSR---QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      .|+..+.||+|+||.||+++. .++..+|+|.+.....   .....+.+|+.++++++|||+++++++|.+++..++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            367788999999999999975 4688999999864322   233568899999999999999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      |+. |+|.+.+....   ..++|..+..++.+++.||.|||+.+   ++||||+|+||+++.++.+||+|||++......
T Consensus       106 ~~~-g~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (317)
T cd06635         106 YCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA  178 (317)
T ss_pred             CCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence            997 47777775432   35899999999999999999999986   999999999999999999999999998754322


Q ss_pred             CceeecccccCCCcccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHh
Q 045835          397 KTHISTRIAGTIGYMAPEYAL---WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVEL  473 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  473 (511)
                           ....++..|+|||++.   .+.++.++|||||||+++||++|+.|+.....        ...         ...+
T Consensus       179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--------~~~---------~~~~  236 (317)
T cd06635         179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSA---------LYHI  236 (317)
T ss_pred             -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH--------HHH---------HHHH
Confidence                 2235788999999874   45789999999999999999999999853210        000         0111


Q ss_pred             hhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          474 VDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       474 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ................+.+++.+||+.+|.+||++.||
T Consensus       237 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i  274 (317)
T cd06635         237 AQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEEL  274 (317)
T ss_pred             HhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHH
Confidence            11111111122345568999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=5.5e-36  Score=295.52  Aligned_cols=260  Identities=25%  Similarity=0.356  Sum_probs=193.5

Q ss_pred             CCcccCceeccCceeEEecccc-CCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      +|+..+.||+|+||.||+|+.. +++.||||++....  ......+.+|++++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            5888999999999999999754 68899999987543  22335788999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +. ++|.+++....  ...+++.....++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||+++......
T Consensus        81 ~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          81 LH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             cc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence            96 68888886533  235899999999999999999999886   9999999999999999999999999997543322


Q ss_pred             ceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccC-c------
Q 045835          398 THISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDG-K------  469 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~-~------  469 (511)
                      .. .....++..|+|||.+.+. .++.++||||||++++||+||+.||......    ..+........... .      
T Consensus       155 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07860         155 RT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI----DQLFRIFRTLGTPDEVVWPGVT  229 (284)
T ss_pred             cc-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHHHhCCCChhhhhhhh
Confidence            11 1223567889999988764 4688999999999999999999998643211    11111110000000 0      


Q ss_pred             -hhHhhhhhh---CC---CCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          470 -LVELVDERL---GS---KYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       470 -~~~~~d~~l---~~---~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                       +.+......   ..   ...+.....+.+++.+|++.+|++|||+.|+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~  278 (284)
T cd07860         230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAA  278 (284)
T ss_pred             HHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHH
Confidence             000000000   00   0011223467899999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.6e-35  Score=293.40  Aligned_cols=201  Identities=27%  Similarity=0.432  Sum_probs=167.7

Q ss_pred             HhcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCc-cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          238 ATNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSR-QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       238 ~~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++++|...+.||+|+||.||+|.. .++..||+|++..... .....+.+|+.+++.++|+||+++.+++.+++..++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            357899999999999999999975 4688999999875433 33346789999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+. ++|.+++....   ..+.+.....++.|++.||+|||+.+   |+|+||||+||+++.++.+||+|||+++....
T Consensus        83 e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  155 (291)
T cd07870          83 EYMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSI  155 (291)
T ss_pred             eccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence            9996 67776664332   24778888999999999999999986   99999999999999999999999999975432


Q ss_pred             CCceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSY  446 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~  446 (511)
                      .... .....++..|+|||.+.+. .++.++|||||||+++||++|+.||..
T Consensus       156 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~  206 (291)
T cd07870         156 PSQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPG  206 (291)
T ss_pred             CCCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            2111 1223468899999998754 578899999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=311.22  Aligned_cols=240  Identities=31%  Similarity=0.468  Sum_probs=197.0

Q ss_pred             CcccCceeccCceeEEeccc-cCCcEEEEEEecccCccc---hHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          242 FDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQG---NREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       242 f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      |.-++.||.|+||.||-++. .+...||||++.-..++.   .++++.|+..|.+++|||.+.+.||+..+...||||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            66678899999999999974 467899999998654443   45788999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      |- ||-.++|.-+.   .++.+..+..|+.+.+.||+|||+++   .||||||+.||||++.+.+||+|||.|.+.... 
T Consensus       108 Cl-GSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-  179 (948)
T KOG0577|consen  108 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-  179 (948)
T ss_pred             Hh-ccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence            96 57777775443   46888899999999999999999986   999999999999999999999999999865433 


Q ss_pred             ceeecccccCCCcccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          398 THISTRIAGTIGYMAPEYAL---WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                          ...+||+.|||||++.   .+.|+-|+||||+||+..||.-.++|.-.+..+.       . ..++-+++      
T Consensus       180 ----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS-------A-LYHIAQNe------  241 (948)
T KOG0577|consen  180 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------A-LYHIAQNE------  241 (948)
T ss_pred             ----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH-------H-HHHHHhcC------
Confidence                3358999999999875   6789999999999999999999999976443211       0 01111111      


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSE  510 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e  510 (511)
                      .|.+   ...+.+..+..++..||++-|.+|||..+
T Consensus       242 sPtL---qs~eWS~~F~~Fvd~CLqKipqeRptse~  274 (948)
T KOG0577|consen  242 SPTL---QSNEWSDYFRNFVDSCLQKIPQERPTSEE  274 (948)
T ss_pred             CCCC---CCchhHHHHHHHHHHHHhhCcccCCcHHH
Confidence            0122   24577888999999999999999999764

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3e-36  Score=293.16  Aligned_cols=245  Identities=26%  Similarity=0.351  Sum_probs=200.3

Q ss_pred             CCcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      +|+..+.||+|+||.||++... +++.+|+|.+....   ....+.+.+|+.++++++||||+++++++.+++..++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5788899999999999999865 58899999997542   2345688999999999999999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      |+++++|.+++...    ..+++.....++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            99999999998654    35889999999999999999999886   999999999999999999999999999865433


Q ss_pred             CceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhh
Q 045835          397 KTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDE  476 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  476 (511)
                      .  ......|+..|+|||.+....++.++|+||||+++++|++|+.|+......      ...+...         ....
T Consensus       154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~---------~~~~  216 (258)
T cd05578         154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT------IRDQIRA---------KQET  216 (258)
T ss_pred             c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc------HHHHHHH---------Hhcc
Confidence            2  122346788999999999888999999999999999999999998743210      1111111         1110


Q ss_pred             hhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCc--CC
Q 045835          477 RLGSKYKKEEAERMIKVSLLCTNASPSLRPTM--SE  510 (511)
Q Consensus       477 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~--~e  510 (511)
                       .....+...+..+.+++.+||+.+|.+||++  +|
T Consensus       217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~  251 (258)
T cd05578         217 -ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKD  251 (258)
T ss_pred             -ccccCcccCcHHHHHHHHHHccCChhHcCCccHHH
Confidence             1123344455789999999999999999998  55

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.6e-35  Score=286.66  Aligned_cols=248  Identities=30%  Similarity=0.403  Sum_probs=202.4

Q ss_pred             CCcccCceeccCceeEEecccc-CCcEEEEEEecccCc--cchHHHHHHHHHHhcCCCCCceeEEEEEEeC--CEEEEEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR--QGNREFLNEIAMISCLQHPNLVKIHGCCVEG--DQLLLVY  315 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~  315 (511)
                      +|...+.||+|++|.||+|... +++.|++|++.....  ...+.+.+|+.++++++||||+++++++.+.  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677899999999999999865 688999999876542  4456889999999999999999999999988  8999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++++|.+++....    .+++..+..++.+++.||+|||+.+   ++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  153 (260)
T cd06606          81 EYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD  153 (260)
T ss_pred             EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence            9999999999986543    6899999999999999999999976   99999999999999999999999999986554


Q ss_pred             CCce-eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          396 DKTH-ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       396 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      .... ......++..|+|||.+.....+.++||||||+++++|++|+.|+.....       ...-.         ..+.
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~---------~~~~  217 (260)
T cd06606         154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-------PMAAL---------YKIG  217 (260)
T ss_pred             ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-------hHHHH---------Hhcc
Confidence            3221 12234678899999999888899999999999999999999999864320       01111         1111


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ........+......+.+++.+|++.+|++||++.|+
T Consensus       218 ~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~l  254 (260)
T cd06606         218 SSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADEL  254 (260)
T ss_pred             ccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHH
Confidence            1112223344446789999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.2e-35  Score=292.88  Aligned_cols=263  Identities=24%  Similarity=0.373  Sum_probs=195.6

Q ss_pred             CCcccCceeccCceeEEecccc-CCcEEEEEEecccCcc-chHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQ-GNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      +|+..++||+|++|.||+|+.. +|..||||.++..... ....+.+|+.++++++|+|++++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5788999999999999999865 6889999998765332 3456789999999999999999999999999999999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      ++ +|.+++..... ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||+++.......
T Consensus        81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            85 88888765432 345899999999999999999999886   99999999999999999999999999975433211


Q ss_pred             eeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh-h
Q 045835          399 HISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD-E  476 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d-~  476 (511)
                       ......++..|++||.+.+. .++.++|||||||+++||++|+.||......+ ......+..... .......+.+ +
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~  232 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFRIMGTP-TESTWPGISQLP  232 (284)
T ss_pred             -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCC-ChhhHHHHhcCc
Confidence             11223568889999988654 57899999999999999999999986432110 000000000000 0000000000 0


Q ss_pred             hhC-----------CCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          477 RLG-----------SKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       477 ~l~-----------~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...           ....+.....+.+++.+|++.+|.+||++.||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~  278 (284)
T cd07836         233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDA  278 (284)
T ss_pred             hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHH
Confidence            000           01112235668899999999999999998764

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-36  Score=325.60  Aligned_cols=256  Identities=30%  Similarity=0.457  Sum_probs=207.7

Q ss_pred             HHHHhcCCcccCceeccCceeEEecccc----C----CcEEEEEEecccCc-cchHHHHHHHHHHhcC-CCCCceeEEEE
Q 045835          235 IKAATNNFDSAKKIGEGGFGPVYKGQLA----D----GTIIAVKQLSSKSR-QGNREFLNEIAMISCL-QHPNLVKIHGC  304 (511)
Q Consensus       235 l~~~~~~f~~~~~lG~G~fG~Vy~g~~~----~----g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~  304 (511)
                      .+...++..+.+.||+|.||.|++|...    .    ...||||.++.... ...+.+..|+++|+.+ +|+|++.++|+
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~  370 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA  370 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence            4444556667779999999999999743    1    45799999986533 4556889999999998 69999999999


Q ss_pred             EEeCCEEEEEEEecCCCCHhHHHhcCC---CCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCC
Q 045835          305 CVEGDQLLLVYEYMENNSLACALFGRE---NCE---------LELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKAT  372 (511)
Q Consensus       305 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~---~~~---------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~  372 (511)
                      |.++...++|.||++.|+|.++|...+   .-.         ..++....+.++.|||.||+||++..   ++||||.++
T Consensus       371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaR  447 (609)
T KOG0200|consen  371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAAR  447 (609)
T ss_pred             eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhh
Confidence            999999999999999999999997665   100         23888999999999999999999885   999999999


Q ss_pred             CeEEcCCCCeEEeecCCcccCCCCCceeecccc--cCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 045835          373 NVLLDRDLNPKISDFGLAKLDEGDKTHISTRIA--GTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPA  449 (511)
Q Consensus       373 NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~  449 (511)
                      |||+.++..+||+|||+++..............  -+..|||||.+....++.|+|||||||+||||+| |..|+...+.
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~  527 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP  527 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence            999999999999999999965554444333223  2557999999999999999999999999999999 7777753110


Q ss_pred             ccccccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCC
Q 045835          450 LEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSE  510 (511)
Q Consensus       450 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e  510 (511)
                                       ..++.+.+.+..+.+.|..+..++.+++..||+.+|++||++.|
T Consensus       528 -----------------~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~  571 (609)
T KOG0200|consen  528 -----------------TEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSE  571 (609)
T ss_pred             -----------------HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHH
Confidence                             11223344455555667778889999999999999999999876

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=4.3e-36  Score=297.03  Aligned_cols=253  Identities=29%  Similarity=0.387  Sum_probs=190.8

Q ss_pred             CCcccCceeccCceeEEecccc-CCcEEEEEEecccC-ccchHHHHHHHHHHhcCC-CCCceeEEEEEEeCCEEEEEEEe
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQ-HPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      +|...+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4556789999999999999754 58899999987543 234457889999999996 99999999999999999999999


Q ss_pred             cCCCCHhHHHhc-CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          318 MENNSLACALFG-RENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       318 ~~~gsL~~~l~~-~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      +.. ++.++... .......+++.....++.+++.||+|||+..  +++||||||+||+++.++.+||+|||+++.....
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            874 55443321 0111245899999999999999999999752  3999999999999999999999999999754332


Q ss_pred             CceeecccccCCCcccccccccC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHh
Q 045835          397 KTHISTRIAGTIGYMAPEYALWG---YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVEL  473 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  473 (511)
                      ...  ....|+..|+|||.+...   .++.++|||||||++|||++|+.||....       ....-...... +     
T Consensus       162 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~-~-----  226 (288)
T cd06616         162 IAK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-------SVFDQLTQVVK-G-----  226 (288)
T ss_pred             Ccc--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-------hHHHHHhhhcC-C-----
Confidence            211  233578899999998766   68999999999999999999999986321       01010000000 0     


Q ss_pred             hhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          474 VDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       474 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..+.+....+...+..+.+++.+||+.+|++|||+.||
T Consensus       227 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i  264 (288)
T cd06616         227 DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKEL  264 (288)
T ss_pred             CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHH
Confidence            01112222223456679999999999999999999875

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-35  Score=291.93  Aligned_cols=259  Identities=25%  Similarity=0.353  Sum_probs=194.0

Q ss_pred             CcccCceeccCceeEEecccc-CCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          242 FDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       242 f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      |+..+.||+|++|.||+|... +|..||+|++....  ......+.+|+++++.++|||++++++++.+++..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567889999999999999754 78999999987543  223357889999999999999999999999999999999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      + ++|.+++.....  ..+++..+..++.|+++||+|||+.+   ++||||+|+||+++.++.++|+|||+++.......
T Consensus        81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence            5 689998865432  35899999999999999999999886   99999999999999999999999999975432221


Q ss_pred             eeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccC--------c
Q 045835          399 HISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDG--------K  469 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~--------~  469 (511)
                      . .....++..|+|||++.+. .++.++||||||+++|||++|+.||......    ..+...........        .
T Consensus       155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd07835         155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI----DQLFRIFRTLGTPDEDVWPGVTS  229 (283)
T ss_pred             c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhCCCChHHhhhhhh
Confidence            1 1223468889999987654 5789999999999999999999998643211    01111110000000        0


Q ss_pred             hhHhhhhhhC------CCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          470 LVELVDERLG------SKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       470 ~~~~~d~~l~------~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +.+.......      ..........+.+++.+|++.+|++|||+.||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~i  277 (283)
T cd07835         230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAA  277 (283)
T ss_pred             chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence            0000000000      01112234578899999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.9e-35  Score=289.73  Aligned_cols=255  Identities=24%  Similarity=0.296  Sum_probs=190.1

Q ss_pred             CcccCceeccCceeEEeccc-cCCcEEEEEEecccC-ccchHHHHHHHHHHhcCC-CCCceeEEEEEEeC--CEEEEEEE
Q 045835          242 FDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQ-HPNLVKIHGCCVEG--DQLLLVYE  316 (511)
Q Consensus       242 f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~--~~~~lV~E  316 (511)
                      |++.++||+|+||.||+|.. .+++.+|+|+++... ........+|+.++.++. |+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            56778999999999999975 468899999987542 222334567888998885 99999999999987  88999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      |++ ++|.+++....   ..++|..+..++.|++.||+|||+.+   ++||||+|+||+++. +.+||+|||+++.....
T Consensus        81 ~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          81 LMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             cCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence            997 57888775432   35899999999999999999999986   999999999999999 99999999999865432


Q ss_pred             CceeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCc--hhHh
Q 045835          397 KTHISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGK--LVEL  473 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~--~~~~  473 (511)
                      ...  ....++..|+|||.+.. +.++.++|||||||+++||++|+.||.....     .....+.........  +.+.
T Consensus       153 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~  225 (282)
T cd07831         153 PPY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE-----LDQIAKIHDVLGTPDAEVLKK  225 (282)
T ss_pred             CCc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH-----HHHHHHHHHHcCCCCHHHHHh
Confidence            221  23457889999997654 5678999999999999999999999964321     111111111110000  0000


Q ss_pred             hhhh--hCC-----------CCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          474 VDER--LGS-----------KYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       474 ~d~~--l~~-----------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ....  ...           ......+..+.+++.+||+.+|++||++.|+
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~  276 (282)
T cd07831         226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQA  276 (282)
T ss_pred             hcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHH
Confidence            0000  000           0012346789999999999999999999874

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.5e-35  Score=289.00  Aligned_cols=237  Identities=22%  Similarity=0.304  Sum_probs=192.7

Q ss_pred             eeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCCCCH
Q 045835          248 IGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSL  323 (511)
Q Consensus       248 lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL  323 (511)
                      ||.|+||.||+++.. +++.+|+|.+....   ....+.+.+|+.+++.++||||+++++++.+++..++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999865 48899999986532   23346789999999999999999999999999999999999999999


Q ss_pred             hHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCceeecc
Q 045835          324 ACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR  403 (511)
Q Consensus       324 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~  403 (511)
                      .+++....    .+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||+++......  ....
T Consensus        81 ~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~  151 (262)
T cd05572          81 WTILRDRG----LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT  151 (262)
T ss_pred             HHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence            99996542    3889999999999999999999986   9999999999999999999999999998655432  1223


Q ss_pred             cccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCCCCC
Q 045835          404 IAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYK  483 (511)
Q Consensus       404 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  483 (511)
                      ..++..|+|||.+....++.++|+||||+++|||++|+.|+.....      +..+.         ...+.+......++
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~---------~~~~~~~~~~~~~~  216 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE------DPMEI---------YNDILKGNGKLEFP  216 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC------CHHHH---------HHHHhccCCCCCCC
Confidence            4678899999999888899999999999999999999999864321      00111         11122111222334


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCc
Q 045835          484 KEEAERMIKVSLLCTNASPSLRPTM  508 (511)
Q Consensus       484 ~~~~~~l~~l~~~Cl~~~p~~RPs~  508 (511)
                      ......+.+++.+||+.+|++||++
T Consensus       217 ~~~~~~~~~~i~~~l~~~p~~R~~~  241 (262)
T cd05572         217 NYIDKAAKDLIKQLLRRNPEERLGN  241 (262)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCC
Confidence            4446789999999999999999994

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-35  Score=288.67  Aligned_cols=246  Identities=24%  Similarity=0.273  Sum_probs=202.4

Q ss_pred             cCCcccCceeccCceeEEeccccC-CcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~-g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      +.|+.++.||+|.-|+||++++.+ +...|+|++....   +........|-+||+.++||-++.|++.++.....+++|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            346678999999999999999865 5889999997653   344456788999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      |||+||+|..+++.+.  ...+++....-.+..++.||+|||..|   ||.|||||+||||-++|++-|+||.|+.....
T Consensus       157 eyCpGGdL~~LrqkQp--~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQP--GKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             ecCCCccHHHHHhhCC--CCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence            9999999999987654  356999999999999999999999987   99999999999999999999999998742210


Q ss_pred             ---------------------------------C-C---------------------ceeecccccCCCcccccccccCC
Q 045835          396 ---------------------------------D-K---------------------THISTRIAGTIGYMAPEYALWGY  420 (511)
Q Consensus       396 ---------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~  420 (511)
                                                       . .                     ...+...+||-.|+|||++.+..
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence                                             0 0                     00112357999999999999999


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCC
Q 045835          421 LTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNA  500 (511)
Q Consensus       421 ~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~  500 (511)
                      .+.++|.|+|||++||||.|+.||.....                 +..+..++-..+.-.-.+..+..+.+|+.+.|.+
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~-----------------~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvK  374 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNN-----------------KETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVK  374 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCc-----------------hhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhcc
Confidence            99999999999999999999999975431                 2234445544433222335667899999999999


Q ss_pred             CCCCCCC
Q 045835          501 SPSLRPT  507 (511)
Q Consensus       501 ~p~~RPs  507 (511)
                      ||++|-.
T Consensus       375 dP~kRlg  381 (459)
T KOG0610|consen  375 DPSKRLG  381 (459)
T ss_pred             Chhhhhc
Confidence            9999976

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.2e-35  Score=293.85  Aligned_cols=263  Identities=25%  Similarity=0.335  Sum_probs=194.2

Q ss_pred             HHhcCCcccCceeccCceeEEecccc-CCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCC----
Q 045835          237 AATNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGD----  309 (511)
Q Consensus       237 ~~~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----  309 (511)
                      ...++|++.+.||+|+||.||+|... +++.||+|+++...  ......+.+|+.++++++|||++++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678999999999999999999865 58899999997543  223356788999999999999999999987654    


Q ss_pred             ------EEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeE
Q 045835          310 ------QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPK  383 (511)
Q Consensus       310 ------~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~k  383 (511)
                            ..++|+||+++ ++...+...   ...+++.....++.|++.||+|||+.+   |+|+||||+||++++++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEE
Confidence                  78999999986 676666443   235899999999999999999999986   99999999999999999999


Q ss_pred             EeecCCcccCCCCCceeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhH
Q 045835          384 ISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWAC  462 (511)
Q Consensus       384 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~  462 (511)
                      |+|||++...............++..|+|||.+.. ..++.++|||||||+++||++|++||......    ..+.....
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~----~~~~~~~~  232 (302)
T cd07864         157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL----AQLELISR  232 (302)
T ss_pred             eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHH
Confidence            99999998654433222223346778999998764 35789999999999999999999998632210    00100000


Q ss_pred             hhhcc--CchhHh--------hhh------hhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          463 HLQQD--GKLVEL--------VDE------RLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       463 ~~~~~--~~~~~~--------~d~------~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....  .....+        .+.      ..... ....+..+.+++.+||+.+|++|||+.+|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~i  296 (302)
T cd07864         233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEA  296 (302)
T ss_pred             HhCCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence            00000  000000        000      00000 01124578999999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.8e-35  Score=293.47  Aligned_cols=263  Identities=23%  Similarity=0.293  Sum_probs=192.4

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccCc--cchHHHHHHHHHHhcCC-CCCceeEEEEEEeCCE-----
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR--QGNREFLNEIAMISCLQ-HPNLVKIHGCCVEGDQ-----  310 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~-----  310 (511)
                      ++|+..+.||+|+||.||+|... +++.||+|.++....  .....+.+|+.+++.++ |||++++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46889999999999999999854 688999999865432  23457889999999995 6999999999987665     


Q ss_pred             EEEEEEecCCCCHhHHHhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcC-CCCeEEeecC
Q 045835          311 LLLVYEYMENNSLACALFGRENC-ELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR-DLNPKISDFG  388 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~-~~~~kl~DfG  388 (511)
                      .++||||+++ +|.+++...... ...+++...+.++.||+.||+|||+.+   ++||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999986 788887653322 346899999999999999999999986   999999999999998 8899999999


Q ss_pred             CcccCCCCCceeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhcc
Q 045835          389 LAKLDEGDKTHISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD  467 (511)
Q Consensus       389 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~  467 (511)
                      +++........ .....+++.|+|||++.+ ..++.++||||||+++|||++|+.||.......    .+..........
T Consensus       157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~----~~~~~~~~~~~~  231 (295)
T cd07837         157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ----QLLHIFKLLGTP  231 (295)
T ss_pred             cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHHHHhCCC
Confidence            99754322111 122346788999998865 467999999999999999999999986432111    000000000000


Q ss_pred             C-----chhHhhh----hhhC----CCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          468 G-----KLVELVD----ERLG----SKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       468 ~-----~~~~~~d----~~l~----~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .     ...+..+    +...    ....+....++.+++.+||+.+|++||++.|+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~ei  288 (295)
T cd07837         232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAA  288 (295)
T ss_pred             ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHH
Confidence            0     0000000    0000    00011245668899999999999999998764

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-35  Score=287.00  Aligned_cols=246  Identities=26%  Similarity=0.319  Sum_probs=195.4

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEeccc-----CccchHHHHHHHHHHhcCCCCCceeEEEEEEeC--CEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK-----SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEG--DQL  311 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~  311 (511)
                      .+|++.+.||+|+||.||+|.. .++..||+|.+...     ..+....+.+|+.++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            5788999999999999999975 45889999987532     123345788999999999999999999998764  468


Q ss_pred             EEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcc
Q 045835          312 LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK  391 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~  391 (511)
                      ++++||+++++|.+++....    .+++....+++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||+++
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~  154 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK  154 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccc
Confidence            89999999999999986432    4788999999999999999999987   9999999999999999999999999998


Q ss_pred             cCCCCCc--eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCc
Q 045835          392 LDEGDKT--HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGK  469 (511)
Q Consensus       392 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  469 (511)
                      .......  .......++..|+|||++.+..++.++|||||||+++||++|+.||......                 ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----------------~~  217 (264)
T cd06653         155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM-----------------AA  217 (264)
T ss_pred             ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH-----------------HH
Confidence            5432111  1112345888999999999888999999999999999999999998632110                 01


Q ss_pred             hhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCC
Q 045835          470 LVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSE  510 (511)
Q Consensus       470 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e  510 (511)
                      ..++.........+......+.+++.+|++ +|..||+..+
T Consensus       218 ~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~  257 (264)
T cd06653         218 IFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEF  257 (264)
T ss_pred             HHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHH
Confidence            111111112233455666789999999999 5799999765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-35  Score=300.75  Aligned_cols=259  Identities=25%  Similarity=0.341  Sum_probs=192.6

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeC-----CEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEG-----DQL  311 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~  311 (511)
                      +++|++.++||+|+||.||+|.. .+|+.||+|.+.... ......+.+|+.++++++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            46899999999999999999974 468999999986432 23445688999999999999999999987654     357


Q ss_pred             EEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcc
Q 045835          312 LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK  391 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~  391 (511)
                      ++++||+.+ +|.+.+...     .+++.....++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++
T Consensus        84 ~lv~e~~~~-~l~~~~~~~-----~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~  154 (336)
T cd07849          84 YIVQELMET-DLYKLIKTQ-----HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR  154 (336)
T ss_pred             EEEehhccc-CHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence            999999975 787776432     4899999999999999999999986   9999999999999999999999999997


Q ss_pred             cCCCCCce--eecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhcc-
Q 045835          392 LDEGDKTH--ISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD-  467 (511)
Q Consensus       392 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~-  467 (511)
                      ........  ......|+..|+|||.+.+ ..++.++|||||||+++||++|+.||.....     ............. 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~-----~~~~~~~~~~~~~~  229 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY-----LHQLNLILGVLGTP  229 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHcCCC
Confidence            54332211  1123467889999998754 4689999999999999999999999863221     0011111111100 


Q ss_pred             --CchhHhhhhhh---------CCCC-----CHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          468 --GKLVELVDERL---------GSKY-----KKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       468 --~~~~~~~d~~l---------~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                        +....+.+...         ....     .+....++.+++.+||+.+|++|||+.|+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~  289 (336)
T cd07849         230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEA  289 (336)
T ss_pred             CHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHH
Confidence              01111111100         0000     11234668999999999999999999874

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.1e-35  Score=287.38  Aligned_cols=237  Identities=25%  Similarity=0.372  Sum_probs=190.8

Q ss_pred             eeccCceeEEecccc-CCcEEEEEEecccCc---cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCCCCH
Q 045835          248 IGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR---QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSL  323 (511)
Q Consensus       248 lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL  323 (511)
                      ||+|+||.||+++.. +|+.+++|.+.....   .....+.+|+.++++++|||++++++.+..++..++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999876 489999999865433   3456788999999999999999999999999999999999999999


Q ss_pred             hHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc-----
Q 045835          324 ACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-----  398 (511)
Q Consensus       324 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~-----  398 (511)
                      .+++....    .+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++........     
T Consensus        81 ~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  153 (265)
T cd05579          81 ASLLENVG----SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND  153 (265)
T ss_pred             HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence            99996543    5899999999999999999999986   99999999999999999999999999875433211     


Q ss_pred             --eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhh
Q 045835          399 --HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDE  476 (511)
Q Consensus       399 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  476 (511)
                        .......++..|+|||.......+.++||||||++++||++|+.||.....     .   .....         +...
T Consensus       154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~---~~~~~---------~~~~  216 (265)
T cd05579         154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-----E---EIFQN---------ILNG  216 (265)
T ss_pred             ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-----H---HHHHH---------HhcC
Confidence              112234578899999999888899999999999999999999999863221     0   11100         1100


Q ss_pred             hhCCCCCHHH--HHHHHHHHHHcCCCCCCCCCCcCC
Q 045835          477 RLGSKYKKEE--AERMIKVSLLCTNASPSLRPTMSE  510 (511)
Q Consensus       477 ~l~~~~~~~~--~~~l~~l~~~Cl~~~p~~RPs~~e  510 (511)
                      .  ...+...  ...+.+++.+|++.+|++|||+.+
T Consensus       217 ~--~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~  250 (265)
T cd05579         217 K--IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKS  250 (265)
T ss_pred             C--cCCCccccCCHHHHHHHHHHhcCCHhhcCCCcc
Confidence            0  1112222  567899999999999999999943

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.7e-35  Score=293.90  Aligned_cols=240  Identities=27%  Similarity=0.437  Sum_probs=192.9

Q ss_pred             cCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCCCCH
Q 045835          245 AKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSL  323 (511)
Q Consensus       245 ~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL  323 (511)
                      ..+||+|+||.||++.. .+++.||||++..........+.+|+.+++.++|+|++++++++..++..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            46799999999999976 46889999998765555566789999999999999999999999999999999999999999


Q ss_pred             hHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCceeecc
Q 045835          324 ACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR  403 (511)
Q Consensus       324 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~  403 (511)
                      .+++...     .+++.....++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++........ ....
T Consensus       105 ~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~  175 (292)
T cd06657         105 TDIVTHT-----RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS  175 (292)
T ss_pred             HHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc-cccc
Confidence            9987432     3789999999999999999999986   99999999999999999999999999875433221 1223


Q ss_pred             cccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCCC--
Q 045835          404 IAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSK--  481 (511)
Q Consensus       404 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~--  481 (511)
                      ..++..|+|||.+.+..++.++||||||++++||++|+.|+......     ...             ..+...+...  
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-----~~~-------------~~~~~~~~~~~~  237 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-----KAM-------------KMIRDNLPPKLK  237 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHH-------------HHHHhhCCcccC
Confidence            46788999999998888999999999999999999999998632210     000             0111111100  


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          482 YKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       482 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ........+.+++.+||+.+|.+||++.||
T Consensus       238 ~~~~~~~~l~~li~~~l~~~P~~R~~~~~l  267 (292)
T cd06657         238 NLHKVSPSLKGFLDRLLVRDPAQRATAAEL  267 (292)
T ss_pred             CcccCCHHHHHHHHHHHhCCcccCcCHHHH
Confidence            111234567889999999999999998764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-35  Score=284.23  Aligned_cols=245  Identities=29%  Similarity=0.456  Sum_probs=199.5

Q ss_pred             CCcccCceeccCceeEEecccc-CCcEEEEEEecccCc--cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR--QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      +|+..+.||+|++|.||++... +++.+++|.+.....  .....+.+|++++++++|||++++++++.+++..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4778899999999999999754 578999999976543  3456789999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +++++|.+++...    ..+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            9999999998654    35899999999999999999999886   9999999999999999999999999998654433


Q ss_pred             ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          398 THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                      .. .....++..|+|||.......+.++||||+|++++||++|+.|+......      ...|.           ... .
T Consensus       154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~------~~~~~-----------~~~-~  214 (254)
T cd06627         154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM------AALFR-----------IVQ-D  214 (254)
T ss_pred             cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH------HHHHH-----------Hhc-c
Confidence            21 22346788999999988888899999999999999999999998632210      00110           000 0


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....+......+.+++.+||+.+|++|||+.|+
T Consensus       215 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~  248 (254)
T cd06627         215 DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQL  248 (254)
T ss_pred             CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHH
Confidence            1112233445678899999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-36  Score=307.98  Aligned_cols=243  Identities=25%  Similarity=0.400  Sum_probs=188.5

Q ss_pred             cccCceeccCceeEEecccc-CCcEEE---EEEec-ccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCC--EEEEEE
Q 045835          243 DSAKKIGEGGFGPVYKGQLA-DGTIIA---VKQLS-SKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGD--QLLLVY  315 (511)
Q Consensus       243 ~~~~~lG~G~fG~Vy~g~~~-~g~~vA---vK~~~-~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~  315 (511)
                      +...+||+|.|-+||||... +|-.||   ||.-. .++....+.|..|+.+|+.|+||||++++.++.+..  ..-+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            45578999999999999753 466666   33221 123344578999999999999999999999998755  488999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCC-CCeEEeecCCcccCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD-LNPKISDFGLAKLDE  394 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~-~~~kl~DfGla~~~~  394 (511)
                      |.|..|+|..++...+    .++.+....+|.||++||.|||++ .|||||||||..||+|+.+ |.+||+|+|||.+..
T Consensus       123 EL~TSGtLr~Y~kk~~----~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r  197 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHR----RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR  197 (632)
T ss_pred             ecccCCcHHHHHHHhc----cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence            9999999999998765    378889999999999999999998 4899999999999999876 789999999998765


Q ss_pred             CCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          395 GDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       395 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      ...   ...+.||+.|||||.+. ..|++.+||||||+.|+||+|+..||+.       +...++- ...+-.|....-+
T Consensus       198 ~s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE-------C~n~AQI-YKKV~SGiKP~sl  265 (632)
T KOG0584|consen  198 KSH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE-------CTNPAQI-YKKVTSGIKPAAL  265 (632)
T ss_pred             ccc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh-------hCCHHHH-HHHHHcCCCHHHh
Confidence            332   23478999999999877 7899999999999999999999999972       2212111 1111112111111


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..     +   ...++.+++.+|+.. .++|||+.|+
T Consensus       266 ~k-----V---~dPevr~fIekCl~~-~~~R~sa~eL  293 (632)
T KOG0584|consen  266 SK-----V---KDPEVREFIEKCLAT-KSERLSAKEL  293 (632)
T ss_pred             hc-----c---CCHHHHHHHHHHhcC-chhccCHHHH
Confidence            11     0   023578899999998 9999998774

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4.7e-35  Score=288.15  Aligned_cols=241  Identities=27%  Similarity=0.362  Sum_probs=190.6

Q ss_pred             eeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCCCCH
Q 045835          248 IGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSL  323 (511)
Q Consensus       248 lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL  323 (511)
                      ||+|+||.||++... +|+.+|+|.+....   ......+.+|++++++++|||++++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999744 68899999986432   22344577899999999999999999999999999999999999999


Q ss_pred             hHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCceeecc
Q 045835          324 ACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR  403 (511)
Q Consensus       324 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~  403 (511)
                      .+++.....  ..+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||++........  ...
T Consensus        81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~  153 (277)
T cd05577          81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKG  153 (277)
T ss_pred             HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--ccc
Confidence            999865432  35899999999999999999999986   99999999999999999999999999976543211  223


Q ss_pred             cccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCCCCC
Q 045835          404 IAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYK  483 (511)
Q Consensus       404 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  483 (511)
                      ..++..|+|||++.+..++.++|||||||+++||++|+.||....... .   ...          +.+... ......+
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~---~~~----------~~~~~~-~~~~~~~  218 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-E---KEE----------LKRRTL-EMAVEYP  218 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-c---HHH----------HHhccc-cccccCC
Confidence            457889999999988889999999999999999999999986432100 0   000          000000 0111223


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCcCC
Q 045835          484 KEEAERMIKVSLLCTNASPSLRPTMSE  510 (511)
Q Consensus       484 ~~~~~~l~~l~~~Cl~~~p~~RPs~~e  510 (511)
                      ......+.+++.+||+.+|++||+..|
T Consensus       219 ~~~~~~~~~li~~~l~~~p~~R~~~~~  245 (277)
T cd05577         219 DKFSPEAKDLCEALLQKDPEKRLGCRG  245 (277)
T ss_pred             ccCCHHHHHHHHHHccCChhHccCCCc
Confidence            344567899999999999999997655

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.1e-36  Score=317.64  Aligned_cols=202  Identities=19%  Similarity=0.284  Sum_probs=159.5

Q ss_pred             HhcCCcccCceeccCceeEEeccccC--CcEEEEE------------------EecccCccchHHHHHHHHHHhcCCCCC
Q 045835          238 ATNNFDSAKKIGEGGFGPVYKGQLAD--GTIIAVK------------------QLSSKSRQGNREFLNEIAMISCLQHPN  297 (511)
Q Consensus       238 ~~~~f~~~~~lG~G~fG~Vy~g~~~~--g~~vAvK------------------~~~~~~~~~~~~~~~Ei~~l~~l~H~n  297 (511)
                      ..++|++.++||+|+||.||++..+.  +...++|                  .+. ........+.+|+.+|++++|||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence            34689999999999999999986432  2222222                  111 11123356789999999999999


Q ss_pred             ceeEEEEEEeCCEEEEEEEecCCCCHhHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEE
Q 045835          298 LVKIHGCCVEGDQLLLVYEYMENNSLACALFGREN-CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL  376 (511)
Q Consensus       298 iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILl  376 (511)
                      |+++++++.+.+..++|+|++. ++|.+++..... ............++.|++.||+|||+.+   |+||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence            9999999999999999999986 467666654321 1122345667789999999999999986   9999999999999


Q ss_pred             cCCCCeEEeecCCcccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 045835          377 DRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNM  444 (511)
Q Consensus       377 d~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~  444 (511)
                      +.++.+||+|||+++..............||..|+|||++.+..++.++|||||||++|||++|+.++
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p  368 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP  368 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            99999999999999866544333334457999999999999999999999999999999999988543

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-37  Score=278.65  Aligned_cols=246  Identities=24%  Similarity=0.327  Sum_probs=196.4

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEeccc--CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK--SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      +++|++.+.||+|.|+.||++.. .+|+.+|+|++...  +..+.+++.+|+.+.+.|+|||||+|.....+....++|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            45688889999999999999964 57888888887532  3446678899999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCC---CCeEEeecCCccc
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD---LNPKISDFGLAKL  392 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~---~~~kl~DfGla~~  392 (511)
                      |+|++++|..-+-.+    ...++...-....||+.+|.|+|..+   |+|||+||.|+||-+.   --+||+|||+|..
T Consensus        90 e~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             ecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence            999999987666443    23567777788999999999999987   9999999999999543   3589999999987


Q ss_pred             CCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhH
Q 045835          393 DEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVE  472 (511)
Q Consensus       393 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  472 (511)
                      ...+  ..-...+||++|||||++...+++..+|||+.||||+-||.|.+||...     +...+.+-            
T Consensus       163 l~~g--~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~-----~~~rlye~------------  223 (355)
T KOG0033|consen  163 VNDG--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE-----DQHRLYEQ------------  223 (355)
T ss_pred             eCCc--cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc-----cHHHHHHH------------
Confidence            6632  2334568999999999999999999999999999999999999999731     11111111            


Q ss_pred             hhhh--hhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCC
Q 045835          473 LVDE--RLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSE  510 (511)
Q Consensus       473 ~~d~--~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e  510 (511)
                      ++..  ...+...+...++..+|+.+||..||++|.|+.|
T Consensus       224 I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~E  263 (355)
T KOG0033|consen  224 IKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADE  263 (355)
T ss_pred             HhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHH
Confidence            1111  1112222344567889999999999999999876

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=3.9e-35  Score=290.54  Aligned_cols=245  Identities=25%  Similarity=0.350  Sum_probs=192.3

Q ss_pred             CCcccCceeccCceeEEeccc----cCCcEEEEEEecccC----ccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQL----ADGTIIAVKQLSSKS----RQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQL  311 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~----~~g~~vAvK~~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~  311 (511)
                      +|++.+.||+|+||.||+++.    .+|..||+|++....    ....+.+.+|+.+++++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477889999999999999874    368899999987532    22345678899999999 599999999999999999


Q ss_pred             EEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcc
Q 045835          312 LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK  391 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~  391 (511)
                      ++||||+++++|.+++....    .+++.....++.|++.||.|||+.+   ++||||+|+|||++.++.+||+|||++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE----RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccce
Confidence            99999999999999986532    4788899999999999999999986   9999999999999999999999999998


Q ss_pred             cCCCCCceeecccccCCCcccccccccC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCc
Q 045835          392 LDEGDKTHISTRIAGTIGYMAPEYALWG--YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGK  469 (511)
Q Consensus       392 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  469 (511)
                      ..............|+..|+|||.+...  .++.++||||||++++||++|+.|+.....    ......+......   
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~----~~~~~~~~~~~~~---  226 (290)
T cd05613         154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE----KNSQAEISRRILK---  226 (290)
T ss_pred             ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc----cccHHHHHHHhhc---
Confidence            6543322222234688899999998753  478899999999999999999999863211    1111111111100   


Q ss_pred             hhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCC
Q 045835          470 LVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPT  507 (511)
Q Consensus       470 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs  507 (511)
                            .  ...++......+.+++.+||+.+|++||+
T Consensus       227 ------~--~~~~~~~~~~~~~~ll~~~l~~~p~~R~~  256 (290)
T cd05613         227 ------S--EPPYPQEMSALAKDIIQRLLMKDPKKRLG  256 (290)
T ss_pred             ------c--CCCCCccCCHHHHHHHHHHhcCCHHHhcC
Confidence                  0  11223344567889999999999999984

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-37  Score=288.90  Aligned_cols=245  Identities=27%  Similarity=0.359  Sum_probs=203.2

Q ss_pred             CCcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecC
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYME  319 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~  319 (511)
                      -|+++++||+|+||.|||+.++ .|..+|||.+...  ...+++..|+.+|++-+.|++|+++|.+.....+++|||||-
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            3778999999999999999765 6999999998754  345789999999999999999999999999999999999999


Q ss_pred             CCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCce
Q 045835          320 NNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH  399 (511)
Q Consensus       320 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~  399 (511)
                      -|++.+.+..+.   .+|++..+..++...++||+|||...   -||||||+.||||+.+|.+||+|||.|..+......
T Consensus       112 AGSiSDI~R~R~---K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK  185 (502)
T KOG0574|consen  112 AGSISDIMRARR---KPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK  185 (502)
T ss_pred             CCcHHHHHHHhc---CCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence            999999996554   47999999999999999999999874   899999999999999999999999999866543322


Q ss_pred             eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhC
Q 045835          400 ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLG  479 (511)
Q Consensus       400 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  479 (511)
                       ...+.||+.|||||++..-.|..++||||+|+...||..|++|+....+...-        ..+  .      -.|-..
T Consensus       186 -RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI--------FMI--P------T~PPPT  248 (502)
T KOG0574|consen  186 -RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI--------FMI--P------TKPPPT  248 (502)
T ss_pred             -hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee--------Eec--c------CCCCCC
Confidence             23467999999999999999999999999999999999999999743321100        000  0      001111


Q ss_pred             CCCCHHHHHHHHHHHHHcCCCCCCCCCCcCC
Q 045835          480 SKYKKEEAERMIKVSLLCTNASPSLRPTMSE  510 (511)
Q Consensus       480 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e  510 (511)
                      -..|...+.++.+++..||-.+|++|-|+.+
T Consensus       249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~  279 (502)
T KOG0574|consen  249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALR  279 (502)
T ss_pred             CCChHhhhhHHHHHHHHHhcCCHHHHHHHHH
Confidence            1235567888999999999999999988643

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.1e-36  Score=277.29  Aligned_cols=245  Identities=23%  Similarity=0.353  Sum_probs=197.4

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCc-----c---chHHHHHHHHHHhcC-CCCCceeEEEEEEeC
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR-----Q---GNREFLNEIAMISCL-QHPNLVKIHGCCVEG  308 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~-----~---~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~  308 (511)
                      -++|...+.||.|..+.|-++..+ +|...|+|++.....     +   ..++-..|+.+|+++ .||+|+++.++++..
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            356888899999999999988654 678899999864321     1   123346799999998 699999999999999


Q ss_pred             CEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecC
Q 045835          309 DQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFG  388 (511)
Q Consensus       309 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfG  388 (511)
                      ..+++|+|.|+.|.|.++|...    ..++++...+|+.|+..|++|||...   |+||||||+|||+|++.++||+|||
T Consensus        96 sF~FlVFdl~prGELFDyLts~----VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFG  168 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTSK----VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFG  168 (411)
T ss_pred             chhhhhhhhcccchHHHHhhhh----eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccc
Confidence            9999999999999999999543    46999999999999999999999986   9999999999999999999999999


Q ss_pred             CcccCCCCCceeecccccCCCccccccccc------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhH
Q 045835          389 LAKLDEGDKTHISTRIAGTIGYMAPEYALW------GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWAC  462 (511)
Q Consensus       389 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~  462 (511)
                      +++..+.+..  -...+||++|+|||.+..      ..|+...|+||+||+||-||.|.+||-....+            
T Consensus       169 Fa~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm------------  234 (411)
T KOG0599|consen  169 FACQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM------------  234 (411)
T ss_pred             eeeccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH------------
Confidence            9997765433  356799999999998753      35788999999999999999999998532210            


Q ss_pred             hhhccCchhHhhhh-h--hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCC
Q 045835          463 HLQQDGKLVELVDE-R--LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSE  510 (511)
Q Consensus       463 ~~~~~~~~~~~~d~-~--l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e  510 (511)
                            -+..++.. .  ...+-..+.+....+|+.+||+.||.+|.|.+|
T Consensus       235 ------lMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake  279 (411)
T KOG0599|consen  235 ------LMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKE  279 (411)
T ss_pred             ------HHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHH
Confidence                  00111111 1  122223455677899999999999999999876

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.3e-35  Score=304.31  Aligned_cols=195  Identities=28%  Similarity=0.380  Sum_probs=168.4

Q ss_pred             CCcccCceeccCceeEEecc-ccCCcEEEEEEecccCccchHHHHHHHHHHhcCC-C-----CCceeEEEEEEeCCEEEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ-H-----PNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H-----~niv~l~g~~~~~~~~~l  313 (511)
                      +|++.+.||+|+||.|-+|. ..+++.||||+++.... -..+...|+.+|..|+ |     -|+|++++|+...++++|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            78899999999999999996 55799999999986532 3345678999999997 4     489999999999999999


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCC--CeEEeecCCcc
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL--NPKISDFGLAK  391 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~--~~kl~DfGla~  391 (511)
                      |+|.+.. +|.++|..+.-  ..++.+....|+.||+.||.+||+.+   |||+||||+||||.+..  .+||+|||.++
T Consensus       266 VfELL~~-NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc  339 (586)
T KOG0667|consen  266 VFELLST-NLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC  339 (586)
T ss_pred             eehhhhh-hHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence            9998865 89999976553  45899999999999999999999886   99999999999997654  69999999998


Q ss_pred             cCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 045835          392 LDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSY  446 (511)
Q Consensus       392 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~  446 (511)
                      .....-.    ....+.-|+|||++.+.+|+.+.||||||||+.||++|.+.|..
T Consensus       340 ~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG  390 (586)
T KOG0667|consen  340 FESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG  390 (586)
T ss_pred             ccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence            6543211    34567789999999999999999999999999999999887764

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=4.4e-35  Score=288.88  Aligned_cols=235  Identities=27%  Similarity=0.311  Sum_probs=181.4

Q ss_pred             ceeccCceeEEecccc-CCcEEEEEEecccCc---cchHHHHHHHHHH---hcCCCCCceeEEEEEEeCCEEEEEEEecC
Q 045835          247 KIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR---QGNREFLNEIAMI---SCLQHPNLVKIHGCCVEGDQLLLVYEYME  319 (511)
Q Consensus       247 ~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l---~~l~H~niv~l~g~~~~~~~~~lV~Ey~~  319 (511)
                      .||+|+||.||++... +++.+|+|.+.....   .....+.+|..++   ...+|||++.+++++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999754 588999998865421   2223344554443   34479999999999999999999999999


Q ss_pred             CCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCce
Q 045835          320 NNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH  399 (511)
Q Consensus       320 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~  399 (511)
                      +++|.+++....    .+++.....++.|++.||+|||+.+   ++||||||+|||+++++.++|+|||++........ 
T Consensus        81 ~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-  152 (279)
T cd05633          81 GGDLHYHLSQHG----VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-  152 (279)
T ss_pred             CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-
Confidence            999999886442    4899999999999999999999987   99999999999999999999999999975432221 


Q ss_pred             eecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhh
Q 045835          400 ISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERL  478 (511)
Q Consensus       400 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  478 (511)
                        ....|+..|+|||.+.. ..++.++|||||||+++||++|+.||......  .   ... .         .+. ....
T Consensus       153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~---~~~-~---------~~~-~~~~  214 (279)
T cd05633         153 --HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--D---KHE-I---------DRM-TLTV  214 (279)
T ss_pred             --cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc--C---HHH-H---------HHH-hhcC
Confidence              22468999999998864 56899999999999999999999998643210  0   000 0         000 0011


Q ss_pred             CCCCCHHHHHHHHHHHHHcCCCCCCCCCC
Q 045835          479 GSKYKKEEAERMIKVSLLCTNASPSLRPT  507 (511)
Q Consensus       479 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs  507 (511)
                      ....+.....++.+++.+||+.+|++||+
T Consensus       215 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~  243 (279)
T cd05633         215 NVELPDSFSPELKSLLEGLLQRDVSKRLG  243 (279)
T ss_pred             CcCCccccCHHHHHHHHHHhcCCHHHhcC
Confidence            22334445667899999999999999994

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3.2e-35  Score=292.21  Aligned_cols=248  Identities=27%  Similarity=0.422  Sum_probs=190.2

Q ss_pred             cCCcccCceeccCceeEEeccccC-CcEEEEEEecccC-ccchHHHHHHHHHHhcCC-CCCceeEEEEEEeCCEEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKS-RQGNREFLNEIAMISCLQ-HPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~-g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      ++|+..+.||+|+||.||+|...+ ++.||||.++... .....++..|+.++.+.. ||||++++++|.+....+++||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            568889999999999999998764 8899999997543 233456777887777775 9999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      |+.+ +|.+++....   ..+++..+..++.+++.||+|||+..  +|+||||+|+||++++++.+||+|||++......
T Consensus        95 ~~~~-~l~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          95 LMST-CLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             ccCc-CHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            9854 6777664422   26899999999999999999999742  3999999999999999999999999999765432


Q ss_pred             CceeecccccCCCcccccccccCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhH
Q 045835          397 KTHISTRIAGTIGYMAPEYALWGY----LTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVE  472 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  472 (511)
                      ...  ....++..|+|||.+....    ++.++||||||+++|||++|+.||.....   +    .+.         +..
T Consensus       169 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~----~~~---------~~~  230 (296)
T cd06618         169 KAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT---E----FEV---------LTK  230 (296)
T ss_pred             Ccc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh---H----HHH---------HHH
Confidence            221  2235778999999987543    78899999999999999999999863211   0    000         111


Q ss_pred             hhhhhhC-CCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          473 LVDERLG-SKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       473 ~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +++.... .........++.+++.+||+.+|++||++.+|
T Consensus       231 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~i  270 (296)
T cd06618         231 ILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYREL  270 (296)
T ss_pred             HhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence            1111110 01111235678999999999999999999764

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=4.5e-35  Score=298.75  Aligned_cols=196  Identities=26%  Similarity=0.363  Sum_probs=166.3

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEeccc--CccchHHHHHHHHHHhcCCCCCceeEEEEEEeC------C
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK--SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEG------D  309 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~  309 (511)
                      .++|+..+.||+|+||.||++.. .+++.||+|.+...  .......+.+|+.++++++||||+++++++...      .
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            47899999999999999999975 46899999998643  223345678899999999999999999998643      3


Q ss_pred             EEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCC
Q 045835          310 QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL  389 (511)
Q Consensus       310 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGl  389 (511)
                      ..++||||+.+ +|.+.+..      .+++.....++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+
T Consensus        95 ~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          95 DVYLVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             cEEEEEeccCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence            57999999964 78777742      2788899999999999999999986   99999999999999999999999999


Q ss_pred             cccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 045835          390 AKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSY  446 (511)
Q Consensus       390 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~  446 (511)
                      ++.......  .....++..|+|||.+.+..++.++|||||||++++|++|+.||..
T Consensus       165 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~  219 (353)
T cd07850         165 ARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG  219 (353)
T ss_pred             ceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence            986543221  2234578899999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2e-35  Score=293.27  Aligned_cols=260  Identities=24%  Similarity=0.341  Sum_probs=191.6

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccCc--cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR--QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      ++|+..+.||+|++|.||+|... +++.||+|.+.....  .....+.+|+.++++++|||++++++++.+.+..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888999999999999999864 688999999865422  334578899999999999999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcC-CCCeEEeecCCcccCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR-DLNPKISDFGLAKLDEG  395 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~-~~~~kl~DfGla~~~~~  395 (511)
                      |++ ++|.+++....  ...+++.....++.||+.||+|||+.+   ++||||+|+||+++. ++.+||+|||++.....
T Consensus        82 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~  155 (294)
T PLN00009         82 YLD-LDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI  155 (294)
T ss_pred             ccc-ccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence            996 57877775432  234678888899999999999999986   999999999999985 45799999999975433


Q ss_pred             CCceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccC------
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDG------  468 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~------  468 (511)
                      ... ......++..|+|||++.+. .++.++|||||||++|||+||+.||......+    .+..-. ......      
T Consensus       156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~----~~~~~~-~~~~~~~~~~~~  229 (294)
T PLN00009        156 PVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID----ELFKIF-RILGTPNEETWP  229 (294)
T ss_pred             Ccc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHH-HHhCCCChhhcc
Confidence            211 12234568899999988654 67899999999999999999999986432110    000000 000000      


Q ss_pred             ---chhHhhhh--hhCCC----CCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          469 ---KLVELVDE--RLGSK----YKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       469 ---~~~~~~d~--~l~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                         .+.+....  .....    ..+....++.+++.+|++.+|++||++.++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~  281 (294)
T PLN00009        230 GVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAA  281 (294)
T ss_pred             ccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHH
Confidence               00000000  00000    011234568899999999999999999764

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=5.2e-35  Score=289.37  Aligned_cols=249  Identities=22%  Similarity=0.344  Sum_probs=194.3

Q ss_pred             CCcccCceeccCceeEEeccc----cCCcEEEEEEecccC----ccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQL----ADGTIIAVKQLSSKS----RQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQL  311 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~----~~g~~vAvK~~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~  311 (511)
                      +|+..+.||+|+||.||+++.    .+++.||||.++...    ......+.+|+.++.++ +|||++++++++..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            467789999999999999863    357889999986432    22345688999999999 599999999999999999


Q ss_pred             EEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcc
Q 045835          312 LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK  391 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~  391 (511)
                      ++||||+++|+|.+++...    ..+++.....++.|+++||.|||+.+   ++||||+|+||+++.++.++|+|||+++
T Consensus        81 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc----CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccc
Confidence            9999999999999998643    24889999999999999999999876   9999999999999999999999999998


Q ss_pred             cCCCCCceeecccccCCCcccccccccCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCc
Q 045835          392 LDEGDKTHISTRIAGTIGYMAPEYALWGY--LTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGK  469 (511)
Q Consensus       392 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  469 (511)
                      ..............|+..|+|||.+.+..  .+.++||||||++++||++|+.|+......    ....+....      
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----~~~~~~~~~------  223 (288)
T cd05583         154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ----NSQSEISRR------  223 (288)
T ss_pred             ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc----chHHHHHHH------
Confidence            65433322223346788999999987664  788999999999999999999998632110    001111111      


Q ss_pred             hhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          470 LVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       470 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                         +...  ....+......+.+++.+||+.+|++|||+.+|
T Consensus       224 ---~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~  260 (288)
T cd05583         224 ---ILKS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGA  260 (288)
T ss_pred             ---HHcc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchH
Confidence               1111  112233344568899999999999999998653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=4.3e-35  Score=293.18  Aligned_cols=243  Identities=28%  Similarity=0.420  Sum_probs=190.5

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEeccc---CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK---SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      +.|+..+.||+|+||.||+|+.. ++..+|+|.+...   ......++.+|+.+++.++|+|++++.+++......++|+
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34777789999999999999854 5788999998643   2233456889999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+. |+|.+++....   ..+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.+||+|||++.....
T Consensus        95 e~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          95 EYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             EccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            9997 68877775332   34889999999999999999999886   99999999999999999999999999975433


Q ss_pred             CCceeecccccCCCcccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhH
Q 045835          396 DKTHISTRIAGTIGYMAPEYAL---WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVE  472 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  472 (511)
                      .     ....++..|+|||.+.   ....+.++|||||||+++||++|+.|+......        ...         ..
T Consensus       168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------~~~---------~~  225 (308)
T cd06634         168 A-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SAL---------YH  225 (308)
T ss_pred             c-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--------HHH---------HH
Confidence            2     2235788999999874   356888999999999999999999987532110        000         00


Q ss_pred             hhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          473 LVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       473 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +................+.+++.+||+.+|++||++.+|
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l  264 (308)
T cd06634         226 IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL  264 (308)
T ss_pred             HhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHH
Confidence            111101111122345678899999999999999998764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.2e-35  Score=298.95  Aligned_cols=263  Identities=23%  Similarity=0.356  Sum_probs=193.3

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEeccc--CccchHHHHHHHHHHhcC-CCCCceeEEEEEEeC--CEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK--SRQGNREFLNEIAMISCL-QHPNLVKIHGCCVEG--DQLL  312 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~--~~~~  312 (511)
                      .++|+..+.||+|+||.||+|... +++.+|+|++...  .......+.+|+.+++++ +||||++++++|...  ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            467889999999999999999864 5789999988542  223345677899999999 999999999998653  4689


Q ss_pred             EEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCccc
Q 045835          313 LVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       313 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~  392 (511)
                      +||||++ ++|..++...     .++|..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus        86 lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          86 LVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            9999997 5898887542     4789999999999999999999986   99999999999999999999999999985


Q ss_pred             CCCCCc----eeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhH-----
Q 045835          393 DEGDKT----HISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWAC-----  462 (511)
Q Consensus       393 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~-----  462 (511)
                      ......    .......|+..|+|||.+.. ..++.++||||||+++|||++|+.||........ ......+..     
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~  235 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEVIGPPSAE  235 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHH
Confidence            543221    12233568889999998765 4678999999999999999999999864321110 000000000     


Q ss_pred             --hhhccCchhHhhhhhhCC------CCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          463 --HLQQDGKLVELVDERLGS------KYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       463 --~~~~~~~~~~~~d~~l~~------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                        .........++++.....      ...+.....+.+++.+||+.+|++|||+.++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~i  292 (337)
T cd07852         236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEA  292 (337)
T ss_pred             HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHH
Confidence              000000011111110000      0111235678999999999999999998764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=8.3e-35  Score=291.07  Aligned_cols=260  Identities=28%  Similarity=0.383  Sum_probs=191.9

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCc--cchHHHHHHHHHHhcCCCCCceeEEEEEEeC--CEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR--QGNREFLNEIAMISCLQHPNLVKIHGCCVEG--DQLLL  313 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l  313 (511)
                      .++|+..+.||+|+||.||+|... +|+.||+|.++....  .....+.+|+.++++++|+|++++++++.+.  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            367999999999999999999864 589999999875432  2233567899999999999999999998765  56899


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      ||||+.+ +|.+++....   ..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++...
T Consensus        86 v~e~~~~-~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~  158 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY  158 (309)
T ss_pred             EEecCCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence            9999975 7888875432   35899999999999999999999987   999999999999999999999999999865


Q ss_pred             CCCCceeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhcc--Cch
Q 045835          394 EGDKTHISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD--GKL  470 (511)
Q Consensus       394 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~--~~~  470 (511)
                      ...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......     ...-.......  ...
T Consensus       159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~-----~~~~~~~~~~~~~~~~  232 (309)
T cd07845         159 GLPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE-----QLDLIIQLLGTPNESI  232 (309)
T ss_pred             CCccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHhcCCCChhh
Confidence            432211 122345778999998865 467899999999999999999999986432110     00000000000  000


Q ss_pred             hHhhhh-------hhCCC----C---CHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          471 VELVDE-------RLGSK----Y---KKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       471 ~~~~d~-------~l~~~----~---~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..-++.       .+...    .   .......+.+++.+|++.||++|||+.||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~i  287 (309)
T cd07845         233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEA  287 (309)
T ss_pred             chhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHH
Confidence            000000       00000    0   01124567899999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-35  Score=287.79  Aligned_cols=257  Identities=25%  Similarity=0.339  Sum_probs=195.8

Q ss_pred             CcccCceeccCceeEEecccc-CCcEEEEEEecccCc--cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          242 FDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR--QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       242 f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      |+..+.||+|++|.||++... +++.+++|.+.....  .....+.+|+.++++++|+|++++++++..++..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            566789999999999999764 688999999875433  24567889999999999999999999999999999999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      ++ +|.+++....   ..+++..+..++.+++.||+|||+.+   ++|+||||+||++++++.+||+|||.+....... 
T Consensus        81 ~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-  152 (283)
T cd05118          81 DT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-  152 (283)
T ss_pred             CC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence            75 8888875532   35899999999999999999999986   9999999999999999999999999998654433 


Q ss_pred             eeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhcc------Cchh
Q 045835          399 HISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD------GKLV  471 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~------~~~~  471 (511)
                      .......++..|+|||.+.+. .++.++||||||+++++|+||+.||......+     ...-.......      ....
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~  227 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID-----QLFKIFRTLGTPDPEVWPKFT  227 (283)
T ss_pred             ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHcCCCchHhcccch
Confidence            112234577889999998876 78999999999999999999999886433111     00000000000      0000


Q ss_pred             H--------hhhhhh--CCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          472 E--------LVDERL--GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       472 ~--------~~d~~l--~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +        ..+...  .....+....++.+++.+||+.+|.+||+++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~l  277 (283)
T cd05118         228 SLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQA  277 (283)
T ss_pred             hhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHH
Confidence            0        000000  001123456789999999999999999999874

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-35  Score=291.57  Aligned_cols=245  Identities=22%  Similarity=0.346  Sum_probs=206.5

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      .-|++.+.||+|.|..|-++++ -.|..||||++....  ......+..|+.-|+.++|||||+|+.+......+|||.|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            4577888999999999999864 379999999997653  3344578899999999999999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEc-CCCCeEEeecCCcccCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD-RDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld-~~~~~kl~DfGla~~~~~  395 (511)
                      .-++|+|.+++..+..   .+.+....+.+.||++|+.|+|+.+   ++||||||+||.+- +-|-+||+|||++..+..
T Consensus        98 LGD~GDl~DyImKHe~---Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEE---GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             ecCCchHHHHHHhhhc---cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            9999999999977653   5889999999999999999999986   99999999999875 457899999999976554


Q ss_pred             CCceeecccccCCCcccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYL-TYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      +..  -+..+|+..|-|||.+.+..| .++.||||+|||||.|+||++||....                 +.+.+--++
T Consensus       172 G~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN-----------------DSETLTmIm  232 (864)
T KOG4717|consen  172 GKK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN-----------------DSETLTMIM  232 (864)
T ss_pred             cch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc-----------------chhhhhhhh
Confidence            332  244689999999999998865 578999999999999999999997432                 223444555


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      |-..  .+|...+.++.+|+..||..+|++|.|.+||
T Consensus       233 DCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI  267 (864)
T KOG4717|consen  233 DCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEI  267 (864)
T ss_pred             cccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHH
Confidence            5433  4677888999999999999999999998775

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.3e-36  Score=297.51  Aligned_cols=248  Identities=27%  Similarity=0.389  Sum_probs=201.3

Q ss_pred             cCCcccCceeccCceeEEeccccCCcEEEEEEecc--cCccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      ..|+++++||+||.+.||++...+.+.+|+|++..  .+.+....|.+|+..|.+| .|.+||+|++|-..++.+|+|||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE  440 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME  440 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence            45889999999999999999988888899988753  3456667899999999999 49999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      |-+. +|..+|.....  ...+| .+..+..|++.++.++|+++   |||.||||.|+|+-+ |.+||+|||+|.....+
T Consensus       441 ~Gd~-DL~kiL~k~~~--~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  441 CGDI-DLNKILKKKKS--IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD  512 (677)
T ss_pred             cccc-cHHHHHHhccC--CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence            8754 89999976543  23445 67788899999999999997   999999999999864 58999999999987776


Q ss_pred             Ccee-ecccccCCCcccccccccC-----------CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhh
Q 045835          397 KTHI-STRIAGTIGYMAPEYALWG-----------YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHL  464 (511)
Q Consensus       397 ~~~~-~~~~~gt~~y~aPE~~~~~-----------~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~  464 (511)
                      .+.+ ....+||+.||+||.+...           +.++++||||+|||||+|+-|++||....         -.|    
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~---------n~~----  579 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII---------NQI----  579 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH---------HHH----
Confidence            6554 3456899999999987532           36789999999999999999999996321         122    


Q ss_pred             hccCchhHhhhhhhCCCCCHHH-HHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          465 QQDGKLVELVDERLGSKYKKEE-AERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       465 ~~~~~~~~~~d~~l~~~~~~~~-~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                         .++..+.||....+++.-- ..++++++..||..||++|||+.||
T Consensus       580 ---aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eL  624 (677)
T KOG0596|consen  580 ---AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPEL  624 (677)
T ss_pred             ---HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHH
Confidence               2456677775544444321 2239999999999999999998775

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=6.6e-35  Score=292.30  Aligned_cols=262  Identities=20%  Similarity=0.241  Sum_probs=189.9

Q ss_pred             ccCceeccCceeEEeccccCCcEEEEEEeccc--CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCCC
Q 045835          244 SAKKIGEGGFGPVYKGQLADGTIIAVKQLSSK--SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENN  321 (511)
Q Consensus       244 ~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g  321 (511)
                      +.+.+|.|+++.|+++.. +++.||||++...  .......+.+|+.+++.++|+||+++++++.+.+..+++|||+++|
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            344556666777777665 6899999998754  3344567899999999999999999999999999999999999999


Q ss_pred             CHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc---
Q 045835          322 SLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT---  398 (511)
Q Consensus       322 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~---  398 (511)
                      +|.+++.....  ..+++.....++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||.+........   
T Consensus        85 ~l~~~l~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~  159 (314)
T cd08216          85 SCEDLLKTHFP--EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR  159 (314)
T ss_pred             CHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence            99999975432  34788999999999999999999986   99999999999999999999999999874322111   


Q ss_pred             ---eeecccccCCCccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhc-------
Q 045835          399 ---HISTRIAGTIGYMAPEYALW--GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQ-------  466 (511)
Q Consensus       399 ---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~-------  466 (511)
                         .......++..|+|||.+..  ..++.++|||||||+++||++|+.||......................       
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (314)
T cd08216         160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY  239 (314)
T ss_pred             ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence               11122356778999999875  358899999999999999999999997432111000000000000000       


Q ss_pred             cCchhH----hhhh----hhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          467 DGKLVE----LVDE----RLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       467 ~~~~~~----~~d~----~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....+    ..++    ............++.+++.+||+.+|++|||+.|+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~l  292 (314)
T cd08216         240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQL  292 (314)
T ss_pred             cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHH
Confidence            000000    0000    01111223445678999999999999999999874

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-35  Score=287.04  Aligned_cols=258  Identities=26%  Similarity=0.343  Sum_probs=191.2

Q ss_pred             CcccCceeccCceeEEecccc-CCcEEEEEEecccCc--cchHHHHHHHHHHhcC---CCCCceeEEEEEEeCCE-----
Q 045835          242 FDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR--QGNREFLNEIAMISCL---QHPNLVKIHGCCVEGDQ-----  310 (511)
Q Consensus       242 f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~-----  310 (511)
                      |++.+.||+|+||.||+|+.. +++.+|+|.++....  .....+.+|+.+++++   +|||++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567889999999999999876 489999999974422  2234566787776655   69999999999998776     


Q ss_pred             EEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCc
Q 045835          311 LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA  390 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla  390 (511)
                      .+++|||+.+ +|.+++.....  ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||++
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcc
Confidence            9999999975 78888865322  35899999999999999999999986   999999999999999999999999999


Q ss_pred             ccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCch
Q 045835          391 KLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKL  470 (511)
Q Consensus       391 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  470 (511)
                      .........  ....++..|+|||.+....++.++|||||||+++||++|++|+......    ..+.............
T Consensus       155 ~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~  228 (287)
T cd07838         155 RIYSFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA----DQLDKIFDVIGLPSEE  228 (287)
T ss_pred             eeccCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH----HHHHHHHHHcCCCChH
Confidence            865433221  2235788899999999889999999999999999999999888632210    1111111000000000


Q ss_pred             ---------hHhhhhhhC---CCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          471 ---------VELVDERLG---SKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       471 ---------~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                               .........   ....++....+.+++.+||+.+|++||++.|+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~i  281 (287)
T cd07838         229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEA  281 (287)
T ss_pred             hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHH
Confidence                     000000000   11112345678899999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.4e-34  Score=290.25  Aligned_cols=241  Identities=30%  Similarity=0.451  Sum_probs=188.9

Q ss_pred             CcccCceeccCceeEEecccc-CCcEEEEEEecccCc---cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          242 FDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR---QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       242 f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      |...+.||+|+||.||+|+.. ++..|++|.+.....   .....+.+|+.+++.++|||++++++++.+.+..++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            566788999999999999753 688999999865432   2335678999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +. |+|.+++....   ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||++...... 
T Consensus       103 ~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~-  174 (313)
T cd06633         103 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPA-  174 (313)
T ss_pred             CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCCC-
Confidence            96 57777775432   35899999999999999999999986   999999999999999999999999998643221 


Q ss_pred             ceeecccccCCCcccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          398 THISTRIAGTIGYMAPEYAL---WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                          ....|+..|+|||++.   ...++.++|||||||++|||++|+.|+.....        .........        
T Consensus       175 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~--------~~~~~~~~~--------  234 (313)
T cd06633         175 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQ--------  234 (313)
T ss_pred             ----CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHh--------
Confidence                2346788999999974   45688999999999999999999999853221        011111100        


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                       ..............+.+++.+||+.+|.+||++.|+
T Consensus       235 -~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~  270 (313)
T cd06633         235 -NDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAEL  270 (313)
T ss_pred             -cCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHH
Confidence             000111112234568899999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.9e-34  Score=281.22  Aligned_cols=246  Identities=21%  Similarity=0.265  Sum_probs=189.9

Q ss_pred             HHHHHHhcCCcccCce--eccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcC-CCCCceeEEEEEEeC
Q 045835          233 KQIKAATNNFDSAKKI--GEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCL-QHPNLVKIHGCCVEG  308 (511)
Q Consensus       233 ~~l~~~~~~f~~~~~l--G~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~  308 (511)
                      .+.....++|++.+.+  |+|+||.||++.. .++..+|+|.+.......     .|+.....+ +|||++++++++...
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~   81 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTL   81 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecC
Confidence            3444455677887777  9999999999975 467889999986542211     122222222 799999999999999


Q ss_pred             CEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCC-CeEEeec
Q 045835          309 DQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL-NPKISDF  387 (511)
Q Consensus       309 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~-~~kl~Df  387 (511)
                      +..++||||+++++|.+++....    .+++.....++.|+++||.|||+.+   ++||||||+||+++.++ .++|+||
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~df  154 (267)
T PHA03390         82 KGHVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDY  154 (267)
T ss_pred             CeeEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecC
Confidence            99999999999999999986542    5899999999999999999999987   99999999999999998 9999999


Q ss_pred             CCcccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhcc
Q 045835          388 GLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD  467 (511)
Q Consensus       388 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~  467 (511)
                      |+++......     ...++..|+|||++.+..++.++||||||++++||++|+.||.....   ....+..|....   
T Consensus       155 g~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~---  223 (267)
T PHA03390        155 GLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED---EELDLESLLKRQ---  223 (267)
T ss_pred             ccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc---chhhHHHHHHhh---
Confidence            9997544322     23578899999999988999999999999999999999999973321   111122221111   


Q ss_pred             CchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCC-cCC
Q 045835          468 GKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPT-MSE  510 (511)
Q Consensus       468 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-~~e  510 (511)
                             ..  ....+......+.+++.+||+.+|.+||+ ++|
T Consensus       224 -------~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~  258 (267)
T PHA03390        224 -------QK--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNE  258 (267)
T ss_pred             -------cc--cCCcccccCHHHHHHHHHHhccChhhCCchHHH
Confidence                   10  11222345667899999999999999996 465

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.5e-34  Score=288.69  Aligned_cols=200  Identities=28%  Similarity=0.425  Sum_probs=164.5

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCC-------
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGD-------  309 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-------  309 (511)
                      ++|+..++||+|+||.||++... +++.||||.+....  ......+.+|+.++++++||||++++++|....       
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            56889999999999999999754 68899999986432  222345678999999999999999999987654       


Q ss_pred             -EEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecC
Q 045835          310 -QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFG  388 (511)
Q Consensus       310 -~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfG  388 (511)
                       ..++||||+.+ +|.+.+....   ..+++.....++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||
T Consensus        92 ~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          92 GSFYLVFEFCEH-DLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             ceEEEEEcCCCc-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence             45999999975 7877775432   35899999999999999999999986   9999999999999999999999999


Q ss_pred             CcccCCCCCc---eeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 045835          389 LAKLDEGDKT---HISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSY  446 (511)
Q Consensus       389 la~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~  446 (511)
                      ++........   .......++..|+|||.+.+. .++.++||||||++++||++|+.|+..
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~  226 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQG  226 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCC
Confidence            9975432211   111234567889999988654 478899999999999999999998864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-34  Score=280.83  Aligned_cols=237  Identities=24%  Similarity=0.277  Sum_probs=183.9

Q ss_pred             CceeccCceeEEecccc-CCcEEEEEEecccCc---cchHHHHHHHHH-HhcCCCCCceeEEEEEEeCCEEEEEEEecCC
Q 045835          246 KKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR---QGNREFLNEIAM-ISCLQHPNLVKIHGCCVEGDQLLLVYEYMEN  320 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~---~~~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~  320 (511)
                      +.||+|+||.||+|... +++.||+|.++....   .....+..|..+ ....+|+|++++++++..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57999999999999754 588999999865421   222334455444 4556899999999999999999999999999


Q ss_pred             CCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCcee
Q 045835          321 NSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI  400 (511)
Q Consensus       321 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~  400 (511)
                      ++|.+++....    .+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||+++....     
T Consensus        82 ~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----  149 (260)
T cd05611          82 GDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----  149 (260)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence            99999986432    4788999999999999999999986   99999999999999999999999999975432     


Q ss_pred             ecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCC
Q 045835          401 STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGS  480 (511)
Q Consensus       401 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  480 (511)
                      .....++..|+|||.+.+..++.++||||||++++||++|+.|+.....        ........ .+.      .....
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~-~~~------~~~~~  214 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP--------DAVFDNIL-SRR------INWPE  214 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHH-hcc------cCCCC
Confidence            1234578899999999888899999999999999999999999863221        01000000 000      00111


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCcC
Q 045835          481 KYKKEEAERMIKVSLLCTNASPSLRPTMS  509 (511)
Q Consensus       481 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~  509 (511)
                      .........+.+++.+||+.+|++||++.
T Consensus       215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~  243 (260)
T cd05611         215 EVKEFCSPEAVDLINRLLCMDPAKRLGAN  243 (260)
T ss_pred             cccccCCHHHHHHHHHHccCCHHHccCCC
Confidence            11223456789999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3.7e-35  Score=288.40  Aligned_cols=243  Identities=23%  Similarity=0.356  Sum_probs=198.3

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEeccc---CccchHHHHHHHHHHhcCC-CCCceeEEEEEEeCCEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK---SRQGNREFLNEIAMISCLQ-HPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV  314 (511)
                      ++|...+.||+|+||.||++... ++..||+|++...   .......+.+|+.++++++ ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888999999999999999764 6899999998653   2233467889999999998 99999999999999999999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      |||+++++|.+++....    .+++.....++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~  153 (280)
T cd05581          81 LEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLD  153 (280)
T ss_pred             EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccC
Confidence            99999999999996543    5999999999999999999999986   9999999999999999999999999998544


Q ss_pred             CCCc-------------------eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccccccc
Q 045835          395 GDKT-------------------HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCT  455 (511)
Q Consensus       395 ~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~  455 (511)
                      ....                   .......++..|+|||......++.++||||||++++|+++|+.|+.....      
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------  227 (280)
T cd05581         154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE------  227 (280)
T ss_pred             CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH------
Confidence            3221                   112234578899999999888899999999999999999999999873320      


Q ss_pred             chhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCc
Q 045835          456 CLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTM  508 (511)
Q Consensus       456 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  508 (511)
                          +.       ....+.  ......+......+.+++.+||+.+|++|||+
T Consensus       228 ----~~-------~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~  267 (280)
T cd05581         228 ----YL-------TFQKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGV  267 (280)
T ss_pred             ----HH-------HHHHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCc
Confidence                00       001111  11122334446678999999999999999999

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=4.9e-35  Score=284.97  Aligned_cols=248  Identities=25%  Similarity=0.392  Sum_probs=192.7

Q ss_pred             CCcccCceeccCceeEEeccccC-CcEEEEEEeccc-----CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSK-----SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~~-g~~vAvK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  314 (511)
                      +|.+.+.||+|+||.||++.... +..+++|.++..     ......++..|+.++++++|||++++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47788999999999999997542 344555555432     122334567899999999999999999999999999999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      |||+++++|.+++.........+++..++.++.|++.||.|||+.+   ++|+||+|+||++++ +.+||+|||+++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999988654333456899999999999999999999986   999999999999986 469999999997654


Q ss_pred             CCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          395 GDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       395 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      .... ......++..|+|||......++.++|+||||+++++|++|+.|+....        ......         .+.
T Consensus       157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~--------~~~~~~---------~~~  218 (260)
T cd08222         157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN--------FLSVVL---------RIV  218 (260)
T ss_pred             CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHH---------HHH
Confidence            3222 2223457889999999988888999999999999999999999885321        111111         111


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      . ......+.....++.+++.+||+.+|++||++.|+
T Consensus       219 ~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i  254 (260)
T cd08222         219 E-GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEI  254 (260)
T ss_pred             c-CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHH
Confidence            1 11122344556788999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.8e-35  Score=298.28  Aligned_cols=263  Identities=24%  Similarity=0.326  Sum_probs=194.1

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEeccc--CccchHHHHHHHHHHhcCCCCCceeEEEEEEeC-----CE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK--SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEG-----DQ  310 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~  310 (511)
                      .++|.+.+.||+|+||.||+++. .+++.||||.+...  .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            35788999999999999999975 46899999998753  233345678899999999999999999988654     34


Q ss_pred             EEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCc
Q 045835          311 LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA  390 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla  390 (511)
                      .++|+||+. ++|.+++...    ..+++.....++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~  155 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLA  155 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccc
Confidence            799999996 6888887543    25899999999999999999999986   999999999999999999999999999


Q ss_pred             ccCCCCCceeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhh-------H
Q 045835          391 KLDEGDKTHISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWA-------C  462 (511)
Q Consensus       391 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~-------~  462 (511)
                      +...... .......++..|+|||.+.. ..++.++|||||||+++||++|+.||....... ......+..       .
T Consensus       156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~  233 (337)
T cd07858         156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH-QLKLITELLGSPSEEDL  233 (337)
T ss_pred             cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhCCCChHHh
Confidence            8654322 12223457889999998865 468999999999999999999999986432100 000000000       0


Q ss_pred             hhhccCchhHhhhhhhC---C---CCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          463 HLQQDGKLVELVDERLG---S---KYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       463 ~~~~~~~~~~~~d~~l~---~---~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .........+.+.....   .   ...++.+.++.+++.+||+.+|++|||+.||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~el  288 (337)
T cd07858         234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEA  288 (337)
T ss_pred             hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHH
Confidence            00111111111111000   0   0112345678999999999999999999874

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.5e-34  Score=287.35  Aligned_cols=254  Identities=20%  Similarity=0.174  Sum_probs=178.7

Q ss_pred             hcCCcccCceeccCceeEEeccccC----CcEEEEEEecccCccch-----------HHHHHHHHHHhcCCCCCceeEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLAD----GTIIAVKQLSSKSRQGN-----------REFLNEIAMISCLQHPNLVKIHG  303 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~~----g~~vAvK~~~~~~~~~~-----------~~~~~Ei~~l~~l~H~niv~l~g  303 (511)
                      .++|.+.++||+|+||.||+|...+    +..+|+|..........           .....+...+..++|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            3579999999999999999998654    34566765433222111           11223444566789999999999


Q ss_pred             EEEeCC----EEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCC
Q 045835          304 CCVEGD----QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD  379 (511)
Q Consensus       304 ~~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~  379 (511)
                      ++....    ..++++|++.. ++.+.+...    ...++.....++.|++.||+|||+.+   |+||||||+|||++.+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~  162 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN  162 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence            877544    34677776643 565555332    13568888999999999999999986   9999999999999999


Q ss_pred             CCeEEeecCCcccCCCCCce------eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccccc
Q 045835          380 LNPKISDFGLAKLDEGDKTH------ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFD  453 (511)
Q Consensus       380 ~~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~  453 (511)
                      +.++|+|||+++........      ......||+.|+|||...+..++.++|||||||+++||++|+.||.......  
T Consensus       163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~--  240 (294)
T PHA02882        163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG--  240 (294)
T ss_pred             CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch--
Confidence            99999999999854322111      1122468999999999999999999999999999999999999997432100  


Q ss_pred             ccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          454 CTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       454 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                        .+..-.    ..+-+..+......   .......+.+++..|++.+|++||++.++
T Consensus       241 --~~~~~~----~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l  289 (294)
T PHA02882        241 --NLIHAA----KCDFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDAL  289 (294)
T ss_pred             --HHHHHh----HHHHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHH
Confidence              010000    00001111111111   12234678999999999999999999764

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-35  Score=287.73  Aligned_cols=262  Identities=26%  Similarity=0.360  Sum_probs=193.1

Q ss_pred             CcccCceeccCceeEEecccc-CCcEEEEEEecccCc-cchHHHHHHHHHHhcCC-CCCceeEEEEEEeCCEEEEEEEec
Q 045835          242 FDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR-QGNREFLNEIAMISCLQ-HPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       242 f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      |.+.+.||+|+||.||+|... +++.|+||++..... .......+|+..+++++ |+|++++++++.+++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567889999999999999875 478899999875432 22234567999999999 999999999999999999999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                       +|+|.+++....  ...+++..+..++.|++.+|.|||+.+   ++|+||+|+||++++++.++|+|||++........
T Consensus        81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (283)
T cd07830          81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP  154 (283)
T ss_pred             -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence             789998886543  235899999999999999999999986   99999999999999999999999999986543222


Q ss_pred             eeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccc--------cchhhhhHhhhccCc
Q 045835          399 HISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDC--------TCLLDWACHLQQDGK  469 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~--------~~l~~~~~~~~~~~~  469 (511)
                        .....++..|+|||.+.. ..++.++|+||||++++||++|++|+......+...        ..-..|.........
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence              123457889999998754 468999999999999999999999886432111000        000011111000000


Q ss_pred             hhHhhhhhhC---CCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          470 LVELVDERLG---SKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       470 ~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ....+.....   ..........+.+++.+||+.+|++|||+.||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei  277 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQA  277 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHH
Confidence            0000000000   00011124678999999999999999999874

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1e-34  Score=293.09  Aligned_cols=261  Identities=21%  Similarity=0.309  Sum_probs=188.7

Q ss_pred             Cceecc--CceeEEeccc-cCCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCC
Q 045835          246 KKIGEG--GFGPVYKGQL-ADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMEN  320 (511)
Q Consensus       246 ~~lG~G--~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~  320 (511)
                      ..||+|  +||+||++.. .+|+.||+|.+....  ....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  9999999975 478999999987542  22345788999999999999999999999999999999999999


Q ss_pred             CCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCce-
Q 045835          321 NSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH-  399 (511)
Q Consensus       321 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~-  399 (511)
                      ++|.+++.....  ..+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.+|++||+.+......... 
T Consensus        84 ~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          84 GSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             CCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence            999999865432  34889999999999999999999886   999999999999999999999999865422111100 


Q ss_pred             --e---ecccccCCCcccccccccC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCccccccc-----chhhhhH-----
Q 045835          400 --I---STRIAGTIGYMAPEYALWG--YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCT-----CLLDWAC-----  462 (511)
Q Consensus       400 --~---~~~~~gt~~y~aPE~~~~~--~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~-----~l~~~~~-----  462 (511)
                        .   .....++..|+|||++.+.  .++.++|||||||+++||++|+.||...........     ....|..     
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence              0   0112345679999998764  478999999999999999999999864321000000     0000000     


Q ss_pred             --hh----------------hccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          463 --HL----------------QQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       463 --~~----------------~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                        ..                ........+.+..+....+......+.+++.+||+.+|++|||+.|+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~  305 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSL  305 (328)
T ss_pred             hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHH
Confidence              00                00000001111112222234566789999999999999999999874

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=8.1e-35  Score=294.53  Aligned_cols=260  Identities=20%  Similarity=0.301  Sum_probs=194.6

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEe----CCEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVE----GDQL  311 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~  311 (511)
                      .++|++.+.||+|+||.||+|.. .++..||+|++....  ......+.+|+.++++++||||+++.+++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            36899999999999999999975 468999999987542  2344567889999999999999999998763    3568


Q ss_pred             EEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcc
Q 045835          312 LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK  391 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~  391 (511)
                      ++|+||+. ++|.+++...    ..+++.....++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+++
T Consensus        84 ~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~  155 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSD----QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR  155 (334)
T ss_pred             EEEEehhh-hhHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccce
Confidence            99999996 5898888543    24899999999999999999999986   9999999999999999999999999997


Q ss_pred             cCCCCCc---eeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhh---
Q 045835          392 LDEGDKT---HISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHL---  464 (511)
Q Consensus       392 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~---  464 (511)
                      .......   .......++..|+|||.+.. ..++.++|||||||++|||++|+.||.......     ........   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~-----~~~~~~~~~g~  230 (334)
T cd07855         156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH-----QLKLILSVLGS  230 (334)
T ss_pred             eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH-----HHHHHHHHhCC
Confidence            5433221   11223468889999998765 468999999999999999999999996432110     00000000   


Q ss_pred             --------hccCchhHhhhhhh-CCCC-----CHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          465 --------QQDGKLVELVDERL-GSKY-----KKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       465 --------~~~~~~~~~~d~~l-~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                              .....+.+..+... ....     .+..+.++.+++.+||+.+|++|||+.|+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~  291 (334)
T cd07855         231 PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQA  291 (334)
T ss_pred             ChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence                    00011111111100 0111     12235779999999999999999999764

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.1e-34  Score=290.83  Aligned_cols=262  Identities=23%  Similarity=0.310  Sum_probs=194.7

Q ss_pred             HHHhcCCcccCceeccCceeEEeccc-cCCcEEEEEEeccc--CccchHHHHHHHHHHhcCCCCCceeEEEEEEe-CCEE
Q 045835          236 KAATNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK--SRQGNREFLNEIAMISCLQHPNLVKIHGCCVE-GDQL  311 (511)
Q Consensus       236 ~~~~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~  311 (511)
                      ...+++|+..+.||+|+||.||++.. .+++.||+|++...  .....+.+.+|+.+++.++|||++++.+++.. ....
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            34678899999999999999999974 47899999988643  22334678899999999999999999999876 5678


Q ss_pred             EEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcc
Q 045835          312 LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK  391 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~  391 (511)
                      ++++||+ +++|.+++...     .+++.....++.|++.||+|||+.+   ++||||+|+||++++++.+||+|||++.
T Consensus        86 ~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~  156 (328)
T cd07856          86 YFVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR  156 (328)
T ss_pred             EEEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccc
Confidence            9999998 56898887532     3788888899999999999999986   9999999999999999999999999997


Q ss_pred             cCCCCCceeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCccccc-------ccchhhhhHh
Q 045835          392 LDEGDKTHISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFD-------CTCLLDWACH  463 (511)
Q Consensus       392 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~-------~~~l~~~~~~  463 (511)
                      ......    ....++..|+|||.+.+ ..++.++||||||++++||++|+.||.........       .....+|...
T Consensus       157 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (328)
T cd07856         157 IQDPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT  232 (328)
T ss_pred             ccCCCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            543211    22356788999998765 57899999999999999999999998643210000       0000111111


Q ss_pred             hhccCchhHhhhhh-hCCCCCH-----HHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          464 LQQDGKLVELVDER-LGSKYKK-----EEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       464 ~~~~~~~~~~~d~~-l~~~~~~-----~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ... +...+++... .....+.     .....+.+++.+||+.+|++|||+.||
T Consensus       233 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~el  285 (328)
T cd07856         233 ICS-ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEA  285 (328)
T ss_pred             ccc-hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence            111 1111111111 1111111     234678999999999999999998764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.8e-34  Score=283.03  Aligned_cols=234  Identities=26%  Similarity=0.318  Sum_probs=180.7

Q ss_pred             ceeccCceeEEecccc-CCcEEEEEEecccCc---cchHHHHHHHH---HHhcCCCCCceeEEEEEEeCCEEEEEEEecC
Q 045835          247 KIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR---QGNREFLNEIA---MISCLQHPNLVKIHGCCVEGDQLLLVYEYME  319 (511)
Q Consensus       247 ~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~---~~~~~~~~Ei~---~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~  319 (511)
                      .||+|+||.||++... +++.||+|.+.....   .....+..|..   .++...|||++++.+++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999754 588999999875422   21223444443   4455689999999999999999999999999


Q ss_pred             CCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCce
Q 045835          320 NNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH  399 (511)
Q Consensus       320 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~  399 (511)
                      +|+|.+++...    ..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++........ 
T Consensus        81 g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~-  152 (278)
T cd05606          81 GGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-  152 (278)
T ss_pred             CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence            99999988543    25899999999999999999999986   99999999999999999999999999975432221 


Q ss_pred             eecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhh
Q 045835          400 ISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERL  478 (511)
Q Consensus       400 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  478 (511)
                        ....|+..|+|||.+.++ .++.++||||+||+++||++|+.||........     ..          ..... ...
T Consensus       153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-----~~----------~~~~~-~~~  214 (278)
T cd05606         153 --HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HE----------IDRMT-LTM  214 (278)
T ss_pred             --cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch-----HH----------HHHHh-hcc
Confidence              234689999999998755 689999999999999999999999864321100     00          00000 011


Q ss_pred             CCCCCHHHHHHHHHHHHHcCCCCCCCCC
Q 045835          479 GSKYKKEEAERMIKVSLLCTNASPSLRP  506 (511)
Q Consensus       479 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RP  506 (511)
                      ....+...+..+.+++.+|++.+|.+||
T Consensus       215 ~~~~~~~~s~~~~~li~~~l~~~p~~R~  242 (278)
T cd05606         215 AVELPDSFSPELRSLLEGLLQRDVNRRL  242 (278)
T ss_pred             CCCCCCcCCHHHHHHHHHHhhcCHHhcc
Confidence            1223333456799999999999999999

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-34  Score=291.67  Aligned_cols=258  Identities=25%  Similarity=0.329  Sum_probs=196.9

Q ss_pred             CCcccCceeccCceeEEecccc-CCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCC-----EEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGD-----QLL  312 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~  312 (511)
                      +|++.+.||+|+||.||+|+.. ++..+|+|++....  ....+.+.+|+.+++.++|+||+++.+++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5788899999999999999865 48899999987643  344567899999999999999999999998775     789


Q ss_pred             EEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCccc
Q 045835          313 LVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       313 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~  392 (511)
                      ++|||+.+ +|.+++....    .+++..+..++.+++.||+|||+.+   |+||||||+|||++.++.++|+|||++..
T Consensus        81 lv~e~~~~-~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          81 IVTELMET-DLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             EEecchhh-hHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence            99999984 7888885432    5899999999999999999999987   99999999999999999999999999986


Q ss_pred             CCCCCc--eeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhh-----
Q 045835          393 DEGDKT--HISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHL-----  464 (511)
Q Consensus       393 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~-----  464 (511)
                      ......  .......++..|+|||.+.+. .++.++||||||+++++|++|+.||.......     ........     
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~-----~~~~i~~~~~~~~  227 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID-----QLNLIVEVLGTPS  227 (330)
T ss_pred             ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH-----HHHHHHHhcCCCC
Confidence            544321  112234578899999999887 89999999999999999999999986433110     00000000     


Q ss_pred             ------hccCchhHhhhhh-hCC-----CCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          465 ------QQDGKLVELVDER-LGS-----KYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       465 ------~~~~~~~~~~d~~-l~~-----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                            .......+.+... ...     ...+.....+.+++.+||+.+|.+|||+.++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~l  286 (330)
T cd07834         228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEA  286 (330)
T ss_pred             hhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence                  0001111111100 000     0111235678999999999999999998764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.1e-34  Score=290.38  Aligned_cols=257  Identities=22%  Similarity=0.307  Sum_probs=188.1

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeC------CE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEG------DQ  310 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~  310 (511)
                      ++|...+.||+|+||.||+|.. .+|+.||||++....  ......+.+|+.+++.++||||+++++++...      ..
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            7899999999999999999975 468999999986432  22345688999999999999999999998754      35


Q ss_pred             EEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCc
Q 045835          311 LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA  390 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla  390 (511)
                      .++|+||+.. +|..++.      ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++
T Consensus        95 ~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          95 FYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             EEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            6999999974 6766541      24889999999999999999999986   999999999999999999999999999


Q ss_pred             ccCCCCCceeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccc-------cchhhhhH
Q 045835          391 KLDEGDKTHISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDC-------TCLLDWAC  462 (511)
Q Consensus       391 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~-------~~l~~~~~  462 (511)
                      +......    ....++..|+|||.+.+ ..++.++|||||||+++||++|+.||........-.       .....+..
T Consensus       165 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07879         165 RHADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ  240 (342)
T ss_pred             cCCCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            8543221    23456888999999876 468999999999999999999999996432100000       00000000


Q ss_pred             hhhccCchhHhhhhh---hCCCC---CHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          463 HLQQDGKLVELVDER---LGSKY---KKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       463 ~~~~~~~~~~~~d~~---l~~~~---~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                       ..........++..   .....   .+.....+.+++.+||+.+|++||++.||
T Consensus       241 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~  294 (342)
T cd07879         241 -KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEA  294 (342)
T ss_pred             -HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence             00000000011000   00000   01234568899999999999999998764

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.6e-34  Score=288.69  Aligned_cols=265  Identities=26%  Similarity=0.344  Sum_probs=189.9

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCc--cchHHHHHHHHHHhcCCCCCceeEEEEEEeCC------
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR--QGNREFLNEIAMISCLQHPNLVKIHGCCVEGD------  309 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------  309 (511)
                      .++|++.++||+|+||.||+|... +++.+|+|++.....  .....+.+|+++++.++||||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999854 688999999865432  22346789999999999999999999876433      


Q ss_pred             --EEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeec
Q 045835          310 --QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF  387 (511)
Q Consensus       310 --~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~Df  387 (511)
                        .+++|+||+.. +|...+...   ...+++..+..++.|+++||+|||+.+   ++|+||||+||++++++.+||+||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcC
Confidence              46999999975 676666542   235899999999999999999999987   999999999999999999999999


Q ss_pred             CCcccCCCCCce----------eecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccc
Q 045835          388 GLAKLDEGDKTH----------ISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTC  456 (511)
Q Consensus       388 Gla~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~  456 (511)
                      |+++........          ..+...++..|+|||.+.+. .++.++|||||||+++||++|++||......... ..
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~-~~  238 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL-HL  238 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH-HH
Confidence            999754322111          11224567889999987654 5899999999999999999999998643211100 00


Q ss_pred             hhhhhHhh-----hccCchhHhhhhhhCCCCC-------HHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          457 LLDWACHL-----QQDGKLVELVDERLGSKYK-------KEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       457 l~~~~~~~-----~~~~~~~~~~d~~l~~~~~-------~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +.......     .....+....+.......+       ......+.+++.+||+.+|++|||+.|+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~el  305 (311)
T cd07866         239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDA  305 (311)
T ss_pred             HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHH
Confidence            00000000     0000000000000000000       1123568899999999999999999764

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.7e-34  Score=290.72  Aligned_cols=258  Identities=23%  Similarity=0.300  Sum_probs=190.5

Q ss_pred             cCCc-ccCceeccCceeEEecccc-CCcEEEEEEecccCccc--------------hHHHHHHHHHHhcCCCCCceeEEE
Q 045835          240 NNFD-SAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQG--------------NREFLNEIAMISCLQHPNLVKIHG  303 (511)
Q Consensus       240 ~~f~-~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~--------------~~~~~~Ei~~l~~l~H~niv~l~g  303 (511)
                      ++|. ..+.||+|+||.||+|... +++.||||.++......              ...+.+|+++++.++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4554 3467999999999999754 68899999986542211              124778999999999999999999


Q ss_pred             EEEeCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeE
Q 045835          304 CCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPK  383 (511)
Q Consensus       304 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~k  383 (511)
                      ++..++..++||||+. |+|.+++...    ..+++.....++.|++.||+|||+.+   ++|+||+|+||+++.++.+|
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRK----IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence            9999999999999997 6898888543    34889999999999999999999986   99999999999999999999


Q ss_pred             EeecCCcccCCCCC-------------ceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 045835          384 ISDFGLAKLDEGDK-------------THISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPA  449 (511)
Q Consensus       384 l~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~  449 (511)
                      |+|||+++......             ........++..|+|||.+.+. .++.++|||||||+++||++|+.|+.....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE  239 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999997544111             0111123467889999998764 478999999999999999999999864321


Q ss_pred             ccccccchhhhhHhhhccCchh---Hhh------------hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          450 LEFDCTCLLDWACHLQQDGKLV---ELV------------DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       450 ~~~~~~~l~~~~~~~~~~~~~~---~~~------------d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .     .....+..........   +..            .+... ........++.+++.+||+.+|++|||+.||
T Consensus       240 ~-----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~  310 (335)
T PTZ00024        240 I-----DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEA  310 (335)
T ss_pred             H-----HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHH
Confidence            1     1111111110000000   000            00000 0011234678899999999999999999875

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.2e-34  Score=289.96  Aligned_cols=267  Identities=21%  Similarity=0.281  Sum_probs=195.8

Q ss_pred             cHHHHHHHhcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 045835          231 TLKQIKAATNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVE  307 (511)
Q Consensus       231 ~~~~l~~~~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~  307 (511)
                      ...++...+++|.+.+.||+|+||.||+|.. .+++.||+|++....  ......+.+|+.++++++||||+++.+++..
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            4566677789999999999999999999974 578899999987532  2234567899999999999999999998864


Q ss_pred             C------CEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCC
Q 045835          308 G------DQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN  381 (511)
Q Consensus       308 ~------~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~  381 (511)
                      .      ...+++++++ +++|.+++...     .+++..+..++.|+++||+|||+.+   |+||||||+||++++++.
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~  158 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCE  158 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCC
Confidence            3      3467888876 77898877432     4899999999999999999999986   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCceeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhh-
Q 045835          382 PKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLD-  459 (511)
Q Consensus       382 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~-  459 (511)
                      +||+|||+++.....    .....++..|+|||.+.+ ..++.++|||||||+++||++|+.||........ ...... 
T Consensus       159 ~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~  233 (345)
T cd07877         159 LKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILRL  233 (345)
T ss_pred             EEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHH
Confidence            999999999854322    123467889999998866 4688999999999999999999999863321100 000000 


Q ss_pred             ------hhHhhhccCchhHhh---hhhhCCCC---CHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          460 ------WACHLQQDGKLVELV---DERLGSKY---KKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       460 ------~~~~~~~~~~~~~~~---d~~l~~~~---~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                            ..............+   .......+   ......++.+++.+|++.+|.+||++.++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~  297 (345)
T cd07877         234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA  297 (345)
T ss_pred             hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHH
Confidence                  000000000000000   00000000   00124568899999999999999998764

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-34  Score=282.83  Aligned_cols=257  Identities=28%  Similarity=0.363  Sum_probs=194.7

Q ss_pred             CcccCceeccCceeEEecccc-CCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          242 FDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       242 f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      |+..+.||+|+||.||+|+.. +++.+|+|.+....  ......+..|+.++++++|+|++++++++.+.+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            456788999999999999865 58999999997653  334467889999999999999999999999999999999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      + ++|.+++....   ..+++..+..++.+++.||+|||+.+   |+||||+|+||++++++.+||+|||+++.......
T Consensus        81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence            8 58999986542   35899999999999999999999986   99999999999999999999999999986543222


Q ss_pred             eeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhcc--Cchh----
Q 045835          399 HISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD--GKLV----  471 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~--~~~~----  471 (511)
                       ......++..|+|||.+... .++.++|||||||+++||++|+.||.......     ...........  +...    
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~  227 (282)
T cd07829         154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID-----QLFKIFQILGTPTEESWPGVT  227 (282)
T ss_pred             -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-----HHHHHHHHhCCCcHHHHHhhc
Confidence             12223457789999998776 88999999999999999999999886432110     11110000000  0000    


Q ss_pred             Hh--hhhhhC---C----CCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          472 EL--VDERLG---S----KYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       472 ~~--~d~~l~---~----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ++  .+....   .    ...+.....+.+++.+||+.+|++||++.||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~  276 (282)
T cd07829         228 KLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEA  276 (282)
T ss_pred             ccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHH
Confidence            00  000000   0    0011124579999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-35  Score=285.87  Aligned_cols=244  Identities=29%  Similarity=0.398  Sum_probs=205.2

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEeccc---CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK---SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      +.|..-++||+||||.||-++.. +|+.+|.|.+..+   .+++..-.++|-.+|++++.+.||.+-=.+...+.+++|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            56888899999999999999754 6889999988543   3455666789999999999999999988889999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ..|.+|+|.-+|.+..+  ..++++...-.+.+|+.||++||...   |+.||+||+|||||+.|+++|+|+|||...+.
T Consensus       265 tlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            99999999999988765  45999999999999999999999986   99999999999999999999999999997776


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      ......  .+||.+|||||++....|+...|.||+||+||||+.|+.||.....                  ....+-+|
T Consensus       340 g~~~~~--rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke------------------Kvk~eEvd  399 (591)
T KOG0986|consen  340 GKPIRG--RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE------------------KVKREEVD  399 (591)
T ss_pred             CCcccc--ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh------------------hhhHHHHH
Confidence            555432  3899999999999999999999999999999999999999974321                  11122233


Q ss_pred             hhh---CCCCCHHHHHHHHHHHHHcCCCCCCCCCCc
Q 045835          476 ERL---GSKYKKEEAERMIKVSLLCTNASPSLRPTM  508 (511)
Q Consensus       476 ~~l---~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  508 (511)
                      .+.   ..+++...+++..++...-|+.||++|---
T Consensus       400 rr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  400 RRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             HHHhcchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence            332   234566667778888888899999999643

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.2e-34  Score=287.93  Aligned_cols=260  Identities=23%  Similarity=0.306  Sum_probs=192.3

Q ss_pred             HhcCCcccCceeccCceeEEeccc-cCCcEEEEEEeccc--CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCC-----
Q 045835          238 ATNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK--SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGD-----  309 (511)
Q Consensus       238 ~~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----  309 (511)
                      ..++|+..+.||+|+||.||++.. .++..||||++...  .......+.+|+.++++++||||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            457899999999999999999974 46899999998643  2223456889999999999999999999987543     


Q ss_pred             -EEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecC
Q 045835          310 -QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFG  388 (511)
Q Consensus       310 -~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfG  388 (511)
                       ..++||||+ +++|.+++..     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence             458999999 6789888753     24889999999999999999999986   9999999999999999999999999


Q ss_pred             CcccCCCCCceeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCccccc-------ccchhhh
Q 045835          389 LAKLDEGDKTHISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFD-------CTCLLDW  460 (511)
Q Consensus       389 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~-------~~~l~~~  460 (511)
                      ++.......    ....++..|+|||.+.. ..++.++|+||||+++++|++|+.||........-       ......|
T Consensus       164 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07880         164 LARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF  239 (343)
T ss_pred             cccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            998643321    22357889999998875 46889999999999999999999998643211000       0000011


Q ss_pred             hHhhhccCchhHhhhhh--hC-C---CCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          461 ACHLQQDGKLVELVDER--LG-S---KYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       461 ~~~~~~~~~~~~~~d~~--l~-~---~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...+. ...........  .. .   .........+.+++.+|++.+|++|||+.++
T Consensus       240 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~  295 (343)
T cd07880         240 VQKLQ-SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEA  295 (343)
T ss_pred             HHhhc-chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHH
Confidence            11110 00001111100  00 0   0111234468899999999999999998764

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.4e-34  Score=293.92  Aligned_cols=261  Identities=25%  Similarity=0.321  Sum_probs=190.2

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeC----------
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEG----------  308 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~----------  308 (511)
                      .+|...+.||+|+||.||+|.. .++..||+|.+........+.+.+|++++++++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            6789999999999999999975 46889999999776666667789999999999999999999876543          


Q ss_pred             ----CEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcC-CCCeE
Q 045835          309 ----DQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR-DLNPK  383 (511)
Q Consensus       309 ----~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~-~~~~k  383 (511)
                          ...++|+||++ ++|.+++...     .+++.....++.|++.||+|||+.+   ++||||||+||+++. ++.+|
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence                35789999997 5888887432     4889999999999999999999986   999999999999984 55789


Q ss_pred             EeecCCcccCCCCCce--eecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhh
Q 045835          384 ISDFGLAKLDEGDKTH--ISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDW  460 (511)
Q Consensus       384 l~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~  460 (511)
                      |+|||+++........  ......++..|+|||.+.. ..++.++|||||||++|||++|+.||............+...
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~  235 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV  235 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            9999999754322111  1122357888999998754 468889999999999999999999996432111000000000


Q ss_pred             hHhhhcc---Cchh----Hhhh-hhhCCCC-----CHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          461 ACHLQQD---GKLV----ELVD-ERLGSKY-----KKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       461 ~~~~~~~---~~~~----~~~d-~~l~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                        .....   ....    .... .......     .+....++.+++.+||+.+|++|||+.||
T Consensus       236 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  297 (342)
T cd07854         236 --PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEA  297 (342)
T ss_pred             --CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHH
Confidence              00000   0000    0000 0000000     11234568899999999999999998764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2e-34  Score=292.71  Aligned_cols=243  Identities=26%  Similarity=0.334  Sum_probs=202.2

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCc--cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR--QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ..+|.+...||+|.|+.|..++.. ++..||||.+.+..-  ...+.+.+|+++|+.|+|||||+|+.+......+++||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            467899999999999999999754 689999999976532  23356889999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+.+|.+.++|..+..    ........++.|+.+|++|||+++   |+|||||++||||+.+.++||+|||++..+..
T Consensus       135 eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  135 EYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             EeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence            99999999999977653    445778889999999999999997   99999999999999999999999999987653


Q ss_pred             CCceeecccccCCCcccccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGY-LTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                        .......+|++.|.|||++.+.. ..+++|+||+|++||-|++|..||+...                     +.++-
T Consensus       208 --~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~---------------------lk~Lr  264 (596)
T KOG0586|consen  208 --GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN---------------------LKELR  264 (596)
T ss_pred             --cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc---------------------ccccc
Confidence              33445578999999999998774 5789999999999999999999997322                     22222


Q ss_pred             hhhhCCC--CCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          475 DERLGSK--YKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       475 d~~l~~~--~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ++.+...  ++--...++.+++.++|-.+|.+|+++.++
T Consensus       265 ~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqi  303 (596)
T KOG0586|consen  265 PRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQI  303 (596)
T ss_pred             chheeeeecccceeechhHHHHHHhhccCccccCCHHHh
Confidence            2323222  223345568889999999999999998764

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-35  Score=296.75  Aligned_cols=248  Identities=23%  Similarity=0.401  Sum_probs=200.2

Q ss_pred             cCCcccCceeccCceeEEeccccC-CcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~-g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      +.++++..||-|+||.||++..++ +-..|-|++...+......|+-||++|+...||+||+|++.+...+.++++.|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            446778899999999999998664 3445678888777777889999999999999999999999999999999999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      .||-+..++....   ..|.+.++.-+|.+++.||.|||++.   |||||||+.|||+.-+|.++|+|||.+-..... .
T Consensus       112 ~GGAVDaimlEL~---r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~  184 (1187)
T KOG0579|consen  112 GGGAVDAIMLELG---RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-R  184 (1187)
T ss_pred             CCchHhHHHHHhc---cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH-H
Confidence            9999998886543   36999999999999999999999986   999999999999999999999999998532211 1


Q ss_pred             eeecccccCCCcccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHh
Q 045835          399 HISTRIAGTIGYMAPEYAL-----WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVEL  473 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  473 (511)
                      .......||+.|||||+.+     ..+|+.++||||||+.|.||..+.+|......+        +.         +.++
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM--------RV---------llKi  247 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM--------RV---------LLKI  247 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH--------HH---------HHHH
Confidence            1223467999999999875     457999999999999999999999987633211        11         1111


Q ss_pred             hhhhhC-CCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          474 VDERLG-SKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       474 ~d~~l~-~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...... .-.|......+.++..+||..+|..||++.++
T Consensus       248 aKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaql  286 (1187)
T KOG0579|consen  248 AKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQL  286 (1187)
T ss_pred             hhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHH
Confidence            111100 11245677889999999999999999998764

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-36  Score=322.64  Aligned_cols=246  Identities=30%  Similarity=0.409  Sum_probs=198.0

Q ss_pred             CCcccCceeccCceeEEecc-ccCCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          241 NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      ++.-...||.|.||.||.|. ..+|...|||-++...  ........+|+.+|..|+|||+|+.+|+-.+.+..++.|||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence            44556789999999999996 5678999999886543  33445678999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      |++|+|.+.+...+    .+++........|++.|+.|||++|   |+||||||.||+|+.+|.+|++|||.|+...+..
T Consensus      1316 C~~GsLa~ll~~gr----i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGR----IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred             hccCcHHHHHHhcc----hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCch
Confidence            99999999996543    2566666778899999999999998   9999999999999999999999999998654432


Q ss_pred             cee---ecccccCCCcccccccccC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchh
Q 045835          398 THI---STRIAGTIGYMAPEYALWG---YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLV  471 (511)
Q Consensus       398 ~~~---~~~~~gt~~y~aPE~~~~~---~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  471 (511)
                      ...   -....||+-|||||.+.+.   ....++||||+|||++||+||+.|+....         .+|+..        
T Consensus      1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d---------ne~aIM-------- 1451 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD---------NEWAIM-------- 1451 (1509)
T ss_pred             hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc---------chhHHH--------
Confidence            111   1246799999999999754   45678999999999999999999997332         134321        


Q ss_pred             HhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCC
Q 045835          472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSE  510 (511)
Q Consensus       472 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e  510 (511)
                      --+-..-.+.+|...+..=.+++.+||+.||++|.++.|
T Consensus      1452 y~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~q 1490 (1509)
T KOG4645|consen 1452 YHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQ 1490 (1509)
T ss_pred             hHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHH
Confidence            112222234566677777889999999999999988754

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=9e-34  Score=273.96  Aligned_cols=235  Identities=26%  Similarity=0.343  Sum_probs=191.1

Q ss_pred             eeccCceeEEecccc-CCcEEEEEEecccCc---cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCCCCH
Q 045835          248 IGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR---QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSL  323 (511)
Q Consensus       248 lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL  323 (511)
                      ||+|+||.||++... +++.+|+|.+.....   .....+.+|+.++++++|||++++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999765 588999999875432   2345788999999999999999999999999999999999999999


Q ss_pred             hHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCceeecc
Q 045835          324 ACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR  403 (511)
Q Consensus       324 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~  403 (511)
                      .+++....    .+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........ ....
T Consensus        81 ~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~  152 (250)
T cd05123          81 FSHLSKEG----RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNT  152 (250)
T ss_pred             HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccC
Confidence            99996542    4899999999999999999999976   99999999999999999999999999986543221 1233


Q ss_pred             cccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCCCCC
Q 045835          404 IAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYK  483 (511)
Q Consensus       404 ~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  483 (511)
                      ..++..|+|||...+...+.++|+||||++++||++|+.||.....     ..+...            +..  .....+
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~------------~~~--~~~~~~  213 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYEK------------ILK--DPLRFP  213 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHH------------Hhc--CCCCCC
Confidence            4678899999999888899999999999999999999999863321     011111            111  111233


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCcC
Q 045835          484 KEEAERMIKVSLLCTNASPSLRPTMS  509 (511)
Q Consensus       484 ~~~~~~l~~l~~~Cl~~~p~~RPs~~  509 (511)
                      ......+.+++.+||..+|++||++.
T Consensus       214 ~~~~~~l~~~i~~~l~~~p~~R~~~~  239 (250)
T cd05123         214 EFLSPEARDLISGLLQKDPTKRLGSG  239 (250)
T ss_pred             CCCCHHHHHHHHHHhcCCHhhCCCcc
Confidence            33356789999999999999999983

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.4e-33  Score=285.28  Aligned_cols=262  Identities=22%  Similarity=0.255  Sum_probs=188.0

Q ss_pred             CCcccCceeccCceeEEecccc-C--CcEEEEEEecccC--ccchHHHHHHHHHHhcC-CCCCceeEEEEEEeC----CE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA-D--GTIIAVKQLSSKS--RQGNREFLNEIAMISCL-QHPNLVKIHGCCVEG----DQ  310 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~-~--g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~----~~  310 (511)
                      +|++.+.||+|+||.||+++.. .  +..||+|++....  ....+.+.+|+.+++++ +||||+++++++...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4778899999999999999754 3  6789999987432  22345678999999999 599999999986533    45


Q ss_pred             EEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCc
Q 045835          311 LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA  390 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla  390 (511)
                      .++++||+. ++|.+++...    ..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSG----QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            788889886 5898888543    25899999999999999999999987   999999999999999999999999999


Q ss_pred             ccCCCCCce---eecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccc-------cchhh
Q 045835          391 KLDEGDKTH---ISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDC-------TCLLD  459 (511)
Q Consensus       391 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~-------~~l~~  459 (511)
                      +........   ......|+..|+|||.+.+ ..++.++|||||||+++||++|+.||........-.       ....+
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE  232 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            854322111   1123468899999998765 468999999999999999999999986432110000       00000


Q ss_pred             hhHhhhccCchhHhhhh---hhCC---CCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          460 WACHLQQDGKLVELVDE---RLGS---KYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       460 ~~~~~~~~~~~~~~~d~---~l~~---~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +...+.. .........   ....   ...+.....+.+++.+|++.+|++|||+.|+
T Consensus       233 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~l  289 (332)
T cd07857         233 TLSRIGS-PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEA  289 (332)
T ss_pred             HHHhhhh-hhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence            0000000 000000000   0000   0011124578999999999999999998764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.7e-34  Score=288.94  Aligned_cols=259  Identities=22%  Similarity=0.322  Sum_probs=193.2

Q ss_pred             HhcCCcccCceeccCceeEEecccc-CCcEEEEEEeccc--CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCE----
Q 045835          238 ATNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK--SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQ----  310 (511)
Q Consensus       238 ~~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----  310 (511)
                      ..++|+..+.||+|+||.||+|+.. +++.||||++...  .......+.+|+.++++++|||++++.+++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            3578999999999999999999864 5789999998643  22234567889999999999999999998766554    


Q ss_pred             --EEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecC
Q 045835          311 --LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFG  388 (511)
Q Consensus       311 --~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfG  388 (511)
                        .++|+||+ +++|.+++..     ..+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence              89999998 5699988854     24899999999999999999999986   9999999999999999999999999


Q ss_pred             CcccCCCCCceeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccch--------hh
Q 045835          389 LAKLDEGDKTHISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCL--------LD  459 (511)
Q Consensus       389 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l--------~~  459 (511)
                      ++......    .....++..|+|||.+.. ..++.++|||||||+++||++|+.||........ ...+        ..
T Consensus       164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~-~~~i~~~~~~~~~~  238 (343)
T cd07851         164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ-LKRIMNLVGTPDEE  238 (343)
T ss_pred             cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCCHH
Confidence            99865432    223457888999998865 3688999999999999999999999864321100 0000        00


Q ss_pred             hhHhhhccCchhHhhhhhh---CCCC---CHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          460 WACHLQQDGKLVELVDERL---GSKY---KKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       460 ~~~~~~~~~~~~~~~d~~l---~~~~---~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +.... ........+....   +..+   ....+.++.+++.+||+.+|++|||+.||
T Consensus       239 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~el  295 (343)
T cd07851         239 LLQKI-SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEA  295 (343)
T ss_pred             HHhhc-cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHH
Confidence            00000 0001111111100   0000   01235678999999999999999999874

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.7e-34  Score=270.38  Aligned_cols=203  Identities=27%  Similarity=0.383  Sum_probs=169.3

Q ss_pred             cCCcccCceeccCceeEEecccc---C--CcEEEEEEecccCc--cchHHHHHHHHHHhcCCCCCceeEEEEEEe-CCEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA---D--GTIIAVKQLSSKSR--QGNREFLNEIAMISCLQHPNLVKIHGCCVE-GDQL  311 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~---~--g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~  311 (511)
                      ..|+....||+|+||.||++.-.   +  ...+|+|+++....  .......+|+.+++.++|||++.|..++.+ +...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            46888999999999999999532   2  23689999975532  334578899999999999999999999887 7789


Q ss_pred             EEEEEecCCCCHhHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCC----CCeEEee
Q 045835          312 LLVYEYMENNSLACALFGRE-NCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD----LNPKISD  386 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~----~~~kl~D  386 (511)
                      ++++||.+. +|...++-++ .....++-.....|+.||+.|+.|||+.-   |+||||||.||||..+    |.+||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence            999999987 6666665433 23356888899999999999999999987   9999999999999887    8999999


Q ss_pred             cCCcccCCCCCce--eecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 045835          387 FGLAKLDEGDKTH--ISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSY  446 (511)
Q Consensus       387 fGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~  446 (511)
                      +|+++++.+.-..  ....++-|+.|.|||.+.+. .||++.||||.|||+.||+|-++.|..
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence            9999987654322  23456789999999998876 799999999999999999998887753

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=266.77  Aligned_cols=243  Identities=26%  Similarity=0.405  Sum_probs=189.2

Q ss_pred             CcccCceeccCceeEEecccc-CCcEEEEEEeccc-CccchHHHHHHHHHHhcCC-CCCceeEEEEEEeCCEEEEEEEec
Q 045835          242 FDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK-SRQGNREFLNEIAMISCLQ-HPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       242 f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      .+.+..||.|+.|.|++.++. .|..+|||.+... +....+.++..+.++.+-+ +|.||+.+|||..+...++-||.|
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM  173 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM  173 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence            345678999999999999865 5899999999765 3455567788888776654 899999999999999999999988


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      .. .++.+|..-   ..++++...-++...++.||.||.+++  .|+|||+||+|||+|+.|++||||||++..+-+...
T Consensus       174 s~-C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA  247 (391)
T KOG0983|consen  174 ST-CAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA  247 (391)
T ss_pred             HH-HHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc
Confidence            53 455555432   235888888899999999999999875  699999999999999999999999999986655444


Q ss_pred             eeecccccCCCcccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          399 HISTRIAGTIGYMAPEYAL---WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      +  ++.+|-+.|||||.+.   ...|+.++||||||+.|+||.||+.||..-..   +..             .+-.+++
T Consensus       248 h--trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t---dFe-------------~ltkvln  309 (391)
T KOG0983|consen  248 H--TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT---DFE-------------VLTKVLN  309 (391)
T ss_pred             c--ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc---cHH-------------HHHHHHh
Confidence            3  4557889999999886   34788999999999999999999999974221   110             1112222


Q ss_pred             ---hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCC
Q 045835          476 ---ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSE  510 (511)
Q Consensus       476 ---~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e  510 (511)
                         |.+...  ...+..+.+++..||++|+.+||...+
T Consensus       310 ~ePP~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~  345 (391)
T KOG0983|consen  310 EEPPLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNK  345 (391)
T ss_pred             cCCCCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHH
Confidence               122111  124667999999999999999998654

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-34  Score=270.93  Aligned_cols=241  Identities=27%  Similarity=0.332  Sum_probs=195.9

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCc---cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSR---QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  314 (511)
                      .++|+.+++||+|+||.|-.++- ..++.+|+|+++..--   .....-+.|-.+|+.-+||.+..|.-.+...+++++|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            46799999999999999999974 4789999999986533   2233456788999999999999998888999999999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      |||..+|.|.-+|.+.    ..+++....-....|+.||.|||+.+   |+.||||.+|.|||.+|++||+||||++..-
T Consensus       247 MeyanGGeLf~HLsre----r~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I  319 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRE----RVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI  319 (516)
T ss_pred             EEEccCceEeeehhhh----hcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence            9999999999888653    35888888888999999999999986   9999999999999999999999999998432


Q ss_pred             CCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          395 GDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       395 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      . ........+||+.|+|||++....|..+.|.|.+|||+|||+||+.||....                  .+.+.+++
T Consensus       320 ~-~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d------------------h~kLFeLI  380 (516)
T KOG0690|consen  320 K-YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD------------------HEKLFELI  380 (516)
T ss_pred             c-ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc------------------hhHHHHHH
Confidence            2 2233456799999999999999999999999999999999999999997322                  22333333


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRP  506 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP  506 (511)
                      --. ...+|.....+...|....|..+|.+|-
T Consensus       381 l~e-d~kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  381 LME-DLKFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             Hhh-hccCCccCCHHHHHHHHHHhhcChHhhc
Confidence            211 0134455555667777778888998885

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=3.1e-33  Score=268.94  Aligned_cols=220  Identities=22%  Similarity=0.182  Sum_probs=176.5

Q ss_pred             cCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCCCCHhHHHhc
Q 045835          251 GGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFG  329 (511)
Q Consensus       251 G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~  329 (511)
                      |.||.||+++. .+++.+|+|+++...     .+..|...+....|||++++++++.+.+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            89999999975 468899999997543     234455555666799999999999999999999999999999999865


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCceeecccccCCC
Q 045835          330 RENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIG  409 (511)
Q Consensus       330 ~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~  409 (511)
                      ..    .+++.....++.|++.||+|||+.+   ++||||||+||+++.++.++++|||++.......    ....++..
T Consensus        79 ~~----~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~  147 (237)
T cd05576          79 FL----NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENM  147 (237)
T ss_pred             hc----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCcc
Confidence            42    4899999999999999999999986   9999999999999999999999999886543321    22345678


Q ss_pred             cccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHH
Q 045835          410 YMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAER  489 (511)
Q Consensus       410 y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  489 (511)
                      |+|||......++.++||||+|++++||++|+.|+...+...                       ........+......
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~  204 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------------------NTHTTLNIPEWVSEE  204 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------------------ccccccCCcccCCHH
Confidence            999999988889999999999999999999998765322100                       000001123334557


Q ss_pred             HHHHHHHcCCCCCCCCCCcC
Q 045835          490 MIKVSLLCTNASPSLRPTMS  509 (511)
Q Consensus       490 l~~l~~~Cl~~~p~~RPs~~  509 (511)
                      +.+++.+|++.+|++||++.
T Consensus       205 ~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         205 ARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHHHHHccCCHHHhcCCC
Confidence            88999999999999999974

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=8.4e-33  Score=303.11  Aligned_cols=145  Identities=27%  Similarity=0.415  Sum_probs=129.7

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|.+.++||+|+||.||+|... +++.||||+++...   ......+.+|+.+++.++||||+++++++...+..++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57889999999999999999865 68899999987542   223357889999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcc
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK  391 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~  391 (511)
                      ||+.+++|.+++....    .+++...+.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999986432    4788999999999999999999986   9999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=8.2e-34  Score=305.62  Aligned_cols=251  Identities=29%  Similarity=0.415  Sum_probs=186.0

Q ss_pred             HHHhcCCcccCceeccCceeEEecccc-CCcEEEEEEeccc-CccchHHHHHHHHHHhcCCCCCceeEEEEEEeC-----
Q 045835          236 KAATNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK-SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEG-----  308 (511)
Q Consensus       236 ~~~~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----  308 (511)
                      .+..++|+.++.||+||||.|||++.+ ||+.+|||++... +........+|+..|++|+|||+|+++..+.+.     
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            456678999999999999999999855 8999999999765 344456788999999999999999976532110     


Q ss_pred             --------------------------------------------------------------------------------
Q 045835          309 --------------------------------------------------------------------------------  308 (511)
Q Consensus       309 --------------------------------------------------------------------------------  308 (511)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ----------------------------------CEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHH
Q 045835          309 ----------------------------------DQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA  354 (511)
Q Consensus       309 ----------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~  354 (511)
                                                        ..+|+-||||+.-+|.+++....-..   .-...++++.+|+.||+
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLa  711 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLA  711 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHH
Confidence                                              12467788888877777765432110   34567889999999999


Q ss_pred             HHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC-----------------CCCceeecccccCCCcccccccc
Q 045835          355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE-----------------GDKTHISTRIAGTIGYMAPEYAL  417 (511)
Q Consensus       355 yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~  417 (511)
                      |+|+++   ||||||||.||+||++..+||+|||+|....                 .......+..+||.-|+|||.+.
T Consensus       712 YIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~  788 (1351)
T KOG1035|consen  712 YIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS  788 (1351)
T ss_pred             HHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence            999997   9999999999999999999999999997511                 00111234568999999999987


Q ss_pred             cC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCC--CCCHHHHHHHHH
Q 045835          418 WG---YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGS--KYKKEEAERMIK  492 (511)
Q Consensus       418 ~~---~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~~l~~  492 (511)
                      ..   .|+.|+|+||+|||++||+.   ||....    +      .      ...+..+-+..+..  .+..+....=..
T Consensus       789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM----E------R------a~iL~~LR~g~iP~~~~f~~~~~~~e~s  849 (1351)
T KOG1035|consen  789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM----E------R------ASILTNLRKGSIPEPADFFDPEHPEEAS  849 (1351)
T ss_pred             ccccccccchhhhHHHHHHHHHHhc---cCCchH----H------H------HHHHHhcccCCCCCCcccccccchHHHH
Confidence            54   59999999999999999986   454211    1      1      11112222222221  223344455678


Q ss_pred             HHHHcCCCCCCCCCCcCCC
Q 045835          493 VSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       493 l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ++.++++.||.+|||+.|+
T Consensus       850 lI~~Ll~hdP~kRPtA~eL  868 (1351)
T KOG1035|consen  850 LIRWLLSHDPSKRPTATEL  868 (1351)
T ss_pred             HHHHHhcCCCccCCCHHHH
Confidence            9999999999999999764

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-33  Score=290.31  Aligned_cols=200  Identities=30%  Similarity=0.465  Sum_probs=171.6

Q ss_pred             CcccCceeccCceeEEeccc-cCCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeC------CEEEE
Q 045835          242 FDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEG------DQLLL  313 (511)
Q Consensus       242 f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~~l  313 (511)
                      +...+.||+|+||.||+|+. ..|+.||||.++... ....+...+|+++|++++|+|||++++.=.+.      ....+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            34567899999999999984 579999999998654 34455678999999999999999999885543      35789


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEc--CCC--CeEEeecCC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD--RDL--NPKISDFGL  389 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld--~~~--~~kl~DfGl  389 (511)
                      |||||.+|||...|....+. ..|++...+.+..+++.||.|||+++   |+||||||.||++-  +++  .-||+|||.
T Consensus        95 vmEyC~gGsL~~~L~~PEN~-~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENA-YGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEeecCCCcHHHHhcCcccc-cCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            99999999999999877654 46999999999999999999999886   99999999999983  333  469999999


Q ss_pred             cccCCCCCceeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 045835          390 AKLDEGDKTHISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYA  447 (511)
Q Consensus       390 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~  447 (511)
                      |+-.+.+.  .....+||..|++||.+.. +.++..+|.|||||++||+.||..||...
T Consensus       171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~  227 (732)
T KOG4250|consen  171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF  227 (732)
T ss_pred             cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence            99776655  4456789999999999985 88999999999999999999999999743

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=5e-35  Score=268.59  Aligned_cols=257  Identities=26%  Similarity=0.321  Sum_probs=193.0

Q ss_pred             cccccHHHHHHHhcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCc-cchHHHHHHHHHHhc-CCCCCceeEEE
Q 045835          227 TISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR-QGNREFLNEIAMISC-LQHPNLVKIHG  303 (511)
Q Consensus       227 ~~~~~~~~l~~~~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~-l~H~niv~l~g  303 (511)
                      ...|+-+.++.       +..||.|.||+|+|-.++ .|+..|||+++.... ..+++++.|.+...+ -+.||||+++|
T Consensus        58 ~~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyG  130 (361)
T KOG1006|consen   58 LHTFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYG  130 (361)
T ss_pred             ccccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence            34555555443       578999999999998764 689999999986644 556678888886544 47999999999


Q ss_pred             EEEeCCEEEEEEEecCCCCHhHHHhc-CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCe
Q 045835          304 CCVEGDQLLLVYEYMENNSLACALFG-RENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP  382 (511)
Q Consensus       304 ~~~~~~~~~lV~Ey~~~gsL~~~l~~-~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~  382 (511)
                      .+..+...|+-||.|.- ||..+... ....+..+++...-.|.....+||.||-+.-  +|||||+||+|||||..|.+
T Consensus       131 a~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~v  207 (361)
T KOG1006|consen  131 ALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDV  207 (361)
T ss_pred             hhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCE
Confidence            99999999999999964 66554321 1112345888888889999999999998764  69999999999999999999


Q ss_pred             EEeecCCcccCCCCCceeecccccCCCcccccccccC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhh
Q 045835          383 KISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWG--YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDW  460 (511)
Q Consensus       383 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~  460 (511)
                      ||||||++..+.+.-  ..+..+|-..|||||.+...  .+..+|||||||++|+|+.||+.|+....            
T Consensus       208 KLCDFGIcGqLv~Si--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~------------  273 (361)
T KOG1006|consen  208 KLCDFGICGQLVDSI--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD------------  273 (361)
T ss_pred             eeecccchHhHHHHH--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH------------
Confidence            999999997654322  22345678889999988633  58999999999999999999999986322            


Q ss_pred             hHhhhccCchhHhhhh---hhCCC-CCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          461 ACHLQQDGKLVELVDE---RLGSK-YKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       461 ~~~~~~~~~~~~~~d~---~l~~~-~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                       ..+   +.+..++..   .+..+ -..+....|..++..|+.++..+||...++
T Consensus       274 -svf---eql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~L  324 (361)
T KOG1006|consen  274 -SVF---EQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDL  324 (361)
T ss_pred             -HHH---HHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhh
Confidence             111   112222211   11111 112356789999999999999999997653

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.2e-32  Score=261.63  Aligned_cols=234  Identities=29%  Similarity=0.403  Sum_probs=189.8

Q ss_pred             CceeEEecccc-CCcEEEEEEecccCccc-hHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCCCCHhHHHhc
Q 045835          252 GFGPVYKGQLA-DGTIIAVKQLSSKSRQG-NREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFG  329 (511)
Q Consensus       252 ~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~  329 (511)
                      +||.||+|... +++.+|+|++....... ...+.+|+..+++++|+|++++.+++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999876 48899999998665544 67899999999999999999999999999999999999999999999865


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCceeecccccCCC
Q 045835          330 RENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIG  409 (511)
Q Consensus       330 ~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~  409 (511)
                      ..    .+++..+..++.++++++.|||+.+   ++|+||+|+||++++++.++|+|||++.......  ......++..
T Consensus        81 ~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~  151 (244)
T smart00220       81 RG----RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE  151 (244)
T ss_pred             cc----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence            43    2889999999999999999999986   9999999999999999999999999998654432  2233467889


Q ss_pred             cccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCCCCCHH--HH
Q 045835          410 YMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKE--EA  487 (511)
Q Consensus       410 y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~--~~  487 (511)
                      |++||.+....++.++||||||++++||++|+.|+....    +....             .+.+...........  ..
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~----~~~~~-------------~~~~~~~~~~~~~~~~~~~  214 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD----QLLEL-------------FKKIGKPKPPFPPPEWKIS  214 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----cHHHH-------------HHHHhccCCCCccccccCC
Confidence            999999988889999999999999999999999986321    11111             111111111110111  45


Q ss_pred             HHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          488 ERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       488 ~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .++.+++.+|+..+|++||++.++
T Consensus       215 ~~~~~~i~~~l~~~p~~Rp~~~~~  238 (244)
T smart00220      215 PEAKDLIRKLLVKDPEKRLTAEEA  238 (244)
T ss_pred             HHHHHHHHHHccCCchhccCHHHH
Confidence            679999999999999999999764

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-33  Score=259.81  Aligned_cols=252  Identities=21%  Similarity=0.312  Sum_probs=192.5

Q ss_pred             cCceeccCceeEEecc-ccCCcEEEEEEecccCccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEEEEEEEecCCCC
Q 045835          245 AKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQLLLVYEYMENNS  322 (511)
Q Consensus       245 ~~~lG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~gs  322 (511)
                      .+.||+|+|+.|-.++ +.+|..+|||++.+..........+|++++..- .|+||++|+++++++...|||||-|.+|+
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            3689999999999885 678999999999888777788899999999877 59999999999999999999999999999


Q ss_pred             HhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCC---CeEEeecCCcccC--CCCC
Q 045835          323 LACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL---NPKISDFGLAKLD--EGDK  397 (511)
Q Consensus       323 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~---~~kl~DfGla~~~--~~~~  397 (511)
                      |..++..+.    .+++....++..+||.||.|||.++   |.||||||+|||..+..   -+||+||.|..-.  ..+-
T Consensus       163 lLshI~~~~----~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~  235 (463)
T KOG0607|consen  163 LLSHIQKRK----HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC  235 (463)
T ss_pred             HHHHHHHhh----hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence            999997664    4899999999999999999999997   99999999999986543   3899999987522  1111


Q ss_pred             cee----ecccccCCCcccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhc--
Q 045835          398 THI----STRIAGTIGYMAPEYAL-----WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQ--  466 (511)
Q Consensus       398 ~~~----~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~--  466 (511)
                      ...    -...+|+..|||||+..     ...|+.+.|.||||||||-||+|.+||.....  .+    ..|-+...=  
T Consensus       236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg--~d----CGWdrGe~Cr~  309 (463)
T KOG0607|consen  236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG--AD----CGWDRGEVCRV  309 (463)
T ss_pred             CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC--Cc----CCccCCCccHH
Confidence            111    22357889999999753     23688999999999999999999999976542  12    223211000  


Q ss_pred             -cCchhHhhhhhhCCCCCHH----HHHHHHHHHHHcCCCCCCCCCCcCC
Q 045835          467 -DGKLVELVDERLGSKYKKE----EAERMIKVSLLCTNASPSLRPTMSE  510 (511)
Q Consensus       467 -~~~~~~~~d~~l~~~~~~~----~~~~l~~l~~~Cl~~~p~~RPs~~e  510 (511)
                       ...+.+-+...- -++|..    .+.+..+++...+..++.+|-++..
T Consensus       310 CQ~~LFesIQEGk-YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~  357 (463)
T KOG0607|consen  310 CQNKLFESIQEGK-YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQ  357 (463)
T ss_pred             HHHHHHHHHhccC-CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhh
Confidence             011222222211 133432    3455677777778889999877654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-33  Score=282.86  Aligned_cols=237  Identities=24%  Similarity=0.381  Sum_probs=192.3

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEEEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      +..|.....+|.|+|+.|-.+.. .+++..+||++.....    +-.+|+.++... +||||+++.+.+.++.+.++|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            56678888899999999999864 4678899999976532    233566555444 79999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEE-cCCCCeEEeecCCcccCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL-DRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILl-d~~~~~kl~DfGla~~~~~  395 (511)
                      .+.++-+.+.+....    ... ..+..|+.+|+.|+.|||++|   ++||||||+|||+ ++.++++|+|||.++....
T Consensus       397 ~l~g~ell~ri~~~~----~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKP----EFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             hccccHHHHHHHhcc----hhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence            999998777664432    123 677789999999999999987   9999999999999 5889999999999997665


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      +    ....+-|..|.|||+.....+++++|+||||++||+||+|+.|+...+..                    .++..
T Consensus       469 ~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--------------------~ei~~  524 (612)
T KOG0603|consen  469 S----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--------------------IEIHT  524 (612)
T ss_pred             h----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--------------------HHHHH
Confidence            4    11234578899999999999999999999999999999999999754421                    23333


Q ss_pred             hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       476 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ....+.+....+....+|+.+||+.+|.+||+|.++
T Consensus       525 ~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i  560 (612)
T KOG0603|consen  525 RIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEI  560 (612)
T ss_pred             hhcCCccccccCHHHHHHHHHhccCChhhCcChhhh
Confidence            334444556667788999999999999999999875

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.98  E-value=3.2e-32  Score=285.19  Aligned_cols=261  Identities=19%  Similarity=0.219  Sum_probs=180.1

Q ss_pred             HhcCCcccCceeccCceeEEeccc-----------------cCCcEEEEEEecccCccchHHH--------------HHH
Q 045835          238 ATNNFDSAKKIGEGGFGPVYKGQL-----------------ADGTIIAVKQLSSKSRQGNREF--------------LNE  286 (511)
Q Consensus       238 ~~~~f~~~~~lG~G~fG~Vy~g~~-----------------~~g~~vAvK~~~~~~~~~~~~~--------------~~E  286 (511)
                      ..++|++.++||+|+||.||+|..                 .+++.||||++........++|              ..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            367899999999999999999953                 2356799999875433323333              446


Q ss_pred             HHHHhcCCCCCc-----eeEEEEEEe--------CCEEEEEEEecCCCCHhHHHhcCCC--------------------C
Q 045835          287 IAMISCLQHPNL-----VKIHGCCVE--------GDQLLLVYEYMENNSLACALFGREN--------------------C  333 (511)
Q Consensus       287 i~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~~--------------------~  333 (511)
                      +.++.+++|.++     ++++++|..        ....++||||+++++|.++|+....                    .
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777776654     678888763        3568999999999999999975321                    1


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCceeecccccCCCcccc
Q 045835          334 ELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAP  413 (511)
Q Consensus       334 ~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aP  413 (511)
                      ...++|..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..............+++.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence            123578889999999999999999986   99999999999999999999999999975433222111122347899999


Q ss_pred             cccccCCC----------------------CcchhHHHHHHHHHHHHhCCC-CCCCCCccc----ccccchhhhhHhhhc
Q 045835          414 EYALWGYL----------------------TYKADVYSFGIVALEIVSGKN-NMSYAPALE----FDCTCLLDWACHLQQ  466 (511)
Q Consensus       414 E~~~~~~~----------------------~~~~DV~S~Gvvl~elltG~~-p~~~~~~~~----~~~~~l~~~~~~~~~  466 (511)
                      |.+.....                      ..+.||||+||+++||++|.. |+.......    .....+..|....  
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~--  457 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK--  457 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc--
Confidence            98754321                      234799999999999999875 553211100    0011122222110  


Q ss_pred             cCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCC---CCCCCcCCC
Q 045835          467 DGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASP---SLRPTMSEV  511 (511)
Q Consensus       467 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p---~~RPs~~eV  511 (511)
                      .        ....-...........+++.+|+..+|   .+|+|+.|+
T Consensus       458 ~--------~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~ea  497 (507)
T PLN03224        458 G--------QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQA  497 (507)
T ss_pred             c--------cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHH
Confidence            0        001111112334567888889998765   789998763

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.98  E-value=5.5e-32  Score=289.92  Aligned_cols=257  Identities=23%  Similarity=0.238  Sum_probs=167.5

Q ss_pred             HhcCCcccCceeccCceeEEecccc-C----CcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEE------EE
Q 045835          238 ATNNFDSAKKIGEGGFGPVYKGQLA-D----GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC------CV  306 (511)
Q Consensus       238 ~~~~f~~~~~lG~G~fG~Vy~g~~~-~----g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~------~~  306 (511)
                      ..++|...++||+|+||.||+|+.. +    +..||||++.....  .+.+..|  .+....+.+++.+...      +.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            4578999999999999999999864 4    68999998764321  1112222  1222222222222111      34


Q ss_pred             eCCEEEEEEEecCCCCHhHHHhcCCCC----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCC
Q 045835          307 EGDQLLLVYEYMENNSLACALFGRENC----------------ELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIK  370 (511)
Q Consensus       307 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk  370 (511)
                      .+...++||||+.+++|.+++......                ........+..++.|++.||+|||+.+   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            567899999999999999998653210                001123345678999999999999986   9999999


Q ss_pred             CCCeEEcC-CCCeEEeecCCcccCCCCCceeecccccCCCcccccccccC----------------------CCCcchhH
Q 045835          371 ATNVLLDR-DLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWG----------------------YLTYKADV  427 (511)
Q Consensus       371 ~~NILld~-~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DV  427 (511)
                      |+|||++. ++.+||+|||+++..............+++.|+|||.+...                      .++.++||
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            99999986 57899999999986544444444456789999999965322                      23456799


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCc-----ccccccchhhhhHhhhccCchhHhhhhhhCCC------CCHHHHHHHHHHHHH
Q 045835          428 YSFGIVALEIVSGKNNMSYAPA-----LEFDCTCLLDWACHLQQDGKLVELVDERLGSK------YKKEEAERMIKVSLL  496 (511)
Q Consensus       428 ~S~Gvvl~elltG~~p~~~~~~-----~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~------~~~~~~~~l~~l~~~  496 (511)
                      |||||+||||+++..+......     .......+..|...          +.+....+      ..........+|+.+
T Consensus       363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~d~~~~~~~dLi~~  432 (566)
T PLN03225        363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKL----------VEPRASPDLRRGFEVLDLDGGAGWELLKS  432 (566)
T ss_pred             HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHh----------hccccchhhhhhhhhccccchHHHHHHHH
Confidence            9999999999997655431100     00001112222111          11110000      000112235589999


Q ss_pred             cCCCCCCCCCCcCCC
Q 045835          497 CTNASPSLRPTMSEV  511 (511)
Q Consensus       497 Cl~~~p~~RPs~~eV  511 (511)
                      ||+.||++|||+.|+
T Consensus       433 mL~~dP~kR~ta~e~  447 (566)
T PLN03225        433 MMRFKGRQRISAKAA  447 (566)
T ss_pred             HccCCcccCCCHHHH
Confidence            999999999999764

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-32  Score=272.70  Aligned_cols=194  Identities=27%  Similarity=0.420  Sum_probs=169.2

Q ss_pred             cCceeccCceeEEeccc-cCCcEEEEEEeccc--CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCCC
Q 045835          245 AKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK--SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENN  321 (511)
Q Consensus       245 ~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g  321 (511)
                      .+.||+|.||+||-|+. ++|+.||||++.+-  ......++.+|+.+|++++||.||.|.-.|+..+..++|||-+.+.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            47899999999999975 47999999999643  3445578899999999999999999999999999999999999776


Q ss_pred             CHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCC---CeEEeecCCcccCCCCCc
Q 045835          322 SLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL---NPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       322 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~---~~kl~DfGla~~~~~~~~  398 (511)
                      -|+.+|....   ..|++..-..+..||+.||.|||.++   |+|+||||+||||.+..   .+||||||.|+...... 
T Consensus       649 MLEMILSsEk---gRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-  721 (888)
T KOG4236|consen  649 MLEMILSSEK---GRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-  721 (888)
T ss_pred             HHHHHHHhhc---ccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh-
Confidence            6777775432   35888888888999999999999986   99999999999997653   59999999999876433 


Q ss_pred             eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 045835          399 HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSY  446 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~  446 (511)
                       ....++||+.|+|||++..+.|...-|+||.|||+|--|+|..||..
T Consensus       722 -FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE  768 (888)
T KOG4236|consen  722 -FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE  768 (888)
T ss_pred             -hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence             34557899999999999999999999999999999999999999974

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.7e-33  Score=296.00  Aligned_cols=208  Identities=28%  Similarity=0.356  Sum_probs=183.6

Q ss_pred             cHHHHHHHhcCCcccCceeccCceeEEecccc-CCcEEEEEEeccc---CccchHHHHHHHHHHhcCCCCCceeEEEEEE
Q 045835          231 TLKQIKAATNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK---SRQGNREFLNEIAMISCLQHPNLVKIHGCCV  306 (511)
Q Consensus       231 ~~~~l~~~~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~  306 (511)
                      ...+++...++|+++++||+|+||.|..++.+ .++.+|+|++...   .+....-|..|-++|..-+.+=|++|.-.|.
T Consensus        66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ  145 (1317)
T KOG0612|consen   66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ  145 (1317)
T ss_pred             HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence            45666777789999999999999999999864 5889999999763   2344567889999999888899999999999


Q ss_pred             eCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEee
Q 045835          307 EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISD  386 (511)
Q Consensus       307 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~D  386 (511)
                      +.+.+|+|||||+||+|-.++....    .+++......+..|.-||.-||+.|   +|||||||.|||||..|++||+|
T Consensus       146 D~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLAD  218 (1317)
T KOG0612|consen  146 DERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLAD  218 (1317)
T ss_pred             CccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeecc
Confidence            9999999999999999999996543    4788888889999999999999987   99999999999999999999999


Q ss_pred             cCCcccCCCCCceeecccccCCCcccccccc----c-CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 045835          387 FGLAKLDEGDKTHISTRIAGTIGYMAPEYAL----W-GYLTYKADVYSFGIVALEIVSGKNNMS  445 (511)
Q Consensus       387 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DV~S~Gvvl~elltG~~p~~  445 (511)
                      ||.+-.+..+..-.+...+|||.|++||++.    + +.|++.+|.||+||++|||+.|..||.
T Consensus       219 FGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY  282 (1317)
T KOG0612|consen  219 FGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY  282 (1317)
T ss_pred             chhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence            9999777766666677789999999999885    3 579999999999999999999999996

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=281.31  Aligned_cols=256  Identities=28%  Similarity=0.431  Sum_probs=207.5

Q ss_pred             HHHHHHHhcCCcccCceeccCceeEEecc-ccCCcEEEEEEecccCccchHHHHHHHHHHhcC-CCCCceeEEEEEEe--
Q 045835          232 LKQIKAATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCL-QHPNLVKIHGCCVE--  307 (511)
Q Consensus       232 ~~~l~~~~~~f~~~~~lG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~--  307 (511)
                      ++.+...++-|++.+.||.|.+|.||+++ .++++.+|+|++..... ...+...|..+|+.. +|||++.++|++..  
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            34444556779999999999999999997 45789999999876543 335677888999888 69999999999874  


Q ss_pred             ---CCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEE
Q 045835          308 ---GDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKI  384 (511)
Q Consensus       308 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl  384 (511)
                         ++++|||||||.+||..+++.+..  ...+.|..+.-|+..+++|+.+||...   ++|||||-.|||++.++.+||
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL  164 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL  164 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence               569999999999999999998765  457999999999999999999999875   999999999999999999999


Q ss_pred             eecCCcccCCCCCceeecccccCCCcccccccccC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhh
Q 045835          385 SDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWG-----YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLD  459 (511)
Q Consensus       385 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~  459 (511)
                      .|||++.......... ....||+.|||||++...     .|+..+|+||+|++..||--|.+|+..+.+..        
T Consensus       165 vDFGvSaQldsT~grR-nT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr--------  235 (953)
T KOG0587|consen  165 VDFGVSAQLDSTVGRR-NTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR--------  235 (953)
T ss_pred             eeeeeeeeeecccccc-cCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh--------
Confidence            9999998655433322 235799999999998643     46778999999999999999999986443211        


Q ss_pred             hhHhhhccCchhHhh-hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          460 WACHLQQDGKLVELV-DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       460 ~~~~~~~~~~~~~~~-d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                               -+..+. .|.+...-+....+++.+++..||.+|-..||++.++
T Consensus       236 ---------aLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~l  279 (953)
T KOG0587|consen  236 ---------ALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEEL  279 (953)
T ss_pred             ---------hhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhh
Confidence                     111111 1222333466788999999999999999999998763

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=4.3e-32  Score=235.89  Aligned_cols=197  Identities=28%  Similarity=0.452  Sum_probs=166.1

Q ss_pred             CCcccCceeccCceeEEecccc-CCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      +|+..++||+|+||+||+|+.. .++.||+|+++...  .......++|+.+|+.++|.|||+++++...+..+.+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4666789999999999999854 58899999987543  33446789999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      |.. +|..+...-   ...++......++.|+++||.|+|+++   +.|||+||.|.|++.+|+.|++|||+++.+.-.-
T Consensus        83 cdq-dlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             hhH-HHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence            975 677766432   235888999999999999999999986   9999999999999999999999999999776544


Q ss_pred             ceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHh-CCCCCC
Q 045835          398 THISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVS-GKNNMS  445 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~ellt-G~~p~~  445 (511)
                      .+.+ ..+-|..|.+|.++.+. -|+...|+||-||++.|+.. |++.|.
T Consensus       156 rcys-aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfp  204 (292)
T KOG0662|consen  156 RCYS-AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  204 (292)
T ss_pred             Eeee-ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCC
Confidence            3333 34568999999998865 58899999999999999987 444443

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.2e-32  Score=261.79  Aligned_cols=241  Identities=25%  Similarity=0.384  Sum_probs=191.6

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccCc---cchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR---QGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV  314 (511)
                      .+|..+.+||+|+||.|.++..+ +.+.+|||+++..--   ...+--+.|-.+|... +-|.+++|..++..-+++++|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            46888899999999999999754 467899999986522   1112234566666655 568899999999999999999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      |||+.+|+|--++..-.    .+.++...-.|..||-||-+||+++   ||.||||..|||||.+|++||+|||+++..-
T Consensus       429 MEyvnGGDLMyhiQQ~G----kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni  501 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVG----KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  501 (683)
T ss_pred             EEEecCchhhhHHHHhc----ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence            99999999998886543    3778888899999999999999998   9999999999999999999999999998422


Q ss_pred             CCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          395 GDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       395 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      -+. ......+||+.|+|||.+..++|+..+|.|||||+|||||.|++||+...     .             .++.+.+
T Consensus       502 ~~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD-----E-------------~elF~aI  562 (683)
T KOG0696|consen  502 FDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED-----E-------------DELFQAI  562 (683)
T ss_pred             cCC-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC-----H-------------HHHHHHH
Confidence            211 22345799999999999999999999999999999999999999997422     1             1122211


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPT  507 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs  507 (511)
                      ... .-.+|...+.+...+...-+...|.+|--
T Consensus       563 ~eh-nvsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  563 MEH-NVSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             HHc-cCcCcccccHHHHHHHHHHhhcCCccccC
Confidence            111 12466677777888888888899998853

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.8e-32  Score=265.60  Aligned_cols=248  Identities=25%  Similarity=0.349  Sum_probs=188.7

Q ss_pred             CCcccCceeccCceeEEecc-ccCCcEEEEEEecccCc-------cchHHHHHHHHHHhcCCCCCceeEEEEEE-eCCEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSR-------QGNREFLNEIAMISCLQHPNLVKIHGCCV-EGDQL  311 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~~-------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~-~~~~~  311 (511)
                      +|-.+++||+|||+.||++. +...+.||||+-.....       .-.+...+|..+-+.|.||.||++++++. +.+.+
T Consensus       464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF  543 (775)
T KOG1151|consen  464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF  543 (775)
T ss_pred             HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence            46677899999999999996 55678999998643211       11234678999999999999999999986 56788


Q ss_pred             EEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcC---CCCeEEeecC
Q 045835          312 LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR---DLNPKISDFG  388 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~---~~~~kl~DfG  388 (511)
                      +-|+|||++.+|.-+|..+.    .++++....|+.||+.||.||.+. ++||||-||||.||||-+   .|.+||+|||
T Consensus       544 CTVLEYceGNDLDFYLKQhk----lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  544 CTVLEYCEGNDLDFYLKQHK----LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             eeeeeecCCCchhHHHHhhh----hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence            99999999999999997664    488999999999999999999987 589999999999999954   4779999999


Q ss_pred             CcccCCCCCce------eecccccCCCcccccccccC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchh
Q 045835          389 LAKLDEGDKTH------ISTRIAGTIGYMAPEYALWG----YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLL  458 (511)
Q Consensus       389 la~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~  458 (511)
                      |++.+..+...      ......||.+|++||++.-+    +++.|+||||.|||+|..+-|+.||.....    ..+++
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs----QQdIL  694 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS----QQDIL  694 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh----HHHHH
Confidence            99987655432      34456899999999998644    578899999999999999999999974321    11111


Q ss_pred             hhhHhhhccCchhHhhhhh-hCCCCCHHHHHHHHHHHHHcCCCCCCCCCC
Q 045835          459 DWACHLQQDGKLVELVDER-LGSKYKKEEAERMIKVSLLCTNASPSLRPT  507 (511)
Q Consensus       459 ~~~~~~~~~~~~~~~~d~~-l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs  507 (511)
                      +.       ..   ++... +.-...+....+...++.+||+..-++|..
T Consensus       695 qe-------NT---IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~D  734 (775)
T KOG1151|consen  695 QE-------NT---ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRID  734 (775)
T ss_pred             hh-------hc---hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhh
Confidence            11       11   11110 111112233455677788888776666643

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=2.8e-31  Score=247.73  Aligned_cols=246  Identities=22%  Similarity=0.260  Sum_probs=189.0

Q ss_pred             hcCCcc-cCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhc-CCCCCceeEEEEEEe----CCEE
Q 045835          239 TNNFDS-AKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISC-LQHPNLVKIHGCCVE----GDQL  311 (511)
Q Consensus       239 ~~~f~~-~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~----~~~~  311 (511)
                      +++|.+ .++||-|-.|.|-.+..+ +++.+|+|++...     ....+|+++--. -.|||||++++++..    ...+
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL  134 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL  134 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence            344544 357999999999998654 6889999998653     244677776433 369999999999864    4577


Q ss_pred             EEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcC---CCCeEEeecC
Q 045835          312 LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR---DLNPKISDFG  388 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~---~~~~kl~DfG  388 (511)
                      ++|||.|++|.|..-+..+..  ..+++.+..+|..||+.|+.|||+.+   |.||||||+|+|...   |-.+||+|||
T Consensus       135 LiVmE~meGGeLfsriq~~g~--~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  135 LIVMECMEGGELFSRIQDRGD--QAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             EeeeecccchHHHHHHHHccc--ccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence            899999999999998876653  56999999999999999999999986   999999999999964   4568999999


Q ss_pred             CcccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccC
Q 045835          389 LAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDG  468 (511)
Q Consensus       389 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~  468 (511)
                      +|+.......  ....+-|+.|.|||++...+++...|+||+||++|-||||-+||.........             .+
T Consensus       210 FAK~t~~~~~--L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais-------------pg  274 (400)
T KOG0604|consen  210 FAKETQEPGD--LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------------PG  274 (400)
T ss_pred             cccccCCCcc--ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC-------------hh
Confidence            9996553221  23346799999999999999999999999999999999999999744321110             00


Q ss_pred             chhHhhhhhhCCCCC----HHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          469 KLVELVDERLGSKYK----KEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       469 ~~~~~~d~~l~~~~~----~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      -...+... . -++|    ...++...+++...|..+|.+|-|+.|+
T Consensus       275 Mk~rI~~g-q-y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~  319 (400)
T KOG0604|consen  275 MKRRIRTG-Q-YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEV  319 (400)
T ss_pred             HHhHhhcc-C-ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHh
Confidence            00111111 1 1222    2446778899999999999999998874

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=3.8e-32  Score=247.82  Aligned_cols=199  Identities=29%  Similarity=0.461  Sum_probs=163.2

Q ss_pred             CCcccCceeccCceeEEecccc-CCcEEEEEEeccc-Ccc-chHHHHHHHHHHhcCCCCCceeEEEEEEe--------CC
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK-SRQ-GNREFLNEIAMISCLQHPNLVKIHGCCVE--------GD  309 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~-~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--------~~  309 (511)
                      .|+-..+||+|.||.||+++.. +|+.||+|+.-.. .+. --...++|+++|..|+|+|++.++..|..        ..
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            4556689999999999999854 5778898876432 222 22456899999999999999999999864        23


Q ss_pred             EEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCC
Q 045835          310 QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL  389 (511)
Q Consensus       310 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGl  389 (511)
                      .+++|+++|+. +|.-+|.+.   ...++..++.+++.++..||.|+|...   |+|||+|+.|+||+.++.+||+|||+
T Consensus        98 t~ylVf~~ceh-DLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence            58999999987 788888543   356889999999999999999999874   99999999999999999999999999


Q ss_pred             cccCCCCCc---eeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 045835          390 AKLDEGDKT---HISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSY  446 (511)
Q Consensus       390 a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~  446 (511)
                      ++.+.....   ...++.+-|..|++||.+.+. .++++.|||.-|||+.||.|+.+.+..
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqg  231 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQG  231 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccC
Confidence            986543322   123344569999999998865 799999999999999999999887763

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-30  Score=246.02  Aligned_cols=249  Identities=23%  Similarity=0.354  Sum_probs=197.2

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEeccc---CccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK---SRQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l  313 (511)
                      .++|+++++||+|+|..|..+++. +.+.+|+|+++..   ......-.+.|-.++.+- +||.+|-|..|+..+..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            367999999999999999999865 5788999998754   233444566777777655 79999999999999999999


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      |.||+++|+|--++...    ..|+++........|..||.|||+.|   ||.||||..|+|+|..+++||+|+|+++..
T Consensus       329 vieyv~ggdlmfhmqrq----rklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             EEEEecCcceeeehhhh----hcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence            99999999998777544    35899999999999999999999998   999999999999999999999999999853


Q ss_pred             CCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHh
Q 045835          394 EGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVEL  473 (511)
Q Consensus       394 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  473 (511)
                      -.. .......+||+.|+|||.+.+..|....|.|++||+++||+.|+.||+.-.. ......-         +.-+.++
T Consensus       402 l~~-gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm-~n~d~nt---------edylfqv  470 (593)
T KOG0695|consen  402 LGP-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGM-DNPDMNT---------EDYLFQV  470 (593)
T ss_pred             CCC-CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecC-CCcccch---------hHHHHHH
Confidence            322 2233457999999999999999999999999999999999999999974321 1111111         1122232


Q ss_pred             hhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCC
Q 045835          474 VDERLGSKYKKEEAERMIKVSLLCTNASPSLRP  506 (511)
Q Consensus       474 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP  506 (511)
                      +-.+. ..+|...+.+...+...-|++||.+|-
T Consensus       471 ilekq-iriprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  471 ILEKQ-IRIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             Hhhhc-ccccceeehhhHHHHHHhhcCCcHHhc
Confidence            22211 234555666777888888999999985

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=6.7e-31  Score=233.34  Aligned_cols=204  Identities=26%  Similarity=0.375  Sum_probs=166.2

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEeccc-CccchHHHHHHHHHHh-cCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK-SRQGNREFLNEIAMIS-CLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~-~~~~~~~~~~Ei~~l~-~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      +.......||+|++|.|-+-++ .+|+..|+|++... ..+..+..++|+.+.. ...+|.+|.++|....+...++.||
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME  125 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME  125 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence            3444567899999999988864 57999999999755 3455567888888754 4579999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      .|.. ||..+...--.....+++...-+|+..+.+||.|||++-  .+||||+||+|||++.+|.+|+||||++..+.+.
T Consensus       126 ~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS  202 (282)
T KOG0984|consen  126 LMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDS  202 (282)
T ss_pred             Hhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence            9975 777665443333456888999999999999999999974  6999999999999999999999999999866543


Q ss_pred             CceeecccccCCCcccccccc----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 045835          397 KTHISTRIAGTIGYMAPEYAL----WGYLTYKADVYSFGIVALEIVSGKNNMSYAP  448 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~  448 (511)
                      -..  +...|-..|||||.+.    ...|+-|+||||||+.+.||.+++.|++...
T Consensus       203 iAk--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  203 IAK--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             hHH--HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence            221  2235677899999875    3378999999999999999999999997543

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=6.1e-31  Score=253.31  Aligned_cols=258  Identities=21%  Similarity=0.263  Sum_probs=193.3

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCCC--C----CceeEEEEEEeCCEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQH--P----NLVKIHGCCVEGDQL  311 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H--~----niv~l~g~~~~~~~~  311 (511)
                      +++|.+..++|+|+||.|-.+... .+..||||+++.-.+ -.+..+-|+.+|.+|.+  |    -+|.+.+++.-.++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            789999999999999999998543 478999999975432 23455779999999942  2    377788889999999


Q ss_pred             EEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEc--------------
Q 045835          312 LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD--------------  377 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld--------------  377 (511)
                      ++|+|.+ +-|+.++|..+.  -.+++..+...|+.|++++++|||+..   ++|-||||+|||+.              
T Consensus       167 Civfell-G~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             EEEEecc-ChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence            9999988 458999996543  456888999999999999999999986   99999999999983              


Q ss_pred             ------CCCCeEEeecCCcccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccc
Q 045835          378 ------RDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALE  451 (511)
Q Consensus       378 ------~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~  451 (511)
                            .+..+||.|||.|.......    ..++.|..|.|||++++-.++.++||||+||||.|+.||...|..-..  
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen--  314 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN--  314 (415)
T ss_pred             ceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc--
Confidence                  13458999999998654333    335678999999999999999999999999999999999988764331  


Q ss_pred             ccccchhhhh----------------HhhhccC-----------chhHhhhhhh----CCCCCHHHHHHHHHHHHHcCCC
Q 045835          452 FDCTCLLDWA----------------CHLQQDG-----------KLVELVDERL----GSKYKKEEAERMIKVSLLCTNA  500 (511)
Q Consensus       452 ~~~~~l~~~~----------------~~~~~~~-----------~~~~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~  500 (511)
                        ...|.-.-                ......+           +...+.++..    .......+..++.+|+.+||..
T Consensus       315 --~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f  392 (415)
T KOG0671|consen  315 --LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF  392 (415)
T ss_pred             --HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence              11111100                0000000           0011111100    0112235577899999999999


Q ss_pred             CCCCCCCcCCC
Q 045835          501 SPSLRPTMSEV  511 (511)
Q Consensus       501 ~p~~RPs~~eV  511 (511)
                      ||.+|+|+.|.
T Consensus       393 DP~~RiTl~EA  403 (415)
T KOG0671|consen  393 DPARRITLREA  403 (415)
T ss_pred             CccccccHHHH
Confidence            99999999873

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=3.6e-31  Score=276.08  Aligned_cols=244  Identities=29%  Similarity=0.348  Sum_probs=182.2

Q ss_pred             CcccCceeccCcee-EEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEEEEEEEecC
Q 045835          242 FDSAKKIGEGGFGP-VYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQLLLVYEYME  319 (511)
Q Consensus       242 f~~~~~lG~G~fG~-Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~  319 (511)
                      |...+.+|.|+-|+ ||+|.+ +|+.||||++-....   ....+|+..|+.- +|||||++++.-.+....|+..|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~~---~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEFF---DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHhH---HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            44456788998876 699988 578999999864322   3457899999877 69999999988888889999999997


Q ss_pred             CCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcC---C--CCeEEeecCCcccCC
Q 045835          320 NNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR---D--LNPKISDFGLAKLDE  394 (511)
Q Consensus       320 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~---~--~~~kl~DfGla~~~~  394 (511)
                      . +|.+++...........-.....+..|++.||++||+.+   |+||||||.||||+.   +  .+++|+|||+++...
T Consensus       587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            5 999999764110001111334677889999999999976   999999999999976   3  468999999999776


Q ss_pred             CCCceeec--ccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCcccccccchhhhhHhhhccCchh
Q 045835          395 GDKTHIST--RIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG-KNNMSYAPALEFDCTCLLDWACHLQQDGKLV  471 (511)
Q Consensus       395 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG-~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  471 (511)
                      .+....+.  ...||-||+|||.+....-+.++||||+|||+|+.++| ++||...-         .+-+..+..+..+.
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~---------~R~~NIl~~~~~L~  733 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL---------ERQANILTGNYTLV  733 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH---------HhhhhhhcCcccee
Confidence            65544333  46799999999999998888999999999999999996 89986321         11111111111111


Q ss_pred             HhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       472 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .+       ....++  ...+|+.+|++++|..||++.+|
T Consensus       734 ~L-------~~~~d~--eA~dLI~~ml~~dP~~RPsa~~V  764 (903)
T KOG1027|consen  734 HL-------EPLPDC--EAKDLISRMLNPDPQLRPSATDV  764 (903)
T ss_pred             ee-------ccCchH--HHHHHHHHhcCCCcccCCCHHHH
Confidence            11       111122  67889999999999999999875

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.4e-31  Score=262.03  Aligned_cols=242  Identities=21%  Similarity=0.298  Sum_probs=196.6

Q ss_pred             cCCcccCceeccCceeEEeccccCCc-EEEEEEeccc---CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLADGT-IIAVKQLSSK---SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~g~-~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      .+++.+..||-|+||.|=+.+.+... ..|+|.++..   .....+....|-.+|...+.|.||+|+-.+.+....|++|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            34566778999999999998775443 4788887654   2334456778999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      |-|-+|.|-..|..+.    .++..+...++..+.+|++|||+++   ||.|||||+|++||.+|-+||.|||+|+....
T Consensus       500 EaClGGElWTiLrdRg----~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~  572 (732)
T KOG0614|consen  500 EACLGGELWTILRDRG----SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS  572 (732)
T ss_pred             HhhcCchhhhhhhhcC----CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence            9999999999997665    4888899999999999999999997   99999999999999999999999999997654


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      ...  .-..+||+.|.|||.+..+..+.++|.||+|++++|||+|++||+...++       ..+..       +.+-+|
T Consensus       573 g~K--TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm-------ktYn~-------ILkGid  636 (732)
T KOG0614|consen  573 GRK--TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM-------KTYNL-------ILKGID  636 (732)
T ss_pred             CCc--eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH-------HHHHH-------HHhhhh
Confidence            432  23579999999999999999999999999999999999999999854321       11111       011111


Q ss_pred             hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCC
Q 045835          476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPT  507 (511)
Q Consensus       476 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs  507 (511)
                         ..++|........+|+.+.+..+|.+|--
T Consensus       637 ---~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  637 ---KIEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             ---hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence               13455566667788888888899999864

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=2.4e-29  Score=254.31  Aligned_cols=202  Identities=24%  Similarity=0.358  Sum_probs=170.6

Q ss_pred             cCCcccCceeccCceeEEecc-ccCCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      .-|..++.||-|+||.|.+++ .++...+|+|.+++.+   +........|-+||..-..+=+|+|+-.|.+++.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            457788899999999999996 4456788999998653   344456788999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC--
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD--  393 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~--  393 (511)
                      ||+++|++-.+|...+    -+.+......+..+.+|+++.|..|   +|||||||.|||||.+|++||+||||+.-+  
T Consensus       709 dYIPGGDmMSLLIrmg----IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW  781 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMG----IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  781 (1034)
T ss_pred             eccCCccHHHHHHHhc----cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccccee
Confidence            9999999999997654    3777777788899999999999887   999999999999999999999999998421  


Q ss_pred             -------CCCCce--------------------------------eecccccCCCcccccccccCCCCcchhHHHHHHHH
Q 045835          394 -------EGDKTH--------------------------------ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVA  434 (511)
Q Consensus       394 -------~~~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl  434 (511)
                             .++..+                                .....+||..|+|||++....++..+|.||.||||
T Consensus       782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil  861 (1034)
T KOG0608|consen  782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL  861 (1034)
T ss_pred             ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence                   111000                                01125799999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCC
Q 045835          435 LEIVSGKNNMSYAP  448 (511)
Q Consensus       435 ~elltG~~p~~~~~  448 (511)
                      +||+.|+.||....
T Consensus       862 ~em~~g~~pf~~~t  875 (1034)
T KOG0608|consen  862 YEMLVGQPPFLADT  875 (1034)
T ss_pred             HHHhhCCCCccCCC
Confidence            99999999997543

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=2.8e-28  Score=227.30  Aligned_cols=207  Identities=37%  Similarity=0.598  Sum_probs=179.3

Q ss_pred             eeccCceeEEeccccC-CcEEEEEEecccCcc-chHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCCCCHhH
Q 045835          248 IGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQ-GNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLAC  325 (511)
Q Consensus       248 lG~G~fG~Vy~g~~~~-g~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~  325 (511)
                      ||+|.+|.||++...+ ++.+++|++...... ....+.+|+..++.++|++++++++++......++++|++.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999998754 889999999765432 34678999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcC-CCCeEEeecCCcccCCCCCceeeccc
Q 045835          326 ALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR-DLNPKISDFGLAKLDEGDKTHISTRI  404 (511)
Q Consensus       326 ~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~-~~~~kl~DfGla~~~~~~~~~~~~~~  404 (511)
                      ++....   ..+++..+..++.++++++++||+.+   ++|+||+|.||+++. +..++|+|||.+........ .....
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~  153 (215)
T cd00180          81 LLKENE---GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI  153 (215)
T ss_pred             HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence            986542   35889999999999999999999986   999999999999999 89999999999986544321 12224


Q ss_pred             ccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCCCCC
Q 045835          405 AGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYK  483 (511)
Q Consensus       405 ~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  483 (511)
                      .+...|++||..... ..+.++|+|++|+++++|                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            567889999998877 888999999999999999                                              


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          484 KEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       484 ~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                          ..+.+++..|++.+|++||++.++
T Consensus       188 ----~~~~~~l~~~l~~~p~~R~~~~~l  211 (215)
T cd00180         188 ----PELKDLIRKMLQKDPEKRPSAKEI  211 (215)
T ss_pred             ----HHHHHHHHHHhhCCcccCcCHHHH
Confidence                468889999999999999998764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=3e-28  Score=230.82  Aligned_cols=199  Identities=34%  Similarity=0.507  Sum_probs=171.7

Q ss_pred             CcccCceeccCceeEEeccccC-CcEEEEEEecccCcc-chHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecC
Q 045835          242 FDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQ-GNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYME  319 (511)
Q Consensus       242 f~~~~~lG~G~fG~Vy~g~~~~-g~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~  319 (511)
                      |...+.||+|++|.||++...+ ++.+|+|.+...... ....+.+|++.+++++|+|++++++++...+..++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4567899999999999998765 889999999866544 56788999999999999999999999999999999999999


Q ss_pred             CCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCce
Q 045835          320 NNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH  399 (511)
Q Consensus       320 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~  399 (511)
                      +++|.+++.....   .+++.....++.+++.++.+||+.+   ++|+||+|+||+++.++.++|+|||++.........
T Consensus        81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       81 GGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence            9999999865431   1789999999999999999999986   999999999999999999999999999866543211


Q ss_pred             eecccccCCCccccccc-ccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 045835          400 ISTRIAGTIGYMAPEYA-LWGYLTYKADVYSFGIVALEIVSGKNNMSY  446 (511)
Q Consensus       400 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DV~S~Gvvl~elltG~~p~~~  446 (511)
                      ......++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            22234577889999998 666788899999999999999999999963

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.9e-30  Score=239.19  Aligned_cols=197  Identities=27%  Similarity=0.382  Sum_probs=162.3

Q ss_pred             CcccCceeccCceeEEeccc-cCCcEEEEEEeccc--CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCC-----EEEE
Q 045835          242 FDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK--SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGD-----QLLL  313 (511)
Q Consensus       242 f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~l  313 (511)
                      .+..+-||-|.||.||..+. ++|+.||.|++..-  +-...+.+.+|+++|.-.+|.|++..++...-..     ++|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            34568899999999999975 47999999998643  2234467889999999999999999988765432     5678


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      ++|.|.. +|..++-.    ...|+-....-+..||++||+|||+.+   |.||||||.|.|+++|...||+||||++..
T Consensus       135 ~TELmQS-DLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARve  206 (449)
T KOG0664|consen  135 LTELMQS-DLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTW  206 (449)
T ss_pred             HHHHHHh-hhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccccc
Confidence            8888854 56665533    345888888889999999999999986   999999999999999999999999999976


Q ss_pred             CCCCceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 045835          394 EGDKTHISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSY  446 (511)
Q Consensus       394 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~  446 (511)
                      ..+...-.+..+-|..|.|||.+++. .|+.+.||||.||++.||+..+-.|..
T Consensus       207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA  260 (449)
T KOG0664|consen  207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA  260 (449)
T ss_pred             chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc
Confidence            65554445556778999999999876 799999999999999999988877653

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.7e-27  Score=234.03  Aligned_cols=131  Identities=24%  Similarity=0.427  Sum_probs=109.2

Q ss_pred             cCCcccCceeccCceeEEecc-ccCCcEEEEEEecccCccchHHHHHHHHHHhcCC-----C---CCceeEEEEEEe---
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ-----H---PNLVKIHGCCVE---  307 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-----H---~niv~l~g~~~~---  307 (511)
                      .+|.+.++||-|.|++||++. ..+.+.||+|+.+.. ..-.+..+.||++|++++     |   .+||+|++.|..   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            578899999999999999995 456789999998753 233355789999999884     3   379999999975   


Q ss_pred             -CCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEE
Q 045835          308 -GDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL  376 (511)
Q Consensus       308 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILl  376 (511)
                       +.+.+||+|++ +.+|..++.....  +.++.....+||.||+.||.|||.++  +|||-||||+|||+
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~Y--rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNY--RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCC--CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence             56899999998 5577777765432  35888999999999999999999987  69999999999999

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.95  E-value=5.8e-28  Score=217.71  Aligned_cols=254  Identities=19%  Similarity=0.339  Sum_probs=191.1

Q ss_pred             hcCCcccCceeccCceeEEecc-ccCCcEEEEEEecccCccchHHHHHHHHHHhcCC-CCCceeEEEEEEeC--CEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ-HPNLVKIHGCCVEG--DQLLLV  314 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~--~~~~lV  314 (511)
                      .++|++.+++|+|.|+.||.|. ..+.+.++||++++-.   .+.+.+|+++|..|+ ||||++|++...+.  ....||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            4678999999999999999996 5577889999997643   357889999999997 99999999998875  467899


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCC-CeEEeecCCcccC
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL-NPKISDFGLAKLD  393 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~-~~kl~DfGla~~~  393 (511)
                      +||+.+-+...+.       ..|+...+...+.+++.||.|+|+.|   |.|||+||.|+++|... .++|+|+|||.+.
T Consensus       114 FE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  183 (338)
T ss_pred             hhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence            9999998876654       23667778889999999999999998   99999999999999765 5899999999876


Q ss_pred             CCCCceeecccccCCCcccccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhh--------
Q 045835          394 EGDKTHISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHL--------  464 (511)
Q Consensus       394 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~--------  464 (511)
                      .......  ..+.+.-|--||.+. ...++..-|+|||||+|..|+..+.||-....   ...+|..-+..+        
T Consensus       184 Hp~~eYn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d---N~DQLVkIakVLGt~el~~Y  258 (338)
T KOG0668|consen  184 HPGKEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD---NYDQLVKIAKVLGTDELYAY  258 (338)
T ss_pred             CCCceee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC---CHHHHHHHHHHhChHHHHHH
Confidence            6543321  123456688999876 45788999999999999999999999864331   222233222111        


Q ss_pred             ------hccCchhHhhhhhhCCCC-------CHH-HHHHHHHHHHHcCCCCCCCCCCcCC
Q 045835          465 ------QQDGKLVELVDERLGSKY-------KKE-EAERMIKVSLLCTNASPSLRPTMSE  510 (511)
Q Consensus       465 ------~~~~~~~~~~d~~l~~~~-------~~~-~~~~l~~l~~~Cl~~~p~~RPs~~e  510 (511)
                            .-+.+...++...-+...       ... ...+.++++.+.|..|-.+|||+.|
T Consensus       259 l~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakE  318 (338)
T KOG0668|consen  259 LNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKE  318 (338)
T ss_pred             HHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHH
Confidence                  112222333332221110       001 1356788999999999999999876

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=8.8e-28  Score=226.58  Aligned_cols=252  Identities=24%  Similarity=0.345  Sum_probs=186.7

Q ss_pred             cCCcccCceeccCceeEEecc-ccCCcEEEEEEeccc--CccchHHHHHHHHHHhcCCCCCceeEEEEEEeC------CE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSK--SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEG------DQ  310 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~-~~~g~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~  310 (511)
                      .+|..+..+|.|.- .|-.+. .-.+++||+|++...  .....+...+|..++..++|+|+++++.++.-.      .+
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            45666777888877 555553 225789999988643  233445678999999999999999999998643      36


Q ss_pred             EEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCc
Q 045835          311 LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA  390 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla  390 (511)
                      .++|||+|.. +|...+.      ..++-.+...|..|++.|++|||+.+   |+||||||+||++..+..+||.|||+|
T Consensus        96 ~y~v~e~m~~-nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a  165 (369)
T KOG0665|consen   96 VYLVMELMDA-NLCQVIL------MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA  165 (369)
T ss_pred             HHHHHHhhhh-HHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence            7999999964 7877775      23777889999999999999999987   999999999999999999999999999


Q ss_pred             ccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCch
Q 045835          391 KLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKL  470 (511)
Q Consensus       391 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  470 (511)
                      +.....  ...+..+.|..|.|||++.+..+.+.+||||.||++.||++|+--|..       ...+-+|......-|..
T Consensus       166 r~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g-------~d~idQ~~ki~~~lgtp  236 (369)
T KOG0665|consen  166 RTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG-------KDHIDQWNKIIEQLGTP  236 (369)
T ss_pred             cccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC-------chHHHHHHHHHHHhcCC
Confidence            854332  455667889999999999988899999999999999999999877652       12223333222211111


Q ss_pred             hH----h-------------------hhhhhC-------CCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          471 VE----L-------------------VDERLG-------SKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       471 ~~----~-------------------~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..    -                   +.+.+.       .+.++-......+++.+||-.+|++|.|..++
T Consensus       237 d~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~da  307 (369)
T KOG0665|consen  237 DPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDA  307 (369)
T ss_pred             CHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHH
Confidence            00    0                   000000       01111224457899999999999999998763

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=8.4e-28  Score=245.13  Aligned_cols=250  Identities=26%  Similarity=0.358  Sum_probs=198.8

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      .++|+....+|+|+||.|||++. ..++..|||.++........-...|+.+++.-+|||||.++|-+...+..++.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            46789999999999999999974 46899999999987777777788899999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      |.+|+|++..+...    ++++.++..++...++||+|||+.+   -+|||||-.|||+++.+.+|++|||.+-..... 
T Consensus        94 cgggslQdiy~~Tg----plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat-  165 (829)
T KOG0576|consen   94 CGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT-  165 (829)
T ss_pred             cCCCcccceeeecc----cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh-
Confidence            99999999887654    5889999999999999999999987   799999999999999999999999998644321 


Q ss_pred             ceeecccccCCCcccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          398 THISTRIAGTIGYMAPEYAL---WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      ........||+.|||||+..   .+.|..++|||+.|+...|+---++|.....       .+  .+..++.    ....
T Consensus       166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh-------pm--r~l~LmT----kS~~  232 (829)
T KOG0576|consen  166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH-------PM--RALFLMT----KSGF  232 (829)
T ss_pred             hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc-------hH--HHHHHhh----ccCC
Confidence            11233467999999999864   5679999999999999999977666543111       00  0101110    0111


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSE  510 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e  510 (511)
                      ++.-. +-+.....-+.+++..|+..+|++|||...
T Consensus       233 qpp~l-kDk~kws~~fh~fvK~altknpKkRptaek  267 (829)
T KOG0576|consen  233 QPPTL-KDKTKWSEFFHNFVKGALTKNPKKRPTAEK  267 (829)
T ss_pred             CCCcc-cCCccchHHHHHHHHHHhcCCCccCCChhh
Confidence            11111 112345667899999999999999999763

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=3.4e-27  Score=264.75  Aligned_cols=194  Identities=17%  Similarity=0.198  Sum_probs=137.0

Q ss_pred             hcCCC-CCceeEEEEE-------EeCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 045835          291 SCLQH-PNLVKIHGCC-------VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRF  362 (511)
Q Consensus       291 ~~l~H-~niv~l~g~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~  362 (511)
                      +.++| +||++++++|       .+...+++++||+ .++|.++|...   ...+++..++.++.||++||+|||+++  
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~g--  100 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQG--  100 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence            34556 6888888887       2334677888987 55999999643   235899999999999999999999987  


Q ss_pred             CeEEccCCCCCeEEcC-------------------CCCeEEeecCCcccCCCCCc---------------eeecccccCC
Q 045835          363 KIVHRDIKATNVLLDR-------------------DLNPKISDFGLAKLDEGDKT---------------HISTRIAGTI  408 (511)
Q Consensus       363 ~iiH~Dlk~~NILld~-------------------~~~~kl~DfGla~~~~~~~~---------------~~~~~~~gt~  408 (511)
                       |+||||||+||||+.                   ++.+|++|||+++.......               .......||+
T Consensus       101 -IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  179 (793)
T PLN00181        101 -IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS  179 (793)
T ss_pred             -eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence             999999999999954                   44566777777653211000               0011135788


Q ss_pred             CcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHH
Q 045835          409 GYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAE  488 (511)
Q Consensus       409 ~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  488 (511)
                      .|||||++.+..++.++|||||||+||||++|.+|+....      ..+....         ...+.+..     .....
T Consensus       180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~------~~~~~~~---------~~~~~~~~-----~~~~~  239 (793)
T PLN00181        180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS------RTMSSLR---------HRVLPPQI-----LLNWP  239 (793)
T ss_pred             ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH------HHHHHHH---------HhhcChhh-----hhcCH
Confidence            8999999999999999999999999999999887754110      0000000         00111111     11223


Q ss_pred             HHHHHHHHcCCCCCCCCCCcCCC
Q 045835          489 RMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       489 ~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ....++.+||+.+|.+||+|.||
T Consensus       240 ~~~~~~~~~L~~~P~~Rps~~ei  262 (793)
T PLN00181        240 KEASFCLWLLHPEPSCRPSMSEL  262 (793)
T ss_pred             HHHHHHHHhCCCChhhCcChHHH
Confidence            45688889999999999999875

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=8.4e-27  Score=234.32  Aligned_cols=195  Identities=25%  Similarity=0.359  Sum_probs=164.2

Q ss_pred             CCcccCceeccCceeEEeccccC-CcEEEEEEecccCc--------cchHHHHHHHHHHhcCC---CCCceeEEEEEEeC
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSR--------QGNREFLNEIAMISCLQ---HPNLVKIHGCCVEG  308 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~~-g~~vAvK~~~~~~~--------~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~  308 (511)
                      .|..++.+|+|+||.|+.+.++. ...|+||.+.+..-        ...-..-.|+.+|..++   |+||+++++++++.
T Consensus       562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd  641 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD  641 (772)
T ss_pred             cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence            58889999999999999998764 56788998864311        01112446999999997   99999999999999


Q ss_pred             CEEEEEEEecC-CCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeec
Q 045835          309 DQLLLVYEYME-NNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF  387 (511)
Q Consensus       309 ~~~~lV~Ey~~-~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~Df  387 (511)
                      +.++|+||-.. +-+|.+++..+.    .++++...-|+.|++.|+++||+++   |+|||||-+||.++.+|-+||+||
T Consensus       642 d~yyl~te~hg~gIDLFd~IE~kp----~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  642 DYYYLETEVHGEGIDLFDFIEFKP----RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             CeeEEEecCCCCCcchhhhhhccC----ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence            99999999664 558888886543    5899999999999999999999997   999999999999999999999999


Q ss_pred             CCcccCCCCCceeecccccCCCcccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCC
Q 045835          388 GLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYL-TYKADVYSFGIVALEIVSGKNNMS  445 (511)
Q Consensus       388 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~Gvvl~elltG~~p~~  445 (511)
                      |.+.+..++.-   ...+||.+|.|||++.+.+| ...-|||++|++||-++....||.
T Consensus       715 gsaa~~ksgpf---d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  715 GSAAYTKSGPF---DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             cchhhhcCCCc---ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99987654432   34579999999999987754 667899999999999999888874

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.93  E-value=4.2e-26  Score=222.81  Aligned_cols=201  Identities=31%  Similarity=0.460  Sum_probs=166.0

Q ss_pred             HHHHhcCCcccCceeccCceeEEecccc----CCcEEEEEEecccCccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCC
Q 045835          235 IKAATNNFDSAKKIGEGGFGPVYKGQLA----DGTIIAVKQLSSKSRQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGD  309 (511)
Q Consensus       235 l~~~~~~f~~~~~lG~G~fG~Vy~g~~~----~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~  309 (511)
                      +....+.|...++||+|+|++||++.+.    .++.||+|.+...+.-  ....+|+++|..+ -+.||+++.+++..++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            3334567899999999999999999754    3578999999765443  4578999999999 5999999999999999


Q ss_pred             EEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCC-CCeEEeecC
Q 045835          310 QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD-LNPKISDFG  388 (511)
Q Consensus       310 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~-~~~kl~DfG  388 (511)
                      ...+|+||++.....+++..       ++...+...+..+..||+++|..|   ||||||||+|+|.+.. +.-.|.|||
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFg  178 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFG  178 (418)
T ss_pred             eeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEech
Confidence            99999999999999888842       667888899999999999999997   9999999999999865 467899999


Q ss_pred             CcccCC-----------------C--C----------------Cc--------eeecccccCCCccccccccc-CCCCcc
Q 045835          389 LAKLDE-----------------G--D----------------KT--------HISTRIAGTIGYMAPEYALW-GYLTYK  424 (511)
Q Consensus       389 la~~~~-----------------~--~----------------~~--------~~~~~~~gt~~y~aPE~~~~-~~~~~~  424 (511)
                      ||....                 .  .                ..        ......+||+||.|||++.. +..+++
T Consensus       179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta  258 (418)
T KOG1167|consen  179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA  258 (418)
T ss_pred             hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence            996110                 0  0                00        00112469999999999875 478999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCC
Q 045835          425 ADVYSFGIVALEIVSGKNNMSYA  447 (511)
Q Consensus       425 ~DV~S~Gvvl~elltG~~p~~~~  447 (511)
                      +||||.|||++-+++++.||-..
T Consensus       259 iDiws~GVI~Lslls~~~PFf~a  281 (418)
T KOG1167|consen  259 IDIWSAGVILLSLLSRRYPFFKA  281 (418)
T ss_pred             cceeeccceeehhhccccccccC
Confidence            99999999999999999999644

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.92  E-value=2.5e-25  Score=203.60  Aligned_cols=160  Identities=25%  Similarity=0.232  Sum_probs=118.5

Q ss_pred             CCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCcee
Q 045835          321 NSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI  400 (511)
Q Consensus       321 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~  400 (511)
                      |+|.+++..+.   ..++|..++.++.|++.||+|||+.+         ||+|||++.++.+|+  ||+++......   
T Consensus         1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---   63 (176)
T smart00750        1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---   63 (176)
T ss_pred             CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc---
Confidence            68999996532   35999999999999999999999874         999999999999999  99998654322   


Q ss_pred             ecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCC
Q 045835          401 STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGS  480 (511)
Q Consensus       401 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  480 (511)
                         ..||..|||||++.+..++.++|||||||++|||+||+.|+.......   ..+..+.......       ++. ..
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~---~~~~~~~~~~~~~-------~~~-~~  129 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS---AILEILLNGMPAD-------DPR-DR  129 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc---HHHHHHHHHhccC-------Ccc-cc
Confidence               257899999999999999999999999999999999999986332110   0011111000000       000 00


Q ss_pred             CCCHHHHH--HHHHHHHHcCCCCCCCCCCcCCC
Q 045835          481 KYKKEEAE--RMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       481 ~~~~~~~~--~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..+.....  .+.+++.+||+.+|++||++.||
T Consensus       130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~l  162 (176)
T smart00750      130 SNLESVSAARSFADFMRVCASRLPQRREAANHY  162 (176)
T ss_pred             ccHHHHHhhhhHHHHHHHHHhcccccccCHHHH
Confidence            11122223  69999999999999999998764

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=9.9e-26  Score=208.06  Aligned_cols=193  Identities=23%  Similarity=0.387  Sum_probs=154.0

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcC-CCCCceeEEEE-EEeCCEEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCL-QHPNLVKIHGC-CVEGDQLLLVYE  316 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~-~~~~~~~~lV~E  316 (511)
                      +.|.+.+.||+|.||.+-+++++ ..+.+++|.+... ....++|.+|..---.| .|.||+.-+++ ++..+.+.+++|
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE  102 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE  102 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence            56889999999999999999875 5678999988643 33457899987654444 58999987765 556678889999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEc-CC-CCeEEeecCCcccCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD-RD-LNPKISDFGLAKLDE  394 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld-~~-~~~kl~DfGla~~~~  394 (511)
                      |++.|+|.+-+...     .+-+....+++.|++.||.|+|++.   ++|||||.+||||- .| .++||||||+.+...
T Consensus       103 ~aP~gdL~snv~~~-----GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  103 FAPRGDLRSNVEAA-----GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             cCccchhhhhcCcc-----cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence            99999998877432     3778888999999999999999986   99999999999983 33 479999999997432


Q ss_pred             CCCceeecccccCCCcccccccccC-----CCCcchhHHHHHHHHHHHHhCCCCCC
Q 045835          395 GDKTHISTRIAGTIGYMAPEYALWG-----YLTYKADVYSFGIVALEIVSGKNNMS  445 (511)
Q Consensus       395 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DV~S~Gvvl~elltG~~p~~  445 (511)
                      ..    -....-+..|.+||.....     ...+.+|||.||++++.+|||+.|+.
T Consensus       175 ~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ  226 (378)
T KOG1345|consen  175 TT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ  226 (378)
T ss_pred             ce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch
Confidence            21    1122345668999976432     45778999999999999999999997

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.3e-25  Score=207.27  Aligned_cols=240  Identities=25%  Similarity=0.394  Sum_probs=189.5

Q ss_pred             cccCceeccCceeEEeccccCCcEEEEEEeccc--CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCC
Q 045835          243 DSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSK--SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMEN  320 (511)
Q Consensus       243 ~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~  320 (511)
                      ....+|.+...|..|+|+++.+. +++|++...  .....++|.+|.-.|+...||||++++|.|.....+.++..||+.
T Consensus       193 nl~tkl~e~hsgelwrgrwqgnd-ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQGND-IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhhccCCCcccccccccCcc-hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            34567889999999999997555 555766533  344456899999999999999999999999999999999999999


Q ss_pred             CCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEe--ecCCcccCCCCCc
Q 045835          321 NSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKIS--DFGLAKLDEGDKT  398 (511)
Q Consensus       321 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~--DfGla~~~~~~~~  398 (511)
                      |||...|++..  ....+-.+..+++.++|+|++|||+.. +-|.---|.+..+++|++.+++|+  |--++....   .
T Consensus       272 gslynvlhe~t--~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfqe~---g  345 (448)
T KOG0195|consen  272 GSLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEV---G  345 (448)
T ss_pred             hHHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeeecc---c
Confidence            99999998754  345677889999999999999999986 334445789999999999998875  222221111   1


Q ss_pred             eeecccccCCCcccccccccCCCC---cchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          399 HISTRIAGTIGYMAPEYALWGYLT---YKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~~~~~~---~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                           ..-.+.||+||.+...+-+   +.+|+|||.+++|||.|.+-||...++.+-.                 +++.-
T Consensus       346 -----r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg-----------------mkial  403 (448)
T KOG0195|consen  346 -----RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG-----------------MKIAL  403 (448)
T ss_pred             -----cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh-----------------hhhhh
Confidence                 1225679999999876533   4789999999999999999999865433211                 34444


Q ss_pred             hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       476 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +.++..+|+..+..+.+|+.-|.+.||.+||.+..|
T Consensus       404 eglrv~ippgis~hm~klm~icmnedpgkrpkfdmi  439 (448)
T KOG0195|consen  404 EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMI  439 (448)
T ss_pred             ccccccCCCCccHHHHHHHHHHhcCCCCcCCCccee
Confidence            667778888999999999999999999999998754

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.91  E-value=2.7e-25  Score=220.93  Aligned_cols=200  Identities=22%  Similarity=0.283  Sum_probs=165.1

Q ss_pred             HhcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCCC------CCceeEEEEEEeCCE
Q 045835          238 ATNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQH------PNLVKIHGCCVEGDQ  310 (511)
Q Consensus       238 ~~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H------~niv~l~g~~~~~~~  310 (511)
                      ..++|.+....|+|-|++|-+|... -|..||||+++... ...+.=+.|+++|++|+.      -|.++|+-.|...++
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH  508 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH  508 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence            4568999999999999999999754 47799999997642 223344689999999963      489999999999999


Q ss_pred             EEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCC-CeEEeecCC
Q 045835          311 LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL-NPKISDFGL  389 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~-~~kl~DfGl  389 (511)
                      +|||+|-+. .+|.+.|..-+. ...|........+.|+..||..|-..+   |+|.||||.|||+++.- .+||||||.
T Consensus       509 LClVFE~Ls-lNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGS  583 (752)
T KOG0670|consen  509 LCLVFEPLS-LNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGS  583 (752)
T ss_pred             eEEEehhhh-chHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCcc
Confidence            999999774 489999976432 345778888899999999999999876   99999999999999865 579999999


Q ss_pred             cccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 045835          390 AKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSY  446 (511)
Q Consensus       390 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~  446 (511)
                      |.......   .+.+.-+..|.|||++.+-.|+...|+||.||.||||.||+-.|..
T Consensus       584 A~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG  637 (752)
T KOG0670|consen  584 ASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG  637 (752)
T ss_pred             cccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence            97544322   1233456679999999999999999999999999999999988763

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=5.1e-24  Score=214.52  Aligned_cols=170  Identities=22%  Similarity=0.169  Sum_probs=130.6

Q ss_pred             HHHHHHHhcCCcccCceeccCceeEEecccc--CCcEEEEEEecccC-----ccchHHHHHHHHHHhcCCCCCceeEEEE
Q 045835          232 LKQIKAATNNFDSAKKIGEGGFGPVYKGQLA--DGTIIAVKQLSSKS-----RQGNREFLNEIAMISCLQHPNLVKIHGC  304 (511)
Q Consensus       232 ~~~l~~~~~~f~~~~~lG~G~fG~Vy~g~~~--~g~~vAvK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~  304 (511)
                      -++.....++|...+.||+|+||.||+|...  +++.||||++....     ....+.|.+|+++|++++|+|+++.+..
T Consensus        10 ~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~   89 (365)
T PRK09188         10 GDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA   89 (365)
T ss_pred             ccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE
Confidence            3445556788999999999999999999754  57788999875331     1234568999999999999999853322


Q ss_pred             EEeCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccC-CCCCeEEcCCCCeE
Q 045835          305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDI-KATNVLLDRDLNPK  383 (511)
Q Consensus       305 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dl-k~~NILld~~~~~k  383 (511)
                         .+..++||||+++++|...  . .     ..   ...++.++++||.|||+.+   |+|||| ||+|||++.++.+|
T Consensus        90 ---~~~~~LVmE~~~G~~L~~~--~-~-----~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ik  152 (365)
T PRK09188         90 ---TGKDGLVRGWTEGVPLHLA--R-P-----HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAA  152 (365)
T ss_pred             ---cCCcEEEEEccCCCCHHHh--C-c-----cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEE
Confidence               2467999999999999632  1 1     00   1457889999999999986   999999 99999999999999


Q ss_pred             EeecCCcccCCCCCce-------eecccccCCCccccccccc
Q 045835          384 ISDFGLAKLDEGDKTH-------ISTRIAGTIGYMAPEYALW  418 (511)
Q Consensus       384 l~DfGla~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~  418 (511)
                      |+|||+++........       .-+...+++.|+|||.+.-
T Consensus       153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            9999999865433211       1134568889999998753

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.88  E-value=1.1e-21  Score=194.63  Aligned_cols=257  Identities=30%  Similarity=0.412  Sum_probs=191.4

Q ss_pred             CcccCceeccCceeEEeccccCCcEEEEEEecccCcc---chHHHHHHHHHHhcCCCC-CceeEEEEEEeCCEEEEEEEe
Q 045835          242 FDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQ---GNREFLNEIAMISCLQHP-NLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       242 f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~---~~~~~~~Ei~~l~~l~H~-niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      |...+.||.|+||.||++...  ..+++|.+......   ....+.+|+.+++.+.|+ +++++.+++......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            567788999999999999876  77899998765433   367899999999999988 799999999777778999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCC-CeEEeecCCcccCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL-NPKISDFGLAKLDEGD  396 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~-~~kl~DfGla~~~~~~  396 (511)
                      +.++++.+++...... ..+.......+..+++.+++|+|+.+   ++|||+||+||+++... .++++|||+++.....
T Consensus        80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            9999999776543211 25788899999999999999999987   99999999999999998 7999999999855433


Q ss_pred             Cce-----eecccccCCCccccccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccC
Q 045835          397 KTH-----ISTRIAGTIGYMAPEYALW---GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDG  468 (511)
Q Consensus       397 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~  468 (511)
                      ...     ......|+..|+|||.+..   ...+...|+||+|++++++++|+.|+...... ...............  
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~--  232 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-SATSQTLKIILELPT--  232 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-ccHHHHHHHHHhcCC--
Confidence            321     2345679999999999987   68899999999999999999999996533210 000001111100000  


Q ss_pred             chhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCC
Q 045835          469 KLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSE  510 (511)
Q Consensus       469 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e  510 (511)
                      .   .................+.+++..|+..+|..|.++.+
T Consensus       233 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~  271 (384)
T COG0515         233 P---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSS  271 (384)
T ss_pred             c---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHH
Confidence            0   00000000000122356788899999999999988653

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=8.5e-22  Score=198.14  Aligned_cols=201  Identities=24%  Similarity=0.250  Sum_probs=163.6

Q ss_pred             CCcccCceeccCceeEEeccccC--CcEEEEEEecccCccchHHHHHHHHHHhcCCC----CCceeEEEEE-EeCCEEEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLAD--GTIIAVKQLSSKSRQGNREFLNEIAMISCLQH----PNLVKIHGCC-VEGDQLLL  313 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~~--g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H----~niv~l~g~~-~~~~~~~l  313 (511)
                      +|.+.++||+|+||.||++....  ...+|+|............+..|+.++..+..    +++..+++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            79999999999999999997544  34788888776544333367889999988873    6888898888 46778899


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCC-----CCeEEeecC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD-----LNPKISDFG  388 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~-----~~~kl~DfG  388 (511)
                      ||+.+ +.+|.++.....  ...++..+..+|+.|++.+|++||+.|   ++||||||.|+++...     ..+.|.|||
T Consensus        99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            99977 779999875443  356999999999999999999999997   9999999999999865     458999999


Q ss_pred             Ccc--cCCCCCce--e-----ecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 045835          389 LAK--LDEGDKTH--I-----STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYA  447 (511)
Q Consensus       389 la~--~~~~~~~~--~-----~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~  447 (511)
                      +++  ........  .     .....||..|.++....+...+++.|+||++.++.|++.|..|+...
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~  240 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEAL  240 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccc
Confidence            998  32222110  1     12245999999999999999999999999999999999999998643

>PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan

Probab=99.87  E-value=1e-22  Score=185.14  Aligned_cols=119  Identities=45%  Similarity=0.732  Sum_probs=87.6

Q ss_pred             CchhhhhhhccCCcceeEeecccCCceeEEEeeeeeeeccccceeecccceEEEEEecccccccccchhhhhcCCCccce
Q 045835           50 GLSELYINARIAPLSLTYFGYCLDNGNYTLSLHFAEIQFSNGITFHSLGRRLFDIYIQDNLVERNFDIKAEASGVLKPVA  129 (511)
Q Consensus        50 ~~~~ly~~~r~~~~~~t~~~~~~~~~~y~v~lhfae~~~~~~~~~~~~g~r~fdiyi~~~~~~~~~~i~~~~~g~~~~~~  129 (511)
                      .++.||+|+|..+.+|+|.+||+++|+|+|+|||||+.+..+......|+|+|||+|+|+.++++|||.+++|+..+++.
T Consensus        54 ~d~~Lyqt~R~g~~~f~Y~ip~~~~G~Y~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~  133 (174)
T PF11721_consen   54 TDDPLYQTERYGPSSFSYDIPVVPNGTYTVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAV  133 (174)
T ss_dssp             HHHHTTT-----SSSEEEEEE--S-EEEEEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---E
T ss_pred             CchhhhHhhcCCCCceEEEEecCCCcEEEEEEEeccccccccccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEE
Confidence            67899999999988999999999999999999999998888667788999999999999999999999999999887777


Q ss_pred             eee-eeeeeceeeEEEEEECCCCCccCCCCCcCC-Cccccc
Q 045835          130 RSY-NVTVTNHIIEIRFHWAGKGTTALPKRGIYG-PLVSAI  168 (511)
Q Consensus       130 ~~f-~v~v~~~~~~i~~~~~g~~~~~~p~~~~~~-p~~~~~  168 (511)
                      +.| .+.|++..+.|+|.|+++++..+|..+..+ |++++|
T Consensus       134 ~~~~~v~v~dg~L~i~f~~~~~~~~~i~~~~~~~~p~IsaI  174 (174)
T PF11721_consen  134 RRFFNVTVTDGTLNIQFVWAGKGTLCIPFIGSYGNPLISAI  174 (174)
T ss_dssp             EEEEEEEEETTEEETTEEEE--SEEEEEEESSSSSSSEEEE
T ss_pred             EEEEEEEEeCCcEEEEEEecCCCcEEeeccccCCCcEEeeC
Confidence            777 999999999999999999999988777777 887764

It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A.

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.85  E-value=1.7e-21  Score=199.87  Aligned_cols=207  Identities=26%  Similarity=0.389  Sum_probs=154.6

Q ss_pred             HhcCCCCCceeEEEEEEeCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccC
Q 045835          290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDI  369 (511)
Q Consensus       290 l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dl  369 (511)
                      |+.+.|.|+.+++|.|.++...+.|.+||..|+|.+.+...   ...++|.....+..+|+.||+|||+..  -..|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~---~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE---DIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc---ccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeee
Confidence            46789999999999999999999999999999999999763   357999999999999999999999864  2399999


Q ss_pred             CCCCeEEcCCCCeEEeecCCcccCCCC-CceeecccccCCCcccccccccC-------CCCcchhHHHHHHHHHHHHhCC
Q 045835          370 KATNVLLDRDLNPKISDFGLAKLDEGD-KTHISTRIAGTIGYMAPEYALWG-------YLTYKADVYSFGIVALEIVSGK  441 (511)
Q Consensus       370 k~~NILld~~~~~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DV~S~Gvvl~elltG~  441 (511)
                      +++|+++|..+.+||+|||+..+.... .........-...|.|||.+...       ..+.++||||||++++|+++.+
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            999999999999999999999866421 11111112234579999988753       2577899999999999999999


Q ss_pred             CCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCCCCC-H-HHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          442 NNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYK-K-EEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       442 ~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~-~-~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .||........ ...+...+..     .-.    +.++.... . +....+..++..||..+|.+||++..|
T Consensus       156 ~~~~~~~~~~~-~~eii~~~~~-----~~~----~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i  217 (484)
T KOG1023|consen  156 GPFDLRNLVED-PDEIILRVKK-----GGS----NPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQI  217 (484)
T ss_pred             CccccccccCC-hHHHHHHHHh-----cCC----CCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHH
Confidence            99975432111 1111111111     000    11111111 1 333469999999999999999998764

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.85  E-value=1.5e-21  Score=183.32  Aligned_cols=172  Identities=16%  Similarity=0.146  Sum_probs=134.5

Q ss_pred             HhcCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHH---------HHHHHHHHhcCCCCCceeEEEEEEeC
Q 045835          238 ATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNRE---------FLNEIAMISCLQHPNLVKIHGCCVEG  308 (511)
Q Consensus       238 ~~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~---------~~~Ei~~l~~l~H~niv~l~g~~~~~  308 (511)
                      ..++|...+++|.|+||.||.... ++..+|||.+++........         +.+|+..+.+++|++|..+..++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            358899999999999999999755 56689999997654333222         67899999999999999999886643


Q ss_pred             --------CEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCC
Q 045835          309 --------DQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL  380 (511)
Q Consensus       309 --------~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~  380 (511)
                              ...+++|||+++.+|.++..        ++.    ....+++.+|..||+.+   ++|||+||+||++++++
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence                    35789999999999987631        222    24568999999999987   99999999999999988


Q ss_pred             CeEEeecCCcccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh
Q 045835          381 NPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS  439 (511)
Q Consensus       381 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt  439 (511)
                       ++|+|||.......+...             ..+.....+..++|+||||+.+..+..
T Consensus       173 -i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        173 -LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             -EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHHH
Confidence             999999988754322111             113444556689999999999876643

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.84  E-value=7.8e-21  Score=176.00  Aligned_cols=139  Identities=18%  Similarity=0.194  Sum_probs=107.4

Q ss_pred             cCceeccCceeEEeccccCCcEEEEEEecccCcc--c-------hHH-----------------HHHHHHHHhcCCCCCc
Q 045835          245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQ--G-------NRE-----------------FLNEIAMISCLQHPNL  298 (511)
Q Consensus       245 ~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~--~-------~~~-----------------~~~Ei~~l~~l~H~ni  298 (511)
                      ...||+|+||.||+|...+|+.||||+++.....  .       ...                 ...|+..+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4689999999999998878999999999754211  1       112                 2349999999988776


Q ss_pred             eeEEEEEEeCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeEEccCCCCCeEEc
Q 045835          299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFL-HEESRFKIVHRDIKATNVLLD  377 (511)
Q Consensus       299 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yL-H~~~~~~iiH~Dlk~~NILld  377 (511)
                      .....+..  ...++||||++++++.......    ..+++.....++.|++.+|.|| |+.+   |+||||||+|||++
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE
Confidence            44333322  2238999999988776543221    2588899999999999999999 6776   99999999999998


Q ss_pred             CCCCeEEeecCCcccC
Q 045835          378 RDLNPKISDFGLAKLD  393 (511)
Q Consensus       378 ~~~~~kl~DfGla~~~  393 (511)
                       ++.++|+|||++...
T Consensus       153 -~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 -DGKLYIIDVSQSVEH  167 (190)
T ss_pred             -CCcEEEEEccccccC
Confidence             478999999999743

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=2.6e-21  Score=176.18  Aligned_cols=200  Identities=26%  Similarity=0.349  Sum_probs=166.1

Q ss_pred             hcCCcccCceeccCceeEEecc-ccCCcEEEEEEecccCccchHHHHHHHHHHhcCCC-CCceeEEEEEEeCCEEEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQH-PNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~E  316 (511)
                      .++|..+++||+|+||.+|.|. ..+|..||||.-+...++  .++.-|..+...|+| ..|..+..+..++..-.+||+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            3679999999999999999996 668999999997655443  467788888888876 567777888888888899999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCC---CCeEEeecCCcccC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD---LNPKISDFGLAKLD  393 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~---~~~kl~DfGla~~~  393 (511)
                      .. +.||++++.   -+...++.++.+-++-|++.-++|+|.++   +|||||||+|.|..-+   ..+.++||||++.+
T Consensus        92 LL-GPsLEdLfn---fC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   92 LL-GPSLEDLFN---FCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             cc-CccHHHHHH---HHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence            87 779998873   34456899999999999999999999997   9999999999998644   45889999999865


Q ss_pred             CCCC--cee----ecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 045835          394 EGDK--THI----STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYA  447 (511)
Q Consensus       394 ~~~~--~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~  447 (511)
                      .+..  .++    .+...||.+|.+--...+...+.+.|+-|+|.+|.++.-|..|+...
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl  224 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL  224 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence            4322  222    23467999999988888888899999999999999999999999754

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=4e-22  Score=213.53  Aligned_cols=249  Identities=23%  Similarity=0.275  Sum_probs=180.7

Q ss_pred             cccCceeccCceeEEeccc-cCCcEEEEEEec----cc-C-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          243 DSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLS----SK-S-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       243 ~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~----~~-~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ...+.+|.|.+|.|+.... ......+.|..+    .. . .+....+..|+.+-+.++|+|++..+..+.+.....-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            3567899999997776642 233333444332    11 1 111122566777888999999988887777777666669


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      |||+. +|..++...    ..+.-..+..+..|+..|++|||+.|   |.|||+|++|+++..++.+||+|||.+..+..
T Consensus       401 E~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~  472 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRY  472 (601)
T ss_pred             hcccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeecc
Confidence            99999 999988654    23677788899999999999999998   99999999999999999999999999976543


Q ss_pred             CC---ceeecccccCCCcccccccccCCCCc-chhHHHHHHHHHHHHhCCCCCCCCCcccccc--cchhhhhHhhhccCc
Q 045835          396 DK---THISTRIAGTIGYMAPEYALWGYLTY-KADVYSFGIVALEIVSGKNNMSYAPALEFDC--TCLLDWACHLQQDGK  469 (511)
Q Consensus       396 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~--~~l~~~~~~~~~~~~  469 (511)
                      ..   .......+|+..|+|||.+....|.+ ..||||.|+++..|++|+.|+......+...  ..-..|.        
T Consensus       473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~--------  544 (601)
T KOG0590|consen  473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQR--------  544 (601)
T ss_pred             CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccccc--------
Confidence            32   24556678999999999999888776 5799999999999999999997654222110  0000000        


Q ss_pred             hhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          470 LVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       470 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                        .+  ..-........+.+...++.++|+.+|.+|.||.+|
T Consensus       545 --~~--~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i  582 (601)
T KOG0590|consen  545 --NI--FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQI  582 (601)
T ss_pred             --cc--ccChHHHHHhchhhHHHHHHHHccCChhheecHHHH
Confidence              00  000011223445678899999999999999999875

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=1.9e-20  Score=177.80  Aligned_cols=199  Identities=27%  Similarity=0.371  Sum_probs=165.8

Q ss_pred             cCCcccCceeccCceeEEecc-ccCCcEEEEEEecccCccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEEEEEEEe
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      -+|.+.++||+|.||..+.|+ +-+++.||||.-..++..  .++..|....+.| ..++|..++=+..++..-.||+|.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A--PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA--PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCCc--chHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            368899999999999999997 567999999986554432  3566777777777 468898888777778888999998


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCC-----CCeEEeecCCccc
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD-----LNPKISDFGLAKL  392 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~-----~~~kl~DfGla~~  392 (511)
                      + +.||+++.   .-|...++.++...||.|++.-++|+|++.   +|.|||||+|+||...     ..+.|.|||+|+.
T Consensus       106 L-GPSLEDLF---D~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  106 L-GPSLEDLF---DLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             h-CcCHHHHH---HHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            7 77998876   234567999999999999999999999997   9999999999999643     3589999999997


Q ss_pred             CCCCCc--eee----cccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 045835          393 DEGDKT--HIS----TRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYA  447 (511)
Q Consensus       393 ~~~~~~--~~~----~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~  447 (511)
                      +.+..+  ++.    ....||.+||+--...+...+.+.|.=|+|-|+.+.|-|..|+...
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL  239 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL  239 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence            654432  222    2356999999999999999999999999999999999999999754

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.83  E-value=6e-20  Score=170.41  Aligned_cols=141  Identities=18%  Similarity=0.191  Sum_probs=110.5

Q ss_pred             cCceeccCceeEEeccccCCcEEEEEEecccCccc--------------------------hHHHHHHHHHHhcCCCCCc
Q 045835          245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQG--------------------------NREFLNEIAMISCLQHPNL  298 (511)
Q Consensus       245 ~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~--------------------------~~~~~~Ei~~l~~l~H~ni  298 (511)
                      ...||+|+||.||+|...+|+.||||+++......                          ...+..|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            57899999999999987789999999987642110                          1123578999999999987


Q ss_pred             eeEEEEEEeCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEEccCCCCCeEEc
Q 045835          299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE-ESRFKIVHRDIKATNVLLD  377 (511)
Q Consensus       299 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiH~Dlk~~NILld  377 (511)
                      .....+....  .++||||++++++.......    ..++.....+++.+++.++.+||+ .+   |+||||||+|||++
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~  152 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH  152 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE
Confidence            5554443332  48999999988654332111    246778889999999999999999 76   99999999999999


Q ss_pred             CCCCeEEeecCCcccCCC
Q 045835          378 RDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       378 ~~~~~kl~DfGla~~~~~  395 (511)
                       ++.++|+|||++.....
T Consensus       153 -~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 -DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             -CCCEEEEEcccceecCC
Confidence             78999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.81  E-value=5.7e-21  Score=204.94  Aligned_cols=243  Identities=21%  Similarity=0.275  Sum_probs=174.0

Q ss_pred             CCcccCceeccCceeEEeccccCCcEEEEEEecccC-ccchHHHHHHHHH--HhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKS-RQGNREFLNEIAM--ISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~--l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      ++...+.||++.|=+|.+++.++|. |+||++-... .-..+.|.++++-  +..++|||.+++.-+-....-.|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            5667889999999999999998887 8899986544 3344555554443  4556899999998876666677888899


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcc--cCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEG  395 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~--~~~~  395 (511)
                      +.+ +|.|-|..+    +-|.....+-|+.|++.||..+|..+   |.|||||.+||||++-.-+.|+||.--+  ..+.
T Consensus       103 vkh-nLyDRlSTR----PFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  103 VKH-NLYDRLSTR----PFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             Hhh-hhhhhhccc----hHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            876 777777443    34677777889999999999999987   9999999999999998889999998776  2333


Q ss_pred             CCce----eecccccCCCcccccccccC-----------CCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhh
Q 045835          396 DKTH----ISTRIAGTIGYMAPEYALWG-----------YLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLD  459 (511)
Q Consensus       396 ~~~~----~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~  459 (511)
                      ++..    .......-..|+|||.+...           ..+++.||||+|||+.||++ |+++|...+        |..
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ--------L~a  246 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ--------LLA  246 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH--------HHh
Confidence            3222    11122234479999976431           26889999999999999988 577775322        222


Q ss_pred             hhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCC
Q 045835          460 WACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSE  510 (511)
Q Consensus       460 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e  510 (511)
                      +...-  ......++.. .       +...+.++++.|++.+|++|-|+.+
T Consensus       247 Yr~~~--~~~~e~~Le~-I-------ed~~~Rnlil~Mi~rdPs~RlSAed  287 (1431)
T KOG1240|consen  247 YRSGN--ADDPEQLLEK-I-------EDVSLRNLILSMIQRDPSKRLSAED  287 (1431)
T ss_pred             HhccC--ccCHHHHHHh-C-------cCccHHHHHHHHHccCchhccCHHH
Confidence            21110  0011111111 0       1125788999999999999999865

>PRK10345 hypothetical protein; Provisional

Probab=99.79  E-value=1.2e-18  Score=163.06  Aligned_cols=136  Identities=15%  Similarity=0.217  Sum_probs=106.2

Q ss_pred             cccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcC-----CCCCceeEEEEEEeCC---E-EEE
Q 045835          243 DSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCL-----QHPNLVKIHGCCVEGD---Q-LLL  313 (511)
Q Consensus       243 ~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-----~H~niv~l~g~~~~~~---~-~~l  313 (511)
                      ...+.||+|+||.||. .-.++.. +||++........+.+.+|+.+++.+     .||||++++|++.++.   . ..+
T Consensus         5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            3467899999999996 2234444 79988765455567899999999999     5799999999998864   3 347


Q ss_pred             EEEe--cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCeEEccCCCCCeEEcC----CCCeEEee
Q 045835          314 VYEY--MENNSLACALFGRENCELELDWPTRQKICLGIARGL-AFLHEESRFKIVHRDIKATNVLLDR----DLNPKISD  386 (511)
Q Consensus       314 V~Ey--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl-~yLH~~~~~~iiH~Dlk~~NILld~----~~~~kl~D  386 (511)
                      |+||  +.+|+|.+++...     .+++.  ..++.+++.++ +|||+++   |+||||||+|||++.    +..++|+|
T Consensus        83 I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            8999  6689999999542     24444  35677888777 9999987   999999999999974    34799999


Q ss_pred             cCCc
Q 045835          387 FGLA  390 (511)
Q Consensus       387 fGla  390 (511)
                      |+-+
T Consensus       153 g~G~  156 (210)
T PRK10345        153 NIGE  156 (210)
T ss_pred             CCCC
Confidence            5444

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=1.1e-18  Score=160.68  Aligned_cols=184  Identities=15%  Similarity=0.077  Sum_probs=136.8

Q ss_pred             cccCceeccCceeEEeccccCCcEEEEEEecccCccc----hHHHHHHHHHHhcCC-CCCceeEEEEEEeCCEEEEEEEe
Q 045835          243 DSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQG----NREFLNEIAMISCLQ-HPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       243 ~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~----~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      .....|++|+||+||.+.- .+..++.+.+.......    ..-|.+|+++|++|+ |+++++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            4567899999999997765 56778877776543311    124789999999995 5889999886    456999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccC-CCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDI-KATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dl-k~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      +++.+|...+..           ....++.+++.+|+++|+++   |+|||| ||+|||++.++.++|+|||++......
T Consensus        80 I~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~  145 (218)
T PRK12274         80 LAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR  145 (218)
T ss_pred             ecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence            999988654311           11346789999999999997   999999 799999999999999999999854432


Q ss_pred             Cce----e--------ecccccCCCcccccccccC-CCC-cchhHHHHHHHHHHHHhCCCCCC
Q 045835          397 KTH----I--------STRIAGTIGYMAPEYALWG-YLT-YKADVYSFGIVALEIVSGKNNMS  445 (511)
Q Consensus       397 ~~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~DV~S~Gvvl~elltG~~p~~  445 (511)
                      ...    .        ......++.|++|+...-. ..+ ...+.++-|.-+|.++|++.+.-
T Consensus       146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence            210    0        0012256778888754322 233 56788899999999999987653

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.78  E-value=1.8e-18  Score=167.30  Aligned_cols=233  Identities=20%  Similarity=0.254  Sum_probs=148.6

Q ss_pred             CcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcCCC----------CCceeEEEEEEe
Q 045835          242 FDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQH----------PNLVKIHGCCVE  307 (511)
Q Consensus       242 f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H----------~niv~l~g~~~~  307 (511)
                      +...+.||.|+++.||.++.. +++.+|||+.....   ....+++.+|.-....+.+          -.++..++...-
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            345678999999999999865 58999999986443   2344566666655544332          222222232221


Q ss_pred             ---------C---C-----EEEEEEEecCCCCHhHHHh---cCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEc
Q 045835          308 ---------G---D-----QLLLVYEYMENNSLACALF---GRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHR  367 (511)
Q Consensus       308 ---------~---~-----~~~lV~Ey~~~gsL~~~l~---~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~  367 (511)
                               .   +     ..+++|+-+ .++|.+++.   ........+....++.+..|+++.+++||+.|   ++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence                     1   1     236778877 457877753   22222223455667788899999999999998   9999


Q ss_pred             cCCCCCeEEcCCCCeEEeecCCcccCCCCCceeecccccCCCccccccccc--------CCCCcchhHHHHHHHHHHHHh
Q 045835          368 DIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALW--------GYLTYKADVYSFGIVALEIVS  439 (511)
Q Consensus       368 Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DV~S~Gvvl~ellt  439 (511)
                      ||+|+|++++.+|.++|+||+.........   .. ...+..|.+||....        -.++.+.|.|++|+++|.|.|
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRY---RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEE---EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCcee---ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            999999999999999999998876433211   11 234577999997643        257889999999999999999


Q ss_pred             CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCC
Q 045835          440 GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLR  505 (511)
Q Consensus       440 G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~R  505 (511)
                      |+.||.........     +|                .. ..+. +.++.+..|+..+|+.+|.+|
T Consensus       246 ~~lPf~~~~~~~~~-----~~----------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  246 GRLPFGLSSPEADP-----EW----------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             SS-STCCCGGGSTS-----GG----------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             ccCCCCCCCccccc-----cc----------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99999754321111     11                11 2455 777889999999999999998

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.76  E-value=2.1e-19  Score=184.57  Aligned_cols=185  Identities=28%  Similarity=0.386  Sum_probs=151.8

Q ss_pred             ceeccCceeEEeccc----cCCcEEEEEEecccCcc--chHHHHHHHHHHhcCC-CCCceeEEEEEEeCCEEEEEEEecC
Q 045835          247 KIGEGGFGPVYKGQL----ADGTIIAVKQLSSKSRQ--GNREFLNEIAMISCLQ-HPNLVKIHGCCVEGDQLLLVYEYME  319 (511)
Q Consensus       247 ~lG~G~fG~Vy~g~~----~~g~~vAvK~~~~~~~~--~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~  319 (511)
                      .+|+|.||.|+..+.    +.|..+|+|.++.....  .......|-.++...+ ||.+|++.-.+..+...+++.++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999998742    34677888888654321  1114456777888886 9999999999999999999999999


Q ss_pred             CCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCce
Q 045835          320 NNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH  399 (511)
Q Consensus       320 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~  399 (511)
                      +|.|...+....    .+++.........++-+++++|+.+   |+|||+|++||+++.+|++++.|||+++..-..+..
T Consensus        81 gg~lft~l~~~~----~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~  153 (612)
T KOG0603|consen   81 GGDLFTRLSKEV----MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA  153 (612)
T ss_pred             cchhhhccccCC----chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence            999987775433    3666666777788999999999987   999999999999999999999999999864432222


Q ss_pred             eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 045835          400 ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMS  445 (511)
Q Consensus       400 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~  445 (511)
                           +||..|||||++.  .....+|.||||++++||+||-.||.
T Consensus       154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~  192 (612)
T KOG0603|consen  154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFG  192 (612)
T ss_pred             -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCc
Confidence                 7899999999988  56778999999999999999999886

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.75  E-value=1.1e-17  Score=157.70  Aligned_cols=134  Identities=22%  Similarity=0.321  Sum_probs=113.9

Q ss_pred             CceeccCceeEEeccccCCcEEEEEEecccCcc--------chHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQ--------GNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~--------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      +.||+|++|.||+|.. +|..+++|+.......        ....+.+|+.++..++|+++.....++...+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            6799999999999987 6678999986543221        123577899999999999998888888888889999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCccc
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~  392 (511)
                      +++++|.+++...       .+ .+..++.+++.+|.+||+.+   ++|||++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999988532       12 78899999999999999986   99999999999999 78899999999875

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.73  E-value=1.7e-17  Score=178.15  Aligned_cols=140  Identities=21%  Similarity=0.270  Sum_probs=113.4

Q ss_pred             HHhcCCcccCceeccCceeEEeccccCCcEEEEEEe-cccCc-------cchHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 045835          237 AATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQL-SSKSR-------QGNREFLNEIAMISCLQHPNLVKIHGCCVEG  308 (511)
Q Consensus       237 ~~~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~-~~~~~-------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~  308 (511)
                      .....|...++||+|+||.||+|.+.+.. +++|+. .....       .....+.+|+.+++.++|++++....++.+.
T Consensus       330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~  408 (535)
T PRK09605        330 EVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP  408 (535)
T ss_pred             ccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence            33455677899999999999999875544 344432 21111       1234688999999999999999988888888


Q ss_pred             CEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecC
Q 045835          309 DQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFG  388 (511)
Q Consensus       309 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfG  388 (511)
                      ...++||||+++++|.+++.            ....++.+++++|.|||+.+   ++||||||+|||+ +++.++|+|||
T Consensus       409 ~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFG  472 (535)
T PRK09605        409 EEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFG  472 (535)
T ss_pred             CCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCc
Confidence            88899999999999998874            35678999999999999986   9999999999999 57789999999


Q ss_pred             CcccC
Q 045835          389 LAKLD  393 (511)
Q Consensus       389 la~~~  393 (511)
                      +++..
T Consensus       473 la~~~  477 (535)
T PRK09605        473 LGKYS  477 (535)
T ss_pred             ccccC
Confidence            99853

>smart00090 RIO RIO-like kinase

Probab=99.73  E-value=2.4e-17  Score=157.88  Aligned_cols=142  Identities=19%  Similarity=0.142  Sum_probs=110.3

Q ss_pred             CCcccCceeccCceeEEecc--ccCCcEEEEEEecccCcc------------------------chHHHHHHHHHHhcCC
Q 045835          241 NFDSAKKIGEGGFGPVYKGQ--LADGTIIAVKQLSSKSRQ------------------------GNREFLNEIAMISCLQ  294 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~--~~~g~~vAvK~~~~~~~~------------------------~~~~~~~Ei~~l~~l~  294 (511)
                      -|.+.+.||+|+||.||+|.  ..+|+.||+|+++.....                        ....+..|+..+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47788999999999999998  568999999998754210                        0123568999999997


Q ss_pred             CCC--ceeEEEEEEeCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCC
Q 045835          295 HPN--LVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKAT  372 (511)
Q Consensus       295 H~n--iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~  372 (511)
                      +..  +.+++++    ...++||||+++++|.......    ..+.......++.|++.++++||+.+  .++||||||+
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~  178 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD----VEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEY  178 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCccccccccc----CCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChh
Confidence            633  4444443    2358999999998887654221    23555667789999999999999875  4999999999


Q ss_pred             CeEEcCCCCeEEeecCCcccC
Q 045835          373 NVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       373 NILld~~~~~kl~DfGla~~~  393 (511)
                      ||+++ ++.++|+|||++...
T Consensus       179 NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      179 NILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             hEEEE-CCCEEEEEChhhhcc
Confidence            99999 789999999998753

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.73  E-value=2.5e-17  Score=153.86  Aligned_cols=144  Identities=19%  Similarity=0.173  Sum_probs=111.3

Q ss_pred             HHHHHhcCCcccCceeccCceeEEeccccCCcEEEEEEecccCcc----------------------chHHHHHHHHHHh
Q 045835          234 QIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQ----------------------GNREFLNEIAMIS  291 (511)
Q Consensus       234 ~l~~~~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~----------------------~~~~~~~Ei~~l~  291 (511)
                      ++......|...+.||+|+||.||++...+|+.||||+++.....                      ....+..|..++.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            333444447788999999999999998888999999987643210                      1123567888999


Q ss_pred             cCCCCC--ceeEEEEEEeCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccC
Q 045835          292 CLQHPN--LVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDI  369 (511)
Q Consensus       292 ~l~H~n--iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dl  369 (511)
                      .+.|++  +.+.++.    ...++||||+++++|......          .....++.+++.++.++|+.+   ++||||
T Consensus        89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl  151 (198)
T cd05144          89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG---IIHGDL  151 (198)
T ss_pred             HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC---CCcCCC
Confidence            998874  4444442    455899999999998765320          234578899999999999976   999999


Q ss_pred             CCCCeEEcCCCCeEEeecCCcccCC
Q 045835          370 KATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       370 k~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      ||+||++++++.++|+|||++....
T Consensus       152 ~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         152 SEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CcccEEEcCCCcEEEEECCccccCC
Confidence            9999999999999999999996443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.72  E-value=3.8e-17  Score=152.63  Aligned_cols=130  Identities=25%  Similarity=0.328  Sum_probs=107.3

Q ss_pred             ceeccCceeEEeccccCCcEEEEEEecccCcc--------chHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          247 KIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQ--------GNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       247 ~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~--------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      .||+|+||.||+|.. ++..|++|........        ....+.+|+.++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999985 5678999986543211        1245678999999999988776666667777789999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCccc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~  392 (511)
                      ++++|.+++....     .      .++.+++.+|.+||+.+   ++|+|++|.||+++ ++.+++.|||+++.
T Consensus        80 ~g~~l~~~~~~~~-----~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN-----D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH-----H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999998874321     0      78999999999999987   99999999999999 78999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.70  E-value=3.1e-17  Score=179.68  Aligned_cols=196  Identities=23%  Similarity=0.277  Sum_probs=154.0

Q ss_pred             HHHHhcCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCC---CCCceeEEEEEEeCCEE
Q 045835          235 IKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ---HPNLVKIHGCCVEGDQL  311 (511)
Q Consensus       235 l~~~~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~  311 (511)
                      .+.....|.+.+.||+|+||+||+|...+|+.||+|+-++....   +|---.+++.+|+   -+-|..+..+..-.+.-
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S  769 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNAS  769 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence            33344678888999999999999999888999999998776543   2222223334444   23344444444556778


Q ss_pred             EEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEc-------CCCCeEE
Q 045835          312 LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD-------RDLNPKI  384 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld-------~~~~~kl  384 (511)
                      +||+||.+.|+|.+++..    ....+|.....++.|+++-++.||..+   |||+||||+|.||.       ++..++|
T Consensus       770 ~lv~ey~~~Gtlld~~N~----~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~l  842 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLINT----NKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYL  842 (974)
T ss_pred             eeeeeccccccHHHhhcc----CCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEE
Confidence            999999999999999953    345889999999999999999999987   99999999999993       2346899


Q ss_pred             eecCCcc---cCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCC
Q 045835          385 SDFGLAK---LDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKN  442 (511)
Q Consensus       385 ~DfGla~---~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~  442 (511)
                      +|||.+-   ++++.  .......+|-++-.+|...++.++..+|-|.++-+++-||.|+.
T Consensus       843 IDfG~siDm~lfp~~--~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  843 IDFGRSIDMKLFPDG--TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EecccceeeeEcCCC--cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            9999985   33333  22344578889999999999999999999999999999999975

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.70  E-value=9.4e-17  Score=156.08  Aligned_cols=190  Identities=25%  Similarity=0.328  Sum_probs=133.7

Q ss_pred             CCCCceeEEEEEEe---------------------------CCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHH
Q 045835          294 QHPNLVKIHGCCVE---------------------------GDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC  346 (511)
Q Consensus       294 ~H~niv~l~g~~~~---------------------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~  346 (511)
                      +|||||++.++|.+                           +..+|+||.-.+. +|..+|..+.     .+...+.-|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-----~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-----RSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-----CchHHHHHHH
Confidence            59999999988753                           2367899987754 8999886543     5556777789


Q ss_pred             HHHHHHHHHHhcCCCCCeEEccCCCCCeEE--cCCC--CeEEeecCCcccCCCCCc-----eeecccccCCCcccccccc
Q 045835          347 LGIARGLAFLHEESRFKIVHRDIKATNVLL--DRDL--NPKISDFGLAKLDEGDKT-----HISTRIAGTIGYMAPEYAL  417 (511)
Q Consensus       347 ~~ia~gl~yLH~~~~~~iiH~Dlk~~NILl--d~~~--~~kl~DfGla~~~~~~~~-----~~~~~~~gt~~y~aPE~~~  417 (511)
                      .|+++|+.|||.++   |.|||+|+.||||  |+|.  ...|+|||.+-......-     ...-...|...-||||+..
T Consensus       348 aQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  348 AQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence            99999999999997   9999999999998  4444  368999998854332111     1111234677899999876


Q ss_pred             cCC------CCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHH
Q 045835          418 WGY------LTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMI  491 (511)
Q Consensus       418 ~~~------~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  491 (511)
                      ..+      --.|+|.|+.|-+.||+++...||........+   ...     .++.+         ....+..+...+.
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~---~r~-----Yqe~q---------LPalp~~vpp~~r  487 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD---TRT-----YQESQ---------LPALPSRVPPVAR  487 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec---hhh-----hhhhh---------CCCCcccCChHHH
Confidence            432      135899999999999999999999742211100   001     11111         1223444455678


Q ss_pred             HHHHHcCCCCCCCCCCcC
Q 045835          492 KVSLLCTNASPSLRPTMS  509 (511)
Q Consensus       492 ~l~~~Cl~~~p~~RPs~~  509 (511)
                      +|+...|+.+|++|||..
T Consensus       488 qlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  488 QLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             HHHHHHhcCCccccCCcc
Confidence            889999999999999864

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.70  E-value=3.2e-18  Score=172.68  Aligned_cols=169  Identities=25%  Similarity=0.354  Sum_probs=127.7

Q ss_pred             EEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCC
Q 045835          310 QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL  389 (511)
Q Consensus       310 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGl  389 (511)
                      .+++.|++|+..+|.+||.++.. ....+|...+.++.|++.|++|   ++   .+|+|+||.||+...+..+||.|||+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence            57899999999999999976543 2357888999999999999999   44   99999999999999999999999999


Q ss_pred             cccCCCCC-----ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHh
Q 045835          390 AKLDEGDK-----THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACH  463 (511)
Q Consensus       390 a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~  463 (511)
                      ........     ....+...||..||+||.+.+..|+.|+||||||++|+|++. -..++..                 
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er-----------------  465 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER-----------------  465 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH-----------------
Confidence            87554433     222345689999999999999999999999999999999998 2222211                 


Q ss_pred             hhccCchhHhhhhhh----CCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCC
Q 045835          464 LQQDGKLVELVDERL----GSKYKKEEAERMIKVSLLCTNASPSLRPTMSE  510 (511)
Q Consensus       464 ~~~~~~~~~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e  510 (511)
                         ...+.++-|..+    ..++|.     =..+..+++...|.+||+..+
T Consensus       466 ---~~t~~d~r~g~ip~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  466 ---IATLTDIRDGIIPPEFLQDYPE-----EYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             ---HHhhhhhhcCCCChHHhhcCcH-----HHHHHHHhcCCCcccCchHHH
Confidence               011111111111    112222     256888999999999996543

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.64  E-value=1.5e-15  Score=134.25  Aligned_cols=135  Identities=22%  Similarity=0.229  Sum_probs=114.7

Q ss_pred             ccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCC--CCceeEEEEEEeCCEEEEEEEecCCC
Q 045835          244 SAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQH--PNLVKIHGCCVEGDQLLLVYEYMENN  321 (511)
Q Consensus       244 ~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~lV~Ey~~~g  321 (511)
                      +.+.||+|.++.||++...+ ..+++|.......  ...+.+|+.++..++|  .++.+++++....+..++++||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            45789999999999998754 7799999865433  4678899999999977  58999999888888899999999987


Q ss_pred             CHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCccc
Q 045835          322 SLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       322 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~  392 (511)
                      ++..+           +......++.++++++++||......++|+|++|+||++++.+.+++.|||+++.
T Consensus        79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            76432           4567778899999999999987545699999999999999989999999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.62  E-value=2.6e-15  Score=138.73  Aligned_cols=136  Identities=21%  Similarity=0.208  Sum_probs=97.1

Q ss_pred             cCceeccCceeEEeccccCCcEEEEEEecccCccc--hHH----------------------HHHHHHHHhcCCCCC--c
Q 045835          245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQG--NRE----------------------FLNEIAMISCLQHPN--L  298 (511)
Q Consensus       245 ~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~--~~~----------------------~~~Ei~~l~~l~H~n--i  298 (511)
                      .+.||+|+||.||+|...+++.||||+++......  ...                      ...|...+..+.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46899999999999988789999999987532111  111                      134555666654432  4


Q ss_pred             eeEEEEEEeCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEEccCCCCCeEEc
Q 045835          299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE-ESRFKIVHRDIKATNVLLD  377 (511)
Q Consensus       299 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiH~Dlk~~NILld  377 (511)
                      .+.+++    ...++||||++++++.........    .. .....++.+++.++.++|. .+   |+|+||||+||+++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE
Confidence            444443    245899999999654321111100    11 5667899999999999998 65   99999999999999


Q ss_pred             CCCCeEEeecCCcccC
Q 045835          378 RDLNPKISDFGLAKLD  393 (511)
Q Consensus       378 ~~~~~kl~DfGla~~~  393 (511)
                       ++.++|+|||.+...
T Consensus       150 -~~~~~liDfg~a~~~  164 (187)
T cd05119         150 -DGKVYIIDVPQAVEI  164 (187)
T ss_pred             -CCcEEEEECcccccc
Confidence             889999999999744

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.58  E-value=1.7e-15  Score=163.34  Aligned_cols=164  Identities=26%  Similarity=0.374  Sum_probs=116.2

Q ss_pred             hcCCcccCceeccCceeEEeccccC-CcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~~-g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      ..+|+.++.|..|+||.||..+++. .+.+|+|+-+..      -+++-  ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~------lilRn--ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------LILRN--ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccccc------hhhhc--cccccCCccee------------------
Confidence            3578899999999999999998764 566777432211      11110  11222222222                  


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                         |+=...+..-.    .++-        +++.+++|||+.+   |+|||+||.|.+|..-|++|++|||+.+..-...
T Consensus       136 ---gDc~tllk~~g----~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~  197 (1205)
T KOG0606|consen  136 ---GDCATLLKNIG----PLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL  197 (1205)
T ss_pred             ---chhhhhcccCC----CCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence               33333332211    1221        2278899999987   9999999999999999999999999997421110


Q ss_pred             --------------ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 045835          398 --------------THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSY  446 (511)
Q Consensus       398 --------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~  446 (511)
                                    ......++||+.|+|||++....|...+|.|++|+|+||.+-|+.||..
T Consensus       198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffG  260 (1205)
T KOG0606|consen  198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG  260 (1205)
T ss_pred             cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccC
Confidence                          0122346899999999999999999999999999999999999999864

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.58  E-value=2e-14  Score=137.99  Aligned_cols=136  Identities=21%  Similarity=0.259  Sum_probs=104.9

Q ss_pred             cCcee-ccCceeEEeccccCCcEEEEEEecccC-------------ccchHHHHHHHHHHhcCCCCCc--eeEEEEEEeC
Q 045835          245 AKKIG-EGGFGPVYKGQLADGTIIAVKQLSSKS-------------RQGNREFLNEIAMISCLQHPNL--VKIHGCCVEG  308 (511)
Q Consensus       245 ~~~lG-~G~fG~Vy~g~~~~g~~vAvK~~~~~~-------------~~~~~~~~~Ei~~l~~l~H~ni--v~l~g~~~~~  308 (511)
                      ...|| .|+.|+||+.... +..++||++....             ......+.+|+.++.+|+|+++  ++.++++...
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            45687 8899999998774 6678998875321             1223467889999999998875  6777775543


Q ss_pred             C----EEEEEEEecCC-CCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeE
Q 045835          309 D----QLLLVYEYMEN-NSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPK  383 (511)
Q Consensus       309 ~----~~~lV~Ey~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~k  383 (511)
                      .    ..++|+|++++ .+|.+++...     .++..    .+.+++.+|.+||+.+   |+||||||.|||++.++.++
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~  182 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFW  182 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEE
Confidence            2    23599999997 6898887432     24433    3568999999999987   99999999999999999999


Q ss_pred             EeecCCcccC
Q 045835          384 ISDFGLAKLD  393 (511)
Q Consensus       384 l~DfGla~~~  393 (511)
                      |+|||.+...
T Consensus       183 LIDfg~~~~~  192 (239)
T PRK01723        183 LIDFDRGELR  192 (239)
T ss_pred             EEECCCcccC
Confidence            9999999753

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.54  E-value=7.4e-16  Score=165.44  Aligned_cols=252  Identities=23%  Similarity=0.308  Sum_probs=183.7

Q ss_pred             cCCcccCceeccCceeEEeccccC--CcEEEEEEecccC--ccchHHHHHHHHHHhcCC-CCCceeEEEEEEeCCEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLAD--GTIIAVKQLSSKS--RQGNREFLNEIAMISCLQ-HPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~--g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV  314 (511)
                      ..|...+.||+|.|+.|-......  ...+|+|.+....  .........|..+-..+. |+|++.+++...+.+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            457777889999999998886533  3456677665443  222223334666666676 99999999999999999999


Q ss_pred             EEecCCCCHhHHH-hcCCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCeEEccCCCCCeEEcCCC-CeEEeecCCcc
Q 045835          315 YEYMENNSLACAL-FGRENCELELDWPTRQKICLGIARGLAFLH-EESRFKIVHRDIKATNVLLDRDL-NPKISDFGLAK  391 (511)
Q Consensus       315 ~Ey~~~gsL~~~l-~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH-~~~~~~iiH~Dlk~~NILld~~~-~~kl~DfGla~  391 (511)
                      .+|..++++.+.+ ....   ...+.......+.|+..++.|+| ..+   +.|+||||+|.+++..+ ..+++|||+|.
T Consensus       100 ~~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At  173 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLAT  173 (601)
T ss_pred             cCcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhc
Confidence            9999999988777 3221   13455566778899999999999 665   99999999999999999 99999999998


Q ss_pred             cCCC--CCceeeccccc-CCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhcc
Q 045835          392 LDEG--DKTHISTRIAG-TIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD  467 (511)
Q Consensus       392 ~~~~--~~~~~~~~~~g-t~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~  467 (511)
                      ....  +........+| ++.|+|||...+ ....+..|+||.|+++.-+++|..|........   .....|....   
T Consensus       174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~---~~~~~~~~~~---  247 (601)
T KOG0590|consen  174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD---GRYSSWKSNK---  247 (601)
T ss_pred             cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc---ccceeecccc---
Confidence            6554  33333445678 999999999887 467788999999999999999999987543211   1122222111   


Q ss_pred             CchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          468 GKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       468 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                              ................++..+|+..+|..|.+.+++
T Consensus       248 --------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~  283 (601)
T KOG0590|consen  248 --------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEEL  283 (601)
T ss_pred             --------cccccCccccCChhhhhcccccccCCchhccccccc
Confidence                    000111222334456777888888999999998774

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.46  E-value=2.6e-13  Score=141.39  Aligned_cols=144  Identities=22%  Similarity=0.259  Sum_probs=100.8

Q ss_pred             CCcccCceeccCceeEEeccccCCcEEEEEEecccCccch----------------------------------------
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGN----------------------------------------  280 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~----------------------------------------  280 (511)
                      .|+ .+.||+|++|.||+|++.+|+.||||+.++......                                        
T Consensus       119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E  197 (437)
T TIGR01982       119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE  197 (437)
T ss_pred             hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence            344 367999999999999999999999999875421100                                        


Q ss_pred             HHHHHHHHHHhcC----CCCCceeEEEEEE-eCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHH-HHH
Q 045835          281 REFLNEIAMISCL----QHPNLVKIHGCCV-EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIAR-GLA  354 (511)
Q Consensus       281 ~~~~~Ei~~l~~l----~H~niv~l~g~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-gl~  354 (511)
                      -+|.+|...+.++    +|.+-+.+-.++. .....++||||+++++|.+.......   ..   .+.+++..++. .+.
T Consensus       198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~---~~~~ia~~~~~~~l~  271 (437)
T TIGR01982       198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GL---DRKALAENLARSFLN  271 (437)
T ss_pred             HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CC---CHHHHHHHHHHHHHH
Confidence            0234455544444    2333333322332 23457999999999999887643211   12   24456666665 467


Q ss_pred             HHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       355 yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      .+|..+   ++|+|++|.||++++++.+++.|||++....
T Consensus       272 ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       272 QVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            888876   9999999999999999999999999997654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.46  E-value=4.7e-14  Score=134.51  Aligned_cols=153  Identities=24%  Similarity=0.312  Sum_probs=119.5

Q ss_pred             HHhcCCCCCceeEEEEEEeC-----CEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 045835          289 MISCLQHPNLVKIHGCCVEG-----DQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFK  363 (511)
Q Consensus       289 ~l~~l~H~niv~l~g~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~  363 (511)
                      -|-++-|.|||++..|+.+.     .+..+++|||..|++..+|.+...++..+......+++-||..||.|||+. .|+
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence            34456799999999998653     467899999999999999988777777888888899999999999999997 589


Q ss_pred             eEEccCCCCCeEEcCCCCeEEeecCCcccCCC---CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhC
Q 045835          364 IVHRDIKATNVLLDRDLNPKISDFGLAKLDEG---DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG  440 (511)
Q Consensus       364 iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG  440 (511)
                      |+|+++..+-|++..++-+|+.--.-......   ..........+-++|.|||+-...+.+-.+|||+||+..+||.-+
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence            99999999999999999888742111110000   000001112356789999988888888999999999999999877


Q ss_pred             CC
Q 045835          441 KN  442 (511)
Q Consensus       441 ~~  442 (511)
                      .-
T Consensus       279 Ei  280 (458)
T KOG1266|consen  279 EI  280 (458)
T ss_pred             ee
Confidence            54

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.31  E-value=6.5e-12  Score=113.90  Aligned_cols=131  Identities=19%  Similarity=0.163  Sum_probs=96.7

Q ss_pred             cCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCce-eEEEEEEeCCEEEEEEEecCCCCH
Q 045835          245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV-KIHGCCVEGDQLLLVYEYMENNSL  323 (511)
Q Consensus       245 ~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~~~gsL  323 (511)
                      .+.|+.|.++.||+++.. +..+++|....... ....+..|+.+++.+.+.+++ +++.+.  ....++||||+++.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            356889999999999865 67899998765432 223567899999988765554 444433  3345799999999877


Q ss_pred             hHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEEccCCCCCeEEcCCCCeEEeecCCccc
Q 045835          324 ACALFGRENCELELDWPTRQKICLGIARGLAFLHEES--RFKIVHRDIKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       324 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~--~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~  392 (511)
                      ...    .     .   ....+..+++++|+.||+.+  ...++|+|++|.||+++ ++.+++.||+.+..
T Consensus        79 ~~~----~-----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTE----D-----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccc----c-----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            532    0     1   11245678999999999875  23469999999999999 66899999999863

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.31  E-value=1.9e-12  Score=133.56  Aligned_cols=244  Identities=24%  Similarity=0.280  Sum_probs=172.5

Q ss_pred             CCcccCceec--cCceeEEeccc---cCCcEEEEEEecccC--ccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEEE
Q 045835          241 NFDSAKKIGE--GGFGPVYKGQL---ADGTIIAVKQLSSKS--RQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQLL  312 (511)
Q Consensus       241 ~f~~~~~lG~--G~fG~Vy~g~~---~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~  312 (511)
                      .|...+.+|.  |.+|.||.+..   .++..+|+|+-+...  .+....=.+|+....++ .|+|.++....+...+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4667788999  99999999976   357889999854332  23333345677777777 4999999888888999999


Q ss_pred             EEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCeEEccCCCCCeEEcCC-CCeEEeec
Q 045835          313 LVYEYMENNSLACALFGRENCELELDWPTRQKICLGIAR----GLAFLHEESRFKIVHRDIKATNVLLDRD-LNPKISDF  387 (511)
Q Consensus       313 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----gl~yLH~~~~~~iiH~Dlk~~NILld~~-~~~kl~Df  387 (511)
                      +-+|++. .+|..+.+....   .++....+....+...    |+..+|+..   ++|-|+||.||++.++ ..++++||
T Consensus       195 iqtE~~~-~sl~~~~~~~~~---~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHTPCN---FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eeecccc-chhHHhhhcccc---cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence            9999886 678777765432   2445556666666666    999999986   9999999999999999 78999999


Q ss_pred             CCcccCCCCC----ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHh
Q 045835          388 GLAKLDEGDK----THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACH  463 (511)
Q Consensus       388 Gla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~  463 (511)
                      |+........    .....+..|...|++||.. .+-++..+|+|++|.+.+|..++-.......        ...|.. 
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~--------~~~W~~-  337 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGK--------NSSWSQ-  337 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCC--------CCCccc-
Confidence            9998655432    1222344677889999954 4678889999999999999999877665431        011211 


Q ss_pred             hhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCC
Q 045835          464 LQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSE  510 (511)
Q Consensus       464 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e  510 (511)
                       .+...        +..++-.....++..+...+++.+|..|++.++
T Consensus       338 -~r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~  375 (524)
T KOG0601|consen  338 -LRQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQI  375 (524)
T ss_pred             -ccccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHH
Confidence             00000        111111112334455788889999998887654

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.28  E-value=2.9e-12  Score=135.32  Aligned_cols=145  Identities=18%  Similarity=0.216  Sum_probs=92.2

Q ss_pred             cCCcccCceeccCceeEEeccccC-CcEEEEEEecccCccc----------------------------------hH---
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQG----------------------------------NR---  281 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~-g~~vAvK~~~~~~~~~----------------------------------~~---  281 (511)
                      ..|+. +.||+|++|.||+|++++ |+.||||++++.....                                  .+   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45776 789999999999999887 9999999997542110                                  01   


Q ss_pred             ---HHHHHHHHHhcCC----CCCceeEEEEEEe-CCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHH-HH
Q 045835          282 ---EFLNEIAMISCLQ----HPNLVKIHGCCVE-GDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA-RG  352 (511)
Q Consensus       282 ---~~~~Ei~~l~~l~----H~niv~l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia-~g  352 (511)
                         +|.+|...+.+++    +.+.+.+=.++.+ ....+|||||++++.+.+.-.-..   ...+.+   .++...+ .-
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~---~g~d~~---~la~~~v~~~  272 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA---AGTDMK---LLAERGVEVF  272 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh---cCCCHH---HHHHHHHHHH
Confidence               1334444444442    3443433333322 456789999999999977421111   011211   1221111 12


Q ss_pred             HHHHhcCCCCCeEEccCCCCCeEEcCCC----CeEEeecCCcccCC
Q 045835          353 LAFLHEESRFKIVHRDIKATNVLLDRDL----NPKISDFGLAKLDE  394 (511)
Q Consensus       353 l~yLH~~~~~~iiH~Dlk~~NILld~~~----~~kl~DfGla~~~~  394 (511)
                      +..+...|   ++|+|+||.||+++.++    .+++.|||++....
T Consensus       273 ~~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        273 FTQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             HHHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            23334444   99999999999999988    89999999997554

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.22  E-value=1e-10  Score=122.09  Aligned_cols=167  Identities=19%  Similarity=0.215  Sum_probs=123.9

Q ss_pred             ccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHH
Q 045835          261 LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWP  340 (511)
Q Consensus       261 ~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~  340 (511)
                      ..++.+|.|...+...........+-++.|+.++||||++++...+.....|+|+|-+.  .|...+....       ..
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-------~~  104 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-------KE  104 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-------HH
Confidence            45788899998876655334456778899999999999999999999999999999884  5666664322       23


Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCceeecccccCCCcccccccccCC
Q 045835          341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGY  420 (511)
Q Consensus       341 ~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  420 (511)
                      ...-.+.||+.||.|||+.+  +++|++|....|+++..|..||++|.++.....-.. ......--..|..|+.+....
T Consensus       105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence            33445789999999999776  699999999999999999999999988864332111 001111122456666443222


Q ss_pred             CCcchhHHHHHHHHHHHHhCC
Q 045835          421 LTYKADVYSFGIVALEIVSGK  441 (511)
Q Consensus       421 ~~~~~DV~S~Gvvl~elltG~  441 (511)
                        -..|.|-||++++|++.|.
T Consensus       182 --~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             --cchhhhhHHHHHHHHhCcc
Confidence              3469999999999999993

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.15  E-value=3.3e-10  Score=107.16  Aligned_cols=142  Identities=21%  Similarity=0.280  Sum_probs=109.5

Q ss_pred             CceeccCceeEEeccccCCcEEEEEEecccCc-cchHHHHHHHHHHhcCCC--CCceeEEEEEEeCC---EEEEEEEecC
Q 045835          246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSR-QGNREFLNEIAMISCLQH--PNLVKIHGCCVEGD---QLLLVYEYME  319 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~---~~~lV~Ey~~  319 (511)
                      +.|+.|..+.||+++..+|..+++|....... .....+..|.++++.+++  .++.+++.++....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            56899999999999887778899998764332 234578899999999976  34577787776542   5689999999


Q ss_pred             CCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------------
Q 045835          320 NNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES---------------------------------------  360 (511)
Q Consensus       320 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~---------------------------------------  360 (511)
                      +.++.+.+..     ..++...+..++.+++++|..||+..                                       
T Consensus        84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            9888765421     13667777888888888888888531                                       


Q ss_pred             --------------CCCeEEccCCCCCeEEcC--CCCeEEeecCCccc
Q 045835          361 --------------RFKIVHRDIKATNVLLDR--DLNPKISDFGLAKL  392 (511)
Q Consensus       361 --------------~~~iiH~Dlk~~NILld~--~~~~kl~DfGla~~  392 (511)
                                    ...++|+|+++.||+++.  +..+.|.||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          234799999999999998  56689999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PLN03150 hypothetical protein; Provisional

Probab=99.12  E-value=1.4e-10  Score=126.44  Aligned_cols=94  Identities=26%  Similarity=0.349  Sum_probs=80.5

Q ss_pred             CchhhhhhhccCCc---ceeEeecccCCceeEEEeeeeeeeccccceeecccceEEEEEecccccccccchhhhhcCCCc
Q 045835           50 GLSELYINARIAPL---SLTYFGYCLDNGNYTLSLHFAEIQFSNGITFHSLGRRLFDIYIQDNLVERNFDIKAEASGVLK  126 (511)
Q Consensus        50 ~~~~ly~~~r~~~~---~~t~~~~~~~~~~y~v~lhfae~~~~~~~~~~~~g~r~fdiyi~~~~~~~~~~i~~~~~g~~~  126 (511)
                      .|+.||+|||.+..   ++||.++++++|+|.|+|||||+..    .....+.|+|||||||+.+.++|||.+.+++...
T Consensus       250 ~P~~VyqTA~~~~~~~~~lty~~~v~~~~~Y~VrLhFaEi~~----~~~~~~~R~F~V~ing~~~~~~~di~~~~g~~~~  325 (623)
T PLN03150        250 YPESLYQSALVSTDTQPDLSYTMDVDPNRNYSVWLHFAEIDN----SITAEGKRVFDVLINGDTAFKDVDIVKMSGERYT  325 (623)
T ss_pred             ChHHHhhhhccccCCCCceEEEeecCCCCCEEEEEEEEeccC----ccCCCceEEEEEEECCEEeecccChhhhcCCccc
Confidence            46789999999764   7999999999999999999999952    2335689999999999999999999998888888


Q ss_pred             cceeeeeeeeeceeeEEEEEE
Q 045835          127 PVARSYNVTVTNHIIEIRFHW  147 (511)
Q Consensus       127 ~~~~~f~v~v~~~~~~i~~~~  147 (511)
                      +++.+|.+.+.+..+.|.+.-
T Consensus       326 ~~~~~~~v~~~~g~l~isl~p  346 (623)
T PLN03150        326 ALVLNKTVAVSGRTLTIVLQP  346 (623)
T ss_pred             ceEEEeEEeecCCeEEEEEee
Confidence            999999988877667777663

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.10  E-value=1.4e-09  Score=100.32  Aligned_cols=137  Identities=15%  Similarity=0.123  Sum_probs=96.8

Q ss_pred             cCceeccCceeEEeccccC-------CcEEEEEEecccCc----------------------cchHHH----HHHHHHHh
Q 045835          245 AKKIGEGGFGPVYKGQLAD-------GTIIAVKQLSSKSR----------------------QGNREF----LNEIAMIS  291 (511)
Q Consensus       245 ~~~lG~G~fG~Vy~g~~~~-------g~~vAvK~~~~~~~----------------------~~~~~~----~~Ei~~l~  291 (511)
                      ...||.|.-+.||.|.-.+       +..+|||+.+....                      .....+    .+|...|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3578999999999996543       47899998653210                      001122    37888898


Q ss_pred             cCCC--CCceeEEEEEEeCCEEEEEEEecCCCCHhH-HHhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeEEc
Q 045835          292 CLQH--PNLVKIHGCCVEGDQLLLVYEYMENNSLAC-ALFGRENCELELDWPTRQKICLGIARGLAFL-HEESRFKIVHR  367 (511)
Q Consensus       292 ~l~H--~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yL-H~~~~~~iiH~  367 (511)
                      ++..  -++.+++++    ..-++||||+.++.+.. .|..     ..++......+..+++.+|..| |..+   ++|+
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHG  149 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHA  149 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence            8853  456666654    45689999998754422 1211     1244456677889999999999 7765   9999


Q ss_pred             cCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          368 DIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       368 Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      ||++.|||+++ +.+.|+|||.+....
T Consensus       150 DLs~~NIL~~~-~~v~iIDF~qav~~~  175 (197)
T cd05146         150 DLSEYNMLWHD-GKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCCHHHEEEEC-CcEEEEECCCceeCC
Confidence            99999999974 679999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.05  E-value=9.1e-11  Score=121.24  Aligned_cols=197  Identities=23%  Similarity=0.237  Sum_probs=145.3

Q ss_pred             HHHHhcCCcccCceeccCceeEEecccc--CCcEEEEEEecccCccchHH--HHHHHHHHhcC-CCCCceeEEEEEEeCC
Q 045835          235 IKAATNNFDSAKKIGEGGFGPVYKGQLA--DGTIIAVKQLSSKSRQGNRE--FLNEIAMISCL-QHPNLVKIHGCCVEGD  309 (511)
Q Consensus       235 l~~~~~~f~~~~~lG~G~fG~Vy~g~~~--~g~~vAvK~~~~~~~~~~~~--~~~Ei~~l~~l-~H~niv~l~g~~~~~~  309 (511)
                      ....+..|..+..||.|.|+.|++...+  ++..+++|.+.........+  -+.|+-+...+ .|.+.++....+...+
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r  339 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR  339 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence            3445567899999999999999998643  57889999887554332222  24555555555 5888888777777777


Q ss_pred             EEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCC-CCeEEeecC
Q 045835          310 QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD-LNPKISDFG  388 (511)
Q Consensus       310 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~-~~~kl~DfG  388 (511)
                      +.++--||++++++.....    ....++...++++..|++.++.++|+..   ++|+|+||+||++..+ +..++.|||
T Consensus       340 ~~~ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~  412 (524)
T KOG0601|consen  340 QGYIPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFG  412 (524)
T ss_pred             cccCchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccc
Confidence            7788999999998876552    2234777888999999999999999876   9999999999999886 788999999


Q ss_pred             CcccCCCCCceeecccccCCCcc--cccccccCCCCcchhHHHHHHHHHHHHhCCC
Q 045835          389 LAKLDEGDKTHISTRIAGTIGYM--APEYALWGYLTYKADVYSFGIVALEIVSGKN  442 (511)
Q Consensus       389 la~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~  442 (511)
                      ++..+.-...    .....-+++  +++......+-.+.|++|||.-+.|.+++..
T Consensus       413 ~~t~~~~~~~----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~  464 (524)
T KOG0601|consen  413 CWTRLAFSSG----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP  464 (524)
T ss_pred             cccccceecc----cccccccccccchhhccccccccccccccccccccccccCcc
Confidence            9863211100    011222344  4444445578889999999999999999864

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.99  E-value=4.3e-09  Score=94.11  Aligned_cols=131  Identities=24%  Similarity=0.296  Sum_probs=99.6

Q ss_pred             CceeccCceeEEeccccCCcEEEEEEecccC---c-----cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKS---R-----QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~---~-----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      ..+++|+-..+|.+.+. |..+.+|.-.++.   +     -....-.+|..++.+++--.+....-+..+.+...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35788999999999764 3446666543321   1     1123457899999988766666666677788899999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCccc
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~  392 (511)
                      +++-.|.+.+...           +..++..+-.-+.-||..+   |+|+||.++||++..+. +.++||||+..
T Consensus        81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999888543           2445666667777899987   99999999999998875 99999999984

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.96  E-value=1.2e-08  Score=103.77  Aligned_cols=169  Identities=19%  Similarity=0.273  Sum_probs=130.3

Q ss_pred             eeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEe----CCEEEEEEEecCC-CCHhHHH
Q 045835          254 GPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVE----GDQLLLVYEYMEN-NSLACAL  327 (511)
Q Consensus       254 G~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~Ey~~~-gsL~~~l  327 (511)
                      .+.||+.. .||..+++|+++....+.......-+++++++.|+|+|++..++..    ...+++||+|.++ ++|.+..
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            56788864 4799999999965443333344456888999999999999998763    4578999999985 5788876


Q ss_pred             hcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          328 FGREN-----------CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       328 ~~~~~-----------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      +....           .....++...+.++.|+..||.++|+.|   +.-+-|.+++||++.+.+++|+..|+..+...+
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            54321           2334678899999999999999999997   888999999999999999999999888765544


Q ss_pred             CceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCC
Q 045835          397 KTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNN  443 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p  443 (511)
                      ...               -+.   --.+-|.=.||.+++-|.||...
T Consensus       447 ~~~---------------~le---~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  447 PTE---------------PLE---SQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCc---------------chh---HHhhhhHHHHHHHHHHHhhcccc
Confidence            311               011   12457888999999999999654

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.94  E-value=9.6e-09  Score=91.47  Aligned_cols=143  Identities=19%  Similarity=0.277  Sum_probs=104.6

Q ss_pred             ccCceeccCceeEEeccccCCcEEEEEEeccc--------CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          244 SAKKIGEGGFGPVYKGQLADGTIIAVKQLSSK--------SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       244 ~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~--------~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ....|-+|+-+.|+++.++ |+...||.-..+        .+-..+...+|+.+|.+.+--.|.-..-++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            5678999999999999885 666666653221        1122345778999998887656655555666777778999


Q ss_pred             EecCC-CCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCC---CeEEeecCCcc
Q 045835          316 EYMEN-NSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL---NPKISDFGLAK  391 (511)
Q Consensus       316 Ey~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~---~~kl~DfGla~  391 (511)
                      ||+++ .++.+++...-.+.  ...+....++..|-+.+.-||..+   |+|+||..+||+|.+++   .+.+.||||+.
T Consensus        90 E~~~g~~~vk~~i~~~~~~~--~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDE--SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             EeccchhHHHHHHHHHccCc--ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchh
Confidence            99987 47888876543321  222233677888888999999987   99999999999997655   35899999997


Q ss_pred             c
Q 045835          392 L  392 (511)
Q Consensus       392 ~  392 (511)
                      .
T Consensus       165 ~  165 (229)
T KOG3087|consen  165 V  165 (229)
T ss_pred             c
Confidence            4

>PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan []

Probab=98.83  E-value=1e-08  Score=103.79  Aligned_cols=91  Identities=30%  Similarity=0.344  Sum_probs=71.3

Q ss_pred             CchhhhhhhccCC-----cceeEeecccCCceeEEEeeeeeeeccccceeecccceEEEEEecccccccccchhh-hhcC
Q 045835           50 GLSELYINARIAP-----LSLTYFGYCLDNGNYTLSLHFAEIQFSNGITFHSLGRRLFDIYIQDNLVERNFDIKA-EASG  123 (511)
Q Consensus        50 ~~~~ly~~~r~~~-----~~~t~~~~~~~~~~y~v~lhfae~~~~~~~~~~~~g~r~fdiyi~~~~~~~~~~i~~-~~~g  123 (511)
                      .|.+||+|||.+.     ++|||.+ ++.+..|.|+||||||+-    .....+.|.|||||+|+.+.+  ++.. ..++
T Consensus       232 ~P~~V~~TA~~~~~~s~~~nltw~~-~~~~~~y~v~lHFaEi~~----~~~~~~~R~F~IyiN~~~~~~--~~~~~~~~~  304 (347)
T PF12819_consen  232 APSAVYQTARTPSNSSDPLNLTWSF-VDPGFSYYVRLHFAEIQS----LSPNNNQREFDIYINGQTAYS--DVSPPYLGA  304 (347)
T ss_pred             ChHHHHHhhhcccccccceEEEecc-CCCCccEEEEEEEeeccc----ccCCCCeEEEEEEECCeEccC--ccCcccccC
Confidence            7899999999973     6889988 999999999999999962    123566899999999999887  5555 3445


Q ss_pred             CCccceeeeeeeeece-eeEEEEEE
Q 045835          124 VLKPVARSYNVTVTNH-IIEIRFHW  147 (511)
Q Consensus       124 ~~~~~~~~f~v~v~~~-~~~i~~~~  147 (511)
                      ...+++++|.+.+++. .+.|.+.-
T Consensus       305 ~~~~~~~d~~~~~~~~~~~~isL~~  329 (347)
T PF12819_consen  305 DTVPYYSDYVVNVPDSGFLNISLGP  329 (347)
T ss_pred             cceEeecceEEEecCCCEEEEEEEe
Confidence            5667899999988764 45555553

This entry represents a malectin-like domain found in a number of plant receptor kinases.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.81  E-value=1.6e-09  Score=117.79  Aligned_cols=243  Identities=19%  Similarity=0.218  Sum_probs=155.9

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  314 (511)
                      .+.|.+.+-+-+|.++.++...-. .|...+.|......   .+..+....+-.++-..+||-+++..--+.-.....|+
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~  882 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV  882 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence            355677777888999998877532 23333334332211   11122222232222223445555444333345678999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      ++|..+++|...|+...    ..+..........+..+++|||...   +.|+|++|.|.|...++..+++|||......
T Consensus       883 ~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg  955 (1205)
T KOG0606|consen  883 GHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG  955 (1205)
T ss_pred             hHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence            99999999999987654    2333333344556778999999864   8999999999999999999999998432100


Q ss_pred             ------CC------------------------CceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 045835          395 ------GD------------------------KTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNM  444 (511)
Q Consensus       395 ------~~------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~  444 (511)
                            ..                        .........||+.|++||...+......+|.|++|++++|.++|.+||
T Consensus       956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen  956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred             cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence                  00                        001122356899999999999999999999999999999999999999


Q ss_pred             CCCCcccccccchhhhhHhhhccCchhHhhhhhhC-----CCCCHHHHHHHHHHHHHcCCCCCCCCCCcC
Q 045835          445 SYAPALEFDCTCLLDWACHLQQDGKLVELVDERLG-----SKYKKEEAERMIKVSLLCTNASPSLRPTMS  509 (511)
Q Consensus       445 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~-----~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~  509 (511)
                      .....                     .++++..+.     ...+.+......++...-+..+|.+|-.|.
T Consensus      1036 na~tp---------------------q~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETP---------------------QQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCcch---------------------hhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            74321                     111111111     122233344556666667777888877664

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.80  E-value=9e-08  Score=93.14  Aligned_cols=141  Identities=16%  Similarity=0.047  Sum_probs=99.3

Q ss_pred             CceeccCceeEEeccccCCcEEEEEEecccCc-----------cchHHHHHHHHHHhcCCCCC--ceeEEEEEEe-----
Q 045835          246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSR-----------QGNREFLNEIAMISCLQHPN--LVKIHGCCVE-----  307 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~-----------~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~~~-----  307 (511)
                      +.+-+-....|.+..+ +|+.+.||+......           .....+.+|...+.++...+  ..+++++...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            3444444455667666 577899997743321           11124778988888774333  3344555543     


Q ss_pred             CCEEEEEEEecCCC-CHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcC-------C
Q 045835          308 GDQLLLVYEYMENN-SLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR-------D  379 (511)
Q Consensus       308 ~~~~~lV~Ey~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~-------~  379 (511)
                      ...-++|+|++++- +|.+++.....  ...+...+..++.+++..+.-||..|   |+|+|++++|||++.       +
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~  181 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREED  181 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCC
Confidence            23568999999986 79888743211  23455677789999999999999997   999999999999985       4


Q ss_pred             CCeEEeecCCccc
Q 045835          380 LNPKISDFGLAKL  392 (511)
Q Consensus       380 ~~~kl~DfGla~~  392 (511)
                      ..+.|+||+.++.
T Consensus       182 ~~~~LIDl~r~~~  194 (268)
T PRK15123        182 LKLSVIDLHRAQI  194 (268)
T ss_pred             ceEEEEECCcccc
Confidence            6799999998863

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.78  E-value=4.7e-08  Score=89.82  Aligned_cols=125  Identities=24%  Similarity=0.224  Sum_probs=81.2

Q ss_pred             eEEeccccCCcEEEEEEecccCc-------------c-------------chHHHHHHHHHHhcCCCC--CceeEEEEEE
Q 045835          255 PVYKGQLADGTIIAVKQLSSKSR-------------Q-------------GNREFLNEIAMISCLQHP--NLVKIHGCCV  306 (511)
Q Consensus       255 ~Vy~g~~~~g~~vAvK~~~~~~~-------------~-------------~~~~~~~Ei~~l~~l~H~--niv~l~g~~~  306 (511)
                      .||.|...+|..+|||..+....             .             ......+|...|.++..-  ++.+++.+- 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            48999888899999998653210             0             012356899999999765  456666542 


Q ss_pred             eCCEEEEEEEecC--CCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCeEEccCCCCCeEEcCCCCeE
Q 045835          307 EGDQLLLVYEYME--NNSLACALFGRENCELELDWPTRQKICLGIARGLAF-LHEESRFKIVHRDIKATNVLLDRDLNPK  383 (511)
Q Consensus       307 ~~~~~~lV~Ey~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~y-LH~~~~~~iiH~Dlk~~NILld~~~~~k  383 (511)
                         .-.+||||++  +..+..+....      ++......++.+++..+.. +|..+   |+|+||.+.|||++++ .+.
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEE
Confidence               3479999999  55554433211      1133456677788886665 46766   9999999999999988 999


Q ss_pred             EeecCCcccC
Q 045835          384 ISDFGLAKLD  393 (511)
Q Consensus       384 l~DfGla~~~  393 (511)
                      |+|||.+...
T Consensus       147 iIDf~qav~~  156 (188)
T PF01163_consen  147 IIDFGQAVDS  156 (188)
T ss_dssp             E--GTTEEET
T ss_pred             EEecCcceec
Confidence            9999998743

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.52  E-value=1.9e-08  Score=105.76  Aligned_cols=147  Identities=22%  Similarity=0.378  Sum_probs=97.5

Q ss_pred             HHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc--------eeecccccCCCccccccccc
Q 045835          347 LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT--------HISTRIAGTIGYMAPEYALW  418 (511)
Q Consensus       347 ~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~  418 (511)
                      .+++.||.|+|...  .++|++|.|++|.++..+..||+.|+.+........        ...--......|.|||++..
T Consensus       106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            45669999999865  799999999999999999999999998864332111        01111234567999999999


Q ss_pred             CCCCcchhHHHHHHHHHHHHhCCCC-CCCCCcccccccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHc
Q 045835          419 GYLTYKADVYSFGIVALEIVSGKNN-MSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLC  497 (511)
Q Consensus       419 ~~~~~~~DV~S~Gvvl~elltG~~p-~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C  497 (511)
                      ...+.++|+||+||+++-+..|..+ +.....       +....        .....+..-...++.+.+.++.+=+.+.
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~-------~~~~~--------~~~~~~~~~~~~~s~~~p~el~~~l~k~  248 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGG-------LLSYS--------FSRNLLNAGAFGYSNNLPSELRESLKKL  248 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCC-------cchhh--------hhhcccccccccccccCcHHHHHHHHHH
Confidence            8999999999999999999854443 321110       00000        0000011011112234445666677778


Q ss_pred             CCCCCCCCCCcCC
Q 045835          498 TNASPSLRPTMSE  510 (511)
Q Consensus       498 l~~~p~~RPs~~e  510 (511)
                      +..++..||++.+
T Consensus       249 l~~~~~~rp~~~~  261 (700)
T KOG2137|consen  249 LNGDSAVRPTLDL  261 (700)
T ss_pred             hcCCcccCcchhh
Confidence            8999999997654

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.51  E-value=6.9e-07  Score=84.77  Aligned_cols=134  Identities=23%  Similarity=0.185  Sum_probs=95.1

Q ss_pred             CcccCceeccCceeEEeccccCCcEEEEEEecccCc----------------------cchHHHHHHHHHHhcCCCC--C
Q 045835          242 FDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSR----------------------QGNREFLNEIAMISCLQHP--N  297 (511)
Q Consensus       242 f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~----------------------~~~~~~~~Ei~~l~~l~H~--n  297 (511)
                      ..+.++||.|.-+.||.|..++|.++|||.-+....                      .......+|.++|.+|.-.  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            456789999999999999999999999996432100                      0113457899999998654  6


Q ss_pred             ceeEEEEEEeCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEc
Q 045835          298 LVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD  377 (511)
Q Consensus       298 iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld  377 (511)
                      +.+.+++    +...+||||+++-.|...-         ++-.....|+..|++-+.-+-..|   ++|+|+++-||+++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~  236 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVT  236 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEe
Confidence            6666554    5678999999986664332         112222334444444444444444   99999999999999


Q ss_pred             CCCCeEEeecCCcc
Q 045835          378 RDLNPKISDFGLAK  391 (511)
Q Consensus       378 ~~~~~kl~DfGla~  391 (511)
                      +++.+.++||--+.
T Consensus       237 ~dg~~~vIDwPQ~v  250 (304)
T COG0478         237 EDGDIVVIDWPQAV  250 (304)
T ss_pred             cCCCEEEEeCcccc
Confidence            99999999997665

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.50  E-value=9.8e-07  Score=87.92  Aligned_cols=195  Identities=15%  Similarity=0.207  Sum_probs=127.8

Q ss_pred             ccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcC-CCCCceeEEEEE------Ee-CCEEEEEE
Q 045835          244 SAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCL-QHPNLVKIHGCC------VE-GDQLLLVY  315 (511)
Q Consensus       244 ~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~------~~-~~~~~lV~  315 (511)
                      ..+-||+|+-+.+|.---- +..| -|+.+........+.   +..|... .||-+-.=+.+=      -+ +...-++|
T Consensus        15 ~gr~LgqGgea~ly~l~e~-~d~V-AKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV-RDQV-AKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecchh-hchh-heeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            4678999999999964211 2233 366654443322222   2233333 455433211110      11 22356777


Q ss_pred             EecCCCC-HhHHHhc--CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCccc
Q 045835          316 EYMENNS-LACALFG--RENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       316 Ey~~~gs-L~~~l~~--~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~  392 (511)
                      ..+.+.. +.+++..  ++..-...+|+..++++..+|.+.+-||+.|   .+-+|++++|+|++++..+.|.|=..-.+
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence            7776542 3333321  1122234789999999999999999999998   78899999999999999999988655444


Q ss_pred             CCCCCceeecccccCCCcccccccc-----cCCCCcchhHHHHHHHHHHHHhC-CCCCCCCC
Q 045835          393 DEGDKTHISTRIAGTIGYMAPEYAL-----WGYLTYKADVYSFGIVALEIVSG-KNNMSYAP  448 (511)
Q Consensus       393 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gvvl~elltG-~~p~~~~~  448 (511)
                      ..++..+  .-.+|...|.+||.-.     +-.-+..+|-|.+||+++++|.| ++||+...
T Consensus       167 ~~ng~~~--~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~  226 (637)
T COG4248         167 NANGTLH--LCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP  226 (637)
T ss_pred             ccCCceE--ecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence            3333322  2347888999999644     33567789999999999999887 99998544

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.47  E-value=2.1e-06  Score=80.63  Aligned_cols=107  Identities=21%  Similarity=0.219  Sum_probs=83.6

Q ss_pred             hHHHHHHHHHHhcCCC--CCceeEEEEEEeCC----EEEEEEEecCCC-CHhHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 045835          280 NREFLNEIAMISCLQH--PNLVKIHGCCVEGD----QLLLVYEYMENN-SLACALFGRENCELELDWPTRQKICLGIARG  352 (511)
Q Consensus       280 ~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~----~~~lV~Ey~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~g  352 (511)
                      ...+.+|...+..+..  -...+.+++.....    .-++|+|++++. +|.+++.....    ++......++.+++..
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~  130 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARL  130 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHH
Confidence            3467788887777743  34555667666532    458999999974 79998865322    4556778899999999


Q ss_pred             HHHHhcCCCCCeEEccCCCCCeEEcCCC---CeEEeecCCcccC
Q 045835          353 LAFLHEESRFKIVHRDIKATNVLLDRDL---NPKISDFGLAKLD  393 (511)
Q Consensus       353 l~yLH~~~~~~iiH~Dlk~~NILld~~~---~~kl~DfGla~~~  393 (511)
                      ++-||+.+   |+|+|++++|||++.+.   .+.++||+.++..
T Consensus       131 i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  131 IAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99999997   99999999999999887   7999999988753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.47  E-value=4e-06  Score=77.73  Aligned_cols=138  Identities=18%  Similarity=0.112  Sum_probs=101.9

Q ss_pred             eeccCceeEEeccccCCcEEEEEEecccC------ccchHHHHHHHHHHhcCCC--CCceeEEEEEEeC----CEEEEEE
Q 045835          248 IGEGGFGPVYKGQLADGTIIAVKQLSSKS------RQGNREFLNEIAMISCLQH--PNLVKIHGCCVEG----DQLLLVY  315 (511)
Q Consensus       248 lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~------~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~----~~~~lV~  315 (511)
                      -|+||-+.|++-.+. |..+-+|+-....      +.+...|.+|...|.++..  -++.++..+....    -.-+||+
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            356888889987764 4468899865221      3466789999999998853  2344444222221    2468999


Q ss_pred             EecCC-CCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCC--eEEeecCCcc
Q 045835          316 EYMEN-NSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN--PKISDFGLAK  391 (511)
Q Consensus       316 Ey~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~--~kl~DfGla~  391 (511)
                      |-+.+ -+|.+++.....  .+.+...+..+..+++..++-||+.+   +.|+|+.+.||+++.++.  ++++||.-++
T Consensus       105 e~L~g~~~L~~~l~~~~~--~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        105 EDMAGFISIADWYAQHAV--SPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EeCCCCccHHHHHhcCCc--CCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            97764 588888855322  23566778899999999999999997   999999999999986666  8999997765

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.29  E-value=3e-06  Score=89.42  Aligned_cols=140  Identities=19%  Similarity=0.225  Sum_probs=90.3

Q ss_pred             CceeccCceeEEeccccCCcEEEEEEecccCccch------------------------------HH----------HHH
Q 045835          246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGN------------------------------RE----------FLN  285 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~------------------------------~~----------~~~  285 (511)
                      +-|+.++-|.||+|++++|+.||||+.++.-....                              ++          +.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            57899999999999999999999999876422110                              01          223


Q ss_pred             HHHHHhcC----C-CCCceeEEEEEEeCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHH-HHHHhcC
Q 045835          286 EIAMISCL----Q-HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARG-LAFLHEE  359 (511)
Q Consensus       286 Ei~~l~~l----~-H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~g-l~yLH~~  359 (511)
                      |..-+.++    + .+++.-..=|..-.....|+|||++|-.+.+...-..   ..++-+   .++..++++ ++.+-..
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~k---~ia~~~~~~f~~q~~~d  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDRK---ELAELLVRAFLRQLLRD  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCHH---HHHHHHHHHHHHHHHhc
Confidence            33333333    1 3333322223333567799999999988888742221   124422   333333322 2222223


Q ss_pred             CCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       360 ~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      |   ++|.|.+|.||+++.++.+.+.|||+.....
T Consensus       285 g---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         285 G---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             C---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence            3   9999999999999999999999999987544

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.29  E-value=1.5e-05  Score=75.94  Aligned_cols=139  Identities=16%  Similarity=0.175  Sum_probs=86.0

Q ss_pred             CceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCC--ceeEEEEEEeCCEEEEEEEecCCCC-
Q 045835          246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPN--LVKIHGCCVEGDQLLLVYEYMENNS-  322 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~~~~~~~~lV~Ey~~~gs-  322 (511)
                      ..||+|..+.||+.   .+..+++|......  ......+|.++++.+..-.  +.+.++++...+...+|||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            67899999999984   24456788876433  3345688999998886443  4667888877888889999999863 


Q ss_pred             HhHHH---------------------hcCCCCCCCCCHHHHHH-HHH----------HHHH-HHHHHhcC-CCCCeEEcc
Q 045835          323 LACAL---------------------FGRENCELELDWPTRQK-ICL----------GIAR-GLAFLHEE-SRFKIVHRD  368 (511)
Q Consensus       323 L~~~l---------------------~~~~~~~~~l~~~~~~~-i~~----------~ia~-gl~yLH~~-~~~~iiH~D  368 (511)
                      +...+                     |.....  ....+.+.. +-.          .+.. ...+|... ....++|+|
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~--~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD  159 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCD--TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD  159 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC--CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence            21111                     111000  111111110 000          0111 12222211 234578999


Q ss_pred             CCCCCeEEcCCCCeEEeecCCccc
Q 045835          369 IKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       369 lk~~NILld~~~~~kl~DfGla~~  392 (511)
                      +.|.||++++++ +.|.||+.+..
T Consensus       160 ~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       160 FQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCCCcEEEcCCC-cEEEechhcCc
Confidence            999999999988 99999998863

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.21  E-value=1.6e-05  Score=73.99  Aligned_cols=137  Identities=19%  Similarity=0.195  Sum_probs=90.4

Q ss_pred             hcCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHH---------HHHHHHhcCC---CCCceeEEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFL---------NEIAMISCLQ---HPNLVKIHGCCV  306 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~---------~Ei~~l~~l~---H~niv~l~g~~~  306 (511)
                      .++|...+.+-......|.+-.. +|..+.+|..+.......+.|.         +++..+.+++   -.....++.+..
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            46777777777777666766665 4677889988765443333322         3333333332   233333333333


Q ss_pred             e-----CCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCC
Q 045835          307 E-----GDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN  381 (511)
Q Consensus       307 ~-----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~  381 (511)
                      .     ....+++|||++|-.|.+...        ++.    .++..++.++.-||+.|   +.|+|..|+|+++++++ 
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-  172 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-  172 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-
Confidence            2     235679999999988765431        222    24456778899999997   99999999999999665 


Q ss_pred             eEEeecCCccc
Q 045835          382 PKISDFGLAKL  392 (511)
Q Consensus       382 ~kl~DfGla~~  392 (511)
                      +++.||+..+.
T Consensus       173 i~iID~~~k~~  183 (229)
T PF06176_consen  173 IRIIDTQGKRM  183 (229)
T ss_pred             EEEEECccccc
Confidence            99999987763

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.17  E-value=9.1e-06  Score=74.91  Aligned_cols=104  Identities=24%  Similarity=0.212  Sum_probs=82.3

Q ss_pred             HHHHHHHhcCCC-CCceeEEEEEEeCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 045835          284 LNEIAMISCLQH-PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRF  362 (511)
Q Consensus       284 ~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~  362 (511)
                      .+|.-+|+.+++ +++.+++|+|-    .+++.||...+++..... .-..-...+|..|.+||.++++.+.+|++....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~-~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYR-PLSQFLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccc-ccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            358888888876 69999999993    377999998776542200 000112468999999999999999999986544


Q ss_pred             CeEEccCCCCCeEEcCCCCeEEeecCCccc
Q 045835          363 KIVHRDIKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       363 ~iiH~Dlk~~NILld~~~~~kl~DfGla~~  392 (511)
                      .+.-.|++++|+-+++++++|+.|...+..
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence            599999999999999999999999987754

Proteins in this uncharacterised family are described as transmembrane proteins.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.09  E-value=6.3e-05  Score=70.94  Aligned_cols=155  Identities=19%  Similarity=0.213  Sum_probs=99.8

Q ss_pred             cccHHHHHHHhcCCcccCcee---ccCceeEEeccccCCcEEEEEEecccCccc-------------------hH-----
Q 045835          229 SFTLKQIKAATNNFDSAKKIG---EGGFGPVYKGQLADGTIIAVKQLSSKSRQG-------------------NR-----  281 (511)
Q Consensus       229 ~~~~~~l~~~~~~f~~~~~lG---~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~-------------------~~-----  281 (511)
                      ..+++.+....++..+....|   .|.-..||+|.-.++..+|||+.+......                   .+     
T Consensus        34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~  113 (268)
T COG1718          34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA  113 (268)
T ss_pred             hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence            456666666666666655554   566778999988889999999986432110                   01     


Q ss_pred             HHHHHHHHHhcCC--CCCceeEEEEEEeCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 045835          282 EFLNEIAMISCLQ--HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE  359 (511)
Q Consensus       282 ~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~  359 (511)
                      ....|..-|+++.  +-.+.+.+++.    .-.|||||+.....    -...-...++.......+..++++.+.-|-..
T Consensus       114 W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~----pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~  185 (268)
T COG1718         114 WARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGL----PAPRLKDVPLELEEAEGLYEDVVEYMRRLYKE  185 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCC----CCCCcccCCcCchhHHHHHHHHHHHHHHHHHh
Confidence            1235666666663  33444445443    34799999965411    01111112222224556667788888877763


Q ss_pred             CCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       360 ~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      +  +++|+||+.=|||+. ++.+.|+|+|-|....
T Consensus       186 a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         186 A--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             c--CcccccchhhheEEE-CCeEEEEECccccccC
Confidence            3  499999999999999 8899999999987443

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.07  E-value=3e-05  Score=73.54  Aligned_cols=144  Identities=18%  Similarity=0.135  Sum_probs=84.9

Q ss_pred             cCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCC--CceeEEEEEEe---CCEEEEEEEecC
Q 045835          245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHP--NLVKIHGCCVE---GDQLLLVYEYME  319 (511)
Q Consensus       245 ~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g~~~~---~~~~~lV~Ey~~  319 (511)
                      ++.|+.|..+.||+....+ ..+++|.....  .....+.+|..+++.+...  .+.+++.++..   ....+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            3568999999999998876 58899987654  3445677888888887533  35667765543   335789999999


Q ss_pred             CCCHhH----------------HH---hcCCCCCCCCCHHHH---------HHH------------HHHHHH-HHHHHhc
Q 045835          320 NNSLAC----------------AL---FGRENCELELDWPTR---------QKI------------CLGIAR-GLAFLHE  358 (511)
Q Consensus       320 ~gsL~~----------------~l---~~~~~~~~~l~~~~~---------~~i------------~~~ia~-gl~yLH~  358 (511)
                      +.++..                .+   +........+.+...         ...            ...+.+ .++.+++
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            988877                11   111001111111110         000            111222 3333332


Q ss_pred             ----CCCCCeEEccCCCCCeEEc-CCCCeEEeecCCcc
Q 045835          359 ----ESRFKIVHRDIKATNVLLD-RDLNPKISDFGLAK  391 (511)
Q Consensus       359 ----~~~~~iiH~Dlk~~NILld-~~~~~kl~DfGla~  391 (511)
                          .....++|+|+.+.|||++ +++.+-|.||+.+.
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence                2345699999999999999 55666899998775

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.03  E-value=5e-07  Score=94.25  Aligned_cols=189  Identities=20%  Similarity=0.131  Sum_probs=134.0

Q ss_pred             cCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCC-ceeEEEEEEeCCEEEEEEEec
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPN-LVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      +-+...+-.++|+++.++|.+-.-.+...++.+...     .+..-++++|.+++||| .++.++-+..++..+++++++
T Consensus       242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~  316 (829)
T KOG0576|consen  242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC  316 (829)
T ss_pred             cchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence            334444567899999999987433333445655433     34456889999999999 666666666677889999999


Q ss_pred             CCC-CHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          319 ENN-SLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       319 ~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      ..+ +.....   ......+...+...++..-+++++|||+..   -+|+|    ||+..+ ...|..||+....+....
T Consensus       317 s~~rs~~~~~---~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~  385 (829)
T KOG0576|consen  317 STGRSSALEM---TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM  385 (829)
T ss_pred             cCCccccccC---ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc
Confidence            877 221111   111122333444556677788999999863   48888    777766 578999999987655433


Q ss_pred             ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 045835          398 THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSY  446 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~  446 (511)
                        ..+...+++.++|||......+..+.|+|+.|+-..++--|-+|-..
T Consensus       386 --~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  386 --KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             --ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence              23345789999999999999999999999999987788777766543

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.02  E-value=8e-05  Score=71.71  Aligned_cols=140  Identities=16%  Similarity=0.124  Sum_probs=85.0

Q ss_pred             eeccCc-eeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCC-CCCceeEEEEEEeCCEEEEEEEecCCCCHhH
Q 045835          248 IGEGGF-GPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ-HPNLVKIHGCCVEGDQLLLVYEYMENNSLAC  325 (511)
Q Consensus       248 lG~G~f-G~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~  325 (511)
                      |-.|.. ..||+.... +..+.||+.....   .....+|+.+++.+. +--+.+++++....+..++|||++++.+|..
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            444555 778998764 4678888875443   335678888888773 4446677887776667899999999987764


Q ss_pred             HH-------------------hcCCCCCCCCC--HHHHHHHHH--------------------HHHHHHHHHhc----CC
Q 045835          326 AL-------------------FGRENCELELD--WPTRQKICL--------------------GIARGLAFLHE----ES  360 (511)
Q Consensus       326 ~l-------------------~~~~~~~~~l~--~~~~~~i~~--------------------~ia~gl~yLH~----~~  360 (511)
                      ..                   +........+.  +..+.....                    .+...++.|-.    ..
T Consensus        82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  161 (244)
T cd05150          82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE  161 (244)
T ss_pred             hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence            32                   11110000111  000110000                    01111222211    12


Q ss_pred             CCCeEEccCCCCCeEEcCCCCeEEeecCCcc
Q 045835          361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAK  391 (511)
Q Consensus       361 ~~~iiH~Dlk~~NILld~~~~~kl~DfGla~  391 (511)
                      .+.++|+|+.|.|||++++....|.||+.+.
T Consensus       162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            3459999999999999998778899998775

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.91  E-value=5.2e-05  Score=79.95  Aligned_cols=139  Identities=15%  Similarity=0.108  Sum_probs=86.3

Q ss_pred             CceeccCceeEEeccccCCcEEEEEEecccCccch-------------------------------H------HHHHHHH
Q 045835          246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGN-------------------------------R------EFLNEIA  288 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~-------------------------------~------~~~~Ei~  288 (511)
                      +-||.-+.|.||+|++++|+.||||+-++.-+...                               +      +|..|.+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            57999999999999999999999999776532210                               0      1233333


Q ss_pred             HH----hcCCCCC------ceeEEEEEEeCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 045835          289 MI----SCLQHPN------LVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE  358 (511)
Q Consensus       289 ~l----~~l~H~n------iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~  358 (511)
                      -.    +.+.|-+      |.+++-.  -.....|+||||+|..+.+...-..   ..++-.....-+.++..-+- ++ 
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~---~gi~~~~i~~~l~~~~~~qI-f~-  319 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDK---RGISPHDILNKLVEAYLEQI-FK-  319 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHH---cCCCHHHHHHHHHHHHHHHH-Hh-
Confidence            22    2223444      2233222  2346799999999987766542211   12443333322222221111 22 


Q ss_pred             CCCCCeEEccCCCCCeEEcC----CCCeEEeecCCcccCC
Q 045835          359 ESRFKIVHRDIKATNVLLDR----DLNPKISDFGLAKLDE  394 (511)
Q Consensus       359 ~~~~~iiH~Dlk~~NILld~----~~~~kl~DfGla~~~~  394 (511)
                         .+++|+|-.|.||+++.    ++.+.+-|||+.....
T Consensus       320 ---~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  320 ---TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             ---cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence               23999999999999984    6789999999997543

>PLN02876 acyl-CoA dehydrogenase

Probab=97.90  E-value=0.00011  Score=83.32  Aligned_cols=79  Identities=16%  Similarity=0.373  Sum_probs=57.5

Q ss_pred             cCceeccCceeEEeccccCC---cEEEEEEecccC-ccchHHHHHHHHHHhcCC-CCCc--eeEEEEEEeC---CEEEEE
Q 045835          245 AKKIGEGGFGPVYKGQLADG---TIIAVKQLSSKS-RQGNREFLNEIAMISCLQ-HPNL--VKIHGCCVEG---DQLLLV  314 (511)
Q Consensus       245 ~~~lG~G~fG~Vy~g~~~~g---~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV  314 (511)
                      .++++.|.+..+|+....++   ..+++|+..... ......+.+|..+|+.+. |+++  .+++.+|.+.   ...++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            56789999999999876553   356777754322 223357889999999995 6665  7888888764   357899


Q ss_pred             EEecCCCCH
Q 045835          315 YEYMENNSL  323 (511)
Q Consensus       315 ~Ey~~~gsL  323 (511)
                      |||+++..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999997653

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.89  E-value=0.0003  Score=65.24  Aligned_cols=134  Identities=19%  Similarity=0.253  Sum_probs=91.9

Q ss_pred             ccCceeccCceeEEeccccCCcEEEEEEecccC----------------ccchHHHHHHHHHHhcCC------CCCceeE
Q 045835          244 SAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKS----------------RQGNREFLNEIAMISCLQ------HPNLVKI  301 (511)
Q Consensus       244 ~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~----------------~~~~~~~~~Ei~~l~~l~------H~niv~l  301 (511)
                      ....||+|+.-.||.  +++.....||+.....                .....+..+|+.-...+.      +.+|.++
T Consensus         5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            356899999999997  4555667889887655                223456677776655554      8899999


Q ss_pred             EEEEEeCCEEEEEEEecCC------CCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeE
Q 045835          302 HGCCVEGDQLLLVYEYMEN------NSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVL  375 (511)
Q Consensus       302 ~g~~~~~~~~~lV~Ey~~~------gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NIL  375 (511)
                      +|+..+.-..-+|+|.+.+      -+|.+++....     ++. ...+.   +-+-.+||-+.+   |+.+|++|.||+
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-----~~~-~~~~~---L~~f~~~l~~~~---Iv~~dl~~~NIv  150 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-----LTE-ELRQA---LDEFKRYLLDHH---IVIRDLNPHNIV  150 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-----ccH-HHHHH---HHHHHHHHHHcC---CeecCCCcccEE
Confidence            9999999999999998754      24777774332     443 33333   334445666554   999999999999


Q ss_pred             EcCCC----CeEEee-cCCcc
Q 045835          376 LDRDL----NPKISD-FGLAK  391 (511)
Q Consensus       376 ld~~~----~~kl~D-fGla~  391 (511)
                      +..+.    .+.|.| ||-..
T Consensus       151 ~~~~~~~~~~lvlIDG~G~~~  171 (199)
T PF10707_consen  151 VQRRDSGEFRLVLIDGLGEKE  171 (199)
T ss_pred             EEecCCCceEEEEEeCCCCcc
Confidence            96432    466665 45443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PRK10593 hypothetical protein; Provisional

Probab=97.76  E-value=0.0004  Score=68.98  Aligned_cols=78  Identities=14%  Similarity=0.083  Sum_probs=57.7

Q ss_pred             cccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCC---CCceeEEEEEEeC---CEEEEEEE
Q 045835          243 DSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQH---PNLVKIHGCCVEG---DQLLLVYE  316 (511)
Q Consensus       243 ~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H---~niv~l~g~~~~~---~~~~lV~E  316 (511)
                      ...+.||+|..+.||+....+++ +.+|..+..  .....|.+|...|+.|.-   ..+.+++++|..+   +..++|||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQGN-PMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             heeeecCCccceeEEEEEcCCCC-EEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            34568999999999998765564 666774331  123478899999988853   4678889888653   56899999


Q ss_pred             ecCCCCH
Q 045835          317 YMENNSL  323 (511)
Q Consensus       317 y~~~gsL  323 (511)
                      ++++.++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9998765

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.65  E-value=0.00041  Score=66.43  Aligned_cols=141  Identities=18%  Similarity=0.190  Sum_probs=76.3

Q ss_pred             CceeccCce-eEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCC---CceeEEEEEEeC---CEEEEEEEec
Q 045835          246 KKIGEGGFG-PVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHP---NLVKIHGCCVEG---DQLLLVYEYM  318 (511)
Q Consensus       246 ~~lG~G~fG-~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~---niv~l~g~~~~~---~~~~lV~Ey~  318 (511)
                      +.|+.|+.. .||+.    +..+++|..+..  .....+.+|.+++..+...   .+.++++.+...   ...+++|+++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            457777766 48875    234667765432  2345788999999877532   334444443322   2347899999


Q ss_pred             CCCCHhHH------------------HhcCCCCCCC------------C-CHHHHH--HHH-------HHHHHH-HHH-H
Q 045835          319 ENNSLACA------------------LFGRENCELE------------L-DWPTRQ--KIC-------LGIARG-LAF-L  356 (511)
Q Consensus       319 ~~gsL~~~------------------l~~~~~~~~~------------l-~~~~~~--~i~-------~~ia~g-l~y-L  356 (511)
                      ++.++.+.                  |+.-......            + .|....  .+.       .+.+.. ++. +
T Consensus        77 ~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  156 (235)
T cd05155          77 EGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAAL  156 (235)
T ss_pred             cCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHh
Confidence            98776422                  1111100000            0 121110  000       011111 111 1


Q ss_pred             hcC--CCCCeEEccCCCCCeEEcCCCCeEEeecCCccc
Q 045835          357 HEE--SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       357 H~~--~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~  392 (511)
                      +..  ..+.++|+|+.+.|||++++...-|.||+.+..
T Consensus       157 ~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         157 RAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             cccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            111  234489999999999999776667999998753

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.55  E-value=0.00076  Score=64.41  Aligned_cols=141  Identities=20%  Similarity=0.238  Sum_probs=80.2

Q ss_pred             CceeccCceeEEeccccC--CcEEEEEEecccCccchHHHHHHHHHHhcCCCCCc-eeEEEEEEeCCEEEEEEEecCCCC
Q 045835          246 KKIGEGGFGPVYKGQLAD--GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNL-VKIHGCCVEGDQLLLVYEYMENNS  322 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~~--g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~gs  322 (511)
                      +.|..|-...+|+....+  +..+++|+....... ...-.+|+.+++.+...++ .++++.+.  +  .++|||+++.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCc
Confidence            456778888999987664  567888876543221 1223468888888854333 44444332  2  37999999876


Q ss_pred             HhHH-----------------HhcCCCCC-------CCC-CHHHHHHHHH----------------------HHH---HH
Q 045835          323 LACA-----------------LFGRENCE-------LEL-DWPTRQKICL----------------------GIA---RG  352 (511)
Q Consensus       323 L~~~-----------------l~~~~~~~-------~~l-~~~~~~~i~~----------------------~ia---~g  352 (511)
                      +...                 +|......       ... .|.....+..                      .+.   ..
T Consensus        79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  158 (235)
T cd05157          79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW  158 (235)
T ss_pred             CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence            5321                 11111100       011 1222111110                      111   11


Q ss_pred             H-HHHhcC-CCCCeEEccCCCCCeEEcC-CCCeEEeecCCcc
Q 045835          353 L-AFLHEE-SRFKIVHRDIKATNVLLDR-DLNPKISDFGLAK  391 (511)
Q Consensus       353 l-~yLH~~-~~~~iiH~Dlk~~NILld~-~~~~kl~DfGla~  391 (511)
                      | +.+... ....++|+|+.+.|||+++ +..+.|.||..+.
T Consensus       159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            1 112211 2345999999999999998 5789999998775

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.51  E-value=0.00046  Score=77.38  Aligned_cols=191  Identities=19%  Similarity=0.155  Sum_probs=128.0

Q ss_pred             HHHHHHHhcCCCCCceeEEEEEEeCCEE----EEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 045835          284 LNEIAMISCLQHPNLVKIHGCCVEGDQL----LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE  359 (511)
Q Consensus       284 ~~Ei~~l~~l~H~niv~l~g~~~~~~~~----~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~  359 (511)
                      ..|+..+.++.|+|++.+++|..+....    .+..|++..-++...+..-.    .++..+.+.++.++..||+|+|+.
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~----~i~~~~~r~~~~~~~~GL~~~h~~  305 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG----SIPLETLRILHQKLLEGLAYLHSL  305 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc----ccCHHHHHHHHHHHhhhHHHHHHh
Confidence            4567778899999999999998764432    24457777777777775433    477788888999999999999998


Q ss_pred             CCCCeEEccCCCC---CeEEcCCCCeEEe--ecCCcccCCCCCceeecccccCCCcccccccccCCCCc--chhHHHHHH
Q 045835          360 SRFKIVHRDIKAT---NVLLDRDLNPKIS--DFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTY--KADVYSFGI  432 (511)
Q Consensus       360 ~~~~iiH~Dlk~~---NILld~~~~~kl~--DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~DV~S~Gv  432 (511)
                      .   ..|.-+..+   +-..+.++...++  ||+..+.........+  ..-+..+.+||.......+.  ..|+|.+|.
T Consensus       306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl  380 (1351)
T KOG1035|consen  306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWCLGL  380 (1351)
T ss_pred             c---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHHHHH
Confidence            4   555555555   5556677777777  8988876554332221  22345677888776665444  479999999


Q ss_pred             HHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          433 VALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       433 vl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .+..+..|..+-.....                    ...+++    ...    ...+.+...+|+..++++|++..++
T Consensus       381 l~~~~~~~~~i~~~~~~--------------------~~~~l~----~~~----~~~~~d~~~~~~~~~~~~Rl~~~~l  431 (1351)
T KOG1035|consen  381 LLLQLSQGEDISEKSAV--------------------PVSLLD----VLS----TSELLDALPKCLDEDSEERLSALEL  431 (1351)
T ss_pred             HHhhhhhcCcccccccc--------------------hhhhhc----ccc----chhhhhhhhhhcchhhhhccchhhh
Confidence            99999998765432110                    001111    111    1145666778888888888877653

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.47  E-value=0.0011  Score=61.11  Aligned_cols=125  Identities=26%  Similarity=0.380  Sum_probs=88.7

Q ss_pred             cCCcccCceeccCc-eeEEeccccCCcEEEEEEecc---cCc------------------cchHHHHHHHHHHhcCC---
Q 045835          240 NNFDSAKKIGEGGF-GPVYKGQLADGTIIAVKQLSS---KSR------------------QGNREFLNEIAMISCLQ---  294 (511)
Q Consensus       240 ~~f~~~~~lG~G~f-G~Vy~g~~~~g~~vAvK~~~~---~~~------------------~~~~~~~~Ei~~l~~l~---  294 (511)
                      .+++.++.||.|.- |.||+.++ +|..+|+|.++.   ...                  .-..-|..|.....+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67888999999999 99999998 577999999321   100                  11124778888877774   


Q ss_pred             CCCc--eeEEEEEEeC------------------CEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHH
Q 045835          295 HPNL--VKIHGCCVEG------------------DQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA  354 (511)
Q Consensus       295 H~ni--v~l~g~~~~~------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~  354 (511)
                      +.++  |+.+||..-.                  ..+.+|.||++...             .+.    .+-+.+|.+-|.
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~----~~~~~~~~~dl~  178 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQ----IRDIPQMLRDLK  178 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccc----hhHHHHHHHHHH
Confidence            4566  9999997421                  13467888776542             122    223455677788


Q ss_pred             HHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCc
Q 045835          355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA  390 (511)
Q Consensus       355 yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla  390 (511)
                      .+|..+   |+-+|+++.|..     .-||+|||.+
T Consensus       179 ~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  179 ILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            899887   999999999986     3588999864

>KOG3593 consensus Predicted receptor-like serine/threonine kinase [Signal transduction mechanisms]

Probab=97.45  E-value=0.00012  Score=68.99  Aligned_cols=100  Identities=21%  Similarity=0.307  Sum_probs=78.1

Q ss_pred             CeEEeecccccCC-CCCCCC--ceeee-ccCCCchhhhhhhccCCcceeEeecccCCceeEEEeeeeeeeccccceeecc
Q 045835           22 NWGFSSTGDFADD-NDDQNT--RYTAT-SDSSGLSELYINARIAPLSLTYFGYCLDNGNYTLSLHFAEIQFSNGITFHSL   97 (511)
Q Consensus        22 ~~~~~~~g~~~~~-~~~~~~--~~~~~-~~~~~~~~ly~~~r~~~~~~t~~~~~~~~~~y~v~lhfae~~~~~~~~~~~~   97 (511)
                      +.|+-..-|.... +...+.  .+.+. +....+-.+|+|+|+.--+|.|..|....|.|.+.|.|||.      ++..-
T Consensus        74 ~ygI~f~aD~~~~VGrasd~G~~l~i~~raeeed~ily~ter~neetFgyd~pik~dgdyalvlkfaev------yF~~~  147 (355)
T KOG3593|consen   74 NYGIRFAADPLEGVGRASDYGMVLGIGCRAEEEDIILYQTERYNEETFGYDVPIKEDGDYALVLKFAEV------YFKTC  147 (355)
T ss_pred             ccceEeeccccccccccCCccceeeccccCChhhhhhhhhcccchhhhcccccccCCCceehhhhHHHH------HHHhh
Confidence            4455555554332 333333  23333 44557888999999999999999999999999999999999      47778


Q ss_pred             cceEEEEEec-ccccccccchhhhhcCCCcc
Q 045835           98 GRRLFDIYIQ-DNLVERNFDIKAEASGVLKP  127 (511)
Q Consensus        98 g~r~fdiyi~-~~~~~~~~~i~~~~~g~~~~  127 (511)
                      +..+||+.+| .+.++|+.||..++|+-+.+
T Consensus       148 q~kvfdvrln~sh~vVk~ldi~~~vg~rg~A  178 (355)
T KOG3593|consen  148 QHKVFDVRLNCSHCVVKALDIFDQVGDRGKA  178 (355)
T ss_pred             hhhheeeeeccceeEEeccchhhhcCCCccc
Confidence            8899999999 99999999999999866554

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.38  E-value=0.0014  Score=58.66  Aligned_cols=127  Identities=22%  Similarity=0.278  Sum_probs=84.7

Q ss_pred             ccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCcee-EEEEEEeCCEEEEEEEecCCCC
Q 045835          244 SAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK-IHGCCVEGDQLLLVYEYMENNS  322 (511)
Q Consensus       244 ~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~-l~g~~~~~~~~~lV~Ey~~~gs  322 (511)
                      ..+.|++|++|.||+|.+. |..+|+|+-+.+++  ...+..|.++|..+.-.++.+ ++.|-.    -.+.|||..+-+
T Consensus        26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~   98 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRP   98 (201)
T ss_pred             hhhhhhcccccEEEEeecc-CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcc
Confidence            4578999999999999986 45789998765544  357889999999887666554 444432    234599999988


Q ss_pred             HhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCC-C-CCeEEcCCCCeEEeecCCccc
Q 045835          323 LACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIK-A-TNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       323 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk-~-~NILld~~~~~kl~DfGla~~  392 (511)
                      |.++-...       +-++.    ..++..---|...|   |-|+.|. | .||++.+ ..+.|+||.-|..
T Consensus        99 L~~~~~~~-------~rk~l----~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~-~~~~iIDFd~At~  155 (201)
T COG2112          99 LGKLEIGG-------DRKHL----LRVLEKAYKLDRLG---IEHGELSRPWKNVLVND-RDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhhcc-------cHHHH----HHHHHHHHHHHHhc---cchhhhcCCceeEEecC-CcEEEEEccchhh
Confidence            87654221       11222    23333322233334   8888887 3 4555554 4899999998874

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.34  E-value=0.0028  Score=61.51  Aligned_cols=140  Identities=15%  Similarity=0.119  Sum_probs=79.3

Q ss_pred             ceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCc-eeEEEEEEeCCEEEEEEEecCCCCHhH
Q 045835          247 KIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNL-VKIHGCCVEGDQLLLVYEYMENNSLAC  325 (511)
Q Consensus       247 ~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~gsL~~  325 (511)
                      .+..|-...+|+... ++..+++|..............+|..+++.+....+ .++++.+.    -.+||||+++..+..
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            345677788998874 566788887654332221235678888888864433 33444432    368999999876542


Q ss_pred             H-----------------HhcCCCCCCCCCHHHHH-HHH---------HHHHHHHHHHhcC-----CCCCeEEccCCCCC
Q 045835          326 A-----------------LFGRENCELELDWPTRQ-KIC---------LGIARGLAFLHEE-----SRFKIVHRDIKATN  373 (511)
Q Consensus       326 ~-----------------l~~~~~~~~~l~~~~~~-~i~---------~~ia~gl~yLH~~-----~~~~iiH~Dlk~~N  373 (511)
                      .                 ||.......+++...+. ...         ..+..-+..+-..     ....++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1                 12211111122222111 110         0111112222111     12358999999999


Q ss_pred             eEEcCCCCeEEeecCCccc
Q 045835          374 VLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       374 ILld~~~~~kl~DfGla~~  392 (511)
                      |++++++ +.|.||..+..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999877 78999998864

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.32  E-value=0.0012  Score=65.58  Aligned_cols=144  Identities=17%  Similarity=0.106  Sum_probs=85.8

Q ss_pred             cCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCC--ceeEEEE------EEeCCEEEEEEE
Q 045835          245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPN--LVKIHGC------CVEGDQLLLVYE  316 (511)
Q Consensus       245 ~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~------~~~~~~~~lV~E  316 (511)
                      .+.|..|....+|+....++ .+++|+...   ........|+.++..+.+.+  +.+++..      ....+..++|++
T Consensus        19 i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDSG-RYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCCC-cEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            45677777789999876544 678888764   22345667777777774332  4444432      123456789999


Q ss_pred             ecCCCCHhH----H----------HhcCC-C------CCCCCCHHHHHH----------HHHHHHHHHHHHhcC----CC
Q 045835          317 YMENNSLAC----A----------LFGRE-N------CELELDWPTRQK----------ICLGIARGLAFLHEE----SR  361 (511)
Q Consensus       317 y~~~gsL~~----~----------l~~~~-~------~~~~l~~~~~~~----------i~~~ia~gl~yLH~~----~~  361 (511)
                      |++|..+..    .          +|... .      ......|.....          ....+...++++...    -.
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999876532    1          11100 0      001123332210          112233445555531    12


Q ss_pred             CCeEEccCCCCCeEEcCCCCeEEeecCCccc
Q 045835          362 FKIVHRDIKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       362 ~~iiH~Dlk~~NILld~~~~~kl~DfGla~~  392 (511)
                      ..++|+|+.|.|||++++..+.|.||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            3599999999999999987788999998863

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.23  E-value=0.0086  Score=61.63  Aligned_cols=76  Identities=17%  Similarity=0.191  Sum_probs=54.1

Q ss_pred             cCceeccCceeEEeccccCC-cEEEEEEecccC-------ccchHHHHHHHHHHhcCC---CCCceeEEEEEEeCCEEEE
Q 045835          245 AKKIGEGGFGPVYKGQLADG-TIIAVKQLSSKS-------RQGNREFLNEIAMISCLQ---HPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       245 ~~~lG~G~fG~Vy~g~~~~g-~~vAvK~~~~~~-------~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~l  313 (511)
                      .+.||.|.+..||+....+| +.+.||.-.+..       +.....+..|.+.|..+.   -.++.+++.+  +.+..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            35789999999999998777 489999854221       123455677888877762   2456677766  4456789


Q ss_pred             EEEecCCCC
Q 045835          314 VYEYMENNS  322 (511)
Q Consensus       314 V~Ey~~~gs  322 (511)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998744

>PLN03150 hypothetical protein; Provisional

Probab=97.13  E-value=0.0016  Score=71.49  Aligned_cols=91  Identities=21%  Similarity=0.248  Sum_probs=65.9

Q ss_pred             CchhhhhhhccCCc----ceeEeecccCCceeEEEeeeeeeeccccceeecccceEEEEEecccc---cccccchhhhhc
Q 045835           50 GLSELYINARIAPL----SLTYFGYCLDNGNYTLSLHFAEIQFSNGITFHSLGRRLFDIYIQDNL---VERNFDIKAEAS  122 (511)
Q Consensus        50 ~~~~ly~~~r~~~~----~~t~~~~~~~~~~y~v~lhfae~~~~~~~~~~~~g~r~fdiyi~~~~---~~~~~~i~~~~~  122 (511)
                      ..+..|+|+|.=|.    ...|.+++.++|+|.||+||....|.+..     ....|||+++++.   +..+|+.     
T Consensus        64 ~~~~~~~t~R~F~~~~g~~~cY~~~~~~~g~ylVRl~F~~~~y~~~~-----~~~~Fdv~~~~~~~~tv~~~~~~-----  133 (623)
T PLN03150         64 FIAPPLKTLRYFPLSDGPENCYNINRVPKGHYSVRVFFGLVAEPNFD-----SEPLFDVSVEGTQISSLKSGWSS-----  133 (623)
T ss_pred             cccchhhccccCCcccccccceEeeecCCCcEEEEEEeecCCcCCCC-----CCCceEEEECcEEEEEEecCccc-----
Confidence            34567999999886    56899999999999999999887654432     2347999999954   3333331     


Q ss_pred             CCCccceeeeeeeeeceeeEEEEEECCCC
Q 045835          123 GVLKPVARSYNVTVTNHIIEIRFHWAGKG  151 (511)
Q Consensus       123 g~~~~~~~~f~v~v~~~~~~i~~~~~g~~  151 (511)
                       ....+.++|.+.+++..+.+.|.-.+.+
T Consensus       134 -~~~~v~~E~i~~~~~~~l~vcf~~~~~~  161 (623)
T PLN03150        134 -HDEQVFAEALVFLTDGSASICFHSTGHG  161 (623)
T ss_pred             -CCCcEEEEEEEEecCCcEEEEEecCCCC
Confidence             1235778888888888777777755433

>PRK05231 homoserine kinase; Provisional

Probab=97.08  E-value=0.02  Score=57.39  Aligned_cols=158  Identities=16%  Similarity=0.138  Sum_probs=83.1

Q ss_pred             cHHHHHHHhcCCcc-----cCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCC--CceeEEE
Q 045835          231 TLKQIKAATNNFDS-----AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHP--NLVKIHG  303 (511)
Q Consensus       231 ~~~~l~~~~~~f~~-----~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g  303 (511)
                      +.+++...-..|.+     .+.|+.|....+|+....+| .+++|+.....   ......|+.++..|...  .+.+.+.
T Consensus         8 s~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~   83 (319)
T PRK05231          8 SDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVA   83 (319)
T ss_pred             CHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCccee
Confidence            34444444444543     34566777788999876655 57888875212   22333455555444211  1223332


Q ss_pred             ------EEEeCCEEEEEEEecCCCCHhH-----------HH---hcCCC-------CCCCCCH-HHHHH-----------
Q 045835          304 ------CCVEGDQLLLVYEYMENNSLAC-----------AL---FGREN-------CELELDW-PTRQK-----------  344 (511)
Q Consensus       304 ------~~~~~~~~~lV~Ey~~~gsL~~-----------~l---~~~~~-------~~~~l~~-~~~~~-----------  344 (511)
                            +....+..++++||+++..+..           .|   |....       ....+.| .....           
T Consensus        84 ~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (319)
T PRK05231         84 RRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQA  163 (319)
T ss_pred             CCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHH
Confidence                  1223556789999999875321           11   11100       0111222 11111           


Q ss_pred             -HH-HHHHHHHHHHhcC----CCCCeEEccCCCCCeEEcCCCCeEEeecCCccc
Q 045835          345 -IC-LGIARGLAFLHEE----SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       345 -i~-~~ia~gl~yLH~~----~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~  392 (511)
                       .. ..+...++.+...    -...++|+|+.+.||+++.+...-|.||+.+..
T Consensus       164 ~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        164 ALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             HHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence             11 1111222333211    133599999999999999776668999998863

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.03  E-value=0.014  Score=58.27  Aligned_cols=158  Identities=16%  Similarity=0.166  Sum_probs=87.6

Q ss_pred             HHHHHHHhcCCcc-----cCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCC--CceeEEEE
Q 045835          232 LKQIKAATNNFDS-----AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHP--NLVKIHGC  304 (511)
Q Consensus       232 ~~~l~~~~~~f~~-----~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g~  304 (511)
                      .+++...-+.|.+     .+.++.|.-..+|+....+| .+++|+.+...  .......|+.++..|...  ++.+++..
T Consensus         9 ~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t   85 (307)
T TIGR00938         9 DEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKS   85 (307)
T ss_pred             HHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccC
Confidence            3444444344433     45667777789998876555 46678765421  123455666777666322  23344332


Q ss_pred             E------EeCCEEEEEEEecCCCCHhH-----------H---HhcCCC----C-C---CCCCHHHHH------------H
Q 045835          305 C------VEGDQLLLVYEYMENNSLAC-----------A---LFGREN----C-E---LELDWPTRQ------------K  344 (511)
Q Consensus       305 ~------~~~~~~~lV~Ey~~~gsL~~-----------~---l~~~~~----~-~---~~l~~~~~~------------~  344 (511)
                      .      ...+..++++||++|..+..           .   +|....    . .   ..-.|....            .
T Consensus        86 ~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~  165 (307)
T TIGR00938        86 RDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAH  165 (307)
T ss_pred             CCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHH
Confidence            1      22456789999998854321           0   111000    0 0   011222111            0


Q ss_pred             HHHHHHHHHHHHhc----CCCCCeEEccCCCCCeEEcCCCCeEEeecCCccc
Q 045835          345 ICLGIARGLAFLHE----ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       345 i~~~ia~gl~yLH~----~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~  392 (511)
                      ....+.+.++++..    .....++|+|+++.||+++++....|.||+.+..
T Consensus       166 ~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       166 MGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             HHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            11123345555543    1234699999999999999988778999998853

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.02  E-value=0.0037  Score=62.16  Aligned_cols=141  Identities=23%  Similarity=0.234  Sum_probs=82.1

Q ss_pred             CceeccCceeEEeccccC-------CcEEEEEEecccCccchHHHHHHHHHHhcCCCCCc-eeEEEEEEeCCEEEEEEEe
Q 045835          246 KKIGEGGFGPVYKGQLAD-------GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNL-VKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~~-------g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey  317 (511)
                      +.+..|-...+|+....+       ++.+++|+...... ......+|..++..+....+ .++++++..    .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            345566667889887654       47888898655332 22345678888877753333 345555532    358999


Q ss_pred             cCCCCHhHH-----------------HhcCCCC--C-----CCCCHHHHHH--------------------------HHH
Q 045835          318 MENNSLACA-----------------LFGRENC--E-----LELDWPTRQK--------------------------ICL  347 (511)
Q Consensus       318 ~~~gsL~~~-----------------l~~~~~~--~-----~~l~~~~~~~--------------------------i~~  347 (511)
                      ++|.++...                 +|.....  .     ...-|.....                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            998776432                 1111110  0     0111111111                          111


Q ss_pred             HHHHHHHHHhc------CCCCCeEEccCCCCCeEEcCC----CCeEEeecCCcc
Q 045835          348 GIARGLAFLHE------ESRFKIVHRDIKATNVLLDRD----LNPKISDFGLAK  391 (511)
Q Consensus       348 ~ia~gl~yLH~------~~~~~iiH~Dlk~~NILld~~----~~~kl~DfGla~  391 (511)
                      .+..-++.|..      .....++|+|+.+.|||++++    +.+.++||..+.
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            22233444432      234569999999999999985    789999998886

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.73  E-value=0.015  Score=57.91  Aligned_cols=146  Identities=18%  Similarity=0.258  Sum_probs=82.0

Q ss_pred             CceeccCceeEEeccccCCcEEEEEEecc--cCccchHHHHHHHHHHhcCCC--CCceeEEEEEEeCC--EEEEEEEecC
Q 045835          246 KKIGEGGFGPVYKGQLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQH--PNLVKIHGCCVEGD--QLLLVYEYME  319 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~--~~~lV~Ey~~  319 (511)
                      +.+-.|..-.+|..... ++..++. ...  ..........+|..+|+.+.-  .-..+.+++|.++.  ..+.||+|++
T Consensus        31 ~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve  108 (321)
T COG3173          31 EEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE  108 (321)
T ss_pred             eeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence            33433333334443332 6667777 321  222334455678888877742  33455678888776  7799999998


Q ss_pred             CCCHhHHHh---------------------cCCCC-------------CCCCCHHHHHHHH--------HHHHHHHHHHh
Q 045835          320 NNSLACALF---------------------GRENC-------------ELELDWPTRQKIC--------LGIARGLAFLH  357 (511)
Q Consensus       320 ~gsL~~~l~---------------------~~~~~-------------~~~l~~~~~~~i~--------~~ia~gl~yLH  357 (511)
                      +..+.+.+.                     +-...             .+--.|....+.+        -....-..+|+
T Consensus       109 Ge~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~  188 (321)
T COG3173         109 GEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLE  188 (321)
T ss_pred             ceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHH
Confidence            833222111                     00000             0001122222111        11233345555


Q ss_pred             cC-----CCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          358 EE-----SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       358 ~~-----~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      ++     +.+.++|+|+++.|++++.+..+=|.||+++.+.
T Consensus       189 ~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         189 ANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             hcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            44     2356999999999999999988999999999764

>PLN02236 choline kinase

Probab=96.37  E-value=0.025  Score=57.44  Aligned_cols=141  Identities=16%  Similarity=0.240  Sum_probs=79.5

Q ss_pred             ceeccCceeEEeccccC-----CcEEEEEEecccCccchHHHHHHHHHHhcCCCCCce-eEEEEEEeCCEEEEEEEecCC
Q 045835          247 KIGEGGFGPVYKGQLAD-----GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV-KIHGCCVEGDQLLLVYEYMEN  320 (511)
Q Consensus       247 ~lG~G~fG~Vy~g~~~~-----g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~~~  320 (511)
                      .|-.|-.-.+|+....+     ++.+++|+......... .-.+|..+++.+...++. ++++.+..+    .|+||+++
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g  117 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA  117 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence            44446667888876432     35788888765433222 235788888887544444 455655332    58999987


Q ss_pred             CCHhHH-----------------HhcCCCC--CCCCCHHHHHHHHHH-----------------HHHHHHHH----hc-C
Q 045835          321 NSLACA-----------------LFGRENC--ELELDWPTRQKICLG-----------------IARGLAFL----HE-E  359 (511)
Q Consensus       321 gsL~~~-----------------l~~~~~~--~~~l~~~~~~~i~~~-----------------ia~gl~yL----H~-~  359 (511)
                      .+|...                 +|.....  .....|.+..++..+                 +...+..|    .. .
T Consensus       118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~  197 (344)
T PLN02236        118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD  197 (344)
T ss_pred             CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence            776421                 1111100  001123332222211                 11112222    22 2


Q ss_pred             CCCCeEEccCCCCCeEEcC-CCCeEEeecCCccc
Q 045835          360 SRFKIVHRDIKATNVLLDR-DLNPKISDFGLAKL  392 (511)
Q Consensus       360 ~~~~iiH~Dlk~~NILld~-~~~~kl~DfGla~~  392 (511)
                      ....++|+|+++.|||+++ +..+.+.||..+..
T Consensus       198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            2346899999999999986 46799999988864

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.30  E-value=0.031  Score=54.92  Aligned_cols=31  Identities=29%  Similarity=0.500  Sum_probs=26.0

Q ss_pred             CCeEEccCCCCCeEEcCCCC-eEEeecCCccc
Q 045835          362 FKIVHRDIKATNVLLDRDLN-PKISDFGLAKL  392 (511)
Q Consensus       362 ~~iiH~Dlk~~NILld~~~~-~kl~DfGla~~  392 (511)
                      +.++|+|+++.|||+++++. .-|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            45899999999999997555 56999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan []

Probab=96.28  E-value=0.025  Score=57.43  Aligned_cols=107  Identities=26%  Similarity=0.373  Sum_probs=73.9

Q ss_pred             CchhhhhhhccCC--cceeEeeccc--CCceeEEEeeeeeeeccccceeec-ccceEEEEEecccccccccchhhhhcCC
Q 045835           50 GLSELYINARIAP--LSLTYFGYCL--DNGNYTLSLHFAEIQFSNGITFHS-LGRRLFDIYIQDNLVERNFDIKAEASGV  124 (511)
Q Consensus        50 ~~~~ly~~~r~~~--~~~t~~~~~~--~~~~y~v~lhfae~~~~~~~~~~~-~g~r~fdiyi~~~~~~~~~~i~~~~~g~  124 (511)
                      ....+|.|||.=|  -.-+|-+++.  ++++|.||+||.-..|... .+.. ...-.||++++.+.... .++.   ...
T Consensus        46 ~~~~~y~taR~F~~g~r~cY~l~~~~~~~~~yliRl~F~~gnyd~~-~fs~~~~~~~FdL~~~~n~~~t-V~~~---~~~  120 (347)
T PF12819_consen   46 DSSPPYQTARIFPEGSRNCYTLPVTPPGGGKYLIRLHFYYGNYDGL-NFSVSSSPPTFDLLLGFNFWST-VNLS---NSP  120 (347)
T ss_pred             ccccccceEEEcCCCCccEEEeeccCCCCceEEEEEEecccccccc-ccccccCCcceEEEECCceeEE-EEec---CCC
Confidence            5578999999987  5678999987  5679999999987765533 2111 23446999999886511 1111   111


Q ss_pred             Cccceeeeeeeee-ceeeEEEEEECCCCCccCCCCCcCCCccccccc
Q 045835          125 LKPVARSYNVTVT-NHIIEIRFHWAGKGTTALPKRGIYGPLVSAISL  170 (511)
Q Consensus       125 ~~~~~~~f~v~v~-~~~~~i~~~~~g~~~~~~p~~~~~~p~~~~~~~  170 (511)
                      ..++.++|.+.++ +..+.|.|.-.+.++         -|.|+++.+
T Consensus       121 ~~~~~~E~ii~v~~~~~l~vclv~~~~g~---------~pFIsaiEl  158 (347)
T PF12819_consen  121 SSPVVKEFIINVTWSDTLSVCLVPTGSGT---------FPFISAIEL  158 (347)
T ss_pred             cceEEEEEEEEEcCCCcEEEEEEeCCCCC---------CCceeEEEE
Confidence            2578999999999 688999988766542         255666654

This entry represents a malectin-like domain found in a number of plant receptor kinases.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.10  E-value=0.0053  Score=60.24  Aligned_cols=133  Identities=17%  Similarity=0.149  Sum_probs=89.6

Q ss_pred             CcccCceeccCceeEEeccccCCcEEEEEEecccC-----------------cc-----chHHHHHHHHHHhcCCC--CC
Q 045835          242 FDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKS-----------------RQ-----GNREFLNEIAMISCLQH--PN  297 (511)
Q Consensus       242 f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~-----------------~~-----~~~~~~~Ei~~l~~l~H--~n  297 (511)
                      +...++||-|.-+.+|.+...+|++.++|.-+...                 ..     ..-...+|...|+.|.-  --
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            56789999999999999998889998888532110                 00     01234567888887742  23


Q ss_pred             ceeEEEEEEeCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEc
Q 045835          298 LVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD  377 (511)
Q Consensus       298 iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld  377 (511)
                      +.+.+++    +..++|||++.+-.|...-+-       .+-++..   ..+..-+--|..+|   +||+|..-=||+++
T Consensus       174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-------~d~~~ly---~~lm~~Iv~la~~G---lIHgDFNEFNimv~  236 (465)
T KOG2268|consen  174 VPKPIDH----NRHCVVMELVDGYPLRQVRHV-------EDPPTLY---DDLMGLIVRLANHG---LIHGDFNEFNIMVK  236 (465)
T ss_pred             CCCcccc----cceeeHHHhhcccceeeeeec-------CChHHHH---HHHHHHHHHHHHcC---ceecccchheeEEe
Confidence            4444444    467899999988777543211       2223333   23333344455555   99999999999999


Q ss_pred             CCCCeEEeecCCcc
Q 045835          378 RDLNPKISDFGLAK  391 (511)
Q Consensus       378 ~~~~~kl~DfGla~  391 (511)
                      ++..++++||--..
T Consensus       237 dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  237 DDDKIVVIDFPQMV  250 (465)
T ss_pred             cCCCEEEeechHhh
Confidence            99999999996543

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.05  E-value=0.00093  Score=76.72  Aligned_cols=159  Identities=13%  Similarity=-0.036  Sum_probs=110.9

Q ss_pred             HHHHHHhcCCCCCceeEEEEEE--eCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC--C
Q 045835          285 NEIAMISCLQHPNLVKIHGCCV--EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE--S  360 (511)
Q Consensus       285 ~Ei~~l~~l~H~niv~l~g~~~--~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~--~  360 (511)
                      .|...++...|+++.....-..  +..+.+.+++|+..|.+.+.+.........++.......-.+...+..-.|+.  .
T Consensus      1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred             hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence            3444555667888776544332  23456889999999999999876544444444443333333334444444443  2


Q ss_pred             CCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhC
Q 045835          361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG  440 (511)
Q Consensus       361 ~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG  440 (511)
                      ...-+|+++|+.|.+|..+..+|+.++|+.+........ .....+++-|+.|+....-.++.++|+|..|+-+++.--|
T Consensus      1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf-~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~ 1436 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSF-FGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDG 1436 (2724)
T ss_pred             CccchhhhhhhhccceecCCcccccccccccccCchHhh-hhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcc
Confidence            335789999999999999999999999999943332222 2234567789999988888899999999999999998777


Q ss_pred             CCCC
Q 045835          441 KNNM  444 (511)
Q Consensus       441 ~~p~  444 (511)
                      ..++
T Consensus      1437 n~~f 1440 (2724)
T KOG1826|consen 1437 NAYF 1440 (2724)
T ss_pred             cHHH
Confidence            7665

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.95  E-value=0.029  Score=55.24  Aligned_cols=143  Identities=23%  Similarity=0.275  Sum_probs=73.3

Q ss_pred             cccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCC---CCCceeEEEEEEeCCEEEEEEEecC
Q 045835          243 DSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ---HPNLVKIHGCCVEGDQLLLVYEYME  319 (511)
Q Consensus       243 ~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~Ey~~  319 (511)
                      +..+.|+.|....+|+.. .+++.+.||.-..   .....|..|.+-|+.|.   --.+.+++++....+..+||+||++
T Consensus        20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~   95 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE   95 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred             eeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence            345678888889999887 4677899998763   23346788888887773   4457788998887777899999998


Q ss_pred             CC--C------HhH---HHhc-CCC-----------------CCCCCCHHHH-----HHHHH--------------HHHH
Q 045835          320 NN--S------LAC---ALFG-REN-----------------CELELDWPTR-----QKICL--------------GIAR  351 (511)
Q Consensus       320 ~g--s------L~~---~l~~-~~~-----------------~~~~l~~~~~-----~~i~~--------------~ia~  351 (511)
                      .+  +      |..   .||. ...                 ..-.-+|..-     +.-..              .+..
T Consensus        96 ~~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~~  175 (288)
T PF03881_consen   96 MGSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLVE  175 (288)
T ss_dssp             -----CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHHH
T ss_pred             CCCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHHH
Confidence            77  1      111   1222 110                 0011234321     11111              1122


Q ss_pred             HHH-HHhcC-CCCCeEEccCCCCCeEEcCCCCeEEeecCC
Q 045835          352 GLA-FLHEE-SRFKIVHRDIKATNVLLDRDLNPKISDFGL  389 (511)
Q Consensus       352 gl~-yLH~~-~~~~iiH~Dlk~~NILld~~~~~kl~DfGl  389 (511)
                      .+. .|+.. .+|.++|+||.+.|++.+.++.+.|.|-..
T Consensus       176 ~~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa~  215 (288)
T PF03881_consen  176 RLPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPAC  215 (288)
T ss_dssp             HHHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S---
T ss_pred             HHHHHhcCCCCCceeeEcCccccceeecCCCCceeecccc
Confidence            111 22321 256799999999999999998899988653

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=95.82  E-value=0.018  Score=59.83  Aligned_cols=49  Identities=22%  Similarity=0.249  Sum_probs=38.0

Q ss_pred             HHHHHHHHHHhcCCCCCceeEEEEEEeC-CEEEEEEEecCCCCHhHHHhcC
Q 045835          281 REFLNEIAMISCLQHPNLVKIHGCCVEG-DQLLLVYEYMENNSLACALFGR  330 (511)
Q Consensus       281 ~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~Ey~~~gsL~~~l~~~  330 (511)
                      .+.+-...+++.+.|+|+...+.+.... .+..+|+|++. -||++.+..+
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~   76 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTG   76 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhc
Confidence            4566777888999999999999887643 35788999885 4888887554

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.76  E-value=0.14  Score=52.82  Aligned_cols=80  Identities=18%  Similarity=0.149  Sum_probs=51.8

Q ss_pred             cCceeccCceeEEeccccCCcEEEEEEecccCc-------cchHHHHHHHHHHhcCC---CCCceeEEEEEEeCCEEEEE
Q 045835          245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSR-------QGNREFLNEIAMISCLQ---HPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       245 ~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~-------~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV  314 (511)
                      .+.||.|....||+.... +..++||+-.....       .....-..|...|+.+.   ..++.+++.+|.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            567899999999998764 45688998652211       12233344566665553   357788888887  446788


Q ss_pred             EEecCCC--CHhHHH
Q 045835          315 YEYMENN--SLACAL  327 (511)
Q Consensus       315 ~Ey~~~g--sL~~~l  327 (511)
                      ||+++++  .+.+-|
T Consensus       114 ME~L~~~~~ilr~~L  128 (418)
T PLN02756        114 MRYLEPPHIILRKGL  128 (418)
T ss_pred             EeecCCcceehhhhh
Confidence            9999772  344443

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.69  E-value=0.25  Score=49.13  Aligned_cols=30  Identities=23%  Similarity=0.345  Sum_probs=25.9

Q ss_pred             CCeEEccCCCCCeEEcCCCCeEEeecCCccc
Q 045835          362 FKIVHRDIKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       362 ~~iiH~Dlk~~NILld~~~~~kl~DfGla~~  392 (511)
                      ..++|+|+.+.||+++. +.+.|.||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            46899999999999998 5688999997753

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.68  E-value=0.11  Score=52.30  Aligned_cols=142  Identities=24%  Similarity=0.338  Sum_probs=84.3

Q ss_pred             ceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCC---CC---ceeEEEEE----EeCCEEEEEEE
Q 045835          247 KIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQH---PN---LVKIHGCC----VEGDQLLLVYE  316 (511)
Q Consensus       247 ~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H---~n---iv~l~g~~----~~~~~~~lV~E  316 (511)
                      .|.+ .-..+|+....+|.. ++|..+..  ....+...|+..|..|.-   +=   +..+-|-.    ..+...+-+++
T Consensus        33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~  108 (331)
T COG2334          33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE  108 (331)
T ss_pred             cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence            3444 446788888877776 78887664  344566677777776631   11   22222221    11237789999


Q ss_pred             ecCCCCHhH-H----H----------hc--------CCCCCCCCCHHH---H----------HHHHHHHHHHHHHHhcCC
Q 045835          317 YMENNSLAC-A----L----------FG--------RENCELELDWPT---R----------QKICLGIARGLAFLHEES  360 (511)
Q Consensus       317 y~~~gsL~~-~----l----------~~--------~~~~~~~l~~~~---~----------~~i~~~ia~gl~yLH~~~  360 (511)
                      |++|..+.. .    +          +.        +.+......|..   +          ......+...+..+.+.-
T Consensus       109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~  188 (331)
T COG2334         109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL  188 (331)
T ss_pred             ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence            999988873 1    1          10        111112344541   0          112334444555544431


Q ss_pred             ----C---CCeEEccCCCCCeEEcCCCC-eEEeecCCccc
Q 045835          361 ----R---FKIVHRDIKATNVLLDRDLN-PKISDFGLAKL  392 (511)
Q Consensus       361 ----~---~~iiH~Dlk~~NILld~~~~-~kl~DfGla~~  392 (511)
                          .   ..+||+|+.|.||+++.+.. +.+.||+-+..
T Consensus       189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             hhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence                1   22899999999999999884 89999998863

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=95.51  E-value=0.21  Score=50.54  Aligned_cols=79  Identities=16%  Similarity=0.164  Sum_probs=49.3

Q ss_pred             ceeccCceeEEeccccCC-cEEEEEEecccC-------ccchHHHHHHHHHHhcCC--CCC-ceeEEEEEEeCCEEEEEE
Q 045835          247 KIGEGGFGPVYKGQLADG-TIIAVKQLSSKS-------RQGNREFLNEIAMISCLQ--HPN-LVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       247 ~lG~G~fG~Vy~g~~~~g-~~vAvK~~~~~~-------~~~~~~~~~Ei~~l~~l~--H~n-iv~l~g~~~~~~~~~lV~  315 (511)
                      .||.|....||++..++| +.|.||.-.+..       +-......-|...|+...  -|. +.+++.+  +.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            478899999999987655 579999854321       222334455666666552  343 4445443  556677999


Q ss_pred             EecCCCC-HhHHH
Q 045835          316 EYMENNS-LACAL  327 (511)
Q Consensus       316 Ey~~~gs-L~~~l  327 (511)
                      |+++... |...|
T Consensus        80 EdL~~~~ilR~~L   92 (370)
T TIGR01767        80 EDLSHHKIARKGL   92 (370)
T ss_pred             hhCccchHHHHHH
Confidence            9996533 43444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=94.88  E-value=1.6  Score=43.90  Aligned_cols=95  Identities=16%  Similarity=0.108  Sum_probs=54.6

Q ss_pred             ccccHHHHHHHhcCCccc---C-ceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCC--Ccee-
Q 045835          228 ISFTLKQIKAATNNFDSA---K-KIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHP--NLVK-  300 (511)
Q Consensus       228 ~~~~~~~l~~~~~~f~~~---~-~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~--niv~-  300 (511)
                      ..++.+.+..+...+...   + ..-.+.-..||+....++..+++|..+.. .....+...|++.+..|.-.  .++. 
T Consensus         9 ~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p   87 (325)
T PRK11768          9 QTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAP   87 (325)
T ss_pred             CCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            345666666665554331   1 11223446799988877888999987532 23445666777777655321  1222 


Q ss_pred             --EEE--EEEeCCEEEEEEEecCCCCH
Q 045835          301 --IHG--CCVEGDQLLLVYEYMENNSL  323 (511)
Q Consensus       301 --l~g--~~~~~~~~~lV~Ey~~~gsL  323 (511)
                        .-|  ....++..+.++++++|...
T Consensus        88 ~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         88 LAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             ccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence              112  12234567889999987643

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=94.58  E-value=0.34  Score=48.32  Aligned_cols=31  Identities=19%  Similarity=0.280  Sum_probs=28.0

Q ss_pred             CCeEEccCCCCCeEEcCCCCeEEeecCCccc
Q 045835          362 FKIVHRDIKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       362 ~~iiH~Dlk~~NILld~~~~~kl~DfGla~~  392 (511)
                      ..++|+|+.+.|+|+++++.+.+.||..+..
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            4699999999999999999999999988864

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=94.57  E-value=0.2  Score=46.89  Aligned_cols=137  Identities=18%  Similarity=0.219  Sum_probs=85.1

Q ss_pred             EEEEEecccCcc-chHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHH
Q 045835          267 IAVKQLSSKSRQ-GNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKI  345 (511)
Q Consensus       267 vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i  345 (511)
                      ..+|+++.-.-. ...-|.++..++++++  .|++|..  .+.-.+-++.|+|.....             .   ..-.|
T Consensus        88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~~i-------------~---~~N~i  147 (308)
T PF07387_consen   88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKIKI-------------N---FSNFI  147 (308)
T ss_pred             hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCccc-------------c---hhHHH
Confidence            445666543333 3456788888888875  5677652  133356788998853211             0   11112


Q ss_pred             HHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCceeecccccCCCcccccccccCCCCcch
Q 045835          346 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKA  425 (511)
Q Consensus       346 ~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  425 (511)
                      ..+ +.+|.-.|+.. ...+|+|..|+||+-|+.|-+||.|-+..-  .+.           .-|.--|   ....|+++
T Consensus       148 ~ag-i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll--~~~-----------V~~vN~~---Y~~lT~~a  209 (308)
T PF07387_consen  148 TAG-IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLL--ENQ-----------VNMVNIE---YESLTQEA  209 (308)
T ss_pred             HHh-HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhh--hhe-----------eeEEeee---ccccChHH
Confidence            222 46677889653 479999999999999999999999987543  111           1122211   12356778


Q ss_pred             hHHHHHHHHHHHHhCC
Q 045835          426 DVYSFGIVALEIVSGK  441 (511)
Q Consensus       426 DV~S~Gvvl~elltG~  441 (511)
                      .+-+|=.-++++....
T Consensus       210 E~~~fv~s~l~~v~~~  225 (308)
T PF07387_consen  210 EVKVFVKSCLKLVEKQ  225 (308)
T ss_pred             HHHHHHHHHHHHHHHH
Confidence            8888877777776643

The function of this family is unknown.

>PRK06148 hypothetical protein; Provisional

Probab=94.57  E-value=0.38  Score=56.02  Aligned_cols=142  Identities=20%  Similarity=0.238  Sum_probs=78.1

Q ss_pred             ceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcC-------CCCCceeEE-----EEEEe-CC--EE
Q 045835          247 KIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCL-------QHPNLVKIH-----GCCVE-GD--QL  311 (511)
Q Consensus       247 ~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-------~H~niv~l~-----g~~~~-~~--~~  311 (511)
                      .|+ |..-.+|+....+|..+++|+.+.....  .....|...|..|       .-|.+++-.     ..... ..  ..
T Consensus        32 ~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~--~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~  108 (1013)
T PRK06148         32 PLD-GERDLNFRLTTDDGADYILKIVNPSEPR--VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL  108 (1013)
T ss_pred             ecC-CcCCceEEEEeCCCCeEEEEEcCCccch--hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence            453 4457788888777888999998764322  2333444555433       233444321     11111 12  46


Q ss_pred             EEEEEecCCCCHhHHH-----------------h------cCCCCCCCCCHHH-----------------HHHHHHHHHH
Q 045835          312 LLVYEYMENNSLACAL-----------------F------GRENCELELDWPT-----------------RQKICLGIAR  351 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l-----------------~------~~~~~~~~l~~~~-----------------~~~i~~~ia~  351 (511)
                      +-+++|+++..+.+..                 +      .+......+.|..                 ...++.++..
T Consensus       109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~  188 (1013)
T PRK06148        109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLA  188 (1013)
T ss_pred             EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHH
Confidence            7789999998776510                 0      0111112244432                 1122222222


Q ss_pred             HHH-----HHhcCCCCCeEEccCCCCCeEEcCCC--CeE-EeecCCccc
Q 045835          352 GLA-----FLHEESRFKIVHRDIKATNVLLDRDL--NPK-ISDFGLAKL  392 (511)
Q Consensus       352 gl~-----yLH~~~~~~iiH~Dlk~~NILld~~~--~~k-l~DfGla~~  392 (511)
                      ...     .|.+. ...+||+|+.+.|||++.+.  .+. |.|||-+..
T Consensus       189 ~~~~~v~p~l~~L-p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        189 RFERNVAPRLAAL-PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHhcC-CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            221     12221 33599999999999999875  454 999998864

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=94.52  E-value=0.22  Score=50.26  Aligned_cols=142  Identities=14%  Similarity=0.192  Sum_probs=77.7

Q ss_pred             CceeccCceeEEeccccC----CcEEEEEEecccCccchHHHHHHHHHHhcCCCCCce-eEEEEEEeCCEEEEEEEecCC
Q 045835          246 KKIGEGGFGPVYKGQLAD----GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV-KIHGCCVEGDQLLLVYEYMEN  320 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~~----g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~~~  320 (511)
                      +.|..|-...+|+....+    +..+++|+....... .-.-.+|..+++.+..-++. ++++++. +.   +|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence            344446666788875433    237888887654332 12235788888888655553 4565553 22   48999977


Q ss_pred             CCHhHH-----------------HhcCCCC--CCCCCHHHHHHHHHH----------------------HHHHHH----H
Q 045835          321 NSLACA-----------------LFGRENC--ELELDWPTRQKICLG----------------------IARGLA----F  355 (511)
Q Consensus       321 gsL~~~-----------------l~~~~~~--~~~l~~~~~~~i~~~----------------------ia~gl~----y  355 (511)
                      .+|...                 +|.....  ...-.|....+...+                      +..-+.    .
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            655321                 1111100  111123332222111                      111121    2


Q ss_pred             HhcC-CCCCeEEccCCCCCeEEcC-CCCeEEeecCCccc
Q 045835          356 LHEE-SRFKIVHRDIKATNVLLDR-DLNPKISDFGLAKL  392 (511)
Q Consensus       356 LH~~-~~~~iiH~Dlk~~NILld~-~~~~kl~DfGla~~  392 (511)
                      +... ...-+.|+|+.+.|||+++ ++.++++||..|..
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            2111 1234799999999999975 46899999998864

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=94.41  E-value=0.28  Score=49.39  Aligned_cols=141  Identities=18%  Similarity=0.192  Sum_probs=92.2

Q ss_pred             cccCceeccCceeEEeccccCCcEEEEEEecccC-----cc----------------ch-----HHHHHHHHHHhcCCCC
Q 045835          243 DSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKS-----RQ----------------GN-----REFLNEIAMISCLQHP  296 (511)
Q Consensus       243 ~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~-----~~----------------~~-----~~~~~Ei~~l~~l~H~  296 (511)
                      ++...|..|.-..||.+.-.+|..+|||+.+...     +.                ..     .....|+.-|.+|+..
T Consensus       147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            3445677888999999998899999999865320     00                00     1134567777777654


Q ss_pred             CceeEEEEEEeCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEE
Q 045835          297 NLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL  376 (511)
Q Consensus       297 niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILl  376 (511)
                      .|.-.--...  ....|||+|+.......    ..-....++......+-.+++.-|.-|...+  +++|.||.-=|+|+
T Consensus       227 GIP~PePIlL--k~hVLVM~FlGrdgw~a----PkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly  298 (520)
T KOG2270|consen  227 GIPCPEPILL--KNHVLVMEFLGRDGWAA----PKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY  298 (520)
T ss_pred             CCCCCCceee--ecceEeeeeccCCCCcC----cccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE
Confidence            4332111111  23478999996432111    1112234666667777778888888888776  69999999999998


Q ss_pred             cCCCCeEEeecCCccc
Q 045835          377 DRDLNPKISDFGLAKL  392 (511)
Q Consensus       377 d~~~~~kl~DfGla~~  392 (511)
                      -+ |.+.|+|-+-+.-
T Consensus       299 hd-G~lyiIDVSQSVE  313 (520)
T KOG2270|consen  299 HD-GKLYIIDVSQSVE  313 (520)
T ss_pred             EC-CEEEEEEcccccc
Confidence            64 5788999887753

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	511
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-69
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		8e-68
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-54
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-53
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-41
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-41
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-40
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		6e-38
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-24
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-24
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-23
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		7e-23
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		7e-23
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-22
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-22
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-22
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-22
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-22
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-22
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-22
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-22
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-22
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-22
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-22
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-22
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-22
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-22
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-22
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-22
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-22
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-22
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-22
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-22
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-22
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-22
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-22
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-22
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-22
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-22
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-22
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		7e-22
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		8e-22
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		9e-22
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-21
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-21
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-21
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-21
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-21
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-21
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-21
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-21
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-21
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-21
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-21
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-21
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-21
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-21
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-21
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		7e-21
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		9e-21
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-20
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-20
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-20
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-20
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-20
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-20
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-20
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-20
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-20
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-20
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-20
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-20
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-20
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-20
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-20
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-20
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-20
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-20
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-20
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-20
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-20
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-20
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-20
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		5e-20
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		5e-20
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		5e-20
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		6e-20
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-20
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		6e-20
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		7e-20
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		7e-20
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		7e-20
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		7e-20
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		7e-20
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		7e-20
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		8e-20
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		8e-20
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		8e-20
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		9e-20
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-19
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-19
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-19
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-19
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-19
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-19
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-19
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-19
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-19
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-19
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-19
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-19
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-19
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-19
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-19
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-19
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-19
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-19
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-19
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-19
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-19
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-19
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-19
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-19
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-19
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-19
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-19
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-19
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-19
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-19
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-19
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-19
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		5e-19
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		5e-19
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-19
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-19
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		6e-19
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		7e-19
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		7e-19
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		7e-19
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		7e-19
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-19
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		8e-19
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-19
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		8e-19
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-19
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		9e-19
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-18
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-18
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-18
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-18
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-18
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-18
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-18
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-18
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-18
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-18
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-18
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-18
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		6e-18
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		7e-18
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-18
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-17
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-17
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-17
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-17
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-17
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-17
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-17
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-17
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-17
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-17
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-17
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-17
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-17
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-17
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-17
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-17
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-17
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-17
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-17
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-17
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-17
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-17
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-17
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-17
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-17
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-17
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-17
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-17
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-17
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-17
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-17
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-17
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-17
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-17
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-17
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-17
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-17
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-17
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		5e-17
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-17
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-17
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-17
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-17
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		6e-17
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		6e-17
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-17
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		6e-17
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-17
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		7e-17
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		7e-17
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		7e-17
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		7e-17
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		7e-17
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		7e-17
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-17
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		7e-17
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		8e-17
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		8e-17
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		8e-17
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		8e-17
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-17
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		8e-17
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-17
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		9e-17
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-17
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		9e-17
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		9e-17
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		9e-17
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-17
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-17
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		9e-17
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		9e-17
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		9e-17
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		9e-17
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		9e-17
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-16
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-16
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-16
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-16
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-16
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-16
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-16
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-16
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-16
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-16
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-16
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-16
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-16
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-16
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-16
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-16
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-16
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-16
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-16
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-16
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-16
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-16
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-16
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-16
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-16
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-16
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-16
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-16
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-16
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-16
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		4e-16
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		5e-16
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		5e-16
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-16
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		5e-16
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		5e-16
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		5e-16
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		6e-16
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		6e-16
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-16
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		7e-16
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		7e-16
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		7e-16
3a7f_A	303	Human Mst3 Kinase Length = 303		7e-16
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		8e-16
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		8e-16
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		8e-16
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-16
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-15
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-15
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-15
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-15
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-15
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-15
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-15
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-15
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-15
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-15
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-15
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-15
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-15
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-15
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-15
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-15
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-15
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-15
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-15
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-15
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-15
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-15
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-15
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-15
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-15
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-15
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-15
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-15
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-15
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-15
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-15
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-15
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-15
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-15
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-15
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-15
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-15
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-15
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-15
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-15
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-15
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-15
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-15
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-15
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-15
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-15
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-15
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-15
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-15
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-15
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-15
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-15
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-15
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-15
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-15
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-15
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-15
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		5e-15
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		5e-15
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		5e-15
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		5e-15
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		5e-15
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-15
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-15
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-15
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		6e-15
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-15
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		7e-15
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-15
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-15
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		7e-15
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		8e-15
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		8e-15
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		9e-15
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-14
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-14
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-14
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-14
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-14
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-14
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-14
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-14
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-14
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-14
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-14
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-14
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-14
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-14
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-14
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-14
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-14
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-14
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-14
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-14
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-14
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-14
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-14
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-14
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-14
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-14
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-14
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-14
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-14
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-14
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-14
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-14
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-14
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-14
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-14
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-14
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-14
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-14
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-14
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-14
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-14
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-14
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-14
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-14
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-14
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		5e-14
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-14
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-14
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-14
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		7e-14
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		7e-14
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		7e-14
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		8e-14
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		8e-14
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		8e-14
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		8e-14
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		8e-14
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		8e-14
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		8e-14
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		9e-14
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-13
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-13
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-13
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-13
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-13
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-13
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-13
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-13
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-13
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-13
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-13
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-13
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-13
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-13
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-13
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		5e-13
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		5e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		7e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-13
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		8e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		8e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		8e-13
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		9e-13
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-13
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-12
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-12
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-12
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-12
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-12
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-12
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-12
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-12
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-12
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-12
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-12
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-12
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-12
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-12
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-12
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-12
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-12
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-12
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-12
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-12
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-12
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-12
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-12
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-12
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-12
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-12
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-12
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-12
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-12
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-12
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-12
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-12
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-12
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-12
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-12
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-12
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-12
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-12
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-12
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-12
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-12
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-12
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-12
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-12
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-12
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-12
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-12
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-12
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-12
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-12
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-12
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-12
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-12
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-12
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-12
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-12
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-12
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-12
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-12
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-12
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-12
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-12
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-12
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		5e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-12
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		5e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-12
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-12
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-12
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		6e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-12
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		6e-12
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		6e-12
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		6e-12
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		6e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		6e-12
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		6e-12
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		6e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		7e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		7e-12
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		7e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		8e-12
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		9e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		9e-12
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		9e-12
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-11
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-11
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-11
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-11
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-11
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-11
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-11
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-11
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-11
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-11
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-11
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-11
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-11
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-11
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-11
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-11
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-11
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-11
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-11
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-11
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-11
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-11
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-11
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-11
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-11
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-11
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-11
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-11
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-11
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-11
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-11
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-11
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		4e-11
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		5e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-11
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-11
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-11
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		6e-11
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		6e-11
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		6e-11
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		6e-11
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		6e-11
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		6e-11
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		6e-11
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		6e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		6e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-11
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		7e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		7e-11
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		8e-11
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		8e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		8e-11
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		8e-11
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		8e-11
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		8e-11
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		8e-11
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		8e-11
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		8e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		8e-11
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		9e-11
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		9e-11
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		9e-11
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		9e-11
4exu_A	371	Mapk13, Inactive Form Length = 371		9e-11
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		9e-11
3hec_A	348	P38 In Complex With Imatinib Length = 348		9e-11
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		9e-11
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		9e-11
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		9e-11
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		9e-11
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		9e-11
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		9e-11
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		9e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		9e-11
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		9e-11
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		9e-11
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		9e-11
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-10
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-10
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-10
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-10
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-10
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-10
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-10
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-10
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-10
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-10
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-10
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-10
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-10
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-10
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-10
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-10
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-10
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-10
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-10
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-10
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-10
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-10
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-10
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-10
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-10
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-10
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-10
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-10
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-10
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-10
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-10
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-10
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-10
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		3e-10
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-10
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-10
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-10
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-10
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-10
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-10
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-10
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-10
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-10
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-10
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-10
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-10
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		4e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-10
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-10
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-10
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-10
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		5e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-10
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-10
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		5e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		5e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		5e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		5e-10
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		5e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		5e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		5e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-10
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		5e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		6e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		6e-10
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		6e-10
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		6e-10
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-10
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		7e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-10
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		7e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		7e-10
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		7e-10
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		7e-10
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		7e-10
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		7e-10
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-10
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		7e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		7e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		7e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		7e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		7e-10
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		8e-10
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		8e-10
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		8e-10
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		8e-10
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-10
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		8e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		8e-10
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		8e-10
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		8e-10
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-10
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		8e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		8e-10
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		9e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		9e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-09
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-09
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-09
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-09
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-09
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-09
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-09
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-09
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-09
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-09
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-09
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-09
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-09
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-09
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-09
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-09
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-09
3soa_A	444	Full-Length Human Camkii Length = 444		3e-09
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-09
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-09
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-09
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-09
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-09
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		4e-09
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-09
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-09
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		4e-09
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-09
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-09
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-09
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		4e-09
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-09
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-09
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-09
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		5e-09
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		5e-09
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		5e-09
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		6e-09
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		6e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		6e-09
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		6e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		6e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		6e-09
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-09
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		7e-09
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		7e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		8e-09
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		8e-09
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-08
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-08
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-08
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-08
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-08
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-08
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-08
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-08
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-08
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-08
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-08
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-08
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-08
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-08
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-08
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-08
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		3e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-08
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-08
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-08
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		4e-08
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-08
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		5e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-08
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		6e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		6e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		7e-08
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		7e-08
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		7e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		8e-08
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		9e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		9e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		9e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-07
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		5e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		5e-07
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		7e-07
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		7e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		8e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		9e-07
3gni_B	389	Structure Of Strad And Mo25 Length = 389		1e-06
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		5e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		5e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		6e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		7e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		8e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		9e-06
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		1e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-05
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-05
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-05
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		2e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-05
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-05
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-05
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-05
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		4e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		7e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		7e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		7e-05
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		7e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-04
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-04
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-04
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-04
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		3e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-04
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		4e-04
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		6e-04
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		7e-04
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		7e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  259 bits (662), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 130/287 (45%), Positives = 182/287 (63%), Gaps = 1/287 (0%)
Query: 226 QTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNR-EFL 284
           Q   F+L++++ A++NF +   +G GGFG VYKG+LADGT++AVK+L  +  QG   +F 
Sbjct: 24  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQ 83
Query: 285 NEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQK 344
            E+ MIS   H NL+++ G C+   + LLVY YM N S+A  L  R   +  LDWP RQ+
Sbjct: 84  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 143
Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI 404
           I LG ARGLA+LH+    KI+HRD+KA N+LLD +    + DFGLAKL +    H+   +
Sbjct: 144 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAV 203
Query: 405 AGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHL 464
            GTIG++APEY   G  + K DV+ +G++ LE+++G+     A     D   LLDW   L
Sbjct: 204 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 263
Query: 465 QQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
            ++ KL  LVD  L   YK EE E++I+V+LLCT +SP  RP MSEV
Sbjct: 264 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 310

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  254 bits (649), Expect = 8e-68,   Method: Compositional matrix adjust.
 Identities = 128/287 (44%), Positives = 180/287 (62%), Gaps = 1/287 (0%)
Query: 226 QTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNR-EFL 284
           Q   F+L++++ A++NF +   +G GGFG VYKG+LADG ++AVK+L  +  QG   +F 
Sbjct: 16  QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQ 75
Query: 285 NEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQK 344
            E+ MIS   H NL+++ G C+   + LLVY YM N S+A  L  R   +  LDWP RQ+
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI 404
           I LG ARGLA+LH+    KI+HRD+KA N+LLD +    + DFGLAKL +    H+   +
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAV 195
Query: 405 AGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHL 464
            G IG++APEY   G  + K DV+ +G++ LE+++G+     A     D   LLDW   L
Sbjct: 196 RGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255
Query: 465 QQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
            ++ KL  LVD  L   YK EE E++I+V+LLCT +SP  RP MSEV
Sbjct: 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  209 bits (532), Expect = 3e-54,   Method: Compositional matrix adjust.
 Identities = 112/288 (38%), Positives = 174/288 (60%), Gaps = 6/288 (2%)
Query: 225 LQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFL 284
            ++    L  ++ ATNNFD    IG G FG VYKG L DG  +A+K+ + +S QG  EF 
Sbjct: 24  FESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFE 83
Query: 285 NEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQK 344
            EI  +S  +HP+LV + G C E ++++L+Y+YMEN +L   L+G +   + + W  R +
Sbjct: 84  TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143
Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL-DEGDKTHISTR 403
           IC+G ARGL +LH  +   I+HRD+K+ N+LLD +  PKI+DFG++K   E D+TH+   
Sbjct: 144 ICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXV 200
Query: 404 IAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACH 463
           + GT+GY+ PEY + G LT K+DVYSFG+V  E++  ++  +   +L  +   L +WA  
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS--AIVQSLPREMVNLAEWAVE 258
Query: 464 LQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
              +G+L ++VD  L  K + E   +    ++ C   S   RP+M +V
Sbjct: 259 SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  206 bits (524), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 173/288 (60%), Gaps = 6/288 (2%)
Query: 225 LQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFL 284
            ++    L  ++ ATNNFD    IG G FG VYKG L DG  +A+K+ + +S QG  EF 
Sbjct: 24  FESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFE 83
Query: 285 NEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQK 344
            EI  +S  +HP+LV + G C E ++++L+Y+YMEN +L   L+G +   + + W  R +
Sbjct: 84  TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143
Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL-DEGDKTHISTR 403
           IC+G ARGL +LH  +   I+HRD+K+ N+LLD +  PKI+DFG++K   E  +TH+   
Sbjct: 144 ICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXV 200
Query: 404 IAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACH 463
           + GT+GY+ PEY + G LT K+DVYSFG+V  E++  ++  +   +L  +   L +WA  
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS--AIVQSLPREMVNLAEWAVE 258
Query: 464 LQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
              +G+L ++VD  L  K + E   +    ++ C   S   RP+M +V
Sbjct: 259 SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 104/239 (43%), Positives = 142/239 (59%), Gaps = 23/239 (9%)
Query: 216 ETAFMKESDLQTISFTLKQIKAATNNFDS------AKKIGEGGFGPVYKGQLADGTIIAV 269
           E   ++ SD +  SF+  ++K  TNNFD         K+GEGGFG VYKG + + T +AV
Sbjct: 1   ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 270 KQLSS----KSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLAC 325
           K+L++     + +  ++F  EI +++  QH NLV++ G   +GD L LVY YM N SL  
Sbjct: 60  KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL-- 117
Query: 326 ALFGRENC---ELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP 382
               R +C      L W  R KI  G A G+ FLHE      +HRDIK+ N+LLD     
Sbjct: 118 --LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTA 172
Query: 383 KISDFGLAKLDEG-DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           KISDFGLA+  E   +T + +RI GT  YMAPE AL G +T K+D+YSFG+V LEI++G
Sbjct: 173 KISDFGLARASEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 230

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  166 bits (421), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 104/239 (43%), Positives = 141/239 (58%), Gaps = 23/239 (9%)
Query: 216 ETAFMKESDLQTISFTLKQIKAATNNFDS------AKKIGEGGFGPVYKGQLADGTIIAV 269
           E   ++ SD +  SF+  ++K  TNNFD         K+GEGGFG VYKG + + T +AV
Sbjct: 1   ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 270 KQLSS----KSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLAC 325
           K+L++     + +  ++F  EI +++  QH NLV++ G   +GD L LVY YM N SL  
Sbjct: 60  KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL-- 117
Query: 326 ALFGRENC---ELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP 382
               R +C      L W  R KI  G A G+ FLHE      +HRDIK+ N+LLD     
Sbjct: 118 --LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTA 172
Query: 383 KISDFGLAKLDEG-DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           KISDFGLA+  E   +T +  RI GT  YMAPE AL G +T K+D+YSFG+V LEI++G
Sbjct: 173 KISDFGLARASEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 230

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  163 bits (413), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 102/232 (43%), Positives = 137/232 (59%), Gaps = 23/232 (9%)
Query: 223 SDLQTISFTLKQIKAATNNFDS------AKKIGEGGFGPVYKGQLADGTIIAVKQLSS-- 274
           SD +  SF+  ++K  TNNFD         K+GEGGFG VYKG + + T +AVK+L++  
Sbjct: 2   SDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMV 60
Query: 275 --KSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGREN 332
              + +  ++F  EI +++  QH NLV++ G   +GD L LVY YM N SL      R +
Sbjct: 61  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL----LDRLS 116
Query: 333 C---ELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL 389
           C      L W  R KI  G A G+ FLHE      +HRDIK+ N+LLD     KISDFGL
Sbjct: 117 CLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGL 173
Query: 390 AKLDEG-DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           A+  E   +  +  RI GT  YMAPE AL G +T K+D+YSFG+V LEI++G
Sbjct: 174 ARASEKFAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 224

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  155 bits (391), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 98/226 (43%), Positives = 130/226 (57%), Gaps = 23/226 (10%)
Query: 229 SFTLKQIKAATNNFDS------AKKIGEGGFGPVYKGQLADGTIIAVKQLSS----KSRQ 278
           SF+  ++K  TNNFD         K GEGGFG VYKG + + T +AVK+L++     + +
Sbjct: 5   SFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 63
Query: 279 GNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENC---EL 335
             ++F  EI + +  QH NLV++ G   +GD L LVY Y  N SL      R +C     
Sbjct: 64  LKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSL----LDRLSCLDGTP 119
Query: 336 ELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG 395
            L W  R KI  G A G+ FLHE      +HRDIK+ N+LLD     KISDFGLA+  E 
Sbjct: 120 PLSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEK 176
Query: 396 DKTHI-STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
               +  +RI GT  Y APE AL G +T K+D+YSFG+V LEI++G
Sbjct: 177 FAQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITG 221

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 74/225 (32%), Positives = 116/225 (51%), Gaps = 12/225 (5%)
Query: 241 NFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNR--EFLNEIAMISCLQHPNL 298
           + +  +KIG G FG V++ +   G+ +AVK L  +     R  EFL E+A++  L+HPN+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
           V   G   +   L +V EY+   SL   L  +     +LD   R  +   +A+G+ +LH 
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSL-YRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALW 418
            +   IVHRD+K+ N+L+D+    K+ DFGL++L +      S   AGT  +MAPE    
Sbjct: 156 RNP-PIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KASXFLXSKXAAGTPEWMAPEVLRD 213
Query: 419 GYLTYKADVYSFGIVALEIVSGK------NNMSYAPALEFDCTCL 457
                K+DVYSFG++  E+ + +      N      A+ F C  L
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL 258

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 74/221 (33%), Positives = 117/221 (52%), Gaps = 14/221 (6%)
Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNR--EFLNEIAMISCLQHPNLVKIHG 303
           +KIG G FG V++ +   G+ +AVK L  +     R  EFL E+A++  L+HPN+V   G
Sbjct: 43  EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFK 363
              +   L +V EY+   SL   L  +     +LD   R  +   +A+G+ +LH  +   
Sbjct: 102 AVTQPPNLSIVTEYLSRGSL-YRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-P 159
Query: 364 IVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR-IAGTIGYMAPEYALWGYLT 422
           IVHR++K+ N+L+D+    K+ DFGL++L     T +S++  AGT  +MAPE        
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS--TFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 423 YKADVYSFGIVALEIVSGK------NNMSYAPALEFDCTCL 457
            K+DVYSFG++  E+ + +      N      A+ F C  L
Sbjct: 218 EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL 258

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 130/276 (47%), Gaps = 8/276 (2%)
Query: 214 HKETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLS 273
           H+ T     S  QT        +    +     K+G+G FG V+ G     T +A+K L 
Sbjct: 241 HRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK 300
Query: 274 SKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENC 333
             +      FL E  ++  L+H  LV+++    E + + +V EYM   SL   L G    
Sbjct: 301 PGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGK 358
Query: 334 ELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 393
            L L  P    +   IA G+A++    R   VHRD++A N+L+  +L  K++DFGLA+L 
Sbjct: 359 YLRL--PQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI 413
Query: 394 EGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFD 453
           E ++          I + APE AL+G  T K+DV+SFGI+  E+ + K  + Y   +  +
Sbjct: 414 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT-KGRVPYPGMVNRE 472
Query: 454 CTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAER 489
               ++    +    +  E + + +   ++KE  ER
Sbjct: 473 VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 508

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 111/226 (49%), Gaps = 7/226 (3%)
Query: 214 HKETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLS 273
           H+ T     S  QT        +    +     K+G+G FG V+ G     T +A+K L 
Sbjct: 158 HRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK 217
Query: 274 SKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENC 333
             +      FL E  ++  L+H  LV+++    E + + +V EYM   SL   L G    
Sbjct: 218 PGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGK 275
Query: 334 ELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 393
            L L  P    +   IA G+A++    R   VHRD++A N+L+  +L  K++DFGLA+L 
Sbjct: 276 YLRL--PQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI 330
Query: 394 EGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
           E ++          I + APE AL+G  T K+DV+SFGI+  E+ +
Sbjct: 331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 130/276 (47%), Gaps = 8/276 (2%)
Query: 214 HKETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLS 273
           H+ T     S  QT        +    +     K+G+G FG V+ G     T +A+K L 
Sbjct: 158 HRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK 217
Query: 274 SKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENC 333
             +      FL E  ++  L+H  LV+++    E + + +V EYM   SL   L G    
Sbjct: 218 PGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGK 275
Query: 334 ELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 393
            L L  P    +   IA G+A++    R   VHRD++A N+L+  +L  K++DFGLA+L 
Sbjct: 276 YLRL--PQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI 330
Query: 394 EGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFD 453
           E ++          I + APE AL+G  T K+DV+SFGI+  E+ + K  + Y   +  +
Sbjct: 331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT-KGRVPYPGMVNRE 389
Query: 454 CTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAER 489
               ++    +    +  E + + +   ++KE  ER
Sbjct: 390 VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 425

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 106/195 (54%), Gaps = 7/195 (3%)
Query: 245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
            +++G G FG V+ G     T +AVK L   S   +  FL E  ++  LQH  LV+++  
Sbjct: 19  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAV 77
Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
             + + + ++ EYMEN SL   L      +L ++      +   IA G+AF+ E +    
Sbjct: 78  VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---Y 131
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYK 424
           +HRD++A N+L+   L+ KI+DFGLA+L E ++          I + APE   +G  T K
Sbjct: 132 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 191
Query: 425 ADVYSFGIVALEIVS 439
           +DV+SFGI+  EIV+
Sbjct: 192 SDVWSFGILLTEIVT 206

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 106/195 (54%), Gaps = 7/195 (3%)
Query: 245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
            +++G G FG V+ G     T +AVK L   S   +  FL E  ++  LQH  LV+++  
Sbjct: 24  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAV 82
Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
             + + + ++ EYMEN SL   L      +L ++      +   IA G+AF+ E +    
Sbjct: 83  VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---Y 136
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYK 424
           +HRD++A N+L+   L+ KI+DFGLA+L E ++          I + APE   +G  T K
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 196
Query: 425 ADVYSFGIVALEIVS 439
           +DV+SFGI+  EIV+
Sbjct: 197 SDVWSFGILLTEIVT 211

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 106/195 (54%), Gaps = 7/195 (3%)
Query: 245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
            +++G G FG V+ G     T +AVK L   S   +  FL E  ++  LQH  LV+++  
Sbjct: 20  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAV 78
Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
             + + + ++ EYMEN SL   L      +L ++      +   IA G+AF+ E +    
Sbjct: 79  VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---Y 132
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYK 424
           +HRD++A N+L+   L+ KI+DFGLA+L E ++          I + APE   +G  T K
Sbjct: 133 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 192
Query: 425 ADVYSFGIVALEIVS 439
           +DV+SFGI+  EIV+
Sbjct: 193 SDVWSFGILLTEIVT 207

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 106/195 (54%), Gaps = 7/195 (3%)
Query: 245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
            +++G G FG V+ G     T +AVK L   S   +  FL E  ++  LQH  LV+++  
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAV 76
Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
             + + + ++ EYMEN SL   L      +L ++      +   IA G+AF+ E +    
Sbjct: 77  VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---Y 130
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYK 424
           +HRD++A N+L+   L+ KI+DFGLA+L E ++          I + APE   +G  T K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 425 ADVYSFGIVALEIVS 439
           +DV+SFGI+  EIV+
Sbjct: 191 SDVWSFGILLTEIVT 205

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 106/195 (54%), Gaps = 7/195 (3%)
Query: 245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
            +++G G FG V+ G     T +AVK L   S   +  FL E  ++  LQH  LV+++  
Sbjct: 26  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAV 84
Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
             + + + ++ EYMEN SL   L      +L ++      +   IA G+AF+ E +    
Sbjct: 85  VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---Y 138
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYK 424
           +HRD++A N+L+   L+ KI+DFGLA+L E ++          I + APE   +G  T K
Sbjct: 139 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 198
Query: 425 ADVYSFGIVALEIVS 439
           +DV+SFGI+  EIV+
Sbjct: 199 SDVWSFGILLTEIVT 213

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 106/195 (54%), Gaps = 7/195 (3%)
Query: 245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
            +++G G FG V+ G     T +AVK L   S   +  FL E  ++  LQH  LV+++  
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAV 76
Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
             + + + ++ EYMEN SL   L      +L ++      +   IA G+AF+ E +    
Sbjct: 77  VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---Y 130
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYK 424
           +HRD++A N+L+   L+ KI+DFGLA+L E ++          I + APE   +G  T K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 425 ADVYSFGIVALEIVS 439
           +DV+SFGI+  EIV+
Sbjct: 191 SDVWSFGILLTEIVT 205

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 130/276 (47%), Gaps = 8/276 (2%)
Query: 214 HKETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLS 273
           H+ T     S  QT        +    +     K+G+G FG V+ G     T +A+K L 
Sbjct: 158 HRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK 217
Query: 274 SKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENC 333
             +      FL E  ++  L+H  LV+++    E + + +V EYM   SL   L G    
Sbjct: 218 PGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVGEYMSKGSLLDFLKGETGK 275
Query: 334 ELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 393
            L L  P    +   IA G+A++    R   VHRD++A N+L+  +L  K++DFGLA+L 
Sbjct: 276 YLRL--PQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI 330
Query: 394 EGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFD 453
           E ++          I + APE AL+G  T K+DV+SFGI+  E+ + K  + Y   +  +
Sbjct: 331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT-KGRVPYPGMVNRE 389
Query: 454 CTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAER 489
               ++    +    +  E + + +   ++KE  ER
Sbjct: 390 VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 425

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 106/195 (54%), Gaps = 7/195 (3%)
Query: 245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
            +++G G FG V+ G     T +AVK L   S   +  FL E  ++  LQH  LV+++  
Sbjct: 27  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAV 85
Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
             + + + ++ EYMEN SL   L      +L ++      +   IA G+AF+ E +    
Sbjct: 86  VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---Y 139
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYK 424
           +HRD++A N+L+   L+ KI+DFGLA+L E ++          I + APE   +G  T K
Sbjct: 140 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 199
Query: 425 ADVYSFGIVALEIVS 439
           +DV+SFGI+  EIV+
Sbjct: 200 SDVWSFGILLTEIVT 214

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 19/216 (8%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQL------ADGTIIAVKQLSSKSRQGNREFLNEIAMISCL 293
           +N    +++GEG FG V+  +        D  ++AVK L   S    ++F  E  +++ L
Sbjct: 13  HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 72
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLA---------CALFGRENCELELDWPTRQK 344
           QH ++VK +G CVEGD L++V+EYM++  L            L    N   EL       
Sbjct: 73  QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLH 132
Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTR 403
           I   IA G+ +L  +     VHRD+   N L+  +L  KI DFG+++ +   D   +   
Sbjct: 133 IAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 189
Query: 404 IAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
               I +M PE  ++   T ++DV+S G+V  EI +
Sbjct: 190 TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 106/195 (54%), Gaps = 7/195 (3%)
Query: 245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
            +++G G FG V+ G     T +AVK L   S   +  FL E  ++  LQH  LV+++  
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAV 76
Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
             + + + ++ EYMEN SL   L      +L ++      +   IA G+AF+ E +    
Sbjct: 77  VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---Y 130
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYK 424
           +HRD++A N+L+   L+ KI+DFGLA+L E ++          I + APE   +G  T K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 425 ADVYSFGIVALEIVS 439
           +DV+SFGI+  EIV+
Sbjct: 191 SDVWSFGILLTEIVT 205

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 106/195 (54%), Gaps = 7/195 (3%)
Query: 245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
            +++G G FG V+ G     T +AVK L   S   +  FL E  ++  LQH  LV+++  
Sbjct: 24  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAV 82
Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
             + + + ++ EYMEN SL   L      +L ++      +   IA G+AF+ E +    
Sbjct: 83  VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---Y 136
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYK 424
           +HRD++A N+L+   L+ KI+DFGLA+L E ++          I + APE   +G  T K
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 196
Query: 425 ADVYSFGIVALEIVS 439
           +DV+SFGI+  EIV+
Sbjct: 197 SDVWSFGILLTEIVT 211

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 106/195 (54%), Gaps = 7/195 (3%)
Query: 245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
            +++G G FG V+ G     T +AVK L   S   +  FL E  ++  LQH  LV+++  
Sbjct: 23  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAV 81
Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
             + + + ++ EYMEN SL   L      +L ++      +   IA G+AF+ E +    
Sbjct: 82  VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---Y 135
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYK 424
           +HRD++A N+L+   L+ KI+DFGLA+L E ++          I + APE   +G  T K
Sbjct: 136 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 195
Query: 425 ADVYSFGIVALEIVS 439
           +DV+SFGI+  EIV+
Sbjct: 196 SDVWSFGILLTEIVT 210

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 106/201 (52%), Gaps = 8/201 (3%)
Query: 247 KIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCV 306
           K+G+G FG V+ G     T +A+K L   +      FL E  ++  L+H  LV+++    
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 307 EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVH 366
           E + + +V EYM   SL   L G     L L  P    +   IA G+A++    R   VH
Sbjct: 74  E-EPIXIVTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIASGMAYVE---RMNYVH 127
Query: 367 RDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKAD 426
           RD++A N+L+  +L  K++DFGLA+L E ++          I + APE AL+G  T K+D
Sbjct: 128 RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 187
Query: 427 VYSFGIVALEIVSGKNNMSYA 447
           V+SFGI+  E+ + K  + Y 
Sbjct: 188 VWSFGILLTELTT-KGRVPYP 207

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 106/195 (54%), Gaps = 7/195 (3%)
Query: 245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
            +++G G FG V+ G     T +AVK L   S   +  FL E  ++  LQH  LV+++  
Sbjct: 28  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAV 86
Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
             + + + ++ EYMEN SL   L      +L ++      +   IA G+AF+ E +    
Sbjct: 87  VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---Y 140
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYK 424
           +HRD++A N+L+   L+ KI+DFGLA+L E ++          I + APE   +G  T K
Sbjct: 141 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 200
Query: 425 ADVYSFGIVALEIVS 439
           +DV+SFGI+  EIV+
Sbjct: 201 SDVWSFGILLTEIVT 215

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 106/195 (54%), Gaps = 7/195 (3%)
Query: 245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
            +++G G FG V+ G     T +AVK L   S   +  FL E  ++  LQH  LV+++  
Sbjct: 13  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAV 71
Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
             + + + ++ EYMEN SL   L      +L ++      +   IA G+AF+ E +    
Sbjct: 72  VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---Y 125
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYK 424
           +HRD++A N+L+   L+ KI+DFGLA+L E ++          I + APE   +G  T K
Sbjct: 126 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 185
Query: 425 ADVYSFGIVALEIVS 439
           +DV+SFGI+  EIV+
Sbjct: 186 SDVWSFGILLTEIVT 200

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 106/201 (52%), Gaps = 8/201 (3%)
Query: 247 KIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCV 306
           K+G+G FG V+ G     T +A+K L   +      FL E  ++  L+H  LV+++    
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 307 EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVH 366
           E + + +V EYM   SL   L G     L L  P    +   IA G+A++    R   VH
Sbjct: 84  E-EPIYIVIEYMSKGSLLDFLKGEMGKYLRL--PQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 367 RDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKAD 426
           RD++A N+L+  +L  K++DFGLA+L E ++          I + APE AL+G  T K+D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 427 VYSFGIVALEIVSGKNNMSYA 447
           V+SFGI+  E+ + K  + Y 
Sbjct: 198 VWSFGILLTELTT-KGRVPYP 217

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 106/201 (52%), Gaps = 8/201 (3%)
Query: 247 KIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCV 306
           K+G+G FG V+ G     T +A+K L   +      FL E  ++  L+H  LV+++    
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 307 EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVH 366
           E + + +V EYM   SL   L G     L L  P    +   IA G+A++    R   VH
Sbjct: 77  E-EPIYIVTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIASGMAYVE---RMNYVH 130
Query: 367 RDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKAD 426
           RD++A N+L+  +L  K++DFGLA+L E ++          I + APE AL+G  T K+D
Sbjct: 131 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 190
Query: 427 VYSFGIVALEIVSGKNNMSYA 447
           V+SFGI+  E+ + K  + Y 
Sbjct: 191 VWSFGILLTELTT-KGRVPYP 210

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 106/201 (52%), Gaps = 8/201 (3%)
Query: 247 KIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCV 306
           K+G+G FG V+ G     T +A+K L   +      FL E  ++  L+H  LV+++    
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 307 EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVH 366
           E + + +V EYM   SL   L G     L L  P    +   IA G+A++    R   VH
Sbjct: 81  E-EPIYIVTEYMNKGSLLDFLKGETGKYLRL--PQLVDMSAQIASGMAYVE---RMNYVH 134
Query: 367 RDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKAD 426
           RD++A N+L+  +L  K++DFGLA+L E ++          I + APE AL+G  T K+D
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSD 194
Query: 427 VYSFGIVALEIVSGKNNMSYA 447
           V+SFGI+  E+ + K  + Y 
Sbjct: 195 VWSFGILLTELTT-KGRVPYP 214

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 102/195 (52%), Gaps = 6/195 (3%)
Query: 245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
            K++G G FG V+ G   + T +AVK L   +    + FL E  ++  LQH  LV+++  
Sbjct: 18  VKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAV 76
Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
               + + ++ EYM   SL   L   E  ++ L  P        IA G+A++    R   
Sbjct: 77  VTREEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RKNY 131
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYK 424
           +HRD++A NVL+   L  KI+DFGLA++ E ++          I + APE   +G  T K
Sbjct: 132 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIK 191
Query: 425 ADVYSFGIVALEIVS 439
           +DV+SFGI+  EIV+
Sbjct: 192 SDVWSFGILLYEIVT 206

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 106/201 (52%), Gaps = 8/201 (3%)
Query: 247 KIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCV 306
           K+G+G FG V+ G     T +A+K L   +      FL E  ++  L+H  LV+++    
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 307 EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVH 366
           E + + +V EYM   SL   L G     L L  P    +   IA G+A++    R   VH
Sbjct: 73  E-EPIYIVTEYMSKGSLLDFLKGEMGKYLRL--PQLVDMAAQIASGMAYVE---RMNYVH 126
Query: 367 RDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKAD 426
           RD++A N+L+  +L  K++DFGLA+L E ++          I + APE AL+G  T K+D
Sbjct: 127 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 186
Query: 427 VYSFGIVALEIVSGKNNMSYA 447
           V+SFGI+  E+ + K  + Y 
Sbjct: 187 VWSFGILLTELTT-KGRVPYP 206

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 106/201 (52%), Gaps = 8/201 (3%)
Query: 247 KIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCV 306
           K+G+G FG V+ G     T +A+K L   +      FL E  ++  L+H  LV+++    
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 307 EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVH 366
           E + + +V EYM   SL   L G     L L  P    +   IA G+A++    R   VH
Sbjct: 84  E-EPIYIVTEYMSKGSLLDFLKGEMGKYLRL--PQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 367 RDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKAD 426
           RD++A N+L+  +L  K++DFGLA+L E ++          I + APE AL+G  T K+D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 427 VYSFGIVALEIVSGKNNMSYA 447
           V+SFGI+  E+ + K  + Y 
Sbjct: 198 VWSFGILLTELTT-KGRVPYP 217

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 106/201 (52%), Gaps = 8/201 (3%)
Query: 247 KIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCV 306
           K+G+G FG V+ G     T +A+K L   +      FL E  ++  L+H  LV+++    
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 307 EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVH 366
           E + + +V EYM   SL   L G     L L  P    +   IA G+A++    R   VH
Sbjct: 75  E-EPIYIVTEYMSKGSLLDFLKGEMGKYLRL--PQLVDMAAQIASGMAYVE---RMNYVH 128
Query: 367 RDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKAD 426
           RD++A N+L+  +L  K++DFGLA+L E ++          I + APE AL+G  T K+D
Sbjct: 129 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 188
Query: 427 VYSFGIVALEIVSGKNNMSYA 447
           V+SFGI+  E+ + K  + Y 
Sbjct: 189 VWSFGILLTELTT-KGRVPYP 208

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 106/201 (52%), Gaps = 8/201 (3%)
Query: 247 KIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCV 306
           K+G+G FG V+ G     T +A+K L   +      FL E  ++  L+H  LV+++    
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 307 EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVH 366
           E + + +V EYM   SL   L G     L L  P    +   IA G+A++    R   VH
Sbjct: 81  E-EPIYIVTEYMNKGSLLDFLKGETGKYLRL--PQLVDMSAQIASGMAYVE---RMNYVH 134
Query: 367 RDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKAD 426
           RD++A N+L+  +L  K++DFGLA+L E ++          I + APE AL+G  T K+D
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 194
Query: 427 VYSFGIVALEIVSGKNNMSYA 447
           V+SFGI+  E+ + K  + Y 
Sbjct: 195 VWSFGILLTELTT-KGRVPYP 214

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 106/201 (52%), Gaps = 8/201 (3%)
Query: 247 KIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCV 306
           K+G+G FG V+ G     T +A+K L   +      FL E  ++  L+H  LV+++    
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 307 EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVH 366
           E + + +V EYM   SL   L G     L L  P    +   IA G+A++    R   VH
Sbjct: 84  E-EPIYIVIEYMSKGSLLDFLKGEMGKYLRL--PQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 367 RDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKAD 426
           RD++A N+L+  +L  K++DFGLA+L E ++          I + APE AL+G  T K+D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 427 VYSFGIVALEIVSGKNNMSYA 447
           V+SFGI+  E+ + K  + Y 
Sbjct: 198 VWSFGILLTELTT-KGRVPYP 217

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 66/194 (34%), Positives = 104/194 (53%), Gaps = 7/194 (3%)
Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           K++G G FG V+ G     T +A+K L   +      FL E  ++  L+H  LV+++   
Sbjct: 15  KRLGNGQFGEVWMGTWNGNTKVAIKTLKPGT-MSPESFLEEAQIMKKLKHDKLVQLYAVV 73
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
            E + + +V EYM   SL   L   E   L+L  P    +   +A G+A++    R   +
Sbjct: 74  SE-EPIYIVTEYMNKGSLLDFLKDGEGRALKL--PNLVDMAAQVAAGMAYIE---RMNYI 127
Query: 366 HRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKA 425
           HRD+++ N+L+   L  KI+DFGLA+L E ++          I + APE AL+G  T K+
Sbjct: 128 HRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 187
Query: 426 DVYSFGIVALEIVS 439
           DV+SFGI+  E+V+
Sbjct: 188 DVWSFGILLTELVT 201

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 109/226 (48%), Gaps = 7/226 (3%)
Query: 214 HKETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLS 273
           H+ T     S  QT        +    +     K+G+G FG V+ G     T +A+K L 
Sbjct: 159 HRLTNVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK 218
Query: 274 SKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENC 333
                    FL E  ++  L+H  LV+++    E + + +V EYM   SL   L G    
Sbjct: 219 P-GNMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGK 276
Query: 334 ELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 393
            L L  P    +   IA G+A++    R   VHRD++A N+L+  +L  K++DFGL +L 
Sbjct: 277 YLRL--PQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLGRLI 331
Query: 394 EGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
           E ++          I + APE AL+G  T K+DV+SFGI+  E+ +
Sbjct: 332 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 377

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 106/201 (52%), Gaps = 8/201 (3%)
Query: 247 KIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCV 306
           K+G+G FG V+ G     T +A+K L   +      FL E  ++  L+H  LV+++    
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 307 EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVH 366
           E + + +V EYM   SL   L G     L L  P    +   IA G+A++    R   VH
Sbjct: 84  E-EPIYIVCEYMSKGSLLDFLKGEMGKYLRL--PQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 367 RDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKAD 426
           RD++A N+L+  +L  K++DFGLA+L E ++          I + APE AL+G  T K+D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 427 VYSFGIVALEIVSGKNNMSYA 447
           V+SFGI+  E+ + K  + Y 
Sbjct: 198 VWSFGILLTELTT-KGRVPYP 217

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 106/195 (54%), Gaps = 7/195 (3%)
Query: 245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
            +++G G FG V+ G     T +AVK L   S   +  FL E  ++  LQH  LV+++  
Sbjct: 14  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAV 72
Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
             + + + ++ EYMEN SL   L      +L ++      +   IA G+AF+ E +    
Sbjct: 73  VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---Y 126
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYK 424
           +HR+++A N+L+   L+ KI+DFGLA+L E ++          I + APE   +G  T K
Sbjct: 127 IHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 186
Query: 425 ADVYSFGIVALEIVS 439
           +DV+SFGI+  EIV+
Sbjct: 187 SDVWSFGILLTEIVT 201

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 106/201 (52%), Gaps = 8/201 (3%)
Query: 247 KIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCV 306
           K+G+G FG V+ G     T +A+K L   +      FL E  ++  ++H  LV+++    
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 307 EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVH 366
           E + + +V EYM   SL   L G     L L  P    +   IA G+A++    R   VH
Sbjct: 84  E-EPIYIVTEYMSKGSLLDFLKGEMGKYLRL--PQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 367 RDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKAD 426
           RD++A N+L+  +L  K++DFGLA+L E ++          I + APE AL+G  T K+D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 427 VYSFGIVALEIVSGKNNMSYA 447
           V+SFGI+  E+ + K  + Y 
Sbjct: 198 VWSFGILLTELTT-KGRVPYP 217

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  101 bits (252), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 105/201 (52%), Gaps = 8/201 (3%)
Query: 247 KIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCV 306
           K+G+G FG V+ G     T +A+K L   +      FL E  ++  L+H  LV+++    
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 307 EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVH 366
           E + + +V EYM   SL   L G     L L  P    +   IA G+A++    R   VH
Sbjct: 84  E-EPIYIVTEYMSKGSLLDFLKGEMGKYLRL--PQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 367 RDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKAD 426
           RD+ A N+L+  +L  K++DFGLA+L E ++          I + APE AL+G  T K+D
Sbjct: 138 RDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 427 VYSFGIVALEIVSGKNNMSYA 447
           V+SFGI+  E+ + K  + Y 
Sbjct: 198 VWSFGILLTELTT-KGRVPYP 217

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 105/201 (52%), Gaps = 8/201 (3%)
Query: 247 KIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCV 306
           K+G+G FG V+ G     T +A+K L   +      FL E  ++  L+H  LV+++    
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 307 EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVH 366
           E + + +V EYM    L   L G     L L  P    +   IA G+A++    R   VH
Sbjct: 84  E-EPIYIVMEYMSKGCLLDFLKGEMGKYLRL--PQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 367 RDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKAD 426
           RD++A N+L+  +L  K++DFGLA+L E ++          I + APE AL+G  T K+D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 427 VYSFGIVALEIVSGKNNMSYA 447
           V+SFGI+  E+ + K  + Y 
Sbjct: 198 VWSFGILLTELTT-KGRVPYP 217

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 101/194 (52%), Gaps = 7/194 (3%)
Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           KK+G G FG V+       T +AVK +   S      FL E  ++  LQH  LVK+H   
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLH-AV 251
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
           V  + + ++ E+M   SL   L   E  +  L  P        IA G+AF+ + +    +
Sbjct: 252 VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YI 306
Query: 366 HRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKA 425
           HRD++A N+L+   L  KI+DFGLA++ E ++          I + APE   +G  T K+
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 366
Query: 426 DVYSFGIVALEIVS 439
           DV+SFGI+ +EIV+
Sbjct: 367 DVWSFGILLMEIVT 380

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 103/195 (52%), Gaps = 6/195 (3%)
Query: 245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
            KK+G G FG V+ G   + T +AVK L   +    + FL E  ++  LQH  LV+++  
Sbjct: 17  VKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAV 75
Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
             + + + ++ E+M   SL   L   E  ++ L  P        IA G+A++    R   
Sbjct: 76  VTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RKNY 130
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYK 424
           +HRD++A NVL+   L  KI+DFGLA++ E ++          I + APE   +G  T K
Sbjct: 131 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIK 190
Query: 425 ADVYSFGIVALEIVS 439
           ++V+SFGI+  EIV+
Sbjct: 191 SNVWSFGILLYEIVT 205

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/227 (32%), Positives = 119/227 (52%), Gaps = 19/227 (8%)
Query: 222 ESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLA----DGTIIAVKQLS-SKS 276
           E   QT+    K++ A   + D  K +G G FG V  G+L         +A+K L    +
Sbjct: 29  EDPTQTVHEFAKELDATNISID--KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 277 RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELE 336
            +  R+FL E +++    HPN++++ G   +   +++V EYMEN SL    F R++   +
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKH---D 141
Query: 337 LDWPTRQKICL--GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 394
             +   Q + +  GIA G+ +L   S    VHRD+ A N+L++ +L  K+SDFGLA++ E
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLE 198
Query: 395 GDKTHISTRIAGTIG--YMAPEYALWGYLTYKADVYSFGIVALEIVS 439
            D     T   G I   + +PE   +   T  +DV+S+GIV  E++S
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 105/201 (52%), Gaps = 8/201 (3%)
Query: 247 KIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCV 306
           K+G+G FG V+ G     T +A+K L   +      FL E  ++  L+H  LV+++    
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 307 EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVH 366
           E + + +V EYM    L   L G     L L  P    +   IA G+A++    R   VH
Sbjct: 84  E-EPIYIVTEYMSKGCLLDFLKGEMGKYLRL--PQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 367 RDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKAD 426
           RD++A N+L+  +L  K++DFGLA+L E ++          I + APE AL+G  T K+D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 427 VYSFGIVALEIVSGKNNMSYA 447
           V+SFGI+  E+ + K  + Y 
Sbjct: 198 VWSFGILLTELTT-KGRVPYP 217

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 101/194 (52%), Gaps = 7/194 (3%)
Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           KK+G G FG V+       T +AVK +   S      FL E  ++  LQH  LVK+H   
Sbjct: 21  KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV- 78
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
           V  + + ++ E+M   SL   L   E  +  L  P        IA G+AF+ + +    +
Sbjct: 79  VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YI 133
Query: 366 HRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKA 425
           HRD++A N+L+   L  KI+DFGLA++ E ++          I + APE   +G  T K+
Sbjct: 134 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 193
Query: 426 DVYSFGIVALEIVS 439
           DV+SFGI+ +EIV+
Sbjct: 194 DVWSFGILLMEIVT 207

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/227 (31%), Positives = 119/227 (52%), Gaps = 19/227 (8%)
Query: 222 ESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLA----DGTIIAVKQLS-SKS 276
           E   QT+    K++ A   + D  K +G G FG V  G+L         +A+K L    +
Sbjct: 29  EDPTQTVHEFAKELDATNISID--KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 277 RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELE 336
            +  R+FL E +++    HPN++++ G   +   +++V EYMEN SL    F R++   +
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKH---D 141
Query: 337 LDWPTRQKICL--GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 394
             +   Q + +  GIA G+ +L   S    VHRD+ A N+L++ +L  K+SDFGL+++ E
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 395 GDKTHISTRIAGTIG--YMAPEYALWGYLTYKADVYSFGIVALEIVS 439
            D     T   G I   + +PE   +   T  +DV+S+GIV  E++S
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 104/195 (53%), Gaps = 7/195 (3%)
Query: 245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
            +++G G  G V+ G     T +AVK L   S   +  FL E  ++  LQH  LV+++  
Sbjct: 18  VERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAV 76
Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
             + + + ++ EYMEN SL   L      +L ++      +   IA G+AF+ E +    
Sbjct: 77  VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---Y 130
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYK 424
           +HRD++A N+L+   L+ KI+DFGLA+L E  +          I + APE   +G  T K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 425 ADVYSFGIVALEIVS 439
           +DV+SFGI+  EIV+
Sbjct: 191 SDVWSFGILLTEIVT 205

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 72/227 (31%), Positives = 119/227 (52%), Gaps = 19/227 (8%)
Query: 222 ESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLA----DGTIIAVKQLS-SKS 276
           E   QT+    K++ A   + D  K +G G FG V  G+L         +A+K L    +
Sbjct: 29  EDPTQTVHEFAKELDATNISID--KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 277 RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELE 336
            +  R+FL E +++    HPN++++ G   +   +++V EYMEN SL    F R++   +
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKH---D 141
Query: 337 LDWPTRQKICL--GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 394
             +   Q + +  GIA G+ +L   S    VHRD+ A N+L++ +L  K+SDFGL+++ E
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 395 GDKTHISTRIAGTIG--YMAPEYALWGYLTYKADVYSFGIVALEIVS 439
            D     T   G I   + +PE   +   T  +DV+S+GIV  E++S
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 72/227 (31%), Positives = 119/227 (52%), Gaps = 19/227 (8%)
Query: 222 ESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLA----DGTIIAVKQLS-SKS 276
           E   QT+    K++ A   + D  K +G G FG V  G+L         +A+K L    +
Sbjct: 29  EDPTQTVHEFAKELDATNISID--KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 277 RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELE 336
            +  R+FL E +++    HPN++++ G   +   +++V EYMEN SL    F R++   +
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKH---D 141
Query: 337 LDWPTRQKICL--GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 394
             +   Q + +  GIA G+ +L   S    VHRD+ A N+L++ +L  K+SDFGL+++ E
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 395 GDKTHISTRIAGTIG--YMAPEYALWGYLTYKADVYSFGIVALEIVS 439
            D     T   G I   + +PE   +   T  +DV+S+GIV  E++S
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 72/227 (31%), Positives = 119/227 (52%), Gaps = 19/227 (8%)
Query: 222 ESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLA----DGTIIAVKQLS-SKS 276
           E   QT+    K++ A   + D  K +G G FG V  G+L         +A+K L    +
Sbjct: 29  EDPTQTVHEFAKELDATNISID--KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 277 RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELE 336
            +  R+FL E +++    HPN++++ G   +   +++V EYMEN SL    F R++   +
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKH---D 141
Query: 337 LDWPTRQKICL--GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 394
             +   Q + +  GIA G+ +L   S    VHRD+ A N+L++ +L  K+SDFGL+++ E
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 395 GDKTHISTRIAGTIG--YMAPEYALWGYLTYKADVYSFGIVALEIVS 439
            D     T   G I   + +PE   +   T  +DV+S+GIV  E++S
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 72/227 (31%), Positives = 119/227 (52%), Gaps = 19/227 (8%)
Query: 222 ESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLA----DGTIIAVKQLS-SKS 276
           E   QT+    K++ A   + D  K +G G FG V  G+L         +A+K L    +
Sbjct: 29  EDPTQTVHEFAKELDATNISID--KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 277 RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELE 336
            +  R+FL E +++    HPN++++ G   +   +++V EYMEN SL    F R++   +
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKH---D 141
Query: 337 LDWPTRQKICL--GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 394
             +   Q + +  GIA G+ +L   S    VHRD+ A N+L++ +L  K+SDFGL+++ E
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 395 GDKTHISTRIAGTIG--YMAPEYALWGYLTYKADVYSFGIVALEIVS 439
            D     T   G I   + +PE   +   T  +DV+S+GIV  E++S
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 72/227 (31%), Positives = 119/227 (52%), Gaps = 19/227 (8%)
Query: 222 ESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLA----DGTIIAVKQLS-SKS 276
           E   QT+    K++ A   + D  K +G G FG V  G+L         +A+K L    +
Sbjct: 27  EDPTQTVHEFAKELDATNISID--KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 84
Query: 277 RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELE 336
            +  R+FL E +++    HPN++++ G   +   +++V EYMEN SL    F R++   +
Sbjct: 85  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKH---D 139
Query: 337 LDWPTRQKICL--GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 394
             +   Q + +  GIA G+ +L   S    VHRD+ A N+L++ +L  K+SDFGL+++ E
Sbjct: 140 AQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 196
Query: 395 GDKTHISTRIAGTIG--YMAPEYALWGYLTYKADVYSFGIVALEIVS 439
            D     T   G I   + +PE   +   T  +DV+S+GIV  E++S
Sbjct: 197 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 243

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 72/227 (31%), Positives = 118/227 (51%), Gaps = 19/227 (8%)
Query: 222 ESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLA----DGTIIAVKQLS-SKS 276
           E   QT+    K++ A   + D  K +G G FG V  G+L         +A+K L    +
Sbjct: 29  EDPTQTVHEFAKELDATNISID--KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 277 RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELE 336
            +  R+FL E +++    HPN++++ G   +   +++V EYMEN SL    F R++   +
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKH---D 141
Query: 337 LDWPTRQKICL--GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 394
             +   Q + +  GIA G+ +L   S    VHRD+ A N+L++ +L  K+SDFGL ++ E
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198
Query: 395 GDKTHISTRIAGTIG--YMAPEYALWGYLTYKADVYSFGIVALEIVS 439
            D     T   G I   + +PE   +   T  +DV+S+GIV  E++S
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 104/201 (51%), Gaps = 19/201 (9%)
Query: 245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
            ++IG G FG V+ G   +   +A+K +   +     +F+ E  ++  L HP LV+++G 
Sbjct: 12  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 305 CVEGDQLLLVYEYMENNSLA------CALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
           C+E   + LV+E+ME+  L+        LF  E         T   +CL +  G+A+L E
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE---------TLLGMCLDVCEGMAYLEE 121
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALW 418
            S   ++HRD+ A N L+  +   K+SDFG+ +    D+   ST     + + +PE   +
Sbjct: 122 AS---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 178
Query: 419 GYLTYKADVYSFGIVALEIVS 439
              + K+DV+SFG++  E+ S
Sbjct: 179 SRYSSKSDVWSFGVLMWEVFS 199

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 118/223 (52%), Gaps = 19/223 (8%)
Query: 226 QTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLA----DGTIIAVKQLS-SKSRQGN 280
           QT+    K++ A   + D  K +G G FG V  G+L         +A+K L    + +  
Sbjct: 4   QTVHEFAKELDATNISID--KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 61
Query: 281 REFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWP 340
           R+FL E +++    HPN++++ G   +   +++V EYMEN SL    F R++   +  + 
Sbjct: 62  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKH---DAQFT 116
Query: 341 TRQKICL--GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT 398
             Q + +  GIA G+ +L   S    VHRD+ A N+L++ +L  K+SDFGL+++ E D  
Sbjct: 117 VIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 173
Query: 399 HISTRIAGTIG--YMAPEYALWGYLTYKADVYSFGIVALEIVS 439
              T   G I   + +PE   +   T  +DV+S+GIV  E++S
Sbjct: 174 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 118/223 (52%), Gaps = 19/223 (8%)
Query: 226 QTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLA----DGTIIAVKQLS-SKSRQGN 280
           QT+    K++ A   + D  K +G G FG V  G+L         +A+K L    + +  
Sbjct: 21  QTVHEFAKELDATNISID--KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 78
Query: 281 REFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWP 340
           R+FL E +++    HPN++++ G   +   +++V EYMEN SL    F R++   +  + 
Sbjct: 79  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKH---DAQFT 133
Query: 341 TRQKICL--GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT 398
             Q + +  GIA G+ +L   S    VHRD+ A N+L++ +L  K+SDFGL+++ E D  
Sbjct: 134 VIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 190
Query: 399 HISTRIAGTIG--YMAPEYALWGYLTYKADVYSFGIVALEIVS 439
              T   G I   + +PE   +   T  +DV+S+GIV  E++S
Sbjct: 191 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 128/270 (47%), Gaps = 37/270 (13%)
Query: 248 IGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVE 307
           +G G FG V K +      +A+KQ+ S+S +  + F+ E+  +S + HPN+VK++G C+ 
Sbjct: 17  VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL- 72
Query: 308 GDQLLLVYEYMENNSLACALFGRENCEL-----ELDWPTRQKICLGIARGLAFLHEESRF 362
            + + LV EY E  SL   L G E          + W      CL  ++G+A+LH     
Sbjct: 73  -NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW------CLQCSQGVAYLHSMQPK 125
Query: 363 KIVHRDIKATNVLLDRDLNP-KISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYL 421
            ++HRD+K  N+LL       KI DFG A      +TH+ T   G+  +MAPE       
Sbjct: 126 ALIHRDLKPPNLLLVAGGTVLKICDFGTAC---DIQTHM-TNNKGSAAWMAPEVFEGSNY 181
Query: 422 TYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSK 481
           + K DV+S+GI+  E+++ +          F     + WA H      L++ + + + S 
Sbjct: 182 SEKCDVFSWGIILWEVITRRKPFDEIGGPAFR----IMWAVHNGTRPPLIKNLPKPIESL 237
Query: 482 YKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
             +            C +  PS RP+M E+
Sbjct: 238 MTR------------CWSKDPSQRPSMEEI 255

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 128/270 (47%), Gaps = 37/270 (13%)
Query: 248 IGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVE 307
           +G G FG V K +      +A+KQ+ S+S +  + F+ E+  +S + HPN+VK++G C+ 
Sbjct: 16  VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL- 71
Query: 308 GDQLLLVYEYMENNSLACALFGRENCEL-----ELDWPTRQKICLGIARGLAFLHEESRF 362
            + + LV EY E  SL   L G E          + W      CL  ++G+A+LH     
Sbjct: 72  -NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW------CLQCSQGVAYLHSMQPK 124
Query: 363 KIVHRDIKATNVLLDRDLNP-KISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYL 421
            ++HRD+K  N+LL       KI DFG A      +TH++    G+  +MAPE       
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTAC---DIQTHMTNN-KGSAAWMAPEVFEGSNY 180
Query: 422 TYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSK 481
           + K DV+S+GI+  E+++ +          F     + WA H      L++ + + + S 
Sbjct: 181 SEKCDVFSWGIILWEVITRRKPFDEIGGPAFR----IMWAVHNGTRPPLIKNLPKPIESL 236
Query: 482 YKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
             +            C +  PS RP+M E+
Sbjct: 237 MTR------------CWSKDPSQRPSMEEI 254

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 140/290 (48%), Gaps = 42/290 (14%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGN-------REFLNEIAM 289
           A N  +  K+IG+GGFG V+KG+L  D +++A+K L     +G        +EF  E+ +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGI 349
           +S L HPN+VK++G      +  +V E++    L   L  + +    + W  + ++ L I
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDI 131
Query: 350 ARGLAFLHEESRFKIVHRDIKATNVLL-----DRDLNPKISDFGLAKLDEGDKTHISTRI 404
           A G+ ++  ++   IVHRD+++ N+ L     +  +  K++DFGL++       H  + +
Sbjct: 132 ALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGL 186
Query: 405 AGTIGYMAPEY--ALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWAC 462
            G   +MAPE   A     T KAD YSF ++   I++G+      P  E+    +     
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE-----GPFDEYSYGKI----- 236
Query: 463 HLQQDGKLVELV-DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                 K + ++ +E L     ++   R+  V  LC +  P  RP  S +
Sbjct: 237 ------KFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYI 280

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 104/201 (51%), Gaps = 19/201 (9%)
Query: 245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
            ++IG G FG V+ G   +   +A+K +   S   + +F+ E  ++  L HP LV+++G 
Sbjct: 32  VQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSED-DFIEEAEVMMKLSHPKLVQLYGV 90
Query: 305 CVEGDQLLLVYEYMENNSLA------CALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
           C+E   + LV+E+ME+  L+        LF  E         T   +CL +  G+A+L E
Sbjct: 91  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE---------TLLGMCLDVCEGMAYLEE 141
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALW 418
                ++HRD+ A N L+  +   K+SDFG+ +    D+   ST     + + +PE   +
Sbjct: 142 AC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 198
Query: 419 GYLTYKADVYSFGIVALEIVS 439
              + K+DV+SFG++  E+ S
Sbjct: 199 SRYSSKSDVWSFGVLMWEVFS 219

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 103/201 (51%), Gaps = 19/201 (9%)
Query: 245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
            ++IG G FG V+ G   +   +A+K +   +     +F+ E  ++  L HP LV+++G 
Sbjct: 15  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGV 73
Query: 305 CVEGDQLLLVYEYMENNSLA------CALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
           C+E   + LV+E+ME+  L+        LF  E         T   +CL +  G+A+L E
Sbjct: 74  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE---------TLLGMCLDVCEGMAYLEE 124
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALW 418
                ++HRD+ A N L+  +   K+SDFG+ +    D+   ST     + + +PE   +
Sbjct: 125 AC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 181
Query: 419 GYLTYKADVYSFGIVALEIVS 439
              + K+DV+SFG++  E+ S
Sbjct: 182 SRYSSKSDVWSFGVLMWEVFS 202

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 108/201 (53%), Gaps = 11/201 (5%)
Query: 245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
            ++IG G FG VYKG+      + +  +++ + Q  + F NE+ ++   +H N++   G 
Sbjct: 17  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
             +  QL +V ++ E +SL   L      E + +      I    ARG+ +LH +S   I
Sbjct: 77  STK-PQLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAKS---I 129
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKL-DEGDKTHISTRIAGTIGYMAPEYALW---GY 420
           +HRD+K+ N+ L  D   KI DFGLA +      +H   +++G+I +MAPE         
Sbjct: 130 IHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 189
Query: 421 LTYKADVYSFGIVALEIVSGK 441
            ++++DVY+FGIV  E+++G+
Sbjct: 190 YSFQSDVYAFGIVLYELMTGQ 210

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 103/201 (51%), Gaps = 19/201 (9%)
Query: 245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
            ++IG G FG V+ G   +   +A+K +   +     +F+ E  ++  L HP LV+++G 
Sbjct: 10  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 305 CVEGDQLLLVYEYMENNSLA------CALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
           C+E   + LV+E+ME+  L+        LF  E         T   +CL +  G+A+L E
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE---------TLLGMCLDVCEGMAYLEE 119
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALW 418
                ++HRD+ A N L+  +   K+SDFG+ +    D+   ST     + + +PE   +
Sbjct: 120 AC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176
Query: 419 GYLTYKADVYSFGIVALEIVS 439
              + K+DV+SFG++  E+ S
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFS 197

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 103/201 (51%), Gaps = 19/201 (9%)
Query: 245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
            ++IG G FG V+ G   +   +A+K +   +     +F+ E  ++  L HP LV+++G 
Sbjct: 12  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 305 CVEGDQLLLVYEYMENNSLA------CALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
           C+E   + LV+E+ME+  L+        LF  E         T   +CL +  G+A+L E
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE---------TLLGMCLDVCEGMAYLEE 121
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALW 418
                ++HRD+ A N L+  +   K+SDFG+ +    D+   ST     + + +PE   +
Sbjct: 122 AC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 178
Query: 419 GYLTYKADVYSFGIVALEIVS 439
              + K+DV+SFG++  E+ S
Sbjct: 179 SRYSSKSDVWSFGVLMWEVFS 199

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 106/197 (53%), Gaps = 10/197 (5%)
Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
           +KIG+G  G VY    +A G  +A++Q++ + +      +NEI ++   ++PN+V     
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
            + GD+L +V EY+   SL   +   E C   +D      +C    + L FLH     ++
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV--TETC---MDEGQIAAVCRECLQALEFLHSN---QV 137
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYK 424
           +HRDIK+ N+LL  D + K++DFG       +++  ST + GT  +MAPE         K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 196
Query: 425 ADVYSFGIVALEIVSGK 441
            D++S GI+A+E++ G+
Sbjct: 197 VDIWSLGIMAIEMIEGE 213

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 118/227 (51%), Gaps = 19/227 (8%)
Query: 222 ESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLA----DGTIIAVKQLS-SKS 276
           E   QT+    K++ A   + D  K +G G FG V  G+L         +A+K L    +
Sbjct: 29  EDPTQTVHEFAKELDATNISID--KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 277 RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELE 336
            +  R+FL E +++    HPN++++ G   +   +++V E MEN SL    F R++   +
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDS--FLRKH---D 141
Query: 337 LDWPTRQKICL--GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 394
             +   Q + +  GIA G+ +L   S    VHRD+ A N+L++ +L  K+SDFGL+++ E
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 395 GDKTHISTRIAGTIG--YMAPEYALWGYLTYKADVYSFGIVALEIVS 439
            D     T   G I   + +PE   +   T  +DV+S+GIV  E++S
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 118/227 (51%), Gaps = 19/227 (8%)
Query: 222 ESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLA----DGTIIAVKQLS-SKS 276
           E   QT+    K++ A   + D  K +G G FG V  G+L         +A+K L    +
Sbjct: 29  EDPTQTVHEFAKELDATNISID--KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 277 RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELE 336
            +  R+FL E +++    HPN++++ G   +   +++V E MEN SL    F R++   +
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDS--FLRKH---D 141
Query: 337 LDWPTRQKICL--GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 394
             +   Q + +  GIA G+ +L   S    VHRD+ A N+L++ +L  K+SDFGL+++ E
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 395 GDKTHISTRIAGTIG--YMAPEYALWGYLTYKADVYSFGIVALEIVS 439
            D     T   G I   + +PE   +   T  +DV+S+GIV  E++S
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 109/201 (54%), Gaps = 11/201 (5%)
Query: 245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
            ++IG G FG VYKG+      + +  +++ + Q  + F NE+ ++   +H N++   G 
Sbjct: 40  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 99
Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
             +  QL +V ++ E +SL   L      E + +      I    A+G+ +LH +S   I
Sbjct: 100 STK-PQLAIVTQWCEGSSLYHHL---HIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 152
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKL-DEGDKTHISTRIAGTIGYMAPEYALW---GY 420
           +HRD+K+ N+ L  DL  KI DFGLA +      +H   +++G+I +MAPE         
Sbjct: 153 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 212
Query: 421 LTYKADVYSFGIVALEIVSGK 441
            ++++DVY+FGIV  E+++G+
Sbjct: 213 YSFQSDVYAFGIVLYELMTGQ 233

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 106/202 (52%), Gaps = 14/202 (6%)
Query: 246 KKIGEGGFGPVYKGQLADGT-----IIAVKQLSSKSRQGNR-EFLNEIAMISCLQHPNLV 299
           K IG G FG VYKG L   +      +A+K L +   +  R +FL E  ++    H N++
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
           ++ G   +   ++++ EYMEN +L    F RE  + E        +  GIA G+ +L   
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDK--FLREK-DGEFSVLQLVGMLRGIAAGMKYL--- 163
Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIG--YMAPEYAL 417
           +    VHRD+ A N+L++ +L  K+SDFGL+++ E D     T   G I   + APE   
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 418 WGYLTYKADVYSFGIVALEIVS 439
           +   T  +DV+SFGIV  E+++
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMT 245

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 116/220 (52%), Gaps = 20/220 (9%)
Query: 229 SFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQL----ADGTIIAVKQLSSK-SRQGNREF 283
           SFT ++I+A+  + +  K IG G  G V  G+L         +A+K L +  + +  R+F
Sbjct: 41  SFT-REIEASRIHIE--KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDF 97
Query: 284 LNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQ 343
           L+E +++    HPN++++ G    G   ++V EYMEN SL   L   +       +   Q
Sbjct: 98  LSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG-----QFTIMQ 152
Query: 344 KICL--GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS 401
            + +  G+  G+ +L   S    VHRD+ A NVL+D +L  K+SDFGL+++ E D     
Sbjct: 153 LVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAX 209
Query: 402 TRIAGTIG--YMAPEYALWGYLTYKADVYSFGIVALEIVS 439
           T   G I   + APE   +   +  +DV+SFG+V  E+++
Sbjct: 210 TTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 109/201 (54%), Gaps = 11/201 (5%)
Query: 245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
            ++IG G FG VYKG+      + +  +++ + Q  + F NE+ ++   +H N++   G 
Sbjct: 41  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
             +  QL +V ++ E +SL   L      E + +      I    A+G+ +LH +S   I
Sbjct: 101 STK-PQLAIVTQWCEGSSLYHHL---HIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 153
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKL-DEGDKTHISTRIAGTIGYMAPEYALW---GY 420
           +HRD+K+ N+ L  DL  KI DFGLA +      +H   +++G+I +MAPE         
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 213
Query: 421 LTYKADVYSFGIVALEIVSGK 441
            ++++DVY+FGIV  E+++G+
Sbjct: 214 YSFQSDVYAFGIVLYELMTGQ 234

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 109/201 (54%), Gaps = 11/201 (5%)
Query: 245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
            ++IG G FG VYKG+      + +  +++ + Q  + F NE+ ++   +H N++   G 
Sbjct: 15  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
             +  QL +V ++ E +SL   L      E + +      I    A+G+ +LH +S   I
Sbjct: 75  STK-PQLAIVTQWCEGSSLYHHL---HIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 127
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKL-DEGDKTHISTRIAGTIGYMAPEYALW---GY 420
           +HRD+K+ N+ L  DL  KI DFGLA +      +H   +++G+I +MAPE         
Sbjct: 128 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 187
Query: 421 LTYKADVYSFGIVALEIVSGK 441
            ++++DVY+FGIV  E+++G+
Sbjct: 188 YSFQSDVYAFGIVLYELMTGQ 208

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 109/201 (54%), Gaps = 11/201 (5%)
Query: 245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
            ++IG G FG VYKG+      + +  +++ + Q  + F NE+ ++   +H N++   G 
Sbjct: 18  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
             +  QL +V ++ E +SL   L      E + +      I    A+G+ +LH +S   I
Sbjct: 78  STK-PQLAIVTQWCEGSSLYHHL---HIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 130
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKL-DEGDKTHISTRIAGTIGYMAPEYALW---GY 420
           +HRD+K+ N+ L  DL  KI DFGLA +      +H   +++G+I +MAPE         
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 190
Query: 421 LTYKADVYSFGIVALEIVSGK 441
            ++++DVY+FGIV  E+++G+
Sbjct: 191 YSFQSDVYAFGIVLYELMTGQ 211

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 108/201 (53%), Gaps = 11/201 (5%)
Query: 245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
            ++IG G FG VYKG+      + +  +++ + Q  + F NE+ ++   +H N++   G 
Sbjct: 29  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
             +  QL +V ++ E +SL   L      E + +      I    ARG+ +LH +S   I
Sbjct: 89  STK-PQLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAKS---I 141
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHISTRIAGTIGYMAPEYALW---GY 420
           +HRD+K+ N+ L  D   KI DFGLA +      +H   +++G+I +MAPE         
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 421 LTYKADVYSFGIVALEIVSGK 441
            ++++DVY+FGIV  E+++G+
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQ 222

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 109/201 (54%), Gaps = 11/201 (5%)
Query: 245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
            ++IG G FG VYKG+      + +  +++ + Q  + F NE+ ++   +H N++   G 
Sbjct: 13  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
             +  QL +V ++ E +SL   L      E + +      I    A+G+ +LH +S   I
Sbjct: 73  STK-PQLAIVTQWCEGSSLYHHL---HIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 125
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKL-DEGDKTHISTRIAGTIGYMAPEYALW---GY 420
           +HRD+K+ N+ L  DL  KI DFGLA +      +H   +++G+I +MAPE         
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 421 LTYKADVYSFGIVALEIVSGK 441
            ++++DVY+FGIV  E+++G+
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQ 206

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 109/201 (54%), Gaps = 11/201 (5%)
Query: 245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
            ++IG G FG VYKG+      + +  +++ + Q  + F NE+ ++   +H N++   G 
Sbjct: 18  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
             +  QL +V ++ E +SL   L      E + +      I    A+G+ +LH +S   I
Sbjct: 78  STK-PQLAIVTQWCEGSSLYHHL---HIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 130
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKL-DEGDKTHISTRIAGTIGYMAPEYALW---GY 420
           +HRD+K+ N+ L  DL  KI DFGLA +      +H   +++G+I +MAPE         
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 190
Query: 421 LTYKADVYSFGIVALEIVSGK 441
            ++++DVY+FGIV  E+++G+
Sbjct: 191 YSFQSDVYAFGIVLYELMTGQ 211

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 107/201 (53%), Gaps = 11/201 (5%)
Query: 245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
            ++IG G FG VYKG+      + +  +++ + Q  + F NE+ ++   +H N++   G 
Sbjct: 29  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
                QL +V ++ E +SL   L      E + +      I    ARG+ +LH +S   I
Sbjct: 89  ST-APQLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAKS---I 141
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHISTRIAGTIGYMAPEYALW---GY 420
           +HRD+K+ N+ L  D   KI DFGLA +      +H   +++G+I +MAPE         
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 421 LTYKADVYSFGIVALEIVSGK 441
            ++++DVY+FGIV  E+++G+
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQ 222

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 111/209 (53%), Gaps = 27/209 (12%)
Query: 248 IGEGGFGPVYKGQLADGTIIAVKQLSSKS----RQGNREFLNEIAMISCLQHPNLVKIHG 303
           IG GGFG VY+     G  +AVK           Q       E  + + L+HPN++ + G
Sbjct: 15  IGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 304 CCVEGDQLLLVYEYMENNSLACALFG-RENCELELDWPTRQKICLGIARGLAFLHEESRF 362
            C++   L LV E+     L   L G R   ++ ++W  +      IARG+ +LH+E+  
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQ------IARGMNYLHDEAIV 127
Query: 363 KIVHRDIKATNVLL-----DRDLNP---KISDFGLAKLDEGDKTHISTRI--AGTIGYMA 412
            I+HRD+K++N+L+     + DL+    KI+DFGLA+     + H +T++  AG   +MA
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMSAAGAYAWMA 182
Query: 413 PEYALWGYLTYKADVYSFGIVALEIVSGK 441
           PE       +  +DV+S+G++  E+++G+
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGE 211

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 68/194 (35%), Positives = 100/194 (51%), Gaps = 17/194 (8%)
Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           KK+G G FG V+       T +AVK +   S      FL E  ++  LQH  LVK+H   
Sbjct: 188 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV- 245
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
           V  + + ++ E+M   SL   L   E  +  L  P        IA G+AF+ + +    +
Sbjct: 246 VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YI 300
Query: 366 HRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKA 425
           HRD++A N+L+   L  KI+DFGLA++  G K          I + APE   +G  T K+
Sbjct: 301 HRDLRAANILVSASLVCKIADFGLARV--GAKF--------PIKWTAPEAINFGSFTIKS 350
Query: 426 DVYSFGIVALEIVS 439
           DV+SFGI+ +EIV+
Sbjct: 351 DVWSFGILLMEIVT 364

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 108/201 (53%), Gaps = 11/201 (5%)
Query: 245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
            ++IG G FG VYKG+      + +  +++ + Q  + F NE+ ++   +H N++   G 
Sbjct: 13  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
                QL +V ++ E +SL   L      E + +      I    A+G+ +LH +S   I
Sbjct: 73  ST-APQLAIVTQWCEGSSLYHHL---HIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 125
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKL-DEGDKTHISTRIAGTIGYMAPEYALW---GY 420
           +HRD+K+ N+ L  DL  KI DFGLA +      +H   +++G+I +MAPE         
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 421 LTYKADVYSFGIVALEIVSGK 441
            ++++DVY+FGIV  E+++G+
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQ 206

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 103/211 (48%), Gaps = 21/211 (9%)
Query: 247 KIGEGGFGPVYKGQL------ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
           ++GEG FG V+  +        D  ++AVK L   S    ++F  E  +++ LQH ++V+
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 301 IHGCCVEGDQLLLVYEYMENNSL----------ACALFGRENCEL-ELDWPTRQKICLGI 349
             G C EG  LL+V+EYM +  L          A  L G E+     L       +   +
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 350 ARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTI 408
           A G+ +L   +    VHRD+   N L+ + L  KI DFG+++ +   D   +  R    I
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 409 GYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
            +M PE  L+   T ++DV+SFG+V  EI +
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 103/211 (48%), Gaps = 21/211 (9%)
Query: 247 KIGEGGFGPVYKGQL------ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
           ++GEG FG V+  +        D  ++AVK L   S    ++F  E  +++ LQH ++V+
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 301 IHGCCVEGDQLLLVYEYMENNSL----------ACALFGRENCEL-ELDWPTRQKICLGI 349
             G C EG  LL+V+EYM +  L          A  L G E+     L       +   +
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 350 ARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTI 408
           A G+ +L   +    VHRD+   N L+ + L  KI DFG+++ +   D   +  R    I
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 409 GYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
            +M PE  L+   T ++DV+SFG+V  EI +
Sbjct: 202 RWMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 109/201 (54%), Gaps = 11/201 (5%)
Query: 245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
            ++IG G FG VYKG+      + +  +++ + Q  + F NE+ ++   +H N++   G 
Sbjct: 41  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
             +  QL +V ++ E +SL   L      E + +      I    A+G+ +LH +S   I
Sbjct: 101 STK-PQLAIVTQWCEGSSLYHHL---HIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 153
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHISTRIAGTIGYMAPEYALW---GY 420
           +HRD+K+ N+ L  DL  KI DFGLA +      +H   +++G+I +MAPE         
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 213
Query: 421 LTYKADVYSFGIVALEIVSGK 441
            ++++DVY+FGIV  E+++G+
Sbjct: 214 YSFQSDVYAFGIVLYELMTGQ 234

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 116/220 (52%), Gaps = 20/220 (9%)
Query: 229 SFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQL----ADGTIIAVKQLSSK-SRQGNREF 283
           SFT ++I+A+  + +  K IG G  G V  G+L         +A+K L +  + +  R+F
Sbjct: 41  SFT-REIEASRIHIE--KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDF 97
Query: 284 LNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQ 343
           L+E +++    HPN++++ G    G   ++V EYMEN SL   L   +       +   Q
Sbjct: 98  LSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG-----QFTIMQ 152
Query: 344 KICL--GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS 401
            + +  G+  G+ +L   S    VHRD+ A NVL+D +L  K+SDFGL+++ E D     
Sbjct: 153 LVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAY 209
Query: 402 TRIAGTIG--YMAPEYALWGYLTYKADVYSFGIVALEIVS 439
           T   G I   + APE   +   +  +DV+SFG+V  E+++
Sbjct: 210 TTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 106/203 (52%), Gaps = 17/203 (8%)
Query: 246 KKIGEGGFGPVYKGQLA----DGTIIAVKQLS-SKSRQGNREFLNEIAMISCLQHPNLVK 300
           + IG G FG V  G+L         +A+K L    + +  R+FL E +++    HPN+V 
Sbjct: 49  RVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVH 108
Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL--GIARGLAFLHE 358
           + G    G  +++V E+MEN +L   L   +       +   Q + +  GIA G+ +L +
Sbjct: 109 LEGVVTRGKPVMIVIEFMENGALDAFLRKHDG-----QFTVIQLVGMLRGIAAGMRYLAD 163
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIG--YMAPEYA 416
                 VHRD+ A N+L++ +L  K+SDFGL+++ E D   + T   G I   + APE  
Sbjct: 164 ---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAI 220
Query: 417 LWGYLTYKADVYSFGIVALEIVS 439
            +   T  +DV+S+GIV  E++S
Sbjct: 221 QYRKFTSASDVWSYGIVMWEVMS 243

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 103/211 (48%), Gaps = 21/211 (9%)
Query: 247 KIGEGGFGPVYKGQL------ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
           ++GEG FG V+  +        D  ++AVK L   S    ++F  E  +++ LQH ++V+
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 301 IHGCCVEGDQLLLVYEYMENNSL----------ACALFGRENCEL-ELDWPTRQKICLGI 349
             G C EG  LL+V+EYM +  L          A  L G E+     L       +   +
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 350 ARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTI 408
           A G+ +L   +    VHRD+   N L+ + L  KI DFG+++ +   D   +  R    I
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 409 GYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
            +M PE  L+   T ++DV+SFG+V  EI +
Sbjct: 196 RWMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 70/223 (31%), Positives = 117/223 (52%), Gaps = 19/223 (8%)
Query: 226 QTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLA----DGTIIAVKQLS-SKSRQGN 280
           QT+    K++ A   + D  K +G G FG V  G+L         +A+K L    + +  
Sbjct: 4   QTVHEFAKELDATNISID--KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 61
Query: 281 REFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWP 340
           R+FL E +++    HPN++++ G   +   +++V E MEN SL    F R++   +  + 
Sbjct: 62  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDS--FLRKH---DAQFT 116
Query: 341 TRQKICL--GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT 398
             Q + +  GIA G+ +L   S    VHRD+ A N+L++ +L  K+SDFGL+++ E D  
Sbjct: 117 VIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 173
Query: 399 HISTRIAGTIG--YMAPEYALWGYLTYKADVYSFGIVALEIVS 439
              T   G I   + +PE   +   T  +DV+S+GIV  E++S
Sbjct: 174 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 248 IGEGGFGPVYK-GQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCV 306
           +G+G FG   K      G ++ +K+L     +  R FL E+ ++ CL+HPN++K  G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 307 EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVH 366
           +  +L  + EY++  +L   +   ++ + +  W  R      IA G+A+LH      I+H
Sbjct: 78  KDKRLNFITEYIKGGTLRGII---KSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIH 131
Query: 367 RDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS-------------TRIAGTIGYMAP 413
           RD+ + N L+  + N  ++DFGLA+L   +KT                  + G   +MAP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 414 EYALWGYLTYKADVYSFGIVALEIVSGKN-NMSYAP 448
           E         K DV+SFGIV  EI+   N +  Y P
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP 227

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 109/201 (54%), Gaps = 11/201 (5%)
Query: 245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
            ++IG G FG VYKG+      + +  +++ + Q  + F NE+ ++   +H N++   G 
Sbjct: 33  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
             +  QL +V ++ E +SL   L      E + +      I    A+G+ +LH +S   I
Sbjct: 93  STK-PQLAIVTQWCEGSSLYHHL---HIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 145
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHISTRIAGTIGYMAPEYALW---GY 420
           +HRD+K+ N+ L  DL  KI DFGLA +      +H   +++G+I +MAPE         
Sbjct: 146 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 205
Query: 421 LTYKADVYSFGIVALEIVSGK 441
            ++++DVY+FGIV  E+++G+
Sbjct: 206 YSFQSDVYAFGIVLYELMTGQ 226

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 72/231 (31%), Positives = 120/231 (51%), Gaps = 19/231 (8%)
Query: 218 AFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLA----DGTIIAVKQLS 273
            F  E   Q +    K+I A+    +  K IG G FG V  G+L         +A+K L 
Sbjct: 9   PFTFEDPNQAVREFAKEIDASCIKIE--KVIGVGEFGEVCSGRLKVPGKREICVAIKTLK 66
Query: 274 SK-SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGREN 332
           +  + +  R+FL+E +++    HPN++ + G   +   ++++ EYMEN SL    F R+N
Sbjct: 67  AGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDA--FLRKN 124
Query: 333 CELELDWPTRQKICL--GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 390
              +  +   Q + +  GI  G+ +L + S    VHRD+ A N+L++ +L  K+SDFG++
Sbjct: 125 ---DGRFTVIQLVGMLRGIGSGMKYLSDMS---AVHRDLAARNILVNSNLVCKVSDFGMS 178
Query: 391 KLDEGDKTHISTRIAGTIG--YMAPEYALWGYLTYKADVYSFGIVALEIVS 439
           ++ E D     T   G I   + APE   +   T  +DV+S+GIV  E++S
Sbjct: 179 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 139/290 (47%), Gaps = 42/290 (14%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGN-------REFLNEIAM 289
           A N  +  K+IG+GGFG V+KG+L  D +++A+K L     +G        +EF  E+ +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGI 349
           +S L HPN+VK++G      +  +V E++    L   L  + +    + W  + ++ L I
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDI 131
Query: 350 ARGLAFLHEESRFKIVHRDIKATNVLL-----DRDLNPKISDFGLAKLDEGDKTHISTRI 404
           A G+ ++  ++   IVHRD+++ N+ L     +  +  K++DFG ++       H  + +
Sbjct: 132 ALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ----QSVHSVSGL 186
Query: 405 AGTIGYMAPEY--ALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWAC 462
            G   +MAPE   A     T KAD YSF ++   I++G+      P  E+    +     
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE-----GPFDEYSYGKI----- 236
Query: 463 HLQQDGKLVELV-DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                 K + ++ +E L     ++   R+  V  LC +  P  RP  S +
Sbjct: 237 ------KFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYI 280

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 109/201 (54%), Gaps = 11/201 (5%)
Query: 245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
            ++IG G FG VYKG+      + +  +++ + Q  + F NE+ ++   +H N++   G 
Sbjct: 13  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
             +  QL +V ++ E +SL   L      E + +      I    A+G+ +LH +S   I
Sbjct: 73  STK-PQLAIVTQWCEGSSLYHHL---HIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 125
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHISTRIAGTIGYMAPEYALW---GY 420
           +HRD+K+ N+ L  DL  KI DFGLA +      +H   +++G+I +MAPE         
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 421 LTYKADVYSFGIVALEIVSGK 441
            ++++DVY+FGIV  E+++G+
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQ 206

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 102/201 (50%), Gaps = 19/201 (9%)
Query: 245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
            ++IG G FG V+ G   +   +A+K +   +     +F+ E  ++  L HP LV+++G 
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 305 CVEGDQLLLVYEYMENNSLA------CALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
           C+E   + LV E+ME+  L+        LF  E         T   +CL +  G+A+L E
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAE---------TLLGMCLDVCEGMAYLEE 122
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALW 418
                ++HRD+ A N L+  +   K+SDFG+ +    D+   ST     + + +PE   +
Sbjct: 123 AC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 179
Query: 419 GYLTYKADVYSFGIVALEIVS 439
              + K+DV+SFG++  E+ S
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFS 200

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 107/213 (50%), Gaps = 22/213 (10%)
Query: 246 KKIGEGGFGPVYKGQL------ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
           +++GEG FG V+  +        D  ++AVK L   +    ++F  E  +++ LQH ++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACALFGR-ENCELELDWPTRQ-----------KICL 347
           K +G C +GD L++V+EYM++  L   L     +  + +D   RQ            I  
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAG 406
            IA G+ +L  +     VHRD+   N L+  +L  KI DFG+++ +   D   +      
Sbjct: 141 QIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197
Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
            I +M PE  ++   T ++DV+SFG++  EI +
Sbjct: 198 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 116/205 (56%), Gaps = 20/205 (9%)
Query: 245 AKKIGEGGFGPVYKG-QLADGTII----AVKQLSSKS-RQGNREFLNEIAMISCLQHPNL 298
            K +G G FG VYKG  + +G  +    A+K L+  +  + N EF++E  +++ + HP+L
Sbjct: 20  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 79
Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGREN---CELELDWPTRQKICLGIARGLAF 355
           V++ G C+    + LV + M +  L   +   ++    +L L+W      C+ IA+G+ +
Sbjct: 80  VRLLGVCL-SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMY 132
Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD-KTHISTRIAGTIGYMAPE 414
           L E    ++VHRD+ A NVL+    + KI+DFGLA+L EGD K + +      I +MA E
Sbjct: 133 LEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 189
Query: 415 YALWGYLTYKADVYSFGIVALEIVS 439
              +   T+++DV+S+G+   E+++
Sbjct: 190 CIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 139/290 (47%), Gaps = 42/290 (14%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGN-------REFLNEIAM 289
           A N  +  K+IG+GGFG V+KG+L  D +++A+K L     +G        +EF  E+ +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGI 349
           +S L HPN+VK++G      +  +V E++    L   L  + +    + W  + ++ L I
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDI 131
Query: 350 ARGLAFLHEESRFKIVHRDIKATNVLL-----DRDLNPKISDFGLAKLDEGDKTHISTRI 404
           A G+ ++  ++   IVHRD+++ N+ L     +  +  K++DF L++       H  + +
Sbjct: 132 ALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ----QSVHSVSGL 186
Query: 405 AGTIGYMAPEY--ALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWAC 462
            G   +MAPE   A     T KAD YSF ++   I++G+      P  E+    +     
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE-----GPFDEYSYGKI----- 236
Query: 463 HLQQDGKLVELV-DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                 K + ++ +E L     ++   R+  V  LC +  P  RP  S +
Sbjct: 237 ------KFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYI 280

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 116/210 (55%), Gaps = 20/210 (9%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADGTII----AVKQLSSKS-RQGNREFLNEIAMISCL 293
                 K +G G FG VYKG  + +G  +    A+K L+  +  + N EF++E  +++ +
Sbjct: 38  TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM 97
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGREN---CELELDWPTRQKICLGIA 350
            HP+LV++ G C+    + LV + M +  L   +   ++    +L L+W      C+ IA
Sbjct: 98  DHPHLVRLLGVCL-SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIA 150
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD-KTHISTRIAGTIG 409
           +G+ +L E    ++VHRD+ A NVL+    + KI+DFGLA+L EGD K + +      I 
Sbjct: 151 KGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 207
Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVS 439
           +MA E   +   T+++DV+S+G+   E+++
Sbjct: 208 WMALECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 100/198 (50%), Gaps = 15/198 (7%)
Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           K++G G FG V  G+      +AVK +   S   + EF  E   +  L HP LVK +G C
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 306 VEGDQLLLVYEYMENNSLACALF----GRENCELELDWPTRQKICLGIARGLAFLHEESR 361
            +   + +V EY+ N  L   L     G E  +L        ++C  +  G+AFL E  +
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQL-------LEMCYDVCEGMAFL-ESHQ 124
Query: 362 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYL 421
           F  +HRD+ A N L+DRDL  K+SDFG+ +    D+   S      + + APE   +   
Sbjct: 125 F--IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKY 182
Query: 422 TYKADVYSFGIVALEIVS 439
           + K+DV++FGI+  E+ S
Sbjct: 183 SSKSDVWAFGILMWEVFS 200

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 105/197 (53%), Gaps = 10/197 (5%)
Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
           +KIG+G  G VY    +A G  +A++Q++ + +      +NEI ++   ++PN+V     
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
            + GD+L +V EY+   SL   +   E C   +D      +C    + L FLH     ++
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV--TETC---MDEGQIAAVCRECLQALEFLHSN---QV 137
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYK 424
           +HRDIK+ N+LL  D + K++DFG       +++  S  + GT  +MAPE         K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS-EMVGTPYWMAPEVVTRKAYGPK 196
Query: 425 ADVYSFGIVALEIVSGK 441
            D++S GI+A+E++ G+
Sbjct: 197 VDIWSLGIMAIEMIEGE 213

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 105/197 (53%), Gaps = 10/197 (5%)
Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
           +KIG+G  G VY    +A G  +A++Q++ + +      +NEI ++   ++PN+V     
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
            + GD+L +V EY+   SL   +   E C   +D      +C    + L FLH     ++
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV--TETC---MDEGQIAAVCRECLQALEFLHSN---QV 137
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYK 424
           +HRDIK+ N+LL  D + K++DFG       +++  S  + GT  +MAPE         K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRKAYGPK 196
Query: 425 ADVYSFGIVALEIVSGK 441
            D++S GI+A+E++ G+
Sbjct: 197 VDIWSLGIMAIEMIEGE 213

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/227 (31%), Positives = 118/227 (51%), Gaps = 19/227 (8%)
Query: 222 ESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLA----DGTIIAVKQLS-SKS 276
           E   Q +    K+I+A+    +  + IG G FG V  G+L         +A+K L    +
Sbjct: 6   EDPNQAVHEFAKEIEASCITIE--RVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYT 63
Query: 277 RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELE 336
            +  R+FL E +++    HPN++ + G   +   +++V EYMEN SL    F ++N   +
Sbjct: 64  EKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDT--FLKKN---D 118
Query: 337 LDWPTRQKICL--GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 394
             +   Q + +  GI+ G+ +L   S    VHRD+ A N+L++ +L  K+SDFGL+++ E
Sbjct: 119 GQFTVIQLVGMLRGISAGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 175
Query: 395 GDKTHISTRIAGTIG--YMAPEYALWGYLTYKADVYSFGIVALEIVS 439
            D     T   G I   + APE   +   T  +DV+S+GIV  E+VS
Sbjct: 176 DDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVS 222

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 106/197 (53%), Gaps = 10/197 (5%)
Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
           +KIG+G  G VY    +A G  +A++Q++ + +      +NEI ++   ++PN+V     
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
            + GD+L +V EY+   SL   +   E C   +D      +C    + L FLH     ++
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVV--TETC---MDEGQIAAVCRECLQALEFLHSN---QV 138
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYK 424
           +HR+IK+ N+LL  D + K++DFG       +++  ST + GT  +MAPE         K
Sbjct: 139 IHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 197
Query: 425 ADVYSFGIVALEIVSGK 441
            D++S GI+A+E++ G+
Sbjct: 198 VDIWSLGIMAIEMIEGE 214

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 105/197 (53%), Gaps = 10/197 (5%)
Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
           +KIG+G  G VY    +A G  +A++Q++ + +      +NEI ++   ++PN+V     
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
            + GD+L +V EY+   SL   +   E C   +D      +C    + L FLH     ++
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVV--TETC---MDEGQIAAVCRECLQALEFLHSN---QV 138
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYK 424
           +HRDIK+ N+LL  D + K++DFG       +++  S  + GT  +MAPE         K
Sbjct: 139 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRKAYGPK 197
Query: 425 ADVYSFGIVALEIVSGK 441
            D++S GI+A+E++ G+
Sbjct: 198 VDIWSLGIMAIEMIEGE 214

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/240 (31%), Positives = 123/240 (51%), Gaps = 28/240 (11%)
Query: 248 IGEGGFGPVYKGQLA----DGTIIAVKQLSSK-SRQGNREFLNEIAMISCLQHPNLVKIH 302
           IG G FG V  G L         +A+K L S  + +  R+FL+E +++    HPN++ + 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL--GIARGLAFLHEES 360
           G   +   ++++ E+MEN SL    F R+N   +  +   Q + +  GIA G+ +L +  
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDS--FLRQN---DGQFTVIQLVGMLRGIAAGMKYLAD-- 153
Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKL---DEGDKTHISTRIAGTIG--YMAPEY 415
               VHRD+ A N+L++ +L  K+SDFGL++    D  D T+ S  + G I   + APE 
Sbjct: 154 -MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA-LGGKIPIRWTAPEA 211
Query: 416 ALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD 475
             +   T  +DV+S+GIV  E+      MSY     +D T   D    ++QD +L   +D
Sbjct: 212 IQYRKFTSASDVWSYGIVMWEV------MSYGERPYWDMTN-QDVINAIEQDYRLPPPMD 264

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/223 (31%), Positives = 118/223 (52%), Gaps = 19/223 (8%)
Query: 226 QTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLA----DGTIIAVKQLSSK-SRQGN 280
           Q +    K+I A+    +  K IG G FG V  G+L         +A+K L +  + +  
Sbjct: 2   QAVREFAKEIDASCIKIE--KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR 59
Query: 281 REFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWP 340
           R+FL+E +++    HPN++ + G   +   ++++ EYMEN SL    F R+N   +  + 
Sbjct: 60  RDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDA--FLRKN---DGRFT 114
Query: 341 TRQKICL--GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT 398
             Q + +  GI  G+ +L + S    VHRD+ A N+L++ +L  K+SDFG++++ E D  
Sbjct: 115 VIQLVGMLRGIGSGMKYLSDMS---YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPE 171
Query: 399 HISTRIAGTIG--YMAPEYALWGYLTYKADVYSFGIVALEIVS 439
              T   G I   + APE   +   T  +DV+S+GIV  E++S
Sbjct: 172 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 214

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 110/213 (51%), Gaps = 14/213 (6%)
Query: 242 FDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
            D+  KIGEG  G V    + + G ++AVK++  + +Q      NE+ ++   QH N+V+
Sbjct: 22  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
           ++   + GD+L +V E++E  +L   +      E ++       +CL + + L+ LH + 
Sbjct: 82  MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLHAQG 136
Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGY 420
              ++HRDIK+ ++LL  D   K+SDFG        +      + GT  +MAPE  L   
Sbjct: 137 ---VIHRDIKSDSILLTHDGRVKLSDFGFCA-QVSKEVPRRKXLVGTPYWMAPE--LISR 190
Query: 421 LTY--KADVYSFGIVALEIVSGKNNMSYAPALE 451
           L Y  + D++S GI+ +E+V G+      P L+
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK 223

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 110/213 (51%), Gaps = 14/213 (6%)
Query: 242 FDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
            D+  KIGEG  G V    + + G ++AVK++  + +Q      NE+ ++   QH N+V+
Sbjct: 26  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 85
Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
           ++   + GD+L +V E++E  +L   +      E ++       +CL + + L+ LH + 
Sbjct: 86  MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLHAQG 140
Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGY 420
              ++HRDIK+ ++LL  D   K+SDFG        +      + GT  +MAPE  L   
Sbjct: 141 ---VIHRDIKSDSILLTHDGRVKLSDFGFCA-QVSKEVPRRKXLVGTPYWMAPE--LISR 194
Query: 421 LTY--KADVYSFGIVALEIVSGKNNMSYAPALE 451
           L Y  + D++S GI+ +E+V G+      P L+
Sbjct: 195 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK 227

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 110/213 (51%), Gaps = 14/213 (6%)
Query: 242 FDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
            D+  KIGEG  G V    + + G ++AVK++  + +Q      NE+ ++   QH N+V+
Sbjct: 31  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 90
Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
           ++   + GD+L +V E++E  +L   +      E ++       +CL + + L+ LH + 
Sbjct: 91  MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLHAQG 145
Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGY 420
              ++HRDIK+ ++LL  D   K+SDFG        +      + GT  +MAPE  L   
Sbjct: 146 ---VIHRDIKSDSILLTHDGRVKLSDFGFCA-QVSKEVPRRKXLVGTPYWMAPE--LISR 199
Query: 421 LTY--KADVYSFGIVALEIVSGKNNMSYAPALE 451
           L Y  + D++S GI+ +E+V G+      P L+
Sbjct: 200 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK 232

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 110/213 (51%), Gaps = 14/213 (6%)
Query: 242 FDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
            D+  KIGEG  G V    + + G ++AVK++  + +Q      NE+ ++   QH N+V+
Sbjct: 33  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 92
Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
           ++   + GD+L +V E++E  +L   +      E ++       +CL + + L+ LH + 
Sbjct: 93  MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLHAQG 147
Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGY 420
              ++HRDIK+ ++LL  D   K+SDFG        +      + GT  +MAPE  L   
Sbjct: 148 ---VIHRDIKSDSILLTHDGRVKLSDFGFCA-QVSKEVPRRKXLVGTPYWMAPE--LISR 201
Query: 421 LTY--KADVYSFGIVALEIVSGKNNMSYAPALE 451
           L Y  + D++S GI+ +E+V G+      P L+
Sbjct: 202 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK 234

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 116/216 (53%), Gaps = 19/216 (8%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKGQLA----DGTIIAVKQLSSK-SRQGNREFLNEI 287
           K+I A+    +  K IG G FG V  G+L         +A+K L +  + +  R+FL+E 
Sbjct: 3   KEIDASCIKIE--KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEA 60
Query: 288 AMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL 347
           +++    HPN++ + G   +   ++++ EYMEN SL    F R+N   +  +   Q + +
Sbjct: 61  SIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDA--FLRKN---DGRFTVIQLVGM 115
Query: 348 --GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIA 405
             GI  G+ +L + S    VHRD+ A N+L++ +L  K+SDFG++++ E D     T   
Sbjct: 116 LRGIGSGMKYLSDMS---YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRG 172
Query: 406 GTIG--YMAPEYALWGYLTYKADVYSFGIVALEIVS 439
           G I   + APE   +   T  +DV+S+GIV  E++S
Sbjct: 173 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 208

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 115/204 (56%), Gaps = 21/204 (10%)
Query: 248 IGEGGFGPVYKGQL-ADG---TIIAVKQLSSK-SRQGNREFLNEIAMISCLQHPNLVKIH 302
           IG G FG V +G+L A G   + +A+K L    + +  REFL+E +++   +HPN++++ 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL--GIARGLAFLHEES 360
           G       ++++ E+MEN +L    F R N   +  +   Q + +  GIA G+ +L E S
Sbjct: 82  GVVTNSMPVMILTEFMENGALDS--FLRLN---DGQFTVIQLVGMLRGIASGMRYLAEMS 136
Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE---GDKTHISTRIAGTIG--YMAPEY 415
               VHRD+ A N+L++ +L  K+SDFGL++  E    D T+ S+ + G I   + APE 
Sbjct: 137 ---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSS-LGGKIPIRWTAPEA 192
Query: 416 ALWGYLTYKADVYSFGIVALEIVS 439
             +   T  +D +S+GIV  E++S
Sbjct: 193 IAFRKFTSASDAWSYGIVMWEVMS 216

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 110/213 (51%), Gaps = 14/213 (6%)
Query: 242 FDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
            D+  KIGEG  G V    + + G ++AVK++  + +Q      NE+ ++   QH N+V+
Sbjct: 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 212
Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
           ++   + GD+L +V E++E  +L   +      E ++       +CL + + L+ LH + 
Sbjct: 213 MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLHAQG 267
Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGY 420
              ++HRDIK+ ++LL  D   K+SDFG        +      + GT  +MAPE  L   
Sbjct: 268 ---VIHRDIKSDSILLTHDGRVKLSDFGFCA-QVSKEVPRRKXLVGTPYWMAPE--LISR 321
Query: 421 LTY--KADVYSFGIVALEIVSGKNNMSYAPALE 451
           L Y  + D++S GI+ +E+V G+      P L+
Sbjct: 322 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK 354

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 110/213 (51%), Gaps = 14/213 (6%)
Query: 242 FDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
            D+  KIGEG  G V    + + G ++AVK++  + +Q      NE+ ++   QH N+V+
Sbjct: 76  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 135
Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
           ++   + GD+L +V E++E  +L   +      E ++       +CL + + L+ LH + 
Sbjct: 136 MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLHAQG 190
Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGY 420
              ++HRDIK+ ++LL  D   K+SDFG        +      + GT  +MAPE  L   
Sbjct: 191 ---VIHRDIKSDSILLTHDGRVKLSDFGFCA-QVSKEVPRRKXLVGTPYWMAPE--LISR 244
Query: 421 LTY--KADVYSFGIVALEIVSGKNNMSYAPALE 451
           L Y  + D++S GI+ +E+V G+      P L+
Sbjct: 245 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK 277

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 114/204 (55%), Gaps = 21/204 (10%)
Query: 248 IGEGGFGPVYKGQL-ADG---TIIAVKQLSSK-SRQGNREFLNEIAMISCLQHPNLVKIH 302
           IG G FG V +G+L A G   + +A+K L    + +  REFL+E +++   +HPN++++ 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL--GIARGLAFLHEES 360
           G       ++++ E+MEN +L    F R N   +  +   Q + +  GIA G+ +L E S
Sbjct: 84  GVVTNSMPVMILTEFMENGALDS--FLRLN---DGQFTVIQLVGMLRGIASGMRYLAEMS 138
Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE---GDKTHISTRIAGTIG--YMAPEY 415
               VHRD+ A N+L++ +L  K+SDFGL++  E    D T  S+ + G I   + APE 
Sbjct: 139 ---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSS-LGGKIPIRWTAPEA 194
Query: 416 ALWGYLTYKADVYSFGIVALEIVS 439
             +   T  +D +S+GIV  E++S
Sbjct: 195 IAFRKFTSASDAWSYGIVMWEVMS 218

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 130/266 (48%), Gaps = 24/266 (9%)
Query: 247 KIGEGGFGPVYKGQLADGTI-IAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           K+G G +G VY+G     ++ +AVK L   + +   EFL E A++  ++HPNLV++ G C
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
                  ++ E+M   +L   L  RE    E++      +   I+  + +L +++    +
Sbjct: 84  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 138
Query: 366 HRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKA 425
           HRD+ A N L+  +   K++DFGL++L  GD           I + APE   +   + K+
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 426 DVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKE 485
           DV++FG++  EI +    MS  P ++                 ++ EL+++    +  + 
Sbjct: 199 DVWAFGVLLWEIAT--YGMSPYPGIDL---------------SQVYELLEKDYRMERPEG 241
Query: 486 EAERMIKVSLLCTNASPSLRPTMSEV 511
             E++ ++   C   +PS RP+ +E+
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 114/229 (49%), Gaps = 33/229 (14%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQLADG-------TIIAVKQLSSK-SRQGNREFLNEIAMIS 291
           NN +  + IGEG FG V++ + A G       T++AVK L  + S     +F  E A+++
Sbjct: 47  NNIEYVRDIGEGAFGRVFQAR-APGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA 105
Query: 292 CLQHPNLVKIHGCCVEGDQLLLVYEYM---ENNSLACALFGRENCEL-ELDWPTR----- 342
              +PN+VK+ G C  G  + L++EYM   + N    ++     C L   D  TR     
Sbjct: 106 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 165
Query: 343 ---------QKICLG--IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 391
                    +++C+   +A G+A+L E    K VHRD+   N L+  ++  KI+DFGL++
Sbjct: 166 PGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR 222
Query: 392 -LDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
            +   D        A  I +M PE   +   T ++DV+++G+V  EI S
Sbjct: 223 NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 129/266 (48%), Gaps = 24/266 (9%)
Query: 247 KIGEGGFGPVYKGQLADGTI-IAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           K+G G FG VY+G     ++ +AVK L   + +   EFL E A++  ++HPNLV++ G C
Sbjct: 18  KLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
                  ++ E+M   +L   L  RE    E+       +   I+  + +L +++    +
Sbjct: 77  TREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKKN---FI 131
Query: 366 HRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKA 425
           HRD+ A N L+  +   K++DFGL++L  GD           I + APE   +   + K+
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKS 191
Query: 426 DVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKE 485
           DV++FG++  EI +    MS  P ++                 ++ EL+++    +  + 
Sbjct: 192 DVWAFGVLLWEIAT--YGMSPYPGID---------------PSQVYELLEKDYRMERPEG 234
Query: 486 EAERMIKVSLLCTNASPSLRPTMSEV 511
             E++ ++   C   +PS RP+ +E+
Sbjct: 235 CPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 130/266 (48%), Gaps = 24/266 (9%)
Query: 247 KIGEGGFGPVYKGQLADGTI-IAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           K+G G +G VY+G     ++ +AVK L   + +   EFL E A++  ++HPNLV++ G C
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
                  ++ E+M   +L   L  RE    E++      +   I+  + +L +++    +
Sbjct: 84  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 138
Query: 366 HRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKA 425
           HRD+ A N L+  +   K++DFGL++L  GD           I + APE   +   + K+
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 426 DVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKE 485
           DV++FG++  EI +    MS  P ++                 ++ EL+++    +  + 
Sbjct: 199 DVWAFGVLLWEIAT--YGMSPYPGIDL---------------SQVYELLEKDYRMERPEG 241
Query: 486 EAERMIKVSLLCTNASPSLRPTMSEV 511
             E++ ++   C   +PS RP+ +E+
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 130/266 (48%), Gaps = 24/266 (9%)
Query: 247 KIGEGGFGPVYKGQLADGTI-IAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           K+G G +G VY+G     ++ +AVK L   + +   EFL E A++  ++HPNLV++ G C
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 79
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
                  ++ E+M   +L   L  RE    E++      +   I+  + +L +++    +
Sbjct: 80  TREPPFYIIIEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 134
Query: 366 HRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKA 425
           HRD+ A N L+  +   K++DFGL++L  GD           I + APE   +   + K+
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKS 194
Query: 426 DVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKE 485
           DV++FG++  EI +    MS  P ++                 ++ EL+++    +  + 
Sbjct: 195 DVWAFGVLLWEIAT--YGMSPYPGIDL---------------SQVYELLEKDYRMERPEG 237
Query: 486 EAERMIKVSLLCTNASPSLRPTMSEV 511
             E++ ++   C   +PS RP+ +E+
Sbjct: 238 CPEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 130/266 (48%), Gaps = 24/266 (9%)
Query: 247 KIGEGGFGPVYKGQLADGTI-IAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           K+G G +G VY+G     ++ +AVK L   + +   EFL E A++  ++HPNLV++ G C
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
                  ++ E+M   +L   L  RE    E++      +   I+  + +L +++    +
Sbjct: 79  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 133
Query: 366 HRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKA 425
           HRD+ A N L+  +   K++DFGL++L  GD           I + APE   +   + K+
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 426 DVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKE 485
           DV++FG++  EI +    MS  P ++                 ++ EL+++    +  + 
Sbjct: 194 DVWAFGVLLWEIAT--YGMSPYPGIDL---------------SQVYELLEKDYRMERPEG 236
Query: 486 EAERMIKVSLLCTNASPSLRPTMSEV 511
             E++ ++   C   +PS RP+ +E+
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 74/306 (24%), Positives = 143/306 (46%), Gaps = 31/306 (10%)
Query: 207 YYLRTKRHKETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTI 266
           +Y   KR+K T +        +S    + +    +     K+G G +G VY+G     ++
Sbjct: 233 HYPAPKRNKPTVY-------GVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSL 285
Query: 267 -IAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLAC 325
            +AVK L   + +   EFL E A++  ++HPNLV++ G C       ++ E+M   +L  
Sbjct: 286 TVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 344
Query: 326 ALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKIS 385
            L  RE    E++      +   I+  + +L +++    +HR++ A N L+  +   K++
Sbjct: 345 YL--RECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVA 399
Query: 386 DFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMS 445
           DFGL++L  GD           I + APE   +   + K+DV++FG++  EI +    MS
Sbjct: 400 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT--YGMS 457
Query: 446 YAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLR 505
             P ++                 ++ EL+++    +  +   E++ ++   C   +PS R
Sbjct: 458 PYPGIDLS---------------QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 502
Query: 506 PTMSEV 511
           P+ +E+
Sbjct: 503 PSFAEI 508

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 130/266 (48%), Gaps = 24/266 (9%)
Query: 247 KIGEGGFGPVYKGQLADGTI-IAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           K+G G +G VY+G     ++ +AVK L   + +   EFL E A++  ++HPNLV++ G C
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
                  ++ E+M   +L   L  RE    E++      +   I+  + +L +++    +
Sbjct: 79  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 133
Query: 366 HRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKA 425
           HRD+ A N L+  +   K++DFGL++L  GD           I + APE   +   + K+
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 426 DVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKE 485
           DV++FG++  EI +    MS  P ++                 ++ EL+++    +  + 
Sbjct: 194 DVWAFGVLLWEIAT--YGMSPYPGIDL---------------SQVYELLEKDYRMERPEG 236
Query: 486 EAERMIKVSLLCTNASPSLRPTMSEV 511
             E++ ++   C   +PS RP+ +E+
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 130/266 (48%), Gaps = 24/266 (9%)
Query: 247 KIGEGGFGPVYKGQLADGTI-IAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           K+G G +G VY+G     ++ +AVK L   + +   EFL E A++  ++HPNLV++ G C
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
                  ++ E+M   +L   L  RE    E++      +   I+  + +L +++    +
Sbjct: 81  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 135
Query: 366 HRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKA 425
           HRD+ A N L+  +   K++DFGL++L  GD           I + APE   +   + K+
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKS 195
Query: 426 DVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKE 485
           DV++FG++  EI +    MS  P ++                 ++ EL+++    +  + 
Sbjct: 196 DVWAFGVLLWEIAT--YGMSPYPGIDL---------------SQVYELLEKDYRMERPEG 238
Query: 486 EAERMIKVSLLCTNASPSLRPTMSEV 511
             E++ ++   C   +PS RP+ +E+
Sbjct: 239 CPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 130/266 (48%), Gaps = 24/266 (9%)
Query: 247 KIGEGGFGPVYKGQLADGTI-IAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           K+G G +G VY+G     ++ +AVK L   + +   EFL E A++  ++HPNLV++ G C
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
                  ++ E+M   +L   L  RE    E++      +   I+  + +L +++    +
Sbjct: 84  TREPPFYIIIEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 138
Query: 366 HRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKA 425
           HRD+ A N L+  +   K++DFGL++L  GD           I + APE   +   + K+
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 426 DVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKE 485
           DV++FG++  EI +    MS  P ++                 ++ EL+++    +  + 
Sbjct: 199 DVWAFGVLLWEIAT--YGMSPYPGIDL---------------SQVYELLEKDYRMERPEG 241
Query: 486 EAERMIKVSLLCTNASPSLRPTMSEV 511
             E++ ++   C   +PS RP+ +E+
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 130/266 (48%), Gaps = 24/266 (9%)
Query: 247 KIGEGGFGPVYKGQLADGTI-IAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           K+G G +G VY+G     ++ +AVK L   + +   EFL E A++  ++HPNLV++ G C
Sbjct: 33  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVC 91
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
                  ++ E+M   +L   L  RE    E++      +   I+  + +L +++    +
Sbjct: 92  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 146
Query: 366 HRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKA 425
           HRD+ A N L+  +   K++DFGL++L  GD           I + APE   +   + K+
Sbjct: 147 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 206
Query: 426 DVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKE 485
           DV++FG++  EI +    MS  P ++                 ++ EL+++    +  + 
Sbjct: 207 DVWAFGVLLWEIAT--YGMSPYPGIDL---------------SQVYELLEKDYRMERPEG 249
Query: 486 EAERMIKVSLLCTNASPSLRPTMSEV 511
             E++ ++   C   +PS RP+ +E+
Sbjct: 250 CPEKVYELMRACWQWNPSDRPSFAEI 275

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 130/266 (48%), Gaps = 24/266 (9%)
Query: 247 KIGEGGFGPVYKGQLADGTI-IAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           K+G G +G VY+G     ++ +AVK L   + +   EFL E A++  ++HPNLV++ G C
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 79
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
                  ++ E+M   +L   L  RE    E++      +   I+  + +L +++    +
Sbjct: 80  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 134
Query: 366 HRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKA 425
           HRD+ A N L+  +   K++DFGL++L  GD           I + APE   +   + K+
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKS 194
Query: 426 DVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKE 485
           DV++FG++  EI +    MS  P ++                 ++ EL+++    +  + 
Sbjct: 195 DVWAFGVLLWEIAT--YGMSPYPGIDL---------------SQVYELLEKDYRMERPEG 237
Query: 486 EAERMIKVSLLCTNASPSLRPTMSEV 511
             E++ ++   C   +PS RP+ +E+
Sbjct: 238 CPEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 130/266 (48%), Gaps = 24/266 (9%)
Query: 247 KIGEGGFGPVYKGQLADGTI-IAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           K+G G +G VY+G     ++ +AVK L   + +   EFL E A++  ++HPNLV++ G C
Sbjct: 24  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 82
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
                  ++ E+M   +L   L  RE    E++      +   I+  + +L +++    +
Sbjct: 83  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 137
Query: 366 HRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKA 425
           HRD+ A N L+  +   K++DFGL++L  GD           I + APE   +   + K+
Sbjct: 138 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 197
Query: 426 DVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKE 485
           DV++FG++  EI +    MS  P ++                 ++ EL+++    +  + 
Sbjct: 198 DVWAFGVLLWEIAT--YGMSPYPGIDL---------------SQVYELLEKDYRMERPEG 240
Query: 486 EAERMIKVSLLCTNASPSLRPTMSEV 511
             E++ ++   C   +PS RP+ +E+
Sbjct: 241 CPEKVYELMRACWQWNPSDRPSFAEI 266

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 130/266 (48%), Gaps = 24/266 (9%)
Query: 247 KIGEGGFGPVYKGQLADGTI-IAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           K+G G +G VY+G     ++ +AVK L   + +   EFL E A++  ++HPNLV++ G C
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
                  ++ E+M   +L   L  RE    E++      +   I+  + +L +++    +
Sbjct: 81  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 135
Query: 366 HRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKA 425
           HRD+ A N L+  +   K++DFGL++L  GD           I + APE   +   + K+
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 195
Query: 426 DVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKE 485
           DV++FG++  EI +    MS  P ++                 ++ EL+++    +  + 
Sbjct: 196 DVWAFGVLLWEIAT--YGMSPYPGIDL---------------SQVYELLEKDYRMERPEG 238
Query: 486 EAERMIKVSLLCTNASPSLRPTMSEV 511
             E++ ++   C   +PS RP+ +E+
Sbjct: 239 CPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 130/266 (48%), Gaps = 24/266 (9%)
Query: 247 KIGEGGFGPVYKGQLADGTI-IAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           K+G G +G VY+G     ++ +AVK L   + +   EFL E A++  ++HPNLV++ G C
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
                  ++ E+M   +L   L  RE    E++      +   I+  + +L +++    +
Sbjct: 84  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 138
Query: 366 HRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKA 425
           HRD+ A N L+  +   K++DFGL++L  GD           I + APE   +   + K+
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 426 DVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKE 485
           DV++FG++  EI +    MS  P ++                 ++ EL+++    +  + 
Sbjct: 199 DVWAFGVLLWEIAT--YGMSPYPGIDL---------------SQVYELLEKDYRMERPEG 241
Query: 486 EAERMIKVSLLCTNASPSLRPTMSEV 511
             E++ ++   C   +PS RP+ +E+
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 130/266 (48%), Gaps = 24/266 (9%)
Query: 247 KIGEGGFGPVYKGQLADGTI-IAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           K+G G +G VY+G     ++ +AVK L   + +   EFL E A++  ++HPNLV++ G C
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
                  ++ E+M   +L   L  RE    E++      +   I+  + +L +++    +
Sbjct: 81  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 135
Query: 366 HRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKA 425
           HRD+ A N L+  +   K++DFGL++L  GD           I + APE   +   + K+
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 195
Query: 426 DVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKE 485
           DV++FG++  EI +    MS  P ++                 ++ EL+++    +  + 
Sbjct: 196 DVWAFGVLLWEIAT--YGMSPYPGIDL---------------SQVYELLEKDYRMERPEG 238
Query: 486 EAERMIKVSLLCTNASPSLRPTMSEV 511
             E++ ++   C   +PS RP+ +E+
Sbjct: 239 CPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 129/266 (48%), Gaps = 24/266 (9%)
Query: 247 KIGEGGFGPVYKGQLADGTI-IAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           K+G G +G VY+G     ++ +AVK L   + +   EFL E A++  ++HPNLV++ G C
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
                  ++ E+M   +L   L  RE    E+       +   I+  + +L +++    +
Sbjct: 79  TREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKKN---FI 133
Query: 366 HRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKA 425
           HRD+ A N L+  +   K++DFGL++L  GD           I + APE   +   + K+
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 426 DVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKE 485
           DV++FG++  EI +    MS  P ++                 ++ EL+++    +  + 
Sbjct: 194 DVWAFGVLLWEIAT--YGMSPYPGIDL---------------SQVYELLEKDYRMERPEG 236
Query: 486 EAERMIKVSLLCTNASPSLRPTMSEV 511
             E++ ++   C   +PS RP+ +E+
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 129/266 (48%), Gaps = 24/266 (9%)
Query: 247 KIGEGGFGPVYKGQLADGTI-IAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           K+G G +G VY+G     ++ +AVK L   + +   EFL E A++  ++HPNLV++ G C
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
                  ++ E+M   +L   L  RE    E+       +   I+  + +L +++    +
Sbjct: 79  TREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKKN---FI 133
Query: 366 HRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKA 425
           HRD+ A N L+  +   K++DFGL++L  GD           I + APE   +   + K+
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 426 DVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKE 485
           DV++FG++  EI +    MS  P ++                 ++ EL+++    +  + 
Sbjct: 194 DVWAFGVLLWEIAT--YGMSPYPGIDL---------------SQVYELLEKDYRMERPEG 236
Query: 486 EAERMIKVSLLCTNASPSLRPTMSEV 511
             E++ ++   C   +PS RP+ +E+
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 129/266 (48%), Gaps = 24/266 (9%)
Query: 247 KIGEGGFGPVYKGQLADGTI-IAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           K+G G +G VY+G     ++ +AVK L   + +   EFL E A++  ++HPNLV++ G C
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
                  ++ E+M   +L   L  RE    E+       +   I+  + +L +++    +
Sbjct: 79  TREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKKN---FI 133
Query: 366 HRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKA 425
           HRD+ A N L+  +   K++DFGL++L  GD           I + APE   +   + K+
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 426 DVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKE 485
           DV++FG++  EI +    MS  P ++                 ++ EL+++    +  + 
Sbjct: 194 DVWAFGVLLWEIAT--YGMSPYPGIDL---------------SQVYELLEKDYRMERPEG 236
Query: 486 EAERMIKVSLLCTNASPSLRPTMSEV 511
             E++ ++   C   +PS RP+ +E+
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 129/266 (48%), Gaps = 24/266 (9%)
Query: 247 KIGEGGFGPVYKGQLADGTI-IAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           K+G G +G VY+G     ++ +AVK L   + +   EFL E A++  ++HPNLV++ G C
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
                  ++ E+M   +L   L  RE    E+       +   I+  + +L +++    +
Sbjct: 79  TREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKKN---FI 133
Query: 366 HRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKA 425
           HRD+ A N L+  +   K++DFGL++L  GD           I + APE   +   + K+
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 426 DVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKE 485
           DV++FG++  EI +    MS  P ++                 ++ EL+++    +  + 
Sbjct: 194 DVWAFGVLLWEIAT--YGMSPYPGIDL---------------SQVYELLEKDYRMERPEG 236
Query: 486 EAERMIKVSLLCTNASPSLRPTMSEV 511
             E++ ++   C   +PS RP+ +E+
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 129/266 (48%), Gaps = 24/266 (9%)
Query: 247 KIGEGGFGPVYKGQLADGTI-IAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           K+G G +G VY+G     ++ +AVK L   + +   EFL E A++  ++HPNLV++ G C
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
                  ++ E+M   +L   L  RE    E+       +   I+  + +L +++    +
Sbjct: 84  TREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKKN---FI 138
Query: 366 HRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKA 425
           HRD+ A N L+  +   K++DFGL++L  GD           I + APE   +   + K+
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 426 DVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKE 485
           DV++FG++  EI +    MS  P ++                 ++ EL+++    +  + 
Sbjct: 199 DVWAFGVLLWEIAT--YGMSPYPGIDL---------------SQVYELLEKDYRMERPEG 241
Query: 486 EAERMIKVSLLCTNASPSLRPTMSEV 511
             E++ ++   C   +PS RP+ +E+
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 129/266 (48%), Gaps = 24/266 (9%)
Query: 247 KIGEGGFGPVYKGQLADGTI-IAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           K+G G +G VY+G     ++ +AVK L   + +   EFL E A++  ++HPNLV++ G C
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
                  ++ E+M   +L   L  RE    E+       +   I+  + +L +++    +
Sbjct: 77  TREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKKN---FI 131
Query: 366 HRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKA 425
           HRD+ A N L+  +   K++DFGL++L  GD           I + APE   +   + K+
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKS 191
Query: 426 DVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKE 485
           DV++FG++  EI +    MS  P ++                 ++ EL+++    +  + 
Sbjct: 192 DVWAFGVLLWEIAT--YGMSPYPGID---------------PSQVYELLEKDYRMERPEG 234
Query: 486 EAERMIKVSLLCTNASPSLRPTMSEV 511
             E++ ++   C   +PS RP+ +E+
Sbjct: 235 CPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 136/304 (44%), Gaps = 56/304 (18%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQL------ADGTIIAVKQLSSKSRQGN-REFLNEIAMISC 292
            N    K +GEG FG V K         A  T +AVK L   +     R+ L+E  ++  
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 293 LQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL--------------ELD 338
           + HP+++K++G C +   LLL+ EY +  SL    F RE+ ++               LD
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG--FLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 339 WPTRQKICLG--------IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 390
            P  + + +G        I++G+ +L E    K+VHRD+ A N+L+      KISDFGL+
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 391 KLDEGDKTHISTRIAGTIG--YMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYA 447
           + D  ++     R  G I   +MA E       T ++DV+SFG++  EIV+ G N     
Sbjct: 198 R-DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256
Query: 448 PALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPT 507
           P              +L + G  +E  D           +E M ++ L C    P  RP 
Sbjct: 257 PPERL---------FNLLKTGHRMERPDNC---------SEEMYRLMLQCWKQEPDKRPV 298
Query: 508 MSEV 511
            +++
Sbjct: 299 FADI 302

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 136/304 (44%), Gaps = 56/304 (18%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQL------ADGTIIAVKQLSSKSRQGN-REFLNEIAMISC 292
            N    K +GEG FG V K         A  T +AVK L   +     R+ L+E  ++  
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 293 LQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL--------------ELD 338
           + HP+++K++G C +   LLL+ EY +  SL    F RE+ ++               LD
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG--FLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 339 WPTRQKICLG--------IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 390
            P  + + +G        I++G+ +L E    K+VHRD+ A N+L+      KISDFGL+
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 391 KLDEGDKTHISTRIAGTIG--YMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYA 447
           + D  ++     R  G I   +MA E       T ++DV+SFG++  EIV+ G N     
Sbjct: 198 R-DVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256
Query: 448 PALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPT 507
           P              +L + G  +E  D           +E M ++ L C    P  RP 
Sbjct: 257 PPERL---------FNLLKTGHRMERPDNC---------SEEMYRLMLQCWKQEPDKRPV 298
Query: 508 MSEV 511
            +++
Sbjct: 299 FADI 302

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 105/207 (50%), Gaps = 10/207 (4%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ 294
           K     FD  +K+GEG +G VYK      G I+A+KQ+  +S    +E + EI+++    
Sbjct: 25  KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCD 82
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
            P++VK +G   +   L +V EY    S++  +  R     E +  T   I     +GL 
Sbjct: 83  SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT---ILQSTLKGLE 139
Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPE 414
           +LH     + +HRDIKA N+LL+ + + K++DFG+A     D       + GT  +MAPE
Sbjct: 140 YLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAG-QLTDXMAKRNXVIGTPFWMAPE 195
Query: 415 YALWGYLTYKADVYSFGIVALEIVSGK 441
                     AD++S GI A+E+  GK
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 74/306 (24%), Positives = 142/306 (46%), Gaps = 31/306 (10%)
Query: 207 YYLRTKRHKETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTI 266
           +Y   KR+K T +        +S    + +    +     K+G G +G VY+G     ++
Sbjct: 194 HYPAPKRNKPTIY-------GVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSL 246
Query: 267 -IAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLAC 325
            +AVK L   + +   EFL E A++  ++HPNLV++ G C       ++ E+M   +L  
Sbjct: 247 TVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 305
Query: 326 ALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKIS 385
            L  RE    E+       +   I+  + +L +++    +HR++ A N L+  +   K++
Sbjct: 306 YL--RECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVA 360
Query: 386 DFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMS 445
           DFGL++L  GD           I + APE   +   + K+DV++FG++  EI +    MS
Sbjct: 361 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT--YGMS 418
Query: 446 YAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLR 505
             P ++                 ++ EL+++    +  +   E++ ++   C   +PS R
Sbjct: 419 PYPGIDLS---------------QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 463
Query: 506 PTMSEV 511
           P+ +E+
Sbjct: 464 PSFAEI 469

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 85/276 (30%), Positives = 131/276 (47%), Gaps = 38/276 (13%)
Query: 248 IGEGGFGPVYKGQLAD--GTII--AVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIH 302
           IG G FG VY G L D  G  I  AVK L+  +  G   +FL E  ++    HPN++ + 
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 303 GCCVEGD-QLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC---LGIARGLAFLHE 358
           G C+  +   L+V  YM++  L      R     E   PT + +    L +A+G+ FL  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 152
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LD-EGDKTHISTRIAGTIGYMAPEY 415
           +   K VHRD+ A N +LD     K++DFGLA+  LD E D  H  T     + +MA E 
Sbjct: 153 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALES 209
Query: 416 ALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD 475
                 T K+DV+SFG++  E+++ +    Y     FD T       +L Q  +L++   
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDIT------VYLLQGRRLLQ--- 259
Query: 476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                   +   + + +V L C +    +RP+ SE+
Sbjct: 260 -------PEYCPDPLYEVMLKCWHPKAEMRPSFSEL 288

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 109/204 (53%), Gaps = 21/204 (10%)
Query: 248 IGEGGFGPVYKGQLA----DGTIIAVKQLSSK-SRQGNREFLNEIAMISCLQHPNLVKIH 302
           IG G FG V  G L         +A+K L S  + +  R+FL+E +++    HPN++ + 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL--GIARGLAFLHEES 360
           G   +   ++++ E+MEN SL    F R+N   +  +   Q + +  GIA G+ +L +  
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDS--FLRQN---DGQFTVIQLVGMLRGIAAGMKYLAD-- 127
Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKL---DEGDKTHISTRIAGTIG--YMAPEY 415
               VHR + A N+L++ +L  K+SDFGL++    D  D T+ S  + G I   + APE 
Sbjct: 128 -MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA-LGGKIPIRWTAPEA 185
Query: 416 ALWGYLTYKADVYSFGIVALEIVS 439
             +   T  +DV+S+GIV  E++S
Sbjct: 186 IQYRKFTSASDVWSYGIVMWEVMS 209

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 129/266 (48%), Gaps = 24/266 (9%)
Query: 247 KIGEGGFGPVYKGQLADGTI-IAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           K+G G +G VY+G     ++ +AVK L   + +   EFL E A++  ++HPNLV++ G C
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
                  ++ E+M   +L   L  RE    E+       +   I+  + +L +++    +
Sbjct: 77  TREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKKN---FI 131
Query: 366 HRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKA 425
           HRD+ A N L+  +   K++DFGL++L  GD           I + APE   +   + K+
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKS 191
Query: 426 DVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKE 485
           DV++FG++  EI +    MS  P ++                 ++ EL+++    +  + 
Sbjct: 192 DVWAFGVLLWEIAT--YGMSPYPGID---------------PSQVYELLEKDYRMERPEG 234
Query: 486 EAERMIKVSLLCTNASPSLRPTMSEV 511
             E++ ++   C   +PS RP+ +E+
Sbjct: 235 CPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/258 (31%), Positives = 124/258 (48%), Gaps = 28/258 (10%)
Query: 267 IAVKQLS-SKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNS--- 322
           +A+K+++  K +    E L EI  +S   HPN+V  +   V  D+L LV + +   S   
Sbjct: 38  VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLD 97
Query: 323 -LACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN 381
            +   +   E+    LD  T   I   +  GL +LH+  +   +HRD+KA N+LL  D +
Sbjct: 98  IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGS 154
Query: 382 PKISDFGLAKL--DEGDKTHISTR--IAGTIGYMAPEYA--LWGYLTYKADVYSFGIVAL 435
            +I+DFG++      GD T    R    GT  +MAPE    + GY  +KAD++SFGI A+
Sbjct: 155 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGY-DFKADIWSFGITAI 213
Query: 436 EIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVE--LVDERLGSKYKKEEAERMIKV 493
           E+ +G       P ++            LQ D   +E  + D+ +  KY K    +MI  
Sbjct: 214 ELATGAAPYHKYPPMKV-------LMLTLQNDPPSLETGVQDKEMLKKYGK-SFRKMIS- 264
Query: 494 SLLCTNASPSLRPTMSEV 511
             LC    P  RPT +E+
Sbjct: 265 --LCLQKDPEKRPTAAEL 280

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 136/304 (44%), Gaps = 56/304 (18%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQL------ADGTIIAVKQLSSKSRQGN-REFLNEIAMISC 292
            N    K +GEG FG V K         A  T +AVK L   +     R+ L+E  ++  
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 293 LQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL--------------ELD 338
           + HP+++K++G C +   LLL+ EY +  SL    F RE+ ++               LD
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG--FLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 339 WPTRQKICLG--------IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 390
            P  + + +G        I++G+ +L E S   +VHRD+ A N+L+      KISDFGL+
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 391 KLDEGDKTHISTRIAGTIG--YMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYA 447
           + D  ++     R  G I   +MA E       T ++DV+SFG++  EIV+ G N     
Sbjct: 198 R-DVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256
Query: 448 PALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPT 507
           P              +L + G  +E  D           +E M ++ L C    P  RP 
Sbjct: 257 PPERL---------FNLLKTGHRMERPDNC---------SEEMYRLMLQCWKQEPDKRPV 298
Query: 508 MSEV 511
            +++
Sbjct: 299 FADI 302

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/258 (31%), Positives = 124/258 (48%), Gaps = 28/258 (10%)
Query: 267 IAVKQLS-SKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNS--- 322
           +A+K+++  K +    E L EI  +S   HPN+V  +   V  D+L LV + +   S   
Sbjct: 43  VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLD 102
Query: 323 -LACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN 381
            +   +   E+    LD  T   I   +  GL +LH+  +   +HRD+KA N+LL  D +
Sbjct: 103 IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGS 159
Query: 382 PKISDFGLAKL--DEGDKTHISTR--IAGTIGYMAPEY--ALWGYLTYKADVYSFGIVAL 435
            +I+DFG++      GD T    R    GT  +MAPE    + GY  +KAD++SFGI A+
Sbjct: 160 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGY-DFKADIWSFGITAI 218
Query: 436 EIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVE--LVDERLGSKYKKEEAERMIKV 493
           E+ +G       P ++            LQ D   +E  + D+ +  KY K    +MI  
Sbjct: 219 ELATGAAPYHKYPPMKV-------LMLTLQNDPPSLETGVQDKEMLKKYGK-SFRKMIS- 269
Query: 494 SLLCTNASPSLRPTMSEV 511
             LC    P  RPT +E+
Sbjct: 270 --LCLQKDPEKRPTAAEL 285

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 83/276 (30%), Positives = 129/276 (46%), Gaps = 38/276 (13%)
Query: 248 IGEGGFGPVYKGQLAD--GTII--AVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIH 302
           IG G FG VY G L D  G  I  AVK L+  +  G   +FL E  ++    HPN++ + 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 303 GCCVEGD-QLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC---LGIARGLAFLHE 358
           G C+  +   L+V  YM++  L      R     E   PT + +    L +A+G+ FL  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 151
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK---LDEGDKTHISTRIAGTIGYMAPEY 415
           +   K VHRD+ A N +LD     K++DFGLA+     E D  H  T     + +MA E 
Sbjct: 152 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 416 ALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD 475
                 T K+DV+SFG++  E+++ +    Y     FD T       +L Q  +L++   
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDIT------VYLLQGRRLLQ--- 258
Query: 476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                   +   + + +V L C +    +RP+ SE+
Sbjct: 259 -------PEYCPDPLYEVMLKCWHPKAEMRPSFSEL 287

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 83/276 (30%), Positives = 129/276 (46%), Gaps = 38/276 (13%)
Query: 248 IGEGGFGPVYKGQLAD--GTII--AVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIH 302
           IG G FG VY G L D  G  I  AVK L+  +  G   +FL E  ++    HPN++ + 
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 303 GCCVEGD-QLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC---LGIARGLAFLHE 358
           G C+  +   L+V  YM++  L      R     E   PT + +    L +A+G+ FL  
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 156
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK---LDEGDKTHISTRIAGTIGYMAPEY 415
           +   K VHRD+ A N +LD     K++DFGLA+     E D  H  T     + +MA E 
Sbjct: 157 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 213
Query: 416 ALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD 475
                 T K+DV+SFG++  E+++ +    Y     FD T       +L Q  +L++   
Sbjct: 214 LQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDIT------VYLLQGRRLLQ--- 263
Query: 476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                   +   + + +V L C +    +RP+ SE+
Sbjct: 264 -------PEYCPDPLYEVMLKCWHPKAEMRPSFSEL 292

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 83/276 (30%), Positives = 129/276 (46%), Gaps = 38/276 (13%)
Query: 248 IGEGGFGPVYKGQLAD--GTII--AVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIH 302
           IG G FG VY G L D  G  I  AVK L+  +  G   +FL E  ++    HPN++ + 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 303 GCCVEGD-QLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC---LGIARGLAFLHE 358
           G C+  +   L+V  YM++  L      R     E   PT + +    L +A+G+ FL  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 151
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK---LDEGDKTHISTRIAGTIGYMAPEY 415
           +   K VHRD+ A N +LD     K++DFGLA+     E D  H  T     + +MA E 
Sbjct: 152 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 416 ALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD 475
                 T K+DV+SFG++  E+++ +    Y     FD T       +L Q  +L++   
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDIT------VYLLQGRRLLQ--- 258
Query: 476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                   +   + + +V L C +    +RP+ SE+
Sbjct: 259 -------PEYCPDPLYEVMLKCWHPKAEMRPSFSEL 287

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 83/276 (30%), Positives = 129/276 (46%), Gaps = 38/276 (13%)
Query: 248 IGEGGFGPVYKGQLAD--GTII--AVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIH 302
           IG G FG VY G L D  G  I  AVK L+  +  G   +FL E  ++    HPN++ + 
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 303 GCCVEGD-QLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC---LGIARGLAFLHE 358
           G C+  +   L+V  YM++  L      R     E   PT + +    L +A+G+ FL  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 152
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK---LDEGDKTHISTRIAGTIGYMAPEY 415
           +   K VHRD+ A N +LD     K++DFGLA+     E D  H  T     + +MA E 
Sbjct: 153 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 209
Query: 416 ALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD 475
                 T K+DV+SFG++  E+++ +    Y     FD T       +L Q  +L++   
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDIT------VYLLQGRRLLQ--- 259
Query: 476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                   +   + + +V L C +    +RP+ SE+
Sbjct: 260 -------PEYCPDPLYEVMLKCWHPKAEMRPSFSEL 288

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 83/276 (30%), Positives = 129/276 (46%), Gaps = 38/276 (13%)
Query: 248 IGEGGFGPVYKGQLAD--GTII--AVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIH 302
           IG G FG VY G L D  G  I  AVK L+  +  G   +FL E  ++    HPN++ + 
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 303 GCCVEGD-QLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC---LGIARGLAFLHE 358
           G C+  +   L+V  YM++  L      R     E   PT + +    L +A+G+ FL  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 149
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK---LDEGDKTHISTRIAGTIGYMAPEY 415
           +   K VHRD+ A N +LD     K++DFGLA+     E D  H  T     + +MA E 
Sbjct: 150 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 206
Query: 416 ALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD 475
                 T K+DV+SFG++  E+++ +    Y     FD T       +L Q  +L++   
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDIT------VYLLQGRRLLQ--- 256
Query: 476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                   +   + + +V L C +    +RP+ SE+
Sbjct: 257 -------PEYCPDPLYEVMLKCWHPKAEMRPSFSEL 285

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 83/276 (30%), Positives = 129/276 (46%), Gaps = 38/276 (13%)
Query: 248 IGEGGFGPVYKGQLAD--GTII--AVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIH 302
           IG G FG VY G L D  G  I  AVK L+  +  G   +FL E  ++    HPN++ + 
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 303 GCCVEGD-QLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC---LGIARGLAFLHE 358
           G C+  +   L+V  YM++  L      R     E   PT + +    L +A+G+ FL  
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 210
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK---LDEGDKTHISTRIAGTIGYMAPEY 415
           +   K VHRD+ A N +LD     K++DFGLA+     E D  H  T     + +MA E 
Sbjct: 211 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 416 ALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD 475
                 T K+DV+SFG++  E+++ +    Y     FD T       +L Q  +L++   
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDIT------VYLLQGRRLLQ--- 317
Query: 476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                   +   + + +V L C +    +RP+ SE+
Sbjct: 318 -------PEYCPDPLYEVMLKCWHPKAEMRPSFSEL 346

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 127/269 (47%), Gaps = 32/269 (11%)
Query: 247 KIGEGGFGPVYKGQLADGTI-IAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           K+G G +G VY G     ++ +AVK L   + +   EFL E A++  ++HPNLV++ G C
Sbjct: 39  KLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 97
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
                  +V EYM   +L   L  RE    E+       +   I+  + +L +++    +
Sbjct: 98  TLEPPFYIVTEYMPYGNLLDYL--RECNREEVTAVVLLYMATQISSAMEYLEKKN---FI 152
Query: 366 HRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKA 425
           HRD+ A N L+  +   K++DFGL++L  GD           I + APE   +   + K+
Sbjct: 153 HRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKS 212
Query: 426 DVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKE 485
           DV++FG++  EI +    MS  P ++            L Q   L+E         Y+ E
Sbjct: 213 DVWAFGVLLWEIAT--YGMSPYPGID------------LSQVYDLLE-------KGYRME 251
Query: 486 EAE----RMIKVSLLCTNASPSLRPTMSE 510
           + E    ++ ++   C   SP+ RP+ +E
Sbjct: 252 QPEGCPPKVYELMRACWKWSPADRPSFAE 280

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 105/208 (50%), Gaps = 14/208 (6%)
Query: 247 KIGEGGFGPV-YKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           KIGEG  G V    +   G  +AVK++  + +Q      NE+ ++    H N+V ++   
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
           + GD+L +V E++E  +L   +      E ++       +CL + R L++LH +    ++
Sbjct: 112 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLSVLRALSYLHNQG---VI 163
Query: 366 HRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTY-- 423
           HRDIK+ ++LL  D   K+SDFG        +      + GT  +MAPE  +   L Y  
Sbjct: 164 HRDIKSDSILLTSDGRIKLSDFGFCA-QVSKEVPKRKXLVGTPYWMAPE--VISRLPYGT 220
Query: 424 KADVYSFGIVALEIVSGKNNMSYAPALE 451
           + D++S GI+ +E++ G+      P L+
Sbjct: 221 EVDIWSLGIMVIEMIDGEPPYFNEPPLQ 248

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 114/212 (53%), Gaps = 14/212 (6%)
Query: 237 AATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNREF-LNEIAMISCLQ 294
           ++++ F   +K+G G +  VYKG     G  +A+K++   S +G     + EI+++  L+
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENN---SLACALFGRENCELELDWPTRQKICLGIAR 351
           H N+V+++      ++L LV+E+M+N+    +     G     LEL+    +     + +
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELN--LVKYFQWQLLQ 119
Query: 352 GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYM 411
           GLAF HE    KI+HRD+K  N+L+++    K+ DFGLA+         S+ +  T+ Y 
Sbjct: 120 GLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYR 175
Query: 412 APEYALWGYLTYKA--DVYSFGIVALEIVSGK 441
           AP+  L G  TY    D++S G +  E+++GK
Sbjct: 176 APD-VLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 102/201 (50%), Gaps = 10/201 (4%)
Query: 242 FDSAKKIGEGGFGPV-YKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
            DS  KIGEG  G V    +   G  +AVK +  + +Q      NE+ ++   QH N+V+
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
           ++   + G++L ++ E+++  +L   +      ++ L+      +C  + + LA+LH + 
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIV-----SQVRLNEEQIATVCEAVLQALAYLHAQG 161
Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGY 420
              ++HRDIK+ ++LL  D   K+SDFG       D       + GT  +MAPE      
Sbjct: 162 ---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKXLVGTPYWMAPEVISRSL 217
Query: 421 LTYKADVYSFGIVALEIVSGK 441
              + D++S GI+ +E+V G+
Sbjct: 218 YATEVDIWSLGIMVIEMVDGE 238

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 101/210 (48%), Gaps = 17/210 (8%)
Query: 242 FDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNRE-FLNEIAMISCLQHPNLV 299
           ++  +++G GGFG V +    D G  +A+KQ   +    NRE +  EI ++  L HPN+V
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 300 KIHGC------CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
                          D  LL  EY E   L   L   ENC    + P R  +   I+  L
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-TLLSDISSAL 134
Query: 354 AFLHEESRFKIVHRDIKATNVLLD---RDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
            +LHE    +I+HRD+K  N++L    + L  KI D G AK  E D+  + T   GT+ Y
Sbjct: 135 RYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTEFVGTLQY 189
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           +APE       T   D +SFG +A E ++G
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 101/210 (48%), Gaps = 17/210 (8%)
Query: 242 FDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNRE-FLNEIAMISCLQHPNLV 299
           ++  +++G GGFG V +    D G  +A+KQ   +    NRE +  EI ++  L HPN+V
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 300 KIHGC------CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
                          D  LL  EY E   L   L   ENC    + P R  +   I+  L
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-TLLSDISSAL 135
Query: 354 AFLHEESRFKIVHRDIKATNVLLD---RDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
            +LHE    +I+HRD+K  N++L    + L  KI D G AK  E D+  + T   GT+ Y
Sbjct: 136 RYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTEFVGTLQY 190
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           +APE       T   D +SFG +A E ++G
Sbjct: 191 LAPELLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 25/203 (12%)
Query: 247 KIGEGGFGPVYKGQLADGTIIAV-KQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           ++G+G FG VYK Q  + +++A  K + +KS +   +++ EI +++   HPN+VK+    
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTR----QKICLGIARGLAFLHEESR 361
              + L ++ E+       CA    +   LEL+ P      Q +C      L +LH+   
Sbjct: 104 YYENNLWILIEF-------CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN-- 154
Query: 362 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR--IAGTIGYMAPEYALWG 419
            KI+HRD+KA N+L   D + K++DFG++     +   I  R    GT  +MAPE  +  
Sbjct: 155 -KIIHRDLKAGNILFTLDGDIKLADFGVSA---KNTRXIQRRDSFIGTPYWMAPEVVMCE 210
Query: 420 Y-----LTYKADVYSFGIVALEI 437
                   YKADV+S GI  +E+
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEM 233

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 25/203 (12%)
Query: 247 KIGEGGFGPVYKGQLADGTIIAV-KQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           ++G+G FG VYK Q  + +++A  K + +KS +   +++ EI +++   HPN+VK+    
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTR----QKICLGIARGLAFLHEESR 361
              + L ++ E+       CA    +   LEL+ P      Q +C      L +LH+   
Sbjct: 104 YYENNLWILIEF-------CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN-- 154
Query: 362 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR--IAGTIGYMAPEYALWG 419
            KI+HRD+KA N+L   D + K++DFG++     +   I  R    GT  +MAPE  +  
Sbjct: 155 -KIIHRDLKAGNILFTLDGDIKLADFGVSA---KNTRXIQRRDXFIGTPYWMAPEVVMCE 210
Query: 420 Y-----LTYKADVYSFGIVALEI 437
                   YKADV+S GI  +E+
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEM 233

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 106/206 (51%), Gaps = 11/206 (5%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQHP 296
            NF   +KIGEG +G VYK +    G ++A+K+  L +++       + EI+++  L HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFL 356
           N+VK+       ++L LV+E++  +      F   +    +  P  +     + +GLAF 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD---LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYA 416
           H     +++HRD+K  N+L++ +   K++DFGLA+   G      T    T+ Y APE  
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRAPEIL 175
Query: 417 L-WGYLTYKADVYSFGIVALEIVSGK 441
           L   Y +   D++S G +  E+V+ +
Sbjct: 176 LGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 25/203 (12%)
Query: 247 KIGEGGFGPVYKGQLADGTIIAV-KQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           ++G+G FG VYK Q  + +++A  K + +KS +   +++ EI +++   HPN+VK+    
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTR----QKICLGIARGLAFLHEESR 361
              + L ++ E+       CA    +   LEL+ P      Q +C      L +LH+   
Sbjct: 104 YYENNLWILIEF-------CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN-- 154
Query: 362 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR--IAGTIGYMAPEYALWG 419
            KI+HRD+KA N+L   D + K++DFG++     +   I  R    GT  +MAPE  +  
Sbjct: 155 -KIIHRDLKAGNILFTLDGDIKLADFGVSA---KNTRTIQRRDSFIGTPYWMAPEVVMCE 210
Query: 420 Y-----LTYKADVYSFGIVALEI 437
                   YKADV+S GI  +E+
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEM 233

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 130/277 (46%), Gaps = 40/277 (14%)
Query: 248 IGEGGFGPVYKGQLAD--GTII--AVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIH 302
           IG G FG VY G L D  G  I  AVK L+  +  G   +FL E  ++    HPN++ + 
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 303 GCCVEGD-QLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC---LGIARGLAFLHE 358
           G C+  +   L+V  YM++  L      R     E   PT + +    L +A+G+ +L  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 150
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK----THISTRIAGTIGYMAPE 414
           +   K VHRD+ A N +LD     K++DFGLA+ D  DK     H  T     + +MA E
Sbjct: 151 K---KFVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLPVKWMALE 206
Query: 415 YALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV 474
                  T K+DV+SFG++  E+++ +    Y     FD T       +L Q  +L++  
Sbjct: 207 SLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDIT------VYLLQGRRLLQ-- 257
Query: 475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                    +   + + +V L C +    +RP+ SE+
Sbjct: 258 --------PEYCPDPLYEVMLKCWHPKAEMRPSFSEL 286

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 130/280 (46%), Gaps = 34/280 (12%)
Query: 246 KKIGEGGFGPVYKGQLAD------GTIIAVKQLSSKSRQGNR-EFLNEIAMISCLQHPNL 298
           +++G+G FG VY+G   D       T +AVK ++  +    R EFLNE +++      ++
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFG-RENCELEL--DWPTRQ---KICLGIARG 352
           V++ G   +G   L+V E M +  L   L   R   E       PT Q   ++   IA G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYM 411
           +A+L+ +   K VHRD+ A N ++  D   KI DFG+ + + E D      +    + +M
Sbjct: 143 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 199
Query: 412 APEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLV 471
           APE    G  T  +D++SFG+V  EI S    ++  P        +L +      DG  +
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITS----LAEQPYQGLSNEQVLKFV----MDGGYL 251
Query: 472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           +  D            ER+  +  +C   +P++RPT  E+
Sbjct: 252 DQPDNC---------PERVTDLMRMCWQFNPNMRPTFLEI 282

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 11/208 (5%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQ 294
           +  NF   +KIGEG +G VYK +    G ++A+K+  L +++       + EI+++  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HPN+VK+       ++L LV+E++  +      F   +    +  P  +     + +GLA
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQD---LKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPE 414
           F H     +++HRD+K  N+L++ +   K++DFGLA+   G      T    T+ Y APE
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRAPE 174
Query: 415 YAL-WGYLTYKADVYSFGIVALEIVSGK 441
             L   Y +   D++S G +  E+V+ +
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 108/220 (49%), Gaps = 24/220 (10%)
Query: 242 FDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGN---REFLNEIAMISCLQHPN 297
           F   ++IG G FG VY  + + +  ++A+K++S   +Q N   ++ + E+  +  L+HPN
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 298 LVKIHGCCVEGDQLLLVYEY-MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFL 356
            ++  GC +      LV EY + + S    +  +   E+E+       +  G  +GLA+L
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI-----AAVTHGALQGLAYL 170
Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYA 416
           H  +   ++HRD+KA N+LL      K+ DFG A +        +    GT  +MAPE  
Sbjct: 171 HSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASI-----MAPANXFVGTPYWMAPEVI 222
Query: 417 LW---GYLTYKADVYSFGIVALEIVSGKN---NMSYAPAL 450
           L    G    K DV+S GI  +E+   K    NM+   AL
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 262

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 126/247 (51%), Gaps = 32/247 (12%)
Query: 220 MKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKG-QLADG----TIIAVKQL-S 273
           M E+  Q +   LK+       F   K +G G FG VYKG  + +G      +A+K+L  
Sbjct: 3   MGEAPNQALLRILKE-----TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 57
Query: 274 SKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL-FGREN 332
           + S + N+E L+E  +++ + +P++ ++ G C+     L+    M+     C L + RE+
Sbjct: 58  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI----MQLMPFGCLLDYVREH 113
Query: 333 -----CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF 387
                 +  L+W      C+ IA+G+ +L +    ++VHRD+ A NVL+    + KI+DF
Sbjct: 114 KDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDF 164
Query: 388 GLAK-LDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMS 445
           GLAK L   +K + +      I +MA E  L    T+++DV+S+G+   E+++ G     
Sbjct: 165 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224
Query: 446 YAPALEF 452
             PA E 
Sbjct: 225 GIPASEI 231

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 130/277 (46%), Gaps = 40/277 (14%)
Query: 248 IGEGGFGPVYKGQLAD--GTII--AVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIH 302
           IG G FG VY G L D  G  I  AVK L+  +  G   +FL E  ++    HPN++ + 
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 303 GCCVEGD-QLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC---LGIARGLAFLHE 358
           G C+  +   L+V  YM++  L      R     E   PT + +    L +A+G+ +L  
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 143
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK----THISTRIAGTIGYMAPE 414
           +   K VHRD+ A N +LD     K++DFGLA+ D  DK     H  T     + +MA E
Sbjct: 144 K---KFVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLPVKWMALE 199
Query: 415 YALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV 474
                  T K+DV+SFG++  E+++ +    Y     FD T       +L Q  +L++  
Sbjct: 200 SLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDIT------VYLLQGRRLLQ-- 250
Query: 475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                    +   + + +V L C +    +RP+ SE+
Sbjct: 251 --------PEYCPDPLYEVMLKCWHPKAEMRPSFSEL 279

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 130/277 (46%), Gaps = 40/277 (14%)
Query: 248 IGEGGFGPVYKGQLAD--GTII--AVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIH 302
           IG G FG VY G L D  G  I  AVK L+  +  G   +FL E  ++    HPN++ + 
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 303 GCCVEGD-QLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC---LGIARGLAFLHE 358
           G C+  +   L+V  YM++  L      R     E   PT + +    L +A+G+ +L  
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 146
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK----THISTRIAGTIGYMAPE 414
           +   K VHRD+ A N +LD     K++DFGLA+ D  DK     H  T     + +MA E
Sbjct: 147 K---KFVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLPVKWMALE 202
Query: 415 YALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV 474
                  T K+DV+SFG++  E+++ +    Y     FD T       +L Q  +L++  
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDIT------VYLLQGRRLLQ-- 253
Query: 475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                    +   + + +V L C +    +RP+ SE+
Sbjct: 254 --------PEYCPDPLYEVMLKCWHPKAEMRPSFSEL 282

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 130/277 (46%), Gaps = 40/277 (14%)
Query: 248 IGEGGFGPVYKGQLAD--GTII--AVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIH 302
           IG G FG VY G L D  G  I  AVK L+  +  G   +FL E  ++    HPN++ + 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 303 GCCVEGD-QLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC---LGIARGLAFLHE 358
           G C+  +   L+V  YM++  L      R     E   PT + +    L +A+G+ +L  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 151
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK----THISTRIAGTIGYMAPE 414
           +   K VHRD+ A N +LD     K++DFGLA+ D  DK     H  T     + +MA E
Sbjct: 152 K---KFVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLPVKWMALE 207
Query: 415 YALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV 474
                  T K+DV+SFG++  E+++ +    Y     FD T       +L Q  +L++  
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDIT------VYLLQGRRLLQ-- 258
Query: 475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                    +   + + +V L C +    +RP+ SE+
Sbjct: 259 --------PEYCPDPLYEVMLKCWHPKAEMRPSFSEL 287

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 130/277 (46%), Gaps = 40/277 (14%)
Query: 248 IGEGGFGPVYKGQLAD--GTII--AVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIH 302
           IG G FG VY G L D  G  I  AVK L+  +  G   +FL E  ++    HPN++ + 
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 303 GCCVEGD-QLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC---LGIARGLAFLHE 358
           G C+  +   L+V  YM++  L      R     E   PT + +    L +A+G+ +L  
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 169
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK----THISTRIAGTIGYMAPE 414
           +   K VHRD+ A N +LD     K++DFGLA+ D  DK     H  T     + +MA E
Sbjct: 170 K---KFVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLPVKWMALE 225
Query: 415 YALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV 474
                  T K+DV+SFG++  E+++ +    Y     FD T       +L Q  +L++  
Sbjct: 226 SLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDIT------VYLLQGRRLLQ-- 276
Query: 475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                    +   + + +V L C +    +RP+ SE+
Sbjct: 277 --------PEYCPDPLYEVMLKCWHPKAEMRPSFSEL 305

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 106/206 (51%), Gaps = 11/206 (5%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQHP 296
            NF   +KIGEG +G VYK +    G ++A+K+  L +++       + EI+++  L HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFL 356
           N+VK+       ++L LV+E++  +      F   +    +  P  +     + +GLAF 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD---LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYA 416
           H     +++HRD+K  N+L++ +   K++DFGLA+   G      T    T+ Y APE  
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRAPEIL 174
Query: 417 L-WGYLTYKADVYSFGIVALEIVSGK 441
           L   Y +   D++S G +  E+V+ +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 106/206 (51%), Gaps = 11/206 (5%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQHP 296
            NF   +KIGEG +G VYK +    G ++A+K+  L +++       + EI+++  L HP
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFL 356
           N+VK+       ++L LV+E++  +      F   +    +  P  +     + +GLAF 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQD---LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYA 416
           H     +++HRD+K  N+L++ +   K++DFGLA+   G      T    T+ Y APE  
Sbjct: 127 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRAPEIL 182
Query: 417 L-WGYLTYKADVYSFGIVALEIVSGK 441
           L   Y +   D++S G +  E+V+ +
Sbjct: 183 LGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 130/277 (46%), Gaps = 40/277 (14%)
Query: 248 IGEGGFGPVYKGQLAD--GTII--AVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIH 302
           IG G FG VY G L D  G  I  AVK L+  +  G   +FL E  ++    HPN++ + 
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 303 GCCVEGD-QLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC---LGIARGLAFLHE 358
           G C+  +   L+V  YM++  L      R     E   PT + +    L +A+G+ +L  
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 170
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK----THISTRIAGTIGYMAPE 414
           +   K VHRD+ A N +LD     K++DFGLA+ D  DK     H  T     + +MA E
Sbjct: 171 K---KFVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLPVKWMALE 226
Query: 415 YALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV 474
                  T K+DV+SFG++  E+++ +    Y     FD T       +L Q  +L++  
Sbjct: 227 SLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDIT------VYLLQGRRLLQ-- 277
Query: 475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                    +   + + +V L C +    +RP+ SE+
Sbjct: 278 --------PEYCPDPLYEVMLKCWHPKAEMRPSFSEL 306

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 108/220 (49%), Gaps = 24/220 (10%)
Query: 242 FDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGN---REFLNEIAMISCLQHPN 297
           F   ++IG G FG VY  + + +  ++A+K++S   +Q N   ++ + E+  +  L+HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 298 LVKIHGCCVEGDQLLLVYEY-MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFL 356
            ++  GC +      LV EY + + S    +  +   E+E+       +  G  +GLA+L
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI-----AAVTHGALQGLAYL 131
Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYA 416
           H  +   ++HRD+KA N+LL      K+ DFG A +        +    GT  +MAPE  
Sbjct: 132 HSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASI-----MAPANXFVGTPYWMAPEVI 183
Query: 417 LW---GYLTYKADVYSFGIVALEIVSGKN---NMSYAPAL 450
           L    G    K DV+S GI  +E+   K    NM+   AL
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 106/206 (51%), Gaps = 11/206 (5%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQHP 296
            NF   +KIGEG +G VYK +    G ++A+K+  L +++       + EI+++  L HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFL 356
           N+VK+       ++L LV+E++  +      F   +    +  P  +     + +GLAF 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD---LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYA 416
           H     +++HRD+K  N+L++ +   K++DFGLA+   G      T    T+ Y APE  
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRAPEIL 175
Query: 417 L-WGYLTYKADVYSFGIVALEIVSGK 441
           L   Y +   D++S G +  E+V+ +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 130/277 (46%), Gaps = 40/277 (14%)
Query: 248 IGEGGFGPVYKGQLAD--GTII--AVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIH 302
           IG G FG VY G L D  G  I  AVK L+  +  G   +FL E  ++    HPN++ + 
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 303 GCCVEGD-QLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC---LGIARGLAFLHE 358
           G C+  +   L+V  YM++  L      R     E   PT + +    L +A+G+ +L  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 149
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK----THISTRIAGTIGYMAPE 414
           +   K VHRD+ A N +LD     K++DFGLA+ D  DK     H  T     + +MA E
Sbjct: 150 K---KFVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLPVKWMALE 205
Query: 415 YALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV 474
                  T K+DV+SFG++  E+++ +    Y     FD T       +L Q  +L++  
Sbjct: 206 SLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDIT------VYLLQGRRLLQ-- 256
Query: 475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                    +   + + +V L C +    +RP+ SE+
Sbjct: 257 --------PEYCPDPLYEVMLKCWHPKAEMRPSFSEL 285

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 106/206 (51%), Gaps = 11/206 (5%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQHP 296
            NF   +KIGEG +G VYK +    G ++A+K+  L +++       + EI+++  L HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFL 356
           N+VK+       ++L LV+E++  +      F   +    +  P  +     + +GLAF 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD---LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYA 416
           H     +++HRD+K  N+L++ +   K++DFGLA+   G      T    T+ Y APE  
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRAPEIL 175
Query: 417 L-WGYLTYKADVYSFGIVALEIVSGK 441
           L   Y +   D++S G +  E+V+ +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 106/206 (51%), Gaps = 11/206 (5%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQHP 296
            NF   +KIGEG +G VYK +    G ++A+K+  L +++       + EI+++  L HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFL 356
           N+VK+       ++L LV+E++  +      F   +    +  P  +     + +GLAF 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD---LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYA 416
           H     +++HRD+K  N+L++ +   K++DFGLA+   G      T    T+ Y APE  
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRAPEIL 174
Query: 417 L-WGYLTYKADVYSFGIVALEIVSGK 441
           L   Y +   D++S G +  E+V+ +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 130/277 (46%), Gaps = 40/277 (14%)
Query: 248 IGEGGFGPVYKGQLAD--GTII--AVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIH 302
           IG G FG VY G L D  G  I  AVK L+  +  G   +FL E  ++    HPN++ + 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 303 GCCVEGD-QLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC---LGIARGLAFLHE 358
           G C+  +   L+V  YM++  L      R     E   PT + +    L +A+G+ +L  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 151
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK----THISTRIAGTIGYMAPE 414
           +   K VHRD+ A N +LD     K++DFGLA+ D  DK     H  T     + +MA E
Sbjct: 152 K---KFVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLPVKWMALE 207
Query: 415 YALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV 474
                  T K+DV+SFG++  E+++ +    Y     FD T       +L Q  +L++  
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDIT------VYLLQGRRLLQ-- 258
Query: 475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                    +   + + +V L C +    +RP+ SE+
Sbjct: 259 --------PEYCPDPLYEVMLKCWHPKAEMRPSFSEL 287

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 130/277 (46%), Gaps = 40/277 (14%)
Query: 248 IGEGGFGPVYKGQLAD--GTII--AVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIH 302
           IG G FG VY G L D  G  I  AVK L+  +  G   +FL E  ++    HPN++ + 
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 303 GCCVEGD-QLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC---LGIARGLAFLHE 358
           G C+  +   L+V  YM++  L      R     E   PT + +    L +A+G+ +L  
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 148
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK----THISTRIAGTIGYMAPE 414
           +   K VHRD+ A N +LD     K++DFGLA+ D  DK     H  T     + +MA E
Sbjct: 149 K---KFVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLPVKWMALE 204
Query: 415 YALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV 474
                  T K+DV+SFG++  E+++ +    Y     FD T       +L Q  +L++  
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDIT------VYLLQGRRLLQ-- 255
Query: 475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                    +   + + +V L C +    +RP+ SE+
Sbjct: 256 --------PEYCPDPLYEVMLKCWHPKAEMRPSFSEL 284

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 108/210 (51%), Gaps = 19/210 (9%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQHP 296
            NF   +KIGEG +G VYK +    G ++A+K+  L +++       + EI+++  L HP
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSL----ACALFGRENCELELDWPTRQKICLGIARG 352
           N+VK+       ++L LV+E++  +      A AL G       +  P  +     + +G
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQG 119
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMA 412
           LAF H     +++HRD+K  N+L++ +   K++DFGLA+   G      T    T+ Y A
Sbjct: 120 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRA 175
Query: 413 PEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           PE  L   Y +   D++S G +  E+V+ +
Sbjct: 176 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 130/277 (46%), Gaps = 40/277 (14%)
Query: 248 IGEGGFGPVYKGQLAD--GTII--AVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIH 302
           IG G FG VY G L D  G  I  AVK L+  +  G   +FL E  ++    HPN++ + 
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 303 GCCVEGD-QLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC---LGIARGLAFLHE 358
           G C+  +   L+V  YM++  L      R     E   PT + +    L +A+G+ +L  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 150
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK----THISTRIAGTIGYMAPE 414
           +   K VHRD+ A N +LD     K++DFGLA+ D  DK     H  T     + +MA E
Sbjct: 151 K---KFVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEXXSVHNKTGAKLPVKWMALE 206
Query: 415 YALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV 474
                  T K+DV+SFG++  E+++ +    Y     FD T       +L Q  +L++  
Sbjct: 207 SLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDIT------VYLLQGRRLLQ-- 257
Query: 475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                    +   + + +V L C +    +RP+ SE+
Sbjct: 258 --------PEYCPDPLYEVMLKCWHPKAEMRPSFSEL 286

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 129/280 (46%), Gaps = 34/280 (12%)
Query: 246 KKIGEGGFGPVYKGQLAD------GTIIAVKQLSSKSRQGNR-EFLNEIAMISCLQHPNL 298
           +++G+G FG VY+G   D       T +AVK ++  +    R EFLNE +++      ++
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFG-RENCELEL--DWPTRQ---KICLGIARG 352
           V++ G   +G   L+V E M +  L   L   R   E       PT Q   ++   IA G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYM 411
           +A+L+ +   K VHRD+ A N ++  D   KI DFG+ + + E D      +    + +M
Sbjct: 143 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 199
Query: 412 APEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLV 471
           APE    G  T  +D++SFG+V  EI S    ++  P        +L +      DG  +
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITS----LAEQPYQGLSNEQVLKFV----MDGGYL 251
Query: 472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           +  D            ER+  +  +C   +P +RPT  E+
Sbjct: 252 DQPDNC---------PERVTDLMRMCWQFNPKMRPTFLEI 282

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 129/280 (46%), Gaps = 34/280 (12%)
Query: 246 KKIGEGGFGPVYKGQLAD------GTIIAVKQLSSKSRQGNR-EFLNEIAMISCLQHPNL 298
           +++G+G FG VY+G   D       T +AVK ++  +    R EFLNE +++      ++
Sbjct: 20  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 79
Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFG-RENCELE--LDWPTRQ---KICLGIARG 352
           V++ G   +G   L+V E M +  L   L   R   E       PT Q   ++   IA G
Sbjct: 80  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 139
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYM 411
           +A+L+ +   K VHRD+ A N ++  D   KI DFG+ + + E D      +    + +M
Sbjct: 140 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 196
Query: 412 APEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLV 471
           APE    G  T  +D++SFG+V  EI S    ++  P        +L +      DG  +
Sbjct: 197 APESLKDGVFTTSSDMWSFGVVLWEITS----LAEQPYQGLSNEQVLKFV----MDGGYL 248
Query: 472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           +  D            ER+  +  +C   +P +RPT  E+
Sbjct: 249 DQPDNC---------PERVTDLMRMCWQFNPKMRPTFLEI 279

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 106/206 (51%), Gaps = 11/206 (5%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQHP 296
            NF   +KIGEG +G VYK +    G ++A+K+  L +++       + EI+++  L HP
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFL 356
           N+VK+       ++L LV+E++  +      F   +    +  P  +     + +GLAF 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQD---LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYA 416
           H     +++HRD+K  N+L++ +   K++DFGLA+   G      T    T+ Y APE  
Sbjct: 127 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRAPEIL 182
Query: 417 L-WGYLTYKADVYSFGIVALEIVSGK 441
           L   Y +   D++S G +  E+V+ +
Sbjct: 183 LGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 118/227 (51%), Gaps = 27/227 (11%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADG----TIIAVKQL-SSKSRQGNREFLNEIAMISCL 293
             F   K +G G FG VYKG  + +G      +A+K+L  + S + N+E L+E  +++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL-FGREN-----CELELDWPTRQKICL 347
            +P++ ++ G C+     L+    M+     C L + RE+      +  L+W      C+
Sbjct: 77  DNPHVCRLLGICLTSTVQLI----MQLMPFGCLLDYVREHKDNIGSQYLLNW------CV 126
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAG 406
            IA+G+ +L +    ++VHRD+ A NVL+    + KI+DFGLAK L   +K + +     
Sbjct: 127 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 183
Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEF 452
            I +MA E  L    T+++DV+S+G+   E+++ G       PA E 
Sbjct: 184 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 230

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 118/227 (51%), Gaps = 27/227 (11%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADG----TIIAVKQL-SSKSRQGNREFLNEIAMISCL 293
             F   K +G G FG VYKG  + +G      +A+K+L  + S + N+E L+E  +++ +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL-FGREN-----CELELDWPTRQKICL 347
            +P++ ++ G C+     L+    M+     C L + RE+      +  L+W      C+
Sbjct: 76  DNPHVCRLLGICLTSTVQLI----MQLMPFGCLLDYVREHKDNIGSQYLLNW------CV 125
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAG 406
            IA+G+ +L +    ++VHRD+ A NVL+    + KI+DFGLAK L   +K + +     
Sbjct: 126 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 182
Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEF 452
            I +MA E  L    T+++DV+S+G+   E+++ G       PA E 
Sbjct: 183 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 229

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 118/227 (51%), Gaps = 27/227 (11%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADG----TIIAVKQL-SSKSRQGNREFLNEIAMISCL 293
             F   K +G G FG VYKG  + +G      +A+K+L  + S + N+E L+E  +++ +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL-FGREN-----CELELDWPTRQKICL 347
            +P++ ++ G C+     L+    M+     C L + RE+      +  L+W      C+
Sbjct: 79  DNPHVCRLLGICLTSTVQLI----MQLMPFGCLLDYVREHKDNIGSQYLLNW------CV 128
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAG 406
            IA+G+ +L +    ++VHRD+ A NVL+    + KI+DFGLAK L   +K + +     
Sbjct: 129 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 185
Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEF 452
            I +MA E  L    T+++DV+S+G+   E+++ G       PA E 
Sbjct: 186 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 232

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 118/227 (51%), Gaps = 27/227 (11%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADG----TIIAVKQL-SSKSRQGNREFLNEIAMISCL 293
             F   K +G G FG VYKG  + +G      +A+K+L  + S + N+E L+E  +++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL-FGREN-----CELELDWPTRQKICL 347
            +P++ ++ G C+     L+    M+     C L + RE+      +  L+W      C+
Sbjct: 75  DNPHVCRLLGICLTSTVQLI----MQLMPFGCLLDYVREHKDNIGSQYLLNW------CV 124
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAG 406
            IA+G+ +L +    ++VHRD+ A NVL+    + KI+DFGLAK L   +K + +     
Sbjct: 125 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEF 452
            I +MA E  L    T+++DV+S+G+   E+++ G       PA E 
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 105/201 (52%), Gaps = 11/201 (5%)
Query: 245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
           + +IG G FG VYKG+      + + ++   + +  + F NE+A++   +H N++   G 
Sbjct: 41  STRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
             + D L +V ++ E +SL   L  +E    +        I    A+G+ +LH ++   I
Sbjct: 101 MTK-DNLAIVTQWCEGSSLYKHLHVQET---KFQMFQLIDIARQTAQGMDYLHAKN---I 153
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKL-DEGDKTHISTRIAGTIGYMAPEYALW---GY 420
           +HRD+K+ N+ L   L  KI DFGLA +      +    +  G++ +MAPE         
Sbjct: 154 IHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNP 213
Query: 421 LTYKADVYSFGIVALEIVSGK 441
            ++++DVYS+GIV  E+++G+
Sbjct: 214 FSFQSDVYSYGIVLYELMTGE 234

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 106/206 (51%), Gaps = 11/206 (5%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQHP 296
            NF   +KIGEG +G VYK +    G ++A+K+  L +++       + EI+++  L HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFL 356
           N+VK+       ++L LV+E++  +      F   +    +  P  +     + +GLAF 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQD---LKTFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYA 416
           H     +++HRD+K  N+L++ +   K++DFGLA+   G      T    T+ Y APE  
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRAPEIL 174
Query: 417 L-WGYLTYKADVYSFGIVALEIVSGK 441
           L   Y +   D++S G +  E+V+ +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 106/201 (52%), Gaps = 21/201 (10%)
Query: 247 KIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           ++G+G FG VYK +  + G + A K + +KS +   +++ EI +++   HP +VK+ G  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDW----PTRQKICLGIARGLAFLHEESR 361
               +L ++ E+    ++   +       LELD     P  Q +C  +   L FLH +  
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIM-------LELDRGLTEPQIQVVCRQMLEALNFLHSK-- 136
Query: 362 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYL 421
            +I+HRD+KA NVL+  + + +++DFG++  +        + I GT  +MAPE  +   +
Sbjct: 137 -RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETM 194
Query: 422 T-----YKADVYSFGIVALEI 437
                 YKAD++S GI  +E+
Sbjct: 195 KDTPYDYKADIWSLGITLIEM 215

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 133/300 (44%), Gaps = 42/300 (14%)
Query: 232 LKQIKAATNNFDSAKKIGEGGFGPVYKGQL---ADG---TIIAVKQLSSKSRQGNRE-FL 284
           LK+I  +   F   +++GE  FG VYKG L   A G     +A+K L  K+    RE F 
Sbjct: 3   LKEISLSAVRF--MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR 60
Query: 285 NEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGR------------EN 332
           +E  + + LQHPN+V + G   +   L +++ Y  +  L   L  R              
Sbjct: 61  HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 333 CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK- 391
            +  L+ P    +   IA G+ +L   S   +VH+D+   NVL+   LN KISD GL + 
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE 177
Query: 392 LDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALE 451
           +   D   +       I +MAPE  ++G  +  +D++S+G+V  E+       SY     
Sbjct: 178 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEV------FSYG---- 227
Query: 452 FDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                L  +  +  QD  +VE++  R       +    +  + + C N  PS RP   ++
Sbjct: 228 -----LQPYCGYSNQD--VVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDI 280

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 19/210 (9%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQHP 296
            NF   +KIGEG +G VYK +    G ++A+K+  L +++       + EI+++  L HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSL----ACALFGRENCELELDWPTRQKICLGIARG 352
           N+VK+       ++L LV+E++  +      A AL G       +  P  +     + +G
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQG 115
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMA 412
           L+F H     +++HRD+K  N+L++ +   K++DFGLA+   G      T    T+ Y A
Sbjct: 116 LSFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRA 171
Query: 413 PEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           PE  L   Y +   D++S G +  E+V+ +
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 11/208 (5%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQ 294
           +  NF   +KIGEG +G VYK +    G ++A+K+  L +++       + EI+++  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HPN+VK+       ++L LV+E++   S+    F   +    +  P  +     + +GLA
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPE 414
           F H     +++HRD+K  N+L++ +   K++DFGLA+   G           T+ Y APE
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWYRAPE 174
Query: 415 YAL-WGYLTYKADVYSFGIVALEIVSGK 441
             L   Y +   D++S G +  E+V+ +
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 106/201 (52%), Gaps = 21/201 (10%)
Query: 247 KIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           ++G+G FG VYK +  + G + A K + +KS +   +++ EI +++   HP +VK+ G  
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDW----PTRQKICLGIARGLAFLHEESR 361
               +L ++ E+    ++   +       LELD     P  Q +C  +   L FLH +  
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIM-------LELDRGLTEPQIQVVCRQMLEALNFLHSK-- 128
Query: 362 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYL 421
            +I+HRD+KA NVL+  + + +++DFG++  +        + I GT  +MAPE  +   +
Sbjct: 129 -RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETM 186
Query: 422 T-----YKADVYSFGIVALEI 437
                 YKAD++S GI  +E+
Sbjct: 187 KDTPYDYKADIWSLGITLIEM 207

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 11/208 (5%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQ 294
           +  NF   +KIGEG +G VYK +    G ++A+K+  L +++       + EI+++  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HPN+VK+       ++L LV+E++   S+    F   +    +  P  +     + +GLA
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPE 414
           F H     +++HRD+K  N+L++ +   K++DFGLA+   G           T+ Y APE
Sbjct: 121 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWYRAPE 176
Query: 415 YAL-WGYLTYKADVYSFGIVALEIVSGK 441
             L   Y +   D++S G +  E+V+ +
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 133/300 (44%), Gaps = 42/300 (14%)
Query: 232 LKQIKAATNNFDSAKKIGEGGFGPVYKGQL---ADG---TIIAVKQLSSKSRQGNRE-FL 284
           LK+I  +   F   +++GE  FG VYKG L   A G     +A+K L  K+    RE F 
Sbjct: 20  LKEISLSAVRF--MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR 77
Query: 285 NEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGR------------EN 332
           +E  + + LQHPN+V + G   +   L +++ Y  +  L   L  R              
Sbjct: 78  HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 137
Query: 333 CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK- 391
            +  L+ P    +   IA G+ +L   S   +VH+D+   NVL+   LN KISD GL + 
Sbjct: 138 VKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE 194
Query: 392 LDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALE 451
           +   D   +       I +MAPE  ++G  +  +D++S+G+V  E+       SY     
Sbjct: 195 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEV------FSYG---- 244
Query: 452 FDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                L  +  +  QD  +VE++  R       +    +  + + C N  PS RP   ++
Sbjct: 245 -----LQPYCGYSNQD--VVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDI 297

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 111/203 (54%), Gaps = 13/203 (6%)
Query: 242 FDSAKKIGEGGFGPVYKGQLADGTIIAVKQLS-SKSRQG-NREFLNEIAMISCLQHPNLV 299
           +   +KIGEG +G VYK Q   G   A+K++   K  +G     + EI+++  L+H N+V
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
           K++       +L+LV+E+++ + L   L   + CE  L+  T +   L +  G+A+ H+ 
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQD-LKKLL---DVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWG 419
              +++HRD+K  N+L++R+   KI+DFGLA+   G      T    T+ Y AP+  L G
Sbjct: 120 ---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEVVTLWYRAPD-VLMG 174
Query: 420 YLTYKA--DVYSFGIVALEIVSG 440
              Y    D++S G +  E+V+G
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 11/208 (5%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQ 294
           +  NF   +KIGEG +G VYK +    G ++A+K+  L +++       + EI+++  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HPN+VK+       ++L LV+E++  +      F   +    +  P  +     + +GLA
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQD---LKTFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPE 414
           F H     +++HRD+K  N+L++ +   K++DFGLA+   G           T+ Y APE
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWYRAPE 176
Query: 415 YAL-WGYLTYKADVYSFGIVALEIVSGK 441
             L   Y +   D++S G +  E+V+ +
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 111/203 (54%), Gaps = 13/203 (6%)
Query: 242 FDSAKKIGEGGFGPVYKGQLADGTIIAVKQLS-SKSRQG-NREFLNEIAMISCLQHPNLV 299
           +   +KIGEG +G VYK Q   G   A+K++   K  +G     + EI+++  L+H N+V
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
           K++       +L+LV+E+++ + L   L   + CE  L+  T +   L +  G+A+ H+ 
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQD-LKKLL---DVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWG 419
              +++HRD+K  N+L++R+   KI+DFGLA+   G      T    T+ Y AP+  L G
Sbjct: 120 ---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEVVTLWYRAPD-VLMG 174
Query: 420 YLTYKA--DVYSFGIVALEIVSG 440
              Y    D++S G +  E+V+G
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 11/208 (5%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQ 294
           +  NF   +KIGEG +G VYK +    G ++A+K+  L +++       + EI+++  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HPN+VK+       ++L LV+E++   S+    F   +    +  P  +     + +GLA
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPE 414
           F H     +++HRD+K  N+L++ +   K++DFGLA+   G           T+ Y APE
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWYRAPE 175
Query: 415 YAL-WGYLTYKADVYSFGIVALEIVSGK 441
             L   Y +   D++S G +  E+V+ +
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 127/247 (51%), Gaps = 32/247 (12%)
Query: 220 MKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKG-QLADG----TIIAVKQL-S 273
           M E+  Q +   LK+       F   K +G G FG VYKG  + +G      +A+K+L  
Sbjct: 3   MGEAPNQALLRILKE-----TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 57
Query: 274 SKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL-FGREN 332
           + S + N+E L+E  +++ + +P++ ++ G C+    + L+ + M      C L + RE+
Sbjct: 58  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM---PFGCLLDYVREH 113
Query: 333 -----CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF 387
                 +  L+W      C+ IA+G+ +L +    ++VHRD+ A NVL+    + KI+DF
Sbjct: 114 KDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDF 164
Query: 388 GLAK-LDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMS 445
           GLAK L   +K + +      I +MA E  L    T+++DV+S+G+   E+++ G     
Sbjct: 165 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224
Query: 446 YAPALEF 452
             PA E 
Sbjct: 225 GIPASEI 231

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 19/212 (8%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQ 294
           +  NF   +KIGEG +G VYK +    G ++A+K+  L +++       + EI+++  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSL----ACALFGRENCELELDWPTRQKICLGIA 350
           HPN+VK+       ++L LV+E++  +      A AL G       +  P  +     + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLL 113
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
           +GLAF H     +++HRD+K  N+L++ +   K++DFGLA+   G           T+ Y
Sbjct: 114 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWY 169
Query: 411 MAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
            APE  L   Y +   D++S G +  E+V+ +
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 127/247 (51%), Gaps = 32/247 (12%)
Query: 220 MKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKG-QLADG----TIIAVKQL-S 273
           M E+  Q +   LK+       F   K +G G FG VYKG  + +G      +A+K+L  
Sbjct: 3   MGEAPNQALLRILKE-----TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 57
Query: 274 SKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL-FGREN 332
           + S + N+E L+E  +++ + +P++ ++ G C+    + L+ + M      C L + RE+
Sbjct: 58  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM---PFGCLLDYVREH 113
Query: 333 -----CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF 387
                 +  L+W      C+ IA+G+ +L +    ++VHRD+ A NVL+    + KI+DF
Sbjct: 114 KDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDF 164
Query: 388 GLAK-LDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMS 445
           GLAK L   +K + +      I +MA E  L    T+++DV+S+G+   E+++ G     
Sbjct: 165 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224
Query: 446 YAPALEF 452
             PA E 
Sbjct: 225 GIPASEI 231

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 19/212 (8%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQ 294
           +  NF   +KIGEG +G VYK +    G ++A+K+  L +++       + EI+++  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSL----ACALFGRENCELELDWPTRQKICLGIA 350
           HPN+VK+       ++L LV+E++  +      A AL G       +  P  +     + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLL 113
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
           +GLAF H     +++HRD+K  N+L++ +   K++DFGLA+   G           T+ Y
Sbjct: 114 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWY 169
Query: 411 MAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
            APE  L   Y +   D++S G +  E+V+ +
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 11/208 (5%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQ 294
           +  NF   +KIGEG +G VYK +    G ++A+K+  L +++       + EI+++  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HPN+VK+       ++L LV+E++  +      F   +    +  P  +     + +GLA
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD---LKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPE 414
           F H     +++HRD+K  N+L++ +   K++DFGLA+   G           T+ Y APE
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWYRAPE 173
Query: 415 YAL-WGYLTYKADVYSFGIVALEIVSGK 441
             L   Y +   D++S G +  E+V+ +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 127/247 (51%), Gaps = 32/247 (12%)
Query: 220 MKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKG-QLADG----TIIAVKQL-S 273
           M E+  Q +   LK+       F   K +G G FG VYKG  + +G      +A+K+L  
Sbjct: 3   MGEAPNQALLRILKE-----TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 57
Query: 274 SKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL-FGREN 332
           + S + N+E L+E  +++ + +P++ ++ G C+    + L+ + M      C L + RE+
Sbjct: 58  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM---PFGCLLDYVREH 113
Query: 333 -----CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF 387
                 +  L+W      C+ IA+G+ +L +    ++VHRD+ A NVL+    + KI+DF
Sbjct: 114 KDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDF 164
Query: 388 GLAK-LDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMS 445
           GLAK L   +K + +      I +MA E  L    T+++DV+S+G+   E+++ G     
Sbjct: 165 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224
Query: 446 YAPALEF 452
             PA E 
Sbjct: 225 GIPASEI 231

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 11/208 (5%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQ 294
           +  NF   +KIGEG +G VYK +    G ++A+K+  L +++       + EI+++  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HPN+VK+       ++L LV+E++   S+    F   +    +  P  +     + +GLA
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPE 414
           F H     +++HRD+K  N+L++ +   K++DFGLA+   G           T+ Y APE
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWYRAPE 176
Query: 415 YAL-WGYLTYKADVYSFGIVALEIVSGK 441
             L   Y +   D++S G +  E+V+ +
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 11/208 (5%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQ 294
           +  NF   +KIGEG +G VYK +    G ++A+K+  L +++       + EI+++  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HPN+VK+       ++L LV+E++  +      F   +    +  P  +     + +GLA
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD---LKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPE 414
           F H     +++HRD+K  N+L++ +   K++DFGLA+   G           T+ Y APE
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWYRAPE 173
Query: 415 YAL-WGYLTYKADVYSFGIVALEIVSGK 441
             L   Y +   D++S G +  E+V+ +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 19/212 (8%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQ 294
           +  NF   +KIGEG +G VYK +    G ++A+K+  L +++       + EI+++  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSL----ACALFGRENCELELDWPTRQKICLGIA 350
           HPN+VK+       ++L LV+E++  +      A AL G       +  P  +     + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTG-------IPLPLIKSYLFQLL 113
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
           +GLAF H     +++HRD+K  N+L++ +   K++DFGLA+   G           T+ Y
Sbjct: 114 QGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWY 169
Query: 411 MAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
            APE  L   Y +   D++S G +  E+V+ +
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 106/217 (48%), Gaps = 22/217 (10%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQL-----ADGTI-IAVKQLSSKSRQGNRE-FLNEIAMISC 292
           NN    K +G G FG V +         D  + +AVK L S +    +E  ++E+ ++S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 293 L-QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL---- 347
           L QH N+V + G C  G  +L++ EY     L    F R   E +LD    + + L    
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN--FLRRKAEADLDKEDGRPLELRDLL 163
Query: 348 ----GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR 403
                +A+G+AFL  ++    +HRD+ A NVLL      KI DFGLA+    D  +I   
Sbjct: 164 HFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 220
Query: 404 IAG-TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
            A   + +MAPE       T ++DV+S+GI+  EI S
Sbjct: 221 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 11/208 (5%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQ 294
           +  NF   +KIGEG +G VYK +    G ++A+K+  L +++       + EI+++  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HPN+VK+       ++L LV+E++  +      F   +    +  P  +     + +GLA
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQD---LKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPE 414
           F H     +++HRD+K  N+L++ +   K++DFGLA+   G           T+ Y APE
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWYRAPE 174
Query: 415 YAL-WGYLTYKADVYSFGIVALEIVSGK 441
             L   Y +   D++S G +  E+V+ +
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 106/217 (48%), Gaps = 22/217 (10%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQL-----ADGTI-IAVKQLSSKSRQGNRE-FLNEIAMISC 292
           NN    K +G G FG V +         D  + +AVK L S +    +E  ++E+ ++S 
Sbjct: 38  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 293 L-QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL---- 347
           L QH N+V + G C  G  +L++ EY     L    F R   E +LD    + + L    
Sbjct: 98  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN--FLRRKAEADLDKEDGRPLELRDLL 155
Query: 348 ----GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR 403
                +A+G+AFL  ++    +HRD+ A NVLL      KI DFGLA+    D  +I   
Sbjct: 156 HFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 212
Query: 404 IAG-TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
            A   + +MAPE       T ++DV+S+GI+  EI S
Sbjct: 213 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 19/212 (8%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQ 294
           +  NF   +KIGEG +G VYK +    G ++A+K+  L +++       + EI+++  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSL----ACALFGRENCELELDWPTRQKICLGIA 350
           HPN+VK+       ++L LV+E++  +      A AL G       +  P  +     + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLL 115
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
           +GLAF H     +++HRD+K  N+L++ +   K++DFGLA+   G           T+ Y
Sbjct: 116 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWY 171
Query: 411 MAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
            APE  L   Y +   D++S G +  E+V+ +
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 111/203 (54%), Gaps = 13/203 (6%)
Query: 242 FDSAKKIGEGGFGPVYKGQLADGTIIAVKQLS-SKSRQG-NREFLNEIAMISCLQHPNLV 299
           +   +KIGEG +G VYK Q   G   A+K++   K  +G     + EI+++  L+H N+V
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
           K++       +L+LV+E+++ + L   L   + CE  L+  T +   L +  G+A+ H+ 
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQD-LKKLL---DVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWG 419
              +++HRD+K  N+L++R+   KI+DFGLA+   G      T    T+ Y AP+  L G
Sbjct: 120 ---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIVTLWYRAPD-VLMG 174
Query: 420 YLTYKA--DVYSFGIVALEIVSG 440
              Y    D++S G +  E+V+G
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 19/212 (8%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQ 294
           +  NF   +KIGEG +G VYK +    G ++A+K+  L +++       + EI+++  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSL----ACALFGRENCELELDWPTRQKICLGIA 350
           HPN+VK+       ++L LV+E++  +      A AL G       +  P  +     + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLL 114
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
           +GLAF H     +++HRD+K  N+L++ +   K++DFGLA+   G           T+ Y
Sbjct: 115 QGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWY 170
Query: 411 MAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
            APE  L   Y +   D++S G +  E+V+ +
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQHP 296
            NF   +KIGEG +G VYK +    G ++A+K+  L +++       + EI+++  L HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFL 356
           N+VK+       ++L LV+E++  +      F   +    +  P  +     + +GLAF 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD---LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYA 416
           H     +++HRD+K  N+L++ +   K++DFGLA+   G           T+ Y APE  
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWYRAPEIL 174
Query: 417 L-WGYLTYKADVYSFGIVALEIVSGK 441
           L   Y +   D++S G +  E+V+ +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 19/210 (9%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQHP 296
            NF   +KIGEG +G VYK +    G ++A+ +  L +++       + EI+++  L HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSL----ACALFGRENCELELDWPTRQKICLGIARG 352
           N+VK+       ++L LV+E++  +      A AL G       +  P  +     + +G
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQG 115
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMA 412
           LAF H     +++HRD+K  N+L++ +   K++DFGLA+   G      T    T+ Y A
Sbjct: 116 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRA 171
Query: 413 PEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           PE  L   Y +   D++S G +  E+V+ +
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 19/210 (9%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQHP 296
            NF   +KIGEG +G VYK +    G ++A+ +  L +++       + EI+++  L HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSL----ACALFGRENCELELDWPTRQKICLGIARG 352
           N+VK+       ++L LV+E++  +      A AL G       +  P  +     + +G
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQG 114
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMA 412
           LAF H     +++HRD+K  N+L++ +   K++DFGLA+   G      T    T+ Y A
Sbjct: 115 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRA 170
Query: 413 PEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           PE  L   Y +   D++S G +  E+V+ +
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 107/216 (49%), Gaps = 16/216 (7%)
Query: 246 KKIGEGGFGPVYKGQ---LAD--GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
           +++G+G FG V   +   L D  G ++AVK+L   + +  R+F  EI ++  LQH N+VK
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 301 IHGCCVEGDQ--LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
             G C    +  L L+ EY+   SL   L   +  +  +D     +    I +G+ +L  
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG--TIGYMAPEYA 416
           +   + +HRD+   N+L++ +   KI DFGL K+   DK     +  G   I + APE  
Sbjct: 133 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 417 LWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEF 452
                +  +DV+SFG+V  E+ +     S +P  EF
Sbjct: 190 TESKFSVASDVWSFGVVLYELFTYIEK-SKSPPAEF 224

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 11/208 (5%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQ 294
           +  NF   +KIGEG +G VYK +    G ++A+K+  L +++       + EI+++  L 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HPN+VK+       ++L LV+E++  +      F   +    +  P  +     + +GLA
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQD---LKKFMDASALTGIPLPLIKSYLFQLLQGLA 121
Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPE 414
           F H     +++HRD+K  N+L++ +   K++DFGLA+   G           T+ Y APE
Sbjct: 122 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWYRAPE 177
Query: 415 YAL-WGYLTYKADVYSFGIVALEIVSGK 441
             L   Y +   D++S G +  E+V+ +
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 19/212 (8%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQ 294
           +  NF   +KIGEG +G VYK +    G ++A+K+  L +++       + EI+++  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSL----ACALFGRENCELELDWPTRQKICLGIA 350
           HPN+VK+       ++L LV+E++  +      A AL G       +  P  +     + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLL 115
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
           +GLAF H     +++HRD+K  N+L++ +   K++DFGLA+   G           T+ Y
Sbjct: 116 QGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWY 171
Query: 411 MAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
            APE  L   Y +   D++S G +  E+V+ +
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 11/208 (5%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQ 294
           +  NF   +KIGEG +G VYK +    G ++A+K+  L +++       + EI+++  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HPN+VK+       ++L LV+E++  +      F   +    +  P  +     + +GLA
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQD---LKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPE 414
           F H     +++HRD+K  N+L++ +   K++DFGLA+   G           T+ Y APE
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWYRAPE 176
Query: 415 YAL-WGYLTYKADVYSFGIVALEIVSGK 441
             L   Y +   D++S G +  E+V+ +
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 119/227 (52%), Gaps = 27/227 (11%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADG----TIIAVKQL-SSKSRQGNREFLNEIAMISCL 293
             F   K +G G FG VYKG  + +G      +A+K+L  + S + N+E L+E  +++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL-FGREN-----CELELDWPTRQKICL 347
            +P++ ++ G C+    + L+ + M      C L + RE+      +  L+W      C+
Sbjct: 77  DNPHVCRLLGICLTS-TVQLITQLM---PFGCLLDYVREHKDNIGSQYLLNW------CV 126
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAG 406
            IA+G+ +L +    ++VHRD+ A NVL+    + KI+DFGLAK L   +K + +     
Sbjct: 127 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 183
Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEF 452
            I +MA E  L    T+++DV+S+G+   E+++ G       PA E 
Sbjct: 184 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 230

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 11/208 (5%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQ 294
           +  NF   +KIGEG +G VYK +    G ++A+K+  L +++       + EI+++  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HPN+VK+       ++L LV+E++  +      F   +    +  P  +     + +GLA
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQD---LKKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPE 414
           F H     +++HRD+K  N+L++ +   K++DFGLA+   G           T+ Y APE
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWYRAPE 175
Query: 415 YAL-WGYLTYKADVYSFGIVALEIVSGK 441
             L   Y +   D++S G +  E+V+ +
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 11/208 (5%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQ 294
           +  NF   +KIGEG +G VYK +    G ++A+K+  L +++       + EI+++  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HPN+VK+       ++L LV+E++  +      F   +    +  P  +     + +GLA
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQD---LKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPE 414
           F H     +++HRD+K  N+L++ +   K++DFGLA+   G           T+ Y APE
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWYRAPE 176
Query: 415 YAL-WGYLTYKADVYSFGIVALEIVSGK 441
             L   Y +   D++S G +  E+V+ +
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 119/227 (52%), Gaps = 27/227 (11%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADG----TIIAVKQL-SSKSRQGNREFLNEIAMISCL 293
             F   K +G G FG VYKG  + +G      +A+K+L  + S + N+E L+E  +++ +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL-FGREN-----CELELDWPTRQKICL 347
            +P++ ++ G C+    + L+ + M      C L + RE+      +  L+W      C+
Sbjct: 69  DNPHVCRLLGICLTS-TVQLITQLM---PFGCLLDYVREHKDNIGSQYLLNW------CV 118
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAG 406
            IA+G+ +L +    ++VHRD+ A NVL+    + KI+DFGLAK L   +K + +     
Sbjct: 119 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 175
Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEF 452
            I +MA E  L    T+++DV+S+G+   E+++ G       PA E 
Sbjct: 176 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 222

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 119/227 (52%), Gaps = 27/227 (11%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADG----TIIAVKQL-SSKSRQGNREFLNEIAMISCL 293
             F   K +G G FG VYKG  + +G      +A+K+L  + S + N+E L+E  +++ +
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL-FGREN-----CELELDWPTRQKICL 347
            +P++ ++ G C+    + L+ + M      C L + RE+      +  L+W      C+
Sbjct: 85  DNPHVCRLLGICLTS-TVQLITQLM---PFGCLLDYVREHKDNIGSQYLLNW------CV 134
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAG 406
            IA+G+ +L +    ++VHRD+ A NVL+    + KI+DFGLAK L   +K + +     
Sbjct: 135 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 191
Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEF 452
            I +MA E  L    T+++DV+S+G+   E+++ G       PA E 
Sbjct: 192 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 238

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 119/227 (52%), Gaps = 27/227 (11%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADG----TIIAVKQL-SSKSRQGNREFLNEIAMISCL 293
             F   K +G G FG VYKG  + +G      +A+K+L  + S + N+E L+E  +++ +
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL-FGREN-----CELELDWPTRQKICL 347
            +P++ ++ G C+    + L+ + M      C L + RE+      +  L+W      C+
Sbjct: 100 DNPHVCRLLGICLTS-TVQLITQLM---PFGCLLDYVREHKDNIGSQYLLNW------CV 149
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAG 406
            IA+G+ +L +    ++VHRD+ A NVL+    + KI+DFGLAK L   +K + +     
Sbjct: 150 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 206
Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEF 452
            I +MA E  L    T+++DV+S+G+   E+++ G       PA E 
Sbjct: 207 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 253

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 129/280 (46%), Gaps = 34/280 (12%)
Query: 246 KKIGEGGFGPVYKGQLAD------GTIIAVKQLSSKSRQGNR-EFLNEIAMISCLQHPNL 298
           +++G+G FG VY+G   D       T +AVK ++  +    R EFLNE +++      ++
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFG-RENCELEL--DWPTRQ---KICLGIARG 352
           V++ G   +G   L+V E M +  L   L   R   E       PT Q   ++   IA G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYM 411
           +A+L+ +   K VHRD+ A N ++  D   KI DFG+ + + E D      +    + +M
Sbjct: 143 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 199
Query: 412 APEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLV 471
           APE    G  T  +D++SFG+V  EI S    ++  P        +L +      DG  +
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITS----LAEQPYQGLSNEQVLKFV----MDGGYL 251
Query: 472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           +  D            ER+  +  +C   +P +RPT  E+
Sbjct: 252 DQPDNC---------PERVTDLMRMCWQFNPKMRPTFLEI 282

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 119/227 (52%), Gaps = 27/227 (11%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADG----TIIAVKQL-SSKSRQGNREFLNEIAMISCL 293
             F   K +G G FG VYKG  + +G      +A+K+L  + S + N+E L+E  +++ +
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL-FGREN-----CELELDWPTRQKICL 347
            +P++ ++ G C+    + L+ + M      C L + RE+      +  L+W      C+
Sbjct: 81  DNPHVCRLLGICLTS-TVQLITQLM---PFGCLLDYVREHKDNIGSQYLLNW------CV 130
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAG 406
            IA+G+ +L +    ++VHRD+ A NVL+    + KI+DFGLAK L   +K + +     
Sbjct: 131 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 187
Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEF 452
            I +MA E  L    T+++DV+S+G+   E+++ G       PA E 
Sbjct: 188 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 234

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 119/227 (52%), Gaps = 27/227 (11%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADG----TIIAVKQL-SSKSRQGNREFLNEIAMISCL 293
             F   K +G G FG VYKG  + +G      +A+K+L  + S + N+E L+E  +++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL-FGREN-----CELELDWPTRQKICL 347
            +P++ ++ G C+    + L+ + M      C L + RE+      +  L+W      C+
Sbjct: 75  DNPHVCRLLGICLTS-TVQLITQLM---PFGCLLDYVREHKDNIGSQYLLNW------CV 124
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAG 406
            IA+G+ +L +    ++VHRD+ A NVL+    + KI+DFGLAK L   +K + +     
Sbjct: 125 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEF 452
            I +MA E  L    T+++DV+S+G+   E+++ G       PA E 
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQHP 296
            NF   +KIGEG +G VYK +    G ++A+K+  L +++       + EI+++  L HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFL 356
           N+VK+       ++L LV+E++  +      F   +    +  P  +     + +GLAF 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD---LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYA 416
           H     +++HRD+K  N+L++ +   K++DFGLA+   G           T+ Y APE  
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWYRAPEIL 174
Query: 417 L-WGYLTYKADVYSFGIVALEIVSGK 441
           L   Y +   D++S G +  E+V+ +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 19/210 (9%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQHP 296
            NF   +KIGEG +G VYK +    G ++A+K+  L +++       + EI+++  L HP
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSL----ACALFGRENCELELDWPTRQKICLGIARG 352
           N+VK+       ++L LV+E++  +      A AL G       +  P  +     + +G
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQG 116
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMA 412
           LAF H     +++HRD+K  N+L++ +   K++DFGLA+   G           T+ Y A
Sbjct: 117 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWYRA 172
Query: 413 PEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           PE  L   Y +   D++S G +  E+V+ +
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 119/227 (52%), Gaps = 27/227 (11%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADG----TIIAVKQL-SSKSRQGNREFLNEIAMISCL 293
             F   K +G G FG VYKG  + +G      +A+K+L  + S + N+E L+E  +++ +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL-FGREN-----CELELDWPTRQKICL 347
            +P++ ++ G C+    + L+ + M      C L + RE+      +  L+W      C+
Sbjct: 82  DNPHVCRLLGICLTS-TVQLITQLM---PFGCLLDYVREHKDNIGSQYLLNW------CV 131
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAG 406
            IA+G+ +L +    ++VHRD+ A NVL+    + KI+DFGLAK L   +K + +     
Sbjct: 132 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 188
Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEF 452
            I +MA E  L    T+++DV+S+G+   E+++ G       PA E 
Sbjct: 189 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 235

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 129/280 (46%), Gaps = 34/280 (12%)
Query: 246 KKIGEGGFGPVYKGQLAD------GTIIAVKQLSSKSRQGNR-EFLNEIAMISCLQHPNL 298
           +++G+G FG VY+G   D       T +AVK ++  +    R EFLNE +++      ++
Sbjct: 22  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 81
Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFG-RENCELE--LDWPTRQ---KICLGIARG 352
           V++ G   +G   L+V E M +  L   L   R   E       PT Q   ++   IA G
Sbjct: 82  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 141
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYM 411
           +A+L+ +   K VHRD+ A N ++  D   KI DFG+ + + E D      +    + +M
Sbjct: 142 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 198
Query: 412 APEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLV 471
           APE    G  T  +D++SFG+V  EI S    ++  P        +L +      DG  +
Sbjct: 199 APESLKDGVFTTSSDMWSFGVVLWEITS----LAEQPYQGLSNEQVLKFV----MDGGYL 250
Query: 472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           +  D            ER+  +  +C   +P +RPT  E+
Sbjct: 251 DQPDNC---------PERVTDLMRMCWQFNPKMRPTFLEI 281

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 107/216 (49%), Gaps = 16/216 (7%)
Query: 246 KKIGEGGFGPVYKGQ---LAD--GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
           +++G+G FG V   +   L D  G ++AVK+L   + +  R+F  EI ++  LQH N+VK
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 301 IHGCCVEGDQ--LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
             G C    +  L L+ EY+   SL   L   +  +  +D     +    I +G+ +L  
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG--TIGYMAPEYA 416
           +   + +HRD+   N+L++ +   KI DFGL K+   DK     +  G   I + APE  
Sbjct: 164 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 220
Query: 417 LWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEF 452
                +  +DV+SFG+V  E+ +     S +P  EF
Sbjct: 221 TESKFSVASDVWSFGVVLYELFTYIEK-SKSPPAEF 255

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 107/216 (49%), Gaps = 16/216 (7%)
Query: 246 KKIGEGGFGPVYKGQ---LAD--GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
           +++G+G FG V   +   L D  G ++AVK+L   + +  R+F  EI ++  LQH N+VK
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 301 IHGCCVEGDQ--LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
             G C    +  L L+ EY+   SL   L   +  +  +D     +    I +G+ +L  
Sbjct: 83  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGT 139
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG--TIGYMAPEYA 416
           +   + +HRD+   N+L++ +   KI DFGL K+   DK     +  G   I + APE  
Sbjct: 140 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 196
Query: 417 LWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEF 452
                +  +DV+SFG+V  E+ +     S +P  EF
Sbjct: 197 TESKFSVASDVWSFGVVLYELFTYIEK-SKSPPAEF 231

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 107/216 (49%), Gaps = 16/216 (7%)
Query: 246 KKIGEGGFGPVYKGQ---LAD--GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
           +++G+G FG V   +   L D  G ++AVK+L   + +  R+F  EI ++  LQH N+VK
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 301 IHGCCVEGDQ--LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
             G C    +  L L+ EY+   SL   L   +  +  +D     +    I +G+ +L  
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG--TIGYMAPEYA 416
           +   + +HRD+   N+L++ +   KI DFGL K+   DK     +  G   I + APE  
Sbjct: 133 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 189
Query: 417 LWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEF 452
                +  +DV+SFG+V  E+ +     S +P  EF
Sbjct: 190 TESKFSVASDVWSFGVVLYELFTYIEK-SKSPPAEF 224

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 107/216 (49%), Gaps = 16/216 (7%)
Query: 246 KKIGEGGFGPVYKGQ---LAD--GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
           +++G+G FG V   +   L D  G ++AVK+L   + +  R+F  EI ++  LQH N+VK
Sbjct: 15  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 74
Query: 301 IHGCCVEGDQ--LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
             G C    +  L L+ EY+   SL   L   +  +  +D     +    I +G+ +L  
Sbjct: 75  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGT 131
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG--TIGYMAPEYA 416
           +   + +HRD+   N+L++ +   KI DFGL K+   DK     +  G   I + APE  
Sbjct: 132 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 188
Query: 417 LWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEF 452
                +  +DV+SFG+V  E+ +     S +P  EF
Sbjct: 189 TESKFSVASDVWSFGVVLYELFTYIEK-SKSPPAEF 223

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 107/216 (49%), Gaps = 16/216 (7%)
Query: 246 KKIGEGGFGPVYKGQ---LAD--GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
           +++G+G FG V   +   L D  G ++AVK+L   + +  R+F  EI ++  LQH N+VK
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 301 IHGCCVEGDQ--LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
             G C    +  L L+ EY+   SL   L   +  +  +D     +    I +G+ +L  
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG--TIGYMAPEYA 416
           +   + +HRD+   N+L++ +   KI DFGL K+   DK     +  G   I + APE  
Sbjct: 133 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 189
Query: 417 LWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEF 452
                +  +DV+SFG+V  E+ +     S +P  EF
Sbjct: 190 TESKFSVASDVWSFGVVLYELFTYIEK-SKSPPAEF 224

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 107/216 (49%), Gaps = 16/216 (7%)
Query: 246 KKIGEGGFGPVYKGQ---LAD--GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
           +++G+G FG V   +   L D  G ++AVK+L   + +  R+F  EI ++  LQH N+VK
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 301 IHGCCVEGDQ--LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
             G C    +  L L+ EY+   SL   L   +  +  +D     +    I +G+ +L  
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGT 130
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG--TIGYMAPEYA 416
           +   + +HRD+   N+L++ +   KI DFGL K+   DK     +  G   I + APE  
Sbjct: 131 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 187
Query: 417 LWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEF 452
                +  +DV+SFG+V  E+ +     S +P  EF
Sbjct: 188 TESKFSVASDVWSFGVVLYELFTYIEK-SKSPPAEF 222

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 107/216 (49%), Gaps = 16/216 (7%)
Query: 246 KKIGEGGFGPVYKGQ---LAD--GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
           +++G+G FG V   +   L D  G ++AVK+L   + +  R+F  EI ++  LQH N+VK
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 301 IHGCCVEGDQ--LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
             G C    +  L L+ EY+   SL   L   +  +  +D     +    I +G+ +L  
Sbjct: 81  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGT 137
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG--TIGYMAPEYA 416
           +   + +HRD+   N+L++ +   KI DFGL K+   DK     +  G   I + APE  
Sbjct: 138 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 194
Query: 417 LWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEF 452
                +  +DV+SFG+V  E+ +     S +P  EF
Sbjct: 195 TESKFSVASDVWSFGVVLYELFTYIEK-SKSPPAEF 229

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 107/216 (49%), Gaps = 16/216 (7%)
Query: 246 KKIGEGGFGPVYKGQ---LAD--GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
           +++G+G FG V   +   L D  G ++AVK+L   + +  R+F  EI ++  LQH N+VK
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 301 IHGCCVEGDQ--LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
             G C    +  L L+ EY+   SL   L   +  +  +D     +    I +G+ +L  
Sbjct: 82  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGT 138
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG--TIGYMAPEYA 416
           +   + +HRD+   N+L++ +   KI DFGL K+   DK     +  G   I + APE  
Sbjct: 139 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 195
Query: 417 LWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEF 452
                +  +DV+SFG+V  E+ +     S +P  EF
Sbjct: 196 TESKFSVASDVWSFGVVLYELFTYIEK-SKSPPAEF 230

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 107/216 (49%), Gaps = 16/216 (7%)
Query: 246 KKIGEGGFGPVYKGQ---LAD--GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
           +++G+G FG V   +   L D  G ++AVK+L   + +  R+F  EI ++  LQH N+VK
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 301 IHGCCVEGDQ--LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
             G C    +  L L+ EY+   SL   L   +  +  +D     +    I +G+ +L  
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG--TIGYMAPEYA 416
           +   + +HRD+   N+L++ +   KI DFGL K+   DK     +  G   I + APE  
Sbjct: 136 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 417 LWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEF 452
                +  +DV+SFG+V  E+ +     S +P  EF
Sbjct: 193 TESKFSVASDVWSFGVVLYELFTYIEK-SKSPPAEF 227

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 107/216 (49%), Gaps = 16/216 (7%)
Query: 246 KKIGEGGFGPVYKGQ---LAD--GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
           +++G+G FG V   +   L D  G ++AVK+L   + +  R+F  EI ++  LQH N+VK
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 301 IHGCCVEGDQ--LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
             G C    +  L L+ EY+   SL   L   +  +  +D     +    I +G+ +L  
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGT 136
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG--TIGYMAPEYA 416
           +   + +HRD+   N+L++ +   KI DFGL K+   DK     +  G   I + APE  
Sbjct: 137 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 193
Query: 417 LWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEF 452
                +  +DV+SFG+V  E+ +     S +P  EF
Sbjct: 194 TESKFSVASDVWSFGVVLYELFTYIEK-SKSPPAEF 228

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 119/227 (52%), Gaps = 27/227 (11%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADG----TIIAVKQL-SSKSRQGNREFLNEIAMISCL 293
             F   K +G G FG VYKG  + +G      +A+K+L  + S + N+E L+E  +++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL-FGREN-----CELELDWPTRQKICL 347
            +P++ ++ G C+    + L+ + M      C L + RE+      +  L+W      C+
Sbjct: 75  DNPHVCRLLGICLTST-VQLITQLM---PFGCLLDYVREHKDNIGSQYLLNW------CV 124
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAG 406
            IA+G+ +L +    ++VHRD+ A NVL+    + KI+DFGLAK L   +K + +     
Sbjct: 125 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEF 452
            I +MA E  L    T+++DV+S+G+   E+++ G       PA E 
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 109/212 (51%), Gaps = 19/212 (8%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQ 294
           +  NF   +KIGEG +G VYK +    G ++A+K+  L +++       + EI+++  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSL----ACALFGRENCELELDWPTRQKICLGIA 350
           HPN+VK+       ++L LV+E+++ +      A AL G       +  P  +     + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTG-------IPLPLIKSYLFQLL 116
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
           +GLAF H     +++HRD+K  N+L++ +   K++DFGLA+   G           T+ Y
Sbjct: 117 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVVTLWY 172
Query: 411 MAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
            APE  L   Y +   D++S G +  E+V+ +
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 117/227 (51%), Gaps = 27/227 (11%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADG----TIIAVKQL-SSKSRQGNREFLNEIAMISCL 293
             F   K +  G FG VYKG  + +G      +A+K+L  + S + N+E L+E  +++ +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL-FGREN-----CELELDWPTRQKICL 347
            +P++ ++ G C+     L+    M+     C L + RE+      +  L+W      C+
Sbjct: 82  DNPHVCRLLGICLTSTVQLI----MQLMPFGCLLDYVREHKDNIGSQYLLNW------CV 131
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAG 406
            IA+G+ +L +    ++VHRD+ A NVL+    + KI+DFGLAK L   +K + +     
Sbjct: 132 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 188
Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEF 452
            I +MA E  L    T+++DV+S+G+   E+++ G       PA E 
Sbjct: 189 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 235

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 107/216 (49%), Gaps = 16/216 (7%)
Query: 246 KKIGEGGFGPVYKGQ---LAD--GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
           +++G+G FG V   +   L D  G ++AVK+L   + +  R+F  EI ++  LQH N+VK
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 301 IHGCCVEGDQ--LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
             G C    +  L L+ EY+   SL   L   +  +  +D     +    I +G+ +L  
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGT 150
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG--TIGYMAPEYA 416
           +   + +HRD+   N+L++ +   KI DFGL K+   DK     +  G   I + APE  
Sbjct: 151 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 207
Query: 417 LWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEF 452
                +  +DV+SFG+V  E+ +     S +P  EF
Sbjct: 208 TESKFSVASDVWSFGVVLYELFTYIEK-SKSPPAEF 242

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 117/227 (51%), Gaps = 27/227 (11%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADG----TIIAVKQL-SSKSRQGNREFLNEIAMISCL 293
             F   K +G G FG VYKG  + +G      +A+K+L  + S + N+E L+E  +++ +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL-FGREN-----CELELDWPTRQKICL 347
            +P++ ++ G C+     L+    M+     C L + RE+      +  L+W      C+
Sbjct: 79  DNPHVCRLLGICLTSTVQLI----MQLMPFGCLLDYVREHKDNIGSQYLLNW------CV 128
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAG 406
            IA+G+ +L +    ++VHRD+ A NVL+    + KI+DFG AK L   +K + +     
Sbjct: 129 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 185
Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEF 452
            I +MA E  L    T+++DV+S+G+   E+++ G       PA E 
Sbjct: 186 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 232

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 117/227 (51%), Gaps = 27/227 (11%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADG----TIIAVKQL-SSKSRQGNREFLNEIAMISCL 293
             F   K +G G FG VYKG  + +G      +A+K+L  + S + N+E L+E  +++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL-FGREN-----CELELDWPTRQKICL 347
            +P++ ++ G C+     L+    M+     C L + RE+      +  L+W      C+
Sbjct: 77  DNPHVCRLLGICLTSTVQLI----MQLMPFGCLLDYVREHKDNIGSQYLLNW------CV 126
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAG 406
            IA+G+ +L +    ++VHRD+ A NVL+    + KI+DFG AK L   +K + +     
Sbjct: 127 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 183
Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEF 452
            I +MA E  L    T+++DV+S+G+   E+++ G       PA E 
Sbjct: 184 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 107/216 (49%), Gaps = 16/216 (7%)
Query: 246 KKIGEGGFGPVYKGQ---LAD--GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
           +++G+G FG V   +   L D  G ++AVK+L   + +  R+F  EI ++  LQH N+VK
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 301 IHGCCVEGDQ--LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
             G C    +  L L+ EY+   SL   L   +  +  +D     +    I +G+ +L  
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGT 150
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG--TIGYMAPEYA 416
           +   + +HRD+   N+L++ +   KI DFGL K+   DK     +  G   I + APE  
Sbjct: 151 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 207
Query: 417 LWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEF 452
                +  +DV+SFG+V  E+ +     S +P  EF
Sbjct: 208 TESKFSVASDVWSFGVVLYELFTYIEK-SKSPPAEF 242

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 117/227 (51%), Gaps = 27/227 (11%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADG----TIIAVKQL-SSKSRQGNREFLNEIAMISCL 293
             F   K +G G FG VYKG  + +G      +A+K+L  + S + N+E L+E  +++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL-FGREN-----CELELDWPTRQKICL 347
            +P++ ++ G C+     L+    M+     C L + RE+      +  L+W      C+
Sbjct: 77  DNPHVCRLLGICLTSTVQLI----MQLMPFGCLLDYVREHKDNIGSQYLLNW------CV 126
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAG 406
            IA+G+ +L +    ++VHRD+ A NVL+    + KI+DFG AK L   +K + +     
Sbjct: 127 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 183
Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEF 452
            I +MA E  L    T+++DV+S+G+   E+++ G       PA E 
Sbjct: 184 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 230

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 114/219 (52%), Gaps = 21/219 (9%)
Query: 245 AKKIGEGGFGPVYKG-QLADG----TIIAVKQL-SSKSRQGNREFLNEIAMISCLQHPNL 298
            K +G G FG VYKG  + DG      +A+K L  + S + N+E L+E  +++ +  P +
Sbjct: 22  VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYV 81
Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALF---GRENCELELDWPTRQKICLGIARGLAF 355
            ++ G C+    + LV + M    L   +    GR   +  L+W      C+ IA+G+++
Sbjct: 82  SRLLGICLTS-TVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNW------CMQIAKGMSY 134
Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT-IGYMAPE 414
           L +    ++VHRD+ A NVL+    + KI+DFGLA+L + D+T          I +MA E
Sbjct: 135 LED---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALE 191
Query: 415 YALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEF 452
             L    T+++DV+S+G+   E+++ G       PA E 
Sbjct: 192 SILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI 230

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 105/216 (48%), Gaps = 16/216 (7%)
Query: 246 KKIGEGGFGPVYKGQ---LAD--GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
           +++G+G FG V   +   L D  G ++AVK+L   + +  R+F  EI ++  LQH N+VK
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 301 IHGCCVEGDQ--LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
             G C    +  L L+ EY+   SL   L         +D     +    I +G+ +L  
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAE---RIDHIKLLQYTSQICKGMEYLGT 135
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG--TIGYMAPEYA 416
           +   + +HRD+   N+L++ +   KI DFGL K+   DK     +  G   I + APE  
Sbjct: 136 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 417 LWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEF 452
                +  +DV+SFG+V  E+ +     S +P  EF
Sbjct: 193 TESKFSVASDVWSFGVVLYELFTYIEK-SKSPPAEF 227

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 118/227 (51%), Gaps = 27/227 (11%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADG----TIIAVKQL-SSKSRQGNREFLNEIAMISCL 293
             F   K +G G FG VYKG  + +G      +A+K+L  + S + N+E L+E  +++ +
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL-FGREN-----CELELDWPTRQKICL 347
            +P++ ++ G C+    + L+ + M      C L + RE+      +  L+W      C+
Sbjct: 72  DNPHVCRLLGICLTS-TVQLITQLM---PFGCLLDYVREHKDNIGSQYLLNW------CV 121
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAG 406
            IA G+ +L +    ++VHRD+ A NVL+    + KI+DFGLAK L   +K + +     
Sbjct: 122 QIAEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 178
Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEF 452
            I +MA E  L    T+++DV+S+G+   E+++ G       PA E 
Sbjct: 179 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 225

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 108/216 (50%), Gaps = 16/216 (7%)
Query: 246 KKIGEGGFGPVYKGQ---LAD--GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
           +++G+G FG V   +   L D  G ++AVK+L   + +  R+F  EI ++  LQH N+VK
Sbjct: 17  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 76
Query: 301 IHGCCVEGDQ--LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
             G C    +  L L+ EY+   SL   L   +  +  +D     +    I +G+ +L  
Sbjct: 77  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGT 133
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG--TIGYMAPEYA 416
           +   + +HR++   N+L++ +   KI DFGL K+   DK +   +  G   I + APE  
Sbjct: 134 K---RYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL 190
Query: 417 LWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEF 452
                +  +DV+SFG+V  E+ +     S +P  EF
Sbjct: 191 TESKFSVASDVWSFGVVLYELFTYIEK-SKSPPAEF 225

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 118/226 (52%), Gaps = 25/226 (11%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADG----TIIAVKQL-SSKSRQGNREFLNEIAMISCL 293
             F   K +G G FG VYKG  + +G      +A+K+L  + S + N+E L+E  +++ +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGREN-----CELELDWPTRQKICLG 348
            +P++ ++ G C+    + L+ + M    L    + RE+      +  L+W      C+ 
Sbjct: 76  DNPHVCRLLGICLTS-TVQLIMQLMPFGXLLD--YVREHKDNIGSQYLLNW------CVQ 126
Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGT 407
           IA+G+ +L +    ++VHRD+ A NVL+    + KI+DFGLAK L   +K + +      
Sbjct: 127 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 183
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEF 452
           I +MA E  L    T+++DV+S+G+   E+++ G       PA E 
Sbjct: 184 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 229

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 34/280 (12%)
Query: 246 KKIGEGGFGPVYKGQLAD------GTIIAVKQLSSKSRQGNR-EFLNEIAMISCLQHPNL 298
           +++G+G FG VY+G   D       T +AVK ++  +    R EFLNE +++      ++
Sbjct: 24  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 83
Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFG-RENCELEL--DWPTRQ---KICLGIARG 352
           V++ G   +G   L+V E M +  L   L   R   E       PT Q   ++   IA G
Sbjct: 84  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 143
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYM 411
           +A+L+ +   K VHR++ A N ++  D   KI DFG+ + + E D      +    + +M
Sbjct: 144 MAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 200
Query: 412 APEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLV 471
           APE    G  T  +D++SFG+V  EI S    ++  P        +L +      DG  +
Sbjct: 201 APESLKDGVFTTSSDMWSFGVVLWEITS----LAEQPYQGLSNEQVLKFV----MDGGYL 252
Query: 472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           +  D            ER+  +  +C   +P++RPT  E+
Sbjct: 253 DQPDNC---------PERVTDLMRMCWQFNPNMRPTFLEI 283

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 107/216 (49%), Gaps = 16/216 (7%)
Query: 246 KKIGEGGFGPVYKGQ---LAD--GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
           +++G+G FG V   +   L D  G ++AVK+L   + +  R+F  EI ++  LQH N+VK
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 301 IHGCCVEGDQ--LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
             G C    +  L L+ E++   SL   L   +  +  +D     +    I +G+ +L  
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGSLREYL---QKHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG--TIGYMAPEYA 416
           +   + +HRD+   N+L++ +   KI DFGL K+   DK     +  G   I + APE  
Sbjct: 136 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 417 LWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEF 452
                +  +DV+SFG+V  E+ +     S +P  EF
Sbjct: 193 TESKFSVASDVWSFGVVLYELFTYIEK-SKSPPAEF 227

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 34/280 (12%)
Query: 246 KKIGEGGFGPVYKGQLAD------GTIIAVKQLSSKSRQGNR-EFLNEIAMISCLQHPNL 298
           +++G+G FG VY+G   D       T +AVK ++  +    R EFLNE +++      ++
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFG-RENCELEL--DWPTRQ---KICLGIARG 352
           V++ G   +G   L+V E M +  L   L   R   E       PT Q   ++   IA G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYM 411
           +A+L+ +   K VHR++ A N ++  D   KI DFG+ + + E D      +    + +M
Sbjct: 143 MAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 199
Query: 412 APEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLV 471
           APE    G  T  +D++SFG+V  EI S    ++  P        +L +      DG  +
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITS----LAEQPYQGLSNEQVLKFV----MDGGYL 251
Query: 472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           +  D            ER+  +  +C   +P++RPT  E+
Sbjct: 252 DQPDNC---------PERVTDLMRMCWQFNPNMRPTFLEI 282

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 118/226 (52%), Gaps = 25/226 (11%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADG----TIIAVKQL-SSKSRQGNREFLNEIAMISCL 293
             F   K +G G FG VYKG  + +G      +A+K+L  + S + N+E L+E  +++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGREN-----CELELDWPTRQKICLG 348
            +P++ ++ G C+    + L+ + M    L    + RE+      +  L+W      C+ 
Sbjct: 75  DNPHVCRLLGICLTS-TVQLITQLMPFGXLLD--YVREHKDNIGSQYLLNW------CVQ 125
Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGT 407
           IA+G+ +L +    ++VHRD+ A NVL+    + KI+DFGLAK L   +K + +      
Sbjct: 126 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEF 452
           I +MA E  L    T+++DV+S+G+   E+++ G       PA E 
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 106/198 (53%), Gaps = 15/198 (7%)
Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           K++G G FG V  G+      +A+K +   S   + EF+ E  ++  L H  LV+++G C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQ--KICLGIARGLAFLHEESRFK 363
            +   + ++ EYM N  L   L      E+   + T+Q  ++C  +   + +L  ES+ +
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLR-----EMRHRFQTQQLLEMCKDVCEAMEYL--ESK-Q 140
Query: 364 IVHRDIKATNVLLDRDLNPKISDFGLAK--LDEGDKTHISTRIAGTIGYMAPEYALWGYL 421
            +HRD+ A N L++     K+SDFGL++  LD+ + + + ++    + +  PE  ++   
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFP--VRWSPPEVLMYSKF 198
Query: 422 TYKADVYSFGIVALEIVS 439
           + K+D+++FG++  EI S
Sbjct: 199 SSKSDIWAFGVLMWEIYS 216

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 129/286 (45%), Gaps = 46/286 (16%)
Query: 246 KKIGEGGFGPVYKGQLAD------GTIIAVKQLSSKSRQGNR-EFLNEIAMISCLQHPNL 298
           +++G+G FG VY+G   D       T +AVK ++  +    R EFLNE +++      ++
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFG-RENCELEL--DWPTRQ---KICLGIARG 352
           V++ G   +G   L+V E M +  L   L   R   E       PT Q   ++   IA G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-------LDEGDKTHISTRIA 405
           +A+L+ +   K VHRD+ A N ++  D   KI DFG+ +         +G K  +  R  
Sbjct: 143 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVR-- 197
Query: 406 GTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQ 465
               +MAPE    G  T  +D++SFG+V  EI S    ++  P        +L +     
Sbjct: 198 ----WMAPESLKDGVFTTSSDMWSFGVVLWEITS----LAEQPYQGLSNEQVLKFV---- 245
Query: 466 QDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
            DG  ++  D            ER+  +  +C   +P +RPT  E+
Sbjct: 246 MDGGYLDQPDNC---------PERVTDLMRMCWQFNPKMRPTFLEI 282

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 73/230 (31%), Positives = 108/230 (46%), Gaps = 46/230 (20%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNE--IAMISCLQHPN 297
           +N    + IG G +G VYKG L D   +AVK  S  +RQ    F+NE  I  +  ++H N
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN---FINEKNIYRVPLMEHDN 68
Query: 298 LVKIHGCCVEGDQ---------LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLG 348
           + +     + GD+          LLV EY  N SL   L    +     DW +  ++   
Sbjct: 69  IARF----IVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS-----DWVSSCRLAHS 119
Query: 349 IARGLAFLHEE------SRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-------LDEG 395
           + RGLA+LH E       +  I HRD+ + NVL+  D    ISDFGL+        +  G
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179
Query: 396 DKTHISTRIAGTIGYMAPEYALWGYLTYK--------ADVYSFGIVALEI 437
           ++ + +    GTI YMAPE  L G +  +         D+Y+ G++  EI
Sbjct: 180 EEDNAAISEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 118/227 (51%), Gaps = 27/227 (11%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADG----TIIAVKQL-SSKSRQGNREFLNEIAMISCL 293
             F   K +G G FG VYKG  + +G      +A+ +L  + S + N+E L+E  +++ +
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL-FGREN-----CELELDWPTRQKICL 347
            +P++ ++ G C+    + L+ + M      C L + RE+      +  L+W      C+
Sbjct: 109 DNPHVCRLLGICLTST-VQLITQLM---PFGCLLDYVREHKDNIGSQYLLNW------CV 158
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAG 406
            IA+G+ +L +    ++VHRD+ A NVL+    + KI+DFGLAK L   +K + +     
Sbjct: 159 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 215
Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEF 452
            I +MA E  L    T+++DV+S+G+   E+++ G       PA E 
Sbjct: 216 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 262

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 118/227 (51%), Gaps = 27/227 (11%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADG----TIIAVKQL-SSKSRQGNREFLNEIAMISCL 293
             F   K +  G FG VYKG  + +G      +A+K+L  + S + N+E L+E  +++ +
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL-FGREN-----CELELDWPTRQKICL 347
            +P++ ++ G C+    + L+ + M      C L + RE+      +  L+W      C+
Sbjct: 75  DNPHVCRLLGICLTS-TVQLITQLM---PFGCLLDYVREHKDNIGSQYLLNW------CV 124
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAG 406
            IA+G+ +L +    ++VHRD+ A NVL+    + KI+DFGLAK L   +K + +     
Sbjct: 125 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEF 452
            I +MA E  L    T+++DV+S+G+   E+++ G       PA E 
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 126/279 (45%), Gaps = 31/279 (11%)
Query: 241 NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ------LSSKSRQGNREFLNEIAMISCL 293
           NF   KKIG G F  VY+   L DG  +A+K+      + +K+R    + + EI ++  L
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARA---DCIKEIDLLKQL 89
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
            HPN++K +   +E ++L +V E  +   L+  +   +  +  +   T  K  + +   L
Sbjct: 90  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAP 413
             +H     +++HRDIK  NV +      K+ D GL +     KT  +  + GT  YM+P
Sbjct: 150 EHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLVGTPYYMSP 205
Query: 414 EYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVEL 473
           E        +K+D++S G +  E+ + ++   Y   +     C            K +E 
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNLYSLC------------KKIEQ 252
Query: 474 VD-ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
            D   L S +  EE  +++    +C N  P  RP ++ V
Sbjct: 253 CDYPPLPSDHYSEELRQLVN---MCINPDPEKRPDVTYV 288

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 118/227 (51%), Gaps = 27/227 (11%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADG----TIIAVKQL-SSKSRQGNREFLNEIAMISCL 293
             F   K +G G FG VYKG  + +G      +A+K+L  + S + N+E L+E  +++ +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL-FGREN-----CELELDWPTRQKICL 347
            +P++ ++ G C+    + L+ + M      C L + RE+      +  L+W      C+
Sbjct: 77  DNPHVCRLLGICLTS-TVQLITQLM---PFGCLLDYVREHKDNIGSQYLLNW------CV 126
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAG 406
            IA+G+ +L +    ++VHRD+ A NVL+    + KI+DFG AK L   +K + +     
Sbjct: 127 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 183
Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEF 452
            I +MA E  L    T+++DV+S+G+   E+++ G       PA E 
Sbjct: 184 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 230

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 118/227 (51%), Gaps = 27/227 (11%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADG----TIIAVKQL-SSKSRQGNREFLNEIAMISCL 293
             F   K +  G FG VYKG  + +G      +A+K+L  + S + N+E L+E  +++ +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL-FGREN-----CELELDWPTRQKICL 347
            +P++ ++ G C+    + L+ + M      C L + RE+      +  L+W      C+
Sbjct: 82  DNPHVCRLLGICLTS-TVQLITQLM---PFGCLLDYVREHKDNIGSQYLLNW------CV 131
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAG 406
            IA+G+ +L +    ++VHRD+ A NVL+    + KI+DFGLAK L   +K + +     
Sbjct: 132 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 188
Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEF 452
            I +MA E  L    T+++DV+S+G+   E+++ G       PA E 
Sbjct: 189 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 235

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 118/227 (51%), Gaps = 27/227 (11%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADG----TIIAVKQL-SSKSRQGNREFLNEIAMISCL 293
             F   K +G G FG VYKG  + +G      +A+K+L  + S + N+E L+E  +++ +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL-FGREN-----CELELDWPTRQKICL 347
            +P++ ++ G C+    + L+ + M      C L + RE+      +  L+W      C+
Sbjct: 75  DNPHVCRLLGICLTS-TVQLITQLM---PFGCLLDYVREHKDNIGSQYLLNW------CV 124
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAG 406
            IA+G+ +L +    ++VHRD+ A NVL+    + KI+DFG AK L   +K + +     
Sbjct: 125 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 181
Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEF 452
            I +MA E  L    T+++DV+S+G+   E+++ G       PA E 
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 118/227 (51%), Gaps = 27/227 (11%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADG----TIIAVKQL-SSKSRQGNREFLNEIAMISCL 293
             F   K +G G FG VYKG  + +G      +A+K+L  + S + N+E L+E  +++ +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL-FGREN-----CELELDWPTRQKICL 347
            +P++ ++ G C+    + L+ + M      C L + RE+      +  L+W      C+
Sbjct: 82  DNPHVCRLLGICLTS-TVQLITQLM---PFGCLLDYVREHKDNIGSQYLLNW------CV 131
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAG 406
            IA+G+ +L +    ++VHRD+ A NVL+    + KI+DFG AK L   +K + +     
Sbjct: 132 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 188
Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEF 452
            I +MA E  L    T+++DV+S+G+   E+++ G       PA E 
Sbjct: 189 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 235

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 107/221 (48%), Gaps = 34/221 (15%)
Query: 246 KKIGEGGFGPVY--------KGQLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCL-QH 295
           K +GEG FG V         K +    T +AVK L S + + +  + ++E+ M+  + +H
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDW-----PTRQ------- 343
            N++ + G C +   L ++ EY    +L   L  RE   LE  +     P  Q       
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 344 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI--- 400
                +ARG+ +L  +   K +HRD+ A NVL+  D   KI+DFGLA+    D  HI   
Sbjct: 154 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 206
Query: 401 --STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
             +T     + +MAPE       T+++DV+SFG++  EI +
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 104/221 (47%), Gaps = 24/221 (10%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQL-----ADGTI-IAVKQLSSKSRQGNRE-FLNEIAMISC 292
           NN    K +G G FG V +         D  + +AVK L S +    +E  ++E+ ++S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 293 L-QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDW-----PTRQ--- 343
           L QH N+V + G C  G  +L++ EY     L   L  +    LE  +     P  Q   
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSS 165
Query: 344 ----KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH 399
                    +A+G+AFL  ++    +HRD+ A NVLL      KI DFGLA+    D  +
Sbjct: 166 RDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 222
Query: 400 ISTRIAG-TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
           I    A   + +MAPE       T ++DV+S+GI+  EI S
Sbjct: 223 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 101/196 (51%), Gaps = 11/196 (5%)
Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           K++G G FG V  G+      +A+K +   S   + EF+ E  ++  L H  LV+++G C
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQ--KICLGIARGLAFLHEESRFK 363
            +   + ++ EYM N  L   L      E+   + T+Q  ++C  +   + +L  ES+ +
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLR-----EMRHRFQTQQLLEMCKDVCEAMEYL--ESK-Q 125
Query: 364 IVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTY 423
            +HRD+ A N L++     K+SDFGL++    D+   S      + +  PE  ++   + 
Sbjct: 126 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 185
Query: 424 KADVYSFGIVALEIVS 439
           K+D+++FG++  EI S
Sbjct: 186 KSDIWAFGVLMWEIYS 201

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 101/196 (51%), Gaps = 11/196 (5%)
Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           K++G G FG V  G+      +A+K +   S   + EF+ E  ++  L H  LV+++G C
Sbjct: 21  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVC 79
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQ--KICLGIARGLAFLHEESRFK 363
            +   + ++ EYM N  L   L      E+   + T+Q  ++C  +   + +L  ES+ +
Sbjct: 80  TKQRPIFIITEYMANGCLLNYLR-----EMRHRFQTQQLLEMCKDVCEAMEYL--ESK-Q 131
Query: 364 IVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTY 423
            +HRD+ A N L++     K+SDFGL++    D+   S      + +  PE  ++   + 
Sbjct: 132 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 191
Query: 424 KADVYSFGIVALEIVS 439
           K+D+++FG++  EI S
Sbjct: 192 KSDIWAFGVLMWEIYS 207

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 101/196 (51%), Gaps = 11/196 (5%)
Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           K++G G FG V  G+      +A+K +   S   + EF+ E  ++  L H  LV+++G C
Sbjct: 14  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQ--KICLGIARGLAFLHEESRFK 363
            +   + ++ EYM N  L   L      E+   + T+Q  ++C  +   + +L  ES+ +
Sbjct: 73  TKQRPIFIITEYMANGCLLNYLR-----EMRHRFQTQQLLEMCKDVCEAMEYL--ESK-Q 124
Query: 364 IVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTY 423
            +HRD+ A N L++     K+SDFGL++    D+   S      + +  PE  ++   + 
Sbjct: 125 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 184
Query: 424 KADVYSFGIVALEIVS 439
           K+D+++FG++  EI S
Sbjct: 185 KSDIWAFGVLMWEIYS 200

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 135/299 (45%), Gaps = 38/299 (12%)
Query: 220 MKESDLQTISFTLKQIKAATNN-FDSAKKIGEGGFGPVYKGQLADGT--IIAVKQLS-SK 275
           M  S +Q+    ++ +KA     F   +KIG+G FG V+KG + + T  ++A+K +   +
Sbjct: 1   MAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEE 59
Query: 276 SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL 335
           +     +   EI ++S    P + K +G  ++  +L ++ EY+   S   AL   E   L
Sbjct: 60  AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS---ALDLLEPGPL 116
Query: 336 ELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG 395
             D      I   I +GL +LH E +   +HRDIKA NVLL      K++DFG+A    G
Sbjct: 117 --DETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA----G 167
Query: 396 DKTHISTR---IAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEF 452
             T    +     GT  +MAPE         KAD++S GI A+E+  G+   S    +  
Sbjct: 168 QLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM-- 225
Query: 453 DCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                           K++ L+ +      +   ++ + +    C N  PS RPT  E+
Sbjct: 226 ----------------KVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKEL 268

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 106/220 (48%), Gaps = 24/220 (10%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQL-----ADGTI-IAVKQLSSKSRQGNRE-FLNEIAMISC 292
           NN    K +G G FG V +         D  + +AVK L S +    +E  ++E+ ++S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 293 L-QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELD---------WPTR 342
           L QH N+V + G C  G  +L++ EY     L      R++  LE D           TR
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDL-LNFLRRKSRVLETDPAFAIANSTLSTR 164
Query: 343 QKICLG--IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI 400
             +     +A+G+AFL  ++    +HRD+ A NVLL      KI DFGLA+    D  +I
Sbjct: 165 DLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221
Query: 401 STRIAG-TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
               A   + +MAPE       T ++DV+S+GI+  EI S
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 101/196 (51%), Gaps = 11/196 (5%)
Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           K++G G FG V  G+      +A+K +   S   + EF+ E  ++  L H  LV+++G C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQ--KICLGIARGLAFLHEESRFK 363
            +   + ++ EYM N  L   L      E+   + T+Q  ++C  +   + +L  ES+ +
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLR-----EMRHRFQTQQLLEMCKDVCEAMEYL--ESK-Q 140
Query: 364 IVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTY 423
            +HRD+ A N L++     K+SDFGL++    D+   S      + +  PE  ++   + 
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 424 KADVYSFGIVALEIVS 439
           K+D+++FG++  EI S
Sbjct: 201 KSDIWAFGVLMWEIYS 216

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 101/196 (51%), Gaps = 11/196 (5%)
Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           K++G G FG V  G+      +A+K +   S   + EF+ E  ++  L H  LV+++G C
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQ--KICLGIARGLAFLHEESRFK 363
            +   + ++ EYM N  L   L      E+   + T+Q  ++C  +   + +L  ES+ +
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLR-----EMRHRFQTQQLLEMCKDVCEAMEYL--ESK-Q 120
Query: 364 IVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTY 423
            +HRD+ A N L++     K+SDFGL++    D+   S      + +  PE  ++   + 
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 424 KADVYSFGIVALEIVS 439
           K+D+++FG++  EI S
Sbjct: 181 KSDIWAFGVLMWEIYS 196

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 105/217 (48%), Gaps = 26/217 (11%)
Query: 246 KKIGEGGFGPVY--------KGQLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCL-QH 295
           K +GEG FG V         K +    T +AVK L S + + +  + ++E+ M+  + +H
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDW-----PTRQ------- 343
            N++ + G C +   L ++ EY    +L   L  R    LE  +     P  Q       
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLV 153
Query: 344 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHIST 402
                +ARG+ +L  +   K +HRD+ A NVL+  D   KI+DFGLA+ +   D    +T
Sbjct: 154 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTT 210
Query: 403 RIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
                + +MAPE       T+++DV+SFG++  EI +
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 101/196 (51%), Gaps = 11/196 (5%)
Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           K++G G FG V  G+      +A+K +   S   + EF+ E  ++  L H  LV+++G C
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQ--KICLGIARGLAFLHEESRFK 363
            +   + ++ EYM N  L   L      E+   + T+Q  ++C  +   + +L  ES+ +
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLR-----EMRHRFQTQQLLEMCKDVCEAMEYL--ESK-Q 125
Query: 364 IVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTY 423
            +HRD+ A N L++     K+SDFGL++    D+   S      + +  PE  ++   + 
Sbjct: 126 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSS 185
Query: 424 KADVYSFGIVALEIVS 439
           K+D+++FG++  EI S
Sbjct: 186 KSDIWAFGVLMWEIYS 201

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 106/220 (48%), Gaps = 24/220 (10%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQL-----ADGTI-IAVKQLSSKSRQGNRE-FLNEIAMISC 292
           NN    K +G G FG V +         D  + +AVK L S +    +E  ++E+ ++S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 293 L-QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELD---------WPTR 342
           L QH N+V + G C  G  +L++ EY     L      R++  LE D           TR
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDL-LNFLRRKSRVLETDPAFAIANSTASTR 164
Query: 343 QKICLG--IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI 400
             +     +A+G+AFL  ++    +HRD+ A NVLL      KI DFGLA+    D  +I
Sbjct: 165 DLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221
Query: 401 STRIAG-TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
               A   + +MAPE       T ++DV+S+GI+  EI S
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 108/220 (49%), Gaps = 21/220 (9%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLADGTI-------IAVKQLSSKSRQGNR-EFLNEI 287
           + A      ++++G+G FG VY+G +A G +       +A+K ++  +    R EFLNE 
Sbjct: 15  EVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 73
Query: 288 AMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELE----LDWPTRQ 343
           +++      ++V++ G   +G   L++ E M    L   L      E+E    L  P+  
Sbjct: 74  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPEMENNPVLAPPSLS 132
Query: 344 KICL---GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTH 399
           K+      IA G+A+L+     K VHRD+ A N ++  D   KI DFG+ + + E D   
Sbjct: 133 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXR 189
Query: 400 ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
              +    + +M+PE    G  T  +DV+SFG+V  EI +
Sbjct: 190 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 108/220 (49%), Gaps = 21/220 (9%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLADGTI-------IAVKQLSSKSRQGNR-EFLNEI 287
           + A      ++++G+G FG VY+G +A G +       +A+K ++  +    R EFLNE 
Sbjct: 6   EVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 64
Query: 288 AMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELE----LDWPTRQ 343
           +++      ++V++ G   +G   L++ E M    L   L      E+E    L  P+  
Sbjct: 65  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPEMENNPVLAPPSLS 123
Query: 344 KICL---GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTH 399
           K+      IA G+A+L+     K VHRD+ A N ++  D   KI DFG+ + + E D   
Sbjct: 124 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXR 180
Query: 400 ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
              +    + +M+PE    G  T  +DV+SFG+V  EI +
Sbjct: 181 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 105/202 (51%), Gaps = 17/202 (8%)
Query: 248 IGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCV 306
           +G+G +G VY G+ L++   IA+K++  +  + ++    EIA+   L+H N+V+  G   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 307 EGDQLLLVYEYMENNSLACALFGR----ENCELELDWPTRQKICLGIARGLAFLHEESRF 362
           E   + +  E +   SL+  L  +    ++ E  + + T+Q     I  GL +LH+    
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ-----ILEGLKYLHDN--- 141
Query: 363 KIVHRDIKATNVLLDRDLNP-KISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYL 421
           +IVHRDIK  NVL++      KISDFG +K   G      T   GT+ YMAPE    G  
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPR 200
Query: 422 TY--KADVYSFGIVALEIVSGK 441
            Y   AD++S G   +E+ +GK
Sbjct: 201 GYGKAADIWSLGCTIIEMATGK 222

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 99/205 (48%), Gaps = 21/205 (10%)
Query: 237 AATNNFDSAKKIGEGGFGPV------YKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMI 290
           A   N+   K +GEG FG V        GQ     II  K L+    QG  E   EI+ +
Sbjct: 10  AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYL 67
Query: 291 SCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
             L+HP+++K++      D++++V EY  N      +   +  E E      ++    I 
Sbjct: 68  RLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQE-----ARRFFQQII 122
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
             + + H   R KIVHRD+K  N+LLD  LN KI+DFGL+ +   D   + T   G+  Y
Sbjct: 123 SAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNI-MTDGNFLKTS-CGSPNY 177
Query: 411 MAPEYALWG--YLTYKADVYSFGIV 433
            APE  + G  Y   + DV+S G++
Sbjct: 178 AAPE-VISGKLYAGPEVDVWSCGVI 201

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 105/202 (51%), Gaps = 17/202 (8%)
Query: 248 IGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCV 306
           +G+G +G VY G+ L++   IA+K++  +  + ++    EIA+   L+H N+V+  G   
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 307 EGDQLLLVYEYMENNSLACALFGR----ENCELELDWPTRQKICLGIARGLAFLHEESRF 362
           E   + +  E +   SL+  L  +    ++ E  + + T+Q     I  GL +LH+    
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ-----ILEGLKYLHDN--- 127
Query: 363 KIVHRDIKATNVLLDRDLNP-KISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYL 421
           +IVHRDIK  NVL++      KISDFG +K   G      T   GT+ YMAPE    G  
Sbjct: 128 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPR 186
Query: 422 TY--KADVYSFGIVALEIVSGK 441
            Y   AD++S G   +E+ +GK
Sbjct: 187 GYGKAADIWSLGCTIIEMATGK 208

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 108/213 (50%), Gaps = 19/213 (8%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCL 293
           +     +   +K+GEG +G VYK + + G I+A+K+  L ++        + EI+++  L
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL 76
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENN---SLACALFGRENCELELDWPTRQKICLGIA 350
            HPN+V +         L LV+E+ME +    L     G ++ ++++           + 
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKI-------YLYQLL 129
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
           RG+A  H+    +I+HRD+K  N+L++ D   K++DFGLA+   G      T    T+ Y
Sbjct: 130 RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARA-FGIPVRSYTHEVVTLWY 185
Query: 411 MAPEYALWGYLTY--KADVYSFGIVALEIVSGK 441
            AP+  L G   Y    D++S G +  E+++GK
Sbjct: 186 RAPD-VLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 125/276 (45%), Gaps = 37/276 (13%)
Query: 242 FDSAKKIGEGGFGPVYKGQLADGT--IIAVKQLS-SKSRQGNREFLNEIAMISCLQHPNL 298
           F   +KIG+G FG V+KG + + T  ++A+K +   ++     +   EI ++S    P +
Sbjct: 9   FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 67
Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
            K +G  ++  +L ++ EY+   S   AL   E   L  D      I   I +GL +LH 
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGS---ALDLLEPGPL--DETQIATILREILKGLDYLHS 122
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR---IAGTIGYMAPEY 415
           E +   +HRDIKA NVLL      K++DFG+A    G  T    +     GT  +MAPE 
Sbjct: 123 EKK---IHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRNXFVGTPFWMAPEV 175
Query: 416 ALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD 475
                   KAD++S GI A+E+  G+   S    +                  K++ L+ 
Sbjct: 176 IKQSAYDSKADIWSLGITAIELARGEPPHSELHPM------------------KVLFLIP 217
Query: 476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           +      +   ++ + +    C N  PS RPT  E+
Sbjct: 218 KNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKEL 253

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 99/205 (48%), Gaps = 21/205 (10%)
Query: 237 AATNNFDSAKKIGEGGFGPVY------KGQLADGTIIAVKQLSSKSRQGNREFLNEIAMI 290
           A   N+   K +GEG FG V        GQ     II  K L+    QG  E   EI+ +
Sbjct: 1   AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYL 58
Query: 291 SCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
             L+HP+++K++      D++++V EY  N      +   +  E E      ++    I 
Sbjct: 59  RLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQE-----ARRFFQQII 113
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
             + + H   R KIVHRD+K  N+LLD  LN KI+DFGL+ +   D   + T   G+  Y
Sbjct: 114 SAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNI-MTDGNFLKTS-CGSPNY 168
Query: 411 MAPEYALWG--YLTYKADVYSFGIV 433
            APE  + G  Y   + DV+S G++
Sbjct: 169 AAPE-VISGKLYAGPEVDVWSCGVI 192

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 99/205 (48%), Gaps = 21/205 (10%)
Query: 237 AATNNFDSAKKIGEGGFGPV------YKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMI 290
           A   N+   K +GEG FG V        GQ     II  K L+    QG  E   EI+ +
Sbjct: 11  AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYL 68
Query: 291 SCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
             L+HP+++K++      D++++V EY  N      +   +  E E      ++    I 
Sbjct: 69  RLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQE-----ARRFFQQII 123
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
             + + H   R KIVHRD+K  N+LLD  LN KI+DFGL+ +   D   + T   G+  Y
Sbjct: 124 SAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNI-MTDGNFLKTS-CGSPNY 178
Query: 411 MAPEYALWG--YLTYKADVYSFGIV 433
            APE  + G  Y   + DV+S G++
Sbjct: 179 AAPE-VISGKLYAGPEVDVWSCGVI 202

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 125/276 (45%), Gaps = 37/276 (13%)
Query: 242 FDSAKKIGEGGFGPVYKGQLADGT--IIAVKQLS-SKSRQGNREFLNEIAMISCLQHPNL 298
           F   +KIG+G FG V+KG + + T  ++A+K +   ++     +   EI ++S    P +
Sbjct: 29  FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 87
Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
            K +G  ++  +L ++ EY+   S   AL   E   L  D      I   I +GL +LH 
Sbjct: 88  TKYYGSYLKDTKLWIIMEYLGGGS---ALDLLEPGPL--DETQIATILREILKGLDYLHS 142
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR---IAGTIGYMAPEY 415
           E +   +HRDIKA NVLL      K++DFG+A    G  T    +     GT  +MAPE 
Sbjct: 143 EKK---IHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRNTFVGTPFWMAPEV 195
Query: 416 ALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD 475
                   KAD++S GI A+E+  G+   S    +                  K++ L+ 
Sbjct: 196 IKQSAYDSKADIWSLGITAIELARGEPPHSELHPM------------------KVLFLIP 237
Query: 476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           +      +   ++ + +    C N  PS RPT  E+
Sbjct: 238 KNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKEL 273

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 125/276 (45%), Gaps = 37/276 (13%)
Query: 242 FDSAKKIGEGGFGPVYKGQLADGT--IIAVKQLS-SKSRQGNREFLNEIAMISCLQHPNL 298
           F   +KIG+G FG V+KG + + T  ++A+K +   ++     +   EI ++S    P +
Sbjct: 9   FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 67
Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
            K +G  ++  +L ++ EY+   S   AL   E   L  D      I   I +GL +LH 
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGS---ALDLLEPGPL--DETQIATILREILKGLDYLHS 122
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR---IAGTIGYMAPEY 415
           E +   +HRDIKA NVLL      K++DFG+A    G  T    +     GT  +MAPE 
Sbjct: 123 EKK---IHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRNTFVGTPFWMAPEV 175
Query: 416 ALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD 475
                   KAD++S GI A+E+  G+   S    +                  K++ L+ 
Sbjct: 176 IKQSAYDSKADIWSLGITAIELARGEPPHSELHPM------------------KVLFLIP 217
Query: 476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           +      +   ++ + +    C N  PS RPT  E+
Sbjct: 218 KNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKEL 253

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 108/213 (50%), Gaps = 19/213 (8%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCL 293
           +     +   +K+GEG +G VYK + + G I+A+K+  L ++        + EI+++  L
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL 76
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENN---SLACALFGRENCELELDWPTRQKICLGIA 350
            HPN+V +         L LV+E+ME +    L     G ++ ++++           + 
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKI-------YLYQLL 129
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
           RG+A  H+    +I+HRD+K  N+L++ D   K++DFGLA+   G      T    T+ Y
Sbjct: 130 RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARA-FGIPVRSYTHEVVTLWY 185
Query: 411 MAPEYALWGYLTY--KADVYSFGIVALEIVSGK 441
            AP+  L G   Y    D++S G +  E+++GK
Sbjct: 186 RAPD-VLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 135/290 (46%), Gaps = 37/290 (12%)
Query: 240 NNFDSAKKIGEGGFGPVYKG------QLADGTIIAVKQLSSKSRQG-NREFLNEIA-MIS 291
           +  +  K +G G FG V +       + A    +AVK L   +    +R  ++E+  +I 
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 292 CLQHPNLVKIHGCCVE-GDQLLLVYEYMENNSLACALFGREN-----CELELDWPTRQK- 344
              H N+V + G C + G  L+++ E+ +  +L+  L  + N      +L  D+ T +  
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHL 146
Query: 345 IC--LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIST 402
           IC    +A+G+ FL   SR K +HRD+ A N+LL      KI DFGLA+    D  ++  
Sbjct: 147 ICYSFQVAKGMEFL--ASR-KXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 203
Query: 403 RIAG-TIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWA 461
             A   + +MAPE       T ++DV+SFG++  EI S     S  P ++ D     +  
Sbjct: 204 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPGVKID-----EEF 256
Query: 462 CHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           C   ++G  +   D      Y   E   M +  L C +  PS RPT SE+
Sbjct: 257 CRRLKEGTRMRAPD------YTTPE---MYQTMLDCWHGEPSQRPTFSEL 297

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 99/205 (48%), Gaps = 21/205 (10%)
Query: 237 AATNNFDSAKKIGEGGFGPV------YKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMI 290
           A   N+   K +GEG FG V        GQ     II  K L+    QG  E   EI+ +
Sbjct: 5   AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYL 62
Query: 291 SCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
             L+HP+++K++      D++++V EY  N      +   +  E E      ++    I 
Sbjct: 63  RLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQE-----ARRFFQQII 117
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
             + + H   R KIVHRD+K  N+LLD  LN KI+DFGL+ +   D   + T   G+  Y
Sbjct: 118 SAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNI-MTDGNFLKTS-CGSPNY 172
Query: 411 MAPEYALWG--YLTYKADVYSFGIV 433
            APE  + G  Y   + DV+S G++
Sbjct: 173 AAPE-VISGKLYAGPEVDVWSCGVI 196

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 110/226 (48%), Gaps = 21/226 (9%)
Query: 230 FTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTI-------IAVKQLSSKSRQGNR- 281
           F   + + A      ++++G+G FG VY+G +A G +       +A+K ++  +    R 
Sbjct: 6   FVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERI 64
Query: 282 EFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELE----L 337
           EFLNE +++      ++V++ G   +G   L++ E M    L   L      E+E    L
Sbjct: 65  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPEMENNPVL 123
Query: 338 DWPTRQKICL---GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LD 393
             P+  K+      IA G+A+L+     K VHRD+ A N ++  D   KI DFG+ + + 
Sbjct: 124 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 180
Query: 394 EGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
           E D      +    + +M+PE    G  T  +DV+SFG+V  EI +
Sbjct: 181 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 105/222 (47%), Gaps = 34/222 (15%)
Query: 245 AKKIGEGGFGPVY--------KGQLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCL-Q 294
            K +GEG FG V         K +    T +AVK L S + + +  + ++E+ M+  + +
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDW-----PTRQ------ 343
           H N++ + G C +   L ++ EY    +L   L  R    LE  +     P  Q      
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 344 -KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIST 402
                 +ARG+ +L  +   K +HRD+ A NVL+  D   KI+DFGLA+    D  HI  
Sbjct: 194 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDY 246
Query: 403 RIAGTIG-----YMAPEYALWGYLTYKADVYSFGIVALEIVS 439
               T G     +MAPE       T+++DV+SFG++  EI +
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 106/221 (47%), Gaps = 34/221 (15%)
Query: 246 KKIGEGGFGPVY--------KGQLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCL-QH 295
           K +GEG FG V         K +    T +AVK L S + + +  + ++E+ M+  + +H
Sbjct: 23  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 82
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDW-----PTRQ------- 343
            N++ + G C +   L ++ EY    +L   L  R    LE  +     P  Q       
Sbjct: 83  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 142
Query: 344 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI--- 400
                +ARG+ +L  +   K +HRD+ A NVL+  D   KI+DFGLA+    D  HI   
Sbjct: 143 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 195
Query: 401 --STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
             +T     + +MAPE       T+++DV+SFG++  EI +
Sbjct: 196 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 103/210 (49%), Gaps = 17/210 (8%)
Query: 239 TNNFDSAKKIGEGGFGPVYKGQLADGTI----IAVKQLSSKSRQGNREFLN-EIAMISCL 293
             ++D  + +GEG +G V   QLA   +    +AVK +  K      E +  EI + + L
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAML 62
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
            H N+VK +G   EG+   L  EY     L    F R   ++ +  P  Q+    +  G+
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE-GDKTHISTRIAGTIGYMA 412
            +LH      I HRDIK  N+LLD   N KISDFGLA +    ++  +  ++ GT+ Y+A
Sbjct: 119 VYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 413 PE-YALWGYLTYKADVYSFGIVALEIVSGK 441
           PE      +     DV+S GIV   +++G+
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 106/221 (47%), Gaps = 34/221 (15%)
Query: 246 KKIGEGGFGPVY--------KGQLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCL-QH 295
           K +GEG FG V         K +    T +AVK L S + + +  + ++E+ M+  + +H
Sbjct: 27  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 86
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDW-----PTRQ------- 343
            N++ + G C +   L ++ EY    +L   L  R    LE  +     P  Q       
Sbjct: 87  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 146
Query: 344 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI--- 400
                +ARG+ +L  +   K +HRD+ A NVL+  D   KI+DFGLA+    D  HI   
Sbjct: 147 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 199
Query: 401 --STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
             +T     + +MAPE       T+++DV+SFG++  EI +
Sbjct: 200 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 125/277 (45%), Gaps = 39/277 (14%)
Query: 242 FDSAKKIGEGGFGPVYKGQLADGT--IIAVKQLS-SKSRQGNREFLNEIAMISCLQHPNL 298
           F    +IG+G FG VYKG + + T  ++A+K +   ++     +   EI ++S    P +
Sbjct: 21  FTKLDRIGKGSFGEVYKG-IDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI 79
Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
            +  G  ++  +L ++ EY+   S   AL   +   LE  +     I   I +GL +LH 
Sbjct: 80  TRYFGSYLKSTKLWIIMEYLGGGS---ALDLLKPGPLEETYIA--TILREILKGLDYLHS 134
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR---IAGTIGYMAPEY 415
           E +   +HRDIKA NVLL    + K++DFG+A    G  T    +     GT  +MAPE 
Sbjct: 135 ERK---IHRDIKAANVLLSEQGDVKLADFGVA----GQLTDTQIKRNXFVGTPFWMAPEV 187
Query: 416 ALWGYLTYKADVYSFGIVALEIVSGK-NNMSYAPALEFDCTCLLDWACHLQQDGKLVELV 474
                  +KAD++S GI A+E+  G+  N    P                    +++ L+
Sbjct: 188 IKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM-------------------RVLFLI 228
Query: 475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
            +      + + ++   +    C N  P  RPT  E+
Sbjct: 229 PKNSPPTLEGQHSKPFKEFVEACLNKDPRFRPTAKEL 265

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 106/221 (47%), Gaps = 34/221 (15%)
Query: 246 KKIGEGGFGPVY--------KGQLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCL-QH 295
           K +GEG FG V         K +    T +AVK L S + + +  + ++E+ M+  + +H
Sbjct: 26  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 85
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDW-----PTRQ------- 343
            N++ + G C +   L ++ EY    +L   L  R    LE  +     P  Q       
Sbjct: 86  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 145
Query: 344 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI--- 400
                +ARG+ +L  +   K +HRD+ A NVL+  D   KI+DFGLA+    D  HI   
Sbjct: 146 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 198
Query: 401 --STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
             +T     + +MAPE       T+++DV+SFG++  EI +
Sbjct: 199 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 106/221 (47%), Gaps = 34/221 (15%)
Query: 246 KKIGEGGFGPVY--------KGQLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCL-QH 295
           K +GEG FG V         K +    T +AVK L S + + +  + ++E+ M+  + +H
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDW-----PTRQ------- 343
            N++ + G C +   L ++ EY    +L   L  R    LE  +     P  Q       
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 344 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI--- 400
                +ARG+ +L  +   K +HRD+ A NVL+  D   KI+DFGLA+    D  HI   
Sbjct: 154 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 206
Query: 401 --STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
             +T     + +MAPE       T+++DV+SFG++  EI +
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 26/217 (11%)
Query: 246 KKIGEGGFGPVY--------KGQLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCL-QH 295
           K +GEG FG V         K +  +   +AVK L   + + +  + ++E+ M+  + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDW-----PTRQ------- 343
            N++ + G C +   L ++ EY    +L   L  R    +E  +     P  Q       
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLV 160
Query: 344 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHIST 402
                +ARG+ +L  +   K +HRD+ A NVL+  +   KI+DFGLA+ ++  D    +T
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 403 RIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
                + +MAPE       T+++DV+SFG++  EI +
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 239 TNNFDSAKKIGEGGFGPVYKGQLADGTI----IAVKQLSSKSRQGNREFLN-EIAMISCL 293
             ++D  + +GEG +G V   QLA   +    +AVK +  K      E +  EI +   L
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
            H N+VK +G   EG+   L  EY     L    F R   ++ +  P  Q+    +  G+
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE-GDKTHISTRIAGTIGYMA 412
            +LH      I HRDIK  N+LLD   N KISDFGLA +    ++  +  ++ GT+ Y+A
Sbjct: 119 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 413 PE-YALWGYLTYKADVYSFGIVALEIVSGK 441
           PE      +     DV+S GIV   +++G+
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 241 NFDSAKKIGEGGFGPVYKG------QLADGTIIAVKQLSSKSRQGNRE-FLNEIAMISCL 293
           N +  K +G G FG V         +      +AVK L  K+    RE  ++E+ M++ L
Sbjct: 46  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 105
Query: 294 -QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGREN--CELELDWPTRQKI----- 345
             H N+V + G C     + L++EY     L   L  +     E E+++  ++++     
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 346 ----------CLG--IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 393
                     C    +A+G+ FL  +S    VHRD+ A NVL+      KI DFGLA+  
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDI 222
Query: 394 EGDKTHISTRIAG-TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
             D  ++    A   + +MAPE    G  T K+DV+S+GI+  EI S
Sbjct: 223 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 239 TNNFDSAKKIGEGGFGPVYKGQLADGTI----IAVKQLSSKSRQGNREFLN-EIAMISCL 293
             ++D  + +GEG +G V   QLA   +    +AVK +  K      E +  EI +   L
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
            H N+VK +G   EG+   L  EY     L    F R   ++ +  P  Q+    +  G+
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE-GDKTHISTRIAGTIGYMA 412
            +LH      I HRDIK  N+LLD   N KISDFGLA +    ++  +  ++ GT+ Y+A
Sbjct: 118 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 174
Query: 413 PE-YALWGYLTYKADVYSFGIVALEIVSGK 441
           PE      +     DV+S GIV   +++G+
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 239 TNNFDSAKKIGEGGFGPVYKGQLADGTI----IAVKQLSSKSRQGNREFLN-EIAMISCL 293
             ++D  + +GEG +G V   QLA   +    +AVK +  K      E +  EI +   L
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
            H N+VK +G   EG+   L  EY     L    F R   ++ +  P  Q+    +  G+
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE-GDKTHISTRIAGTIGYMA 412
            +LH      I HRDIK  N+LLD   N KISDFGLA +    ++  +  ++ GT+ Y+A
Sbjct: 118 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVA 174
Query: 413 PE-YALWGYLTYKADVYSFGIVALEIVSGK 441
           PE      +     DV+S GIV   +++G+
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 239 TNNFDSAKKIGEGGFGPVYKGQLADGTI----IAVKQLSSKSRQGNREFLN-EIAMISCL 293
             ++D  + +GEG +G V   QLA   +    +AVK +  K      E +  EI +   L
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
            H N+VK +G   EG+   L  EY     L    F R   ++ +  P  Q+    +  G+
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE-GDKTHISTRIAGTIGYMA 412
            +LH      I HRDIK  N+LLD   N KISDFGLA +    ++  +  ++ GT+ Y+A
Sbjct: 119 VYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 413 PE-YALWGYLTYKADVYSFGIVALEIVSGK 441
           PE      +     DV+S GIV   +++G+
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 239 TNNFDSAKKIGEGGFGPVYKGQLADGTI----IAVKQLSSKSRQGNREFLN-EIAMISCL 293
             ++D  + +GEG +G V   QLA   +    +AVK +  K      E +  EI +   L
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKML 61
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
            H N+VK +G   EG+   L  EY     L    F R   ++ +  P  Q+    +  G+
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE-GDKTHISTRIAGTIGYMA 412
            +LH      I HRDIK  N+LLD   N KISDFGLA +    ++  +  ++ GT+ Y+A
Sbjct: 118 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVA 174
Query: 413 PE-YALWGYLTYKADVYSFGIVALEIVSGK 441
           PE      +     DV+S GIV   +++G+
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 239 TNNFDSAKKIGEGGFGPVYKGQLADGTI----IAVKQLSSKSRQGNREFLN-EIAMISCL 293
             ++D  + +GEG +G V   QLA   +    +AVK +  K      E +  EI +   L
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
            H N+VK +G   EG+   L  EY     L    F R   ++ +  P  Q+    +  G+
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE-GDKTHISTRIAGTIGYMA 412
            +LH      I HRDIK  N+LLD   N KISDFGLA +    ++  +  ++ GT+ Y+A
Sbjct: 118 VYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVA 174
Query: 413 PE-YALWGYLTYKADVYSFGIVALEIVSGK 441
           PE      +     DV+S GIV   +++G+
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 239 TNNFDSAKKIGEGGFGPVYKGQLADGTI----IAVKQLSSKSRQGNREFLN-EIAMISCL 293
             ++D  + +GEG +G V   QLA   +    +AVK +  K      E +  EI +   L
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
            H N+VK +G   EG+   L  EY     L    F R   ++ +  P  Q+    +  G+
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE-GDKTHISTRIAGTIGYMA 412
            +LH      I HRDIK  N+LLD   N KISDFGLA +    ++  +  ++ GT+ Y+A
Sbjct: 118 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 174
Query: 413 PE-YALWGYLTYKADVYSFGIVALEIVSGK 441
           PE      +     DV+S GIV   +++G+
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 239 TNNFDSAKKIGEGGFGPVYKGQLADGTI----IAVKQLSSKSRQGNREFLN-EIAMISCL 293
             ++D  + +GEG +G V   QLA   +    +AVK +  K      E +  EI +   L
Sbjct: 4   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 60
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
            H N+VK +G   EG+   L  EY     L    F R   ++ +  P  Q+    +  G+
Sbjct: 61  NHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV 116
Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE-GDKTHISTRIAGTIGYMA 412
            +LH      I HRDIK  N+LLD   N KISDFGLA +    ++  +  ++ GT+ Y+A
Sbjct: 117 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 173
Query: 413 PE-YALWGYLTYKADVYSFGIVALEIVSGK 441
           PE      +     DV+S GIV   +++G+
Sbjct: 174 PELLKRREFHAEPVDVWSCGIVLTAMLAGE 203

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 239 TNNFDSAKKIGEGGFGPVYKGQLADGTI----IAVKQLSSKSRQGNREFLN-EIAMISCL 293
             ++D  + +GEG +G V   QLA   +    +AVK +  K      E +  EI +   L
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
            H N+VK +G   EG+   L  EY     L    F R   ++ +  P  Q+    +  G+
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE-GDKTHISTRIAGTIGYMA 412
            +LH      I HRDIK  N+LLD   N KISDFGLA +    ++  +  ++ GT+ Y+A
Sbjct: 118 VYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 174
Query: 413 PE-YALWGYLTYKADVYSFGIVALEIVSGK 441
           PE      +     DV+S GIV   +++G+
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 105/215 (48%), Gaps = 16/215 (7%)
Query: 247 KIGEGGFGPV---YKGQLAD--GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKI 301
           ++G+G FG V       L D  G ++AVKQL        R+F  EI ++  L    +VK 
Sbjct: 17  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 76
Query: 302 HGCCV-EGDQ-LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
            G     G Q L LV EY+ +  L   L   +     LD          I +G+ +L   
Sbjct: 77  RGVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEYLGSR 133
Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG--TIGYMAPEYAL 417
              + VHRD+ A N+L++ + + KI+DFGLAKL   DK +   R  G   I + APE   
Sbjct: 134 ---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 190
Query: 418 WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEF 452
               + ++DV+SFG+V  E+ +   + S +P+ EF
Sbjct: 191 DNIFSRQSDVWSFGVVLYELFT-YCDKSCSPSAEF 224

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 239 TNNFDSAKKIGEGGFGPVYKGQLADGTI----IAVKQLSSKSRQGNREFLN-EIAMISCL 293
             ++D  + +GEG +G V   QLA   +    +AVK +  K      E +  EI +   L
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
            H N+VK +G   EG+   L  EY     L    F R   ++ +  P  Q+    +  G+
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE-GDKTHISTRIAGTIGYMA 412
            +LH      I HRDIK  N+LLD   N KISDFGLA +    ++  +  ++ GT+ Y+A
Sbjct: 118 VYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 174
Query: 413 PE-YALWGYLTYKADVYSFGIVALEIVSGK 441
           PE      +     DV+S GIV   +++G+
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 129/270 (47%), Gaps = 35/270 (12%)
Query: 248 IGEGGFGPVYKGQLADGTIIAVKQLSSKS---RQGNREFLN-EIAMISCLQHPNLVKIHG 303
           +G+GGF   Y+    D   +   ++  KS   +   +E ++ EIA+   L +P++V  HG
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENC--ELELDWPTRQKICLGIARGLAFLHEESR 361
              + D + +V E     SL   L  R     E E  +  RQ I     +G+ +LH    
Sbjct: 110 FFEDDDFVYVVLEICRRRSL-LELHKRRKAVTEPEARYFMRQTI-----QGVQYLHNN-- 161
Query: 362 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYL 421
            +++HRD+K  N+ L+ D++ KI DFGLA   E D     T + GT  Y+APE       
Sbjct: 162 -RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT-LCGTPNYIAPEVLCKKGH 219
Query: 422 TYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSK 481
           +++ D++S G +   ++ GK          F+ +CL +    +++        +E    +
Sbjct: 220 SFEVDIWSLGCILYTLLVGKP--------PFETSCLKETYIRIKK--------NEYSVPR 263
Query: 482 YKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           +    A  +I+  L   +A P+LRP+++E+
Sbjct: 264 HINPVASALIRRML---HADPTLRPSVAEL 290

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 239 TNNFDSAKKIGEGGFGPVYKGQLADGTI----IAVKQLSSKSRQGNREFLN-EIAMISCL 293
             ++D  + +GEG +G V   QLA   +    +AVK +  K      E +  EI +   L
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
            H N+VK +G   EG+   L  EY     L    F R   ++ +  P  Q+    +  G+
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE-GDKTHISTRIAGTIGYMA 412
            +LH      I HRDIK  N+LLD   N KISDFGLA +    ++  +  ++ GT+ Y+A
Sbjct: 119 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 413 PE-YALWGYLTYKADVYSFGIVALEIVSGK 441
           PE      +     DV+S GIV   +++G+
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 26/217 (11%)
Query: 246 KKIGEGGFGPVY--------KGQLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCL-QH 295
           K +GEG FG V         K +  +   +AVK L   + + +  + ++E+ M+  + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDW-----PTRQ------- 343
            N++ + G C +   L ++ EY    +L   L  R    +E  +     P  Q       
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 344 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHIST 402
                +ARG+ +L  +   K +HRD+ A NVL+  +   KI+DFGLA+ ++  D    +T
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 403 RIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
                + +MAPE       T+++DV+SFG++  EI +
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 239 TNNFDSAKKIGEGGFGPVYKGQLADGTI----IAVKQLSSKSRQGNREFLN-EIAMISCL 293
             ++D  + +GEG +G V   QLA   +    +AVK +  K      E +  EI +   L
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
            H N+VK +G   EG+   L  EY     L    F R   ++ +  P  Q+    +  G+
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE-GDKTHISTRIAGTIGYMA 412
            +LH      I HRDIK  N+LLD   N KISDFGLA +    ++  +  ++ GT+ Y+A
Sbjct: 119 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 413 PE-YALWGYLTYKADVYSFGIVALEIVSGK 441
           PE      +     DV+S GIV   +++G+
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 239 TNNFDSAKKIGEGGFGPVYKGQLADGTI----IAVKQLSSKSRQGNREFLN-EIAMISCL 293
             ++D  + +GEG +G V   QLA   +    +AVK +  K      E +  EI +   L
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
            H N+VK +G   EG+   L  EY     L    F R   ++ +  P  Q+    +  G+
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE-GDKTHISTRIAGTIGYMA 412
            +LH      I HRDIK  N+LLD   N KISDFGLA +    ++  +  ++ GT+ Y+A
Sbjct: 119 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 413 PE-YALWGYLTYKADVYSFGIVALEIVSGK 441
           PE      +     DV+S GIV   +++G+
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 239 TNNFDSAKKIGEGGFGPVYKGQLADGTI----IAVKQLSSKSRQGNREFLN-EIAMISCL 293
             ++D  + +GEG +G V   QLA   +    +AVK +  K      E +  EI +   L
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
            H N+VK +G   EG+   L  EY     L    F R   ++ +  P  Q+    +  G+
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE-GDKTHISTRIAGTIGYMA 412
            +LH      I HRDIK  N+LLD   N KISDFGLA +    ++  +  ++ GT+ Y+A
Sbjct: 119 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 413 PE-YALWGYLTYKADVYSFGIVALEIVSGK 441
           PE      +     DV+S GIV   +++G+
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 239 TNNFDSAKKIGEGGFGPVYKGQLADGTI----IAVKQLSSKSRQGNREFLN-EIAMISCL 293
             ++D  + +GEG +G V   QLA   +    +AVK +  K      E +  EI +   L
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
            H N+VK +G   EG+   L  EY     L    F R   ++ +  P  Q+    +  G+
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE-GDKTHISTRIAGTIGYMA 412
            +LH      I HRDIK  N+LLD   N KISDFGLA +    ++  +  ++ GT+ Y+A
Sbjct: 118 VYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 174
Query: 413 PE-YALWGYLTYKADVYSFGIVALEIVSGK 441
           PE      +     DV+S GIV   +++G+
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 108/221 (48%), Gaps = 26/221 (11%)
Query: 234 QIKAATNN-------FDSAKKIGEGGFGPVYKGQLADGT--IIAVKQLS-SKSRQGNREF 283
           Q+    NN       F   ++IG+G FG V+KG + + T  ++A+K +   ++     + 
Sbjct: 10  QVPGMQNNIADPEELFTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDI 68
Query: 284 LNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQ 343
             EI ++S      + K +G  ++G +L ++ EY+   S    L      E ++    ++
Sbjct: 69  QQEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKE 128
Query: 344 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR 403
                I +GL +LH E +   +HRDIKA NVLL    + K++DFG+A    G  T    +
Sbjct: 129 -----ILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVA----GQLTDTQIK 176
Query: 404 ---IAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
                GT  +MAPE         KAD++S GI A+E+  G+
Sbjct: 177 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGE 217

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 239 TNNFDSAKKIGEGGFGPVYKGQLADGTI----IAVKQLSSKSRQGNREFLN-EIAMISCL 293
             ++D  + +GEG +G V   QLA   +    +AVK +  K      E +  EI +   L
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
            H N+VK +G   EG+   L  EY     L    F R   ++ +  P  Q+    +  G+
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE-GDKTHISTRIAGTIGYMA 412
            +LH      I HRDIK  N+LLD   N KISDFGLA +    ++  +  ++ GT+ Y+A
Sbjct: 118 VYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 174
Query: 413 PE-YALWGYLTYKADVYSFGIVALEIVSGK 441
           PE      +     DV+S GIV   +++G+
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 111/212 (52%), Gaps = 16/212 (7%)
Query: 236 KAATNNFDSAKK---IGEGGFGPVYK-GQLADGTIIAVKQLSSKSRQGNREFLNEIAMIS 291
           + A N+F +  K   +G G FG V+K  + A G  +A K + ++  +   E  NEI++++
Sbjct: 82  QGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMN 141
Query: 292 CLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIAR 351
            L H NL++++      + ++LV EY++   L   +        ELD     K    I  
Sbjct: 142 QLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMK---QICE 198
Query: 352 GLAFLHEESRFKIVHRDIKATNVL-LDRDLNP-KISDFGLA-KLDEGDKTHISTRIAGTI 408
           G+  +H+     I+H D+K  N+L ++RD    KI DFGLA +    +K  ++    GT 
Sbjct: 199 GIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF---GTP 252
Query: 409 GYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            ++APE   + ++++  D++S G++A  ++SG
Sbjct: 253 EFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/195 (35%), Positives = 100/195 (51%), Gaps = 13/195 (6%)
Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           + IG+G FG V  G    G  +AVK +  K+    + FL E ++++ L+H NLV++ G  
Sbjct: 18  QTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 74
Query: 306 VEGDQ-LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
           VE    L +V EYM   SL   L  R    L  D     K  L +   + +L E + F  
Sbjct: 75  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD--CLLKFSLDVCEAMEYL-EGNNF-- 129
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYK 424
           VHRD+ A NVL+  D   K+SDFGL K  E   T  + ++   + + APE       + K
Sbjct: 130 VHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREAAFSTK 185
Query: 425 ADVYSFGIVALEIVS 439
           +DV+SFGI+  EI S
Sbjct: 186 SDVWSFGILLWEIYS 200

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 239 TNNFDSAKKIGEGGFGPVYKGQLADGTI----IAVKQLSSKSRQGNREFLN-EIAMISCL 293
             ++D  + +GEG +G V   QLA   +    +AVK +  K      E +  EI +   L
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKML 61
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
            H N+VK +G   EG+   L  EY     L    F R   ++ +  P  Q+    +  G+
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE-GDKTHISTRIAGTIGYMA 412
            +LH      I HRDIK  N+LLD   N KISDFGLA +    ++  +  ++ GT+ Y+A
Sbjct: 118 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 174
Query: 413 PE-YALWGYLTYKADVYSFGIVALEIVSGK 441
           PE      +     DV+S GIV   +++G+
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 239 TNNFDSAKKIGEGGFGPVYKGQLADGTI----IAVKQLSSKSRQGNREFLN-EIAMISCL 293
             ++D  + +GEG +G V   QLA   +    +AVK +  K      E +  EI +   L
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
            H N+VK +G   EG+   L  EY     L    F R   ++ +  P  Q+    +  G+
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE-GDKTHISTRIAGTIGYMA 412
            +LH      I HRDIK  N+LLD   N KISDFGLA +    ++  +  ++ GT+ Y+A
Sbjct: 118 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVA 174
Query: 413 PE-YALWGYLTYKADVYSFGIVALEIVSGK 441
           PE      +     DV+S GIV   +++G+
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 105/223 (47%), Gaps = 22/223 (9%)
Query: 232 LKQIKAATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMI 290
           L  ++     F+  + +G G +G VYKG+ +  G + A+K +     +   E   EI M+
Sbjct: 16  LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINML 74
Query: 291 SCL-QHPNLVKIHGCCVEG------DQLLLVYEYMENNSLACALFGRENCELELDWPTRQ 343
                H N+   +G  ++       DQL LV E+    S+   +   +   L+ +W    
Sbjct: 75  KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY- 133
Query: 344 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL-AKLDEGDKTHIST 402
            IC  I RGL+ LH+    K++HRDIK  NVLL  +   K+ DFG+ A+LD         
Sbjct: 134 -ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR--TVGRRN 187
Query: 403 RIAGTIGYMAPEYALW-----GYLTYKADVYSFGIVALEIVSG 440
              GT  +MAPE             +K+D++S GI A+E+  G
Sbjct: 188 TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 239 TNNFDSAKKIGEGGFGPVYKGQLADGTI----IAVKQLSSKSRQGNREFLN-EIAMISCL 293
             ++D  + +GEG +G V   QLA   +    +AVK +  K      E +  EI +   L
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKML 62
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
            H N+VK +G   EG+   L  EY     L    F R   ++ +  P  Q+    +  G+
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE-GDKTHISTRIAGTIGYMA 412
            +LH      I HRDIK  N+LLD   N KISDFGLA +    ++  +  ++ GT+ Y+A
Sbjct: 119 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVA 175
Query: 413 PE-YALWGYLTYKADVYSFGIVALEIVSGK 441
           PE      +     DV+S GIV   +++G+
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 105/215 (48%), Gaps = 16/215 (7%)
Query: 247 KIGEGGFGPV---YKGQLAD--GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKI 301
           ++G+G FG V       L D  G ++AVKQL        R+F  EI ++  L    +VK 
Sbjct: 18  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 77
Query: 302 HGCCV-EGDQ-LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
            G     G Q L LV EY+ +  L   L   +     LD          I +G+ +L   
Sbjct: 78  RGVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEYLGSR 134
Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG--TIGYMAPEYAL 417
              + VHRD+ A N+L++ + + KI+DFGLAKL   DK +   R  G   I + APE   
Sbjct: 135 ---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 191
Query: 418 WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEF 452
               + ++DV+SFG+V  E+ +   + S +P+ EF
Sbjct: 192 DNIFSRQSDVWSFGVVLYELFT-YCDKSCSPSAEF 225

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 105/215 (48%), Gaps = 16/215 (7%)
Query: 247 KIGEGGFGPV---YKGQLAD--GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKI 301
           ++G+G FG V       L D  G ++AVKQL        R+F  EI ++  L    +VK 
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 302 HGCCV-EGDQ-LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
            G     G Q L LV EY+ +  L   L   +     LD          I +G+ +L   
Sbjct: 90  RGVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEYLGSR 146
Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG--TIGYMAPEYAL 417
              + VHRD+ A N+L++ + + KI+DFGLAKL   DK +   R  G   I + APE   
Sbjct: 147 ---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 203
Query: 418 WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEF 452
               + ++DV+SFG+V  E+ +   + S +P+ EF
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFT-YCDKSCSPSAEF 237

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/195 (35%), Positives = 100/195 (51%), Gaps = 13/195 (6%)
Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           + IG+G FG V  G    G  +AVK +  K+    + FL E ++++ L+H NLV++ G  
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 306 VEGDQ-LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
           VE    L +V EYM   SL   L  R    L  D     K  L +   + +L E + F  
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD--CLLKFSLDVCEAMEYL-EGNNF-- 310
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYK 424
           VHRD+ A NVL+  D   K+SDFGL K  E   T  + ++   + + APE       + K
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTK 366
Query: 425 ADVYSFGIVALEIVS 439
           +DV+SFGI+  EI S
Sbjct: 367 SDVWSFGILLWEIYS 381

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 108/220 (49%), Gaps = 21/220 (9%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLADGTI-------IAVKQLSSKSRQGNR-EFLNEI 287
           + A      ++++G+G FG VY+G +A G +       +A+K ++  +    R EFLNE 
Sbjct: 15  EVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 73
Query: 288 AMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELE----LDWPTRQ 343
           +++      ++V++ G   +G   L++ E M    L   L      E+E    L  P+  
Sbjct: 74  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPEMENNPVLAPPSLS 132
Query: 344 KICL---GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTH 399
           K+      IA G+A+L+     K VHRD+ A N ++  D   KI DFG+ + + E D   
Sbjct: 133 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 189
Query: 400 ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
              +    + +M+PE    G  T  +DV+SFG+V  EI +
Sbjct: 190 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/240 (30%), Positives = 109/240 (45%), Gaps = 19/240 (7%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLADGTI----IAVKQLSSKSRQGN---REFLNEIA 288
           K     +    K+G GG   VY   LA+ TI    +A+K +    R+     + F  E+ 
Sbjct: 7   KIINERYKIVDKLGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVH 63
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLG 348
             S L H N+V +     E D   LV EY+E  +L+   +   +  L +D  T       
Sbjct: 64  NSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSE--YIESHGPLSVD--TAINFTNQ 119
Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGT 407
           I  G+   H+    +IVHRDIK  N+L+D +   KI DFG+AK L E   T  +  + GT
Sbjct: 120 ILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGT 175
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD 467
           + Y +PE A         D+YS GIV  E++ G+   +   A+      + D   ++  D
Sbjct: 176 VQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTD 235

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/195 (35%), Positives = 100/195 (51%), Gaps = 13/195 (6%)
Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           + IG+G FG V  G    G  +AVK +  K+    + FL E ++++ L+H NLV++ G  
Sbjct: 27  QTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 306 VEGDQ-LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
           VE    L +V EYM   SL   L  R    L  D     K  L +   + +L E + F  
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD--CLLKFSLDVCEAMEYL-EGNNF-- 138
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYK 424
           VHRD+ A NVL+  D   K+SDFGL K  E   T  + ++   + + APE       + K
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTK 194
Query: 425 ADVYSFGIVALEIVS 439
           +DV+SFGI+  EI S
Sbjct: 195 SDVWSFGILLWEIYS 209

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 108/220 (49%), Gaps = 21/220 (9%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLADGTI-------IAVKQLSSKSRQGNR-EFLNEI 287
           + A      ++++G+G FG VY+G +A G +       +A+K ++  +    R EFLNE 
Sbjct: 43  EVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 101
Query: 288 AMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELE----LDWPTRQ 343
           +++      ++V++ G   +G   L++ E M    L   L      E+E    L  P+  
Sbjct: 102 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPEMENNPVLAPPSLS 160
Query: 344 KICL---GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTH 399
           K+      IA G+A+L+     K VHRD+ A N ++  D   KI DFG+ + + E D   
Sbjct: 161 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 217
Query: 400 ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
              +    + +M+PE    G  T  +DV+SFG+V  EI +
Sbjct: 218 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 108/220 (49%), Gaps = 21/220 (9%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLADGTI-------IAVKQLSSKSRQGNR-EFLNEI 287
           + A      ++++G+G FG VY+G +A G +       +A+K ++  +    R EFLNE 
Sbjct: 14  EVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 72
Query: 288 AMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELE----LDWPTRQ 343
           +++      ++V++ G   +G   L++ E M    L   L      E+E    L  P+  
Sbjct: 73  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPEMENNPVLAPPSLS 131
Query: 344 KICL---GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTH 399
           K+      IA G+A+L+     K VHRD+ A N ++  D   KI DFG+ + + E D   
Sbjct: 132 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 188
Query: 400 ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
              +    + +M+PE    G  T  +DV+SFG+V  EI +
Sbjct: 189 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 108/220 (49%), Gaps = 21/220 (9%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLADGTI-------IAVKQLSSKSRQGNR-EFLNEI 287
           + A      ++++G+G FG VY+G +A G +       +A+K ++  +    R EFLNE 
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 66
Query: 288 AMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELE----LDWPTRQ 343
           +++      ++V++ G   +G   L++ E M    L   L      E+E    L  P+  
Sbjct: 67  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPEMENNPVLAPPSLS 125
Query: 344 KICL---GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTH 399
           K+      IA G+A+L+     K VHRD+ A N ++  D   KI DFG+ + + E D   
Sbjct: 126 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 182
Query: 400 ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
              +    + +M+PE    G  T  +DV+SFG+V  EI +
Sbjct: 183 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/195 (35%), Positives = 100/195 (51%), Gaps = 13/195 (6%)
Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           + IG+G FG V  G    G  +AVK +  K+    + FL E ++++ L+H NLV++ G  
Sbjct: 12  QTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 306 VEGDQ-LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
           VE    L +V EYM   SL   L  R    L  D     K  L +   + +L E + F  
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD--CLLKFSLDVCEAMEYL-EGNNF-- 123
Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYK 424
           VHRD+ A NVL+  D   K+SDFGL K  E   T  + ++   + + APE       + K
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTK 179
Query: 425 ADVYSFGIVALEIVS 439
           +DV+SFGI+  EI S
Sbjct: 180 SDVWSFGILLWEIYS 194

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 108/220 (49%), Gaps = 21/220 (9%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLADGTI-------IAVKQLSSKSRQGNR-EFLNEI 287
           + A      ++++G+G FG VY+G +A G +       +A+K ++  +    R EFLNE 
Sbjct: 14  EVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 72
Query: 288 AMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELE----LDWPTRQ 343
           +++      ++V++ G   +G   L++ E M    L   L      E+E    L  P+  
Sbjct: 73  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPEMENNPVLAPPSLS 131
Query: 344 KICL---GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTH 399
           K+      IA G+A+L+     K VHRD+ A N ++  D   KI DFG+ + + E D   
Sbjct: 132 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 188
Query: 400 ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
              +    + +M+PE    G  T  +DV+SFG+V  EI +
Sbjct: 189 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 108/220 (49%), Gaps = 21/220 (9%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLADGTI-------IAVKQLSSKSRQGNR-EFLNEI 287
           + A      ++++G+G FG VY+G +A G +       +A+K ++  +    R EFLNE 
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 79
Query: 288 AMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELE----LDWPTRQ 343
           +++      ++V++ G   +G   L++ E M    L   L      E+E    L  P+  
Sbjct: 80  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPEMENNPVLAPPSLS 138
Query: 344 KICL---GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTH 399
           K+      IA G+A+L+     K VHRD+ A N ++  D   KI DFG+ + + E D   
Sbjct: 139 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 195
Query: 400 ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
              +    + +M+PE    G  T  +DV+SFG+V  EI +
Sbjct: 196 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/217 (33%), Positives = 110/217 (50%), Gaps = 19/217 (8%)
Query: 246 KKIGEGGFGPVY---KGQLADGT--IIAVKQLSSKSRQGNRE-FLNEIAMISCLQHPNLV 299
           + +GEG FG V         DGT  ++AVK L + +   +R  +  EI ++  L H +++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 300 KIHGCCVEGD--QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH 357
           K  GCC +     L LV EY+   SL   L  R +  L       Q+IC     G+A+LH
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQIC----EGMAYLH 151
Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTH-ISTRIAGTIGYMAPEY 415
            +     +HRD+ A NVLLD D   KI DFGLAK + EG + + +       + + APE 
Sbjct: 152 AQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPEC 208
Query: 416 ALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEF 452
                  Y +DV+SFG+   E+++  ++ S +P  +F
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLTHCDS-SQSPPTKF 244

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 106/221 (47%), Gaps = 34/221 (15%)
Query: 246 KKIGEGGFGPVY--------KGQLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCL-QH 295
           K +GEG FG V         K +    T +AVK L S + + +  + ++E+ M+  + +H
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDW-----PTRQ------- 343
            N++ + G C +   L ++ EY    +L   L  R    LE  +     P  Q       
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 153
Query: 344 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI--- 400
                +ARG+ +L  +   K +HRD+ A NVL+  D   KI+DFGLA+    D  HI   
Sbjct: 154 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 206
Query: 401 --STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
             +T     + +MAPE       T+++DV+SFG++  EI +
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 26/217 (11%)
Query: 246 KKIGEGGFGPVY--------KGQLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCL-QH 295
           K +GEG FG V         K +  +   +AVK L   + + +  + ++E+ M+  + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDW-----PTRQ------- 343
            N++ + G C +   L ++ EY    +L   L  R    +E  +     P  Q       
Sbjct: 101 KNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 344 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHIST 402
                +ARG+ +L  +   K +HRD+ A NVL+  +   KI+DFGLA+ ++  D    +T
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 403 RIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
                + +MAPE       T+++DV+SFG++  EI +
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 107/228 (46%), Gaps = 31/228 (13%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQL-----ADGTI-IAVKQLSSKSRQGNRE-FLNEIAMISC 292
           NN    K +G G FG V +         D  + +AVK L S +    +E  ++E+ ++S 
Sbjct: 31  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 293 L-QHPNLVKIHGCCVEGDQLLLVYEYMENNSL-------ACALFGR--------ENCELE 336
           L QH N+V + G C  G  +L++ EY     L       A A+ G         E  + E
Sbjct: 91  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKE 150
Query: 337 LDWPTRQKICL----GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL 392
              P   +  L     +A+G+AFL  ++    +HRD+ A NVLL      KI DFGLA+ 
Sbjct: 151 DGRPLELRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARD 207
Query: 393 DEGDKTHISTRIAG-TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
              D  +I    A   + +MAPE       T ++DV+S+GI+  EI S
Sbjct: 208 IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 26/218 (11%)
Query: 245 AKKIGEGGFGPVY--------KGQLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCL-Q 294
            K +GEG FG V         K +  +   +AVK L   + + +  + ++E+ M+  + +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGK 99
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDW-----PTRQ------ 343
           H N++ + G C +   L ++ EY    +L   L  R    +E  +     P  Q      
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 344 -KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHIS 401
                 +ARG+ +L  +   K +HRD+ A NVL+  +   KI+DFGLA+ ++  D    +
Sbjct: 160 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 402 TRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
           T     + +MAPE       T+++DV+SFG++  EI +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 106/221 (47%), Gaps = 34/221 (15%)
Query: 246 KKIGEGGFGPVY--------KGQLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCL-QH 295
           K +GEG FG V         K +    T +AVK L S + + +  + ++E+ M+  + +H
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDW-----PTRQ------- 343
            N++ + G C +   L ++ EY    +L   L  R    LE  +     P  Q       
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 138
Query: 344 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI--- 400
                +ARG+ +L  +   K +HRD+ A NVL+  D   KI+DFGLA+    D  HI   
Sbjct: 139 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 191
Query: 401 --STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
             +T     + +MAPE       T+++DV+SFG++  EI +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 26/218 (11%)
Query: 245 AKKIGEGGFGPVY--------KGQLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCL-Q 294
            K +GEG FG V         K +  +   +AVK L   + + +  + ++E+ M+  + +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDW-----PTRQ------ 343
           H N++ + G C +   L ++ EY    +L   L  R    +E  +     P  Q      
Sbjct: 100 HKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 344 -KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHIS 401
                 +ARG+ +L  +   K +HRD+ A NVL+  +   KI+DFGLA+ ++  D    +
Sbjct: 160 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 402 TRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
           T     + +MAPE       T+++DV+SFG++  EI +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 26/218 (11%)
Query: 245 AKKIGEGGFGPVY--------KGQLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCL-Q 294
            K +GEG FG V         K +  +   +AVK L   + + +  + ++E+ M+  + +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDW-----PTRQ------ 343
           H N++ + G C +   L ++ EY    +L   L  R    +E  +     P  Q      
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 344 -KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHIS 401
                 +ARG+ +L  +   K +HRD+ A NVL+  +   KI+DFGLA+ ++  D    +
Sbjct: 160 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNT 216
Query: 402 TRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
           T     + +MAPE       T+++DV+SFG++  EI +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 246 KKIGEGGFG-PVYKGQLADGTIIAVKQ-----LSSKSRQGNREFLNEIAMISCLQHPNLV 299
           +KIGEG FG  +      DG    +K+     +SSK R+ +R    E+A+++ ++HPN+V
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRR---EVAVLANMKHPNIV 86
Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
           +      E   L +V +Y E   L    F R N +  + +   Q +   +   LA  H  
Sbjct: 87  QYRESFEENGSLYIVMDYCEGGDL----FKRINAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWG 419
            R KI+HRDIK+ N+ L +D   ++ DFG+A++       ++    GT  Y++PE     
Sbjct: 143 DR-KILHRDIKSQNIFLTKDGTVQLGDFGIARV-LNSTVELARACIGTPYYLSPEICENK 200
Query: 420 YLTYKADVYSFGIVALEIVSGKN 442
               K+D+++ G V  E+ + K+
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKH 223

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 101/207 (48%), Gaps = 17/207 (8%)
Query: 240 NNFDSAKKIGEGGFGPVYK-GQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNL 298
           +++D  +++G G FG V++  + A G   A K + +           EI  +S L+HP L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGREN--CELELDWPTRQKICLGIARGLAFL 356
           V +H    + ++++++YE+M    L   +    N   E E     RQ     + +GL  +
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ-----VCKGLCHM 165
Query: 357 HEESRFKIVHRDIKATNVLL--DRDLNPKISDFGL-AKLDEGDKTHISTRIAGTIGYMAP 413
           HE +    VH D+K  N++    R    K+ DFGL A LD      ++T   GT  + AP
Sbjct: 166 HENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAP 219
Query: 414 EYALWGYLTYKADVYSFGIVALEIVSG 440
           E A    + Y  D++S G+++  ++SG
Sbjct: 220 EVAEGKPVGYYTDMWSVGVLSYILLSG 246

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 115/234 (49%), Gaps = 19/234 (8%)
Query: 232 LKQIKAATNNFDSAKKIGEGGFGPVYKGQLA--DGTI--IAVK--QLSSKSRQGNREFLN 285
           L+ +    N     K +GEG FG V +G L   DGT   +AVK  +L + S++   EFL+
Sbjct: 26  LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLS 85
Query: 286 EIAMISCLQHPNLVKIHGCCVEGD-----QLLLVYEYMENNSLAC-ALFGR-ENCELELD 338
           E A +    HPN++++ G C+E       + +++  +M+   L    L+ R E     + 
Sbjct: 86  EAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIP 145
Query: 339 WPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT 398
             T  K  + IA G+ +L   S    +HRD+ A N +L  D+   ++DFGL+K       
Sbjct: 146 LQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDY 202
Query: 399 HISTRIAGT-IGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALE 451
           +   RIA   + ++A E       T K+DV++FG+   EI +    M+  P ++
Sbjct: 203 YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT--RGMTPYPGVQ 254

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 130/293 (44%), Gaps = 40/293 (13%)
Query: 240 NNFDSAKKIGEGGFGPVYKG------QLADGTIIAVKQLSSKSRQG-NREFLNEIA-MIS 291
           +  +  K +G G FG V +       + A    +AVK L   +    +R  ++E+  +I 
Sbjct: 28  DRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 87
Query: 292 CLQHPNLVKIHGCCVE-GDQLLLVYEYMENNSLACALFGRENCELELDWPT--------- 341
              H N+V + G C + G  L+++ E+ +  +L+  L  + N  +    P          
Sbjct: 88  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTL 147
Query: 342 RQKIC--LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH 399
              IC    +A+G+ FL   SR K +HRD+ A N+LL      KI DFGLA+    D   
Sbjct: 148 EHLICYSFQVAKGMEFL--ASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 204
Query: 400 ISTRIAG-TIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLL 458
           +    A   + +MAPE       T ++DV+SFG++  EI S     S  P ++ D     
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPGVKID----- 257
Query: 459 DWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           +  C   ++G  +   D      Y   E   M +  L C +  PS RPT SE+
Sbjct: 258 EEFCRRLKEGTRMRAPD------YTTPE---MYQTMLDCWHGEPSQRPTFSEL 301

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 128/270 (47%), Gaps = 35/270 (12%)
Query: 248 IGEGGFGPVYKGQLADGTIIAVKQLSSKS---RQGNREFLN-EIAMISCLQHPNLVKIHG 303
           +G+GGF   Y+    D   +   ++  KS   +   +E ++ EIA+   L +P++V  HG
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENC--ELELDWPTRQKICLGIARGLAFLHEESR 361
              + D + +V E     SL   L  R     E E  +  RQ I     +G+ +LH    
Sbjct: 110 FFEDDDFVYVVLEICRRRSL-LELHKRRKAVTEPEARYFMRQTI-----QGVQYLHNN-- 161
Query: 362 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYL 421
            +++HRD+K  N+ L+ D++ KI DFGLA   E D       + GT  Y+APE       
Sbjct: 162 -RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKXLCGTPNYIAPEVLCKKGH 219
Query: 422 TYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSK 481
           +++ D++S G +   ++ GK          F+ +CL +    +++        +E    +
Sbjct: 220 SFEVDIWSLGCILYTLLVGKP--------PFETSCLKETYIRIKK--------NEYSVPR 263
Query: 482 YKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           +    A  +I+  L   +A P+LRP+++E+
Sbjct: 264 HINPVASALIRRML---HADPTLRPSVAEL 290

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 124/270 (45%), Gaps = 35/270 (12%)
Query: 248 IGEGGFGPVYKGQLADGTIIAVKQLSSKS---RQGNREFLN-EIAMISCLQHPNLVKIHG 303
           +G+GGF   ++   AD   +   ++  KS   +   RE ++ EI++   L H ++V  HG
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENC--ELELDWPTRQKICLGIARGLAFLHEESR 361
              + D + +V E     SL   L  R     E E  +  RQ     I  G  +LH   R
Sbjct: 85  FFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEARYYLRQ-----IVLGCQYLH---R 135
Query: 362 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYL 421
            +++HRD+K  N+ L+ DL  KI DFGLA   E D     T + GT  Y+APE       
Sbjct: 136 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGH 194
Query: 422 TYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSK 481
           +++ DV+S G +   ++ GK          F+ +CL +    +++        +E    K
Sbjct: 195 SFEVDVWSIGCIMYTLLVGKP--------PFETSCLKETYLRIKK--------NEYSIPK 238
Query: 482 YKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           +    A  +I+  L      P+ RPT++E+
Sbjct: 239 HINPVAASLIQKML---QTDPTARPTINEL 265

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 133/288 (46%), Gaps = 41/288 (14%)
Query: 246 KKIGEGGFGPVYKG------QLADGTIIAVKQLSSKSRQG-NREFLNEIA-MISCLQHPN 297
           K +G G FG V +       + A    +AVK L   +    +R  ++E+  +I    H N
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 298 LVKIHGCCVE-GDQLLLVYEYMENNSLACALFGRENC---------ELELDWPTRQK-IC 346
           +V + G C + G  L+++ E+ +  +L+  L  + N          +L  D+ T +  IC
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 347 --LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI 404
               +A+G+ FL   SR K +HRD+ A N+LL      KI DFGLA+    D  ++    
Sbjct: 144 YSFQVAKGMEFL--ASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 405 AG-TIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACH 463
           A   + +MAPE       T ++DV+SFG++  EI S     S  P ++ D     +  C 
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPGVKID-----EEFCR 253
Query: 464 LQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
             ++G  +   D      Y   E   M +  L C +  PS RPT SE+
Sbjct: 254 RLKEGTRMRAPD------YTTPE---MYQTMLDCWHGEPSQRPTFSEL 292

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 133/288 (46%), Gaps = 41/288 (14%)
Query: 246 KKIGEGGFGPVYKG------QLADGTIIAVKQLSSKSRQG-NREFLNEIA-MISCLQHPN 297
           K +G G FG V +       + A    +AVK L   +    +R  ++E+  +I    H N
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 298 LVKIHGCCVE-GDQLLLVYEYMENNSLACALFGRENC---------ELELDWPTRQK-IC 346
           +V + G C + G  L+++ E+ +  +L+  L  + N          +L  D+ T +  IC
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 347 --LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI 404
               +A+G+ FL   SR K +HRD+ A N+LL      KI DFGLA+    D  ++    
Sbjct: 144 YSFQVAKGMEFL--ASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 405 AG-TIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACH 463
           A   + +MAPE       T ++DV+SFG++  EI S     S  P ++ D     +  C 
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPGVKID-----EEFCR 253
Query: 464 LQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
             ++G  +   D      Y   E   M +  L C +  PS RPT SE+
Sbjct: 254 RLKEGTRMRAPD------YTTPE---MYQTMLDCWHGEPSQRPTFSEL 292

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 124/270 (45%), Gaps = 35/270 (12%)
Query: 248 IGEGGFGPVYKGQLADGTIIAVKQLSSKS---RQGNREFLN-EIAMISCLQHPNLVKIHG 303
           +G+GGF   ++   AD   +   ++  KS   +   RE ++ EI++   L H ++V  HG
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENC--ELELDWPTRQKICLGIARGLAFLHEESR 361
              + D + +V E     SL   L  R     E E  +  RQ     I  G  +LH   R
Sbjct: 85  FFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEARYYLRQ-----IVLGCQYLH---R 135
Query: 362 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYL 421
            +++HRD+K  N+ L+ DL  KI DFGLA   E D     T + GT  Y+APE       
Sbjct: 136 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGH 194
Query: 422 TYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSK 481
           +++ DV+S G +   ++ GK          F+ +CL +    +++        +E    K
Sbjct: 195 SFEVDVWSIGCIMYTLLVGKP--------PFETSCLKETYLRIKK--------NEYSIPK 238
Query: 482 YKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           +    A  +I+  L      P+ RPT++E+
Sbjct: 239 HINPVAASLIQKML---QTDPTARPTINEL 265

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 26/218 (11%)
Query: 245 AKKIGEGGFGPVY--------KGQLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCL-Q 294
            K +GEG FG V         K +  +   +AVK L   + + +  + ++E+ M+  + +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDW-----PTRQ------ 343
           H N++ + G C +   L ++ EY    +L   L  R    +E  +     P  Q      
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 344 -KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHIS 401
                 +ARG+ +L  +   K +HRD+ A NVL+  +   +I+DFGLA+ ++  D    +
Sbjct: 160 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKT 216
Query: 402 TRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
           T     + +MAPE       T+++DV+SFG++  EI +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 131/287 (45%), Gaps = 39/287 (13%)
Query: 245 AKKIGEGGFGPVYKG------QLADGTIIAVKQLSSKSRQG-NREFLNEIA-MISCLQHP 296
            K +G G FG V +       + A    +AVK L   +    +R  ++E+  +I    H 
Sbjct: 34  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 93
Query: 297 NLVKIHGCCVE-GDQLLLVYEYMENNSLACALFGRENC-------ELELDWPTRQKI--- 345
           N+V + G C + G  L+++ E+ +  +L+  L  + N        +L  D+ T + +   
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXY 153
Query: 346 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIA 405
              +A+G+ FL   SR K +HRD+ A N+LL      KI DFGLA+    D   +    A
Sbjct: 154 SFQVAKGMEFL--ASR-KXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 406 G-TIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHL 464
              + +MAPE       T ++DV+SFG++  EI S     S  P ++ D     +  C  
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPGVKID-----EEFCRR 263
Query: 465 QQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
            ++G  +   D      Y   E   M +  L C +  PS RPT SE+
Sbjct: 264 LKEGTRMRAPD------YTTPE---MYQTMLDCWHGEPSQRPTFSEL 301

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 124/270 (45%), Gaps = 35/270 (12%)
Query: 248 IGEGGFGPVYKGQLADGTIIAVKQLSSKS---RQGNREFLN-EIAMISCLQHPNLVKIHG 303
           +G+GGF   ++   AD   +   ++  KS   +   RE ++ EI++   L H ++V  HG
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENC--ELELDWPTRQKICLGIARGLAFLHEESR 361
              + D + +V E     SL   L  R     E E  +  RQ     I  G  +LH   R
Sbjct: 89  FFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEARYYLRQ-----IVLGCQYLH---R 139
Query: 362 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYL 421
            +++HRD+K  N+ L+ DL  KI DFGLA   E D     T + GT  Y+APE       
Sbjct: 140 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGH 198
Query: 422 TYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSK 481
           +++ DV+S G +   ++ GK          F+ +CL +    +++        +E    K
Sbjct: 199 SFEVDVWSIGCIMYTLLVGKP--------PFETSCLKETYLRIKK--------NEYSIPK 242
Query: 482 YKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           +    A  +I+  L      P+ RPT++E+
Sbjct: 243 HINPVAASLIQKML---QTDPTARPTINEL 269

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 101/210 (48%), Gaps = 17/210 (8%)
Query: 239 TNNFDSAKKIGEGGFGPVYKGQLADGTI----IAVKQLSSKSRQGNREFLN-EIAMISCL 293
             ++D  + +GEG  G V   QLA   +    +AVK +  K      E +  EI +   L
Sbjct: 5   VEDWDLVQTLGEGAAGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
            H N+VK +G   EG+   L  EY     L    F R   ++ +  P  Q+    +  G+
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE-GDKTHISTRIAGTIGYMA 412
            +LH      I HRDIK  N+LLD   N KISDFGLA +    ++  +  ++ GT+ Y+A
Sbjct: 118 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 174
Query: 413 PE-YALWGYLTYKADVYSFGIVALEIVSGK 441
           PE      +     DV+S GIV   +++G+
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 128/270 (47%), Gaps = 35/270 (12%)
Query: 248 IGEGGFGPVYKGQLADGTIIAVKQLSSKS---RQGNREFLN-EIAMISCLQHPNLVKIHG 303
           +G+GGF   Y+    D   +   ++  KS   +   +E ++ EIA+   L +P++V  HG
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENC--ELELDWPTRQKICLGIARGLAFLHEESR 361
              + D + +V E     SL   L  R     E E  +  RQ I     +G+ +LH    
Sbjct: 110 FFEDDDFVYVVLEICRRRSL-LELHKRRKAVTEPEARYFMRQTI-----QGVQYLHNN-- 161
Query: 362 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYL 421
            +++HRD+K  N+ L+ D++ KI DFGLA   E D       + GT  Y+APE       
Sbjct: 162 -RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKDLCGTPNYIAPEVLCKKGH 219
Query: 422 TYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSK 481
           +++ D++S G +   ++ GK          F+ +CL +    +++        +E    +
Sbjct: 220 SFEVDIWSLGCILYTLLVGKP--------PFETSCLKETYIRIKK--------NEYSVPR 263
Query: 482 YKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           +    A  +I+  L   +A P+LRP+++E+
Sbjct: 264 HINPVASALIRRML---HADPTLRPSVAEL 290

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 133/289 (46%), Gaps = 41/289 (14%)
Query: 245 AKKIGEGGFGPVYKG------QLADGTIIAVKQLSSKSRQG-NREFLNEIA-MISCLQHP 296
            K +G G FG V +       + A    +AVK L   +    +R  ++E+  +I    H 
Sbjct: 69  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 128
Query: 297 NLVKIHGCCVE-GDQLLLVYEYMENNSLACALFGRENC---------ELELDWPTRQK-I 345
           N+V + G C + G  L+++ E+ +  +L+  L  + N          +L  D+ T +  I
Sbjct: 129 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 188
Query: 346 C--LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR 403
           C    +A+G+ FL   SR K +HRD+ A N+LL      KI DFGLA+    D  ++   
Sbjct: 189 CYSFQVAKGMEFL--ASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 245
Query: 404 IAG-TIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWAC 462
            A   + +MAPE       T ++DV+SFG++  EI S     S  P ++ D     +  C
Sbjct: 246 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPGVKID-----EEFC 298
Query: 463 HLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
              ++G  +   D      Y   E   M +  L C +  PS RPT SE+
Sbjct: 299 RRLKEGTRMRAPD------YTTPE---MYQTMLDCWHGEPSQRPTFSEL 338

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 101/207 (48%), Gaps = 17/207 (8%)
Query: 240 NNFDSAKKIGEGGFGPVYK-GQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNL 298
           +++D  +++G G FG V++  + A G   A K + +           EI  +S L+HP L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGREN--CELELDWPTRQKICLGIARGLAFL 356
           V +H    + ++++++YE+M    L   +    N   E E     RQ     + +GL  +
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ-----VCKGLCHM 271
Query: 357 HEESRFKIVHRDIKATNVLL--DRDLNPKISDFGL-AKLDEGDKTHISTRIAGTIGYMAP 413
           HE +    VH D+K  N++    R    K+ DFGL A LD      ++T   GT  + AP
Sbjct: 272 HENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAP 325
Query: 414 EYALWGYLTYKADVYSFGIVALEIVSG 440
           E A    + Y  D++S G+++  ++SG
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLSYILLSG 352

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 26/218 (11%)
Query: 245 AKKIGEGGFGPVY--------KGQLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCL-Q 294
            K +GEG FG V         K +  +   +AVK L   + + +  + ++E+ M+  + +
Sbjct: 27  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 86
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDW-----PTRQ------ 343
           H N++ + G C +   L ++ EY    +L   L  R    +E  +     P  Q      
Sbjct: 87  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 146
Query: 344 -KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHIS 401
                 +ARG+ +L  +   K +HRD+ A NVL+  +   KI+DFGLA+ ++  D    +
Sbjct: 147 VSCTYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKT 203
Query: 402 TRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
           T     + +MAPE       T+++DV+SFG++  EI +
Sbjct: 204 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 133/289 (46%), Gaps = 41/289 (14%)
Query: 245 AKKIGEGGFGPVYKG------QLADGTIIAVKQLSSKSRQG-NREFLNEIA-MISCLQHP 296
            K +G G FG V +       + A    +AVK L   +    +R  ++E+  +I    H 
Sbjct: 34  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 93
Query: 297 NLVKIHGCCVE-GDQLLLVYEYMENNSLACALFGRENC---------ELELDWPTRQK-I 345
           N+V + G C + G  L+++ E+ +  +L+  L  + N          +L  D+ T +  I
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLI 153
Query: 346 C--LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR 403
           C    +A+G+ FL   SR K +HRD+ A N+LL      KI DFGLA+    D  ++   
Sbjct: 154 CYSFQVAKGMEFL--ASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 210
Query: 404 IAG-TIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWAC 462
            A   + +MAPE       T ++DV+SFG++  EI S     S  P ++ D     +  C
Sbjct: 211 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPGVKID-----EEFC 263
Query: 463 HLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
              ++G  +   D      Y   E   M +  L C +  PS RPT SE+
Sbjct: 264 RRLKEGTRMRAPD------YTTPE---MYQTMLDCWHGEPSQRPTFSEL 303

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 26/217 (11%)
Query: 246 KKIGEGGFGPVY--------KGQLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCL-QH 295
           K +GEG FG V         K +  +   +AVK L   + + +  + ++E+ M+  + +H
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDW-----PTRQ------- 343
            N++ + G C +   L ++ EY    +L   L  R    +E  +     P  Q       
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 344 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHIST 402
                +ARG+ +L  +   K +HRD+ A NVL+  +   KI+DFGLA+ ++  D    +T
Sbjct: 207 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 403 RIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
                + +MAPE       T+++DV+SFG++  EI +
Sbjct: 264 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 128/270 (47%), Gaps = 35/270 (12%)
Query: 248 IGEGGFGPVYKGQLADGTIIAVKQLSSKS---RQGNREFLN-EIAMISCLQHPNLVKIHG 303
           +G+GGF   Y+    D   +   ++  KS   +   +E ++ EIA+   L +P++V  HG
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENC--ELELDWPTRQKICLGIARGLAFLHEESR 361
              + D + +V E     SL   L  R     E E  +  RQ I     +G+ +LH    
Sbjct: 94  FFEDDDFVYVVLEICRRRSL-LELHKRRKAVTEPEARYFMRQTI-----QGVQYLHNN-- 145
Query: 362 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYL 421
            +++HRD+K  N+ L+ D++ KI DFGLA   E D       + GT  Y+APE       
Sbjct: 146 -RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKDLCGTPNYIAPEVLCKKGH 203
Query: 422 TYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSK 481
           +++ D++S G +   ++ GK          F+ +CL +    +++        +E    +
Sbjct: 204 SFEVDIWSLGCILYTLLVGKP--------PFETSCLKETYIRIKK--------NEYSVPR 247
Query: 482 YKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           +    A  +I+  L   +A P+LRP+++E+
Sbjct: 248 HINPVASALIRRML---HADPTLRPSVAEL 274

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 133/288 (46%), Gaps = 41/288 (14%)
Query: 246 KKIGEGGFGPVYKG------QLADGTIIAVKQLSSKSRQG-NREFLNEIA-MISCLQHPN 297
           K +G G FG V +       + A    +AVK L   +    +R  ++E+  +I    H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 298 LVKIHGCCVE-GDQLLLVYEYMENNSLACALFGRENC---------ELELDWPTRQK-IC 346
           +V + G C + G  L+++ E+ +  +L+  L  + N          +L  D+ T +  IC
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 347 --LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI 404
               +A+G+ FL   SR K +HRD+ A N+LL      KI DFGLA+    D  ++    
Sbjct: 153 YSFQVAKGMEFL--ASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 405 AG-TIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACH 463
           A   + +MAPE       T ++DV+SFG++  EI S     S  P ++ D     +  C 
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPGVKID-----EEFCR 262
Query: 464 LQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
             ++G  +   D      Y   E   M +  L C +  PS RPT SE+
Sbjct: 263 RLKEGTRMRAPD------YTTPE---MYQTMLDCWHGEPSQRPTFSEL 301

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 105/219 (47%), Gaps = 19/219 (8%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLADGTI-------IAVKQLSSKSRQGNR-EFLNEI 287
           + A      ++++G+G FG VY+G +A G +       +A+K ++  +    R EFLNE 
Sbjct: 11  EVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 69
Query: 288 AMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELE---LDWPTRQK 344
           +++      ++V++ G   +G   L++ E M    L   L            L  P+  K
Sbjct: 70  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 129
Query: 345 ICL---GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHI 400
           +      IA G+A+L+     K VHRD+ A N ++  D   KI DFG+ + + E D    
Sbjct: 130 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 186
Query: 401 STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
             +    + +M+PE    G  T  +DV+SFG+V  EI +
Sbjct: 187 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 105/219 (47%), Gaps = 19/219 (8%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLADGTI-------IAVKQLSSKSRQGNR-EFLNEI 287
           + A      ++++G+G FG VY+G +A G +       +A+K ++  +    R EFLNE 
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 79
Query: 288 AMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELE---LDWPTRQK 344
           +++      ++V++ G   +G   L++ E M    L   L            L  P+  K
Sbjct: 80  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139
Query: 345 ICL---GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHI 400
           +      IA G+A+L+     K VHRD+ A N ++  D   KI DFG+ + + E D    
Sbjct: 140 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196
Query: 401 STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
             +    + +M+PE    G  T  +DV+SFG+V  EI +
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 21/220 (9%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLADGTI-------IAVKQLSSKSRQGNR-EFLNEI 287
           + A      ++++G+G FG VY+G +A G +       +A+K ++  +    R EFLNE 
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 66
Query: 288 AMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELE----LDWPTRQ 343
           +++      ++V++ G   +G   L++ E M    L   L      E+E    L  P+  
Sbjct: 67  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPEMENNPVLAPPSLS 125
Query: 344 KICL---GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTH 399
           K+      IA G+A+L+     K VHRD+ A N  +  D   KI DFG+ + + E D   
Sbjct: 126 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYR 182
Query: 400 ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
              +    + +M+PE    G  T  +DV+SFG+V  EI +
Sbjct: 183 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 26/218 (11%)
Query: 245 AKKIGEGGFGPVY--------KGQLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCL-Q 294
            K +GEG FG V         K +  +   +AVK L   + + +  + ++E+ M+  + +
Sbjct: 32  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 91
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDW-----PTRQ------ 343
           H N++ + G C +   L ++ EY    +L   L  R    +E  +     P  Q      
Sbjct: 92  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 151
Query: 344 -KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHIS 401
                 +ARG+ +L  +   K +HRD+ A NVL+  +   KI+DFGLA+ ++  D    +
Sbjct: 152 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 208
Query: 402 TRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
           T     + +MAPE       T+++DV+SFG++  EI +
Sbjct: 209 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 26/218 (11%)
Query: 245 AKKIGEGGFGPVY--------KGQLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCL-Q 294
            K +GEG FG V         K +  +   +AVK L   + + +  + ++E+ M+  + +
Sbjct: 29  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 88
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDW-----PTRQ------ 343
           H N++ + G C +   L ++ EY    +L   L  R    +E  +     P  Q      
Sbjct: 89  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 148
Query: 344 -KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHIS 401
                 +ARG+ +L  +   K +HRD+ A NVL+  +   KI+DFGLA+ ++  D    +
Sbjct: 149 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 205
Query: 402 TRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
           T     + +MAPE       T+++DV+SFG++  EI +
Sbjct: 206 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 107/217 (49%), Gaps = 19/217 (8%)
Query: 246 KKIGEGGFGPVY---KGQLADGT--IIAVKQLSSKSRQGNRE-FLNEIAMISCLQHPNLV 299
           + +GEG FG V         DGT  ++AVK L +     +R  +  EI ++  L H +++
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHII 79
Query: 300 KIHGCCVEGDQ--LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH 357
           K  GCC +  +  L LV EY+   SL   L  R +  L       Q+IC     G+A+LH
Sbjct: 80  KYKGCCEDQGEKSLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQIC----EGMAYLH 134
Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG--TIGYMAPEY 415
            +     +HR++ A NVLLD D   KI DFGLAK       +   R  G   + + APE 
Sbjct: 135 SQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 191
Query: 416 ALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEF 452
                  Y +DV+SFG+   E+++  ++ S +P  +F
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELLTHCDS-SQSPPTKF 227

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 132/288 (45%), Gaps = 41/288 (14%)
Query: 246 KKIGEGGFGPVYKG------QLADGTIIAVKQLSSKSRQG-NREFLNEIA-MISCLQHPN 297
           K +G G FG V +       + A    +AVK L   +    +R  ++E+  +I    H N
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 298 LVKIHGCCVE-GDQLLLVYEYMENNSLACALFGRENC---------ELELDWPTRQK-IC 346
           +V + G C + G  L+++ E+ +  +L+  L  + N          +L  D+ T +  IC
Sbjct: 84  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 347 --LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI 404
               +A+G+ FL   SR K +HRD+ A N+LL      KI DFGLA+    D   +    
Sbjct: 144 YSFQVAKGMEFL--ASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 405 AG-TIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACH 463
           A   + +MAPE       T ++DV+SFG++  EI S     S  P ++ D     +  C 
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPGVKID-----EEFCR 253
Query: 464 LQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
             ++G  +   D      Y   E   M +  L C +  PS RPT SE+
Sbjct: 254 RLKEGTRMRAPD------YTTPE---MYQTMLDCWHGEPSQRPTFSEL 292

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 104/215 (48%), Gaps = 16/215 (7%)
Query: 247 KIGEGGFGPVYKGQ---LAD--GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKI 301
           ++G+G FG V   +   L D  G ++AVKQL        R+F  EI ++  L    +VK 
Sbjct: 14  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 73
Query: 302 HGCCVEG--DQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
            G        +L LV EY+ +  L   L   +     LD          I +G+ +L   
Sbjct: 74  RGVSYGPGRPELRLVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEYLGSR 130
Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG--TIGYMAPEYAL 417
              + VHRD+ A N+L++ + + KI+DFGLAKL   DK     R  G   I + APE   
Sbjct: 131 ---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLS 187
Query: 418 WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEF 452
               + ++DV+SFG+V  E+ +   + S +P+ EF
Sbjct: 188 DNIFSRQSDVWSFGVVLYELFT-YCDKSCSPSAEF 221

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 132/288 (45%), Gaps = 41/288 (14%)
Query: 246 KKIGEGGFGPVYKG------QLADGTIIAVKQLSSKSRQG-NREFLNEIA-MISCLQHPN 297
           K +G G FG V +       + A    +AVK L   +    +R  ++E+  +I    H N
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 298 LVKIHGCCVE-GDQLLLVYEYMENNSLACALFGRENC---------ELELDWPTRQK-IC 346
           +V + G C + G  L+++ E+ +  +L+  L  + N          +L  D+ T +  IC
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 347 --LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI 404
               +A+G+ FL   SR K +HRD+ A N+LL      KI DFGLA+    D   +    
Sbjct: 144 YSFQVAKGMEFL--ASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 405 AG-TIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACH 463
           A   + +MAPE       T ++DV+SFG++  EI S     S  P ++ D     +  C 
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPGVKID-----EEFCR 253
Query: 464 LQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
             ++G  +   D      Y   E   M +  L C +  PS RPT SE+
Sbjct: 254 RLKEGTRMRAPD------YTTPE---MYQTMLDCWHGEPSQRPTFSEL 292

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 133/294 (45%), Gaps = 45/294 (15%)
Query: 240 NNFDSAKKIGEGGFGPVYKG------QLADGTIIAVKQLSSKSRQG-NREFLNEIA-MIS 291
           +  +  K +G G FG V +       + A    +AVK L   +    +R  ++E+  +I 
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 292 CLQHPNLVKIHGCCVE-GDQLLLVYEYMENNSLACALFGREN-----CELELDWPTRQKI 345
              H N+V + G C + G  L+++ E+ +  +L+  L  + N      +L  D+ T + +
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHL 146
Query: 346 C---LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIST 402
                 +A+G+ FL   SR K +HRD+ A N+LL      KI DFGLA+    D  ++  
Sbjct: 147 IXYSFQVAKGMEFL--ASR-KXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRK 203
Query: 403 RIAG-TIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWA 461
             A   + +MAPE       T ++DV+SFG++  EI S     S  P ++ D        
Sbjct: 204 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPGVKID-------- 253
Query: 462 CHLQQDGKLVELVDERL--GSKYKKEE--AERMIKVSLLCTNASPSLRPTMSEV 511
                     E    RL  G++ +  +     M +  L C +  PS RPT SE+
Sbjct: 254 ----------EEFXRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL 297

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 107/217 (49%), Gaps = 19/217 (8%)
Query: 246 KKIGEGGFGPVY---KGQLADGT--IIAVKQLSSKSRQGNRE-FLNEIAMISCLQHPNLV 299
           + +GEG FG V         DGT  ++AVK L +     +R  +  EI ++  L H +++
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHII 79
Query: 300 KIHGCCVEGDQ--LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH 357
           K  GCC +  +  L LV EY+   SL   L  R +  L       Q+IC     G+A+LH
Sbjct: 80  KYKGCCEDQGEKSLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQIC----EGMAYLH 134
Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG--TIGYMAPEY 415
            +     +HR++ A NVLLD D   KI DFGLAK       +   R  G   + + APE 
Sbjct: 135 AQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 191
Query: 416 ALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEF 452
                  Y +DV+SFG+   E+++  ++ S +P  +F
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELLTHCDS-SQSPPTKF 227

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 105/204 (51%), Gaps = 20/204 (9%)
Query: 246 KKIGEGGFGPVYKG-QLADGTII----AVKQLSSKS-RQGNREFLNEIAMISCLQHPNLV 299
           K +G G FG V+KG  + +G  I     +K +  KS RQ  +   + +  I  L H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACALF---GRENCELELDWPTRQKICLGIARGLAFL 356
           ++ G C  G  L LV +Y+   SL   +    G    +L L+W  +      IA+G+ +L
Sbjct: 79  RLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IAKGMYYL 131
Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPEY 415
            E     +VHR++ A NVLL      +++DFG+A  L   DK  + +     I +MA E 
Sbjct: 132 EEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 188
Query: 416 ALWGYLTYKADVYSFGIVALEIVS 439
             +G  T+++DV+S+G+   E+++
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 15/209 (7%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSK--SRQGNREFLN-EIAMIS 291
           K +  +F   + +G G FG V+  +   +G   A+K L  +   R    E  N E  M+S
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 292 CLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIAR 351
            + HP ++++ G   +  Q+ ++ +Y+E   L   L   +     +      ++CL    
Sbjct: 62  IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA--- 118
Query: 352 GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYM 411
            L +LH +    I++RD+K  N+LLD++ + KI+DFG AK        ++  + GT  Y+
Sbjct: 119 -LEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKY----VPDVTYXLCGTPDYI 170
Query: 412 APEYALWGYLTYKADVYSFGIVALEIVSG 440
           APE           D +SFGI+  E+++G
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 105/204 (51%), Gaps = 20/204 (9%)
Query: 246 KKIGEGGFGPVYKG-QLADGTII----AVKQLSSKS-RQGNREFLNEIAMISCLQHPNLV 299
           K +G G FG V+KG  + +G  I     +K +  KS RQ  +   + +  I  L H ++V
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACALF---GRENCELELDWPTRQKICLGIARGLAFL 356
           ++ G C  G  L LV +Y+   SL   +    G    +L L+W  +      IA+G+ +L
Sbjct: 97  RLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IAKGMYYL 149
Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPEY 415
            E     +VHR++ A NVLL      +++DFG+A  L   DK  + +     I +MA E 
Sbjct: 150 EEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 206
Query: 416 ALWGYLTYKADVYSFGIVALEIVS 439
             +G  T+++DV+S+G+   E+++
Sbjct: 207 IHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 132/288 (45%), Gaps = 41/288 (14%)
Query: 246 KKIGEGGFGPVYKG------QLADGTIIAVKQLSSKSRQG-NREFLNEIA-MISCLQHPN 297
           K +G G FG V +       + A    +AVK L   +    +R  ++E+  +I    H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 298 LVKIHGCCVE-GDQLLLVYEYMENNSLACALFGRENC---------ELELDWPTRQK-IC 346
           +V + G C + G  L+++ E+ +  +L+  L  + N          +L  D+ T +  IC
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 347 --LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI 404
               +A+G+ FL   SR K +HRD+ A N+LL      KI DFGLA+    D   +    
Sbjct: 153 YSFQVAKGMEFL--ASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 405 AG-TIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACH 463
           A   + +MAPE       T ++DV+SFG++  EI S     S  P ++ D     +  C 
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPGVKID-----EEFCR 262
Query: 464 LQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
             ++G  +   D      Y   E   M +  L C +  PS RPT SE+
Sbjct: 263 RLKEGTRMRAPD------YTTPE---MYQTMLDCWHGEPSQRPTFSEL 301

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 11/199 (5%)
Query: 245 AKKIGEGGFGPVYKGQL-ADGTIIAVKQL-SSKSRQGNREFLNEIAMISCLQHPNLVKIH 302
            ++IG G FG V+ G+L AD T++AVK    +       +FL E  ++    HPN+V++ 
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRF 362
           G C +   + +V E ++           E   L +   T  ++    A G+ +L  +   
Sbjct: 179 GVCTQKQPIYIVMELVQGGDF-LTFLRTEGARLRVK--TLLQMVGDAAAGMEYLESKC-- 233
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIST--RIAGTIGYMAPEYALWGY 420
             +HRD+ A N L+      KISDFG+++ +E D  + ++       + + APE   +G 
Sbjct: 234 -CIHRDLAARNCLVTEKNVLKISDFGMSR-EEADGVYAASGGLRQVPVKWTAPEALNYGR 291
Query: 421 LTYKADVYSFGIVALEIVS 439
            + ++DV+SFGI+  E  S
Sbjct: 292 YSSESDVWSFGILLWETFS 310

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 99/215 (46%), Gaps = 35/215 (16%)
Query: 241 NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVK-----QLSSKSRQGNREFLNEIAMISCLQ 294
           N+   K IG+G F  V   + +  G  +AV+     QL+S S Q   +   E+ ++  L 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQ---KLFREVRIMKVLN 71
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENC-ELELDWPTRQKICLGIARGL 353
           HPN+VK+         L LV EY     +   L       E E     RQ     I   +
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ-----IVSAV 126
Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-------KLDEGDKTHISTRIAG 406
            + H++    IVHRD+KA N+LLD D+N KI+DFG +       KLDE           G
Sbjct: 127 QYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDE---------FCG 174
Query: 407 TIGYMAPE-YALWGYLTYKADVYSFGIVALEIVSG 440
           +  Y APE +    Y   + DV+S G++   +VSG
Sbjct: 175 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 106/205 (51%), Gaps = 18/205 (8%)
Query: 246 KKIGEGGFGPV----YKGQLAD-GTIIAVKQLSSKSRQGNR--EFLNEIAMISCLQHPNL 298
           + +GEG FG V    Y  +  + G  +AVK L  +S  GN   +   EI ++  L H N+
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENI 85
Query: 299 VKIHGCCVE--GDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFL 356
           VK  G C E  G+ + L+ E++ + SL   L   +N   +++   + K  + I +G+ +L
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN---KINLKQQLKYAVQICKGMDYL 142
Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR--IAGTIGYMAPE 414
              SR + VHRD+ A NVL++ +   KI DFGL K  E DK   + +      + + APE
Sbjct: 143 G--SR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPE 199
Query: 415 YALWGYLTYKADVYSFGIVALEIVS 439
             +       +DV+SFG+   E+++
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 132/288 (45%), Gaps = 41/288 (14%)
Query: 246 KKIGEGGFGPVYKG------QLADGTIIAVKQLSSKSRQG-NREFLNEIA-MISCLQHPN 297
           K +G G FG V +       + A    +AVK L   +    +R  ++E+  +I    H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 298 LVKIHGCCVE-GDQLLLVYEYMENNSLACALFGRENC---------ELELDWPTRQK-IC 346
           +V + G C + G  L+++ E+ +  +L+  L  + N          +L  D+ T +  IC
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 347 --LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI 404
               +A+G+ FL   SR K +HRD+ A N+LL      KI DFGLA+    D   +    
Sbjct: 153 YSFQVAKGMEFL--ASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGD 209
Query: 405 AG-TIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACH 463
           A   + +MAPE       T ++DV+SFG++  EI S     S  P ++ D     +  C 
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPGVKID-----EEFCR 262
Query: 464 LQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
             ++G  +   D      Y   E   M +  L C +  PS RPT SE+
Sbjct: 263 RLKEGTRMRAPD------YTTPE---MYQTMLDCWHGEPSQRPTFSEL 301

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 241 NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVK-----QLSSKSRQGNREFLNEIAMISCLQ 294
           N+   K IG+G F  V   + +  G  +AVK     QL+S S Q   +   E+ ++  L 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQ---KLFREVRIMKVLN 71
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENC-ELELDWPTRQKICLGIARGL 353
           HPN+VK+         L LV EY     +   L       E E     RQ     I   +
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ-----IVSAV 126
Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHISTRIAGTIGYMA 412
            + H++    IVHRD+KA N+LLD D+N KI+DFG + +   G+K        G+  Y A
Sbjct: 127 QYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAA 180
Query: 413 PE-YALWGYLTYKADVYSFGIVALEIVSG 440
           PE +    Y   + DV+S G++   +VSG
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 104/217 (47%), Gaps = 26/217 (11%)
Query: 246 KKIGEGGFGPVY--------KGQLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCL-QH 295
           K +GEG FG V         K +  +   +AVK L   + + +  + ++E+ M+  + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDW-----PTRQ------- 343
            N++ + G C +   L ++  Y    +L   L  R    +E  +     P  Q       
Sbjct: 101 KNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 344 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHIST 402
                +ARG+ +L  +   K +HRD+ A NVL+  +   KI+DFGLA+ ++  D    +T
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 403 RIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
                + +MAPE       T+++DV+SFG++  EI +
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 110/222 (49%), Gaps = 32/222 (14%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSKSRQGNREFLNEIAMISCL 293
           N+      IGEG FG V K ++       D  I  +K+ +SK    +R+F  E+ ++  L
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD--DHRDFAGELEVLCKL 82
Query: 294 -QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELD------------WP 340
             HPN++ + G C     L L  EY  + +L    F R++  LE D              
Sbjct: 83  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD--FLRKSRVLETDPAFAIANSTASTLS 140
Query: 341 TRQKICLG--IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT 398
           ++Q +     +ARG+ +L   S+ + +HRD+ A N+L+  +   KI+DFGL++   G + 
Sbjct: 141 SQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEV 194
Query: 399 HISTRIAG-TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
           ++   +    + +MA E   +   T  +DV+S+G++  EIVS
Sbjct: 195 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 18/205 (8%)
Query: 246 KKIGEGGFGPV----YKGQLAD-GTIIAVKQLSSKSRQGNR--EFLNEIAMISCLQHPNL 298
           + +GEG FG V    Y  +  + G  +AVK L  +S  GN   +   EI ++  L H N+
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENI 73
Query: 299 VKIHGCCVE--GDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFL 356
           VK  G C E  G+ + L+ E++ + SL   L   +N   +++   + K  + I +G+ +L
Sbjct: 74  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN---KINLKQQLKYAVQICKGMDYL 130
Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR--IAGTIGYMAPE 414
                 + VHRD+ A NVL++ +   KI DFGL K  E DK   + +      + + APE
Sbjct: 131 GSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPE 187
Query: 415 YALWGYLTYKADVYSFGIVALEIVS 439
             +       +DV+SFG+   E+++
Sbjct: 188 CLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 241 NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVK-----QLSSKSRQGNREFLNEIAMISCLQ 294
           N+   K IG+G F  V   + +  G  +AVK     QL+S S Q   +   E+ ++  L 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQ---KLFREVRIMKVLN 71
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENC-ELELDWPTRQKICLGIARGL 353
           HPN+VK+         L LV EY     +   L       E E     RQ     I   +
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ-----IVSAV 126
Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHISTRIAGTIGYMA 412
            + H++    IVHRD+KA N+LLD D+N KI+DFG + +   G+K        G+  Y A
Sbjct: 127 QYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAA 180
Query: 413 PE-YALWGYLTYKADVYSFGIVALEIVSG 440
           PE +    Y   + DV+S G++   +VSG
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 108/212 (50%), Gaps = 16/212 (7%)
Query: 236 KAATNNFDSAKKIGEGGFGPVY---KGQLAD-GTIIAVKQLSS---KSRQGNREFLNEIA 288
           KA  ++F+  K +G+G FG V+   K    D G + A+K L     K R   R  + E  
Sbjct: 24  KADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKM-ERD 82
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLG 348
           +++ + HP +VK+H       +L L+ +++    L    F R + E+       +     
Sbjct: 83  ILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAE 138
Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTI 408
           +A GL  LH      I++RD+K  N+LLD + + K++DFGL+K +  D    +    GT+
Sbjct: 139 LALGLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK-EAIDHEKKAYSFCGTV 194
Query: 409 GYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            YMAPE       ++ AD +S+G++  E+++G
Sbjct: 195 EYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 110/222 (49%), Gaps = 32/222 (14%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSKSRQGNREFLNEIAMISCL 293
           N+      IGEG FG V K ++       D  I  +K+ +SK    +R+F  E+ ++  L
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD--DHRDFAGELEVLCKL 72
Query: 294 -QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELD------------WP 340
             HPN++ + G C     L L  EY  + +L    F R++  LE D              
Sbjct: 73  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD--FLRKSRVLETDPAFAIANSTASTLS 130
Query: 341 TRQKICLG--IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT 398
           ++Q +     +ARG+ +L   S+ + +HRD+ A N+L+  +   KI+DFGL++   G + 
Sbjct: 131 SQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEV 184
Query: 399 HISTRIAG-TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
           ++   +    + +MA E   +   T  +DV+S+G++  EIVS
Sbjct: 185 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 123/270 (45%), Gaps = 35/270 (12%)
Query: 248 IGEGGFGPVYKGQLADGTIIAVKQLSSKS---RQGNREFLN-EIAMISCLQHPNLVKIHG 303
           +G+GGF   ++   AD   +   ++  KS   +   RE ++ EI++   L H ++V  HG
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENC--ELELDWPTRQKICLGIARGLAFLHEESR 361
              + D + +V E     SL   L  R     E E  +  RQ     I  G  +LH   R
Sbjct: 83  FFEDNDFVFVVLELCRRRSLL-ELHKRRKALTEPEARYYLRQ-----IVLGCQYLH---R 133
Query: 362 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYL 421
            +++HRD+K  N+ L+ DL  KI DFGLA   E D       + GT  Y+APE       
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGH 192
Query: 422 TYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSK 481
           +++ DV+S G +   ++ GK          F+ +CL +    +++        +E    K
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKP--------PFETSCLKETYLRIKK--------NEYSIPK 236
Query: 482 YKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           +    A  +I+  L      P+ RPT++E+
Sbjct: 237 HINPVAASLIQKML---QTDPTARPTINEL 263

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 19/217 (8%)
Query: 234 QIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMIS- 291
           QIK    +F+  K +G+G FG V+  +        A+K L       + +   E  M+  
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDV--ECTMVEK 69
Query: 292 -----CLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC 346
                  +HP L  +       + L  V EY+    L   ++  ++C  + D        
Sbjct: 70  RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCH-KFDLSRATFYA 125
Query: 347 LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE-GDKTHISTRIA 405
             I  GL FLH +    IV+RD+K  N+LLD+D + KI+DFG+ K +  GD    +    
Sbjct: 126 AEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNEFC 180
Query: 406 GTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKN 442
           GT  Y+APE  L     +  D +SFG++  E++ G++
Sbjct: 181 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 217

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 16/212 (7%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLADGT-------IIAVKQLSSKSRQGNREFLNEIA 288
           KA  + F+  K +G+G FG V+  +   G+       +  +K+ + K R   R  +    
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLG 348
           ++    HP +VK+H       +L L+ +++    L    F R + E+       +     
Sbjct: 80  LVEV-NHPFIVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAE 134
Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTI 408
           +A  L  LH      I++RD+K  N+LLD + + K++DFGL+K +  D    +    GT+
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTV 190
Query: 409 GYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            YMAPE       T  AD +SFG++  E+++G
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 123/270 (45%), Gaps = 35/270 (12%)
Query: 248 IGEGGFGPVYKGQLADGTIIAVKQLSSKS---RQGNREFLN-EIAMISCLQHPNLVKIHG 303
           +G+GGF   ++   AD   +   ++  KS   +   RE ++ EI++   L H ++V  HG
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENC--ELELDWPTRQKICLGIARGLAFLHEESR 361
              + D + +V E     SL   L  R     E E  +  RQ     I  G  +LH   R
Sbjct: 107 FFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEARYYLRQ-----IVLGCQYLH---R 157
Query: 362 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYL 421
            +++HRD+K  N+ L+ DL  KI DFGLA   E D       + GT  Y+APE       
Sbjct: 158 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGH 216
Query: 422 TYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSK 481
           +++ DV+S G +   ++ GK          F+ +CL +    +++        +E    K
Sbjct: 217 SFEVDVWSIGCIMYTLLVGKP--------PFETSCLKETYLRIKK--------NEYSIPK 260
Query: 482 YKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           +    A  +I+  L      P+ RPT++E+
Sbjct: 261 HINPVAASLIQKML---QTDPTARPTINEL 287

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 16/212 (7%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLADGT-------IIAVKQLSSKSRQGNREFLNEIA 288
           KA  + F+  K +G+G FG V+  +   G+       +  +K+ + K R   R  +    
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLG 348
           ++    HP +VK+H       +L L+ +++    L    F R + E+       +     
Sbjct: 80  LVEV-NHPFIVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAE 134
Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTI 408
           +A  L  LH      I++RD+K  N+LLD + + K++DFGL+K +  D    +    GT+
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTV 190
Query: 409 GYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            YMAPE       T  AD +SFG++  E+++G
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 125/278 (44%), Gaps = 42/278 (15%)
Query: 244 SAKKIGEGGFGPVYKGQLADGTI----IAVKQLSSKSRQGNRE-FLNEIAMISCLQHPNL 298
           S + IG+G FG VY G+  D        A+K LS  +     E FL E  ++  L HPN+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 299 VKIHGCCVEGDQLL-LVYEYMENNSLACALFGRENCELELDWPTRQKIC---LGIARGLA 354
           + + G  +  + L  ++  YM +  L   +   +        PT + +    L +ARG+ 
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN------PTVKDLISFGLQVARGME 138
Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDE---GDKTHISTRIAGTIG 409
           +L E+   K VHRD+ A N +LD     K++DFGLA+  LD      + H   R+   + 
Sbjct: 139 YLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP--VK 193
Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGK 469
           + A E       T K+DV+SFG++  E+++ +    Y     FD T  L     L Q   
Sbjct: 194 WTALESLQTYRFTTKSDVWSFGVLLWELLT-RGAPPYRHIDPFDLTHFLAQGRRLPQ--- 249
Query: 470 LVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPT 507
                      +Y  +    + +V   C  A P++RPT
Sbjct: 250 ----------PEYCPDS---LYQVMQQCWEADPAVRPT 274

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 123/270 (45%), Gaps = 35/270 (12%)
Query: 248 IGEGGFGPVYKGQLADGTIIAVKQLSSKS---RQGNREFLN-EIAMISCLQHPNLVKIHG 303
           +G+GGF   ++   AD   +   ++  KS   +   RE ++ EI++   L H ++V  HG
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENC--ELELDWPTRQKICLGIARGLAFLHEESR 361
              + D + +V E     SL   L  R     E E  +  RQ     I  G  +LH   R
Sbjct: 109 FFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEARYYLRQ-----IVLGCQYLH---R 159
Query: 362 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYL 421
            +++HRD+K  N+ L+ DL  KI DFGLA   E D       + GT  Y+APE       
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGH 218
Query: 422 TYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSK 481
           +++ DV+S G +   ++ GK          F+ +CL +    +++        +E    K
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKP--------PFETSCLKETYLRIKK--------NEYSIPK 262
Query: 482 YKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           +    A  +I+  L      P+ RPT++E+
Sbjct: 263 HINPVAASLIQKML---QTDPTARPTINEL 289

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 16/212 (7%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLADGT-------IIAVKQLSSKSRQGNREFLNEIA 288
           KA  + F+  K +G+G FG V+  +   G+       +  +K+ + K R   R  +    
Sbjct: 21  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 80
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLG 348
           ++    HP +VK+H       +L L+ +++    L    F R + E+       +     
Sbjct: 81  LVEV-NHPFIVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAE 135
Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTI 408
           +A  L  LH      I++RD+K  N+LLD + + K++DFGL+K +  D    +    GT+
Sbjct: 136 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTV 191
Query: 409 GYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            YMAPE       T  AD +SFG++  E+++G
Sbjct: 192 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 104/218 (47%), Gaps = 26/218 (11%)
Query: 245 AKKIGEGGFGPVY--------KGQLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCL-Q 294
            K +GEG FG V         K +  +   +AVK L   + + +  + ++E+ M+  + +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDW-----PTRQ------ 343
           H N++ + G C +   L ++  Y    +L   L  R    +E  +     P  Q      
Sbjct: 100 HKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 344 -KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHIS 401
                 +ARG+ +L  +   K +HRD+ A NVL+  +   KI+DFGLA+ ++  D    +
Sbjct: 160 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 402 TRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
           T     + +MAPE       T+++DV+SFG++  EI +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 11/199 (5%)
Query: 245 AKKIGEGGFGPVYKGQL-ADGTIIAVKQL-SSKSRQGNREFLNEIAMISCLQHPNLVKIH 302
            ++IG G FG V+ G+L AD T++AVK    +       +FL E  ++    HPN+V++ 
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRF 362
           G C +   + +V E ++           E   L +   T  ++    A G+ +L  +   
Sbjct: 179 GVCTQKQPIYIVMELVQGGDF-LTFLRTEGARLRVK--TLLQMVGDAAAGMEYLESKC-- 233
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIST--RIAGTIGYMAPEYALWGY 420
             +HRD+ A N L+      KISDFG+++ +E D    ++       + + APE   +G 
Sbjct: 234 -CIHRDLAARNCLVTEKNVLKISDFGMSR-EEADGVXAASGGLRQVPVKWTAPEALNYGR 291
Query: 421 LTYKADVYSFGIVALEIVS 439
            + ++DV+SFGI+  E  S
Sbjct: 292 YSSESDVWSFGILLWETFS 310

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 126/297 (42%), Gaps = 46/297 (15%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQLADGTI-------IAVKQLSSKSRQGNRE-FLNEIAMIS 291
           N     K +G G FG V +   A G I       +AVK L   +    RE  ++E+ ++S
Sbjct: 46  NRLSFGKTLGAGAFGKVVEAT-AYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLS 104
Query: 292 CL-QHPNLVKIHGCCVEGDQLLLVYEYM-----------ENNSLACALFG---RENCELE 336
            L  H N+V + G C  G   L++ EY            + +S  C+       E+ EL 
Sbjct: 105 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 164
Query: 337 LDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD 396
           LD          +A+G+AFL  ++    +HRD+ A N+LL      KI DFGLA+  + D
Sbjct: 165 LDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARHIKND 221
Query: 397 KTHISTRIAG-TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDC 454
             ++    A   + +MAPE       T+++DV+S+GI   E+ S G +     P      
Sbjct: 222 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV----- 276
Query: 455 TCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                       D K  +++ E       +     M  +   C +A P  RPT  ++
Sbjct: 277 ------------DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 321

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 241 NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVK-----QLSSKSRQGNREFLNEIAMISCLQ 294
           N+   K IG+G F  V   + +  G  +AV+     QL+S S Q   +   E+ ++  L 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQ---KLFREVRIMKVLN 71
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENC-ELELDWPTRQKICLGIARGL 353
           HPN+VK+         L LV EY     +   L       E E     RQ     I   +
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ-----IVSAV 126
Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHISTRIAGTIGYMA 412
            + H++    IVHRD+KA N+LLD D+N KI+DFG + +   G+K        G+  Y A
Sbjct: 127 QYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAA 180
Query: 413 PE-YALWGYLTYKADVYSFGIVALEIVSG 440
           PE +    Y   + DV+S G++   +VSG
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 241 NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVK-----QLSSKSRQGNREFLNEIAMISCLQ 294
           N+   K IG+G F  V   + +  G  +AVK     QL+S S Q   +   E+ ++  L 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQ---KLFREVRIMKVLN 71
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENC-ELELDWPTRQKICLGIARGL 353
           HPN+VK+         L LV EY     +   L       E E     RQ     I   +
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ-----IVSAV 126
Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHISTRIAGTIGYMA 412
            + H++    IVHRD+KA N+LLD D+N KI+DFG + +   G+K        G   Y A
Sbjct: 127 QYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDA---FCGAPPYAA 180
Query: 413 PE-YALWGYLTYKADVYSFGIVALEIVSG 440
           PE +    Y   + DV+S G++   +VSG
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 239 TNNFDSAKKIGEGGFGPVY------KGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISC 292
           ++ +   + +G+G FG V        GQ     +I+ +Q+  K+ +     L E+ ++  
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDK--ESLLREVQLLKQ 82
Query: 293 LQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARG 352
           L HPN++K++    +     LV E      L   +  R+    E+D     +I   +  G
Sbjct: 83  LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFS-EVDAA---RIIRQVLSG 138
Query: 353 LAFLHEESRFKIVHRDIKATNVLLD---RDLNPKISDFGLAKLDEGDKTHISTRIAGTIG 409
           + ++H+    KIVHRD+K  N+LL+   +D N +I DFGL+   E  K  +  +I GT  
Sbjct: 139 ITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK-KMKDKI-GTAY 193
Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           Y+APE  L G    K DV+S G++   ++SG
Sbjct: 194 YIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 126/297 (42%), Gaps = 46/297 (15%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQLADGTI-------IAVKQLSSKSRQGNRE-FLNEIAMIS 291
           N     K +G G FG V +   A G I       +AVK L   +    RE  ++E+ ++S
Sbjct: 23  NRLSFGKTLGAGAFGKVVEAT-AYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLS 81
Query: 292 CL-QHPNLVKIHGCCVEGDQLLLVYEYM-----------ENNSLACALFG---RENCELE 336
            L  H N+V + G C  G   L++ EY            + +S  C+       E+ EL 
Sbjct: 82  YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 337 LDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD 396
           LD          +A+G+AFL  ++    +HRD+ A N+LL      KI DFGLA+  + D
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKND 198
Query: 397 KTHISTRIAG-TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDC 454
             ++    A   + +MAPE       T+++DV+S+GI   E+ S G +     P      
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV----- 253
Query: 455 TCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                       D K  +++ E       +     M  +   C +A P  RPT  ++
Sbjct: 254 ------------DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 8/212 (3%)
Query: 235 IKAATNNFDSAKKIGEGGFGPVYK-GQLADGTIIAVKQLS--SKSRQGNREFLNEIAMIS 291
           + +   +++    IG G +G   K  + +DG I+  K+L   S +    +  ++E+ ++ 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 292 CLQHPNLVKIHGCCVE--GDQLLLVYEYMENNSLACALFG--RENCELELDWPTRQKICL 347
            L+HPN+V+ +   ++     L +V EY E   LA  +    +E   L+ ++  R    L
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            +A        +    ++HRD+K  NV LD   N K+ DFGLA++   D T  +    GT
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKTFVGT 179
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
             YM+PE         K+D++S G +  E+ +
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 239 TNNFDSAKKIGEGGFGPVY------KGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISC 292
           ++ +   + +G+G FG V        GQ     +I+ +Q+  K+ +     L E+ ++  
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDK--ESLLREVQLLKQ 105
Query: 293 LQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARG 352
           L HPN++K++    +     LV E      L   +  R+    E+D     +I   +  G
Sbjct: 106 LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFS-EVDAA---RIIRQVLSG 161
Query: 353 LAFLHEESRFKIVHRDIKATNVLLD---RDLNPKISDFGLAKLDEGDKTHISTRIAGTIG 409
           + ++H+    KIVHRD+K  N+LL+   +D N +I DFGL+   E  K  +  +I GT  
Sbjct: 162 ITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MKDKI-GTAY 216
Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           Y+APE  L G    K DV+S G++   ++SG
Sbjct: 217 YIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 126/297 (42%), Gaps = 46/297 (15%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQLADGTI-------IAVKQLSSKSRQGNRE-FLNEIAMIS 291
           N     K +G G FG V +   A G I       +AVK L   +    RE  ++E+ ++S
Sbjct: 41  NRLSFGKTLGAGAFGKVVEAT-AYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLS 99
Query: 292 CL-QHPNLVKIHGCCVEGDQLLLVYEYM-----------ENNSLACALFG---RENCELE 336
            L  H N+V + G C  G   L++ EY            + +S  C+       E+ EL 
Sbjct: 100 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 159
Query: 337 LDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD 396
           LD          +A+G+AFL  ++    +HRD+ A N+LL      KI DFGLA+  + D
Sbjct: 160 LDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKND 216
Query: 397 KTHISTRIAG-TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDC 454
             ++    A   + +MAPE       T+++DV+S+GI   E+ S G +     P      
Sbjct: 217 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV----- 271
Query: 455 TCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                       D K  +++ E       +     M  +   C +A P  RPT  ++
Sbjct: 272 ------------DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 316

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 239 TNNFDSAKKIGEGGFGPVY------KGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISC 292
           ++ +   + +G+G FG V        GQ     +I+ +Q+  K+ +     L E+ ++  
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDK--ESLLREVQLLKQ 106
Query: 293 LQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARG 352
           L HPN++K++    +     LV E      L   +  R+    E+D     +I   +  G
Sbjct: 107 LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFS-EVDAA---RIIRQVLSG 162
Query: 353 LAFLHEESRFKIVHRDIKATNVLLD---RDLNPKISDFGLAKLDEGDKTHISTRIAGTIG 409
           + ++H+    KIVHRD+K  N+LL+   +D N +I DFGL+   E  K  +  +I GT  
Sbjct: 163 ITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MKDKI-GTAY 217
Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           Y+APE  L G    K DV+S G++   ++SG
Sbjct: 218 YIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 126/297 (42%), Gaps = 46/297 (15%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQLADGTI-------IAVKQLSSKSRQGNRE-FLNEIAMIS 291
           N     K +G G FG V +   A G I       +AVK L   +    RE  ++E+ ++S
Sbjct: 46  NRLSFGKTLGAGAFGKVVEAT-AYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLS 104
Query: 292 CL-QHPNLVKIHGCCVEGDQLLLVYEYM-----------ENNSLACALFG---RENCELE 336
            L  H N+V + G C  G   L++ EY            + +S  C+       E+ EL 
Sbjct: 105 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 164
Query: 337 LDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD 396
           LD          +A+G+AFL  ++    +HRD+ A N+LL      KI DFGLA+  + D
Sbjct: 165 LDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKND 221
Query: 397 KTHISTRIAG-TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDC 454
             ++    A   + +MAPE       T+++DV+S+GI   E+ S G +     P      
Sbjct: 222 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV----- 276
Query: 455 TCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                       D K  +++ E       +     M  +   C +A P  RPT  ++
Sbjct: 277 ------------DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 321

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 104/211 (49%), Gaps = 21/211 (9%)
Query: 239 TNNFDSAKKIGEGGFGPVY------KGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISC 292
           ++ +   + +G+G FG V        GQ     +I+ +Q+  K+       L E+ ++  
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKT--DKESLLREVQLLKQ 88
Query: 293 LQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARG 352
           L HPN++K++    +     LV E      L   +  R+    E+D     +I   +  G
Sbjct: 89  LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFS-EVD---AARIIRQVLSG 144
Query: 353 LAFLHEESRFKIVHRDIKATNVLLD---RDLNPKISDFGLAKLDEGDKTHISTRIAGTIG 409
           + ++H+    KIVHRD+K  N+LL+   +D N +I DFGL+   E  K  +  +I GT  
Sbjct: 145 ITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MKDKI-GTAY 199
Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           Y+APE  L G    K DV+S G++   ++SG
Sbjct: 200 YIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 98/209 (46%), Gaps = 13/209 (6%)
Query: 237 AATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKS---RQGNREFLNEI-AMIS 291
           A  ++F   K IG+G FG V   +  A+    AVK L  K+   ++  +  ++E   ++ 
Sbjct: 35  AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK 94
Query: 292 CLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIAR 351
            ++HP LV +H      D+L  V +Y+    L   L  RE C LE   P  +     IA 
Sbjct: 95  NVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHL-QRERCFLE---PRARFYAAEIAS 150
Query: 352 GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYM 411
            L +LH      IV+RD+K  N+LLD   +  ++DFGL K +    +  ST   GT  Y+
Sbjct: 151 ALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-FCGTPEYL 206
Query: 412 APEYALWGYLTYKADVYSFGIVALEIVSG 440
           APE           D +  G V  E++ G
Sbjct: 207 APEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 8/212 (3%)
Query: 235 IKAATNNFDSAKKIGEGGFGPVYK-GQLADGTIIAVKQLS--SKSRQGNREFLNEIAMIS 291
           + +   +++    IG G +G   K  + +DG I+  K+L   S +    +  ++E+ ++ 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 292 CLQHPNLVKIHGCCVE--GDQLLLVYEYMENNSLACALFG--RENCELELDWPTRQKICL 347
            L+HPN+V+ +   ++     L +V EY E   LA  +    +E   L+ ++  R    L
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            +A        +    ++HRD+K  NV LD   N K+ DFGLA++   D T  +    GT
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGT 179
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
             YM+PE         K+D++S G +  E+ +
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 126/297 (42%), Gaps = 46/297 (15%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQLADGTI-------IAVKQLSSKSRQGNRE-FLNEIAMIS 291
           N     K +G G FG V +   A G I       +AVK L   +    RE  ++E+ ++S
Sbjct: 39  NRLSFGKTLGAGAFGKVVEAT-AYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLS 97
Query: 292 CL-QHPNLVKIHGCCVEGDQLLLVYEYM-----------ENNSLACALFG---RENCELE 336
            L  H N+V + G C  G   L++ EY            + +S  C+       E+ EL 
Sbjct: 98  YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 157
Query: 337 LDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD 396
           LD          +A+G+AFL  ++    +HRD+ A N+LL      KI DFGLA+  + D
Sbjct: 158 LDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKND 214
Query: 397 KTHISTRIAG-TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDC 454
             ++    A   + +MAPE       T+++DV+S+GI   E+ S G +     P      
Sbjct: 215 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV----- 269
Query: 455 TCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                       D K  +++ E       +     M  +   C +A P  RPT  ++
Sbjct: 270 ------------DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 314

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 241 NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVK-----QLSSKSRQGNREFLNEIAMISCLQ 294
           N+   K IG+G F  V   + +  G  +AVK     QL+S S Q   +   E+ ++  L 
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQ---KLFREVRIMKVLN 64
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRE-NCELELDWPTRQKICLGIARGL 353
           HPN+VK+         L LV EY     +   L       E E     RQ     I   +
Sbjct: 65  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQ-----IVSAV 119
Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHISTRIAGTIGYMA 412
            + H++    IVHRD+KA N+LLD D+N KI+DFG + +   G+K        G+  Y A
Sbjct: 120 QYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAA 173
Query: 413 PE-YALWGYLTYKADVYSFGIVALEIVSG 440
           PE +    Y   + DV+S G++   +VSG
Sbjct: 174 PELFQGKKYDGPEVDVWSLGVILYTLVSG 202

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 248 IGEGGFGPV-----YKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIH 302
           +GEG FG V     YK Q         +QL  KS    R    EI+ +  L+HP+++K++
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMR-VEREISYLKLLRHPHIIKLY 75
Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRF 362
                   +++V EY         +  +   E E     +Q IC      + + H   R 
Sbjct: 76  DVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIIC-----AIEYCH---RH 127
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWG--Y 420
           KIVHRD+K  N+LLD +LN KI+DFGL+ +   D   + T   G+  Y APE  + G  Y
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNI-MTDGNFLKTS-CGSPNYAAPE-VINGKLY 184
Query: 421 LTYKADVYSFGIVALEIVSGK 441
              + DV+S GIV   ++ G+
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGR 205

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/234 (30%), Positives = 110/234 (47%), Gaps = 40/234 (17%)
Query: 225 LQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQG-NREF 283
            Q++   L ++KA             G FG V+K QL +   +AVK    + +Q    E+
Sbjct: 21  FQSMPLQLLEVKA------------RGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEY 67
Query: 284 LNEIAMISCLQHPNLVKIHGCCVEGDQ----LLLVYEYMENNSLACALFGRENCELELDW 339
             E+  +  ++H N+++  G    G      L L+  + E  SL+   F + N    + W
Sbjct: 68  --EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSD--FLKANV---VSW 120
Query: 340 PTRQKICLGIARGLAFLHEE-------SRFKIVHRDIKATNVLLDRDLNPKISDFGLA-K 391
                I   +ARGLA+LHE+        +  I HRDIK+ NVLL  +L   I+DFGLA K
Sbjct: 121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180
Query: 392 LDEGDKTHISTRIAGTIGYMAPEYALWGYLTY------KADVYSFGIVALEIVS 439
            + G     +    GT  YMAPE  L G + +      + D+Y+ G+V  E+ S
Sbjct: 181 FEAGKSAGDTHGQVGTRRYMAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 32/214 (14%)
Query: 248 IGEGGFGPVYKGQLA------DGTIIAVKQLSSKSRQGNREFLNEIAMISCL-QHPNLVK 300
           IGEG FG V K ++       D  I  +K+ +SK    +R+F  E+ ++  L  HPN++ 
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD--DHRDFAGELEVLCKLGHHPNIIN 87
Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELD------------WPTRQKICLG 348
           + G C     L L  EY  + +L    F R++  LE D              ++Q +   
Sbjct: 88  LLGACEHRGYLYLAIEYAPHGNLLD--FLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 145
Query: 349 --IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG 406
             +ARG+ +L   S+ + +HR++ A N+L+  +   KI+DFGL++   G + ++   +  
Sbjct: 146 ADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGR 199
Query: 407 -TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
             + +MA E   +   T  +DV+S+G++  EIVS
Sbjct: 200 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 19/217 (8%)
Query: 234 QIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMIS- 291
           QIK    +F   K +G+G FG V+  +        A+K L       + +   E  M+  
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDV--ECTMVEK 68
Query: 292 -----CLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC 346
                  +HP L  +       + L  V EY+    L   ++  ++C  + D        
Sbjct: 69  RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCH-KFDLSRATFYA 124
Query: 347 LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE-GDKTHISTRIA 405
             I  GL FLH +    IV+RD+K  N+LLD+D + KI+DFG+ K +  GD    +    
Sbjct: 125 AEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNXFC 179
Query: 406 GTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKN 442
           GT  Y+APE  L     +  D +SFG++  E++ G++
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 216

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 247 KIGEGGFGPVYKG--QLADGTI-IAVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIH 302
           ++G G FG V +G  ++    I +A+K L   + + +  E + E  ++  L +P +V++ 
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRF 362
           G C + + L+LV E      L   L G+     E+      ++   ++ G+ +L E++  
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEEKN-- 130
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG--TIGYMAPEYALWGY 420
             VHRD+ A NVLL      KISDFGL+K    D ++ + R AG   + + APE   +  
Sbjct: 131 -FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 189
Query: 421 LTYKADVYSFGIVALEIVS 439
            + ++DV+S+G+   E +S
Sbjct: 190 FSSRSDVWSYGVTMWEALS 208

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 104/216 (48%), Gaps = 20/216 (9%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQLAD--GTIIAVKQLSSKSRQGNREF--LNEIAMISCL 293
           A   ++   +IGEG +G V+K +     G  +A+K++  ++ +       + E+A++  L
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 294 Q---HPNLVKIHGCCV-----EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKI 345
           +   HPN+V++   C         +L LV+E+++ +      +  +  E  +   T + +
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD---LTTYLDKVPEPGVPTETIKDM 125
Query: 346 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIA 405
              + RGL FLH     ++VHRD+K  N+L+      K++DFGLA++         T + 
Sbjct: 126 MFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVV 180
Query: 406 GTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
            T+ Y APE  L        D++S G +  E+   K
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 104/216 (48%), Gaps = 20/216 (9%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQLAD--GTIIAVKQLSSKSRQGNREF--LNEIAMISCL 293
           A   ++   +IGEG +G V+K +     G  +A+K++  ++ +       + E+A++  L
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 294 Q---HPNLVKIHGCCV-----EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKI 345
           +   HPN+V++   C         +L LV+E+++ +      +  +  E  +   T + +
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD---LTTYLDKVPEPGVPTETIKDM 125
Query: 346 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIA 405
              + RGL FLH     ++VHRD+K  N+L+      K++DFGLA++         T + 
Sbjct: 126 MFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVV 180
Query: 406 GTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
            T+ Y APE  L        D++S G +  E+   K
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 241 NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVK-----QLSSKSRQGNREFLNEIAMISCLQ 294
           N+   K IG+G F  V   + +  G  +AVK     QL+  S Q   +   E+ ++  L 
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQ---KLFREVRIMKILN 72
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENC-ELELDWPTRQKICLGIARGL 353
           HPN+VK+         L LV EY     +   L       E E     RQ     I   +
Sbjct: 73  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ-----IVSAV 127
Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHISTRIAGTIGYMA 412
            + H++    IVHRD+KA N+LLD D+N KI+DFG + +   G+K        G+  Y A
Sbjct: 128 QYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT---FCGSPPYAA 181
Query: 413 PE-YALWGYLTYKADVYSFGIVALEIVSG 440
           PE +    Y   + DV+S G++   +VSG
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 104/216 (48%), Gaps = 20/216 (9%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQLAD--GTIIAVKQLSSKSRQGNREF--LNEIAMISCL 293
           A   ++   +IGEG +G V+K +     G  +A+K++  ++ +       + E+A++  L
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 294 Q---HPNLVKIHGCCV-----EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKI 345
           +   HPN+V++   C         +L LV+E+++ +      +  +  E  +   T + +
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD---LTTYLDKVPEPGVPTETIKDM 125
Query: 346 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIA 405
              + RGL FLH     ++VHRD+K  N+L+      K++DFGLA++         T + 
Sbjct: 126 MFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVV 180
Query: 406 GTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
            T+ Y APE  L        D++S G +  E+   K
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 13/205 (6%)
Query: 242 FDSAKKIGEGGFGPVY-KGQLADGTIIAVKQLSSKSRQGNREFLN-EIAMISCLQHPNLV 299
           F   +K+G G FG V+   + + G    +K ++    Q   E +  EI ++  L HPN++
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
           KI     +   + +V E  E   L   +   +     L      ++   +   LA+ H +
Sbjct: 84  KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 360 SRFKIVHRDIKATNVLLDRDLNP----KISDFGLAKLDEGDKTHISTRIAGTIGYMAPEY 415
               +VH+D+K  N+L  +D +P    KI DFGLA+L + D+   ST  AGT  YMAPE 
Sbjct: 144 H---VVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEH--STNAAGTALYMAPE- 196
Query: 416 ALWGYLTYKADVYSFGIVALEIVSG 440
                +T+K D++S G+V   +++G
Sbjct: 197 VFKRDVTFKCDIWSAGVVMYFLLTG 221

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 241 NFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQL--SSKSRQGNREFLNEIAMISCLQHPN 297
            ++   KIGEG +G V+K +  D G I+A+K+   S       +  L EI M+  L+HPN
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSL-ACALFGR---ENCELELDWPTRQKICLGIARGL 353
           LV +        +L LV+EY ++  L     + R   E+    + W T Q +        
Sbjct: 64  LVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAV-------- 115
Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAP 413
            F H+ +    +HRD+K  N+L+ +    K+ DFG A+L  G   +    +A T  Y +P
Sbjct: 116 NFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSP 171
Query: 414 EYALWGYLTY--KADVYSFGIVALEIVSG 440
           E  L G   Y    DV++ G V  E++SG
Sbjct: 172 E-LLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 8/212 (3%)
Query: 235 IKAATNNFDSAKKIGEGGFGPVYK-GQLADGTIIAVKQLS--SKSRQGNREFLNEIAMIS 291
           + +   +++    IG G +G   K  + +DG I+  K+L   S +    +  ++E+ ++ 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 292 CLQHPNLVKIHGCCVE--GDQLLLVYEYMENNSLACALFG--RENCELELDWPTRQKICL 347
            L+HPN+V+ +   ++     L +V EY E   LA  +    +E   L+ ++  R    L
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            +A        +    ++HRD+K  NV LD   N K+ DFGLA++   D+   +    GT
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDED-FAKEFVGT 179
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
             YM+PE         K+D++S G +  E+ +
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 20/212 (9%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQL--SSKSRQGNREFLNEIAMISCLQ 294
           +   +++   +GEG +G V K +  D G I+A+K+   S   +   +  + EI ++  L+
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL---ELDWPTRQKICLGIAR 351
           H NLV +   C +  +  LV+E++++  L       ++ EL    LD+   QK    I  
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDHTIL-------DDLELFPNGLDYQVVQKYLFQIIN 135
Query: 352 GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYM 411
           G+ F H  +   I+HRDIK  N+L+ +    K+ DFG A+            +A T  Y 
Sbjct: 136 GIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYR 191
Query: 412 APEYALWGYLTY--KADVYSFGIVALEIVSGK 441
           APE  L G + Y    DV++ G +  E+  G+
Sbjct: 192 APE-LLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 241 NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVK-----QLSSKSRQGNREFLNEIAMISCLQ 294
           N+   K IG+G F  V   + +  G  +A+K     QL+  S Q   +   E+ ++  L 
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQ---KLFREVRIMKILN 69
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENC-ELELDWPTRQKICLGIARGL 353
           HPN+VK+         L L+ EY     +   L       E E     RQ     I   +
Sbjct: 70  HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ-----IVSAV 124
Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHISTRIAGTIGYMA 412
            + H++   +IVHRD+KA N+LLD D+N KI+DFG + +   G K        G+  Y A
Sbjct: 125 QYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT---FCGSPPYAA 178
Query: 413 PE-YALWGYLTYKADVYSFGIVALEIVSG 440
           PE +    Y   + DV+S G++   +VSG
Sbjct: 179 PELFQGKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 97/214 (45%), Gaps = 27/214 (12%)
Query: 244 SAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSR--------------QGNREFLNEIAM 289
             +K+G G +G V   +  +G      ++  KS+              + + E  NEI++
Sbjct: 40  KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGI 349
           +  L HPN++K+     +     LV E+ E   L   +  R     + D      I   I
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQI 155
Query: 350 ARGLAFLHEESRFKIVHRDIKATNVLLDRD---LNPKISDFGLAKLDEGDKTHISTRIAG 406
             G+ +LH+ +   IVHRDIK  N+LL+     LN KI DFGL+     D   +  R+ G
Sbjct: 156 LSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD-YKLRDRL-G 210
Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           T  Y+APE     Y   K DV+S G++   ++ G
Sbjct: 211 TAYYIAPEVLKKKY-NEKCDVWSCGVIMYILLCG 243

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 241 NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVK-----QLSSKSRQGNREFLNEIAMISCLQ 294
           N+   K IG+G F  V   + +  G  +AVK     QL+S S Q   +   E+ +   L 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQ---KLFREVRIXKVLN 71
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALF--GRENCELELDWPTRQKICLGIARG 352
           HPN+VK+         L LV EY     +   L   GR   E E     RQ     I   
Sbjct: 72  HPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXK-EKEARAKFRQ-----IVSA 125
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHISTRIAGTIGYM 411
           + + H++    IVHRD+KA N+LLD D N KI+DFG + +   G+K        G   Y 
Sbjct: 126 VQYCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA---FCGAPPYA 179
Query: 412 APE-YALWGYLTYKADVYSFGIVALEIVSG 440
           APE +    Y   + DV+S G++   +VSG
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 112/232 (48%), Gaps = 21/232 (9%)
Query: 216 ETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKG------QLADGTIIAV 269
           E+ F    +L+     LK+     N   +  ++G G FG V +G      +  D  I  +
Sbjct: 316 ESPFSDPEELKDKKLFLKR----DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL 371
Query: 270 KQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFG 329
           KQ + K+     E + E  ++  L +P +V++ G C + + L+LV E      L   L G
Sbjct: 372 KQGTEKA--DTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG 428
Query: 330 RENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL 389
           +     E+      ++   ++ G+ +L E++    VHR++ A NVLL      KISDFGL
Sbjct: 429 KRE---EIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGL 482
Query: 390 AKLDEGDKTHISTRIAG--TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
           +K    D ++ + R AG   + + APE   +   + ++DV+S+G+   E +S
Sbjct: 483 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 106/224 (47%), Gaps = 30/224 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAM-- 289
           ++ +A  N+ ++  ++G G  G V+K +    G +IAVKQ+    R GN+E    I M  
Sbjct: 18  QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR---RSGNKEENKRILMDL 74
Query: 290 -ISCLQH--PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKI- 345
            +    H  P +V+  G  +    + +  E M      CA    E  +  +  P  ++I 
Sbjct: 75  DVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGT----CA----EKLKKRMQGPIPERIL 126
Query: 346 ---CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIST 402
               + I + L +L E  +  ++HRD+K +N+LLD     K+ DFG++     DK     
Sbjct: 127 GKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA--KD 182
Query: 403 RIAGTIGYMAPEYALWGYLT-----YKADVYSFGIVALEIVSGK 441
           R AG   YMAPE       T      +ADV+S GI  +E+ +G+
Sbjct: 183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 14/213 (6%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFL-NEIAMI 290
           KQ +   + +D    +G G F  V   +      ++A+K ++ K+ +G    + NEIA++
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 70
Query: 291 SCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
             ++HPN+V +      G  L L+ + +    L   +   +    E D     ++   + 
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV-EKGFYTERD---ASRLIFQVL 126
Query: 351 RGLAFLHEESRFKIVHRDIKATNVL---LDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
             + +LH+     IVHRD+K  N+L   LD D    ISDFGL+K++  D   + +   GT
Sbjct: 127 DAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGT 181
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            GY+APE       +   D +S G++A  ++ G
Sbjct: 182 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 17/212 (8%)
Query: 235 IKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLS----SKSRQG-NREFLNEIA 288
           +K+    ++    +GEG F  VYK +  +   I+A+K++     S+++ G NR  L EI 
Sbjct: 5   VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLG 348
           ++  L HPN++ +         + LV+++ME +     +  ++N  L L     +   L 
Sbjct: 65  LLQELSHPNIIGLLDAFGHKSNISLVFDFMETD---LEVIIKDN-SLVLTPSHIKAYMLM 120
Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTI 408
             +GL +LH+     I+HRD+K  N+LLD +   K++DFGLAK   G           T 
Sbjct: 121 TLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNRAYXHQVVTR 176
Query: 409 GYMAPEYALWGYLTY--KADVYSFGIVALEIV 438
            Y APE  L+G   Y    D+++ G +  E++
Sbjct: 177 WYRAPEL-LFGARMYGVGVDMWAVGCILAELL 207

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 104/200 (52%), Gaps = 15/200 (7%)
Query: 247 KIGEGGFGPVYKGQ--LADGTIIAVKQLSSKSRQGNR-EFLNEIAMISCLQHPNLVKIHG 303
           K+GEG +  VYKG+  L D  ++A+K++  +  +G     + E++++  L+H N+V +H 
Sbjct: 9   KLGEGTYATVYKGKSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFK 363
                  L LV+EY++ + L   L   ++C   ++    +     + RGLA+ H   R K
Sbjct: 68  IIHTEKSLTLVFEYLDKD-LKQYL---DDCGNIINMHNVKLFLFQLLRGLAYCH---RQK 120
Query: 364 IVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTY 423
           ++HRD+K  N+L++     K++DFGLA+            +  T+ Y  P+  L G   Y
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPD-ILLGSTDY 178
Query: 424 --KADVYSFGIVALEIVSGK 441
             + D++  G +  E+ +G+
Sbjct: 179 STQIDMWGVGCIFYEMATGR 198

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 18/206 (8%)
Query: 242 FDSAKKIGEGGFGPVY----KGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPN 297
           +   KK+G G +G V     K    +  I  +++ +S S   N + L E+A++  L HPN
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRK-TSVSTSSNSKLLEEVAVLKLLDHPN 97
Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH 357
           ++K++    +     LV E  +   L   +  R     E+D      I   +  G+ +LH
Sbjct: 98  IMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFN-EVDAAV---IIKQVLSGVTYLH 153
Query: 358 EESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPE 414
              +  IVHRD+K  N+LL   ++D   KI DFGL+ + E  K  +  R+ GT  Y+APE
Sbjct: 154 ---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK-MKERL-GTAYYIAPE 208
Query: 415 YALWGYLTYKADVYSFGIVALEIVSG 440
                Y   K DV+S G++   +++G
Sbjct: 209 VLRKKY-DEKCDVWSIGVILFILLAG 233

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 239 TNNFDSAKKIGEGGFGPVY------KGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISC 292
           ++ +   + +G+G FG V        GQ     +I+ +Q+  K+ +     L E+ ++  
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDK--ESLLREVQLLKQ 82
Query: 293 LQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARG 352
           L HPN+ K++    +     LV E      L   +  R+    E+D     +I   +  G
Sbjct: 83  LDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFS-EVDAA---RIIRQVLSG 138
Query: 353 LAFLHEESRFKIVHRDIKATNVLLD---RDLNPKISDFGLAKLDEGDKTHISTRIAGTIG 409
           + + H+    KIVHRD+K  N+LL+   +D N +I DFGL+   E  K        GT  
Sbjct: 139 ITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDK--IGTAY 193
Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           Y+APE  L G    K DV+S G++   ++SG
Sbjct: 194 YIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 241 NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVK-----QLSSKSRQGNREFLNEIAMISCLQ 294
           N+   K IG+G F  V   + +  G  +A+K     QL+  S Q   +   E+ ++  L 
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQ---KLFREVRIMKILN 72
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALF--GRENCELELDWPTRQKICLGIARG 352
           HPN+VK+         L L+ EY     +   L   GR   E E     RQ     I   
Sbjct: 73  HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMK-EKEARSKFRQ-----IVSA 126
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHISTRIAGTIGYM 411
           + + H++   +IVHRD+KA N+LLD D+N KI+DFG + +   G K        G   Y 
Sbjct: 127 VQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA---FCGAPPYA 180
Query: 412 APE-YALWGYLTYKADVYSFGIVALEIVSG 440
           APE +    Y   + DV+S G++   +VSG
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 108/219 (49%), Gaps = 15/219 (6%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNR-EFLNEIAMISCLQHPN 297
           ++F+   ++G G  G V K Q    G I+A K +  + +   R + + E+ ++     P 
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH 357
           +V  +G      ++ +  E+M+  SL   L   +    E+      K+ + + RGLA+L 
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEI----LGKVSIAVLRGLAYLR 131
Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEGDKTHISTRIAGTIGYMAPEY 415
           E  + +I+HRD+K +N+L++     K+ DFG++   +D      ++    GT  YMAPE 
Sbjct: 132 E--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMAPER 184
Query: 416 ALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDC 454
               + + ++D++S G+  +E+  G+  +    A E + 
Sbjct: 185 LQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEA 223

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 104/206 (50%), Gaps = 13/206 (6%)
Query: 241 NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKS--RQGNREFLNEIAMISC-LQHP 296
           +F     +G+G F  VY+ + +  G  +A+K +  K+  + G  + +     I C L+HP
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFL 356
           ++++++    + + + LV E   N  +   L  R     E +    +     I  G+ +L
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEA---RHFMHQIITGMLYL 128
Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHISTRIAGTIGYMAPEY 415
           H      I+HRD+  +N+LL R++N KI+DFGLA +L    + H +  + GT  Y++PE 
Sbjct: 129 HSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEI 183
Query: 416 ALWGYLTYKADVYSFGIVALEIVSGK 441
           A       ++DV+S G +   ++ G+
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGR 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 96/204 (47%), Gaps = 18/204 (8%)
Query: 246 KKIGEGGFGPVY---KGQLADGT--IIAVKQLSSKSRQGNRE-FLNEIAMISCLQHPNLV 299
           + +GEG FG V         DGT  ++AVK L        R  +  EI ++  L H ++V
Sbjct: 15  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIV 74
Query: 300 KIHGCCVEGDQ--LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH 357
           K  GCC +  +  + LV EY+   SL   L  R    L       Q+IC     G+A+LH
Sbjct: 75  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYL-PRHCVGLAQLLLFAQQIC----EGMAYLH 129
Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG--TIGYMAPEY 415
            +     +HR + A NVLLD D   KI DFGLAK       +   R  G   + + APE 
Sbjct: 130 AQH---YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 186
Query: 416 ALWGYLTYKADVYSFGIVALEIVS 439
                  Y +DV+SFG+   E+++
Sbjct: 187 LKECKFYYASDVWSFGVTLYELLT 210

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 110/229 (48%), Gaps = 41/229 (17%)
Query: 241 NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNRE-FLNEIAMISCLQHPNL 298
           +F+  + +G GGFG V++ +   D    A+K++   +R+  RE  + E+  ++ L+HP +
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALF------GRENCELELDW--------PTRQK 344
           V+     +E +      E ++ +S    L+       +EN +   DW           + 
Sbjct: 66  VRYFNAWLEKN----TTEKLQPSSPKVYLYIQMQLCRKENLK---DWMNGRCTIEERERS 118
Query: 345 ICL----GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL---DEGDK 397
           +CL     IA  + FLH +    ++HRD+K +N+    D   K+ DFGL      DE ++
Sbjct: 119 VCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175
Query: 398 THIS-----TRIAGTIG---YMAPEYALWGYLTYKADVYSFGIVALEIV 438
           T ++      R  G +G   YM+PE       ++K D++S G++  E++
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 104/214 (48%), Gaps = 16/214 (7%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKGQLADGT-IIAVKQLSSKSRQG---NREFLNEIA 288
           K+ + A  +F+  + +G+G FG VY  +      I+A+K L     +      +   E+ 
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL-ELDWPTRQKICL 347
           + S L+HPN+++++G   +  ++ L+ EY    ++      RE  +L + D         
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY-----RELQKLSKFDEQRTATYIT 116
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            +A  L++ H +   +++HRDIK  N+LL      KI+DFG +      +    T ++GT
Sbjct: 117 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSR---RTTLSGT 170
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           + Y+ PE         K D++S G++  E + GK
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 96/204 (47%), Gaps = 18/204 (8%)
Query: 246 KKIGEGGFGPVY---KGQLADGT--IIAVKQLSSKSRQGNRE-FLNEIAMISCLQHPNLV 299
           + +GEG FG V         DGT  ++AVK L        R  +  EI ++  L H ++V
Sbjct: 14  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIV 73
Query: 300 KIHGCCVEGDQ--LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH 357
           K  GCC +  +  + LV EY+   SL   L  R    L       Q+IC     G+A+LH
Sbjct: 74  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYL-PRHCVGLAQLLLFAQQIC----EGMAYLH 128
Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG--TIGYMAPEY 415
            +     +HR + A NVLLD D   KI DFGLAK       +   R  G   + + APE 
Sbjct: 129 AQH---YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 185
Query: 416 ALWGYLTYKADVYSFGIVALEIVS 439
                  Y +DV+SFG+   E+++
Sbjct: 186 LKECKFYYASDVWSFGVTLYELLT 209

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 103/214 (48%), Gaps = 16/214 (7%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKGQLADGT-IIAVKQLSSKSRQG---NREFLNEIA 288
           K+ + A  +F+  + +G+G FG VY  +      I+A+K L     +      +   E+ 
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL-ELDWPTRQKICL 347
           + S L+HPN+++++G   +  ++ L+ EY    ++      RE  +L + D         
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY-----RELQKLSKFDEQRTATYIT 118
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            +A  L++ H +   +++HRDIK  N+LL      KI+DFG +      +    T + GT
Sbjct: 119 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGT 172
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           + Y+ PE         K D++S G++  E + GK
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 103/214 (48%), Gaps = 16/214 (7%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKGQLADGT-IIAVKQLSSKSRQG---NREFLNEIA 288
           K+ + A  +F+  + +G+G FG VY  +      I+A+K L     +      +   E+ 
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL-ELDWPTRQKICL 347
           + S L+HPN+++++G   +  ++ L+ EY    ++      RE  +L + D         
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY-----RELQKLSKFDEQRTATYIT 118
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            +A  L++ H +   +++HRDIK  N+LL      KI+DFG +      +    T + GT
Sbjct: 119 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGT 172
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           + Y+ PE         K D++S G++  E + GK
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 94/196 (47%), Gaps = 12/196 (6%)
Query: 248 IGEGGFGPVYKGQLAD----GTIIAVKQLSSKSRQGNRE-FLNEIAMISCLQHPNLVKIH 302
           IGEG FG V++G           +A+K   + +    RE FL E   +    HP++VK+ 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRF 362
           G   E + + ++ E      L   L  R+     LD  +       ++  LA+L E  RF
Sbjct: 458 GVITE-NPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYL-ESKRF 512
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLT 422
             VHRDI A NVL+  +   K+ DFGL++  E    + +++    I +MAPE   +   T
Sbjct: 513 --VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 423 YKADVYSFGIVALEIV 438
             +DV+ FG+   EI+
Sbjct: 571 SASDVWMFGVCMWEIL 586

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 103/214 (48%), Gaps = 16/214 (7%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKGQLADGT-IIAVKQLSSKSRQG---NREFLNEIA 288
           K+ + A  +F+  + +G+G FG VY  +      I+A+K L     +      +   E+ 
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL-ELDWPTRQKICL 347
           + S L+HPN+++++G   +  ++ L+ EY    ++      RE  +L + D         
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY-----RELQKLSKFDEQRTATYIT 120
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            +A  L++ H +   +++HRDIK  N+LL      KI+DFG +      +    T + GT
Sbjct: 121 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGT 174
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           + Y+ PE         K D++S G++  E + GK
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 103/214 (48%), Gaps = 16/214 (7%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKGQLADGT-IIAVKQLSSKSRQG---NREFLNEIA 288
           K+ + A  +F+  + +G+G FG VY  +      I+A+K L     +      +   E+ 
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL-ELDWPTRQKICL 347
           + S L+HPN+++++G   +  ++ L+ EY    ++      RE  +L + D         
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY-----RELQKLSKFDEQRTATYIT 120
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            +A  L++ H +   +++HRDIK  N+LL      KI+DFG +      +    T + GT
Sbjct: 121 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGT 174
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           + Y+ PE         K D++S G++  E + GK
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 22/211 (10%)
Query: 242 FDSAKKIGEGGFGPVYK------GQLADGTIIAVKQLSSKSRQGNREFLN-EIAMISCLQ 294
           +D+ +++G G F  V K      G       I  ++  S  R  +RE +  E++++  +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HPN++ +H        ++L+ E +    L   L  +E+   E       +    I  G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE----EATEFLKQILNGVY 128
Query: 355 FLHEESRFKIVHRDIKATNV-LLDRDL-NP--KISDFGLA-KLDEGDKTHISTRIAGTIG 409
           +LH     +I H D+K  N+ LLDR++  P  KI DFGLA K+D G++      I GT  
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPA 182
Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           ++APE   +  L  +AD++S G++   ++SG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 103/214 (48%), Gaps = 16/214 (7%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKGQLADGT-IIAVKQLSSKSRQG---NREFLNEIA 288
           K+ + A  +F+  + +G+G FG VY  +      I+A+K L     +      +   E+ 
Sbjct: 1   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL-ELDWPTRQKICL 347
           + S L+HPN+++++G   +  ++ L+ EY    ++      RE  +L + D         
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY-----RELQKLSKFDEQRTATYIT 115
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            +A  L++ H +   +++HRDIK  N+LL      KI+DFG +      +    T + GT
Sbjct: 116 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGT 169
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           + Y+ PE         K D++S G++  E + GK
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 103/214 (48%), Gaps = 16/214 (7%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKGQLADGT-IIAVKQLSSKSRQG---NREFLNEIA 288
           K+ + A  +F+  + +G+G FG VY  +      I+A+K L     +      +   E+ 
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL-ELDWPTRQKICL 347
           + S L+HPN+++++G   +  ++ L+ EY    ++      RE  +L + D         
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY-----RELQKLSKFDEQRTATYIT 120
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            +A  L++ H +   +++HRDIK  N+LL      KI+DFG +      +    T + GT
Sbjct: 121 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGT 174
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           + Y+ PE         K D++S G++  E + GK
Sbjct: 175 LDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 105/216 (48%), Gaps = 20/216 (9%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFL-NEIAMI 290
           KQ +   + +D    +G G F  V   +      ++A+K ++ ++ +G    + NEIA++
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVL 70
Query: 291 SCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQ---KICL 347
             ++HPN+V +      G  L L+ + +        LF R    +E  + T +   ++  
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGE----LFDR---IVEKGFYTERDASRLIF 123
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVL---LDRDLNPKISDFGLAKLDEGDKTHISTRI 404
            +   + +LH+     IVHRD+K  N+L   LD D    ISDFGL+K++  D   + +  
Sbjct: 124 QVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTA 178
Query: 405 AGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            GT GY+APE       +   D +S G++A  ++ G
Sbjct: 179 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 102/213 (47%), Gaps = 14/213 (6%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFL-NEIAMI 290
           KQ +   + +D    +G G F  V   +      ++A+K ++ ++ +G    + NEIA++
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVL 70
Query: 291 SCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
             ++HPN+V +      G  L L+ + +    L   +  +     E D     ++   + 
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK-GFYTERD---ASRLIFQVL 126
Query: 351 RGLAFLHEESRFKIVHRDIKATNVL---LDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
             + +LH+     IVHRD+K  N+L   LD D    ISDFGL+K++  D   + +   GT
Sbjct: 127 DAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGT 181
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            GY+APE       +   D +S G++A  ++ G
Sbjct: 182 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQLADG-TIIAVKQ--LSSKSRQGNREFLNEIAMISCLQHP 296
             ++  +KIGEG +G V+K +  +   I+A+K+  L           L EI ++  L+H 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFL 356
           N+V++H       +L LV+E+ + +         ++C  +LD    +     + +GL F 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYF----DSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYA 416
           H  +   ++HRD+K  N+L++R+   K++DFGLA+   G      +    T+ Y  P+  
Sbjct: 118 HSRN---VLHRDLKPQNLLINRNGELKLADFGLARA-FGIPVRCYSAEVVTLWYRPPD-V 172
Query: 417 LWGYLTYKA--DVYSFGIVALEIVSG 440
           L+G   Y    D++S G +  E+ + 
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANA 198

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 103/214 (48%), Gaps = 16/214 (7%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKGQLADGT-IIAVKQLSSKSRQG---NREFLNEIA 288
           K+ + A  +F+  + +G+G FG VY  +      I+A+K L     +      +   E+ 
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL-ELDWPTRQKICL 347
           + S L+HPN+++++G   +  ++ L+ EY    ++      RE  +L + D         
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY-----RELQKLSKFDEQRTATYIT 116
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            +A  L++ H +   +++HRDIK  N+LL      KI+DFG +      +    T + GT
Sbjct: 117 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGT 170
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           + Y+ PE         K D++S G++  E + GK
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 16/209 (7%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQLADGT-IIAVKQLSSKSRQG---NREFLNEIAMISCL 293
           A  +F+  + +G+G FG VY  +      I+A+K L     +      +   E+ + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL-ELDWPTRQKICLGIARG 352
           +HPN+++++G   +  ++ L+ EY    ++      RE  +L + D          +A  
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVY-----RELQKLSKFDEQRTATYITELANA 120
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMA 412
           L++ H +   +++HRDIK  N+LL      KI+DFG +      +    T + GT+ Y+ 
Sbjct: 121 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTELCGTLDYLP 174
Query: 413 PEYALWGYLTYKADVYSFGIVALEIVSGK 441
           PE         K D++S G++  E + GK
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 102/236 (43%), Gaps = 18/236 (7%)
Query: 216 ETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVY---------KGQLADGTI 266
           E     + +L+T + T    K    NF+  K +G G +G V+          G+L    +
Sbjct: 30  EQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKV 89
Query: 267 IAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACA 326
           +    +  K++           +    Q P LV +H       +L L+ +Y+    L   
Sbjct: 90  LKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTH 149
Query: 327 LFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISD 386
           L  RE         T  ++ + +   +  L    +  I++RDIK  N+LLD + +  ++D
Sbjct: 150 LSQRERF-------TEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTD 202
Query: 387 FGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTY--KADVYSFGIVALEIVSG 440
           FGL+K    D+T  +    GTI YMAP+    G   +    D +S G++  E+++G
Sbjct: 203 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 16/209 (7%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQLADGT-IIAVKQLSSKSRQG---NREFLNEIAMISCL 293
           A  +F+  + +G+G FG VY  +      I+A+K L     +      +   E+ + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL-ELDWPTRQKICLGIARG 352
           +HPN+++++G   +  ++ L+ EY    ++      RE  +L + D          +A  
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVY-----RELQKLSKFDEQRTATYITELANA 120
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMA 412
           L++ H +   +++HRDIK  N+LL      KI+DFG +      +    T + GT+ Y+ 
Sbjct: 121 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTXLCGTLDYLP 174
Query: 413 PEYALWGYLTYKADVYSFGIVALEIVSGK 441
           PE         K D++S G++  E + GK
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 105/216 (48%), Gaps = 20/216 (9%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFL-NEIAMI 290
           KQ +   + +D    +G G F  V   +      ++A+K ++ ++ +G    + NEIA++
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVL 70
Query: 291 SCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQ---KICL 347
             ++HPN+V +      G  L L+ + +        LF R    +E  + T +   ++  
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGE----LFDR---IVEKGFYTERDASRLIF 123
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVL---LDRDLNPKISDFGLAKLDEGDKTHISTRI 404
            +   + +LH+     IVHRD+K  N+L   LD D    ISDFGL+K++  D   + +  
Sbjct: 124 QVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTA 178
Query: 405 AGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            GT GY+APE       +   D +S G++A  ++ G
Sbjct: 179 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 107/230 (46%), Gaps = 41/230 (17%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNL 298
           ++F+    +G+G FG V K + A D    A+K++   + +     L+E+ +++ L H  +
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYV 64
Query: 299 VKIHGCCVE-------------GDQLLLVYEYMENNSLACALFGRENCELELD--WPTRQ 343
           V+ +   +E                L +  EY EN +L   L   EN   + D  W    
Sbjct: 65  VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTL-YDLIHSENLNQQRDEYW---- 119
Query: 344 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA----------KLD 393
           ++   I   L+++H +    I+HRD+K  N+ +D   N KI DFGLA          KLD
Sbjct: 120 RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 394 E----GDKTHISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIV 438
                G   ++++ I GT  Y+A E     G+   K D+YS GI+  E++
Sbjct: 177 SQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 16/209 (7%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQLADGT-IIAVKQLSSKSRQG---NREFLNEIAMISCL 293
           A  +F+  + +G+G FG VY  +      I+A+K L     +      +   E+ + S L
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL-ELDWPTRQKICLGIARG 352
           +HPN+++++G   +  ++ L+ EY    ++      RE  +L + D          +A  
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVY-----RELQKLSKFDEQRTATYITELANA 119
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMA 412
           L++ H +   +++HRDIK  N+LL      KI+DFG +      +    T + GT+ Y+ 
Sbjct: 120 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLP 173
Query: 413 PEYALWGYLTYKADVYSFGIVALEIVSGK 441
           PE         K D++S G++  E + GK
Sbjct: 174 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 16/209 (7%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQLADGT-IIAVKQLSSKSRQG---NREFLNEIAMISCL 293
           A  +F+  + +G+G FG VY  +      I+A+K L     +      +   E+ + S L
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL-ELDWPTRQKICLGIARG 352
           +HPN+++++G   +  ++ L+ EY    ++      RE  +L + D          +A  
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVY-----RELQKLSKFDEQRTATYITELANA 124
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMA 412
           L++ H +   +++HRDIK  N+LL      KI+DFG +      +    T + GT+ Y+ 
Sbjct: 125 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLP 178
Query: 413 PEYALWGYLTYKADVYSFGIVALEIVSGK 441
           PE         K D++S G++  E + GK
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 14/213 (6%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFL-NEIAMI 290
           KQ +     F+  + +G G F  V   +  A G + AVK +  K+ +G    + NEIA++
Sbjct: 15  KQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVL 74
Query: 291 SCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
             ++H N+V +       + L LV + +    L    F R    +E  + T +     I 
Sbjct: 75  RKIKHENIVALEDIYESPNHLYLVMQLVSGGEL----FDRI---VEKGFYTEKDASTLIR 127
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
           + L  ++   R  IVHRD+K  N+L    D +    ISDFGL+K+ EG K  + +   GT
Sbjct: 128 QVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM-EG-KGDVMSTACGT 185
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            GY+APE       +   D +S G++A  ++ G
Sbjct: 186 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 22/211 (10%)
Query: 242 FDSAKKIGEGGFGPVYK------GQLADGTIIAVKQLSSKSRQGNREFLN-EIAMISCLQ 294
           +D+ +++G G F  V K      G       I  ++  S  R  +RE +  E++++  +Q
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HPN++ +H        ++L+ E +    L   L  +E+   E       +    I  G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE----EATEFLKQILNGVY 128
Query: 355 FLHEESRFKIVHRDIKATNV-LLDRDL-NP--KISDFGLA-KLDEGDKTHISTRIAGTIG 409
           +LH     +I H D+K  N+ LLDR++  P  KI DFGLA K+D G++      I GT  
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPE 182
Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           ++APE   +  L  +AD++S G++   ++SG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 16/209 (7%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQLADGT-IIAVKQLSSKSRQG---NREFLNEIAMISCL 293
           A  +F+  + +G+G FG VY  +      I+A+K L     +      +   E+ + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL-ELDWPTRQKICLGIARG 352
           +HPN+++++G   +  ++ L+ EY    ++      RE  +L + D          +A  
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVY-----RELQKLSKFDEQRTATYITELANA 120
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMA 412
           L++ H +   +++HRDIK  N+LL      KI+DFG +      +    T + GT+ Y+ 
Sbjct: 121 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLP 174
Query: 413 PEYALWGYLTYKADVYSFGIVALEIVSGK 441
           PE         K D++S G++  E + GK
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 22/211 (10%)
Query: 242 FDSAKKIGEGGFGPVYK------GQLADGTIIAVKQLSSKSRQGNREFLN-EIAMISCLQ 294
           +D+ +++G G F  V K      G       I  ++  S  R  +RE +  E++++  +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HPN++ +H        ++L+ E +    L   L  +E+   E       +    I  G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE----EATEFLKQILNGVY 128
Query: 355 FLHEESRFKIVHRDIKATNV-LLDRDL-NP--KISDFGLA-KLDEGDKTHISTRIAGTIG 409
           +LH     +I H D+K  N+ LLDR++  P  KI DFGLA K+D G++      I GT  
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPE 182
Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           ++APE   +  L  +AD++S G++   ++SG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 22/211 (10%)
Query: 242 FDSAKKIGEGGFGPVYK------GQLADGTIIAVKQLSSKSRQGNREFLN-EIAMISCLQ 294
           +D+ +++G G F  V K      G       I  ++  S  R  +RE +  E++++  +Q
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HPN++ +H        ++L+ E +    L   L  +E+   E       +    I  G+ 
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE----EATEFLKQILNGVY 127
Query: 355 FLHEESRFKIVHRDIKATNV-LLDRDL-NP--KISDFGLA-KLDEGDKTHISTRIAGTIG 409
           +LH     +I H D+K  N+ LLDR++  P  KI DFGLA K+D G++      I GT  
Sbjct: 128 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPE 181
Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           ++APE   +  L  +AD++S G++   ++SG
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 103/214 (48%), Gaps = 16/214 (7%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKGQLADGT-IIAVKQLSSKSRQG---NREFLNEIA 288
           K+ + A  +F+  + +G+G FG VY  +      I+A+K L     +      +   E+ 
Sbjct: 18  KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 77
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL-ELDWPTRQKICL 347
           + S L+HPN+++++G   +  ++ L+ EY    ++      RE  +L + D         
Sbjct: 78  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY-----RELQKLSKFDEQRTATYIT 132
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            +A  L++ H +   +++HRDIK  N+LL      KI+DFG +      +    T + GT
Sbjct: 133 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGT 186
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           + Y+ PE         K D++S G++  E + GK
Sbjct: 187 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 22/211 (10%)
Query: 242 FDSAKKIGEGGFGPVYK------GQLADGTIIAVKQLSSKSRQGNREFLN-EIAMISCLQ 294
           +D+ +++G G F  V K      G       I  ++  S  R  +RE +  E++++  +Q
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HPN++ +H        ++L+ E +    L   L  +E+   E       +    I  G+ 
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE----EATEFLKQILNGVY 127
Query: 355 FLHEESRFKIVHRDIKATNV-LLDRDL-NP--KISDFGLA-KLDEGDKTHISTRIAGTIG 409
           +LH     +I H D+K  N+ LLDR++  P  KI DFGLA K+D G++      I GT  
Sbjct: 128 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPE 181
Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           ++APE   +  L  +AD++S G++   ++SG
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 14/213 (6%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKGQLADGT-IIAVKQLSSKSRQG---NREFLNEIA 288
           K+ + A  +F+  + +G+G FG VY  +      I+A+K L     +      +   E+ 
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLG 348
           + S L+HPN+++++G   +  ++ L+ EY     +   L        + D          
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLS----KFDEQRTATYITE 121
Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTI 408
           +A  L++ H +   +++HRDIK  N+LL      KI+DFG +      +    T + GT+
Sbjct: 122 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTL 175
Query: 409 GYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
            Y+ PE         K D++S G++  E + GK
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 107/230 (46%), Gaps = 41/230 (17%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNL 298
           ++F+    +G+G FG V K + A D    A+K++   + +     L+E+ +++ L H  +
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYV 64
Query: 299 VKIHGCCVE-------------GDQLLLVYEYMENNSLACALFGRENCELELD--WPTRQ 343
           V+ +   +E                L +  EY EN +L   L   EN   + D  W    
Sbjct: 65  VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL-YDLIHSENLNQQRDEYW---- 119
Query: 344 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA----------KLD 393
           ++   I   L+++H +    I+HRD+K  N+ +D   N KI DFGLA          KLD
Sbjct: 120 RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 394 E----GDKTHISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIV 438
                G   ++++ I GT  Y+A E     G+   K D+YS GI+  E++
Sbjct: 177 SQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 93/196 (47%), Gaps = 12/196 (6%)
Query: 248 IGEGGFGPVYKGQLAD----GTIIAVKQLSSKSRQGNRE-FLNEIAMISCLQHPNLVKIH 302
           IGEG FG V++G           +A+K   + +    RE FL E   +    HP++VK+ 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRF 362
           G   E + + ++ E      L   L  R+     LD  +       ++  LA+L E  RF
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYL-ESKRF 132
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLT 422
             VHRDI A NVL+  +   K+ DFGL++  E      +++    I +MAPE   +   T
Sbjct: 133 --VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRFT 190
Query: 423 YKADVYSFGIVALEIV 438
             +DV+ FG+   EI+
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQLADGT-IIAVKQLSSKSRQG---NREFLNEIAMISCLQH 295
            +FD  + +G+G FG VY  +      I+A+K L     +      +   E+ + S L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL-ELDWPTRQKICLGIARGLA 354
           PN+++++G   +  ++ L+ EY    ++      RE  +L   D          +A  L+
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVY-----RELQKLSRFDEQRTATYITELANALS 126
Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPE 414
           + H +   +++HRDIK  N+LL  +   KI+DFG +      +    T + GT+ Y+ PE
Sbjct: 127 YCHSK---RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPE 180
Query: 415 YALWGYLTYKADVYSFGIVALEIVSG 440
                    K D++S G++  E + G
Sbjct: 181 MIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 103/214 (48%), Gaps = 16/214 (7%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKGQLADGT-IIAVKQLSSKSRQG---NREFLNEIA 288
           K+ + A  +F+  + +G+G FG VY  +      I+A+K L     +      +   E+ 
Sbjct: 27  KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 86
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL-ELDWPTRQKICL 347
           + S L+HPN+++++G   +  ++ L+ EY    ++      RE  +L + D         
Sbjct: 87  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY-----RELQKLSKFDEQRTATYIT 141
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            +A  L++ H +   +++HRDIK  N+LL      KI+DFG +      +    T + GT
Sbjct: 142 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGT 195
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           + Y+ PE         K D++S G++  E + GK
Sbjct: 196 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 16/209 (7%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQLADGT-IIAVKQLSSKSRQG---NREFLNEIAMISCL 293
           A  +F+  + +G+G FG VY  +      I+A+K L     +      +   E+ + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL-ELDWPTRQKICLGIARG 352
           +HPN+++++G   +  ++ L+ EY    ++      RE  +L + D          +A  
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVY-----RELQKLSKFDEQRTATYITELANA 120
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMA 412
           L++ H +   +++HRDIK  N+LL      KI+DFG +      +    T + GT+ Y+ 
Sbjct: 121 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYLP 174
Query: 413 PEYALWGYLTYKADVYSFGIVALEIVSGK 441
           PE         K D++S G++  E + GK
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 103/210 (49%), Gaps = 19/210 (9%)
Query: 239 TNNFDSAKKIGEGGFGPVY--KGQL--ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ 294
           ++ +   KK+G G +G V   K +L  A+  I  +K+ S  +   +   L+E+A++  L 
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HPN++K++    +     LV E      L   +  R+    E+D     K  L    G  
Sbjct: 63  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFS-EVDAAVIMKQVLS---GTT 118
Query: 355 FLHEESRFKIVHRDIKATNVLLD---RDLNPKISDFGL-AKLDEGDKTHISTRIAGTIGY 410
           +LH   +  IVHRD+K  N+LL+   RD   KI DFGL A  + G K  +  R+ GT  Y
Sbjct: 119 YLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK--MKERL-GTAYY 172
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           +APE     Y   K DV+S G++   ++ G
Sbjct: 173 IAPEVLRKKY-DEKCDVWSCGVILYILLCG 201

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 94/196 (47%), Gaps = 12/196 (6%)
Query: 248 IGEGGFGPVYKGQLAD----GTIIAVKQLSSKSRQGNRE-FLNEIAMISCLQHPNLVKIH 302
           IGEG FG V++G           +A+K   + +    RE FL E   +    HP++VK+ 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRF 362
           G   E + + ++ E      L   L  R+     LD  +       ++  LA+L E  RF
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYL-ESKRF 132
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLT 422
             VHRDI A NVL+  +   K+ DFGL++  E    + +++    I +MAPE   +   T
Sbjct: 133 --VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 423 YKADVYSFGIVALEIV 438
             +DV+ FG+   EI+
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 239 TNNFDSAKKIGEGGFGPVY--KGQL--ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ 294
           ++ +   KK+G G +G V   K +L  A+  I  +K+ S  +   +   L+E+A++  L 
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HPN++K++    +     LV E      L   +  R+    E+D     K  L    G  
Sbjct: 80  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFS-EVDAAVIMKQVLS---GTT 135
Query: 355 FLHEESRFKIVHRDIKATNVLLD---RDLNPKISDFGL-AKLDEGDKTHISTRIAGTIGY 410
           +LH+ +   IVHRD+K  N+LL+   RD   KI DFGL A  + G K  +  R+ GT  Y
Sbjct: 136 YLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK--MKERL-GTAYY 189
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           +APE     Y   K DV+S G++   ++ G
Sbjct: 190 IAPEVLRKKY-DEKCDVWSCGVILYILLCG 218

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 33/211 (15%)
Query: 251 GGFGPVYKGQLADGTIIAVKQLS---SKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVE 307
           G FG V+K QL +   +AVK       +S Q  RE  +   M    +H NL++       
Sbjct: 26  GRFGCVWKAQLMN-DFVAVKIFPLQDKQSWQSEREIFSTPGM----KHENLLQFIAAEKR 80
Query: 308 GD----QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRF- 362
           G     +L L+  + +  SL   L G       + W     +   ++RGL++LHE+  + 
Sbjct: 81  GSNLEVELWLITAFHDKGSLTDYLKGNI-----ITWNELCHVAETMSRGLSYLHEDVPWC 135
Query: 363 -------KIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHISTRIAGTIGYMAPE 414
                   I HRD K+ NVLL  DL   ++DFGLA + + G     +    GT  YMAPE
Sbjct: 136 RGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPE 195
Query: 415 YALWGYLTY------KADVYSFGIVALEIVS 439
             L G + +      + D+Y+ G+V  E+VS
Sbjct: 196 -VLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 22/211 (10%)
Query: 242 FDSAKKIGEGGFGPVYK------GQLADGTIIAVKQLSSKSRQGNREFLN-EIAMISCLQ 294
           +D+ +++G G F  V K      G       I  ++  S  R  +RE +  E++++  +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HPN++ +H        ++L+ E +    L   L  +E+   E       +    I  G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE----EATEFLKQILNGVY 128
Query: 355 FLHEESRFKIVHRDIKATNV-LLDRDL-NP--KISDFGLA-KLDEGDKTHISTRIAGTIG 409
           +LH     +I H D+K  N+ LLDR++  P  KI DFGLA K+D G++      I GT  
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPE 182
Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           ++APE   +  L  +AD++S G++   ++SG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 94/196 (47%), Gaps = 12/196 (6%)
Query: 248 IGEGGFGPVYKGQLAD----GTIIAVKQLSSKSRQGNRE-FLNEIAMISCLQHPNLVKIH 302
           IGEG FG V++G           +A+K   + +    RE FL E   +    HP++VK+ 
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRF 362
           G   E + + ++ E      L   L  R+     LD  +       ++  LA+L E  RF
Sbjct: 106 GVITE-NPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYL-ESKRF 160
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLT 422
             VHRDI A NVL+  +   K+ DFGL++  E    + +++    I +MAPE   +   T
Sbjct: 161 --VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 218
Query: 423 YKADVYSFGIVALEIV 438
             +DV+ FG+   EI+
Sbjct: 219 SASDVWMFGVCMWEIL 234

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 93/196 (47%), Gaps = 12/196 (6%)
Query: 248 IGEGGFGPVYKGQLAD----GTIIAVKQLSSKSRQGNRE-FLNEIAMISCLQHPNLVKIH 302
           IGEG FG V++G           +A+K   + +    RE FL E   +    HP++VK+ 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRF 362
           G   E + + ++ E      L   L  R+     LD  +       ++  LA+L E  RF
Sbjct: 458 GVITE-NPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYL-ESKRF 512
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLT 422
             VHRDI A NVL+      K+ DFGL++  E    + +++    I +MAPE   +   T
Sbjct: 513 --VHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 423 YKADVYSFGIVALEIV 438
             +DV+ FG+   EI+
Sbjct: 571 SASDVWMFGVCMWEIL 586

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 16/209 (7%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQLADGT-IIAVKQLSSKSRQG---NREFLNEIAMISCL 293
           A  +F+  + +G+G FG VY  +      I+A+K L     +      +   E+ + S L
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL-ELDWPTRQKICLGIARG 352
           +HPN+++++G   +  ++ L+ EY    ++      RE  +L + D          +A  
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVY-----RELQKLSKFDEQRTATYITELANA 117
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMA 412
           L++ H +   +++HRDIK  N+LL      KI+DFG +      +    T + GT+ Y+ 
Sbjct: 118 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLP 171
Query: 413 PEYALWGYLTYKADVYSFGIVALEIVSGK 441
           PE         K D++S G++  E + GK
Sbjct: 172 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 101/215 (46%), Gaps = 20/215 (9%)
Query: 235 IKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKS---RQGNREFLNEIAMI 290
           I    N+F   + IG GGFG VY  + AD G + A+K L  K    +QG    LNE  M+
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 291 SCLQH---PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL 347
           S +     P +V +       D+L  + + M    L   L  +     E D    +    
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADM---RFYAA 299
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            I  GL  +H  +RF +V+RD+K  N+LLD   + +ISD GLA      K H S    GT
Sbjct: 300 EIILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GT 353
Query: 408 IGYMAPEYALWGYLTY--KADVYSFGIVALEIVSG 440
            GYMAPE    G + Y   AD +S G +  +++ G
Sbjct: 354 HGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRG 387

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 22/211 (10%)
Query: 242 FDSAKKIGEGGFGPVYK------GQLADGTIIAVKQLSSKSRQGNREFLN-EIAMISCLQ 294
           +D+ +++G G F  V K      G       I  ++  S  R  +RE +  E++++  +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HPN++ +H        ++L+ E +    L   L  +E+   E       +    I  G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE----EATEFLKQILNGVY 128
Query: 355 FLHEESRFKIVHRDIKATNV-LLDRDL-NP--KISDFGLA-KLDEGDKTHISTRIAGTIG 409
           +LH     +I H D+K  N+ LLDR++  P  KI DFGLA K+D G++      I GT  
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPE 182
Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           ++APE   +  L  +AD++S G++   ++SG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 101/215 (46%), Gaps = 20/215 (9%)
Query: 235 IKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKS---RQGNREFLNEIAMI 290
           I    N+F   + IG GGFG VY  + AD G + A+K L  K    +QG    LNE  M+
Sbjct: 183 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 242
Query: 291 SCLQH---PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL 347
           S +     P +V +       D+L  + + M    L   L  +     E D    +    
Sbjct: 243 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADM---RFYAA 298
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            I  GL  +H  +RF +V+RD+K  N+LLD   + +ISD GLA      K H S    GT
Sbjct: 299 EIILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GT 352
Query: 408 IGYMAPEYALWGYLTY--KADVYSFGIVALEIVSG 440
            GYMAPE    G + Y   AD +S G +  +++ G
Sbjct: 353 HGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRG 386

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 22/211 (10%)
Query: 242 FDSAKKIGEGGFGPVYK------GQLADGTIIAVKQLSSKSRQGNREFLN-EIAMISCLQ 294
           +D+ +++G G F  V K      G       I  ++  S  R  +RE +  E++++  +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HPN++ +H        ++L+ E +    L   L  +E+   E       +    I  G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE----EATEFLKQILNGVY 128
Query: 355 FLHEESRFKIVHRDIKATNV-LLDRDL-NP--KISDFGLA-KLDEGDKTHISTRIAGTIG 409
           +LH     +I H D+K  N+ LLDR++  P  KI DFGLA K+D G++      I GT  
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPE 182
Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           ++APE   +  L  +AD++S G++   ++SG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 94/196 (47%), Gaps = 12/196 (6%)
Query: 248 IGEGGFGPVYKGQLAD----GTIIAVKQLSSKSRQGNRE-FLNEIAMISCLQHPNLVKIH 302
           IGEG FG V++G           +A+K   + +    RE FL E   +    HP++VK+ 
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRF 362
           G   E + + ++ E      L   L  R+     LD  +       ++  LA+L E  RF
Sbjct: 80  GVITE-NPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYL-ESKRF 134
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLT 422
             VHRDI A NVL+  +   K+ DFGL++  E    + +++    I +MAPE   +   T
Sbjct: 135 --VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 192
Query: 423 YKADVYSFGIVALEIV 438
             +DV+ FG+   EI+
Sbjct: 193 SASDVWMFGVCMWEIL 208

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 22/211 (10%)
Query: 242 FDSAKKIGEGGFGPVYK------GQLADGTIIAVKQLSSKSRQGNREFLN-EIAMISCLQ 294
           +D+ +++G G F  V K      G       I  ++  S  R  +RE +  E++++  +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HPN++ +H        ++L+ E +    L   L  +E+   E       +    I  G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE----EATEFLKQILNGVY 128
Query: 355 FLHEESRFKIVHRDIKATNV-LLDRDL-NP--KISDFGLA-KLDEGDKTHISTRIAGTIG 409
           +LH     +I H D+K  N+ LLDR++  P  KI DFGLA K+D G++      I GT  
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPE 182
Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           ++APE   +  L  +AD++S G++   ++SG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 94/196 (47%), Gaps = 12/196 (6%)
Query: 248 IGEGGFGPVYKGQLAD----GTIIAVKQLSSKSRQGNRE-FLNEIAMISCLQHPNLVKIH 302
           IGEG FG V++G           +A+K   + +    RE FL E   +    HP++VK+ 
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRF 362
           G   E + + ++ E      L   L  R+     LD  +       ++  LA+L E  RF
Sbjct: 75  GVITE-NPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYL-ESKRF 129
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLT 422
             VHRDI A NVL+  +   K+ DFGL++  E    + +++    I +MAPE   +   T
Sbjct: 130 --VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 187
Query: 423 YKADVYSFGIVALEIV 438
             +DV+ FG+   EI+
Sbjct: 188 SASDVWMFGVCMWEIL 203

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 94/196 (47%), Gaps = 12/196 (6%)
Query: 248 IGEGGFGPVYKGQLAD----GTIIAVKQLSSKSRQGNRE-FLNEIAMISCLQHPNLVKIH 302
           IGEG FG V++G           +A+K   + +    RE FL E   +    HP++VK+ 
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRF 362
           G   E + + ++ E      L   L  R+     LD  +       ++  LA+L E  RF
Sbjct: 83  GVITE-NPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYL-ESKRF 137
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLT 422
             VHRDI A NVL+  +   K+ DFGL++  E    + +++    I +MAPE   +   T
Sbjct: 138 --VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 195
Query: 423 YKADVYSFGIVALEIV 438
             +DV+ FG+   EI+
Sbjct: 196 SASDVWMFGVCMWEIL 211

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 94/196 (47%), Gaps = 12/196 (6%)
Query: 248 IGEGGFGPVYKGQLAD----GTIIAVKQLSSKSRQGNRE-FLNEIAMISCLQHPNLVKIH 302
           IGEG FG V++G           +A+K   + +    RE FL E   +    HP++VK+ 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRF 362
           G   E + + ++ E      L   L  R+     LD  +       ++  LA+L E  RF
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYL-ESKRF 132
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLT 422
             VHRDI A NVL+  +   K+ DFGL++  E    + +++    I +MAPE   +   T
Sbjct: 133 --VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 423 YKADVYSFGIVALEIV 438
             +DV+ FG+   EI+
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 22/211 (10%)
Query: 242 FDSAKKIGEGGFGPVYK------GQLADGTIIAVKQLSSKSRQGNREFLN-EIAMISCLQ 294
           +D+ +++G G F  V K      G       I  ++  S  R  +RE +  E++++  +Q
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HPN++ +H        ++L+ E +    L   L  +E+   E       +    I  G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE----EATEFLKQILNGVY 128
Query: 355 FLHEESRFKIVHRDIKATNV-LLDRDL-NP--KISDFGLA-KLDEGDKTHISTRIAGTIG 409
           +LH     +I H D+K  N+ LLDR++  P  KI DFGLA K+D G++      I GT  
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPE 182
Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           ++APE   +  L  +AD++S G++   ++SG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 22/211 (10%)
Query: 242 FDSAKKIGEGGFGPVYK------GQLADGTIIAVKQLSSKSRQGNREFLN-EIAMISCLQ 294
           +D+ +++G G F  V K      G       I  ++  S  R  +RE +  E++++  +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HPN++ +H        ++L+ E +    L   L  +E+   E       +    I  G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE----EATEFLKQILNGVY 128
Query: 355 FLHEESRFKIVHRDIKATNV-LLDRDL-NP--KISDFGLA-KLDEGDKTHISTRIAGTIG 409
           +LH     +I H D+K  N+ LLDR++  P  KI DFGLA K+D G++      I GT  
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPE 182
Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           ++APE   +  L  +AD++S G++   ++SG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 22/211 (10%)
Query: 242 FDSAKKIGEGGFGPVYK------GQLADGTIIAVKQLSSKSRQGNREFLN-EIAMISCLQ 294
           +D+ +++G G F  V K      G       I  ++  S  R  +RE +  E++++  +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HPN++ +H        ++L+ E +    L   L  +E+   E       +    I  G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE----EATEFLKQILNGVY 128
Query: 355 FLHEESRFKIVHRDIKATNV-LLDRDL-NP--KISDFGLA-KLDEGDKTHISTRIAGTIG 409
           +LH     +I H D+K  N+ LLDR++  P  KI DFGLA K+D G++      I GT  
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPE 182
Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           ++APE   +  L  +AD++S G++   ++SG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 94/196 (47%), Gaps = 12/196 (6%)
Query: 248 IGEGGFGPVYKGQLAD----GTIIAVKQLSSKSRQGNRE-FLNEIAMISCLQHPNLVKIH 302
           IGEG FG V++G           +A+K   + +    RE FL E   +    HP++VK+ 
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRF 362
           G   E + + ++ E      L   L  R+     LD  +       ++  LA+L E  RF
Sbjct: 81  GVITE-NPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYL-ESKRF 135
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLT 422
             VHRDI A NVL+  +   K+ DFGL++  E    + +++    I +MAPE   +   T
Sbjct: 136 --VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 193
Query: 423 YKADVYSFGIVALEIV 438
             +DV+ FG+   EI+
Sbjct: 194 SASDVWMFGVCMWEIL 209

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 93/196 (47%), Gaps = 12/196 (6%)
Query: 248 IGEGGFGPVYKGQLAD----GTIIAVKQLSSKSRQGNRE-FLNEIAMISCLQHPNLVKIH 302
           IGEG FG V++G           +A+K   + +    RE FL E   +    HP++VK+ 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRF 362
           G   E + + ++ E      L   L  R+     LD  +       ++  LA+L E  RF
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYL-ESKRF 132
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLT 422
             VHRDI A NVL+      K+ DFGL++  E    + +++    I +MAPE   +   T
Sbjct: 133 --VHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 423 YKADVYSFGIVALEIV 438
             +DV+ FG+   EI+
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 22/211 (10%)
Query: 242 FDSAKKIGEGGFGPVYK------GQLADGTIIAVKQLSSKSRQGNREFLN-EIAMISCLQ 294
           +D+ +++G G F  V K      G       I  ++  S  R  +RE +  E++++  +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HPN++ +H        ++L+ E +    L   L  +E+   E       +    I  G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE----EATEFLKQILNGVY 128
Query: 355 FLHEESRFKIVHRDIKATNV-LLDRDL-NP--KISDFGLA-KLDEGDKTHISTRIAGTIG 409
           +LH     +I H D+K  N+ LLDR++  P  KI DFGLA K+D G++      I GT  
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPE 182
Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           ++APE   +  L  +AD++S G++   ++SG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 16/209 (7%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQLADGT-IIAVKQLSSKSRQG---NREFLNEIAMISCL 293
           A  +F+  + +G+G FG VY  +  +   I+A+K L     +      +   E+ + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL-ELDWPTRQKICLGIARG 352
           +HPN+++++G   +  ++ L+ EY    ++      RE  +L + D          +A  
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVY-----RELQKLSKFDEQRTATYITELANA 120
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMA 412
           L++ H +   K++HRDIK  N+LL      KI+DFG +      +      + GT+ Y+ 
Sbjct: 121 LSYCHSK---KVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RAALCGTLDYLP 174
Query: 413 PEYALWGYLTYKADVYSFGIVALEIVSGK 441
           PE         K D++S G++  E + GK
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 101/215 (46%), Gaps = 20/215 (9%)
Query: 235 IKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKS---RQGNREFLNEIAMI 290
           I    N+F   + IG GGFG VY  + AD G + A+K L  K    +QG    LNE  M+
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 291 SCLQH---PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL 347
           S +     P +V +       D+L  + + M    L   L  +     E D    +    
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADM---RFYAA 299
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            I  GL  +H  +RF +V+RD+K  N+LLD   + +ISD GLA      K H S    GT
Sbjct: 300 EIILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GT 353
Query: 408 IGYMAPEYALWGYLTY--KADVYSFGIVALEIVSG 440
            GYMAPE    G + Y   AD +S G +  +++ G
Sbjct: 354 HGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 101/215 (46%), Gaps = 20/215 (9%)
Query: 235 IKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKS---RQGNREFLNEIAMI 290
           I    N+F   + IG GGFG VY  + AD G + A+K L  K    +QG    LNE  M+
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 291 SCLQH---PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL 347
           S +     P +V +       D+L  + + M    L   L  +     E D    +    
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADM---RFYAA 299
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            I  GL  +H  +RF +V+RD+K  N+LLD   + +ISD GLA      K H S    GT
Sbjct: 300 EIILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GT 353
Query: 408 IGYMAPEYALWGYLTY--KADVYSFGIVALEIVSG 440
            GYMAPE    G + Y   AD +S G +  +++ G
Sbjct: 354 HGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRG 387

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 22/211 (10%)
Query: 242 FDSAKKIGEGGFGPVYK------GQLADGTIIAVKQLSSKSRQGNREFLN-EIAMISCLQ 294
           +D+ +++G G F  V K      G       I  ++  S  R  +RE +  E++++  +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HPN++ +H        ++L+ E +    L   L  +E+   E       +    I  G+ 
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEE----EATEFLKQILNGVY 128
Query: 355 FLHEESRFKIVHRDIKATNV-LLDRDL-NP--KISDFGLA-KLDEGDKTHISTRIAGTIG 409
           +LH     +I H D+K  N+ LLDR++  P  KI DFGLA K+D G++      I GT  
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPE 182
Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           ++APE   +  L  +AD++S G++   ++SG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 103/214 (48%), Gaps = 16/214 (7%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKGQLADGT-IIAVKQLSSKSRQG---NREFLNEIA 288
           K+ + A  +F+  + +G+G FG VY  +      I+A+K L     +      +   E+ 
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL-ELDWPTRQKICL 347
           + S L+HPN+++++G   +  ++ L+ EY    ++      RE  +L + D         
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY-----RELQKLSKFDEQRTATYIT 118
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            +A  L++ H +   +++HRDIK  N+LL      KI++FG +      +    T + GT
Sbjct: 119 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR---RTTLCGT 172
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           + Y+ PE         K D++S G++  E + GK
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 102/214 (47%), Gaps = 16/214 (7%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKGQLADGT-IIAVKQLSSKSRQG---NREFLNEIA 288
           K+ + A  +F+  + +G+G FG VY  +      I+A+K L     +      +   E+ 
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL-ELDWPTRQKICL 347
           + S L+HPN+++++G   +  ++ L+ EY    ++      RE  +L + D         
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY-----RELQKLSKFDEQRTATYIT 118
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            +A  L++ H +   +++HRDIK  N+LL      KI+DFG +      +      + GT
Sbjct: 119 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RXXLCGT 172
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           + Y+ PE         K D++S G++  E + GK
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 112/213 (52%), Gaps = 22/213 (10%)
Query: 240 NNFDSAKKIGEGGFGPVYK------GQLADGTIIAVKQLSSKSRQGNREFLN-EIAMISC 292
           ++++  +++G G F  V K      G+      I  ++LSS  R  +RE +  E+ ++  
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 293 LQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARG 352
           ++HPN++ +H        ++L+ E +    L   L  +E+  L  D  T  +    I  G
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEAT--QFLKQILDG 120
Query: 353 LAFLHEESRFKIVHRDIKATNV-LLDRDL-NPKIS--DFGLA-KLDEGDKTHISTRIAGT 407
           + +LH +   +I H D+K  N+ LLD+++ NP+I   DFG+A K++ G++      I GT
Sbjct: 121 VHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGT 174
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             ++APE   +  L  +AD++S G++   ++SG
Sbjct: 175 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 103/214 (48%), Gaps = 16/214 (7%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKGQLADGT-IIAVKQLSSKSRQG---NREFLNEIA 288
           K+ + A  +F+  + +G+G FG VY  +      I+A+K L     +      +   E+ 
Sbjct: 3   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 62
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL-ELDWPTRQKICL 347
           + S L+HPN+++++G   +  ++ L+ EY    ++      RE  +L + D         
Sbjct: 63  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY-----RELQKLSKFDEQRTATYIT 117
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            +A  L++ H +   +++HRDIK  N+LL      KI++FG +      +    T + GT
Sbjct: 118 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR---RTTLCGT 171
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           + Y+ PE         K D++S G++  E + GK
Sbjct: 172 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 27/208 (12%)
Query: 247 KIGEGGFGPVYKGQLADGTI------IAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
           +IG G F  VYKG   + T+      +  ++L+   RQ    F  E   +  LQHPN+V+
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ---RFKEEAEXLKGLQHPNIVR 89
Query: 301 IHG---CCVEGDQ-LLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICLGIARGLA 354
            +      V+G + ++LV E   + +L   L  F     ++   W      C  I +GL 
Sbjct: 90  FYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSW------CRQILKGLQ 143
Query: 355 FLHEESRFKIVHRDIKATNVLLDRDL-NPKISDFGLAKLDEGDKTHISTRIAGTIGYMAP 413
           FLH  +   I+HRD+K  N+ +     + KI D GLA L    +   +  + GT  + AP
Sbjct: 144 FLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFXAP 199
Query: 414 EYALWGYLTYKADVYSFGIVALEIVSGK 441
           E     Y     DVY+FG   LE  + +
Sbjct: 200 EXYEEKY-DESVDVYAFGXCXLEXATSE 226

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNR-----EFLNEIAMISCLQHPNLVK 300
           K++G G FG V KG      ++    +     + N      E L E  ++  L +P +V+
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQK----ICLGIARGLAFL 356
           + G C E +  +LV E  E         G  N  L+ +   + K    +   ++ G+ +L
Sbjct: 73  MIGIC-EAESWMLVMEMAE--------LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL 123
Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG--TIGYMAPE 414
            EES F  VHRD+ A NVLL      KISDFGL+K    D+ +   +  G   + + APE
Sbjct: 124 -EESNF--VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 415 YALWGYLTYKADVYSFGIVALEIVS 439
              +   + K+DV+SFG++  E  S
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 102/214 (47%), Gaps = 16/214 (7%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKGQLADGT-IIAVKQLSSKSRQG---NREFLNEIA 288
           K+ + A  +F+  + +G+G FG VY  +      I+A+K L     +      +   E+ 
Sbjct: 3   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 62
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL-ELDWPTRQKICL 347
           + S L+HPN+++++G   +  ++ L+ EY    ++      RE  +L + D         
Sbjct: 63  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY-----RELQKLSKFDEQRTATYIT 117
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            +A  L++ H +   +++HRDIK  N+LL      KI+DFG +      +      + GT
Sbjct: 118 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RXXLCGT 171
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           + Y+ PE         K D++S G++  E + GK
Sbjct: 172 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNR-----EFLNEIAMISCLQHPNLVK 300
           K++G G FG V KG      ++    +     + N      E L E  ++  L +P +V+
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQK----ICLGIARGLAFL 356
           + G C E +  +LV E  E         G  N  L+ +   + K    +   ++ G+ +L
Sbjct: 93  MIGIC-EAESWMLVMEMAE--------LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL 143
Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG--TIGYMAPE 414
            EES F  VHRD+ A NVLL      KISDFGL+K    D+ +   +  G   + + APE
Sbjct: 144 -EESNF--VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 200
Query: 415 YALWGYLTYKADVYSFGIVALEIVS 439
              +   + K+DV+SFG++  E  S
Sbjct: 201 CINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNR-----EFLNEIAMISCLQHPNLVK 300
           K++G G FG V KG      ++    +     + N      E L E  ++  L +P +V+
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQK----ICLGIARGLAFL 356
           + G C E +  +LV E  E         G  N  L+ +   + K    +   ++ G+ +L
Sbjct: 93  MIGIC-EAESWMLVMEMAE--------LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL 143
Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG--TIGYMAPE 414
            EES F  VHRD+ A NVLL      KISDFGL+K    D+ +   +  G   + + APE
Sbjct: 144 -EESNF--VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 200
Query: 415 YALWGYLTYKADVYSFGIVALEIVS 439
              +   + K+DV+SFG++  E  S
Sbjct: 201 CINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNR-----EFLNEIAMISCLQHPNLVK 300
           K++G G FG V KG      ++    +     + N      E L E  ++  L +P +V+
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQK----ICLGIARGLAFL 356
           + G C E +  +LV E  E         G  N  L+ +   + K    +   ++ G+ +L
Sbjct: 83  MIGIC-EAESWMLVMEMAE--------LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL 133
Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG--TIGYMAPE 414
            EES F  VHRD+ A NVLL      KISDFGL+K    D+ +   +  G   + + APE
Sbjct: 134 -EESNF--VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 190
Query: 415 YALWGYLTYKADVYSFGIVALEIVS 439
              +   + K+DV+SFG++  E  S
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNR-----EFLNEIAMISCLQHPNLVK 300
           K++G G FG V KG      ++    +     + N      E L E  ++  L +P +V+
Sbjct: 11  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 70
Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQK----ICLGIARGLAFL 356
           + G C E +  +LV E  E         G  N  L+ +   + K    +   ++ G+ +L
Sbjct: 71  MIGIC-EAESWMLVMEMAE--------LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL 121
Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG--TIGYMAPE 414
            EES F  VHRD+ A NVLL      KISDFGL+K    D+ +   +  G   + + APE
Sbjct: 122 -EESNF--VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 178
Query: 415 YALWGYLTYKADVYSFGIVALEIVS 439
              +   + K+DV+SFG++  E  S
Sbjct: 179 CINYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNR-----EFLNEIAMISCLQHPNLVK 300
           K++G G FG V KG      ++    +     + N      E L E  ++  L +P +V+
Sbjct: 31  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 90
Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQK----ICLGIARGLAFL 356
           + G C E +  +LV E  E         G  N  L+ +   + K    +   ++ G+ +L
Sbjct: 91  MIGIC-EAESWMLVMEMAE--------LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL 141
Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG--TIGYMAPE 414
            EES F  VHRD+ A NVLL      KISDFGL+K    D+ +   +  G   + + APE
Sbjct: 142 -EESNF--VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 198
Query: 415 YALWGYLTYKADVYSFGIVALEIVS 439
              +   + K+DV+SFG++  E  S
Sbjct: 199 CINYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 112/213 (52%), Gaps = 22/213 (10%)
Query: 240 NNFDSAKKIGEGGFGPVYK------GQLADGTIIAVKQLSSKSRQGNREFLN-EIAMISC 292
           ++++  +++G G F  V K      G+      I  ++LSS  R  +RE +  E+ ++  
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 71
Query: 293 LQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARG 352
           ++HPN++ +H        ++L+ E +    L   L  +E+  L  D  T  +    I  G
Sbjct: 72  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEAT--QFLKQILDG 127
Query: 353 LAFLHEESRFKIVHRDIKATNV-LLDRDL-NPKIS--DFGLA-KLDEGDKTHISTRIAGT 407
           + +LH +   +I H D+K  N+ LLD+++ NP+I   DFG+A K++ G++      I GT
Sbjct: 128 VHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGT 181
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             ++APE   +  L  +AD++S G++   ++SG
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 102/204 (50%), Gaps = 14/204 (6%)
Query: 242 FDSAKKIGEGGFGPVYKGQLADG-TIIAVKQ--LSSKSRQGNREFLNEIAMISCLQHPNL 298
           ++  +KIGEG +G V+K +  +   I+A+K+  L           L EI ++  L+H N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
           V++H       +L LV+E+ + +         ++C  +LD    +     + +GL F H 
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQDLKKYF----DSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALW 418
            +   ++HRD+K  N+L++R+   K+++FGLA+   G      +    T+ Y  P+  L+
Sbjct: 120 RN---VLHRDLKPQNLLINRNGELKLANFGLARA-FGIPVRCYSAEVVTLWYRPPD-VLF 174
Query: 419 GYLTYKA--DVYSFGIVALEIVSG 440
           G   Y    D++S G +  E+ + 
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANA 198

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 102/214 (47%), Gaps = 16/214 (7%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKGQLADGT-IIAVKQLSSKSRQG---NREFLNEIA 288
           K+ + A  +F+  + +G+G FG VY  +      I+A+K L     +      +   E+ 
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL-ELDWPTRQKICL 347
           + S L+HPN+++++G   +  ++ L+ EY    ++      RE  +L + D         
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY-----RELQKLSKFDEQRTATYIT 116
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            +A  L++ H +   +++HRDIK  N+LL      KI+DFG +      +      + GT
Sbjct: 117 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDT---LCGT 170
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           + Y+ PE         K D++S G++  E + GK
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNR-----EFLNEIAMISCLQHPNLVK 300
           K++G G FG V KG      ++    +     + N      E L E  ++  L +P +V+
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQK----ICLGIARGLAFL 356
           + G C E +  +LV E  E         G  N  L+ +   + K    +   ++ G+ +L
Sbjct: 77  MIGIC-EAESWMLVMEMAE--------LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL 127
Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG--TIGYMAPE 414
            EES F  VHRD+ A NVLL      KISDFGL+K    D+ +   +  G   + + APE
Sbjct: 128 -EESNF--VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 184
Query: 415 YALWGYLTYKADVYSFGIVALEIVS 439
              +   + K+DV+SFG++  E  S
Sbjct: 185 CINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/235 (23%), Positives = 113/235 (48%), Gaps = 23/235 (9%)
Query: 240 NNFDSAKKIGEGGFGPVYK-GQLADGTIIAVKQLSSKSRQGNR-EFLNEIAMISCLQHPN 297
           ++F+   ++G G  G V+K      G ++A K +  + +   R + + E+ ++     P 
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICLGIARGLAF 355
           +V  +G      ++ +  E+M+  SL   L   GR      +      K+ + + +GL +
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR------IPEQILGKVSIAVIKGLTY 181
Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEGDKTHISTRIAGTIGYMAP 413
           L E  + KI+HRD+K +N+L++     K+ DFG++   +D      ++    GT  YM+P
Sbjct: 182 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSP 234
Query: 414 EYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDG 468
           E     + + ++D++S G+  +E+  G+  +    A E +    L + C ++ D 
Sbjct: 235 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE----LMFGCQVEGDA 285

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNR-----EFLNEIAMISCLQHPNLVK 300
           K++G G FG V KG      ++    +     + N      E L E  ++  L +P +V+
Sbjct: 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 434
Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQK----ICLGIARGLAFL 356
           + G C E +  +LV E  E         G  N  L+ +   + K    +   ++ G+ +L
Sbjct: 435 MIGIC-EAESWMLVMEMAE--------LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL 485
Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG--TIGYMAPE 414
            EES F  VHRD+ A NVLL      KISDFGL+K    D+ +   +  G   + + APE
Sbjct: 486 -EESNF--VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 542
Query: 415 YALWGYLTYKADVYSFGIVALEIVS 439
              +   + K+DV+SFG++  E  S
Sbjct: 543 CINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/235 (23%), Positives = 113/235 (48%), Gaps = 23/235 (9%)
Query: 240 NNFDSAKKIGEGGFGPVYK-GQLADGTIIAVKQLSSKSRQGNR-EFLNEIAMISCLQHPN 297
           ++F+   ++G G  G V+K      G ++A K +  + +   R + + E+ ++     P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICLGIARGLAF 355
           +V  +G      ++ +  E+M+  SL   L   GR      +      K+ + + +GL +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR------IPEQILGKVSIAVIKGLTY 119
Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEGDKTHISTRIAGTIGYMAP 413
           L E  + KI+HRD+K +N+L++     K+ DFG++   +D      ++    GT  YM+P
Sbjct: 120 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSP 172
Query: 414 EYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDG 468
           E     + + ++D++S G+  +E+  G+  +    A E +    L + C ++ D 
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE----LMFGCQVEGDA 223

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNR-----EFLNEIAMISCLQHPNLVK 300
           K++G G FG V KG      ++    +     + N      E L E  ++  L +P +V+
Sbjct: 376 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 435
Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQK----ICLGIARGLAFL 356
           + G C E +  +LV E  E         G  N  L+ +   + K    +   ++ G+ +L
Sbjct: 436 MIGIC-EAESWMLVMEMAE--------LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL 486
Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG--TIGYMAPE 414
            EES F  VHRD+ A NVLL      KISDFGL+K    D+ +   +  G   + + APE
Sbjct: 487 -EESNF--VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 543
Query: 415 YALWGYLTYKADVYSFGIVALEIVS 439
              +   + K+DV+SFG++  E  S
Sbjct: 544 CINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQLADGT-IIAVKQLSSKSRQG---NREFLNEIAMISCL 293
           A  +F+  + +G+G FG VY  +      I+A+K L     +      +   E+ + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL-ELDWPTRQKICLGIARG 352
           +HPN+++++G   +  ++ L+ EY    ++      RE  +L + D          +A  
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVY-----RELQKLSKFDEQRTATYITELANA 120
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMA 412
           L++ H +   +++HRDIK  N+LL      KI+DFG +      +      + GT+ Y+ 
Sbjct: 121 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RXXLCGTLDYLP 174
Query: 413 PEYALWGYLTYKADVYSFGIVALEIVSGK 441
           PE         K D++S G++  E + GK
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/235 (23%), Positives = 113/235 (48%), Gaps = 23/235 (9%)
Query: 240 NNFDSAKKIGEGGFGPVYK-GQLADGTIIAVKQLSSKSRQGNR-EFLNEIAMISCLQHPN 297
           ++F+   ++G G  G V+K      G ++A K +  + +   R + + E+ ++     P 
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICLGIARGLAF 355
           +V  +G      ++ +  E+M+  SL   L   GR      +      K+ + + +GL +
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR------IPEQILGKVSIAVIKGLTY 146
Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEGDKTHISTRIAGTIGYMAP 413
           L E  + KI+HRD+K +N+L++     K+ DFG++   +D      ++    GT  YM+P
Sbjct: 147 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSP 199
Query: 414 EYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDG 468
           E     + + ++D++S G+  +E+  G+  +    A E +    L + C ++ D 
Sbjct: 200 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE----LMFGCQVEGDA 250

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 91/211 (43%), Gaps = 14/211 (6%)
Query: 236 KAATNNFDSAKKIGEGGFGPV-YKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ 294
           K   N+FD  K +G+G FG V    + A G   A+K L  +      E  + +     LQ
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 295 ---HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC-LGIA 350
              HP L  +       D+L  V EY     L   L  RE    E     R +     I 
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTE----ERARFYGAEIV 115
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
             L +LH      +V+RDIK  N++LD+D + KI+DFGL K    D   + T   GT  Y
Sbjct: 116 SALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEY 171
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           +APE           D +  G+V  E++ G+
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 98/213 (46%), Gaps = 14/213 (6%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKGQLADGT-IIAVKQLSSKSRQG---NREFLNEIA 288
           K+ + A  +F+  + +G+G FG VY  +      I+A+K L     +      +   E+ 
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLG 348
           + S L+HPN+++++G   +  ++ L+ EY     +   L        + D          
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLS----KFDEQRTATYITE 121
Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTI 408
           +A  L++ H +   +++HRDIK  N+LL      KI+DFG +      +      + GT+
Sbjct: 122 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RXXLXGTL 175
Query: 409 GYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
            Y+ PE         K D++S G++  E + GK
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 91/211 (43%), Gaps = 14/211 (6%)
Query: 236 KAATNNFDSAKKIGEGGFGPV-YKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ 294
           K   N+FD  K +G+G FG V    + A G   A+K L  +      E  + +     LQ
Sbjct: 4   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 63
Query: 295 ---HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC-LGIA 350
              HP L  +       D+L  V EY     L   L  RE    E     R +     I 
Sbjct: 64  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTE----ERARFYGAEIV 118
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
             L +LH      +V+RDIK  N++LD+D + KI+DFGL K    D   + T   GT  Y
Sbjct: 119 SALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEY 174
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           +APE           D +  G+V  E++ G+
Sbjct: 175 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/235 (23%), Positives = 113/235 (48%), Gaps = 23/235 (9%)
Query: 240 NNFDSAKKIGEGGFGPVYK-GQLADGTIIAVKQLSSKSRQGNR-EFLNEIAMISCLQHPN 297
           ++F+   ++G G  G V+K      G ++A K +  + +   R + + E+ ++     P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICLGIARGLAF 355
           +V  +G      ++ +  E+M+  SL   L   GR      +      K+ + + +GL +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR------IPEQILGKVSIAVIKGLTY 119
Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEGDKTHISTRIAGTIGYMAP 413
           L E  + KI+HRD+K +N+L++     K+ DFG++   +D      ++    GT  YM+P
Sbjct: 120 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSP 172
Query: 414 EYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDG 468
           E     + + ++D++S G+  +E+  G+  +    A E +    L + C ++ D 
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE----LMFGCQVEGDA 223

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 91/211 (43%), Gaps = 14/211 (6%)
Query: 236 KAATNNFDSAKKIGEGGFGPV-YKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ 294
           K   N+FD  K +G+G FG V    + A G   A+K L  +      E  + +     LQ
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 295 ---HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC-LGIA 350
              HP L  +       D+L  V EY     L   L  RE    E     R +     I 
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTE----ERARFYGAEIV 115
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
             L +LH      +V+RDIK  N++LD+D + KI+DFGL K    D   + T   GT  Y
Sbjct: 116 SALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEY 171
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           +APE           D +  G+V  E++ G+
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQLADGT-IIAVKQLSSKSRQG---NREFLNEIAMISCL 293
           A  +F+  + +G+G FG VY  +      I+A+K L     +      +   E+ + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL-ELDWPTRQKICLGIARG 352
           +HPN+++++G   +  ++ L+ EY    ++      RE  +L + D          +A  
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVY-----RELQKLSKFDEQRTATYITELANA 120
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMA 412
           L++ H +   +++HRDIK  N+LL      KI+DFG +      +      + GT+ Y+ 
Sbjct: 121 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RAALCGTLDYLP 174
Query: 413 PEYALWGYLTYKADVYSFGIVALEIVSGK 441
           PE         K D++S G++  E + GK
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQLADGT-IIAVKQLSSKSRQG---NREFLNEIAMISCL 293
           A  +F+  + +G+G FG VY  +      I+A+K L     +      +   E+ + S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL-ELDWPTRQKICLGIARG 352
           +HPN+++++G   +  ++ L+ EY    ++      RE  +L + D          +A  
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVY-----RELQKLSKFDEQRTATYITELANA 123
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMA 412
           L++ H +   +++HRDIK  N+LL      KI+DFG +      +      + GT+ Y+ 
Sbjct: 124 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RAALCGTLDYLP 177
Query: 413 PEYALWGYLTYKADVYSFGIVALEIVSGK 441
           PE         K D++S G++  E + GK
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 100/200 (50%), Gaps = 18/200 (9%)
Query: 248 IGEGGFGPVYKGQ----LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHG 303
           +G+G FG V K +      +  +  + + S+K++  +   L E+ ++  L HPN++K+  
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST-ILREVELLKKLDHPNIMKLFE 88
Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFK 363
              +     +V E      L   +  R+    E D     +I   +  G+ ++H   +  
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFS-EHDAA---RIIKQVFSGITYMH---KHN 141
Query: 364 IVHRDIKATNVLL---DRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGY 420
           IVHRD+K  N+LL   ++D + KI DFGL+   + + T +  RI GT  Y+APE  L G 
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTAYYIAPE-VLRGT 198
Query: 421 LTYKADVYSFGIVALEIVSG 440
              K DV+S G++   ++SG
Sbjct: 199 YDEKCDVWSAGVILYILLSG 218

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/235 (23%), Positives = 113/235 (48%), Gaps = 23/235 (9%)
Query: 240 NNFDSAKKIGEGGFGPVYK-GQLADGTIIAVKQLSSKSRQGNR-EFLNEIAMISCLQHPN 297
           ++F+   ++G G  G V+K      G ++A K +  + +   R + + E+ ++     P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICLGIARGLAF 355
           +V  +G      ++ +  E+M+  SL   L   GR      +      K+ + + +GL +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR------IPEQILGKVSIAVIKGLTY 119
Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEGDKTHISTRIAGTIGYMAP 413
           L E  + KI+HRD+K +N+L++     K+ DFG++   +D      ++    GT  YM+P
Sbjct: 120 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSP 172
Query: 414 EYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDG 468
           E     + + ++D++S G+  +E+  G+  +    A E +    L + C ++ D 
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE----LMFGCQVEGDA 223

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/235 (23%), Positives = 113/235 (48%), Gaps = 23/235 (9%)
Query: 240 NNFDSAKKIGEGGFGPVYK-GQLADGTIIAVKQLSSKSRQGNR-EFLNEIAMISCLQHPN 297
           ++F+   ++G G  G V+K      G ++A K +  + +   R + + E+ ++     P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICLGIARGLAF 355
           +V  +G      ++ +  E+M+  SL   L   GR      +      K+ + + +GL +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR------IPEQILGKVSIAVIKGLTY 119
Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEGDKTHISTRIAGTIGYMAP 413
           L E  + KI+HRD+K +N+L++     K+ DFG++   +D      ++    GT  YM+P
Sbjct: 120 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSP 172
Query: 414 EYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDG 468
           E     + + ++D++S G+  +E+  G+  +    A E +    L + C ++ D 
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE----LMFGCQVEGDA 223

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 92/197 (46%), Gaps = 12/197 (6%)
Query: 248 IGEGGFGPVYKG----QLADGTIIAVKQLSSKSRQGNRE-FLNEIAMISCLQHPNLVKIH 302
           +GEG FG VY+G       +   +AVK         N+E F++E  ++  L HP++VK+ 
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRF 362
           G  +E +   ++ E      L   L   +N    L   T     L I + +A+L      
Sbjct: 80  GI-IEEEPTWIIMELYPYGELGHYLERNKN---SLKVLTLVLYSLQICKAMAYLES---I 132
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLT 422
             VHRDI   N+L+      K+ DFGL++  E +  + ++     I +M+PE   +   T
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT 192
Query: 423 YKADVYSFGIVALEIVS 439
             +DV+ F +   EI+S
Sbjct: 193 TASDVWMFAVCMWEILS 209

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 92/197 (46%), Gaps = 12/197 (6%)
Query: 248 IGEGGFGPVYKG----QLADGTIIAVKQLSSKSRQGNRE-FLNEIAMISCLQHPNLVKIH 302
           +GEG FG VY+G       +   +AVK         N+E F++E  ++  L HP++VK+ 
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRF 362
           G  +E +   ++ E      L   L   +N    L   T     L I + +A+L      
Sbjct: 76  GI-IEEEPTWIIMELYPYGELGHYLERNKN---SLKVLTLVLYSLQICKAMAYLES---I 128
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLT 422
             VHRDI   N+L+      K+ DFGL++  E +  + ++     I +M+PE   +   T
Sbjct: 129 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT 188
Query: 423 YKADVYSFGIVALEIVS 439
             +DV+ F +   EI+S
Sbjct: 189 TASDVWMFAVCMWEILS 205

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 37/226 (16%)
Query: 241 NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
           +F   + IG GGFG V+K +   DG    ++++   + +  RE    +  ++ L H N+V
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAERE----VKALAKLDHVNIV 68
Query: 300 KIHGC-------CVEGDQLLLVYEYMENNS-------LACALFGRENCEL---------- 335
             +GC           D  L   +Y   NS         C     E C+           
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 336 ---ELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL 392
              +LD     ++   I +G+ ++H +   K++HRD+K +N+ L      KI DFGL   
Sbjct: 129 RGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVTS 185
Query: 393 DEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIV 438
            + D     TR  GT+ YM+PE         + D+Y+ G++  E++
Sbjct: 186 LKNDGKR--TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 104/208 (50%), Gaps = 19/208 (9%)
Query: 240 NNFDSAKKIGEGGFGPVYK-GQLADGTIIAVKQLSSKSRQGNR-EFLNEIAMISCLQHPN 297
           ++F+   ++G G  G V+K      G ++A K +  + +   R + + E+ ++     P 
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICLGIARGLAF 355
           +V  +G      ++ +  E+M+  SL   L   GR      +      K+ + + +GL +
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR------IPEQILGKVSIAVIKGLTY 122
Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEGDKTHISTRIAGTIGYMAP 413
           L E  + KI+HRD+K +N+L++     K+ DFG++   +DE     ++    GT  YM+P
Sbjct: 123 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDE-----MANEFVGTRSYMSP 175
Query: 414 EYALWGYLTYKADVYSFGIVALEIVSGK 441
           E     + + ++D++S G+  +E+  G+
Sbjct: 176 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 92/197 (46%), Gaps = 12/197 (6%)
Query: 248 IGEGGFGPVYKG----QLADGTIIAVKQLSSKSRQGNRE-FLNEIAMISCLQHPNLVKIH 302
           +GEG FG VY+G       +   +AVK         N+E F++E  ++  L HP++VK+ 
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRF 362
           G  +E +   ++ E      L   L   +N    L   T     L I + +A+L      
Sbjct: 92  GI-IEEEPTWIIMELYPYGELGHYLERNKN---SLKVLTLVLYSLQICKAMAYLES---I 144
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLT 422
             VHRDI   N+L+      K+ DFGL++  E +  + ++     I +M+PE   +   T
Sbjct: 145 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT 204
Query: 423 YKADVYSFGIVALEIVS 439
             +DV+ F +   EI+S
Sbjct: 205 TASDVWMFAVCMWEILS 221

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 118/273 (43%), Gaps = 26/273 (9%)
Query: 247 KIGEGGFGPVYKG-QLADGTIIAVKQL-SSKSRQGNREFLNEI-AMISCLQHPNLVKIHG 303
           +IG G +G V K      G I+AVK++ S+   +  ++ L ++  ++     P +V+ +G
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFK 363
                    +  E M  +      +     +  +      KI L   + L  L E    K
Sbjct: 89  ALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LK 146
Query: 364 IVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEY-----ALW 418
           I+HRDIK +N+LLDR  N K+ DFG++   +   +   TR AG   YMAPE      +  
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGIS--GQLVDSIAKTRDAGCRPYMAPERIDPSASRQ 204
Query: 419 GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERL 478
           GY   ++DV+S GI   E+ +G+    Y             W     Q  ++V+    +L
Sbjct: 205 GY-DVRSDVWSLGITLYELATGR--FPYP-----------KWNSVFDQLTQVVKGDPPQL 250
Query: 479 GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
            +  ++E +   I    LC     S RP   E+
Sbjct: 251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKEL 283

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 108/245 (44%), Gaps = 37/245 (15%)
Query: 211 TKRHKETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAV 269
           T  HKE       +L       K I      + +   +G G +G V     +  G  IAV
Sbjct: 28  TMSHKERPTFYRQELN------KTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAV 81
Query: 270 KQLSS--KSRQGNREFLNEIAMISCLQHPNLVKIHGCCV------EGDQLLLVYEYME-- 319
           K+LS   +S    +    E+ ++  ++H N++ +           E + + LV   M   
Sbjct: 82  KKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGAD 141
Query: 320 -NNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR 378
            NN + C     ++          Q +   I RGL ++H      I+HRD+K +N+ ++ 
Sbjct: 142 LNNIVKCQKLTDDHV---------QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNE 189
Query: 379 DLNPKISDFGLAKLDEGDKT-HISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALE 436
           D   KI DFGLA+  + + T +++TR      Y APE  L W +     D++S G +  E
Sbjct: 190 DCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNMTVDIWSVGCIMAE 244
Query: 437 IVSGK 441
           +++G+
Sbjct: 245 LLTGR 249

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNR-----EFLNEIAMISCLQHPNLVK 300
           K++G G FG V KG      ++    +     + N      E L E  ++  L +P +V+
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQK----ICLGIARGLAFL 356
           + G C E +  +LV E  E         G  N  L+ +   + K    +   ++ G+ +L
Sbjct: 77  MIGIC-EAESWMLVMEMAE--------LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL 127
Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG--TIGYMAPE 414
            EES F  VHRD+ A NVLL      KISDFGL+K    D+     +  G   + + APE
Sbjct: 128 -EESNF--VHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPE 184
Query: 415 YALWGYLTYKADVYSFGIVALEIVS 439
              +   + K+DV+SFG++  E  S
Sbjct: 185 CINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 16/206 (7%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQLADGT-IIAVKQLSSKSRQG---NREFLNEIAMISCLQH 295
            +FD  + +G+G FG VY  +      I+A+K L     +      +   E+ + S L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL-ELDWPTRQKICLGIARGLA 354
           PN+++++G   +  ++ L+ EY    ++      RE  +L   D          +A  L+
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVY-----RELQKLSRFDEQRTATYITELANALS 126
Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPE 414
           + H +   +++HRDIK  N+LL  +   KI+DFG +      +      + GT+ Y+ PE
Sbjct: 127 YCHSK---RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDT---LCGTLDYLPPE 180
Query: 415 YALWGYLTYKADVYSFGIVALEIVSG 440
                    K D++S G++  E + G
Sbjct: 181 MIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQLADGT-IIAVKQLSSKSRQG---NREFLNEIAMISCL 293
           A  +F+  + +G+G FG VY  +      I+A+K L     +      +   E+ + S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL-ELDWPTRQKICLGIARG 352
           +HPN+++++G   +  ++ L+ EY    ++      RE  +L + D          +A  
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVY-----RELQKLSKFDEQRTATYITELANA 123
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMA 412
           L++ H +   +++HRDIK  N+LL      KI+DFG +      +      + GT+ Y+ 
Sbjct: 124 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RDDLCGTLDYLP 177
Query: 413 PEYALWGYLTYKADVYSFGIVALEIVSGK 441
           PE         K D++S G++  E + GK
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 101/200 (50%), Gaps = 18/200 (9%)
Query: 248 IGEGGFGPVYKGQ----LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHG 303
           +G+G FG V K +      +  +  + + S+K++  +   L E+ ++  L HPN++K+  
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-TILREVELLKKLDHPNIMKLFE 88
Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFK 363
              +     +V E      L   +  R+    E D     +I   +  G+ ++H+ +   
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFS-EHD---AARIIKQVFSGITYMHKHN--- 141
Query: 364 IVHRDIKATNVLL---DRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGY 420
           IVHRD+K  N+LL   ++D + KI DFGL+   + + T +  RI GT  Y+APE  L G 
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTAYYIAPE-VLRGT 198
Query: 421 LTYKADVYSFGIVALEIVSG 440
              K DV+S G++   ++SG
Sbjct: 199 YDEKCDVWSAGVILYILLSG 218

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 102/214 (47%), Gaps = 16/214 (7%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKGQLADGT-IIAVKQLSSKSRQG---NREFLNEIA 288
           K+ + A  +F+  + +G+G FG VY  +      I+A+K L     +      +   E+ 
Sbjct: 27  KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 86
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL-ELDWPTRQKICL 347
           + S L+HPN+++++G   +  ++ L+ EY    ++      RE  +L + D         
Sbjct: 87  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY-----RELQKLSKFDEQRTATYIT 141
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            +A  L++ H +   +++HRDIK  N+LL      KI+DFG +      +      + GT
Sbjct: 142 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RDDLCGT 195
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           + Y+ PE         K D++S G++  E + GK
Sbjct: 196 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 22/218 (10%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFL-----NEIAMIS 291
           AT+ ++   +IG G +G VYK +    G  +A+K +   +  G    L      E+A++ 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 292 CLQ---HPNLVKIHGCCVEGD-----QLLLVYEYMENNSLACALFGRENCELELDWPTRQ 343
            L+   HPN+V++   C         ++ LV+E+++ + L   L       L  +  T +
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPGLPAE--TIK 123
Query: 344 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR 403
            +     RGL FLH      IVHRD+K  N+L+      K++DFGLA++         T 
Sbjct: 124 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LTP 178
Query: 404 IAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           +  T+ Y APE  L        D++S G +  E+   K
Sbjct: 179 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 105/210 (50%), Gaps = 18/210 (8%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSK---SRQGNREFLNEIAMISCLQH 295
           ++F+  + IG+G FG V   Q  D   + A+K ++ +    R   R    E+ ++  L+H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           P LV +     + + + +V + +    L   L  ++N   + +  T +     +   L +
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL--QQNVHFKEE--TVKLFICELVMALDY 130
Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEY 415
           L  +   +I+HRD+K  N+LLD   +  I+DF +A +   + T I+T +AGT  YMAPE 
Sbjct: 131 LQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITT-MAGTKPYMAPEM 185
Query: 416 AL----WGYLTYKADVYSFGIVALEIVSGK 441
                  GY ++  D +S G+ A E++ G+
Sbjct: 186 FSSRKGAGY-SFAVDWWSLGVTAYELLRGR 214

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 101/200 (50%), Gaps = 18/200 (9%)
Query: 248 IGEGGFGPVYKGQ----LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHG 303
           +G+G FG V K +      +  +  + + S+K++  +   L E+ ++  L HPN++K+  
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-TILREVELLKKLDHPNIMKLFE 88
Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFK 363
              +     +V E      L   +  R+    E D     +I   +  G+ ++H+ +   
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFS-EHD---AARIIKQVFSGITYMHKHN--- 141
Query: 364 IVHRDIKATNVLL---DRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGY 420
           IVHRD+K  N+LL   ++D + KI DFGL+   + + T +  RI GT  Y+APE  L G 
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTAYYIAPE-VLRGT 198
Query: 421 LTYKADVYSFGIVALEIVSG 440
              K DV+S G++   ++SG
Sbjct: 199 YDEKCDVWSAGVILYILLSG 218

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 21/207 (10%)
Query: 242 FDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
           +D  +++G G FG V++  + A G +   K +++          NEI++++ L HP L+ 
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIAR----GLAFL 356
           +H    +  +++L+ E++        LF R   E   D+   +   +   R    GL  +
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGE----LFDRIAAE---DYKMSEAEVINYMRQACEGLKHM 165
Query: 357 HEESRFKIVHRDIKATNVLLD--RDLNPKISDFGLA-KLDEGDKTHISTRIAGTIGYMAP 413
           HE S   IVH DIK  N++ +  +  + KI DFGLA KL+  +   ++T    T  + AP
Sbjct: 166 HEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAP 219
Query: 414 EYALWGYLTYKADVYSFGIVALEIVSG 440
           E      + +  D+++ G++   ++SG
Sbjct: 220 EIVDREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 97/223 (43%), Gaps = 27/223 (12%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSK-SRQGNREFLNEIA 288
           +    N    + +G G FG VY+GQ++          +AVK L    S Q   +FL E  
Sbjct: 27  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 86
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALF---GRENCELELDWPTRQKI 345
           +IS L H N+V+  G  ++     ++ E M    L   L     R +    L       +
Sbjct: 87  IISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 146
Query: 346 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP----KISDFGLAKLDEGDKTHIS 401
              IA G  +L EE+ F  +HRDI A N LL     P    KI DFG+A+    D    S
Sbjct: 147 ARDIACGCQYL-EENHF--IHRDIAARNCLLTCP-GPGRVAKIGDFGMAR----DIYRAS 198
Query: 402 TRIAG-----TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
               G      + +M PE  + G  T K D +SFG++  EI S
Sbjct: 199 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 111/213 (52%), Gaps = 22/213 (10%)
Query: 240 NNFDSAKKIGEGGFGPVYK------GQLADGTIIAVKQLSSKSRQGNREFLN-EIAMISC 292
           ++++  +++G G F  V K      G+      I  ++L S  R  +RE +  E+ ++  
Sbjct: 26  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILRE 85
Query: 293 LQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARG 352
           ++HPN++ +H        ++L+ E +    L   L  +E+  L  D  T  +    I  G
Sbjct: 86  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEAT--QFLKQILDG 141
Query: 353 LAFLHEESRFKIVHRDIKATNV-LLDRDL-NPKIS--DFGLA-KLDEGDKTHISTRIAGT 407
           + +LH +   +I H D+K  N+ LLD+++ NP+I   DFG+A K++ G++      I GT
Sbjct: 142 VHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGT 195
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             ++APE   +  L  +AD++S G++   ++SG
Sbjct: 196 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 105/230 (45%), Gaps = 41/230 (17%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNL 298
           ++F+    +G+G FG V K + A D    A+K++   + +     L+E+ +++ L H  +
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVXLLASLNHQYV 64
Query: 299 VKIHGCCVE-------------GDQLLLVYEYMENNSLACALFGRENCELELD--WPTRQ 343
           V+ +   +E                L +  EY EN +L   L   EN   + D  W    
Sbjct: 65  VRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTL-YDLIHSENLNQQRDEYW---- 119
Query: 344 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA----------KLD 393
           ++   I   L+++H +    I+HR++K  N+ +D   N KI DFGLA          KLD
Sbjct: 120 RLFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 394 E----GDKTHISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIV 438
                G   ++++ I GT  Y+A E     G+   K D YS GI+  E +
Sbjct: 177 SQNLPGSSDNLTSAI-GTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 97/223 (43%), Gaps = 27/223 (12%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSK-SRQGNREFLNEIA 288
           +    N    + +G G FG VY+GQ++          +AVK L    S Q   +FL E  
Sbjct: 41  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 100
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALF---GRENCELELDWPTRQKI 345
           +IS L H N+V+  G  ++     ++ E M    L   L     R +    L       +
Sbjct: 101 IISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 160
Query: 346 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP----KISDFGLAKLDEGDKTHIS 401
              IA G  +L EE+ F  +HRDI A N LL     P    KI DFG+A+    D    S
Sbjct: 161 ARDIACGCQYL-EENHF--IHRDIAARNCLLTCP-GPGRVAKIGDFGMAR----DIYRAS 212
Query: 402 TRIAG-----TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
               G      + +M PE  + G  T K D +SFG++  EI S
Sbjct: 213 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 101/225 (44%), Gaps = 35/225 (15%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPV---YKGQLADGTIIAVKQLSS--KSRQGNREFLNEI 287
           K +          + +G G +G V   Y  +L     +AVK+LS   +S    R    E+
Sbjct: 13  KTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQK--VAVKKLSRPFQSLIHARRTYREL 70
Query: 288 AMISCLQHPNLVKI-----HGCCVEG-DQLLLVYEYME---NNSLACALFGRENCELELD 338
            ++  L+H N++ +         +E   ++ LV   M    NN + C     E+      
Sbjct: 71  RLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHV----- 125
Query: 339 WPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDK 397
               Q +   + RGL ++H      I+HRD+K +NV ++ D   +I DFGLA+  DE   
Sbjct: 126 ----QFLVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADEEMT 178
Query: 398 THISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
            +++TR      Y APE  L W +     D++S G +  E++ GK
Sbjct: 179 GYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 18/223 (8%)
Query: 232 LKQIKAATNNFDSAKKIGEGGFGPVYKGQLA--DGTII--AVKQLSSK--SRQGNREFLN 285
           L+ +      F   + +G+G FG V + QL   DG+ +  AVK L +   +     EFL 
Sbjct: 15  LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR 74
Query: 286 EIAMISCLQHPNLVKIHGCCVEGDQ------LLLVYEYMENNSLACALFGRENCELELDW 339
           E A +    HP++ K+ G  +           +++  +M++  L   L      E   + 
Sbjct: 75  EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134
Query: 340 P--TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGD 396
           P  T  +  + IA G+ +L   S    +HRD+ A N +L  D+   ++DFGL+ K+  GD
Sbjct: 135 PLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
Query: 397 KTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
                      + ++A E       T  +DV++FG+   EI++
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 19/215 (8%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREF--LNEIAMISCLQ 294
           AT+ ++   +IG G +G VYK +    G  +A+K +   + +       + E+A++  L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 295 ---HPNLVKIHGCCVEGD-----QLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC 346
              HPN+V++   C         ++ LV+E+++ + L   L       L  +  T + + 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPGLPAE--TIKDLM 118
Query: 347 LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG 406
               RGL FLH      IVHRD+K  N+L+      K++DFGLA++           +  
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV-- 173
Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           T+ Y APE  L        D++S G +  E+   K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 29/215 (13%)
Query: 241 NFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
           ++   K IG G FG VY+ +L D G ++A+K++    R  NRE    + ++  L H N+V
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 110
Query: 300 KI----HGCCVEGDQ--LLLVYEYMENNSLACAL-FGRENCELELDWPTRQKICLGIARG 352
           ++    +    + D+  L LV +Y+       A  + R    L + +   +     + R 
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY--VKLYMYQLFRS 168
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNP-KISDFGLAK---LDEGDKTHISTRIAGTI 408
           LA++H    F I HRDIK  N+LLD D    K+ DFG AK     E + ++I +R     
Sbjct: 169 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---- 221
Query: 409 GYMAPEYALWGYLTYKA--DVYSFGIVALEIVSGK 441
            Y APE  ++G   Y +  DV+S G V  E++ G+
Sbjct: 222 -YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 90/211 (42%), Gaps = 14/211 (6%)
Query: 236 KAATNNFDSAKKIGEGGFGPV-YKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ 294
           K   N+FD  K +G+G FG V    + A G   A+K L  +      E  + +     LQ
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 295 ---HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC-LGIA 350
              HP L  +       D+L  V EY     L   L  RE    E     R +     I 
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTE----ERARFYGAEIV 115
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
             L +LH      +V+RDIK  N++LD+D + KI+DFGL K    D   +     GT  Y
Sbjct: 116 SALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX-FCGTPEY 171
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           +APE           D +  G+V  E++ G+
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 29/215 (13%)
Query: 241 NFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
           ++   K IG G FG VY+ +L D G ++A+K++    R  NRE    + ++  L H N+V
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 112
Query: 300 KI----HGCCVEGDQ--LLLVYEYMENNSLACAL-FGRENCELELDWPTRQKICLGIARG 352
           ++    +    + D+  L LV +Y+       A  + R    L + +   +     + R 
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY--VKLYMYQLFRS 170
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNP-KISDFGLAK---LDEGDKTHISTRIAGTI 408
           LA++H    F I HRDIK  N+LLD D    K+ DFG AK     E + ++I +R     
Sbjct: 171 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---- 223
Query: 409 GYMAPEYALWGYLTYKA--DVYSFGIVALEIVSGK 441
            Y APE  ++G   Y +  DV+S G V  E++ G+
Sbjct: 224 -YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 90/211 (42%), Gaps = 14/211 (6%)
Query: 236 KAATNNFDSAKKIGEGGFGPV-YKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ 294
           K   N+FD  K +G+G FG V    + A G   A+K L  +      E  + +     LQ
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 295 ---HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC-LGIA 350
              HP L  +       D+L  V EY     L   L  RE    E     R +     I 
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTE----ERARFYGAEIV 115
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
             L +LH      +V+RDIK  N++LD+D + KI+DFGL K    D   +     GT  Y
Sbjct: 116 SALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX-FCGTPEY 171
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           +APE           D +  G+V  E++ G+
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 29/215 (13%)
Query: 241 NFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
           ++   K IG G FG VY+ +L D G ++A+K++    R  NRE    + ++  L H N+V
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 81
Query: 300 KI----HGCCVEGDQ--LLLVYEYMENNSLACAL-FGRENCELELDWPTRQKICLGIARG 352
           ++    +    + D+  L LV +Y+       A  + R    L + +   +     + R 
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY--VKLYMYQLFRS 139
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNP-KISDFGLAK---LDEGDKTHISTRIAGTI 408
           LA++H    F I HRDIK  N+LLD D    K+ DFG AK     E + ++I +R     
Sbjct: 140 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---- 192
Query: 409 GYMAPEYALWGYLTYKA--DVYSFGIVALEIVSGK 441
            Y APE  ++G   Y +  DV+S G V  E++ G+
Sbjct: 193 -YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 90/211 (42%), Gaps = 14/211 (6%)
Query: 236 KAATNNFDSAKKIGEGGFGPV-YKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ 294
           K   N+FD  K +G+G FG V    + A G   A+K L  +      E  + +     LQ
Sbjct: 6   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 65
Query: 295 ---HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC-LGIA 350
              HP L  +       D+L  V EY     L   L  RE    E     R +     I 
Sbjct: 66  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTE----ERARFYGAEIV 120
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
             L +LH      +V+RDIK  N++LD+D + KI+DFGL K    D   +     GT  Y
Sbjct: 121 SALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX-FCGTPEY 176
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           +APE           D +  G+V  E++ G+
Sbjct: 177 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 90/211 (42%), Gaps = 14/211 (6%)
Query: 236 KAATNNFDSAKKIGEGGFGPV-YKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ 294
           K   N+FD  K +G+G FG V    + A G   A+K L  +      E  + +     LQ
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 295 ---HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC-LGIA 350
              HP L  +       D+L  V EY     L   L  RE    E     R +     I 
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTE----ERARFYGAEIV 115
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
             L +LH      +V+RDIK  N++LD+D + KI+DFGL K    D   +     GT  Y
Sbjct: 116 SALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX-FCGTPEY 171
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           +APE           D +  G+V  E++ G+
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 29/215 (13%)
Query: 241 NFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
           ++   K IG G FG VY+ +L D G ++A+K++    R  NRE    + ++  L H N+V
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 104
Query: 300 KI----HGCCVEGDQ--LLLVYEYMENNSLACAL-FGRENCELELDWPTRQKICLGIARG 352
           ++    +    + D+  L LV +Y+       A  + R    L + +   +     + R 
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY--VKLYMYQLFRS 162
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNP-KISDFGLAK---LDEGDKTHISTRIAGTI 408
           LA++H    F I HRDIK  N+LLD D    K+ DFG AK     E + ++I +R     
Sbjct: 163 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---- 215
Query: 409 GYMAPEYALWGYLTYKA--DVYSFGIVALEIVSGK 441
            Y APE  ++G   Y +  DV+S G V  E++ G+
Sbjct: 216 -YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 101/225 (44%), Gaps = 35/225 (15%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPV---YKGQLADGTIIAVKQLSS--KSRQGNREFLNEI 287
           K +          + +G G +G V   Y  +L     +AVK+LS   +S    R    E+
Sbjct: 21  KTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQK--VAVKKLSRPFQSLIHARRTYREL 78
Query: 288 AMISCLQHPNLVKI-----HGCCVEG-DQLLLVYEYME---NNSLACALFGRENCELELD 338
            ++  L+H N++ +         +E   ++ LV   M    NN + C     E+      
Sbjct: 79  RLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHV----- 133
Query: 339 WPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDK 397
               Q +   + RGL ++H      I+HRD+K +NV ++ D   +I DFGLA+  DE   
Sbjct: 134 ----QFLVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMT 186
Query: 398 THISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
            +++TR      Y APE  L W +     D++S G +  E++ GK
Sbjct: 187 GYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 29/215 (13%)
Query: 241 NFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
           ++   K IG G FG VY+ +L D G ++A+K++    R  NRE    + ++  L H N+V
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 114
Query: 300 KI----HGCCVEGDQ--LLLVYEYMENNSLACAL-FGRENCELELDWPTRQKICLGIARG 352
           ++    +    + D+  L LV +Y+       A  + R    L + +   +     + R 
Sbjct: 115 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY--VKLYMYQLFRS 172
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNP-KISDFGLAK---LDEGDKTHISTRIAGTI 408
           LA++H    F I HRDIK  N+LLD D    K+ DFG AK     E + ++I +R     
Sbjct: 173 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---- 225
Query: 409 GYMAPEYALWGYLTYKA--DVYSFGIVALEIVSGK 441
            Y APE  ++G   Y +  DV+S G V  E++ G+
Sbjct: 226 -YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 29/215 (13%)
Query: 241 NFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
           ++   K IG G FG VY+ +L D G ++A+K++    R  NRE    + ++  L H N+V
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 155
Query: 300 KI----HGCCVEGDQ--LLLVYEYMENNSLACAL-FGRENCELELDWPTRQKICLGIARG 352
           ++    +    + D+  L LV +Y+       A  + R    L + +   +     + R 
Sbjct: 156 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY--VKLYMYQLFRS 213
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNP-KISDFGLAK---LDEGDKTHISTRIAGTI 408
           LA++H    F I HRDIK  N+LLD D    K+ DFG AK     E + ++I +R     
Sbjct: 214 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---- 266
Query: 409 GYMAPEYALWGYLTYKA--DVYSFGIVALEIVSGK 441
            Y APE  ++G   Y +  DV+S G V  E++ G+
Sbjct: 267 -YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 19/215 (8%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREF--LNEIAMISCLQ 294
           AT+ ++   +IG G +G VYK +    G  +A+K +   + +       + E+A++  L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 295 ---HPNLVKIHGCCVEGD-----QLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC 346
              HPN+V++   C         ++ LV+E+++ + L   L       L  +  T + + 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPGLPAE--TIKDLM 118
Query: 347 LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG 406
               RGL FLH      IVHRD+K  N+L+      K++DFGLA++           +  
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVV-- 173
Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           T+ Y APE  L        D++S G +  E+   K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 29/215 (13%)
Query: 241 NFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
           ++   K IG G FG VY+ +L D G ++A+K++    R  NRE    + ++  L H N+V
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 89
Query: 300 KI----HGCCVEGDQ--LLLVYEYMENNSLACAL-FGRENCELELDWPTRQKICLGIARG 352
           ++    +    + D+  L LV +Y+       A  + R    L + +   +     + R 
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY--VKLYMYQLFRS 147
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNP-KISDFGLAK---LDEGDKTHISTRIAGTI 408
           LA++H    F I HRDIK  N+LLD D    K+ DFG AK     E + ++I +R     
Sbjct: 148 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---- 200
Query: 409 GYMAPEYALWGYLTYKA--DVYSFGIVALEIVSGK 441
            Y APE  ++G   Y +  DV+S G V  E++ G+
Sbjct: 201 -YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 24/203 (11%)
Query: 248 IGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNR------EFLNEIAMISCLQHPNLVK 300
           +G G FG V  G+    G  +AVK L+   RQ  R      +   EI  +   +HP+++K
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILN---RQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
           ++        + +V EY+    L    F        LD    +++   I  G+ + H   
Sbjct: 81  LYQVISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSGVDYCH--- 133
Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPEYALWG 419
           R  +VHRD+K  NVLLD  +N KI+DFGL+  + +G+    S    G+  Y APE  + G
Sbjct: 134 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXS---CGSPNYAAPE-VISG 189
Query: 420 --YLTYKADVYSFGIVALEIVSG 440
             Y   + D++S G++   ++ G
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCG 212

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 102/224 (45%), Gaps = 31/224 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + CA    ++        
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHV------- 123
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 124 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 178
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGKN 442
           ++TR      Y APE  L W +     D++S G +  E+++G+ 
Sbjct: 179 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 29/215 (13%)
Query: 241 NFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
           ++   K IG G FG VY+ +L D G ++A+K++    R  NRE    + ++  L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 76
Query: 300 KI----HGCCVEGDQ--LLLVYEYMENNSLACAL-FGRENCELELDWPTRQKICLGIARG 352
           ++    +    + D+  L LV +Y+       A  + R    L + +   +     + R 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY--VKLYMYQLFRS 134
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNP-KISDFGLAK---LDEGDKTHISTRIAGTI 408
           LA++H    F I HRDIK  N+LLD D    K+ DFG AK     E + ++I +R     
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---- 187
Query: 409 GYMAPEYALWGYLTYKA--DVYSFGIVALEIVSGK 441
            Y APE  ++G   Y +  DV+S G V  E++ G+
Sbjct: 188 -YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSK-SRQGNREFLNEIA 288
           +    N    + +G G FG VY+GQ++          +AVK L    S Q   +FL E  
Sbjct: 53  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 112
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALF---GRENCELELDWPTRQKI 345
           +IS   H N+V+  G  ++     ++ E M    L   L     R +    L       +
Sbjct: 113 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 172
Query: 346 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP----KISDFGLAKLDEGDKTHIS 401
              IA G  +L EE+ F  +HRDI A N LL     P    KI DFG+A+    D    S
Sbjct: 173 ARDIACGCQYL-EENHF--IHRDIAARNCLLTCP-GPGRVAKIGDFGMAR----DIYRAS 224
Query: 402 TRIAG-----TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
               G      + +M PE  + G  T K D +SFG++  EI S
Sbjct: 225 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSK-SRQGNREFLNEIA 288
           +    N    + +G G FG VY+GQ++          +AVK L    S Q   +FL E  
Sbjct: 33  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 92
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALF---GRENCELELDWPTRQKI 345
           +IS   H N+V+  G  ++     ++ E M    L   L     R +    L       +
Sbjct: 93  IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 152
Query: 346 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP----KISDFGLAKLDEGDKTHIS 401
              IA G  +L EE+ F  +HRDI A N LL     P    KI DFG+A+    D    S
Sbjct: 153 ARDIACGCQYL-EENHF--IHRDIAARNCLLTCP-GPGRVAKIGDFGMAR----DIYRAS 204
Query: 402 TRIAG-----TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
               G      + +M PE  + G  T K D +SFG++  EI S
Sbjct: 205 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 12/206 (5%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKS--RQGNREFLN-EIAMISCLQH 295
            +F   K +GEG F  V    +LA     A+K L  +   ++    ++  E  ++S L H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           P  VK++ C  + ++L     Y +N  L   +    +     D    +     I   L +
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 152
Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPE 414
           LH +    I+HRD+K  N+LL+ D++ +I+DFG AK L    K   +    GT  Y++PE
Sbjct: 153 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 209
Query: 415 YALWGYLTYKADVYSFGIVALEIVSG 440
                     +D+++ G +  ++V+G
Sbjct: 210 LLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSK-SRQGNREFLNEIA 288
           +    N    + +G G FG VY+GQ++          +AVK L    S Q   +FL E  
Sbjct: 27  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 86
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALF---GRENCELELDWPTRQKI 345
           +IS   H N+V+  G  ++     ++ E M    L   L     R +    L       +
Sbjct: 87  IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 146
Query: 346 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP----KISDFGLAKLDEGDKTHIS 401
              IA G  +L EE+ F  +HRDI A N LL     P    KI DFG+A+    D    S
Sbjct: 147 ARDIACGCQYL-EENHF--IHRDIAARNCLLTCP-GPGRVAKIGDFGMAR----DIYRAS 198
Query: 402 TRIAG-----TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
               G      + +M PE  + G  T K D +SFG++  EI S
Sbjct: 199 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSK-SRQGNREFLNEIA 288
           +    N    + +G G FG VY+GQ++          +AVK L    S Q   +FL E  
Sbjct: 41  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEAL 100
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALF---GRENCELELDWPTRQKI 345
           +IS   H N+V+  G  ++     ++ E M    L   L     R +    L       +
Sbjct: 101 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 160
Query: 346 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP----KISDFGLAKLDEGDKTHIS 401
              IA G  +L EE+ F  +HRDI A N LL     P    KI DFG+A+    D    S
Sbjct: 161 ARDIACGCQYL-EENHF--IHRDIAARNCLLTCP-GPGRVAKIGDFGMAR----DIYRAS 212
Query: 402 TRIAG-----TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
               G      + +M PE  + G  T K D +SFG++  EI S
Sbjct: 213 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSK-SRQGNREFLNEIA 288
           +    N    + +G G FG VY+GQ++          +AVK L    S Q   +FL E  
Sbjct: 43  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 102
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALF---GRENCELELDWPTRQKI 345
           +IS   H N+V+  G  ++     ++ E M    L   L     R +    L       +
Sbjct: 103 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 162
Query: 346 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP----KISDFGLAKLDEGDKTHIS 401
              IA G  +L EE+ F  +HRDI A N LL     P    KI DFG+A+    D    S
Sbjct: 163 ARDIACGCQYL-EENHF--IHRDIAARNCLLTCP-GPGRVAKIGDFGMAR----DIYRAS 214
Query: 402 TRIAG-----TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
               G      + +M PE  + G  T K D +SFG++  EI S
Sbjct: 215 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSK-SRQGNREFLNEIA 288
           +    N    + +G G FG VY+GQ++          +AVK L    S Q   +FL E  
Sbjct: 41  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 100
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALF---GRENCELELDWPTRQKI 345
           +IS   H N+V+  G  ++     ++ E M    L   L     R +    L       +
Sbjct: 101 IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 160
Query: 346 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP----KISDFGLAKLDEGDKTHIS 401
              IA G  +L EE+ F  +HRDI A N LL     P    KI DFG+A+    D    S
Sbjct: 161 ARDIACGCQYL-EENHF--IHRDIAARNCLLTCP-GPGRVAKIGDFGMAR----DIYRAS 212
Query: 402 TRIAG-----TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
               G      + +M PE  + G  T K D +SFG++  EI S
Sbjct: 213 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 103/208 (49%), Gaps = 19/208 (9%)
Query: 240 NNFDSAKKIGEGGFGPVYK-GQLADGTIIAVKQLSSKSRQGNR-EFLNEIAMISCLQHPN 297
           ++F+   ++G G  G V+K      G ++A K +  + +   R + + E+ ++     P 
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICLGIARGLAF 355
           +V  +G      ++ +  E+M+  SL   L   GR      +      K+ + + +GL +
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR------IPEQILGKVSIAVIKGLTY 138
Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEGDKTHISTRIAGTIGYMAP 413
           L E  + KI+HRD+K +N+L++     K+ DFG++   +D      ++    GT  YM+P
Sbjct: 139 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSP 191
Query: 414 EYALWGYLTYKADVYSFGIVALEIVSGK 441
           E     + + ++D++S G+  +E+  G+
Sbjct: 192 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 103/208 (49%), Gaps = 19/208 (9%)
Query: 240 NNFDSAKKIGEGGFGPVYK-GQLADGTIIAVKQLSSKSRQGNR-EFLNEIAMISCLQHPN 297
           ++F+   ++G G  G V+K      G ++A K +  + +   R + + E+ ++     P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICLGIARGLAF 355
           +V  +G      ++ +  E+M+  SL   L   GR      +      K+ + + +GL +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR------IPEQILGKVSIAVIKGLTY 119
Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEGDKTHISTRIAGTIGYMAP 413
           L E  + KI+HRD+K +N+L++     K+ DFG++   +D      ++    GT  YM+P
Sbjct: 120 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSP 172
Query: 414 EYALWGYLTYKADVYSFGIVALEIVSGK 441
           E     + + ++D++S G+  +E+  G+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSK-SRQGNREFLNEIA 288
           +    N    + +G G FG VY+GQ++          +AVK L    S Q   +FL E  
Sbjct: 26  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 85
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALF---GRENCELELDWPTRQKI 345
           +IS   H N+V+  G  ++     ++ E M    L   L     R +    L       +
Sbjct: 86  IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 346 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP----KISDFGLAKLDEGDKTHIS 401
              IA G  +L EE+ F  +HRDI A N LL     P    KI DFG+A+    D    S
Sbjct: 146 ARDIACGCQYL-EENHF--IHRDIAARNCLLTCP-GPGRVAKIGDFGMAR----DIYRAS 197
Query: 402 TRIAG-----TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
               G      + +M PE  + G  T K D +SFG++  EI S
Sbjct: 198 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 19/215 (8%)
Query: 238 ATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREF--LNEIAMISCLQ 294
           AT+ ++   +IG G +G VYK +    G  +A+K +   + +       + E+A++  L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 295 ---HPNLVKIHGCCVEGD-----QLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC 346
              HPN+V++   C         ++ LV+E+++ + L   L       L  +  T + + 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPGLPAE--TIKDLM 118
Query: 347 LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG 406
               RGL FLH      IVHRD+K  N+L+      K++DFGLA++           +  
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LDPVVV 173
Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           T+ Y APE  L        D++S G +  E+   K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSK-SRQGNREFLNEIA 288
           +    N    + +G G FG VY+GQ++          +AVK L    S Q   +FL E  
Sbjct: 26  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 85
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALF---GRENCELELDWPTRQKI 345
           +IS   H N+V+  G  ++     ++ E M    L   L     R +    L       +
Sbjct: 86  IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 346 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP----KISDFGLAKLDEGDKTHIS 401
              IA G  +L EE+ F  +HRDI A N LL     P    KI DFG+A+    D    S
Sbjct: 146 ARDIACGCQYL-EENHF--IHRDIAARNCLLTCP-GPGRVAKIGDFGMAR----DIYRAS 197
Query: 402 TRIAG-----TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
               G      + +M PE  + G  T K D +SFG++  EI S
Sbjct: 198 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 29/215 (13%)
Query: 241 NFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
           ++   K IG G FG VY+ +L D G ++A+K++    R  NRE    + ++  L H N+V
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 110
Query: 300 KI----HGCCVEGDQ--LLLVYEYMENNSLACAL-FGRENCELELDWPTRQKICLGIARG 352
           ++    +    + D+  L LV +Y+       A  + R    L + +   +     + R 
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY--VKLYMYQLFRS 168
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNP-KISDFGLAK---LDEGDKTHISTRIAGTI 408
           LA++H    F I HRDIK  N+LLD D    K+ DFG AK     E + + I +R     
Sbjct: 169 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY---- 221
Query: 409 GYMAPEYALWGYLTYKA--DVYSFGIVALEIVSGK 441
            Y APE  ++G   Y +  DV+S G V  E++ G+
Sbjct: 222 -YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSK-SRQGNREFLNEIA 288
           +    N    + +G G FG VY+GQ++          +AVK L    S Q   +FL E  
Sbjct: 18  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 77
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALF---GRENCELELDWPTRQKI 345
           +IS   H N+V+  G  ++     ++ E M    L   L     R +    L       +
Sbjct: 78  IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 137
Query: 346 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP----KISDFGLAKLDEGDKTHIS 401
              IA G  +L EE+ F  +HRDI A N LL     P    KI DFG+A+    D    S
Sbjct: 138 ARDIACGCQYL-EENHF--IHRDIAARNCLLTCP-GPGRVAKIGDFGMAR----DIYRAS 189
Query: 402 TRIAG-----TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
               G      + +M PE  + G  T K D +SFG++  EI S
Sbjct: 190 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSK-SRQGNREFLNEIA 288
           +    N    + +G G FG VY+GQ++          +AVK L    S Q   +FL E  
Sbjct: 27  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 86
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALF---GRENCELELDWPTRQKI 345
           +IS   H N+V+  G  ++     ++ E M    L   L     R +    L       +
Sbjct: 87  IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 146
Query: 346 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP----KISDFGLAKLDEGDKTHIS 401
              IA G  +L EE+ F  +HRDI A N LL     P    KI DFG+A+    D    S
Sbjct: 147 ARDIACGCQYL-EENHF--IHRDIAARNCLLTCP-GPGRVAKIGDFGMAQ----DIYRAS 198
Query: 402 TRIAG-----TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
               G      + +M PE  + G  T K D +SFG++  EI S
Sbjct: 199 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEI-----AMISCLQ 294
            +FD  + IG G +  V   +L     I   ++  K    + E ++ +            
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 64
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HP LV +H C     +L  V EY+    L   +  +     E      +     I+  L 
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE----HARFYSAEISLALN 120
Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEGDKTHISTRIAGTIGYMA 412
           +LHE     I++RD+K  NVLLD + + K++D+G+ K  L  GD T   +   GT  Y+A
Sbjct: 121 YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIA 174
Query: 413 PEYALWGYLTYKADVYSFGIVALEIVSGKN 442
           PE        +  D ++ G++  E+++G++
Sbjct: 175 PEILRGEDYGFSVDWWALGVLMFEMMAGRS 204

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEI-----AMISCLQ 294
            +FD  + IG G +  V   +L     I   ++  K    + E ++ +            
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HP LV +H C     +L  V EY+    L   +  +     E      +     I+  L 
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE----HARFYSAEISLALN 124
Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEGDKTHISTRIAGTIGYMA 412
           +LHE     I++RD+K  NVLLD + + K++D+G+ K  L  GD T   +   GT  Y+A
Sbjct: 125 YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIA 178
Query: 413 PEYALWGYLTYKADVYSFGIVALEIVSGKN 442
           PE        +  D ++ G++  E+++G++
Sbjct: 179 PEILRGEDYGFSVDWWALGVLMFEMMAGRS 208

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   IG G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 20  KTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 132
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 133 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY 187
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 188 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEI-----AMISCLQ 294
            +FD  + IG G +  V   +L     I   ++  K    + E ++ +            
Sbjct: 20  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 79
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HP LV +H C     +L  V EY+    L   +      + +L     +     I+  L 
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEISLALN 135
Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEGDKTHISTRIAGTIGYMA 412
           +LHE     I++RD+K  NVLLD + + K++D+G+ K  L  GD T   +   GT  Y+A
Sbjct: 136 YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIA 189
Query: 413 PEYALWGYLTYKADVYSFGIVALEIVSGKN 442
           PE        +  D ++ G++  E+++G++
Sbjct: 190 PEILRGEDYGFSVDWWALGVLMFEMMAGRS 219

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 29/215 (13%)
Query: 241 NFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
           ++   K IG G FG VY+ +L D G ++A+K++    R  NRE    + ++  L H N+V
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 88
Query: 300 KI----HGCCVEGDQ--LLLVYEYMENNSLACAL-FGRENCELELDWPTRQKICLGIARG 352
           ++    +    + D+  L LV +Y+       A  + R    L + +   +     + R 
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY--VKLYMYQLFRS 146
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNP-KISDFGLAK---LDEGDKTHISTRIAGTI 408
           LA++H    F I HRDIK  N+LLD D    K+ DFG AK     E + + I +R     
Sbjct: 147 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY---- 199
Query: 409 GYMAPEYALWGYLTYKA--DVYSFGIVALEIVSGK 441
            Y APE  ++G   Y +  DV+S G V  E++ G+
Sbjct: 200 -YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 94/219 (42%), Gaps = 13/219 (5%)
Query: 228 ISFTLKQIKAATNNFDSAKKIGEGGFGPV-YKGQLADGTIIAVKQLSSKSRQGNREFLNE 286
           +S    + +   N F+  K +G+G FG V    + A G   A+K L  +      E  + 
Sbjct: 139 VSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT 198
Query: 287 IAMISCLQ---HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQ 343
           +     LQ   HP L  +       D+L  V EY     L   L  RE    E     R 
Sbjct: 199 LTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSE----DRA 253
Query: 344 KIC-LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIST 402
           +     I   L +LH E    +V+RD+K  N++LD+D + KI+DFGL K    D   + T
Sbjct: 254 RFYGAEIVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 311
Query: 403 RIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
              GT  Y+APE           D +  G+V  E++ G+
Sbjct: 312 -FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 94/219 (42%), Gaps = 13/219 (5%)
Query: 228 ISFTLKQIKAATNNFDSAKKIGEGGFGPV-YKGQLADGTIIAVKQLSSKSRQGNREFLNE 286
           +S    + +   N F+  K +G+G FG V    + A G   A+K L  +      E  + 
Sbjct: 136 VSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT 195
Query: 287 IAMISCLQ---HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQ 343
           +     LQ   HP L  +       D+L  V EY     L   L  RE    E     R 
Sbjct: 196 LTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSE----DRA 250
Query: 344 KIC-LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIST 402
           +     I   L +LH E    +V+RD+K  N++LD+D + KI+DFGL K    D   + T
Sbjct: 251 RFYGAEIVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 308
Query: 403 RIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
              GT  Y+APE           D +  G+V  E++ G+
Sbjct: 309 -FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 248 IGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIHGCC 305
           IGEG +G V       +   +A+K++S    Q   +  L EI ++   +H N++ I+   
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCEL-ELDWPTRQKICL---GIARGLAFLHEESR 361
                     E M++  L   L G +  +L +    +   IC     I RGL ++H  + 
Sbjct: 111 RAP-----TIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN- 164
Query: 362 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS--TRIAGTIGYMAPEYAL-- 417
             ++HRD+K +N+LL+   + KI DFGLA++ + D  H    T    T  Y APE  L  
Sbjct: 165 --VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 222
Query: 418 WGYLTYKADVYSFGIVALEIVSGK 441
            GY T   D++S G +  E++S +
Sbjct: 223 KGY-TKSIDIWSVGCILAEMLSNR 245

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 29/215 (13%)
Query: 241 NFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
           ++   K IG G FG VY+ +L D G ++A+K++    R  NRE    + ++  L H N+V
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 88
Query: 300 KI----HGCCVEGDQ--LLLVYEYMENNSLACAL-FGRENCELELDWPTRQKICLGIARG 352
           ++    +    + D+  L LV +Y+       A  + R    L + +   +     + R 
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY--VKLYMYQLFRS 146
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNP-KISDFGLAK---LDEGDKTHISTRIAGTI 408
           LA++H    F I HRDIK  N+LLD D    K+ DFG AK     E + + I +R     
Sbjct: 147 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY---- 199
Query: 409 GYMAPEYALWGYLTYKA--DVYSFGIVALEIVSGK 441
            Y APE  ++G   Y +  DV+S G V  E++ G+
Sbjct: 200 -YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 248 IGEGGFGPVYKG---------QLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNL 298
           +G+G F  ++KG         QL + T + +K L    R  +  F    +M+S L H +L
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHE-TEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
           V  +G CV GD+ +LV E+++  SL   L   +NC + + W  + ++   +A  + FL E
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC-INILW--KLEVAKQLAAAMHFLEE 131
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL-DEGDKTHISTR--IAGTIGYMAPE- 414
            +   ++H ++ A N+LL R+ + K  +    KL D G    +  +  +   I ++ PE 
Sbjct: 132 NT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPEC 188
Query: 415 YALWGYLTYKADVYSFGIVALEIVSG 440
                 L    D +SFG    EI SG
Sbjct: 189 IENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 29/215 (13%)
Query: 241 NFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
           ++   K IG G FG VY+ +L D G ++A+K++    R  NRE    + ++  L H N+V
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 84
Query: 300 KI----HGCCVEGDQ--LLLVYEYMENNSLACAL-FGRENCELELDWPTRQKICLGIARG 352
           ++    +    + D+  L LV +Y+       A  + R    L + +   +     + R 
Sbjct: 85  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY--VKLYMYQLFRS 142
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNP-KISDFGLAK---LDEGDKTHISTRIAGTI 408
           LA++H    F I HRDIK  N+LLD D    K+ DFG AK     E + + I +R     
Sbjct: 143 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY---- 195
Query: 409 GYMAPEYALWGYLTYKA--DVYSFGIVALEIVSGK 441
            Y APE  ++G   Y +  DV+S G V  E++ G+
Sbjct: 196 -YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 29/215 (13%)
Query: 241 NFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
           ++   K IG G FG VY+ +L D G ++A+K++    R  NRE    + ++  L H N+V
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 95
Query: 300 KI----HGCCVEGDQ--LLLVYEYMENNSLACAL-FGRENCELELDWPTRQKICLGIARG 352
           ++    +    + D+  L LV +Y+       A  + R    L + +   +     + R 
Sbjct: 96  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY--VKLYMYQLFRS 153
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNP-KISDFGLAK---LDEGDKTHISTRIAGTI 408
           LA++H    F I HRDIK  N+LLD D    K+ DFG AK     E + + I +R     
Sbjct: 154 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY---- 206
Query: 409 GYMAPEYALWGYLTYKA--DVYSFGIVALEIVSGK 441
            Y APE  ++G   Y +  DV+S G V  E++ G+
Sbjct: 207 -YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEI-----AMISCLQ 294
            +FD  + IG G +  V   +L     I   ++  K    + E ++ +            
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HP LV +H C     +L  V EY+    L   +      + +L     +     I+  L 
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEISLALN 167
Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEGDKTHISTRIAGTIGYMA 412
           +LHE     I++RD+K  NVLLD + + K++D+G+ K  L  GD T   +   GT  Y+A
Sbjct: 168 YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIA 221
Query: 413 PEYALWGYLTYKADVYSFGIVALEIVSGKN 442
           PE        +  D ++ G++  E+++G++
Sbjct: 222 PEILRGEDYGFSVDWWALGVLMFEMMAGRS 251

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 29/215 (13%)
Query: 241 NFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
           ++   K IG G FG VY+ +L D G ++A+K++    R  NRE    + ++  L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 76
Query: 300 KI----HGCCVEGDQ--LLLVYEYMENNSLACAL-FGRENCELELDWPTRQKICLGIARG 352
           ++    +    + D+  L LV +Y+       A  + R    L + +   +     + R 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY--VKLYMYQLFRS 134
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNP-KISDFGLAK---LDEGDKTHISTRIAGTI 408
           LA++H    F I HRDIK  N+LLD D    K+ DFG AK     E + + I +R     
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY---- 187
Query: 409 GYMAPEYALWGYLTYKA--DVYSFGIVALEIVSGK 441
            Y APE  ++G   Y +  DV+S G V  E++ G+
Sbjct: 188 -YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 29/215 (13%)
Query: 241 NFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
           ++   K IG G FG VY+ +L D G ++A+K++    R  NRE    + ++  L H N+V
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 77
Query: 300 KI----HGCCVEGDQ--LLLVYEYMENNSLACAL-FGRENCELELDWPTRQKICLGIARG 352
           ++    +    + D+  L LV +Y+       A  + R    L + +   +     + R 
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY--VKLYMYQLFRS 135
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNP-KISDFGLAK---LDEGDKTHISTRIAGTI 408
           LA++H    F I HRDIK  N+LLD D    K+ DFG AK     E + + I +R     
Sbjct: 136 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY---- 188
Query: 409 GYMAPEYALWGYLTYKA--DVYSFGIVALEIVSGK 441
            Y APE  ++G   Y +  DV+S G V  E++ G+
Sbjct: 189 -YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 29/215 (13%)
Query: 241 NFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
           ++   K IG G FG VY+ +L D G ++A+K++    R  NRE    + ++  L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 76
Query: 300 KI----HGCCVEGDQ--LLLVYEYMENNSLACAL-FGRENCELELDWPTRQKICLGIARG 352
           ++    +    + D+  L LV +Y+       A  + R    L + +   +     + R 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY--VKLYMYQLFRS 134
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNP-KISDFGLAK---LDEGDKTHISTRIAGTI 408
           LA++H    F I HRDIK  N+LLD D    K+ DFG AK     E + + I +R     
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY---- 187
Query: 409 GYMAPEYALWGYLTYKA--DVYSFGIVALEIVSGK 441
            Y APE  ++G   Y +  DV+S G V  E++ G+
Sbjct: 188 -YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 132
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 133 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY 187
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 188 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 29/215 (13%)
Query: 241 NFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
           ++   K IG G FG VY+ +L D G ++A+K++    R  NRE    + ++  L H N+V
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 80
Query: 300 KI----HGCCVEGDQ--LLLVYEYMENNSLACAL-FGRENCELELDWPTRQKICLGIARG 352
           ++    +    + D+  L LV +Y+       A  + R    L + +   +     + R 
Sbjct: 81  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY--VKLYMYQLFRS 138
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNP-KISDFGLAK---LDEGDKTHISTRIAGTI 408
           LA++H    F I HRDIK  N+LLD D    K+ DFG AK     E + + I +R     
Sbjct: 139 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY---- 191
Query: 409 GYMAPEYALWGYLTYKA--DVYSFGIVALEIVSGK 441
            Y APE  ++G   Y +  DV+S G V  E++ G+
Sbjct: 192 -YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 104/218 (47%), Gaps = 17/218 (7%)
Query: 232 LKQIKAATNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQ---GNREFLNEI 287
           L++     N F   + +G+GGFG V   Q+ A G + A K+L  K  +   G    LNE 
Sbjct: 176 LERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK 235
Query: 288 AMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL 347
            ++  +    +V +       D L LV   M    L   ++       +  +P  + +  
Sbjct: 236 QILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG----QAGFPEARAVFY 291
Query: 348 G--IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHISTRI 404
              I  GL  LH E   +IV+RD+K  N+LLD   + +ISD GLA  + EG    I  R+
Sbjct: 292 AAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV 346
Query: 405 AGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKN 442
            GT+GYMAPE       T+  D ++ G +  E+++G++
Sbjct: 347 -GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 30/214 (14%)
Query: 242 FDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKI 301
           + + K IG G FG V++ +L +   +A+K++    R  NR    E+ ++  ++HPN+V +
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKHPNVVDL 97
Query: 302 HGCCVE-GDQ-----LLLVYEYMENNSLACALFGRENCELELDWPTR--QKICLGIARGL 353
                  GD+     L LV EY+       +   R   +L+   P    +     + R L
Sbjct: 98  KAFFYSNGDKKDEVFLNLVLEYVPETVYRAS---RHYAKLKQTMPMLLIKLYMYQLLRSL 154
Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNP-KISDFGLAKL---DEGDKTHISTRIAGTIG 409
           A++H      I HRDIK  N+LLD      K+ DFG AK+    E + + I +R      
Sbjct: 155 AYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY----- 206
Query: 410 YMAPEYALWGYLTYKA--DVYSFGIVALEIVSGK 441
           Y APE  ++G   Y    D++S G V  E++ G+
Sbjct: 207 YRAPEL-IFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 129
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 130 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 184
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 185 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 127
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 128 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 182
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 183 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 85
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 86  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 138
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 139 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY 193
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 194 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRL 86
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 139
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 140 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 194
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 195 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 13  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 72
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 73  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 125
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 126 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 180
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 181 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 104/218 (47%), Gaps = 17/218 (7%)
Query: 232 LKQIKAATNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQ---GNREFLNEI 287
           L++     N F   + +G+GGFG V   Q+ A G + A K+L  K  +   G    LNE 
Sbjct: 176 LERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK 235
Query: 288 AMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL 347
            ++  +    +V +       D L LV   M    L   ++       +  +P  + +  
Sbjct: 236 QILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG----QAGFPEARAVFY 291
Query: 348 G--IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHISTRI 404
              I  GL  LH E   +IV+RD+K  N+LLD   + +ISD GLA  + EG    I  R+
Sbjct: 292 AAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV 346
Query: 405 AGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKN 442
            GT+GYMAPE       T+  D ++ G +  E+++G++
Sbjct: 347 -GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 71
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 72  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 124
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 125 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 179
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 180 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 133
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 134 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 188
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 189 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 104/215 (48%), Gaps = 29/215 (13%)
Query: 241 NFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
           ++   K IG G FG VY+ +L D G ++A+K++    R  NRE    + ++  L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 76
Query: 300 KIH------GCCVEGDQLLLVYEYMENNSLACAL-FGRENCELELDWPTRQKICLGIARG 352
           ++       G   +   L LV +Y+       A  + R    L + +   +     + R 
Sbjct: 77  RLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY--VKLYMYQLFRS 134
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNP-KISDFGLAK---LDEGDKTHISTRIAGTI 408
           LA++H    F I HRDIK  N+LLD D    K+ DFG AK     E + + I +R     
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY---- 187
Query: 409 GYMAPEYALWGYLTYKA--DVYSFGIVALEIVSGK 441
            Y APE  ++G   Y +  DV+S G V  E++ G+
Sbjct: 188 -YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 34  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 93
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 94  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 146
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 147 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 201
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 202 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 26/214 (12%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHP 296
             + S   +G G +G V        G  +A+K+LS   +S    +    E+ ++  +QH 
Sbjct: 42  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 101
Query: 297 NLVKIHGCCVEGDQL------LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           N++ +         L       LV  +M+ +     + G E  E ++     Q +   + 
Sbjct: 102 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTD--LQKIMGMEFSEEKI-----QYLVYQML 154
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-HISTRIAGTIG 409
           +GL ++H      +VHRD+K  N+ ++ D   KI DFGLA+  + + T ++ TR      
Sbjct: 155 KGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----W 206
Query: 410 YMAPEYAL-WGYLTYKADVYSFGIVALEIVSGKN 442
           Y APE  L W +     D++S G +  E+++GK 
Sbjct: 207 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 240

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 132
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 133 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 187
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 188 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 123
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 124 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 178
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 179 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 242 FDSAKKIGEGGFGPVYKGQLADGT----IIAVKQLSS----KSRQGNREFLNEIAMISCL 293
           F+  + +G+GG+G V++ +   G     I A+K L      ++ +       E  ++  +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIAR-- 351
           +HP +V +      G +L L+ EY+    L   L  RE   +E         C  +A   
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL-EREGIFME------DTACFYLAEIS 131
Query: 352 -GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
             L  LH++    I++RD+K  N++L+   + K++DFGL K    D T ++    GTI Y
Sbjct: 132 MALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHXFCGTIEY 187
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           MAPE  +        D +S G +  ++++G
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 86
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 139
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 140 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 194
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 195 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 133
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 134 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 188
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 189 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 129
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 130 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 184
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 185 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 86
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 139
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 140 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 194
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 195 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 129
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 130 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 184
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 185 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 127
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 128 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 182
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 183 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 99/215 (46%), Gaps = 21/215 (9%)
Query: 239 TNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNR---EFLNEIAMISCLQ 294
           ++ ++  + +G GG   V+  + L D   +AVK L +   +       F  E    + L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 295 HPNLVKIHGC----CVEGDQLLLVYEYMENNSLACALFGRENCELELDW-PTRQ-KICLG 348
           HP +V ++         G    +V EY++  +L      R+    E    P R  ++   
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL------RDIVHTEGPMTPKRAIEVIAD 124
Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL--DEGDKTHISTRIAG 406
             + L F H+     I+HRD+K  N+L+      K+ DFG+A+   D G+    +  + G
Sbjct: 125 ACQALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIG 181
Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           T  Y++PE A    +  ++DVYS G V  E+++G+
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 132
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 133 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 187
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 188 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 14  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 73
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 74  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 126
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 127 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 181
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 182 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 242 FDSAKKIGEGGFGPVYKGQLADGT----IIAVKQLSS----KSRQGNREFLNEIAMISCL 293
           F+  + +G+GG+G V++ +   G     I A+K L      ++ +       E  ++  +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIAR-- 351
           +HP +V +      G +L L+ EY+    L   L  RE   +E         C  +A   
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL-EREGIFME------DTACFYLAEIS 131
Query: 352 -GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
             L  LH++    I++RD+K  N++L+   + K++DFGL K    D T ++    GTI Y
Sbjct: 132 MALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHTFCGTIEY 187
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           MAPE  +        D +S G +  ++++G
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 94/219 (42%), Gaps = 19/219 (8%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSK-SRQGNREFLNEIA 288
           +    N    + +G G FG VY+GQ++          +AVK L    S Q   +FL E  
Sbjct: 67  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 126
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALF---GRENCELELDWPTRQKI 345
           +IS   H N+V+  G  ++     ++ E M    L   L     R +    L       +
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186
Query: 346 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP----KISDFGLAK-LDEGDKTHI 400
              IA G  +L EE+ F  +HRDI A N LL     P    KI DFG+A+ +        
Sbjct: 187 ARDIACGCQYL-EENHF--IHRDIAARNCLLTCP-GPGRVAKIGDFGMARDIYRAGYYRK 242
Query: 401 STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
                  + +M PE  + G  T K D +SFG++  EI S
Sbjct: 243 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 71
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 72  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 124
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 125 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 179
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 180 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 147
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 148 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 202
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 203 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 134
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 135 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 189
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 190 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 127
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 128 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 182
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 183 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 127
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 128 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 182
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 183 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 92/213 (43%), Gaps = 19/213 (8%)
Query: 234 QIKAATNNFDSAKKIGEGGFGPVY-KGQLADGTIIAVKQLSSKSRQGNREF---LNEIAM 289
           Q  A  + F+  K IG G FG V     +  G   A+K L  +     ++    LNE  +
Sbjct: 35  QNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICL 347
           +  +  P LVK+     +   L +V EYM    +   L   GR         P  +    
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGR------FSEPHARFYAA 148
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            I     +LH      +++RD+K  N+L+D+    K++DFG AK  +G     +  + GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGT 201
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             Y+APE  L        D ++ G++  E+ +G
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 127
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 128 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 182
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 183 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 127
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 128 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 182
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 183 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 38  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 97
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 98  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 150
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 151 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 205
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 206 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 127
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 128 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 182
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 183 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 85
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 86  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 138
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 139 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 193
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 194 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 92/213 (43%), Gaps = 19/213 (8%)
Query: 234 QIKAATNNFDSAKKIGEGGFGPVY-KGQLADGTIIAVKQLSSKSRQGNREF---LNEIAM 289
           Q  A  + F+  K IG G FG V     +  G   A+K L  +     ++    LNE  +
Sbjct: 35  QNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICL 347
           +  +  P LVK+     +   L +V EYM    +   L   GR         P  +    
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGR------FSEPHARFYAA 148
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            I     +LH      +++RD+K  N+L+D+    K++DFG AK  +G     +  + GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGT 201
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             Y+APE  L        D ++ G++  E+ +G
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 129
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 130 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGY 184
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 185 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 123
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 124 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 178
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 179 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 133
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 134 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGY 188
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 189 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 127
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 128 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 182
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 183 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 147
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 148 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 202
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 203 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 94/219 (42%), Gaps = 19/219 (8%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSK-SRQGNREFLNEIA 288
           +    N    + +G G FG VY+GQ++          +AVK L    S Q   +FL E  
Sbjct: 44  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 103
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALF---GRENCELELDWPTRQKI 345
           +IS   H N+V+  G  ++     ++ E M    L   L     R +    L       +
Sbjct: 104 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 163
Query: 346 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP----KISDFGLAK-LDEGDKTHI 400
              IA G  +L EE+ F  +HRDI A N LL     P    KI DFG+A+ +        
Sbjct: 164 ARDIACGCQYL-EENHF--IHRDIAARNCLLTCP-GPGRVAKIGDFGMARDIYRAGYYRK 219
Query: 401 STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
                  + +M PE  + G  T K D +SFG++  EI S
Sbjct: 220 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 30/216 (13%)
Query: 241 NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
           +F   + IG GGFG V+K +   DG    +K++   + +  RE    +  ++ L H N+V
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIV 67
Query: 300 KIHGCCVEGDQLLLVYEYMENNS----LACALFGRENCEL-------------ELDWPTR 342
             +GC    D      E    NS      C     E C+              +LD    
Sbjct: 68  HYNGCW---DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 343 QKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIST 402
            ++   I +G+ ++H +   K+++RD+K +N+ L      KI DFGL    + D      
Sbjct: 125 LELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--X 179
Query: 403 RIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIV 438
           R  GT+ YM+PE         + D+Y+ G++  E++
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 133
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 134 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 188
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 189 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 34  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 93
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 94  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 146
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 147 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 201
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 202 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 98/225 (43%), Gaps = 35/225 (15%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 127
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI 400
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+       H 
Sbjct: 128 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HT 175
Query: 401 STRIAGTIG---YMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
              +AG +    Y APE  L W +     D++S G +  E+++G+
Sbjct: 176 DDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 25  KTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 84
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 85  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 137
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 138 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 192
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 193 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 99/214 (46%), Gaps = 37/214 (17%)
Query: 248 IGEGGFGPVYKGQLADGTIIAVKQLSSKSRQG-NREFLNEIAMISCLQHPNLVKIHGCCV 306
           +G+G +G V++G L  G  +AVK  SS+  Q   RE   EI     L+H N++      +
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRE--TEIYNTVLLRHDNILGFIASDM 72
Query: 307 ----EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE--- 359
                  QL L+  Y E+ SL      R+  E  L      ++ +  A GLA LH E   
Sbjct: 73  TSRNSSTQLWLITHYHEHGSLY-DFLQRQTLEPHLA----LRLAVSAACGLAHLHVEIFG 127
Query: 360 --SRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--------LDEGDKTHISTRIAGTIG 409
              +  I HRD K+ NVL+  +L   I+D GLA         LD G+   +     GT  
Sbjct: 128 TQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRV-----GTKR 182
Query: 410 YMAPEY-----ALWGYLTYK-ADVYSFGIVALEI 437
           YMAPE          + +YK  D+++FG+V  EI
Sbjct: 183 YMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 100/219 (45%), Gaps = 26/219 (11%)
Query: 232 LKQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQL--SSKSRQG-NREFLNEI 287
           + + K   ++FD  + +G+G FG VY   +  +  I+A+K L  S   ++G   +   EI
Sbjct: 6   MPKRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREI 65
Query: 288 AMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKI 345
            + S L+HPN+++++    +  ++ L+ E+     L   L   GR       D       
Sbjct: 66  EIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR------FDEQRSATF 119
Query: 346 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIST--- 402
              +A  L + HE    K++HRDIK  N+L+      KI+DFG +        H  +   
Sbjct: 120 MEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRR 169
Query: 403 -RIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             + GT+ Y+ PE         K D++  G++  E + G
Sbjct: 170 RXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 98/225 (43%), Gaps = 35/225 (15%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 127
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI 400
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+       H 
Sbjct: 128 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HT 175
Query: 401 STRIAGTIG---YMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
              +AG +    Y APE  L W +     D++S G +  E+++G+
Sbjct: 176 DDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 109/233 (46%), Gaps = 27/233 (11%)
Query: 220 MKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLAD--GT--IIAVKQLSSK 275
           M   D +  S  L ++K    NF     +G+G FG V    LAD  GT  + A+K L   
Sbjct: 1   MPSEDRKQPSNNLDRVKLTDFNFLMV--LGKGSFGKV---MLADRKGTEELYAIKILKKD 55
Query: 276 SRQGNREF---LNEIAMISCLQHPN-LVKIHGCCVEGDQLLLVYEYMENNSLACAL--FG 329
               + +    + E  +++ L  P  L ++H C    D+L  V EY+    L   +   G
Sbjct: 56  VVIQDDDVECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG 115
Query: 330 RENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL 389
           +         P        I+ GL FLH+     I++RD+K  NV+LD + + KI+DFG+
Sbjct: 116 K------FKEPQAVFYAAEISIGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGM 166
Query: 390 AKLDEGDKTHISTR-IAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
            K  E     ++TR   GT  Y+APE   +       D +++G++  E+++G+
Sbjct: 167 CK--EHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 93/212 (43%), Gaps = 15/212 (7%)
Query: 236 KAATNNFDSAKKIGEGGFGPV-YKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ 294
           +   N F+  K +G+G FG V    + A G   A+K L  +      E  + +     LQ
Sbjct: 4   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 63
Query: 295 ---HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC-LGIA 350
              HP L  +       D+L  V EY     L   L  RE    E     R +     I 
Sbjct: 64  NSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSE----DRARFYGAEIV 118
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR-IAGTIG 409
             L +LH E    +V+RD+K  N++LD+D + KI+DFGL K  EG K   + +   GT  
Sbjct: 119 SALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPE 174
Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           Y+APE           D +  G+V  E++ G+
Sbjct: 175 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 26/219 (11%)
Query: 232 LKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGT-IIAVKQL--SSKSRQG-NREFLNEI 287
           + + K   ++FD  + +G+G FG VY  +      I+A+K L  S   ++G   +   EI
Sbjct: 7   MPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREI 66
Query: 288 AMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKI 345
            + S L+HPN+++++    +  ++ L+ E+     L   L   GR       D       
Sbjct: 67  EIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR------FDEQRSATF 120
Query: 346 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIST--- 402
              +A  L + HE    K++HRDIK  N+L+      KI+DFG +        H  +   
Sbjct: 121 MEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRR 170
Query: 403 -RIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             + GT+ Y+ PE         K D++  G++  E + G
Sbjct: 171 RXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 98/225 (43%), Gaps = 35/225 (15%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 123
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI 400
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+       H 
Sbjct: 124 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HT 171
Query: 401 STRIAGTIG---YMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
              +AG +    Y APE  L W +     D++S G +  E+++G+
Sbjct: 172 DDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 93/212 (43%), Gaps = 15/212 (7%)
Query: 236 KAATNNFDSAKKIGEGGFGPV-YKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ 294
           +   N F+  K +G+G FG V    + A G   A+K L  +      E  + +     LQ
Sbjct: 6   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 65
Query: 295 ---HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC-LGIA 350
              HP L  +       D+L  V EY     L   L  RE    E     R +     I 
Sbjct: 66  NSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSE----DRARFYGAEIV 120
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR-IAGTIG 409
             L +LH E    +V+RD+K  N++LD+D + KI+DFGL K  EG K   + +   GT  
Sbjct: 121 SALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPE 176
Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           Y+APE           D +  G+V  E++ G+
Sbjct: 177 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 101/211 (47%), Gaps = 27/211 (12%)
Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGC 304
           + IG+G FG V++G+   G  +AVK  SS+  R   RE   EI     L+H N++     
Sbjct: 10  ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAA 66
Query: 305 CVEGD----QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE- 359
             + +    QL LV +Y E+ SL   L  R    +E       K+ L  A GLA LH E 
Sbjct: 67  DNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVE----GMIKLALSTASGLAHLHMEI 121
Query: 360 ----SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI---STRIAGTIGYMA 412
                +  I HRD+K+ N+L+ ++    I+D GLA   +     I        GT  YMA
Sbjct: 122 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 181
Query: 413 PEYA-----LWGYLTYK-ADVYSFGIVALEI 437
           PE       +  + ++K AD+Y+ G+V  EI
Sbjct: 182 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 93/212 (43%), Gaps = 15/212 (7%)
Query: 236 KAATNNFDSAKKIGEGGFGPV-YKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ 294
           +   N F+  K +G+G FG V    + A G   A+K L  +      E  + +     LQ
Sbjct: 5   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 64
Query: 295 ---HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC-LGIA 350
              HP L  +       D+L  V EY     L   L  RE    E     R +     I 
Sbjct: 65  NSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSE----DRARFYGAEIV 119
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR-IAGTIG 409
             L +LH E    +V+RD+K  N++LD+D + KI+DFGL K  EG K   + +   GT  
Sbjct: 120 SALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPE 175
Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           Y+APE           D +  G+V  E++ G+
Sbjct: 176 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 101/211 (47%), Gaps = 27/211 (12%)
Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGC 304
           + IG+G FG V++G+   G  +AVK  SS+  R   RE   EI     L+H N++     
Sbjct: 35  ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAA 91
Query: 305 CVEGD----QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE- 359
             + +    QL LV +Y E+ SL   L  R    +E       K+ L  A GLA LH E 
Sbjct: 92  DNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVE----GMIKLALSTASGLAHLHMEI 146
Query: 360 ----SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI---STRIAGTIGYMA 412
                +  I HRD+K+ N+L+ ++    I+D GLA   +     I        GT  YMA
Sbjct: 147 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 206
Query: 413 PEYA-----LWGYLTYK-ADVYSFGIVALEI 437
           PE       +  + ++K AD+Y+ G+V  EI
Sbjct: 207 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 101/211 (47%), Gaps = 27/211 (12%)
Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGC 304
           + IG+G FG V++G+   G  +AVK  SS+  R   RE   EI     L+H N++     
Sbjct: 48  ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAA 104
Query: 305 CVEGD----QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE- 359
             + +    QL LV +Y E+ SL   L  R    +E       K+ L  A GLA LH E 
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVE----GMIKLALSTASGLAHLHMEI 159
Query: 360 ----SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI---STRIAGTIGYMA 412
                +  I HRD+K+ N+L+ ++    I+D GLA   +     I        GT  YMA
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 413 PEYA-----LWGYLTYK-ADVYSFGIVALEI 437
           PE       +  + ++K AD+Y+ G+V  EI
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 21/215 (9%)
Query: 239 TNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNR---EFLNEIAMISCLQ 294
           ++ ++  + +G GG   V+  + L D   +AVK L +   +       F  E    + L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 295 HPNLVKIHGC----CVEGDQLLLVYEYMENNSLACALFGRENCELELDW-PTRQ-KICLG 348
           HP +V ++         G    +V EY++  +L      R+    E    P R  ++   
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL------RDIVHTEGPMTPKRAIEVIAD 124
Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL--DEGDKTHISTRIAG 406
             + L F H+     I+HRD+K  N+++      K+ DFG+A+   D G+    +  + G
Sbjct: 125 ACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           T  Y++PE A    +  ++DVYS G V  E+++G+
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 15/211 (7%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREF---LNEIAMIS 291
           +   +NF+  + +G+G FG V   ++ + G + AVK L       + +    + E  ++S
Sbjct: 19  RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS 78
Query: 292 CLQ-HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
             + HP L ++  C    D+L  V E++    L   +F  +      D    +     I 
Sbjct: 79  LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL---MFHIQKSR-RFDEARARFYAAEII 134
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIST-RIAGTIG 409
             L FLH++    I++RD+K  NVLLD + + K++DFG+ K  EG    ++T    GT  
Sbjct: 135 SALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPD 189
Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           Y+APE           D ++ G++  E++ G
Sbjct: 190 YIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 21/215 (9%)
Query: 239 TNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNR---EFLNEIAMISCLQ 294
           ++ ++  + +G GG   V+  + L D   +AVK L +   +       F  E    + L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 295 HPNLVKIHGC----CVEGDQLLLVYEYMENNSLACALFGRENCELELDW-PTRQ-KICLG 348
           HP +V ++         G    +V EY++  +L      R+    E    P R  ++   
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL------RDIVHTEGPMTPKRAIEVIAD 124
Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL--DEGDKTHISTRIAG 406
             + L F H+     I+HRD+K  N+++      K+ DFG+A+   D G+    +  + G
Sbjct: 125 ACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           T  Y++PE A    +  ++DVYS G V  E+++G+
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 19/216 (8%)
Query: 231 TLKQIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREF---LNE 286
           T  Q  A  + FD  K +G G FG V   +  + G   A+K L  +     ++    LNE
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 287 IAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQK 344
             ++  +  P LVK+     +   L +V EY+    +   L   GR         P  + 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR------FSEPHARF 145
Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI 404
               I     +LH      +++RD+K  N+L+D+    +++DFG AK  +G     +  +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 405 AGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           AGT  Y+APE  L        D ++ G++  E+ +G
Sbjct: 199 AGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 100/223 (44%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 127
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T  
Sbjct: 128 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGX 182
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 183 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 100/223 (44%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 134
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+    + T +
Sbjct: 135 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY 189
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 190 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 12/210 (5%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKS--RQGNREFLN-EIAMIS 291
           K    +F   K +GEG F  V    +LA     A+K L  +   ++    ++  E  ++S
Sbjct: 6   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 65
Query: 292 CLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIAR 351
            L HP  VK++    + ++L     Y +N  L   +    +     D    +     I  
Sbjct: 66  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVS 121
Query: 352 GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGY 410
            L +LH +    I+HRD+K  N+LL+ D++ +I+DFG AK L    K   +    GT  Y
Sbjct: 122 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 178
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           ++PE          +D+++ G +  ++V+G
Sbjct: 179 VSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 12/210 (5%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKS--RQGNREFLN-EIAMIS 291
           K    +F   K +GEG F  V    +LA     A+K L  +   ++    ++  E  ++S
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 292 CLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIAR 351
            L HP  VK++    + ++L     Y +N  L   +    +     D    +     I  
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVS 119
Query: 352 GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGY 410
            L +LH +    I+HRD+K  N+LL+ D++ +I+DFG AK L    K   +    GT  Y
Sbjct: 120 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 176
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           ++PE          +D+++ G +  ++V+G
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 100/223 (44%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 134
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+    + T +
Sbjct: 135 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY 189
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 190 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 101/211 (47%), Gaps = 27/211 (12%)
Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGC 304
           + IG+G FG V++G+   G  +AVK  SS+  R   RE   EI     L+H N++     
Sbjct: 15  ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAA 71
Query: 305 CVEGD----QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE- 359
             + +    QL LV +Y E+ SL   L  R    +E       K+ L  A GLA LH E 
Sbjct: 72  DNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVE----GMIKLALSTASGLAHLHMEI 126
Query: 360 ----SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI---STRIAGTIGYMA 412
                +  I HRD+K+ N+L+ ++    I+D GLA   +     I        GT  YMA
Sbjct: 127 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 186
Query: 413 PEYA-----LWGYLTYK-ADVYSFGIVALEI 437
           PE       +  + ++K AD+Y+ G+V  EI
Sbjct: 187 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 100/223 (44%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 134
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+    + T +
Sbjct: 135 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY 189
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 190 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 12/210 (5%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKS--RQGNREFLN-EIAMIS 291
           K    +F   K +GEG F  V    +LA     A+K L  +   ++    ++  E  ++S
Sbjct: 3   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 62
Query: 292 CLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIAR 351
            L HP  VK++    + ++L     Y +N  L   +    +     D    +     I  
Sbjct: 63  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVS 118
Query: 352 GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGY 410
            L +LH +    I+HRD+K  N+LL+ D++ +I+DFG AK L    K   +    GT  Y
Sbjct: 119 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 175
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           ++PE          +D+++ G +  ++V+G
Sbjct: 176 VSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 100/209 (47%), Gaps = 27/209 (12%)
Query: 248 IGEGGFGPVYKGQLADGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCV 306
           IG+G FG V++G+   G  +AVK  SS+  R   RE   EI     L+H N++       
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADN 67
Query: 307 EGD----QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE--- 359
           + +    QL LV +Y E+ SL   L  R    +E       K+ L  A GLA LH E   
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVE----GMIKLALSTASGLAHLHMEIVG 122
Query: 360 --SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI---STRIAGTIGYMAPE 414
              +  I HRD+K+ N+L+ ++    I+D GLA   +     I        GT  YMAPE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 415 YA-----LWGYLTYK-ADVYSFGIVALEI 437
                  +  + ++K AD+Y+ G+V  EI
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 12/210 (5%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKS--RQGNREFLN-EIAMIS 291
           K    +F   K +GEG F  V    +LA     A+K L  +   ++    ++  E  ++S
Sbjct: 5   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 64
Query: 292 CLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIAR 351
            L HP  VK++    + ++L     Y +N  L   +    +     D    +     I  
Sbjct: 65  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVS 120
Query: 352 GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGY 410
            L +LH +    I+HRD+K  N+LL+ D++ +I+DFG AK L    K   +    GT  Y
Sbjct: 121 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 177
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           ++PE          +D+++ G +  ++V+G
Sbjct: 178 VSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 248 IGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIHGCC 305
           IGEG +G V       +   +A+K++S    Q   +  L EI ++   +H N++ I+   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL---GIARGLAFLHEESRF 362
                  +   Y+  + +   L+    C+      +   IC     I RGL ++H  +  
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKCQ----HLSNDHICYFLYQILRGLKYIHSAN-- 148
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS--TRIAGTIGYMAPEYAL--W 418
            ++HRD+K +N+LL+   + KI DFGLA++ + D  H    T    T  Y APE  L   
Sbjct: 149 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 419 GYLTYKADVYSFGIVALEIVSGK 441
           GY T   D++S G +  E++S +
Sbjct: 208 GY-TKSIDIWSVGCILAEMLSNR 229

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 100/209 (47%), Gaps = 27/209 (12%)
Query: 248 IGEGGFGPVYKGQLADGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCV 306
           IG+G FG V++G+   G  +AVK  SS+  R   RE   EI     L+H N++       
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADN 70
Query: 307 EGD----QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE--- 359
           + +    QL LV +Y E+ SL   L  R    +E       K+ L  A GLA LH E   
Sbjct: 71  KDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVE----GMIKLALSTASGLAHLHMEIVG 125
Query: 360 --SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI---STRIAGTIGYMAPE 414
              +  I HRD+K+ N+L+ ++    I+D GLA   +     I        GT  YMAPE
Sbjct: 126 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 185
Query: 415 YA-----LWGYLTYK-ADVYSFGIVALEI 437
                  +  + ++K AD+Y+ G+V  EI
Sbjct: 186 VLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 100/223 (44%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 38  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 97
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 98  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 150
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTH 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  D+    +
Sbjct: 151 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGY 205
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 206 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 99/218 (45%), Gaps = 21/218 (9%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL----ELDWPTRQKI 345
           +  ++H N++ +         L    E   +  L   L G +   +    +L     Q +
Sbjct: 75  LKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL 130
Query: 346 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-HISTRI 404
              I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +++TR 
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR- 186
Query: 405 AGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
                Y APE  L W +     D++S G +  E+++G+
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 248 IGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIHGCC 305
           IGEG +G V       +   +A+K++S    Q   +  L EI ++   +H N++ I+   
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL---GIARGLAFLHEESRF 362
                  +   Y+  + +   L+      L+    +   IC     I RGL ++H  +  
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKL----LKTQHLSNDHICYFLYQILRGLKYIHSAN-- 146
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS--TRIAGTIGYMAPEYAL--W 418
            ++HRD+K +N+LL+   + KI DFGLA++ + D  H    T    T  Y APE  L   
Sbjct: 147 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 419 GYLTYKADVYSFGIVALEIVSGK 441
           GY T   D++S G +  E++S +
Sbjct: 206 GY-TKSIDIWSVGCILAEMLSNR 227

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 127
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI D+GLA+  + + T +
Sbjct: 128 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGY 182
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 183 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 248 IGEGGFGPVYKG---------QLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNL 298
           +G+G F  ++KG         QL + T + +K L    R  +  F    +M+S L H +L
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHE-TEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
           V  +G C  GD+ +LV E+++  SL   L   +NC + + W  + ++   +A  + FL E
Sbjct: 75  VLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNC-INILW--KLEVAKQLAWAMHFLEE 131
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL-DEGDKTHISTR--IAGTIGYMAPE- 414
            +   ++H ++ A N+LL R+ + K  +    KL D G    +  +  +   I ++ PE 
Sbjct: 132 NT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPEC 188
Query: 415 YALWGYLTYKADVYSFGIVALEIVSG 440
                 L    D +SFG    EI SG
Sbjct: 189 IENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 108/222 (48%), Gaps = 23/222 (10%)
Query: 231 TLKQIKAATNNFDSAKKIGEGGFGPVYKGQ-----LADGTIIAVKQLSSKSRQG--NREF 283
           T KQ K   + +D  +++G G F  V K +     L        K+ S  SR+G    E 
Sbjct: 4   TFKQQKVE-DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEI 62
Query: 284 LNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQ 343
             E++++  + HPN++ +H        ++L+ E +    L   L  +E+    L      
Sbjct: 63  EREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES----LSEEEAT 118
Query: 344 KICLGIARGLAFLHEESRFKIVHRDIKATNV-LLDRDL---NPKISDFGLA-KLDEGDKT 398
                I  G+ +LH +   KI H D+K  N+ LLD+++   + K+ DFGLA ++++G + 
Sbjct: 119 SFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF 175
Query: 399 HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
                I GT  ++APE   +  L  +AD++S G++   ++SG
Sbjct: 176 ---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 102/213 (47%), Gaps = 25/213 (11%)
Query: 239 TNNFDSAKKIGEGGFGPVYK------GQLADGTIIAVKQLSSKSRQGNREFLNEIAMISC 292
           ++N+D  +++G+G F  V +      G      II  K+LS++  Q   +   E  +   
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ---KLEREARICRK 84
Query: 293 LQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRE-NCELELDWPTRQKICLGIAR 351
           LQHPN+V++H    E     LV++ +    L   +  RE   E +     +Q     I  
Sbjct: 85  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ-----ILE 139
Query: 352 GLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLA-KLDEGDKTHISTRIAGT 407
            +A+ H      IVHR++K  N+LL    +    K++DFGLA ++++ +  H     AGT
Sbjct: 140 SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGT 193
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            GY++PE       +   D+++ G++   ++ G
Sbjct: 194 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 35/225 (15%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPV---YKGQLADGTIIAVKQLSS--KSRQGNREFLNEI 287
           K +          + +G G +G V   Y  +L     +AVK+LS   +S    R    E+
Sbjct: 21  KTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQK--VAVKKLSRPFQSLIHARRTYREL 78
Query: 288 AMISCLQHPNLVKI-----HGCCVEG-DQLLLVYEYME---NNSLACALFGRENCELELD 338
            ++  L+H N++ +         +E   ++ LV   M    NN +       E+      
Sbjct: 79  RLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHV----- 133
Query: 339 WPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDK 397
               Q +   + RGL ++H      I+HRD+K +NV ++ D   +I DFGLA+  DE   
Sbjct: 134 ----QFLVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMT 186
Query: 398 THISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
            +++TR      Y APE  L W +     D++S G +  E++ GK
Sbjct: 187 GYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 12/206 (5%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKS--RQGNREFLN-EIAMISCLQH 295
            +F   K +GEG F  V    +LA     A+K L  +   ++    ++  E  ++S L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           P  VK++    + ++L     Y +N  L   +    +     D    +     I   L +
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGS----FDETCTRFYTAEIVSALEY 147
Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPE 414
           LH +    I+HRD+K  N+LL+ D++ +I+DFG AK L    K   +    GT  Y++PE
Sbjct: 148 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 204
Query: 415 YALWGYLTYKADVYSFGIVALEIVSG 440
                  +  +D+++ G +  ++V+G
Sbjct: 205 LLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 94/193 (48%), Gaps = 21/193 (10%)
Query: 239 TNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREF--LNEIAMISCLQH 295
            + ++   KIG+G FG V+K +    G  +A+K++  ++ +       L EI ++  L+H
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 75
Query: 296 PNLVKIHGCCVEG--------DQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL 347
            N+V +   C             + LV+++ E++ LA  L    N  ++      +++  
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLL---SNVLVKFTLSEIKRVMQ 131
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG- 406
            +  GL ++H   R KI+HRD+KA NVL+ RD   K++DFGLA+     K     R    
Sbjct: 132 MLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNR 188
Query: 407 --TIGYMAPEYAL 417
             T+ Y  PE  L
Sbjct: 189 VVTLWYRPPELLL 201

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 26/228 (11%)
Query: 226 QTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQL----ADGTIIAVKQLSS---KSRQ 278
           + I   ++ ++    ++D  K IG G FG V   QL    A   + A+K LS      R 
Sbjct: 61  EKIVKKIRGLQMKAEDYDVVKVIGRGAFGEV---QLVRHKASQKVYAMKLLSKFEMIKRS 117
Query: 279 GNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLL-LVYEYMENNSLACALFGRENCELEL 337
            +  F  E  +++    P +V++  C  + D+ L +V EYM    L   +    N ++  
Sbjct: 118 DSAFFWEERDIMAFANSPWVVQLF-CAFQDDKYLYMVMEYMPGGDLVNLM---SNYDVPE 173
Query: 338 DWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGD 396
            W   +     +   L  +H      ++HRD+K  N+LLD+  + K++DFG   K+DE  
Sbjct: 174 KWA--KFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 228
Query: 397 KTHISTRIAGTIGYMAPEYALW----GYLTYKADVYSFGIVALEIVSG 440
             H  T + GT  Y++PE        GY   + D +S G+   E++ G
Sbjct: 229 MVHCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 98/214 (45%), Gaps = 26/214 (12%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHP 296
             + S   +G G +G V        G  +A+K+LS   +S    +    E+ ++  +QH 
Sbjct: 24  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 83
Query: 297 NLVKIHGCCVEGDQL------LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           N++ +         L       LV  +M+ +     + G +  E ++     Q +   + 
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYLVMPFMQTD--LQKIMGLKFSEEKI-----QYLVYQML 136
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-HISTRIAGTIG 409
           +GL ++H      +VHRD+K  N+ ++ D   KI DFGLA+  + + T ++ TR      
Sbjct: 137 KGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----W 188
Query: 410 YMAPEYAL-WGYLTYKADVYSFGIVALEIVSGKN 442
           Y APE  L W +     D++S G +  E+++GK 
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 29/215 (13%)
Query: 241 NFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
           ++   K IG G FG VY+ +L D G ++A+K++       NRE    + ++  L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRE----LQIMRKLDHCNIV 76
Query: 300 KI----HGCCVEGDQ--LLLVYEYMENNSLACAL-FGRENCELELDWPTRQKICLGIARG 352
           ++    +    + D+  L LV +Y+       A  + R    L + +   +     + R 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY--VKLYMYQLFRS 134
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNP-KISDFGLAK---LDEGDKTHISTRIAGTI 408
           LA++H    F I HRDIK  N+LLD D    K+ DFG AK     E + ++I +R     
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---- 187
Query: 409 GYMAPEYALWGYLTYKA--DVYSFGIVALEIVSGK 441
            Y APE  ++G   Y +  DV+S G V  E++ G+
Sbjct: 188 -YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 94/193 (48%), Gaps = 21/193 (10%)
Query: 239 TNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREF--LNEIAMISCLQH 295
            + ++   KIG+G FG V+K +    G  +A+K++  ++ +       L EI ++  L+H
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 296 PNLVKIHGCCVEG--------DQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL 347
            N+V +   C             + LV+++ E++ LA  L    N  ++      +++  
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLL---SNVLVKFTLSEIKRVMQ 132
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG- 406
            +  GL ++H   R KI+HRD+KA NVL+ RD   K++DFGLA+     K     R    
Sbjct: 133 MLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNR 189
Query: 407 --TIGYMAPEYAL 417
             T+ Y  PE  L
Sbjct: 190 VVTLWYRPPELLL 202

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 13/208 (6%)
Query: 242 FDSAKKIGEGGFGPVYK------GQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQH 295
           ++  + IG+G F  V +      GQ     I+ V + +S       +   E ++   L+H
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           P++V++         L +V+E+M+   L   +  R +                I   L +
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNP---KISDFGLAKLDEGDKTHISTRIAGTIGYMA 412
            H+ +   I+HRD+K  NVLL    N    K+ DFG+A +  G+   ++    GT  +MA
Sbjct: 146 CHDNN---IIHRDVKPENVLLASKENSAPVKLGDFGVA-IQLGESGLVAGGRVGTPHFMA 201
Query: 413 PEYALWGYLTYKADVYSFGIVALEIVSG 440
           PE           DV+  G++   ++SG
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 92/213 (43%), Gaps = 19/213 (8%)
Query: 234 QIKAATNNFDSAKKIGEGGFGPVY-KGQLADGTIIAVKQLSSKSRQGNREF---LNEIAM 289
           Q  A  + F+  K +G G FG V     +  G   A+K L  +     +E    LNE  +
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRI 94
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICL 347
           +  +  P LVK+     +   L +V EY     +   L   GR         P  +    
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR------FSEPHARFYAA 148
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            I     +LH      +++RD+K  N+++D+    K++DFGLAK  +G     +  + GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGR----TWXLCGT 201
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             Y+APE  L        D ++ G++  E+ +G
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 99/218 (45%), Gaps = 21/218 (9%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL----ELDWPTRQKI 345
           +  ++H N++ +         L    E   +  L   L G +   +    +L     Q +
Sbjct: 75  LKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL 130
Query: 346 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-HISTRI 404
              I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +++TR 
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 186
Query: 405 AGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
                Y APE  L W +     D++S G +  E+++G+
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 29/215 (13%)
Query: 241 NFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
           ++   K IG G FG VY+ +L D G ++A+K++       NRE    + ++  L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRE----LQIMRKLDHCNIV 76
Query: 300 KI----HGCCVEGDQ--LLLVYEYMENNSLACAL-FGRENCELELDWPTRQKICLGIARG 352
           ++    +    + D+  L LV +Y+       A  + R    L + +   +     + R 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY--VKLYMYQLFRS 134
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNP-KISDFGLAK---LDEGDKTHISTRIAGTI 408
           LA++H    F I HRDIK  N+LLD D    K+ DFG AK     E + ++I +R     
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---- 187
Query: 409 GYMAPEYALWGYLTYKA--DVYSFGIVALEIVSGK 441
            Y APE  ++G   Y +  DV+S G V  E++ G+
Sbjct: 188 -YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 97/225 (43%), Gaps = 35/225 (15%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 147
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI 400
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+       H 
Sbjct: 148 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HT 195
Query: 401 STRIAGTIG---YMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
              + G +    Y APE  L W +     D++S G +  E+++G+
Sbjct: 196 DDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 92/213 (43%), Gaps = 19/213 (8%)
Query: 234 QIKAATNNFDSAKKIGEGGFGPVY-KGQLADGTIIAVKQLSSKSRQGNREF---LNEIAM 289
           Q  A  + F+  K IG G FG V     +  G   A+K L  +     ++    LNE  +
Sbjct: 35  QNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICL 347
           +  +  P LVK+     +   L +V EY+    +   L   GR         P  +    
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR------FSEPHARFYAA 148
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            I     +LH      +++RD+K  N+L+D+    K++DFG AK  +G     +  + GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGT 201
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             Y+APE  L        D ++ G++  E+ +G
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 248 IGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIHGCC 305
           IGEG +G V       +   +A+K++S    Q   +  L EI ++   +H N++ I+   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL---GIARGLAFLHEESRF 362
                  +   Y+  + +   L+      L+    +   IC     I RGL ++H  +  
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKL----LKTQHLSNDHICYFLYQILRGLKYIHSAN-- 144
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS--TRIAGTIGYMAPEYAL--W 418
            ++HRD+K +N+LL+   + KI DFGLA++ + D  H    T    T  Y APE  L   
Sbjct: 145 -VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 419 GYLTYKADVYSFGIVALEIVSGK 441
           GY T   D++S G +  E++S +
Sbjct: 204 GY-TKSIDIWSVGCILAEMLSNR 225

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 12/206 (5%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKS--RQGNREFLN-EIAMISCLQH 295
            +F   K +GEG F  V    +LA     A+K L  +   ++    ++  E  ++S L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           P  VK++    + ++L     Y +N  L   +    +     D    +     I   L +
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 144
Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPE 414
           LH +    I+HRD+K  N+LL+ D++ +I+DFG AK L    K   +    GT  Y++PE
Sbjct: 145 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 201
Query: 415 YALWGYLTYKADVYSFGIVALEIVSG 440
                     +D+++ G +  ++V+G
Sbjct: 202 LLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 12/206 (5%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKS--RQGNREFLN-EIAMISCLQH 295
            +F   K +GEG F  V    +LA     A+K L  +   ++    ++  E  ++S L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           P  VK++    + ++L     Y +N  L   +    +     D    +     I   L +
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 144
Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPE 414
           LH +    I+HRD+K  N+LL+ D++ +I+DFG AK L    K   +    GT  Y++PE
Sbjct: 145 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 201
Query: 415 YALWGYLTYKADVYSFGIVALEIVSG 440
                     +D+++ G +  ++V+G
Sbjct: 202 LLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 94/193 (48%), Gaps = 21/193 (10%)
Query: 239 TNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREF--LNEIAMISCLQH 295
            + ++   KIG+G FG V+K +    G  +A+K++  ++ +       L EI ++  L+H
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 296 PNLVKIHGCCVEG--------DQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL 347
            N+V +   C             + LV+++ E++ LA  L    N  ++      +++  
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLL---SNVLVKFTLSEIKRVMQ 132
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG- 406
            +  GL ++H   R KI+HRD+KA NVL+ RD   K++DFGLA+     K     R    
Sbjct: 133 MLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNR 189
Query: 407 --TIGYMAPEYAL 417
             T+ Y  PE  L
Sbjct: 190 VVTLWYRPPELLL 202

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 248 IGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIHGCC 305
           IGEG +G V       +   +A+K++S    Q   +  L EI ++   +H N++ I+   
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL---GIARGLAFLHEESRF 362
                  +   Y+  + +   L+      L+    +   IC     I RGL ++H  +  
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKL----LKTQHLSNDHICYFLYQILRGLKYIHSAN-- 146
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS--TRIAGTIGYMAPEYAL--W 418
            ++HRD+K +N+LL+   + KI DFGLA++ + D  H    T    T  Y APE  L   
Sbjct: 147 -VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 419 GYLTYKADVYSFGIVALEIVSGK 441
           GY T   D++S G +  E++S +
Sbjct: 206 GY-TKSIDIWSVGCILAEMLSNR 227

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 12/206 (5%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKS--RQGNREFLN-EIAMISCLQH 295
            +F   K +GEG F  V    +LA     A+K L  +   ++    ++  E  ++S L H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           P  VK++    + ++L     Y +N  L   +    +     D    +     I   L +
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 129
Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPE 414
           LH +    I+HRD+K  N+LL+ D++ +I+DFG AK L    K   +    GT  Y++PE
Sbjct: 130 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 186
Query: 415 YALWGYLTYKADVYSFGIVALEIVSG 440
                     +D+++ G +  ++V+G
Sbjct: 187 LLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 94/193 (48%), Gaps = 21/193 (10%)
Query: 239 TNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREF--LNEIAMISCLQH 295
            + ++   KIG+G FG V+K +    G  +A+K++  ++ +       L EI ++  L+H
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 296 PNLVKIHGCCVEGDQ--------LLLVYEYMENNSLACALFGRENCELELDWPTRQKICL 347
            N+V +   C             + LV+++ E++ LA  L    N  ++      +++  
Sbjct: 77  ENVVNLIEICRTKASPYNRCKASIYLVFDFCEHD-LAGLL---SNVLVKFTLSEIKRVMQ 132
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG- 406
            +  GL ++H   R KI+HRD+KA NVL+ RD   K++DFGLA+     K     R    
Sbjct: 133 MLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNR 189
Query: 407 --TIGYMAPEYAL 417
             T+ Y  PE  L
Sbjct: 190 VVTLWYRPPELLL 202

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 12/206 (5%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKS--RQGNREFLN-EIAMISCLQH 295
            +F   K +GEG F  V    +LA     A+K L  +   ++    ++  E  ++S L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           P  VK++    + ++L     Y +N  L   +    +     D    +     I   L +
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 147
Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPE 414
           LH +    I+HRD+K  N+LL+ D++ +I+DFG AK L    K   +    GT  Y++PE
Sbjct: 148 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 415 YALWGYLTYKADVYSFGIVALEIVSG 440
                     +D+++ G +  ++V+G
Sbjct: 205 LLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 12/206 (5%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKS--RQGNREFLN-EIAMISCLQH 295
            +F   K +GEG F  V    +LA     A+K L  +   ++    ++  E  ++S L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           P  VK++    + ++L     Y +N  L   +    +     D    +     I   L +
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 145
Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPE 414
           LH +    I+HRD+K  N+LL+ D++ +I+DFG AK L    K   +    GT  Y++PE
Sbjct: 146 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202
Query: 415 YALWGYLTYKADVYSFGIVALEIVSG 440
                     +D+++ G +  ++V+G
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 12/206 (5%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKS--RQGNREFLN-EIAMISCLQH 295
            +F   K +GEG F  V    +LA     A+K L  +   ++    ++  E  ++S L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           P  VK++    + ++L     Y +N  L   +    +     D    +     I   L +
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 145
Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPE 414
           LH +    I+HRD+K  N+LL+ D++ +I+DFG AK L    K   +    GT  Y++PE
Sbjct: 146 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202
Query: 415 YALWGYLTYKADVYSFGIVALEIVSG 440
                     +D+++ G +  ++V+G
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 102/213 (47%), Gaps = 25/213 (11%)
Query: 239 TNNFDSAKKIGEGGFGPVYK------GQLADGTIIAVKQLSSKSRQGNREFLNEIAMISC 292
           ++N+D  +++G+G F  V +      G      II  K+LS++  Q   +   E  +   
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ---KLEREARICRK 61
Query: 293 LQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRE-NCELELDWPTRQKICLGIAR 351
           LQHPN+V++H    E     LV++ +    L   +  RE   E +     +Q     I  
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ-----ILE 116
Query: 352 GLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLA-KLDEGDKTHISTRIAGT 407
            +A+ H      IVHR++K  N+LL    +    K++DFGLA ++++ +  H     AGT
Sbjct: 117 SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGT 170
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            GY++PE       +   D+++ G++   ++ G
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 100/224 (44%), Gaps = 33/224 (14%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQL-SSKSRQGNREFLNEIAMISCLQ 294
           +         K+IG+G +G V+ G+   G  +AVK   +++     RE   EI     ++
Sbjct: 33  RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRE--TEIYQTVLMR 89
Query: 295 HPNLVKIHGCCVEGD----QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           H N++      ++G     QL L+ +Y EN SL   L         LD  +  K+     
Sbjct: 90  HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSV 144
Query: 351 RGLAFLHEE-----SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI----S 401
            GL  LH E      +  I HRD+K+ N+L+ ++    I+D GLA     D   +    +
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPN 204
Query: 402 TRIAGTIGYMAPEYA--------LWGYLTYKADVYSFGIVALEI 437
           TR+ GT  YM PE             Y+   AD+YSFG++  E+
Sbjct: 205 TRV-GTKRYMPPEVLDESLNRNHFQSYIM--ADMYSFGLILWEV 245

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 12/206 (5%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKS--RQGNREFLN-EIAMISCLQH 295
            +F   K +GEG F  V    +LA     A+K L  +   ++    ++  E  ++S L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           P  VK++    + ++L     Y +N  L   +    +     D    +     I   L +
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 147
Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPE 414
           LH +    I+HRD+K  N+LL+ D++ +I+DFG AK L    K   +    GT  Y++PE
Sbjct: 148 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 415 YALWGYLTYKADVYSFGIVALEIVSG 440
                     +D+++ G +  ++V+G
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 102/213 (47%), Gaps = 25/213 (11%)
Query: 239 TNNFDSAKKIGEGGFGPVYK------GQLADGTIIAVKQLSSKSRQGNREFLNEIAMISC 292
           ++N+D  +++G+G F  V +      G      II  K+LS++  Q   +   E  +   
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ---KLEREARICRK 61
Query: 293 LQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRE-NCELELDWPTRQKICLGIAR 351
           LQHPN+V++H    E     LV++ +    L   +  RE   E +     +Q     I  
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ-----ILE 116
Query: 352 GLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLA-KLDEGDKTHISTRIAGT 407
            +A+ H      IVHR++K  N+LL    +    K++DFGLA ++++ +  H     AGT
Sbjct: 117 SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGT 170
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            GY++PE       +   D+++ G++   ++ G
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 102/213 (47%), Gaps = 25/213 (11%)
Query: 239 TNNFDSAKKIGEGGFGPVYK------GQLADGTIIAVKQLSSKSRQGNREFLNEIAMISC 292
           ++N+D  +++G+G F  V +      G      II  K+LS++  Q   +   E  +   
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ---KLEREARICRK 60
Query: 293 LQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRE-NCELELDWPTRQKICLGIAR 351
           LQHPN+V++H    E     LV++ +    L   +  RE   E +     +Q     I  
Sbjct: 61  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ-----ILE 115
Query: 352 GLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLA-KLDEGDKTHISTRIAGT 407
            +A+ H      IVHR++K  N+LL    +    K++DFGLA ++++ +  H     AGT
Sbjct: 116 SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGT 169
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            GY++PE       +   D+++ G++   ++ G
Sbjct: 170 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 248 IGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIHGCC 305
           IGEG +G V       +   +A+K++S    Q   +  L EI ++   +H N++ I+   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL---GIARGLAFLHEESRF 362
                  +   Y+  + +   L+      L+    +   IC     I RGL ++H  +  
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKL----LKTQHLSNDHICYFLYQILRGLKYIHSAN-- 144
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS--TRIAGTIGYMAPEYAL--W 418
            ++HRD+K +N+LL+   + KI DFGLA++ + D  H    T    T  Y APE  L   
Sbjct: 145 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 419 GYLTYKADVYSFGIVALEIVSGK 441
           GY T   D++S G +  E++S +
Sbjct: 204 GY-TKSIDIWSVGCILAEMLSNR 225

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 8/201 (3%)
Query: 246 KKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQ---GNREFLNEIAMISCLQHPNLVKI 301
           + +G GGFG V+  Q+ A G + A K+L+ K  +   G +  + E  +++ +    +V +
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 302 HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESR 361
                    L LV   M    +   ++  +        P        I  GL  LH+ + 
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN- 309
Query: 362 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYL 421
             I++RD+K  NVLLD D N +ISD GLA   +  +T  +   AGT G+MAPE  L    
Sbjct: 310 --IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEEY 366
Query: 422 TYKADVYSFGIVALEIVSGKN 442
            +  D ++ G+   E+++ + 
Sbjct: 367 DFSVDYFALGVTLYEMIAARG 387

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 248 IGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIHGCC 305
           IGEG +G V       +   +A+K++S    Q   +  L EI ++   +H N++ I+   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL---GIARGLAFLHEESRF 362
                  +   Y+  + +   L+      L+    +   IC     I RGL ++H  +  
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKL----LKTQHLSNDHICYFLYQILRGLKYIHSAN-- 144
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS--TRIAGTIGYMAPEYAL--W 418
            ++HRD+K +N+LL+   + KI DFGLA++ + D  H    T    T  Y APE  L   
Sbjct: 145 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 419 GYLTYKADVYSFGIVALEIVSGK 441
           GY T   D++S G +  E++S +
Sbjct: 204 GY-TKSIDIWSVGCILAEMLSNR 225

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 12/206 (5%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKS--RQGNREFLN-EIAMISCLQH 295
            +F   K +GEG F  V    +LA     A+K L  +   ++    ++  E  ++S L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           P  VK++    + ++L     Y +N  L   +    +     D    +     I   L +
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 148
Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPE 414
           LH +    I+HRD+K  N+LL+ D++ +I+DFG AK L    K   +    GT  Y++PE
Sbjct: 149 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 205
Query: 415 YALWGYLTYKADVYSFGIVALEIVSG 440
                     +D+++ G +  ++V+G
Sbjct: 206 LLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 12/206 (5%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKS--RQGNREFLN-EIAMISCLQH 295
            +F   K +GEG F  V    +LA     A+K L  +   ++    ++  E  ++S L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           P  VK++    + ++L     Y +N  L   +    +     D    +     I   L +
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 148
Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPE 414
           LH +    I+HRD+K  N+LL+ D++ +I+DFG AK L    K   +    GT  Y++PE
Sbjct: 149 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 205
Query: 415 YALWGYLTYKADVYSFGIVALEIVSG 440
                     +D+++ G +  ++V+G
Sbjct: 206 LLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 8/201 (3%)
Query: 246 KKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQ---GNREFLNEIAMISCLQHPNLVKI 301
           + +G GGFG V+  Q+ A G + A K+L+ K  +   G +  + E  +++ +    +V +
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 302 HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESR 361
                    L LV   M    +   ++  +        P        I  GL  LH+ + 
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN- 309
Query: 362 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYL 421
             I++RD+K  NVLLD D N +ISD GLA   +  +T  +   AGT G+MAPE  L    
Sbjct: 310 --IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEEY 366
Query: 422 TYKADVYSFGIVALEIVSGKN 442
            +  D ++ G+   E+++ + 
Sbjct: 367 DFSVDYFALGVTLYEMIAARG 387

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 12/206 (5%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKS--RQGNREFLN-EIAMISCLQH 295
            +F   K +GEG F  V    +LA     A+K L  +   ++    ++  E  ++S L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           P  VK++    + ++L     Y +N  L   +    +     D    +     I   L +
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 147
Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPE 414
           LH +    I+HRD+K  N+LL+ D++ +I+DFG AK L    K   +    GT  Y++PE
Sbjct: 148 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 415 YALWGYLTYKADVYSFGIVALEIVSG 440
                     +D+++ G +  ++V+G
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 12/206 (5%)
Query: 240 NNFDSAKKIGEGGFGP-VYKGQLADGTIIAVKQLSSKS--RQGNREFLN-EIAMISCLQH 295
            +F   K +GEG F   V   +LA     A+K L  +   ++    ++  E  ++S L H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           P  VK++    + ++L     Y +N  L   +    +     D    +     I   L +
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 145
Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPE 414
           LH +    I+HRD+K  N+LL+ D++ +I+DFG AK L    K   +    GT  Y++PE
Sbjct: 146 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202
Query: 415 YALWGYLTYKADVYSFGIVALEIVSG 440
                     +D+++ G +  ++V+G
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 12/206 (5%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKS--RQGNREFLN-EIAMISCLQH 295
            +F   K +GEG F  V    +LA     A+K L  +   ++    ++  E  ++S L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           P  VK++    + ++L     Y +N  L   +    +     D    +     I   L +
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 147
Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPE 414
           LH +    I+HRD+K  N+LL+ D++ +I+DFG AK L    K   +    GT  Y++PE
Sbjct: 148 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 415 YALWGYLTYKADVYSFGIVALEIVSG 440
                     +D+++ G +  ++V+G
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 8/201 (3%)
Query: 246 KKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQ---GNREFLNEIAMISCLQHPNLVKI 301
           + +G GGFG V+  Q+ A G + A K+L+ K  +   G +  + E  +++ +    +V +
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 302 HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESR 361
                    L LV   M    +   ++  +        P        I  GL  LH+ + 
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN- 309
Query: 362 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYL 421
             I++RD+K  NVLLD D N +ISD GLA   +  +T  +   AGT G+MAPE  L    
Sbjct: 310 --IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEEY 366
Query: 422 TYKADVYSFGIVALEIVSGKN 442
            +  D ++ G+   E+++ + 
Sbjct: 367 DFSVDYFALGVTLYEMIAARG 387

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 8/201 (3%)
Query: 246 KKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQ---GNREFLNEIAMISCLQHPNLVKI 301
           + +G GGFG V+  Q+ A G + A K+L+ K  +   G +  + E  +++ +    +V +
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 302 HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESR 361
                    L LV   M    +   ++  +        P        I  GL  LH+ + 
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN- 309
Query: 362 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYL 421
             I++RD+K  NVLLD D N +ISD GLA   +  +T  +   AGT G+MAPE  L    
Sbjct: 310 --IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEEY 366
Query: 422 TYKADVYSFGIVALEIVSGKN 442
            +  D ++ G+   E+++ + 
Sbjct: 367 DFSVDYFALGVTLYEMIAARG 387

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 12/206 (5%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKS--RQGNREFLN-EIAMISCLQH 295
            +F   K +GEG F  V    +LA     A+K L  +   ++    ++  E  ++S L H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           P  VK++    + ++L     Y +N  L   +    +     D    +     I   L +
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 150
Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPE 414
           LH +    I+HRD+K  N+LL+ D++ +I+DFG AK L    K   +    GT  Y++PE
Sbjct: 151 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 207
Query: 415 YALWGYLTYKADVYSFGIVALEIVSG 440
                     +D+++ G +  ++V+G
Sbjct: 208 LLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 12/206 (5%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKS--RQGNREFLN-EIAMISCLQH 295
            +F   K +GEG F  V    +LA     A+K L  +   ++    ++  E  ++S L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           P  VK++    + ++L     Y +N  L   +    +     D    +     I   L +
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 147
Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPE 414
           LH +    I+HRD+K  N+LL+ D++ +I+DFG AK L    K   +    GT  Y++PE
Sbjct: 148 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 415 YALWGYLTYKADVYSFGIVALEIVSG 440
                     +D+++ G +  ++V+G
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 103/215 (47%), Gaps = 39/215 (18%)
Query: 248 IGEGGFGPVYKGQLADGTIIAVKQLSSKSRQG-NREFLNEIAMISCLQHPNLVKIHGCCV 306
           +G+G +G V++G    G  +AVK  SS+  +   RE   E+     L+H N++      +
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIASDM 101
Query: 307 ----EGDQLLLVYEYMENNSLACALFGRENCELE-LDWPTRQKICLGIARGLAFLHEE-- 359
                  QL L+  Y E  SL   L      +L  LD  +  +I L IA GLA LH E  
Sbjct: 102 TSRHSSTQLWLITHYHEMGSLYDYL------QLTTLDTVSCLRIVLSIASGLAHLHIEIF 155
Query: 360 ---SRFKIVHRDIKATNVLLDRDLNPKISDFGLA--------KLDEGDKTHISTRIAGTI 408
               +  I HRD+K+ N+L+ ++    I+D GLA        +LD G+   +     GT 
Sbjct: 156 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-----GTK 210
Query: 409 GYMAPEY-----ALWGYLTYK-ADVYSFGIVALEI 437
            YMAPE       +  + +YK  D+++FG+V  E+
Sbjct: 211 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 248 IGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQG-NREFLNEIAMISCLQHPNLVKIHGCC 305
           IGEG +G V       +   +A+K++S    Q   +  L EI ++   +H N++ I+   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL---GIARGLAFLHEESRF 362
                  +   Y+  + +   L+      L+    +   IC     I RGL ++H  +  
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKL----LKTQHLSNDHICYFLYQILRGLKYIHSAN-- 148
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS--TRIAGTIGYMAPEYAL--W 418
            ++HRD+K +N+LL+   + KI DFGLA++ + D  H    T    T  Y APE  L   
Sbjct: 149 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 419 GYLTYKADVYSFGIVALEIVSGK 441
           GY T   D++S G +  E++S +
Sbjct: 208 GY-TKSIDIWSVGCILAEMLSNR 229

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 12/206 (5%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKS--RQGNREFLN-EIAMISCLQH 295
            +F   K +GEG F  V    +LA     A+K L  +   ++    ++  E  ++S L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           P  VK++    + ++L     Y +N  L   +    +     D    +     I   L +
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 145
Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPE 414
           LH +    I+HRD+K  N+LL+ D++ +I+DFG AK L    K   +    GT  Y++PE
Sbjct: 146 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPE 202
Query: 415 YALWGYLTYKADVYSFGIVALEIVSG 440
                     +D+++ G +  ++V+G
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 248 IGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIHGCC 305
           IGEG +G V       +   +A+K++S    Q   +  L EI ++   +H N++ I+   
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL---GIARGLAFLHEESRF 362
                  +   Y+  + +   L+      L+    +   IC     I RGL ++H  +  
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKL----LKTQHLSNDHICYFLYQILRGLKYIHSAN-- 152
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS--TRIAGTIGYMAPEYAL--W 418
            ++HRD+K +N+LL+   + KI DFGLA++ + D  H    T    T  Y APE  L   
Sbjct: 153 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 211
Query: 419 GYLTYKADVYSFGIVALEIVSGK 441
           GY T   D++S G +  E++S +
Sbjct: 212 GY-TKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 248 IGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIHGCC 305
           IGEG +G V       +   +A+K++S    Q   +  L EI ++   +H N++ I+   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL---GIARGLAFLHEESRF 362
                  +   Y+  + +   L+      L+    +   IC     I RGL ++H  +  
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKL----LKTQHLSNDHICYFLYQILRGLKYIHSAN-- 144
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS--TRIAGTIGYMAPEYAL--W 418
            ++HRD+K +N+LL+   + KI DFGLA++ + D  H    T    T  Y APE  L   
Sbjct: 145 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 419 GYLTYKADVYSFGIVALEIVSGK 441
           GY T   D++S G +  E++S +
Sbjct: 204 GY-TKSIDIWSVGCILAEMLSNR 225

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 103/215 (47%), Gaps = 39/215 (18%)
Query: 248 IGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIHGCCV 306
           +G+G +G V++G    G  +AVK  SS+  +   RE   E+     L+H N++      +
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIASDM 72
Query: 307 ----EGDQLLLVYEYMENNSLACALFGRENCELE-LDWPTRQKICLGIARGLAFLHEE-- 359
                  QL L+  Y E  SL   L      +L  LD  +  +I L IA GLA LH E  
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYL------QLTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 360 ---SRFKIVHRDIKATNVLLDRDLNPKISDFGLA--------KLDEGDKTHISTRIAGTI 408
               +  I HRD+K+ N+L+ ++    I+D GLA        +LD G+   +     GT 
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-----GTK 181
Query: 409 GYMAPEY-----ALWGYLTYK-ADVYSFGIVALEI 437
            YMAPE       +  + +YK  D+++FG+V  E+
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 89/210 (42%), Gaps = 21/210 (10%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHP 296
             +   K IG G  G V        G  +AVK+LS   +++   +    E+ ++ C+ H 
Sbjct: 22  KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHK 81
Query: 297 NLVKI------HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           N++ +           E   + LV E M+ N   C +   E     + +   Q +C    
Sbjct: 82  NIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYLLYQMLC---- 135
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
            G+  LH      I+HRD+K +N+++  D   KI DFGLA+        + T    T  Y
Sbjct: 136 -GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TASTNFMMTPYVVTRYY 189
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            APE  L        D++S G +  E+V G
Sbjct: 190 RAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 248 IGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIHGCC 305
           IGEG +G V       +   +A+K++S    Q   +  L EI ++   +H N++ I+   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL---GIARGLAFLHEESRF 362
                  +   Y+  + +   L+      L+    +   IC     I RGL ++H  +  
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKL----LKTQHLSNDHICYFLYQILRGLKYIHSAN-- 144
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS--TRIAGTIGYMAPEYAL--W 418
            ++HRD+K +N+LL+   + KI DFGLA++ + D  H    T    T  Y APE  L   
Sbjct: 145 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 419 GYLTYKADVYSFGIVALEIVSGK 441
           GY T   D++S G +  E++S +
Sbjct: 204 GY-TKSIDIWSVGCILAEMLSNR 225

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 103/215 (47%), Gaps = 39/215 (18%)
Query: 248 IGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIHGCCV 306
           +G+G +G V++G    G  +AVK  SS+  +   RE   E+     L+H N++      +
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIASDM 72
Query: 307 ----EGDQLLLVYEYMENNSLACALFGRENCELE-LDWPTRQKICLGIARGLAFLHEE-- 359
                  QL L+  Y E  SL   L      +L  LD  +  +I L IA GLA LH E  
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYL------QLTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 360 ---SRFKIVHRDIKATNVLLDRDLNPKISDFGLA--------KLDEGDKTHISTRIAGTI 408
               +  I HRD+K+ N+L+ ++    I+D GLA        +LD G+   +     GT 
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-----GTK 181
Query: 409 GYMAPEY-----ALWGYLTYK-ADVYSFGIVALEI 437
            YMAPE       +  + +YK  D+++FG+V  E+
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 248 IGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIHGCC 305
           IGEG +G V       +   +A+K++S    Q   +  L EI ++   +H N++ I+   
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL---GIARGLAFLHEESRF 362
                  +   Y+  + +   L+      L+    +   IC     I RGL ++H  +  
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKL----LKTQHLSNDHICYFLYQILRGLKYIHSAN-- 146
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS--TRIAGTIGYMAPEYAL--W 418
            ++HRD+K +N+LL+   + KI DFGLA++ + D  H    T    T  Y APE  L   
Sbjct: 147 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 419 GYLTYKADVYSFGIVALEIVSGK 441
           GY T   D++S G +  E++S +
Sbjct: 206 GY-TKSIDIWSVGCILAEMLSNR 227

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 78/167 (46%), Gaps = 17/167 (10%)
Query: 283 FLNEIAMISCLQHPNLVKIHGC----CVEGDQLLLVYEYMENNSLACALFGRENCELELD 338
           F  E    + L HP +V ++         G    +V EY++  +L      R+    E  
Sbjct: 59  FRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTL------RDIVHTEGP 112
Query: 339 W-PTRQ-KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL--DE 394
             P R  ++     + L F H+     I+HRD+K  N+++      K+ DFG+A+   D 
Sbjct: 113 MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADS 169
Query: 395 GDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           G+    +  + GT  Y++PE A    +  ++DVYS G V  E+++G+
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 89/170 (52%), Gaps = 17/170 (10%)
Query: 271 QLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGR 330
           ++S KS+    +F NE+ +I+ +++   +   G     D++ ++YEYMEN+S+    F  
Sbjct: 80  KISIKSKYD--DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSIL--KFDE 135
Query: 331 ENCELELDW----PTRQKICL--GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKI 384
               L+ ++    P +   C+   +    +++H E    I HRD+K +N+L+D++   K+
Sbjct: 136 YFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKL 193
Query: 385 SDFGLAKLDEGDKTHISTRIAGTIGYMAPEY--ALWGYLTYKADVYSFGI 432
           SDFG ++    DK    +R  GT  +M PE+      Y   K D++S GI
Sbjct: 194 SDFGESEY-MVDKKIKGSR--GTYEFMPPEFFSNESSYNGAKVDIWSLGI 240

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 248 IGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIHGCC 305
           IGEG +G V       +   +A+K++S    Q   +  L EI ++   +H N++ I+   
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL---GIARGLAFLHEESRF 362
                  +   Y+  + +   L+      L+    +   IC     I RGL ++H  +  
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKL----LKTQHLSNDHICYFLYQILRGLKYIHSAN-- 164
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS--TRIAGTIGYMAPEYAL--W 418
            ++HRD+K +N+LL+   + KI DFGLA++ + D  H    T    T  Y APE  L   
Sbjct: 165 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 223
Query: 419 GYLTYKADVYSFGIVALEIVSGK 441
           GY T   D++S G +  E++S +
Sbjct: 224 GY-TKSIDIWSVGCILAEMLSNR 245

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 19/216 (8%)
Query: 231 TLKQIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREF---LNE 286
           T  Q  A  + FD  K +G G FG V   +  + G   A+K L  +     ++    LNE
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 287 IAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQK 344
             ++  +  P LVK+     +   L +V EY+    +   L   GR         P  + 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR------FSEPHARF 145
Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI 404
               I     +LH      +++RD+K  N+L+D+    +++DFG AK  +G     +  +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 405 AGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            GT  Y+APE  L        D ++ G++  E+ +G
Sbjct: 199 XGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 19/216 (8%)
Query: 231 TLKQIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREF---LNE 286
           T  Q  A  + FD  K +G G FG V   +  + G   A+K L  +     ++    LNE
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 287 IAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQK 344
             ++  +  P LVK+     +   L +V EY+    +   L   GR         P  + 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR------FSEPHARF 145
Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI 404
               I     +LH      +++RD+K  N+L+D+    +++DFG AK  +G     +  +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 405 AGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            GT  Y+APE  L        D ++ G++  E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 76/154 (49%), Gaps = 19/154 (12%)
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HPN++++           LV++ M+   L    F     ++ L     +KI   +   + 
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKETRKIMRALLEVIC 138
Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHISTRIAGTIGYMAP 413
            LH   +  IVHRD+K  N+LLD D+N K++DFG + +LD G+K      + GT  Y+AP
Sbjct: 139 ALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EVCGTPSYLAP 192
Query: 414 EYALW-------GYLTYKADVYSFGIVALEIVSG 440
           E           GY   + D++S G++   +++G
Sbjct: 193 EIIECSMNDNHPGY-GKEVDMWSTGVIMYTLLAG 225

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 19/216 (8%)
Query: 231 TLKQIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREF---LNE 286
           T  Q  A  + FD  K +G G FG V   +  + G   A+K L  +     ++    LNE
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 287 IAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQK 344
             ++  +  P LVK+     +   L +V EY+    +   L   GR         P  + 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR------FSEPHARF 145
Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI 404
               I     +LH      +++RD+K  N+L+D+    +++DFG AK  +G     +  +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 405 AGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            GT  Y+APE  L        D ++ G++  E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 248 IGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIHGCC 305
           IGEG +G V       +   +A+K++S    Q   +  L EI ++   +H N++ I+   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL---GIARGLAFLHEESRF 362
                  +   Y+  + +   L+      L+    +   IC     I RGL ++H  +  
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKL----LKTQHLSNDHICYFLYQILRGLKYIHSAN-- 148
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS--TRIAGTIGYMAPEYAL--W 418
            ++HRD+K +N+LL+   + KI DFGLA++ + D  H    T    T  Y APE  L   
Sbjct: 149 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 419 GYLTYKADVYSFGIVALEIVSGK 441
           GY T   D++S G +  E++S +
Sbjct: 208 GY-TKSIDIWSVGCILAEMLSNR 229

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 76/154 (49%), Gaps = 19/154 (12%)
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HPN++++           LV++ M+   L    F     ++ L     +KI   +   + 
Sbjct: 70  HPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKETRKIMRALLEVIC 125
Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHISTRIAGTIGYMAP 413
            LH   +  IVHRD+K  N+LLD D+N K++DFG + +LD G+K      + GT  Y+AP
Sbjct: 126 ALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EVCGTPSYLAP 179
Query: 414 EYALW-------GYLTYKADVYSFGIVALEIVSG 440
           E           GY   + D++S G++   +++G
Sbjct: 180 EIIECSMNDNHPGY-GKEVDMWSTGVIMYTLLAG 212

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 248 IGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIHGCC 305
           IGEG +G V         T +A+K++S    Q   +  L EI ++   +H N++ I    
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL---GIARGLAFLHEESRF 362
                  +   Y+  + +   L+      L+    +   IC     I RGL ++H  +  
Sbjct: 111 RASTLEAMRDVYIVQDLMETDLYKL----LKSQQLSNDHICYFLYQILRGLKYIHSAN-- 164
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKL--DEGDKTHISTRIAGTIGYMAPEYAL--W 418
            ++HRD+K +N+L++   + KI DFGLA++   E D T   T    T  Y APE  L   
Sbjct: 165 -VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSK 223
Query: 419 GYLTYKADVYSFGIVALEIVSGK 441
           GY T   D++S G +  E++S +
Sbjct: 224 GY-TKSIDIWSVGCILAEMLSNR 245

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 19/216 (8%)
Query: 231 TLKQIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREF---LNE 286
           T  Q  A  + FD  K +G G FG V   +  + G   A+K L  +     ++    LNE
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 287 IAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQK 344
             ++  +  P LVK+     +   L +V EY+    +   L   GR         P  + 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR------FSEPHARF 145
Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI 404
               I     +LH      +++RD+K  N+L+D+    +++DFG AK  +G     +  +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 405 AGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            GT  Y+APE  L        D ++ G++  E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 19/216 (8%)
Query: 231 TLKQIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREF---LNE 286
           T  Q  A  + FD  K +G G FG V   +  + G   A+K L  +     ++    LNE
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 287 IAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQK 344
             ++  +  P LVK+     +   L +V EY+    +   L   GR         P  + 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR------FSEPHARF 145
Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI 404
               I     +LH      +++RD+K  N+L+D+    +++DFG AK  +G     +  +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 405 AGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            GT  Y+APE  L        D ++ G++  E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 19/216 (8%)
Query: 231 TLKQIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREF---LNE 286
           T  Q  A  + FD  K +G G FG V   +  + G   A+K L  +     ++    LNE
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 287 IAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQK 344
             ++  +  P LVK+     +   L +V EY+    +   L   GR         P  + 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR------FXEPHARF 145
Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI 404
               I     +LH      +++RD+K  N+L+D+    +++DFG AK  +G     +  +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 405 AGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            GT  Y+APE  L        D ++ G++  E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 19/216 (8%)
Query: 231 TLKQIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREF---LNE 286
           T  Q  A  + FD  K +G G FG V   +  + G   A+K L  +     ++    LNE
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 287 IAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQK 344
             ++  +  P LVK+     +   L +V EY+    +   L   GR         P  + 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR------FSEPHARF 145
Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI 404
               I     +LH      +++RD+K  N+L+D+    +++DFG AK  +G     +  +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 405 AGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            GT  Y+APE  L        D ++ G++  E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 79/164 (48%), Gaps = 20/164 (12%)
Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG-T 407
           +A+G+ FL   SR K +HRD+ A N+LL      KI DFGLA+    D  ++    A   
Sbjct: 202 VAKGMEFL--ASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD 467
           + +MAPE       T ++DV+SFG++  EI S     S  P ++ D     +  C   ++
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPGVKID-----EEFCRRLKE 311
Query: 468 GKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           G  +   D      Y   E   M +  L C +  PS RPT SE+
Sbjct: 312 GTRMRAPD------YTTPE---MYQTMLDCWHGEPSQRPTFSEL 346

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 19/216 (8%)
Query: 231 TLKQIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREF---LNE 286
           T  Q  A  + FD  K +G G FG V   +  + G   A+K L  +     ++    LNE
Sbjct: 33  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 287 IAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQK 344
             ++  +  P LVK+     +   L +V EY+    +   L   GR         P  + 
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR------FSEPHARF 146
Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI 404
               I     +LH      +++RD+K  N+L+D+    +++DFG AK  +G     +  +
Sbjct: 147 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 199
Query: 405 AGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            GT  Y+APE  L        D ++ G++  E+ +G
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 248 IGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIHGCC 305
           IGEG +G V       +   +A+K++S    Q   +  L EI ++   +H N++ I+   
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL---GIARGLAFLHEESRF 362
                  +   Y+  + +   L+      L+    +   IC     I RGL ++H  +  
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKL----LKTQHLSNDHICYFLYQILRGLKYIHSAN-- 149
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS--TRIAGTIGYMAPEYAL--W 418
            ++HRD+K +N+LL+   + KI DFGLA++ + D  H    T    T  Y APE  L   
Sbjct: 150 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 208
Query: 419 GYLTYKADVYSFGIVALEIVSGK 441
           GY T   D++S G +  E++S +
Sbjct: 209 GY-TKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 248 IGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIHGCC 305
           IGEG +G V       +   +A+K++S    Q   +  L EI ++   +H N++ I+   
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL---GIARGLAFLHEESRF 362
                  +   Y+  + +   L+      L+    +   IC     I RGL ++H  +  
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKL----LKTQHLSNDHICYFLYQILRGLKYIHSAN-- 150
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS--TRIAGTIGYMAPEYAL--W 418
            ++HRD+K +N+LL+   + KI DFGLA++ + D  H    T    T  Y APE  L   
Sbjct: 151 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 209
Query: 419 GYLTYKADVYSFGIVALEIVSGK 441
           GY T   D++S G +  E++S +
Sbjct: 210 GY-TKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 248 IGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIHGCC 305
           IGEG +G V       +   +A+K++S    Q   +  L EI ++   +H N++ I+   
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL---GIARGLAFLHEESRF 362
                  +   Y+  + +   L+      L+    +   IC     I RGL ++H  +  
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKL----LKTQHLSNDHICYFLYQILRGLKYIHSAN-- 141
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS--TRIAGTIGYMAPEYAL--W 418
            ++HRD+K +N+LL+   + KI DFGLA++ + D  H    T    T  Y APE  L   
Sbjct: 142 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 200
Query: 419 GYLTYKADVYSFGIVALEIVSGK 441
           GY T   D++S G +  E++S +
Sbjct: 201 GY-TKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 248 IGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIHGCC 305
           IGEG +G V       +   +A+K++S    Q   +  L EI ++   +H N++ I+   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL---GIARGLAFLHEESRF 362
                  +   Y+  + +   L+      L+    +   IC     I RGL ++H  +  
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKL----LKTQHLSNDHICYFLYQILRGLKYIHSAN-- 148
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS--TRIAGTIGYMAPEYAL--W 418
            ++HRD+K +N+LL+   + KI DFGLA++ + D  H    T    T  Y APE  L   
Sbjct: 149 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 419 GYLTYKADVYSFGIVALEIVSGK 441
           GY T   D++S G +  E++S +
Sbjct: 208 GY-TKSIDIWSVGCILAEMLSNR 229

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 76/154 (49%), Gaps = 19/154 (12%)
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HPN++++           LV++ M+   L    F     ++ L     +KI   +   + 
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKETRKIMRALLEVIC 138
Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHISTRIAGTIGYMAP 413
            LH   +  IVHRD+K  N+LLD D+N K++DFG + +LD G+K      + GT  Y+AP
Sbjct: 139 ALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---SVCGTPSYLAP 192
Query: 414 EYALW-------GYLTYKADVYSFGIVALEIVSG 440
           E           GY   + D++S G++   +++G
Sbjct: 193 EIIECSMNDNHPGY-GKEVDMWSTGVIMYTLLAG 225

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 19/216 (8%)
Query: 231 TLKQIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREF---LNE 286
           T  Q  A  + FD  K +G G FG V   +  + G   A+K L  +     ++    LNE
Sbjct: 27  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 86
Query: 287 IAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQK 344
             ++  +  P LVK+     +   L +V EY+    +   L   GR         P  + 
Sbjct: 87  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR------FXEPHARF 140
Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI 404
               I     +LH      +++RD+K  N+L+D+    +++DFG AK  +G     +  +
Sbjct: 141 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 193
Query: 405 AGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            GT  Y+APE  L        D ++ G++  E+ +G
Sbjct: 194 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 19/216 (8%)
Query: 231 TLKQIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREF---LNE 286
           T  Q  A  + FD  K +G G FG V   +  + G   A+K L  +     ++    LNE
Sbjct: 19  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 78
Query: 287 IAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQK 344
             ++  +  P LVK+     +   L +V EY+    +   L   GR         P  + 
Sbjct: 79  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR------FSEPHARF 132
Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI 404
               I     +LH      +++RD+K  N+L+D     +++DFG AK  +G     +  +
Sbjct: 133 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGR----TWXL 185
Query: 405 AGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            GT  Y+APE  L        D ++ G++  E+ +G
Sbjct: 186 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 19/213 (8%)
Query: 234 QIKAATNNFDSAKKIGEGGFGPVY-KGQLADGTIIAVKQLSSKSRQGNREF---LNEIAM 289
           Q  A  + F+  K +G G FG V     +  G   A+K L  +     +E    LNE  +
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRI 94
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICL 347
           +  +  P LVK+     +   L +V EY     +   L   GR         P  +    
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR------FSEPHARFYAA 148
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            I     +LH      +++RD+K  N+++D+    +++DFGLAK  +G     +  + GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGR----TWXLCGT 201
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             Y+APE  L        D ++ G++  E+ +G
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 79/164 (48%), Gaps = 20/164 (12%)
Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG-T 407
           +A+G+ FL   SR K +HRD+ A N+LL      KI DFGLA+    D  ++    A   
Sbjct: 200 VAKGMEFL--ASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD 467
           + +MAPE       T ++DV+SFG++  EI S     S  P ++ D     +  C   ++
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPGVKID-----EEFCRRLKE 309
Query: 468 GKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           G  +   D      Y   E   M +  L C +  PS RPT SE+
Sbjct: 310 GTRMRAPD------YTTPE---MYQTMLDCWHGEPSQRPTFSEL 344

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 19/216 (8%)
Query: 231 TLKQIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREF---LNE 286
           T  Q  A  + FD  K +G G FG V   +  + G   A+K L  +     ++    LNE
Sbjct: 53  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 112
Query: 287 IAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQK 344
             ++  +  P LVK+     +   L +V EY+    +   L   GR         P  + 
Sbjct: 113 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR------FSEPHARF 166
Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI 404
               I     +LH      +++RD+K  N+L+D+    +++DFG AK  +G     +  +
Sbjct: 167 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----ATWTL 219
Query: 405 AGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            GT  Y+APE  L        D ++ G++  E+ +G
Sbjct: 220 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 248 IGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIHGCC 305
           IGEG +G V       +   +A+K++S    Q   +  L EI ++   +H N++ I+   
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL---GIARGLAFLHEESRF 362
                  +   Y+  + +   L+      L+    +   IC     I RGL ++H  +  
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKL----LKTQHLSNDHICYFLYQILRGLKYIHSAN-- 142
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS--TRIAGTIGYMAPEYAL--W 418
            ++HRD+K +N+LL+   + KI DFGLA++ + D  H    T    T  Y APE  L   
Sbjct: 143 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 201
Query: 419 GYLTYKADVYSFGIVALEIVSGK 441
           GY T   D++S G +  E++S +
Sbjct: 202 GY-TKSIDIWSVGCILAEMLSNR 223

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 19/216 (8%)
Query: 231 TLKQIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREF---LNE 286
           T  Q  A  + FD  K +G G FG V   +  + G   A+K L  +     ++    LNE
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 287 IAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQK 344
             ++  +  P LVK+     +   L +V EY+    +   L   GR         P  + 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR------FXEPHARF 145
Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI 404
               I     +LH      +++RD+K  N+L+D+    +++DFG AK  +G     +  +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 405 AGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            GT  Y+APE  L        D ++ G++  E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 79/164 (48%), Gaps = 20/164 (12%)
Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG-T 407
           +A+G+ FL   SR K +HRD+ A N+LL      KI DFGLA+    D  ++    A   
Sbjct: 207 VAKGMEFL--ASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD 467
           + +MAPE       T ++DV+SFG++  EI S     S  P ++ D     +  C   ++
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPGVKID-----EEFCRRLKE 316
Query: 468 GKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           G  +   D      Y   E   M +  L C +  PS RPT SE+
Sbjct: 317 GTRMRAPD------YTTPE---MYQTMLDCWHGEPSQRPTFSEL 351

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 79/164 (48%), Gaps = 20/164 (12%)
Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG-T 407
           +A+G+ FL   SR K +HRD+ A N+LL      KI DFGLA+    D  ++    A   
Sbjct: 209 VAKGMEFL--ASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD 467
           + +MAPE       T ++DV+SFG++  EI S     S  P ++ D     +  C   ++
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPGVKID-----EEFCRRLKE 318
Query: 468 GKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           G  +   D      Y   E   M +  L C +  PS RPT SE+
Sbjct: 319 GTRMRAPD------YTTPE---MYQTMLDCWHGEPSQRPTFSEL 353

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 127
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI  FGLA+  + + T +
Sbjct: 128 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGY 182
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 183 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 248 IGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIHGCC 305
           IGEG +G V       +   +A+K++S    Q   +  L EI ++   +H N++ I+   
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL---GIARGLAFLHEESRF 362
                  +   Y+  + +   L+      L+    +   IC     I RGL ++H  +  
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKL----LKTQHLSNDHICYFLYQILRGLKYIHSAN-- 142
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS--TRIAGTIGYMAPEYAL--W 418
            ++HRD+K +N+LL+   + KI DFGLA++ + D  H    T    T  Y APE  L   
Sbjct: 143 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 201
Query: 419 GYLTYKADVYSFGIVALEIVSGK 441
           GY T   D++S G +  E++S +
Sbjct: 202 GY-TKSIDIWSVGCILAEMLSNR 223

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 19/216 (8%)
Query: 231 TLKQIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREF---LNE 286
           T  Q  A  + FD  K +G G FG V   +  + G   A+K L  +     ++    LNE
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 287 IAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQK 344
             ++  +  P LVK+     +   L +V EY+    +   L   GR         P  + 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR------FXEPHARF 145
Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI 404
               I     +LH      +++RD+K  N+L+D+    +++DFG AK  +G     +  +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 405 AGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            GT  Y+APE  L        D ++ G++  E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 78/167 (46%), Gaps = 17/167 (10%)
Query: 283 FLNEIAMISCLQHPNLVKIHGC----CVEGDQLLLVYEYMENNSLACALFGRENCELELD 338
           F  E    + L HP +V ++         G    +V EY++  +L      R+    E  
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL------RDIVHTEGP 112
Query: 339 W-PTRQ-KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL--DE 394
             P R  ++     + L F H+     I+HRD+K  N+++      K+ DFG+A+   D 
Sbjct: 113 MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADS 169
Query: 395 GDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           G+    +  + GT  Y++PE A    +  ++DVYS G V  E+++G+
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 105/215 (48%), Gaps = 29/215 (13%)
Query: 241 NFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
           ++   K IG G FG VY+ +L D G ++A+K++       NRE    + ++  L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRE----LQIMRKLDHCNIV 76
Query: 300 KI----HGCCVEGDQ--LLLVYEYMENNSLACAL-FGRENCELELDWPTRQKICLGIARG 352
           ++    +    + D+  L LV +Y+       A  + R    L + +   +     + R 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIY--VKLYMYQLFRS 134
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNP-KISDFGLAK---LDEGDKTHISTRIAGTI 408
           LA++H    F I HRDIK  N+LLD D    K+ DFG AK     E + + I +R     
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY---- 187
Query: 409 GYMAPEYALWGYLTYKA--DVYSFGIVALEIVSGK 441
            Y APE  ++G   Y +  DV+S G V  E++ G+
Sbjct: 188 -YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 71/148 (47%), Gaps = 12/148 (8%)
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICLGIARGL 353
           P L ++H C    D+L  V EY+    L   +   GR         P        IA GL
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR------FKEPHAVFYAAEIAIGL 455
Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAP 413
            FL  +    I++RD+K  NV+LD + + KI+DFG+ K +  D    +    GT  Y+AP
Sbjct: 456 FFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-TTKXFCGTPDYIAP 511
Query: 414 EYALWGYLTYKADVYSFGIVALEIVSGK 441
           E   +       D ++FG++  E+++G+
Sbjct: 512 EIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 71/148 (47%), Gaps = 12/148 (8%)
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICLGIARGL 353
           P L ++H C    D+L  V EY+    L   +   GR         P        IA GL
Sbjct: 81  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR------FKEPHAVFYAAEIAIGL 134
Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAP 413
            FL  +    I++RD+K  NV+LD + + KI+DFG+ K +  D    +    GT  Y+AP
Sbjct: 135 FFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-TTKXFCGTPDYIAP 190
Query: 414 EYALWGYLTYKADVYSFGIVALEIVSGK 441
           E   +       D ++FG++  E+++G+
Sbjct: 191 EIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 21/222 (9%)
Query: 223 SDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGT-IIAVKQL--SSKSRQG 279
            D+ T  FT+       ++F+  + +G+G FG VY  +      I+A+K L  S   ++G
Sbjct: 13  PDILTRHFTI-------DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEG 65
Query: 280 -NREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELD 338
              +   EI + + L HPN+++++    +  ++ L+ EY     L   L  +++C    D
Sbjct: 66  VEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKEL--QKSCTF--D 121
Query: 339 WPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT 398
                 I   +A  L + H +   K++HRDIK  N+LL      KI+DFG +      + 
Sbjct: 122 EQRTATIMEELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLR- 177
Query: 399 HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
                + GT+ Y+ PE         K D++  G++  E++ G
Sbjct: 178 --RKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 127
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DF LA+  + + T +
Sbjct: 128 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGY 182
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 183 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 19/216 (8%)
Query: 231 TLKQIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREF---LNE 286
           T  Q  A  + FD  K +G G FG V   +  + G   A+K L  +     ++    LNE
Sbjct: 53  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 112
Query: 287 IAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQK 344
             ++  +  P LVK+     +   L +V EY+    +   L   GR         P  + 
Sbjct: 113 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR------FXEPHARF 166
Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI 404
               I     +LH      +++RD+K  N+L+D+    +++DFG AK  +G     +  +
Sbjct: 167 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 219
Query: 405 AGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            GT  Y+APE  L        D ++ G++  E+ +G
Sbjct: 220 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 21/208 (10%)
Query: 242 FDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHPNL 298
           +   K IG G  G V        G  +AVK+LS   +++   +    E+ ++ C+ H N+
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 85
Query: 299 VKI------HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARG 352
           + +           E   + LV E M+ N   C +   E     + +   Q +C     G
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYLLYQMLC-----G 138
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMA 412
           +  LH      I+HRD+K +N+++  D   KI DFGLA+        + T    T  Y A
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRA 193
Query: 413 PEYALWGYLTYKADVYSFGIVALEIVSG 440
           PE  L        D++S G +  E+V G
Sbjct: 194 PEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 19/216 (8%)
Query: 231 TLKQIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREF---LNE 286
           T  Q  A  + FD  K +G G FG V   +  + G   A+K L  +     ++    LNE
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 287 IAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQK 344
             ++  +  P LVK+     +   L +V EY+    +   L   GR         P  + 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR------FAEPHARF 145
Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI 404
               I     +LH      +++RD+K  N+L+D+    +++DFG AK  +G     +  +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 405 AGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            GT  Y+APE  L        D ++ G++  E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 110/229 (48%), Gaps = 40/229 (17%)
Query: 242 FDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLS---SKSRQGNREFLNEIAMISCLQ-HP 296
           ++  KK+G+G +G V+K      G ++AVK++      S    R F  EI +++ L  H 
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF-REIMILTELSGHE 69
Query: 297 NLVKIHGCC-VEGDQ-LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           N+V +      + D+ + LV++YME +  A     R N    L+   +Q +   + + + 
Sbjct: 70  NIVNLLNVLRADNDRDVYLVFDYMETDLHAVI---RANI---LEPVHKQYVVYQLIKVIK 123
Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK---------------LDEG---- 395
           +LH      ++HRD+K +N+LL+ + + K++DFGL++               ++E     
Sbjct: 124 YLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 396 -DKTHISTRIAGTIGYMAPEYALWGYLTYKA--DVYSFGIVALEIVSGK 441
            D   I T    T  Y APE  L G   Y    D++S G +  EI+ GK
Sbjct: 181 DDDQPILTDYVATRWYRAPE-ILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 127
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI D GLA+  + + T +
Sbjct: 128 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGY 182
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 183 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 78/167 (46%), Gaps = 17/167 (10%)
Query: 283 FLNEIAMISCLQHPNLVKIHGC----CVEGDQLLLVYEYMENNSLACALFGRENCELELD 338
           F  E    + L HP +V ++         G    +V EY++  +L      R+    E  
Sbjct: 76  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL------RDIVHTEGP 129
Query: 339 W-PTRQ-KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL--DE 394
             P R  ++     + L F H+     I+HRD+K  N+++      K+ DFG+A+   D 
Sbjct: 130 MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADS 186
Query: 395 GDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           G+    +  + GT  Y++PE A    +  ++DVYS G V  E+++G+
Sbjct: 187 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 233

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 127
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI D GLA+  + + T +
Sbjct: 128 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGY 182
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 183 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 19/213 (8%)
Query: 234 QIKAATNNFDSAKKIGEGGFGPVY-KGQLADGTIIAVKQLSSKSRQGNREF---LNEIAM 289
           Q  A  + F+  K +G G FG V     +  G   A+K L  +     ++    LNE  +
Sbjct: 21  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 80
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICL 347
           +  +  P LVK+     +   L +V EY+    +   L   GR         P  +    
Sbjct: 81  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR------FSEPHARFYAA 134
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            I     +LH      +++RD+K  N+L+D+    +++DFG AK  +G     +  + GT
Sbjct: 135 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGT 187
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             Y+APE  L        D ++ G++  E+ +G
Sbjct: 188 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 19/213 (8%)
Query: 234 QIKAATNNFDSAKKIGEGGFGPVY-KGQLADGTIIAVKQLSSKSRQGNREF---LNEIAM 289
           Q  A  + F+  K +G G FG V     +  G   A+K L  +     ++    LNE  +
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICL 347
           +  +  P LVK+     +   L +V EY+    +   L   GR         P  +    
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR------FSEPHARFYAA 148
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            I     +LH      +++RD+K  N+L+D+    +++DFG AK  +G     +  + GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGT 201
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             Y+APE  L        D ++ G++  E+ +G
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 19/213 (8%)
Query: 234 QIKAATNNFDSAKKIGEGGFGPVY-KGQLADGTIIAVKQLSSKSRQGNREF---LNEIAM 289
           Q  A  + F+  K +G G FG V     +  G   A+K L  +     ++    LNE  +
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICL 347
           +  +  P LVK+     +   L +V EY+    +   L   GR         P  +    
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR------FSEPHARFYAA 148
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            I     +LH      +++RD+K  N+L+D+    +++DFG AK  +G     +  + GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGT 201
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             Y+APE  L        D ++ G++  E+ +G
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 19/213 (8%)
Query: 234 QIKAATNNFDSAKKIGEGGFGPVY-KGQLADGTIIAVKQLSSKSRQGNREF---LNEIAM 289
           Q  A  + F+  K +G G FG V     +  G   A+K L  +     ++    LNE  +
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICL 347
           +  +  P LVK+     +   L +V EY+    +   L   GR         P  +    
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR------FSEPHARFYAA 149
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            I     +LH      +++RD+K  N+L+D+    +++DFG AK  +G     +  + GT
Sbjct: 150 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGT 202
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             Y+APE  L        D ++ G++  E+ +G
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 19/213 (8%)
Query: 234 QIKAATNNFDSAKKIGEGGFGPVY-KGQLADGTIIAVKQLSSKSRQGNREF---LNEIAM 289
           Q  A  + F+  K +G G FG V     +  G   A+K L  +     ++    LNE  +
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICL 347
           +  +  P LVK+     +   L +V EY+    +   L   GR         P  +    
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR------FSEPHARFYAA 148
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            I     +LH      +++RD+K  N+L+D+    +++DFG AK  +G     +  + GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGT 201
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             Y+APE  L        D ++ G++  E+ +G
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 248 IGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIHGCC 305
           IGEG +G V       +   +A++++S    Q   +  L EI ++   +H N++ I+   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL---GIARGLAFLHEESRF 362
                  +   Y+  + +   L+      L+    +   IC     I RGL ++H  +  
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKL----LKTQHLSNDHICYFLYQILRGLKYIHSAN-- 148
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS--TRIAGTIGYMAPEYAL--W 418
            ++HRD+K +N+LL+   + KI DFGLA++ + D  H    T    T  Y APE  L   
Sbjct: 149 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 419 GYLTYKADVYSFGIVALEIVSGK 441
           GY T   D++S G +  E++S +
Sbjct: 208 GY-TKSIDIWSVGCILAEMLSNR 229

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 34/228 (14%)
Query: 246 KKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIH-- 302
           K +G GG G V+     D    +A+K++     Q  +  L EI +I  L H N+VK+   
Sbjct: 17  KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 303 ------------GCCVEGDQLLLVYEYMEN---NSLACALFGRENCELELDWPTRQKICL 347
                       G   E + + +V EYME    N L       E+  L            
Sbjct: 77  LGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL---------FMY 127
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLD-RDLNPKISDFGLAKLDEGDKTHISTRIAG 406
            + RGL ++H  +   ++HRD+K  N+ ++  DL  KI DFGLA++ +   +H      G
Sbjct: 128 QLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 407 TIG--YMAPEYALWGYLTYKA-DVYSFGIVALEIVSGKNNMSYAPALE 451
            +   Y +P   L      KA D+++ G +  E+++GK   + A  LE
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE 232

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 94/216 (43%), Gaps = 19/216 (8%)
Query: 231 TLKQIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREF---LNE 286
           T  Q  A  + FD  K +G G FG V   +  + G   A+K L  +     ++    LNE
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 287 IAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQK 344
             ++  +  P LVK+     +   L +V EY+    +   L   GR         P  + 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR------FSEPHARF 145
Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI 404
               I     +LH      +++RD+K  N+L+D+    +++DFG AK  +G     +  +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 405 AGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            GT  Y+APE  L        D ++ G++  ++ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 127
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI D GLA+  + + T +
Sbjct: 128 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGY 182
Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L W +     D++S G +  E+++G+
Sbjct: 183 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 25/211 (11%)
Query: 248 IGEGGFGPVY-KGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCV 306
           +G G F  V+   Q   G + A+K +       +    NEIA++  ++H N+V +     
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 307 EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA---FLHEESRFK 363
                 LV + +    L    F R    LE    T +   L I + L+   +LHE     
Sbjct: 77  STTHYYLVMQLVSGGEL----FDRI---LERGVYTEKDASLVIQQVLSAVKYLHENG--- 126
Query: 364 IVHRDIKATNVL-LDRDLNPKI--SDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGY 420
           IVHRD+K  N+L L  + N KI  +DFGL+K+++     I +   GT GY+APE      
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---IMSTACGTPGYVAPEVLAQKP 183
Query: 421 LTYKADVYSFGIVALEIVSGKNNMSYAPALE 451
            +   D +S G++   ++ G     Y P  E
Sbjct: 184 YSKAVDCWSIGVITYILLCG-----YPPFYE 209

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 19/213 (8%)
Query: 234 QIKAATNNFDSAKKIGEGGFGPVY-KGQLADGTIIAVKQLSSKSRQGNREF---LNEIAM 289
           Q  A  + F+  K +G G FG V     +  G   A+K L  +     ++    LNE  +
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICL 347
           +  +  P LVK+     +   L +V EY     +   L   GR         P  +    
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR------FSEPHARFYAA 148
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            I     +LH      +++RD+K  N+++D+    K++DFG AK  +G     +  + GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGT 201
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             Y+APE  L        D ++ G++  E+ +G
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL----ELDWPTRQKI 345
           +  ++H N++ +         L    E   +  L   L G +   +    +L     Q +
Sbjct: 75  LKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFL 130
Query: 346 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-HISTRI 404
              I RGL ++H      I+HRD+K +N+ ++ D   KI DFGL +  + + T +++TR 
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVATR- 186
Query: 405 AGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
                Y APE  L W +     D++S G +  E+++G+
Sbjct: 187 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 19/213 (8%)
Query: 234 QIKAATNNFDSAKKIGEGGFGPVY-KGQLADGTIIAVKQLSSKSRQGNREF---LNEIAM 289
           Q  A  + F+  K +G G FG V     +  G   A+K L  +     ++    LNE  +
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICL 347
           +  +  P LVK+     +   L +V EY+    +   L   GR         P  +    
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR------FSEPHARFYAA 148
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            I     +LH      +++RD+K  N+L+D+    +++DFG AK  +G     +  + GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGT 201
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             Y+APE  L        D ++ G++  E+ +G
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 19/213 (8%)
Query: 234 QIKAATNNFDSAKKIGEGGFGPVY-KGQLADGTIIAVKQLSSKSRQGNREF---LNEIAM 289
           Q  A  + F+  K +G G FG V     +  G   A+K L  +     ++    LNE  +
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICL 347
           +  +  P LVK+     +   L +V EY+    +   L   GR         P  +    
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR------FSEPHARFYAA 149
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            I     +LH      +++RD+K  N+L+D+    +++DFG AK  +G     +  + GT
Sbjct: 150 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGT 202
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             Y+APE  L        D ++ G++  E+ +G
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 19/213 (8%)
Query: 234 QIKAATNNFDSAKKIGEGGFGPVY-KGQLADGTIIAVKQLSSKSRQGNREF---LNEIAM 289
           Q  A  + F+  K +G G FG V     +  G   A+K L  +     ++    LNE  +
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICL 347
           +  +  P LVK+     +   L +V EY+    +   L   GR         P  +    
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR------FXEPHARFYAA 148
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            I     +LH      +++RD+K  N+L+D+    +++DFG AK  +G     +  + GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGT 201
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             Y+APE  L        D ++ G++  E+ +G
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 19/213 (8%)
Query: 234 QIKAATNNFDSAKKIGEGGFGPVY-KGQLADGTIIAVKQLSSKSRQGNREF---LNEIAM 289
           Q  A  + F+  K +G G FG V     +  G   A+K L  +     ++    LNE  +
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICL 347
           +  +  P LVK+     +   L +V EY+    +   L   GR         P  +    
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR------FXEPHARFYAA 149
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            I     +LH      +++RD+K  N+L+D+    +++DFG AK  +G     +  + GT
Sbjct: 150 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGT 202
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             Y+APE  L        D ++ G++  E+ +G
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 24/203 (11%)
Query: 248 IGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNR------EFLNEIAMISCLQHPNLVK 300
           +G G FG V  G+    G  +AVK L+   RQ  R      +   EI  +   +HP+++K
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILN---RQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
           ++          +V EY+    L   +      E E++    +++   I   + + H   
Sbjct: 76  LYQVISTPTDFFMVMEYVSGGELFDYICKHGRVE-EME---ARRLFQQILSAVDYCH--- 128
Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPEYALWG 419
           R  +VHRD+K  NVLLD  +N KI+DFGL+  + +G+    S    G+  Y APE  + G
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPE-VISG 184
Query: 420 --YLTYKADVYSFGIVALEIVSG 440
             Y   + D++S G++   ++ G
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCG 207

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 19/213 (8%)
Query: 234 QIKAATNNFDSAKKIGEGGFGPVY-KGQLADGTIIAVKQLSSKSRQGNREF---LNEIAM 289
           Q  A  + F+  K +G G FG V     +  G   A+K L  +     ++    LNE  +
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICL 347
           +  +  P LVK+     +   L +V EY+    +   L   GR         P  +    
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR------FXEPHARFYAA 148
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            I     +LH      +++RD+K  N+L+D+    +++DFG AK  +G     +  + GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGT 201
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             Y+APE  L        D ++ G++  E+ +G
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 19/213 (8%)
Query: 234 QIKAATNNFDSAKKIGEGGFGPVY-KGQLADGTIIAVKQLSSKSRQGNREF---LNEIAM 289
           Q  A  + F+  K +G G FG V     +  G   A+K L  +     ++    LNE  +
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICL 347
           +  +  P LVK+     +   L +V EY     +   L   GR         P  +    
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR------FXEPHARFYAA 148
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            I     +LH      +++RD+K  N+++D+    K++DFG AK  +G     +  + GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGT 201
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             Y+APE  L        D ++ G++  E+ +G
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 19/213 (8%)
Query: 234 QIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREF---LNEIAM 289
           Q  A  + F+  K +G G FG V   +  + G   A+K L  +     ++    LNE  +
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICL 347
           +  +  P LVK+     +   L +V EY+    +   L   GR         P  +    
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGR------FSEPHARFYAA 148
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            I     +LH      +++RD+K  N+L+D+    +++DFG AK  +G     +  + GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGT 201
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             Y+APE  L        D ++ G++  E+ +G
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 19/216 (8%)
Query: 231 TLKQIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREF---LNE 286
           T  Q  A  + FD  K +G G FG V   +  + G   A+K L  +     ++    LNE
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 287 IAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQK 344
             ++  +  P LVK+     +   L +V EY+    +   L   GR         P  + 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR------FSEPHARF 145
Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI 404
               I     +LH      +++RD+K  N+++D+    +++DFG AK  +G     +  +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 405 AGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            GT  Y+APE  +        D ++ G++  E+ +G
Sbjct: 199 CGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 19/213 (8%)
Query: 234 QIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREF---LNEIAM 289
           Q  A  + F+  K +G G FG V   +  + G   A+K L  +     ++    LNE  +
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICL 347
           +  +  P LVK+     +   L +V EY+    +   L   GR         P  +    
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGR------FSEPHARFYAA 148
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            I     +LH      +++RD+K  N+L+D+    +++DFG AK  +G     +  + GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGT 201
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             Y+APE  L        D ++ G++  E+ +G
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 19/213 (8%)
Query: 234 QIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREF---LNEIAM 289
           Q  A  + F+  K +G G FG V   +  + G   A+K L  +     ++    LNE  +
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICL 347
           +  +  P LVK+     +   L +V EY+    +   L   GR         P  +    
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGR------FSEPHARFYAA 148
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            I     +LH      +++RD+K  N+L+D+    +++DFG AK  +G     +  + GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGT 201
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             Y+APE  L        D ++ G++  E+ +G
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 25/211 (11%)
Query: 242 FDSAKKIGEGGFGPV---YKGQLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHP 296
           + + K IG G  G V   Y   L     +A+K+LS   +++   +    E+ ++ C+ H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 297 NLVKI------HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           N++ +           E   + LV E M+ N            ++ELD      +   + 
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQV-------IQMELDHERMSYLLYQML 136
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
            G+  LH      I+HRD+K +N+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 137 XGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
            APE  L        D++S G +  E+V  K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 248 IGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIHGCC 305
           IGEG +G V       +   +A+K++S    Q   +  L EI ++   +H N++ I+   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL---GIARGLAFLHEESRF 362
                  +   Y+  + +   L+      L+    +   IC     I RGL ++H  +  
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKL----LKTQHLSNDHICYFLYQILRGLKYIHSAN-- 148
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS--TRIAGTIGYMAPEYAL--W 418
            ++HRD+K +N+LL+   + KI DFGLA++ + D  H         T  Y APE  L   
Sbjct: 149 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 207
Query: 419 GYLTYKADVYSFGIVALEIVSGK 441
           GY T   D++S G +  E++S +
Sbjct: 208 GY-TKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 248 IGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIHGCC 305
           IGEG +G V       +   +A+K++S    Q   +  L EI ++   +H N++ I+   
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL---GIARGLAFLHEESRF 362
                  +   Y+  + +   L+      L+    +   IC     I RGL ++H  +  
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKL----LKTQHLSNDHICYFLYQILRGLKYIHSAN-- 149
Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS--TRIAGTIGYMAPEYAL--W 418
            ++HRD+K +N+LL+   + KI DFGLA++ + D  H         T  Y APE  L   
Sbjct: 150 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 208
Query: 419 GYLTYKADVYSFGIVALEIVSGK 441
           GY T   D++S G +  E++S +
Sbjct: 209 GY-TKSIDIWSVGCILAEMLSNR 230

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 19/213 (8%)
Query: 234 QIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREF---LNEIAM 289
           Q  A  + F+  K +G G FG V   +  + G   A+K L  +     ++    LNE  +
Sbjct: 28  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 87
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICL 347
           +  +  P LVK+     +   L +V EY+    +   L   GR         P  +    
Sbjct: 88  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR------FSEPHARFYAA 141
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            I     +LH      +++RD+K  N+L+D+    +++DFG AK  +G     +  + GT
Sbjct: 142 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGT 194
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             Y+APE  L        D ++ G++  E+ +G
Sbjct: 195 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 25/211 (11%)
Query: 242 FDSAKKIGEGGFGPV---YKGQLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHP 296
           + + K IG G  G V   Y   L     +A+K+LS   +++   +    E+ ++ C+ H 
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 297 NLVKI------HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           N++ +           E   + LV E M+ N            ++ELD      +   + 
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQV-------IQMELDHERMSYLLYQML 129
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
            G+  LH      I+HRD+K +N+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 130 XGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYY 184
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
            APE  L        D++S G +  E+V  K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 239 TNNFDSAKKIGEGGFGPVYK------GQLADGTIIAVKQLSSKSRQGNREFLNEIAMISC 292
           T  +   +++G+G F  V +      GQ     II  K+LS++  Q   +   E  +   
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ---KLEREARICRL 66
Query: 293 LQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARG 352
           L+HPN+V++H    E     L+++ +    L   +  RE       + +       I + 
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE-------YYSEADASHCIQQI 119
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLN---PKISDFGLAKLDEGDKTHISTRIAGTIG 409
           L  +    +  +VHR++K  N+LL   L     K++DFGLA   EG++       AGT G
Sbjct: 120 LEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFGFAGTPG 178
Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           Y++PE           D+++ G++   ++ G
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 246 KKIGEGGFGPVYK------GQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
           +++G+G F  V +      GQ     II  K+LS++  Q   +   E  +   L+HPN+V
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQ---KLEREARICRLLKHPNIV 84
Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
           ++H    E     L+++ +    L   +  RE       + +       I + L  +   
Sbjct: 85  RLHDSISEEGHHYLIFDLVTGGELFEDIVARE-------YYSEADASHCIQQILEAVLHC 137
Query: 360 SRFKIVHRDIKATNVLLDRDLN---PKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYA 416
            +  +VHRD+K  N+LL   L     K++DFGLA   EG++       AGT GY++PE  
Sbjct: 138 HQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFGFAGTPGYLSPEVL 196
Query: 417 LWGYLTYKADVYSFGIVALEIVSG 440
                    D+++ G++   ++ G
Sbjct: 197 RKDPYGKPVDLWACGVILYILLVG 220

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 100/229 (43%), Gaps = 30/229 (13%)
Query: 232 LKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGN----------- 280
           + ++ A  + +   + I  G +G V  G  ++G  +A+K++ +    G            
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 281 REFLNEIAMISCLQHPNLVKIHGCCVEGDQ-----LLLVYEYMENNSLACALFGRENCEL 335
           +  L EI +++   HPN++ +    V  ++     L LV E M  + LA  +    +  +
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD-LAQVI---HDQRI 129
Query: 336 ELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG 395
            +     Q     I  GL  LHE     +VHRD+   N+LL  + +  I DF LA+ D  
Sbjct: 130 VISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTA 186
Query: 396 D--KTHISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           D  KTH  T       Y APE  + +   T   D++S G V  E+ + K
Sbjct: 187 DANKTHYVTH----RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 25/211 (11%)
Query: 242 FDSAKKIGEGGFGPV---YKGQLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHP 296
           + + K IG G  G V   Y   L     +A+K+LS   +++   +    E+ ++ C+ H 
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 297 NLVKI------HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           N++ +           E   + LV E M+ N   C +   E     + +   Q +C    
Sbjct: 85  NIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLC---- 138
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
            G+  LH      I+HRD+K +N+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 139 -GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 192
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
            APE  L        D++S G +  E+V  K
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 100/229 (43%), Gaps = 30/229 (13%)
Query: 232 LKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGN----------- 280
           + ++ A  + +   + I  G +G V  G  ++G  +A+K++ +    G            
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 281 REFLNEIAMISCLQHPNLVKIHGCCVEGDQ-----LLLVYEYMENNSLACALFGRENCEL 335
           +  L EI +++   HPN++ +    V  ++     L LV E M  + LA  +    +  +
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD-LAQVI---HDQRI 129
Query: 336 ELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG 395
            +     Q     I  GL  LHE     +VHRD+   N+LL  + +  I DF LA+ D  
Sbjct: 130 VISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTA 186
Query: 396 D--KTHISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           D  KTH  T       Y APE  + +   T   D++S G V  E+ + K
Sbjct: 187 DANKTHYVTH----RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 25/211 (11%)
Query: 242 FDSAKKIGEGGFGPV---YKGQLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHP 296
           + + K IG G  G V   Y   L     +A+K+LS   +++   +    E+ ++ C+ H 
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121
Query: 297 NLVKI------HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           N++ +           E   + LV E M+ N   C +      ++ELD      +   + 
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVI-----QMELDHERMSYLLYQML 174
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
            G+  LH      I+HRD+K +N+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 175 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 229
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
            APE  L        D++S G +  E+V  K
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 25/211 (11%)
Query: 242 FDSAKKIGEGGFGPV---YKGQLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHP 296
           + + K IG G  G V   Y   L     +A+K+LS   +++   +    E+ ++ C+ H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 297 NLVKI------HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           N++ +           E   + LV E M+ N   C +   E     + +   Q +C    
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLC---- 137
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
            G+  LH      I+HRD+K +N+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 138 -GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
            APE  L        D++S G +  E+V  K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 25/211 (11%)
Query: 242 FDSAKKIGEGGFGPV---YKGQLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHP 296
           + + K IG G  G V   Y   L     +A+K+LS   +++   +    E+ ++ C+ H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 297 NLVKI------HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           N++ +           E   + LV E M+ N   C +   E     + +   Q +C    
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLC---- 137
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
            G+  LH      I+HRD+K +N+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 138 -GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
            APE  L        D++S G +  E+V  K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 31/223 (13%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAM 289
           K I      + +   +G G +G V        G  +AVK+LS   +S    +    E+ +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 290 ISCLQHPNLVKIHGCCV------EGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +  ++H N++ +           E + + LV   M    NN + C     ++        
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV------- 127
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-H 399
             Q +   I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T +
Sbjct: 128 --QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 182
Query: 400 ISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGK 441
           ++TR      Y APE  L   +     D++S G +  E+++G+
Sbjct: 183 VATR-----WYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 19/216 (8%)
Query: 231 TLKQIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREF---LNE 286
           T  Q  A  + FD  K +G G FG V   +  + G   A+K L  +     ++    LNE
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 287 IAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQK 344
             ++  +  P LVK+     +   L +V EY+    +   L   GR         P  + 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR------FSEPHARF 145
Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI 404
               I     +LH      +++RD+K  N+L+D+    +++DFG AK  +G     +  +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 405 AGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            GT  Y+AP   L        D ++ G++  E+ +G
Sbjct: 199 CGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 60/215 (27%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQLA----DGTIIAVKQLSSKS--RQGN------------- 280
           N +    +IG+G +G V   +LA    D T  A+K LS K   RQ               
Sbjct: 13  NQYTLKDEIGKGSYGVV---KLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPA 69
Query: 281 -----------REFLNEIAMISCLQHPNLVKIHGCCVEG--DQLLLVYEYMENNSLACAL 327
                       +   EIA++  L HPN+VK+     +   D L +V+E +    +    
Sbjct: 70  PGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---- 125
Query: 328 FGRENCELELDWPTRQKICLGIAR--------GLAFLHEESRFKIVHRDIKATNVLLDRD 379
                    ++ PT + +    AR        G+ +LH +   KI+HRDIK +N+L+  D
Sbjct: 126 ---------MEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGED 173
Query: 380 LNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPE 414
            + KI+DFG++   +G    +S  + GT  +MAPE
Sbjct: 174 GHIKIADFGVSNEFKGSDALLSNTV-GTPAFMAPE 207

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 19/213 (8%)
Query: 234 QIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREF---LNEIAM 289
           Q  A  + F+  K +G G FG V   +  + G   A+K L  +     ++    LNE  +
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICL 347
           +  +  P LVK+     +   L +V EY+    +   L   GR         P  +    
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR------FSEPHARFYAA 149
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            I     +LH      +++RD+K  N+L+D+    +++DFG AK  +G     +  + GT
Sbjct: 150 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGT 202
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             Y+APE  L        D ++ G++  E+ +G
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 19/213 (8%)
Query: 234 QIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREF---LNEIAM 289
           Q  A  + F+  K +G G FG V   +  + G   A+K L  +     ++    LNE  +
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICL 347
           +  +  P LVK+     +   L +V EY+    +   L   GR         P  +    
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR------FSEPHARFYAA 149
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            I     +LH      +++RD+K  N+L+D+    +++DFG AK  +G     +  + GT
Sbjct: 150 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGT 202
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             Y+APE  L        D ++ G++  E+ +G
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 25/211 (11%)
Query: 242 FDSAKKIGEGGFGPV---YKGQLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHP 296
           + + K IG G  G V   Y   L     +A+K+LS   +++   +    E+ ++ C+ H 
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 297 NLVKI------HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           N++ +           E   + LV E M+ N   C +   E     + +   Q +C    
Sbjct: 85  NIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLC---- 138
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
            G+  LH      I+HRD+K +N+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 139 -GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 192
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
            APE  L        D++S G +  E+V  K
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 25/211 (11%)
Query: 242 FDSAKKIGEGGFGPV---YKGQLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHP 296
           + + K IG G  G V   Y   L     +A+K+LS   +++   +    E+ ++ C+ H 
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 297 NLVKI------HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           N++ +           E   + LV E M+ N   C +   E     + +   Q +C    
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLC---- 130
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
            G+  LH      I+HRD+K +N+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 131 -GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 184
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
            APE  L        D++S G +  E+V  K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 25/211 (11%)
Query: 242 FDSAKKIGEGGFGPV---YKGQLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHP 296
           + + K IG G  G V   Y   L     +A+K+LS   +++   +    E+ ++ C+ H 
Sbjct: 25  YQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 82
Query: 297 NLVKI------HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           N++ +           E   + LV E M+ N   C +   E     + +   Q +C    
Sbjct: 83  NIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLC---- 136
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
            G+  LH      I+HRD+K +N+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 137 -GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 190
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
            APE  L        D++S G +  E+V  K
Sbjct: 191 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 19/213 (8%)
Query: 234 QIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREF---LNEIAM 289
           Q  A  + F+  K +G G FG V   +  + G   A+K L  +     ++    LNE  +
Sbjct: 28  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 87
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICL 347
           +  +  P LVK+     +   L +V EY+    +   L   GR         P  +    
Sbjct: 88  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR------FXEPHARFYAA 141
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            I     +LH      +++RD+K  N+L+D+    +++DFG AK  +G     +  + GT
Sbjct: 142 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGT 194
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             Y+APE  L        D ++ G++  E+ +G
Sbjct: 195 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 19/213 (8%)
Query: 234 QIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREF---LNEIAM 289
           Q  A  + F+  K +G G FG V   +  + G   A+K L  +     ++    LNE  +
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICL 347
           +  +  P LVK+     +   L +V EY+    +   L   GR         P  +    
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR------FSEPHARFYAA 149
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            I     +LH      +++RD+K  N+L+D+    +++DFG AK  +G     +  + GT
Sbjct: 150 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGT 202
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             Y+APE  L        D ++ G++  E+ +G
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 25/211 (11%)
Query: 242 FDSAKKIGEGGFGPV---YKGQLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHP 296
           + + K IG G  G V   Y   L     +A+K+LS   +++   +    E+ ++ C+ H 
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 77
Query: 297 NLVKI------HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           N++ +           E   + LV E M+ N   C +   E     + +   Q +C    
Sbjct: 78  NIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLC---- 131
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
            G+  LH      I+HRD+K +N+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 132 -GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 185
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
            APE  L        D++S G +  E+V  K
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 130/298 (43%), Gaps = 42/298 (14%)
Query: 228 ISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSS--KSRQGNREFL 284
           IS   +  +   ++ +   ++G G +G V K + +  G I+AVK++ +   S++  R  +
Sbjct: 39  ISIGNQNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLM 98
Query: 285 NEIAMISCLQHPNLVKIHGCCV-EGDQLLLVYEYMENNSLACALFGRENCELELDWPTR- 342
           +    +  +  P  V  +G    EGD    V+  ME    +   F ++  +     P   
Sbjct: 99  DLDISMRTVDCPFTVTFYGALFREGD----VWICMELMDTSLDKFYKQVIDKGQTIPEDI 154
Query: 343 -QKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEGDKTH 399
             KI + I + L  LH  S+  ++HRD+K +NVL++     K+ DFG++   +D   KT 
Sbjct: 155 LGKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTI 212
Query: 400 ISTRIAGTIGYMAPEYA-----LWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDC 454
                AG   YMAPE         GY + K+D++S GI  +E+            L F  
Sbjct: 213 ----DAGCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELA----------ILRFPY 257
Query: 455 TCLLDWACHLQQDGKLVELVDERLGS-KYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                W    QQ  ++VE    +L + K+  E     +  +  C   +   RPT  E+
Sbjct: 258 DS---WGTPFQQLKQVVEEPSPQLPADKFSAE----FVDFTSQCLKKNSKERPTYPEL 308

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 25/211 (11%)
Query: 242 FDSAKKIGEGGFGPV---YKGQLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHP 296
           + + K IG G  G V   Y   L     +A+K+LS   +++   +    E+ ++ C+ H 
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 77
Query: 297 NLVKI------HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           N++ +           E   + LV E M+ N   C +   E     + +   Q +C    
Sbjct: 78  NIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLC---- 131
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
            G+  LH      I+HRD+K +N+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 132 -GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 185
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
            APE  L        D++S G +  E+V  K
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 24/203 (11%)
Query: 248 IGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNR------EFLNEIAMISCLQHPNLVK 300
           +G G FG V  G+    G  +AVK L+   RQ  R      +   EI  +   +HP+++K
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILN---RQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
           ++          +V EY+    L   +      E E++    +++   I   + + H   
Sbjct: 76  LYQVISTPTDFFMVMEYVSGGELFDYICKHGRVE-EME---ARRLFQQILSAVDYCH--- 128
Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPEYALWG 419
           R  +VHRD+K  NVLLD  +N KI+DFGL+  + +G+    S    G+  Y APE  + G
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS---CGSPNYAAPE-VISG 184
Query: 420 --YLTYKADVYSFGIVALEIVSG 440
             Y   + D++S G++   ++ G
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCG 207

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 90/201 (44%), Gaps = 16/201 (7%)
Query: 246 KKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
           K +GEG F    K          AVK +S +     ++ +  + +  C  HPN+VK+H  
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKL--CEGHPNIVKLHEV 74
Query: 305 CVEGDQLLLVYEYMENNSLACALFGREN-CELELDWPTRQKICLGIARGLAFLHEESRFK 363
             +     LV E +    L   +  +++  E E  +  R+     +   ++ +H+     
Sbjct: 75  FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRK-----LVSAVSHMHD---VG 126
Query: 364 IVHRDIKATNVLL---DRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGY 420
           +VHRD+K  N+L    + +L  KI DFG A+L   D   + T    T+ Y APE      
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP-CFTLHYAAPELLNQNG 185
Query: 421 LTYKADVYSFGIVALEIVSGK 441
                D++S G++   ++SG+
Sbjct: 186 YDESCDLWSLGVILYTMLSGQ 206

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 91/213 (42%), Gaps = 19/213 (8%)
Query: 234 QIKAATNNFDSAKKIGEGGFGPVY-KGQLADGTIIAVKQLSSKSRQGNREF---LNEIAM 289
           Q  A  + F+  K +G G FG V     +  G   A+K L  +     ++    LNE  +
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICL 347
           +  +  P LVK+     +   L +V EY     +   L   GR         P  +    
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR------FSEPHARFYAA 148
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            I     +LH      +++RD+K  N+++D+    +++DFG AK  +G     +  + GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGR----TWXLCGT 201
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             Y+APE  L        D ++ G++  E+ +G
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 19/213 (8%)
Query: 234 QIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREF---LNEIAM 289
           Q  A  + F+  K +G G FG V   +  + G   A+K L  +     ++    LNE  +
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICL 347
           +  +  P LVK+     +   L +V EY     +   L   GR         P  +    
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR------FSEPHARFYAA 149
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            I     +LH      +++RD+K  N+++D+    K++DFG AK  +G     +  + GT
Sbjct: 150 QIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGT 202
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             Y+APE  L        D ++ G++  E+ +G
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 19/213 (8%)
Query: 234 QIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREF---LNEIAM 289
           Q  A  + F+  K +G G FG V   +  + G   A+K L  +     ++    LNE  +
Sbjct: 56  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 115
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICL 347
           +  +  P LVK+     +   L +V EY+    +   L   GR         P  +    
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR------FSEPHARFYAA 169
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            I     +LH      +++RD+K  N+L+D+    +++DFG AK  +G     +  + GT
Sbjct: 170 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGT 222
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             Y+APE  L        D ++ G++  E+ +G
Sbjct: 223 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 25/211 (11%)
Query: 242 FDSAKKIGEGGFGPV---YKGQLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHP 296
           + + K IG G  G V   Y   L     +A+K+LS   +++   +    E+ ++ C+ H 
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121
Query: 297 NLVKI------HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           N++ +           E   + LV E M+ N   C +      ++ELD      +   + 
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVI-----QMELDHERMSYLLYQML 174
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
            G+  LH      I+HRD+K +N+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 175 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 229
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
            APE  L        D++S G +  E+V  K
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 237 AATNNFDSAKKIGEGGFGPVYK------GQLADGTIIAVKQLSSKSRQGNREFLNEIAMI 290
           + T+ +   +++G+G F  V +      GQ     II  K+LS++  Q   +   E  + 
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQ---KLEREARIC 57
Query: 291 SCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
             L+HPN+V++H    E     LV++ +    L   +  RE       + +       I 
Sbjct: 58  RLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE-------YYSEADASHCIQ 110
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
           + L  ++      IVHRD+K  N+LL    +    K++DFGLA   +GD+       AGT
Sbjct: 111 QILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ-QAWFGFAGT 169
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            GY++PE           D+++ G++   ++ G
Sbjct: 170 PGYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 128/290 (44%), Gaps = 40/290 (13%)
Query: 235 IKAATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSS--KSRQGNREFLNEIAMIS 291
           ++   ++ +   ++G G +G V K + +  G I+AVK++ +   S++  R  ++    + 
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 292 CLQHPNLVKIHGCCV-EGDQLLLVYEYMENNSLACALFGRENCELELDWP--TRQKICLG 348
            +  P  V  +G    EGD    V+  ME    +   F ++  +     P     KI + 
Sbjct: 62  TVDCPFTVTFYGALFREGD----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVS 117
Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI-AGT 407
           I + L  LH  S+  ++HRD+K +NVL++     K+ DFG++     D   ++  I AG 
Sbjct: 118 IVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VAKDIDAGC 172
Query: 408 IGYMAPEYA-----LWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWAC 462
             YMAPE         GY + K+D++S GI  +E+   +          +D      W  
Sbjct: 173 KPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILR--------FPYDS-----WGT 218
Query: 463 HLQQDGKLVELVDERL-GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
             QQ  ++VE    +L   K+  E     +  +  C   +   RPT  E+
Sbjct: 219 PFQQLKQVVEEPSPQLPADKFSAE----FVDFTSQCLKKNSKERPTYPEL 264

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 77/164 (46%), Gaps = 15/164 (9%)
Query: 239 TNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGN---REFLNEIAMISCL- 293
           T  F   +KIG G FG V+K  +  DG I A+K+ S K   G+   +  L E+   + L 
Sbjct: 6   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLG 64
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
           QH ++V+      E D +L+  EY    SLA A+               + + L + RGL
Sbjct: 65  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 124
Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK 397
            ++H  S   +VH DIK +N+ + R   P       A  +EGD+
Sbjct: 125 RYIHSMS---LVHMDIKPSNIFISRTSIPN------AASEEGDE 159

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 77/164 (46%), Gaps = 15/164 (9%)
Query: 239 TNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGN---REFLNEIAMISCL- 293
           T  F   +KIG G FG V+K  +  DG I A+K+ S K   G+   +  L E+   + L 
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLG 68
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
           QH ++V+      E D +L+  EY    SLA A+               + + L + RGL
Sbjct: 69  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK 397
            ++H  S   +VH DIK +N+ + R   P       A  +EGD+
Sbjct: 129 RYIHSMS---LVHMDIKPSNIFISRTSIPN------AASEEGDE 163

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 77/164 (46%), Gaps = 15/164 (9%)
Query: 239 TNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGN---REFLNEIAMISCL- 293
           T  F   +KIG G FG V+K  +  DG I A+K+ S K   G+   +  L E+   + L 
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLG 66
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
           QH ++V+      E D +L+  EY    SLA A+               + + L + RGL
Sbjct: 67  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 126
Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK 397
            ++H  S   +VH DIK +N+ + R   P       A  +EGD+
Sbjct: 127 RYIHSMS---LVHMDIKPSNIFISRTSIPN------AASEEGDE 161

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 19/213 (8%)
Query: 234 QIKAATNNFDSAKKIGEGGFGPVY-KGQLADGTIIAVKQLSSKSRQGNREF---LNEIAM 289
           Q  A  + F+  K +G G FG V     +  G   A+K L  +     ++    LNE  +
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICL 347
           +  +  P L K+     +   L +V EY     +   L   GR         P  +    
Sbjct: 96  LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR------FSEPHARFYAA 149
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            I     +LH      +++RD+K  N+++D+    K++DFG AK  +G     +  + GT
Sbjct: 150 QIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGT 202
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             Y+APE  L        D ++ G++  E+ +G
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 77/164 (46%), Gaps = 15/164 (9%)
Query: 239 TNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGN---REFLNEIAMISCL- 293
           T  F   +KIG G FG V+K  +  DG I A+K+ S K   G+   +  L E+   + L 
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLG 66
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
           QH ++V+      E D +L+  EY    SLA A+               + + L + RGL
Sbjct: 67  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 126
Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK 397
            ++H  S   +VH DIK +N+ + R   P       A  +EGD+
Sbjct: 127 RYIHSMS---LVHMDIKPSNIFISRTSIPN------AASEEGDE 161

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 237 AATNNFDSAKKIGEGGFGPVYK------GQLADGTIIAVKQLSSKSRQGNREFLNEIAMI 290
           + T+ +   +++G+G F  V +      GQ     II  K+LS++  Q   +   E  + 
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQ---KLEREARIC 57
Query: 291 SCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
             L+HPN+V++H    E     LV++ +    L   +  RE       + +       I 
Sbjct: 58  RLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE-------YYSEADASHCIQ 110
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
           + L  ++      IVHRD+K  N+LL    +    K++DFGLA   +GD+       AGT
Sbjct: 111 QILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ-QAWFGFAGT 169
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            GY++PE           D+++ G++   ++ G
Sbjct: 170 PGYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 19/213 (8%)
Query: 234 QIKAATNNFDSAKKIGEGGFGPVY-KGQLADGTIIAVKQLSSKSRQGNREF---LNEIAM 289
           Q  A  + F+  K +G G FG V     +  G   A+K L  +     ++    LNE  +
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICL 347
           +  +  P L K+     +   L +V EY     +   L   GR         P  +    
Sbjct: 96  LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR------FSEPHARFYAA 149
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            I     +LH      +++RD+K  N+++D+    K++DFG AK  +G     +  + GT
Sbjct: 150 QIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGT 202
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             Y+APE  L        D ++ G++  E+ +G
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 242 FDSAKKIGEGGFGPV---YKGQLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHP 296
           + + K IG G  G V   Y   L     +A+K+LS   +++   +    E+ ++ C+ H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 297 NLVKI------HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           N++ +           E   + +V E M+ N   C +   E     + +   Q +C    
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLC---- 137
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
            G+  LH      I+HRD+K +N+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 138 -GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            APE  L        D++S G +  E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 242 FDSAKKIGEGGFGPV---YKGQLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHP 296
           + + K IG G  G V   Y   L     +A+K+LS   +++   +    E+ ++ C+ H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 297 NLVKI------HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           N++ +           E   + +V E M+ N   C +   E     + +   Q +C    
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLC---- 137
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
            G+  LH      I+HRD+K +N+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 138 -GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            APE  L        D++S G +  E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 242 FDSAKKIGEGGFGPV---YKGQLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHP 296
           + + K IG G  G V   Y   L     +A+K+LS   +++   +    E+ ++ C+ H 
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 297 NLVKI------HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           N++ +           E   + +V E M+ N   C +   E     + +   Q +C    
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLC---- 138
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
            G+  LH      I+HRD+K +N+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 139 -GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 192
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            APE  L        D++S G +  E++ G
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 19/213 (8%)
Query: 234 QIKAATNNFDSAKKIGEGGFGPVY-KGQLADGTIIAVKQLSSKSRQGNREF---LNEIAM 289
           Q  A  + F+  K +G G FG V     +  G   A+K L  +     ++    LNE  +
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICL 347
           +  +  P L K+     +   L +V EY     +   L   GR         P  +    
Sbjct: 96  LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR------FXEPHARFYAA 149
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            I     +LH      +++RD+K  N+++D+    K++DFG AK  +G     +  + GT
Sbjct: 150 QIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGT 202
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             Y+APE  L        D ++ G++  E+ +G
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 19/216 (8%)
Query: 231 TLKQIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREF---LNE 286
           T  Q  A  + FD  K +G G FG V   +  + G   A+K L  +     ++    LNE
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 287 IAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQK 344
             ++  +  P LVK+     +   L +V EY+    +   L   GR         P  + 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR------FSEPHARF 145
Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI 404
               I     +LH      +++RD+K  N+L+D+    +++DFG AK  +G     +  +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 405 AGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            GT   +APE  L        D ++ G++  E+ +G
Sbjct: 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 22/211 (10%)
Query: 242 FDSAKKIGEGGFGPVYKGQ-----LADGTIIAVKQLSSKSRQG--NREFLNEIAMISCLQ 294
           +D  +++G G F  V K +     L        K+ S  SR+G    E   E++++  + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           H N++ +H        ++L+ E +    L   L  +E+   E            I  G+ 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE----EATSFIKQILDGVN 129
Query: 355 FLHEESRFKIVHRDIKATNV-LLDRDL---NPKISDFGLA-KLDEGDKTHISTRIAGTIG 409
           +LH +   KI H D+K  N+ LLD+++   + K+ DFGLA ++++G +      I GT  
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPE 183
Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           ++APE   +  L  +AD++S G++   ++SG
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 242 FDSAKKIGEGGFGPV---YKGQLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHP 296
           + + K IG G  G V   Y   L     +A+K+LS   +++   +    E+ ++ C+ H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 297 NLVKI------HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           N++ +           E   + +V E M+ N   C +   E     + +   Q +C    
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLC---- 137
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
            G+  LH      I+HRD+K +N+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 138 -GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPEVVTRYY 191
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            APE  L        D++S G +  E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 239 TNNFDSAKKIGEGGFGPVYK------GQLADGTIIAVKQLSSKSRQGNREFLNEIAMISC 292
           T+++   +++G+G F  V +       Q     II  K+LS++  Q   +   E  +   
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQ---KLEREARICRL 86
Query: 293 LQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARG 352
           L+HPN+V++H    E     LV++ +    L   +  RE       + +       I + 
Sbjct: 87  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE-------YYSEADASHCIHQI 139
Query: 353 LAFLHEESRFKIVHRDIKATNVLLD---RDLNPKISDFGLAKLDEGDKTHISTRIAGTIG 409
           L  ++   +  IVHRD+K  N+LL    +    K++DFGLA   +G++       AGT G
Sbjct: 140 LESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQ-QAWFGFAGTPG 198
Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           Y++PE           D+++ G++   ++ G
Sbjct: 199 YLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 22/211 (10%)
Query: 242 FDSAKKIGEGGFGPVYKGQ-----LADGTIIAVKQLSSKSRQG--NREFLNEIAMISCLQ 294
           +D  +++G G F  V K +     L        K+ S  SR+G    E   E++++  + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           H N++ +H        ++L+ E +    L   L  +E+   E            I  G+ 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE----EATSFIKQILDGVN 129
Query: 355 FLHEESRFKIVHRDIKATNV-LLDRDL---NPKISDFGLA-KLDEGDKTHISTRIAGTIG 409
           +LH +   KI H D+K  N+ LLD+++   + K+ DFGLA ++++G +      I GT  
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPE 183
Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           ++APE   +  L  +AD++S G++   ++SG
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 22/211 (10%)
Query: 242 FDSAKKIGEGGFGPVYKGQ-----LADGTIIAVKQLSSKSRQG--NREFLNEIAMISCLQ 294
           +D  +++G G F  V K +     L        K+ S  SR+G    E   E++++  + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           H N++ +H        ++L+ E +    L   L  +E+   E            I  G+ 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE----EATSFIKQILDGVN 129
Query: 355 FLHEESRFKIVHRDIKATNV-LLDRDL---NPKISDFGLA-KLDEGDKTHISTRIAGTIG 409
           +LH +   KI H D+K  N+ LLD+++   + K+ DFGLA ++++G +      I GT  
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPE 183
Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           ++APE   +  L  +AD++S G++   ++SG
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 22/211 (10%)
Query: 242 FDSAKKIGEGGFGPVYKGQ-----LADGTIIAVKQLSSKSRQG--NREFLNEIAMISCLQ 294
           +D  +++G G F  V K +     L        K+ S  SR+G    E   E++++  + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           H N++ +H        ++L+ E +    L   L  +E+   E            I  G+ 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE----EATSFIKQILDGVN 129
Query: 355 FLHEESRFKIVHRDIKATNV-LLDRDL---NPKISDFGLA-KLDEGDKTHISTRIAGTIG 409
           +LH +   KI H D+K  N+ LLD+++   + K+ DFGLA ++++G +      I GT  
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPE 183
Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           ++APE   +  L  +AD++S G++   ++SG
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 22/211 (10%)
Query: 242 FDSAKKIGEGGFGPVYKGQ-----LADGTIIAVKQLSSKSRQG--NREFLNEIAMISCLQ 294
           +D  +++G G F  V K +     L        K+ S  SR+G    E   E++++  + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           H N++ +H        ++L+ E +    L   L  +E+   E            I  G+ 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE----EATSFIKQILDGVN 129
Query: 355 FLHEESRFKIVHRDIKATNV-LLDRDL---NPKISDFGLA-KLDEGDKTHISTRIAGTIG 409
           +LH +   KI H D+K  N+ LLD+++   + K+ DFGLA ++++G +      I GT  
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPE 183
Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           ++APE   +  L  +AD++S G++   ++SG
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 92/203 (45%), Gaps = 24/203 (11%)
Query: 247 KIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISC--LQHPNLVKIHG 303
           ++G G FG V++ +    G   AVK++         E      +++C  L  P +V ++G
Sbjct: 100 RLGRGSFGEVHRMEDKQTGFQCAVKKV-------RLEVFRAEELMACAGLTSPRIVPLYG 152
Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA-RGLAFLHEESRF 362
              EG  + +  E +E  SL   L   + C  E     R    LG A  GL +LH     
Sbjct: 153 AVREGPWVNIFMELLEGGSLG-QLVKEQGCLPE----DRALYYLGQALEGLEYLHSR--- 204
Query: 363 KIVHRDIKATNVLLDRD-LNPKISDFGLAKLDEGDKTHIST----RIAGTIGYMAPEYAL 417
           +I+H D+KA NVLL  D  +  + DFG A   + D    S      I GT  +MAPE  L
Sbjct: 205 RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVL 264
Query: 418 WGYLTYKADVYSFGIVALEIVSG 440
                 K DV+S   + L +++G
Sbjct: 265 GRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 242 FDSAKKIGEGGFGPV---YKGQLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHP 296
           + + K IG G  G V   Y   L     +A+K+LS   +++   +    E+ ++ C+ H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 297 NLVKI------HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           N++ +           E   + +V E M+ N         +  ++ELD      +   + 
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANL-------SQVIQMELDHERMSYLLYQML 136
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
            G+  LH      I+HRD+K +N+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 137 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            APE  L        D++S G +  E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 242 FDSAKKIGEGGFGPV---YKGQLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHP 296
           + + K IG G  G V   Y   L     +A+K+LS   +++   +    E+ ++ C+ H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 297 NLVKI------HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           N++ +           E   + +V E M+ N         +  ++ELD      +   + 
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANL-------SQVIQMELDHERMSYLLYQML 136
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
            G+  LH      I+HRD+K +N+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 137 CGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            APE  L        D++S G +  E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 25/210 (11%)
Query: 242 FDSAKKIGEGGFGPV---YKGQLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHP 296
           + + K IG G  G V   Y   L     +A+K+LS   +++   +    E+ ++ C+ H 
Sbjct: 28  YQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 85
Query: 297 NLVKI------HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           N++ +           E   + +V E M+ N   C +   E     + +   Q +C    
Sbjct: 86  NIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLC---- 139
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
            G+  LH      I+HRD+K +N+++  D   KI DFGLA+      + +      T  Y
Sbjct: 140 -GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMVPFVVTRYY 193
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            APE  L        D++S G +  E++ G
Sbjct: 194 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 246 KKIGEGGFGPVYKGQL----ADGTIIAVKQLSS---KSRQGNREFLNEIAMISCLQHPNL 298
           +K+G+G FG V +G+          +AVK L        +   +F+ E+  +  L H NL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
           ++++G  +    + +V E     SL   L   +   L     T  +  + +A G+ +L E
Sbjct: 78  IRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGYL-E 132
Query: 359 ESRFKIVHRDIKATNVLL-DRDLNPKISDFGLAK-LDEGDKTHISTRIAGT-IGYMAPEY 415
             RF  +HRD+ A N+LL  RDL  KI DFGL + L + D  ++          + APE 
Sbjct: 133 SKRF--IHRDLAARNLLLATRDLV-KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 189
Query: 416 ALWGYLTYKADVYSFGIVALEIVS 439
                 ++ +D + FG+   E+ +
Sbjct: 190 LKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 19/213 (8%)
Query: 234 QIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREF---LNEIAM 289
           Q  A  + F+  + +G G FG V   +  + G   A+K L  +     ++    LNE  +
Sbjct: 36  QNTAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICL 347
              +  P LVK+     +   L +V EY     +   L   GR         P  +    
Sbjct: 96  QQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGR------FSEPHARFYAA 149
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            I     +LH      +++RD+K  N+L+D+    K++DFG AK  +G     +  + GT
Sbjct: 150 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGT 202
Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             Y+APE  L        D ++ G++  E+ +G
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 246 KKIGEGGFGPVYKGQL----ADGTIIAVKQLSS---KSRQGNREFLNEIAMISCLQHPNL 298
           +K+G+G FG V +G+          +AVK L        +   +F+ E+  +  L H NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
           ++++G  V    + +V E     SL   L   +   L     T  +  + +A G+ +L E
Sbjct: 74  IRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGYL-E 128
Query: 359 ESRFKIVHRDIKATNVLL-DRDLNPKISDFGLAK-LDEGDKTHISTRIAGT-IGYMAPEY 415
             RF  +HRD+ A N+LL  RDL  KI DFGL + L + D  ++          + APE 
Sbjct: 129 SKRF--IHRDLAARNLLLATRDLV-KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185
Query: 416 ALWGYLTYKADVYSFGIVALEIVS 439
                 ++ +D + FG+   E+ +
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 246 KKIGEGGFGPVYKGQL----ADGTIIAVKQLSS---KSRQGNREFLNEIAMISCLQHPNL 298
           +K+G+G FG V +G+          +AVK L        +   +F+ E+  +  L H NL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
           ++++G  +    + +V E     SL   L   +   L     T  +  + +A G+ +L E
Sbjct: 78  IRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGYL-E 132
Query: 359 ESRFKIVHRDIKATNVLL-DRDLNPKISDFGLAK-LDEGDKTHISTRIAGT-IGYMAPEY 415
             RF  +HRD+ A N+LL  RDL  KI DFGL + L + D  ++          + APE 
Sbjct: 133 SKRF--IHRDLAARNLLLATRDLV-KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 189
Query: 416 ALWGYLTYKADVYSFGIVALEIVS 439
                 ++ +D + FG+   E+ +
Sbjct: 190 LKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 246 KKIGEGGFGPVYKGQL----ADGTIIAVKQLSS---KSRQGNREFLNEIAMISCLQHPNL 298
           +K+G+G FG V +G+          +AVK L        +   +F+ E+  +  L H NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
           ++++G  V    + +V E     SL   L   +   L     T  +  + +A G+ +L E
Sbjct: 74  IRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGYL-E 128
Query: 359 ESRFKIVHRDIKATNVLL-DRDLNPKISDFGLAK-LDEGDKTHISTRIAGT-IGYMAPEY 415
             RF  +HRD+ A N+LL  RDL  KI DFGL + L + D  ++          + APE 
Sbjct: 129 SKRF--IHRDLAARNLLLATRDLV-KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185
Query: 416 ALWGYLTYKADVYSFGIVALEIVS 439
                 ++ +D + FG+   E+ +
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 25/211 (11%)
Query: 242 FDSAKKIGEGGFGPV---YKGQLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHP 296
           + + K IG G  G V   Y   L     +A+K+LS   +++   +    E+ ++ C+ H 
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 77
Query: 297 NLVKI------HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           N++ +           E   + +V E M+ N   C +      ++ELD      +   + 
Sbjct: 78  NIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVI-----QMELDHERMSYLLYQML 130
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
            G+  LH      I+HRD+K +N+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 131 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 185
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
            APE  L        D++S G +  E+V  K
Sbjct: 186 RAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 246 KKIGEGGFGPVYKGQL----ADGTIIAVKQLSS---KSRQGNREFLNEIAMISCLQHPNL 298
           +K+G+G FG V +G+          +AVK L        +   +F+ E+  +  L H NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
           ++++G  +    + +V E     SL   L   +   L     T  +  + +A G+ +L E
Sbjct: 84  IRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGYL-E 138
Query: 359 ESRFKIVHRDIKATNVLL-DRDLNPKISDFGLAK-LDEGDKTHISTRIAGT-IGYMAPEY 415
             RF  +HRD+ A N+LL  RDL  KI DFGL + L + D  ++          + APE 
Sbjct: 139 SKRF--IHRDLAARNLLLATRDLV-KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 195
Query: 416 ALWGYLTYKADVYSFGIVALEIVS 439
                 ++ +D + FG+   E+ +
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 242 FDSAKKIGEGGFGPV---YKGQLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHP 296
           + + K IG G  G V   Y   L     +A+K+LS   +++   +    E+ ++  + H 
Sbjct: 26  YQNLKPIGSGAQGIVVAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 297 NLVKI------HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           N++ +           E   + +V E M+ N         +  ++ELD      +   + 
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANL-------SQVIQMELDHERMSYLLYQML 136
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
            G+  LH      I+HRD+K +N+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 137 VGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            APE  L        D++S G++  E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 25/211 (11%)
Query: 242 FDSAKKIGEGGFGPV---YKGQLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHP 296
           + + K IG G  G V   Y   L     +A+K+LS   +++   +    E+ ++ C+ H 
Sbjct: 31  YQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 88
Query: 297 NLVKI------HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           N++ +           E   + +V E M+ N   C +      ++ELD      +   + 
Sbjct: 89  NIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVI-----QMELDHERMSYLLYQML 141
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
            G+  LH      I+HRD+K +N+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 142 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 196
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
            APE  L        D++S G +  E+V  K
Sbjct: 197 RAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 91/203 (44%), Gaps = 24/203 (11%)
Query: 247 KIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISC--LQHPNLVKIHG 303
           ++G G FG V++ +    G   AVK++         E      +++C  L  P +V ++G
Sbjct: 81  RLGRGSFGEVHRMEDKQTGFQCAVKKV-------RLEVFRAEELMACAGLTSPRIVPLYG 133
Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA-RGLAFLHEESRF 362
              EG  + +  E +E  SL   L   + C  E     R    LG A  GL +LH     
Sbjct: 134 AVREGPWVNIFMELLEGGSLG-QLVKEQGCLPE----DRALYYLGQALEGLEYLHSR--- 185
Query: 363 KIVHRDIKATNVLLDRD-LNPKISDFGLAKLDE----GDKTHISTRIAGTIGYMAPEYAL 417
           +I+H D+KA NVLL  D  +  + DFG A   +    G        I GT  +MAPE  L
Sbjct: 186 RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVL 245
Query: 418 WGYLTYKADVYSFGIVALEIVSG 440
                 K DV+S   + L +++G
Sbjct: 246 GRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 242 FDSAKKIGEGGFGPV---YKGQLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHP 296
           + + K IG G  G V   Y   L     +A+K+LS   +++   +    E+ ++  + H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 297 NLVKI------HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           N++ +           E   + +V E M+ N         +  ++ELD      +   + 
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANL-------SQVIQMELDHERMSYLLYQML 136
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
            G+  LH      I+HRD+K +N+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 137 VGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            APE  L        D++S G++  E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 246 KKIGEGGFGPVYKGQL----ADGTIIAVKQLSS---KSRQGNREFLNEIAMISCLQHPNL 298
           +K+G+G FG V +G+          +AVK L        +   +F+ E+  +  L H NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
           ++++G  +    + +V E     SL   L   +   L     T  +  + +A G+ +L E
Sbjct: 84  IRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGYL-E 138
Query: 359 ESRFKIVHRDIKATNVLL-DRDLNPKISDFGLAKLDEGDKTH--ISTRIAGTIGYMAPEY 415
             RF  +HRD+ A N+LL  RDL  KI DFGL +    +  H  +         + APE 
Sbjct: 139 SKRF--IHRDLAARNLLLATRDLV-KIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPES 195
Query: 416 ALWGYLTYKADVYSFGIVALEIVS 439
                 ++ +D + FG+   E+ +
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 101/216 (46%), Gaps = 27/216 (12%)
Query: 246 KKIGEGGFGPV--YKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHG 303
           +K+GEGGF  V   +G L DG   A+K++    +Q   E   E  M     HPN++++  
Sbjct: 35  QKLGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVA 93
Query: 304 CCVE----GDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC---LGIARGLAFL 356
            C+       +  L+  + +  +L   +   E  + + ++ T  +I    LGI RGL  +
Sbjct: 94  YCLRERGAKHEAWLLLPFFKRGTLWNEI---ERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD----EGDKTHISTRIAG----TI 408
           H +      HRD+K TN+LL  +  P + D G         EG +  ++ +       TI
Sbjct: 151 HAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 409 GYMAPE-YALWGY--LTYKADVYSFGIVALEIVSGK 441
            Y APE +++  +  +  + DV+S G V   ++ G+
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 246 KKIGEGGFGPVYKGQL----ADGTIIAVKQLSS---KSRQGNREFLNEIAMISCLQHPNL 298
           +K+G+G FG V +G+          +AVK L        +   +F+ E+  +  L H NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
           ++++G  V    + +V E     SL   L   +   L     T  +  + +A G+ +L E
Sbjct: 74  IRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGYL-E 128
Query: 359 ESRFKIVHRDIKATNVLL-DRDLNPKISDFGLAKLDEGDKTH--ISTRIAGTIGYMAPEY 415
             RF  +HRD+ A N+LL  RDL  KI DFGL +    +  H  +         + APE 
Sbjct: 129 SKRF--IHRDLAARNLLLATRDLV-KIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPES 185
Query: 416 ALWGYLTYKADVYSFGIVALEIVS 439
                 ++ +D + FG+   E+ +
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 29/219 (13%)
Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNREFLNEIA---------M 289
             +D    IG G    V +    A G   AVK +   + + + E L E+          +
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGI 349
                HP+++ +         + LV++ M    L    F     ++ L     + I   +
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVALSEKETRSIMRSL 209
Query: 350 ARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHISTRIAGTI 408
              ++FLH  +   IVHRD+K  N+LLD ++  ++SDFG +  L+ G+K      + GT 
Sbjct: 210 LEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR---ELCGTP 263
Query: 409 GYMAPEY-------ALWGYLTYKADVYSFGIVALEIVSG 440
           GY+APE           GY   + D+++ G++   +++G
Sbjct: 264 GYLAPEILKCSMDETHPGY-GKEVDLWACGVILFTLLAG 301

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 25/221 (11%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ 294
           +   + F   +  G+G FG V  G + + G  +A+K++    R  NRE L  +  ++ L 
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLH 77
Query: 295 HPNLVKIHG---CCVEGDQ----LLLVYEYMENN-SLACALFGRENCELELDWPTRQKIC 346
           HPN+V++        E D+    L +V EY+ +     C  + R         P   K+ 
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVA---PPPILIKVF 134
Query: 347 L-GIARGLAFLHEESRFKIVHRDIKATNVLLDR-DLNPKISDFGLAK---LDEGDKTHIS 401
           L  + R +  LH  S   + HRDIK  NVL++  D   K+ DFG AK     E +  +I 
Sbjct: 135 LFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC 193
Query: 402 TRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGK 441
           +R      Y APE      + T   D++S G +  E++ G+
Sbjct: 194 SRY-----YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 86/192 (44%), Gaps = 15/192 (7%)
Query: 229 SFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIA 288
           S  L++        +  + IG+G FG VY G+      I +  +   +    + F  E+ 
Sbjct: 22  SIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVM 81
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLG 348
                +H N+V   G C+    L ++    +  +L   +    + ++ LD    ++I   
Sbjct: 82  AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV---RDAKIVLDVNKTRQIAQE 138
Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPK--ISDFGLAKLD---EGDKTHISTR 403
           I +G+ +LH +    I+H+D+K+ NV  D   N K  I+DFGL  +    +  +     R
Sbjct: 139 IVKGMGYLHAKG---ILHKDLKSKNVFYD---NGKVVITDFGLFSISGVLQAGRREDKLR 192
Query: 404 IA-GTIGYMAPE 414
           I  G + ++APE
Sbjct: 193 IQNGWLCHLAPE 204

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 100/221 (45%), Gaps = 18/221 (8%)
Query: 227 TISFTLKQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNRE--F 283
           ++S +      + + +    K+GEG +G VYK         +A+K++  +  +       
Sbjct: 21  SMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA 80
Query: 284 LNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQ 343
           + E++++  LQH N++++        +L L++EY EN+      +  +N ++ +     +
Sbjct: 81  IREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEND---LKKYMDKNPDVSMR--VIK 135
Query: 344 KICLGIARGLAFLHEESRFKIVHRDIKATNVLL---DRDLNP--KISDFGLAKLDEGDKT 398
                +  G+ F H     + +HRD+K  N+LL   D    P  KI DFGLA+   G   
Sbjct: 136 SFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA-FGIPI 191
Query: 399 HISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIV 438
              T    T+ Y  PE  L   + +   D++S   +  E++
Sbjct: 192 RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 91/206 (44%), Gaps = 20/206 (9%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCL----Q 294
            +F    ++G G +G V+K +   DG + AVK+  S  R G ++   ++A +       Q
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR-GPKDRARKLAEVGSHEKVGQ 115
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLA--CALFGRENCELELDWPTRQKICLGIARG 352
           HP  V++     EG  L L  E +   SL   C  +G    E ++ W   +   L     
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTE-LCGPSLQQHCEAWGASLPEAQV-WGYLRDTLLA---- 169
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMA 412
           LA LH +    +VH D+K  N+ L      K+ DFGL  L E           G   YMA
Sbjct: 170 LAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGL--LVELGTAGAGEVQEGDPRYMA 224
Query: 413 PEYALWGYLTYKADVYSFGIVALEIV 438
           PE  L G     ADV+S G+  LE+ 
Sbjct: 225 PEL-LQGSYGTAADVFSLGLTILEVA 249

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 13/208 (6%)
Query: 242 FDSAKKIGEGGFGPVYK------GQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQH 295
           ++  + IG+G F  V +      GQ     I+ V + +S       +   E ++   L+H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           P++V++         L +V+E+M+   L   +  R +                I   L +
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNP---KISDFGLAKLDEGDKTHISTRIAGTIGYMA 412
            H+ +   I+HRD+K   VLL    N    K+  FG+A +  G+   ++    GT  +MA
Sbjct: 146 CHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA-IQLGESGLVAGGRVGTPHFMA 201
Query: 413 PEYALWGYLTYKADVYSFGIVALEIVSG 440
           PE           DV+  G++   ++SG
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 25/211 (11%)
Query: 242 FDSAKKIGEGGFGPV---YKGQLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHP 296
           + + K IG G  G V   Y   L     +A+K+LS   +++   +    E+ ++  + H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHK 83
Query: 297 NLVKI------HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           N++ +           E   + LV E M+ N   C +   E     + +   Q +C    
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLC---- 137
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
            G+  LH      I+HRD+K +N+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 138 -GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
            APE  L        D++S G +  E+V  K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 13/208 (6%)
Query: 242 FDSAKKIGEGGFGPVYK------GQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQH 295
           ++  + IG+G F  V +      GQ     I+ V + +S       +   E ++   L+H
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           P++V++         L +V+E+M+   L   +  R +                I   L +
Sbjct: 88  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNP---KISDFGLAKLDEGDKTHISTRIAGTIGYMA 412
            H+ +   I+HRD+K   VLL    N    K+  FG+A +  G+   ++    GT  +MA
Sbjct: 148 CHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA-IQLGESGLVAGGRVGTPHFMA 203
Query: 413 PEYALWGYLTYKADVYSFGIVALEIVSG 440
           PE           DV+  G++   ++SG
Sbjct: 204 PEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 90/211 (42%), Gaps = 25/211 (11%)
Query: 242 FDSAKKIGEGGFGPV---YKGQLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHP 296
           + + K IG G  G V   Y   L     +A+K+LS   +++   +    E+ ++  + H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHK 83
Query: 297 NLVKI------HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           N++ +           E   + LV E M+ N            ++ELD      +   + 
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQV-------IQMELDHERMSYLLYQML 136
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
            G+  LH      I+HRD+K +N+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 137 XGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
            APE  L        D++S G +  E+V  K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 25/211 (11%)
Query: 242 FDSAKKIGEGGFGPV---YKGQLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHP 296
           + + K IG G  G V   Y   L     +A+K+LS   +++   +    E+ ++ C+ H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 297 NLVKI------HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           N++ +           E   + +V E M+ N   C +      ++ELD      +   + 
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVI-----QMELDHERMSYLLYQML 136
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
            G+  LH      I+HRD+K +N+++  D   KI DFGLA+   G    +   +  T  Y
Sbjct: 137 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMEPEVV-TRYY 191
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
            APE  L        D++S G +  E+V  K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 92/201 (45%), Gaps = 20/201 (9%)
Query: 247 KIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           ++G G FG V++ +    G   AVK++  +  +     + E+   + L  P +V ++G  
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAV 119
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA-RGLAFLHEESRFKI 364
            EG  + +  E +E  SL   L  +  C  E     R    LG A  GL +LH     +I
Sbjct: 120 REGPWVNIFMELLEGGSLG-QLIKQMGCLPE----DRALYYLGQALEGLEYLHTR---RI 171
Query: 365 VHRDIKATNVLLDRD-LNPKISDFGLAKLDEGDKTHIST----RIAGTIGYMAPEYALWG 419
           +H D+KA NVLL  D     + DFG A   + D    S      I GT  +MAPE  +  
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 420 YLTYKADVYSFGIVALEIVSG 440
               K D++S   + L +++G
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNG 252

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 24/166 (14%)
Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI---STRIA 405
           +ARG+ FL   S  K +HRD+ A N+LL  +   KI DFGLA+    +  ++    TR+ 
Sbjct: 208 VARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 406 GTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQ 465
             + +MAPE       + K+DV+S+G++  EI S     S  P ++ D     D+   L+
Sbjct: 265 --LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGG--SPYPGVQMD----EDFCSRLR 316
Query: 466 QDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           +  ++          +Y   E   + ++ L C +  P  RP  +E+
Sbjct: 317 EGMRM-------RAPEYSTPE---IYQIMLDCWHRDPKERPRFAEL 352

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 93/211 (44%), Gaps = 21/211 (9%)
Query: 237 AATNNFDSAKKIGEGGFGPVYK-GQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQH 295
           A ++ F+   ++G G    VY+  Q       A+K L  K     +    EI ++  L H
Sbjct: 50  ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGVLLRLSH 107
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGR---ENCELELDWPTRQKICLGIARG 352
           PN++K+        ++ LV E +        LF R   +    E D     K    I   
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGE----LFDRIVEKGYYSERDAADAVK---QILEA 160
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDR---DLNPKISDFGLAKLDEGDKTHISTRIAGTIG 409
           +A+LHE     IVHRD+K  N+L      D   KI+DFGL+K+ E     +   + GT G
Sbjct: 161 VAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE--HQVLMKTVCGTPG 215
Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           Y APE         + D++S GI+   ++ G
Sbjct: 216 YCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 240 NNFD--SAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSR-QGNR-EFLNEIAMISCLQ 294
           NNF   ++K++G G F  V +    + G   A K L  + R Q  R E L+EIA++   +
Sbjct: 27  NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86
Query: 295 H-PNLVKIHGCCVEGDQLLLVYEYM---ENNSLACALFGRENCELELDWPTRQKICLGIA 350
             P ++ +H       +++L+ EY    E  SL          E ++    +Q     I 
Sbjct: 87  SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQ-----IL 141
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNP----KISDFGLAKLDEGDKTHISTRIAG 406
            G+ +LH+ +   IVH D+K  N+LL   + P    KI DFG+++   G    +   I G
Sbjct: 142 EGVYYLHQNN---IVHLDLKPQNILLS-SIYPLGDIKIVDFGMSR-KIGHACELR-EIMG 195
Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVA 434
           T  Y+APE   +  +T   D+++ GI+A
Sbjct: 196 TPEYLAPEILNYDPITTATDMWNIGIIA 223

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 92/201 (45%), Gaps = 20/201 (9%)
Query: 247 KIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           ++G G FG V++ +    G   AVK++  +  +     + E+   + L  P +V ++G  
Sbjct: 81  RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAV 135
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA-RGLAFLHEESRFKI 364
            EG  + +  E +E  SL   L  +  C  E     R    LG A  GL +LH     +I
Sbjct: 136 REGPWVNIFMELLEGGSLG-QLIKQMGCLPE----DRALYYLGQALEGLEYLHTR---RI 187
Query: 365 VHRDIKATNVLLDRD-LNPKISDFGLAKLDEGDKTHIST----RIAGTIGYMAPEYALWG 419
           +H D+KA NVLL  D     + DFG A   + D    S      I GT  +MAPE  +  
Sbjct: 188 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 247
Query: 420 YLTYKADVYSFGIVALEIVSG 440
               K D++S   + L +++G
Sbjct: 248 PCDAKVDIWSSCCMMLHMLNG 268

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 239 TNNFDSAKKIGEGGFGP--VYKGQLADGTIIAVKQL---SSKSRQGNREFLNEIAMISCL 293
           ++ +D  K IG G FG   + + +L    ++AVK +   ++      RE +N       L
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLT-KELVAVKYIERGAAIDENVQREIINH----RSL 73
Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALF--GRENCELELDWPTRQKICLGIAR 351
           +HPN+V+     +    L ++ EY     L   +   GR + E E  +  +Q     +  
Sbjct: 74  RHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFS-EDEARFFFQQ-----LLS 127
Query: 352 GLAFLHEESRFKIVHRDIKATNVLLDRDLNP--KISDFGLAKLDEGDKTHISTRIAGTIG 409
           G+++ H     +I HRD+K  N LLD    P  KI DFG +K         ST   GT  
Sbjct: 128 GVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPA 182
Query: 410 YMAPEYAL-WGYLTYKADVYSFGIVALEIVSG 440
           Y+APE  L   Y    ADV+S G+    ++ G
Sbjct: 183 YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 99/244 (40%), Gaps = 52/244 (21%)
Query: 235 IKAATNNFDSAKKIGEGGFGPVY----KGQLADGTIIAVKQLSSKSRQGNREFLNEIAMI 290
           +   +N F    KIGEG F  VY    + Q+     IA+K L   S       +   A +
Sbjct: 16  VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHP-----IRIAAEL 70
Query: 291 SCLQ----HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC 346
            CL       N++ +  C  + D +++   Y+E+ S    L         L +   ++  
Sbjct: 71  QCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNS-------LSFQEVREYM 123
Query: 347 LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP-KISDFGLAKLDEGDKTHISTRI- 404
           L + + L  +H+   F IVHRD+K +N L +R L    + DFGLA+     K  +   + 
Sbjct: 124 LNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQ 180
Query: 405 --------------------------AGTIGYMAPEY-ALWGYLTYKADVYSFGIVALEI 437
                                     AGT G+ APE        T   D++S G++ L +
Sbjct: 181 SEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSL 240
Query: 438 VSGK 441
           +SG+
Sbjct: 241 LSGR 244

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 86/199 (43%), Gaps = 15/199 (7%)
Query: 247 KIGEGGFGPVYKGQLADGTIIAVKQLSSK--SRQGNREFLNEIAMISCLQHPNLVKIHGC 304
           K+ E   G ++KG+   G  I VK L  +  S + +R+F  E   +    HPN++ + G 
Sbjct: 17  KLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 305 C--VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRF 362
           C         L+  +M   SL   L   E     +D     K  L +ARG+AFLH     
Sbjct: 76  CQSPPAPHPTLITHWMPYGSLYNVL--HEGTNFVVDQSQAVKFALDMARGMAFLHTLEPL 133
Query: 363 KIVHRDIKATNVLLDRDLNPKIS--DFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGY 420
            I    + + +V++D D+  +IS  D   +    G + +    +A       PE      
Sbjct: 134 -IPRHALNSRSVMIDEDMTARISMADVKFSFQSPG-RMYAPAWVAPEALQKKPE----DT 187
Query: 421 LTYKADVYSFGIVALEIVS 439
               AD++SF ++  E+V+
Sbjct: 188 NRRSADMWSFAVLLWELVT 206

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 90/211 (42%), Gaps = 25/211 (11%)
Query: 242 FDSAKKIGEGGFGPV---YKGQLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHP 296
           + + K IG G  G V   Y   L     +A+K+LS   +++   +    E+ ++  + H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHK 83
Query: 297 NLVKI------HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           N++ +           E   + LV E M+ N            ++ELD      +   + 
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQV-------IQMELDHERMSYLLYQML 136
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
            G+  LH      I+HRD+K +N+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 137 CGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
            APE  L        D++S G +  E+V  K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 92/201 (45%), Gaps = 20/201 (9%)
Query: 247 KIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           ++G G FG V++ +    G   AVK++  +  +     + E+   + L  P +V ++G  
Sbjct: 79  RLGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAV 133
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA-RGLAFLHEESRFKI 364
            EG  + +  E +E  SL   L  +  C  E     R    LG A  GL +LH     +I
Sbjct: 134 REGPWVNIFMELLEGGSLG-QLIKQMGCLPE----DRALYYLGQALEGLEYLHTR---RI 185
Query: 365 VHRDIKATNVLLDRD-LNPKISDFGLAKLDEGDKTHIST----RIAGTIGYMAPEYALWG 419
           +H D+KA NVLL  D     + DFG A   + D    S      I GT  +MAPE  +  
Sbjct: 186 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 245
Query: 420 YLTYKADVYSFGIVALEIVSG 440
               K D++S   + L +++G
Sbjct: 246 PCDAKVDIWSSCCMMLHMLNG 266

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 93/211 (44%), Gaps = 20/211 (9%)
Query: 239 TNNFDSAKKIGEGGFGPVYK------GQLADGTIIAVKQLSSKSRQGNREFLNEIAMISC 292
           T+ +   + IG+G F  V +      G      II  K+LS++  Q   +   E  +   
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQ---KLEREARICRL 59
Query: 293 LQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARG 352
           L+H N+V++H    E     LV++ +    L   +  RE       + +       I + 
Sbjct: 60  LKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE-------YYSEADASHCIQQI 112
Query: 353 LAFLHEESRFKIVHRDIKATNVLLD---RDLNPKISDFGLAKLDEGDKTHISTRIAGTIG 409
           L  +    +  +VHRD+K  N+LL    +    K++DFGLA   +GD+       AGT G
Sbjct: 113 LEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQ-QAWFGFAGTPG 171
Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           Y++PE           D+++ G++   ++ G
Sbjct: 172 YLSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 25/211 (11%)
Query: 242 FDSAKKIGEGGFGPV---YKGQLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHP 296
           + + K IG G  G V   Y   L     +A+K+LS   +++   +    E+ ++ C+ H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 297 NLVKI------HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           N++ +           E   + +V E M+ N   C +      ++ELD      +   + 
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVI-----QMELDHERMSYLLYQML 136
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
            G+  LH      I+HRD+K +N+++  D   KI DFGLA+   G    +   +  T  Y
Sbjct: 137 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMEPEVV-TRYY 191
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
            APE  L        D++S G +  E+V  K
Sbjct: 192 RAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 100/227 (44%), Gaps = 26/227 (11%)
Query: 226 QTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQL--SSKSRQGNRE 282
           Q ++ T  +++A   +    + +G G +G V        G  +A+K+L    +S    + 
Sbjct: 14  QEVTKTAWEVRAVYRDL---QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 70
Query: 283 FLNEIAMISCLQHPNLVKIHGCCVEGDQL------LLVYEYMENNSLACALFGRENCELE 336
              E+ ++  ++H N++ +       + L       LV  +M  +       G+     +
Sbjct: 71  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTD------LGKLMKHEK 124
Query: 337 LDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD 396
           L     Q +   + +GL ++H      I+HRD+K  N+ ++ D   KI DFGLA+  + D
Sbjct: 125 LGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR--QAD 179
Query: 397 KTHISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGKN 442
                  +  T  Y APE  L W   T   D++S G +  E+++GK 
Sbjct: 180 SEMXGXVV--TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 25/210 (11%)
Query: 242 FDSAKKIGEGGFGPV---YKGQLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHP 296
           + + K IG G  G V   Y   L     +A+K+LS   +++   +    E+ ++  + H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 297 NLVKI------HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           N++ +           E   + +V E M+ N         +  ++ELD      +   + 
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANL-------SQVIQMELDHERMSYLLYQML 136
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
            G+  LH      I+HRD+K +N+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 137 VGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            APE  L        D++S G +  E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 99/222 (44%), Gaps = 29/222 (13%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLADGT-------IIAVKQLSSKSRQGNREFLN--- 285
           KA  + +  +K +G G  G V K      T       II+ ++ +  S +     LN   
Sbjct: 145 KALRDEYIMSKTLGSGACGEV-KLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVET 203
Query: 286 EIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKI 345
           EI ++  L HP ++KI     + +   +V E ME   L   + G +     L   T +  
Sbjct: 204 EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR----LKEATCKLY 258
Query: 346 CLGIARGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEGDKTHIST 402
              +   + +LHE     I+HRD+K  NVLL   + D   KI+DFG +K+    +T +  
Sbjct: 259 FYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMR 313
Query: 403 RIAGTIGYMAPEYAL----WGYLTYKADVYSFGIVALEIVSG 440
            + GT  Y+APE  +     GY     D +S G++    +SG
Sbjct: 314 TLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSG 354

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 27/221 (12%)
Query: 236 KAATNNFDSAKKIGEGGFGPV---YKGQLADGT---IIAVKQLSSKSRQGNREFLN---E 286
           KA  + +  +K +G G  G V   ++ +        II+ ++ +  S +     LN   E
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190
Query: 287 IAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC 346
           I ++  L HP ++KI     + +   +V E ME   L   + G +     L   T +   
Sbjct: 191 IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR----LKEATCKLYF 245
Query: 347 LGIARGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEGDKTHISTR 403
             +   + +LHE     I+HRD+K  NVLL   + D   KI+DFG +K+    +T +   
Sbjct: 246 YQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT 300
Query: 404 IAGTIGYMAPEYAL----WGYLTYKADVYSFGIVALEIVSG 440
           + GT  Y+APE  +     GY     D +S G++    +SG
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSG 340

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 239 TNNFDSAKKIGEGGFG--PVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHP 296
           ++ ++  K IG G FG   + + + A+  ++AVK +  +  + +     EI     L+HP
Sbjct: 18  SDRYELVKDIGAGNFGVARLMRDKQAN-ELVAVKYIE-RGEKIDENVKREIINHRSLRHP 75
Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICLGIARGLA 354
           N+V+     +    L +V EY     L   +   GR   E E  +  +Q I      G++
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLIS-----GVS 129
Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNP--KISDFGLAKLDEGDKTHISTRIA-GTIGYM 411
           + H     ++ HRD+K  N LLD    P  KI+DFG +K       H   + A GT  Y+
Sbjct: 130 YAHA---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSK---ASVLHSQPKSAVGTPAYI 183
Query: 412 APEYALWG-YLTYKADVYSFGIVALEIVSG 440
           APE  L   Y    ADV+S G+    ++ G
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 27/221 (12%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSK------SRQGNREF--LNE 286
           KA  + +  +K +G G  G V    +      +A+K +S +      +R+ +       E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 287 IAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC 346
           I ++  L HP ++KI     + +   +V E ME   L   + G +     L   T +   
Sbjct: 66  IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR----LKEATCKLYF 120
Query: 347 LGIARGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEGDKTHISTR 403
             +   + +LHE     I+HRD+K  NVLL   + D   KI+DFG +K+    +T +   
Sbjct: 121 YQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT 175
Query: 404 IAGTIGYMAPEYAL----WGYLTYKADVYSFGIVALEIVSG 440
           + GT  Y+APE  +     GY     D +S G++    +SG
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSG 215

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 25/210 (11%)
Query: 242 FDSAKKIGEGGFGPV---YKGQLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHP 296
           + + K IG G  G V   Y   L     +A+K+LS   +++   +    E+ ++  + H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 297 NLVKI------HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           N++ +           E   + +V E M+ N         +  ++ELD      +   + 
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANL-------SQVIQMELDHERMSYLLYQML 136
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
            G+  LH      I+HRD+K +N+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 137 CGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSG 440
            APE  L        D++S G +  E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 27/221 (12%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSK------SRQGNREF--LNE 286
           KA  + +  +K +G G  G V    +      +A+K +S +      +R+ +       E
Sbjct: 5   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 64
Query: 287 IAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC 346
           I ++  L HP ++KI     + +   +V E ME   L   + G +     L   T +   
Sbjct: 65  IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR----LKEATCKLYF 119
Query: 347 LGIARGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEGDKTHISTR 403
             +   + +LHE     I+HRD+K  NVLL   + D   KI+DFG +K+    +T +   
Sbjct: 120 YQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT 174
Query: 404 IAGTIGYMAPEYAL----WGYLTYKADVYSFGIVALEIVSG 440
           + GT  Y+APE  +     GY     D +S G++    +SG
Sbjct: 175 LCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSG 214

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 98/228 (42%), Gaps = 19/228 (8%)
Query: 232 LKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSK----SRQGNREFLNEI 287
           ++ ++    +++  K IG G FG V   +      +   +L SK     R  +  F  E 
Sbjct: 66  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 125
Query: 288 AMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL 347
            +++    P +V++     +   L +V EYM    L   +    N ++   W   +    
Sbjct: 126 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWA--RFYTA 180
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHISTRIAG 406
            +   L  +H       +HRD+K  N+LLD+  + K++DFG   K+++       T + G
Sbjct: 181 EVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-G 236
Query: 407 TIGYMAPEYALW----GYLTYKADVYSFGIVALEIVSGKNNMSYAPAL 450
           T  Y++PE        GY   + D +S G+   E++ G     YA +L
Sbjct: 237 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF-YADSL 283

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 27/221 (12%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSK------SRQGNREF--LNE 286
           KA  + +  +K +G G  G V    +      +A+K +S +      +R+ +       E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 287 IAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC 346
           I ++  L HP ++KI     + +   +V E ME   L   + G +     L   T +   
Sbjct: 66  IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR----LKEATCKLYF 120
Query: 347 LGIARGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEGDKTHISTR 403
             +   + +LHE     I+HRD+K  NVLL   + D   KI+DFG +K+    +T +   
Sbjct: 121 YQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT 175
Query: 404 IAGTIGYMAPEYAL----WGYLTYKADVYSFGIVALEIVSG 440
           + GT  Y+APE  +     GY     D +S G++    +SG
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSG 215

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 94/218 (43%), Gaps = 18/218 (8%)
Query: 232 LKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSK----SRQGNREFLNEI 287
           ++ ++    +++  K IG G FG V   +      +   +L SK     R  +  F  E 
Sbjct: 66  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 125
Query: 288 AMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL 347
            +++    P +V++     +   L +V EYM    L   +    N ++   W   +    
Sbjct: 126 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWA--RFYTA 180
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHISTRIAG 406
            +   L  +H       +HRD+K  N+LLD+  + K++DFG   K+++       T + G
Sbjct: 181 EVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-G 236
Query: 407 TIGYMAPEYALW----GYLTYKADVYSFGIVALEIVSG 440
           T  Y++PE        GY   + D +S G+   E++ G
Sbjct: 237 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 94/218 (43%), Gaps = 18/218 (8%)
Query: 232 LKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSK----SRQGNREFLNEI 287
           ++ ++    +++  K IG G FG V   +      +   +L SK     R  +  F  E 
Sbjct: 61  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 120
Query: 288 AMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL 347
            +++    P +V++     +   L +V EYM    L   +    N ++   W   +    
Sbjct: 121 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWA--RFYTA 175
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHISTRIAG 406
            +   L  +H       +HRD+K  N+LLD+  + K++DFG   K+++       T + G
Sbjct: 176 EVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-G 231
Query: 407 TIGYMAPEYALW----GYLTYKADVYSFGIVALEIVSG 440
           T  Y++PE        GY   + D +S G+   E++ G
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 27/221 (12%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSK------SRQGNREF--LNE 286
           KA  + +  +K +G G  G V    +      +A+K +S +      +R+ +       E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 287 IAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC 346
           I ++  L HP ++KI     + +   +V E ME   L   + G +     L   T +   
Sbjct: 66  IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR----LKEATCKLYF 120
Query: 347 LGIARGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEGDKTHISTR 403
             +   + +LHE     I+HRD+K  NVLL   + D   KI+DFG +K+    +T +   
Sbjct: 121 YQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT 175
Query: 404 IAGTIGYMAPEYAL----WGYLTYKADVYSFGIVALEIVSG 440
           + GT  Y+APE  +     GY     D +S G++    +SG
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSG 215

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 27/221 (12%)
Query: 236 KAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSK------SRQGNREF--LNE 286
           KA  + +  +K +G G  G V    +      +A+K +S +      +R+ +       E
Sbjct: 12  KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 71
Query: 287 IAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC 346
           I ++  L HP ++KI     + +   +V E ME   L   + G +     L   T +   
Sbjct: 72  IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR----LKEATCKLYF 126
Query: 347 LGIARGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEGDKTHISTR 403
             +   + +LHE     I+HRD+K  NVLL   + D   KI+DFG +K+    +T +   
Sbjct: 127 YQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT 181
Query: 404 IAGTIGYMAPEYAL----WGYLTYKADVYSFGIVALEIVSG 440
           + GT  Y+APE  +     GY     D +S G++    +SG
Sbjct: 182 LCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSG 221

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 84/195 (43%), Gaps = 33/195 (16%)
Query: 268 AVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL 327
           AVK +    R  + E   EI ++   QHPN++ +     +G  + LV E M    L    
Sbjct: 56  AVKVIDKSKRDPSEEI--EI-LLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGEL---- 108
Query: 328 FGRENCELELDWPTRQK---------ICLGIARGLAFLHEESRFKIVHRDIKATNVL-LD 377
                    LD   RQK         +   I + + +LH +    +VHRD+K +N+L +D
Sbjct: 109 ---------LDKILRQKFFSEREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVD 156
Query: 378 RDLNP---KISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVA 434
              NP   +I DFG AK    +   + T    T  ++APE           D++S GI+ 
Sbjct: 157 ESGNPECLRICDFGFAKQLRAENGLLMTPCY-TANFVAPEVLKRQGYDEGCDIWSLGILL 215
Query: 435 LEIVSGKNNMSYAPA 449
             +++G    +  P+
Sbjct: 216 YTMLAGYTPFANGPS 230

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 91/208 (43%), Gaps = 18/208 (8%)
Query: 239 TNNFDSAKKIGEGGFGPV-YKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPN 297
           ++ ++  K IG G FG            ++AVK +  +  + +     EI     L+HPN
Sbjct: 17  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE-RGEKIDENVKREIINHRSLRHPN 75
Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICLGIARGLAF 355
           +V+     +    L +V EY     L   +   GR + E E  +  +Q I      G+++
Sbjct: 76  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS-EDEARFFFQQLIS-----GVSY 129
Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNP--KISDFGLAKLDEGDKTHISTRIAGTIGYMAP 413
            H     ++ HRD+K  N LLD    P  KI DFG +K         ST   GT  Y+AP
Sbjct: 130 CHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAP 184
Query: 414 EYALWG-YLTYKADVYSFGIVALEIVSG 440
           E  L   Y    ADV+S G+    ++ G
Sbjct: 185 EVLLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 91/211 (43%), Gaps = 24/211 (11%)
Query: 239 TNNFDSAKKIGEGGFGPV-YKGQLADGTIIAVKQLSSKSRQG---NREFLNEIAMISCLQ 294
           ++ ++  K IG G FG            ++AVK +    +      RE +N       L+
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINH----RSLR 73
Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICLGIARG 352
           HPN+V+     +    L +V EY     L   +   GR + E E  +  +Q I      G
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS-EDEARFFFQQLIS-----G 127
Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNP--KISDFGLAKLDEGDKTHISTRIAGTIGY 410
           +++ H     ++ HRD+K  N LLD    P  KI DFG +K         ST   GT  Y
Sbjct: 128 VSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAY 182
Query: 411 MAPEYALWG-YLTYKADVYSFGIVALEIVSG 440
           +APE  L   Y    ADV+S G+    ++ G
Sbjct: 183 IAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 84/195 (43%), Gaps = 33/195 (16%)
Query: 268 AVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL 327
           AVK +    R  + E   EI ++   QHPN++ +     +G  + LV E M    L    
Sbjct: 56  AVKVIDKSKRDPSEEI--EI-LLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGEL---- 108
Query: 328 FGRENCELELDWPTRQK---------ICLGIARGLAFLHEESRFKIVHRDIKATNVL-LD 377
                    LD   RQK         +   I + + +LH +    +VHRD+K +N+L +D
Sbjct: 109 ---------LDKILRQKFFSEREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVD 156
Query: 378 RDLNP---KISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVA 434
              NP   +I DFG AK    +   + T    T  ++APE           D++S GI+ 
Sbjct: 157 ESGNPECLRICDFGFAKQLRAENGLLMTPCY-TANFVAPEVLKRQGYDEGCDIWSLGILL 215
Query: 435 LEIVSGKNNMSYAPA 449
             +++G    +  P+
Sbjct: 216 YTMLAGYTPFANGPS 230

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 54/105 (51%), Gaps = 14/105 (13%)
Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL---DEGDKTHIS 401
           I + IA  + FLH +    ++HRD+K +N+    D   K+ DFGL      DE ++T ++
Sbjct: 169 IFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 402 TRIA--------GTIGYMAPEYALWGYLTYKADVYSFGIVALEIV 438
              A        GT  YM+PE       ++K D++S G++  E++
Sbjct: 226 PMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 73/159 (45%), Gaps = 11/159 (6%)
Query: 286 EIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKI 345
           EIA++S ++H N++K+           LV   ME +     LF   +    LD P    I
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLV---MEKHGSGLDLFAFIDRHPRLDEPLASYI 135
Query: 346 CLGIARGLAFLHEESRFK-IVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI 404
              +   + +L    R K I+HRDIK  N+++  D   K+ DFG A   E  K   +   
Sbjct: 136 FRQLVSAVGYL----RLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT--F 189
Query: 405 AGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKN 442
            GTI Y APE  +   Y   + +++S G+    +V  +N
Sbjct: 190 CGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEEN 228

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 117/285 (41%), Gaps = 33/285 (11%)
Query: 226 QTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNRE-- 282
           + I   LK+++   ++F+  K IG G F  V   ++   G + A+K ++        E  
Sbjct: 47  EPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVS 106
Query: 283 -FLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDW 339
            F  E  ++       + ++H    + + L LV EY     L   L  FG E    E+  
Sbjct: 107 CFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMAR 165
Query: 340 PTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH 399
               +I + I           R   VHRDIK  N+LLDR  + +++DFG       D T 
Sbjct: 166 FYLAEIVMAI-------DSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218
Query: 400 ISTRIAGTIGYMAPE-------YALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEF 452
            S    GT  Y++PE           G    + D ++ G+ A E+  G+    YA +   
Sbjct: 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF-YADSTAE 277
Query: 453 DCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLC 497
               ++ +  HL      + LVDE +      EEA   I+  LLC
Sbjct: 278 TYGKIVHYKEHLS-----LPLVDEGV-----PEEARDFIQ-RLLC 311

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 36/225 (16%)
Query: 239 TNNFDSAKKIGEGGFGPVYKGQLADGTII--AVKQLSSKSRQGNREFLNEIAMISCLQHP 296
           T+ ++  + IG G +  V K  +   T +  AVK +    R    E   EI ++   QHP
Sbjct: 21  TDGYEVKEDIGVGSYS-VCKRCIHKATNMEFAVKIIDKSKRDPTEEI--EI-LLRYGQHP 76
Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQK---------ICL 347
           N++ +     +G  + +V E M+   L             LD   RQK         +  
Sbjct: 77  NIITLKDVYDDGKYVYVVTELMKGGEL-------------LDKILRQKFFSEREASAVLF 123
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVL-LDRDLNP---KISDFGLAKLDEGDKTHISTR 403
            I + + +LH +    +VHRD+K +N+L +D   NP   +I DFG AK    +   + T 
Sbjct: 124 TITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP 180
Query: 404 IAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAP 448
              T  ++APE           D++S G++   +++G    +  P
Sbjct: 181 CY-TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP 224

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 129/294 (43%), Gaps = 48/294 (16%)
Query: 234 QIKAATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQL-SSKSRQGNREFLNEIAM-- 289
           ++KA  ++ +   ++G G +G V K + +  G I AVK++ ++ + Q  +  L ++ +  
Sbjct: 30  EVKA--DDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISX 87
Query: 290 --ISCLQHPNLVKIHGCCV-EGDQLLLVYEYMENNSLACALFGRENCELELDWPTR--QK 344
             + C   P  V  +G    EGD    V+   E    +   F ++  +     P     K
Sbjct: 88  RTVDC---PFTVTFYGALFREGD----VWICXELXDTSLDKFYKQVIDKGQTIPEDILGK 140
Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI 404
           I + I + L  LH  S+  ++HRD+K +NVL++     K  DFG++     D   ++  I
Sbjct: 141 IAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDD---VAKDI 195
Query: 405 -AGTIGYMAPEYA-----LWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLL 458
            AG   Y APE         GY + K+D++S GI  +E+   +          +D     
Sbjct: 196 DAGCKPYXAPERINPELNQKGY-SVKSDIWSLGITXIELAILR--------FPYDS---- 242
Query: 459 DWACHLQQDGKLVELVDERLGS-KYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
            W    QQ  ++VE    +L + K+  E     +  +  C   +   RPT  E+
Sbjct: 243 -WGTPFQQLKQVVEEPSPQLPADKFSAE----FVDFTSQCLKKNSKERPTYPEL 291

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/193 (24%), Positives = 81/193 (41%), Gaps = 28/193 (14%)
Query: 286 EIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNS---LACALFGRENCELELDWPTR 342
           E+ +     HPN+V      +  ++L +V  +M   S   L C  F     EL + +   
Sbjct: 76  ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAY--- 132
Query: 343 QKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF--GLAKLDEGDKTHI 400
             I  G+ + L ++H       VHR +KA+++L+  D    +S     L+ +  G +  +
Sbjct: 133 --ILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRV 187
Query: 401 STRI----AGTIGYMAPEYA---LWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEF- 452
                      + +++PE     L GY   K+D+YS GI A E+ +G       PA +  
Sbjct: 188 VHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQML 246
Query: 453 ------DCTCLLD 459
                    CLLD
Sbjct: 247 LEKLNGTVPCLLD 259

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/193 (24%), Positives = 81/193 (41%), Gaps = 28/193 (14%)
Query: 286 EIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNS---LACALFGRENCELELDWPTR 342
           E+ +     HPN+V      +  ++L +V  +M   S   L C  F     EL + +   
Sbjct: 60  ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAY--- 116
Query: 343 QKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF--GLAKLDEGDKTHI 400
             I  G+ + L ++H       VHR +KA+++L+  D    +S     L+ +  G +  +
Sbjct: 117 --ILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRV 171
Query: 401 STRI----AGTIGYMAPEYA---LWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEF- 452
                      + +++PE     L GY   K+D+YS GI A E+ +G       PA +  
Sbjct: 172 VHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQML 230
Query: 453 ------DCTCLLD 459
                    CLLD
Sbjct: 231 LEKLNGTVPCLLD 243

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 84/174 (48%), Gaps = 17/174 (9%)
Query: 232 LKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTI-IAVKQLSSKSRQ--GNREFLNEIA 288
           +K +K   +N++    IG G +G VY     +    +A+K+++         +  L EI 
Sbjct: 21  IKNVKVP-DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREIT 79
Query: 289 MISCLQHPNLVKIHGCCV-----EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQ 343
           +++ L+   ++++H   +     + D+L +V E  +++     LF      + L     +
Sbjct: 80  ILNRLKSDYIIRLHDLIIPEDLLKFDELYIVLEIADSD--LKKLFK---TPIFLTEQHVK 134
Query: 344 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK 397
            I   +  G  F+HE     I+HRD+K  N LL++D + KI DFGLA+    DK
Sbjct: 135 TILYNLLLGEKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDK 185

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 68/155 (43%), Gaps = 13/155 (8%)
Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ-HPNLVKIHG 303
           + + EGGF  VY+ Q +  G   A+K+L S   + NR  + E+  +  L  HPN+V+   
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 304 CCVEGDQ--------LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
               G +         LL+ E  +   +      +      L   T  KI     R +  
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVE--FLKKMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 390
           +H + +  I+HRD+K  N+LL      K+ DFG A
Sbjct: 152 MHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 63/155 (40%), Gaps = 21/155 (13%)
Query: 293 LQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARG 352
           LQ P++V IH       QL +    +    LA  L              R++  L   R 
Sbjct: 91  LQEPHVVPIHDFGEIDGQLYVDXRLINGVDLAAXL--------------RRQGPLAPPRA 136
Query: 353 LAFLHE-------ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIA 405
           +A + +              HRD+K  N+L+  D    + DFG+A     +K        
Sbjct: 137 VAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV 196
Query: 406 GTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           GT+ Y APE     + TY+AD+Y+   V  E ++G
Sbjct: 197 GTLYYXAPERFSESHATYRADIYALTCVLYECLTG 231

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 87/190 (45%), Gaps = 26/190 (13%)
Query: 268 AVKQLSSKSRQGNREFLNEIAMI-SCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACA 326
           AVK +  +          E+ M+  C  H N++++     E D+  LV+E M   S+   
Sbjct: 42  AVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSH 101
Query: 327 LFGRENC-ELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR--DLNP- 382
           +  R +  ELE        +   +A  L FLH +    I HRD+K  N+L +    ++P 
Sbjct: 102 IHKRRHFNELEAS-----VVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPV 153
Query: 383 KISDFGLA---KLDEGDKTHIST----RIAGTIGYMAPEYA-----LWGYLTYKADVYSF 430
           KI DFGL    KL+ GD + IST       G+  YMAPE              + D++S 
Sbjct: 154 KICDFGLGSGIKLN-GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSL 212
Query: 431 GIVALEIVSG 440
           G++   ++SG
Sbjct: 213 GVILYILLSG 222

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 102/244 (41%), Gaps = 48/244 (19%)
Query: 232 LKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMI- 290
           +K+++    +F+  K IG G FG V           AV ++ +  R    + LN+  M+ 
Sbjct: 66  VKEMQLHREDFEIIKVIGRGAFGEV-----------AVVKMKNTERIYAMKILNKWEMLK 114
Query: 291 ----SCLQHPNLVKIHGCCV----------EGDQLLLVYEYMENNSLACALFGRENCELE 336
               +C +    V ++G C           + + L LV +Y     L   L   E+    
Sbjct: 115 RAETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFED---- 170
Query: 337 LDWPTRQKICLGIAR---GLAFLHEES--RFKIVHRDIKATNVLLDRDLNPKISDFGLAK 391
                  K+   +AR   G   L  +S  +   VHRDIK  NVLLD + + +++DFG   
Sbjct: 171 -------KLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCL 223
Query: 392 LDEGDKTHISTRIAGTIGYMAPEYAL-----WGYLTYKADVYSFGIVALEIVSGKNNMSY 446
               D T  S+   GT  Y++PE         G    + D +S G+   E++ G+    Y
Sbjct: 224 KMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF-Y 282
Query: 447 APAL 450
           A +L
Sbjct: 283 AESL 286

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 102/244 (41%), Gaps = 48/244 (19%)
Query: 232 LKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMI- 290
           +K+++    +F+  K IG G FG V           AV ++ +  R    + LN+  M+ 
Sbjct: 82  VKEMQLHREDFEIIKVIGRGAFGEV-----------AVVKMKNTERIYAMKILNKWEMLK 130
Query: 291 ----SCLQHPNLVKIHGCCV----------EGDQLLLVYEYMENNSLACALFGRENCELE 336
               +C +    V ++G C           + + L LV +Y     L   L   E+    
Sbjct: 131 RAETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFED---- 186
Query: 337 LDWPTRQKICLGIAR---GLAFLHEES--RFKIVHRDIKATNVLLDRDLNPKISDFGLAK 391
                  K+   +AR   G   L  +S  +   VHRDIK  NVLLD + + +++DFG   
Sbjct: 187 -------KLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCL 239
Query: 392 LDEGDKTHISTRIAGTIGYMAPEYAL-----WGYLTYKADVYSFGIVALEIVSGKNNMSY 446
               D T  S+   GT  Y++PE         G    + D +S G+   E++ G+    Y
Sbjct: 240 KMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF-Y 298
Query: 447 APAL 450
           A +L
Sbjct: 299 AESL 302

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/216 (22%), Positives = 98/216 (45%), Gaps = 21/216 (9%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK--SRQGNREFLNEIAMISCLQHP 296
           + ++  + IG G +G V   +    G  +A+K++ +        +  L E+ ++   +H 
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 113
Query: 297 NLVKIHGCCV------EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           N++ I           E   + +V + ME++ L   +   +   LE      +     + 
Sbjct: 114 NIIAIKDILRPTVPYGEFKSVYVVLDLMESD-LHQIIHSSQPLTLE----HVRYFLYQLL 168
Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK---LDEGDKTHISTRIAGT 407
           RGL ++H     +++HRD+K +N+L++ +   KI DFG+A+       +  +  T    T
Sbjct: 169 RGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 225
Query: 408 IGYMAPEYALWGY-LTYKADVYSFGIVALEIVSGKN 442
             Y APE  L  +  T   D++S G +  E+++ + 
Sbjct: 226 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 98/218 (44%), Gaps = 25/218 (11%)
Query: 240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK--SRQGNREFLNEIAMISCLQHP 296
           + ++  + IG G +G V   +    G  +A+K++ +        +  L E+ ++   +H 
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 114
Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL--------G 348
           N++ I       D L     Y E  S+   L   E+ +L     + Q + L         
Sbjct: 115 NIIAIK------DILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQ 167
Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK---LDEGDKTHISTRIA 405
           + RGL ++H     +++HRD+K +N+L++ +   KI DFG+A+       +  +  T   
Sbjct: 168 LLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYV 224
Query: 406 GTIGYMAPEYALWGY-LTYKADVYSFGIVALEIVSGKN 442
            T  Y APE  L  +  T   D++S G +  E+++ + 
Sbjct: 225 ATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 18/208 (8%)
Query: 239 TNNFDSAKKIGEGGFGPV-YKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPN 297
           ++ ++  K IG G FG            ++AVK +  +  + +     EI     L+HPN
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE-RGEKIDENVKREIINHRSLRHPN 76
Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICLGIARGLAF 355
           +V+     +    L +V EY     L   +   GR + E E  +  +Q I      G+++
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS-EDEARFFFQQLIS-----GVSY 130
Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNP--KISDFGLAKLDEGDKTHISTRIAGTIGYMAP 413
            H     ++ HRD+K  N LLD    P  KI  FG +K         ST   GT  Y+AP
Sbjct: 131 CHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKST--VGTPAYIAP 185
Query: 414 EYALWG-YLTYKADVYSFGIVALEIVSG 440
           E  L   Y    ADV+S G+    ++ G
Sbjct: 186 EVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 90/198 (45%), Gaps = 16/198 (8%)
Query: 248 IGEGGFGPVYKGQLADGTII--AVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           IG G +G V K  +  GT I  A K++     +    F  EI ++  L HPN+++++   
Sbjct: 34  IGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 92
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
            +   + LV E          LF R   +         +I   +   +A+ H   +  + 
Sbjct: 93  EDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAVAYCH---KLNVA 145
Query: 366 HRDIKATNVLL--DRDLNP-KISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLT 422
           HRD+K  N L   D   +P K+ DFGLA   +  K  + T++ GT  Y++P+  L G   
Sbjct: 146 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MRTKV-GTPYYVSPQ-VLEGLYG 202
Query: 423 YKADVYSFGIVALEIVSG 440
            + D +S G++   ++ G
Sbjct: 203 PECDEWSAGVMMYVLLCG 220

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 90/198 (45%), Gaps = 16/198 (8%)
Query: 248 IGEGGFGPVYKGQLADGTII--AVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           IG G +G V K  +  GT I  A K++     +    F  EI ++  L HPN+++++   
Sbjct: 17  IGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
            +   + LV E          LF R   +         +I   +   +A+ H   +  + 
Sbjct: 76  EDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAVAYCH---KLNVA 128
Query: 366 HRDIKATNVLL--DRDLNP-KISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLT 422
           HRD+K  N L   D   +P K+ DFGLA   +  K  + T++ GT  Y++P+  L G   
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MRTKV-GTPYYVSPQ-VLEGLYG 185
Query: 423 YKADVYSFGIVALEIVSG 440
            + D +S G++   ++ G
Sbjct: 186 PECDEWSAGVMMYVLLCG 203

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 99/224 (44%), Gaps = 40/224 (17%)
Query: 244 SAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREF----LNEIAMIS-CLQHPNL 298
           S K +G G  G V       G  +AVK++         +F    L EI +++    HPN+
Sbjct: 37  SEKILGYGSSGTVVFQGSFQGRPVAVKRMLI-------DFCDIALMEIKLLTESDDHPNV 89
Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGR----ENCELELDWPTRQKICLGIARGLA 354
           ++ + C    D+ L +   + N +L   +  +    EN +L+ ++     +   IA G+A
Sbjct: 90  IRYY-CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEY-NPISLLRQIASGVA 147
Query: 355 FLHEESRFKIVHRDIKATNVLLD-------------RDLNPKISDFGL-AKLDEGDKTHI 400
            LH     KI+HRD+K  N+L+               +L   ISDFGL  KLD G     
Sbjct: 148 HLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFR 204
Query: 401 S--TRIAGTIGYMAPEY---ALWGYLTYKADVYSFGIVALEIVS 439
                 +GT G+ APE    +    LT   D++S G V   I+S
Sbjct: 205 XNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 99/224 (44%), Gaps = 40/224 (17%)
Query: 244 SAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREF----LNEIAMIS-CLQHPNL 298
           S K +G G  G V       G  +AVK++         +F    L EI +++    HPN+
Sbjct: 37  SEKILGYGSSGTVVFQGSFQGRPVAVKRMLI-------DFCDIALMEIKLLTESDDHPNV 89
Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGR----ENCELELDWPTRQKICLGIARGLA 354
           ++ + C    D+ L +   + N +L   +  +    EN +L+ ++     +   IA G+A
Sbjct: 90  IRYY-CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEY-NPISLLRQIASGVA 147
Query: 355 FLHEESRFKIVHRDIKATNVLLD-------------RDLNPKISDFGL-AKLDEGDKTHI 400
            LH     KI+HRD+K  N+L+               +L   ISDFGL  KLD G     
Sbjct: 148 HLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFR 204
Query: 401 S--TRIAGTIGYMAPEY---ALWGYLTYKADVYSFGIVALEIVS 439
                 +GT G+ APE    +    LT   D++S G V   I+S
Sbjct: 205 XNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 94/228 (41%), Gaps = 16/228 (7%)
Query: 232 LKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNRE----FLNEI 287
           +KQ++    +F+  K IG G FG V   +L +   +   ++ +K     R     F  E 
Sbjct: 66  VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREER 125
Query: 288 AMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL 347
            ++       +  +H    + + L LV +Y     L   L   E      D    +    
Sbjct: 126 DVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE------DRLPEEMARF 179
Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            +A  +  +    +   VHRDIK  N+L+D + + +++DFG       D T  S+   GT
Sbjct: 180 YLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGT 239
Query: 408 IGYMAPEYALW-----GYLTYKADVYSFGIVALEIVSGKNNMSYAPAL 450
             Y++PE         G    + D +S G+   E++ G+    YA +L
Sbjct: 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF-YAESL 286

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 92/224 (41%), Gaps = 34/224 (15%)
Query: 239 TNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPN 297
           T+ ++  + IG G +    +    A     AVK +    R    E   EI ++   QHPN
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEI--EI-LLRYGQHPN 77
Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQK---------ICLG 348
           ++ +     +G  + +V E  +   L             LD   RQK         +   
Sbjct: 78  IITLKDVYDDGKYVYVVTELXKGGEL-------------LDKILRQKFFSEREASAVLFT 124
Query: 349 IARGLAFLHEESRFKIVHRDIKATNVL-LDRDLNP---KISDFGLAKLDEGDKTHISTRI 404
           I + + +LH +    +VHRD+K +N+L +D   NP   +I DFG AK    +   + T  
Sbjct: 125 ITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPC 181
Query: 405 AGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAP 448
             T  ++APE           D++S G++    ++G    +  P
Sbjct: 182 Y-TANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGP 224

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 100/228 (43%), Gaps = 44/228 (19%)
Query: 244 SAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREF----LNEIAMIS-CLQHPNL 298
           S K +G G  G V       G  +AVK++         +F    L EI +++    HPN+
Sbjct: 19  SEKILGYGSSGTVVFQGSFQGRPVAVKRMLI-------DFCDIALMEIKLLTESDDHPNV 71
Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGR----ENCELELDWPTRQKICLGIARGLA 354
           ++ + C    D+ L +   + N +L   +  +    EN +L+ ++     +   IA G+A
Sbjct: 72  IRYY-CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEY-NPISLLRQIASGVA 129
Query: 355 FLHEESRFKIVHRDIKATNVLLD-------------RDLNPKISDFGLAKLDEGDKTHIS 401
            LH     KI+HRD+K  N+L+               +L   ISDFGL K  +  ++   
Sbjct: 130 HLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 402 TRI---AGTIGYMAPE-------YALWGYLTYKADVYSFGIVALEIVS 439
           T +   +GT G+ APE             LT   D++S G V   I+S
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 110/244 (45%), Gaps = 56/244 (22%)
Query: 248 IGEGGFGPVYKGQLADGT--IIAVKQLS-SKSRQGN----REFLNEIAMISCLQHPNLVK 300
           IG+G +G V +  + + T  I A+K ++ +K RQ N         E+ ++  L HPN+ +
Sbjct: 34  IGQGSYG-VVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 301 IHGCCVEGDQLLLVYE-------------YMENNSLACAL-------FGRENCELE---- 336
           ++    +   + LV E             ++++++  CA+            C  E    
Sbjct: 93  LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 337 --------LDWPTRQKICLGIAR----GLAFLHEESRFKIVHRDIKATNVLL--DRDLNP 382
                   LD+  R+K+   I R     L +LH +    I HRDIK  N L   ++    
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEI 209
Query: 383 KISDFGLA----KLDEGDKTHISTRIAGTIGYMAPEYALWGYLTY--KADVYSFGIVALE 436
           K+ DFGL+    KL+ G+   ++T+ AGT  ++APE       +Y  K D +S G++   
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTK-AGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268
Query: 437 IVSG 440
           ++ G
Sbjct: 269 LLMG 272

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 96/232 (41%), Gaps = 50/232 (21%)
Query: 242 FDSAKKIGEGGFGPVYK--GQLADGTIIAVKQLSSKSR--QGNR------EFLNEI---A 288
           ++    +GEG FG V +     A G  +AVK + +  R  +  R      E LN     +
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLG 348
              C+Q     + HG       + +V+E +    L+   F +EN  L       +K+   
Sbjct: 76  TFRCVQMLEWFEHHG------HICIVFELL---GLSTYDFIKENGFLPFRLDHIRKMAYQ 126
Query: 349 IARGLAFLHEESRFKIVHRDIKATNVL-------------LDRD----LNP--KISDFGL 389
           I + + FLH     K+ H D+K  N+L             + RD    +NP  K+ DFG 
Sbjct: 127 ICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183
Query: 390 AKLD-EGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           A  D E   T +STR      Y APE  L    +   DV+S G + +E   G
Sbjct: 184 ATYDDEHHSTLVSTR-----HYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 86/190 (45%), Gaps = 26/190 (13%)
Query: 268 AVKQLSSKSRQGNREFLNEIAMI-SCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACA 326
           AVK +  +          E+ M+  C  H N++++     E D+  LV+E M   S+   
Sbjct: 42  AVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSH 101
Query: 327 LFGRENC-ELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR--DLNP- 382
           +  R +  ELE        +   +A  L FLH +    I HRD+K  N+L +    ++P 
Sbjct: 102 IHKRRHFNELEAS-----VVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPV 153
Query: 383 KISDFGLA---KLDEGDKTHIST----RIAGTIGYMAPEYA-----LWGYLTYKADVYSF 430
           KI DF L    KL+ GD + IST       G+  YMAPE              + D++S 
Sbjct: 154 KICDFDLGSGIKLN-GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSL 212
Query: 431 GIVALEIVSG 440
           G++   ++SG
Sbjct: 213 GVILYILLSG 222

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 90/209 (43%), Gaps = 20/209 (9%)
Query: 239 TNNFDSAKKIGEGGFGPV-YKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPN 297
           ++ ++  K IG G FG            ++AVK +  +  + +     EI     L+HPN
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE-RGEKIDENVKREIINHRSLRHPN 76
Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICLGIARGLAF 355
           +V+     +    L +V EY     L   +   GR + E E  +  +Q I      G+++
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS-EDEARFFFQQLIS-----GVSY 130
Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNP--KISDFGLAKLDEGDKTHISTR-IAGTIGYMA 412
            H     ++ HRD+K  N LLD    P  KI  FG +K       H   +   GT  Y+A
Sbjct: 131 CHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKDTVGTPAYIA 184
Query: 413 PEYALWG-YLTYKADVYSFGIVALEIVSG 440
           PE  L   Y    ADV+S G+    ++ G
Sbjct: 185 PEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 80/199 (40%), Gaps = 15/199 (7%)
Query: 247 KIGEGGFGPVYKGQLADGTIIAVKQLSSK--SRQGNREFLNEIAMISCLQHPNLVKIHGC 304
           K+ E   G ++KG+   G  I VK L  +  S + +R+F  E   +    HPN++ + G 
Sbjct: 17  KLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 305 C--VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRF 362
           C         L+  +    SL   L   E     +D     K  L  ARG AFLH     
Sbjct: 76  CQSPPAPHPTLITHWXPYGSLYNVL--HEGTNFVVDQSQAVKFALDXARGXAFLHTLEPL 133
Query: 363 KIVHRDIKATNVLLDRDLNPKIS--DFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGY 420
            I    + + +V +D D   +IS  D   +    G + +    +A       PE      
Sbjct: 134 -IPRHALNSRSVXIDEDXTARISXADVKFSFQSPG-RXYAPAWVAPEALQKKPE----DT 187
Query: 421 LTYKADVYSFGIVALEIVS 439
               AD +SF ++  E+V+
Sbjct: 188 NRRSADXWSFAVLLWELVT 206

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 89/214 (41%), Gaps = 24/214 (11%)
Query: 240 NNFDSAKKIGEGGFGPVYKG---QLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ-H 295
           N F   +KIG G FG +Y G   Q  +   I ++ + +K  Q     L E  +   LQ  
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LLYESKIYRILQGG 62
Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
             +  +    VEGD  +LV + +  +      F    C  +L   T   +   +   + F
Sbjct: 63  TGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEF 118
Query: 356 LHEESRFKIVHRDIKATNVL--LDRDLNP-KISDFGLAK--LDEGDKTHISTR----IAG 406
           +H +S    +HRDIK  N L  L R  N   I DFGLAK   D     HI  R    + G
Sbjct: 119 VHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           T  Y +    L    + + D+ S G V +  + G
Sbjct: 176 TARYASVNTHLGIEQSRRDDLESLGYVLMYFLRG 209

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 100/220 (45%), Gaps = 34/220 (15%)
Query: 239 TNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQ-GNREFLNEIAMISCLQHP 296
           +++F     +GEG +G V        G I+A+K++    +       L EI ++   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 297 NLVKIHGCCVEG-----DQLLLVYEYMENN---SLACALFGRENCELELDWPTRQKICLG 348
           N++ I            +++ ++ E M+ +    ++  +   ++          Q     
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHI---------QYFIYQ 120
Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDE---------GDKT 398
             R +  LH  +   ++HRD+K +N+L++ + + K+ DFGLA+ +DE         G ++
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 399 HISTRIAGTIGYMAPEYALWGYLTYKA-DVYSFGIVALEI 437
            ++  +A T  Y APE  L      +A DV+S G +  E+
Sbjct: 178 GMTEXVA-TRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 247 KIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQG-NREFLNEIAMISCLQHPNLVKIHGCC 305
           K+G G +G VYK +  DG       L      G +     EIA++  L+HPN++ +    
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 306 VE--GDQLLLVYEYMENNSLACALFGR----ENCELELDWPTRQKICLGIARGLAFLHEE 359
           +     ++ L+++Y E++      F R        ++L     + +   I  G+ +LH  
Sbjct: 88  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 147
Query: 360 SRFKIVHRDIKATNVLL----DRDLNPKISDFGLAKLDEGDKTHIS--TRIAGTIGYMAP 413
               ++HRD+K  N+L+          KI+D G A+L       ++    +  T  Y AP
Sbjct: 148 W---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204
Query: 414 EYALWG-YLTYKADVYSFGIVALEIVSGK 441
           E  L   + T   D+++ G +  E+++ +
Sbjct: 205 ELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/219 (22%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 239 TNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQ-GNREFLNEIAMISCLQHP 296
           +++F     +GEG +G V        G I+A+K++    +       L EI ++   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 297 NLVKIHGCCVEG-----DQLLLVYEYMENN---SLACALFGRENCELELDWPTRQKICLG 348
           N++ I            +++ ++ E M+ +    ++  +   ++          Q     
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHI---------QYFIYQ 120
Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDE--GDKTHISTRIA 405
             R +  LH  +   ++HRD+K +N+L++ + + K+ DFGLA+ +DE   D +  + + +
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 406 GTIG------YMAPEYALWGYLTYKA-DVYSFGIVALEI 437
           G +       Y APE  L      +A DV+S G +  E+
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 81/200 (40%), Gaps = 22/200 (11%)
Query: 224 DLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVK--QLSSKSRQGNR 281
           DL T +   + +      +   K+IG GG   V++       I A+K   L     Q   
Sbjct: 12  DLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD 71
Query: 282 EFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPT 341
            + NEIA ++ LQ              D+++ +Y+Y   +     +    N +L   W  
Sbjct: 72  SYRNEIAYLNKLQQ-----------HSDKIIRLYDYEITDQYIYMVMECGNIDLN-SWLK 119
Query: 342 RQKICLGIARG------LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG 395
           ++K      R       L  +H   +  IVH D+K  N L+  D   K+ DFG+A   + 
Sbjct: 120 KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQP 178
Query: 396 DKTH-ISTRIAGTIGYMAPE 414
           D T  +     GT+ YM PE
Sbjct: 179 DTTSVVKDSQVGTVNYMPPE 198

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 239 TNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQ-GNREFLNEIAMISCLQHP 296
           +++F     +GEG +G V        G I+A+K++    +       L EI ++   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 297 NLVKIHGCCVEG-----DQLLLVYEYMENN---SLACALFGRENCELELDWPTRQKICLG 348
           N++ I            +++ ++ E M+ +    ++  +   ++          Q     
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHI---------QYFIYQ 120
Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDE--GDKTHIS---- 401
             R +  LH  +   ++HRD+K +N+L++ + + K+ DFGLA+ +DE   D +  +    
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 402 --TRIAGTIGYMAPEYALWGYLTYKA-DVYSFGIVALEI 437
             T    T  Y APE  L      +A DV+S G +  E+
Sbjct: 178 GMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 73/170 (42%), Gaps = 28/170 (16%)
Query: 352 GLAFLHEESRFKIVHRDIKATNVLLDR-----DLNPKISDFGLAKLDEGDKTHISTR--I 404
           GLA LH      IVHRD+K  N+L+        +   ISDFGL K     +   S R  +
Sbjct: 130 GLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV 186
Query: 405 AGTIGYMAPEYA---LWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWA 461
            GT G++APE          TY  D++S G V   ++S + +  +  +L+     LL  A
Sbjct: 187 PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS-EGSHPFGKSLQRQANILLG-A 244
Query: 462 CHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           C L        L  E+      +E  E+MI +        P  RP+   V
Sbjct: 245 CSLDC------LHPEKHEDVIARELIEKMIAM-------DPQKRPSAKHV 281

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 98/228 (42%), Gaps = 44/228 (19%)
Query: 244 SAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREF----LNEIAMIS-CLQHPNL 298
           S K +G G  G V       G  +AVK++         +F    L EI +++    HPN+
Sbjct: 19  SEKILGYGSSGTVVFQGSFQGRPVAVKRMLI-------DFCDIALMEIKLLTESDDHPNV 71
Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGR----ENCELELDWPTRQKICLGIARGLA 354
           ++ + C    D+ L +   + N +L   +  +    EN +L+ ++     +   IA G+A
Sbjct: 72  IRYY-CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEY-NPISLLRQIASGVA 129
Query: 355 FLHEESRFKIVHRDIKATNVLLD-------------RDLNPKISDFGLA-KLDEGDKTHI 400
            LH     KI+HRD+K  N+L+               +L   ISDFGL  KLD G     
Sbjct: 130 HLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFR 186
Query: 401 S--TRIAGTIGYMAPE-------YALWGYLTYKADVYSFGIVALEIVS 439
                 +GT G+ APE             LT   D++S G V   I+S
Sbjct: 187 XNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 245 AKKIGEGGFGPVYK-GQLADGTIIAVKQLSSKSRQGNREFL--NEIAMISCLQHPNLVKI 301
           A+ +G G FG V++  + +       K +  K   G  + L   EI++++  +H N++ +
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHL 66
Query: 302 HGCCVEGDQLLLVYEYMENNSLACALFGRENCE-LELDWPTRQKICLGIARGLAFLHEES 360
           H      ++L++++E++        +F R N    EL+          +   L FLH  +
Sbjct: 67  HESFESMEELVMIFEFIS----GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 361 RFKIVHRDIKATNVLLD--RDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPEYAL 417
              I H DI+  N++    R    KI +FG A+ L  GD   +   +     Y APE   
Sbjct: 123 ---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQ 176
Query: 418 WGYLTYKADVYSFGIVALEIVSGKN 442
              ++   D++S G +   ++SG N
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGIN 201

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 74/178 (41%), Gaps = 22/178 (12%)
Query: 246 KKIGEGGFGPVYKGQLADGTIIAVK--QLSSKSRQGNREFLNEIAMISCLQHPNLVKIHG 303
           K+IG GG   V++       I A+K   L     Q    + NEIA ++ LQ         
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ-------- 113
Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARG------LAFLH 357
                D+++ +Y+Y   +     +    N +L   W  ++K      R       L  +H
Sbjct: 114 ---HSDKIIRLYDYEITDQYIYMVMECGNIDLN-SWLKKKKSIDPWERKSYWKNMLEAVH 169
Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH-ISTRIAGTIGYMAPE 414
              +  IVH D+K  N L+  D   K+ DFG+A   + D T  +     GT+ YM PE
Sbjct: 170 TIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 226

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 74/178 (41%), Gaps = 22/178 (12%)
Query: 246 KKIGEGGFGPVYKGQLADGTIIAVK--QLSSKSRQGNREFLNEIAMISCLQHPNLVKIHG 303
           K+IG GG   V++       I A+K   L     Q    + NEIA ++ LQ         
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ-------- 66
Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARG------LAFLH 357
                D+++ +Y+Y   +     +    N +L   W  ++K      R       L  +H
Sbjct: 67  ---HSDKIIRLYDYEITDQYIYMVMECGNIDLN-SWLKKKKSIDPWERKSYWKNMLEAVH 122
Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH-ISTRIAGTIGYMAPE 414
              +  IVH D+K  N L+  D   K+ DFG+A   + D T  +     GT+ YM PE
Sbjct: 123 TIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 74/178 (41%), Gaps = 22/178 (12%)
Query: 246 KKIGEGGFGPVYKGQLADGTIIAVK--QLSSKSRQGNREFLNEIAMISCLQHPNLVKIHG 303
           K+IG GG   V++       I A+K   L     Q    + NEIA ++ LQ         
Sbjct: 18  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ-------- 69
Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARG------LAFLH 357
                D+++ +Y+Y   +     +    N +L   W  ++K      R       L  +H
Sbjct: 70  ---HSDKIIRLYDYEITDQYIYMVMECGNIDLN-SWLKKKKSIDPWERKSYWKNMLEAVH 125
Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH-ISTRIAGTIGYMAPE 414
              +  IVH D+K  N L+  D   K+ DFG+A   + D T  +     GT+ YM PE
Sbjct: 126 TIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 182

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 74/178 (41%), Gaps = 22/178 (12%)
Query: 246 KKIGEGGFGPVYKGQLADGTIIAVK--QLSSKSRQGNREFLNEIAMISCLQHPNLVKIHG 303
           K+IG GG   V++       I A+K   L     Q    + NEIA ++ LQ         
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ-------- 113
Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARG------LAFLH 357
                D+++ +Y+Y   +     +    N +L   W  ++K      R       L  +H
Sbjct: 114 ---HSDKIIRLYDYEITDQYIYMVMECGNIDLN-SWLKKKKSIDPWERKSYWKNMLEAVH 169
Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH-ISTRIAGTIGYMAPE 414
              +  IVH D+K  N L+  D   K+ DFG+A   + D T  +     GT+ YM PE
Sbjct: 170 TIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 226

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 95/231 (41%), Gaps = 48/231 (20%)
Query: 242 FDSAKKIGEGGFGPVYK--GQLADGTIIAVKQLSSKSR--QGNR------EFLNEI---A 288
           ++    +GEG FG V +     A G  +AVK + +  R  +  R      E LN     +
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLG 348
              C+Q     + HG       + +V+E +    L+   F +EN  L       +K+   
Sbjct: 76  TFRCVQMLEWFEHHG------HICIVFELL---GLSTYDFIKENGFLPFRLDHIRKMAYQ 126
Query: 349 IARGLAFLHEESRFKIVHRDIKATNVL-------------LDRD----LNP--KISDFGL 389
           I + + FLH     K+ H D+K  N+L             + RD    +NP  K+ DFG 
Sbjct: 127 ICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183
Query: 390 AKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
           A  D+    H ST +     Y APE  L    +   DV+S G + +E   G
Sbjct: 184 ATYDD---EHHSTLVXXR-HYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 74/178 (41%), Gaps = 22/178 (12%)
Query: 246 KKIGEGGFGPVYKGQLADGTIIAVK--QLSSKSRQGNREFLNEIAMISCLQHPNLVKIHG 303
           K+IG GG   V++       I A+K   L     Q    + NEIA ++ LQ         
Sbjct: 14  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ-------- 65
Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARG------LAFLH 357
                D+++ +Y+Y   +     +    N +L   W  ++K      R       L  +H
Sbjct: 66  ---HSDKIIRLYDYEITDQYIYMVMECGNIDLN-SWLKKKKSIDPWERKSYWKNMLEAVH 121
Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH-ISTRIAGTIGYMAPE 414
              +  IVH D+K  N L+  D   K+ DFG+A   + D T  +     GT+ YM PE
Sbjct: 122 TIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 178

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 80/200 (40%), Gaps = 22/200 (11%)
Query: 224 DLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVK--QLSSKSRQGNR 281
           DL T +   + +      +   K+IG GG   V++       I A+K   L     Q   
Sbjct: 12  DLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD 71
Query: 282 EFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPT 341
            + NEIA ++ LQ              D+++ +Y+Y   +     +    N +L   W  
Sbjct: 72  SYRNEIAYLNKLQQ-----------HSDKIIRLYDYEITDQYIYMVMECGNIDLN-SWLK 119
Query: 342 RQKICLGIARG------LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG 395
           ++K      R       L  +H   +  IVH D+K  N L+  D   K+ DFG+A   + 
Sbjct: 120 KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQP 178
Query: 396 DKTH-ISTRIAGTIGYMAPE 414
           D    +     GT+ YM PE
Sbjct: 179 DXXXVVKDSQVGTVNYMPPE 198

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 25/210 (11%)
Query: 248 IGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNREFLNEI-AMISCLQHPNLVKIHGCC 305
           +GEG +  V     L +G   AVK +  ++         E+  +  C  + N++++    
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFF 80
Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
            +  +  LV+E ++  S+   +  +++     +     ++   +A  L FLH +    I 
Sbjct: 81  EDDTRFYLVFEKLQGGSILAHIQKQKH----FNEREASRVVRDVAAALDFLHTKG---IA 133
Query: 366 HRDIKATNVLLD--RDLNP-KISDFGLA---KLDEGDKTHIS----TRIAGTIGYMAPEY 415
           HRD+K  N+L +    ++P KI DF L    KL+    T I+    T   G+  YMAPE 
Sbjct: 134 HRDLKPENILCESPEKVSPVKICDFDLGSGMKLN-NSCTPITTPELTTPCGSAEYMAPEV 192
Query: 416 A-----LWGYLTYKADVYSFGIVALEIVSG 440
                    +   + D++S G+V   ++SG
Sbjct: 193 VEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 75/170 (44%), Gaps = 17/170 (10%)
Query: 279 GNREFLNEIAMISCLQHPNLVKIHGCCV--EGDQLLLVYEYMENNSLACALFGRENCELE 336
           G      EI ++  L+H N++++       E  ++ +V EY       C +    +   E
Sbjct: 49  GEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEY-----CVCGMQEMLDSVPE 103
Query: 337 LDWPTRQK---ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 393
             +P  Q     C  +  GL +LH +    IVH+DIK  N+LL      KIS  G+A+  
Sbjct: 104 KRFPVCQAHGYFC-QLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEAL 159
Query: 394 EGDKTHISTRIA-GTIGYMAPEYA--LWGYLTYKADVYSFGIVALEIVSG 440
                  + R + G+  +  PE A  L  +  +K D++S G+    I +G
Sbjct: 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 75/152 (49%), Gaps = 16/152 (10%)
Query: 248 IGEGGFGPVYKG-QLADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
           IG G +G V +     +  ++A+K++    +     +  L EIA+++ L H ++VK+   
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDI 120
Query: 305 CVEGD-----QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
            +  D     +L +V E  +++     LF       EL   T   +   +  G+ ++H  
Sbjct: 121 VIPKDVEKFDELYVVLEIADSD--FKKLFRTPVYLTELHIKT---LLYNLLVGVKYVHSA 175
Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 391
               I+HRD+K  N L+++D + K+ DFGLA+
Sbjct: 176 G---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/256 (22%), Positives = 103/256 (40%), Gaps = 33/256 (12%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNREFLN------ 285
           K+ +   + +     +G GGFG VY G +++D   +A+K +         E  N      
Sbjct: 1   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 60
Query: 286 EIAMISCLQH--PNLVKIHGCCVEGDQLLLVYEYMEN-NSLACALFGRENCELELDWPTR 342
           E+ ++  +      ++++       D  +L+ E ME    L   +  R   + EL     
Sbjct: 61  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEEL----A 116
Query: 343 QKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP-KISDFGLAKLDEGDKTHIS 401
           +     +   +   H      ++HRDIK  N+L+D +    K+ DFG   L    K  + 
Sbjct: 117 RSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGAL---LKDTVY 170
Query: 402 TRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSG-----------KNNMSYAPA 449
           T   GT  Y  PE+  +  Y    A V+S GI+  ++V G           +  + +   
Sbjct: 171 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 230
Query: 450 LEFDCTCLLDWACHLQ 465
           +  +C  L+ W   L+
Sbjct: 231 VSSECQHLIRWCLALR 246

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 73/178 (41%), Gaps = 22/178 (12%)
Query: 246 KKIGEGGFGPVYKGQLADGTIIAVK--QLSSKSRQGNREFLNEIAMISCLQHPNLVKIHG 303
           K+IG GG   V++       I A+K   L     Q    + NEIA ++ LQ         
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ-------- 113
Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARG------LAFLH 357
                D+++ +Y+Y   +     +    N +L   W  ++K      R       L  +H
Sbjct: 114 ---HSDKIIRLYDYEITDQYIYMVMECGNIDLN-SWLKKKKSIDPWERKSYWKNMLEAVH 169
Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH-ISTRIAGTIGYMAPE 414
              +  IVH D+K  N L+  D   K+ DFG+A   + D T  +     G + YM PE
Sbjct: 170 TIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 97/228 (42%), Gaps = 50/228 (21%)
Query: 248 IGEGGFGPVY----KGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHG 303
           IG G +G VY    K    +  I  V ++        R  L EI +++ L+   +++++ 
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKR-ILREITILNRLKSDYIIRLYD 92
Query: 304 CCVEGD-----QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
             +  D     +L +V E  +++     LF      + L     + I   +  G  F+HE
Sbjct: 93  LIIPDDLLKFDELYIVLEIADSD--LKKLFK---TPIFLTEEHIKTILYNLLLGENFIHE 147
Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-------------LDEGDK-------- 397
                I+HRD+K  N LL++D + K+ DFGLA+             L+E ++        
Sbjct: 148 SG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 398 -----THISTRIAGTIGYMAPEYALWGY-LTYKADVYSFGIVALEIVS 439
                +H+ TR      Y APE  L     T   D++S G +  E+++
Sbjct: 205 KKQLTSHVVTR-----WYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 100/259 (38%), Gaps = 60/259 (23%)
Query: 222 ESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADG----TIIAVKQLSSKSR 277
           + D + + F+ K+     N F   +K+G+G FG V   Q  D      +  V+ +   +R
Sbjct: 17  QGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTR 76
Query: 278 QGNRE--FLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM---------ENNSLACA 326
               E   L +I       + N+VK HG  +  D + L++E +          NN     
Sbjct: 77  SAKIEADILKKIQNDDINNN-NIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNG-- 133
Query: 327 LFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD--------- 377
            F  E+ +L          C+ I + L +L + S   + H D+K  N+LLD         
Sbjct: 134 -FHIEDIKL---------YCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLI 180
Query: 378 ----------------RDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYL 421
                           +    K+ DFG A      K+     I  T  Y APE  L    
Sbjct: 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATF----KSDYHGSIINTRQYRAPEVILNLGW 236
Query: 422 TYKADVYSFGIVALEIVSG 440
              +D++SFG V  E+ +G
Sbjct: 237 DVSSDMWSFGCVLAELYTG 255

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 62/256 (24%), Positives = 105/256 (41%), Gaps = 31/256 (12%)
Query: 232 LKQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNREFLN--EIA 288
           +K+ +   + +     +G GGFG VY G +++D   +A+K +         E  N   + 
Sbjct: 23  MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 82
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPT-RQKICL 347
           M   L    L K+        +LL  +E    +S    L   E  +   D+ T R  +  
Sbjct: 83  MEVVL----LKKVSSGFSGVIRLLDWFE--RPDSFVLILERPEPVQDLFDFITERGALQE 136
Query: 348 GIARGLAFLHEES-----RFKIVHRDIKATNVLLDRDLNP-KISDFGLAKLDEGDKTHIS 401
            +AR   +   E+        ++HRDIK  N+L+D +    K+ DFG   L    K  + 
Sbjct: 137 ELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL---LKDTVY 193
Query: 402 TRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSG-----------KNNMSYAPA 449
           T   GT  Y  PE+  +  Y    A V+S GI+  ++V G           +  + +   
Sbjct: 194 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 253
Query: 450 LEFDCTCLLDWACHLQ 465
           +  +C  L+ W   L+
Sbjct: 254 VSXECQHLIRWCLALR 269

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 62/256 (24%), Positives = 105/256 (41%), Gaps = 31/256 (12%)
Query: 232 LKQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNREFLN--EIA 288
           +K+ +   + +     +G GGFG VY G +++D   +A+K +         E  N   + 
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPT-RQKICL 347
           M   L    L K+        +LL  +E    +S    L   E  +   D+ T R  +  
Sbjct: 61  MEVVL----LKKVSSGFSGVIRLLDWFE--RPDSFVLILERPEPVQDLFDFITERGALQE 114
Query: 348 GIARGLAFLHEES-----RFKIVHRDIKATNVLLDRDLNP-KISDFGLAKLDEGDKTHIS 401
            +AR   +   E+        ++HRDIK  N+L+D +    K+ DFG   L    K  + 
Sbjct: 115 ELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL---LKDTVY 171
Query: 402 TRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSG-----------KNNMSYAPA 449
           T   GT  Y  PE+  +  Y    A V+S GI+  ++V G           +  + +   
Sbjct: 172 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 231
Query: 450 LEFDCTCLLDWACHLQ 465
           +  +C  L+ W   L+
Sbjct: 232 VSSECQHLIRWCLALR 247

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 24/222 (10%)
Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNREFLN------ 285
           K  +A    +     +G+GGFG V+ G +L D   +A+K +      G     +      
Sbjct: 24  KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL 83
Query: 286 EIAMISCLQ----HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELEL-DWP 340
           E+A++  +     HP ++++       +  +LV   +E    A  LF     +  L + P
Sbjct: 84  EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLV---LERPLPAQDLFDYITEKGPLGEGP 140
Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD-RDLNPKISDFGLAKLDEGDKTH 399
           +R   C       A  H  SR  +VHRDIK  N+L+D R    K+ DFG   L   +   
Sbjct: 141 SR---CFFGQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY- 195
Query: 400 ISTRIAGTIGYMAPEY-ALWGYLTYKADVYSFGIVALEIVSG 440
             T   GT  Y  PE+ +   Y    A V+S GI+  ++V G
Sbjct: 196 --TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	511
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	0.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-164
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-160
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-83
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-70
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-59
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-59
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-58
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-57
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-57
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-56
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-56
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-55
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-55
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	8e-54
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-53
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-53
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-52
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-46
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-45
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	9e-45
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	9e-45
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-44
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-43
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-43
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-43
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-43
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-43
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-43
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-43
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-43
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-43
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-43
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-42
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-42
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-42
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-42
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-42
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-42
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-42
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-42
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	7e-42
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-41
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-41
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-41
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-41
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-41
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-41
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-41
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-41
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-41
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-40
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-40
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-40
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-40
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-40
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-40
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-40
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-40
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-40
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-40
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-40
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	7e-40
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	9e-40
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-39
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-39
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-39
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-39
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-39
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-39
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-39
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-39
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	5e-39
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	5e-39
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-39
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	8e-39
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-38
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-38
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-38
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-38
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-38
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-38
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-38
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-37
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-37
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-37
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-37
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-37
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-37
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-36
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-36
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-36
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-36
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-36
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-35
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-35
2jwp_A	174	Malectin, MGC80075; sugar binding, sugar binding p	3e-35
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	7e-35
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-34
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-34
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-34
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-31
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-31
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-31
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	5e-31
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-31
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-30
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-30
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	7e-30
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-29
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-29
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-29
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-29
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-29
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-28
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-28
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-28
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-28
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-28
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-28
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-28
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-27
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-27
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-27
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-27
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-27
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-26
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-09
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-26
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-26
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-26
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-26
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-26
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	6e-26
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-26
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-25
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-25
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-25
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-25
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-25
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-25
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	6e-25
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	8e-25
3o0g_A	292	Cell division protein kinase 5; kinase activator c	9e-25
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-24
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-24
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-24
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-24
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-24
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-24
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-24
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-24
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-24
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-24
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-24
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-24
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	9e-24
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-23
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-23
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-23
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-23
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-23
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-23
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-23
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-23
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-23
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-23
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	5e-23
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-23
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	6e-23
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	7e-23
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	7e-23
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-22
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-22
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-22
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-22
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-22
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	8e-22
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-21
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-21
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-21
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-21
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	8e-21
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-20
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-20
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-20
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-20
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-20
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	5e-20
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-19
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-19
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-19
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	8e-19
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-18
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-18
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-18
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	6e-18
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-17
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-17
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-17
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-17
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-17
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-17
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	7e-17
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	8e-17
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	8e-17
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-16
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-16
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-16
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-16
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-16
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	5e-16
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	6e-16
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	7e-16
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	8e-16
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	6e-15
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-14
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-14
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-14
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-13
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-13
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-13
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-13
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-13
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-12
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-12
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-11
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-10
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-10
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	5e-10
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-06
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	6e-06
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	7e-06

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  519 bits (1340), Expect = 0.0
 Identities = 132/287 (45%), Positives = 185/287 (64%), Gaps = 1/287 (0%)

Query: 226 QTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGN-REFL 284
           Q   F+L++++ A++NF +   +G GGFG VYKG+LADGT++AVK+L  +  QG   +F 
Sbjct: 16  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQ 75

Query: 285 NEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQK 344
            E+ MIS   H NL+++ G C+   + LLVY YM N S+A  L  R   +  LDWP RQ+
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135

Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI 404
           I LG ARGLA+LH+    KI+HRD+KA N+LLD +    + DFGLAKL +   TH++T +
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 195

Query: 405 AGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHL 464
            GTIG++APEY   G  + K DV+ +G++ LE+++G+     A     D   LLDW   L
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255

Query: 465 QQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
            ++ KL  LVD  L   YK EE E++I+V+LLCT +SP  RP MSEV
Sbjct: 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  467 bits (1203), Expect = e-164
 Identities = 114/283 (40%), Positives = 174/283 (61%), Gaps = 6/283 (2%)

Query: 230 FTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAM 289
             L  ++ ATNNFD    IG G FG VYKG L DG  +A+K+ + +S QG  EF  EI  
Sbjct: 29  VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88

Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGI 349
           +S  +HP+LV + G C E ++++L+Y+YMEN +L   L+G +   + + W  R +IC+G 
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148

Query: 350 ARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL-DEGDKTHISTRIAGTI 408
           ARGL +LH  +   I+HRD+K+ N+LLD +  PKI+DFG++K   E D+TH+ST + GT+
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTL 205

Query: 409 GYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDG 468
           GY+ PEY + G LT K+DVYSFG+V  E++  ++ +    +L  +   L +WA     +G
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV--QSLPREMVNLAEWAVESHNNG 263

Query: 469 KLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           +L ++VD  L  K + E   +    ++ C   S   RP+M +V
Sbjct: 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  456 bits (1176), Expect = e-160
 Identities = 111/304 (36%), Positives = 168/304 (55%), Gaps = 23/304 (7%)

Query: 220 MKESDLQTISFTLKQIKAATNNFDS------AKKIGEGGFGPVYKGQLADGTIIAVKQLS 273
           ++ SD +  SF+  ++K  TNNFD         K+GEGGFG VYKG + + T +AVK+L+
Sbjct: 5   LEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLA 63

Query: 274 S----KSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFG 329
           +     + +  ++F  EI +++  QH NLV++ G   +GD L LVY YM N SL   L  
Sbjct: 64  AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 123

Query: 330 RENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL 389
            +     L W  R KI  G A G+ FLHE      +HRDIK+ N+LLD     KISDFGL
Sbjct: 124 LDGTPP-LSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGL 179

Query: 390 AKL-DEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAP 448
           A+  ++  +T +++RI GT  YMAPE  L G +T K+D+YSFG+V LEI++G   +    
Sbjct: 180 ARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHR 238

Query: 449 ALEFDCTCLLDWACHLQQD-GKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPT 507
               +   LLD    ++ +   + + +D+++         E M  V+  C +   + RP 
Sbjct: 239 ----EPQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPD 293

Query: 508 MSEV 511
           + +V
Sbjct: 294 IKKV 297

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  260 bits (666), Expect = 2e-83
 Identities = 72/313 (23%), Positives = 118/313 (37%), Gaps = 28/313 (8%)

Query: 220 MKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQG 279
                   +    + +   +      +    G FG V+K QL     +AVK    + +Q 
Sbjct: 4   HHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS 62

Query: 280 NREFLNEIAMISCLQHPNLVKIHGCCVEGD----QLLLVYEYMENNSLACALFGRENCEL 335
             +   E+  +  ++H N+++  G    G      L L+  + E  SL+  L        
Sbjct: 63  -WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---- 117

Query: 336 ELDWPTRQKICLGIARGLAFLHEE-------SRFKIVHRDIKATNVLLDRDLNPKISDFG 388
            + W     I   +ARGLA+LHE+        +  I HRDIK+ NVLL  +L   I+DFG
Sbjct: 118 -VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176

Query: 389 LAKLDEGDKTHI-STRIAGTIGYMAPEYA-----LWGYLTYKADVYSFGIVALEIVSGKN 442
           LA   E  K+   +    GT  YMAPE              + D+Y+ G+V  E+ S   
Sbjct: 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCT 236

Query: 443 NMSYAP---ALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAER-MIKVSLLCT 498
                     L F+       +    Q+  + +     L   ++K      + +    C 
Sbjct: 237 AADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECW 296

Query: 499 NASPSLRPTMSEV 511
           +     R +   V
Sbjct: 297 DHDAEARLSAGCV 309

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  227 bits (581), Expect = 1e-70
 Identities = 73/321 (22%), Positives = 121/321 (37%), Gaps = 49/321 (15%)

Query: 228 ISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNE- 286
           +     +     +N    + IG G +G VYKG L D   +AVK  S  +RQ    F+NE 
Sbjct: 1   MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEK 56

Query: 287 -IAMISCLQHPNLVKIHGCCVEGD-----QLLLVYEYMENNSLACALFGRENCELELDWP 340
            I  +  ++H N+ +              + LLV EY  N SL   L          DW 
Sbjct: 57  NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-----SDWV 111

Query: 341 TRQKICLGIARGLAFLHEE------SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL-- 392
           +  ++   + RGLA+LH E       +  I HRD+ + NVL+  D    ISDFGL+    
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171

Query: 393 -----DEGDKTHISTRIAGTIGYMAPEYA-------LWGYLTYKADVYSFGIVALEIVSG 440
                  G++ + +    GTI YMAPE                + D+Y+ G++  EI   
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231

Query: 441 KNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDE--------RLGSKYKKEEA--ERM 490
             ++    ++       + +   +       ++           +    +K+       +
Sbjct: 232 CTDLFPGESVP---EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSL 288

Query: 491 IKVSLLCTNASPSLRPTMSEV 511
            +    C +     R T    
Sbjct: 289 KETIEDCWDQDAEARLTAQXA 309

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  197 bits (502), Expect = 2e-59
 Identities = 72/285 (25%), Positives = 130/285 (45%), Gaps = 48/285 (16%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGN-------REFLNEIAMISCLQHPN 297
           K+IG+GGFG V+KG+ + D +++A+K L     +G        +EF  E+ ++S L HPN
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH 357
           +VK++G         +V E++    L   L  + +    + W  + ++ L IA G+ ++ 
Sbjct: 85  IVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALGIEYMQ 139

Query: 358 EESRFKIVHRDIKATNVLLD-----RDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMA 412
            ++   IVHRD+++ N+ L        +  K++DFGL++       H  + + G   +MA
Sbjct: 140 NQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWMA 194

Query: 413 PEYALWGYLTY--KADVYSFGIVALEIVSGK---NNMSYAPALEFDCTCLLDWACHLQQD 467
           PE       +Y  KAD YSF ++   I++G+   +  SY                   + 
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI----------------KF 238

Query: 468 GKLVELVDERLG-SKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
             ++     R    +        +I+   LC +  P  RP  S +
Sbjct: 239 INMIREEGLRPTIPEDCPPRLRNVIE---LCWSGDPKKRPHFSYI 280

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  197 bits (502), Expect = 3e-59
 Identities = 77/271 (28%), Positives = 128/271 (47%), Gaps = 35/271 (12%)

Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           + +G G FG V K +      +A+KQ+ S+S +  + F+ E+  +S + HPN+VK++G C
Sbjct: 14  EVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC 70

Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
           +  + + LV EY E  SL   L G E              CL  ++G+A+LH      ++
Sbjct: 71  L--NPVCLVMEYAEGGSLYNVLHGAEPLP-YYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127

Query: 366 HRDIKATNVLLDRDLN-PKISDFGLAKLDEGDKTHISTRIAGTIGYMAPE-YALWGYLTY 423
           HRD+K  N+LL       KI DFG A     D     T   G+  +MAPE +    Y + 
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEGSNY-SE 182

Query: 424 KADVYSFGIVALEIVSGK---NNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGS 480
           K DV+S+GI+  E+++ +   + +             + WA H      L++ + + +  
Sbjct: 183 KCDVFSWGIILWEVITRRKPFDEIGGPAF-------RIMWAVHNGTRPPLIKNLPKPI-- 233

Query: 481 KYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                  E ++     C +  PS RP+M E+
Sbjct: 234 -------ESLMT---RCWSKDPSQRPSMEEI 254

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  195 bits (497), Expect = 2e-58
 Identities = 67/204 (32%), Positives = 107/204 (52%), Gaps = 18/204 (8%)

Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGN--REFLNEIAMISCLQHPNLVKIHG 303
           +KIG G FG V++ +   G+ +AVK L  +        EFL E+A++  L+HPN+V   G
Sbjct: 43  EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101

Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFK 363
              +   L +V EY+   SL   L  +     +LD   R  +   +A+G+ +LH  +   
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-P 159

Query: 364 IVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPE------YAL 417
           IVHR++K+ N+L+D+    K+ DFGL++L +      S   AGT  +MAPE         
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRL-KASTFLSSKSAAGTPEWMAPEVLRDEPS-- 216

Query: 418 WGYLTYKADVYSFGIVALEIVSGK 441
                 K+DVYSFG++  E+ + +
Sbjct: 217 ----NEKSDVYSFGVILWELATLQ 236

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  192 bits (491), Expect = 1e-57
 Identities = 68/285 (23%), Positives = 114/285 (40%), Gaps = 46/285 (16%)

Query: 246 KKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
           + +G+G FG   K      G ++ +K+L     +  R FL E+ ++ CL+HPN++K  G 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
             +  +L  + EY++  +L   +   ++   +  W  R      IA G+A+LH      I
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLH---SMNI 129

Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH-------------ISTRIAGTIGYM 411
           +HRD+ + N L+  + N  ++DFGLA+L   +KT                  + G   +M
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189

Query: 412 APEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLV 471
           APE         K DV+SFGIV  EI+   N                        D  L 
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP--------------RTMDFGLN 235

Query: 472 ELVDERLGSKYKKEEA-----ERMIKVSLLCTNASPSLRPTMSEV 511
                                     +++ C +  P  RP+  ++
Sbjct: 236 VRGFLDR-------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKL 273

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  191 bits (488), Expect = 6e-57
 Identities = 71/291 (24%), Positives = 116/291 (39%), Gaps = 36/291 (12%)

Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNE--IAMISCLQHPNLVKIHG 303
           K+IG+G +G V+ G+   G  +AVK   +        +  E  I     ++H N++    
Sbjct: 43  KQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIA 98

Query: 304 CCVEGD----QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
             ++G     QL L+ +Y EN SL             LD  +  K+      GL  LH E
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSL-YDYLKSTT----LDAKSMLKLAYSSVSGLCHLHTE 153

Query: 360 SRF-----KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI---STRIAGTIGYM 411
                    I HRD+K+ N+L+ ++    I+D GLA     D   +        GT  YM
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213

Query: 412 APEYALWGYLTY-------KADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHL 464
            PE  L   L          AD+YSFG++  E+     +       +     L+      
Sbjct: 214 PPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272

Query: 465 QQDGKLVELVDER--LGSKYKKEEAERMIKVSLL--CTNASPSLRPTMSEV 511
           +   ++V +   R    +++  +E  R +   L+  C   +P+ R T   V
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMG-KLMTECWAHNPASRLTALRV 322

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  187 bits (478), Expect = 3e-56
 Identities = 64/278 (23%), Positives = 106/278 (38%), Gaps = 44/278 (15%)

Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGN--REFLNEIAMISCLQHPNLVKIHG 303
            K+ E   G ++KG+   G  I VK L  +       R+F  E   +    HPN++ + G
Sbjct: 16  TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 304 CCVE--GDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESR 361
            C         L+  +M   SL   L   E     +D     K  L +ARG+AFLH    
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVL--HEGTNFVVDQSQAVKFALDMARGMAFLHTLEP 132

Query: 362 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWG-- 419
             I    + + +V++D D+  +IS   +    +      S        ++APE AL    
Sbjct: 133 -LIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPE-ALQKKP 184

Query: 420 YLTY--KADVYSFGIVALEIVSGK---NNMSYAPALEFDCTCLLDWACHLQQDGKLVELV 474
             T    AD++SF ++  E+V+ +    ++S                    + G  V L 
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREVPFADLSNM------------------EIGMKVALE 226

Query: 475 DERLG-SKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
             R            +++K   +C N  P+ RP    +
Sbjct: 227 GLRPTIPPGISPHVSKLMK---ICMNEDPAKRPKFDMI 261

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  187 bits (478), Expect = 3e-56
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 21/208 (10%)

Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQL----SSKSRQGNREFLNEIAMISCLQHPNLVKI 301
           + IG GGFG VY+     G  +AVK           Q       E  + + L+HPN++ +
Sbjct: 13  EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 302 HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESR 361
            G C++   L LV E+     L   L G+      +         + IARG+ +LH+E+ 
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLSGKR-----IPPDILVNWAVQIARGMNYLHDEAI 126

Query: 362 FKIVHRDIKATNVLLDRDLNP--------KISDFGLAKLDEGDKTHISTRIAGTIGYMAP 413
             I+HRD+K++N+L+ + +          KI+DFGLA+             AG   +MAP
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGAYAWMAP 183

Query: 414 EYALWGYLTYKADVYSFGIVALEIVSGK 441
           E       +  +DV+S+G++  E+++G+
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGE 211

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  185 bits (472), Expect = 5e-55
 Identities = 68/289 (23%), Positives = 116/289 (40%), Gaps = 32/289 (11%)

Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNE--IAMISCLQHPNLVKIHG 303
           + +G+G +G V++G    G  +AVK  SS   +  + +  E  +     L+H N++    
Sbjct: 14  ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69

Query: 304 CCVEGD----QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
             +       QL L+  Y E  SL   L  +      LD  +  +I L IA GLA LH E
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL--QLT---TLDTVSCLRIVLSIASGLAHLHIE 124

Query: 360 SRF-----KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI---STRIAGTIGYM 411
                    I HRD+K+ N+L+ ++    I+D GLA +       +   +    GT  YM
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184

Query: 412 APE------YALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQ 465
           APE               + D+++FG+V  E+     +       +     ++      +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244

Query: 466 QDGKLVELVDERL---GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
              K+V +  +R       +       + K+   C   +PS R T   +
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  181 bits (461), Expect = 2e-53
 Identities = 65/202 (32%), Positives = 106/202 (52%), Gaps = 15/202 (7%)

Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGN--REFLNEIAMISCLQHPNLVKIHG 303
           ++IG G FG VYKG+   G + AVK L+  +      + F NE+ ++   +H N++   G
Sbjct: 30  QRIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFK 363
                 QL +V ++ E +SL   L   E    + +      I    ARG+ +LH +    
Sbjct: 88  YSTA-PQLAIVTQWCEGSSLYHHLHASET---KFEMKKLIDIARQTARGMDYLHAK---S 140

Query: 364 IVHRDIKATNVLLDRDLNPKISDFGLAKL-DEGDKTHISTRIAGTIGYMAPE---YALWG 419
           I+HRD+K+ N+ L  D   KI DFGLA        +H   +++G+I +MAPE        
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200

Query: 420 YLTYKADVYSFGIVALEIVSGK 441
             ++++DVY+FGIV  E+++G+
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQ 222

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  182 bits (464), Expect = 2e-53
 Identities = 76/290 (26%), Positives = 117/290 (40%), Gaps = 34/290 (11%)

Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNE--IAMISCLQHPNLVKIHG 303
           + IG+G FG V++G+   G  +AVK  SS   +  R +  E  I     L+H N++    
Sbjct: 48  ESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103

Query: 304 CCVEGD----QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
              + +    QL LV +Y E+ SL   L         +      K+ L  A GLA LH E
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHME 158

Query: 360 SRF-----KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI---STRIAGTIGYM 411
                    I HRD+K+ N+L+ ++    I+D GLA   +     I        GT  YM
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218

Query: 412 APEYALWGYLTY-------KADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHL 464
           APE  L   +         +AD+Y+ G+V  EI    +        +     L+     +
Sbjct: 219 APE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277

Query: 465 QQDGKLVELVDERL---GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           ++  K+V     R          E    M K+   C  A+ + R T   +
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 327

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  179 bits (455), Expect = 3e-52
 Identities = 55/284 (19%), Positives = 108/284 (38%), Gaps = 47/284 (16%)

Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGN--REFLNEIAMISCLQHPNLVKIHG 303
           + IG+G FG VY G+   G + A++ +  +    +  + F  E+      +H N+V   G
Sbjct: 39  ELIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFK 363
            C+    L ++    +  +L   +   +     LD    ++I   I +G+ +LH +    
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKI---VLDVNKTRQIAQEIVKGMGYLHAK---G 150

Query: 364 IVHRDIKATNVLLDRDLNPKISDFGLAKL----DEGDKTHISTRIAGTIGYMAPEYALWG 419
           I+H+D+K+ NV  D +    I+DFGL  +      G +        G + ++APE     
Sbjct: 151 ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209

Query: 420 YL---------TYKADVYSFGIVALEIVSGK---NNMSYAPALEFDCTCLLDWACHLQQD 467
                      +  +DV++ G +  E+ + +           +         W       
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII---------WQMG---T 257

Query: 468 GKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           G    L    +G +        ++     C       RPT +++
Sbjct: 258 GMKPNLSQIGMGKEIS-----DILL---FCWAFEQEERPTFTKL 293

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  164 bits (417), Expect = 4e-46
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 15/200 (7%)

Query: 246 KKIGEGGFGPVYKGQL-ADGTIIAVKQL-SSKSRQGNREFLNEIAMISCLQHPNLVKIHG 303
           ++IG G FG V+ G+L AD T++AVK    +       +FL E  ++    HPN+V++ G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179

Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFK 363
            C +   + +V E ++       L  R      L   T  ++    A G+ +L  +    
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFL--RTEGA-RLRVKTLLQMVGDAAAGMEYLESK---C 233

Query: 364 IVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT----IGYMAPEYALWG 419
            +HRD+ A N L+      KISDFG+++ +      +     G     + + APE   +G
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADG---VYAASGGLRQVPVKWTAPEALNYG 290

Query: 420 YLTYKADVYSFGIVALEIVS 439
             + ++DV+SFGI+  E  S
Sbjct: 291 RYSSESDVWSFGILLWETFS 310

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  159 bits (404), Expect = 3e-45
 Identities = 66/201 (32%), Positives = 101/201 (50%), Gaps = 11/201 (5%)

Query: 246 KKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
             +G+G +G VY G  L++   IA+K++  +  + ++    EIA+   L+H N+V+  G 
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87

Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
             E   + +  E +   SL+ AL   +   L+ +  T       I  GL +LH+    +I
Sbjct: 88  FSENGFIKIFMEQVPGGSLS-ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QI 143

Query: 365 VHRDIKATNVLLD-RDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPE---YALWGY 420
           VHRDIK  NVL++      KISDFG +K   G      T   GT+ YMAPE       GY
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGY 202

Query: 421 LTYKADVYSFGIVALEIVSGK 441
               AD++S G   +E+ +GK
Sbjct: 203 -GKAADIWSLGCTIIEMATGK 222

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  158 bits (401), Expect = 9e-45
 Identities = 70/285 (24%), Positives = 128/285 (44%), Gaps = 37/285 (12%)

Query: 246 KKIGEGGFGPVYKGQL-----ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
           +++G+G FG V   +        G ++AVK+L   + +  R+F  EI ++  LQH N+VK
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 301 IHGCCVEGDQ--LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
             G C    +  L L+ EY+   SL   L  +++ E  +D     +    I +G+ +L  
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKE-RIDHIKLLQYTSQICKGMEYL-- 130

Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT--IGYMAPEYA 416
            ++ + +HRD+   N+L++ +   KI DFGL K+   DK     +  G   I + APE  
Sbjct: 131 GTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189

Query: 417 LWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDE 476
                +  +DV+SFG+V  E+       +Y    +      +    + +Q   +V  + E
Sbjct: 190 TESKFSVASDVWSFGVVLYEL------FTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243

Query: 477 RLGSKYKKEEAERMIK----------VSLLCTNASPSLRPTMSEV 511
            L      +   R+ +          +   C N + + RP+  ++
Sbjct: 244 LL------KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 282

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  159 bits (403), Expect = 9e-45
 Identities = 70/285 (24%), Positives = 129/285 (45%), Gaps = 37/285 (12%)

Query: 246 KKIGEGGFGPVYKGQL-----ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
           +++G+G FG V   +        G ++AVK+L   + +  R+F  EI ++  LQH N+VK
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 301 IHGCCVEGDQ--LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
             G C    +  L L+ EY+   SL   L  +++ E  +D     +    I +G+ +L  
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKE-RIDHIKLLQYTSQICKGMEYL-- 161

Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT--IGYMAPEYA 416
            ++ + +HRD+   N+L++ +   KI DFGL K+   DK +   +  G   I + APE  
Sbjct: 162 GTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL 220

Query: 417 LWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDE 476
                +  +DV+SFG+V  E+       +Y    +      +    + +Q   +V  + E
Sbjct: 221 TESKFSVASDVWSFGVVLYEL------FTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274

Query: 477 RLGSKYKKEEAERMIK----------VSLLCTNASPSLRPTMSEV 511
            L      +   R+ +          +   C N + + RP+  ++
Sbjct: 275 LL------KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 313

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  157 bits (400), Expect = 4e-44
 Identities = 80/286 (27%), Positives = 124/286 (43%), Gaps = 40/286 (13%)

Query: 246 KKIGEGGFGPVYKGQL-----ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
            ++G+G FG V   +        G ++AVKQL        R+F  EI ++  L    +VK
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 301 IHGCCVEGDQ--LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
             G      +  L LV EY+ +  L   L  + +    LD          I +G+ +L  
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRA-RLDASRLLLYSSQICKGMEYL-G 144

Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT--IGYMAPEYA 416
             R   VHRD+ A N+L++ + + KI+DFGLAKL   DK +   R  G   I + APE  
Sbjct: 145 SRRC--VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 202

Query: 417 LWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD 475
                + ++DV+SFG+V  E+ +      S +P+ EF      +          L+EL+ 
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFTYCD--KSCSPSAEFLRMMGCERDVPALSR--LLELL- 257

Query: 476 ERLGSKYKKEEAERMIK----------VSLLCTNASPSLRPTMSEV 511
                    EE +R+            +  LC   SP  RP+ S +
Sbjct: 258 ---------EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 294

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  156 bits (396), Expect = 1e-43
 Identities = 61/201 (30%), Positives = 108/201 (53%), Gaps = 14/201 (6%)

Query: 246 KKIGEGGFGPVYKGQLADG-----TIIAVKQL-SSKSRQGNREFLNEIAMISCLQHPNLV 299
           K +G G FG VYKG            +A+K+L  + S + N+E L+E  +++ + +P++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
           ++ G C+    + L+ + M    L   +  RE+ +  +        C+ IA+G+ +L E+
Sbjct: 81  RLLGICLT-STVQLITQLMPFGCLLDYV--REHKD-NIGSQYLLNWCVQIAKGMNYL-ED 135

Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPEYALW 418
            R   VHRD+ A NVL+    + KI+DFGLAK L   +K + +      I +MA E  L 
Sbjct: 136 RRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193

Query: 419 GYLTYKADVYSFGIVALEIVS 439
              T+++DV+S+G+   E+++
Sbjct: 194 RIYTHQSDVWSYGVTVWELMT 214

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  154 bits (392), Expect = 2e-43
 Identities = 59/206 (28%), Positives = 89/206 (43%), Gaps = 21/206 (10%)

Query: 246 KKIGEGGFGPVYKG-QLADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQHPNLVKIH 302
            +IG G F  VYKG        +A  +      ++   + F  E  M+  LQHPN+V+ +
Sbjct: 32  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91

Query: 303 GCCV----EGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICLGIARGLAFL 356
                       ++LV E M + +L   L  F        +     +  C  I +GL FL
Sbjct: 92  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV------MKIKVLRSWCRQILKGLQFL 145

Query: 357 HEESRFKIVHRDIKATNVLLDRDL-NPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEY 415
           H  +   I+HRD+K  N+ +     + KI D GLA L           + GT  +MAPE 
Sbjct: 146 HTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEM 201

Query: 416 ALWGYLTYKADVYSFGIVALEIVSGK 441
               Y     DVY+FG+  LE+ + +
Sbjct: 202 YEEKY-DESVDVYAFGMCMLEMATSE 226

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  154 bits (391), Expect = 2e-43
 Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 17/199 (8%)

Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQL--SSKSRQGNREFLNEIAMISCLQHPNLVKIHG 303
           K++G G FG V  G+      +A+K +   S S     EF+ E  ++  L H  LV+++G
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYG 86

Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFK 363
            C +   + ++ EYM N  L   L  RE            ++C  +   + +L E  +F 
Sbjct: 87  VCTKQRPIFIITEYMANGCLLNYL--REM-RHRFQTQQLLEMCKDVCEAMEYL-ESKQF- 141

Query: 364 IVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT---IGYMAPEYALWGY 420
            +HRD+ A N L++     K+SDFGL++    D     T   G+   + +  PE  ++  
Sbjct: 142 -LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD---EYTSSVGSKFPVRWSPPEVLMYSK 197

Query: 421 LTYKADVYSFGIVALEIVS 439
            + K+D+++FG++  EI S
Sbjct: 198 FSSKSDIWAFGVLMWEIYS 216

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  155 bits (394), Expect = 2e-43
 Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 21/212 (9%)

Query: 246 KKIGEGGFGPVYKGQLADG------TIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
            ++GEG FG V+  +  +        ++AVK L   S    ++F  E  +++ LQH ++V
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 300 KIHGCCVEGDQLLLVYEYMENNSL-----------ACALFGRENCELELDWPTRQKICLG 348
           +  G C EG  LL+V+EYM +  L                G +     L       +   
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGT 407
           +A G+ +L        VHRD+   N L+ + L  KI DFG+++ +   D   +  R    
Sbjct: 167 VAAGMVYL--AGL-HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 223

Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
           I +M PE  L+   T ++DV+SFG+V  EI +
Sbjct: 224 IRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  154 bits (392), Expect = 2e-43
 Identities = 72/286 (25%), Positives = 120/286 (41%), Gaps = 39/286 (13%)

Query: 246 KKIGEGGFGPVYKGQLA-----DGTIIAVKQL-SSKSRQGNREFLNEIAMISCLQHPNLV 299
           + +GEG FG V   +        G  +AVK L          +   EI ++  L H N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 300 KIHGCCVE--GDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH 357
           K  G C E  G+ + L+ E++ + SL   L   +N   +++   + K  + I +G+ +L 
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN---KINLKQQLKYAVQICKGMDYL- 142

Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT--IGYMAPEY 415
             SR + VHRD+ A NVL++ +   KI DFGL K  E DK + + +      + + APE 
Sbjct: 143 -GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPEC 200

Query: 416 ALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD 475
            +       +DV+SFG+   E+      ++Y  +        L           +  LV 
Sbjct: 201 LMQSKFYIASDVWSFGVTLHEL------LTYCDSDSSPMALFLKMIGPTHGQMTVTRLV- 253

Query: 476 ERLGSKYKKEEAERMIK----------VSLLCTNASPSLRPTMSEV 511
             L      +E +R+            +   C    PS R +   +
Sbjct: 254 NTL------KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNL 293

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  153 bits (390), Expect = 4e-43
 Identities = 59/213 (27%), Positives = 105/213 (49%), Gaps = 22/213 (10%)

Query: 246 KKIGEGGFGPVYKGQLADG------TIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
           +++GEG FG V+  +  +        ++AVK L   +    ++F  E  +++ LQH ++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 300 KIHGCCVEGDQLLLVYEYMENNSL-----ACALFGRENCELELDWPTRQ-------KICL 347
           K +G C +GD L++V+EYM++  L     A         + +      +        I  
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAG 406
            IA G+ +L   S+   VHRD+   N L+  +L  KI DFG+++ +   D   +      
Sbjct: 141 QIASGMVYL--ASQ-HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197

Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
            I +M PE  ++   T ++DV+SFG++  EI +
Sbjct: 198 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  153 bits (388), Expect = 4e-43
 Identities = 59/198 (29%), Positives = 104/198 (52%), Gaps = 15/198 (7%)

Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQL--SSKSRQGNREFLNEIAMISCLQHPNLVKIHG 303
           ++IG G FG V+ G   +   +A+K +   + S +   +F+ E  ++  L HP LV+++G
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYG 70

Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFK 363
            C+E   + LV E+ME+  L+  L  R          T   +CL +  G+A+L EE+   
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYL--RTQ-RGLFAAETLLGMCLDVCEGMAYL-EEACV- 125

Query: 364 IVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD--KTHISTRIAGTIGYMAPEYALWGYL 421
            +HRD+ A N L+  +   K+SDFG+ +    D   +   T+    + + +PE   +   
Sbjct: 126 -IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP--VKWASPEVFSFSRY 182

Query: 422 TYKADVYSFGIVALEIVS 439
           + K+DV+SFG++  E+ S
Sbjct: 183 SSKSDVWSFGVLMWEVFS 200

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  158 bits (401), Expect = 6e-43
 Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 11/197 (5%)

Query: 246 KKIGEGGFGPVYKGQL-ADGTIIAVKQL--SSKSRQGNREFLNEIAMISCLQHPNLVKIH 302
            K+G G +G VY+G        +AVK L   +   +   EFL E A++  ++HPNLV++ 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 282

Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRF 362
           G C       ++ E+M   +L   L  RE    E+       +   I+  + +L  E + 
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYL--EKK- 337

Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLT 422
             +HR++ A N L+  +   K++DFGL++L  GD           I + APE   +   +
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 397

Query: 423 YKADVYSFGIVALEIVS 439
            K+DV++FG++  EI +
Sbjct: 398 IKSDVWAFGVLLWEIAT 414

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  153 bits (388), Expect = 6e-43
 Identities = 59/199 (29%), Positives = 101/199 (50%), Gaps = 15/199 (7%)

Query: 246 KKIGEGGFGPVYKGQLADGTI-IAVKQL--SSKSRQGNREFLNEIAMISCLQHPNLVKIH 302
            K+G G +G VY+G     ++ +AVK L   +   +   EFL E A++  ++HPNLV++ 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 75

Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRF 362
           G C       ++ E+M   +L   L  RE    E+       +   I+  + +L  E + 
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYL--EKK- 130

Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD--KTHISTRIAGTIGYMAPEYALWGY 420
             +HRD+ A N L+  +   K++DFGL++L  GD    H   +    I + APE   +  
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAYNK 188

Query: 421 LTYKADVYSFGIVALEIVS 439
            + K+DV++FG++  EI +
Sbjct: 189 FSIKSDVWAFGVLLWEIAT 207

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  154 bits (390), Expect = 6e-43
 Identities = 76/286 (26%), Positives = 116/286 (40%), Gaps = 41/286 (14%)

Query: 246 KKIGEGGFGPVYKGQL-----ADGTIIAVKQL-SSKSRQGNREFLNEIAMISCLQHPNLV 299
           + +GEG FG V            G ++AVK L +    Q    +  EI ++  L H +++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 300 KIHGCCVE--GDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH 357
           K  GCC +     L LV EY+   SL   L    +    +           I  G+A+L 
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRH---SIGLAQLLLFAQQICEGMAYL- 150

Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT--IGYMAPEY 415
             ++   +HRD+ A NVLLD D   KI DFGLAK       +   R  G   + + APE 
Sbjct: 151 -HAQ-HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 208

Query: 416 ALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD 475
                  Y +DV+SFG+   E+      +++  + +   T  L+     Q    ++ L  
Sbjct: 209 LKEYKFYYASDVWSFGVTLYEL------LTHCDSSQSPPTKFLELIGIAQGQMTVLRLT- 261

Query: 476 ERLGSKYKKEEAERMIK----------VSLLCTNASPSLRPTMSEV 511
           E L      E  ER+ +          +   C     S RPT   +
Sbjct: 262 ELL------ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENL 301

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  151 bits (385), Expect = 1e-42
 Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 17/199 (8%)

Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQL--SSKSRQGNREFLNEIAMISCLQHPNLVKIHG 303
           K++G G FG V  G+      +AVK +   S S     EF  E   +  L HP LVK +G
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKLSHPKLVKFYG 70

Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFK 363
            C +   + +V EY+ N  L   L  R +    L+     ++C  +  G+AFL E  +F 
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYL--RSH-GKGLEPSQLLEMCYDVCEGMAFL-ESHQF- 125

Query: 364 IVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT---IGYMAPEYALWGY 420
            +HRD+ A N L+DRDL  K+SDFG+ +    D+        GT   + + APE   +  
Sbjct: 126 -IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY---VSSVGTKFPVKWSAPEVFHYFK 181

Query: 421 LTYKADVYSFGIVALEIVS 439
            + K+DV++FGI+  E+ S
Sbjct: 182 YSSKSDVWAFGILMWEVFS 200

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  153 bits (389), Expect = 1e-42
 Identities = 59/257 (22%), Positives = 101/257 (39%), Gaps = 24/257 (9%)

Query: 194 SLIILVVSILGWRYYLRTKRHKETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGF 253
           SL  L  +       L+    +          + +     + +   +      ++G G F
Sbjct: 12  SLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSF 71

Query: 254 GPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLL 312
           G V++ +    G   AVK++  +  +     + E+   + L  P +V ++G   EG  + 
Sbjct: 72  GEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVN 126

Query: 313 LVYEYMENNSLACAL--FGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIK 370
           +  E +E  SL   +   G    E    +   Q        GL +LH     +I+H D+K
Sbjct: 127 IFMELLEGGSLGQLIKQMGCLP-EDRALYYLGQ-----ALEGLEYLHTR---RILHGDVK 177

Query: 371 ATNVLLDRDLNP-KISDFGLAKLDEGDKTHISTR----IAGTIGYMAPE-YALWGYLTYK 424
           A NVLL  D +   + DFG A   + D    S      I GT  +MAPE          K
Sbjct: 178 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC-DAK 236

Query: 425 ADVYSFGIVALEIVSGK 441
            D++S   + L +++G 
Sbjct: 237 VDIWSSCCMMLHMLNGC 253

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  151 bits (384), Expect = 2e-42
 Identities = 68/195 (34%), Positives = 97/195 (49%), Gaps = 13/195 (6%)

Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           + IG+G FG V  G    G  +AVK +  K+    + FL E ++++ L+H NLV++ G  
Sbjct: 27  QTIGKGEFGDVMLG-DYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 306 VEGD-QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
           VE    L +V EYM   SL   L  R      L      K  L +   + +L  E     
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYL--EGN-NF 138

Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYK 424
           VHRD+ A NVL+  D   K+SDFGL K  E   T  + ++   + + APE       + K
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTK 194

Query: 425 ADVYSFGIVALEIVS 439
           +DV+SFGI+  EI S
Sbjct: 195 SDVWSFGILLWEIYS 209

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  151 bits (384), Expect = 2e-42
 Identities = 71/199 (35%), Positives = 108/199 (54%), Gaps = 17/199 (8%)

Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQL--SSKSRQGNREFLNEIAMISCLQHPNLVKIHG 303
           +++G G FG V+ G     T +AVK L   S S      FL E  ++  LQH  LV+++ 
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRLYA 75

Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFK 363
              + + + ++ EYMEN SL   L  +    ++L       +   IA G+AF+ EE  + 
Sbjct: 76  VVTQ-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFI-EERNY- 130

Query: 364 IVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT---IGYMAPEYALWGY 420
            +HRD++A N+L+   L+ KI+DFGLA+L E +     T   G    I + APE   +G 
Sbjct: 131 -IHRDLRAANILVSDTLSCKIADFGLARLIEDN---EYTAREGAKFPIKWTAPEAINYGT 186

Query: 421 LTYKADVYSFGIVALEIVS 439
            T K+DV+SFGI+  EIV+
Sbjct: 187 FTIKSDVWSFGILLTEIVT 205

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  154 bits (390), Expect = 3e-42
 Identities = 61/201 (30%), Positives = 108/201 (53%), Gaps = 13/201 (6%)

Query: 246 KKIGEGGFGPVYKGQL----ADGTIIAVKQL-SSKSRQGNREFLNEIAMISCLQHPNLVK 300
           K +G G FG V  G+L         +A+K L    + +  R+FL E +++    HPN+++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
           + G   +   +++V EYMEN SL   L  R++ + +        +  GIA G+ +L  + 
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFL--RKH-DAQFTVIQLVGMLRGIASGMKYL-SDM 166

Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKL--DEGDKTHISTRIAGTIGYMAPEYALW 418
            +  VHRD+ A N+L++ +L  K+SDFGL ++  D+ +  + +      I + +PE   +
Sbjct: 167 GY--VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224

Query: 419 GYLTYKADVYSFGIVALEIVS 439
              T  +DV+S+GIV  E++S
Sbjct: 225 RKFTSASDVWSYGIVLWEVMS 245

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  155 bits (394), Expect = 3e-42
 Identities = 68/195 (34%), Positives = 97/195 (49%), Gaps = 13/195 (6%)

Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           + IG+G FG V  G    G  +AVK +  K+    + FL E ++++ L+H NLV++ G  
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 306 V-EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
           V E   L +V EYM   SL   L  R      L      K  L +   + +L  E     
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYL--EGN-NF 310

Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYK 424
           VHRD+ A NVL+  D   K+SDFGL K  E   T  + ++   + + APE       + K
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTK 366

Query: 425 ADVYSFGIVALEIVS 439
           +DV+SFGI+  EI S
Sbjct: 367 SDVWSFGILLWEIYS 381

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  152 bits (385), Expect = 5e-42
 Identities = 66/202 (32%), Positives = 106/202 (52%), Gaps = 14/202 (6%)

Query: 246 KKIGEGGFGPVYKGQLADGTI-----IAVKQL-SSKSRQGNREFLNEIAMISCLQHPNLV 299
           K IG G FG VYKG L   +      +A+K L +  + +   +FL E  ++    H N++
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109

Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
           ++ G   +   ++++ EYMEN +L   L  RE  + E        +  GIA G+ +L   
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFL--REK-DGEFSVLQLVGMLRGIAAGMKYL-AN 165

Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT--IGYMAPEYAL 417
             +  VHRD+ A N+L++ +L  K+SDFGL+++ E D     T   G   I + APE   
Sbjct: 166 MNY--VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223

Query: 418 WGYLTYKADVYSFGIVALEIVS 439
           +   T  +DV+SFGIV  E+++
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMT 245

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  150 bits (381), Expect = 5e-42
 Identities = 60/199 (30%), Positives = 98/199 (49%), Gaps = 13/199 (6%)

Query: 247 KIGEGGFGPVYKGQL--ADGTI-IAVKQL-SSKSRQGNREFLNEIAMISCLQHPNLVKIH 302
           ++G G FG V +G        I +A+K L     +    E + E  ++  L +P +V++ 
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRF 362
           G C + + L+LV E      L   L      E E+      ++   ++ G+ +L EE  F
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFL--VGKRE-EIPVSNVAELLHQVSMGMKYL-EEKNF 131

Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT--IGYMAPEYALWGY 420
             VHRD+ A NVLL      KISDFGL+K    D ++ + R AG   + + APE   +  
Sbjct: 132 --VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 189

Query: 421 LTYKADVYSFGIVALEIVS 439
            + ++DV+S+G+   E +S
Sbjct: 190 FSSRSDVWSYGVTMWEALS 208

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  151 bits (383), Expect = 7e-42
 Identities = 64/201 (31%), Positives = 106/201 (52%), Gaps = 13/201 (6%)

Query: 246 KKIGEGGFGPVYKGQL----ADGTIIAVKQL-SSKSRQGNREFLNEIAMISCLQHPNLVK 300
           K IG G  G V  G+L         +A+K L +  + +  R+FL+E +++    HPN+++
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
           + G    G   ++V EYMEN SL   L  R + + +        +  G+  G+ +L  + 
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFL--RTH-DGQFTIMQLVGMLRGVGAGMRYL-SDL 170

Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT--IGYMAPEYALW 418
            +  VHRD+ A NVL+D +L  K+SDFGL+++ E D     T   G   I + APE   +
Sbjct: 171 GY--VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228

Query: 419 GYLTYKADVYSFGIVALEIVS 439
              +  +DV+SFG+V  E+++
Sbjct: 229 RTFSSASDVWSFGVVMWEVLA 249

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  150 bits (381), Expect = 1e-41
 Identities = 72/282 (25%), Positives = 126/282 (44%), Gaps = 35/282 (12%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQL------SSKSRQGNREFLNEIAMISC 292
            NF   KKIG G F  VY+   L DG  +A+K++       +K+R    + + EI ++  
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARA---DCIKEIDLLKQ 88

Query: 293 LQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARG 352
           L HPN++K +   +E ++L +V E  +   L+  +   +  +  +   T  K  + +   
Sbjct: 89  LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148

Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMA 412
           L  +H     +++HRDIK  NV +      K+ D GL +      T   + + GT  YM+
Sbjct: 149 LEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMS 204

Query: 413 PEYALW---GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGK 469
           PE       GY  +K+D++S G +  E+ + +           D   L      L +  K
Sbjct: 205 PE--RIHENGY-NFKSDIWSLGCLLYEMAALQ------SPFYGDKMNLYS----LCK--K 249

Query: 470 LVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           + +     L S +  EE  +++    +C N  P  RP ++ V
Sbjct: 250 IEQCDYPPLPSDHYSEELRQLVN---MCINPDPEKRPDVTYV 288

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  150 bits (380), Expect = 1e-41
 Identities = 61/216 (28%), Positives = 101/216 (46%), Gaps = 27/216 (12%)

Query: 246 KKIGEGGFGPVYKGQLADG------TIIAVKQLSSK-SRQGNREFLNEIAMISCLQHPNL 298
           +++GE  FG VYKG L           +A+K L  K       EF +E  + + LQHPN+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 299 VKIHGCCVEGDQLLLVYEYMENNSL------------ACALFGRENCELELDWPTRQKIC 346
           V + G   +   L +++ Y  +  L              +       +  L+ P    + 
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 347 LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGD--KTHISTR 403
             IA G+ +L   S   +VH+D+   NVL+   LN KISD GL  ++   D  K   ++ 
Sbjct: 135 AQIAAGMEYL--SSH-HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191

Query: 404 IAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
           +   I +MAPE  ++G  +  +D++S+G+V  E+ S
Sbjct: 192 LP--IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  150 bits (382), Expect = 1e-41
 Identities = 61/201 (30%), Positives = 108/201 (53%), Gaps = 14/201 (6%)

Query: 246 KKIGEGGFGPVYKGQLADG-----TIIAVKQL-SSKSRQGNREFLNEIAMISCLQHPNLV 299
           K +G G FG VYKG            +A+K+L  + S + N+E L+E  +++ + +P++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
           ++ G C+    + L+ + M    L   +  RE+ +  +        C+ IA+G+ +L E+
Sbjct: 81  RLLGICLT-STVQLITQLMPFGCLLDYV--REHKD-NIGSQYLLNWCVQIAKGMNYL-ED 135

Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPEYALW 418
            R   VHRD+ A NVL+    + KI+DFGLAK L   +K + +      I +MA E  L 
Sbjct: 136 RRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193

Query: 419 GYLTYKADVYSFGIVALEIVS 439
              T+++DV+S+G+   E+++
Sbjct: 194 RIYTHQSDVWSYGVTVWELMT 214

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  150 bits (381), Expect = 1e-41
 Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 14/201 (6%)

Query: 246 KKIGEGGFGPVYKGQLADG-----TIIAVKQL-SSKSRQGNREFLNEIAMISCLQHPNLV 299
           K +G G FG V+KG            + +K +     RQ  +   + +  I  L H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
           ++ G C  G  L LV +Y+   SL   +  R++    L         + IA+G+ +L EE
Sbjct: 79  RLLGLC-PGSSLQLVTQYLPLGSLLDHV--RQHRG-ALGPQLLLNWGVQIAKGMYYL-EE 133

Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT-IGYMAPEYALW 418
                VHR++ A NVLL      +++DFG+A L   D   +    A T I +MA E   +
Sbjct: 134 HGM--VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 191

Query: 419 GYLTYKADVYSFGIVALEIVS 439
           G  T+++DV+S+G+   E+++
Sbjct: 192 GKYTHQSDVWSYGVTVWELMT 212

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  150 bits (381), Expect = 2e-41
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 17/208 (8%)

Query: 246 KKIGEGGFGPVYKGQLADG------TIIAVKQLSSKSRQGNR-EFLNEIAMISCLQHPNL 298
           +++G+G FG VY+G           T +A+K ++  +    R EFLNE +++      ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGR---ENCELELDWPTRQ---KICLGIARG 352
           V++ G   +G   L++ E M    L   L            L  P+     ++   IA G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHISTRIAGTIGYM 411
           +A+L   +  K VHRD+ A N ++  D   KI DFG+   + E D      +    + +M
Sbjct: 151 MAYL--NAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 207

Query: 412 APEYALWGYLTYKADVYSFGIVALEIVS 439
           +PE    G  T  +DV+SFG+V  EI +
Sbjct: 208 SPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  151 bits (382), Expect = 2e-41
 Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 23/212 (10%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQHP 296
             +   +KIGEG FG     +   DG    +K+  +S  S +   E   E+A+++ ++HP
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELE----LDWPTRQKICLGIARG 352
           N+V+      E   L +V +Y E   L   +  ++    +    LDW   Q     I   
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW-FVQ-----ICLA 137

Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMA 412
           L  +H+    KI+HRDIK+ N+ L +D   ++ DFG+A++           I GT  Y++
Sbjct: 138 LKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLS 193

Query: 413 PEYALW---GYLTYKADVYSFGIVALEIVSGK 441
           PE  +     Y   K+D+++ G V  E+ + K
Sbjct: 194 PE--ICENKPY-NNKSDIWALGCVLYELCTLK 222

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  153 bits (388), Expect = 2e-41
 Identities = 65/194 (33%), Positives = 103/194 (53%), Gaps = 7/194 (3%)

Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
            K+G+G FG V+ G     T +A+K L   +      FL E  ++  L+H  LV+++   
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
            E + + +V EYM   SL   L  +      L  P    +   IA G+A++ E   +  V
Sbjct: 249 SE-EPIYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYV-ERMNY--V 302

Query: 366 HRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKA 425
           HRD++A N+L+  +L  K++DFGLA+L E ++          I + APE AL+G  T K+
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362

Query: 426 DVYSFGIVALEIVS 439
           DV+SFGI+  E+ +
Sbjct: 363 DVWSFGILLTELTT 376

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  154 bits (391), Expect = 2e-41
 Identities = 66/196 (33%), Positives = 105/196 (53%), Gaps = 11/196 (5%)

Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQL--SSKSRQGNREFLNEIAMISCLQHPNLVKIHG 303
            K+G+G FG V+ G     T +A+K L   + S +    FL E  ++  L+H  LV+++ 
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLVQLYA 329

Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFK 363
              E + + +V EYM   SL   L  +      L  P    +   IA G+A++ E   + 
Sbjct: 330 VVSE-EPIYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYV-ERMNY- 384

Query: 364 IVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTY 423
            VHRD++A N+L+  +L  K++DFGLA+L E ++          I + APE AL+G  T 
Sbjct: 385 -VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 443

Query: 424 KADVYSFGIVALEIVS 439
           K+DV+SFGI+  E+ +
Sbjct: 444 KSDVWSFGILLTELTT 459

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  148 bits (376), Expect = 3e-41
 Identities = 64/201 (31%), Positives = 99/201 (49%), Gaps = 15/201 (7%)

Query: 246 KKIGEGGFGPVYKGQL---ADGTIIAVKQL--SSKSRQGNREFLNEIAMISCLQHPNLVK 300
           K++G G FG V KG          +AVK L   +       E L E  ++  L +P +V+
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82

Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
           + G C E +  +LV E  E   L   L  ++N  ++       ++   ++ G+ +L EES
Sbjct: 83  MIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD--KNIIELVHQVSMGMKYL-EES 136

Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT--IGYMAPEYALW 418
            F  VHRD+ A NVLL      KISDFGL+K    D+ +   +  G   + + APE   +
Sbjct: 137 NF--VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 194

Query: 419 GYLTYKADVYSFGIVALEIVS 439
              + K+DV+SFG++  E  S
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFS 215

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  148 bits (375), Expect = 1e-40
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 22/211 (10%)

Query: 246 KKIGEGGFGPVYKGQLADG---TIIAVKQL-SSKSRQGNREFLNEIA-MISCLQHPNLVK 300
             IGEG FG V K ++         A+K++    S+  +R+F  E+  +     HPN++ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 301 IHGCCVEGDQLLLVYEYMENNSL-----ACALFGRENCELELDWPTRQ-------KICLG 348
           + G C     L L  EY  + +L        +   +      +                 
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTI 408
           +ARG+ +L    + + +HRD+ A N+L+  +   KI+DFGL++  E        R+   +
Sbjct: 151 VARGMDYL--SQK-QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP--V 205

Query: 409 GYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
            +MA E   +   T  +DV+S+G++  EIVS
Sbjct: 206 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  151 bits (382), Expect = 1e-40
 Identities = 66/194 (34%), Positives = 101/194 (52%), Gaps = 7/194 (3%)

Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           KK+G G FG V+       T +AVK +   S      FL E  ++  LQH  LVK+H   
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIV 365
            + + + ++ E+M   SL   L  + +   +   P        IA G+AF+  E R   +
Sbjct: 253 TK-EPIYIITEFMAKGSLLDFL--KSDEGSKQPLPKLIDFSAQIAEGMAFI--EQR-NYI 306

Query: 366 HRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKA 425
           HRD++A N+L+   L  KI+DFGLA++ E ++          I + APE   +G  T K+
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 366

Query: 426 DVYSFGIVALEIVS 439
           DV+SFGI+ +EIV+
Sbjct: 367 DVWSFGILLMEIVT 380

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  153 bits (388), Expect = 1e-40
 Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 13/200 (6%)

Query: 246 KKIGEGGFGPVYKGQL--ADGTI-IAVKQL-SSKSRQGNREFLNEIAMISCLQHPNLVKI 301
            ++G G FG V +G        I +A+K L     +    E + E  ++  L +P +V++
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401

Query: 302 HGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESR 361
            G C + + L+LV E      L   L      E E+      ++   ++ G+ +L EE  
Sbjct: 402 IGVC-QAEALMLVMEMAGGGPLHKFL--VGKRE-EIPVSNVAELLHQVSMGMKYL-EEKN 456

Query: 362 FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT--IGYMAPEYALWG 419
           F  VHR++ A NVLL      KISDFGL+K    D ++ + R AG   + + APE   + 
Sbjct: 457 F--VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 514

Query: 420 YLTYKADVYSFGIVALEIVS 439
             + ++DV+S+G+   E +S
Sbjct: 515 KFSSRSDVWSYGVTMWEALS 534

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  147 bits (372), Expect = 2e-40
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 15/203 (7%)

Query: 246 KKIGEGGFGPVYKGQLADG----TIIAVKQL-SSKSRQGNREFLNEIAMISCLQHPNLVK 300
           + IG+G FG VY G+  D        A+K L      Q    FL E  ++  L HPN++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 301 IHGCCVEGD-QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
           + G  +  +    ++  YM +  L   +  R   +            L +ARG+ +L   
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSP-QRNPTVKDLISFGLQVARGMEYL--A 141

Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGT--IGYMAPEYA 416
            + K VHRD+ A N +LD     K++DFGLA+ + + +   +         + + A E  
Sbjct: 142 EQ-KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL 200

Query: 417 LWGYLTYKADVYSFGIVALEIVS 439
                T K+DV+SFG++  E+++
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLT 223

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  146 bits (371), Expect = 2e-40
 Identities = 65/224 (29%), Positives = 118/224 (52%), Gaps = 16/224 (7%)

Query: 223 SDLQTISFTLKQIKAATN---NFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQ 278
           SD + +   L+ I +  +    +   +KIG+G  G VY    +A G  +A++Q++ + + 
Sbjct: 1   SDEEILE-KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP 59

Query: 279 GNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELD 338
                +NEI ++   ++PN+V      + GD+L +V EY+   SL   +      E ++ 
Sbjct: 60  KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI- 118

Query: 339 WPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL-AKLDEGDK 397
                 +C    + L FLH     +++HRDIK+ N+LL  D + K++DFG  A++   ++
Sbjct: 119 ----AAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQ 170

Query: 398 THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           +  ST + GT  +MAPE         K D++S GI+A+E++ G+
Sbjct: 171 SKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  145 bits (369), Expect = 3e-40
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 28/211 (13%)

Query: 246 KKIGEGGFGPVYKGQL--------ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPN 297
           + +G+G F  ++KG             T + +K L    R  +  F    +M+S L H +
Sbjct: 14  ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH 357
           LV  +G CV GD+ +LV E+++  SL   L  ++N    ++   + ++   +A  + FL 
Sbjct: 74  LVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKN-CINILWKLEVAKQLAAAMHFL- 129

Query: 358 EESRFKIVHRDIKATNVLLDRDLNP--------KISDFGLAKLDEGDKTHISTRIAGTIG 409
           EE+    +H ++ A N+LL R+ +         K+SD G++            +    I 
Sbjct: 130 EENTL--IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD---ILQER--IP 182

Query: 410 YMAPEYALWG-YLTYKADVYSFGIVALEIVS 439
           ++ PE       L    D +SFG    EI S
Sbjct: 183 WVPPECIENPKNLNLATDKWSFGTTLWEICS 213

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  145 bits (369), Expect = 4e-40
 Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 15/203 (7%)

Query: 246 KKIGEGGFGPVYKGQLADG----TIIAVKQL-SSKSRQGNREFLNEIAMISCLQHPNLVK 300
           + IG G FG VY G L D        AVK L          +FL E  ++    HPN++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 301 IHGCCVEGD-QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
           + G C+  +   L+V  YM++  L   +  R                L +A+G+ +L   
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFI--RNE-THNPTVKDLIGFGLQVAKGMKYL-AS 146

Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGT--IGYMAPEYA 416
            +F  VHRD+ A N +LD     K++DFGLA+ + + +   +  +      + +MA E  
Sbjct: 147 KKF--VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204

Query: 417 LWGYLTYKADVYSFGIVALEIVS 439
                T K+DV+SFG++  E+++
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMT 227

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  145 bits (368), Expect = 4e-40
 Identities = 58/199 (29%), Positives = 94/199 (47%), Gaps = 12/199 (6%)

Query: 246 KKIGEGGFGPVYKGQLADG----TIIAVKQL-SSKSRQGNREFLNEIAMISCLQHPNLVK 300
           + IGEG FG V++G           +A+K   +  S     +FL E   +    HP++VK
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80

Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
           + G   E + + ++ E      L   L  +   +  LD  +       ++  LA+L E  
Sbjct: 81  LIGVITE-NPVWIIMELCTLGELRSFL--QVR-KYSLDLASLILYAYQLSTALAYL-ESK 135

Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGY 420
           RF  VHRDI A NVL+  +   K+ DFGL++  E    + +++    I +MAPE   +  
Sbjct: 136 RF--VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 193

Query: 421 LTYKADVYSFGIVALEIVS 439
            T  +DV+ FG+   EI+ 
Sbjct: 194 FTSASDVWMFGVCMWEILM 212

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  145 bits (369), Expect = 4e-40
 Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 16/203 (7%)

Query: 246 KKIGEGGFGPVYKGQL----ADGTIIAVKQL---SSKSRQGNREFLNEIAMISCLQHPNL 298
           +K+G+G FG V +G+          +AVK L        +   +F+ E+  +  L H NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83

Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
           ++++G  +    + +V E     SL   L  R++        T  +  + +A G+ +L E
Sbjct: 84  IRLYGVVLT-PPMKMVTELAPLGSLLDRL--RKHQG-HFLLGTLSRYAVQVAEGMGYL-E 138

Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT--IGYMAPEYA 416
             RF  +HRD+ A N+LL      KI DFGL +    +  H   +        + APE  
Sbjct: 139 SKRF--IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 196

Query: 417 LWGYLTYKADVYSFGIVALEIVS 439
                ++ +D + FG+   E+ +
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFT 219

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  145 bits (368), Expect = 4e-40
 Identities = 56/202 (27%), Positives = 91/202 (45%), Gaps = 18/202 (8%)

Query: 246 KKIGEGGFGPVYKGQL----ADGTIIAVKQL-SSKSRQGNREFLNEIAMISCLQHPNLVK 300
           + +GEG FG VY+G       +   +AVK      +     +F++E  ++  L HP++VK
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77

Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
           + G   E +   ++ E      L   L    N    L   T     L I + +A+L E  
Sbjct: 78  LIGII-EEEPTWIIMELYPYGELGHYL--ERNKN-SLKVLTLVLYSLQICKAMAYL-ESI 132

Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT---IGYMAPEYAL 417
               VHRDI   N+L+      K+ DFGL++  E +      + + T   I +M+PE   
Sbjct: 133 NC--VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY---YKASVTRLPIKWMSPESIN 187

Query: 418 WGYLTYKADVYSFGIVALEIVS 439
           +   T  +DV+ F +   EI+S
Sbjct: 188 FRRFTTASDVWMFAVCMWEILS 209

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  146 bits (370), Expect = 5e-40
 Identities = 59/221 (26%), Positives = 112/221 (50%), Gaps = 15/221 (6%)

Query: 226 QTISFTLKQIKAATN---NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNR 281
           +     L+ +    +     DS  KIGEG  G V   +    G  +AVK +  + +Q   
Sbjct: 28  EQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRE 87

Query: 282 EFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPT 341
              NE+ ++   QH N+V+++   + G++L ++ E+++  +L   +      ++ L+   
Sbjct: 88  LLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV-----SQVRLNEEQ 142

Query: 342 RQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL-AKLDEGDKTHI 400
              +C  + + LA+LH +    ++HRDIK+ ++LL  D   K+SDFG  A++ + D    
Sbjct: 143 IATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK-DVPKR 198

Query: 401 STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
            + + GT  +MAPE         + D++S GI+ +E+V G+
Sbjct: 199 KSLV-GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  145 bits (369), Expect = 7e-40
 Identities = 59/208 (28%), Positives = 86/208 (41%), Gaps = 17/208 (8%)

Query: 246 KKIGEGGFGPVYKGQLADG------TIIAVKQLSSK-SRQGNREFLNEIAMISCLQHPNL 298
           + +G G FG VY+GQ++          +AVK L    S Q   +FL E  +IS   H N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQ---KICLGIARGLAF 355
           V+  G  ++     ++ E M    L   L        +           +   IA G  +
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 356 LHEESRFKIVHRDIKATNVLLDR---DLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYM 411
           L  E     +HRDI A N LL         KI DFG+A+ +               + +M
Sbjct: 156 L--EEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212

Query: 412 APEYALWGYLTYKADVYSFGIVALEIVS 439
            PE  + G  T K D +SFG++  EI S
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  145 bits (368), Expect = 9e-40
 Identities = 58/210 (27%), Positives = 102/210 (48%), Gaps = 21/210 (10%)

Query: 246 KKIGEGGFGPVYKGQLADG----TIIAVKQL--SSKSRQGNREFLNEIAMISCLQHPNLV 299
           K +GEG FG V +G L         +AVK +   + S++   EFL+E A +    HPN++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 300 KIHGCCVEGD-----QLLLVYEYMENNSLACALFGRENCELELDWPTRQ--KICLGIARG 352
           ++ G C+E       + +++  +M+   L   L            P +   K  + IA G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGD--KTHISTRIAGTIG 409
           + +L   +R   +HRD+ A N +L  D+   ++DFGL+K +  GD  +     ++   + 
Sbjct: 160 MEYL--SNR-NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP--VK 214

Query: 410 YMAPEYALWGYLTYKADVYSFGIVALEIVS 439
           ++A E       T K+DV++FG+   EI +
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  144 bits (366), Expect = 1e-39
 Identities = 66/298 (22%), Positives = 122/298 (40%), Gaps = 51/298 (17%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNRE-FLNEIAMISCLQHPN 297
            +F+  + +G GGFG V++ +   D    A+K++   +R+  RE  + E+  ++ L+HP 
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 298 LVKIHGCCVEGDQ------------LLLVYEYMENNSLACALFGRENCELELDWPTRQKI 345
           +V+     +E +             L +  +     +L   + GR   E E +      I
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIE-ERERSVCLHI 123

Query: 346 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIA 405
            L IA  + FLH +    ++HRD+K +N+    D   K+ DFGL    + D+   +    
Sbjct: 124 FLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180

Query: 406 -----------GTIGYMAPE-YALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFD 453
                      GT  YM+PE      Y ++K D++S G++  E       + Y  + + +
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSY-SHKVDIFSLGLILFE-------LLYPFSTQME 232

Query: 454 CTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
               L           +  L    L ++    E   M++  +L  +  P  RP    +
Sbjct: 233 RVRTLT---------DVRNLKFPPLFTQKYPCEYV-MVQ-DMLSPS--PMERPEAINI 277

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  144 bits (366), Expect = 1e-39
 Identities = 54/230 (23%), Positives = 87/230 (37%), Gaps = 38/230 (16%)

Query: 239 TNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCL-Q 294
           T  F   +KIG G FG V+K     DG I A+K+           +  L E+   + L Q
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           H ++V+      E D +L+  EY    SLA A+               + + L + RGL 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNP-------------------KISDFGLAKLDEG 395
           ++H      +VH DIK +N+ + R   P                   KI D G       
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186

Query: 396 DKTHISTRIAGTIGYMAPEYALW----GYLTYKADVYSFGIVALEIVSGK 441
            +        G   ++A E  +      +L  KAD+++  +  +     +
Sbjct: 187 PQVEE-----GDSRFLANE--VLQENYTHL-PKADIFALALTVVCAAGAE 228

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  146 bits (371), Expect = 1e-39
 Identities = 59/208 (28%), Positives = 85/208 (40%), Gaps = 17/208 (8%)

Query: 246 KKIGEGGFGPVYKGQL------ADGTIIAVKQLSSK-SRQGNREFLNEIAMISCLQHPNL 298
           + +G G FG VY+GQ+           +AVK L    S Q   +FL E  +IS   H N+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQ---KICLGIARGLAF 355
           V+  G  ++     ++ E M    L   L        +           +   IA G  +
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 356 LHEESRFKIVHRDIKATNVLLDR---DLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYM 411
           L  E     +HRDI A N LL         KI DFG+A+ +               + +M
Sbjct: 197 L--EEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM 253

Query: 412 APEYALWGYLTYKADVYSFGIVALEIVS 439
            PE  + G  T K D +SFG++  EI S
Sbjct: 254 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  145 bits (367), Expect = 1e-39
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 22/211 (10%)

Query: 246 KKIGEGGFGPVYKGQLADG----TIIAVKQL--SSKSRQGNREFLNEIAMISCLQHPNLV 299
           + +G+G FG V + QL         +AVK L     +     EFL E A +    HP++ 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 300 KIHGCCVEGD------QLLLVYEYMENNSLACALFGR--ENCELELDWPTRQKICLGIAR 351
           K+ G  +           +++  +M++  L   L           L   T  +  + IA 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 352 GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGD--KTHISTRIAGTI 408
           G+ +L   SR   +HRD+ A N +L  D+   ++DFGL+ K+  GD  +   ++++   +
Sbjct: 149 GMEYL--SSR-NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLP--V 203

Query: 409 GYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
            ++A E       T  +DV++FG+   EI++
Sbjct: 204 KWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  145 bits (368), Expect = 2e-39
 Identities = 62/224 (27%), Positives = 100/224 (44%), Gaps = 35/224 (15%)

Query: 246 KKIGEGGFGPVYKGQLADG------TIIAVKQLSSK-SRQGNREFLNEIAMISCLQHPNL 298
           + IGEG FG V++ +          T++AVK L  + S     +F  E A+++   +PN+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 299 VKIHGCCVEGDQLLLVYEYMENNSL----------ACALFGRENCELELDWPTRQ----- 343
           VK+ G C  G  + L++EYM    L                  +        +       
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 344 -----KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGD- 396
                 I   +A G+A+L    R K VHRD+   N L+  ++  KI+DFGL+  +   D 
Sbjct: 173 CAEQLCIARQVAAGMAYL--SER-KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229

Query: 397 -KTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
            K   +  I   I +M PE   +   T ++DV+++G+V  EI S
Sbjct: 230 YKADGNDAIP--IRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  146 bits (369), Expect = 2e-39
 Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 15/203 (7%)

Query: 246 KKIGEGGFGPVYKGQLADG----TIIAVKQL-SSKSRQGNREFLNEIAMISCLQHPNLVK 300
           + IG G FG VY G L D        AVK L          +FL E  ++    HPN++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 301 IHGCCVEGD-QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
           + G C+  +   L+V  YM++  L   +  R                L +A+G+ FL   
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFI--RNE-THNPTVKDLIGFGLQVAKGMKFL-AS 210

Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGT--IGYMAPEYA 416
            +F  VHRD+ A N +LD     K++DFGLA+ + + +   +  +      + +MA E  
Sbjct: 211 KKF--VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268

Query: 417 LWGYLTYKADVYSFGIVALEIVS 439
                T K+DV+SFG++  E+++
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMT 291

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  144 bits (365), Expect = 2e-39
 Identities = 69/231 (29%), Positives = 111/231 (48%), Gaps = 14/231 (6%)

Query: 215 KETAFMKESDLQTISFTLKQIKAATN---NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVK 270
            ET  ++    + +   L +          FD  +K+GEG +G VYK      G I+A+K
Sbjct: 2   LETVQLRNPPRRQLK-KLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK 60

Query: 271 QLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGR 330
           Q+  +S    +E + EI+++     P++VK +G   +   L +V EY    S++  +  R
Sbjct: 61  QVPVESD--LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR 118

Query: 331 ENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 390
                 L       I     +GL +LH     + +HRDIKA N+LL+ + + K++DFG+A
Sbjct: 119 NKT---LTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVA 172

Query: 391 KLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
                     +T I GT  +MAPE          AD++S GI A+E+  GK
Sbjct: 173 GQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  142 bits (361), Expect = 4e-39
 Identities = 68/290 (23%), Positives = 122/290 (42%), Gaps = 53/290 (18%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNL 298
            +F   + IG GGFG V+K +   DG    +K++    +  N +   E+  ++ L H N+
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNI 66

Query: 299 VKIHGCCVEGD----------------QLLLVYEYMENNSLACALFGRENCELELDWPTR 342
           V  +GC    D                 L +  E+ +  +L   +  R   +L+      
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV--LA 124

Query: 343 QKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIST 402
            ++   I +G+ ++H +   K+++RD+K +N+ L      KI DFGL    + D     T
Sbjct: 125 LELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--T 179

Query: 403 RIAGTIGYMAPE-YALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWA 461
           R  GT+ YM+PE  +   Y   + D+Y+ G++  E++   +      A E          
Sbjct: 180 RSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCD-----TAFE---------- 223

Query: 462 CHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                     +L D  +   + K+E   +++  LL     P  RP  SE+
Sbjct: 224 ----TSKFFTDLRDGIISDIFDKKEKT-LLQ-KLLSKK--PEDRPNTSEI 265

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  143 bits (362), Expect = 5e-39
 Identities = 69/302 (22%), Positives = 125/302 (41%), Gaps = 54/302 (17%)

Query: 239 TNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPN 297
            ++F+    +G+G FG V K +   D    A+K++   + +     L+E+ +++ L H  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQY 63

Query: 298 LVKIHGCCVEGDQ-------------LLLVYEYMENNSLACALFGRENCELELDWPTRQK 344
           +V+ +   +E                L +  EY EN +L   L   EN   + D     +
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLY-DLIHSENLNQQRD--EYWR 120

Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL------------ 392
           +   I   L+++H +    I+HRD+K  N+ +D   N KI DFGLAK             
Sbjct: 121 LFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177

Query: 393 --DEGDKTHISTRIAGTIGYMAPE-YALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPA 449
               G   ++++ I GT  Y+A E     G+   K D+YS GI+  E       M Y   
Sbjct: 178 QNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE-------MIYPF- 228

Query: 450 LEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMS 509
                   +    ++ +  + V +         K +  +++I+  L+  +  P+ RP   
Sbjct: 229 --STGMERV----NILKKLRSVSIEFPPDFDDNKMKVEKKIIR-LLIDHD--PNKRPGAR 279

Query: 510 EV 511
            +
Sbjct: 280 TL 281

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  143 bits (362), Expect = 5e-39
 Identities = 59/211 (27%), Positives = 107/211 (50%), Gaps = 23/211 (10%)

Query: 242 FDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
           ++   ++G+G FG VYK +    G + A K + +KS +   +++ EI +++   HP +VK
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
           + G      +L ++ E+    ++   +      +  L  P  Q +C  +   L FLH + 
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIM---LELDRGLTEPQIQVVCRQMLEALNFLHSK- 136

Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGL-AKLDEGD---KTHISTRIAGTIGYMAPEYA 416
             +I+HRD+KA NVL+  + + +++DFG+ AK  +      + I     GT  +MAPE  
Sbjct: 137 --RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPYWMAPEVV 189

Query: 417 LW------GYLTYKADVYSFGIVALEIVSGK 441
           +        Y  YKAD++S GI  +E+   +
Sbjct: 190 MCETMKDTPY-DYKADIWSLGITLIEMAQIE 219

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  143 bits (364), Expect = 5e-39
 Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 34/221 (15%)

Query: 246 KKIGEGGFGPVYKGQLAD--------GTIIAVKQLSSK-SRQGNREFLNEIAMISCL-QH 295
           K +GEG FG V   +              +AVK L    + +   + ++E+ M+  + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSL-----ACALFGRENCELELDWPTRQ------- 343
            N++ + G C +   L ++ EY    +L     A    G E        P  Q       
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 344 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR 403
                +ARG+ +L   S+ K +HRD+ A NVL+  +   KI+DFGLA+    D  +I   
Sbjct: 161 SCTYQLARGMEYL--ASQ-KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYY 213

Query: 404 IAGTIG-----YMAPEYALWGYLTYKADVYSFGIVALEIVS 439
              T G     +MAPE       T+++DV+SFG++  EI +
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  142 bits (361), Expect = 8e-39
 Identities = 68/224 (30%), Positives = 105/224 (46%), Gaps = 35/224 (15%)

Query: 246 KKIGEGGFGPVYKGQLADG------TIIAVKQL-SSKSRQGNREFLNEIAMISCLQHPNL 298
           K +GEG FG V K            T +AVK L  + S    R+ L+E  ++  + HP++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88

Query: 299 VKIHGCCVEGDQLLLVYEYMENNSL------------ACALFGRENCELELDWPTRQKIC 346
           +K++G C +   LLL+ EY +  SL                 G       LD P  + + 
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 347 LG--------IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGD- 396
           +G        I++G+ +L      K+VHRD+ A N+L+      KISDFGL+  + E D 
Sbjct: 149 MGDLISFAWQISQGMQYL--AEM-KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205

Query: 397 -KTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
                  RI   + +MA E       T ++DV+SFG++  EIV+
Sbjct: 206 YVKRSQGRIP--VKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  143 bits (363), Expect = 1e-38
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 34/221 (15%)

Query: 246 KKIGEGGFGPVYKGQLAD--------GTIIAVKQLSSK-SRQGNREFLNEIAMISCL-QH 295
           K +GEG FG V   +              +AVK L    + +   + ++E+ M+  + +H
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146

Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSL------------ACALFGRENCELELDWPTRQ 343
            N++ + G C +   L ++ EY    +L              +       E ++ +    
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 344 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR 403
                +ARG+ +L   S+ K +HRD+ A NVL+  +   KI+DFGLA+    D  +I   
Sbjct: 207 SCTYQLARGMEYL--ASQ-KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYY 259

Query: 404 IAGTIG-----YMAPEYALWGYLTYKADVYSFGIVALEIVS 439
              T G     +MAPE       T+++DV+SFG++  EI +
Sbjct: 260 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  148 bits (375), Expect = 1e-38
 Identities = 58/199 (29%), Positives = 94/199 (47%), Gaps = 12/199 (6%)

Query: 246 KKIGEGGFGPVYKGQLADG----TIIAVKQL-SSKSRQGNREFLNEIAMISCLQHPNLVK 300
           + IGEG FG V++G           +A+K   +  S     +FL E   +    HP++VK
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455

Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
           + G   E + + ++ E      L   L  +   +  LD  +       ++  LA+L E  
Sbjct: 456 LIGVITE-NPVWIIMELCTLGELRSFL--QVR-KFSLDLASLILYAYQLSTALAYL-ESK 510

Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGY 420
           RF  VHRDI A NVL+  +   K+ DFGL++  E    + +++    I +MAPE   +  
Sbjct: 511 RF--VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 568

Query: 421 LTYKADVYSFGIVALEIVS 439
            T  +DV+ FG+   EI+ 
Sbjct: 569 FTSASDVWMFGVCMWEILM 587

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  142 bits (359), Expect = 1e-38
 Identities = 58/207 (28%), Positives = 82/207 (39%), Gaps = 18/207 (8%)

Query: 241 NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNRE---FLNEIAMISCL-QH 295
           +F    ++G G +G V+K +   DG + AVK+ S    +G ++    L E+     + QH
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRARKLAEVGSHEKVGQH 116

Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           P  V++     EG  L L  E     SL       E     L               LA 
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCGP-SLQQHC---EAWGASLPEAQVWGYLRDTLLALAH 172

Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPE 414
           LH +    +VH D+K  N+ L      K+ DFGL   L          +  G   YMAPE
Sbjct: 173 LHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE--VQE-GDPRYMAPE 226

Query: 415 YALWGYLTYKADVYSFGIVALEIVSGK 441
                Y    ADV+S G+  LE+    
Sbjct: 227 LLQGSY-GTAADVFSLGLTILEVACNM 252

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  141 bits (358), Expect = 2e-38
 Identities = 61/295 (20%), Positives = 115/295 (38%), Gaps = 35/295 (11%)

Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMIS 291
             +     ++   +K+GEGGF  V   + L DG   A+K++    +Q   E   E  M  
Sbjct: 22  HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR 81

Query: 292 CLQHPNLVKIHGCCVE----GDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL 347
              HPN++++   C+       +  L+  + +  +L   +   ++    L       + L
Sbjct: 82  LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL 141

Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIA-- 405
           GI RGL  +H +      HRD+K TN+LL  +  P + D G               +   
Sbjct: 142 GICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQ 198

Query: 406 ------GTIGYMAPE-YALWGY--LTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTC 456
                  TI Y APE +++  +  +  + DV+S G V   ++ G+      P   +D   
Sbjct: 199 DWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE-----GP---YDMVF 250

Query: 457 LLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
               +  L    +L          ++      +++  S++  +  P  RP +  +
Sbjct: 251 QKGDSVALAVQNQL----SIPQSPRH-SSALWQLLN-SMMTVD--PHQRPHIPLL 297

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  141 bits (357), Expect = 3e-38
 Identities = 67/214 (31%), Positives = 107/214 (50%), Gaps = 16/214 (7%)

Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNREFL-NEIAMISCLQHPN 297
           ++++  + IG G    V           +A+K+++ +  Q + + L  EI  +S   HPN
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLA----CALFGRENCELELDWPTRQKICLGIARGL 353
           +V  +   V  D+L LV + +   S+       +   E+    LD  T   I   +  GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL-AKL-DEGDKTHISTR--IAGTIG 409
            +LH+      +HRD+KA N+LL  D + +I+DFG+ A L   GD T    R    GT  
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 410 YMAPE--YALWGYLTYKADVYSFGIVALEIVSGK 441
           +MAPE    + GY  +KAD++SFGI A+E+ +G 
Sbjct: 192 WMAPEVMEQVRGY-DFKADIWSFGITAIELATGA 224

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  141 bits (358), Expect = 3e-38
 Identities = 59/213 (27%), Positives = 88/213 (41%), Gaps = 22/213 (10%)

Query: 246 KKIGEGGFGPVYKGQLAD------GTIIAVKQL-SSKSRQGNREFLNEIAMISCL-QHPN 297
           K +G G FG V +              +AVK L S+         ++E+ ++S L QH N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSL----------ACALFGRENCELELDWPTRQKICL 347
           +V + G C  G  +L++ EY     L                                  
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHISTRIAG 406
            +A+G+AFL   S+   +HRD+ A NVLL      KI DFGLA  +       +      
Sbjct: 172 QVAQGMAFL--ASK-NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228

Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
            + +MAPE       T ++DV+S+GI+  EI S
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  142 bits (360), Expect = 4e-38
 Identities = 48/243 (19%), Positives = 91/243 (37%), Gaps = 24/243 (9%)

Query: 213 RHKETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEG--GFGPVYKGQ-LADGTIIAV 269
            H     M+    Q +S            ++    IG+G      V   +    G  + V
Sbjct: 2   AHHHHHHMENLYFQGMS----SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTV 57

Query: 270 KQ--LSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL 327
           ++  L + S +       E+ +     HPN+V      +  ++L +V  +M   S    +
Sbjct: 58  RRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI 117

Query: 328 FGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF 387
               +    ++      I  G+ + L ++H       VHR +KA+++L+  D    +S  
Sbjct: 118 --CTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGL 172

Query: 388 GLAK--LDEGDK----THISTRIAGTIGYMAPE---YALWGYLTYKADVYSFGIVALEIV 438
                 +  G +              + +++PE     L GY   K+D+YS GI A E+ 
Sbjct: 173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELA 231

Query: 439 SGK 441
           +G 
Sbjct: 232 NGH 234

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  139 bits (352), Expect = 2e-37
 Identities = 58/217 (26%), Positives = 91/217 (41%), Gaps = 26/217 (11%)

Query: 246 KKIGEGGFGPVYKGQLAD------GTIIAVKQLSSKSRQGNR-EFLNEIAMISCL-QHPN 297
           K +G G FG V +              +AVK L   +    R   ++E+ ++S L  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSL-----------ACALFGRENCELELDWPTRQK-- 344
           +V + G C  G   L++ EY     L            C+       E +      +   
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 345 -ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHIST 402
                +A+G+AFL   S+   +HRD+ A N+LL      KI DFGLA  +       +  
Sbjct: 149 SFSYQVAKGMAFL--ASK-NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205

Query: 403 RIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
                + +MAPE       T+++DV+S+GI   E+ S
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  139 bits (353), Expect = 2e-37
 Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 15/218 (6%)

Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQL-SSKSRQGNREFLNEIAMI 290
           +       +     +IG G +G V K      G I+AVK++ S+   +  ++ L ++ ++
Sbjct: 15  QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74

Query: 291 -SCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGI 349
                 P +V+ +G         +  E M  +      +     +  +      KI L  
Sbjct: 75  MRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLAT 134

Query: 350 ARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL-AKLDEGDKTHISTRIAGTI 408
            + L  L E    KI+HRDIK +N+LLDR  N K+ DFG+  +L     +   TR AG  
Sbjct: 135 VKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQL---VDSIAKTRDAGCR 189

Query: 409 GYMAPE-----YALWGYLTYKADVYSFGIVALEIVSGK 441
            YMAPE      +  GY   ++DV+S GI   E+ +G+
Sbjct: 190 PYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGR 226

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  140 bits (355), Expect = 2e-37
 Identities = 66/221 (29%), Positives = 100/221 (45%), Gaps = 34/221 (15%)

Query: 246 KKIGEGGFGPVYKGQLAD--------GTIIAVKQL-SSKSRQGNREFLNEIA-MISCLQH 295
           K +GEG FG V   +            T +AVK L S  + +   + ++E+  M    +H
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134

Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSL-----ACALFGRENCELELDWPTRQ------- 343
            N++ + G C +   L ++ EY    +L     A    G E        P  Q       
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 344 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR 403
                +ARG+ +L   S+ K +HRD+ A NVL+  D   KI+DFGLA+    D  HI   
Sbjct: 195 SCAYQVARGMEYL--ASK-KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 247

Query: 404 IAGTIG-----YMAPEYALWGYLTYKADVYSFGIVALEIVS 439
              T G     +MAPE       T+++DV+SFG++  EI +
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  137 bits (348), Expect = 2e-37
 Identities = 69/281 (24%), Positives = 123/281 (43%), Gaps = 30/281 (10%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQHP 296
            +++    IG G +G   K +  +DG I+  K+    S +    +  ++E+ ++  L+HP
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 297 NLVKIHGCCVE--GDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           N+V+ +   ++     L +V EY E   LA  +         LD     ++   +   L 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 355 FLHE--ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMA 412
             H   +    ++HRD+K  NV LD   N K+ DFGLA++   D +   T + GT  YM+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMS 184

Query: 413 PEYALWGYLTY--KADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKL 470
           PE      ++Y  K+D++S G +  E+ +        P   F      +    L    K+
Sbjct: 185 PE--QMNRMSYNEKSDIWSLGCLLYELCALM------PP--FTAFSQKE----LAG--KI 228

Query: 471 VELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
            E    R+  +Y  +E   +I   +L        RP++ E+
Sbjct: 229 REGKFRRIPYRY-SDELNEIIT-RMLNLK--DYHRPSVEEI 265

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  138 bits (349), Expect = 3e-37
 Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 11/202 (5%)

Query: 242 FDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNRE-FLNEIAMISCLQHPNLV 299
           F   +KIG+G FG V+KG       ++A+K +  +  +   E    EI ++S    P + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
           K +G  ++  +L ++ EY+   S    L      E ++       I   I +GL +LH E
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQI-----ATILREILKGLDYLHSE 138

Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWG 419
              K +HRDIKA NVLL      K++DFG+A      +   +T + GT  +MAPE     
Sbjct: 139 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQS 194

Query: 420 YLTYKADVYSFGIVALEIVSGK 441
               KAD++S GI A+E+  G+
Sbjct: 195 AYDSKADIWSLGITAIELARGE 216

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  138 bits (350), Expect = 3e-37
 Identities = 58/220 (26%), Positives = 93/220 (42%), Gaps = 33/220 (15%)

Query: 246 KKIGEGGFGPVYKGQLAD------GTIIAVKQL-SSKSRQGNREFLNEIA-MISCLQHPN 297
           K +G G FG V +              +AVK L    +   +R  ++E+  +I    H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 298 LVKIHGCCVEGDQ-LLLVYEYMENNSLACALFGRENCELELDWPTRQ------------K 344
           +V + G C +    L+++ E+ +  +L+  L  + N  +                     
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI 404
               +A+G+ FL   SR K +HRD+ A N+LL      KI DFGLA+    D       +
Sbjct: 153 YSFQVAKGMEFL--ASR-KCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYV 205

Query: 405 AGTIG-----YMAPEYALWGYLTYKADVYSFGIVALEIVS 439
                     +MAPE       T ++DV+SFG++  EI S
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  137 bits (348), Expect = 1e-36
 Identities = 61/226 (26%), Positives = 90/226 (39%), Gaps = 39/226 (17%)

Query: 246 KKIGEGGFGPVYKGQLADG------TIIAVKQL-SSKSRQGNREFLNEIAMISCL-QHPN 297
           K +G G FG V                +AVK L            ++E+ M++ L  H N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSL-----------ACALFGRENCELELDWPTRQKIC 346
           +V + G C     + L++EY     L           +      EN +   +      + 
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170

Query: 347 LG--------IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT 398
                     +A+G+ FL  E +   VHRD+ A NVL+      KI DFGLA+    D  
Sbjct: 171 FEDLLCFAYQVAKGMEFL--EFK-SCVHRDLAARNVLVTHGKVVKICDFGLAR----DIM 223

Query: 399 HISTRIAGTIG-----YMAPEYALWGYLTYKADVYSFGIVALEIVS 439
             S  +          +MAPE    G  T K+DV+S+GI+  EI S
Sbjct: 224 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  137 bits (346), Expect = 2e-36
 Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 25/210 (11%)

Query: 242 FDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREF---LNEIAMISCLQHPN 297
           F   ++IG G FG VY  + + +  ++A+K++S   +Q N ++   + E+  +  L+HPN
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH 357
            ++  GC +      LV EY    S +  L   E  +  L       +  G  +GLA+LH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLG-SASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLH 171

Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR--IAGTIGYMAPEY 415
                 ++HRD+KA N+LL      K+ DFG A       + ++      GT  +MAPE 
Sbjct: 172 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSA-------SIMAPANSFVGTPYWMAPEV 221

Query: 416 ALW----GYLTYKADVYSFGIVALEIVSGK 441
            L      Y   K DV+S GI  +E+   K
Sbjct: 222 ILAMDEGQY-DGKVDVWSLGITCIELAERK 250

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  137 bits (346), Expect = 2e-36
 Identities = 50/231 (21%), Positives = 108/231 (46%), Gaps = 17/231 (7%)

Query: 215 KETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLS 273
            E    +     T    + ++K   ++F+   ++G G  G V+K      G ++A K + 
Sbjct: 10  DEQQRKRLEAFLTQKQKVGELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH 67

Query: 274 SKSRQG-NREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGREN 332
            + +     + + E+ ++     P +V  +G      ++ +  E+M+  SL   +  +  
Sbjct: 68  LEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAG 126

Query: 333 CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK- 391
              E       K+ + + +GL +L E+   KI+HRD+K +N+L++     K+ DFG++  
Sbjct: 127 RIPE---QILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 181

Query: 392 -LDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
            +D    + +     GT  YM+PE     + + ++D++S G+  +E+  G+
Sbjct: 182 LIDSMANSFV-----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  135 bits (342), Expect = 2e-36
 Identities = 51/210 (24%), Positives = 95/210 (45%), Gaps = 14/210 (6%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQL-SSKSRQGNREFLNEIAMI-SCLQHP 296
           ++ +   ++G G +G V K + +  G I+AVK++ ++ + Q  +  L ++ +    +  P
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFL 356
             V  +G       + +  E M + SL        +    +      KI + I + L  L
Sbjct: 67  FTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125

Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPE-- 414
           H +    ++HRD+K +NVL++     K+ DFG++              AG   YMAPE  
Sbjct: 126 HSK--LSVIHRDVKPSNVLINALGQVKMCDFGISG--YLVDDVAKDIDAGCKPYMAPERI 181

Query: 415 ---YALWGYLTYKADVYSFGIVALEIVSGK 441
                  GY + K+D++S GI  +E+   +
Sbjct: 182 NPELNQKGY-SVKSDIWSLGITMIELAILR 210

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  134 bits (339), Expect = 1e-35
 Identities = 61/233 (26%), Positives = 109/233 (46%), Gaps = 24/233 (10%)

Query: 220 MKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQL-SSKSR 277
            K++   TI    ++ +A  N+ ++  ++G G  G V+K +    G +IAVKQ+  S ++
Sbjct: 7   GKQTGYLTIG--GQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK 64

Query: 278 QGNREFLNEIA-MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLA--CALFGRENCE 334
           + N+  L ++  ++     P +V+  G  +    + +  E M   +      + G    E
Sbjct: 65  EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIP-E 123

Query: 335 LELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE 394
             L      K+ + I + L +L E+    ++HRD+K +N+LLD     K+ DFG++    
Sbjct: 124 RIL-----GKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISG--R 174

Query: 395 GDKTHISTRIAGTIGYMAPE------YALWGYLTYKADVYSFGIVALEIVSGK 441
                   R AG   YMAPE           Y   +ADV+S GI  +E+ +G+
Sbjct: 175 LVDDKAKDRSAGCAAYMAPERIDPPDPTKPDY-DIRADVWSLGISLVELATGQ 226

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  136 bits (343), Expect = 3e-35
 Identities = 64/282 (22%), Positives = 106/282 (37%), Gaps = 36/282 (12%)

Query: 241 NFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIA-MISCLQHPNLV 299
           +F     +G G  G +    + D   +AVK++  +          E+  +    +HPN++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD---REVQLLRESDEHPNVI 81

Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
           +      +     +  E     +L   +  ++   L L+      +      GLA LH  
Sbjct: 82  RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHLHSL 137

Query: 360 SRFKIVHRDIKATNVLL-----DRDLNPKISDFGLAKLDEGDKTHISTR--IAGTIGYMA 412
               IVHRD+K  N+L+        +   ISDFGL K     +   S R  + GT G++A
Sbjct: 138 ---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194

Query: 413 PEY---ALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGK 469
           PE          TY  D++S G V   ++S        P   F  +     A  L     
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISE----GSHP---FGKSLQRQ-ANILLGACS 246

Query: 470 LVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           L  L  E+         A  +I+  ++  +  P  RP+   V
Sbjct: 247 LDCLHPEKHED----VIARELIE-KMIAMD--PQKRPSAKHV 281

>2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174

 Score =  128 bits (324), Expect = 3e-35
 Identities = 30/169 (17%), Positives = 56/169 (33%), Gaps = 20/169 (11%)

Query: 9   GGGAATFHLQDDTNWG----FSSTGDFADDNDDQNTRYTATSDSSGLSELYINARIAPLS 64
           GG +         ++         G  +D         +   D      LY   R    S
Sbjct: 13  GGESHVD--VHGIHYRKDPLEGRVGRASDYGMKLPILRSNPEDQ----VLYQTERYNEDS 66

Query: 65  LTYFGYCLDNGNYTLSLHFAEIQFSNGITFHSLGRRLFDIYIQDNLVERNFDIKAEASGV 124
             Y     + G Y L L FAE+ F+         +++FD+ +  + V ++ DI     G 
Sbjct: 67  FGYDIPIKEEGEYVLVLKFAEVYFA------QSQQKVFDVRVNGHTVVKDLDIFDRV-GH 119

Query: 125 LKPVARSYNVTVTNHIIEIRFH---WAGKGTTALPKRGIYGPLVSAISL 170
                    +++    + ++     + GK +    K     P V A+ +
Sbjct: 120 STAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDNPKVCALFI 168

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  132 bits (333), Expect = 7e-35
 Identities = 63/319 (19%), Positives = 117/319 (36%), Gaps = 51/319 (15%)

Query: 214 HKETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQ-- 271
           H         DL T +   + +      +   K+IG GG   V++       I A+K   
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN 61

Query: 272 LSSKSRQGNREFLNEIAMISCLQHPNL--VKIHGCCVEGDQLLLVYEYMENNSLA--CAL 327
           L     Q    + NEIA ++ LQ  +   ++++   +    + +V E   N  L      
Sbjct: 62  LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK 120

Query: 328 FGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF 387
                    +D   R+     +   +  +H+     IVH D+K  N L+      K+ DF
Sbjct: 121 KKS------IDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDF 170

Query: 388 GLAK-LDEGDKTHISTRIAGTIGYMAPE-----------YALWGYLTYKADVYSFGIVAL 435
           G+A  +     + +     GT+ YM PE                 ++ K+DV+S G +  
Sbjct: 171 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 230

Query: 436 EIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKK---EEAERMIK 492
            +  GK      P           +   + Q  KL  ++D     ++     ++ + ++K
Sbjct: 231 YMTYGK-----TP-----------FQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLK 274

Query: 493 VSLLCTNASPSLRPTMSEV 511
              L  +  P  R ++ E+
Sbjct: 275 -CCLKRD--PKQRISIPEL 290

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  131 bits (332), Expect = 2e-34
 Identities = 59/287 (20%), Positives = 109/287 (37%), Gaps = 51/287 (17%)

Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQHPNL--VKI 301
           K+IG GG   V++       I A+K   L     Q    + NEIA ++ LQ  +   +++
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 302 HGCCVEGDQLLLVYEYMENNSLA--CALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
           +   +    + +V E   N  L               +D   R+     +   +  +H+ 
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS------IDPWERKSYWKNMLEAVHTIHQH 127

Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPE---- 414
               IVH D+K  N L+      K+ DFG+A  +     + +     GT+ YM PE    
Sbjct: 128 ---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183

Query: 415 -------YALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD 467
                        ++ K+DV+S G +   +  GK      P           +   + Q 
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK-----TP-----------FQQIINQI 227

Query: 468 GKLVELVDERLGSKYKK---EEAERMIKVSLLCTNASPSLRPTMSEV 511
            KL  ++D     ++     ++ + ++K   L  +  P  R ++ E+
Sbjct: 228 SKLHAIIDPNHEIEFPDIPEKDLQDVLK-CCLKRD--PKQRISIPEL 271

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  132 bits (334), Expect = 2e-34
 Identities = 50/214 (23%), Positives = 84/214 (39%), Gaps = 29/214 (13%)

Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQ--LSSKSRQGNREFLNEIAMISCLQHPNL--VKI 301
           K+IG GG   V++       I A+K   L     Q    + NEIA ++ LQ  +   +++
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 302 HGCCVEGDQLLLVYEYMENNSLA--CALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
           +   +    + +V E   N  L               +D   R+     +   +  +H+ 
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS------IDPWERKSYWKNMLEAVHTIHQH 174

Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR-IAGTIGYMAPE---- 414
               IVH D+K  N L+      K+ DFG+A   + D T +      G + YM PE    
Sbjct: 175 ---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230

Query: 415 -------YALWGYLTYKADVYSFGIVALEIVSGK 441
                        ++ K+DV+S G +   +  GK
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  130 bits (328), Expect = 4e-34
 Identities = 65/217 (29%), Positives = 98/217 (45%), Gaps = 28/217 (12%)

Query: 242 FDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMIS-CLQHPNLV 299
           F+  + +G G +G VYKG+ +  G + A+K +         E   EI M+     H N+ 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIA 84

Query: 300 KIHGC------CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
             +G           DQL LV E+    S+   +   +   L+ +W     IC  I RGL
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICREILRGL 142

Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR---IAGTIGY 410
           + LH+    K++HRDIK  NVLL  +   K+ DFG++            R     GT  +
Sbjct: 143 SHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS----AQLDRTVGRRNTFIGTPYW 195

Query: 411 MAPE------YALWGYLTYKADVYSFGIVALEIVSGK 441
           MAPE           Y  +K+D++S GI A+E+  G 
Sbjct: 196 MAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGA 231

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  121 bits (307), Expect = 2e-31
 Identities = 63/202 (31%), Positives = 90/202 (44%), Gaps = 15/202 (7%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFL----NEIAMISCLQHPNLVK 300
            K+G GG   VY  +       +A+K +     +   E L     E+   S L H N+V 
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKVAIKAIFI-PPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
           +     E D   LV EY+E  +L+  +         L   T       I  G+   H   
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAH--- 128

Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPEYALWG 419
             +IVHRDIK  N+L+D +   KI DFG+AK L E   T  +  + GT+ Y +PE A   
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQYFSPEQAKGE 187

Query: 420 YLTYKADVYSFGIVALEIVSGK 441
                 D+YS GIV  E++ G+
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGE 209

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  124 bits (313), Expect = 3e-31
 Identities = 69/307 (22%), Positives = 105/307 (34%), Gaps = 63/307 (20%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIA-MISCLQHPNL 298
           N   S K +G G  G V       G  +AVK++           L EI  +     HPN+
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML---IDFCDIALMEIKLLTESDDHPNV 71

Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGR-------ENCELELDWPTRQKICLGIAR 351
           ++ +        L +  E          L          +             +   IA 
Sbjct: 72  IRYYCSETTDRFLYIALELCN-----LNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126

Query: 352 GLAFLHEESRFKIVHRDIKATNVLLD-------------RDLNPKISDFGLAKLDEGDKT 398
           G+A LH     KI+HRD+K  N+L+               +L   ISDFGL K  +  ++
Sbjct: 127 GVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183

Query: 399 HISTR---IAGTIGYMAPE-------YALWGYLTYKADVYSFGIVALEIVSGKNNMSYAP 448
              T     +GT G+ APE             LT   D++S G V   I+S        P
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG----KHP 239

Query: 449 ALEFDCTCLLDWACHLQQD----GKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSL 504
              F          + ++     G       + L  +    EA  +I   ++  +  P  
Sbjct: 240 ---F-------GDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLIS-QMIDHD--PLK 286

Query: 505 RPTMSEV 511
           RPT  +V
Sbjct: 287 RPTAMKV 293

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  122 bits (309), Expect = 3e-31
 Identities = 62/327 (18%), Positives = 119/327 (36%), Gaps = 58/327 (17%)

Query: 223 SDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLA--DGTIIAVKQLSSKSRQGN 280
           S+L  ++  +K+     N++   + + +G F  +    L   D    A+K+      +  
Sbjct: 14  SNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKII---LCEKDNKFYALKKYEKSLLEKK 70

Query: 281 REFL-----------------NEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMEN--- 320
           R+F                  NE+ +I+ +++   +   G     D++ ++YEYMEN   
Sbjct: 71  RDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSI 130

Query: 321 -NSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD 379
                      +N    +     + I   +    +++H  +   I HRD+K +N+L+D++
Sbjct: 131 LKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKN 188

Query: 380 LNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTY---KADVYSFGIVALE 436
              K+SDFG ++     K   S    GT  +M PE       +Y   K D++S GI    
Sbjct: 189 GRVKLSDFGESEYMVDKKIKGS---RGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYV 244

Query: 437 IVSGKNNMSYAPALEFD------------CTCLLDWACHLQQDGKLVELVDERLGSKYKK 484
           +          P   F              T  +++          +        + +  
Sbjct: 245 MFYN-----VVP---FSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLS 296

Query: 485 EEAERMIKVSLLCTNASPSLRPTMSEV 511
            E    +K   L  N  P+ R T  + 
Sbjct: 297 NEDIDFLK-LFLRKN--PAERITSEDA 320

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  122 bits (308), Expect = 5e-31
 Identities = 34/228 (14%), Positives = 69/228 (30%), Gaps = 22/228 (9%)

Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKGQ------LADGTIIAVKQLSSKSRQGNREFLNE 286
            + +  +        +GEG F  VY+          +     +K     +          
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117

Query: 287 IAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL-FGRENCELELDWPTRQKI 345
           +  +        +K +   +  +  +LV E     +L  A+   +   E  +        
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177

Query: 346 CLGIARGLAFLHEESRFKIVHRDIKATNVLL-----------DRDLNPKISDFGLAK-LD 393
            + +   +  +H+    +I+H DIK  N +L           D      + D G +  + 
Sbjct: 178 AMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234

Query: 394 EGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
              K  I T    T G+   E        Y+ D +        ++ G 
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  121 bits (305), Expect = 6e-31
 Identities = 56/202 (27%), Positives = 84/202 (41%), Gaps = 15/202 (7%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFL----NEIAMISCLQHPNLVK 300
           + +G GG G VY+ +      I+A+K +S  +   +  F      E      LQ P++V 
Sbjct: 40  RLVGRGGMGDVYEAEDTVRERIVALKLMSE-TLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
           IH       QL +    +    LA  L  R    L         I   I   L   H   
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVA--IVRQIGSALDAAHAA- 153

Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPEYALWG 419
                HRD+K  N+L+  D    + DFG+A    +   T +   + GT+ YMAPE     
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPERFSES 210

Query: 420 YLTYKADVYSFGIVALEIVSGK 441
           + TY+AD+Y+   V  E ++G 
Sbjct: 211 HATYRADIYALTCVLYECLTGS 232

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  125 bits (315), Expect = 1e-30
 Identities = 78/301 (25%), Positives = 118/301 (39%), Gaps = 50/301 (16%)

Query: 241 NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFL-NEIAMISCLQHPNL 298
            ++  +++G GGFG V +      G  +A+KQ   +    NRE    EI ++  L HPN+
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 299 VKIH------GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARG 352
           V               D  LL  EY E   L   L   ENC   L     + +   I+  
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC-GLKEGPIRTLLSDISSA 133

Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNP---KISDFGLAK-LDEGDKTHISTRIAGTI 408
           L +LHE    +I+HRD+K  N++L         KI D G AK LD+G+       + GT+
Sbjct: 134 LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT--EFV-GTL 187

Query: 409 GYMAPE-YALWGYLTYKADVYSFGIVALEIVSG-----------------KNNMSYAPAL 450
            Y+APE      Y T   D +SFG +A E ++G                 +   +    +
Sbjct: 188 QYLAPELLEQKKY-TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246

Query: 451 EFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSE 510
             D T  + ++  L     L         S     + ER ++  L         R T  +
Sbjct: 247 YDDLTGAVKFSSVLPTPNHL---------SGILAGKLERWLQCML---MWHQRQRGTDPQ 294

Query: 511 V 511
            
Sbjct: 295 N 295

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  119 bits (301), Expect = 2e-30
 Identities = 49/216 (22%), Positives = 81/216 (37%), Gaps = 30/216 (13%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFL-NEIAMISCLQHPNLVKIHG 303
             +G+G    V++G+    G + A+K  ++ S     +    E  ++  L H N+VK+  
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74

Query: 304 C--CVEGDQLLLVYEYMENNSLACALFGRENC----ELELDWPTRQKICLGIARGLAFLH 357
                     +L+ E+    SL   L    N     E E     R      +  G+  L 
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD-----VVGGMNHLR 129

Query: 358 EESRFKIVHRDIKATNVLL----DRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAP 413
           E     IVHR+IK  N++     D     K++DFG A+    D     +   GT  Y+ P
Sbjct: 130 EN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDEQFVSLY-GTEEYLHP 184

Query: 414 E------YALWGYLTY--KADVYSFGIVALEIVSGK 441
           +              Y    D++S G+      +G 
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  119 bits (301), Expect = 7e-30
 Identities = 49/216 (22%), Positives = 81/216 (37%), Gaps = 30/216 (13%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFL-NEIAMISCLQHPNLVKIHG 303
             +G+G    V++G+    G + A+K  ++ S     +    E  ++  L H N+VK+  
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74

Query: 304 C--CVEGDQLLLVYEYMENNSLACALFGRENC----ELELDWPTRQKICLGIARGLAFLH 357
                     +L+ E+    SL   L    N     E E     R      +  G+  L 
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD-----VVGGMNHLR 129

Query: 358 EESRFKIVHRDIKATNVLL----DRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAP 413
           E     IVHR+IK  N++     D     K++DFG A+    D     +   GT  Y+ P
Sbjct: 130 EN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDEQFVSLY-GTEEYLHP 184

Query: 414 E------YALWGYLTY--KADVYSFGIVALEIVSGK 441
           +              Y    D++S G+      +G 
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  117 bits (295), Expect = 2e-29
 Identities = 68/289 (23%), Positives = 112/289 (38%), Gaps = 59/289 (20%)

Query: 241 NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLS----SKSRQGNREFLNEIAMISCLQH 295
            +   + +G+GGF   ++        + A K +      K  Q  +    EI++   L H
Sbjct: 42  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAH 100

Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
            ++V  HG   + D + +V E     SL      R+     L  P  +     I  G  +
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQY 156

Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEY 415
           LH     +++HRD+K  N+ L+ DL  KI DFGLA   E D       + GT  Y+APE 
Sbjct: 157 LHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEV 212

Query: 416 ALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD 475
                 +++ DV+S G +   ++ GK          F+                      
Sbjct: 213 LSKKGHSFEVDVWSIGCIMYTLLVGK--------PPFE---------------------T 243

Query: 476 ERLGSKYKK-------------EEAERMIKVSLLCTNASPSLRPTMSEV 511
             L   Y +               A  +I+  +L T+  P+ RPT++E+
Sbjct: 244 SCLKETYLRIKKNEYSIPKHINPVAASLIQ-KMLQTD--PTARPTINEL 289

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  116 bits (292), Expect = 2e-29
 Identities = 65/282 (23%), Positives = 115/282 (40%), Gaps = 45/282 (15%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLS----SKSRQGNREFLNEIAMISCLQ 294
            +F+  + +G+G FG VY  +      I+A+K L      K+   ++    E+ + S L+
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLR 67

Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HPN+++++G   +  ++ L+ EY    ++    +       + D          +A  L+
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALS 123

Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPE 414
           + H     +++HRDIK  N+LL      KI+DFG +      +      + GT+ Y+ PE
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D-LCGTLDYLPPE 177

Query: 415 YALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV 474
                    K D++S G++  E + G       P   F+                  E  
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVG-----KPP---FE-------------ANTYQETY 216

Query: 475 DERLGSKYK-----KEEAERMIKVSLLCTNASPSLRPTMSEV 511
                 ++       E A  +I   LL  N  PS RP + EV
Sbjct: 217 KRISRVEFTFPDFVTEGARDLIS-RLLKHN--PSQRPMLREV 255

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  117 bits (294), Expect = 2e-29
 Identities = 52/219 (23%), Positives = 82/219 (37%), Gaps = 25/219 (11%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEI-AMISCLQHPNLVKIHG 303
           + + EGGF  VY+ Q +  G   A+K+L S   + NR  + E+  M     HPN+V+   
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93

Query: 304 CCV-------EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFL 356
                      G    L+   +    L   L   E+    L   T  KI     R +  +
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP-LSCDTVLKIFYQTCRAVQHM 152

Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIA----------- 405
           H   +  I+HRD+K  N+LL      K+ DFG A        +  +              
Sbjct: 153 HR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211

Query: 406 GTIGYMAPE-YALWGYLTY--KADVYSFGIVALEIVSGK 441
            T  Y  PE   L+       K D+++ G +   +   +
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  116 bits (292), Expect = 2e-29
 Identities = 69/289 (23%), Positives = 113/289 (39%), Gaps = 59/289 (20%)

Query: 241 NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLS----SKSRQGNREFLNEIAMISCLQH 295
            +   + +G+GGF   ++        + A K +      K  Q  +    EI++   L H
Sbjct: 16  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAH 74

Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
            ++V  HG   + D + +V E     SL      R+     L  P  +     I  G  +
Sbjct: 75  QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQY 130

Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEY 415
           LH   R +++HRD+K  N+ L+ DL  KI DFGLA   E D       + GT  Y+APE 
Sbjct: 131 LH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEV 186

Query: 416 ALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD 475
                 +++ DV+S G +   ++ GK          F+                      
Sbjct: 187 LSKKGHSFEVDVWSIGCIMYTLLVGK--------PPFE---------------------T 217

Query: 476 ERLGSKYKK-------------EEAERMIKVSLLCTNASPSLRPTMSEV 511
             L   Y +               A  +I+  +L T+  P+ RPT++E+
Sbjct: 218 SCLKETYLRIKKNEYSIPKHINPVAASLIQ-KMLQTD--PTARPTINEL 263

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  114 bits (289), Expect = 5e-29
 Identities = 68/296 (22%), Positives = 120/296 (40%), Gaps = 58/296 (19%)

Query: 234 QIKAATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLS----SKSRQGNREFLNEIA 288
            I     +F     +G+G F  VY+ + +  G  +A+K +      K+    R   NE+ 
Sbjct: 5   CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVK 63

Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLG 348
           +   L+HP++++++    + + + LV E   N  +   L  R            +     
Sbjct: 64  IHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP---FSENEARHFMHQ 120

Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTI 408
           I  G+ +LH      I+HRD+  +N+LL R++N KI+DFGLA   +       T + GT 
Sbjct: 121 IITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTP 176

Query: 409 GYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDG 468
            Y++PE A       ++DV+S G +   ++ G+          FD               
Sbjct: 177 NYISPEIATRSAHGLESDVWSLGCMFYTLLIGR--------PPFD--------------- 213

Query: 469 KLVELVDERLGSKYKK-------------EEAERMIKVSLLCTNASPSLRPTMSEV 511
                  + + +   K              EA+ +I   LL  N  P+ R ++S V
Sbjct: 214 ------TDTVKNTLNKVVLADYEMPSFLSIEAKDLIH-QLLRRN--PADRLSLSSV 260

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  117 bits (296), Expect = 1e-28
 Identities = 74/314 (23%), Positives = 122/314 (38%), Gaps = 41/314 (13%)

Query: 209 LRTKRHKETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTII 267
             +   +   F  +       F   +    +  +   KK+G G +G V            
Sbjct: 6   HHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVER 65

Query: 268 AVKQLSSKSRQGNRE---FLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLA 324
           A+K +  K+          L E+A++  L HPN++K++    +     LV E  +   L 
Sbjct: 66  AIKIIR-KTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELF 124

Query: 325 CALFGREN-CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL---DRDL 380
             +  R    E++        I   +  G+ +LH+     IVHRD+K  N+LL   ++D 
Sbjct: 125 DEIIHRMKFNEVDA-----AVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDA 176

Query: 381 NPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             KI DFGL+ + E  K        GT  Y+APE  L      K DV+S G++   +++G
Sbjct: 177 LIKIVDFGLSAVFENQKKM--KERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAG 233

Query: 441 KNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKK---EEAERMIKVSLLC 497
                Y P   F            Q+  + VE       S   K   E A+ +IK  +L 
Sbjct: 234 -----YPP---F-------GGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIK-QMLQ 277

Query: 498 TNASPSLRPTMSEV 511
            +     R +  + 
Sbjct: 278 FD--SQRRISAQQA 289

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  118 bits (298), Expect = 1e-28
 Identities = 43/204 (21%), Positives = 77/204 (37%), Gaps = 26/204 (12%)

Query: 247 KIGEGGFGPVYKG--QLADGTIIAVKQLSSKSRQGNRE-FLNEIAMISCLQHPNLVKIHG 303
            I  GG G +Y    +  +G  + +K L        +   + E   ++ + HP++V+I  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 304 CCVEGDQLL-----LVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
                D+       +V EY+   SL  +   +      L         L I   L++LH 
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK------LPVAEAIAYLLEILPALSYLHS 200

Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPEYAL 417
                +V+ D+K  N++L  +   K+ D G    ++          + GT G+ APE   
Sbjct: 201 I---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPEIVR 250

Query: 418 WGYLTYKADVYSFGIVALEIVSGK 441
               T   D+Y+ G     +    
Sbjct: 251 -TGPTVATDIYTVGRTLAALTLDL 273

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  113 bits (285), Expect = 2e-28
 Identities = 63/302 (20%), Positives = 115/302 (38%), Gaps = 59/302 (19%)

Query: 227 TISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLS-SKSRQGNRE-- 282
           T    + + K   ++FD  + +G+G FG VY  +   +  I+A+K L  S+  +   E  
Sbjct: 1   TALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 60

Query: 283 FLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTR 342
              EI + S L+HPN+++++    +  ++ L+ E+     L    +         D    
Sbjct: 61  LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRS 116

Query: 343 QKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIST 402
                 +A  L + H     K++HRDIK  N+L+      KI+DFG +      +    T
Sbjct: 117 ATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR--T 171

Query: 403 RIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWAC 462
            + GT+ Y+ PE         K D++  G++  E + G       P   FD         
Sbjct: 172 -MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG-----MPP---FD--------- 213

Query: 463 HLQQDGKLVELVDERLGSKYKK-------------EEAERMIKVSLLCTNASPSLRPTMS 509
                              +++             + ++ +I   LL  +  P  R  + 
Sbjct: 214 ------------SPSHTETHRRIVNVDLKFPPFLSDGSKDLIS-KLLRYH--PPQRLPLK 258

Query: 510 EV 511
            V
Sbjct: 259 GV 260

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  114 bits (287), Expect = 2e-28
 Identities = 52/208 (25%), Positives = 93/208 (44%), Gaps = 21/208 (10%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFL----NEIAMISCLQHPNLVK 300
           + +G GG   V+  + L D   +AVK L +     +  F      E    + L HP +V 
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRA-DLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 301 IH--GCCVEGDQLLLVY---EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           ++  G   E     L Y   EY++  +L   +         +      ++     + L F
Sbjct: 77  VYDTGE-AETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNF 131

Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHIST-RIAGTIGYMAP 413
            H   +  I+HRD+K  N+++      K+ DFG+A+ + +   +   T  + GT  Y++P
Sbjct: 132 SH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

Query: 414 EYALWGYLTYKADVYSFGIVALEIVSGK 441
           E A    +  ++DVYS G V  E+++G+
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGE 216

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  116 bits (292), Expect = 4e-28
 Identities = 63/226 (27%), Positives = 98/226 (43%), Gaps = 31/226 (13%)

Query: 229 SFTLKQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNRE----F 283
            F        ++ +   + +G+G FG V        G   AVK +S K +   +      
Sbjct: 15  MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS-KRQVKQKTDKESL 73

Query: 284 LNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACA---LFGR---ENCELEL 337
           L E+ ++  L HPN++K++    +     LV E             LF          E+
Sbjct: 74  LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEV-------YTGGELFDEIISRKRFSEV 126

Query: 338 DWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDE 394
           D     +I   +  G+ ++H+    KIVHRD+K  N+LL    +D N +I DFGL+   E
Sbjct: 127 D---AARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180

Query: 395 GDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG 440
             K        GT  Y+APE  L G    K DV+S G++   ++SG
Sbjct: 181 ASKKM--KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  114 bits (287), Expect = 5e-28
 Identities = 59/207 (28%), Positives = 101/207 (48%), Gaps = 31/207 (14%)

Query: 241 NFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
                + +G G FG V+K  + A G  +A K + ++  +   E  NEI++++ L H NL+
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149

Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACA---LFGR---ENCEL-ELD--WPTRQKICLGIA 350
           +++      + ++LV EY            LF R   E+  L ELD     +Q     I 
Sbjct: 150 QLYDAFESKNDIVLVMEY-------VDGGELFDRIIDESYNLTELDTILFMKQ-----IC 197

Query: 351 RGLAFLHEESRFKIVHRDIKATNVLL-DRDLNP-KISDFGLAK-LDEGDKTHISTRIAGT 407
            G+  +H+     I+H D+K  N+L  +RD    KI DFGLA+     +K        GT
Sbjct: 198 EGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL---KVNFGT 251

Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVA 434
             ++APE   + ++++  D++S G++A
Sbjct: 252 PEFLAPEVVNYDFVSFPTDMWSVGVIA 278

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  114 bits (287), Expect = 6e-28
 Identities = 32/234 (13%), Positives = 65/234 (27%), Gaps = 41/234 (17%)

Query: 246 KKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNREF--------------------- 283
             +G+       +      G    V       R  +                        
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 284 ----LNEIAMISCLQHPNLVKIHGCCVEGD-----QLLLVYEYMENN--SLACALFGREN 332
               L  I     ++ P   K+    ++           +Y  M++N  +    L    +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 333 CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL 392
               L    R ++ L + R LA LH    + +VH  ++  +++LD+     ++ F     
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260

Query: 393 DEGDKTHISTRIAGTIGYMAPEYALW-----GYLTYKADVYSFGIVALEIVSGK 441
           D         R        A     +       +T+  D ++ G+    I    
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  112 bits (281), Expect = 2e-27
 Identities = 30/301 (9%), Positives = 66/301 (21%), Gaps = 53/301 (17%)

Query: 246 KKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNRE---FLNEIAMISCLQHPNLVKI 301
           + +  G    V+    +      A+K  +  +     E           + L   +  + 
Sbjct: 68  EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127

Query: 302 HGCC--------------------------VEGDQLLLVYEYMENN--SLACALFGRENC 333
                                               LL+      +   L   L      
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187

Query: 334 ELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD 393
             +        +   + R  A L  +    +VH      N+ +  D    + D       
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALW-K 243

Query: 394 EGDKTHISTRIAGTIGYMAPEYALWGYLTY--KADVYSFGIVALEIVSGKNNMSYAPALE 451
            G +       +  + Y   E+      T+    + +  G+    +        + P   
Sbjct: 244 VGTRGPA---SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL-----FLP--- 292

Query: 452 FDC-TCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSE 510
           F   T  +  +                       +  + +I    L  +     R    E
Sbjct: 293 FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG-RFLNFD--RRRRLLPLE 349

Query: 511 V 511
            
Sbjct: 350 A 350

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  110 bits (276), Expect = 3e-27
 Identities = 57/196 (29%), Positives = 90/196 (45%), Gaps = 17/196 (8%)

Query: 246 KKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNRE-FLNEIAMISCLQHPNLVKIHG 303
           +K+G G FG V+   + + G    +K ++    Q   E    EI ++  L HPN++KI  
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87

Query: 304 CCVEGDQLLLVYEYMENNSL---ACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
              +   + +V E  E   L     +   R     E       ++   +   LA+ H + 
Sbjct: 88  VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGY---VAELMKQMMNALAYFHSQ- 143

Query: 361 RFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYAL 417
              +VH+D+K  N+L          KI DFGLA+L + D+    T  AGT  YMAPE   
Sbjct: 144 --HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAAGTALYMAPE-VF 198

Query: 418 WGYLTYKADVYSFGIV 433
              +T+K D++S G+V
Sbjct: 199 KRDVTFKCDIWSAGVV 214

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  113 bits (284), Expect = 3e-27
 Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 20/203 (9%)

Query: 246 KKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNRE---FLNEIAMISCLQHPNLVKI 301
             +G+G FG V K          AVK ++ K+   N++    L E+ ++  L HPN++K+
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVIN-KASAKNKDTSTILREVELLKKLDHPNIMKL 86

Query: 302 HGCCVEGDQLLLVYEYMENNSLACALFGREN-CELELDWPTRQKICLGIARGLAFLHEES 360
                +     +V E      L   +  R+   E +       +I   +  G+ ++H+  
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA-----ARIIKQVFSGITYMHKH- 140

Query: 361 RFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYAL 417
              IVHRD+K  N+LL   ++D + KI DFGL+   + +         GT  Y+APE  L
Sbjct: 141 --NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPE-VL 195

Query: 418 WGYLTYKADVYSFGIVALEIVSG 440
            G    K DV+S G++   ++SG
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSG 218

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  112 bits (280), Expect = 4e-27
 Identities = 32/240 (13%), Positives = 70/240 (29%), Gaps = 52/240 (21%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNRE---------------------- 282
             +G+       +      G    V       R  +                        
Sbjct: 79  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138

Query: 283 ------FLNEIAMISCLQHPNLVKIHGCC--VEGDQLLLVYEYMENN--SLACALFGREN 332
                 F+    ++   Q   ++++      +       +Y  M++N  +    L    +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 333 CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL 392
               L    R ++ L + R LA LH    + +VH  ++  +++LD+     ++ F     
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255

Query: 393 DEGDKTHISTRIAGTIGYMAPEYALW-----------GYLTYKADVYSFGIVALEIVSGK 441
           D           + + G+  PE                 +T+  D ++ G+V   I    
Sbjct: 256 DGARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  113 bits (285), Expect = 4e-27
 Identities = 62/247 (25%), Positives = 101/247 (40%), Gaps = 29/247 (11%)

Query: 212 KRHKETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVK 270
              +E  + +   +    +  K+      ++   +K+G G +G V    +    +  A+K
Sbjct: 8   SSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIK 67

Query: 271 QLS-------------SKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY 317
            +                  + + E  NEI+++  L HPN++K+     +     LV E+
Sbjct: 68  VIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEF 127

Query: 318 MENNSLACALFGREN-CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL 376
            E   L   +  R    E +        I   I  G+ +LH+     IVHRDIK  N+LL
Sbjct: 128 YEGGELFEQIINRHKFDECDA-----ANIMKQILSGICYLHKH---NIVHRDIKPENILL 179

Query: 377 ---DRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIV 433
              +  LN KI DFGL+     D         GT  Y+APE  L      K DV+S G++
Sbjct: 180 ENKNSLLNIKIVDFGLSSFFSKDYKL--RDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVI 236

Query: 434 ALEIVSG 440
              ++ G
Sbjct: 237 MYILLCG 243

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  109 bits (274), Expect = 1e-26
 Identities = 46/250 (18%), Positives = 90/250 (36%), Gaps = 35/250 (14%)

Query: 273 SSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGREN 332
              S         +I  +      N V           L +  +     +L   +  R  
Sbjct: 98  PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWM-NRRC 156

Query: 333 CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL 392
              + +      I + IA  + FLH +    ++HRD+K +N+    D   K+ DFGL   
Sbjct: 157 SLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTA 213

Query: 393 DEGD-----------KTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
            + D                T   GT  YM+PE       ++K D++S G++  E     
Sbjct: 214 MDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE----- 268

Query: 442 NNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNAS 501
             + Y+ + + +   ++           +  L    L ++   +E   M++  +L  +  
Sbjct: 269 --LLYSFSTQMERVRIIT---------DVRNLKFPLLFTQKYPQEHM-MVQ-DMLSPS-- 313

Query: 502 PSLRPTMSEV 511
           P+ RP  +++
Sbjct: 314 PTERPEATDI 323

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 56.8 bits (137), Expect = 6e-09
 Identities = 19/73 (26%), Positives = 39/73 (53%), Gaps = 2/73 (2%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNRE-FLNEIAMISCLQHPN 297
            +F+  + +G GGFG V++ +   D    A+K++   +R+  RE  + E+  ++ L+HP 
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 298 LVKIHGCCVEGDQ 310
           +V+     +E   
Sbjct: 66  IVRYFNAWLETPP 78

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  110 bits (276), Expect = 1e-26
 Identities = 52/209 (24%), Positives = 96/209 (45%), Gaps = 31/209 (14%)

Query: 239 TNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPN 297
            + +D  +++G G FG V++  + A G +   K +++          NEI++++ L HP 
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACA---LFGR---ENCEL-ELD--WPTRQKICLG 348
           L+ +H    +  +++L+ E+        +   LF R   E+ ++ E +     RQ     
Sbjct: 110 LINLHDAFEDKYEMVLILEF-------LSGGELFDRIAAEDYKMSEAEVINYMRQ----- 157

Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLL-DRDLNP-KISDFGLA-KLDEGDKTHISTRIA 405
              GL  +HE     IVH DIK  N++   +  +  KI DFGLA KL+  +         
Sbjct: 158 ACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV---KVTT 211

Query: 406 GTIGYMAPEYALWGYLTYKADVYSFGIVA 434
            T  + APE      + +  D+++ G++ 
Sbjct: 212 ATAEFAAPEIVDREPVGFYTDMWAIGVLG 240

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  109 bits (274), Expect = 1e-26
 Identities = 54/272 (19%), Positives = 92/272 (33%), Gaps = 56/272 (20%)

Query: 221 KESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVK-----QLSS 274
             S  + + F    +      +     IG+G +G V    +     I A+K     ++  
Sbjct: 7   HSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ 66

Query: 275 KSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSL----------- 323
            + +       E+ ++  L HPN+ +++    +   + LV E      L           
Sbjct: 67  INPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDS 126

Query: 324 --------------ACALFGRENCELELDWPTRQ-----------KICLGIARGLAFLHE 358
                          C     E     +                  I   I   L +LH 
Sbjct: 127 TGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN 186

Query: 359 ESRFKIVHRDIKATNVLL--DRDLNPKISDFGLAKL----DEGDKTHISTRIAGTIGYMA 412
                I HRDIK  N L   ++    K+ DFGL+K     + G+   ++T  AGT  ++A
Sbjct: 187 ---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT-KAGTPYFVA 242

Query: 413 PE---YALWGYLTYKADVYSFGIVALEIVSGK 441
           PE        Y   K D +S G++   ++ G 
Sbjct: 243 PEVLNTTNESY-GPKCDAWSAGVLLHLLLMGA 273

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  107 bits (270), Expect = 2e-26
 Identities = 55/201 (27%), Positives = 88/201 (43%), Gaps = 30/201 (14%)

Query: 246 KKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNRE---FLNEIAMISCLQHPNLVKI 301
             +G+G FG V K          AVK ++ K+   N++    L E+ ++  L HPN++K+
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVIN-KASAKNKDTSTILREVELLKKLDHPNIMKL 86

Query: 302 HGCCVEGDQLLLVYEYMENNSLACA---LFGR---ENCELELDWPTRQKICLGIARGLAF 355
                +     +V E             LF          E D     +I   +  G+ +
Sbjct: 87  FEILEDSSSFYIVGEL-------YTGGELFDEIIKRKRFSEHD---AARIIKQVFSGITY 136

Query: 356 LHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMA 412
           +H+     IVHRD+K  N+LL   ++D + KI DFGL+   + +         GT  Y+A
Sbjct: 137 MHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIA 191

Query: 413 PEYALWGYLTYKADVYSFGIV 433
           PE     Y   K DV+S G++
Sbjct: 192 PEVLRGTY-DEKCDVWSAGVI 211

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  108 bits (272), Expect = 2e-26
 Identities = 62/214 (28%), Positives = 105/214 (49%), Gaps = 21/214 (9%)

Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNRE------FLNEIAM 289
           +     +   +K+GEG +G VYK + + G I+A+K    + R    +       + EI++
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALK----RIRLDAEDEGIPSTAIREISL 72

Query: 290 ISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGI 349
           +  L HPN+V +         L LV+E+ME + L   L   +  +  L     +     +
Sbjct: 73  LKELHHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVL---DENKTGLQDSQIKIYLYQL 128

Query: 350 ARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIG 409
            RG+A  H+    +I+HRD+K  N+L++ D   K++DFGLA+   G      T    T+ 
Sbjct: 129 LRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARA-FGIPVRSYTHEVVTLW 184

Query: 410 YMAPEYALWGYLTYKA--DVYSFGIVALEIVSGK 441
           Y AP+  L G   Y    D++S G +  E+++GK
Sbjct: 185 YRAPD-VLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  107 bits (270), Expect = 3e-26
 Identities = 50/202 (24%), Positives = 84/202 (41%), Gaps = 34/202 (16%)

Query: 246 KKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNRE-FLNEIAMISCLQHPNLVKIHG 303
           + +G G F  V+   Q   G + A+K +  KS         NEIA++  ++H N+V +  
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIK-KSPAFRDSSLENEIAVLKKIKHENIVTLED 73

Query: 304 CCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQ---------KICLGIARGLA 354
                    LV + +          G    EL  D    +          +   +   + 
Sbjct: 74  IYESTTHYYLVMQLVS---------G---GEL-FDRILERGVYTEKDASLVIQQVLSAVK 120

Query: 355 FLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYM 411
           +LHE     IVHRD+K  N+L    + +    I+DFGL+K+++       +   GT GY+
Sbjct: 121 YLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---STACGTPGYV 174

Query: 412 APEYALWGYLTYKADVYSFGIV 433
           APE       +   D +S G++
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVI 196

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  106 bits (266), Expect = 6e-26
 Identities = 49/198 (24%), Positives = 79/198 (39%), Gaps = 26/198 (13%)

Query: 246 KKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
             IG G +G V    Q       A K++     +    F  EI ++  L HPN+++++  
Sbjct: 15  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74

Query: 305 CVEGDQLLLVYEYMENNSLACA---LFGR---ENCELELDWPTRQKICLGIARGLAFLHE 358
             +   + LV E        C    LF R   +    E D     +I   +   +A+ H+
Sbjct: 75  FEDNTDIYLVMEL-------CTGGELFERVVHKRVFRESD---AARIMKDVLSAVAYCHK 124

Query: 359 ESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEY 415
                + HRD+K  N L      D   K+ DFGLA   +  K        GT  Y++P+ 
Sbjct: 125 L---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPYYVSPQV 179

Query: 416 ALWGYLTYKADVYSFGIV 433
               Y   + D +S G++
Sbjct: 180 LEGLY-GPECDEWSAGVM 196

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  107 bits (269), Expect = 6e-26
 Identities = 54/206 (26%), Positives = 102/206 (49%), Gaps = 13/206 (6%)

Query: 240 NNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQG-NREFLNEIAMISCLQHPN 297
             +    K+GEG +  VYKG       ++A+K++  +  +G     + E++++  L+H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH 357
           +V +H        L LV+EY++ + L   L   ++C   ++    +     + RGLA+ H
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDKD-LKQYL---DDCGNIINMHNVKLFLFQLLRGLAYCH 117

Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYAL 417
            +   K++HRD+K  N+L++     K++DFGLA+  +   T        T+ Y  P+  L
Sbjct: 118 RQ---KVLHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYDNEVVTLWYRPPD-IL 172

Query: 418 WGYLTYKA--DVYSFGIVALEIVSGK 441
            G   Y    D++  G +  E+ +G+
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMATGR 198

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  109 bits (275), Expect = 1e-25
 Identities = 65/219 (29%), Positives = 93/219 (42%), Gaps = 22/219 (10%)

Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSK---SRQGNREFLNE-- 286
             I    N+F   + IG GGFG VY  + AD G + A+K L  K    +QG    LNE  
Sbjct: 182 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 241

Query: 287 -IAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKI 345
            ++++S    P +V +       D+L  + + M    L   L                + 
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DMRF 296

Query: 346 CLG-IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRI 404
               I  GL  +H      +V+RD+K  N+LLD   + +ISD GLA      K H     
Sbjct: 297 YAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--AS- 350

Query: 405 AGTIGYMAPEYAL--WGYLTYKADVYSFGIVALEIVSGK 441
            GT GYMAPE       Y    AD +S G +  +++ G 
Sbjct: 351 VGTHGYMAPEVLQKGVAY-DSSADWFSLGCMLFKLLRGH 388

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  109 bits (273), Expect = 2e-25
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 25/206 (12%)

Query: 239 TNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPN 297
            +++D  +++G G FG V++  + A G   A K + +           EI  +S L+HP 
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACALFGR---ENCEL-ELD--WPTRQKICLGIAR 351
           LV +H    + ++++++YE+M        LF +   E+ ++ E +     RQ     + +
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGE----LFEKVADEHNKMSEDEAVEYMRQ-----VCK 266

Query: 352 GLAFLHEESRFKIVHRDIKATNVLL-DRDLNP-KISDFGLA-KLDEGDKTHISTRIAGTI 408
           GL  +HE      VH D+K  N++   +  N  K+ DFGL   LD      +     GT 
Sbjct: 267 GLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTA 320

Query: 409 GYMAPEYALWGYLTYKADVYSFGIVA 434
            + APE A    + Y  D++S G+++
Sbjct: 321 EFAAPEVAEGKPVGYYTDMWSVGVLS 346

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  104 bits (263), Expect = 2e-25
 Identities = 65/210 (30%), Positives = 109/210 (51%), Gaps = 21/210 (10%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNRE------FLNEIAMISCL 293
             +   +KIGEG +G VYK Q   G   A+K    K R    +       + EI+++  L
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALK----KIRLEKEDEGIPSTTIREISILKEL 57

Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
           +H N+VK++       +L+LV+E+++ + L   L   + CE  L+  T +   L +  G+
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLL---DVCEGGLESVTAKSFLLQLLNGI 113

Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAP 413
           A+ H+    +++HRD+K  N+L++R+   KI+DFGLA+   G      T    T+ Y AP
Sbjct: 114 AYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARA-FGIPVRKYTHEIVTLWYRAP 169

Query: 414 EYALWGYLTYKA--DVYSFGIVALEIVSGK 441
           +  L G   Y    D++S G +  E+V+G 
Sbjct: 170 D-VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  104 bits (263), Expect = 3e-25
 Identities = 63/211 (29%), Positives = 113/211 (53%), Gaps = 12/211 (5%)

Query: 237 AATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQG-NREFLNEIAMISCLQ 294
           ++++ F   +K+G G +  VYKG     G  +A+K++   S +G     + EI+++  L+
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61

Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICLGIARG 352
           H N+V+++      ++L LV+E+M+N+ L   +      N    L+    +     + +G
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDND-LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120

Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMA 412
           LAF HE    KI+HRD+K  N+L+++    K+ DFGLA+   G   +  +    T+ Y A
Sbjct: 121 LAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARA-FGIPVNTFSSEVVTLWYRA 176

Query: 413 PEYALWGYLTYKA--DVYSFGIVALEIVSGK 441
           P+  L G  TY    D++S G +  E+++GK
Sbjct: 177 PD-VLMGSRTYSTSIDIWSCGCILAEMITGK 206

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  105 bits (264), Expect = 3e-25
 Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 17/215 (7%)

Query: 235 IKAATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLN-----EIA 288
           +K+    ++    +GEG F  VYK +      I+A+K++    R   ++ +N     EI 
Sbjct: 5   VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64

Query: 289 MISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLG 348
           ++  L HPN++ +         + LV+++ME + L   +   ++  L L     +   L 
Sbjct: 65  LLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVII---KDNSLVLTPSHIKAYMLM 120

Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTI 408
             +GL +LH    + I+HRD+K  N+LLD +   K++DFGLAK   G      T    T 
Sbjct: 121 TLQGLEYLH--QHW-ILHRDLKPNNLLLDENGVLKLADFGLAKS-FGSPNRAYTHQVVTR 176

Query: 409 GYMAPEYALWGYLTYKA--DVYSFGIVALEIVSGK 441
            Y APE  L+G   Y    D+++ G +  E++   
Sbjct: 177 WYRAPE-LLFGARMYGVGVDMWAVGCILAELLLRV 210

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  104 bits (262), Expect = 4e-25
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 30/215 (13%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNRE------FLNEIAMISC 292
             ++   KIGEG +G V+K +    G I+A+K    K  +   +       L EI M+  
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK----KFLESEDDPVIKKIALREIRMLKQ 58

Query: 293 LQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARG 352
           L+HPNLV +        +L LV+EY ++  +   L   +  +  +     + I     + 
Sbjct: 59  LKHPNLVNLLEVFRRKRRLHLVFEYCDHT-VLHEL---DRYQRGVPEHLVKSITWQTLQA 114

Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL--DEGDK-TH-ISTRIAGTI 408
           + F H+      +HRD+K  N+L+ +    K+ DFG A+L     D     ++TR     
Sbjct: 115 VNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR----- 166

Query: 409 GYMAPEYALWGYLTYKA--DVYSFGIVALEIVSGK 441
            Y +PE  L G   Y    DV++ G V  E++SG 
Sbjct: 167 WYRSPE-LLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  104 bits (262), Expect = 6e-25
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 24/212 (11%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNRE------FLNEIAMISC 292
             +++   +GEG +G V K +    G I+A+K    K  + + +       + EI ++  
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK----KFLESDDDKMVKKIAMREIKLLKQ 80

Query: 293 LQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARG 352
           L+H NLV +   C +  +  LV+E++++  +   L   E     LD+   QK    I  G
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFVDHT-ILDDL---ELFPNGLDYQVVQKYLFQIING 136

Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMA 412
           + F H      I+HRDIK  N+L+ +    K+ DFG A+        +      T  Y A
Sbjct: 137 IGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFART-LAAPGEVYDDEVATRWYRA 192

Query: 413 PEYALWGYLTYKA--DVYSFG-IVALEIVSGK 441
           PE  L G + Y    DV++ G +V  E+  G+
Sbjct: 193 PE-LLVGDVKYGKAVDVWAIGCLVT-EMFMGE 222

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  104 bits (262), Expect = 8e-25
 Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 25/218 (11%)

Query: 239 TNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPN 297
            + F   +  G+G FG V  G+    G  +A+K++    R  NRE L  +  ++ L HPN
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPN 80

Query: 298 LVKIHGC-CVEGDQ------LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           +V++       G++      L +V EY+ +  L          ++       +     + 
Sbjct: 81  IVQLQSYFYTLGERDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLI 139

Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDR---DLNPKISDFGLAK-LDEGDK-TH-ISTRI 404
           R +  LH  S   + HRDIK  NVL++     L  K+ DFG AK L   +     I +R 
Sbjct: 140 RSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTL--KLCDFGSAKKLSPSEPNVAYICSRY 196

Query: 405 AGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
                Y APE      + T   D++S G +  E++ G+
Sbjct: 197 -----YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  102 bits (258), Expect = 9e-25
 Identities = 55/209 (26%), Positives = 103/209 (49%), Gaps = 22/209 (10%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNRE------FLNEIAMISC 292
             ++  +KIGEG +G V+K +      I+A+K    + R  + +       L EI ++  
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALK----RVRLDDDDEGVPSSALREICLLKE 57

Query: 293 LQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARG 352
           L+H N+V++H       +L LV+E+ + + L       ++C  +LD    +     + +G
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFCDQD-LKKYF---DSCNGDLDPEIVKSFLFQLLKG 113

Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMA 412
           L F H      ++HRD+K  N+L++R+   K+++FGLA+   G      +    T+ Y  
Sbjct: 114 LGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARA-FGIPVRCYSAEVVTLWYRP 169

Query: 413 PEYALWGYLTYKA--DVYSFGIVALEIVS 439
           P+  L+G   Y    D++S G +  E+ +
Sbjct: 170 PD-VLFGAKLYSTSIDMWSAGCIFAELAN 197

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  104 bits (261), Expect = 1e-24
 Identities = 45/197 (22%), Positives = 77/197 (39%), Gaps = 13/197 (6%)

Query: 246 KKIGEGGFGPVYKG-QLADGT-----IIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
           + IG+G F  V +      G      I+ V + +S       +   E ++   L+HP++V
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89

Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
           ++         L +V+E+M+   L   +  R +                I   L + H+ 
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149

Query: 360 SRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYA 416
               I+HRD+K   VLL   +     K+  FG+A            R+ GT  +MAPE  
Sbjct: 150 ---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEVV 205

Query: 417 LWGYLTYKADVYSFGIV 433
                    DV+  G++
Sbjct: 206 KREPYGKPVDVWGCGVI 222

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  103 bits (260), Expect = 1e-24
 Identities = 60/230 (26%), Positives = 98/230 (42%), Gaps = 37/230 (16%)

Query: 220 MKESDLQTISFTLKQIKAA-TNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSR 277
           M+   + +I   L +     T+ ++  + IG G +    +    A     AVK +    R
Sbjct: 1   MQTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR 60

Query: 278 QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELEL 337
               E   EI ++   QHPN++ +     +G  + +V E M+         G    EL L
Sbjct: 61  DPTEE--IEI-LLRYGQHPNIITLKDVYDDGKYVYVVTELMKG--------G----EL-L 104

Query: 338 DWPTRQK---------ICLGIARGLAFLHEESRFKIVHRDIKATNVLL-DRDLNP---KI 384
           D   RQK         +   I + + +LH +    +VHRD+K +N+L  D   NP   +I
Sbjct: 105 DKILRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRI 161

Query: 385 SDFGLAKLDEGDKTHISTRIAGTIGYMAPE-YALWGYLTYKADVYSFGIV 433
            DFG AK    +   + T    T  ++APE     GY     D++S G++
Sbjct: 162 CDFGFAKQLRAENGLLMT-PCYTANFVAPEVLERQGY-DAACDIWSLGVL 209

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  106 bits (266), Expect = 1e-24
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 8/214 (3%)

Query: 232 LKQIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSK---SRQGNREFLNEI 287
           L+      + F   + +G GGFG V+  Q+   G + A K+L+ K    R+G +  + E 
Sbjct: 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236

Query: 288 AMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL 347
            +++ +    +V +         L LV   M    +   ++  +        P       
Sbjct: 237 KILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA 296

Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
            I  GL  LH+     I++RD+K  NVLLD D N +ISD GLA   +  +T      AGT
Sbjct: 297 QIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY-AGT 352

Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
            G+MAPE  L     +  D ++ G+   E+++ +
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  103 bits (258), Expect = 1e-24
 Identities = 44/209 (21%), Positives = 85/209 (40%), Gaps = 32/209 (15%)

Query: 239 TNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPN 297
              +  A+ +G G FG V++  + +       K +             EI++++  +H N
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRN 62

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACA---LFGR---ENCEL-ELD--WPTRQKICLG 348
           ++ +H      ++L++++E+        +   +F R      EL E +      Q     
Sbjct: 63  ILHLHESFESMEELVMIFEF-------ISGLDIFERINTSAFELNEREIVSYVHQ----- 110

Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP--KISDFGLA-KLDEGDKTHISTRIA 405
           +   L FLH  +   I H DI+  N++     +   KI +FG A +L  GD   +   + 
Sbjct: 111 VCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LF 164

Query: 406 GTIGYMAPEYALWGYLTYKADVYSFGIVA 434
               Y APE      ++   D++S G + 
Sbjct: 165 TAPEYYAPEVHQHDVVSTATDMWSLGTLV 193

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  102 bits (257), Expect = 1e-24
 Identities = 59/231 (25%), Positives = 94/231 (40%), Gaps = 63/231 (27%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLN------------------- 285
            +IG+G +G V       D T  A+K LS K +   +                       
Sbjct: 19  DEIGKGSYGVVKLAYNENDNTYYAMKVLS-KKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77

Query: 286 --------EIAMISCLQHPNLVKIHGCCV----EGDQLLLVYEYMENNSLACALFGRENC 333
                   EIA++  L HPN+VK+    V      D L +V+E +    +          
Sbjct: 78  GPIEQVYQEIAILKKLDHPNVVKLV--EVLDDPNEDHLYMVFELVNQGPV---------- 125

Query: 334 ELELDWPTRQKICLGIAR--------GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKIS 385
              ++ PT + +    AR        G+ +LH     KI+HRDIK +N+L+  D + KI+
Sbjct: 126 ---MEVPTLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIA 179

Query: 386 DFGLAKLDEGDKTHISTRIAGTIGYMAPE---YALWGYLTYKADVYSFGIV 433
           DFG++   +G    +S    GT  +MAPE        +     DV++ G+ 
Sbjct: 180 DFGVSNEFKGSDALLSNT-VGTPAFMAPESLSETRKIFSGKALDVWAMGVT 229

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  103 bits (260), Expect = 2e-24
 Identities = 60/208 (28%), Positives = 92/208 (44%), Gaps = 26/208 (12%)

Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           K IG G FG V++ +L +   +A+K    K  Q  R    E+ ++  ++HPN+V +    
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIK----KVLQDKRFKNRELQIMRIVKHPNVVDLKAFF 101

Query: 306 VEGDQ------LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
                      L LV EY+    +  A       +  +     +     + R LA++H  
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH-- 158

Query: 360 SRFKIVHRDIKATNVLLDRDLNP-KISDFGLAK-LDEGDK-TH-ISTRIAGTIGYMAPEY 415
               I HRDIK  N+LLD      K+ DFG AK L  G+     I +R      Y APE 
Sbjct: 159 -SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----YRAPE- 211

Query: 416 ALWGYLTY--KADVYSFGIVALEIVSGK 441
            ++G   Y    D++S G V  E++ G+
Sbjct: 212 LIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  105 bits (264), Expect = 2e-24
 Identities = 68/241 (28%), Positives = 102/241 (42%), Gaps = 17/241 (7%)

Query: 208 YLRTKRHKETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTI 266
           YL      +       +       L++     N F   + +G+GGFG V   Q+   G +
Sbjct: 152 YLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKM 211

Query: 267 IAVKQLSSK---SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSL 323
            A K+L  K    R+G    LNE  ++  +    +V +       D L LV   M    L
Sbjct: 212 YACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDL 271

Query: 324 ACALFGRENCELELDWPTRQKICLG-IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP 382
              ++             R       I  GL  LH E   +IV+RD+K  N+LLD   + 
Sbjct: 272 KFHIYHMGQAGFPEA---RAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHI 325

Query: 383 KISDFGLAK-LDEGDKTHISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSG 440
           +ISD GLA  + EG       R  GT+GYMAPE      Y T+  D ++ G +  E+++G
Sbjct: 326 RISDLGLAVHVPEGQTIK--GR-VGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAG 381

Query: 441 K 441
           +
Sbjct: 382 Q 382

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  102 bits (255), Expect = 4e-24
 Identities = 57/303 (18%), Positives = 105/303 (34%), Gaps = 87/303 (28%)

Query: 241 NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLN---------EIAMI 290
            + +   +G G FG V+          + VK +  K +     ++          EIA++
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIK-KEKVLEDCWIEDPKLGKVTLEIAIL 83

Query: 291 SCLQHPNLVKIHGCCVEGDQLLLV----------YEYMENN-----SLACALFGRENCEL 335
           S ++H N++K+           LV          + +++ +      LA  +F       
Sbjct: 84  SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIF------- 136

Query: 336 ELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL-AKLDE 394
                 RQ     +   + +L       I+HRDIK  N+++  D   K+ DFG  A L+ 
Sbjct: 137 ------RQ-----LVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER 182

Query: 395 GDKTHISTRIAGTIGYMAPE-YALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFD 453
           G   +      GTI Y APE      Y   + +++S G+    +V             F 
Sbjct: 183 GKLFYTF---CGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFE--------ENPFC 231

Query: 454 CTCLLDWACHLQQDGKLVELVDERLGSKYKK-----EEAERMIKVSLLCTNASPSLRPTM 508
                               ++E + +         +E   ++   LL     P  R T+
Sbjct: 232 E-------------------LEETVEAAIHPPYLVSKELMSLVS-GLLQPV--PERRTTL 269

Query: 509 SEV 511
            ++
Sbjct: 270 EKL 272

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  102 bits (256), Expect = 4e-24
 Identities = 56/251 (22%), Positives = 96/251 (38%), Gaps = 47/251 (18%)

Query: 210 RTKRHKETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIA 268
              +  E  + +    +         K     +D    IG G    V +    A G   A
Sbjct: 64  AQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFA 123

Query: 269 VKQLSSKSRQGNRE--------FLNEIA-MISCLQHPNLVKIHGCCVEGDQLLLVYEYME 319
           VK +   + + + E           E   +     HP+++ +         + LV++ M 
Sbjct: 124 VKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMR 183

Query: 320 NNSLACALFGRENCELELDWPTRQK---------ICLGIARGLAFLHEESRFKIVHRDIK 370
                    G    EL  D+ T +          I   +   ++FLH      IVHRD+K
Sbjct: 184 K--------G----EL-FDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLK 227

Query: 371 ATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPE-------YALWGYLT 422
             N+LLD ++  ++SDFG +  L+ G+K      + GT GY+APE           GY  
Sbjct: 228 PENILLDDNMQIRLSDFGFSCHLEPGEKL---RELCGTPGYLAPEILKCSMDETHPGY-G 283

Query: 423 YKADVYSFGIV 433
            + D+++ G++
Sbjct: 284 KEVDLWACGVI 294

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  101 bits (253), Expect = 6e-24
 Identities = 61/299 (20%), Positives = 103/299 (34%), Gaps = 89/299 (29%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLN-------EIAMISCLQH-- 295
             +G GGFG VY G  ++D   +A+K +  K R  +   L        E+ ++  +    
Sbjct: 49  PLLGSGGFGSVYSGIRVSDNLPVAIKHVE-KDRISDWGELPNGTRVPMEVVLLKKVSSGF 107

Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENN---------------SLACALFGRENCELELDWP 340
             ++++       D  +L+ E  E                  LA + F            
Sbjct: 108 SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF------------ 155

Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD-LNPKISDFGLAKLDEGDKTH 399
             Q     +   +   H      ++HRDIK  N+L+D +    K+ DFG   L +     
Sbjct: 156 -WQ-----VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT 206

Query: 400 ISTRIAGTIGYMAPEYALWG--YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCL 457
                 GT  Y  PE+ +    Y    A V+S GI+  ++V G         + F+    
Sbjct: 207 DF---DGTRVYSPPEW-IRYHRYHGRSAAVWSLGILLYDMVCG--------DIPFE---- 250

Query: 458 LDWACHLQQDGKLVELVDERLGSKYKK-----EEAERMIKVSLLCTNASPSLRPTMSEV 511
                            +E +  +         E + +I+   L     PS RPT  E+
Sbjct: 251 ---------------HDEEIIRGQVFFRQRVSSECQHLIR-WCLALR--PSDRPTFEEI 291

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  102 bits (255), Expect = 6e-24
 Identities = 55/209 (26%), Positives = 102/209 (48%), Gaps = 24/209 (11%)

Query: 239 TNNFDSAKKIGEGGFGPVYKG-QLADGT-----IIAVKQLSSKSRQGNREFL-NEIAMIS 291
            + +D  +++G G F  V K  + + G       I  +Q  +  R   RE +  E++++ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 292 CLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGREN-CELELDWPTRQKICLGIA 350
            + HPN++ +H        ++L+ E +    L   L  +E+  E E     +Q     I 
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ-----IL 125

Query: 351 RGLAFLHEESRFKIVHRDIKATNVLL-DRDLNP---KISDFGLAK-LDEGDKTHISTRIA 405
            G+ +LH +   KI H D+K  N++L D+++     K+ DFGLA  +++G +      I 
Sbjct: 126 DGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIF 179

Query: 406 GTIGYMAPEYALWGYLTYKADVYSFGIVA 434
           GT  ++APE   +  L  +AD++S G++ 
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  102 bits (256), Expect = 9e-24
 Identities = 54/205 (26%), Positives = 84/205 (40%), Gaps = 29/205 (14%)

Query: 246 KKIGEGGFGPVYKG-QLADGTIIAVKQLS--------SKSRQGNREFLNEIAMISCLQHP 296
           K +G G  G V    +      +A++ +S        ++          EI ++  L HP
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200

Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFL 356
            ++KI     + +   +V E ME       LF +      L   T +     +   + +L
Sbjct: 201 CIIKIKN-FFDAEDYYIVLELMEGGE----LFDKVVGNKRLKEATCKLYFYQMLLAVQYL 255

Query: 357 HEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMA 412
           HE     I+HRD+K  NVLL   + D   KI+DFG +K L E         + GT  Y+A
Sbjct: 256 HEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM---RTLCGTPTYLA 309

Query: 413 PE----YALWGYLTYKADVYSFGIV 433
           PE        GY     D +S G++
Sbjct: 310 PEVLVSVGTAGY-NRAVDCWSLGVI 333

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  100 bits (252), Expect = 1e-23
 Identities = 54/209 (25%), Positives = 100/209 (47%), Gaps = 24/209 (11%)

Query: 239 TNNFDSAKKIGEGGFGPVYK------GQLADGTIIAVKQLSSKSRQGNRE-FLNEIAMIS 291
            + +D  +++G G F  V K      G       I  +Q  +  R  +RE    E++++ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 292 CLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGREN-CELELDWPTRQKICLGIA 350
            + H N++ +H        ++L+ E +    L   L  +E+  E E     +Q     I 
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ-----IL 125

Query: 351 RGLAFLHEESRFKIVHRDIKATNVLL-DRDLNP---KISDFGLA-KLDEGDKTHISTRIA 405
            G+ +LH +   KI H D+K  N++L D+++     K+ DFGLA ++++G +      I 
Sbjct: 126 DGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIF 179

Query: 406 GTIGYMAPEYALWGYLTYKADVYSFGIVA 434
           GT  ++APE   +  L  +AD++S G++ 
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  100 bits (250), Expect = 1e-23
 Identities = 57/216 (26%), Positives = 92/216 (42%), Gaps = 48/216 (22%)

Query: 246 KKIGEGGFGPVYKG-QLADGTIIAVK--------QLSSKSRQGNRE-FLNEIAMISCL-Q 294
           + +G G    V +          AVK          S++  Q  RE  L E+ ++  +  
Sbjct: 23  EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82

Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQK---------I 345
           HPN++++           LV++ M+         G    EL  D+ T +          I
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKK--------G----EL-FDYLTEKVTLSEKETRKI 129

Query: 346 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRI 404
              +   +  LH+     IVHRD+K  N+LLD D+N K++DFG +  LD G+K      +
Sbjct: 130 MRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REV 183

Query: 405 AGTIGYMAPE-------YALWGYLTYKADVYSFGIV 433
            GT  Y+APE           GY   + D++S G++
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVI 218

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  100 bits (252), Expect = 1e-23
 Identities = 74/289 (25%), Positives = 116/289 (40%), Gaps = 70/289 (24%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLS-SKSRQGNREFLN-EIAMISCLQHPNLVKIH 302
           K IG+G F  V   + +  G  +A+K +  ++    + + L  E+ ++  L HPN+VK+ 
Sbjct: 21  KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80

Query: 303 GCCVEGDQLLLVYEYMENNSL--------------ACALFGRENCELELDWPTRQKICLG 348
                   L L+ EY     +              A + F             RQ     
Sbjct: 81  EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF-------------RQ----- 122

Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTI 408
           I   + + H   + +IVHRD+KA N+LLD D+N KI+DFG +         +     G  
Sbjct: 123 IVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAF-CGAP 177

Query: 409 GYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD 467
            Y APE      Y   + DV+S G++   +VSG        +L FD              
Sbjct: 178 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG--------SLPFD-------------G 216

Query: 468 GKLVELVDERLGSKYKK-----EEAERMIKVSLLCTNASPSLRPTMSEV 511
             L EL +  L  KY+       + E ++K   L  N  P  R T+ ++
Sbjct: 217 QNLKELRERVLRGKYRIPFYMSTDCENLLK-RFLVLN--PIKRGTLEQI 262

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 99.6 bits (249), Expect = 1e-23
 Identities = 54/216 (25%), Positives = 99/216 (45%), Gaps = 38/216 (17%)

Query: 239 TNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVK-----QLSSKSRQGNRE-FLNEIAMIS 291
            ++++  +++G G F  V K  Q   G   A K     +LSS  R  +RE    E+ ++ 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 292 CLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACA---LFGR---ENCELELD--WPTRQ 343
            ++HPN++ +H        ++L+ E         +   LF     +    E +     +Q
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILEL-------VSGGELFDFLAEKESLTEDEATQFLKQ 116

Query: 344 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP----KISDFGLAK-LDEGDKT 398
                I  G+ +LH +   +I H D+K  N++L     P    K+ DFG+A  ++ G++ 
Sbjct: 117 -----ILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF 168

Query: 399 HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVA 434
                I GT  ++APE   +  L  +AD++S G++ 
Sbjct: 169 KN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  100 bits (252), Expect = 2e-23
 Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 40/226 (17%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNRE--F----LNEIAMISC 292
           + ++   KIG+G FG V+K +    G  +A+K    K    N +  F    L EI ++  
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALK----KVLMENEKEGFPITALREIKILQL 72

Query: 293 LQHPNLVKIHGCCVE--------GDQLLLVYEYMENNSLACALFGRENCELELDWPTRQK 344
           L+H N+V +   C             + LV+++ E++ LA  L    N  ++      ++
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLL---SNVLVKFTLSEIKR 128

Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-------KLDEGDK 397
           +   +  GL ++H     KI+HRD+KA NVL+ RD   K++DFGLA              
Sbjct: 129 VMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185

Query: 398 THISTRIAGTIGYMAPEYALWGYLTYKA--DVYSFGIVALEIVSGK 441
           T+   R+  T+ Y  PE  L G   Y    D++  G +  E+ +  
Sbjct: 186 TN---RVV-TLWYRPPEL-LLGERDYGPPIDLWGAGCIMAEMWTRS 226

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 98.8 bits (247), Expect = 2e-23
 Identities = 72/291 (24%), Positives = 108/291 (37%), Gaps = 69/291 (23%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLN-EIAMISCLQHPNLVKIHG 303
           + +GEG +G V           +AVK +  K      E +  EI +   L H N+VK +G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 304 CCVEGDQLLLVYEYMENNSL--------------ACALFGRENCELELDWPTRQKICLGI 349
              EG+   L  EY     L              A   F              Q +    
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF-------------HQLMA--- 116

Query: 350 ARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL-DEGDKTHISTRIAGTI 408
             G+ +LH      I HRDIK  N+LLD   N KISDFGLA +    ++  +  ++ GT+
Sbjct: 117 --GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171

Query: 409 GYMAPE-YALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD 467
            Y+APE      +     DV+S GIV   +++G         L +D            Q 
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG--------ELPWD------------QP 211

Query: 468 GKLVELVDERLGSKYKK-------EEAERMIKVSLLCTNASPSLRPTMSEV 511
               +   +    K               ++   +L  N  PS R T+ ++
Sbjct: 212 SDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH-KILVEN--PSARITIPDI 259

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 99.3 bits (248), Expect = 3e-23
 Identities = 50/227 (22%), Positives = 83/227 (36%), Gaps = 56/227 (24%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLN-------EIAMISCL---- 293
             +G+GGFG V+ G  L D   +A+K +  ++R      L+       E+A++  +    
Sbjct: 37  PLLGKGGFGTVFAGHRLTDRLQVAIKVIP-RNRVLGWSPLSDSVTCPLEVALLWKVGAGG 95

Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENN---------------SLACALFGRENCELELD 338
            HP ++++       +  +LV E                      +   F          
Sbjct: 96  GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF---------- 145

Query: 339 WPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP-KISDFGLAKLDEGDK 397
               Q     +   +   H      +VHRDIK  N+L+D      K+ DFG   L   + 
Sbjct: 146 ---GQ-----VVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP 194

Query: 398 THISTRIAGTIGYMAPEYALWG--YLTYKADVYSFGIVALEIVSGKN 442
                   GT  Y  PE+ +    Y    A V+S GI+  ++V G  
Sbjct: 195 YTDF---DGTRVYSPPEW-ISRHQYHALPATVWSLGILLYDMVCGDI 237

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  100 bits (251), Expect = 4e-23
 Identities = 66/216 (30%), Positives = 99/216 (45%), Gaps = 27/216 (12%)

Query: 239 TNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPN 297
             ++   K IG G FG VY+ +L D G ++A+K    K  Q  R    E+ ++  L H N
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCN 108

Query: 298 LVKIHGC-CVEGDQ-----LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIAR 351
           +V++       G++     L LV +Y+    +          +  L     +     + R
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFR 167

Query: 352 GLAFLHEESRFKIVHRDIKATNVLLDRDLNP-KISDFGLAK-LDEGDK-TH-ISTRIAGT 407
            LA++H    F I HRDIK  N+LLD D    K+ DFG AK L  G+     I +R    
Sbjct: 168 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 221

Query: 408 IGYMAPEYALWGYLTY--KADVYSFGIVALEIVSGK 441
             Y APE  ++G   Y    DV+S G V  E++ G+
Sbjct: 222 --YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 98.9 bits (247), Expect = 4e-23
 Identities = 54/219 (24%), Positives = 81/219 (36%), Gaps = 57/219 (26%)

Query: 246 KKIGEGGFGPVYKG-QLADGTIIAVKQLS--------SKSRQGNREFLNEIAMISCLQHP 296
           K +G G  G V    +      +A+K +S        ++          EI ++  L HP
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75

Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSL--------------ACALFGRENCELELDWPTR 342
            ++KI     + +   +V E ME   L                  F              
Sbjct: 76  CIIKIKN-FFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-------------Y 121

Query: 343 QKICLGIARGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAK-LDEGDKT 398
           Q     +   + +LHE     I+HRD+K  NVLL   + D   KI+DFG +K L E    
Sbjct: 122 Q-----MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 173

Query: 399 HISTRIAGTIGYMAPE----YALWGYLTYKADVYSFGIV 433
                + GT  Y+APE        GY     D +S G++
Sbjct: 174 ---RTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVI 208

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 98.0 bits (245), Expect = 4e-23
 Identities = 50/197 (25%), Positives = 89/197 (45%), Gaps = 21/197 (10%)

Query: 246 KKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNRE---FLNEIAMISCLQHPNLVKI 301
           +++G+G F  V +      G   A K ++   +   R+      E  +   LQHPN+V++
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIIN-TKKLSARDFQKLEREARICRKLQHPNIVRL 70

Query: 302 HGCCVEGDQLLLVYEYMENNSLACALFGREN-CELELDWPTRQKICLGIARGLAFLHEES 360
           H    E     LV++ +    L   +  RE   E +     +Q     I   +A+ H   
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ-----ILESIAYCHSN- 124

Query: 361 RFKIVHRDIKATNVLL---DRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPEYA 416
              IVHR++K  N+LL    +    K++DFGLA  +++ +        AGT GY++PE  
Sbjct: 125 --GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---HGFAGTPGYLSPEVL 179

Query: 417 LWGYLTYKADVYSFGIV 433
                +   D+++ G++
Sbjct: 180 KKDPYSKPVDIWACGVI 196

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 98.9 bits (247), Expect = 5e-23
 Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 38/216 (17%)

Query: 239 TNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVK-----QLSSKSRQGNREFL-NEIAMIS 291
            + +D+ +++G G F  V K  + + G   A K     +  S  R  +RE +  E++++ 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 292 CLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACA---LFGR---ENCELELD--WPTRQ 343
            +QHPN++ +H        ++L+ E         A   LF     +    E +     +Q
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILEL-------VAGGELFDFLAEKESLTEEEATEFLKQ 122

Query: 344 KICLGIARGLAFLHEESRFKIVHRDIKATNVLL----DRDLNPKISDFGLA-KLDEGDKT 398
                I  G+ +LH     +I H D+K  N++L          KI DFGLA K+D G++ 
Sbjct: 123 -----ILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174

Query: 399 HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVA 434
                I GT  ++APE   +  L  +AD++S G++ 
Sbjct: 175 ---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 98.5 bits (246), Expect = 5e-23
 Identities = 72/291 (24%), Positives = 108/291 (37%), Gaps = 69/291 (23%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLN-EIAMISCLQHPNLVKIHG 303
           + +GEG +G V           +AVK +  K      E +  EI +   L H N+VK +G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 304 CCVEGDQLLLVYEYMENNSL--------------ACALFGRENCELELDWPTRQKICLGI 349
              EG+   L  EY     L              A   F              Q +    
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF-------------HQLMA--- 116

Query: 350 ARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL-DEGDKTHISTRIAGTI 408
             G+ +LH      I HRDIK  N+LLD   N KISDFGLA +    ++  +  ++ GT+
Sbjct: 117 --GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171

Query: 409 GYMAPE-YALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD 467
            Y+APE      +     DV+S GIV   +++G         L +D            Q 
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG--------ELPWD------------QP 211

Query: 468 GKLVELVDERLGSKYKK-------EEAERMIKVSLLCTNASPSLRPTMSEV 511
               +   +    K               ++   +L  N  PS R T+ ++
Sbjct: 212 SDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH-KILVEN--PSARITIPDI 259

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 98.5 bits (246), Expect = 6e-23
 Identities = 56/245 (22%), Positives = 99/245 (40%), Gaps = 28/245 (11%)

Query: 211 TKRHKETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAV 269
              H  T   +     ++S +      + + +    K+GEG +G VYK         +A+
Sbjct: 5   HHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAI 64

Query: 270 KQLSSKSRQGNREF------LNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSL 323
           K    + R  + E       + E++++  LQH N++++        +L L++EY EN+  
Sbjct: 65  K----RIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEND-- 118

Query: 324 ACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP- 382
              L    +   ++     +     +  G+ F H     + +HRD+K  N+LL       
Sbjct: 119 ---LKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASE 172

Query: 383 ----KISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKA--DVYSFGIVALE 436
               KI DFGLA+   G      T    T+ Y  PE  L G   Y    D++S   +  E
Sbjct: 173 TPVLKIGDFGLARA-FGIPIRQFTHEIITLWYRPPE-ILLGSRHYSTSVDIWSIACIWAE 230

Query: 437 IVSGK 441
           ++   
Sbjct: 231 MLMKT 235

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 98.5 bits (246), Expect = 7e-23
 Identities = 52/194 (26%), Positives = 84/194 (43%), Gaps = 18/194 (9%)

Query: 246 KKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNREFLNEIA-MISCLQHPNLVKIHG 303
           K +GEG F    K          AVK +S +     +    EI  +  C  HPN+VK+H 
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ---KEITALKLCEGHPNIVKLHE 73

Query: 304 CCVEGDQLLLVYEYMENNSLACALFGREN-CELELDWPTRQKICLGIARGLAFLHEESRF 362
              +     LV E +    L   +  +++  E E  +  R+     +   ++ +H+    
Sbjct: 74  VFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRK-----LVSAVSHMHDV--- 125

Query: 363 KIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWG 419
            +VHRD+K  N+L    + +L  KI DFG A+L   D   + T    T+ Y APE     
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFTLHYAAPELLNQN 184

Query: 420 YLTYKADVYSFGIV 433
                 D++S G++
Sbjct: 185 GYDESCDLWSLGVI 198

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 98.5 bits (246), Expect = 7e-23
 Identities = 61/240 (25%), Positives = 105/240 (43%), Gaps = 37/240 (15%)

Query: 214 HKETAFMKESDLQTISFTLKQIKAATNNFD-SAKKIGEGGFGPVYKG-QLADGTIIAVKQ 271
           H         DL T +   + ++   N +  ++K++G G F  V +    + G   A K 
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKF 61

Query: 272 LS-SKSRQGNRE-FLNEIAMISCLQH-PNLVKIHGCCVEGDQLLLVYEYMENNSLACA-- 326
           L   +  Q  R   L+EIA++   +  P ++ +H       +++L+ EY        A  
Sbjct: 62  LKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEY-------AAGG 114

Query: 327 -LFGR---ENCEL--ELD--WPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL-- 376
            +F     E  E+  E D     +Q     I  G+ +LH+     IVH D+K  N+LL  
Sbjct: 115 EIFSLCLPELAEMVSENDVIRLIKQ-----ILEGVYYLHQN---NIVHLDLKPQNILLSS 166

Query: 377 -DRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVA 434
                + KI DFG+++ +    +      I GT  Y+APE   +  +T   D+++ GI+A
Sbjct: 167 IYPLGDIKIVDFGMSRKIGHACELRE---IMGTPEYLAPEILNYDPITTATDMWNIGIIA 223

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 97.4 bits (243), Expect = 2e-22
 Identities = 54/229 (23%), Positives = 100/229 (43%), Gaps = 21/229 (9%)

Query: 214 HKETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKG-QLADGTIIAVKQL 272
           H  +    +   +   F +      ++N+D  +++G+G F  V +      G   A K +
Sbjct: 3   HMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII 62

Query: 273 SSKSRQGNRE---FLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFG 329
           +   +   R+      E  +   LQHPN+V++H    E     LV++ +    L   +  
Sbjct: 63  N-TKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA 121

Query: 330 REN-CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKIS 385
           RE   E +     +Q     I   +A+ H      IVHR++K  N+LL    +    K++
Sbjct: 122 REFYSEADASHCIQQ-----ILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLA 173

Query: 386 DFGLAK-LDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIV 433
           DFGLA  +++ +        AGT GY++PE       +   D+++ G++
Sbjct: 174 DFGLAIEVNDSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVI 219

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 96.6 bits (241), Expect = 2e-22
 Identities = 71/294 (24%), Positives = 109/294 (37%), Gaps = 47/294 (15%)

Query: 246 KKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNREFLNEIA-MISCLQHPNLVKIHG 303
             +GEG    V     L      AVK +  +          E+  +  C  H N++++  
Sbjct: 19  DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78

Query: 304 CCVEGDQLLLVYEYMENNSLACALFGREN-CELELDWPTRQKICLGIARGLAFLHEESRF 362
              E D+  LV+E M   S+   +  R +  ELE     +      +A  L FLH +   
Sbjct: 79  FFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQD-----VASALDFLHNK--- 130

Query: 363 KIVHRDIKATNVLL---DRDLNPKISDFGLAKL--DEGDKTHISTR----IAGTIGYMAP 413
            I HRD+K  N+L    ++    KI DF L       GD + IST       G+  YMAP
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190

Query: 414 E---YALWGYLTY--KADVYSFGIVALEIVSGKNNMSYAPALEF--DCTCLLDWACHLQQ 466
           E           Y  + D++S G++   ++SG     Y P   F   C     W      
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSG-----YPP---FVGRCGSDCGWDRGEAC 242

Query: 467 DGKLVELVDERLGSKYK---------KEEAERMIKVSLLCTNASPSLRPTMSEV 511
                 L +     KY+            A+ +I   LL  +     R + ++V
Sbjct: 243 PACQNMLFESIQEGKYEFPDKDWAHISCAAKDLIS-KLLVRD--AKQRLSAAQV 293

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 98.5 bits (246), Expect = 2e-22
 Identities = 48/201 (23%), Positives = 88/201 (43%), Gaps = 28/201 (13%)

Query: 246 KKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNRE--FLNEIAMISCLQHPNLVKIH 302
           +++G+G F  V +  ++  G   A   +++K            E  +   L+HPN+V++H
Sbjct: 17  EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76

Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGREN-CELELDWPTRQKICLGIARGLAFLHEESR 361
               E     L+++ +    L   +  RE   E +     +Q     I   +   H+   
Sbjct: 77  DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQ-----ILEAVLHCHQM-- 129

Query: 362 FKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPE---- 414
             +VHR++K  N+LL    +    K++DFGLA   EG++       AGT GY++PE    
Sbjct: 130 -GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG-FAGTPGYLSPEVLRK 187

Query: 415 --YALWGYLTYKADVYSFGIV 433
             Y          D+++ G++
Sbjct: 188 DPY------GKPVDLWACGVI 202

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 97.4 bits (243), Expect = 3e-22
 Identities = 54/217 (24%), Positives = 99/217 (45%), Gaps = 32/217 (14%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSK---SRQGNREFLNEIAMISCLQH 295
           ++F+  + IG+G FG V   Q  D   + A+K ++ +    R   R    E+ ++  L+H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 296 PNLVKIHGCCVEGDQLLLVYEYM---ENNSLACALF---GRENCELELDWPTRQKICLG- 348
           P LV +     + + + +V + +   +       L     +     E       K+ +  
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGD-------LRYHLQQNVHFKE----ETVKLFICE 123

Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTI 408
           +   L +L      +I+HRD+K  N+LLD   +  I+DF +A +   +    +  +AGT 
Sbjct: 124 LVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTK 178

Query: 409 GYMAPE----YALWGYLTYKADVYSFGIVALEIVSGK 441
            YMAPE        GY ++  D +S G+ A E++ G+
Sbjct: 179 PYMAPEMFSSRKGAGY-SFAVDWWSLGVTAYELLRGR 214

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 97.6 bits (243), Expect = 4e-22
 Identities = 50/214 (23%), Positives = 94/214 (43%), Gaps = 27/214 (12%)

Query: 247 KIGEGGFGPVYKGQ---LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHG 303
           K+G G +G VYK +     D    A+KQ+       +     EIA++  L+HPN++ +  
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQK 85

Query: 304 CCVE--GDQLLLVYEYMENNSLA-----CALFGRENCELELDWPTRQKICLGIARGLAFL 356
             +     ++ L+++Y E++ L                ++L     + +   I  G+ +L
Sbjct: 86  VFLSHADRKVWLLFDYAEHD-LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144

Query: 357 HEESRFKIVHRDIKATNVLLDRDLNP----KISDFGLAKL---DEGDKTHISTRIAGTIG 409
           H      ++HRD+K  N+L+  +       KI+D G A+L          +   +  T  
Sbjct: 145 HAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFW 200

Query: 410 YMAPEYALWGYLTYKA--DVYSFGIVALEIVSGK 441
           Y APE  L G   Y    D+++ G +  E+++ +
Sbjct: 201 YRAPEL-LLGARHYTKAIDIWAIGCIFAELLTSE 233

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 94.9 bits (237), Expect = 8e-22
 Identities = 47/169 (27%), Positives = 79/169 (46%), Gaps = 22/169 (13%)

Query: 238 ATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLS-SKSRQGNREF----LNEIA--- 288
           AT+ ++   +IG G +G VYK +    G  +A+K +       G        + E+A   
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66

Query: 289 MISCLQHPNLVKIHGCCV-----EGDQLLLVYEYMENNSLACALFGRENC-ELELDWPTR 342
            +   +HPN+V++   C         ++ LV+E+++ + L   L   +      L   T 
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYL---DKAPPPGLPAETI 122

Query: 343 QKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 391
           + +     RGL FLH      IVHRD+K  N+L+      K++DFGLA+
Sbjct: 123 KDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLAR 168

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 93.9 bits (234), Expect = 2e-21
 Identities = 54/217 (24%), Positives = 85/217 (39%), Gaps = 38/217 (17%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLS----SKSRQGNREFLNEIAMISCLQHPNLVK 300
             +GEG +G V +          AVK L      +   G      EI ++  L+H N+++
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70

Query: 301 IHG--CCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIAR------- 351
           +       E  ++ +V EY                E+ LD    ++  +  A        
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGMQ----------EM-LDSVPEKRFPVCQAHGYFCQLI 119

Query: 352 -GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL----DEGDKTHISTRIAG 406
            GL +LH      IVH+DIK  N+LL      KIS  G+A+        D    S    G
Sbjct: 120 DGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS---QG 173

Query: 407 TIGYMAPEYA--LWGYLTYKADVYSFGIVALEIVSGK 441
           +  +  PE A  L  +  +K D++S G+    I +G 
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 94.3 bits (235), Expect = 3e-21
 Identities = 55/207 (26%), Positives = 82/207 (39%), Gaps = 45/207 (21%)

Query: 246 KKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
            ++G G    VY+  Q       A+K L     +  +    EI ++  L HPN++K+   
Sbjct: 59  SELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEI 116

Query: 305 CVEGDQLLLVYEYMENNSL--------------ACALFGRENCELELDWPTRQKICLGIA 350
                ++ LV E +    L              A                 +Q     I 
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAV-------------KQ-----IL 158

Query: 351 RGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
             +A+LHE     IVHRD+K  N+L      D   KI+DFGL+K+ E         + GT
Sbjct: 159 EAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--KTVCGT 213

Query: 408 IGYMAPE-YALWGYLTYKADVYSFGIV 433
            GY APE      Y   + D++S GI+
Sbjct: 214 PGYCAPEILRGCAY-GPEVDMWSVGII 239

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 93.8 bits (233), Expect = 4e-21
 Identities = 59/266 (22%), Positives = 93/266 (34%), Gaps = 75/266 (28%)

Query: 246 KKIGEGGFGPVYKGQL------ADGTIIAVKQL-SSKSRQGNREFLNEIAM--------- 289
           K +G G FG V +         A    +AVK L    +   +R  ++E+ +         
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87

Query: 290 ------------------ISCLQHPNLV-------------------------------- 299
                             +   +  NL                                 
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147

Query: 300 --KIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQ---KICLGIARGLA 354
             K     +   Q      ++E  SL+         +L  D+ T +        +A+G+ 
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207

Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT-IGYMAP 413
           FL   SR K +HRD+ A N+LL      KI DFGLA+    D  ++    A   + +MAP
Sbjct: 208 FL--ASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 264

Query: 414 EYALWGYLTYKADVYSFGIVALEIVS 439
           E       T ++DV+SFG++  EI S
Sbjct: 265 ETIFDRVYTIQSDVWSFGVLLWEIFS 290

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 92.3 bits (230), Expect = 4e-21
 Identities = 65/292 (22%), Positives = 114/292 (39%), Gaps = 75/292 (25%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLN----EIAMISCLQHPNLVK 300
             +G G FG V  G+    G  +AVK L+ + +  + + +     EI  +   +HP+++K
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILN-RQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75

Query: 301 IHGCCVEGDQLLLVYEYMENNSL--------------ACALFGRENCELELDWPTRQKIC 346
           ++          +V EY+    L              A  LF             +Q + 
Sbjct: 76  LYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLF-------------QQILS 122

Query: 347 LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL-DEGDKTHISTRIA 405
                 + + H   R  +VHRD+K  NVLLD  +N KI+DFGL+ +  +G+    S    
Sbjct: 123 -----AVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---C 171

Query: 406 GTIGYMAPE-YALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHL 464
           G+  Y APE  +   Y   + D++S G++   ++ G         L FD           
Sbjct: 172 GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCG--------TLPFD----------- 212

Query: 465 QQDGKLVELVDERLGSKYKK-----EEAERMIKVSLLCTNASPSLRPTMSEV 511
             D  +  L  +  G  +            ++   +L  +  P  R T+ ++
Sbjct: 213 --DEHVPTLFKKIRGGVFYIPEYLNRSVATLLM-HMLQVD--PLKRATIKDI 259

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 94.1 bits (234), Expect = 8e-21
 Identities = 53/226 (23%), Positives = 95/226 (42%), Gaps = 19/226 (8%)

Query: 226 QTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKS--RQGNRE 282
           +  +  +KQ++    +F+  K IG G FG V   +L +   + A+K L+     ++    
Sbjct: 60  KPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETA 119

Query: 283 -FLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPT 341
            F  E  ++       +  +H    + + L LV +Y     L   L   E+   E     
Sbjct: 120 CFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPE----E 175

Query: 342 RQKICLG-IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI 400
             +  L  +   +  +H+      VHRDIK  N+L+D + + +++DFG       D T  
Sbjct: 176 MARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 232

Query: 401 STRIAGTIGYMAPE------YALWGYLTYKADVYSFGIVALEIVSG 440
           S+   GT  Y++PE           Y   + D +S G+   E++ G
Sbjct: 233 SSVAVGTPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYG 277

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 91.9 bits (229), Expect = 1e-20
 Identities = 56/237 (23%), Positives = 92/237 (38%), Gaps = 38/237 (16%)

Query: 223 SDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNR 281
             LQ      +  K    +F   K +GEG F  V   +  A     A+K L  +      
Sbjct: 13  GSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN 72

Query: 282 EF---LNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSL------------ACA 326
           +      E  ++S L HP  VK++    + ++L     Y +N  L             C 
Sbjct: 73  KVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT 132

Query: 327 LF-GRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKIS 385
            F   E                 I   L +LH      I+HRD+K  N+LL+ D++ +I+
Sbjct: 133 RFYTAE-----------------IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQIT 172

Query: 386 DFGLAKLDEGDKTHISTR-IAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           DFG AK+   +          GT  Y++PE          +D+++ G +  ++V+G 
Sbjct: 173 DFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 91.0 bits (226), Expect = 1e-20
 Identities = 21/201 (10%), Positives = 46/201 (22%), Gaps = 45/201 (22%)

Query: 247 KIGEGGFGPVYKGQLAD---GTIIAVKQL---SSKSRQGNREFLNEIAMISCLQHPNLVK 300
             G       ++    D      +A+  +           +E L+    +S +  P + +
Sbjct: 38  FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
           +          L+V E++   SL                    +    +A      H   
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRAG 149

Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGY 420
              +       + V +  D        G   L                  M         
Sbjct: 150 ---VALSIDHPSRVRVSID--------GDVVL-------------AYPATMPDA------ 179

Query: 421 LTYKADVYSFGIVALEIVSGK 441
              + D+   G     ++  +
Sbjct: 180 -NPQDDIRGIGASLYALLVNR 199

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 91.6 bits (228), Expect = 2e-20
 Identities = 50/198 (25%), Positives = 79/198 (39%), Gaps = 24/198 (12%)

Query: 246 KKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
           + +G G  G V +      G   A+K L   S +  +E   +         P++V I   
Sbjct: 35  QVLGLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQEV--DH-HWQASGGPHIVCILDV 90

Query: 305 C----VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQ--KICLGIARGLAFLHE 358
                     LL++ E ME   L    F R     +  +  R+  +I   I   + FLH 
Sbjct: 91  YENMHHGKRCLLIIMECMEGGEL----FSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS 146

Query: 359 ESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEY 415
                I HRD+K  N+L    ++D   K++DFG AK    +   + T    T  Y+APE 
Sbjct: 147 H---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQT-PCYTPYYVAPEV 200

Query: 416 ALWGYLTYKADVYSFGIV 433
                     D++S G++
Sbjct: 201 LGPEKYDKSCDMWSLGVI 218

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 90.0 bits (224), Expect = 5e-20
 Identities = 46/169 (27%), Positives = 81/169 (47%), Gaps = 28/169 (16%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQ--LADGTIIAVKQLSSKSRQGNRE------FLNEIA--- 288
             ++   +IGEG +G V+K +     G  +A+K    + R    E       + E+A   
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALK----RVRVQTGEEGMPLSTIREVAVLR 66

Query: 289 MISCLQHPNLVKIHGCCV-----EGDQLLLVYEYMENNSLACALFGRENC-ELELDWPTR 342
            +   +HPN+V++   C         +L LV+E+++ + L   L   +   E  +   T 
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYL---DKVPEPGVPTETI 122

Query: 343 QKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 391
           + +   + RGL FLH     ++VHRD+K  N+L+      K++DFGLA+
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 168

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 91.8 bits (228), Expect = 5e-20
 Identities = 64/291 (21%), Positives = 115/291 (39%), Gaps = 73/291 (25%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLN----EIAMISCLQHPNLVK 300
             +G G FG V  G+    G  +AVK L+ + +  + + +     EI  +   +HP+++K
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILN-RQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80

Query: 301 IHGCCVEGDQLLLVYEYMENNSL--------------ACALFGRENCELELDWPTRQKIC 346
           ++        + +V EY+    L              +  LF             +Q + 
Sbjct: 81  LYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLF-------------QQILS 127

Query: 347 LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAG 406
                G+ + H   R  +VHRD+K  NVLLD  +N KI+DFGL+ +    +  + T   G
Sbjct: 128 -----GVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTS-CG 177

Query: 407 TIGYMAPE-YALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQ 465
           +  Y APE  +   Y   + D++S G++   ++ G         L FD            
Sbjct: 178 SPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCG--------TLPFD------------ 217

Query: 466 QDGKLVELVDERLGSKYK-----KEEAERMIKVSLLCTNASPSLRPTMSEV 511
            D  +  L  +     +            ++K  +L  +  P  R T+ ++
Sbjct: 218 -DDHVPTLFKKICDGIFYTPQYLNPSVISLLK-HMLQVD--PMKRATIKDI 264

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 89.7 bits (223), Expect = 1e-19
 Identities = 53/206 (25%), Positives = 78/206 (37%), Gaps = 42/206 (20%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
           K IG G FG     +      ++AVK +  +    +     EI     L+HPN+V+    
Sbjct: 26  KDIGSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFKEV 84

Query: 305 CVEGDQLLLVYEYMENNSL--------------ACALFGRENCELELDWPTRQKICLGIA 350
            +    L ++ EY     L              A   F             +Q +     
Sbjct: 85  ILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFF-------------QQLLS---- 127

Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNP--KISDFGLAKLDEGDKTHISTRIAGTI 408
            G+++ H     +I HRD+K  N LLD    P  KI DFG +K          + + GT 
Sbjct: 128 -GVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTV-GTP 181

Query: 409 GYMAPE-YALWGYLTYKADVYSFGIV 433
            Y+APE      Y    ADV+S G+ 
Sbjct: 182 AYIAPEVLLRQEYDGKIADVWSCGVT 207

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 71/291 (24%), Positives = 117/291 (40%), Gaps = 74/291 (25%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLN----EIAMISCLQHPNLVK 300
           + +GEG FG V           +A+K +S +      +       EI+ +  L+HP+++K
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFIS-RQLLKKSDMHMRVEREISYLKLLRHPHIIK 73

Query: 301 IHGCCVEGDQLLLVYEY---------MENNSL----ACALFGRENCELELDWPTRQKICL 347
           ++        +++V EY         +E   +        F             +Q IC 
Sbjct: 74  LYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFF-------------QQIIC- 119

Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL-DEGDKTHISTRIAG 406
                + + H   R KIVHRD+K  N+LLD +LN KI+DFGL+ +  +G+    S    G
Sbjct: 120 ----AIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS---CG 169

Query: 407 TIGYMAPE-YALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQ 465
           +  Y APE      Y   + DV+S GIV   ++ G         L FD            
Sbjct: 170 SPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVG--------RLPFD------------ 209

Query: 466 QDGKLVELVDERLGSKYK-----KEEAERMIKVSLLCTNASPSLRPTMSEV 511
            D  +  L  +     Y         A+ +I+  ++  +  P  R T+ E+
Sbjct: 210 -DEFIPNLFKKVNSCVYVMPDFLSPGAQSLIR-RMIVAD--PMQRITIQEI 256

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 88.6 bits (220), Expect = 3e-19
 Identities = 47/206 (22%), Positives = 74/206 (35%), Gaps = 39/206 (18%)

Query: 246 KKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNREFLNEIA-MISCLQHPNLVKIHG 303
           + +G G  G V +          A+K L    +        E+       Q P++V+I  
Sbjct: 68  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVD 122

Query: 304 ----CCVEGDQLLLVYEYMENNSL-------ACALFG-RENCELELDWPTRQKICLGIAR 351
                      LL+V E ++   L           F  RE  E+      +      I  
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI-----MKS-----IGE 172

Query: 352 GLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEGDKTHISTRIAGTI 408
            + +LH      I HRD+K  N+L      +   K++DFG AK      +   T    T 
Sbjct: 173 AIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--TTPCYTP 227

Query: 409 GYMAPE-YALWGYLTYKADVYSFGIV 433
            Y+APE      Y     D++S G++
Sbjct: 228 YYVAPEVLGPEKY-DKSCDMWSLGVI 252

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 87.5 bits (217), Expect = 8e-19
 Identities = 57/235 (24%), Positives = 95/235 (40%), Gaps = 35/235 (14%)

Query: 226 QTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNRE-- 282
           + I   LK+++   ++F+  K IG G F  V   ++   G + A+K ++ K     R   
Sbjct: 47  EPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMN-KWDMLKRGEV 105

Query: 283 --FLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWP 340
             F  E  ++       + ++H    + + L LV EY     L   L  +    +  +  
Sbjct: 106 SCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLL-SKFGERIPAEM- 163

Query: 341 TRQKICLGIAR--------GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL 392
                    AR         +  +H       VHRDIK  N+LLDR  + +++DFG    
Sbjct: 164 ---------ARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLK 211

Query: 393 DEGDKTHISTRIAGTIGYMAPE-----YALWGYLTY--KADVYSFGIVALEIVSG 440
              D T  S    GT  Y++PE         G  +Y  + D ++ G+ A E+  G
Sbjct: 212 LRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 87.1 bits (216), Expect = 1e-18
 Identities = 64/220 (29%), Positives = 95/220 (43%), Gaps = 15/220 (6%)

Query: 228 ISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREF--- 283
           +S    + +   N F+  K +G+G FG V   +    G   A+K L  +      E    
Sbjct: 136 VSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT 195

Query: 284 LNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQ 343
           L E  ++   +HP L  +       D+L  V EY     L   L  RE    E     R 
Sbjct: 196 LTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSE----DRA 250

Query: 344 KICLG-IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIST 402
           +     I   L +LH  S   +V+RD+K  N++LD+D + KI+DFGL K    D   + T
Sbjct: 251 RFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 308

Query: 403 RIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGK 441
              GT  Y+APE      Y     D +  G+V  E++ G+
Sbjct: 309 -FCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGR 346

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 85.9 bits (213), Expect = 3e-18
 Identities = 53/249 (21%), Positives = 95/249 (38%), Gaps = 37/249 (14%)

Query: 209 LRTKRHKETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTII 267
           LR  ++ +    +  D       ++ ++    +++  K IG G FG V   +      + 
Sbjct: 41  LRKNKNIDNFLSRYKDTIN---KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVY 97

Query: 268 AVKQLSSKSRQGNRE----FLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSL 323
           A+K LS K     R     F  E  +++    P +V++     +   L +V EYM    L
Sbjct: 98  AMKLLS-KFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL 156

Query: 324 ACALFGRENCELELDWPTRQKICLGIAR--------GLAFLHEESRFKIVHRDIKATNVL 375
              +             +   +    AR         L  +H       +HRD+K  N+L
Sbjct: 157 VNLM-------------SNYDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNML 200

Query: 376 LDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPE--YALWGYLTYKADV--YSFG 431
           LD+  + K++DFG       +         GT  Y++PE   +  G   Y  +   +S G
Sbjct: 201 LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 260

Query: 432 IVALEIVSG 440
           +   E++ G
Sbjct: 261 VFLYEMLVG 269

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 84.9 bits (209), Expect = 3e-18
 Identities = 39/196 (19%), Positives = 67/196 (34%), Gaps = 45/196 (22%)

Query: 238 ATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQL--------SSKSRQGNREFLNEIAM 289
            T      +KIGEG FG V++   AD T +A+K +        +   ++   E L EI +
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 290 ---------ISCLQHPNLVKIHGC-CVEGD---QLLLVYEYM--ENNSLACALFGRENCE 334
                      C +    + ++   CV+G     LL  +++      S        ++ +
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 335 LEL-------------------DWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVL 375
           L +                      T + I   +   LA        +  HRD+   NVL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194

Query: 376 LDRDLNPKISDFGLAK 391
           L +    K+      K
Sbjct: 195 LKKTSLKKLHYTLNGK 210

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 83.8 bits (208), Expect = 6e-18
 Identities = 65/240 (27%), Positives = 110/240 (45%), Gaps = 38/240 (15%)

Query: 222 ESDLQTISFTL----KQIKAATNNFDSAKKIGEGGFGPVY----KGQLADGTIIAVKQLS 273
           E  ++ I+ T        KA  + F+  K +G+G FG V+            + A+K L 
Sbjct: 2   EGSIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK 61

Query: 274 SKSRQGNREF--LNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM---ENNSLACALF 328
             + +         E  ++  + HP +VK+H       +L L+ +++   +       LF
Sbjct: 62  KATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGD-------LF 114

Query: 329 ---GRENCELELDWPTRQKICLG-IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKI 384
               +E    E       K  L  +A  L  LH      I++RD+K  N+LLD + + K+
Sbjct: 115 TRLSKEVMFTE----EDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKL 167

Query: 385 SDFGLAK--LDEGDKTHISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGK 441
           +DFGL+K  +D   K +  +   GT+ YMAPE     G+ T  AD +SFG++  E+++G 
Sbjct: 168 TDFGLSKESIDHEKKAY--S-FCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGT 223

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 83.0 bits (206), Expect = 1e-17
 Identities = 65/237 (27%), Positives = 105/237 (44%), Gaps = 42/237 (17%)

Query: 226 QTISFTLKQIKAATNNFDSAKKIGEGGFGPVY---KGQLAD-GTIIAVKQLSSKSRQGNR 281
              S      K     F+  + +G+GG+G V+   K   A+ G I A+K L       N 
Sbjct: 3   SETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNA 62

Query: 282 EFLNEIA-------MISCLQHPNLVKIHGCCVEGDQLLLVYEYM---ENNSLACALF--- 328
               + A       ++  ++HP +V +      G +L L+ EY+   E       LF   
Sbjct: 63  ---KDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGE-------LFMQL 112

Query: 329 GRENCELELDWPTRQKICLG-IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF 387
            RE   +E          L  I+  L  LH+     I++RD+K  N++L+   + K++DF
Sbjct: 113 EREGIFME----DTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDF 165

Query: 388 GLAK--LDEGDKTHISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGK 441
           GL K  + +G  TH  T   GTI YMAPE  +  G+     D +S G +  ++++G 
Sbjct: 166 GLCKESIHDGTVTH--T-FCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGA 218

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 60/234 (25%), Positives = 99/234 (42%), Gaps = 23/234 (9%)

Query: 215 KETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLS 273
           KE     + D      T  Q  A  + FD  K +G G FG V   +  + G   A+K L 
Sbjct: 16  KEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD 75

Query: 274 SKSRQGNREF---LNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM---ENNSLACAL 327
            +     ++    LNE  ++  +  P LVK+     +   L +V EY+   E       +
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE-------M 128

Query: 328 FGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF 387
           F           P  +     I     +LH      +++RD+K  N+L+D+    +++DF
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185

Query: 388 GLAKLDEGDKTHISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSG 440
           G AK  +  +T   T + GT   +APE  L  GY     D ++ G++  E+ +G
Sbjct: 186 GFAKRVK-GRTW--T-LCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAG 234

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 69/251 (27%), Positives = 109/251 (43%), Gaps = 44/251 (17%)

Query: 215 KETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVY---KGQLAD-GTIIAVK 270
            E     + +L+T + T    K    NF+  K +G G +G V+   K    D G + A+K
Sbjct: 29  GEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMK 88

Query: 271 QLS-----SKSRQ-----GNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM-- 318
            L       K++        R+ L  I      Q P LV +H       +L L+ +Y+  
Sbjct: 89  VLKKATIVQKAKTTEHTRTERQVLEHIR-----QSPFLVTLHYAFQTETKLHLILDYING 143

Query: 319 -ENNSLACALF---GRENCELELDWPTRQKICLG-IARGLAFLHEESRFKIVHRDIKATN 373
            E       LF    +     E       +I +G I   L  LH+     I++RDIK  N
Sbjct: 144 GE-------LFTHLSQRERFTE----HEVQIYVGEIVLALEHLHK---LGIIYRDIKLEN 189

Query: 374 VLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPE---YALWGYLTYKADVYSF 430
           +LLD + +  ++DFGL+K    D+T  +    GTI YMAP+       G+     D +S 
Sbjct: 190 ILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGH-DKAVDWWSL 248

Query: 431 GIVALEIVSGK 441
           G++  E+++G 
Sbjct: 249 GVLMYELLTGA 259

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 84.3 bits (208), Expect = 2e-17
 Identities = 57/218 (26%), Positives = 92/218 (42%), Gaps = 27/218 (12%)

Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISC-- 292
           +    +F+    +G+G FG V   +      + AVK L  K         +++       
Sbjct: 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK-KDVVIQD---DDVECTMVEK 392

Query: 293 ------LQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKIC 346
                  + P L ++H C    D+L  V EY+    L                P      
Sbjct: 393 RVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL----MYHIQQVGRFKEPHAVFYA 448

Query: 347 LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEGDKTHISTRI 404
             IA GL FL       I++RD+K  NV+LD + + KI+DFG+ K  + +G  T   T  
Sbjct: 449 AEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT--KT-F 502

Query: 405 AGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGK 441
            GT  Y+APE   +  Y     D ++FG++  E+++G+
Sbjct: 503 CGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQ 539

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 82.4 bits (204), Expect = 3e-17
 Identities = 57/220 (25%), Positives = 92/220 (41%), Gaps = 37/220 (16%)

Query: 239 TNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLN---------EIA 288
              + + K IG G  G V           +A+K+LS       R F N         E+ 
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELV 76

Query: 289 MISCLQHPNLVKIH------GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTR 342
           ++ C+ H N++ +           E   + +V E M+ N   C +      ++ELD    
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQV-----IQMELDHERM 129

Query: 343 QKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIST 402
             +   +  G+  LH      I+HRD+K +N+++  D   KI DFGLA+      + + T
Sbjct: 130 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMT 184

Query: 403 RIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
               T  Y APE  L  GY     D++S G +  E++ G 
Sbjct: 185 PYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGG 223

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 81.9 bits (203), Expect = 5e-17
 Identities = 68/221 (30%), Positives = 100/221 (45%), Gaps = 33/221 (14%)

Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIA----MI 290
            A  ++F   K IG+G FG V   +  A+    AVK L  K+    +E  + ++    ++
Sbjct: 34  HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLL 93

Query: 291 SCLQHPNLVKIHGCCVEGDQLLLVYEYM---ENNSLACALF---GRENCELELDWPTRQK 344
             ++HP LV +H      D+L  V +Y+   E       LF    RE C LE     R +
Sbjct: 94  KNVKHPFLVGLHFSFQTADKLYFVLDYINGGE-------LFYHLQRERCFLE----PRAR 142

Query: 345 ICLG-IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEGDKTHIS 401
                IA  L +LH      IV+RD+K  N+LLD   +  ++DFGL K  ++    T  S
Sbjct: 143 FYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT--S 197

Query: 402 TRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGK 441
           T   GT  Y+APE      Y     D +  G V  E++ G 
Sbjct: 198 T-FCGTPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGL 236

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 81.3 bits (201), Expect = 7e-17
 Identities = 56/248 (22%), Positives = 92/248 (37%), Gaps = 59/248 (23%)

Query: 239 TNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPN 297
           +  +   K +G G FG V +    + G   A+K++    R  NRE    + ++  L H N
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDHVN 61

Query: 298 LVKI----HGCCVEGDQLL----------------------------------LVYEYME 319
           ++K+    +    E  +                                    ++ EY+ 
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121

Query: 320 NN-SLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR 378
           +        F R    + ++          + R + F+H      I HRDIK  N+L++ 
Sbjct: 122 DTLHKVLKSFIRSGRSIPMN--LISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNS 176

Query: 379 DLNP-KISDFGLAK-LDEGDK-TH-ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIV 433
             N  K+ DFG AK L   +     I +R      Y APE  L     T   D++S G V
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATEYTPSIDLWSIGCV 231

Query: 434 ALEIVSGK 441
             E++ GK
Sbjct: 232 FGELILGK 239

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 80.3 bits (199), Expect = 8e-17
 Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 45/224 (20%)

Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREF---LNEIAMIS 291
           K +  +F   + +G G FG V+  +    G   A+K L  +     ++     +E  M+S
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61

Query: 292 CLQHPNLVKIHGCCVEGDQLLLVYEYME--------------NNSLACALFGRENCELEL 337
            + HP ++++ G   +  Q+ ++ +Y+E               N +A   +  E      
Sbjct: 62  IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAK-FYAAE------ 114

Query: 338 DWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK 397
                      +   L +LH      I++RD+K  N+LLD++ + KI+DFG AK    D 
Sbjct: 115 -----------VCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYV-PDV 159

Query: 398 THISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSG 440
           T+  T + GT  Y+APE      Y     D +SFGI+  E+++G
Sbjct: 160 TY--T-LCGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAG 199

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 80.7 bits (200), Expect = 8e-17
 Identities = 66/220 (30%), Positives = 95/220 (43%), Gaps = 32/220 (14%)

Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREF---LNEIAMIS 291
           K   N+FD  K +G+G FG V   +  A G   A+K L  +      E    + E  ++ 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60

Query: 292 CLQHPNLVKIHGCCVEGDQLLLVYEYM---ENNSLACALF---GRENCELELDWPTRQKI 345
             +HP L  +       D+L  V EY    E       LF    RE    E     R + 
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGE-------LFFHLSRERVFTE----ERARF 109

Query: 346 CLG-IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEGDKTHIST 402
               I   L +LH      +V+RDIK  N++LD+D + KI+DFGL K  + +G      T
Sbjct: 110 YGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KT 164

Query: 403 RIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGK 441
              GT  Y+APE      Y     D +  G+V  E++ G+
Sbjct: 165 -FCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGR 202

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 52/223 (23%), Positives = 90/223 (40%), Gaps = 32/223 (14%)

Query: 239 TNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLS--SKSRQGNREFLN---------EI 287
            + +   + I  G +G V  G  ++G  +A+K++       +      +         EI
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 288 AMISCLQHPNLVKIHGCCV-----EGDQLLLVYEYMENNSLACALFGRENCELELDWPTR 342
            +++   HPN++ +    V        +L LV E M  +     +   +   +       
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD--LAQVIHDQRIVISPQ--HI 136

Query: 343 QKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT---H 399
           Q     I  GL  LHE     +VHRD+   N+LL  + +  I DF LA+ D  D     +
Sbjct: 137 QYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHY 193

Query: 400 ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           ++ R      Y APE  + +   T   D++S G V  E+ + K
Sbjct: 194 VTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 81.4 bits (201), Expect = 1e-16
 Identities = 65/253 (25%), Positives = 106/253 (41%), Gaps = 44/253 (17%)

Query: 206 RYYLRTKRHKETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQ-LADG 264
           ++Y  +K   +  F    ++   +FT+         + + K IG G  G V         
Sbjct: 35  KHYNMSKSKVDNQFYSV-EVGDSTFTV------LKRYQNLKPIGSGAQGIVCAAYDAVLD 87

Query: 265 TIIAVKQLSSKSRQGNREFLN---------EIAMISCLQHPNLVKIH------GCCVEGD 309
             +A+K+LS       R F N         E+ ++ C+ H N++ +           E  
Sbjct: 88  RNVAIKKLS-------RPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140

Query: 310 QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDI 369
            + LV E M+ N L   +      ++ELD      +   +  G+  LH  S   I+HRD+
Sbjct: 141 DVYLVMELMDAN-LCQVI------QMELDHERMSYLLYQMLCGIKHLH--SA-GIIHRDL 190

Query: 370 KATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYAL-WGYLTYKADVY 428
           K +N+++  D   KI DFGLA+      + + T    T  Y APE  L  GY     D++
Sbjct: 191 KPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGY-KENVDIW 247

Query: 429 SFGIVALEIVSGK 441
           S G +  E+V  K
Sbjct: 248 SVGCIMGEMVRHK 260

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 61/219 (27%), Positives = 93/219 (42%), Gaps = 25/219 (11%)

Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIA--- 288
            QIK    +F   K +G+G FG V+  +        A+K L       + +    +    
Sbjct: 10  LQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKR 69

Query: 289 -MISCLQHPNLVKIHGCCVEGDQLLLVYEYM---ENNSLACALFGRENCELELDWPTRQK 344
            +    +HP L  +       + L  V EY+   +       L        + D      
Sbjct: 70  VLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGD-------LMYHIQSCHKFDLSRATF 122

Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD--EGDKTHIST 402
               I  GL FLH      IV+RD+K  N+LLD+D + KI+DFG+ K +     KT  +T
Sbjct: 123 YAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NT 177

Query: 403 RIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSG 440
              GT  Y+APE  L   Y  +  D +SFG++  E++ G
Sbjct: 178 -FCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIG 214

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 79.6 bits (197), Expect = 2e-16
 Identities = 58/233 (24%), Positives = 98/233 (42%), Gaps = 26/233 (11%)

Query: 221 KESDLQTISFTLKQIKAAT-NNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQ 278
           KES  +     +        +NF+  + +G+G FG V   ++ + G + AVK L      
Sbjct: 3   KESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL 62

Query: 279 GNREFLNEIA----MISCLQHPNLVKIHGCCVEGDQLLLVYEYM---ENNSLACALFGRE 331
            + +    +     +     HP L ++  C    D+L  V E++   +       L    
Sbjct: 63  QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGD-------LMFHI 115

Query: 332 NCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 391
                 D    +     I   L FLH+     I++RD+K  NVLLD + + K++DFG+ K
Sbjct: 116 QKSRRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK 172

Query: 392 --LDEGDKTHISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGK 441
             +  G  T  +T   GT  Y+APE      Y     D ++ G++  E++ G 
Sbjct: 173 EGICNGVTT--AT-FCGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGH 221

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 79.6 bits (197), Expect = 2e-16
 Identities = 57/234 (24%), Positives = 96/234 (41%), Gaps = 33/234 (14%)

Query: 223 SDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNR 281
           + +        + +    +F+    +G+G FG V   +      + AVK L  K      
Sbjct: 3   NTVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK-KDVVIQD 61

Query: 282 EFLNEIAMISC--------LQHPNLVKIHGCCVEGDQLLLVYEYM---ENNSLACALFGR 330
              +++              + P L ++H C    D+L  V EY+   +       L   
Sbjct: 62  ---DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGD-------LMYH 111

Query: 331 ENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 390
                    P        IA GL FL       I++RD+K  NV+LD + + KI+DFG+ 
Sbjct: 112 IQQVGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMC 168

Query: 391 K--LDEGDKTHISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGK 441
           K  + +G  T   T   GT  Y+APE   +  Y     D ++FG++  E+++G+
Sbjct: 169 KENIWDGVTTK--T-FCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQ 218

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 78.5 bits (194), Expect = 5e-16
 Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 40/221 (18%)

Query: 239 TNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLN---------EIA 288
              + S   +G G +G V        G  +A+K+LS       R F +         E+ 
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRELL 75

Query: 289 MISCLQHPNLVKIH------GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTR 342
           ++  +QH N++ +                 LV  +M+ + L   +       L+      
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD-LQKIM------GLKFSEEKI 128

Query: 343 QKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH-IS 401
           Q +   + +GL ++H      +VHRD+K  N+ ++ D   KI DFGLA+  + + T  + 
Sbjct: 129 QYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV 185

Query: 402 TRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           TR      Y APE  L W +     D++S G +  E+++GK
Sbjct: 186 TRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 78.0 bits (193), Expect = 6e-16
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 21/211 (9%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIA----MISCLQ 294
            +FD  + IG G +  V   +L     I A+K +  +    + +                
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68

Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLG-IARGL 353
           HP LV +H C     +L  V EY+    L   +  R+    E       +     I+  L
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPE----EHARFYSAEISLAL 123

Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEGDKTHISTRIAGTIGYM 411
            +LHE     I++RD+K  NVLLD + + K++D+G+ K  L  GD T   T   GT  Y+
Sbjct: 124 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS--T-FCGTPNYI 177

Query: 412 APEYALW-GYLTYKADVYSFGIVALEIVSGK 441
           APE      Y  +  D ++ G++  E+++G+
Sbjct: 178 APEILRGEDY-GFSVDWWALGVLMFEMMAGR 207

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 78.5 bits (194), Expect = 7e-16
 Identities = 54/216 (25%), Positives = 89/216 (41%), Gaps = 31/216 (14%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIA----MISCLQ 294
            +FD  + IG G +  V   +L     I A++ +  +    + +                
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111

Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSL-----ACALFGRENCELELDWPTRQKICLG- 348
           HP LV +H C     +L  V EY+    L            E            +     
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE----------HARFYSAE 161

Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK--LDEGDKTHISTRIAG 406
           I+  L +LHE     I++RD+K  NVLLD + + K++D+G+ K  L  GD T       G
Sbjct: 162 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST---FCG 215

Query: 407 TIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGK 441
           T  Y+APE      Y  +  D ++ G++  E+++G+
Sbjct: 216 TPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGR 250

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 78.1 bits (193), Expect = 8e-16
 Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 25/214 (11%)

Query: 239 TNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQH 295
              +   + +G G +G V        G  +A+K+L    +S    +    E+ ++  ++H
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83

Query: 296 PNLVKIH------GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGI 349
            N++ +           +     LV  +M  +     L   E    +L     Q +   +
Sbjct: 84  ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTD--LGKLMKHE----KLGEDRIQFLVYQM 137

Query: 350 ARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-HISTRIAGTI 408
            +GL ++H      I+HRD+K  N+ ++ D   KI DFGLA+  + + T ++ TR     
Sbjct: 138 LKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW---- 190

Query: 409 GYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
            Y APE  L W   T   D++S G +  E+++GK
Sbjct: 191 -YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 55/217 (25%), Positives = 98/217 (45%), Gaps = 31/217 (14%)

Query: 239 TNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSS--KSRQGNREFLNEIAMISCLQH 295
              + +   +G G +G V        G  +AVK+LS   +S    +    E+ ++  ++H
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87

Query: 296 PNLVKIH------GCCVEGDQLLLVYEYME---NNSLACALFGRENCELELDWPTRQKIC 346
            N++ +           E + + LV   M    NN + C     ++          Q + 
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV---------QFLI 138

Query: 347 LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-HISTRIA 405
             I RGL ++H      I+HRD+K +N+ ++ D   KI DFGLA+    + T +++TR  
Sbjct: 139 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW- 194

Query: 406 GTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
               Y APE  L W +     D++S G +  E+++G+
Sbjct: 195 ----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 75.4 bits (186), Expect = 6e-15
 Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 27/217 (12%)

Query: 239 TNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLS--SKSRQGNREFLNEIAMISCLQH 295
              + +   IGEG +G V       +   +A+K++S         R  L EI ++   +H
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFRH 84

Query: 296 PNLVKIH-----GCCVEGDQLLLVYEYME---NNSLACALFGRENCELELDWPTRQKICL 347
            N++ I+         +   + +V + ME      L       ++               
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI---------CYFLY 135

Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL--DEGDKTHISTRIA 405
            I RGL ++H  +   ++HRD+K +N+LL+   + KI DFGLA++   + D T   T   
Sbjct: 136 QILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192

Query: 406 GTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
            T  Y APE  L     T   D++S G +  E++S +
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 38/160 (23%), Positives = 60/160 (37%), Gaps = 29/160 (18%)

Query: 246 KKIGEGGFGPVYKG-QLADGTIIAVKQLSSKSRQGNREFLNEIA-MISCLQHPNLVKIHG 303
           + +G G  G V +          A+K L    +        E+       Q P++V+I  
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVD 78

Query: 304 CC----VEGDQLLLVYEYM---ENNSLACALFGRENCELELDWPTRQ--KICLGIARGLA 354
                      LL+V E +   E       LF R     +  +  R+  +I   I   + 
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGE-------LFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131

Query: 355 FLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAK 391
           +LH      I HRD+K  N+L      +   K++DFG AK
Sbjct: 132 YLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 72.4 bits (178), Expect = 3e-14
 Identities = 50/183 (27%), Positives = 76/183 (41%), Gaps = 20/183 (10%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQH-PN 297
           N +   +KIG G FG +Y G  +A G  +A+K    K++        E  +   +Q    
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVG 66

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH 357
           +  I  C  EGD  ++V E +   SL   LF    C  +    T   +   +   + ++H
Sbjct: 67  IPTIRWCGAEGDYNVMVMELL-GPSLE-DLF--NFCSRKFSLKTVLLLADQMISRIEYIH 122

Query: 358 EESRFKIVHRDIKATNVLLDRDLNPK---ISDFGLAK--LDEGDKTHISTR----IAGTI 408
            ++    +HRD+K  N L+          I DFGLAK   D     HI  R    + GT 
Sbjct: 123 SKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179

Query: 409 GYM 411
            Y 
Sbjct: 180 RYA 182

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 71.9 bits (177), Expect = 5e-14
 Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 34/225 (15%)

Query: 239 TNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPN 297
            + +   K +G GG G V+          +A+K++     Q  +  L EI +I  L H N
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69

Query: 298 LVKIH--------------GCCVEGDQLLLVYEYME---NNSLACALFGRENCELELDWP 340
           +VK+               G   E + + +V EYME    N L       E+        
Sbjct: 70  IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHA------- 122

Query: 341 TRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD-RDLNPKISDFGLAKL--DEGDK 397
             +     + RGL ++H  +   ++HRD+K  N+ ++  DL  KI DFGLA++       
Sbjct: 123 --RLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177

Query: 398 THISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
               +    T  Y +P   L     T   D+++ G +  E+++GK
Sbjct: 178 KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 72.0 bits (177), Expect = 5e-14
 Identities = 53/192 (27%), Positives = 76/192 (39%), Gaps = 36/192 (18%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQH-PN 297
            NF   KKIG G FG +  G+ L     +A+K    KSR        E      L     
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDG 66

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQ---KICLGIA---- 350
           + +++     G    +V   +E       L G  + E   D   R    K  L IA    
Sbjct: 67  IPQVYYFGPCGKYNAMV---LE-------LLGP-SLEDLFDLCDRTFSLKTVLMIAIQLI 115

Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPK-----ISDFGLAK--LDEGDKTHISTR 403
             + ++H ++   +++RD+K  N L+ R  N       I DF LAK  +D   K HI  R
Sbjct: 116 SRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYR 172

Query: 404 ----IAGTIGYM 411
               + GT  YM
Sbjct: 173 EHKSLTGTARYM 184

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 46/185 (24%), Positives = 79/185 (42%), Gaps = 22/185 (11%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQH-PN 297
            ++   ++IGEG FG +++G  L +   +A+K    +S     +  +E      L     
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTG 67

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH 357
           +  ++    EG   +LV + +   SL   L   + C  +    T       +   +  +H
Sbjct: 68  IPNVYYFGQEGLHNVLVIDLL-GPSLE-DLL--DLCGRKFSVKTVAMAAKQMLARVQSIH 123

Query: 358 EESRFKIVHRDIKATNVLLDRDLNPK-----ISDFGLAK--LDEGDKTHISTR----IAG 406
           E+S   +V+RDIK  N L+ R  +       + DFG+ K   D   K HI  R    ++G
Sbjct: 124 EKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 180

Query: 407 TIGYM 411
           T  YM
Sbjct: 181 TARYM 185

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 46/205 (22%), Positives = 92/205 (44%), Gaps = 27/205 (13%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ-HPNLVKIHG 303
           +K+G G +  V++   + +   + VK L    ++   +   EI ++  L+  PN++ +  
Sbjct: 42  RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLA- 97

Query: 304 CCVEGDQ---LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
             V+        LV+E++ N      L+        L     +     I + L + H  S
Sbjct: 98  DIVKDPVSRTPALVFEHVNNTDFK-QLYQT------LTDYDIRFYMYEILKALDYCH--S 148

Query: 361 RFKIVHRDIKATNVLLD---RDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYAL 417
              I+HRD+K  NV++D   R L  ++ D+GLA+     + + + R+A +  +  PE  +
Sbjct: 149 M-GIMHRDVKPHNVMIDHEHRKL--RLIDWGLAEFYHPGQEY-NVRVA-SRYFKGPELLV 203

Query: 418 -WGYLTYKADVYSFGIVALEIVSGK 441
            +    Y  D++S G +   ++  K
Sbjct: 204 DYQMYDYSLDMWSLGCMLASMIFRK 228

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 54/183 (29%), Positives = 79/183 (43%), Gaps = 20/183 (10%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ-HPN 297
           N F   +KIG G FG +Y G  +     +A+K  + K++  + + L E  +   LQ    
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTG 64

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH 357
           +  +    VEGD  +LV + +   SL   LF    C  +L   T   +   +   + F+H
Sbjct: 65  IPNVRWFGVEGDYNVLVMDLL-GPSLE-DLF--NFCSRKLSLKTVLMLADQMINRVEFVH 120

Query: 358 EESRFKIVHRDIKATNVLLDRDLNPK---ISDFGLAKL--DEGDKTHISTR----IAGTI 408
            +S    +HRDIK  N L+          I DFGLAK   D     HI  R    + GT 
Sbjct: 121 SKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177

Query: 409 GYM 411
            Y 
Sbjct: 178 RYA 180

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 71.8 bits (176), Expect = 1e-13
 Identities = 38/167 (22%), Positives = 75/167 (44%), Gaps = 30/167 (17%)

Query: 239 TNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLN---------EIA 288
            + ++    IG G +G V +     +  ++A+K++        R F +         EIA
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIA 104

Query: 289 MISCLQHPNLVKIH-----GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQ 343
           +++ L H ++VK+          + D+L +V E  +++        R    L       +
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSD-FKKLF--RTPVYLTEL--HIK 159

Query: 344 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 390
            +   +  G+ ++H      I+HRD+K  N L+++D + K+ DFGLA
Sbjct: 160 TLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA 203

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 50/223 (22%), Positives = 90/223 (40%), Gaps = 42/223 (18%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSR---QGNRE--FLNEIAMISCLQHPNLV 299
           +K+G G F  V+  + + + T +A+K +            E   L  +      +  ++ 
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 300 KIHGCCV-----------EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLG 348
             H   +            G  +++V+E +  N LA     ++     +     ++I   
Sbjct: 85  ANH--ILKLLDHFNHKGPNGVHVVMVFEVLGENLLA---LIKKYEHRGIPLIYVKQISKQ 139

Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP------KISDFGLAKLDEGDKT-HIS 401
           +  GL ++H      I+H DIK  NVL++   +P      KI+D G A   +   T  I 
Sbjct: 140 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 197

Query: 402 TRIAGTIGYMAPEYAL---WGYLTYKADVYSFGIVALEIVSGK 441
           TR      Y +PE  L   WG     AD++S   +  E+++G 
Sbjct: 198 TRE-----YRSPEVLLGAPWG---CGADIWSTACLIFELITGD 232

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 68.0 bits (167), Expect = 1e-12
 Identities = 48/224 (21%), Positives = 94/224 (41%), Gaps = 34/224 (15%)

Query: 239 TNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLS--SKSRQGNREFLNEIAMISCLQH 295
           +++F     +GEG +G V        G I+A+K++    K     R  L EI ++   +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT-LREIKILKHFKH 68

Query: 296 PNLVKIH-----GCCVEGDQLLLVYEYME---NNSLACALFGRENCELELDWPTRQKICL 347
            N++ I            +++ ++ E M+   +  ++  +   ++          Q    
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHI---------QYFIY 119

Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
              R +  LH  +   ++HRD+K +N+L++ + + K+ DFGLA++ +      S      
Sbjct: 120 QTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176

Query: 408 IG---------YMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
            G         Y APE  L     +   DV+S G +  E+   +
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 45/200 (22%), Positives = 85/200 (42%), Gaps = 31/200 (15%)

Query: 239 TNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLN---------EIA 288
            +N+     IG G +G VY          +A+K+++       R F +         EI 
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-------RMFEDLIDCKRILREIT 77

Query: 289 MISCLQHPNLVKIHGCCV-----EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQ 343
           +++ L+   +++++   +     + D+L +V E  +++ L      +    L  +    +
Sbjct: 78  ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSD-LKKLF--KTPIFLTEE--HIK 132

Query: 344 KICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA-KLDEGDKTHIST 402
            I   +  G  F+HE     I+HRD+K  N LL++D + K+ DFGLA  ++    T+I  
Sbjct: 133 TILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVN 189

Query: 403 RIAGTIGYMAPEYALWGYLT 422
            +            L   LT
Sbjct: 190 DLEENEEPGPHNKNLKKQLT 209

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 41/198 (20%), Positives = 66/198 (33%), Gaps = 42/198 (21%)

Query: 246 KKIGEGGFGPVYKGQLADGTII------AVKQLSSKSRQGNRE--FLNEIAMISCLQHPN 297
             IG+GGFG +Y   +     +       VK   S +     E  F    A    +Q   
Sbjct: 41  LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100

Query: 298 LV---------KIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQ---KI 345
                      K  G  +                +    FG  + +   +   ++   K 
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKN------GKSYRFMIMDRFGS-DLQKIYEANAKRFSRKT 153

Query: 346 CLGIA----RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKI--SDFGLAK--LDEGDK 397
            L ++      L ++HE      VH DIKA+N+LL+     ++   D+GLA     EG  
Sbjct: 154 VLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210

Query: 398 THISTR----IAGTIGYM 411
              +        GTI + 
Sbjct: 211 KAYAADPKRCHDGTIEFT 228

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 53/219 (24%), Positives = 85/219 (38%), Gaps = 48/219 (21%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSR---QGNRE-----FLNE---------I 287
           K IG+G FG V K         +A+K + ++ R   Q   E      L +         I
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162

Query: 288 AMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKI 345
            M+      N    H C        + +E +  N     L    ++N       P  +K 
Sbjct: 163 HMLENFTFRN----HIC--------MTFELLSMN-----LYELIKKNKFQGFSLPLVRKF 205

Query: 346 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP--KISDFGLA-KLDEGDKTHIST 402
              I + L  LH   + +I+H D+K  N+LL +      K+ DFG +    +   T+I +
Sbjct: 206 AHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQS 262

Query: 403 RIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
           R      Y APE  L        D++S G +  E+++G 
Sbjct: 263 RF-----YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 49/212 (23%), Positives = 85/212 (40%), Gaps = 32/212 (15%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSR---QGNREFLNEIAMISCLQHP----- 296
             IG+G FG V K     +   +A+K + +K     Q       E+ ++  +        
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMK 115

Query: 297 -NLVKIHGCCVEGDQLLLVYEYMENNSLACALFG--RENCELELDWPTRQKICLGIARGL 353
             +V +    +  + L LV+E +  N     L+   R      +     +K    +   L
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYN-----LYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170

Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNP--KISDFGLA-KLDEGDKTHISTRIAGTIGY 410
            FL       I+H D+K  N+LL        KI DFG + +L +    +I +R      Y
Sbjct: 171 LFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----Y 224

Query: 411 MAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
            +PE  L   Y     D++S G + +E+ +G+
Sbjct: 225 RSPEVLLGMPY-DLAIDMWSLGCILVEMHTGE 255

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 60.1 bits (146), Expect = 5e-10
 Identities = 52/241 (21%), Positives = 98/241 (40%), Gaps = 58/241 (24%)

Query: 239 TNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLN---------EIA 288
              ++  KK+G+G +G V+K      G ++AVK++          F N         EI 
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFREIM 60

Query: 289 MISCLQ-HPNLVKIHGCCV--EGDQLLLVYEYME---NNSLACALFGRENCELELDWPTR 342
           +++ L  H N+V +           + LV++YME   +  +   +    +          
Sbjct: 61  ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHK--------- 111

Query: 343 QKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIST 402
           Q +   + + + +LH  S   ++HRD+K +N+LL+ + + K++DFGL++     +   + 
Sbjct: 112 QYVVYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN 168

Query: 403 RIAGTIGYMAPEYALWGYLT-------YKA--------------DVYSFG-IVALEIVSG 440
                             LT       Y+A              D++S G I+  EI+ G
Sbjct: 169 IPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILG-EILCG 227

Query: 441 K 441
           K
Sbjct: 228 K 228

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 60.3 bits (146), Expect = 5e-10
 Identities = 55/261 (21%), Positives = 92/261 (35%), Gaps = 78/261 (29%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ-----HPNLV 299
           +K+G G F  V+    +     +A+K + S         L+EI ++  ++      PN  
Sbjct: 43  RKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNRE 101

Query: 300 ---------KIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
                    KI G  V G  + +V+E + ++ L    +  ++    L  P  +KI   + 
Sbjct: 102 MVVQLLDDFKISG--VNGTHICMVFEVLGHHLLK---WIIKSNYQGLPLPCVKKIIQQVL 156

Query: 351 RGLAFLHEESRFKIVHRDIKATNVLL---------------------------------- 376
           +GL +LH +   +I+H DIK  N+LL                                  
Sbjct: 157 QGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214

Query: 377 ---------------DRDLNPKISDFGLAKLDEGDKTH-ISTRIAGTIGYMAPEYALWGY 420
                             L  KI+D G A       T  I TR      Y + E  +   
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSG 269

Query: 421 LTYKADVYSFGIVALEIVSGK 441
               AD++S   +A E+ +G 
Sbjct: 270 YNTPADIWSTACMAFELATGD 290

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 28/203 (13%), Positives = 59/203 (29%), Gaps = 52/203 (25%)

Query: 246 KKIGEGGFGPVYKGQ---------LADGTIIAVKQLSSKS----------RQGNREFLNE 286
                   G +Y+                  ++K  +             R      +N+
Sbjct: 48  SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107

Query: 287 IAMISCLQHPNLVKIHGCCVEGDQL-LLVYEYMENNSLACALFGRENCELELDWPTRQK- 344
              +       +    G  V  D+   LV   +          GR + +  LD   +   
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLV---LP-------SLGR-SLQSALDVSPKHVL 156

Query: 345 -----ICLG---IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKI--SDFGLAKLDE 394
                + +    +   L FLHE      VH ++ A N+ +D +   ++  + +G A    
Sbjct: 157 SERSVLQVACRLLDA-LEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYC 212

Query: 395 GDKTHISTR------IAGTIGYM 411
               H++          G + ++
Sbjct: 213 PSGKHVAYVEGSRSPHEGDLEFI 235

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 57.0 bits (138), Expect = 5e-09
 Identities = 39/193 (20%), Positives = 67/193 (34%), Gaps = 35/193 (18%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
           KKIG GGFG +Y           A   +  + ++ N    +E+     +   + +K    
Sbjct: 43  KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQE-NGPLFSELKFYQRVAKKDCIKKWIE 101

Query: 305 CVEGDQL---------LLVYEYMENNSLACALFGRENCELELDWPTRQK------ICLG- 348
             + D L         L  ++      +     G +   L+              + LG 
Sbjct: 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID---LQKISGQNGTFKKSTVLQLGI 158

Query: 349 --IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKI--SDFGLAK--LDEGDKTHIST 402
             +   L ++HE      VH DIKA N+LL      ++  +D+GL+      G+      
Sbjct: 159 RMLDV-LEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQE 214

Query: 403 R----IAGTIGYM 411
                  GTI + 
Sbjct: 215 NPRKGHNGTIEFT 227

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 57.9 bits (139), Expect = 5e-09
 Identities = 61/439 (13%), Positives = 122/439 (27%), Gaps = 94/439 (21%)

Query: 76  NYTLSLHFAEIQFSNGITFHSLGRRLF---DIYIQDNLVERNFDIKAEASGVL-----KP 127
           N  L +H  + +    +        L    ++  Q+      F++  +   +L     K 
Sbjct: 222 NIKLRIHSIQAELRRLLKSKPYENCLLVLLNV--QNAKAWNAFNLSCK---ILLTTRFKQ 276

Query: 128 VARSYNVTVTNHIIEIRFHWAGKGTTALPKRGIYGPLVSAISLNDPKLKPGKKKVVPIVV 187
           V    +   T HI            T    + +   L+  +      L        P  +
Sbjct: 277 VTDFLSAATTTHISLDHHSM---TLTPDEVKSL---LLKYLDCRPQDLPREVLTTNPRRL 330

Query: 188 GVVAGLSLIILVVSILGWRYYLRTKRHKETAFMKESDLQTISFTLKQ-------IKAATN 240
            ++A      +   +  W  +      K T  ++ S L  +     +       +     
Sbjct: 331 SIIAES----IRDGLATWDNWKHVNCDKLTTIIESS-LNVLEPAEYRKMFDRLSV----- 380

Query: 241 NFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKS---RQGNRE--FLNEIAMISCLQH 295
            F  +  I       ++   +    ++ V +L   S   +Q       +  I +   ++ 
Sbjct: 381 -FPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKL 439

Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
            N   +H   V+   +   +   +++ L             LD    Q     I   L  
Sbjct: 440 ENEYALHRSIVDHYNIPKTF---DSDDLI---------PPYLD----QYFYSHIGHHLKN 483

Query: 356 LHEESRFKIVHRDIKATNVLLD-RDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPE 414
           +    R  +         V LD R L  KI     A    G   +   ++          
Sbjct: 484 IEHPERMTLF------RMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLK--------F 529

Query: 415 YALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPAL-EFDCTCLLDWACHLQQDGKLVEL 473
           Y    Y+      Y   + A+              L     T LL  A  L  + + +  
Sbjct: 530 YK--PYICDNDPKYERLVNAIL----DFLPKIEENLICSKYTDLLRIA--LMAEDEAI-- 579

Query: 474 VDERLGSKYKKEEAERMIK 492
                   +  EEA + ++
Sbjct: 580 --------F--EEAHKQVQ 588

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 48.7 bits (115), Expect = 4e-06
 Identities = 61/456 (13%), Positives = 133/456 (29%), Gaps = 132/456 (28%)

Query: 76  NYTLSLHFAEIQFSNGITFHSLGRRLFDIYIQDNLVERNFDIKAEASGVLKPVARSYNVT 135
           ++ +     E Q+          + +  ++        NFD K +   + K +     + 
Sbjct: 4   HHHMDFETGEHQYQY--------KDILSVFEDA--FVDNFDCK-DVQDMPKSILSKEEI- 51

Query: 136 VTNHIIEIRFHWAGKGTTALPKRGIYGPLVSAISLNDPKLKPGKKKVVPIVVGVVAGLSL 195
             +HII                  ++  L+S         K   +++V   V  V  ++ 
Sbjct: 52  --DHIIM-------SKDAVSGTLRLFWTLLS---------KQ--EEMVQKFVEEVLRINY 91

Query: 196 IILVVSILGWRYYLRTKRHKETAFMKESD-LQTIS--FT---------LKQIKAATNNFD 243
             L+      +   R        ++++ D L   +  F            +++ A     
Sbjct: 92  KFLMSP---IKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELR 148

Query: 244 SAKKI---GEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK 300
            AK +   G  G G   K      T +A+    S   Q   +F                K
Sbjct: 149 PAKNVLIDGVLGSG---K------TWVALDVCLSYKVQCKMDF----------------K 183

Query: 301 IH----GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFL 356
           I       C   + +L   E ++       L  +    ++ +W +R      I   +  +
Sbjct: 184 IFWLNLKNCNSPETVL---EMLQK------LLYQ----IDPNWTSRSDHSSNIKLRIHSI 230

Query: 357 HEESRFKIVHRDIKATNVLLD-RDL-NPKISDFGLAKLDEGDKTHISTR--------IAG 406
             E R  +  +  +  N LL   ++ N K         +   K  ++TR         A 
Sbjct: 231 QAELRRLLKSKPYE--NCLLVLLNVQNAKA----WNAFNLSCKILLTTRFKQVTDFLSAA 284

Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWAC--HL 464
           T  +++ ++        +            +            L+     L       + 
Sbjct: 285 TTTHISLDHHSMTLTPDEV---------KSL--------LLKYLDCRPQDLPREVLTTNP 327

Query: 465 QQDGKLVELVDERLG-----SKYKKEEAERMIKVSL 495
           ++   + E + + L           ++   +I+ SL
Sbjct: 328 RRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSL 363

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 48/240 (20%), Positives = 78/240 (32%), Gaps = 72/240 (30%)

Query: 246 KKIGEGGFGPVYKG--QLADGTIIAVKQLSSKSR---QGNRE-----FLNE--------- 286
             +GEG FG V +        + +A+K + +  +       E      + E         
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 84

Query: 287 IAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQK 344
           + M            H C        + +E +  N        F +EN       P  + 
Sbjct: 85  VLMSDWFNFHG----HMC--------IAFELLGKN-----TFEFLKENNFQPYPLPHVRH 127

Query: 345 ICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP-------------------KIS 385
           +   +   L FLHE    ++ H D+K  N+L                          +++
Sbjct: 128 MAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184

Query: 386 DFGLAKLDEGDKTH---ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           DFG A  D   + H   ++TR      Y  PE  L  G+     DV+S G +  E   G 
Sbjct: 185 DFGSATFD--HEHHTTIVATRH-----YRPPEVILELGW-AQPCDVWSIGCILFEYYRGF 236

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 47.3 bits (113), Expect = 6e-06
 Identities = 61/242 (25%), Positives = 89/242 (36%), Gaps = 76/242 (31%)

Query: 246 KKIGEGGFGPVYKGQ--LADGTIIAVKQLSSKSR---QGNRE-----FLNE--------- 286
             +GEG FG V +     A G  +AVK + +  R       E      LN          
Sbjct: 20  DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRC 79

Query: 287 IAMISCLQHPNLVKIHGCCV-EGDQLLL---VYEYMENNSLACALFGRENCELELDWPTR 342
           + M+   +H      H C V E    LL    Y+++           +EN  L       
Sbjct: 80  VQMLEWFEHHG----HICIVFE----LLGLSTYDFI-----------KENGFLPFRLDHI 120

Query: 343 QKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP-------------------K 383
           +K+   I + + FLH     K+ H D+K  N+L  +                       K
Sbjct: 121 RKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIK 177

Query: 384 ISDFGLAKLDEGDKTH---ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVS 439
           + DFG A  D  D+ H   +STR      Y APE  L  G+ +   DV+S G + +E   
Sbjct: 178 VVDFGSATYD--DEHHSTLVSTRH-----YRAPEVILALGW-SQPCDVWSIGCILIEYYL 229

Query: 440 GK 441
           G 
Sbjct: 230 GF 231

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 47.3 bits (113), Expect = 7e-06
 Identities = 55/236 (23%), Positives = 90/236 (38%), Gaps = 60/236 (25%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSR---QGNREFLNEIAMISCLQH-----P 296
           +K+G+G FG V   Q + +    AVK + +  +           E  ++  +Q+      
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNN 96

Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSLACAL--FGRENCELELDWPTRQKICLGIARGLA 354
           N+VK HG  +  D + L++E +  +     L      N          +  C+ I + L 
Sbjct: 97  NIVKYHGKFMYYDHMCLIFEPLGPS-----LYEIITRNNYNGFHIEDIKLYCIEILKALN 151

Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNP-------------------------KISDFGL 389
           +L +     + H D+K  N+LLD                              K+ DFG 
Sbjct: 152 YLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208

Query: 390 AKLDEGDKTH---ISTRIAGTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK 441
           A        H   I+TR      Y APE  L  G+    +D++SFG V  E+ +G 
Sbjct: 209 ATFK--SDYHGSIINTRQ-----YRAPEVILNLGW-DVSSDMWSFGCVLAELYTGS 256

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	511
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.89
2jwp_A	174	Malectin, MGC80075; sugar binding, sugar binding p	99.83
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.79
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.64
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.33
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.16
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.99
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.93
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.55
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.53
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.36
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.33
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.17
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.07
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.86
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.85
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.67
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.65
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.28
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.05
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.99
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.99
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.88
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.78
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.77
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.6
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	95.72
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.71
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	95.49
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.44
3mes_A	424	Choline kinase; malaria, structural genomics, stru	92.27
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	87.79
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	87.1
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	86.47
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	86.05
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	81.18

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.7e-57  Score=446.79  Aligned_cols=251  Identities=29%  Similarity=0.487  Sum_probs=208.0

Q ss_pred             cCCcccCceeccCceeEEecccc------CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  313 (511)
                      ++|.+.++||+|+||.||+|++.      ++..||||+++.......++|.+|+.+|++++|||||+++|+|.+++.+++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            56788899999999999999753      477899999987766677889999999999999999999999999999999


Q ss_pred             EEEecCCCCHhHHHhcCC---------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEE
Q 045835          314 VYEYMENNSLACALFGRE---------NCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKI  384 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl  384 (511)
                      |||||++|+|.++|....         .....++|.++++++.|||+||+|||+++   |+||||||+||||++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence            999999999999997642         23456999999999999999999999986   999999999999999999999


Q ss_pred             eecCCcccCCCCCc-eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhH
Q 045835          385 SDFGLAKLDEGDKT-HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWAC  462 (511)
Q Consensus       385 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~  462 (511)
                      +|||+|+....... .......||+.|||||++.++.++.++|||||||+||||+| |+.||.....     ..      
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-----~~------  238 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-----NE------  238 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----HH------
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----HH------
Confidence            99999986543322 23334568999999999999999999999999999999999 8999974321     11      


Q ss_pred             hhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          463 HLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       463 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                             +...+........|..++.++.+|+.+||+.+|++||||.||
T Consensus       239 -------~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i  280 (299)
T 4asz_A          239 -------VIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI  280 (299)
T ss_dssp             -------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             -------HHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence                   111122222233455666789999999999999999999874

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.9e-56  Score=446.08  Aligned_cols=251  Identities=27%  Similarity=0.447  Sum_probs=202.0

Q ss_pred             cCCcccCceeccCceeEEecccc------CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  313 (511)
                      ++|.+.++||+|+||.||+|++.      +++.||||+++.......++|.+|+.+|++++|||||+++|+|.+.+.+++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45677889999999999999753      478899999987776677889999999999999999999999999999999


Q ss_pred             EEEecCCCCHhHHHhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCe
Q 045835          314 VYEYMENNSLACALFGREN-----------CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP  382 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~  382 (511)
                      |||||++|+|.++|+....           ...+++|.++++|+.|||+||+|||+.+   |+||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence            9999999999999976432           1246999999999999999999999986   9999999999999999999


Q ss_pred             EEeecCCcccCCCCC-ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhh
Q 045835          383 KISDFGLAKLDEGDK-THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDW  460 (511)
Q Consensus       383 kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~  460 (511)
                      ||+|||+++...... ........||+.|||||++.+..++.++|||||||+||||+| |+.||.....     ..+   
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-----~~~---  269 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-----TEA---  269 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-----HHH---
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-----HHH---
Confidence            999999998654332 333445679999999999999999999999999999999999 8999964321     111   


Q ss_pred             hHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          461 ACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       461 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                                .+.+....+.+.|..++.++.+|+.+||+.||++||||.||
T Consensus       270 ----------~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei  310 (329)
T 4aoj_A          270 ----------IDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDV  310 (329)
T ss_dssp             ----------HHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHH
T ss_pred             ----------HHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHH
Confidence                      11122222234455566789999999999999999999875

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2e-56  Score=444.14  Aligned_cols=250  Identities=28%  Similarity=0.441  Sum_probs=205.7

Q ss_pred             CCcccCceeccCceeEEecccc------CCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  313 (511)
                      +++..++||+|+||.||+|++.      +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++.+++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            4556789999999999999863      46789999997543 3445789999999999999999999999999999999


Q ss_pred             EEEecCCCCHhHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCC
Q 045835          314 VYEYMENNSLACALFGREN------------CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN  381 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~  381 (511)
                      |||||++|+|.++|..+..            ....++|..+.+|+.|||+||+|||+++   |+||||||+||||++++.
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence            9999999999999975421            1346999999999999999999999986   999999999999999999


Q ss_pred             eEEeecCCcccCCCC-CceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhh
Q 045835          382 PKISDFGLAKLDEGD-KTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLD  459 (511)
Q Consensus       382 ~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~  459 (511)
                      +||+|||+++..... .........||+.|||||++.++.++.++|||||||+||||+| |+.||.....     ..   
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-----~~---  255 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-----QD---  255 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-----HH---
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH-----HH---
Confidence            999999999865332 2223345679999999999999999999999999999999999 8999864321     11   


Q ss_pred             hhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          460 WACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       460 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                                +.+.+........+.+++..+.+|+.+||+.+|++||||.||
T Consensus       256 ----------~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei  297 (308)
T 4gt4_A          256 ----------VVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDI  297 (308)
T ss_dssp             ----------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             ----------HHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence                      122222222234455667789999999999999999999875

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-54  Score=429.00  Aligned_cols=250  Identities=29%  Similarity=0.459  Sum_probs=195.6

Q ss_pred             cCCcccCceeccCceeEEeccccCCcEEEEEEeccc--CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSK--SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      +++.+.++||+|+||.||+|++.+  .||||+++..  .....+.|.+|+.+|++++|||||+++|+|.+ +.+++||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy  112 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW  112 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence            567788999999999999998753  5999998743  23445689999999999999999999999865 568999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      |++|+|.++|+...   ..++|.++..|+.|||+||+|||+++   |+||||||+||||++++.+||+|||+|+......
T Consensus       113 ~~gGsL~~~l~~~~---~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          113 CEGSSLYKHLHVQE---TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             CSSCBHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred             CCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence            99999999997543   35999999999999999999999986   9999999999999999999999999998654322


Q ss_pred             -ceeecccccCCCccccccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHh
Q 045835          398 -THISTRIAGTIGYMAPEYALW---GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVEL  473 (511)
Q Consensus       398 -~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  473 (511)
                       ........||+.|||||++..   +.++.++|||||||+||||+||+.||......        .........+    .
T Consensus       187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~--------~~~~~~~~~~----~  254 (307)
T 3omv_A          187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR--------DQIIFMVGRG----Y  254 (307)
T ss_dssp             -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--------HHHHHHHHTT----C
T ss_pred             cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH--------HHHHHHHhcC----C
Confidence             223345689999999999864   46899999999999999999999999643210        1111111111    0


Q ss_pred             hhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          474 VDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       474 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..+.+ ...+.+++..+.+|+.+||+.+|++||||.||
T Consensus       255 ~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei  291 (307)
T 3omv_A          255 ASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQI  291 (307)
T ss_dssp             CCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHH
T ss_pred             CCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHH
Confidence            01111 12344556779999999999999999999874

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=8.7e-53  Score=421.98  Aligned_cols=246  Identities=26%  Similarity=0.408  Sum_probs=206.0

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      +.|+..++||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+++.+++|||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            5689999999999999999975 469999999997665556677899999999999999999999999999999999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      ++|+|.+++...     .+++.....++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+.......
T Consensus       154 ~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  225 (346)
T 4fih_A          154 EGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  225 (346)
T ss_dssp             TTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred             CCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence            999999998643     4899999999999999999999987   99999999999999999999999999987654332


Q ss_pred             eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhh-h
Q 045835          399 HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDE-R  477 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~-~  477 (511)
                       ..+..+||+.|||||++.+..++.++|||||||++|||++|+.||.....     .....            .+.+. .
T Consensus       226 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~~~~~------------~i~~~~~  287 (346)
T 4fih_A          226 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----LKAMK------------MIRDNLP  287 (346)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHH------------HHHHSSC
T ss_pred             -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HHHHH------------HHHcCCC
Confidence             23456899999999999999999999999999999999999999963221     11111            11111 0


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....+...+.++.+|+.+||+.||++|||+.|+
T Consensus       288 ~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~  321 (346)
T 4fih_A          288 PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAEL  321 (346)
T ss_dssp             CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            0112223445678999999999999999998764

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.3e-53  Score=424.87  Aligned_cols=248  Identities=21%  Similarity=0.372  Sum_probs=199.4

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      ++|++.++||+|+||.||+|+. .+|+.||||++....  ....+.|.+|+.+|++++|||||++++++.+++.+++|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            5799999999999999999975 468999999997542  3345678999999999999999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      ||++|+|.++|....  ...+++...+.++.||+.||+|||+++   |+||||||+||||++++.+||+|||+|+.....
T Consensus       104 y~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          104 YCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             CCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred             CCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence            999999999997543  235789999999999999999999987   999999999999999999999999999865432


Q ss_pred             CceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhh
Q 045835          397 KTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDE  476 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  476 (511)
                      . ...+..+||+.|||||++.+..++.++|||||||+||||+||+.||....        ..+..         ..++..
T Consensus       179 ~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~---------~~i~~~  240 (350)
T 4b9d_A          179 V-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS--------MKNLV---------LKIISG  240 (350)
T ss_dssp             H-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHH---------HHHHHT
T ss_pred             c-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHH---------HHHHcC
Confidence            1 22334679999999999999999999999999999999999999996422        11111         111111


Q ss_pred             hhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          477 RLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       477 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .. ...+...+.++.+|+.+||+.||++|||+.|+
T Consensus       241 ~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~  274 (350)
T 4b9d_A          241 SF-PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSI  274 (350)
T ss_dssp             CC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence            11 12233445678999999999999999998764

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.1e-53  Score=428.55  Aligned_cols=261  Identities=26%  Similarity=0.386  Sum_probs=211.7

Q ss_pred             cHHHHHHHhcCCcccCceeccCceeEEecccc------CCcEEEEEEecccCc-cchHHHHHHHHHHhcCCC-CCceeEE
Q 045835          231 TLKQIKAATNNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSKSR-QGNREFLNEIAMISCLQH-PNLVKIH  302 (511)
Q Consensus       231 ~~~~l~~~~~~f~~~~~lG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H-~niv~l~  302 (511)
                      ..++.+...++|++.++||+|+||.||+|++.      .++.||||+++.... ...++|.+|+.+|++++| ||||+++
T Consensus        55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~  134 (353)
T 4ase_A           55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL  134 (353)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence            34445556688999999999999999999753      246899999976543 345679999999999965 8999999


Q ss_pred             EEEEeC-CEEEEEEEecCCCCHhHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccC
Q 045835          303 GCCVEG-DQLLLVYEYMENNSLACALFGREN------------CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDI  369 (511)
Q Consensus       303 g~~~~~-~~~~lV~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dl  369 (511)
                      |+|.+. +.+++|||||++|+|.++|+....            ....++|..+..++.|||+||+|||+++   ||||||
T Consensus       135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDL  211 (353)
T 4ase_A          135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL  211 (353)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCcc
Confidence            999764 568999999999999999975432            1345899999999999999999999986   999999


Q ss_pred             CCCCeEEcCCCCeEEeecCCcccCCCCCc-eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 045835          370 KATNVLLDRDLNPKISDFGLAKLDEGDKT-HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYA  447 (511)
Q Consensus       370 k~~NILld~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~  447 (511)
                      ||+||||++++.+||+|||+|+....+.. .......||+.|||||++.++.++.++|||||||+||||+| |+.||...
T Consensus       212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~  291 (353)
T 4ase_A          212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  291 (353)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999996544333 33445679999999999999999999999999999999998 99999643


Q ss_pred             CcccccccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          448 PALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       448 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...        +         .+...+....+...|..++.++.+++.+||+.||++||||.||
T Consensus       292 ~~~--------~---------~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~ei  338 (353)
T 4ase_A          292 KID--------E---------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL  338 (353)
T ss_dssp             CCS--------H---------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CHH--------H---------HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHH
Confidence            210        0         1222333333344455566789999999999999999999874

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.4e-52  Score=412.72  Aligned_cols=246  Identities=22%  Similarity=0.315  Sum_probs=206.0

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEeccc---CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK---SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|++.+.||+|+||.||+|+. .+|+.||||++...   .....+.+.+|+++|++++|||||++++++.+++.+++||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            4699999999999999999974 57899999999743   2344567899999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      |||++|+|.+++....    .+++.....++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+....
T Consensus       112 Ey~~gG~L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~  184 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP  184 (311)
T ss_dssp             CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence            9999999999996543    5999999999999999999999987   99999999999999999999999999997643


Q ss_pred             C-CceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          396 D-KTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       396 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      . ........+||+.|||||++.+..++.++||||+||++|||+||+.||....     ...+.            ..++
T Consensus       185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-----~~~~~------------~~i~  247 (311)
T 4aw0_A          185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-----EGLIF------------AKII  247 (311)
T ss_dssp             TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHH------------HHHH
T ss_pred             CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHH------------HHHH
Confidence            3 2233445789999999999999999999999999999999999999996322     11111            1111


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..  ...++...+.++.+|+.+||+.||++|||+.|+
T Consensus       248 ~~--~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~  282 (311)
T 4aw0_A          248 KL--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM  282 (311)
T ss_dssp             HT--CCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGG
T ss_pred             cC--CCCCCcccCHHHHHHHHHHccCCHhHCcChHHH
Confidence            11  112344445678999999999999999999863

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.3e-52  Score=416.90  Aligned_cols=262  Identities=27%  Similarity=0.328  Sum_probs=193.8

Q ss_pred             cCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCC----EEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGD----QLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~lV~  315 (511)
                      +++.+.++||+|+||.||+|++ +|+.||||+++..... ...+..|+..+.+++|||||+++|+|.+.+    .+++||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            3567788999999999999987 5899999999754321 122345666677899999999999998754    689999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEEccCCCCCeEEcCCCCeEEeecCCc
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE-----SRFKIVHRDIKATNVLLDRDLNPKISDFGLA  390 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-----~~~~iiH~Dlk~~NILld~~~~~kl~DfGla  390 (511)
                      |||++|+|.++|+..     .++|..+.+++.|+|+||+|||++     +.++|+||||||+||||++++++||+|||++
T Consensus        81 Ey~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             ECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             cCCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            999999999999754     489999999999999999999986     2346999999999999999999999999999


Q ss_pred             ccCCCCCcee---ecccccCCCcccccccccC------CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhh
Q 045835          391 KLDEGDKTHI---STRIAGTIGYMAPEYALWG------YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWA  461 (511)
Q Consensus       391 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~  461 (511)
                      +.........   ....+||+.|||||++.+.      .++.++|||||||+||||+||++|+.........   ...+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p---~~~~~  232 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP---YYDLV  232 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT---TTTTS
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc---chhcc
Confidence            8654433221   2345799999999998754      4678999999999999999999887533211100   00000


Q ss_pred             HhhhccCchh-HhhhhhhCCCCC-----HHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          462 CHLQQDGKLV-ELVDERLGSKYK-----KEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       462 ~~~~~~~~~~-~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ........+. .+.+..++...+     .+.+..+.+|+.+||+.||++||||.||
T Consensus       233 ~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei  288 (303)
T 3hmm_A          233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI  288 (303)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHH
T ss_pred             cccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHH
Confidence            0000000011 112222222222     3566789999999999999999999875

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.7e-52  Score=408.38  Aligned_cols=244  Identities=26%  Similarity=0.390  Sum_probs=193.5

Q ss_pred             cccCceeccCceeEEecccc-CCcEEEEEEeccc--CccchHHHHHHHHHHhcCCCCCceeEEEEEEe----CCEEEEEE
Q 045835          243 DSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK--SRQGNREFLNEIAMISCLQHPNLVKIHGCCVE----GDQLLLVY  315 (511)
Q Consensus       243 ~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~  315 (511)
                      +..++||+|+||.||+|... ++..||||++...  .....+.|.+|+.+|++++|||||+++++|.+    ++.+++||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            56678999999999999754 6889999999654  23344679999999999999999999999875    34689999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcC-CCCeEEeecCCcccCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR-DLNPKISDFGLAKLDE  394 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~-~~~~kl~DfGla~~~~  394 (511)
                      |||++|+|.+++....    .+++..+..++.||+.||+|||+++ ++|+||||||+||||+. ++.+||+|||+|+...
T Consensus       109 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            9999999999997543    5899999999999999999999875 46999999999999984 7899999999998654


Q ss_pred             CCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          395 GDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       395 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      ...   ....+||+.|||||++.+ .++.++|||||||+||||+||+.||.....       ........ ..+.     
T Consensus       184 ~~~---~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~-------~~~~~~~i-~~~~-----  246 (290)
T 3fpq_A          184 ASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYRRV-TSGV-----  246 (290)
T ss_dssp             TTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHHHHH-TTTC-----
T ss_pred             CCc---cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-------HHHHHHHH-HcCC-----
Confidence            332   234689999999998764 699999999999999999999999963221       11111111 1110     


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                         .....+...+.++.+|+.+||+.||++|||+.|+
T Consensus       247 ---~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~  280 (290)
T 3fpq_A          247 ---KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL  280 (290)
T ss_dssp             ---CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             ---CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence               0011122223468899999999999999999764

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.5e-51  Score=422.91  Aligned_cols=247  Identities=26%  Similarity=0.404  Sum_probs=206.4

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      .+.|+..++||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|+.++|||||++++++.+++.+++||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            35799999999999999999975 46899999999876666667799999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      |++|+|.+++...     .+++.....++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+......
T Consensus       230 ~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~  301 (423)
T 4fie_A          230 LEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  301 (423)
T ss_dssp             CTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred             CCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence            9999999998643     4899999999999999999999987   9999999999999999999999999998665433


Q ss_pred             ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          398 THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                      . .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.....     .....            .+.+..
T Consensus       302 ~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~~~~~------------~i~~~~  363 (423)
T 4fie_A          302 P-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----LKAMK------------MIRDNL  363 (423)
T ss_dssp             C-CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHH------------HHHHSC
T ss_pred             c-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HHHHH------------HHHcCC
Confidence            2 23456899999999999999999999999999999999999999963221     11111            111100


Q ss_pred             -hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 -LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 -l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                       .....+...+..+.+|+.+||+.||++|||+.|+
T Consensus       364 ~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~el  398 (423)
T 4fie_A          364 PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAEL  398 (423)
T ss_dssp             CCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence             0111223345678999999999999999998764

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=7.1e-52  Score=414.13  Aligned_cols=243  Identities=24%  Similarity=0.238  Sum_probs=197.5

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      +.|+..++||+|+||.||+|+. .+|+.||||+++....     ..+|+.+|++++|||||++++++.+++.+++|||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            4678888999999999999975 4689999999975422     247999999999999999999999999999999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCC-CeEEeecCCcccCCCCC
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL-NPKISDFGLAKLDEGDK  397 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~-~~kl~DfGla~~~~~~~  397 (511)
                      ++|+|.++|....    .+++.....++.||+.||+|||+++   |+||||||+||||+.++ .+||+|||+|+......
T Consensus       133 ~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          133 EGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             TTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             CCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            9999999997543    5999999999999999999999986   99999999999999997 69999999998654332


Q ss_pred             ce----eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHh
Q 045835          398 TH----ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVEL  473 (511)
Q Consensus       398 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  473 (511)
                      ..    .....+||+.|||||++.+..++.++|||||||++|||+||+.||.....     ..+..            .+
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~------------~i  268 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR-----GPLCL------------KI  268 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC-----SCCHH------------HH
T ss_pred             cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH-----HHHHH------------HH
Confidence            11    12335799999999999999999999999999999999999999974321     11111            11


Q ss_pred             hhhh-hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          474 VDER-LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       474 ~d~~-l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .... ...+.++..+..+.+++.+||+.||++|||+.||
T Consensus       269 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el  307 (336)
T 4g3f_A          269 ASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMEL  307 (336)
T ss_dssp             HHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHH
Confidence            1110 0012344456678999999999999999998763

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4.8e-51  Score=397.85  Aligned_cols=243  Identities=24%  Similarity=0.363  Sum_probs=188.1

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|++.+.||+|+||.||+|+. .+|+.||||+++...   ......+.+|+.+|++++|||||++++++.+++..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            5899999999999999999975 478999999997542   234467899999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+ +|+|.+++....    .+++.....++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+|+....
T Consensus        93 Ey~-~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD  164 (275)
T ss_dssp             ECC-CEEHHHHHHHSC----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred             eCC-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence            999 689999986543    5999999999999999999999987   99999999999999999999999999986543


Q ss_pred             CCceeecccccCCCcccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYL-TYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      ..  .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||....        ......         .+.
T Consensus       165 ~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~--------~~~~~~---------~i~  225 (275)
T 3hyh_A          165 GN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES--------IPVLFK---------NIS  225 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHH---------HHH
T ss_pred             CC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC--------HHHHHH---------HHH
Confidence            22  2234689999999999988765 689999999999999999999996322        111111         111


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...  ..++...+.++.+|+.+||+.||++|||+.|+
T Consensus       226 ~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~s~~ei  260 (275)
T 3hyh_A          226 NGV--YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEI  260 (275)
T ss_dssp             HTC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             cCC--CCCCCCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence            111  12333445678899999999999999998764

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3e-51  Score=404.70  Aligned_cols=243  Identities=23%  Similarity=0.310  Sum_probs=194.0

Q ss_pred             cCCcccCceeccCceeEEeccc----cCCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL----ADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~----~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  313 (511)
                      ++|++.+.||+|+||.||+|+.    ..++.||||+++...  ......+.+|+.+|++++|||||++++++.+++.+++
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            5799999999999999999964    246899999997542  2233468899999999999999999999999999999


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      |||||++|+|.+++....    .+++.....++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+|+..
T Consensus       104 vmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             EEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            999999999999997543    5999999999999999999999987   999999999999999999999999999864


Q ss_pred             CCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHh
Q 045835          394 EGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVEL  473 (511)
Q Consensus       394 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  473 (511)
                      ..... .....+||+.|||||++.+..++.++|||||||++|||+||+.||.....     ..+.            ..+
T Consensus       177 ~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-----~~~~------------~~i  238 (304)
T 3ubd_A          177 IDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-----KETM------------TMI  238 (304)
T ss_dssp             ----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHH------------HHH
T ss_pred             cCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH-----HHHH------------HHH
Confidence            43222 23346899999999999999999999999999999999999999973221     1111            111


Q ss_pred             hhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcC
Q 045835          474 VDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMS  509 (511)
Q Consensus       474 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~  509 (511)
                      ...  ...++...+.++.+|+.+||+.||++|||+.
T Consensus       239 ~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~  272 (304)
T 3ubd_A          239 LKA--KLGMPQFLSPEAQSLLRMLFKRNPANRLGAG  272 (304)
T ss_dssp             HHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCS
T ss_pred             HcC--CCCCCCcCCHHHHHHHHHHcccCHHHCCCCC
Confidence            111  1123444556789999999999999999963

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=7.2e-50  Score=395.75  Aligned_cols=245  Identities=24%  Similarity=0.394  Sum_probs=185.9

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCc-cchHHHHHHHHHHhcCCCCCceeEEEEEEeCC--------
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSR-QGNREFLNEIAMISCLQHPNLVKIHGCCVEGD--------  309 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--------  309 (511)
                      ++|++.+.||+|+||.||+|+. .+|+.||||+++.... ...+.+.+|+.+|++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            4689999999999999999975 4789999999975443 33467899999999999999999999987644        


Q ss_pred             ----EEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEe
Q 045835          310 ----QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKIS  385 (511)
Q Consensus       310 ----~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~  385 (511)
                          .+++|||||++|+|.+++..... ....++...+.++.||+.||+|||+++   |+||||||+||||+.++.+||+
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence                36899999999999999976532 223567788999999999999999987   9999999999999999999999


Q ss_pred             ecCCcccCCCCCce-----------eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccc
Q 045835          386 DFGLAKLDEGDKTH-----------ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDC  454 (511)
Q Consensus       386 DfGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~  454 (511)
                      |||+|+........           ..+..+||+.|||||++.+..++.++|||||||++|||++   ||....    + 
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~----~-  232 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM----E-  232 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH----H-
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc----H-
Confidence            99999865432211           1223579999999999999999999999999999999996   654110    0 


Q ss_pred             cchhhhhHhhhccCchhHhhhhhhCCCCCH---HHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          455 TCLLDWACHLQQDGKLVELVDERLGSKYKK---EEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       455 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~---~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                        ..             ..+.......+++   +....+.+++.+||+.||++|||+.|+
T Consensus       233 --~~-------------~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~ei  277 (299)
T 4g31_A          233 --RV-------------RTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI  277 (299)
T ss_dssp             --HH-------------HHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             --HH-------------HHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHH
Confidence              00             0011111112222   233456789999999999999998764

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.5e-48  Score=391.49  Aligned_cols=285  Identities=46%  Similarity=0.784  Sum_probs=249.4

Q ss_pred             cccccHHHHHHHhcCCcccCceeccCceeEEeccccCCcEEEEEEecccCc-cchHHHHHHHHHHhcCCCCCceeEEEEE
Q 045835          227 TISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSR-QGNREFLNEIAMISCLQHPNLVKIHGCC  305 (511)
Q Consensus       227 ~~~~~~~~l~~~~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~  305 (511)
                      ...+++.++...+++|+..+.||+|+||.||+|+..+++.||||++..... .....+.+|+.+++.++||||++++++|
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            356889999999999999999999999999999988899999999975432 2334789999999999999999999999


Q ss_pred             EeCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEe
Q 045835          306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKIS  385 (511)
Q Consensus       306 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~  385 (511)
                      .+.+..++||||+++|+|.+++.........++|..+..++.|++.||+|||+...++|+||||||+|||++.++.+||+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~  176 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG  176 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence            99999999999999999999998776556679999999999999999999999833349999999999999999999999


Q ss_pred             ecCCcccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhh
Q 045835          386 DFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQ  465 (511)
Q Consensus       386 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~  465 (511)
                      |||+++..............||+.|+|||.+.+..++.++||||||+++|||++|+.||............+.+|.....
T Consensus       177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  256 (326)
T 3uim_A          177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL  256 (326)
T ss_dssp             CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred             cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence            99999876655555555567999999999999889999999999999999999999999643322344556778888888


Q ss_pred             ccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          466 QDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       466 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ....+..+.+..+....+.+.+..+.+++.+||+.+|++|||+.||
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el  302 (326)
T 3uim_A          257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV  302 (326)
T ss_dssp             SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHH
T ss_pred             hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHH
Confidence            8888888888888888899999999999999999999999999874

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=7.8e-48  Score=385.72  Aligned_cols=277  Identities=40%  Similarity=0.732  Sum_probs=239.5

Q ss_pred             ccHHHHHHHhcCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 045835          230 FTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGD  309 (511)
Q Consensus       230 ~~~~~l~~~~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~  309 (511)
                      +++.++..++++|+..+.||+|+||.||+|+..+++.||||++........+.+.+|+.+++.++||||++++++|.+.+
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  108 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN  108 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            44455566788999999999999999999998889999999998776666778999999999999999999999999999


Q ss_pred             EEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCC
Q 045835          310 QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL  389 (511)
Q Consensus       310 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGl  389 (511)
                      ..++||||+++|+|.+++.........++|..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~  185 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI  185 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence            999999999999999999765544456999999999999999999999986   99999999999999999999999999


Q ss_pred             cccCCCC-CceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccC
Q 045835          390 AKLDEGD-KTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDG  468 (511)
Q Consensus       390 a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~  468 (511)
                      ++..... .........||..|+|||.+.+..++.++||||||+++|||+||+.||....  ..+......|.......+
T Consensus       186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~--~~~~~~~~~~~~~~~~~~  263 (321)
T 2qkw_B          186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL--PREMVNLAEWAVESHNNG  263 (321)
T ss_dssp             CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSS--SSSCCCHHHHTHHHHTTT
T ss_pred             ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccC--cHHHHHHHHHhhhccccc
Confidence            9864322 2222334568999999999999999999999999999999999999997543  233445667776666677


Q ss_pred             chhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          469 KLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       469 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .+.+++++.+....+.+....+.+++.+||+.+|++|||+.||
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el  306 (321)
T 2qkw_B          264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV  306 (321)
T ss_dssp             CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHH
Confidence            7778888887778889999999999999999999999999874

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-46  Score=386.12  Aligned_cols=259  Identities=19%  Similarity=0.287  Sum_probs=196.5

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEe------CCE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVE------GDQ  310 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------~~~  310 (511)
                      ++|++.+.||+|+||.||+|+. .+|+.||||+++...  ....+.+.+|+.+|+.++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            5799999999999999999975 479999999997543  2334578899999999999999999999864      357


Q ss_pred             EEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCc
Q 045835          311 LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA  390 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla  390 (511)
                      +++|||||+ |+|.+++...    ..+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~----~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSS----QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSS----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEeCCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence            899999996 6799998653    35999999999999999999999987   999999999999999999999999999


Q ss_pred             ccCCCCC---ceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhh-
Q 045835          391 KLDEGDK---THISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQ-  465 (511)
Q Consensus       391 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~-  465 (511)
                      +......   .......+||+.|||||++.+. .++.++||||+||++|||++|++||.....     .....-+.... 
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~-----~~~l~~I~~~~g  280 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY-----VHQLQLIMMVLG  280 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH-----HHHHHHHHHHHC
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH-----HHHHHHHHHhcC
Confidence            8654321   2223456899999999998875 679999999999999999999999974321     11111111000 


Q ss_pred             ----------ccCchhHhhhhhhC-CCCC-----HHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          466 ----------QDGKLVELVDERLG-SKYK-----KEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       466 ----------~~~~~~~~~d~~l~-~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                                ........+..... ...+     +....++.+|+.+||+.||++|||+.|+
T Consensus       281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~  342 (398)
T 4b99_A          281 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAA  342 (398)
T ss_dssp             CCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             CCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence                      00011111111000 0011     1124568899999999999999998763

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.6e-46  Score=378.90  Aligned_cols=198  Identities=28%  Similarity=0.422  Sum_probs=169.7

Q ss_pred             HHhcCCcccCceeccCceeEEeccc----cCCcEEEEEEecccCccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEE
Q 045835          237 AATNNFDSAKKIGEGGFGPVYKGQL----ADGTIIAVKQLSSKSRQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQL  311 (511)
Q Consensus       237 ~~~~~f~~~~~lG~G~fG~Vy~g~~----~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~  311 (511)
                      ...++|++.++||+|+||.||+|+.    ..++.||||++....  ....+.+|+.+|+.+ +|||||++++++.+.+..
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            3457899999999999999999964    246789999986543  345688999999988 699999999999999999


Q ss_pred             EEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCC-CCeEEeecCCc
Q 045835          312 LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD-LNPKISDFGLA  390 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~-~~~kl~DfGla  390 (511)
                      ++||||+++|+|.+++.       .+++.....++.|++.||+|||+++   |+||||||+|||++.+ +.+||+|||+|
T Consensus        96 ~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla  165 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLA  165 (361)
T ss_dssp             EEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence            99999999999999982       3889999999999999999999987   9999999999999887 79999999999


Q ss_pred             ccCCCCCc---------------------------eeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCC
Q 045835          391 KLDEGDKT---------------------------HISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKN  442 (511)
Q Consensus       391 ~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~  442 (511)
                      +.......                           ...+..+||+.|||||++.+. .++.++||||+||+++||+||+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~  245 (361)
T 4f9c_A          166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY  245 (361)
T ss_dssp             EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred             cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence            85433211                           112235799999999999875 58999999999999999999999


Q ss_pred             CCCC
Q 045835          443 NMSY  446 (511)
Q Consensus       443 p~~~  446 (511)
                      ||..
T Consensus       246 Pf~~  249 (361)
T 4f9c_A          246 PFYK  249 (361)
T ss_dssp             SSSC
T ss_pred             CCCC
Confidence            9964

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.1e-45  Score=395.10  Aligned_cols=249  Identities=22%  Similarity=0.342  Sum_probs=204.2

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      ++|++.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|+.++|||||++++++.+.+.+++|||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            6899999999999999999975 468999999998765555677899999999999999999999999999999999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCC--CCeEEeecCCcccCCCC
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD--LNPKISDFGLAKLDEGD  396 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~--~~~kl~DfGla~~~~~~  396 (511)
                      ++|+|.++|....   ..+++.....++.||+.||+|||+++   |+||||||+|||++.+  +.+||+|||+++.....
T Consensus       237 ~gg~L~~~i~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          237 SGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCBHHHHHTCTT---SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             CCCcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            9999999986432   35899999999999999999999987   9999999999999865  78999999999976543


Q ss_pred             CceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhh
Q 045835          397 KTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDE  476 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  476 (511)
                      ..  ....+||+.|||||++.+..++.++||||+||++|||++|+.||.....     ......+   ...       +.
T Consensus       311 ~~--~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~-----~~~~~~i---~~~-------~~  373 (573)
T 3uto_A          311 QS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-----DETLRNV---KSC-------DW  373 (573)
T ss_dssp             SE--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHHHH---HTT-------CC
T ss_pred             Cc--eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HHHHHHH---HhC-------CC
Confidence            32  2345799999999999999999999999999999999999999974321     1111110   000       00


Q ss_pred             hhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          477 RLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       477 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..........+..+.+|+.+||+.||.+|||+.|+
T Consensus       374 ~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~  408 (573)
T 3uto_A          374 NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA  408 (573)
T ss_dssp             CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence            01111112334568899999999999999998763

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.9e-45  Score=391.93  Aligned_cols=241  Identities=25%  Similarity=0.317  Sum_probs=196.1

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC---ccchHHHHH---HHHHHhcCCCCCceeEEEEEEeCCEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS---RQGNREFLN---EIAMISCLQHPNLVKIHGCCVEGDQLL  312 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~---Ei~~l~~l~H~niv~l~g~~~~~~~~~  312 (511)
                      ++|++.++||+|+||.||+|+. .+|+.||||++....   ......+.+   ++.+++.++|||||++++++.+.+.++
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            5799999999999999999975 468999999996431   222233334   467778889999999999999999999


Q ss_pred             EEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCccc
Q 045835          313 LVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       313 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~  392 (511)
                      +|||||++|+|.++|....    .+++.....++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+.
T Consensus       269 lVmEy~~GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD  341 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence            9999999999999997543    5999999999999999999999987   99999999999999999999999999986


Q ss_pred             CCCCCceeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchh
Q 045835          393 DEGDKTHISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLV  471 (511)
Q Consensus       393 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  471 (511)
                      .....   ....+||+.|||||++.. ..++.++||||+||+||||++|++||.....     ...             .
T Consensus       342 ~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~-----~~~-------------~  400 (689)
T 3v5w_A          342 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT-----KDK-------------H  400 (689)
T ss_dssp             CSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC-----CCH-------------H
T ss_pred             cCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----HHH-------------H
Confidence            65433   234689999999999975 4799999999999999999999999963211     001             1


Q ss_pred             Hhhhh--hhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCc
Q 045835          472 ELVDE--RLGSKYKKEEAERMIKVSLLCTNASPSLRPTM  508 (511)
Q Consensus       472 ~~~d~--~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  508 (511)
                      ++...  .....++...+.++.+|+.+||+.||++|++.
T Consensus       401 ~i~~~i~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~  439 (689)
T 3v5w_A          401 EIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGC  439 (689)
T ss_dssp             HHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTC
T ss_pred             HHHHhhcCCCCCCCccCCHHHHHHHHHHccCCHhHCCCC
Confidence            11111  11123344556678999999999999999984

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=5.9e-44  Score=353.90  Aligned_cols=248  Identities=25%  Similarity=0.398  Sum_probs=206.0

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      .++|+..+.||+|+||.||+|.. .+++.||||++........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            46799999999999999999974 57899999999876666667899999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +++|+|.+++...     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus        99 ~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (297)
T 3fxz_A           99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (297)
T ss_dssp             CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             CCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence            9999999999653     4899999999999999999999987   9999999999999999999999999998654433


Q ss_pred             ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          398 THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                      .. .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......        ........        ...
T Consensus       171 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~~~~--------~~~  233 (297)
T 3fxz_A          171 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--------RALYLIAT--------NGT  233 (297)
T ss_dssp             CC-BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHH--------HCS
T ss_pred             cc-cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHh--------CCC
Confidence            22 23457999999999999999999999999999999999999999643210        00000000        001


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....+...+..+.+++.+||+.||++|||+.|+
T Consensus       234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el  267 (297)
T 3fxz_A          234 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKEL  267 (297)
T ss_dssp             CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             CCCCCccccCHHHHHHHHHHccCChhHCcCHHHH
Confidence            1112233445678999999999999999999764

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.2e-43  Score=355.81  Aligned_cols=261  Identities=27%  Similarity=0.387  Sum_probs=211.9

Q ss_pred             ccccccHHHHHHHhcC----------CcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCC
Q 045835          226 QTISFTLKQIKAATNN----------FDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ  294 (511)
Q Consensus       226 ~~~~~~~~~l~~~~~~----------f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~  294 (511)
                      +...++.++++.+++.          |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++
T Consensus        21 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~  100 (321)
T 2c30_A           21 QSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ  100 (321)
T ss_dssp             ----CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCC
T ss_pred             cCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCC
Confidence            3446788888888865          677789999999999999865 78999999998776666778999999999999


Q ss_pred             CCCceeEEEEEEeCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCe
Q 045835          295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNV  374 (511)
Q Consensus       295 H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NI  374 (511)
                      ||||+++++++...+..++||||+++++|.+++...     .+++..+..++.|++.||+|||+.+   |+||||||+||
T Consensus       101 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NI  172 (321)
T 2c30_A          101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSI  172 (321)
T ss_dssp             CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGE
T ss_pred             CCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHE
Confidence            999999999999999999999999999999998532     4899999999999999999999986   99999999999


Q ss_pred             EEcCCCCeEEeecCCcccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccc
Q 045835          375 LLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDC  454 (511)
Q Consensus       375 Lld~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~  454 (511)
                      |++.++.+||+|||+++........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.....     
T Consensus       173 ll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~-----  246 (321)
T 2c30_A          173 LLTLDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP-----  246 (321)
T ss_dssp             EECTTCCEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----
T ss_pred             EECCCCcEEEeeeeeeeecccCccc-cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----
Confidence            9999999999999999865443222 2345799999999999999999999999999999999999999963321     


Q ss_pred             cchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          455 TCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       455 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ......   ...      ...+.+  ..+......+.+++.+||+.+|++|||+.||
T Consensus       247 ~~~~~~---~~~------~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~el  292 (321)
T 2c30_A          247 VQAMKR---LRD------SPPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQEL  292 (321)
T ss_dssp             HHHHHH---HHH------SSCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             HHHHHH---Hhc------CCCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            001111   000      000000  1112334568899999999999999999764

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.4e-44  Score=357.39  Aligned_cols=250  Identities=27%  Similarity=0.477  Sum_probs=204.4

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      ++|...++||+|+||.||++... +++.||+|++........+.|.+|+.++++++||||+++++++.+++..++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            56888999999999999999754 68999999997766667788999999999999999999999999999999999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      ++|+|.+++....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        90 ~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           90 KGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             TTCBHHHHHHHCC---TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             CCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            9999999997642   35899999999999999999999987   99999999999999999999999999986543322


Q ss_pred             ee-------------ecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhh
Q 045835          399 HI-------------STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQ  465 (511)
Q Consensus       399 ~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~  465 (511)
                      ..             .....||+.|+|||.+.+..++.++||||||+++|||++|..|+..........           
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~-----------  232 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF-----------  232 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS-----------
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH-----------
Confidence            11             113578999999999999999999999999999999999999886432111110           


Q ss_pred             ccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          466 QDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       466 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                       ........+....    ...+..+.+++.+||+.+|++|||+.||
T Consensus       233 -~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~~l  273 (310)
T 3s95_A          233 -GLNVRGFLDRYCP----PNCPPSFFPITVRCCDLDPEKRPSFVKL  273 (310)
T ss_dssp             -SBCHHHHHHHTCC----TTCCTTHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             -hhhhhccccccCC----CCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence             0111222222222    2333468899999999999999999764

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.6e-43  Score=349.15  Aligned_cols=275  Identities=39%  Similarity=0.624  Sum_probs=224.7

Q ss_pred             ccccccHHHHHHHhcCCccc------CceeccCceeEEeccccCCcEEEEEEecccC----ccchHHHHHHHHHHhcCCC
Q 045835          226 QTISFTLKQIKAATNNFDSA------KKIGEGGFGPVYKGQLADGTIIAVKQLSSKS----RQGNREFLNEIAMISCLQH  295 (511)
Q Consensus       226 ~~~~~~~~~l~~~~~~f~~~------~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~----~~~~~~~~~Ei~~l~~l~H  295 (511)
                      ....|++.++..++++|...      +.||+|+||.||+|.. +++.||||++....    ....+.+.+|+.++++++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            34678999999999999887      8999999999999987 57899999986532    2335678999999999999


Q ss_pred             CCceeEEEEEEeCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeE
Q 045835          296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVL  375 (511)
Q Consensus       296 ~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NIL  375 (511)
                      |||+++++++.+.+..++||||+++++|.+++..... ...+++..+..++.|++.||+|||+.+   |+||||||+||+
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil  165 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL  165 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEE
Confidence            9999999999999999999999999999999965322 345899999999999999999999987   999999999999


Q ss_pred             EcCCCCeEEeecCCcccCCCCC-ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccc
Q 045835          376 LDRDLNPKISDFGLAKLDEGDK-THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDC  454 (511)
Q Consensus       376 ld~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~  454 (511)
                      ++.++.+||+|||+++...... ........||..|+|||.+.+ .++.++||||||+++|||++|+.||.....    .
T Consensus       166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~  240 (307)
T 2nru_A          166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE----P  240 (307)
T ss_dssp             ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS----S
T ss_pred             EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc----h
Confidence            9999999999999998654332 222334578999999998764 588999999999999999999999974331    1


Q ss_pred             cchhhhhHhhhc-cCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          455 TCLLDWACHLQQ-DGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       455 ~~l~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..+..+...... ...+.+.+++.+. ..+......+.+++.+||+.+|.+|||+.||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l  297 (307)
T 2nru_A          241 QLLLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKV  297 (307)
T ss_dssp             SBTTHHHHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HHHHHHHHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHH
Confidence            222333322222 2334555555443 4567788899999999999999999999764

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=9.8e-45  Score=377.83  Aligned_cols=259  Identities=21%  Similarity=0.261  Sum_probs=209.2

Q ss_pred             ccHHHHHHHhcCCcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEE
Q 045835          230 FTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCC  305 (511)
Q Consensus       230 ~~~~~l~~~~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~  305 (511)
                      +.++++...+++|++.++||+|+||.||+|+.. +++.||||+++...   ......+.+|..++..++||||++++++|
T Consensus        64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  143 (437)
T 4aw2_A           64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF  143 (437)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            456667777889999999999999999999865 57899999996532   22234588999999999999999999999


Q ss_pred             EeCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEe
Q 045835          306 VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKIS  385 (511)
Q Consensus       306 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~  385 (511)
                      .+.+..++||||+++|+|.+++....   ..+++..+..++.|++.||+|||+.+   |+||||||+||||+.++.+||+
T Consensus       144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~---~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~  217 (437)
T 4aw2_A          144 QDDNNLYLVMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLA  217 (437)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred             eeCCEEEEEEecCCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEc
Confidence            99999999999999999999997532   35899999999999999999999987   9999999999999999999999


Q ss_pred             ecCCcccCCCCCceeecccccCCCcccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhh
Q 045835          386 DFGLAKLDEGDKTHISTRIAGTIGYMAPEYAL-----WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDW  460 (511)
Q Consensus       386 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~  460 (511)
                      |||+++.............+||+.|+|||++.     .+.++.++|||||||++|||++|+.||.....     ...   
T Consensus       218 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~-----~~~---  289 (437)
T 4aw2_A          218 DFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-----VET---  289 (437)
T ss_dssp             CCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHH---
T ss_pred             chhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh-----hHH---
Confidence            99999876555444455568999999999987     56789999999999999999999999974321     001   


Q ss_pred             hHhhhccCchhHhhhhhhCCCCC---HHHHHHHHHHHHHcCCCCCCC--CCCcCCC
Q 045835          461 ACHLQQDGKLVELVDERLGSKYK---KEEAERMIKVSLLCTNASPSL--RPTMSEV  511 (511)
Q Consensus       461 ~~~~~~~~~~~~~~d~~l~~~~~---~~~~~~l~~l~~~Cl~~~p~~--RPs~~eV  511 (511)
                               ...++.......++   ...+..+.+|+.+||..+|++  ||++.||
T Consensus       290 ---------~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~ei  336 (437)
T 4aw2_A          290 ---------YGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDF  336 (437)
T ss_dssp             ---------HHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHH
T ss_pred             ---------HHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHH
Confidence                     11111111111111   224567889999999988888  9998663

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=9.5e-44  Score=363.50  Aligned_cols=252  Identities=27%  Similarity=0.434  Sum_probs=204.7

Q ss_pred             hcCCcccCceeccCceeEEeccc--------cCCcEEEEEEecccC-ccchHHHHHHHHHHhcC-CCCCceeEEEEEEeC
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL--------ADGTIIAVKQLSSKS-RQGNREFLNEIAMISCL-QHPNLVKIHGCCVEG  308 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~--------~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~  308 (511)
                      .++|++.+.||+|+||.||+|+.        .++..||||+++... ....+.+.+|+.+++.+ +||||++++++|.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            36788999999999999999964        235679999997553 23446789999999999 899999999999999


Q ss_pred             CEEEEEEEecCCCCHhHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEE
Q 045835          309 DQLLLVYEYMENNSLACALFGREN------------CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL  376 (511)
Q Consensus       309 ~~~~lV~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILl  376 (511)
                      +..++||||+++|+|.+++.....            ....+++..++.++.||+.||+|||+.+   |+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence            999999999999999999976432            1235899999999999999999999987   9999999999999


Q ss_pred             cCCCCeEEeecCCcccCCCCCc-eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccc
Q 045835          377 DRDLNPKISDFGLAKLDEGDKT-HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDC  454 (511)
Q Consensus       377 d~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~  454 (511)
                      +.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||+| |+.||.....     
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~-----  311 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-----  311 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH-----
Confidence            9999999999999986543222 12233457789999999999999999999999999999999 9999864321     


Q ss_pred             cchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          455 TCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       455 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .             .+...+........+..+...+.+++.+||+.+|++|||+.||
T Consensus       312 ~-------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~el  355 (370)
T 2psq_A          312 E-------------ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL  355 (370)
T ss_dssp             G-------------GHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             H-------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            1             1112222222233444556679999999999999999999864

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.5e-43  Score=355.92  Aligned_cols=245  Identities=24%  Similarity=0.342  Sum_probs=202.1

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEeccc--CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK--SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      .++|++.+.||+|+||.||+|+. .+|+.||||++...  .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            35799999999999999999975 57899999999754  2334467889999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++|+|.+++....    .+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        94 e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHG----RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV  166 (328)
T ss_dssp             CCCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred             ECCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence            9999999999996543    4899999999999999999999987   99999999999999999999999999986543


Q ss_pred             CCceeecccccCCCcccccccccCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLT-YKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      ..  ......||+.|+|||.+.+..+. .++|||||||+++||++|+.||....        ..+...         .+.
T Consensus       167 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~---------~i~  227 (328)
T 3fe3_A          167 GG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN--------LKELRE---------RVL  227 (328)
T ss_dssp             SC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHH---------HHH
T ss_pred             CC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC--------HHHHHH---------HHH
Confidence            32  22446799999999999887764 89999999999999999999996432        111111         111


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...  ...+...+..+.+++.+||+.||.+|||+.|+
T Consensus       228 ~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~ei  262 (328)
T 3fe3_A          228 RGK--YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQI  262 (328)
T ss_dssp             HCC--CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHH
T ss_pred             hCC--CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence            111  12233345678899999999999999999764

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=356.86  Aligned_cols=248  Identities=28%  Similarity=0.457  Sum_probs=200.7

Q ss_pred             cCCcccCceeccCceeEEecccc----CCcEEEEEEeccc-CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA----DGTIIAVKQLSSK-SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~----~g~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  314 (511)
                      ++|++.+.||+|+||.||+|+..    .+..||||+++.. .....+.|.+|+.++++++||||+++++++.+++..++|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            56788899999999999999863    3556999999764 334456799999999999999999999999999999999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      |||+++|+|.+++....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       129 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          129 TEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             eeCCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            99999999999996542   35899999999999999999999987   9999999999999999999999999998654


Q ss_pred             CCCc--eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchh
Q 045835          395 GDKT--HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLV  471 (511)
Q Consensus       395 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  471 (511)
                      ....  .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||.....     .             .+.
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----~-------------~~~  264 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-----R-------------DVI  264 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH-----H-------------HHH
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH-----H-------------HHH
Confidence            4322  12223346778999999998999999999999999999999 9999863321     0             111


Q ss_pred             HhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       472 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..+........+...+..+.+++.+||+.+|++|||+.||
T Consensus       265 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ei  304 (325)
T 3kul_A          265 SSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQI  304 (325)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHH
Confidence            1122222223344556779999999999999999999864

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=9e-44  Score=346.88  Aligned_cols=247  Identities=27%  Similarity=0.454  Sum_probs=204.0

Q ss_pred             cCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecC
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYME  319 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~  319 (511)
                      ++|+..+.||+|+||.||+|...+++.||+|++.... ...+++.+|+.++++++||||+++++++.+.+..++||||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            5688899999999999999998888899999997543 334679999999999999999999999999999999999999


Q ss_pred             CCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCce
Q 045835          320 NNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH  399 (511)
Q Consensus       320 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~  399 (511)
                      +++|.+++....   ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++........
T Consensus        89 ~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  162 (269)
T 4hcu_A           89 HGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  162 (269)
T ss_dssp             TCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred             CCcHHHHHHhcC---cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence            999999996543   35899999999999999999999987   999999999999999999999999999865443322


Q ss_pred             eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhh
Q 045835          400 ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERL  478 (511)
Q Consensus       400 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  478 (511)
                      ......+|..|+|||.+....++.++||||||++++||++ |+.||.....        .+.          .+.+....
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~--------~~~----------~~~~~~~~  224 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEV----------VEDISTGF  224 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHH----------HHHHHTTC
T ss_pred             cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH--------HHH----------HHHHhcCc
Confidence            3334456778999999998999999999999999999999 9999864321        011          11111111


Q ss_pred             CCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          479 GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       479 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ....+......+.+++.+||+.+|++|||+.|+
T Consensus       225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l  257 (269)
T 4hcu_A          225 RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRL  257 (269)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHH
Confidence            222233345678999999999999999999764

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=6.9e-44  Score=364.89  Aligned_cols=248  Identities=28%  Similarity=0.475  Sum_probs=192.6

Q ss_pred             cCCcccCceeccCceeEEecccc----CCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA----DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~----~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  314 (511)
                      ++|++.+.||+|+||.||+|+..    ++..||||+++... ....+.|.+|+.++++++||||++++++|.+.+..++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            57889999999999999999764    46789999997543 33456799999999999999999999999999999999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      |||+++|+|.+++....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       125 ~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            99999999999996542   35899999999999999999999986   9999999999999999999999999998654


Q ss_pred             CCCcee--ecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchh
Q 045835          395 GDKTHI--STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLV  471 (511)
Q Consensus       395 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  471 (511)
                      ......  .....++..|+|||++.+..++.++|||||||++|||++ |+.||.....     .             .+.
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-----~-------------~~~  260 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-----Q-------------DVI  260 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-----H-------------HHH
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----H-------------HHH
Confidence            432211  112235778999999999999999999999999999998 9999863321     0             112


Q ss_pred             HhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       472 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +.++.......+...+..+.+++.+||+.+|++||++.||
T Consensus       261 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i  300 (373)
T 2qol_A          261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQI  300 (373)
T ss_dssp             HHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHH
Confidence            2222222233344556779999999999999999999764

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.5e-43  Score=354.98  Aligned_cols=261  Identities=27%  Similarity=0.355  Sum_probs=199.5

Q ss_pred             hcCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCC----EEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGD----QLLLV  314 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~lV  314 (511)
                      .++|++.++||+|+||.||+|+.. ++.||||++..... ....+..|+.++++++||||+++++++.+..    .+++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            367899999999999999999875 78999999975432 2345567999999999999999999998744    47999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-------CCCCeEEccCCCCCeEEcCCCCeEEeec
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE-------SRFKIVHRDIKATNVLLDRDLNPKISDF  387 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-------~~~~iiH~Dlk~~NILld~~~~~kl~Df  387 (511)
                      |||+++|+|.+++...     .++|..+..++.|++.||+|||+.       ...+|+||||||+|||++.++.+||+||
T Consensus       101 ~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF  175 (322)
T 3soc_A          101 TAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF  175 (322)
T ss_dssp             EECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence            9999999999999653     389999999999999999999987       0113999999999999999999999999


Q ss_pred             CCcccCCCCCce-eecccccCCCccccccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhh
Q 045835          388 GLAKLDEGDKTH-ISTRIAGTIGYMAPEYALW-----GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWA  461 (511)
Q Consensus       388 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~  461 (511)
                      |+++........ ......||+.|+|||.+.+     ..++.++|||||||++|||+||+.||.......     ...+.
T Consensus       176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-----~~~~~  250 (322)
T 3soc_A          176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY-----MLPFE  250 (322)
T ss_dssp             TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCC-----CCTTH
T ss_pred             CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchh-----ccchh
Confidence            999865433221 2233578999999999886     356678999999999999999999997432111     11111


Q ss_pred             HhhhccCchhHhhhh----hhCCCC-----CHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          462 CHLQQDGKLVELVDE----RLGSKY-----KKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       462 ~~~~~~~~~~~~~d~----~l~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..........++.+.    ......     .......+.+++.+||+.||++|||+.||
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el  309 (322)
T 3soc_A          251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV  309 (322)
T ss_dssp             HHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             hhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHH
Confidence            111111122222111    111111     22456779999999999999999999874

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.1e-43  Score=343.95  Aligned_cols=248  Identities=28%  Similarity=0.432  Sum_probs=204.6

Q ss_pred             hcCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      .++|++.+.||+|+||.||+|+..++..||||++.... ....++.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            46788999999999999999998888899999997543 33467999999999999999999999999999999999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      ++++|.+++....   ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.......
T Consensus        86 ~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  159 (268)
T 3sxs_A           86 SNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY  159 (268)
T ss_dssp             TTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred             CCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence            9999999996542   35899999999999999999999987   99999999999999999999999999987655444


Q ss_pred             eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          399 HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                      .......+|..|+|||.+.+..++.++||||||++++||++ |+.||......        ...          ..+...
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~----------~~~~~~  221 (268)
T 3sxs_A          160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS--------EVV----------LKVSQG  221 (268)
T ss_dssp             EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH--------HHH----------HHHHTT
T ss_pred             hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH--------HHH----------HHHHcC
Confidence            43344556778999999998899999999999999999999 99998643210        110          001111


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....+...+..+.+++.+||+.+|++|||+.||
T Consensus       222 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l  255 (268)
T 3sxs_A          222 HRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQL  255 (268)
T ss_dssp             CCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred             CCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHH
Confidence            1112222334578999999999999999999764

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1e-43  Score=354.36  Aligned_cols=254  Identities=28%  Similarity=0.431  Sum_probs=197.0

Q ss_pred             HHhcCCcccCceeccCceeEEeccccCCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEE
Q 045835          237 AATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       237 ~~~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  314 (511)
                      ...++|++.+.||+|+||.||+|+. +++.||||++....  ....+++.+|+.++++++||||+++++++.+.+..++|
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV  112 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence            3456789999999999999999976 58889999987543  23345789999999999999999999999999999999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      |||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus       113 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  190 (309)
T 3p86_A          113 TEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA  190 (309)
T ss_dssp             EECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred             EecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence            999999999999975431 224899999999999999999999874 349999999999999999999999999998544


Q ss_pred             CCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          395 GDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       395 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      .... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....     .....            .+.
T Consensus       191 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~-----~~~~~------------~~~  252 (309)
T 3p86_A          191 STFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP-----AQVVA------------AVG  252 (309)
T ss_dssp             ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH-----HHHHH------------HHH
T ss_pred             cccc-ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHH------------HHH
Confidence            3221 22345789999999999999999999999999999999999999964321     00111            010


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ........+......+.+++.+||+.+|++|||+.||
T Consensus       253 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l  289 (309)
T 3p86_A          253 FKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATI  289 (309)
T ss_dssp             HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             hcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            1111223344455678999999999999999999764

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.5e-44  Score=367.67  Aligned_cols=249  Identities=25%  Similarity=0.419  Sum_probs=202.8

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      .++|.+.+.||+|+||.||+|+.. +++.||||+++... ......|.+|+.+|++++||||++++++|.+.+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            356888999999999999999875 68999999987543 2334568899999999999999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      |+++|+|.+++....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       193 ~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~  266 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG  266 (377)
T ss_dssp             CCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred             cCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence            999999999996532   35899999999999999999999987   999999999999999999999999999864432


Q ss_pred             Cceee-cccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          397 KTHIS-TRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       397 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      ..... ....++..|+|||.+..+.++.++|||||||++|||+| |+.||.....     .             .+.+.+
T Consensus       267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~-----~-------------~~~~~~  328 (377)
T 3cbl_A          267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-----Q-------------QTREFV  328 (377)
T ss_dssp             EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH-----H-------------HHHHHH
T ss_pred             ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----H-------------HHHHHH
Confidence            21111 11235678999999998999999999999999999998 9999864321     0             112222


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ....+...+..++..+.+++.+||+.+|++|||+.||
T Consensus       329 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i  365 (377)
T 3cbl_A          329 EKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTI  365 (377)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence            2222233344456678999999999999999999864

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=5e-44  Score=375.46  Aligned_cols=249  Identities=29%  Similarity=0.474  Sum_probs=204.6

Q ss_pred             HhcCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          238 ATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       238 ~~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      ..++|++.+.||+|+||.||+|...++..||||+++... ...+.|.+|+.+|++++||||+++++++. .+..++||||
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~  263 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF  263 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred             chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence            356788899999999999999998888999999997643 45678999999999999999999999986 5678999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +++|+|.+++....  ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       264 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~  338 (454)
T 1qcf_A          264 MAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE  338 (454)
T ss_dssp             CTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred             cCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence            99999999996432  235889999999999999999999986   9999999999999999999999999998654332


Q ss_pred             ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhh
Q 045835          398 THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDE  476 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  476 (511)
                      ........+|..|+|||.+..+.++.++|||||||++|||+| |+.||.....     .             ++.+.+..
T Consensus       339 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~-----~-------------~~~~~i~~  400 (454)
T 1qcf_A          339 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-----P-------------EVIRALER  400 (454)
T ss_dssp             HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----H-------------HHHHHHHH
T ss_pred             eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH-----H-------------HHHHHHHc
Confidence            222223456788999999999999999999999999999999 9999863321     0             11112222


Q ss_pred             hhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          477 RLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       477 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..+...+..++..+.+++.+||+.+|++|||+.+|
T Consensus       401 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i  435 (454)
T 1qcf_A          401 GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYI  435 (454)
T ss_dssp             TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence            22233344556789999999999999999999764

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.3e-43  Score=376.11  Aligned_cols=249  Identities=26%  Similarity=0.453  Sum_probs=208.5

Q ss_pred             hcCCcccCceeccCceeEEeccccC-CcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~~-g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      .++|++.++||+|+||.||+|+... +..||||+++... ...++|.+|+.+|++++||||++++++|.+.+..++||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            4568889999999999999998654 8899999997543 3457899999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +++|+|.+++....  ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus       298 ~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  372 (495)
T 1opk_A          298 MTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT  372 (495)
T ss_dssp             CTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred             cCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence            99999999997543  235899999999999999999999987   9999999999999999999999999998765443


Q ss_pred             ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhh
Q 045835          398 THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDE  476 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  476 (511)
                      ........++..|+|||.+....++.++|||||||++|||+| |+.||.....                  ..+.+.+..
T Consensus       373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~------------------~~~~~~~~~  434 (495)
T 1opk_A          373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------------------SQVYELLEK  434 (495)
T ss_dssp             EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG------------------GGHHHHHHT
T ss_pred             eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH------------------HHHHHHHHc
Confidence            333334456789999999999999999999999999999999 9998864321                  112223333


Q ss_pred             hhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          477 RLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       477 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..+...+..++..+.+|+.+||+.+|++|||+.||
T Consensus       435 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el  469 (495)
T 1opk_A          435 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI  469 (495)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHH
Confidence            33334455566789999999999999999999864

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.5e-44  Score=354.63  Aligned_cols=261  Identities=26%  Similarity=0.405  Sum_probs=202.7

Q ss_pred             hcCCcccCceeccCceeEEeccc-----cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeC--CEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-----ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEG--DQL  311 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-----~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~  311 (511)
                      .++|++.++||+|+||.||++++     .+++.||||++........+.+.+|+.++++++||||++++++|...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            35788999999999999999973     36889999999876666667899999999999999999999999653  568


Q ss_pred             EEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcc
Q 045835          312 LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK  391 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~  391 (511)
                      ++||||+++|+|.+++....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             EEEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence            99999999999999997643   35899999999999999999999986   9999999999999999999999999998


Q ss_pred             cCCCCCc--eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhh----h
Q 045835          392 LDEGDKT--HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHL----Q  465 (511)
Q Consensus       392 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~----~  465 (511)
                      .......  .......++..|+|||.+.+..++.++||||||+++|||+||..|+.....      ....+....    .
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~------~~~~~~~~~~~~~~  236 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA------EFMRMIGNDKQGQM  236 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH------HHHHHHCTTCCTHH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChH------HHHhhhcCccccch
Confidence            6543322  122234567789999999999999999999999999999999998763221      000000000    0


Q ss_pred             ccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          466 QDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       466 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ....+.+.+........+...+..+.+++.+||+.+|++|||+.||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el  282 (295)
T 3ugc_A          237 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL  282 (295)
T ss_dssp             HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             hHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHH
Confidence            0001222223333334455666789999999999999999999864

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.2e-43  Score=360.63  Aligned_cols=263  Identities=26%  Similarity=0.389  Sum_probs=209.4

Q ss_pred             cccHHHHHHHhcCCcccCceeccCceeEEecc------ccCCcEEEEEEecccCc-cchHHHHHHHHHHhcC-CCCCcee
Q 045835          229 SFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQ------LADGTIIAVKQLSSKSR-QGNREFLNEIAMISCL-QHPNLVK  300 (511)
Q Consensus       229 ~~~~~~l~~~~~~f~~~~~lG~G~fG~Vy~g~------~~~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~  300 (511)
                      .+...+.....++|++.+.||+|+||.||+|+      ..+++.||||+++.... ...+.+.+|+.+++++ +||||++
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            45556666677899999999999999999996      23568999999976433 3346789999999999 8999999


Q ss_pred             EEEEEEeCC-EEEEEEEecCCCCHhHHHhcCCCC----------------------------------------------
Q 045835          301 IHGCCVEGD-QLLLVYEYMENNSLACALFGRENC----------------------------------------------  333 (511)
Q Consensus       301 l~g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~----------------------------------------------  333 (511)
                      ++++|.+.+ ..++||||+++|+|.+++......                                              
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            999998765 489999999999999999765321                                              


Q ss_pred             ----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          334 ----------------ELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       334 ----------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                                      ...+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence                            122889999999999999999999987   9999999999999999999999999998654332


Q ss_pred             -ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          398 -THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       398 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                       ........||..|+|||++.+..++.++|||||||++|||+| |+.||......                 ..+...+.
T Consensus       248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----------------~~~~~~~~  310 (359)
T 3vhe_A          248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-----------------EEFCRRLK  310 (359)
T ss_dssp             TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-----------------HHHHHHHH
T ss_pred             cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh-----------------HHHHHHHH
Confidence             223344568899999999999999999999999999999998 99998643210                 01112222


Q ss_pred             hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       476 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .......+......+.+++.+||+.+|++|||+.||
T Consensus       311 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el  346 (359)
T 3vhe_A          311 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL  346 (359)
T ss_dssp             HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence            222223334445678999999999999999999874

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.5e-42  Score=349.98  Aligned_cols=240  Identities=25%  Similarity=0.337  Sum_probs=198.9

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEeccc---CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK---SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|+..+.||+|+||.||+++.. +|+.||+|+++..   .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            57899999999999999999754 6899999999754   2344567899999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++|+|..++....    .+++.....++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        85 E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           85 EYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             ECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            9999999999986542    5899999999999999999999987   99999999999999999999999999985432


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      ... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....     ..+..            .+..
T Consensus       158 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~------------~i~~  219 (337)
T 1o6l_A          158 DGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLFE------------LILM  219 (337)
T ss_dssp             TTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH------------HHHH
T ss_pred             CCC-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH-----HHHHH------------HHHc
Confidence            222 23345799999999999999999999999999999999999999963221     10111            1111


Q ss_pred             hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCC
Q 045835          476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRP  506 (511)
Q Consensus       476 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP  506 (511)
                      ..  ..++...+..+.+++.+||+.+|++||
T Consensus       220 ~~--~~~p~~~s~~~~~li~~lL~~dP~~R~  248 (337)
T 1o6l_A          220 EE--IRFPRTLSPEAKSLLAGLLKKDPKQRL  248 (337)
T ss_dssp             CC--CCCCTTSCHHHHHHHHHHTCSSTTTST
T ss_pred             CC--CCCCCCCCHHHHHHHHHHhhcCHHHhc
Confidence            11  123334456789999999999999999

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.7e-43  Score=345.94  Aligned_cols=248  Identities=24%  Similarity=0.406  Sum_probs=201.6

Q ss_pred             hcCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      .++|++.+.||+|+||.||++...++..||||++.... ...+++.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            46788999999999999999998888899999997543 33467999999999999999999999999999999999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      ++++|.+++....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus       102 ~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  175 (283)
T 3gen_A          102 ANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  175 (283)
T ss_dssp             TTCBHHHHHHCGG---GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred             CCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence            9999999996532   35899999999999999999999987   99999999999999999999999999986544332


Q ss_pred             eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          399 HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                      .......+|..|+|||.+....++.++||||||+++|||+| |+.||......        +          ..+.+...
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--------~----------~~~~~~~~  237 (283)
T 3gen_A          176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--------E----------TAEHIAQG  237 (283)
T ss_dssp             HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--------H----------HHHHHHTT
T ss_pred             ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--------H----------HHHHHhcc
Confidence            22233456788999999998899999999999999999998 99998643210        0          11111111


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....+......+.+++.+||+.+|++|||+.||
T Consensus       238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l  271 (283)
T 3gen_A          238 LRLYRPHLASEKVYTIMYSCWHEKADERPTFKIL  271 (283)
T ss_dssp             CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred             cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHH
Confidence            2222233345678999999999999999999764

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.1e-42  Score=364.93  Aligned_cols=243  Identities=30%  Similarity=0.430  Sum_probs=200.7

Q ss_pred             hcCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCC-EEEEEEEe
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGD-QLLLVYEY  317 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey  317 (511)
                      .++|++.+.||+|+||.||+|... ++.||||+++...  ..+.|.+|+.+|++++||||++++++|.+.+ ..++||||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            457888999999999999999875 7899999997643  4578999999999999999999999998765 79999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +++|+|.+++....  ...+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       269 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  343 (450)
T 1k9a_A          269 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  343 (450)
T ss_dssp             CTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             cCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence            99999999997543  234789999999999999999999986   9999999999999999999999999998543221


Q ss_pred             ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhh
Q 045835          398 THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDE  476 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  476 (511)
                          ....++..|+|||.+.+..++.++|||||||++|||+| |+.||.....                  .++.+.+..
T Consensus       344 ----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~------------------~~~~~~i~~  401 (450)
T 1k9a_A          344 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------------------KDVVPRVEK  401 (450)
T ss_dssp             -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT------------------TTHHHHHHT
T ss_pred             ----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH------------------HHHHHHHHc
Confidence                12356889999999999999999999999999999998 9999864321                  111122222


Q ss_pred             hhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          477 RLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       477 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..+...+..++..+.+++.+||+.+|++|||+.||
T Consensus       402 ~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l  436 (450)
T 1k9a_A          402 GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQL  436 (450)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            22333455566789999999999999999999764

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.9e-43  Score=347.43  Aligned_cols=249  Identities=28%  Similarity=0.377  Sum_probs=194.6

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCc---cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSR---QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|++.+.||+|+||.||+++. .+++.||+|++.....   ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   90 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM   90 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence            5789999999999999999974 4688999999864432   33457899999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++++|.+++....    .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        91 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           91 EYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             ECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            9999999999996543    5899999999999999999999987   99999999999999999999999999986654


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      ..........||+.|+|||.+.+..++.++||||||+++|||+||+.||.....        .......... ..... .
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--------~~~~~~~~~~-~~~~~-~  233 (294)
T 4eqm_A          164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA--------VSIAIKHIQD-SVPNV-T  233 (294)
T ss_dssp             -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH--------HHHHHHHHSS-CCCCH-H
T ss_pred             ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHhhc-cCCCc-c
Confidence            433333446799999999999999999999999999999999999999964321        0111111111 00000 0


Q ss_pred             hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCC-CcC
Q 045835          476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRP-TMS  509 (511)
Q Consensus       476 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-s~~  509 (511)
                      ..    .+.+.+..+.+++.+||+.+|++|| ++.
T Consensus       234 ~~----~~~~~~~~l~~li~~~l~~dp~~R~~~~~  264 (294)
T 4eqm_A          234 TD----VRKDIPQSLSNVILRATEKDKANRYKTIQ  264 (294)
T ss_dssp             HH----SCTTSCHHHHHHHHHHSCSSGGGSCSSHH
T ss_pred             hh----cccCCCHHHHHHHHHHhcCCHhHccccHH
Confidence            11    1222345788999999999999999 543

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4.2e-43  Score=352.55  Aligned_cols=247  Identities=26%  Similarity=0.450  Sum_probs=195.9

Q ss_pred             cCCcccCceeccCceeEEecccc-CCc----EEEEEEeccc-CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGT----IIAVKQLSSK-SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~----~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  313 (511)
                      ++|+..++||+|+||.||+|+.. +++    .||+|.+... .....+.|.+|+.++++++||||++++++|.++. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            56889999999999999999753 444    3688888643 3355678999999999999999999999998755 789


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      |+||+++|+|.+++....   ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        94 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEECCTTCBHHHHHHHST---TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             EEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            999999999999997643   35899999999999999999999986   999999999999999999999999999865


Q ss_pred             CCCCc-eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchh
Q 045835          394 EGDKT-HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLV  471 (511)
Q Consensus       394 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  471 (511)
                      ..... .......+|..|+|||.+.+..++.++|||||||++|||+| |+.||.....                  ..+.
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------------------~~~~  229 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA------------------SEIS  229 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG------------------GGHH
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH------------------HHHH
Confidence            43322 22233456889999999999999999999999999999999 9999864321                  1122


Q ss_pred             HhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       472 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +.+........+......+.+++.+||+.+|++|||+.||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~el  269 (327)
T 3poz_A          230 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFREL  269 (327)
T ss_dssp             HHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHH
T ss_pred             HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence            3333333333444556679999999999999999999764

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=8.1e-43  Score=349.98  Aligned_cols=249  Identities=28%  Similarity=0.392  Sum_probs=198.3

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccCc-cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR-QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      ++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   86 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence            67999999999999999999754 789999999865432 3345688999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +++|+|.+++...    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        87 ~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           87 CSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             CTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             CCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            9999999988543    34899999999999999999999987   9999999999999999999999999998643222


Q ss_pred             -ceeecccccCCCcccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          398 -THISTRIAGTIGYMAPEYALWGYL-TYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       398 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                       ........||+.|+|||.+.+..+ +.++|||||||++|||++|+.||......   ......|..             
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~~~~~-------------  223 (323)
T 3tki_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS---CQEYSDWKE-------------  223 (323)
T ss_dssp             EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT---SHHHHHHHT-------------
T ss_pred             cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH---HHHHHHHhc-------------
Confidence             222334679999999999987765 78999999999999999999999743211   111111111             


Q ss_pred             hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       476 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..............+.+++.+||+.+|++|||+.|+
T Consensus       224 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ei  259 (323)
T 3tki_A          224 KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDI  259 (323)
T ss_dssp             TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             ccccCCccccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            111111112334567899999999999999999764

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.9e-42  Score=354.73  Aligned_cols=252  Identities=22%  Similarity=0.340  Sum_probs=200.0

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l  313 (511)
                      .++|++.++||+|+||.||+++.. +++.||||+++...   ......+.+|..++.++ +||||+++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            357999999999999999999854 57899999997542   23345678999999877 89999999999999999999


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      ||||+++|+|..++....    .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       131 V~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~  203 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  203 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence            999999999999986543    4899999999999999999999987   999999999999999999999999999853


Q ss_pred             CCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHh
Q 045835          394 EGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVEL  473 (511)
Q Consensus       394 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  473 (511)
                      .... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..............+...        ..+
T Consensus       204 ~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~--------~~i  274 (396)
T 4dc2_A          204 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF--------QVI  274 (396)
T ss_dssp             CCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHH--------HHH
T ss_pred             ccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHH--------HHH
Confidence            3222 2234468999999999999999999999999999999999999999643211110000011110        011


Q ss_pred             hhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCc
Q 045835          474 VDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTM  508 (511)
Q Consensus       474 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  508 (511)
                      ...  ...++......+.+++.+||+.||++||++
T Consensus       275 ~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          275 LEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             HHC--CCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             hcc--ccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            111  123344456678999999999999999996

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=5e-42  Score=349.27  Aligned_cols=245  Identities=22%  Similarity=0.324  Sum_probs=200.9

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCcc------chHHHHHHHHHHhcCCCCCceeEEEEEEeCCEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQ------GNREFLNEIAMISCLQHPNLVKIHGCCVEGDQL  311 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~  311 (511)
                      .++|++.+.||+|+||.||+++.. +|+.||+|.+......      ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            467999999999999999999754 6899999999754321      346789999999999999999999999999999


Q ss_pred             EEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCC----CeEEeec
Q 045835          312 LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL----NPKISDF  387 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~----~~kl~Df  387 (511)
                      ++||||+++|+|.+++...    ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++    .+||+||
T Consensus        91 ~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTC----SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            9999999999999999543    35899999999999999999999987   99999999999998877    7999999


Q ss_pred             CCcccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhcc
Q 045835          388 GLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD  467 (511)
Q Consensus       388 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~  467 (511)
                      |+++.......  .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....     ..+..        
T Consensus       164 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~-----~~~~~--------  228 (361)
T 2yab_A          164 GLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----QETLA--------  228 (361)
T ss_dssp             SSCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHH--------
T ss_pred             CCceEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-----HHHHH--------
Confidence            99986554322  2345799999999999998999999999999999999999999964221     00110        


Q ss_pred             CchhHhhhhhhCCCCCH----HHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          468 GKLVELVDERLGSKYKK----EEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       468 ~~~~~~~d~~l~~~~~~----~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                          .+...  ...++.    ..+..+.+++.+||+.||++|||+.|+
T Consensus       229 ----~i~~~--~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~  270 (361)
T 2yab_A          229 ----NITAV--SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEA  270 (361)
T ss_dssp             ----HHHTT--CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             ----HHHhc--CCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence                01000  011111    224568899999999999999998763

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.1e-43  Score=363.70  Aligned_cols=256  Identities=19%  Similarity=0.287  Sum_probs=206.9

Q ss_pred             cHHHHHHHhcCCcccCceeccCceeEEecccc-CCcEEEEEEeccc---CccchHHHHHHHHHHhcCCCCCceeEEEEEE
Q 045835          231 TLKQIKAATNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK---SRQGNREFLNEIAMISCLQHPNLVKIHGCCV  306 (511)
Q Consensus       231 ~~~~l~~~~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~  306 (511)
                      .+.++....++|++.++||+|+||.||+++.. +++.||+|+++..   .......+.+|+.+++.++||||+++++++.
T Consensus        60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~  139 (410)
T 3v8s_A           60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ  139 (410)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            34455566789999999999999999999865 5889999998652   2233346889999999999999999999999


Q ss_pred             eCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEee
Q 045835          307 EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISD  386 (511)
Q Consensus       307 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~D  386 (511)
                      +.+..++||||+++|+|.+++...     .+++.....++.||+.||+|||+.+   |+||||||+|||++.++.+||+|
T Consensus       140 ~~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~D  211 (410)
T 3v8s_A          140 DDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLAD  211 (410)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEec
Confidence            999999999999999999998643     4889999999999999999999987   99999999999999999999999


Q ss_pred             cCCcccCCCCCceeecccccCCCcccccccccCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhH
Q 045835          387 FGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGY----LTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWAC  462 (511)
Q Consensus       387 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~  462 (511)
                      ||+++.............+||+.|+|||++....    ++.++|||||||++|||++|+.||.....        .+.  
T Consensus       212 FG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~--  281 (410)
T 3v8s_A          212 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGT--  281 (410)
T ss_dssp             CTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHH--
T ss_pred             cceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh--------hhH--
Confidence            9999876554443444568999999999998655    78999999999999999999999963321        010  


Q ss_pred             hhhccCchhHhhhhhhCCCCC--HHHHHHHHHHHHHcCCCCCCC--CCCcCCC
Q 045835          463 HLQQDGKLVELVDERLGSKYK--KEEAERMIKVSLLCTNASPSL--RPTMSEV  511 (511)
Q Consensus       463 ~~~~~~~~~~~~d~~l~~~~~--~~~~~~l~~l~~~Cl~~~p~~--RPs~~eV  511 (511)
                             ...++.......++  ...+..+.+|+.+||+.+|.+  ||++.||
T Consensus       282 -------~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei  327 (410)
T 3v8s_A          282 -------YSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEI  327 (410)
T ss_dssp             -------HHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHH
T ss_pred             -------HHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHH
Confidence                   11122211111111  134567889999999999988  9998764

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.1e-43  Score=370.41  Aligned_cols=248  Identities=30%  Similarity=0.468  Sum_probs=198.3

Q ss_pred             hcCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      .++|++.++||+|+||.||+|...++..||||+++... ...++|.+|+.+|++++||||+++++++.+ +..++||||+
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~  260 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  260 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence            45688899999999999999998888889999997643 345689999999999999999999999876 6789999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      ++|+|.+++....  ...+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++.......
T Consensus       261 ~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  335 (452)
T 1fmk_A          261 SKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  335 (452)
T ss_dssp             TTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             cCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence            9999999996432  235899999999999999999999986   99999999999999999999999999986544332


Q ss_pred             eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          399 HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                      .......++..|+|||.+..+.++.++|||||||++|||+| |+.||.....        .          ++.+.+...
T Consensus       336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--------~----------~~~~~i~~~  397 (452)
T 1fmk_A          336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------R----------EVLDQVERG  397 (452)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------H----------HHHHHHHTT
T ss_pred             ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH--------H----------HHHHHHHcC
Confidence            22233456789999999999999999999999999999999 9999863321        0          111112222


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .+...+..++..+.+++.+||+.+|++|||+.+|
T Consensus       398 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l  431 (452)
T 1fmk_A          398 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYL  431 (452)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            2233445566789999999999999999999764

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.2e-43  Score=350.92  Aligned_cols=242  Identities=26%  Similarity=0.336  Sum_probs=189.6

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccCc--cchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR--QGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|+..++||+|+||+||+|+.. +++.||||++.....  .....+..|+..+.++ +||||++++++|.+++..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            67999999999999999999865 789999999865432  2333455666666555 9999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+ +++|.+++....   ..++|..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       137 e~~-~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWG---ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             ECC-CCBHHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             ecc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            999 679998886543   35999999999999999999999986   99999999999999999999999999986543


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      ..  ......||+.|+|||++.+ .++.++|||||||++|||++|+.|+....          .|.  ....+.      
T Consensus       210 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----------~~~--~~~~~~------  268 (311)
T 3p1a_A          210 AG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----------GWQ--QLRQGY------  268 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----------HHH--HHTTTC------
T ss_pred             CC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----------HHH--HHhccC------
Confidence            22  2234568999999998875 78999999999999999999977654211          110  001111      


Q ss_pred             hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       476 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                        .....+......+.+++.+||+.+|++|||+.||
T Consensus       269 --~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el  302 (311)
T 3p1a_A          269 --LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEAL  302 (311)
T ss_dssp             --CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             --CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence              0001111234578999999999999999999764

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.3e-43  Score=358.06  Aligned_cols=252  Identities=28%  Similarity=0.425  Sum_probs=204.6

Q ss_pred             hcCCcccCceeccCceeEEeccc--------cCCcEEEEEEecccC-ccchHHHHHHHHHHhcC-CCCCceeEEEEEEeC
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL--------ADGTIIAVKQLSSKS-RQGNREFLNEIAMISCL-QHPNLVKIHGCCVEG  308 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~--------~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~  308 (511)
                      .++|.+.+.||+|+||.||+|+.        ..+..||||++.... ......+.+|+.+++++ +||||++++++|.+.
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            46788999999999999999974        234679999997543 33446789999999999 999999999999999


Q ss_pred             CEEEEEEEecCCCCHhHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEE
Q 045835          309 DQLLLVYEYMENNSLACALFGREN------------CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL  376 (511)
Q Consensus       309 ~~~~lV~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILl  376 (511)
                      +..++||||+++|+|.+++.....            ....+++..++.++.|++.||+|||+.+   |+||||||+|||+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence            999999999999999999976532            1235899999999999999999999986   9999999999999


Q ss_pred             cCCCCeEEeecCCcccCCCCCc-eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccc
Q 045835          377 DRDLNPKISDFGLAKLDEGDKT-HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDC  454 (511)
Q Consensus       377 d~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~  454 (511)
                      +.++.+||+|||+++....... .......+|..|+|||.+.+..++.++|||||||+++||++ |+.||.....     
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~-----  299 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-----  299 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----
Confidence            9999999999999986543221 22333457889999999999999999999999999999999 9999863321     


Q ss_pred             cchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          455 TCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       455 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .             .+.+.+........+......+.+++.+||+.+|++|||+.||
T Consensus       300 ~-------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el  343 (382)
T 3tt0_A          300 E-------------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL  343 (382)
T ss_dssp             H-------------HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             H-------------HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            1             1112222222233344455679999999999999999999864

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.2e-42  Score=348.56  Aligned_cols=246  Identities=22%  Similarity=0.381  Sum_probs=195.7

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCC-------
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGD-------  309 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-------  309 (511)
                      .++|++.+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+.++++++||||++++++|.+.+       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            357899999999999999999865 78999999997543 334567999999999999999999999987654       


Q ss_pred             --------------------------------------------------EEEEEEEecCCCCHhHHHhcCCCCCCCCCH
Q 045835          310 --------------------------------------------------QLLLVYEYMENNSLACALFGRENCELELDW  339 (511)
Q Consensus       310 --------------------------------------------------~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~  339 (511)
                                                                        ..++||||+++++|.+++..... ....++
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~  163 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH  163 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence                                                              28999999999999999976543 334677


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc-----------eeecccccCC
Q 045835          340 PTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT-----------HISTRIAGTI  408 (511)
Q Consensus       340 ~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~-----------~~~~~~~gt~  408 (511)
                      ..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.......           .......||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            889999999999999999987   99999999999999999999999999986554321           1123356999


Q ss_pred             CcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCCCCC---HH
Q 045835          409 GYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYK---KE  485 (511)
Q Consensus       409 ~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~---~~  485 (511)
                      .|+|||.+.+..++.++|||||||+++||++|..|+..          .             .++.........+   ..
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~----------~-------------~~~~~~~~~~~~~~~~~~  297 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME----------R-------------VRIITDVRNLKFPLLFTQ  297 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH----------H-------------HHHHHHHHTTCCCHHHHH
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH----------H-------------HHHHHHhhccCCCccccc
Confidence            99999999999999999999999999999998765320          0             0011111111112   23


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          486 EAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       486 ~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ....+.+++.+||+.+|++|||+.|+
T Consensus       298 ~~~~~~~li~~~l~~~p~~Rps~~~~  323 (332)
T 3qd2_B          298 KYPQEHMMVQDMLSPSPTERPEATDI  323 (332)
T ss_dssp             HCHHHHHHHHHHHCSSGGGSCCHHHH
T ss_pred             CChhHHHHHHHHccCCCCcCCCHHHH
Confidence            44567899999999999999999764

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-42  Score=345.09  Aligned_cols=245  Identities=19%  Similarity=0.273  Sum_probs=201.0

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      .++|++.+.||+|+||.||+++.. +++.+|+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            467899999999999999999754 68899999987543 3345688999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcC--CCCeEEeecCCcccCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR--DLNPKISDFGLAKLDEG  395 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~--~~~~kl~DfGla~~~~~  395 (511)
                      +++|+|.+++....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.  ++.+||+|||+++....
T Consensus        83 ~~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~  156 (321)
T 1tki_A           83 ISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             CCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence            99999999995432   35899999999999999999999987   999999999999997  78999999999987654


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      ...  .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....     .   +..         ..+..
T Consensus       157 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~---~~~---------~~i~~  217 (321)
T 1tki_A          157 GDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-----Q---QII---------ENIMN  217 (321)
T ss_dssp             TCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-----H---HHH---------HHHHH
T ss_pred             CCc--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH-----H---HHH---------HHHHc
Confidence            332  2335689999999999988899999999999999999999999964321     0   111         11111


Q ss_pred             hhhCCCCCH----HHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          476 ERLGSKYKK----EEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       476 ~~l~~~~~~----~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...  ..+.    ..+..+.+++.+||+.||++|||+.|+
T Consensus       218 ~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~  255 (321)
T 1tki_A          218 AEY--TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA  255 (321)
T ss_dssp             TCC--CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             CCC--CCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            111  1111    234578999999999999999999764

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=8.7e-43  Score=347.19  Aligned_cols=252  Identities=30%  Similarity=0.454  Sum_probs=204.6

Q ss_pred             hcCCcccCceeccCceeEEeccc------cCCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL------ADGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQL  311 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~------~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~  311 (511)
                      .++|.+.+.||+|+||.||+|+.      .++..||||++.... ....+.+.+|+.++++++||||+++++++.+.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            46788999999999999999964      245789999997543 33446789999999999999999999999999999


Q ss_pred             EEEEEecCCCCHhHHHhcCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCC
Q 045835          312 LLVYEYMENNSLACALFGREN--------------------CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKA  371 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~  371 (511)
                      ++||||+++++|.+++.....                    ....+++..++.++.|++.||+|||+.+   |+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence            999999999999999976432                    1234889999999999999999999987   99999999


Q ss_pred             CCeEEcCCCCeEEeecCCcccCCCCCce-eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 045835          372 TNVLLDRDLNPKISDFGLAKLDEGDKTH-ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPA  449 (511)
Q Consensus       372 ~NILld~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~  449 (511)
                      +|||++.++.+||+|||+++........ ......+|..|+|||.+.+..++.++||||||++++||++ |+.||.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999999865443322 2223456788999999998899999999999999999999 9999864321


Q ss_pred             ccccccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          450 LEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       450 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                           .             .+.+.+........+...+..+.+++.+||+.+|++|||+.||
T Consensus       259 -----~-------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l  302 (314)
T 2ivs_A          259 -----E-------------RLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADI  302 (314)
T ss_dssp             -----G-------------GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             -----H-------------HHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence                 1             1112222222223344456679999999999999999999764

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-43  Score=360.81  Aligned_cols=252  Identities=27%  Similarity=0.376  Sum_probs=201.3

Q ss_pred             hcCCcccCceeccCceeEEecccc------CCcEEEEEEeccc-CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSK-SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQL  311 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~------~g~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~  311 (511)
                      .++|++.+.||+|+||.||+|+..      ++..||||+++.. .......+.+|+.++++++||||+++++++.+....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            357889999999999999999843      4678999999654 334455789999999999999999999999999999


Q ss_pred             EEEEEecCCCCHhHHHhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCC---CeEEe
Q 045835          312 LLVYEYMENNSLACALFGRE---NCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL---NPKIS  385 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~---~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~---~~kl~  385 (511)
                      ++||||+++|+|.+++....   .....+++..++.++.|++.||+|||+.+   |+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999997643   22245899999999999999999999987   99999999999999554   59999


Q ss_pred             ecCCcccCCCC-CceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHh
Q 045835          386 DFGLAKLDEGD-KTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACH  463 (511)
Q Consensus       386 DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~  463 (511)
                      |||+++..... .........||+.|+|||.+.+..++.++|||||||++|||++ |+.||.....     .        
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~-----~--------  293 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-----Q--------  293 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----H--------
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----H--------
Confidence            99999743211 1111223457889999999999999999999999999999998 9999864321     1        


Q ss_pred             hhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          464 LQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       464 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                           .+.+.+........+...+..+.+++.+||+.+|++|||+.||
T Consensus       294 -----~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ei  336 (367)
T 3l9p_A          294 -----EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII  336 (367)
T ss_dssp             -----HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             -----HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence                 1111222222223344455678999999999999999999764

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.3e-42  Score=342.16  Aligned_cols=246  Identities=25%  Similarity=0.356  Sum_probs=193.2

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCc--------------------------cchHHHHHHHHHHhc
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSR--------------------------QGNREFLNEIAMISC  292 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~--------------------------~~~~~~~~Ei~~l~~  292 (511)
                      ++|++.+.||+|+||.||+|+. .+++.||||++.....                          ...+.+.+|+.++++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            6799999999999999999975 4688999999865421                          113568899999999


Q ss_pred             CCCCCceeEEEEEEe--CCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCC
Q 045835          293 LQHPNLVKIHGCCVE--GDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIK  370 (511)
Q Consensus       293 l~H~niv~l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk  370 (511)
                      ++||||+++++++.+  .+..++||||+++++|.+++..     ..+++..+..++.|++.||+|||+.+   |+|||||
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk  164 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK  164 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence            999999999999987  5689999999999999876532     35899999999999999999999987   9999999


Q ss_pred             CCCeEEcCCCCeEEeecCCcccCCCCCceeecccccCCCcccccccccCC---CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 045835          371 ATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGY---LTYKADVYSFGIVALEIVSGKNNMSYA  447 (511)
Q Consensus       371 ~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DV~S~Gvvl~elltG~~p~~~~  447 (511)
                      |+|||++.++.+||+|||+++....... ......||+.|+|||.+....   .+.++|||||||++|||++|+.||...
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  243 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE  243 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             HHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence            9999999999999999999986554332 233457999999999987664   478899999999999999999998632


Q ss_pred             CcccccccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          448 PALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       448 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .        ...+...         +.............+..+.+++.+||+.+|++|||+.||
T Consensus       244 ~--------~~~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~  290 (298)
T 2zv2_A          244 R--------IMCLHSK---------IKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEI  290 (298)
T ss_dssp             S--------HHHHHHH---------HHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred             c--------HHHHHHH---------HhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHH
Confidence            2        1111111         111111111112334578999999999999999999764

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.7e-42  Score=348.07  Aligned_cols=249  Identities=24%  Similarity=0.373  Sum_probs=202.3

Q ss_pred             HHHhcCCcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCE
Q 045835          236 KAATNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQ  310 (511)
Q Consensus       236 ~~~~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~  310 (511)
                      ....++|.+.+.||+|+||.||+|+.. +++.||||+++...   ......+..|..++..+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            344578999999999999999999864 68999999997542   33456678899999877 99999999999999999


Q ss_pred             EEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCc
Q 045835          311 LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA  390 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla  390 (511)
                      .++||||+++|+|.+++....    .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a  165 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMC  165 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhh
Confidence            999999999999999996532    4899999999999999999999987   999999999999999999999999999


Q ss_pred             ccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCch
Q 045835          391 KLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKL  470 (511)
Q Consensus       391 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  470 (511)
                      +....... .....+||+.|+|||.+.+..++.++|||||||++|||++|+.||.....     ..+..           
T Consensus       166 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~-----------  228 (345)
T 1xjd_A          166 KENMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-----EELFH-----------  228 (345)
T ss_dssp             BCCCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH-----------
T ss_pred             hhcccCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH-----HHHHH-----------
Confidence            85432222 23346799999999999999999999999999999999999999963221     11111           


Q ss_pred             hHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcC-CC
Q 045835          471 VELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMS-EV  511 (511)
Q Consensus       471 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~-eV  511 (511)
                       .+...  ...++......+.+++.+||+.+|++||++. ||
T Consensus       229 -~i~~~--~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i  267 (345)
T 1xjd_A          229 -SIRMD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDI  267 (345)
T ss_dssp             -HHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCG
T ss_pred             -HHHhC--CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHH
Confidence             11111  1123333456789999999999999999987 53

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=4.9e-42  Score=342.35  Aligned_cols=260  Identities=24%  Similarity=0.324  Sum_probs=197.8

Q ss_pred             hcCCcccCceeccCceeEEeccccCCcEEEEEEecccCc--cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSR--QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      .++|++.++||+|+||.||+|+..+++.||+|++.....  .....+.+|+.++++++||||+++++++.+++..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            367999999999999999999988899999999975432  234678899999999999999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      |+++ +|.+++....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       100 ~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A          100 FMEK-DLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             CCSE-EHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             CCCC-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            9985 7888776433   35899999999999999999999987   999999999999999999999999999865432


Q ss_pred             CceeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccC-------
Q 045835          397 KTHISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDG-------  468 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~-------  468 (511)
                      ... .....||..|+|||.+.+ ..++.++|||||||+++||++|+.||......    ..+... .......       
T Consensus       173 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i-~~~~~~~~~~~~~~  246 (311)
T 3niz_A          173 VRS-YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD----DQLPKI-FSILGTPNPREWPQ  246 (311)
T ss_dssp             CC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT----THHHHH-HHHHCCCCTTTSGG
T ss_pred             ccc-ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH----HHHHHH-HHHHCCCChHHhhh
Confidence            222 233568999999999876 56899999999999999999999999743311    111111 1100000       


Q ss_pred             --chhHhhhhhhC--CC-----CCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          469 --KLVELVDERLG--SK-----YKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       469 --~~~~~~d~~l~--~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                        .+....+....  ..     ..+....++.+++.+||+.||++|||+.|+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  298 (311)
T 3niz_A          247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDA  298 (311)
T ss_dssp             GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred             hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHH
Confidence              00000000000  00     011223568899999999999999999764

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.8e-42  Score=351.62  Aligned_cols=243  Identities=24%  Similarity=0.384  Sum_probs=197.0

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEeccc---CccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK---SRQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l  313 (511)
                      .++|++.+.||+|+||.||+++.. +++.||||+++..   .......+.+|..+++.+ +||||+++++++.+.+..++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            468999999999999999999754 6899999999753   233445688999999988 79999999999999999999


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      ||||+++|+|..++....    .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       102 v~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence            999999999999996543    4899999999999999999999987   999999999999999999999999999854


Q ss_pred             CCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHh
Q 045835          394 EGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVEL  473 (511)
Q Consensus       394 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  473 (511)
                      .... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ..+.            ..+
T Consensus       175 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~~------------~~i  236 (353)
T 3txo_A          175 ICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-----DDLF------------EAI  236 (353)
T ss_dssp             CC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHH------------HHH
T ss_pred             ccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH-----HHHH------------HHH
Confidence            3222 223345799999999999988999999999999999999999999964321     1011            111


Q ss_pred             hhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCc
Q 045835          474 VDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTM  508 (511)
Q Consensus       474 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  508 (511)
                      ....  ..++......+.+++.+||+.+|++||++
T Consensus       237 ~~~~--~~~p~~~~~~~~~li~~lL~~dP~~R~~~  269 (353)
T 3txo_A          237 LNDE--VVYPTWLHEDATGILKSFMTKNPTMRLGS  269 (353)
T ss_dssp             HHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred             HcCC--CCCCCCCCHHHHHHHHHHhhhCHHHccCC
Confidence            1111  12333445678899999999999999997

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.4e-42  Score=350.64  Aligned_cols=248  Identities=22%  Similarity=0.325  Sum_probs=200.5

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC-----ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS-----RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  313 (511)
                      ++|++.+.||+|+||.||+|.. .+++.||||++....     ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            5689999999999999999975 468999999986421     2245679999999999999999999999999999999


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCC---eEEeecCCc
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN---PKISDFGLA  390 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~---~kl~DfGla  390 (511)
                      ||||+++++|.+.+.........+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.   +||+|||++
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            99999999999888654333445899999999999999999999987   999999999999987654   999999999


Q ss_pred             ccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCch
Q 045835          391 KLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKL  470 (511)
Q Consensus       391 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  470 (511)
                      +....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....      ..+..           
T Consensus       181 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~-----------  242 (351)
T 3c0i_A          181 IQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK------ERLFE-----------  242 (351)
T ss_dssp             EECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH------HHHHH-----------
T ss_pred             eEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH------HHHHH-----------
Confidence            86654322 2334579999999999999899999999999999999999999996321      00100           


Q ss_pred             hHhhhhhhCCCCCH----HHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          471 VELVDERLGSKYKK----EEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       471 ~~~~d~~l~~~~~~----~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                       .+.....  ..+.    ..+..+.+++.+||+.||++|||+.|+
T Consensus       243 -~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~  284 (351)
T 3c0i_A          243 -GIIKGKY--KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEA  284 (351)
T ss_dssp             -HHHHTCC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             -HHHcCCC--CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence             1111100  0111    224578999999999999999998763

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.4e-42  Score=341.86  Aligned_cols=254  Identities=26%  Similarity=0.375  Sum_probs=192.4

Q ss_pred             hcCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhc--CCCCCceeEEEEEEeC----CEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISC--LQHPNLVKIHGCCVEG----DQLL  312 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~----~~~~  312 (511)
                      .++|++.+.||+|+||.||+|+. +++.||||++...   ....+..|.+++..  ++||||+++++++...    ...+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            46799999999999999999987 6889999998653   23456667776665  8999999999997653    4689


Q ss_pred             EEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCeEEccCCCCCeEEcCCCCeEE
Q 045835          313 LVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH--------EESRFKIVHRDIKATNVLLDRDLNPKI  384 (511)
Q Consensus       313 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH--------~~~~~~iiH~Dlk~~NILld~~~~~kl  384 (511)
                      +||||+++|+|.+++...     .+++..++.++.|++.||+|||        +.+   |+||||||+|||++.++.+||
T Consensus        83 lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl  154 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI  154 (301)
T ss_dssp             EEECCCTTCBHHHHHTTC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred             EehhhccCCCHHHHHhhc-----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence            999999999999999432     4899999999999999999999        654   999999999999999999999


Q ss_pred             eecCCcccCCCCCcee---ecccccCCCcccccccccC------CCCcchhHHHHHHHHHHHHhC----------CCCCC
Q 045835          385 SDFGLAKLDEGDKTHI---STRIAGTIGYMAPEYALWG------YLTYKADVYSFGIVALEIVSG----------KNNMS  445 (511)
Q Consensus       385 ~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~DV~S~Gvvl~elltG----------~~p~~  445 (511)
                      +|||+++.........   .....||+.|+|||.+.+.      .+++++|||||||++|||+||          +.||.
T Consensus       155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~  234 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY  234 (301)
T ss_dssp             CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence            9999997654333221   2234789999999999876      455799999999999999999          66665


Q ss_pred             CCCcccccccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          446 YAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       446 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .......   .................+    .....+......+.+++.+||+.+|++|||+.||
T Consensus       235 ~~~~~~~---~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i  293 (301)
T 3q4u_A          235 DVVPNDP---SFEDMRKVVCVDQQRPNI----PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI  293 (301)
T ss_dssp             TTSCSSC---CHHHHHHHHTTSCCCCCC----CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             ccCCCCc---chhhhhHHHhccCCCCCC----ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHH
Confidence            3221111   111111100000000000    0001223567889999999999999999999864

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=5.9e-43  Score=352.97  Aligned_cols=254  Identities=27%  Similarity=0.425  Sum_probs=203.1

Q ss_pred             HHhcCCcccCceeccCceeEEecccc------CCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 045835          237 AATNNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGD  309 (511)
Q Consensus       237 ~~~~~f~~~~~lG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~  309 (511)
                      ...++|++.+.||+|+||.||+|+..      +++.||||+++... ....+.+.+|+.++++++||||++++++|.+.+
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  123 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK  123 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence            34578999999999999999999764      34789999997643 334567899999999999999999999999999


Q ss_pred             EEEEEEEecCCCCHhHHHhcCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccC
Q 045835          310 QLLLVYEYMENNSLACALFGRENC--------------------ELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDI  369 (511)
Q Consensus       310 ~~~lV~Ey~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dl  369 (511)
                      ..++||||+++|+|.+++......                    ...+++..++.++.|++.||+|||+.+   |+||||
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dl  200 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL  200 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence            999999999999999999764211                    146899999999999999999999987   999999


Q ss_pred             CCCCeEEcCCCCeEEeecCCcccCCCCCc-eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 045835          370 KATNVLLDRDLNPKISDFGLAKLDEGDKT-HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYA  447 (511)
Q Consensus       370 k~~NILld~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~  447 (511)
                      ||+|||++.++.+||+|||+++....... .......+|..|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence            99999999999999999999975432211 12233467889999999999999999999999999999999 99998632


Q ss_pred             CcccccccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          448 PALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       448 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..     ..+..            .+.+ ......+...+..+.+++.+||+.+|++|||+.||
T Consensus       281 ~~-----~~~~~------------~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~  326 (343)
T 1luf_A          281 AH-----EEVIY------------YVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSI  326 (343)
T ss_dssp             CH-----HHHHH------------HHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             Ch-----HHHHH------------HHhC-CCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence            21     00111            1111 11112334445679999999999999999999764

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.2e-42  Score=339.09  Aligned_cols=246  Identities=28%  Similarity=0.463  Sum_probs=191.6

Q ss_pred             cCCcccCceeccCceeEEeccccCCcEEEEEEecccCc----cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSR----QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|+..+.||+|+||.||+|... ++.||||+++....    ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            57889999999999999999874 88999999875432    33467899999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcC--------CCCeEEeec
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR--------DLNPKISDF  387 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~--------~~~~kl~Df  387 (511)
                      ||+++++|.+++..     ..+++..+..++.|++.||+|||+.+..+|+||||||+|||++.        ++.+||+||
T Consensus        86 e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           86 EFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             ECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            99999999999853     25899999999999999999999987556999999999999986        678999999


Q ss_pred             CCcccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhcc
Q 045835          388 GLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD  467 (511)
Q Consensus       388 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~  467 (511)
                      |+++.......   ....||..|+|||.+.+..++.++||||||++++||++|+.||......        ..       
T Consensus       161 g~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~-------  222 (271)
T 3dtc_A          161 GLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL--------AV-------  222 (271)
T ss_dssp             CC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH--------HH-------
T ss_pred             Ccccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HH-------
Confidence            99985543222   2346899999999999999999999999999999999999999643210        00       


Q ss_pred             CchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          468 GKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       468 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                        ...+.........+...+..+.+++.+||+.+|++|||+.||
T Consensus       223 --~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~  264 (271)
T 3dtc_A          223 --AYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNI  264 (271)
T ss_dssp             --HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             --HHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHH
Confidence              011111122223344455679999999999999999999864

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.1e-42  Score=341.52  Aligned_cols=248  Identities=25%  Similarity=0.375  Sum_probs=188.9

Q ss_pred             hcCCcccCceeccCceeEEeccccC----CcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLAD----GTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~~----g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  313 (511)
                      .++|++.+.||+|+||.||+|....    +..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            4678899999999999999997542    4579999987543 334567899999999999999999999984 567899


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      ||||+++++|.+++....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        93 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             EEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence            999999999999996543   35899999999999999999999987   999999999999999999999999999866


Q ss_pred             CCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhH
Q 045835          394 EGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVE  472 (511)
Q Consensus       394 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  472 (511)
                      ............+|+.|+|||.+....++.++||||||+++|||++ |+.||.....     ......            
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~-----~~~~~~------------  229 (281)
T 1mp8_A          167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----NDVIGR------------  229 (281)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHHH------------
T ss_pred             CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH-----HHHHHH------------
Confidence            5433333333456788999999998899999999999999999997 9999864321     111111            


Q ss_pred             hhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          473 LVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       473 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                       +........+...+..+.+++.+||+.+|++|||+.||
T Consensus       230 -i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l  267 (281)
T 1mp8_A          230 -IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL  267 (281)
T ss_dssp             -HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             -HHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence             11111122334455678999999999999999999764

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.6e-42  Score=343.30  Aligned_cols=245  Identities=22%  Similarity=0.325  Sum_probs=200.1

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCc------cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR------QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQL  311 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~  311 (511)
                      .++|++.+.||+|+||.||++... +|+.||+|++.....      ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            356889999999999999999754 689999999875432      1356789999999999999999999999999999


Q ss_pred             EEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCC----CeEEeec
Q 045835          312 LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL----NPKISDF  387 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~----~~kl~Df  387 (511)
                      ++||||+++++|.+++...    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++    .+||+||
T Consensus        90 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTS----SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEcCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            9999999999999999643    35899999999999999999999987   99999999999999887    7999999


Q ss_pred             CCcccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhcc
Q 045835          388 GLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD  467 (511)
Q Consensus       388 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~  467 (511)
                      |+++.......  .....||+.|+|||.+....++.++|||||||++|||++|+.||.....     .   +.....   
T Consensus       163 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~---~~~~~~---  229 (326)
T 2y0a_A          163 GLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----Q---ETLANV---  229 (326)
T ss_dssp             TTCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----H---HHHHHH---
T ss_pred             CCCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH-----H---HHHHHH---
Confidence            99986543322  2345799999999999989999999999999999999999999963221     0   000000   


Q ss_pred             CchhHhhhhhhCCCCCH----HHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          468 GKLVELVDERLGSKYKK----EEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       468 ~~~~~~~d~~l~~~~~~----~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                            ...  ....+.    ..+..+.+++.+||+.+|++|||+.|+
T Consensus       230 ------~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~  269 (326)
T 2y0a_A          230 ------SAV--NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS  269 (326)
T ss_dssp             ------HHT--CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             ------Hhc--CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence                  000  001111    224568899999999999999999764

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-42  Score=350.46  Aligned_cols=254  Identities=28%  Similarity=0.414  Sum_probs=203.1

Q ss_pred             HhcCCcccCceeccCceeEEeccc------cCCcEEEEEEecccC-ccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCC
Q 045835          238 ATNNFDSAKKIGEGGFGPVYKGQL------ADGTIIAVKQLSSKS-RQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGD  309 (511)
Q Consensus       238 ~~~~f~~~~~lG~G~fG~Vy~g~~------~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~  309 (511)
                      ..++|++.+.||+|+||.||+|+.      .++..||||++.... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            457899999999999999999975      245689999997542 33456799999999999 8999999999999999


Q ss_pred             EEEEEEEecCCCCHhHHHhcCCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCC
Q 045835          310 QLLLVYEYMENNSLACALFGRENC-------------------ELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIK  370 (511)
Q Consensus       310 ~~~lV~Ey~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk  370 (511)
                      ..++||||+++|+|.+++......                   ...+++..++.++.|++.||+|||+.+   |+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence            999999999999999999764321                   124799999999999999999999987   9999999


Q ss_pred             CCCeEEcCCCCeEEeecCCcccCCCCC-ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 045835          371 ATNVLLDRDLNPKISDFGLAKLDEGDK-THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAP  448 (511)
Q Consensus       371 ~~NILld~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~  448 (511)
                      |+|||++.++.+||+|||+++...... ........+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            999999999999999999998553332 222334567889999999999999999999999999999998 999986432


Q ss_pred             cccccccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          449 ALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       449 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..    .             .....+........+......+.+++.+||+.+|.+|||+.||
T Consensus       280 ~~----~-------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  325 (344)
T 1rjb_A          280 VD----A-------------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL  325 (344)
T ss_dssp             CS----H-------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             cH----H-------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence            10    0             1112222222233344456679999999999999999999764

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=7.5e-42  Score=342.13  Aligned_cols=237  Identities=24%  Similarity=0.373  Sum_probs=198.3

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|++.+.||+|+||.||+++.. +|+.||+|+++...   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            57889999999999999999754 68999999997542   234567889999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++|+|.+++....    .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        86 e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           86 DYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             CCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            9999999999997543    4899999999999999999999986   99999999999999999999999999986543


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      .    .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....        ...         ...++.
T Consensus       159 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~---------~~~i~~  217 (318)
T 1fot_A          159 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--------MKT---------YEKILN  217 (318)
T ss_dssp             C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHH---------HHHHHH
T ss_pred             c----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHH---------HHHHHh
Confidence            2    2335799999999999999999999999999999999999999964221        011         111111


Q ss_pred             hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCC
Q 045835          476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRP  506 (511)
Q Consensus       476 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP  506 (511)
                      ..  ..++......+.+++.+||+.+|++||
T Consensus       218 ~~--~~~p~~~~~~~~~li~~lL~~dp~~R~  246 (318)
T 1fot_A          218 AE--LRFPPFFNEDVKDLLSRLITRDLSQRL  246 (318)
T ss_dssp             CC--CCCCTTSCHHHHHHHHHHTCSCTTTCT
T ss_pred             CC--CCCCCCCCHHHHHHHHHHhccCHHHcC
Confidence            11  123334456789999999999999999

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.3e-43  Score=360.36  Aligned_cols=258  Identities=22%  Similarity=0.271  Sum_probs=206.5

Q ss_pred             cccHHHHHHHhcCCcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEE
Q 045835          229 SFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGC  304 (511)
Q Consensus       229 ~~~~~~l~~~~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~  304 (511)
                      .++++++....++|++.+.||+|+||.||+++.. +|+.||||+++...   ......+.+|..++..++||||++++++
T Consensus        50 ~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~  129 (412)
T 2vd5_A           50 VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA  129 (412)
T ss_dssp             HHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred             hhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence            3456666667789999999999999999999864 68999999996532   2233458899999999999999999999


Q ss_pred             EEeCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEE
Q 045835          305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKI  384 (511)
Q Consensus       305 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl  384 (511)
                      +.+.+..++||||+++|+|.+++....   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||
T Consensus       130 ~~~~~~~~lVmE~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL  203 (412)
T 2vd5_A          130 FQDENYLYLVMEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRL  203 (412)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHHHS---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEE
T ss_pred             EeeCCEEEEEEcCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEE
Confidence            999999999999999999999996532   25899999999999999999999987   999999999999999999999


Q ss_pred             eecCCcccCCCCCceeecccccCCCcccccccc-------cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccch
Q 045835          385 SDFGLAKLDEGDKTHISTRIAGTIGYMAPEYAL-------WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCL  457 (511)
Q Consensus       385 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l  457 (511)
                      +|||+++.............+||+.|+|||++.       ...++.++|||||||++|||++|+.||.....     .  
T Consensus       204 ~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~--  276 (412)
T 2vd5_A          204 ADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST-----A--  276 (412)
T ss_dssp             CCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH-----H--
T ss_pred             eechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH-----H--
Confidence            999999876554443344568999999999987       35789999999999999999999999964321     0  


Q ss_pred             hhhhHhhhccCchhHhhhhh--hC-CCCCHHHHHHHHHHHHHcCCCCCCCC---CCcCC
Q 045835          458 LDWACHLQQDGKLVELVDER--LG-SKYKKEEAERMIKVSLLCTNASPSLR---PTMSE  510 (511)
Q Consensus       458 ~~~~~~~~~~~~~~~~~d~~--l~-~~~~~~~~~~l~~l~~~Cl~~~p~~R---Ps~~e  510 (511)
                       +.         ...++...  +. ...+...+..+.+++.+||+ +|.+|   |++.|
T Consensus       277 -~~---------~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~e  324 (412)
T 2vd5_A          277 -ET---------YGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGD  324 (412)
T ss_dssp             -HH---------HHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHH
T ss_pred             -HH---------HHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHH
Confidence             00         11111111  10 11122345678999999999 99998   46654

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.1e-42  Score=338.32  Aligned_cols=247  Identities=26%  Similarity=0.431  Sum_probs=202.9

Q ss_pred             cCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecC
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYME  319 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~  319 (511)
                      ++|+..+.||+|+||.||++...+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            56888999999999999999988888999999976433 34689999999999999999999999999999999999999


Q ss_pred             CCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCce
Q 045835          320 NNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH  399 (511)
Q Consensus       320 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~  399 (511)
                      +++|.+++....   ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++........
T Consensus        87 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  160 (267)
T 3t9t_A           87 HGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  160 (267)
T ss_dssp             TCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred             CCcHHHHHhhCc---ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccc
Confidence            999999996543   35899999999999999999999987   999999999999999999999999999865433222


Q ss_pred             eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhh
Q 045835          400 ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERL  478 (511)
Q Consensus       400 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  478 (511)
                      ......++..|+|||.+....++.++||||||++++||++ |+.||.....        .+...          .+....
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~----------~i~~~~  222 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVVE----------DISTGF  222 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHH----------HHHTTC
T ss_pred             ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH--------HHHHH----------HHhcCC
Confidence            2233456788999999998899999999999999999999 8998863221        11111          111111


Q ss_pred             CCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          479 GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       479 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ....+......+.+++.+||+.+|++|||+.|+
T Consensus       223 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l  255 (267)
T 3t9t_A          223 RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRL  255 (267)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             cCCCCccCcHHHHHHHHHHccCChhhCcCHHHH
Confidence            112233345678999999999999999999764

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-41  Score=340.56  Aligned_cols=265  Identities=20%  Similarity=0.239  Sum_probs=205.2

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCC--EEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGD--QLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~  315 (511)
                      ++|.+.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++...+  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            56889999999999999999765 58999999997543 344567889999999999999999999998765  789999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEE----cCCCCeEEeecCCcc
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL----DRDLNPKISDFGLAK  391 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILl----d~~~~~kl~DfGla~  391 (511)
                      ||+++++|.+++..... ...+++..++.++.|++.||+|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        89 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             ECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             eCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            99999999999976432 234899999999999999999999987   9999999999999    888889999999998


Q ss_pred             cCCCCCceeecccccCCCcccccccc--------cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHh
Q 045835          392 LDEGDKTHISTRIAGTIGYMAPEYAL--------WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACH  463 (511)
Q Consensus       392 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~  463 (511)
                      ........  ....||..|+|||.+.        ...++.++|||||||++|||++|+.||............+......
T Consensus       165 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          165 ELEDDEQF--VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             ECCTTCCB--CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             ecCCCCce--eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            76543322  3356899999999886        5688999999999999999999999996432211111111111000


Q ss_pred             hhccCchhH---hh--------hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          464 LQQDGKLVE---LV--------DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       464 ~~~~~~~~~---~~--------d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      . .......   ..        +-......+......+.+++.+||+.||++|||+.|+
T Consensus       243 ~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~el  300 (319)
T 4euu_A          243 K-PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF  300 (319)
T ss_dssp             C-CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHH
T ss_pred             C-CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHh
Confidence            0 0000000   00        0011224567788889999999999999999999764

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=9.7e-43  Score=348.76  Aligned_cols=255  Identities=23%  Similarity=0.388  Sum_probs=188.4

Q ss_pred             HHHhcCCcccCceeccCceeEEeccccC-C---cEEEEEEeccc--CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 045835          236 KAATNNFDSAKKIGEGGFGPVYKGQLAD-G---TIIAVKQLSSK--SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGD  309 (511)
Q Consensus       236 ~~~~~~f~~~~~lG~G~fG~Vy~g~~~~-g---~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~  309 (511)
                      ....++|++.+.||+|+||.||+|+... +   ..||||+++..  .....+.+.+|+.++++++||||+++++++....
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            3345789999999999999999998653 2   27999999754  3344578999999999999999999999998776


Q ss_pred             EE------EEEEEecCCCCHhHHHhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCC
Q 045835          310 QL------LLVYEYMENNSLACALFGRE--NCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN  381 (511)
Q Consensus       310 ~~------~lV~Ey~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~  381 (511)
                      ..      ++||||+++|+|.+++....  .....+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSC
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCC
Confidence            55      99999999999999986532  22235899999999999999999999987   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCc-eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhh
Q 045835          382 PKISDFGLAKLDEGDKT-HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLD  459 (511)
Q Consensus       382 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~  459 (511)
                      +||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||.....     ..+  
T Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----~~~--  248 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-----AEI--  248 (323)
T ss_dssp             EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGH--
T ss_pred             EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh-----HHH--
Confidence            99999999986543221 12223456788999999999999999999999999999999 8999864321     111  


Q ss_pred             hhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          460 WACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       460 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                                 ...+........+...+..+.+++.+||+.+|++|||+.||
T Consensus       249 -----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  289 (323)
T 3qup_A          249 -----------YNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCL  289 (323)
T ss_dssp             -----------HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred             -----------HHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHH
Confidence                       11111111122334455679999999999999999997653

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.1e-41  Score=344.89  Aligned_cols=251  Identities=22%  Similarity=0.343  Sum_probs=200.0

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV  314 (511)
                      ++|+..+.||+|+||.||+++.. +++.||+|+++...   ....+.+.+|..+++++ +||||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            56889999999999999999864 58899999997542   23345678999999887 899999999999999999999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      |||+++|+|.+++....    .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        89 ~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred             EeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence            99999999999996542    4899999999999999999999987   9999999999999999999999999998533


Q ss_pred             CCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          395 GDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       395 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      .... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..................        ..+.
T Consensus       162 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--------~~i~  232 (345)
T 3a8x_A          162 RPGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF--------QVIL  232 (345)
T ss_dssp             CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHH--------HHHH
T ss_pred             CCCC-cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHH--------HHHH
Confidence            2221 233467999999999999999999999999999999999999999643211100000001100        0111


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCc
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTM  508 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  508 (511)
                      ..  ...++...+..+.+++.+||+.+|++||++
T Consensus       233 ~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          233 EK--QIRIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             HC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             cC--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence            11  122344455678999999999999999996

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.5e-41  Score=340.99  Aligned_cols=242  Identities=24%  Similarity=0.340  Sum_probs=177.6

Q ss_pred             cCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCC-CCCceeEEEEEEeCCEEEEEEEecCCCC
Q 045835          245 AKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ-HPNLVKIHGCCVEGDQLLLVYEYMENNS  322 (511)
Q Consensus       245 ~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gs  322 (511)
                      .+.||+|+||.||++... +++.||||++...   ....+.+|+.+++.+. ||||+++++++.++...++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            378999999999999764 6899999999643   3457789999999997 9999999999999999999999999999


Q ss_pred             HhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCC---CeEEeecCCcccCCCCCce
Q 045835          323 LACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL---NPKISDFGLAKLDEGDKTH  399 (511)
Q Consensus       323 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~---~~kl~DfGla~~~~~~~~~  399 (511)
                      |.+++....    .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++   .+||+|||+++........
T Consensus        93 L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~  165 (325)
T 3kn6_A           93 LFERIKKKK----HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP  165 (325)
T ss_dssp             HHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred             HHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence            999997643    5899999999999999999999987   99999999999997765   7999999999865443322


Q ss_pred             eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhC
Q 045835          400 ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLG  479 (511)
Q Consensus       400 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  479 (511)
                       .....||..|+|||.+.+..++.++|||||||++|||++|+.||....... ..             ....++++....
T Consensus       166 -~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~-------------~~~~~~~~~i~~  230 (325)
T 3kn6_A          166 -LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSL-TC-------------TSAVEIMKKIKK  230 (325)
T ss_dssp             -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--------C-------------CCHHHHHHHHTT
T ss_pred             -ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccc-cc-------------ccHHHHHHHHHc
Confidence             233568999999999999999999999999999999999999997432110 00             011111111111


Q ss_pred             CC--CC----HHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          480 SK--YK----KEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       480 ~~--~~----~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..  .+    ...+..+.+++.+||+.||++|||+.||
T Consensus       231 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~el  268 (325)
T 3kn6_A          231 GDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGL  268 (325)
T ss_dssp             TCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTS
T ss_pred             CCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHH
Confidence            11  11    2235678999999999999999999986

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.9e-42  Score=340.61  Aligned_cols=250  Identities=26%  Similarity=0.448  Sum_probs=208.9

Q ss_pred             HhcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          238 ATNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       238 ~~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      ..++|++.+.||+|+||.||+|... ++..||+|++... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            3567889999999999999999865 4889999999754 3345678999999999999999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      |+++++|.+++....  ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus        90 ~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           90 FMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             CCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred             cCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence            999999999997543  245899999999999999999999987   999999999999999999999999999876655


Q ss_pred             CceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          397 KTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      .........+|..|+|||.+.+..++.++||||||++++||++ |+.||.....                  ..+.+.+.
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~------------------~~~~~~~~  226 (288)
T 3kfa_A          165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------------------SQVYELLE  226 (288)
T ss_dssp             SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG------------------GGHHHHHH
T ss_pred             ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------------------HHHHHHHh
Confidence            4444445567889999999999999999999999999999999 9998864321                  11122222


Q ss_pred             hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       476 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .......+...+..+.+++.+||+.+|++|||+.||
T Consensus       227 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~  262 (288)
T 3kfa_A          227 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI  262 (288)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             ccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHH
Confidence            223333444556679999999999999999999764

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=6e-42  Score=337.62  Aligned_cols=259  Identities=26%  Similarity=0.355  Sum_probs=196.3

Q ss_pred             cCCcccCceeccCceeEEeccccCCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      ++|+..+.||+|+||.||+|+..+++.||+|++....  ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            4688999999999999999988789999999996543  23346788999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +++ +|.+++....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (288)
T ss_dssp             CSE-EHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             cCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence            985 8988886432   35899999999999999999999986   9999999999999999999999999998654322


Q ss_pred             ceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccC------ch
Q 045835          398 THISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDG------KL  470 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~------~~  470 (511)
                      . ......||+.|+|||.+.+. .++.++|||||||+++||++|+.||......    ..+.. ........      ..
T Consensus       155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----~~~~~-~~~~~~~~~~~~~~~~  228 (288)
T 1ob3_A          155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA----DQLMR-IFRILGTPNSKNWPNV  228 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHH-HHHHHCCCCTTTSTTG
T ss_pred             c-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHH-HHHHHCCCChhhchhh
Confidence            1 12334689999999998764 6899999999999999999999999743211    00111 00000000      00


Q ss_pred             hH--hhhhhhC-------CCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          471 VE--LVDERLG-------SKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       471 ~~--~~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .+  ..++...       ..........+.+++.+||+.||++|||+.|+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~  278 (288)
T 1ob3_A          229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA  278 (288)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHH
Confidence            00  0011000       01112234578899999999999999998764

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=9.3e-42  Score=349.67  Aligned_cols=243  Identities=23%  Similarity=0.381  Sum_probs=199.7

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEeccc---CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK---SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|++.+.||+|+||.||+++.. +++.||+|++...   .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            57899999999999999999754 5889999998643   2344567899999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+.+|+|..++...    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        95 e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQN----VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             CCCTTEEHHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             ecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            999999999999654    24899999999999999999999987   99999999999999999999999999986543


Q ss_pred             CCceeecccccCCCccccccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhH
Q 045835          396 DKTHISTRIAGTIGYMAPEYALW---GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVE  472 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  472 (511)
                      ..  ......||+.|+|||++..   ..++.++|||||||++|||++|+.||......     ......          .
T Consensus       168 ~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-----~~~~~~----------~  230 (384)
T 4fr4_A          168 ET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST-----SSKEIV----------H  230 (384)
T ss_dssp             TC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS-----CHHHHH----------H
T ss_pred             CC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc-----cHHHHH----------H
Confidence            32  2234679999999999874   45899999999999999999999999643211     011111          1


Q ss_pred             hhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCC
Q 045835          473 LVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPT  507 (511)
Q Consensus       473 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs  507 (511)
                      .+.. ....++...+..+.+++.+||+.+|++||+
T Consensus       231 ~~~~-~~~~~p~~~s~~~~~li~~lL~~dP~~R~s  264 (384)
T 4fr4_A          231 TFET-TVVTYPSAWSQEMVSLLKKLLEPNPDQRFS  264 (384)
T ss_dssp             HHHH-CCCCCCTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred             HHhh-cccCCCCcCCHHHHHHHHHHhcCCHhHhcc
Confidence            1111 112334445667999999999999999998

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.1e-42  Score=349.81  Aligned_cols=248  Identities=24%  Similarity=0.352  Sum_probs=197.4

Q ss_pred             hcCCcccCceeccCceeEEeccccCCcEEEEEEecccC--ccchHHHHHHHHHHhcCCC--CCceeEEEEEEeCCEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQH--PNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~lV  314 (511)
                      .++|++.+.||+|+||.||++...+++.||||++....  ......+.+|+.++++++|  |||+++++++.+.+..++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            45689999999999999999988889999999987543  3344678999999999987  9999999999999999999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      || +.+++|.+++....    .+++..+..++.|++.||+|||+.+   |+||||||+|||++ ++.+||+|||+++...
T Consensus        88 ~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~  158 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  158 (343)
T ss_dssp             EC-CCSEEHHHHHHHSC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred             Ee-CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence            99 56889999997643    5899999999999999999999987   99999999999997 5789999999998654


Q ss_pred             CCCce-eecccccCCCccccccccc-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhH
Q 045835          395 GDKTH-ISTRIAGTIGYMAPEYALW-----------GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWAC  462 (511)
Q Consensus       395 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~  462 (511)
                      ..... ......||+.|+|||++..           ..++.++|||||||++|||++|+.||.....      ..     
T Consensus       159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~-----  227 (343)
T 3dbq_A          159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------QI-----  227 (343)
T ss_dssp             -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS------HH-----
T ss_pred             cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh------HH-----
Confidence            33222 2334579999999999865           6789999999999999999999999963211      00     


Q ss_pred             hhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          463 HLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       463 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                           ..+..++++.....++......+.+++.+||+.+|++|||+.||
T Consensus       228 -----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~  271 (343)
T 3dbq_A          228 -----SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL  271 (343)
T ss_dssp             -----HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             -----HHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence                 11233444444344444445678999999999999999999764

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3e-42  Score=347.46  Aligned_cols=243  Identities=24%  Similarity=0.331  Sum_probs=198.5

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEeccc---CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK---SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|.+.+.||+|+||.||+|.. .+++.||||++...   .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5789999999999999999985 57899999998643   2233457899999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+ +|+|.+++....    .+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++.....
T Consensus        89 E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           89 EYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             CCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             ECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            999 689988886543    4899999999999999999999987   99999999999999999999999999986544


Q ss_pred             CCceeecccccCCCcccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYL-TYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      ...  .....||+.|+|||.+.+..+ ++++|||||||++|||++|+.||.......     +.             +.+
T Consensus       161 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-----~~-------------~~i  220 (336)
T 3h4j_B          161 GNF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN-----LF-------------KKV  220 (336)
T ss_dssp             SBT--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT-----CB-------------CCC
T ss_pred             Ccc--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH-----HH-------------HHH
Confidence            322  234579999999999987765 789999999999999999999996432100     00             000


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ... ....+...+..+.+++.+||+.||.+|||+.|+
T Consensus       221 ~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~ei  256 (336)
T 3h4j_B          221 NSC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEI  256 (336)
T ss_dssp             CSS-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             HcC-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            000 011223344568899999999999999999764

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.8e-41  Score=337.78  Aligned_cols=259  Identities=24%  Similarity=0.361  Sum_probs=188.3

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      .++|+..+.||+|+||.||+|... +++.||+|+++... ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            467999999999999999999754 68999999997543 3344678999999999999999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          317 YMENNSLACALFGRE--NCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       317 y~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      |++ |+|.+++....  .....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 59999886432  22245899999999999999999999986   9999999999999999999999999998654


Q ss_pred             CCCceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhc-------
Q 045835          395 GDKTHISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQ-------  466 (511)
Q Consensus       395 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~-------  466 (511)
                      ..... .....||..|+|||.+.+. .++.++|||||||++|||++|+.||......     ...........       
T Consensus       160 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~i~~~~~~~~~~~~  233 (317)
T 2pmi_A          160 IPVNT-FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE-----EQLKLIFDIMGTPNESLW  233 (317)
T ss_dssp             SCCCC-CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCSCCTTTC
T ss_pred             CCccc-CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCCChhHh
Confidence            32221 2334689999999998764 6899999999999999999999999743311     11111100000       


Q ss_pred             -----------------cCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          467 -----------------DGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       467 -----------------~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                                       ...+.+.+.+.....    ....+.+++.+||+.||++|||+.|+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~L~~dP~~Rpt~~e~  291 (317)
T 2pmi_A          234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEP----LDGNLMDFLHGLLQLNPDMRLSAKQA  291 (317)
T ss_dssp             GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSC----CCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             hhhhhhhhcccccccccchhHHHhhccccccc----CCHHHHHHHHHHCCCCcccCCCHHHH
Confidence                             011112222222222    23568999999999999999998764

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.5e-42  Score=338.34  Aligned_cols=248  Identities=30%  Similarity=0.474  Sum_probs=202.0

Q ss_pred             hcCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      .++|++.+.||+|+||.||+|...++..||||.+.... ...+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   89 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM   89 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence            46788999999999999999998888899999997543 34568999999999999999999999986 45689999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      ++++|.+++....  ...+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+++.......
T Consensus        90 ~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  164 (279)
T 1qpc_A           90 ENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (279)
T ss_dssp             TTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             CCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence            9999999985432  235899999999999999999999987   99999999999999999999999999987654433


Q ss_pred             eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          399 HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                      .......++..|+|||.+....++.++||||||++++||++ |+.||.....     .   +.          .+.+...
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~---~~----------~~~~~~~  226 (279)
T 1qpc_A          165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-----P---EV----------IQNLERG  226 (279)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----H---HH----------HHHHHTT
T ss_pred             ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH-----H---HH----------HHHHhcc
Confidence            33334457889999999998899999999999999999999 8988863221     0   11          1111111


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....+......+.+++.+||+.+|++|||+.+|
T Consensus       227 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l  260 (279)
T 1qpc_A          227 YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYL  260 (279)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             cCCCCcccccHHHHHHHHHHhccChhhCCCHHHH
Confidence            1122233445678999999999999999998764

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.3e-42  Score=344.05  Aligned_cols=253  Identities=28%  Similarity=0.474  Sum_probs=205.4

Q ss_pred             hcCCcccCceeccCceeEEeccc------cCCcEEEEEEecccCc-cchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL------ADGTIIAVKQLSSKSR-QGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQ  310 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~------~~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~  310 (511)
                      .++|+..+.||+|+||.||+|+.      .+++.||||+++.... ...+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            46788999999999999999963      3567899999975533 3446789999999999 99999999999999999


Q ss_pred             EEEEEEecCCCCHhHHHhcCCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEE
Q 045835          311 LLLVYEYMENNSLACALFGRENC--------------ELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL  376 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~~--------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILl  376 (511)
                      .++||||+++|+|.+++......              ...+++..++.++.|++.||+|||+.+   |+||||||+|||+
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence            99999999999999999765321              235899999999999999999999986   9999999999999


Q ss_pred             cCCCCeEEeecCCcccCCCCCce-eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccc
Q 045835          377 DRDLNPKISDFGLAKLDEGDKTH-ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDC  454 (511)
Q Consensus       377 d~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~  454 (511)
                      +.++.+||+|||+++........ ......+|..|+|||.+.+..++.++||||||++++||+| |+.||......    
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----  254 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD----  254 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS----
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch----
Confidence            99999999999999865543322 2233457889999999999999999999999999999999 99998643210    


Q ss_pred             cchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          455 TCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       455 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                                   ....+.+........+...+..+.+++.+||+.+|.+|||+.||
T Consensus       255 -------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el  298 (313)
T 1t46_A          255 -------------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI  298 (313)
T ss_dssp             -------------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             -------------hHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence                         01122222222222333445678999999999999999999764

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=9.2e-42  Score=350.45  Aligned_cols=250  Identities=20%  Similarity=0.317  Sum_probs=202.8

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      .++|++.+.||+|+||.||+|... +++.||+|++..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            367999999999999999999754 6889999999766555556789999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcC--CCCeEEeecCCcccCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR--DLNPKISDFGLAKLDEG  395 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~--~~~~kl~DfGla~~~~~  395 (511)
                      +++|+|.+++....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.  ++.+||+|||+++....
T Consensus       130 ~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~  203 (387)
T 1kob_A          130 LSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  203 (387)
T ss_dssp             CCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             CCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCC
Confidence            99999999986432   35899999999999999999999987   999999999999974  46799999999987654


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      ...  .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .....   ......       
T Consensus       204 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-----~~~~~---~i~~~~-------  266 (387)
T 1kob_A          204 DEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-----LETLQ---NVKRCD-------  266 (387)
T ss_dssp             TSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHH---HHHHCC-------
T ss_pred             Ccc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH-----HHHHH---HHHhCC-------
Confidence            332  2234689999999999999999999999999999999999999974321     00111   000000       


Q ss_pred             hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       476 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...........+..+.+++.+||+.||++|||+.|+
T Consensus       267 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~el  302 (387)
T 1kob_A          267 WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA  302 (387)
T ss_dssp             CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            001111122345578999999999999999998764

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.1e-41  Score=347.27  Aligned_cols=247  Identities=22%  Similarity=0.304  Sum_probs=200.0

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      .++|++.+.||+|+||.||+|... +++.||+|++....  ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            467999999999999999999754 68999999997543  233457889999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCC---CeEEeecCCccc
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL---NPKISDFGLAKL  392 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~---~~kl~DfGla~~  392 (511)
                      ||+++|+|.+++...    ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++   .+||+|||+++.
T Consensus       108 e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          108 DLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             CCCCSCBHHHHHTTC----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            999999999998654    25899999999999999999999987   99999999999998654   599999999986


Q ss_pred             CCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhH
Q 045835          393 DEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVE  472 (511)
Q Consensus       393 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  472 (511)
                      ......  .....||+.|+|||++.+..++.++|||||||++|||++|+.||....     ...+...            
T Consensus       181 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~-----~~~~~~~------------  241 (362)
T 2bdw_A          181 VNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-----QHRLYAQ------------  241 (362)
T ss_dssp             CTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHH------------
T ss_pred             ecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHH------------
Confidence            553322  234579999999999999899999999999999999999999986322     1111111            


Q ss_pred             hhhhhh--CCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          473 LVDERL--GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       473 ~~d~~l--~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +.....  ........+..+.+++.+||+.||++|||+.|+
T Consensus       242 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~  282 (362)
T 2bdw_A          242 IKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQA  282 (362)
T ss_dssp             HHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             HHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            101000  001112234578899999999999999998763

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3.8e-42  Score=348.70  Aligned_cols=243  Identities=28%  Similarity=0.428  Sum_probs=196.0

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCc---cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSR---QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      +.|+..+.||+|+||.||+|+. .+++.||||++.....   ...+.+.+|+.++++++||||+++++++.+++..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4588899999999999999974 5789999999975432   23357889999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+. |+|.+++....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       134 e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             ECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             ecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            9997 68888875432   35899999999999999999999987   99999999999999999999999999986543


Q ss_pred             CCceeecccccCCCcccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhH
Q 045835          396 DKTHISTRIAGTIGYMAPEYAL---WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVE  472 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  472 (511)
                      .     ....||+.|+|||.+.   .+.++.++|||||||++|||++|+.||.....        ......         
T Consensus       207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~--------~~~~~~---------  264 (348)
T 1u5q_A          207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYH---------  264 (348)
T ss_dssp             B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHH---------
T ss_pred             C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHH---------
Confidence            2     2346899999999884   56789999999999999999999999863321        111111         


Q ss_pred             hhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          473 LVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       473 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +.........+......+.+++.+||+.+|++|||+.||
T Consensus       265 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l  303 (348)
T 1u5q_A          265 IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL  303 (348)
T ss_dssp             HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHH
Confidence            111111111122334568899999999999999998764

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.2e-41  Score=345.20  Aligned_cols=238  Identities=22%  Similarity=0.321  Sum_probs=199.6

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|+..+.||+|+||.||+++.. +|+.||||++....   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            57899999999999999999854 68999999996532   234567889999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++|+|.+++....    .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       121 e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence            9999999999997543    4899999999999999999999987   99999999999999999999999999986543


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      ..    ....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....        .+..         ..+..
T Consensus       194 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~---------~~i~~  252 (350)
T 1rdq_E          194 RT----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIY---------EKIVS  252 (350)
T ss_dssp             CB----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHH---------HHHHH
T ss_pred             Cc----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH--------HHHH---------HHHHc
Confidence            22    235789999999999999999999999999999999999999964321        0111         11111


Q ss_pred             hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCC
Q 045835          476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPT  507 (511)
Q Consensus       476 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs  507 (511)
                      ..  ..++......+.+++.+||+.+|++||+
T Consensus       253 ~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~  282 (350)
T 1rdq_E          253 GK--VRFPSHFSSDLKDLLRNLLQVDLTKRFG  282 (350)
T ss_dssp             CC--CCCCTTCCHHHHHHHHHHSCSCTTTCTT
T ss_pred             CC--CCCCCCCCHHHHHHHHHHhhcCHHhccC
Confidence            11  1233344567899999999999999998

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.4e-42  Score=351.08  Aligned_cols=258  Identities=17%  Similarity=0.201  Sum_probs=198.7

Q ss_pred             hcCCcccCceeccCceeEEeccccC------CcEEEEEEecccCccc-----------hHHHHHHHHHHhcCCCCCceeE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLAD------GTIIAVKQLSSKSRQG-----------NREFLNEIAMISCLQHPNLVKI  301 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~~------g~~vAvK~~~~~~~~~-----------~~~~~~Ei~~l~~l~H~niv~l  301 (511)
                      .++|.+.++||+|+||.||+|....      ++.||||++.......           ...+..|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4679999999999999999997654      4789999987543211           1234456667788899999999


Q ss_pred             EEEEEeC----CEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEc
Q 045835          302 HGCCVEG----DQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD  377 (511)
Q Consensus       302 ~g~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld  377 (511)
                      ++++...    ...++||||+ +++|.+++....   ..+++..++.++.|++.||+|||+.+   |+||||||+|||++
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~  186 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence            9999874    4589999999 999999997542   35999999999999999999999986   99999999999999


Q ss_pred             --CCCCeEEeecCCcccCCCCCce------eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 045835          378 --RDLNPKISDFGLAKLDEGDKTH------ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPA  449 (511)
Q Consensus       378 --~~~~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~  449 (511)
                        .++.+||+|||+++........      ......||+.|+|||.+.+..++.++|||||||++|||+||+.||.... 
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~-  265 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL-  265 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT-
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc-
Confidence              8899999999999865432211      1123459999999999999999999999999999999999999997321 


Q ss_pred             ccccccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          450 LEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       450 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                         .......+.. ......+.+++++.+..   ...+..+.+++..||+.+|++||++.+|
T Consensus       266 ---~~~~~~~~~~-~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l  320 (364)
T 3op5_A          266 ---KDPKYVRDSK-IRYRENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENL  320 (364)
T ss_dssp             ---TCHHHHHHHH-HHHHHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred             ---cCHHHHHHHH-HHhhhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHH
Confidence               1111111111 11123455566655431   1234568899999999999999998764

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.8e-42  Score=347.52  Aligned_cols=247  Identities=27%  Similarity=0.416  Sum_probs=196.1

Q ss_pred             cCCcccCceeccCceeEEecccc-CCc----EEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGT----IIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~----~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  313 (511)
                      ++|+..+.||+|+||.||+|+.. +++    .||+|.+.... ......+.+|+.++++++||||++++++|. ++..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            56888999999999999999753 444    38888875432 344456789999999999999999999986 456889


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      ||||+++|+|.+++....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        92 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             EEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             EEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence            999999999999996542   35899999999999999999999987   999999999999999999999999999876


Q ss_pred             CCCCc-eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchh
Q 045835          394 EGDKT-HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLV  471 (511)
Q Consensus       394 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  471 (511)
                      ..... .......+|..|+|||.+.+..++.++|||||||++|||+| |+.||.....                  ..+.
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------------------~~~~  227 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL------------------AEVP  227 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT------------------THHH
T ss_pred             CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH------------------HHHH
Confidence            54332 22334567889999999999999999999999999999999 9999974321                  1112


Q ss_pred             HhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       472 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +.+........+......+.+++.+||+.+|++|||+.||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el  267 (325)
T 3kex_A          228 DLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKEL  267 (325)
T ss_dssp             HHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHH
T ss_pred             HHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHH
Confidence            2222222222333344568899999999999999999764

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.3e-42  Score=348.76  Aligned_cols=263  Identities=27%  Similarity=0.388  Sum_probs=208.3

Q ss_pred             cCCcccCceeccCceeEEeccc-----cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEE--eCCEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-----ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCV--EGDQLL  312 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-----~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~--~~~~~~  312 (511)
                      ++|++.+.||+|+||.||++++     .+++.||||++........+.+.+|+.++++++||||+++++++.  +....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            5788999999999999999973     468899999998776666678999999999999999999999987  456789


Q ss_pred             EEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCccc
Q 045835          313 LVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       313 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~  392 (511)
                      +||||+++++|.+++....   ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       103 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             EEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence            9999999999999996532   25899999999999999999999986   99999999999999999999999999986


Q ss_pred             CCCCCce--eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCch
Q 045835          393 DEGDKTH--ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKL  470 (511)
Q Consensus       393 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  470 (511)
                      .......  ......+|..|+|||.+.+..++.++||||||++++||++|+.|+.......   .....+.........+
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~  253 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF---LRMMGCERDVPALSRL  253 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH---HHHCC----CCHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh---hhhcccccccccHHHH
Confidence            6543322  2233457888999999998899999999999999999999999875321100   0000000000001122


Q ss_pred             hHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          471 VELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       471 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .+.+........+...+..+.+++.+||+.+|++|||+.||
T Consensus       254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el  294 (327)
T 3lxl_A          254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL  294 (327)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHH
Confidence            33333344444555667789999999999999999999864

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=7.7e-42  Score=349.65  Aligned_cols=243  Identities=23%  Similarity=0.341  Sum_probs=193.4

Q ss_pred             ccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCCCC
Q 045835          244 SAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNS  322 (511)
Q Consensus       244 ~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs  322 (511)
                      ..+.||+|+||.||+|+. .+|+.||+|+++.......+.+.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            356899999999999975 4689999999987665666789999999999999999999999999999999999999999


Q ss_pred             HhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEE--cCCCCeEEeecCCcccCCCCCcee
Q 045835          323 LACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL--DRDLNPKISDFGLAKLDEGDKTHI  400 (511)
Q Consensus       323 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILl--d~~~~~kl~DfGla~~~~~~~~~~  400 (511)
                      |.+++....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||+  +.++.+||+|||+++.......  
T Consensus       173 L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--  244 (373)
T 2x4f_A          173 LFDRIIDES---YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--  244 (373)
T ss_dssp             EHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred             HHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence            999886542   35899999999999999999999987   9999999999999  6678899999999986644322  


Q ss_pred             ecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhh--
Q 045835          401 STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERL--  478 (511)
Q Consensus       401 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l--  478 (511)
                      .....||+.|+|||++....++.++|||||||++|||++|+.||......        +..         ..++....  
T Consensus       245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--------~~~---------~~i~~~~~~~  307 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA--------ETL---------NNILACRWDL  307 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHH---------HHHHHTCCCS
T ss_pred             cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--------HHH---------HHHHhccCCC
Confidence            22346999999999999999999999999999999999999999643210        111         11111110  


Q ss_pred             CCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          479 GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       479 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...........+.+++.+||+.+|++|||+.|+
T Consensus       308 ~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~  340 (373)
T 2x4f_A          308 EDEEFQDISEEAKEFISKLLIKEKSWRISASEA  340 (373)
T ss_dssp             CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             ChhhhccCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence            001112234578999999999999999998764

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.8e-41  Score=342.72  Aligned_cols=243  Identities=24%  Similarity=0.379  Sum_probs=200.8

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEeccc---CccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK---SRQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l  313 (511)
                      .++|+..+.||+|+||.||+++.. +++.||||+++..   .......+..|..++..+ +||||+++++++.+.+..++
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            468999999999999999999865 4789999999754   233456788999999988 89999999999999999999


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      ||||+++|+|.+++....    .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        99 v~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            999999999999996543    4899999999999999999999987   999999999999999999999999999854


Q ss_pred             CCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHh
Q 045835          394 EGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVEL  473 (511)
Q Consensus       394 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  473 (511)
                      ..... .....+||+.|+|||.+.+..++.++|||||||++|||++|+.||.....     ..+.            ..+
T Consensus       172 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~~------------~~i  233 (353)
T 2i0e_A          172 IWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELF------------QSI  233 (353)
T ss_dssp             CCTTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHH------------HHH
T ss_pred             ccCCc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH-----HHHH------------HHH
Confidence            32221 23346799999999999999999999999999999999999999963221     1111            111


Q ss_pred             hhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCc
Q 045835          474 VDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTM  508 (511)
Q Consensus       474 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  508 (511)
                      +...  ..++...+..+.+++.+||+.+|++||+.
T Consensus       234 ~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~  266 (353)
T 2i0e_A          234 MEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGC  266 (353)
T ss_dssp             HHCC--CCCCTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred             HhCC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            1111  12334455678999999999999999975

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2e-41  Score=348.41  Aligned_cols=204  Identities=19%  Similarity=0.272  Sum_probs=175.6

Q ss_pred             hcCCcccCceecc--CceeEEecccc-CCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEE
Q 045835          239 TNNFDSAKKIGEG--GFGPVYKGQLA-DGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       239 ~~~f~~~~~lG~G--~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  313 (511)
                      .++|++.++||+|  +||.||+++.. +++.||||++....  ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4679999999999  99999999865 68999999997543  3334678889999999999999999999999999999


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      ||||+++|+|.+++.....  ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus       104 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            9999999999999976432  34899999999999999999999987   999999999999999999999999998643


Q ss_pred             CCCC------ceeecccccCCCccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 045835          394 EGDK------THISTRIAGTIGYMAPEYALW--GYLTYKADVYSFGIVALEIVSGKNNMSYA  447 (511)
Q Consensus       394 ~~~~------~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~Gvvl~elltG~~p~~~~  447 (511)
                      ....      ........||..|+|||.+.+  ..++.++|||||||++|||++|+.||...
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  240 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM  240 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence            2111      111223468999999999987  57999999999999999999999999743

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.1e-42  Score=344.77  Aligned_cols=259  Identities=28%  Similarity=0.413  Sum_probs=204.5

Q ss_pred             CcccCceeccCceeEEeccc-----cCCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEe--CCEEEE
Q 045835          242 FDSAKKIGEGGFGPVYKGQL-----ADGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVE--GDQLLL  313 (511)
Q Consensus       242 f~~~~~lG~G~fG~Vy~g~~-----~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~l  313 (511)
                      |++.++||+|+||.||++.+     .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+  ....++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            48899999999999987753     267899999997653 2345678999999999999999999999998  468899


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      ||||+++|+|.+++...     .+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       113 v~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             EECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccc
Confidence            99999999999999643     3899999999999999999999987   999999999999999999999999999876


Q ss_pred             CCCCc--eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchh
Q 045835          394 EGDKT--HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLV  471 (511)
Q Consensus       394 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  471 (511)
                      .....  .......+|..|+|||.+.+..++.++||||||++++||+||+.|+.....   ....+..+.........+.
T Consensus       185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~  261 (318)
T 3lxp_A          185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPT---KFLELIGIAQGQMTVLRLT  261 (318)
T ss_dssp             CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH---HHHHHHCSCCHHHHHHHHH
T ss_pred             cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccch---hhhhhhcccccchhHHHHH
Confidence            54332  223345678889999999998999999999999999999999998863211   0001111111111122334


Q ss_pred             HhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       472 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +.++.......+...+..+.+++.+||+.+|++|||+.||
T Consensus       262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el  301 (318)
T 3lxp_A          262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENL  301 (318)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHH
Confidence            4444444445555667789999999999999999999764

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.2e-41  Score=335.93  Aligned_cols=260  Identities=22%  Similarity=0.308  Sum_probs=196.9

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccCc--cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR--QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      ++|+..++||+|+||.||+|+.. +++.||||++.....  .....+.+|+.++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            47889999999999999999754 689999999975432  334678899999999999999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      |+++ +|.+.+....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        82 ~~~~-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  154 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSE-EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred             cCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence            9986 5555554322   35899999999999999999999987   999999999999999999999999999865433


Q ss_pred             CceeecccccCCCcccccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccC------c
Q 045835          397 KTHISTRIAGTIGYMAPEYALWGY-LTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDG------K  469 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~------~  469 (511)
                      .. ......||..|+|||.+.+.. ++.++|||||||+++||++|+.|+.......    .............      .
T Consensus       155 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~----~~~~~i~~~~~~~~~~~~~~  229 (292)
T 3o0g_A          155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD----DQLKRIFRLLGTPTEEQWPS  229 (292)
T ss_dssp             CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH----HHHHHHHHHHCCCCTTTCTT
T ss_pred             cc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH----HHHHHHHHHhCCCChhhhhh
Confidence            22 223456899999999998765 8999999999999999999988864322111    1111111100000      0


Q ss_pred             hhHhhhh---------hhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          470 LVELVDE---------RLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       470 ~~~~~d~---------~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..+..+.         .......+.....+.+++.+||+.||++|||+.|+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~  280 (292)
T 3o0g_A          230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA  280 (292)
T ss_dssp             GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHH
Confidence            0000000         00011222345678899999999999999999764

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=8.3e-42  Score=335.14  Aligned_cols=244  Identities=24%  Similarity=0.353  Sum_probs=197.1

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccC--ccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS--RQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV  314 (511)
                      .++|++.+.||+|+||.||+|... +++.||||++....  .....++.+|+..+..+ +||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            467999999999999999999865 78999999997542  33456788999999999 999999999999999999999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCC---------------
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD---------------  379 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~---------------  379 (511)
                      |||+++++|.+++.........+++..+..++.|++.||+|||+.+   |+||||||+|||++.+               
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            9999999999999764332345899999999999999999999987   9999999999999844               


Q ss_pred             ----CCeEEeecCCcccCCCCCceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccc
Q 045835          380 ----LNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDC  454 (511)
Q Consensus       380 ----~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~  454 (511)
                          ..+||+|||++.......     ...||..|+|||.+.+. .+++++|||||||+++||++|++++....      
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------  235 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD------  235 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH------
T ss_pred             cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh------
Confidence                479999999998654432     23589999999999866 66789999999999999999987654211      


Q ss_pred             cchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          455 TCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       455 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                          .+          ..+... .....+......+.+++.+||+.+|++|||+.|+
T Consensus       236 ----~~----------~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l  277 (289)
T 1x8b_A          236 ----QW----------HEIRQG-RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMAL  277 (289)
T ss_dssp             ----HH----------HHHHTT-CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             ----HH----------HHHHcC-CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHH
Confidence                01          011111 1122333445678999999999999999999764

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.2e-41  Score=342.14  Aligned_cols=244  Identities=22%  Similarity=0.322  Sum_probs=191.0

Q ss_pred             hcCCcccCceeccCceeEEeccc----cCCcEEEEEEecccC----ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL----ADGTIIAVKQLSSKS----RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQ  310 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~----~~g~~vAvK~~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~  310 (511)
                      .++|++.+.||+|+||.||+++.    .+++.||+|+++...    ......+.+|+.+++.++||||+++++++.+.+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            35799999999999999999975    478999999997542    2334567899999999999999999999999999


Q ss_pred             EEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCc
Q 045835          311 LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA  390 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla  390 (511)
                      .++||||+++++|.+++....    .+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~  168 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLC  168 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred             EEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcc
Confidence            999999999999999996543    4889999999999999999999987   999999999999999999999999999


Q ss_pred             ccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCch
Q 045835          391 KLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKL  470 (511)
Q Consensus       391 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  470 (511)
                      +....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....        ....         
T Consensus       169 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~---------  230 (327)
T 3a62_A          169 KESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR--------KKTI---------  230 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHH---------
T ss_pred             cccccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH--------HHHH---------
Confidence            75432221 22345799999999999999999999999999999999999999964321        0111         


Q ss_pred             hHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcC
Q 045835          471 VELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMS  509 (511)
Q Consensus       471 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~  509 (511)
                      ..+....  ...+......+.+++.+||+.+|++||++.
T Consensus       231 ~~i~~~~--~~~p~~~~~~~~~li~~~L~~dp~~R~~~~  267 (327)
T 3a62_A          231 DKILKCK--LNLPPYLTQEARDLLKKLLKRNAASRLGAG  267 (327)
T ss_dssp             HHHHHTC--CCCCTTSCHHHHHHHHHHSCSCGGGSTTSS
T ss_pred             HHHHhCC--CCCCCCCCHHHHHHHHHHHhcCHhhccCCC
Confidence            1111111  123334456789999999999999999653

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=5.8e-42  Score=352.73  Aligned_cols=247  Identities=24%  Similarity=0.350  Sum_probs=196.8

Q ss_pred             cCCcccCceeccCceeEEeccccCCcEEEEEEecccC--ccchHHHHHHHHHHhcCC--CCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQ--HPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|++.+.||+|+||.||++...+++.||||++....  ......+.+|+.+|++++  ||||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            4589999999999999999988789999999987543  334567899999999996  599999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      | +.+++|.+++....    .+++..+..++.||+.||+|||+.+   |+||||||+|||++ ++.+||+|||+++....
T Consensus       136 E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             E-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             e-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            9 67889999997643    5889999999999999999999986   99999999999996 57899999999986543


Q ss_pred             CCc-eeecccccCCCccccccccc-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHh
Q 045835          396 DKT-HISTRIAGTIGYMAPEYALW-----------GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACH  463 (511)
Q Consensus       396 ~~~-~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~  463 (511)
                      ... .......||+.|+|||++..           ..++.++|||||||++|||++|+.||.....       ..     
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-------~~-----  274 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-------QI-----  274 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-------HH-----
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-------HH-----
Confidence            322 22334579999999999865           4689999999999999999999999963210       00     


Q ss_pred             hhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          464 LQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       464 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                          ..+..++++......+......+.+++.+||+.+|++|||+.||
T Consensus       275 ----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~el  318 (390)
T 2zmd_A          275 ----SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL  318 (390)
T ss_dssp             ----HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             ----HHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHH
Confidence                11233344333333333335678999999999999999999764

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.8e-42  Score=341.79  Aligned_cols=260  Identities=26%  Similarity=0.390  Sum_probs=202.4

Q ss_pred             cCCcccCceeccCceeEEecc-----ccCCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeC--CEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQ-----LADGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEG--DQL  311 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~-----~~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~  311 (511)
                      ++|+..+.||+|+||.||+|+     ..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.  +..
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            458889999999999999997     3468899999997543 34457889999999999999999999999876  668


Q ss_pred             EEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcc
Q 045835          312 LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK  391 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~  391 (511)
                      ++||||+++++|.+++....   ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEEeCCCCcHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence            99999999999999995433   35899999999999999999999987   9999999999999999999999999998


Q ss_pred             cCCCCCc--eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhh---c
Q 045835          392 LDEGDKT--HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQ---Q  466 (511)
Q Consensus       392 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~---~  466 (511)
                      .......  .......||..|+|||.+.+..++.++||||||++++||++|+.|+.....      ..........   .
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~  248 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA------LFLKMIGPTHGQMT  248 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH------HHHHHHCSCCGGGH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh------HHhhccCCcccccC
Confidence            7654432  223345678889999999999999999999999999999999987642110      0000000000   0


Q ss_pred             cCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          467 DGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       467 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...+...+........+...+..+.+++.+||+.+|.+|||+.||
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  293 (302)
T 4e5w_A          249 VTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNL  293 (302)
T ss_dssp             HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred             HHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHH
Confidence            011222222223334455566789999999999999999999764

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=9.2e-43  Score=372.98  Aligned_cols=249  Identities=30%  Similarity=0.469  Sum_probs=203.7

Q ss_pred             HhcCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          238 ATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       238 ~~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      ..++|++.++||+|+||.||+|.+.++..||||+++... ...++|.+|+.+|++++||||++++++|.+ +..++||||
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            456788899999999999999998888889999997643 345689999999999999999999999876 678999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +++|+|.++|....  ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus       343 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  417 (535)
T 2h8h_A          343 MSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE  417 (535)
T ss_dssp             CTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred             hcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence            99999999996432  234899999999999999999999986   9999999999999999999999999998654322


Q ss_pred             ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhh
Q 045835          398 THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDE  476 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  476 (511)
                      ........++..|+|||.+....++.++|||||||+||||++ |+.||.....     .             ++.+.+..
T Consensus       418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-----~-------------~~~~~i~~  479 (535)
T 2h8h_A          418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----R-------------EVLDQVER  479 (535)
T ss_dssp             HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-----H-------------HHHHHHHT
T ss_pred             eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----H-------------HHHHHHHc
Confidence            222223456788999999999999999999999999999999 8999863221     0             11111222


Q ss_pred             hhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          477 RLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       477 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..+...+..+...+.+|+.+||+.+|++|||+.+|
T Consensus       480 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l  514 (535)
T 2h8h_A          480 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYL  514 (535)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            22223344556789999999999999999999764

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.9e-41  Score=330.43  Aligned_cols=244  Identities=20%  Similarity=0.276  Sum_probs=200.6

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      .++|.+.+.||+|+||.||+|... ++..||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            457899999999999999999754 5778999999876666678899999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEE---cCCCCeEEeecCCcccCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILl---d~~~~~kl~DfGla~~~~  394 (511)
                      +++++|.+++....    .+++..+..++.|++.||+|||+.+   |+||||||+|||+   +.++.+||+|||++....
T Consensus        88 ~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           88 CTGGELFERVVHKR----VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             CCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             cCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            99999999886543    4899999999999999999999987   9999999999999   788999999999998654


Q ss_pred             CCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          395 GDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       395 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      ....  .....||+.|+|||.+.+ .++.++||||||++++||++|+.||......        +..         ..+.
T Consensus       161 ~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~---------~~~~  220 (277)
T 3f3z_A          161 PGKM--MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS--------EVM---------LKIR  220 (277)
T ss_dssp             TTSC--BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHH---------HHHH
T ss_pred             Cccc--hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH--------HHH---------HHHH
Confidence            3332  233568999999998765 4899999999999999999999999643210        000         0111


Q ss_pred             hhhhCCCCCH----HHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          475 DERLGSKYKK----EEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       475 d~~l~~~~~~----~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...  ...+.    .....+.+++.+||+.+|++|||+.|+
T Consensus       221 ~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~  259 (277)
T 3f3z_A          221 EGT--FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQA  259 (277)
T ss_dssp             HCC--CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             hCC--CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            110  11122    234578999999999999999998763

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.6e-41  Score=333.98  Aligned_cols=248  Identities=29%  Similarity=0.508  Sum_probs=197.8

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccc-------hHHHHHHHHHHhcCCCCCceeEEEEEEeCCE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQG-------NREFLNEIAMISCLQHPNLVKIHGCCVEGDQ  310 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~-------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~  310 (511)
                      .++|++.+.||+|+||.||+|+. .+++.||||++.......       .+.+.+|+.++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            36788999999999999999975 478999999986543221       267899999999999999999999986655 


Q ss_pred             EEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCC-----eEEe
Q 045835          311 LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN-----PKIS  385 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~-----~kl~  385 (511)
                       ++||||+++|+|.+.+....   ..+++..+..++.|++.||+|||+.+ .+|+||||||+|||++.++.     +||+
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~  171 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVA  171 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred             -eEEEEecCCCCHHHHHhccc---CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeC
Confidence             69999999999999886543   36899999999999999999999874 34999999999999988776     9999


Q ss_pred             ecCCcccCCCCCceeecccccCCCcccccccc--cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHh
Q 045835          386 DFGLAKLDEGDKTHISTRIAGTIGYMAPEYAL--WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACH  463 (511)
Q Consensus       386 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~  463 (511)
                      |||+++.....    .....||+.|+|||.+.  ...++.++|||||||++|||++|+.||......     .. ...  
T Consensus       172 Dfg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~-~~~--  239 (287)
T 4f0f_A          172 DFGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG-----KI-KFI--  239 (287)
T ss_dssp             CCTTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC-----HH-HHH--
T ss_pred             CCCcccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc-----HH-HHH--
Confidence            99999854322    23357899999999984  456789999999999999999999999643211     00 000  


Q ss_pred             hhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          464 LQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       464 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                             ..+.........+...+..+.+++.+||+.+|++|||+.||
T Consensus       240 -------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  280 (287)
T 4f0f_A          240 -------NMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYI  280 (287)
T ss_dssp             -------HHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             -------HHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHH
Confidence                   11112222333444556779999999999999999999764

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=9.1e-42  Score=347.64  Aligned_cols=250  Identities=22%  Similarity=0.297  Sum_probs=191.0

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      .++|++.+.||+|+||.||+++.. +++.||||++.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            467999999999999999999764 78999999997543 3346788999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCC--eEEeecCCcccCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN--PKISDFGLAKLDEG  395 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~--~kl~DfGla~~~~~  395 (511)
                      +++|+|.+++....    .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.  +||+|||+++....
T Consensus        98 ~~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~  170 (361)
T 3uc3_A           98 ASGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  170 (361)
T ss_dssp             CCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred             CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence            99999999986543    4899999999999999999999987   999999999999988765  99999999974322


Q ss_pred             CCceeecccccCCCcccccccccCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYK-ADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      ..  ......||+.|+|||.+.+..++.+ +|||||||++|||++|+.||......    .......         ..+.
T Consensus       171 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~~~---------~~~~  235 (361)
T 3uc3_A          171 HS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP----RDYRKTI---------QRIL  235 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C----CCHHHHH---------HHHH
T ss_pred             cC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH----HHHHHHH---------HHHh
Confidence            21  1233569999999999988877665 89999999999999999999743211    1111111         1111


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...............+.+|+.+||+.+|++|||+.|+
T Consensus       236 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el  272 (361)
T 3uc3_A          236 SVKYSIPDDIRISPECCHLISRIFVADPATRISIPEI  272 (361)
T ss_dssp             TTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred             cCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence            1111111111234578899999999999999998764

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=4.7e-41  Score=357.90  Aligned_cols=252  Identities=24%  Similarity=0.365  Sum_probs=206.3

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|...+.||+|+||.||+++.. +|+.||+|++....   ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            67889999999999999999864 68999999996532   234567899999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++|+|.+++.........+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            999999999999765544456999999999999999999999987   99999999999999999999999999986544


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      .... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......    ........         .+..
T Consensus       342 ~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~----~~~~~~~~---------~i~~  407 (543)
T 3c4z_A          342 GQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK----VENKELKQ---------RVLE  407 (543)
T ss_dssp             TCCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC----CCHHHHHH---------HHHH
T ss_pred             CCcc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc----hhHHHHHH---------HHhh
Confidence            3322 23357999999999999999999999999999999999999999743210    00111111         1111


Q ss_pred             hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCC
Q 045835          476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSE  510 (511)
Q Consensus       476 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e  510 (511)
                      .  ...++...+..+.+++.+||+.+|++||++.+
T Consensus       408 ~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~  440 (543)
T 3c4z_A          408 Q--AVTYPDKFSPASKDFCEALLQKDPEKRLGFRD  440 (543)
T ss_dssp             C--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBT
T ss_pred             c--ccCCCcccCHHHHHHHHHhccCCHhHCCCCcc
Confidence            1  11234445667899999999999999998753

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=5.4e-42  Score=333.75  Aligned_cols=245  Identities=23%  Similarity=0.351  Sum_probs=198.6

Q ss_pred             cCCcccCceeccCceeEEeccccCCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeC--CEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEG--DQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~  315 (511)
                      ++|++.+.||+|+||.||+|+.. ++.||||++....  ....+.+.+|+.++++++||||+++++++.+.  +..++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            56889999999999999999874 8899999997543  33446799999999999999999999999887  7889999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++|+|.+++....  ...+++..+..++.|++.||+|||+.+ ++++||||||+|||++.++.++|+|||++.....
T Consensus        89 e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~  165 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS  165 (271)
T ss_dssp             ECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred             cccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence            9999999999997643  235899999999999999999999874 3599999999999999999999999988764322


Q ss_pred             CCceeecccccCCCcccccccccCCCC---cchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhH
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLT---YKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVE  472 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  472 (511)
                            ....||+.|+|||.+.+...+   .++||||||+++|||++|+.||.....        .+.         ...
T Consensus       166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------~~~---------~~~  222 (271)
T 3kmu_A          166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN--------MEI---------GMK  222 (271)
T ss_dssp             ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH--------HHH---------HHH
T ss_pred             ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh--------HHH---------HHH
Confidence                  123678999999998866444   489999999999999999999964321        010         111


Q ss_pred             hhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          473 LVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       473 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +.........+...+..+.+++.+||+.+|++|||+.||
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  261 (271)
T 3kmu_A          223 VALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMI  261 (271)
T ss_dssp             HHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            222222233444556679999999999999999999764

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=8.6e-42  Score=343.84  Aligned_cols=252  Identities=27%  Similarity=0.432  Sum_probs=202.2

Q ss_pred             hcCCcccCceeccCceeEEeccc--------cCCcEEEEEEecccC-ccchHHHHHHHHHHhcC-CCCCceeEEEEEEeC
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL--------ADGTIIAVKQLSSKS-RQGNREFLNEIAMISCL-QHPNLVKIHGCCVEG  308 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~--------~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~  308 (511)
                      .++|.+.+.||+|+||.||+|+.        .++..||||++.... ......+.+|+.+++++ +||||++++++|.+.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            46789999999999999999975        346789999997543 23456789999999999 899999999999999


Q ss_pred             CEEEEEEEecCCCCHhHHHhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEE
Q 045835          309 DQLLLVYEYMENNSLACALFGRENC------------ELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL  376 (511)
Q Consensus       309 ~~~~lV~Ey~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILl  376 (511)
                      +..++||||+++|+|.+++......            ...+++..++.++.|++.||+|||+.+   |+||||||+|||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence            9999999999999999999764321            234899999999999999999999987   9999999999999


Q ss_pred             cCCCCeEEeecCCcccCCCCCce-eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccc
Q 045835          377 DRDLNPKISDFGLAKLDEGDKTH-ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDC  454 (511)
Q Consensus       377 d~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~  454 (511)
                      +.++.+||+|||+++........ ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||.....     
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----  265 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-----  265 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH-----
Confidence            99999999999999865443322 2233456788999999998899999999999999999999 9999864321     


Q ss_pred             cchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          455 TCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       455 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                         .+          +.+.+........+......+.+++.+||+.+|.+|||+.||
T Consensus       266 ---~~----------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el  309 (334)
T 2pvf_A          266 ---EE----------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL  309 (334)
T ss_dssp             ---HH----------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             ---HH----------HHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence               01          111111122223334455678999999999999999999764

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=7.5e-42  Score=358.13  Aligned_cols=245  Identities=25%  Similarity=0.330  Sum_probs=191.4

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEeccc---CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK---SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  314 (511)
                      .++|++.+.||+|+||.||+++. .+|+.||||++...   .......+.+|+.+++.++||||++++++|.+.+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            36799999999999999999974 46899999999753   333445678999999999999999999999999999999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE-ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      |||+++|+|.+++....    .+++..+..++.|++.||+|||+ .+   |+||||||+|||++.++.+||+|||+++..
T Consensus       227 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~  299 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG  299 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred             EeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence            99999999999996543    58999999999999999999998 65   999999999999999999999999999854


Q ss_pred             CCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHh
Q 045835          394 EGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVEL  473 (511)
Q Consensus       394 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  473 (511)
                      ..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ..+...            +
T Consensus       300 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~------------i  361 (446)
T 4ejn_A          300 IKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFEL------------I  361 (446)
T ss_dssp             CC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH------------H
T ss_pred             cCCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHHHHH------------H
Confidence            33222 23346799999999999999999999999999999999999999964321     111111            1


Q ss_pred             hhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCC-----CcCC
Q 045835          474 VDERLGSKYKKEEAERMIKVSLLCTNASPSLRP-----TMSE  510 (511)
Q Consensus       474 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~e  510 (511)
                      ...  ...++......+.+++.+||+.||++||     ++.|
T Consensus       362 ~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~e  401 (446)
T 4ejn_A          362 LME--EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKE  401 (446)
T ss_dssp             HHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHH
T ss_pred             HhC--CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHH
Confidence            111  1122334456789999999999999999     7655

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.6e-41  Score=354.55  Aligned_cols=248  Identities=22%  Similarity=0.312  Sum_probs=199.7

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      .++|++.+.||+|+||.||++.. .+|+.+|+|++....  ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            46799999999999999999964 478999999987543  233457899999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEc---CCCCeEEeecCCccc
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD---RDLNPKISDFGLAKL  392 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld---~~~~~kl~DfGla~~  392 (511)
                      ||+++|+|.+.+....    .+++..+..++.||+.||+|||+.+   |+||||||+|||++   .++.+||+|||+++.
T Consensus        90 E~~~gg~L~~~i~~~~----~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           90 DLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             CCCBCCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            9999999999987643    4899999999999999999999987   99999999999998   467899999999986


Q ss_pred             CCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhH
Q 045835          393 DEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVE  472 (511)
Q Consensus       393 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  472 (511)
                      ...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....     ..+..            .
T Consensus       163 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-----~~~~~------------~  224 (444)
T 3soa_A          163 VEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-----HRLYQ------------Q  224 (444)
T ss_dssp             CCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHH------------H
T ss_pred             ecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-----HHHHH------------H
Confidence            554332 22345799999999999998999999999999999999999999963221     11111            1


Q ss_pred             hhhhhh--CCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          473 LVDERL--GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       473 ~~d~~l--~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +.....  ........+..+.+++.+||+.||++|||+.|+
T Consensus       225 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~  265 (444)
T 3soa_A          225 IKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEA  265 (444)
T ss_dssp             HHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             HHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence            111100  011112335678899999999999999998763

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.2e-42  Score=370.60  Aligned_cols=246  Identities=25%  Similarity=0.401  Sum_probs=196.0

Q ss_pred             CCcccC-ceeccCceeEEecccc---CCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          241 NFDSAK-KIGEGGFGPVYKGQLA---DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       241 ~f~~~~-~lG~G~fG~Vy~g~~~---~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++.+.+ .||+|+||.||+|.+.   ++..||||+++... ....++|.+|+.+|++++|||||+++++|.. +..++||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            344444 7999999999999753   45679999997653 3456789999999999999999999999976 5689999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++|+|.+++...   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       415 E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          415 EMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA  488 (613)
T ss_dssp             ECCTTCBHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred             EeCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence            999999999999643   235899999999999999999999986   99999999999999999999999999986543


Q ss_pred             CCceee--cccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhH
Q 045835          396 DKTHIS--TRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVE  472 (511)
Q Consensus       396 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  472 (511)
                      ......  ....+|+.|+|||++....++.++|||||||++|||+| |+.||.....     .             ++.+
T Consensus       489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-----~-------------~~~~  550 (613)
T 2ozo_A          489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----P-------------EVMA  550 (613)
T ss_dssp             -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS-----H-------------HHHH
T ss_pred             CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH-----H-------------HHHH
Confidence            322211  12345689999999999999999999999999999998 9999974321     1             1122


Q ss_pred             hhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          473 LVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       473 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .+....+...+..++..+.+++.+||+.+|++||++.+|
T Consensus       551 ~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l  589 (613)
T 2ozo_A          551 FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTV  589 (613)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHH
T ss_pred             HHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            222222334455566789999999999999999999764

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.5e-41  Score=344.54  Aligned_cols=246  Identities=24%  Similarity=0.315  Sum_probs=185.4

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      .++|++.+.||+|+||.||+|+.. +++.||||+++...  ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  129 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL  129 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence            467999999999999999999865 57899999997543  335688999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcC---CCCeEEeecCCcccCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR---DLNPKISDFGLAKLDE  394 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~---~~~~kl~DfGla~~~~  394 (511)
                      +++|+|.+++...    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.   ++.+||+|||+++...
T Consensus       130 ~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          130 VTGGELFDRIVEK----GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CCSCBHHHHHTTC----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            9999999999653    24899999999999999999999987   999999999999975   8899999999998654


Q ss_pred             CCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          395 GDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       395 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......    ..+.            ..+.
T Consensus       203 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~------------~~i~  264 (349)
T 2w4o_A          203 HQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD----QFMF------------RRIL  264 (349)
T ss_dssp             ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH----HHHH------------HHHH
T ss_pred             ccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc----HHHH------------HHHH
Confidence            322  223457899999999999999999999999999999999999998633210    0000            0111


Q ss_pred             hhhh--CCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          475 DERL--GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       475 d~~l--~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ....  ......+....+.+++.+||+.||++|||+.|+
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~  303 (349)
T 2w4o_A          265 NCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQA  303 (349)
T ss_dssp             TTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             hCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            1100  111122345678999999999999999998763

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=7e-42  Score=335.67  Aligned_cols=248  Identities=25%  Similarity=0.367  Sum_probs=195.9

Q ss_pred             hcCCcccCceeccCceeEEeccccC----CcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLAD----GTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~~----g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  313 (511)
                      .++|.+.+.||+|+||.||+|+..+    +..||+|.+.... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            4678899999999999999997532    3469999997653 3345678999999999999999999999865 45689


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      ||||+++++|.+++....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        90 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             EEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             EEecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence            999999999999996532   35899999999999999999999987   999999999999999999999999999865


Q ss_pred             CCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhH
Q 045835          394 EGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVE  472 (511)
Q Consensus       394 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  472 (511)
                      ............+|..|+|||.+....++.++||||||+++|||+| |+.||.....     ...             .+
T Consensus       164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~-----~~~-------------~~  225 (281)
T 3cc6_A          164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-----KDV-------------IG  225 (281)
T ss_dssp             ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG-----GGH-------------HH
T ss_pred             ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh-----HHH-------------HH
Confidence            5433333334457889999999998899999999999999999998 9999863321     111             11


Q ss_pred             hhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          473 LVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       473 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .+........+......+.+++.+||+.+|++|||+.||
T Consensus       226 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el  264 (281)
T 3cc6_A          226 VLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTEL  264 (281)
T ss_dssp             HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHH
Confidence            111111122233345678999999999999999999764

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.5e-42  Score=345.82  Aligned_cols=257  Identities=21%  Similarity=0.215  Sum_probs=196.9

Q ss_pred             HHHHhcCCcccCceeccCceeEEeccc-cCCcEEEEEEeccc-----CccchHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 045835          235 IKAATNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK-----SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEG  308 (511)
Q Consensus       235 l~~~~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~  308 (511)
                      +....++|++.+.||+|+||.||+|.. .++..||+|++...     .....+.+.+|+.++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            345567899999999999999999975 46889999998643     234456899999999999999999999999999


Q ss_pred             CEEEEEEEecCCCCHhHHHhcCCC------------------------------------CCCCCCHHHHHHHHHHHHHH
Q 045835          309 DQLLLVYEYMENNSLACALFGREN------------------------------------CELELDWPTRQKICLGIARG  352 (511)
Q Consensus       309 ~~~~lV~Ey~~~gsL~~~l~~~~~------------------------------------~~~~l~~~~~~~i~~~ia~g  352 (511)
                      +..++||||+++|+|.+++.....                                    ....+++..+..++.|++.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            999999999999999999852100                                    01123567788899999999


Q ss_pred             HHHHhcCCCCCeEEccCCCCCeEEcCCC--CeEEeecCCcccCCC---CCceeecccccCCCccccccccc--CCCCcch
Q 045835          353 LAFLHEESRFKIVHRDIKATNVLLDRDL--NPKISDFGLAKLDEG---DKTHISTRIAGTIGYMAPEYALW--GYLTYKA  425 (511)
Q Consensus       353 l~yLH~~~~~~iiH~Dlk~~NILld~~~--~~kl~DfGla~~~~~---~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~  425 (511)
                      |+|||+.+   |+||||||+|||++.++  .+||+|||+++....   ..........||+.|+|||.+..  ..++.++
T Consensus       181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            99999987   99999999999998776  899999999985432   11112334578999999999875  6789999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCC--CCCHHHHHHHHHHHHHcCCCCCC
Q 045835          426 DVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGS--KYKKEEAERMIKVSLLCTNASPS  503 (511)
Q Consensus       426 DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~~l~~l~~~Cl~~~p~  503 (511)
                      |||||||++|||++|+.||......        +.         ...++......  .........+.+++.+||+.+|+
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~--------~~---------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  320 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDA--------DT---------ISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVD  320 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHH--------HH---------HHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTT
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChH--------HH---------HHHHHhcccccCCcccccCCHHHHHHHHHHcCCChh
Confidence            9999999999999999999643211        11         11111111111  11112345788999999999999


Q ss_pred             CCCCcCCC
Q 045835          504 LRPTMSEV  511 (511)
Q Consensus       504 ~RPs~~eV  511 (511)
                      +|||+.|+
T Consensus       321 ~Rps~~~~  328 (345)
T 3hko_A          321 ERFDAMRA  328 (345)
T ss_dssp             TSCCHHHH
T ss_pred             HCCCHHHH
Confidence            99998764

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-41  Score=334.15  Aligned_cols=247  Identities=25%  Similarity=0.403  Sum_probs=199.8

Q ss_pred             cCCcccC-ceeccCceeEEecccc---CCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEE
Q 045835          240 NNFDSAK-KIGEGGFGPVYKGQLA---DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       240 ~~f~~~~-~lG~G~fG~Vy~g~~~---~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  314 (511)
                      ++|.+.+ .||+|+||.||+|...   ++..||||+++... ....+.+.+|+.++++++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4566666 8999999999999743   57789999997643 34456789999999999999999999999 55679999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      |||+++++|.+++...   ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus        88 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             EECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEeCCCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence            9999999999999643   235899999999999999999999987   9999999999999999999999999998664


Q ss_pred             CCCcee--ecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchh
Q 045835          395 GDKTHI--STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLV  471 (511)
Q Consensus       395 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  471 (511)
                      ......  .....+|..|+|||.+.+..++.++||||||+++|||+| |+.||.....     ..+             .
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~~~-------------~  223 (287)
T 1u59_A          162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----PEV-------------M  223 (287)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-----HHH-------------H
T ss_pred             cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-----HHH-------------H
Confidence            433221  122346889999999998899999999999999999998 9999864321     111             1


Q ss_pred             HhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       472 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +.+........+...+..+.+++.+||+.+|++|||+.||
T Consensus       224 ~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l  263 (287)
T 1u59_A          224 AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTV  263 (287)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred             HHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            1111122223444556789999999999999999999764

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.1e-41  Score=332.55  Aligned_cols=253  Identities=21%  Similarity=0.231  Sum_probs=199.5

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEEEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      .++|++.+.||+|+||.||+|+. .+++.||||++....  ....+.+|+.+++.+ +|+|++++++++.+....++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            35799999999999999999974 578999999986543  234688999999999 89999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCC-----eEEeecCCcc
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN-----PKISDFGLAK  391 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~-----~kl~DfGla~  391 (511)
                      |+ +++|.+++....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.     +||+|||+++
T Consensus        87 ~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           87 LL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             ec-CCCHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            99 999999997543   35899999999999999999999986   999999999999987776     9999999998


Q ss_pred             cCCCCCce------eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhh
Q 045835          392 LDEGDKTH------ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQ  465 (511)
Q Consensus       392 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~  465 (511)
                      ........      ......||..|+|||.+.+..++.++||||||+++|||++|+.||.......  ............
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~  237 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT--NKQKYERIGEKK  237 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC--HHHHHHHHHHHH
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccc--cHHHHHHHHhhc
Confidence            65433221      1234579999999999999999999999999999999999999997532111  000001000000


Q ss_pred             ccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          466 QDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       466 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....     +.+..    ..+..+.+++.+||+.+|++|||+.+|
T Consensus       238 ~~~~~-----~~~~~----~~~~~l~~li~~~l~~dp~~RP~~~~l  274 (298)
T 1csn_A          238 QSTPL-----RELCA----GFPEEFYKYMHYARNLAFDATPDYDYL  274 (298)
T ss_dssp             HHSCH-----HHHTT----TSCHHHHHHHHHHHHCCTTCCCCHHHH
T ss_pred             cCccH-----HHHHh----hCcHHHHHHHHHHhcCCcccCCCHHHH
Confidence            00000     11111    234578999999999999999999764

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.8e-41  Score=343.41  Aligned_cols=211  Identities=27%  Similarity=0.371  Sum_probs=182.0

Q ss_pred             ccccccHHHHHHHhcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCC-----CCCce
Q 045835          226 QTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ-----HPNLV  299 (511)
Q Consensus       226 ~~~~~~~~~l~~~~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-----H~niv  299 (511)
                      ....+++++.....++|.+.++||+|+||.||+|+. .+++.||||++... ......+..|+.+++.++     ||||+
T Consensus        21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv   99 (360)
T 3llt_A           21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIV   99 (360)
T ss_dssp             GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred             cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence            344566666666678999999999999999999975 46889999999742 334456788999999886     99999


Q ss_pred             eEEEEEEeCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcC-
Q 045835          300 KIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR-  378 (511)
Q Consensus       300 ~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~-  378 (511)
                      ++++++...+..++||||+ +++|.+++.....  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++. 
T Consensus       100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~  173 (360)
T 3llt_A          100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDP  173 (360)
T ss_dssp             CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCT
T ss_pred             cccceeeECCeeEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccc
Confidence            9999999999999999999 8999999976532  34899999999999999999999987   999999999999986 


Q ss_pred             ------------------------CCCeEEeecCCcccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHH
Q 045835          379 ------------------------DLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVA  434 (511)
Q Consensus       379 ------------------------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl  434 (511)
                                              ++.+||+|||+++......    ....||+.|+|||.+.+..++.++|||||||++
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il  249 (360)
T 3llt_A          174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL  249 (360)
T ss_dssp             TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred             cccccccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence                                    7889999999998644322    235789999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCC
Q 045835          435 LEIVSGKNNMSYA  447 (511)
Q Consensus       435 ~elltG~~p~~~~  447 (511)
                      |||++|+.||...
T Consensus       250 ~ell~g~~pf~~~  262 (360)
T 3llt_A          250 AELYTGSLLFRTH  262 (360)
T ss_dssp             HHHHHSSCSCCCS
T ss_pred             HHHHHCCCCCCCC
Confidence            9999999999743

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.2e-41  Score=335.74  Aligned_cols=259  Identities=24%  Similarity=0.313  Sum_probs=194.5

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccCc--cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR--QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      ++|+..+.||+|+||.||+|+.. +|+.||||++.....  ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57899999999999999999864 589999999865432  234568899999999999999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      |+++++|.+++....    .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        83 ~~~~~~l~~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           83 YCDHTVLHELDRYQR----GVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             CCSEEHHHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             eCCCchHHHHHhhhc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence            999999998886432    4899999999999999999999987   999999999999999999999999999865533


Q ss_pred             CceeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccC--chhHh
Q 045835          397 KTHISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDG--KLVEL  473 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~--~~~~~  473 (511)
                      ... .....||..|+|||.+.+ ..++.++||||||++++||++|+.||.......     ............  .....
T Consensus       156 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~  229 (311)
T 4agu_A          156 SDY-YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD-----QLYLIRKTLGDLIPRHQQV  229 (311)
T ss_dssp             -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHHHCSCCHHHHHH
T ss_pred             ccc-cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHhcccccccccc
Confidence            222 233468999999999876 578999999999999999999999997433111     111000000000  00000


Q ss_pred             hh----------hhhCCCCC-----HHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          474 VD----------ERLGSKYK-----KEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       474 ~d----------~~l~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..          +......+     +..+..+.+++.+||+.||++|||+.||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  282 (311)
T 4agu_A          230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQL  282 (311)
T ss_dssp             HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHH
T ss_pred             cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHH
Confidence            00          00000000     1234568899999999999999999764

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.8e-41  Score=338.51  Aligned_cols=252  Identities=21%  Similarity=0.204  Sum_probs=198.5

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEEEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      .++|++.+.||+|+||.||+|+. .+++.||||++.....  ...+.+|+.+++++ +||||+++++++..++..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            36789999999999999999974 5789999999875432  34688999999999 99999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCC-----eEEeecCCcc
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN-----PKISDFGLAK  391 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~-----~kl~DfGla~  391 (511)
                      |+ +++|.+++....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.     +||+|||+++
T Consensus        86 ~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~  158 (330)
T 2izr_A           86 LL-GPSLEDLFDLCD---RTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK  158 (330)
T ss_dssp             CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred             eC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence            99 999999997542   35999999999999999999999987   999999999999999887     9999999998


Q ss_pred             cCCCCCce------eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhh
Q 045835          392 LDEGDKTH------ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQ  465 (511)
Q Consensus       392 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~  465 (511)
                      ........      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....     ..+.+......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~-----~~~~~~~~~i~  233 (330)
T 2izr_A          159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA-----DTLKERYQKIG  233 (330)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----SSHHHHHHHHH
T ss_pred             eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc-----ccHHHHHHHHH
Confidence            65432221      12346799999999999999999999999999999999999999974321     11111111000


Q ss_pred             ccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          466 QDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       466 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .. . .......+...    .+ .+.+++..||+.+|.+||++.+|
T Consensus       234 ~~-~-~~~~~~~~~~~----~p-~~~~li~~~l~~~p~~RP~~~~l  272 (330)
T 2izr_A          234 DT-K-RATPIEVLCEN----FP-EMATYLRYVRRLDFFEKPDYDYL  272 (330)
T ss_dssp             HH-H-HHSCHHHHTTT----CH-HHHHHHHHHHHCCTTCCCCHHHH
T ss_pred             hh-h-ccCCHHHHhcc----Ch-HHHHHHHHHHhCCCCCCCCHHHH
Confidence            00 0 00000001111    22 79999999999999999998764

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4.9e-42  Score=336.10  Aligned_cols=254  Identities=24%  Similarity=0.357  Sum_probs=200.3

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEe--CCEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVE--GDQLLL  313 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~l  313 (511)
                      .++|++.+.||+|+||.||+++.. +++.||+|.+....  ....+.+.+|+.++++++||||+++++++.+  ....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            367899999999999999999764 68999999997543  3345678999999999999999999999865  568999


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEEccCCCCCeEEcCCCCeEEeecCCcc
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES--RFKIVHRDIKATNVLLDRDLNPKISDFGLAK  391 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~--~~~iiH~Dlk~~NILld~~~~~kl~DfGla~  391 (511)
                      ||||+++++|.+++.........+++..++.++.|++.||+|||+.+  ..+|+||||||+|||++.++.+||+|||+++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            99999999999999764433445899999999999999999999975  1349999999999999999999999999998


Q ss_pred             cCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchh
Q 045835          392 LDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLV  471 (511)
Q Consensus       392 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  471 (511)
                      ....... ......||..|+|||.+.+..++.++||||||+++|||++|+.||.....     ..+.             
T Consensus       165 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~-------------  225 (279)
T 2w5a_A          165 ILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----KELA-------------  225 (279)
T ss_dssp             HC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHH-------------
T ss_pred             eeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-----HHHH-------------
Confidence            6543322 12234689999999999988999999999999999999999999864321     1111             


Q ss_pred             HhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       472 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +.+........+......+.+++.+||+.+|++|||+.||
T Consensus       226 ~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l  265 (279)
T 2w5a_A          226 GKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI  265 (279)
T ss_dssp             HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHH
Confidence            1111111112333445678999999999999999999764

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.1e-41  Score=330.42  Aligned_cols=246  Identities=24%  Similarity=0.365  Sum_probs=180.8

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|++.+.||+|+||.||+|+. .+++.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            5788999999999999999975 578999999996432   233467899999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++++|.+++....   ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        91 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           91 EMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             ECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             ecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            9999999999997542   35899999999999999999999986   99999999999999999999999999986543


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      .... .....||+.|+|||.+.+..++.++||||||++++||++|+.||.......     .            +..+..
T Consensus       165 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~------------~~~~~~  226 (278)
T 3cok_A          165 PHEK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-----T------------LNKVVL  226 (278)
T ss_dssp             ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------------CCS
T ss_pred             CCCc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-----H------------HHHHhh
Confidence            2221 223568999999999998899999999999999999999999987432110     0            000000


Q ss_pred             hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       476 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..  ...+......+.+++.+||+.+|++|||+.||
T Consensus       227 ~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~  260 (278)
T 3cok_A          227 AD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSV  260 (278)
T ss_dssp             SC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             cc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHH
Confidence            00  11222334578899999999999999999764

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=6.2e-42  Score=341.36  Aligned_cols=263  Identities=26%  Similarity=0.392  Sum_probs=207.5

Q ss_pred             cccHHHHHHHhcCCcccCceeccCceeEEeccc------cCCcEEEEEEecccCc-cchHHHHHHHHHHhcC-CCCCcee
Q 045835          229 SFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQL------ADGTIIAVKQLSSKSR-QGNREFLNEIAMISCL-QHPNLVK  300 (511)
Q Consensus       229 ~~~~~~l~~~~~~f~~~~~lG~G~fG~Vy~g~~------~~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~  300 (511)
                      .+...+.....++|++.+.||+|+||.||+|+.      .+++.||||+++.... ...+.+.+|+.+++++ +||||++
T Consensus        16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~   95 (316)
T 2xir_A           16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   95 (316)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence            344455555678899999999999999999963      3568899999976433 3345789999999999 7999999


Q ss_pred             EEEEEEeCC-EEEEEEEecCCCCHhHHHhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEc
Q 045835          301 IHGCCVEGD-QLLLVYEYMENNSLACALFGRENC------------ELELDWPTRQKICLGIARGLAFLHEESRFKIVHR  367 (511)
Q Consensus       301 l~g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~  367 (511)
                      +++++...+ ..++||||+++|+|.+++......            ...+++..+..++.|++.||+|||+.+   |+||
T Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~  172 (316)
T 2xir_A           96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR  172 (316)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred             EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccc
Confidence            999998755 589999999999999999765431            123789999999999999999999986   9999


Q ss_pred             cCCCCCeEEcCCCCeEEeecCCcccCCCCCc-eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 045835          368 DIKATNVLLDRDLNPKISDFGLAKLDEGDKT-HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMS  445 (511)
Q Consensus       368 Dlk~~NILld~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~  445 (511)
                      ||||+||+++.++.+||+|||+++....... .......+|..|+|||.+.+..++.++||||||+++|||+| |+.||.
T Consensus       173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~  252 (316)
T 2xir_A          173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  252 (316)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence            9999999999999999999999986543322 22334567889999999999999999999999999999998 999986


Q ss_pred             CCCcccccccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          446 YAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       446 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....    .             .+...+........+......+.+++.+||+.+|.+|||+.||
T Consensus       253 ~~~~~----~-------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el  301 (316)
T 2xir_A          253 GVKID----E-------------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL  301 (316)
T ss_dssp             TCCCS----H-------------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             ccchh----H-------------HHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            43210    0             0111111111122233345678999999999999999999864

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-41  Score=346.27  Aligned_cols=245  Identities=25%  Similarity=0.342  Sum_probs=196.8

Q ss_pred             cCCcccCceeccCceeEEeccc----cCCcEEEEEEecccC----ccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL----ADGTIIAVKQLSSKS----RQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQ  310 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~----~~g~~vAvK~~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~  310 (511)
                      ++|++.+.||+|+||.||+++.    .+++.||||+++...    ......+.+|+.+++.+ +||||+++++++...+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            5799999999999999999976    368999999987532    23345677899999999 69999999999999999


Q ss_pred             EEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCc
Q 045835          311 LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA  390 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla  390 (511)
                      .++||||+++|+|.+++....    .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             EEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            999999999999999997543    4899999999999999999999986   999999999999999999999999999


Q ss_pred             ccCCCCCceeecccccCCCccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccC
Q 045835          391 KLDEGDKTHISTRIAGTIGYMAPEYALW--GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDG  468 (511)
Q Consensus       391 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~  468 (511)
                      +..............||+.|+|||++.+  ..++.++|||||||++|||++|+.||......    ..........    
T Consensus       207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~----~~~~~~~~~~----  278 (355)
T 1vzo_A          207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK----NSQAEISRRI----  278 (355)
T ss_dssp             EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC----CCHHHHHHHH----
T ss_pred             eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc----chHHHHHHHH----
Confidence            8654433333344679999999999985  35789999999999999999999999643211    1111111111    


Q ss_pred             chhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCC
Q 045835          469 KLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRP  506 (511)
Q Consensus       469 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP  506 (511)
                           ..  ....++.+....+.+++.+||+.+|++||
T Consensus       279 -----~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~  309 (355)
T 1vzo_A          279 -----LK--SEPPYPQEMSALAKDLIQRLLMKDPKKRL  309 (355)
T ss_dssp             -----HH--CCCCCCTTSCHHHHHHHHHHTCSSGGGST
T ss_pred             -----hc--cCCCCCcccCHHHHHHHHHHhhhCHHHhc
Confidence                 11  11223444556789999999999999999

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.7e-41  Score=344.28  Aligned_cols=243  Identities=24%  Similarity=0.345  Sum_probs=190.9

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHH-HhcCCCCCceeEEEEEEeCCEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAM-ISCLQHPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~lV  314 (511)
                      ++|++.+.||+|+||.||+++.. +++.||||+++...   ......+.+|..+ ++.++||||+++++++.+.+..++|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            57899999999999999999865 58899999997543   2233456677776 5778999999999999999999999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      |||+++|+|.+++....    .+++.....++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       118 ~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          118 LDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            99999999999996533    4889999999999999999999987   9999999999999999999999999998533


Q ss_pred             CCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          395 GDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       395 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      ... ......+||+.|+|||.+.+..++.++|||||||++|||++|+.||.....        .+.         ...++
T Consensus       191 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~---------~~~i~  252 (373)
T 2r5t_A          191 EHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--------AEM---------YDNIL  252 (373)
T ss_dssp             CCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH--------HHH---------HHHHH
T ss_pred             cCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--------HHH---------HHHHH
Confidence            222 123346799999999999999999999999999999999999999963221        011         11111


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMS  509 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~  509 (511)
                      ...+  .++......+.+++.+||+.+|++||++.
T Consensus       253 ~~~~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~  285 (373)
T 2r5t_A          253 NKPL--QLKPNITNSARHLLEGLLQKDRTKRLGAK  285 (373)
T ss_dssp             HSCC--CCCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred             hccc--CCCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence            1111  22333456789999999999999999985

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.7e-41  Score=330.17  Aligned_cols=244  Identities=25%  Similarity=0.397  Sum_probs=198.1

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  314 (511)
                      .++|++.+.||+|+||.||+|... ++..||||++....   ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            467899999999999999999754 57799999986432   23356789999999999999999999999999999999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      |||+++++|.+++....    .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        88 ~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~  160 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP  160 (279)
T ss_dssp             ECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred             EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence            99999999999986543    4899999999999999999999986   9999999999999999999999999986543


Q ss_pred             CCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          395 GDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       395 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      ...   .....||..|+|||.+.+..++.++||||||++++||++|+.||.....        .+...         .+.
T Consensus       161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~---------~~~  220 (279)
T 3fdn_A          161 SSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYK---------RIS  220 (279)
T ss_dssp             ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHH---------HHH
T ss_pred             ccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH--------HHHHH---------HHH
Confidence            322   2335689999999999999999999999999999999999999863221        00000         000


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                        ......+......+.+++.+||+.+|++|||+.||
T Consensus       221 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~  255 (279)
T 3fdn_A          221 --RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREV  255 (279)
T ss_dssp             --HTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             --hCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHH
Confidence              11122333345678899999999999999999864

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.9e-41  Score=340.61  Aligned_cols=247  Identities=26%  Similarity=0.444  Sum_probs=194.3

Q ss_pred             cCCcccCceeccCceeEEecccc-CCc----EEEEEEeccc-CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGT----IIAVKQLSSK-SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~----~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  313 (511)
                      ++|++.++||+|+||.||+|... +++    .||+|.+... .......+.+|+.++++++||||++++++|.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            57899999999999999999753 444    3678877543 3455678999999999999999999999998765 789


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      |+||+.+|+|.+++....   ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        94 v~~~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EECCCSSCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            999999999999997643   35899999999999999999999987   999999999999999999999999999865


Q ss_pred             CCCCc-eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchh
Q 045835          394 EGDKT-HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLV  471 (511)
Q Consensus       394 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  471 (511)
                      ..... .......+|..|+|||.+.+..++.++|||||||++|||++ |+.||.....                  ..+.
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~------------------~~~~  229 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA------------------SEIS  229 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG------------------GGHH
T ss_pred             cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH------------------HHHH
Confidence            43222 12223456788999999999999999999999999999999 9999974321                  1122


Q ss_pred             HhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       472 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +.+........+......+.+++.+||+.+|.+|||+.||
T Consensus       230 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el  269 (327)
T 3lzb_A          230 SILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFREL  269 (327)
T ss_dssp             HHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            2233322233344456679999999999999999999864

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=5.1e-42  Score=337.70  Aligned_cols=242  Identities=25%  Similarity=0.389  Sum_probs=195.5

Q ss_pred             cCCcccCceeccCceeEEeccccC-C-------cEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLAD-G-------TIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQL  311 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~-g-------~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~  311 (511)
                      ++|.+.+.||+|+||.||+|+... +       ..||+|++........+.+.+|+.++++++||||+++++++.+++..
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN   87 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence            568889999999999999997542 3       47999999876666778899999999999999999999999999999


Q ss_pred             EEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCC--------eE
Q 045835          312 LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN--------PK  383 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~--------~k  383 (511)
                      ++||||+++|+|.+++....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.        +|
T Consensus        88 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           88 ILVQEFVKFGSLDTYLKKNK---NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             EEEEECCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence            99999999999999997543   34899999999999999999999987   999999999999998887        99


Q ss_pred             EeecCCcccCCCCCceeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhH
Q 045835          384 ISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWAC  462 (511)
Q Consensus       384 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~  462 (511)
                      |+|||++......     ....||..|+|||.+.+ ..++.++||||||+++|||++|..|+....    +   ....  
T Consensus       162 l~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~----~---~~~~--  227 (289)
T 4fvq_A          162 LSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL----D---SQRK--  227 (289)
T ss_dssp             ECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS----C---HHHH--
T ss_pred             eccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc----c---hHHH--
Confidence            9999999754322     22457889999999987 679999999999999999999655443211    0   0000  


Q ss_pred             hhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          463 HLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       463 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                              ......  ....+......+.+++.+||+.+|++|||+.||
T Consensus       228 --------~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  266 (289)
T 4fvq_A          228 --------LQFYED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAI  266 (289)
T ss_dssp             --------HHHHHT--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHH
T ss_pred             --------HHHhhc--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence                    001111  111122224468899999999999999999764

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.3e-41  Score=339.51  Aligned_cols=254  Identities=22%  Similarity=0.312  Sum_probs=198.5

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEe----CCEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVE----GDQLLL  313 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~l  313 (511)
                      .++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|+.+++.++||||+++++++..    ....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            46799999999999999999975 5789999999977666666789999999999999999999999973    347899


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      ||||+++|+|.+++.........+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            99999999999999764333456999999999999999999999986   999999999999999999999999998754


Q ss_pred             CCCCce--------eecccccCCCcccccccccCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhH
Q 045835          394 EGDKTH--------ISTRIAGTIGYMAPEYALWGY---LTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWAC  462 (511)
Q Consensus       394 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~  462 (511)
                      ......        ......||..|+|||.+....   ++.++||||||+++|||++|+.||.....             
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------------  251 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ-------------  251 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHH-------------
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhc-------------
Confidence            321100        011235799999999987543   78999999999999999999999852110             


Q ss_pred             hhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          463 HLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       463 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                         ....+...+........+......+.+++.+||+.+|.+|||+.||
T Consensus       252 ---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  297 (317)
T 2buj_A          252 ---KGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLL  297 (317)
T ss_dssp             ---TTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             ---ccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHH
Confidence               0001111111111112223345679999999999999999999764

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=7.6e-42  Score=340.78  Aligned_cols=250  Identities=21%  Similarity=0.308  Sum_probs=191.2

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCc---cchHHHHHHHHHHhcCCCCCceeEEEEEEeCC----E
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSR---QGNREFLNEIAMISCLQHPNLVKIHGCCVEGD----Q  310 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~  310 (511)
                      .++|++.+.||+|+||.||+++. .+++.||||+++....   .....+.+|+.++++++||||+++++++....    .
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            36799999999999999999984 5789999999976432   23357889999999999999999999987643    3


Q ss_pred             EEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCc
Q 045835          311 LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA  390 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla  390 (511)
                      .++||||+++++|.+++....    .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             cEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence            499999999999999996543    5899999999999999999999987   999999999999999999999999999


Q ss_pred             ccCCCCCc--eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccC
Q 045835          391 KLDEGDKT--HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDG  468 (511)
Q Consensus       391 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~  468 (511)
                      +.......  .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....        ...........
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--------~~~~~~~~~~~  235 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--------VSVAYQHVRED  235 (311)
T ss_dssp             ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHCC
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHhcCC
Confidence            86543222  122335689999999999999999999999999999999999999964321        11111111111


Q ss_pred             chhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCC
Q 045835          469 KLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSE  510 (511)
Q Consensus       469 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e  510 (511)
                      ...   .....    ...+..+.+++.+||+.+|++||+..+
T Consensus       236 ~~~---~~~~~----~~~~~~l~~li~~~l~~dP~~R~~~~~  270 (311)
T 3ork_A          236 PIP---PSARH----EGLSADLDAVVLKALAKNPENRYQTAA  270 (311)
T ss_dssp             CCC---HHHHS----TTCCHHHHHHHHHHTCSSGGGSCSSHH
T ss_pred             CCC---ccccc----CCCCHHHHHHHHHHHhcCHhhChhhHH
Confidence            000   00001    123456889999999999999998754

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.2e-41  Score=339.38  Aligned_cols=259  Identities=25%  Similarity=0.392  Sum_probs=194.2

Q ss_pred             HHHHHHHhcCCcccCceeccCceeEEecccc----CCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEE
Q 045835          232 LKQIKAATNNFDSAKKIGEGGFGPVYKGQLA----DGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCC  305 (511)
Q Consensus       232 ~~~l~~~~~~f~~~~~lG~G~fG~Vy~g~~~----~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~  305 (511)
                      ++++....++|.+.+.||+|+||.||+|...    .+..||||+++...  ....+.+.+|+.++++++||||+++++++
T Consensus        26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  105 (313)
T 3brb_A           26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC  105 (313)
T ss_dssp             TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence            3444445678999999999999999999753    34589999987543  33346789999999999999999999999


Q ss_pred             EeCC-----EEEEEEEecCCCCHhHHHhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcC
Q 045835          306 VEGD-----QLLLVYEYMENNSLACALFGRE--NCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR  378 (511)
Q Consensus       306 ~~~~-----~~~lV~Ey~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~  378 (511)
                      .+.+     ..++||||+++|+|.+++....  .....+++..++.++.|++.||+|||+.+   |+||||||+|||++.
T Consensus       106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~  182 (313)
T 3brb_A          106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRD  182 (313)
T ss_dssp             EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECT
T ss_pred             eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcC
Confidence            8755     3599999999999999985432  22346999999999999999999999986   999999999999999


Q ss_pred             CCCeEEeecCCcccCCCCCc-eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccc
Q 045835          379 DLNPKISDFGLAKLDEGDKT-HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTC  456 (511)
Q Consensus       379 ~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~  456 (511)
                      ++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....     ..
T Consensus       183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~~  257 (313)
T 3brb_A          183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-----HE  257 (313)
T ss_dssp             TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----GG
T ss_pred             CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH-----HH
Confidence            99999999999986543221 12233457889999999999999999999999999999999 8888864321     11


Q ss_pred             hhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          457 LLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       457 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +..             .+........+...+..+.+++.+||+.+|++|||+.||
T Consensus       258 ~~~-------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  299 (313)
T 3brb_A          258 MYD-------------YLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVL  299 (313)
T ss_dssp             HHH-------------HHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred             HHH-------------HHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHH
Confidence            111             111111122334455679999999999999999999764

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4.9e-41  Score=353.45  Aligned_cols=244  Identities=23%  Similarity=0.357  Sum_probs=200.5

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|.+.+.||+|+||.||+|+.. +|+.||||++....   ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            57889999999999999999864 78999999996532   233467899999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++|+|.+++...    ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        96 E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           96 EYVSGGELFDYICKN----GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             ECCSSEEHHHHTTSS----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            999999999999643    35899999999999999999999986   99999999999999999999999999987554


Q ss_pred             CCceeecccccCCCcccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYL-TYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      ...  .....||+.|+|||.+.+..+ +.++|||||||++|||++|+.||.....        ....         ..+.
T Consensus       169 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~--------~~~~---------~~i~  229 (476)
T 2y94_A          169 GEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV--------PTLF---------KKIC  229 (476)
T ss_dssp             TCC--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS--------HHHH---------HHHH
T ss_pred             ccc--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH--------HHHH---------HHHh
Confidence            322  234579999999999987754 7899999999999999999999963221        1111         1111


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +...  ..+......+.+++.+||+.||++|||+.||
T Consensus       230 ~~~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~ei  264 (476)
T 2y94_A          230 DGIF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDI  264 (476)
T ss_dssp             TTCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             cCCc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence            1111  1222334568899999999999999999764

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=5.8e-41  Score=332.77  Aligned_cols=245  Identities=30%  Similarity=0.424  Sum_probs=201.8

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      +.|+..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            5688999999999999999974 468899999997543 34457899999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +++++|.+++..     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus       102 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A          102 LGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             CTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            999999999853     24899999999999999999999987   9999999999999999999999999998654332


Q ss_pred             ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          398 THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                      . ......||..|+|||.+.+..++.++||||||++++||++|+.|+.....     ....             ..+...
T Consensus       174 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~-------------~~~~~~  234 (303)
T 3a7i_A          174 I-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP-----MKVL-------------FLIPKN  234 (303)
T ss_dssp             C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHH-------------HHHHHS
T ss_pred             c-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH-----HHHH-------------HHhhcC
Confidence            2 12335689999999999999999999999999999999999999863321     0010             011111


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....+......+.+++.+||+.+|++|||+.||
T Consensus       235 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  268 (303)
T 3a7i_A          235 NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKEL  268 (303)
T ss_dssp             CCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             CCCCCccccCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            1112223344568999999999999999999764

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=8.1e-41  Score=334.83  Aligned_cols=245  Identities=22%  Similarity=0.310  Sum_probs=200.4

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCcc------chHHHHHHHHHHhcCCCCCceeEEEEEEeCCEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQ------GNREFLNEIAMISCLQHPNLVKIHGCCVEGDQL  311 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~  311 (511)
                      .++|++.+.||+|+||.||+++.. +|+.||||.+......      ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            356899999999999999999754 6899999999754321      356799999999999999999999999999999


Q ss_pred             EEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCC----CeEEeec
Q 045835          312 LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL----NPKISDF  387 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~----~~kl~Df  387 (511)
                      ++||||+++++|.+++...    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++    .+||+||
T Consensus        91 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTC----SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence            9999999999999999653    25899999999999999999999987   99999999999999888    7999999


Q ss_pred             CCcccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhcc
Q 045835          388 GLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD  467 (511)
Q Consensus       388 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~  467 (511)
                      |+++.......  .....||+.|+|||.+.+..++.++||||||++++||++|+.||.....        .+....... 
T Consensus       164 g~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~i~~-  232 (321)
T 2a2a_A          164 GLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLANITS-  232 (321)
T ss_dssp             TTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHT-
T ss_pred             ccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHh-
Confidence            99986544322  2345689999999999999999999999999999999999999964321        011111000 


Q ss_pred             CchhHhhhhhhCCCCCH----HHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          468 GKLVELVDERLGSKYKK----EEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       468 ~~~~~~~d~~l~~~~~~----~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                              .  ....+.    ..+..+.+++.+||+.+|++|||+.|+
T Consensus       233 --------~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~  270 (321)
T 2a2a_A          233 --------V--SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEA  270 (321)
T ss_dssp             --------T--CCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHH
T ss_pred             --------c--ccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHH
Confidence                    0  001111    224568899999999999999998764

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4.5e-41  Score=328.55  Aligned_cols=250  Identities=28%  Similarity=0.392  Sum_probs=200.6

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            357899999999999999999764 68999999997543 3345678999999999999999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      |+++++|.+++...    ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++......
T Consensus        86 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           86 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             ecCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence            99999999988543    35899999999999999999999987   999999999999999999999999999854322


Q ss_pred             C-ceeecccccCCCcccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          397 K-THISTRIAGTIGYMAPEYALWGYL-TYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       397 ~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      . ........||..|+|||.+.+..+ +.++||||||++++||++|+.||.....   .......|..            
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~------------  223 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD---SCQEYSDWKE------------  223 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT---TSHHHHHHHT------------
T ss_pred             cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch---HHHHHHHhhh------------
Confidence            2 122234568999999999987664 7899999999999999999999974321   1111112211            


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                       ..............+.+++.+||+.+|++|||+.||
T Consensus       224 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  259 (276)
T 2yex_A          224 -KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDI  259 (276)
T ss_dssp             -TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             -cccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHH
Confidence             000001112334568899999999999999999764

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=6.1e-41  Score=329.17  Aligned_cols=247  Identities=23%  Similarity=0.317  Sum_probs=199.7

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      .++|++.+.||+|+||.||+|... +++.||+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            468999999999999999999754 68899999997543  233467889999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCC---eEEeecCCccc
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN---PKISDFGLAKL  392 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~---~kl~DfGla~~  392 (511)
                      ||+++++|.+.+....    .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.   +||+|||++..
T Consensus        85 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~  157 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE  157 (284)
T ss_dssp             CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             ecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence            9999999998886543    4899999999999999999999987   999999999999987655   99999999986


Q ss_pred             CCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhH
Q 045835          393 DEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVE  472 (511)
Q Consensus       393 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  472 (511)
                      ......  .....||+.|+|||.+.+..++.++||||||++++||++|+.||.....     ......            
T Consensus       158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~~~~------------  218 (284)
T 3kk8_A          158 VNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----HRLYAQ------------  218 (284)
T ss_dssp             CCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH------------
T ss_pred             cccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch-----hHHHHH------------
Confidence            543322  2335689999999999999999999999999999999999999863221     001110            


Q ss_pred             hhhhhh--CCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          473 LVDERL--GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       473 ~~d~~l--~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +.....  ...........+.+++.+||+.+|++|||+.|+
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~  259 (284)
T 3kk8_A          219 IKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQA  259 (284)
T ss_dssp             HHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             HHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHH
Confidence            000000  011112334568899999999999999999764

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3e-41  Score=335.74  Aligned_cols=261  Identities=26%  Similarity=0.331  Sum_probs=195.9

Q ss_pred             HhcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC-----ccchHHHHHHHHHHhcCC---CCCceeEEEEEEeC
Q 045835          238 ATNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS-----RQGNREFLNEIAMISCLQ---HPNLVKIHGCCVEG  308 (511)
Q Consensus       238 ~~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~-----~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~  308 (511)
                      .+++|++.++||+|+||.||+|+. .+++.||||++....     ......+.+|+.+++.++   ||||++++++|...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            357899999999999999999975 568999999987432     122346778888777664   99999999999876


Q ss_pred             C-----EEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeE
Q 045835          309 D-----QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPK  383 (511)
Q Consensus       309 ~-----~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~k  383 (511)
                      .     ..++||||+. ++|.+++.....  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+|
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k  160 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK  160 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence            5     5899999997 599999975432  34899999999999999999999987   99999999999999999999


Q ss_pred             EeecCCcccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHh
Q 045835          384 ISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACH  463 (511)
Q Consensus       384 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~  463 (511)
                      |+|||+++.......  .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......     ........
T Consensus       161 l~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~i~~  233 (308)
T 3g33_A          161 LADFGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-----DQLGKIFD  233 (308)
T ss_dssp             ECSCSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH-----HHHHHHHH
T ss_pred             EeeCccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHH
Confidence            999999986543322  24457899999999999999999999999999999999999999643211     11111110


Q ss_pred             hhccCchh------HhhhhhhCC-------CCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          464 LQQDGKLV------ELVDERLGS-------KYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       464 ~~~~~~~~------~~~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ........      .+.......       ...++....+.+++.+||+.||++|||+.|+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~  294 (308)
T 3g33_A          234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRA  294 (308)
T ss_dssp             HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHH
Confidence            00000000      000000000       0011234678899999999999999999764

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.1e-41  Score=341.43  Aligned_cols=239  Identities=22%  Similarity=0.318  Sum_probs=197.9

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCc--------cchHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSR--------QGNREFLNEIAMISCLQHPNLVKIHGCCVEGD  309 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~--------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~  309 (511)
                      .++|++.+.||+|+||.||+|+. .+++.||||++.....        .....+.+|+.++++++||||+++++++.+.+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            46799999999999999999974 5689999999975421        12345778999999999999999999999999


Q ss_pred             EEEEEEEecCCC-CHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecC
Q 045835          310 QLLLVYEYMENN-SLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFG  388 (511)
Q Consensus       310 ~~~lV~Ey~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfG  388 (511)
                      ..++||||+..| +|.+++....    .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRHP----RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTCC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence            999999999877 9999986543    4899999999999999999999987   9999999999999999999999999


Q ss_pred             CcccCCCCCceeecccccCCCcccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhcc
Q 045835          389 LAKLDEGDKTHISTRIAGTIGYMAPEYALWGYL-TYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD  467 (511)
Q Consensus       389 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~  467 (511)
                      +++.......  .....||+.|+|||.+.+..+ +.++|||||||++|||++|+.||.....                  
T Consensus       176 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------------------  235 (335)
T 3dls_A          176 SAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------------------  235 (335)
T ss_dssp             TCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------------------
T ss_pred             cceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------------------
Confidence            9986654332  233568999999999987766 8899999999999999999999863210                  


Q ss_pred             CchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          468 GKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       468 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                           ......  ..+...+..+.+++.+||+.+|++|||+.||
T Consensus       236 -----~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~el  272 (335)
T 3dls_A          236 -----TVEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKL  272 (335)
T ss_dssp             -----GTTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             -----HHhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHH
Confidence                 000000  1111234568899999999999999999764

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-41  Score=341.11  Aligned_cols=248  Identities=27%  Similarity=0.454  Sum_probs=193.7

Q ss_pred             cCCcccCceeccCceeEEeccccC-----CcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLAD-----GTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~-----g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  313 (511)
                      ++|...+.||+|+||.||+|....     +..||||+++... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            457778999999999999997542     2469999997543 2334578999999999999999999999999999999


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      ||||+++|+|.+++....   ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       124 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             EEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            999999999999996542   35899999999999999999999987   999999999999999999999999999865


Q ss_pred             CCCCce--eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCch
Q 045835          394 EGDKTH--ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKL  470 (511)
Q Consensus       394 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  470 (511)
                      ......  ......+|..|+|||.+....++.++||||||+++|||++ |+.||.....     .             .+
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-----~-------------~~  259 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----H-------------EV  259 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----H-------------HH
T ss_pred             ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-----H-------------HH
Confidence            433211  1122346778999999998999999999999999999999 9999863221     0             01


Q ss_pred             hHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          471 VELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       471 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .+.+........+......+.+++.+||+.+|++||++.||
T Consensus       260 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l  300 (333)
T 1mqb_A          260 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADI  300 (333)
T ss_dssp             HHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            11111111222333455678999999999999999999764

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.3e-41  Score=331.90  Aligned_cols=250  Identities=25%  Similarity=0.356  Sum_probs=194.9

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      ++|.+.++||+|+||.||+++. .++..||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            5688999999999999999975 468899999987543 34457889999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEE---cCCCCeEEeecCCcccCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILl---d~~~~~kl~DfGla~~~~  394 (511)
                      +++|+|.+++.........+++..+..++.|++.||+|||+.+   |+||||||+|||+   +.++.+||+|||+++...
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            9999999998654333346999999999999999999999987   9999999999999   456789999999998654


Q ss_pred             CCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          395 GDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       395 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      ....  .....||..|+|||.+. +.++.++||||||++++||++|+.||.....     .......   ..       .
T Consensus       179 ~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~-----~~~~~~~---~~-------~  240 (285)
T 3is5_A          179 SDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL-----EEVQQKA---TY-------K  240 (285)
T ss_dssp             ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHH---HH-------C
T ss_pred             Cccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH-----HHHHhhh---cc-------C
Confidence            3322  23456899999999875 5789999999999999999999999964321     0011100   00       0


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .+..... .......+.+++.+||+.+|++|||+.||
T Consensus       241 ~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~  276 (285)
T 3is5_A          241 EPNYAVE-CRPLTPQAVDLLKQMLTKDPERRPSAAQV  276 (285)
T ss_dssp             CCCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred             Ccccccc-cCcCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            0000000 00123568899999999999999999864

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-40  Score=334.47  Aligned_cols=255  Identities=27%  Similarity=0.386  Sum_probs=193.1

Q ss_pred             HHHHhcCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcC--CCCCceeEEEEEEeC----
Q 045835          235 IKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCL--QHPNLVKIHGCCVEG----  308 (511)
Q Consensus       235 l~~~~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l--~H~niv~l~g~~~~~----  308 (511)
                      -....++|++.++||+|+||.||+|+.. ++.||||++....   ...+..|.+++..+  +||||+++++++...    
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~  107 (337)
T 3mdy_A           32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW  107 (337)
T ss_dssp             HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred             ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence            3344578999999999999999999875 8999999986432   23455566666554  999999999999987    


Q ss_pred             CEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeEEccCCCCCeEEcCCCCeE
Q 045835          309 DQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES-----RFKIVHRDIKATNVLLDRDLNPK  383 (511)
Q Consensus       309 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~-----~~~iiH~Dlk~~NILld~~~~~k  383 (511)
                      ...++||||+++|+|.+++...     .+++..++.++.|++.||+|||+.+     .++|+||||||+|||++.++.+|
T Consensus       108 ~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  182 (337)
T 3mdy_A          108 TQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC  182 (337)
T ss_dssp             CEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             CceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence            7899999999999999999653     4899999999999999999999871     12499999999999999999999


Q ss_pred             EeecCCcccCCCCCcee---ecccccCCCcccccccccCCCCcc------hhHHHHHHHHHHHHhCCC----------CC
Q 045835          384 ISDFGLAKLDEGDKTHI---STRIAGTIGYMAPEYALWGYLTYK------ADVYSFGIVALEIVSGKN----------NM  444 (511)
Q Consensus       384 l~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~DV~S~Gvvl~elltG~~----------p~  444 (511)
                      |+|||+++.........   .....||..|+|||.+.....+.+      +|||||||++|||+||..          |+
T Consensus       183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~  262 (337)
T 3mdy_A          183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY  262 (337)
T ss_dssp             ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence            99999997654332221   123578999999999987766665      999999999999999944          44


Q ss_pred             CCCCcccccccchhhhhHhhhccCchhHhh-hhhhCCCCC-----HHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          445 SYAPALEFDCTCLLDWACHLQQDGKLVELV-DERLGSKYK-----KEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       445 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~-d~~l~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ........   ....+          .+.+ ...+....+     .++...+.+++.+||+.+|++|||+.||
T Consensus       263 ~~~~~~~~---~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el  322 (337)
T 3mdy_A          263 HDLVPSDP---SYEDM----------REIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV  322 (337)
T ss_dssp             TTTSCSSC---CHHHH----------HHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             hhhcCCCC---chhhh----------HHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHH
Confidence            32111000   00011          1111 111122222     2677889999999999999999999764

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=5.8e-42  Score=344.60  Aligned_cols=257  Identities=28%  Similarity=0.412  Sum_probs=204.2

Q ss_pred             HHHHhcCCcccCceeccCceeEEeccccC------CcEEEEEEecccCc-cchHHHHHHHHHHhcC-CCCCceeEEEEEE
Q 045835          235 IKAATNNFDSAKKIGEGGFGPVYKGQLAD------GTIIAVKQLSSKSR-QGNREFLNEIAMISCL-QHPNLVKIHGCCV  306 (511)
Q Consensus       235 l~~~~~~f~~~~~lG~G~fG~Vy~g~~~~------g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~  306 (511)
                      .....++|...+.||+|+||.||+|....      ...||+|.+..... ...+.+.+|+.+++.+ +||||++++++|.
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            33445789999999999999999997532      24799999976532 3446789999999999 8999999999999


Q ss_pred             eCCEEEEEEEecCCCCHhHHHhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEE
Q 045835          307 EGDQLLLVYEYMENNSLACALFGREN----------CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL  376 (511)
Q Consensus       307 ~~~~~~lV~Ey~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILl  376 (511)
                      +.+..++||||+++|+|.+++.....          ....+++..++.++.|++.||+|||+.+   |+||||||+|||+
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLL  197 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEE
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEE
Confidence            99999999999999999999865321          1235799999999999999999999986   9999999999999


Q ss_pred             cCCCCeEEeecCCcccCCCCCc-eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccc
Q 045835          377 DRDLNPKISDFGLAKLDEGDKT-HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDC  454 (511)
Q Consensus       377 d~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~  454 (511)
                      +.++.+||+|||+++....... .......+|..|+|||.+.+..++.++||||||+++|||+| |+.||......    
T Consensus       198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----  273 (333)
T 2i1m_A          198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN----  273 (333)
T ss_dssp             EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS----
T ss_pred             CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh----
Confidence            9999999999999985433222 22233457889999999999999999999999999999999 99888643210    


Q ss_pred             cchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          455 TCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       455 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                                   ....+++........+...+..+.+++.+||+.+|.+|||+.||
T Consensus       274 -------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l  317 (333)
T 2i1m_A          274 -------------SKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI  317 (333)
T ss_dssp             -------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             -------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHH
Confidence                         01122222222222333345678999999999999999999864

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3.9e-41  Score=335.92  Aligned_cols=258  Identities=21%  Similarity=0.272  Sum_probs=195.3

Q ss_pred             cCCccc-CceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEEEEEEE
Q 045835          240 NNFDSA-KKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       240 ~~f~~~-~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      +.|.+. +.||+|+||.||+|.. .+++.||||++..........+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            467774 7899999999999974 47899999999876666677899999999885 79999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCC---eEEeecCCcccC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN---PKISDFGLAKLD  393 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~---~kl~DfGla~~~  393 (511)
                      |+++|+|.+++....    .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.   +||+|||+++..
T Consensus        92 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           92 KMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             CCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             cCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            999999999997543    4899999999999999999999986   999999999999998776   999999999754


Q ss_pred             CCCCc------eeecccccCCCccccccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhH
Q 045835          394 EGDKT------HISTRIAGTIGYMAPEYALW-----GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWAC  462 (511)
Q Consensus       394 ~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~  462 (511)
                      .....      .......||..|+|||.+..     ..++.++|||||||++|||++|+.||........      .|..
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~------~~~~  238 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC------GWDR  238 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCS------CC--
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccc------cccc
Confidence            32111      11123458999999999875     5688999999999999999999999975432110      0100


Q ss_pred             hhhc---cCchhHhhhhhhCCCCCH----HHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          463 HLQQ---DGKLVELVDERLGSKYKK----EEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       463 ~~~~---~~~~~~~~d~~l~~~~~~----~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ....   ...+.+.+... ....+.    .....+.+++.+||+.||++|||+.|+
T Consensus       239 ~~~~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~  293 (316)
T 2ac3_A          239 GEACPACQNMLFESIQEG-KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQV  293 (316)
T ss_dssp             --CCHHHHHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             cccchhHHHHHHHHHhcc-CcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHH
Confidence            0000   00011111111 111222    134578999999999999999999764

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.2e-42  Score=343.69  Aligned_cols=257  Identities=26%  Similarity=0.429  Sum_probs=204.2

Q ss_pred             cCCcccCceeccCceeEEeccc-----cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCC--EEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-----ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGD--QLL  312 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-----~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~  312 (511)
                      ++|++.+.||+|+||.||+++.     .+++.||||++........+.+.+|+.++++++||||+++++++...+  ..+
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  120 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK  120 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence            5688899999999999999973     468899999998766666678999999999999999999999987644  679


Q ss_pred             EEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCccc
Q 045835          313 LVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       313 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~  392 (511)
                      +||||+++++|.+++....   ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       121 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          121 LIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             EEECCCTTCBHHHHHHHST---TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEECCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            9999999999999997643   35899999999999999999999986   99999999999999999999999999987


Q ss_pred             CCCCCce--eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhcc---
Q 045835          393 DEGDKTH--ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD---  467 (511)
Q Consensus       393 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~---  467 (511)
                      .......  ......++..|+|||.+.+..++.++||||||++++||+||+.|+....         ..+.......   
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~---------~~~~~~~~~~~~~  265 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP---------AEFMRMIGNDKQG  265 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHH---------HHHHHHHCTTCCT
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCH---------HHHHHhhccccch
Confidence            6543322  1223456778999999998889999999999999999999998875221         0000000000   


Q ss_pred             ----CchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          468 ----GKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       468 ----~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                          ..+.+.+........+...+..+.+++.+||+.+|++|||+.||
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el  313 (326)
T 2w1i_A          266 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL  313 (326)
T ss_dssp             HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             hhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHH
Confidence                01222333322333444556789999999999999999999764

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.1e-40  Score=327.30  Aligned_cols=246  Identities=25%  Similarity=0.356  Sum_probs=201.7

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  314 (511)
                      .++|...+.||+|+||.||++... +++.+|+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            357889999999999999999865 57899999986542   23446788999999999999999999999999999999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      |||+++++|.+++....    .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        94 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             EECCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            99999999999886532    5899999999999999999999987   9999999999999999999999999998654


Q ss_pred             CCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          395 GDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       395 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      .... ......||..|+|||.+.+..++.++||||||++++||++|+.||.....        .+....         +.
T Consensus       167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~---------~~  228 (294)
T 2rku_A          167 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--------KETYLR---------IK  228 (294)
T ss_dssp             STTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHH---------HH
T ss_pred             cCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHH---------Hh
Confidence            3222 12335689999999999988999999999999999999999999864321        111001         11


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...  ...+......+.+++.+||+.+|++|||+.|+
T Consensus       229 ~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l  263 (294)
T 2rku_A          229 KNE--YSIPKHINPVAASLIQKMLQTDPTARPTINEL  263 (294)
T ss_dssp             TTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGG
T ss_pred             hcc--CCCccccCHHHHHHHHHHcccChhhCcCHHHH
Confidence            110  11223334568899999999999999999885

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=328.98  Aligned_cols=250  Identities=26%  Similarity=0.368  Sum_probs=197.5

Q ss_pred             CCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecC
Q 045835          241 NFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYME  319 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~  319 (511)
                      .|.....||+|+||.||+|.. .+++.||||.+........+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            345566999999999999974 5688999999987666666789999999999999999999999999999999999999


Q ss_pred             CCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcC-CCCeEEeecCCcccCCCCCc
Q 045835          320 NNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR-DLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       320 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~-~~~~kl~DfGla~~~~~~~~  398 (511)
                      +++|.+++..... ...+++..+..++.|++.||+|||+.+   |+||||||+||+++. ++.+||+|||+++.......
T Consensus       103 ~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~  178 (295)
T 2clq_A          103 GGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP  178 (295)
T ss_dssp             EEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence            9999999976432 335778999999999999999999986   999999999999988 89999999999986543222


Q ss_pred             eeecccccCCCcccccccccCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhh
Q 045835          399 HISTRIAGTIGYMAPEYALWGY--LTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDE  476 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  476 (511)
                       ......||..|+|||.+....  ++.++||||||+++|||++|+.||.....     .....+           .....
T Consensus       179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~-----------~~~~~  241 (295)
T 2clq_A          179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE-----PQAAMF-----------KVGMF  241 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS-----HHHHHH-----------HHHHH
T ss_pred             -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc-----hhHHHH-----------hhccc
Confidence             123456899999999987653  89999999999999999999999852210     000000           00011


Q ss_pred             hhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          477 RLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       477 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ......+......+.+++.+||+.+|++|||+.|+
T Consensus       242 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l  276 (295)
T 2clq_A          242 KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDL  276 (295)
T ss_dssp             CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHH
T ss_pred             cccccccccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence            11223344455678999999999999999998764

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=6.5e-42  Score=342.45  Aligned_cols=261  Identities=24%  Similarity=0.384  Sum_probs=205.8

Q ss_pred             ccHHHHHHHhcCCcccCceeccCceeEEecccc------CCcEEEEEEecccCc-cchHHHHHHHHHHhcCCCCCceeEE
Q 045835          230 FTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSKSR-QGNREFLNEIAMISCLQHPNLVKIH  302 (511)
Q Consensus       230 ~~~~~l~~~~~~f~~~~~lG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~  302 (511)
                      +..++.....++|++.+.||+|+||.||+|+..      +++.||||.+..... .....+.+|+.+++.++||||++++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            334455556788999999999999999999754      367899999975432 3345789999999999999999999


Q ss_pred             EEEEeCCEEEEEEEecCCCCHhHHHhcCCC------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEE
Q 045835          303 GCCVEGDQLLLVYEYMENNSLACALFGREN------CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL  376 (511)
Q Consensus       303 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILl  376 (511)
                      +++.+.+..++||||+++|+|.+++.....      ....+++..++.++.|++.||+|||+.+   |+||||||+|||+
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli  171 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV  171 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEE
Confidence            999999999999999999999999865321      1135789999999999999999999987   9999999999999


Q ss_pred             cCCCCeEEeecCCcccCCCCCc-eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccc
Q 045835          377 DRDLNPKISDFGLAKLDEGDKT-HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDC  454 (511)
Q Consensus       377 d~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~  454 (511)
                      +.++.+||+|||+++....... .......+|..|+|||.+.+..++.++||||||+++|||++ |+.|+.....     
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----  246 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-----  246 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-----
T ss_pred             cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH-----
Confidence            9999999999999985433221 11223456889999999999999999999999999999999 8888863221     


Q ss_pred             cchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          455 TCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       455 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..+...             +........+...+..+.+++.+||+.+|++|||+.||
T Consensus       247 ~~~~~~-------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~  290 (322)
T 1p4o_A          247 EQVLRF-------------VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI  290 (322)
T ss_dssp             HHHHHH-------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHH-------------HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence            111111             11111112233445678999999999999999999764

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.3e-41  Score=343.78  Aligned_cols=201  Identities=27%  Similarity=0.451  Sum_probs=162.3

Q ss_pred             HhcCCcccCceeccCceeEEeccc-cCCcEEEEEEeccc--CccchHHHHHHHHHHhcCC-CCCceeEEEEEEeCC--EE
Q 045835          238 ATNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK--SRQGNREFLNEIAMISCLQ-HPNLVKIHGCCVEGD--QL  311 (511)
Q Consensus       238 ~~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~--~~  311 (511)
                      ..++|++.+.||+|+||.||+|.. .+|+.||||++...  .......+.+|+.+++.+. ||||+++++++...+  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            357899999999999999999974 46899999998643  2334456789999999997 999999999998654  78


Q ss_pred             EEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcc
Q 045835          312 LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK  391 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~  391 (511)
                      ++|||||+ ++|..++...     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        87 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            99999998 5899888653     4889999999999999999999987   9999999999999999999999999998


Q ss_pred             cCCCC--------------------CceeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 045835          392 LDEGD--------------------KTHISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYA  447 (511)
Q Consensus       392 ~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~  447 (511)
                      .....                    .....+...||+.|+|||.+.+ ..++.++|||||||+++||++|++||...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  234 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS  234 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence            54321                    1112234579999999999886 67999999999999999999999999743

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4e-41  Score=337.88  Aligned_cols=249  Identities=27%  Similarity=0.434  Sum_probs=197.1

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcE--EEEEEeccc-CccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTI--IAVKQLSSK-SRQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~--vAvK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV  314 (511)
                      ++|++.+.||+|+||.||+|+.. ++..  ||+|.+... .....+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            57889999999999999999754 5554  499998753 334456789999999999 999999999999999999999


Q ss_pred             EEecCCCCHhHHHhcCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCe
Q 045835          315 YEYMENNSLACALFGRE------------NCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP  382 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~  382 (511)
                      |||+++++|.+++....            .....+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            99999999999997653            22346899999999999999999999987   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhh
Q 045835          383 KISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWA  461 (511)
Q Consensus       383 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~  461 (511)
                      ||+|||+++......  ......++..|+|||.+....++.++||||||+++|||+| |+.||.....        .+. 
T Consensus       182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~~-  250 (327)
T 1fvr_A          182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AEL-  250 (327)
T ss_dssp             EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHH-
T ss_pred             EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH--------HHH-
Confidence            999999997432211  1122356889999999998889999999999999999998 9999864321        011 


Q ss_pred             HhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          462 CHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       462 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                               .+.+........+......+.+++.+||+.+|++|||+.|+
T Consensus       251 ---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el  291 (327)
T 1fvr_A          251 ---------YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI  291 (327)
T ss_dssp             ---------HHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             ---------HHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence                     11111111222333445678999999999999999998764

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.6e-41  Score=336.44  Aligned_cols=246  Identities=30%  Similarity=0.471  Sum_probs=190.3

Q ss_pred             cCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecC
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYME  319 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~  319 (511)
                      ++|++.+.||+|+||.||+|+.. ++.||||++...  ...+.|.+|+.++++++||||+++++++.  +..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence            56888999999999999999874 788999998643  34467999999999999999999999886  34789999999


Q ss_pred             CCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCC-eEEeecCCcccCCCCCc
Q 045835          320 NNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN-PKISDFGLAKLDEGDKT  398 (511)
Q Consensus       320 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~-~kl~DfGla~~~~~~~~  398 (511)
                      +|+|.+++..... ...+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||+++.....  
T Consensus        83 ~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--  159 (307)
T 2eva_A           83 GGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--  159 (307)
T ss_dssp             TCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred             CCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence            9999999976432 234789999999999999999999943335999999999999998886 799999999754322  


Q ss_pred             eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhh
Q 045835          399 HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERL  478 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  478 (511)
                        .....||..|+|||.+.+..++.++||||||++++||++|+.||......    .....|.            +....
T Consensus       160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~------------~~~~~  221 (307)
T 2eva_A          160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP----AFRIMWA------------VHNGT  221 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS----HHHHHHH------------HHTTC
T ss_pred             --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc----HHHHHHH------------HhcCC
Confidence              12346899999999999999999999999999999999999998643210    0000110            01111


Q ss_pred             CCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          479 GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       479 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ....+...+..+.+++.+||+.+|++|||+.||
T Consensus       222 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el  254 (307)
T 2eva_A          222 RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEI  254 (307)
T ss_dssp             CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCcccccCHHHHHHHHHHhcCChhhCcCHHHH
Confidence            122233345578999999999999999999764

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.3e-41  Score=331.91  Aligned_cols=247  Identities=27%  Similarity=0.383  Sum_probs=197.0

Q ss_pred             hcCCcccC-ceeccCceeEEeccc---cCCcEEEEEEecccCc--cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEE
Q 045835          239 TNNFDSAK-KIGEGGFGPVYKGQL---ADGTIIAVKQLSSKSR--QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLL  312 (511)
Q Consensus       239 ~~~f~~~~-~lG~G~fG~Vy~g~~---~~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  312 (511)
                      .++|.+.+ .||+|+||.||+|..   .+++.||||+++....  ...+++.+|+.+++.++||||+++++++ +.+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            35677777 999999999999953   2468899999975432  2356799999999999999999999999 667789


Q ss_pred             EEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCccc
Q 045835          313 LVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       313 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~  392 (511)
                      +||||+++++|.+++....    .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        94 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  166 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA  166 (291)
T ss_dssp             EEEECCTTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEeCCCCCHHHHHHhCc----CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence            9999999999999997543    4899999999999999999999987   99999999999999999999999999986


Q ss_pred             CCCCCcee--ecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCc
Q 045835          393 DEGDKTHI--STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGK  469 (511)
Q Consensus       393 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  469 (511)
                      ........  .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.....     ..             
T Consensus       167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~-------------  228 (291)
T 1xbb_A          167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----SE-------------  228 (291)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HH-------------
T ss_pred             eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH-----HH-------------
Confidence            65433322  222346788999999998889999999999999999999 9999864321     11             


Q ss_pred             hhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          470 LVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       470 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +.+.+........+...+..+.+++.+||+.+|++|||+.||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  270 (291)
T 1xbb_A          229 VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAV  270 (291)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            111122222223344556679999999999999999999764

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=343.47  Aligned_cols=256  Identities=19%  Similarity=0.196  Sum_probs=190.3

Q ss_pred             cCCcccCceeccCceeEEecccc----CCcEEEEEEecccCcc-----------chHHHHHHHHHHhcCCCCCceeEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA----DGTIIAVKQLSSKSRQ-----------GNREFLNEIAMISCLQHPNLVKIHGC  304 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~----~g~~vAvK~~~~~~~~-----------~~~~~~~Ei~~l~~l~H~niv~l~g~  304 (511)
                      ++|.+.+.||+|+||.||+|...    ++..+|||+.......           ....+.+|+..++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            57889999999999999999864    5678999998754321           22346788899999999999999999


Q ss_pred             EEe----CCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCC
Q 045835          305 CVE----GDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL  380 (511)
Q Consensus       305 ~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~  380 (511)
                      +..    ....++||||+ +++|.+++....    .+++..++.++.|++.||+|||+.+   |+||||||+|||++.++
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence            988    77899999999 999999986543    5999999999999999999999986   99999999999999887


Q ss_pred             --CeEEeecCCcccCCCCCc------eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccc
Q 045835          381 --NPKISDFGLAKLDEGDKT------HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEF  452 (511)
Q Consensus       381 --~~kl~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~  452 (511)
                        .+||+|||+++.......      .......||..|+|||.+.+..++.++|||||||++|||++|+.||.....   
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~---  265 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK---  265 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT---
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc---
Confidence              999999999986532211      111345789999999999999999999999999999999999999952110   


Q ss_pred             cccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          453 DCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       453 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .............  ..+...+.....   ....+..+.+++.+||+.+|++|||+.+|
T Consensus       266 ~~~~~~~~~~~~~--~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l  319 (345)
T 2v62_A          266 DPVAVQTAKTNLL--DELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQAL  319 (345)
T ss_dssp             CHHHHHHHHHHHH--HTTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred             ccHHHHHHHHhhc--ccccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHH
Confidence            1011111110000  001111111110   01234578999999999999999999764

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4.8e-41  Score=334.46  Aligned_cols=253  Identities=24%  Similarity=0.383  Sum_probs=191.0

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|++.+.||+|+||.||+|.. .+|+.||||++....   ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            5689999999999999999975 578999999997532   334467899999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++++|.+++.........+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++....
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            999999999998653333346899999999999999999999987   99999999999999999999999999986543


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      ... ......|+..|+|||.+....++.++||||||+++|||++|+.||.....      ..........         .
T Consensus       189 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~---------~  252 (310)
T 2wqm_A          189 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKIE---------Q  252 (310)
T ss_dssp             -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C------CHHHHHHHHH---------T
T ss_pred             CCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch------hHHHHHHHhh---------c
Confidence            222 12234689999999999999999999999999999999999999863210      1111111110         0


Q ss_pred             hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       476 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..............+.+++.+||+.||++|||+.||
T Consensus       253 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~i  288 (310)
T 2wqm_A          253 CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYV  288 (310)
T ss_dssp             TCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             ccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHH
Confidence            011111112334578999999999999999999764

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3.8e-41  Score=330.24  Aligned_cols=239  Identities=25%  Similarity=0.406  Sum_probs=195.5

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEe----------
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVE----------  307 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----------  307 (511)
                      .++|+..+.||+|+||.||+|+.. +++.||+|++....    ..+.+|+.++++++||||+++++++..          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            467899999999999999999865 78999999997543    356789999999999999999999864          


Q ss_pred             ------CCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCC
Q 045835          308 ------GDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN  381 (511)
Q Consensus       308 ------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~  381 (511)
                            ....++||||+++++|.+++....  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence                  345899999999999999997543  235899999999999999999999986   999999999999999999


Q ss_pred             eEEeecCCcccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhh
Q 045835          382 PKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWA  461 (511)
Q Consensus       382 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~  461 (511)
                      +||+|||+++.......  .....||+.|+|||.+.+..++.++||||||+++|||++|..|+...          ..+.
T Consensus       161 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----------~~~~  228 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----------SKFF  228 (284)
T ss_dssp             EEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----------HHHH
T ss_pred             EEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----------HHHH
Confidence            99999999986554322  23346899999999999999999999999999999999998775310          0110


Q ss_pred             HhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          462 CHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       462 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                               ..+.+...    +......+.+++.+||+.+|++|||+.||
T Consensus       229 ---------~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~  265 (284)
T 2a19_B          229 ---------TDLRDGII----SDIFDKKEKTLLQKLLSKKPEDRPNTSEI  265 (284)
T ss_dssp             ---------HHHHTTCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             ---------HHhhcccc----cccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence                     11111111    22233467899999999999999999764

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-41  Score=346.50  Aligned_cols=247  Identities=28%  Similarity=0.402  Sum_probs=186.1

Q ss_pred             CCcccCceeccCceeEEecccc--CC--cEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEe-CCEEEEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA--DG--TIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVE-GDQLLLV  314 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~--~g--~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV  314 (511)
                      .|...+.||+|+||.||+|+..  ++  ..||||.++... ....+.|.+|+.++++++||||++++++|.+ ++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4667789999999999999753  22  368999987543 3445689999999999999999999999865 4578999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      |||+++|+|.+++....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       170 ~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EECCCCCCHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence            99999999999996543   35889999999999999999999987   9999999999999999999999999998543


Q ss_pred             CCCc---eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCch
Q 045835          395 GDKT---HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKL  470 (511)
Q Consensus       395 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  470 (511)
                      ....   .......+|..|+|||.+.+..++.++|||||||++|||+| |.+||.....     ......          
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~-----~~~~~~----------  308 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----FDITVY----------  308 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS-----SCHHHH----------
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH-----HHHHHH----------
Confidence            3221   11223457788999999999999999999999999999999 6667653221     111111          


Q ss_pred             hHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          471 VELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       471 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                         +........+...+..+.+++.+||+.+|++|||+.||
T Consensus       309 ---~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~el  346 (373)
T 3c1x_A          309 ---LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSEL  346 (373)
T ss_dssp             ---HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             ---HHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence               11111112233345678999999999999999999864

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.5e-41  Score=368.31  Aligned_cols=240  Identities=28%  Similarity=0.399  Sum_probs=193.3

Q ss_pred             CceeccCceeEEecccc---CCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCC
Q 045835          246 KKIGEGGFGPVYKGQLA---DGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMEN  320 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~---~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~  320 (511)
                      ++||+|+||.||+|.+.   .++.||||+++...  ....+++.+|+.+|++++|||||+++++|.+ +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999543   46789999997643  2345789999999999999999999999964 568899999999


Q ss_pred             CCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc--
Q 045835          321 NSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT--  398 (511)
Q Consensus       321 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~--  398 (511)
                      |+|.+++....    .+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++.......  
T Consensus       454 g~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          454 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             CCHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            99999996543    5899999999999999999999987   99999999999999999999999999986544322  


Q ss_pred             eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          399 HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                      .......+|..|+|||++....++.++|||||||++|||++ |+.||.....                  ..+.+.+...
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~------------------~~~~~~i~~~  588 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG------------------SEVTAMLEKG  588 (635)
T ss_dssp             --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------------------HHHHHHHHTT
T ss_pred             ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH------------------HHHHHHHHcC
Confidence            22233456788999999999999999999999999999998 9999964321                  0122223333


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....+..++..+.+++.+||+.+|++|||+.+|
T Consensus       589 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l  622 (635)
T 4fl3_A          589 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAV  622 (635)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence            3334455566789999999999999999999764

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2e-41  Score=333.51  Aligned_cols=251  Identities=24%  Similarity=0.330  Sum_probs=185.6

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCc-c-chHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSR-Q-GNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~-~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      .++|++.+.||+|+||.||+++. .+++.||||+++.... . ..+.+.++...++.++||||+++++++.+++..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            46789999999999999999975 5789999999975422 2 2233445556688899999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE-SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      ||++ |+|.+++.........+++..+..++.|++.||+|||+. +   |+||||||+|||++.++.+||+|||+++...
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9998 588887765323334699999999999999999999997 6   9999999999999999999999999998654


Q ss_pred             CCCceeecccccCCCccccccc----ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCch
Q 045835          395 GDKTHISTRIAGTIGYMAPEYA----LWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKL  470 (511)
Q Consensus       395 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  470 (511)
                      ....  .....||+.|+|||.+    ....++.++||||||++++||++|+.||......      ..          .+
T Consensus       162 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~----------~~  223 (290)
T 3fme_A          162 DDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP------FQ----------QL  223 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH------HH----------HH
T ss_pred             cccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch------HH----------HH
Confidence            3322  2234689999999996    5667899999999999999999999999632210      00          11


Q ss_pred             hHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          471 VELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       471 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .+.+........+...+..+.+++.+||+.+|++|||+.||
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~  264 (290)
T 3fme_A          224 KQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPEL  264 (290)
T ss_dssp             HHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHH
Confidence            11122111111222345678999999999999999999764

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2e-40  Score=325.25  Aligned_cols=248  Identities=22%  Similarity=0.326  Sum_probs=196.7

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccCc------cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR------QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLL  312 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  312 (511)
                      ++|++.+.||+|+||.||+++.. +++.||+|.+.....      ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            56889999999999999999865 689999999875421      23567999999999999999999999999999999


Q ss_pred             EEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCC----CeEEeecC
Q 045835          313 LVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL----NPKISDFG  388 (511)
Q Consensus       313 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~----~~kl~DfG  388 (511)
                      +||||+++++|.+++...    ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++    .+||+|||
T Consensus        85 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            999999999999999653    25899999999999999999999986   99999999999999877    79999999


Q ss_pred             CcccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccC
Q 045835          389 LAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDG  468 (511)
Q Consensus       389 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~  468 (511)
                      +++.......  .....|+..|+|||.+....++.++||||||++++||++|+.||.....     .   +........ 
T Consensus       158 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~---~~~~~~~~~-  226 (283)
T 3bhy_A          158 IAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK-----Q---ETLTNISAV-  226 (283)
T ss_dssp             TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----H---HHHHHHHTT-
T ss_pred             cceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch-----H---HHHHHhHhc-
Confidence            9986543322  2334689999999999989999999999999999999999999864321     0   000000000 


Q ss_pred             chhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          469 KLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       469 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..  -..+..    ....+..+.+++.+||+.+|++|||+.|+
T Consensus       227 ~~--~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~  263 (283)
T 3bhy_A          227 NY--DFDEEY----FSNTSELAKDFIRRLLVKDPKRRMTIAQS  263 (283)
T ss_dssp             CC--CCCHHH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             cc--CCcchh----cccCCHHHHHHHHHHccCCHhHCcCHHHH
Confidence            00  000000    01224568899999999999999998764

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=9.6e-41  Score=356.59  Aligned_cols=248  Identities=27%  Similarity=0.358  Sum_probs=203.2

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEeccc---CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK---SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  314 (511)
                      .++|+..+.||+|+||.||+++.. +|+.||||++...   .......+.+|+.+|+.++||||+++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999764 6899999999653   233456788999999999999999999999999999999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      |||+++|+|.+++....  ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       263 mEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             ECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence            99999999999997543  235899999999999999999999987   9999999999999999999999999998765


Q ss_pred             CCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          395 GDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       395 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      ....  .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......    ...          .+.+.+
T Consensus       338 ~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~----~~~----------~i~~~i  401 (576)
T 2acx_A          338 EGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI----KRE----------EVERLV  401 (576)
T ss_dssp             TTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC----CHH----------HHHHHH
T ss_pred             cCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch----hHH----------HHHHHh
Confidence            4332  233579999999999999899999999999999999999999997432100    000          011111


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCc
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTM  508 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  508 (511)
                      . .....++...+..+.+|+.+||+.||++||++
T Consensus       402 ~-~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~  434 (576)
T 2acx_A          402 K-EVPEEYSERFSPQARSLCSQLLCKDPAERLGC  434 (576)
T ss_dssp             H-HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred             h-cccccCCccCCHHHHHHHHHhccCCHHHcCCC
Confidence            1 11223344455678999999999999999943

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.9e-41  Score=331.99  Aligned_cols=251  Identities=30%  Similarity=0.487  Sum_probs=187.3

Q ss_pred             hcCCcccCceeccCceeEEeccccCCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      .++|++.++||+|+||.||+|+..  ..||||+++...  ....+.|.+|+.++++++||||+++++++ ..+..++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            467999999999999999999864  359999997543  33446789999999999999999999976 4566899999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      |+++++|.+++....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       100 ~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  173 (289)
T 3og7_A          100 WCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW  173 (289)
T ss_dssp             CCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred             ecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccc
Confidence            999999999995432   45899999999999999999999987   999999999999999999999999999754321


Q ss_pred             -CceeecccccCCCcccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhH
Q 045835          397 -KTHISTRIAGTIGYMAPEYAL---WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVE  472 (511)
Q Consensus       397 -~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  472 (511)
                       .........||..|+|||.+.   ...++.++||||||++++||++|+.||......    ..+.....    .+..  
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~----~~~~--  243 (289)
T 3og7_A          174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR----DQIIEMVG----RGSL--  243 (289)
T ss_dssp             ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH----HHHHHHHH----HTSC--
T ss_pred             cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH----HHHHHHhc----cccc--
Confidence             122223456899999999986   567889999999999999999999999643211    11111110    1000  


Q ss_pred             hhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          473 LVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       473 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                        .+. ........+..+.+++.+||+.+|++|||+.||
T Consensus       244 --~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el  279 (289)
T 3og7_A          244 --SPD-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRI  279 (289)
T ss_dssp             --CCC-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             --Ccc-hhhccccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence              000 011223445679999999999999999999764

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.6e-40  Score=333.30  Aligned_cols=245  Identities=25%  Similarity=0.351  Sum_probs=201.2

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|.+.+.||+|+||.||++... +++.+|+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  120 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL  120 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            56888999999999999999764 57899999986542   234467889999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++++|.+++...    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       121 e~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          121 ELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             CCCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ecCCCCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            999999999988653    25899999999999999999999987   99999999999999999999999999986543


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      ... ......||..|+|||.+.+..++.++||||||+++|||++|+.||.....        .+....         +..
T Consensus       194 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~---------~~~  255 (335)
T 2owb_A          194 DGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--------KETYLR---------IKK  255 (335)
T ss_dssp             TTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHH---------HHH
T ss_pred             Ccc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH--------HHHHHH---------Hhc
Confidence            222 12335689999999999988999999999999999999999999864321        111100         111


Q ss_pred             hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       476 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .  ....+......+.+++.+||+.||++|||+.|+
T Consensus       256 ~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el  289 (335)
T 2owb_A          256 N--EYSIPKHINPVAASLIQKMLQTDPTARPTINEL  289 (335)
T ss_dssp             T--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGG
T ss_pred             C--CCCCCccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence            1  011223334568899999999999999999875

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.2e-40  Score=329.91  Aligned_cols=249  Identities=25%  Similarity=0.294  Sum_probs=189.7

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCc---cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR---QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  314 (511)
                      -++|++.+.||+|+||.||+++.. +++.||+|++.....   ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            478999999999999999999854 688999999975432   2346788999999999999999999999999999999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      |||+++++|.+++....    .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       113 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EECCCCEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             EEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            99999999999996542    4899999999999999999999987   9999999999999999999999999998655


Q ss_pred             CCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          395 GDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       395 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      ...........|+..|+|||.+.+..++.++||||||+++|||++|+.||.....     ..+..   ........    
T Consensus       186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~---~~~~~~~~----  253 (309)
T 2h34_A          186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-----SVMGA---HINQAIPR----  253 (309)
T ss_dssp             -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-----HHHHH---HHHSCCCC----
T ss_pred             ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-----HHHHH---HhccCCCC----
Confidence            4333333345689999999999999999999999999999999999999863210     00000   00000000    


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCC-CcCC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRP-TMSE  510 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-s~~e  510 (511)
                          ....+...+..+.+++.+||+.+|++|| |+.+
T Consensus       254 ----~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~  286 (309)
T 2h34_A          254 ----PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGD  286 (309)
T ss_dssp             ----GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHH
T ss_pred             ----ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHH
Confidence                0111223345688999999999999999 7765

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.7e-40  Score=342.81  Aligned_cols=247  Identities=21%  Similarity=0.252  Sum_probs=187.3

Q ss_pred             cCCccc-CceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHh-cCCCCCceeEEEEEEe----CCEEE
Q 045835          240 NNFDSA-KKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMIS-CLQHPNLVKIHGCCVE----GDQLL  312 (511)
Q Consensus       240 ~~f~~~-~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~-~l~H~niv~l~g~~~~----~~~~~  312 (511)
                      ++|... +.||+|+||.||++... +++.||||++...     ..+.+|+.++. ..+||||+++++++..    ...++
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            456665 68999999999999754 6889999998632     46778888874 5589999999999876    56789


Q ss_pred             EEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcC---CCCeEEeecCC
Q 045835          313 LVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR---DLNPKISDFGL  389 (511)
Q Consensus       313 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~---~~~~kl~DfGl  389 (511)
                      +||||+++|+|.+++....  ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.   ++.+||+|||+
T Consensus       136 lv~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence            9999999999999997643  235899999999999999999999986   999999999999998   78899999999


Q ss_pred             cccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCc
Q 045835          390 AKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGK  469 (511)
Q Consensus       390 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  469 (511)
                      ++......  ......||+.|+|||++....++.++|||||||++|||++|+.||.......... ....          
T Consensus       211 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~~~----------  277 (400)
T 1nxk_A          211 AKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-GMKT----------  277 (400)
T ss_dssp             CEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC-SHHH----------
T ss_pred             ccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH-HHHH----------
Confidence            98654322  1234578999999999999999999999999999999999999997433211100 0000          


Q ss_pred             hhHhhhhhh--CCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          470 LVELVDERL--GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       470 ~~~~~d~~l--~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                        .+.....  ........+..+.+|+.+||+.||++|||+.||
T Consensus       278 --~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ei  319 (400)
T 1nxk_A          278 --RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF  319 (400)
T ss_dssp             --HHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             --HHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence              1111100  001112345678999999999999999998764

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=4e-41  Score=340.27  Aligned_cols=249  Identities=21%  Similarity=0.339  Sum_probs=195.8

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEEEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      .++|++.+.||+|+||.||++... +++.||||++.....    .+.+|++++.++ +||||+++++++.+++..++|||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            467999999999999999999754 688999999975433    235688888887 79999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCC----CCeEEeecCCccc
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD----LNPKISDFGLAKL  392 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~----~~~kl~DfGla~~  392 (511)
                      |+++|+|.+++....    .+++..+..++.||+.||+|||+.+   |+||||||+|||+.++    +.+||+|||+++.
T Consensus        97 ~~~gg~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           97 LMKGGELLDKILRQK----FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             CCCSCBHHHHHHTCT----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             CCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            999999999996543    4899999999999999999999987   9999999999998543    3599999999986


Q ss_pred             CCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhH
Q 045835          393 DEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVE  472 (511)
Q Consensus       393 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  472 (511)
                      ...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....  ..   ..+....+. .+.   
T Consensus       170 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~---~~~~~~~i~-~~~---  239 (342)
T 2qr7_A          170 LRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD--DT---PEEILARIG-SGK---  239 (342)
T ss_dssp             CBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT--SC---HHHHHHHHH-HCC---
T ss_pred             CcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc--CC---HHHHHHHHc-cCC---
Confidence            543322 22345789999999999888899999999999999999999999974321  01   111111100 000   


Q ss_pred             hhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          473 LVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       473 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                         ..+........+..+.+++.+||+.||++|||+.||
T Consensus       240 ---~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~i  275 (342)
T 2qr7_A          240 ---FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALV  275 (342)
T ss_dssp             ---CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             ---cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence               001111223445678999999999999999998764

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.1e-40  Score=346.44  Aligned_cols=247  Identities=24%  Similarity=0.332  Sum_probs=187.8

Q ss_pred             HhcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC--------ccchHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 045835          238 ATNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS--------RQGNREFLNEIAMISCLQHPNLVKIHGCCVEG  308 (511)
Q Consensus       238 ~~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~--------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~  308 (511)
                      ..++|.+.+.||+|+||.||+|.. .+++.||||++....        ......+.+|+.+|++++||||+++++++. .
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence            467899999999999999999975 468899999986532        112235789999999999999999999975 5


Q ss_pred             CEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCC---CCeEEe
Q 045835          309 DQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD---LNPKIS  385 (511)
Q Consensus       309 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~---~~~kl~  385 (511)
                      +..++||||+++|+|.+++...    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.+   ..+||+
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             CceEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence            6689999999999999988543    35899999999999999999999987   9999999999999754   459999


Q ss_pred             ecCCcccCCCCCceeecccccCCCccccccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhH
Q 045835          386 DFGLAKLDEGDKTHISTRIAGTIGYMAPEYALW---GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWAC  462 (511)
Q Consensus       386 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~  462 (511)
                      |||+++.....  .......||+.|+|||++..   ..++.++|||||||++|||++|+.||......    ..+..   
T Consensus       285 DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~----~~~~~---  355 (419)
T 3i6u_A          285 DFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ----VSLKD---  355 (419)
T ss_dssp             CSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS----CCHHH---
T ss_pred             ecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch----HHHHH---
Confidence            99999865432  22334679999999999863   57889999999999999999999999643211    11111   


Q ss_pred             hhhccCchhHhhhhhhCCCCC---HHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          463 HLQQDGKLVELVDERLGSKYK---KEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       463 ~~~~~~~~~~~~d~~l~~~~~---~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                                .+........+   ...+..+.+++.+||+.+|++|||+.|+
T Consensus       356 ----------~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~  397 (419)
T 3i6u_A          356 ----------QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA  397 (419)
T ss_dssp             ----------HHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             ----------HHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHH
Confidence                      11111100001   1234578999999999999999998763

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4.1e-41  Score=338.72  Aligned_cols=261  Identities=28%  Similarity=0.402  Sum_probs=189.8

Q ss_pred             hcCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHH--HhcCCCCCceeEEEEEEe-----CCEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAM--ISCLQHPNLVKIHGCCVE-----GDQL  311 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~--l~~l~H~niv~l~g~~~~-----~~~~  311 (511)
                      .++|++.+.||+|+||.||+|+. +++.||||++....   ...+..|.++  +..++||||+++++.+..     ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            36789999999999999999976 68999999997543   2344445444  456899999999987653     2367


Q ss_pred             EEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC------CCCeEEccCCCCCeEEcCCCCeEEe
Q 045835          312 LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES------RFKIVHRDIKATNVLLDRDLNPKIS  385 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~------~~~iiH~Dlk~~NILld~~~~~kl~  385 (511)
                      ++||||+++|+|.+++....     .++..+..++.|++.||+|||+..      .++|+||||||+|||++.++.+||+
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~  162 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS  162 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred             EEEEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence            89999999999999996543     589999999999999999999981      1139999999999999999999999


Q ss_pred             ecCCcccCCCCC-------ceeecccccCCCccccccccc-------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCccc
Q 045835          386 DFGLAKLDEGDK-------THISTRIAGTIGYMAPEYALW-------GYLTYKADVYSFGIVALEIVSGKNNMSYAPALE  451 (511)
Q Consensus       386 DfGla~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~  451 (511)
                      |||+++......       ........||..|+|||.+.+       ..++.++|||||||++|||++|+.|+.......
T Consensus       163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~  242 (336)
T 3g2f_A          163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP  242 (336)
T ss_dssp             CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred             eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence            999998654321       111223569999999999876       456789999999999999999987764332211


Q ss_pred             ccccchhhhhHhhhccCch---hHhh-hhhhCCCC------CHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          452 FDCTCLLDWACHLQQDGKL---VELV-DERLGSKY------KKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       452 ~~~~~l~~~~~~~~~~~~~---~~~~-d~~l~~~~------~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ....   .+..........   ..++ ....+..+      ....+..+.+++.+||+.+|++|||+.||
T Consensus       243 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~  309 (336)
T 3g2f_A          243 EYQM---AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXA  309 (336)
T ss_dssp             CCCC---TTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             HHHH---hhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHH
Confidence            1110   000001011111   1111 11111111      22466789999999999999999999874

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.1e-40  Score=333.24  Aligned_cols=260  Identities=23%  Similarity=0.386  Sum_probs=195.9

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccCc--cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR--QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      ++|+..+.||+|+||.||+|+.. +++.||||++.....  ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            57889999999999999999864 589999999865432  234567899999999999999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      |+++++|.+++....    .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       105 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          105 FVDHTILDDLELFPN----GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             CCSEEHHHHHHHSTT----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             cCCcchHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            999999988875432    4899999999999999999999987   999999999999999999999999999865432


Q ss_pred             CceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHh-----------h
Q 045835          397 KTHISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACH-----------L  464 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~-----------~  464 (511)
                      .. ......||..|+|||.+.+. .++.++|||||||++|||++|+.||.......    .+......           .
T Consensus       178 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~  252 (331)
T 4aaa_A          178 GE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID----QLYHIMMCLGNLIPRHQELF  252 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCSCCHHHHHHH
T ss_pred             cc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH----HHHHHHHHhCCCChhhhhHh
Confidence            22 22335689999999998875 78999999999999999999999997433111    11111000           0


Q ss_pred             hccCchhHhhhhhhCCCCC-----HHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          465 QQDGKLVELVDERLGSKYK-----KEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       465 ~~~~~~~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...........+......+     +..+..+.+++.+||+.||++|||+.||
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el  304 (331)
T 4aaa_A          253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAEL  304 (331)
T ss_dssp             HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGG
T ss_pred             hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHH
Confidence            0000000000001111111     1235679999999999999999999885

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.4e-40  Score=328.19  Aligned_cols=250  Identities=22%  Similarity=0.273  Sum_probs=193.5

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEE-EeCCEEEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC-VEGDQLLLVYE  316 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~-~~~~~~~lV~E  316 (511)
                      .++|++.+.||+|+||.||+|+. .+++.||||++......  ..+.+|+.+++.++|++++..++.+ .+.+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence            57899999999999999999974 57899999987654322  3578999999999998877777666 56778899999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEE---cCCCCeEEeecCCcccC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLD  393 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILl---d~~~~~kl~DfGla~~~  393 (511)
                      |+ +++|.+++....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||+   +.++.+||+|||+++..
T Consensus        86 ~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           86 LL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             CC-CCBHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             cc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            99 999999996432   35899999999999999999999987   9999999999999   78899999999999865


Q ss_pred             CCCCc------eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhcc
Q 045835          394 EGDKT------HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD  467 (511)
Q Consensus       394 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~  467 (511)
                      .....      .......||..|+|||.+.+..++.++|||||||++|||++|+.||........  ...          
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~----------  226 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK--RQK----------  226 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS--SSH----------
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhh--hhh----------
Confidence            43322      112345789999999999999999999999999999999999999975332111  001          


Q ss_pred             CchhHhhhhhhCCC---CCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          468 GKLVELVDERLGSK---YKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       468 ~~~~~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                        ...+........   .....+..+.+++.+||+.+|++|||+.||
T Consensus       227 --~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l  271 (296)
T 4hgt_A          227 --YERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYL  271 (296)
T ss_dssp             --HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHH
T ss_pred             --hhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHH
Confidence              111111111100   001124578999999999999999999764

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-40  Score=329.42  Aligned_cols=248  Identities=27%  Similarity=0.364  Sum_probs=195.3

Q ss_pred             CCcccCceeccCceeEEeccccC----CcEEEEEEecccCc-cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEE-EEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLAD----GTIIAVKQLSSKSR-QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQL-LLV  314 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~~----g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~-~lV  314 (511)
                      .|...++||+|+||.||+|+..+    +..||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            45667899999999999997432    23799999975433 3456789999999999999999999999876655 999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      +||+.+|+|.+++....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       102 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             ECCCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             EecccCCCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            99999999999996532   35899999999999999999999987   9999999999999999999999999998543


Q ss_pred             CCCc---eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchh
Q 045835          395 GDKT---HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLV  471 (511)
Q Consensus       395 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  471 (511)
                      ....   .......+|..|+|||.+.+..++.++||||||++++||++|+.|+....    +...             +.
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~----~~~~-------------~~  238 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI----DPFD-------------LT  238 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS----CGGG-------------HH
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC----CHHH-------------HH
Confidence            3221   12223467889999999999999999999999999999999665543211    1111             11


Q ss_pred             HhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       472 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +.+........+...+..+.+++.+||+.+|.+|||+.||
T Consensus       239 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l  278 (298)
T 3pls_A          239 HFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVL  278 (298)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHH
Confidence            1222222222333445678999999999999999998764

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1e-40  Score=331.33  Aligned_cols=248  Identities=22%  Similarity=0.360  Sum_probs=198.4

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      .++|.+.+.||+|+||.||+++.. +|+.||+|.+..........+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            457899999999999999999754 6899999999865554556789999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEE---cCCCCeEEeecCCcccCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILl---d~~~~~kl~DfGla~~~~  394 (511)
                      +++++|.+++....    .+++..+..++.|++.||+|||+.+   |+||||||+||++   +.++.+||+|||+++...
T Consensus        88 ~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           88 VSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             CCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             CCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            99999999986543    4899999999999999999999987   9999999999999   788899999999997544


Q ss_pred             CCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          395 GDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       395 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      ...   .....||..|+|||.+.+..++.++||||||++++||++|+.||.....     ..+..   .... +..    
T Consensus       161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~---~i~~-~~~----  224 (304)
T 2jam_A          161 NGI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-----SKLFE---KIKE-GYY----  224 (304)
T ss_dssp             CBT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHH---HHHH-CCC----
T ss_pred             CCc---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHH---HHHc-CCC----
Confidence            321   2234689999999999999999999999999999999999999863221     01111   0000 000    


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                        ..........+..+.+++.+||+.+|++|||+.|+
T Consensus       225 --~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~  259 (304)
T 2jam_A          225 --EFESPFWDDISESAKDFICHLLEKDPNERYTCEKA  259 (304)
T ss_dssp             --CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHH
T ss_pred             --CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence              00111222345678999999999999999998763

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.8e-41  Score=330.86  Aligned_cols=243  Identities=30%  Similarity=0.432  Sum_probs=191.7

Q ss_pred             hcCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeC-CEEEEEEEe
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEG-DQLLLVYEY  317 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~Ey  317 (511)
                      .++|++.+.||+|+||.||+++. .|+.||||+++...  ..+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            36788999999999999999987 48899999997543  456789999999999999999999997654 468999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +++++|.+++....  ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++......
T Consensus        97 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  171 (278)
T 1byg_A           97 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  171 (278)
T ss_dssp             CTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             CCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence            99999999996532  123789999999999999999999987   9999999999999999999999999997543321


Q ss_pred             ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhh
Q 045835          398 THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDE  476 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  476 (511)
                          ....++..|+|||.+.+..++.++||||||++++||+| |+.||.....     ...             ...+..
T Consensus       172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-----~~~-------------~~~~~~  229 (278)
T 1byg_A          172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDV-------------VPRVEK  229 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-----GGH-------------HHHHTT
T ss_pred             ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----HHH-------------HHHHhc
Confidence                22357889999999998999999999999999999998 9999864321     011             111111


Q ss_pred             hhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          477 RLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       477 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ......+...+..+.+++.+||+.+|++|||+.||
T Consensus       230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l  264 (278)
T 1byg_A          230 GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQL  264 (278)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHH
Confidence            12223334455678999999999999999998764

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.8e-41  Score=337.86  Aligned_cols=259  Identities=19%  Similarity=0.317  Sum_probs=190.9

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccCcc-chHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQ-GNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      ++|...+.||+|+||.||+|+.. +++.||||++...... ....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57889999999999999999864 6899999999754322 222456799999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      ++ |+|.+++....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  154 (324)
T 3mtl_A           82 LD-KDLKQYLDDCG---NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT  154 (324)
T ss_dssp             CS-EEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred             cc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence            98 58988886543   35899999999999999999999987   9999999999999999999999999998544322


Q ss_pred             ceeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhcc---CchhHh
Q 045835          398 THISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD---GKLVEL  473 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~---~~~~~~  473 (511)
                      . ......||..|+|||.+.+ ..++.++|||||||+++||++|+.||......     ............   ......
T Consensus       155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~i~~~~~~~~~~~~~~~  228 (324)
T 3mtl_A          155 K-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE-----EQLHFIFRILGTPTEETWPGI  228 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCCCCTTTSTTG
T ss_pred             c-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCCCChHhchhh
Confidence            2 2233468999999999876 57899999999999999999999999743211     111111111000   000000


Q ss_pred             hh---------hhhCCC----CCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          474 VD---------ERLGSK----YKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       474 ~d---------~~l~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..         +.....    ..+.....+.+++.+||+.||++|||+.|+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~  279 (324)
T 3mtl_A          229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDA  279 (324)
T ss_dssp             GGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             hcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHH
Confidence            00         000000    011224568899999999999999999764

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.7e-40  Score=327.74  Aligned_cols=253  Identities=22%  Similarity=0.260  Sum_probs=196.6

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEE-EeCCEEEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC-VEGDQLLLVYE  316 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~-~~~~~~~lV~E  316 (511)
                      .++|++.+.||+|+||.||+|+. .+++.||||++.....  ...+.+|+.+++.++|++++..++++ .+.+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46899999999999999999984 5789999999875433  34689999999999998877766665 56778899999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEE---cCCCCeEEeecCCcccC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLD  393 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILl---d~~~~~kl~DfGla~~~  393 (511)
                      |+ +++|.+++....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||+   +.++.+||+|||+++..
T Consensus        86 ~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             ec-CCCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            99 899999996432   35899999999999999999999987   9999999999999   48889999999999865


Q ss_pred             CCCCce------eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhcc
Q 045835          394 EGDKTH------ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD  467 (511)
Q Consensus       394 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~  467 (511)
                      ......      ......||..|+|||.+.+..++.++|||||||++|||++|+.||........  ...........  
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~--  234 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK--RQKYERISEKK--  234 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS--SSHHHHHHHHH--
T ss_pred             cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhh--hhhhhhhcccc--
Confidence            443221      12345789999999999999999999999999999999999999975331111  11111100000  


Q ss_pred             CchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          468 GKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       468 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                         .....+.+..    ..+..+.+++.+||+.+|++|||+.||
T Consensus       235 ---~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l  271 (296)
T 3uzp_A          235 ---MSTPIEVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYL  271 (296)
T ss_dssp             ---HHSCHHHHTT----TSCHHHHHHHHHHHTSCTTCCCCHHHH
T ss_pred             ---cCCchHHHHh----hCCHHHHHHHHHHHhcCcCcCCCHHHH
Confidence               0000011112    223568999999999999999998764

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.4e-40  Score=325.22  Aligned_cols=243  Identities=23%  Similarity=0.356  Sum_probs=200.7

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|++.+.||+|+||.||+|+.. ++..||||++....   ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57889999999999999999764 57899999986432   233467899999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++++|.+++....    .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        94 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           94 EFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            9999999999996543    4899999999999999999999986   99999999999999999999999999975443


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      ..   .....|+..|+|||.+.+..++.++||||||++++||++|+.||......        +..         ..+..
T Consensus       167 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~---------~~~~~  226 (284)
T 2vgo_A          167 LR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT--------ETH---------RRIVN  226 (284)
T ss_dssp             SC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHH---------HHHHT
T ss_pred             cc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh--------HHH---------HHHhc
Confidence            22   22356899999999999989999999999999999999999999643210        110         11111


Q ss_pred             hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       476 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .  ...++......+.+++.+||+.+|.+|||+.||
T Consensus       227 ~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l  260 (284)
T 2vgo_A          227 V--DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGV  260 (284)
T ss_dssp             T--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             c--ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHH
Confidence            1  112233345678999999999999999998764

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.5e-40  Score=326.05  Aligned_cols=246  Identities=26%  Similarity=0.384  Sum_probs=194.1

Q ss_pred             CCcccCceeccCceeEEeccc-cCCcEEEEEEeccc--CccchHHHHHHHHHHhcCCCCCceeEEEEEEe----CCEEEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK--SRQGNREFLNEIAMISCLQHPNLVKIHGCCVE----GDQLLL  313 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~l  313 (511)
                      .|.+.+.||+|+||.||+|.. .++..||+|.+...  .....+.+.+|+.++++++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            477788999999999999975 46789999998754  23345678999999999999999999999876    356899


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEc-CCCCeEEeecCCccc
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD-RDLNPKISDFGLAKL  392 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld-~~~~~kl~DfGla~~  392 (511)
                      ||||+++++|.+++...    ..+++..+..++.|++.||+|||+.+ .+|+||||||+|||++ .++.+||+|||++..
T Consensus       107 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            99999999999999653    24899999999999999999999874 3599999999999998 788999999999976


Q ss_pred             CCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhH
Q 045835          393 DEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVE  472 (511)
Q Consensus       393 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  472 (511)
                      ......   ....||+.|+|||.+. +.++.++||||||++++||++|+.||.....       ......... .+.   
T Consensus       182 ~~~~~~---~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~~~-~~~---  246 (290)
T 1t4h_A          182 KRASFA---KAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYRRVT-SGV---  246 (290)
T ss_dssp             CCTTSB---EESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHHHHHT-TTC---
T ss_pred             cccccc---ccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc-------HHHHHHHHh-ccC---
Confidence            543322   2346899999999776 5699999999999999999999999964321       111111111 000   


Q ss_pred             hhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          473 LVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       473 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                           .....+......+.+++.+||+.+|++|||+.||
T Consensus       247 -----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el  280 (290)
T 1t4h_A          247 -----KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL  280 (290)
T ss_dssp             -----CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             -----CccccCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence                 0011111223468999999999999999999764

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=5.9e-42  Score=351.02  Aligned_cols=241  Identities=14%  Similarity=0.143  Sum_probs=187.8

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEeccc---CccchHHHHHHH---HHHhcCCCCCceeEE-------EE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK---SRQGNREFLNEI---AMISCLQHPNLVKIH-------GC  304 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~---~~~~~~~~~~Ei---~~l~~l~H~niv~l~-------g~  304 (511)
                      .++|.+.+.||+|+||.||+|+. .+|+.||||++...   .....+.+.+|+   .++++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46788899999999999999985 56899999999743   333456788999   556666899999998       77


Q ss_pred             EEeCC-----------------EEEEEEEecCCCCHhHHHhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 045835          305 CVEGD-----------------QLLLVYEYMENNSLACALFGREN---CELELDWPTRQKICLGIARGLAFLHEESRFKI  364 (511)
Q Consensus       305 ~~~~~-----------------~~~lV~Ey~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~i  364 (511)
                      +.+.+                 ..++||||+ +|+|.+++.....   ....+++..++.++.||+.||+|||+.+   |
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            66553                 278999999 6899999975321   1123456888999999999999999987   9


Q ss_pred             EEccCCCCCeEEcCCCCeEEeecCCcccCCCCCceeecccccCCCcccccccccC-----------CCCcchhHHHHHHH
Q 045835          365 VHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWG-----------YLTYKADVYSFGIV  433 (511)
Q Consensus       365 iH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DV~S~Gvv  433 (511)
                      +||||||+|||++.++.+||+|||+++....    ......| ..|+|||++.+.           .++.++|||||||+
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            9999999999999999999999999985332    2234567 999999999887           89999999999999


Q ss_pred             HHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          434 ALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       434 l~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +|||++|+.||.......     ...            .+.. . ...+    +..+.+++.+||+.||++|||+.|+
T Consensus       303 l~elltg~~Pf~~~~~~~-----~~~------------~~~~-~-~~~~----~~~~~~li~~~L~~dp~~Rpt~~e~  357 (377)
T 3byv_A          303 IYWIWCADLPITKDAALG-----GSE------------WIFR-S-CKNI----PQPVRALLEGFLRYPKEDRLLPLQA  357 (377)
T ss_dssp             HHHHHHSSCCC------C-----CSG------------GGGS-S-CCCC----CHHHHHHHHHHTCSSGGGCCCHHHH
T ss_pred             HHHHHHCCCCCccccccc-----chh------------hhhh-h-ccCC----CHHHHHHHHHHcCCCchhCCCHHHH
Confidence            999999999986432110     001            0110 0 0122    3568899999999999999999764

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3.6e-41  Score=338.19  Aligned_cols=252  Identities=28%  Similarity=0.377  Sum_probs=197.2

Q ss_pred             hcCCcccCceeccCceeEEeccc------cCCcEEEEEEeccc-CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL------ADGTIIAVKQLSSK-SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQL  311 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~------~~g~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~  311 (511)
                      .++|++.+.||+|+||.||+|+.      .++..||||++... .......+.+|+.++++++||||+++++++.+....
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            46899999999999999999974      24678999999744 334456789999999999999999999999999999


Q ss_pred             EEEEEecCCCCHhHHHhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcC---CCCeEEe
Q 045835          312 LLVYEYMENNSLACALFGREN---CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR---DLNPKIS  385 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~---~~~~kl~  385 (511)
                      ++||||+++++|.+++.....   ....+++..++.++.|++.||+|||+.+   |+||||||+|||++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999976532   1245899999999999999999999987   999999999999994   4569999


Q ss_pred             ecCCcccCCCCC-ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHh
Q 045835          386 DFGLAKLDEGDK-THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACH  463 (511)
Q Consensus       386 DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~  463 (511)
                      |||+++...... ........+|..|+|||.+....++.++||||||+++|||+| |+.||.....     ....     
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~~~~-----  255 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-----QEVL-----  255 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----HHHH-----
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH-----HHHH-----
Confidence            999997432221 112223467889999999999999999999999999999998 9998863221     1111     


Q ss_pred             hhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          464 LQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       464 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                              +.+........+......+.+++.+||+.+|.+|||+.||
T Consensus       256 --------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  295 (327)
T 2yfx_A          256 --------EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII  295 (327)
T ss_dssp             --------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             --------HHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence                    1111111122333445678999999999999999999764

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=9.3e-41  Score=330.34  Aligned_cols=248  Identities=26%  Similarity=0.368  Sum_probs=193.0

Q ss_pred             cCCcccCceeccCceeEEeccccC----CcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEe-CCEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLAD----GTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVE-GDQLLL  313 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~----g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~l  313 (511)
                      .+|++.+.||+|+||.||+|+..+    ...+|+|.+.... ....+.+.+|+.++++++||||++++++|.+ ++..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            468888999999999999997542    2358999987543 3344678999999999999999999999764 457899


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      ||||+++|+|.+++....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       105 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             EEECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             EEeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence            999999999999996532   35899999999999999999999987   999999999999999999999999999865


Q ss_pred             CCCCc---eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCcccccccchhhhhHhhhccCc
Q 045835          394 EGDKT---HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG-KNNMSYAPALEFDCTCLLDWACHLQQDGK  469 (511)
Q Consensus       394 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG-~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  469 (511)
                      .....   .......+|..|+|||.+.+..++.++||||||++++||++| .+|+.....     .....          
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~-----~~~~~----------  243 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----FDITV----------  243 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT-----TTHHH----------
T ss_pred             cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH-----HHHHH----------
Confidence            43221   112334578889999999999999999999999999999995 555542211     11111          


Q ss_pred             hhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          470 LVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       470 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                         .+........+...+..+.+++.+||+.+|++|||+.||
T Consensus       244 ---~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el  282 (298)
T 3f66_A          244 ---YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSEL  282 (298)
T ss_dssp             ---HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             ---HHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence               111111112223344578999999999999999999764

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.9e-40  Score=348.82  Aligned_cols=197  Identities=27%  Similarity=0.375  Sum_probs=164.7

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEeccc--CccchHHHHHHHHHHhcCCCCCceeEEEEEEeC------C
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK--SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEG------D  309 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~  309 (511)
                      .++|++.++||+|+||.||+|.. .+++.||||++...  .....+.+.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            46799999999999999999974 46899999999754  333456788999999999999999999999654      4


Q ss_pred             EEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCC
Q 045835          310 QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL  389 (511)
Q Consensus       310 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGl  389 (511)
                      ..++||||++++ |.+.+..      .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       141 ~~~lv~E~~~~~-l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~  210 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  210 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred             eEEEEEeCCCCC-HHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence            679999999865 6555532      3889999999999999999999987   99999999999999999999999999


Q ss_pred             cccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 045835          390 AKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYA  447 (511)
Q Consensus       390 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~  447 (511)
                      ++......  ..+...||+.|+|||++.+..++.++|||||||+++||++|+.||...
T Consensus       211 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~  266 (464)
T 3ttj_A          211 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR  266 (464)
T ss_dssp             C-----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eeecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            98654322  234467999999999999999999999999999999999999999743

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.9e-40  Score=340.60  Aligned_cols=261  Identities=22%  Similarity=0.270  Sum_probs=193.5

Q ss_pred             HHHhcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeC------
Q 045835          236 KAATNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEG------  308 (511)
Q Consensus       236 ~~~~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------  308 (511)
                      ....++|++.+.||+|+||.||+|+. .+|+.||||++......    ..+|+.+++.++||||+++++++...      
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            34567899999999999999999974 57899999998654332    24799999999999999999998543      


Q ss_pred             --------------------------------CEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 045835          309 --------------------------------DQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFL  356 (511)
Q Consensus       309 --------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yL  356 (511)
                                                      ...++||||++ |+|.+.+.........+++..+..++.|+++||+||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                            34889999998 588877764322334699999999999999999999


Q ss_pred             hcCCCCCeEEccCCCCCeEEc-CCCCeEEeecCCcccCCCCCceeecccccCCCcccccccccC-CCCcchhHHHHHHHH
Q 045835          357 HEESRFKIVHRDIKATNVLLD-RDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVA  434 (511)
Q Consensus       357 H~~~~~~iiH~Dlk~~NILld-~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl  434 (511)
                      |+.+   |+||||||+|||++ .++.+||+|||+++........  ....||..|+|||.+.+. .++.++||||+||++
T Consensus       158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  232 (383)
T 3eb0_A          158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS--VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF  232 (383)
T ss_dssp             HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC--CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred             HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC--cCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence            9987   99999999999998 6889999999999865443322  334689999999998765 589999999999999


Q ss_pred             HHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh--hh-------------hCCCCCHHHHHHHHHHHHHcCC
Q 045835          435 LEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD--ER-------------LGSKYKKEEAERMIKVSLLCTN  499 (511)
Q Consensus       435 ~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d--~~-------------l~~~~~~~~~~~l~~l~~~Cl~  499 (511)
                      +||++|+.||......    ..+..... ........++..  +.             ....++...+..+.+|+.+||+
T Consensus       233 ~ell~g~~pf~~~~~~----~~~~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  307 (383)
T 3eb0_A          233 GELILGKPLFSGETSI----DQLVRIIQ-IMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR  307 (383)
T ss_dssp             HHHHHSSCSSCCSSHH----HHHHHHHH-HHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred             HHHHhCCCCCCCCChH----HHHHHHHH-HhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHcc
Confidence            9999999999743211    11111111 111111111100  00             0000122334568999999999


Q ss_pred             CCCCCCCCcCCC
Q 045835          500 ASPSLRPTMSEV  511 (511)
Q Consensus       500 ~~p~~RPs~~eV  511 (511)
                      .+|++|||+.|+
T Consensus       308 ~dP~~R~t~~e~  319 (383)
T 3eb0_A          308 YEPDLRINPYEA  319 (383)
T ss_dssp             SSGGGSCCHHHH
T ss_pred             CChhhCCCHHHH
Confidence            999999998764

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=9.4e-41  Score=339.83  Aligned_cols=268  Identities=23%  Similarity=0.316  Sum_probs=198.2

Q ss_pred             ccHHHHHHHhcCCcccCceeccCceeEEeccccCCcEEEEEEecccCcc-----------chHHHHHHHHHHhcCCCCCc
Q 045835          230 FTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQ-----------GNREFLNEIAMISCLQHPNL  298 (511)
Q Consensus       230 ~~~~~l~~~~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~-----------~~~~~~~Ei~~l~~l~H~ni  298 (511)
                      ....++....++|.+.+.||+|+||.||+|...+|+.||||++......           ..+.+.+|+.++++++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            4567888889999999999999999999998878999999998653221           12678999999999999999


Q ss_pred             eeEEEEEEeC-----CEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCC
Q 045835          299 VKIHGCCVEG-----DQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATN  373 (511)
Q Consensus       299 v~l~g~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~N  373 (511)
                      +++++++...     ...++||||++ |+|.+++....   ..+++..+..++.|++.||+|||+.+   |+||||||+|
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N  164 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGN  164 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHH
Confidence            9999999653     36899999998 68888886432   35899999999999999999999987   9999999999


Q ss_pred             eEEcCCCCeEEeecCCcccCCCCCceeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccc
Q 045835          374 VLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEF  452 (511)
Q Consensus       374 ILld~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~  452 (511)
                      ||++.++.+||+|||+++.......  .....||..|+|||.+.+ ..++.++|||||||+++||++|+.||......  
T Consensus       165 Il~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--  240 (362)
T 3pg1_A          165 ILLADNNDITICDFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY--  240 (362)
T ss_dssp             EEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--
T ss_pred             EEEcCCCCEEEEecCcccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH--
Confidence            9999999999999999985433222  234568999999999876 67999999999999999999999999743211  


Q ss_pred             cccchhhhhHhhhccCch-----------hHhhhhhhCC-------CCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          453 DCTCLLDWACHLQQDGKL-----------VELVDERLGS-------KYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       453 ~~~~l~~~~~~~~~~~~~-----------~~~~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                         ....-..........           .+.+...+..       ...+.....+.+++.+||+.+|++|||+.|+
T Consensus       241 ---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  314 (362)
T 3pg1_A          241 ---NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQA  314 (362)
T ss_dssp             ---HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             ---HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHH
Confidence               011111111111111           1111111100       0011224568899999999999999998764

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.8e-40  Score=324.42  Aligned_cols=244  Identities=21%  Similarity=0.333  Sum_probs=192.1

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|.+.+.||+|+||.||+|+.. +++.||||++....   ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            57889999999999999999865 68999999986532   234567899999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++++|.+++....    .+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        91 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           91 EYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             ECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             eccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            9999999999996543    4899999999999999999999987   99999999999999999999999999986543


Q ss_pred             CCceeecccccCCCcccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYL-TYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      ...  .....|++.|+|||.+.+..+ +.++||||||++++||++|+.||.....        ....          +.+
T Consensus       164 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~----------~~~  223 (276)
T 2h6d_A          164 GEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV--------PTLF----------KKI  223 (276)
T ss_dssp             ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHH----------HHH
T ss_pred             Ccc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH--------HHHH----------HHh
Confidence            322  223468999999999987765 6899999999999999999999863220        0110          001


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ... ....+......+.+++.+||+.+|++|||+.||
T Consensus       224 ~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~  259 (276)
T 2h6d_A          224 RGG-VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDI  259 (276)
T ss_dssp             HHC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             hcC-cccCchhcCHHHHHHHHHHccCChhhCCCHHHH
Confidence            110 011223334568899999999999999999764

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=343.68  Aligned_cols=262  Identities=19%  Similarity=0.242  Sum_probs=203.3

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCC--EEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGD--QLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~  315 (511)
                      ++|.+.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            56889999999999999999865 58999999997543 344567889999999999999999999998765  789999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEE----cCCCCeEEeecCCcc
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL----DRDLNPKISDFGLAK  391 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILl----d~~~~~kl~DfGla~  391 (511)
                      ||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        89 e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             CCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             ecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            99999999999965432 234899999999999999999999987   9999999999999    788889999999998


Q ss_pred             cCCCCCceeecccccCCCccccccccc--------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHh
Q 045835          392 LDEGDKTHISTRIAGTIGYMAPEYALW--------GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACH  463 (511)
Q Consensus       392 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~  463 (511)
                      .......  .....||..|+|||.+..        ..++.++|||||||++|||++|+.||.........    .+....
T Consensus       165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~----~~~~~~  238 (396)
T 4eut_A          165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN----KEVMYK  238 (396)
T ss_dssp             ECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC----HHHHHH
T ss_pred             EccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch----HHHHHH
Confidence            6544322  233568999999998865        56788999999999999999999999643211111    111111


Q ss_pred             hhccC---chh----------Hhh-hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          464 LQQDG---KLV----------ELV-DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       464 ~~~~~---~~~----------~~~-d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....   ...          +.. +.......+......+.+++.+||+.||++|||+.|+
T Consensus       239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~  300 (396)
T 4eut_A          239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF  300 (396)
T ss_dssp             HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHH
T ss_pred             HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHH
Confidence            11000   000          000 0011123457788889999999999999999998763

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=6.6e-41  Score=340.79  Aligned_cols=262  Identities=21%  Similarity=0.342  Sum_probs=201.0

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      ++|++.+.||+|+||.||++... ++..||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            57899999999999999999764 68999999997653 33456789999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE-SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      +++++|.+++....    .+++..+..++.+++.||+|||+. +   |+||||||+|||++.++.+||+|||+++.....
T Consensus       113 ~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  185 (360)
T 3eqc_A          113 MDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  185 (360)
T ss_dssp             CTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             CCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence            99999999996543    489999999999999999999985 5   999999999999999999999999999743211


Q ss_pred             CceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccc---------------------c
Q 045835          397 KTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDC---------------------T  455 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~---------------------~  455 (511)
                         ......||..|+|||.+.+..++.++|||||||+++||++|+.||..........                     .
T Consensus       186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (360)
T 3eqc_A          186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  262 (360)
T ss_dssp             ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred             ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence               1223578999999999999999999999999999999999999996432110000                     0


Q ss_pred             chhhhhHhhhccCchhHhhhhhhC----CCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          456 CLLDWACHLQQDGKLVELVDERLG----SKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       456 ~l~~~~~~~~~~~~~~~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .+..+...........++++....    .......+..+.+++.+||+.+|++|||+.|+
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  322 (360)
T 3eqc_A          263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL  322 (360)
T ss_dssp             -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHH
T ss_pred             cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHH
Confidence            000000000111112222222211    11112235578999999999999999999764

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=6.7e-40  Score=334.33  Aligned_cols=252  Identities=21%  Similarity=0.334  Sum_probs=200.7

Q ss_pred             HHHHHhcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCcc--------chHHHHHHHHHHhcC-CCCCceeEEE
Q 045835          234 QIKAATNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQ--------GNREFLNEIAMISCL-QHPNLVKIHG  303 (511)
Q Consensus       234 ~l~~~~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~--------~~~~~~~Ei~~l~~l-~H~niv~l~g  303 (511)
                      ......++|++.+.||+|+||.||+|+.. +|+.||||+++.....        ..+.+.+|+.+++++ +||||+++++
T Consensus        88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  167 (365)
T 2y7j_A           88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID  167 (365)
T ss_dssp             HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence            34445578999999999999999999865 7899999998754321        134678999999999 7999999999


Q ss_pred             EEEeCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeE
Q 045835          304 CCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPK  383 (511)
Q Consensus       304 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~k  383 (511)
                      ++......++||||+++++|.+++...    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+|
T Consensus       168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ik  240 (365)
T 2y7j_A          168 SYESSSFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR  240 (365)
T ss_dssp             EEEBSSEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred             EEeeCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence            999999999999999999999999653    35899999999999999999999987   99999999999999999999


Q ss_pred             EeecCCcccCCCCCceeecccccCCCccccccccc------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccch
Q 045835          384 ISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALW------GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCL  457 (511)
Q Consensus       384 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l  457 (511)
                      |+|||++........  .....||+.|+|||++.+      ..++.++|||||||++|||++|+.||.....     ...
T Consensus       241 l~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-----~~~  313 (365)
T 2y7j_A          241 LSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ-----ILM  313 (365)
T ss_dssp             ECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHH
T ss_pred             EEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH-----HHH
Confidence            999999986543322  234579999999998863      3588899999999999999999999863221     001


Q ss_pred             hhhhHhhhccCchhHhhhhhhCCCCC--HHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          458 LDWACHLQQDGKLVELVDERLGSKYK--KEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       458 ~~~~~~~~~~~~~~~~~d~~l~~~~~--~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...            +.........+  ...+..+.+++.+||+.+|++|||+.|+
T Consensus       314 ~~~------------i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~el  357 (365)
T 2y7j_A          314 LRM------------IMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQA  357 (365)
T ss_dssp             HHH------------HHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             HHH------------HHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            111            00100000000  0123568899999999999999998764

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.9e-40  Score=332.16  Aligned_cols=258  Identities=27%  Similarity=0.362  Sum_probs=200.1

Q ss_pred             ccHHHHHHHhcCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhc--CCCCCceeEEEEEEe
Q 045835          230 FTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISC--LQHPNLVKIHGCCVE  307 (511)
Q Consensus       230 ~~~~~l~~~~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~  307 (511)
                      ..+..-....++|.+.+.||+|+||.||+|+. +++.||||++...   ....+.+|.+++..  ++||||+++++++..
T Consensus        32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~  107 (342)
T 1b6c_B           32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNK  107 (342)
T ss_dssp             SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred             CceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence            33333445567899999999999999999987 5899999999643   34577888888887  799999999999988


Q ss_pred             CC----EEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCeEEccCCCCCeE
Q 045835          308 GD----QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH--------EESRFKIVHRDIKATNVL  375 (511)
Q Consensus       308 ~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH--------~~~~~~iiH~Dlk~~NIL  375 (511)
                      ..    ..++||||+++|+|.+++...     .+++..++.++.|++.||+|||        +.+   |+||||||+|||
T Consensus       108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIl  179 (342)
T 1b6c_B          108 DNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNIL  179 (342)
T ss_dssp             CCSSCCCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEE
T ss_pred             cCCccceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEE
Confidence            76    799999999999999999653     4899999999999999999999        554   999999999999


Q ss_pred             EcCCCCeEEeecCCcccCCCCCce---eecccccCCCcccccccccC------CCCcchhHHHHHHHHHHHHhC------
Q 045835          376 LDRDLNPKISDFGLAKLDEGDKTH---ISTRIAGTIGYMAPEYALWG------YLTYKADVYSFGIVALEIVSG------  440 (511)
Q Consensus       376 ld~~~~~kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~DV~S~Gvvl~elltG------  440 (511)
                      ++.++.+||+|||+++........   ......||..|+|||.+...      .++.++|||||||++|||+||      
T Consensus       180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~  259 (342)
T 1b6c_B          180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  259 (342)
T ss_dssp             ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred             ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence            999999999999999865443322   12345789999999998765      234789999999999999999      


Q ss_pred             ----CCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCCCCC-----HHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          441 ----KNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYK-----KEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       441 ----~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                          +.||.......   .....+...         +....+....+     .+....+.+++.+||+.+|++|||+.||
T Consensus       260 ~~~~~~p~~~~~~~~---~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i  327 (342)
T 1b6c_B          260 HEDYQLPYYDLVPSD---PSVEEMRKV---------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI  327 (342)
T ss_dssp             CCCCCCTTTTTSCSS---CCHHHHHHH---------HTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             ccccccCccccCcCc---ccHHHHHHH---------HHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHH
Confidence                55654322111   111111111         11111222222     3667789999999999999999999864

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.6e-40  Score=333.94  Aligned_cols=261  Identities=20%  Similarity=0.283  Sum_probs=188.9

Q ss_pred             HhcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCc--cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEE
Q 045835          238 ATNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSR--QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       238 ~~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  314 (511)
                      ..++|++.++||+|+||.||+|+. .+++.||||+++....  .....+.+|+.++++++||||+++++++.+++..++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            346899999999999999999974 4789999999975432  2345678999999999999999999999999999999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEE-----cCCCCeEEeecCC
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL-----DRDLNPKISDFGL  389 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILl-----d~~~~~kl~DfGl  389 (511)
                      |||++ |+|.+++....    .+++..+..++.|++.||+|||+.+   |+||||||+|||+     +.++.+||+|||+
T Consensus       112 ~e~~~-~~L~~~~~~~~----~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~  183 (329)
T 3gbz_A          112 FEYAE-NDLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL  183 (329)
T ss_dssp             EECCS-EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred             EecCC-CCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence            99998 49999986543    4899999999999999999999987   9999999999999     4555699999999


Q ss_pred             cccCCCCCceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhcc-
Q 045835          390 AKLDEGDKTHISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD-  467 (511)
Q Consensus       390 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~-  467 (511)
                      ++........ .....||..|+|||.+.+. .++.++|||||||+++||++|+.||......    ..+.......... 
T Consensus       184 a~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~~~~~~~~~~~  258 (329)
T 3gbz_A          184 ARAFGIPIRQ-FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI----DQLFKIFEVLGLPD  258 (329)
T ss_dssp             HHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHHHCCCC
T ss_pred             ccccCCcccc-cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH----HHHHHHHHHhCCCc
Confidence            9865432222 2334689999999999875 5899999999999999999999999643211    0011110000000 


Q ss_pred             -CchhHh------hh--hhhCCC-----CCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          468 -GKLVEL------VD--ERLGSK-----YKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       468 -~~~~~~------~d--~~l~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                       ......      .+  +.....     .+......+.+++.+||+.||++|||+.|+
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~  316 (329)
T 3gbz_A          259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNA  316 (329)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHH
Confidence             000000      00  000000     001123568899999999999999999764

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=7.9e-40  Score=328.45  Aligned_cols=253  Identities=19%  Similarity=0.277  Sum_probs=196.7

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCC-CCCceeEEEEEEe--CCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ-HPNLVKIHGCCVE--GDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~--~~~~~lV~  315 (511)
                      ++|++.++||+|+||.||+|+. .+++.||||+++..   ..+.+.+|+.++++++ ||||+++++++.+  ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            6789999999999999999974 57899999999743   3467899999999997 9999999999998  66789999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCC-CeEEeecCCcccCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL-NPKISDFGLAKLDE  394 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~-~~kl~DfGla~~~~  394 (511)
                      ||+++++|.+++.       .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++ .+||+|||+++...
T Consensus       113 e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          113 EHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             ECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             eccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            9999999998873       3788999999999999999999987   99999999999999777 89999999998654


Q ss_pred             CCCceeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHh
Q 045835          395 GDKTHISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVEL  473 (511)
Q Consensus       395 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  473 (511)
                      ....  .....||..|+|||.+.. ..++.++|||||||+++||++|+.||......   ...+..... ......+.+.
T Consensus       183 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~---~~~l~~~~~-~~~~~~~~~~  256 (330)
T 3nsz_A          183 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN---YDQLVRIAK-VLGTEDLYDY  256 (330)
T ss_dssp             TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH---HHHHHHHHH-HHCHHHHHHH
T ss_pred             CCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch---HHHHHHHHH-hcCCchhhhH
Confidence            3322  233468999999999877 67999999999999999999999998543211   111111110 0001111111


Q ss_pred             hhh-----------------------hhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          474 VDE-----------------------RLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       474 ~d~-----------------------~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ++.                       ......+......+.+++.+||+.||++|||+.|+
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~  317 (330)
T 3nsz_A          257 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA  317 (330)
T ss_dssp             HHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             HHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHH
Confidence            111                       01111112245678999999999999999999764

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.1e-40  Score=332.88  Aligned_cols=260  Identities=21%  Similarity=0.301  Sum_probs=202.1

Q ss_pred             ccHHHHHHHhcCCccc-CceeccCceeEEecccc-CCcEEEEEEecccC--ccchHHHHHHHHHHhcC-CCCCceeEEEE
Q 045835          230 FTLKQIKAATNNFDSA-KKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS--RQGNREFLNEIAMISCL-QHPNLVKIHGC  304 (511)
Q Consensus       230 ~~~~~l~~~~~~f~~~-~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~  304 (511)
                      ..+.......+.|.+. +.||+|+||.||+|... +++.||||++....  ......+.+|+.+++.+ +||||++++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~   97 (327)
T 3lm5_A           18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV   97 (327)
T ss_dssp             CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            3344445556677777 88999999999999754 68999999987542  33457889999999999 56999999999


Q ss_pred             EEeCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcC---CCC
Q 045835          305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR---DLN  381 (511)
Q Consensus       305 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~---~~~  381 (511)
                      +.+.+..++||||+++|+|.+++....  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.   ++.
T Consensus        98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~  172 (327)
T 3lm5_A           98 YENTSEIILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGD  172 (327)
T ss_dssp             EECSSEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCC
T ss_pred             EEeCCeEEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCc
Confidence            999999999999999999999985432  245899999999999999999999987   999999999999998   789


Q ss_pred             eEEeecCCcccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhh
Q 045835          382 PKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWA  461 (511)
Q Consensus       382 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~  461 (511)
                      +||+|||+++.......  .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......        +..
T Consensus       173 ~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~  242 (327)
T 3lm5_A          173 IKIVDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ--------ETY  242 (327)
T ss_dssp             EEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHH
T ss_pred             EEEeeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--------HHH
Confidence            99999999986543222  23357899999999999999999999999999999999999999643210        000


Q ss_pred             HhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          462 CHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       462 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....       ................+.+++.+||+.+|++|||+.|+
T Consensus       243 ~~i~~-------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~l  285 (327)
T 3lm5_A          243 LNISQ-------VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEIC  285 (327)
T ss_dssp             HHHHH-------TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             HHHHh-------cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            00000       00011112222345678899999999999999998764

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=5e-40  Score=333.16  Aligned_cols=200  Identities=28%  Similarity=0.417  Sum_probs=169.9

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEe--------C
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVE--------G  308 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--------~  308 (511)
                      ++|++.+.||+|+||.||+|+. .+|+.||||++....  ......+.+|+.+++.++||||+++++++..        .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            5799999999999999999986 578999999986543  2334578899999999999999999999987        4


Q ss_pred             CEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecC
Q 045835          309 DQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFG  388 (511)
Q Consensus       309 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfG  388 (511)
                      +..++||||+++ +|.+.+....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             ceEEEEEeccCC-CHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence            468999999985 7777775432   35899999999999999999999987   9999999999999999999999999


Q ss_pred             CcccCCCCC---ceeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 045835          389 LAKLDEGDK---THISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSY  446 (511)
Q Consensus       389 la~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~  446 (511)
                      +++......   ........||+.|+|||.+.+ ..++.++|||||||+++||++|+.||..
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  231 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG  231 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCC
Confidence            998654221   122234568999999998876 4689999999999999999999999874

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.7e-40  Score=348.93  Aligned_cols=246  Identities=25%  Similarity=0.353  Sum_probs=194.0

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      .++|+..++||+|+||.||+|+.. ++..||||++....  ......+.+|+.+++.++||||++++++|.+....++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            356899999999999999999864 68899999997543  334567899999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCC---CCeEEeecCCccc
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD---LNPKISDFGLAKL  392 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~---~~~kl~DfGla~~  392 (511)
                      ||+++|+|.+.+....    .+++..+..++.|++.||+|||+.+   |+||||||+|||++..   +.+||+|||+++.
T Consensus       116 e~~~~g~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          116 ECYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            9999999999886543    4899999999999999999999987   9999999999999764   4599999999986


Q ss_pred             CCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhH
Q 045835          393 DEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVE  472 (511)
Q Consensus       393 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  472 (511)
                      ......  .....||+.|+|||++. +.++.++|||||||++|||++|+.||.....     ..+..   .         
T Consensus       189 ~~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~---~---------  248 (494)
T 3lij_A          189 FENQKK--MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD-----QEILR---K---------  248 (494)
T ss_dssp             CBTTBC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH---H---------
T ss_pred             CCCCcc--ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHH---H---------
Confidence            554322  23457999999999876 5689999999999999999999999974321     01111   0         


Q ss_pred             hhhhhhC--CCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          473 LVDERLG--SKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       473 ~~d~~l~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +......  .......+..+.+++.+||+.+|.+|||+.|+
T Consensus       249 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~  289 (494)
T 3lij_A          249 VEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQA  289 (494)
T ss_dssp             HHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHH
Confidence            1111000  00111234568899999999999999998763

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.6e-40  Score=328.92  Aligned_cols=260  Identities=29%  Similarity=0.431  Sum_probs=183.2

Q ss_pred             HhcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          238 ATNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       238 ~~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ..++|++.+.||+|+||.||+|.. .+++.||||++.... .....++.+|+.++++++||||+++++++...+..++||
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            357899999999999999999975 468899999986543 334567889999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcC----CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcc
Q 045835          316 EYMENNSLACALFGR----ENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK  391 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~  391 (511)
                      ||+++++|.+++...    ......+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            999999999998641    112345899999999999999999999987   9999999999999999999999999997


Q ss_pred             cCCCCC----ceeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhc
Q 045835          392 LDEGDK----THISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQ  466 (511)
Q Consensus       392 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~  466 (511)
                      ......    ........||+.|+|||.+.. ..++.++||||||++++||++|+.||.......     ....  ....
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~--~~~~  242 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK-----VLML--TLQN  242 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-----HHHH--HHTS
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh-----HHHH--Hhcc
Confidence            554321    111233568999999999876 578999999999999999999999997433111     1000  0000


Q ss_pred             c-Cchh-HhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          467 D-GKLV-ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       467 ~-~~~~-~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      . .... ...++..    .......+.+++.+||+.+|++|||+.||
T Consensus       243 ~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~l  285 (303)
T 2vwi_A          243 DPPSLETGVQDKEM----LKKYGKSFRKMISLCLQKDPEKRPTAAEL  285 (303)
T ss_dssp             SCCCTTC-----CC----CCCCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             CCCccccccccchh----hhhhhHHHHHHHHHHccCChhhCcCHHHH
Confidence            0 0000 0111111    12234568899999999999999999764

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-40  Score=334.43  Aligned_cols=263  Identities=25%  Similarity=0.329  Sum_probs=193.2

Q ss_pred             HHhcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCc-----cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCE
Q 045835          237 AATNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR-----QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQ  310 (511)
Q Consensus       237 ~~~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~-----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~  310 (511)
                      ...++|+..+.||+|+||.||+|+.. +|+.||||++.....     ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34578999999999999999999864 589999999975322     123468899999999999999999999999999


Q ss_pred             EEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCc
Q 045835          311 LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA  390 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla  390 (511)
                      .++||||+++ +|.+++....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLA  159 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred             eEEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccc
Confidence            9999999986 8888885432   35889999999999999999999987   999999999999999999999999999


Q ss_pred             ccCCCCCceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhcc--
Q 045835          391 KLDEGDKTHISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD--  467 (511)
Q Consensus       391 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~--  467 (511)
                      +....... ......||+.|+|||.+.+. .++.++|||||||++|||++|++||......    ..+..........  
T Consensus       160 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~----~~~~~i~~~~~~~~~  234 (346)
T 1ua2_A          160 KSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL----DQLTRIFETLGTPTE  234 (346)
T ss_dssp             STTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHHHCCCCT
T ss_pred             eeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH----HHHHHHHHHcCCCCh
Confidence            86543322 22345789999999998754 5899999999999999999999988643211    0111110000000  


Q ss_pred             C---chhHhhhh---hhCCCCC-----HHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          468 G---KLVELVDE---RLGSKYK-----KEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       468 ~---~~~~~~d~---~l~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .   ....+.+.   ......+     ......+.+++.+||+.+|++|||+.|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  289 (346)
T 1ua2_A          235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA  289 (346)
T ss_dssp             TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHH
T ss_pred             hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHH
Confidence            0   00000000   0000111     2234678999999999999999999764

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=7.3e-41  Score=336.27  Aligned_cols=249  Identities=23%  Similarity=0.295  Sum_probs=181.5

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCC-CCCceeEEEEEEe--------C
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ-HPNLVKIHGCCVE--------G  308 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~--------~  308 (511)
                      ..+|++.++||+|+||.||+|+. .+++.||||++........+.+.+|+.+++++. ||||+++++++..        .
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            45788999999999999999985 468999999997666666678899999999996 9999999999953        3


Q ss_pred             CEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecC
Q 045835          309 DQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFG  388 (511)
Q Consensus       309 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfG  388 (511)
                      ...++||||+. |+|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||||+|||++.++.+||+|||
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg  183 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG  183 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence            45899999996 799988865221 235999999999999999999999874 359999999999999999999999999


Q ss_pred             CcccCCCCCce-----------eecccccCCCccccccc---ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccc
Q 045835          389 LAKLDEGDKTH-----------ISTRIAGTIGYMAPEYA---LWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDC  454 (511)
Q Consensus       389 la~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~  454 (511)
                      +++........           ......||+.|+|||.+   ....++.++|||||||++|||++|+.||......    
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----  259 (337)
T 3ll6_A          184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL----  259 (337)
T ss_dssp             TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred             cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH----
Confidence            99865432211           01134589999999998   5667899999999999999999999998632210    


Q ss_pred             cchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          455 TCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       455 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                                       ++++.......+......+.+++.+||+.+|++|||+.||
T Consensus       260 -----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~  299 (337)
T 3ll6_A          260 -----------------RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEV  299 (337)
T ss_dssp             -----------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHH
T ss_pred             -----------------HhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHH
Confidence                             1111111111111223357889999999999999998764

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.1e-40  Score=333.95  Aligned_cols=260  Identities=20%  Similarity=0.292  Sum_probs=199.5

Q ss_pred             hcCCcccCceeccCceeEEeccccCCcEEEEEEecccCccc-----------------hHHHHHHHHHHhcCCCCCceeE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQG-----------------NREFLNEIAMISCLQHPNLVKI  301 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~-----------------~~~~~~Ei~~l~~l~H~niv~l  301 (511)
                      .++|.+.+.||+|+||.||+|.. +++.||||++.......                 ...+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            36799999999999999999988 89999999987542211                 1789999999999999999999


Q ss_pred             EEEEEeCCEEEEEEEecCCCCHhHH------HhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEEccCCCCCe
Q 045835          302 HGCCVEGDQLLLVYEYMENNSLACA------LFGRENCELELDWPTRQKICLGIARGLAFLHE-ESRFKIVHRDIKATNV  374 (511)
Q Consensus       302 ~g~~~~~~~~~lV~Ey~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiH~Dlk~~NI  374 (511)
                      ++++.+.+..++||||+++++|.++      +...  ....+++..+..++.|++.||+|||+ .+   |+||||||+||
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Ni  183 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNI  183 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhE
Confidence            9999999999999999999999998      5332  13469999999999999999999998 76   99999999999


Q ss_pred             EEcCCCCeEEeecCCcccCCCCCceeecccccCCCcccccccccC-CCCc-chhHHHHHHHHHHHHhCCCCCCCCCcccc
Q 045835          375 LLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWG-YLTY-KADVYSFGIVALEIVSGKNNMSYAPALEF  452 (511)
Q Consensus       375 Lld~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DV~S~Gvvl~elltG~~p~~~~~~~~~  452 (511)
                      +++.++.+||+|||++......   ......||..|+|||.+.+. .++. ++||||||++++||++|+.||......  
T Consensus       184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--  258 (348)
T 2pml_X          184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--  258 (348)
T ss_dssp             EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--
T ss_pred             EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--
Confidence            9999999999999999865433   23345789999999999877 6666 999999999999999999999743210  


Q ss_pred             cccchhhhhHhhh-c-cCchhHhhhh---hhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          453 DCTCLLDWACHLQ-Q-DGKLVELVDE---RLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       453 ~~~~l~~~~~~~~-~-~~~~~~~~d~---~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                        ..+........ . .........+   .............+.+++.+||+.+|.+|||+.|+
T Consensus       259 --~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~  320 (348)
T 2pml_X          259 --VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDA  320 (348)
T ss_dssp             --HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             --HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHH
Confidence              11111110000 0 0000000000   00000113345678999999999999999999764

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.1e-40  Score=348.22  Aligned_cols=193  Identities=25%  Similarity=0.393  Sum_probs=152.8

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEeccc--CccchHHHHHHHHHHhcCCCCCceeEEEEEEeC-----CEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK--SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEG-----DQL  311 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~  311 (511)
                      ++|++.+.||+|+||.||+|+.. +++.||||++...  .....+.+.+|+.+|+.++||||+++++++...     ...
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            67999999999999999999754 6899999998653  233446789999999999999999999999543     578


Q ss_pred             EEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcc
Q 045835          312 LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK  391 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~  391 (511)
                      ++||||+. ++|.+++...    ..+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus       133 ~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          133 YVVLEIAD-SDFKKLFRTP----VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEECCCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEeccc-cchhhhcccC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence            99999985 6899888643    35999999999999999999999987   9999999999999999999999999998


Q ss_pred             cCCCCCc--------------------------eeecccccCCCccccccc-ccCCCCcchhHHHHHHHHHHHHhC
Q 045835          392 LDEGDKT--------------------------HISTRIAGTIGYMAPEYA-LWGYLTYKADVYSFGIVALEIVSG  440 (511)
Q Consensus       392 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DV~S~Gvvl~elltG  440 (511)
                      .......                          ...+..+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            6532211                          112345789999999986 456799999999999999999994

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=5.6e-40  Score=359.99  Aligned_cols=243  Identities=24%  Similarity=0.379  Sum_probs=202.0

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEeccc---CccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK---SRQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l  313 (511)
                      .++|++.++||+|+||.||+|+.. +++.||||+++..   .......+..|..++..+ +||||+++++++.+.+.+++
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            467999999999999999999854 6889999999753   234456788999999988 79999999999999999999


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      ||||+++|+|.+++....    .+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++..
T Consensus       420 V~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            999999999999997543    4899999999999999999999987   999999999999999999999999999854


Q ss_pred             CCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHh
Q 045835          394 EGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVEL  473 (511)
Q Consensus       394 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  473 (511)
                      ..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ..+.            ..+
T Consensus       493 ~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-----~~~~------------~~i  554 (674)
T 3pfq_A          493 IWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELF------------QSI  554 (674)
T ss_dssp             CCTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHH------------HHH
T ss_pred             ccCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-----HHHH------------HHH
Confidence            33222 23446799999999999999999999999999999999999999974221     1111            111


Q ss_pred             hhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCc
Q 045835          474 VDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTM  508 (511)
Q Consensus       474 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  508 (511)
                      +...  ..++.....++.+|+.+||+.+|++||++
T Consensus       555 ~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          555 MEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGC  587 (674)
T ss_dssp             HSSC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred             HhCC--CCCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence            1111  22344556678999999999999999997

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=333.70  Aligned_cols=257  Identities=26%  Similarity=0.407  Sum_probs=196.6

Q ss_pred             cHHHHHHHhcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcC-CCCCceeEEEEEEe-
Q 045835          231 TLKQIKAATNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCL-QHPNLVKIHGCCVE-  307 (511)
Q Consensus       231 ~~~~l~~~~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~-  307 (511)
                      .+.++....++|++.+.||+|+||.||+|+. .+++.||||++.... .....+.+|+.+++++ +||||+++++++.. 
T Consensus        15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   93 (326)
T 2x7f_A           15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK   93 (326)
T ss_dssp             -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred             cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence            3444555678899999999999999999985 478999999987543 3446889999999999 89999999999987 


Q ss_pred             -----CCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCe
Q 045835          308 -----GDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP  382 (511)
Q Consensus       308 -----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~  382 (511)
                           .+..++||||+++++|.+++....  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~  168 (326)
T 2x7f_A           94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV  168 (326)
T ss_dssp             C--CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred             cCccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence                 468899999999999999997643  245899999999999999999999987   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCceeecccccCCCcccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccch
Q 045835          383 KISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYAL-----WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCL  457 (511)
Q Consensus       383 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l  457 (511)
                      ||+|||++........ ......||..|+|||.+.     ...++.++|||||||++|||++|+.||......       
T Consensus       169 kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------  240 (326)
T 2x7f_A          169 KLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-------  240 (326)
T ss_dssp             EECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-------
T ss_pred             EEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-------
Confidence            9999999986543221 122346899999999987     567899999999999999999999998633210       


Q ss_pred             hhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          458 LDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       458 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                       .-.         ..+.........+...+..+.+++.+||+.+|.+|||+.||
T Consensus       241 -~~~---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  284 (326)
T 2x7f_A          241 -RAL---------FLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQL  284 (326)
T ss_dssp             -HHH---------HHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             -HHH---------HHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHH
Confidence             000         00111101111122234578999999999999999998764

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=9.5e-40  Score=347.42  Aligned_cols=244  Identities=26%  Similarity=0.380  Sum_probs=195.7

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCc-------------cchHHHHHHHHHHhcCCCCCceeEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR-------------QGNREFLNEIAMISCLQHPNLVKIHGC  304 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~-------------~~~~~~~~Ei~~l~~l~H~niv~l~g~  304 (511)
                      .++|.+.++||+|+||.||+|+.. +++.||||++.....             ...+.+.+|+.++++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            467999999999999999999754 578999999875421             334678999999999999999999999


Q ss_pred             EEeCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCC---C
Q 045835          305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL---N  381 (511)
Q Consensus       305 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~---~  381 (511)
                      +.+....++||||+++|+|.+.+....    .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++   .
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence            999999999999999999999986543    4899999999999999999999987   99999999999998776   6


Q ss_pred             eEEeecCCcccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhh
Q 045835          382 PKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWA  461 (511)
Q Consensus       382 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~  461 (511)
                      +||+|||+++.......  .....||+.|+|||.+. +.++.++||||+||++|||++|+.||.....     .   +..
T Consensus       188 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~---~~~  256 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND-----Q---DII  256 (504)
T ss_dssp             EEECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----H---HHH
T ss_pred             EEEEECCCCEEcCCCCc--cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-----H---HHH
Confidence            99999999986654322  23457999999999876 5689999999999999999999999974321     0   111


Q ss_pred             HhhhccCchhHhhhhhhCCCCC----HHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          462 CHLQQDGKLVELVDERLGSKYK----KEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       462 ~~~~~~~~~~~~~d~~l~~~~~----~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...         .....  .++    ...+..+.+++.+||+.+|.+|||+.|+
T Consensus       257 ~~i---------~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~  299 (504)
T 3q5i_A          257 KKV---------EKGKY--YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEA  299 (504)
T ss_dssp             HHH---------HHCCC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HHH---------HcCCC--CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence            111         01000  011    1224568999999999999999998764

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=8.1e-40  Score=326.04  Aligned_cols=249  Identities=28%  Similarity=0.394  Sum_probs=196.6

Q ss_pred             HhcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          238 ATNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       238 ~~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      ..++|++.+.||+|+||.||+|... +|+.||||.+....  ..+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            3568999999999999999999764 58999999997543  34678999999999999999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      |+++++|.+++...   ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++......
T Consensus       105 ~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          105 YCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             CCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             cCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            99999999998632   235899999999999999999999987   999999999999999999999999999765432


Q ss_pred             CceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhh
Q 045835          397 KTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDE  476 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  476 (511)
                      .. ......||..|+|||.+....++.++||||||++++||++|+.||......        .........        .
T Consensus       179 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~--------~  241 (314)
T 3com_A          179 MA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM--------RAIFMIPTN--------P  241 (314)
T ss_dssp             BS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHS--------C
T ss_pred             cc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHhcC--------C
Confidence            22 123356899999999999989999999999999999999999998643210        000000000        0


Q ss_pred             hhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          477 RLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       477 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ......+......+.+++.+||+.+|.+|||+.|+
T Consensus       242 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~l  276 (314)
T 3com_A          242 PPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQL  276 (314)
T ss_dssp             CCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred             CcccCCcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            00011122334678999999999999999998764

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.9e-40  Score=349.68  Aligned_cols=246  Identities=26%  Similarity=0.374  Sum_probs=199.8

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccC---ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  314 (511)
                      .++|+..+.||+|+||.||+++.. +++.||||++....   ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            357899999999999999999764 78999999986442   34557799999999999999999999999999999999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEE---cCCCCeEEeecCCcc
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAK  391 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILl---d~~~~~kl~DfGla~  391 (511)
                      |||+.+|+|.+.+....    .+++..+..++.|++.||+|||+.+   |+||||||+|||+   +.++.+||+|||+++
T Consensus       105 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRK----RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             ECCCCSCBHHHHHHTCS----CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            99999999999986543    4899999999999999999999987   9999999999999   567899999999998


Q ss_pred             cCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchh
Q 045835          392 LDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLV  471 (511)
Q Consensus       392 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  471 (511)
                      .......  .....||+.|+|||.+.+ .++.++|||||||++|||++|++||.....     ..+...           
T Consensus       178 ~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~-----------  238 (484)
T 3nyv_A          178 HFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE-----YDILKK-----------  238 (484)
T ss_dssp             HBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH-----------
T ss_pred             Ecccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH-----HHHHHH-----------
Confidence            6554332  233569999999998865 689999999999999999999999974321     111111           


Q ss_pred             HhhhhhhCC--CCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          472 ELVDERLGS--KYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       472 ~~~d~~l~~--~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                       +.......  ......+..+.+++.+||+.+|++|||+.|+
T Consensus       239 -i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~  279 (484)
T 3nyv_A          239 -VEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDA  279 (484)
T ss_dssp             -HHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             -HHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence             11111110  1112345678999999999999999998763

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.2e-40  Score=330.10  Aligned_cols=250  Identities=23%  Similarity=0.413  Sum_probs=195.7

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            467999999999999999999865 5889999999877666778899999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +++++|.+++....   ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.......
T Consensus        98 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  171 (302)
T 2j7t_A           98 CPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL  171 (302)
T ss_dssp             CTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred             CCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence            99999999886532   35899999999999999999999986   9999999999999999999999999975321110


Q ss_pred             ceeecccccCCCcccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhH
Q 045835          398 THISTRIAGTIGYMAPEYAL-----WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVE  472 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  472 (511)
                       .......||..|+|||.+.     ...++.++||||||++++||++|+.|+.....        ...........    
T Consensus       172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~----  238 (302)
T 2j7t_A          172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKSD----  238 (302)
T ss_dssp             -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHSC----
T ss_pred             -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH--------HHHHHHHhccC----
Confidence             1112346899999999883     56789999999999999999999999864321        01111110000    


Q ss_pred             hhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          473 LVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       473 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                          ......+...+..+.+++.+||+.+|++|||+.||
T Consensus       239 ----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  273 (302)
T 2j7t_A          239 ----PPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQL  273 (302)
T ss_dssp             ----CCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred             ----CcccCCccccCHHHHHHHHHHcccChhhCCCHHHH
Confidence                00011223345678999999999999999998764

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.9e-40  Score=343.65  Aligned_cols=199  Identities=26%  Similarity=0.377  Sum_probs=166.8

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEeccc--CccchHHHHHHHHHHhcCCCCCceeEEEEEEeC-----CE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK--SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEG-----DQ  310 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~  310 (511)
                      .++|.+.+.||+|+||.||+|+. .+++.||||++...  .....+.+.+|+.+|+.++||||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            46899999999999999999975 46889999999753  223446789999999999999999999999876     57


Q ss_pred             EEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCc
Q 045835          311 LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA  390 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla  390 (511)
                      .++||||+. ++|.+++...    ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla  176 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTP----IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA  176 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecCC-cCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence            999999987 5999998653    35899999999999999999999987   999999999999999999999999999


Q ss_pred             ccCCCCCc---------------------eeecccccCCCccccccc-ccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 045835          391 KLDEGDKT---------------------HISTRIAGTIGYMAPEYA-LWGYLTYKADVYSFGIVALEIVSGKNNMS  445 (511)
Q Consensus       391 ~~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DV~S~Gvvl~elltG~~p~~  445 (511)
                      +.......                     ...+...||..|+|||.+ ....++.++|||||||+++||++|..|+.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            86543221                     112456789999999986 45679999999999999999999766654

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=7.9e-40  Score=323.49  Aligned_cols=247  Identities=21%  Similarity=0.305  Sum_probs=199.1

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccC---------ccchHHHHHHHHHHhcCC-CCCceeEEEEEEe
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS---------RQGNREFLNEIAMISCLQ-HPNLVKIHGCCVE  307 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~---------~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~  307 (511)
                      .++|++.+.||+|+||.||+|... +++.||||++....         ....+.+.+|+.+++++. ||||+++++++.+
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            468999999999999999999864 68899999997543         122356789999999995 9999999999999


Q ss_pred             CCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeec
Q 045835          308 GDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF  387 (511)
Q Consensus       308 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~Df  387 (511)
                      .+..++||||+++++|.+++...    ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+||
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred             CCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence            99999999999999999999653    35899999999999999999999987   999999999999999999999999


Q ss_pred             CCcccCCCCCceeecccccCCCcccccccc------cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhh
Q 045835          388 GLAKLDEGDKTHISTRIAGTIGYMAPEYAL------WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWA  461 (511)
Q Consensus       388 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~  461 (511)
                      |++........  .....|+..|+|||.+.      ...++.++||||||++++||++|+.||.....     .   ...
T Consensus       169 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~---~~~  238 (298)
T 1phk_A          169 GFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-----M---LML  238 (298)
T ss_dssp             TTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----H---HHH
T ss_pred             cchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH-----H---HHH
Confidence            99986543322  23356899999999885      45688999999999999999999999864321     0   010


Q ss_pred             HhhhccCchhHhhhhhhC--CCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          462 CHLQQDGKLVELVDERLG--SKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       462 ~~~~~~~~~~~~~d~~l~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .         .+......  .......+..+.+++.+||+.+|++|||+.|+
T Consensus       239 ~---------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  281 (298)
T 1phk_A          239 R---------MIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA  281 (298)
T ss_dssp             H---------HHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             H---------HHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHH
Confidence            0         11111111  11112345678999999999999999998764

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=5.8e-40  Score=347.51  Aligned_cols=246  Identities=24%  Similarity=0.355  Sum_probs=197.4

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEeccc--CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK--SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      .++|++.++||+|+||.||+++.. +++.||||++...  .......+.+|+.++++++||||+++++++.+....++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            467999999999999999999754 6899999998643  2334568899999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEc---CCCCeEEeecCCccc
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD---RDLNPKISDFGLAKL  392 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld---~~~~~kl~DfGla~~  392 (511)
                      ||+++|+|.+.+....    .+++..+..++.|++.||+|||+.+   |+||||||+|||++   .++.+||+|||+++.
T Consensus       101 e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             EcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            9999999999886543    4899999999999999999999987   99999999999995   456799999999986


Q ss_pred             CCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhH
Q 045835          393 DEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVE  472 (511)
Q Consensus       393 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  472 (511)
                      ......  .....||+.|+|||++.+ .++.++|||||||++|||++|+.||.....     ..+..            .
T Consensus       174 ~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~------------~  233 (486)
T 3mwu_A          174 FQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-----YDILK------------R  233 (486)
T ss_dssp             BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH------------H
T ss_pred             CCCCCc--cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHH------------H
Confidence            543322  234579999999998875 599999999999999999999999964321     01111            1


Q ss_pred             hhhhhhCC--CCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          473 LVDERLGS--KYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       473 ~~d~~l~~--~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +.......  ......+..+.+++.+||+.+|++|||+.|+
T Consensus       234 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~  274 (486)
T 3mwu_A          234 VETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC  274 (486)
T ss_dssp             HHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            11111110  1112335678899999999999999998763

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=5.2e-40  Score=334.97  Aligned_cols=241  Identities=16%  Similarity=0.133  Sum_probs=192.7

Q ss_pred             HhcCCcccCceeccCceeEEecc------ccCCcEEEEEEecccCccchHHHHHHHHHHhcCC---CCCceeEEEEEEeC
Q 045835          238 ATNNFDSAKKIGEGGFGPVYKGQ------LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ---HPNLVKIHGCCVEG  308 (511)
Q Consensus       238 ~~~~f~~~~~lG~G~fG~Vy~g~------~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~  308 (511)
                      ..++|.+.++||+|+||.||+|.      ..+++.||||+++...   ..++..|+.+++.++   |+||+++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            35678999999999999999993      4568899999997543   457788888888886   99999999999999


Q ss_pred             CEEEEEEEecCCCCHhHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcC---------
Q 045835          309 DQLLLVYEYMENNSLACALFGREN-CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR---------  378 (511)
Q Consensus       309 ~~~~lV~Ey~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~---------  378 (511)
                      +..++||||+++|+|.+++..... ....++|..++.++.|++.||+|||+.+   |+||||||+|||++.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence            999999999999999999975321 2346999999999999999999999986   999999999999998         


Q ss_pred             --CCCeEEeecCCcccCC-CCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccccccc
Q 045835          379 --DLNPKISDFGLAKLDE-GDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCT  455 (511)
Q Consensus       379 --~~~~kl~DfGla~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~  455 (511)
                        ++.+||+|||+++... ...........||..|+|||++.+..++.++|||||||++|||+||+.||......     
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-----  291 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG-----  291 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT-----
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC-----
Confidence              8999999999997532 12233345567999999999999999999999999999999999999998522110     


Q ss_pred             chhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCC
Q 045835          456 CLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPT  507 (511)
Q Consensus       456 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs  507 (511)
                         .|        .    ++..+... +  ....+.+++..|++.+|.+||+
T Consensus       292 ---~~--------~----~~~~~~~~-~--~~~~~~~~~~~~l~~~p~~r~~  325 (365)
T 3e7e_A          292 ---EC--------K----PEGLFRRL-P--HLDMWNEFFHVMLNIPDCHHLP  325 (365)
T ss_dssp             ---EE--------E----ECSCCTTC-S--SHHHHHHHHHHHHCCCCTTCCC
T ss_pred             ---ce--------e----echhcccc-C--cHHHHHHHHHHHcCCCCCCcch
Confidence               00        0    00001111 1  1345678888999999999965

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=8.9e-41  Score=328.99  Aligned_cols=248  Identities=23%  Similarity=0.366  Sum_probs=189.2

Q ss_pred             cCCcccCceeccCceeEEecccc--CCc--EEEEEEeccc---CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA--DGT--IIAVKQLSSK---SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLL  312 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~--~g~--~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  312 (511)
                      ++|++.+.||+|+||.||+|+..  +++  .||||+++..   .....+.+.+|+.++++++||||+++++++.+.. .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            57889999999999999999753  333  6899998754   2334567899999999999999999999998765 88


Q ss_pred             EEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCccc
Q 045835          313 LVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       313 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~  392 (511)
                      +|+||+++++|.+++....   ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++.
T Consensus        97 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence            9999999999999996542   35899999999999999999999986   99999999999999999999999999986


Q ss_pred             CCCCCce--eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCc
Q 045835          393 DEGDKTH--ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGK  469 (511)
Q Consensus       393 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  469 (511)
                      .......  ......+|..|+|||.+....++.++||||||++++||++ |+.||.....        .+...       
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~-------  235 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--------SQILH-------  235 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHH-------
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH--------HHHHH-------
Confidence            6543322  1223457888999999998889999999999999999999 9999864321        11111       


Q ss_pred             hhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          470 LVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       470 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                        .+.........+...+..+.+++.+||+.+|++|||+.||
T Consensus       236 --~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l  275 (291)
T 1u46_A          236 --KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL  275 (291)
T ss_dssp             --HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             --HHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHH
Confidence              1111111112233445679999999999999999999764

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=9.7e-40  Score=335.77  Aligned_cols=260  Identities=23%  Similarity=0.310  Sum_probs=198.4

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCC--------CCCceeEEEEEE---
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ--------HPNLVKIHGCCV---  306 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~--------H~niv~l~g~~~---  306 (511)
                      .++|++.++||+|+||.||+|+. .+++.||||++... ......+.+|+.+++.++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            36799999999999999999974 46889999999743 334467889999999885        788999999988   


Q ss_pred             -eCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEEccCCCCCeEEcCCC----
Q 045835          307 -EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE-SRFKIVHRDIKATNVLLDRDL----  380 (511)
Q Consensus       307 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~iiH~Dlk~~NILld~~~----  380 (511)
                       +....++||||+ +++|.+.+....  ...+++..+..++.||+.||+|||++ +   |+||||||+|||++.++    
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~  188 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIR  188 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhh
Confidence             456789999999 556666665432  23589999999999999999999997 6   99999999999999775    


Q ss_pred             ---------------------------------------------CeEEeecCCcccCCCCCceeecccccCCCcccccc
Q 045835          381 ---------------------------------------------NPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEY  415 (511)
Q Consensus       381 ---------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~  415 (511)
                                                                   .+||+|||+++.....    .....||..|+|||+
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHH
T ss_pred             hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChh
Confidence                                                         7999999999865432    233468999999999


Q ss_pred             cccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccccc-ccchhhhhHhhhcc-------------------C-------
Q 045835          416 ALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFD-CTCLLDWACHLQQD-------------------G-------  468 (511)
Q Consensus       416 ~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~-~~~l~~~~~~~~~~-------------------~-------  468 (511)
                      +.+..++.++|||||||++|||++|+.||......... ..............                   +       
T Consensus       265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  344 (397)
T 1wak_A          265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK  344 (397)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence            99999999999999999999999999999743321110 00000000000000                   0       


Q ss_pred             ----chhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          469 ----KLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       469 ----~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                          .+.+.+..  ....+.+....+.+|+.+||+.||++|||+.||
T Consensus       345 ~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~  389 (397)
T 1wak_A          345 LKPWGLFEVLVE--KYEWSQEEAAGFTDFLLPMLELIPEKRATAAEC  389 (397)
T ss_dssp             CCCCCHHHHHHH--TSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHH
T ss_pred             cCCcchhHhhhh--hcccchhhHHHHHHHHHHHhccChhhcCCHHHH
Confidence                00011111  123467778899999999999999999999874

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.3e-40  Score=340.32  Aligned_cols=250  Identities=11%  Similarity=0.028  Sum_probs=178.9

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCc---cchHHHHHHH---HHHhcCCCCCceeEE-------EEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSR---QGNREFLNEI---AMISCLQHPNLVKIH-------GCC  305 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei---~~l~~l~H~niv~l~-------g~~  305 (511)
                      .+|...+.||+|+||.||+|+. .+++.||||++.....   ...+.+.+|+   .+|+. +||||++++       +++
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence            4588899999999999999985 4789999999986542   2344667784   45555 799988755       555


Q ss_pred             EeC-----------------CEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCC
Q 045835          306 VEG-----------------DQLLLVYEYMENNSLACALFGRENCELELDWPTR------QKICLGIARGLAFLHEESRF  362 (511)
Q Consensus       306 ~~~-----------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~ia~gl~yLH~~~~~  362 (511)
                      ...                 ...++||||++ |+|.+++....   ..+.+..+      ..++.||+.||+|||+++  
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--  214 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQSKG--  214 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence            443                 34899999999 89999997542   23566666      788899999999999987  


Q ss_pred             CeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCceeecccccCCCccccccccc--CCCCcchhHHHHHHHHHHHHhC
Q 045835          363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALW--GYLTYKADVYSFGIVALEIVSG  440 (511)
Q Consensus       363 ~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~Gvvl~elltG  440 (511)
                       |+||||||+|||++.++.+||+|||+++.....    .....+|+.|+|||.+.+  ..++.++|||||||++|||+||
T Consensus       215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg  289 (371)
T 3q60_A          215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL  289 (371)
T ss_dssp             -EEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             -CccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence             999999999999999999999999999865321    113456799999999987  6899999999999999999999


Q ss_pred             CCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          441 KNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       441 ~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +.||........     ..|.     ....................+..+.+++.+||+.||++|||+.|+
T Consensus       290 ~~Pf~~~~~~~~-----~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~  350 (371)
T 3q60_A          290 FLPFGLVTPGIK-----GSWK-----RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEA  350 (371)
T ss_dssp             SCSTTBCCTTCT-----TCCC-----BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHH
T ss_pred             CCCCCCcCcccc-----cchh-----hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence            999974421110     0010     000000001111111112345678999999999999999998764

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.2e-39  Score=326.37  Aligned_cols=249  Identities=26%  Similarity=0.344  Sum_probs=191.8

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCc--------cchHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR--------QGNREFLNEIAMISCLQHPNLVKIHGCCVEGD  309 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~--------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~  309 (511)
                      .++|.+.+.||+|+||.||+|... +++.||||++.....        .....+.+|+.++++++||||+++++++..++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            467999999999999999999754 688999999864321        12245889999999999999999999987655


Q ss_pred             EEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCC---eEEee
Q 045835          310 QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN---PKISD  386 (511)
Q Consensus       310 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~---~kl~D  386 (511)
                       .++||||+++++|.+++...    ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++.   +||+|
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             -eEEEEecCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence             89999999999999998643    35899999999999999999999987   999999999999987654   99999


Q ss_pred             cCCcccCCCCCceeecccccCCCcccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHh
Q 045835          387 FGLAKLDEGDKTHISTRIAGTIGYMAPEYAL---WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACH  463 (511)
Q Consensus       387 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~  463 (511)
                      ||+++......  ......||..|+|||.+.   ...++.++|||||||++|||++|+.||......    ..+..... 
T Consensus       161 fg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~-  233 (322)
T 2ycf_A          161 FGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ----VSLKDQIT-  233 (322)
T ss_dssp             CTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS----SCHHHHHH-
T ss_pred             Cccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH----HHHHHHHH-
Confidence            99998654322  123356899999999874   567899999999999999999999999643211    11111110 


Q ss_pred             hhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          464 LQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       464 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                         .+... . .+..    .......+.+++.+||+.+|++|||+.|+
T Consensus       234 ---~~~~~-~-~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~  272 (322)
T 2ycf_A          234 ---SGKYN-F-IPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEA  272 (322)
T ss_dssp             ---HTCCC-C-CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             ---hCccc-c-Cchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHH
Confidence               00000 0 0000    01224578999999999999999998764

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.7e-39  Score=329.99  Aligned_cols=268  Identities=21%  Similarity=0.263  Sum_probs=188.4

Q ss_pred             HHHHHHhcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCE-
Q 045835          233 KQIKAATNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQ-  310 (511)
Q Consensus       233 ~~l~~~~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-  310 (511)
                      .+.....++|++.+.||+|+||.||+|+. .+++.||||++.... .....+.+|+..++.++||||+++++++..... 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            44556678999999999999999999986 468999999986543 233467788889999999999999999976433 


Q ss_pred             ------EEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh--cCCCCCeEEccCCCCCeEEcC-CCC
Q 045835          311 ------LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH--EESRFKIVHRDIKATNVLLDR-DLN  381 (511)
Q Consensus       311 ------~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH--~~~~~~iiH~Dlk~~NILld~-~~~  381 (511)
                            .++||||+++ +|...+.........+++..+..++.|++.||.|||  +.+   |+||||||+|||++. ++.
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~  170 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT  170 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence                  7899999986 555444332222346889999999999999999999  665   999999999999997 899


Q ss_pred             eEEeecCCcccCCCCCceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhh
Q 045835          382 PKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDW  460 (511)
Q Consensus       382 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~  460 (511)
                      +||+|||+++.......  .....||..|+|||.+.+. .++.++|||||||++|||++|+.||......    ..+...
T Consensus       171 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~----~~~~~~  244 (360)
T 3e3p_A          171 LKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA----GQLHEI  244 (360)
T ss_dssp             EEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHH
T ss_pred             EEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH----HHHHHH
Confidence            99999999986554332  2335689999999998655 5899999999999999999999999743211    111111


Q ss_pred             hHhhhccC-chhHhhhh----------------hhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          461 ACHLQQDG-KLVELVDE----------------RLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       461 ~~~~~~~~-~~~~~~d~----------------~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ........ .....+++                ......+......+.+++.+||+.||++|||+.||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~  312 (360)
T 3e3p_A          245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEA  312 (360)
T ss_dssp             HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHH
Confidence            11100000 00000000                00111222346789999999999999999998764

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.1e-40  Score=332.32  Aligned_cols=251  Identities=24%  Similarity=0.341  Sum_probs=196.7

Q ss_pred             HHHhcCCcccCceeccCceeEEeccccCCcEEEEEEecccC--ccchHHHHHHHHHHhcCC--CCCceeEEEEEEeCCEE
Q 045835          236 KAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQ--HPNLVKIHGCCVEGDQL  311 (511)
Q Consensus       236 ~~~~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~  311 (511)
                      ....++|++.+.||+|+||.||++...+++.||||++....  ......+.+|+.++++++  ||||+++++++.+.+..
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~  103 (313)
T 3cek_A           24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI  103 (313)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred             eeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence            33457799999999999999999988889999999997543  334567899999999997  59999999999999999


Q ss_pred             EEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcc
Q 045835          312 LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK  391 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~  391 (511)
                      ++||| +.+++|.+++....    .+++..+..++.|++.||+|||+.+   |+||||||+|||+++ +.+||+|||+++
T Consensus       104 ~lv~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~  174 (313)
T 3cek_A          104 YMVME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIAN  174 (313)
T ss_dssp             EEEEC-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSC
T ss_pred             EEEEe-cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccc
Confidence            99999 66889999997543    5899999999999999999999986   999999999999975 789999999998


Q ss_pred             cCCCCCce-eecccccCCCccccccccc-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhh
Q 045835          392 LDEGDKTH-ISTRIAGTIGYMAPEYALW-----------GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLD  459 (511)
Q Consensus       392 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~  459 (511)
                      ........ ......||..|+|||.+..           ..++.++||||||+++|||++|+.||......      .  
T Consensus       175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------~--  246 (313)
T 3cek_A          175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------I--  246 (313)
T ss_dssp             C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH------H--
T ss_pred             cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH------H--
Confidence            65433221 2234568999999999875           47889999999999999999999998632210      0  


Q ss_pred             hhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          460 WACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       460 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                              ..+..++++......+......+.+++.+||+.+|++|||+.||
T Consensus       247 --------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el  290 (313)
T 3cek_A          247 --------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL  290 (313)
T ss_dssp             --------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             --------HHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHH
Confidence                    01223333333333333345678999999999999999999764

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.4e-39  Score=321.17  Aligned_cols=248  Identities=21%  Similarity=0.255  Sum_probs=194.6

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC----ccchHHHHHHHHHHhcCCCCCceeEEEEEE--eCCEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS----RQGNREFLNEIAMISCLQHPNLVKIHGCCV--EGDQL  311 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~--~~~~~  311 (511)
                      .++|.+.+.||+|+||.||++.. .+++.||+|++....    ......+.+|+.++++++||||+++++++.  +....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            36899999999999999999975 468899999997542    234567899999999999999999999985  44578


Q ss_pred             EEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcc
Q 045835          312 LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK  391 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~  391 (511)
                      ++||||++++ |.+++....  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE  157 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence            9999999977 777775533  245899999999999999999999987   9999999999999999999999999998


Q ss_pred             cCCCC-CceeecccccCCCcccccccccCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccC
Q 045835          392 LDEGD-KTHISTRIAGTIGYMAPEYALWGY--LTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDG  468 (511)
Q Consensus       392 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~  468 (511)
                      ..... .........||..|+|||.+.+..  .+.++||||||++++||++|+.||....        ..+....     
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~-----  224 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--------IYKLFEN-----  224 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHH-----
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch--------HHHHHHH-----
Confidence            65432 222233456899999999987643  4789999999999999999999986322        1111111     


Q ss_pred             chhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          469 KLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       469 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                          +...  ....+......+.+++.+||+.||++|||+.|+
T Consensus       225 ----i~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  261 (305)
T 2wtk_C          225 ----IGKG--SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQI  261 (305)
T ss_dssp             ----HHHC--CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             ----HhcC--CCCCCCccCHHHHHHHHHHccCChhhCCCHHHH
Confidence                1111  112233345578899999999999999999764

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.3e-39  Score=332.96  Aligned_cols=260  Identities=22%  Similarity=0.274  Sum_probs=188.4

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCC------E
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGD------Q  310 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------~  310 (511)
                      ++|++.+.||+|+||.||+|.. .+++.||||++....  ......+.+|+.+++.++||||+++++++...+      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            6799999999999999999974 468899999997532  233457889999999999999999999997654      7


Q ss_pred             EEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCc
Q 045835          311 LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA  390 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla  390 (511)
                      .++||||+++ +|.+.+..      .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       105 ~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          105 VYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             eEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence            8999999985 78887742      3889999999999999999999987   999999999999999999999999999


Q ss_pred             ccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccccc-------ccchhhhh--
Q 045835          391 KLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFD-------CTCLLDWA--  461 (511)
Q Consensus       391 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~-------~~~l~~~~--  461 (511)
                      +......  ......||..|+|||.+.+..++.++|||||||+++||++|+.||........-       .....++.  
T Consensus       175 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  252 (371)
T 2xrw_A          175 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  252 (371)
T ss_dssp             -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred             ccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            8654321  223457899999999999999999999999999999999999999743211000       00000000  


Q ss_pred             -----Hhhhc------cCchhHhhhhhhCCC---CCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          462 -----CHLQQ------DGKLVELVDERLGSK---YKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       462 -----~~~~~------~~~~~~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                           .....      .....+++.......   .+......+.+|+.+||+.||++|||+.|+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~  316 (371)
T 2xrw_A          253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA  316 (371)
T ss_dssp             SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHH
Confidence                 00000      000111111111111   112336779999999999999999999764

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=8.3e-40  Score=339.88  Aligned_cols=257  Identities=25%  Similarity=0.327  Sum_probs=189.9

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeC----C--EEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEG----D--QLL  312 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~----~--~~~  312 (511)
                      .+|+..+.||+|+||.||+|+.. +|+.||||++.....    .+.+|+.+|+.++||||+++++++...    +  .++
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            35888999999999999999864 689999999865432    234799999999999999999998642    2  367


Q ss_pred             EEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCC-CCeEEeecCCcc
Q 045835          313 LVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD-LNPKISDFGLAK  391 (511)
Q Consensus       313 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~-~~~kl~DfGla~  391 (511)
                      +||||+++ +|.+.+.........+++..+..++.||++||+|||+.+   |+||||||+|||++.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999986 566665432222346999999999999999999999986   9999999999999965 568999999998


Q ss_pred             cCCCCCceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCch
Q 045835          392 LDEGDKTHISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKL  470 (511)
Q Consensus       392 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  470 (511)
                      .......  .....||..|+|||++.+. .++.++|||||||++|||++|+.||.....    ...+......+. ....
T Consensus       206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~----~~~l~~i~~~lg-~p~~  278 (420)
T 1j1b_A          206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG----VDQLVEIIKVLG-TPTR  278 (420)
T ss_dssp             ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHC-SCCH
T ss_pred             hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhC-CCCH
Confidence            6543322  2335789999999998765 799999999999999999999999974321    111222111110 0000


Q ss_pred             hHh--hhhh--------hCC-----CCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          471 VEL--VDER--------LGS-----KYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       471 ~~~--~d~~--------l~~-----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..+  +++.        +..     .++......+.+|+.+||+.||++|||+.|+
T Consensus       279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~  334 (420)
T 1j1b_A          279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA  334 (420)
T ss_dssp             HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHH
Confidence            000  0000        000     0112234678999999999999999998763

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.6e-40  Score=333.79  Aligned_cols=255  Identities=21%  Similarity=0.303  Sum_probs=190.6

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCC------
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGD------  309 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------  309 (511)
                      .++|+..+.||+|+||.||+|.. .+|+.||||++....  ....+.+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            36789999999999999999975 468999999996432  233457889999999999999999999998653      


Q ss_pred             EEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCC
Q 045835          310 QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL  389 (511)
Q Consensus       310 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGl  389 (511)
                      ..++||||+ +++|.+++...     .+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence            469999999 78999998652     4899999999999999999999987   99999999999999999999999999


Q ss_pred             cccCCCCCceeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhh---
Q 045835          390 AKLDEGDKTHISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQ---  465 (511)
Q Consensus       390 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~---  465 (511)
                      ++.....    .+...+|..|+|||.+.+ ..++.++||||+||+++||++|+.||......     ....-.....   
T Consensus       175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~l~~i~~~~g~~  245 (367)
T 1cm8_A          175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-----DQLKEIMKVTGTP  245 (367)
T ss_dssp             CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHHHCCC
T ss_pred             ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHhcCCC
Confidence            9865432    233578999999999887 68999999999999999999999999743211     0111000000   


Q ss_pred             --------ccCchhHhhhhhh---C---CCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          466 --------QDGKLVELVDERL---G---SKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       466 --------~~~~~~~~~d~~l---~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                              ........+....   .   ..........+.+|+.+||+.||++|||+.|+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~  305 (367)
T 1cm8_A          246 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA  305 (367)
T ss_dssp             CHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             CHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHH
Confidence                    0000011111000   0   01112335578999999999999999998763

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=4e-40  Score=360.03  Aligned_cols=249  Identities=24%  Similarity=0.374  Sum_probs=197.0

Q ss_pred             HhcCCcccCceeccCceeEEecccc----CCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEE
Q 045835          238 ATNNFDSAKKIGEGGFGPVYKGQLA----DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLL  312 (511)
Q Consensus       238 ~~~~f~~~~~lG~G~fG~Vy~g~~~----~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  312 (511)
                      ..++|++.+.||+|+||.||+|...    .+..||||++.... ....+.|.+|+.++++++||||+++++++. .+..+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~  466 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW  466 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence            3467888899999999999999753    24679999987543 334467899999999999999999999985 45689


Q ss_pred             EEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCccc
Q 045835          313 LVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       313 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~  392 (511)
                      +||||+++|+|.+++....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       467 lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~  540 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY  540 (656)
T ss_dssp             EEEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred             EEEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCee
Confidence            9999999999999997543   35899999999999999999999987   99999999999999999999999999987


Q ss_pred             CCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchh
Q 045835          393 DEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLV  471 (511)
Q Consensus       393 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  471 (511)
                      .............+|+.|+|||.+....++.++|||||||++|||++ |+.||.....     ....             
T Consensus       541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-----~~~~-------------  602 (656)
T 2j0j_A          541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----NDVI-------------  602 (656)
T ss_dssp             CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHH-------------
T ss_pred             cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH-----HHHH-------------
Confidence            65443333334457789999999998999999999999999999997 9999864321     1111             


Q ss_pred             HhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       472 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..+........+...+..+.+++.+||+.+|++|||+.||
T Consensus       603 ~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el  642 (656)
T 2j0j_A          603 GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL  642 (656)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHH
Confidence            1111111222344555678999999999999999999764

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=324.96  Aligned_cols=259  Identities=25%  Similarity=0.307  Sum_probs=189.9

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEE------------
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCV------------  306 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~------------  306 (511)
                      ++|.+.+.||+|+||.||+|... +++.||||++........+.+.+|+.++++++||||+++++++.            
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            57889999999999999999865 58999999998766666678999999999999999999999873            


Q ss_pred             --eCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEc-CCCCeE
Q 045835          307 --EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD-RDLNPK  383 (511)
Q Consensus       307 --~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld-~~~~~k  383 (511)
                        +....++||||++ |+|.+++..     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++ +++.+|
T Consensus        91 ~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           91 LTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred             ccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence              3468899999998 699999853     24889999999999999999999987   99999999999997 567999


Q ss_pred             EeecCCcccCCCCCc--eeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhh
Q 045835          384 ISDFGLAKLDEGDKT--HISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDW  460 (511)
Q Consensus       384 l~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~  460 (511)
                      |+|||+++.......  .......+|..|+|||.+.. ..++.++||||||+++|||++|+.||.......    .+...
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~----~~~~~  237 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE----QMQLI  237 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHH
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH----HHHHH
Confidence            999999986543211  11223457889999998865 689999999999999999999999997433110    00000


Q ss_pred             hHhhh--cc-------CchhHhhhhhhC-CCC-----CHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          461 ACHLQ--QD-------GKLVELVDERLG-SKY-----KKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       461 ~~~~~--~~-------~~~~~~~d~~l~-~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....  ..       ..+...+..... ...     ....+..+.+++.+||+.||++|||+.|+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  303 (320)
T 2i6l_A          238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEA  303 (320)
T ss_dssp             HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHH
Confidence            00000  00       000000111110 000     11235678999999999999999999764

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.3e-39  Score=330.21  Aligned_cols=259  Identities=23%  Similarity=0.305  Sum_probs=196.5

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeC-----CEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEG-----DQL  311 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~  311 (511)
                      .++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            46799999999999999999974 468899999997543 23346789999999999999999999999764     368


Q ss_pred             EEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcc
Q 045835          312 LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK  391 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~  391 (511)
                      ++||||+. |+|.+++...     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       106 ~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  176 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR  176 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence            99999998 5899988643     4899999999999999999999987   9999999999999999999999999998


Q ss_pred             cCCCCCce--eecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccC
Q 045835          392 LDEGDKTH--ISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDG  468 (511)
Q Consensus       392 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~  468 (511)
                      ........  ......||+.|+|||.+.. ..++.++|||||||+++||++|+.||......     .............
T Consensus       177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~i~~~~~~~  251 (364)
T 3qyz_A          177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL-----DQLNHILGILGSP  251 (364)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG-----GHHHHHHHHHCSC
T ss_pred             ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH-----HHHHHHHHHhCCC
Confidence            65432221  1234578999999998764 45899999999999999999999999743311     1111111110000


Q ss_pred             ch-----------hHhhhhhh-CCCCC-----HHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          469 KL-----------VELVDERL-GSKYK-----KEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       469 ~~-----------~~~~d~~l-~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..           ........ ....+     ......+.+++.+||+.||++|||+.|+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~  311 (364)
T 3qyz_A          252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA  311 (364)
T ss_dssp             CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             CHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence            00           00000000 00011     1224568999999999999999998764

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.6e-39  Score=336.99  Aligned_cols=198  Identities=22%  Similarity=0.316  Sum_probs=170.7

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcC------CCCCceeEEEEEEeCCEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCL------QHPNLVKIHGCCVEGDQL  311 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l------~H~niv~l~g~~~~~~~~  311 (511)
                      ..+|++.++||+|+||.||+|.. .+++.||||+++.. ......+.+|+.+++.+      +|+||+++++++...+..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            45799999999999999999975 45899999999753 23345677888888776      577999999999999999


Q ss_pred             EEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCC--eEEeecCC
Q 045835          312 LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN--PKISDFGL  389 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~--~kl~DfGl  389 (511)
                      ++||||+. ++|.+++.....  ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.  +||+|||+
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             EEEEeccC-CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence            99999996 689998876432  34899999999999999999999986   999999999999999987  99999999


Q ss_pred             cccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 045835          390 AKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYA  447 (511)
Q Consensus       390 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~  447 (511)
                      ++.....    .....||+.|+|||++.+..++.++|||||||++|||+||++||...
T Consensus       249 a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          249 SCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             CEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            9764432    22357899999999999999999999999999999999999999743

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.9e-39  Score=323.72  Aligned_cols=257  Identities=22%  Similarity=0.282  Sum_probs=199.0

Q ss_pred             hcCCcccCceeccCceeEEeccc--cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCC------CceeEEEEEEeCCE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL--ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHP------NLVKIHGCCVEGDQ  310 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~--~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~------niv~l~g~~~~~~~  310 (511)
                      .++|++.+.||+|+||.||+|..  .+++.||||+++.. ......+.+|+.+++.++|+      +++++++++.+.+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            35799999999999999999974  36889999999753 23346788999999888765      49999999999999


Q ss_pred             EEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcC------------
Q 045835          311 LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR------------  378 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~------------  378 (511)
                      .++||||+ +++|.+++.....  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.            
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred             EEEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence            99999999 8899999976432  35889999999999999999999987   999999999999987            


Q ss_pred             -------CCCeEEeecCCcccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccc
Q 045835          379 -------DLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALE  451 (511)
Q Consensus       379 -------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~  451 (511)
                             ++.+||+|||+++......    ....||..|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  241 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE  241 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred             cccccccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence                   6689999999998644322    23578999999999999999999999999999999999999997432110


Q ss_pred             ccccchhhhhHhhhcc-------------------------CchhHhhhhhh-----CCCCCHHHHHHHHHHHHHcCCCC
Q 045835          452 FDCTCLLDWACHLQQD-------------------------GKLVELVDERL-----GSKYKKEEAERMIKVSLLCTNAS  501 (511)
Q Consensus       452 ~~~~~l~~~~~~~~~~-------------------------~~~~~~~d~~l-----~~~~~~~~~~~l~~l~~~Cl~~~  501 (511)
                           ...........                         ......+....     ....+......+.+++.+||+.|
T Consensus       242 -----~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  316 (339)
T 1z57_A          242 -----HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD  316 (339)
T ss_dssp             -----HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred             -----HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence                 00000000000                         00000000000     01123456778999999999999


Q ss_pred             CCCCCCcCCC
Q 045835          502 PSLRPTMSEV  511 (511)
Q Consensus       502 p~~RPs~~eV  511 (511)
                      |++|||+.||
T Consensus       317 P~~Rpt~~el  326 (339)
T 1z57_A          317 PAKRITLREA  326 (339)
T ss_dssp             TTTSCCHHHH
T ss_pred             cccccCHHHH
Confidence            9999999864

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.9e-39  Score=324.96  Aligned_cols=261  Identities=25%  Similarity=0.366  Sum_probs=196.8

Q ss_pred             HhcCCcccCceeccCceeEEeccc--cCCcEEEEEEecccC--ccchHHHHHHHHHHhcC---CCCCceeEEEEEE----
Q 045835          238 ATNNFDSAKKIGEGGFGPVYKGQL--ADGTIIAVKQLSSKS--RQGNREFLNEIAMISCL---QHPNLVKIHGCCV----  306 (511)
Q Consensus       238 ~~~~f~~~~~lG~G~fG~Vy~g~~--~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~----  306 (511)
                      +.++|++.+.||+|+||.||+|+.  .+++.||||++....  ......+.+|+.+++.+   +||||++++++|.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            457899999999999999999976  468899999987432  22234567788777766   8999999999997    


Q ss_pred             -eCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEe
Q 045835          307 -EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKIS  385 (511)
Q Consensus       307 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~  385 (511)
                       .....++||||+. |+|.+++.....  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence             4567899999998 699999876432  34899999999999999999999987   9999999999999999999999


Q ss_pred             ecCCcccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhh
Q 045835          386 DFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQ  465 (511)
Q Consensus       386 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~  465 (511)
                      |||+++......  ......||..|+|||.+.+..++.++||||||+++|||++|+.||......     ..........
T Consensus       163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~i~~~~  235 (326)
T 1blx_A          163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-----DQLGKILDVI  235 (326)
T ss_dssp             SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHH
T ss_pred             cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHHHHc
Confidence            999998654322  223456899999999999999999999999999999999999999743311     1111110000


Q ss_pred             ccCchhH----------hhhh---hhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          466 QDGKLVE----------LVDE---RLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       466 ~~~~~~~----------~~d~---~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .......          ....   .............+.+++.+||+.+|++|||+.|+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~  294 (326)
T 1blx_A          236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA  294 (326)
T ss_dssp             CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             CCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence            0000000          0000   00001122334678899999999999999998763

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=337.57  Aligned_cols=253  Identities=15%  Similarity=0.158  Sum_probs=195.0

Q ss_pred             cCCcccCceeccCceeEEeccccC---------CcEEEEEEecccCccchHHHHHHHHHHhcCCCCCcee----------
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLAD---------GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVK----------  300 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~---------g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~----------  300 (511)
                      ++|.+.+.||+|+||.||+|+...         ++.||||++...     ..+.+|+.++++++||||++          
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            679999999999999999998653         788999998754     36889999999999999988          


Q ss_pred             -----EEEEEEe-CCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCe
Q 045835          301 -----IHGCCVE-GDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNV  374 (511)
Q Consensus       301 -----l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NI  374 (511)
                           +++++.. +...++||||+ +++|.+++....  ...+++..++.++.|++.||+|||+.+   |+||||||+||
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI  190 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI  190 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence                 7888887 77899999999 999999997542  245999999999999999999999986   99999999999


Q ss_pred             EEcCCC--CeEEeecCCcccCCCCCce------eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 045835          375 LLDRDL--NPKISDFGLAKLDEGDKTH------ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSY  446 (511)
Q Consensus       375 Lld~~~--~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~  446 (511)
                      |++.++  .+||+|||+++........      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999998  8999999999865432211      11234789999999999999999999999999999999999999863


Q ss_pred             CCcccccccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          447 APALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       447 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...   ....+..........  ...+.+...   .....+..+.+++.+||+.+|++|||+.||
T Consensus       271 ~~~---~~~~~~~~~~~~~~~--~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  327 (352)
T 2jii_A          271 CLP---NTEDIMKQKQKFVDK--PGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAML  327 (352)
T ss_dssp             GTT---CHHHHHHHHHHHHHS--CCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred             CCc---CHHHHHHHHHhccCC--hhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHH
Confidence            220   111111111111000  000000000   001224578999999999999999999764

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.9e-39  Score=334.48  Aligned_cols=257  Identities=23%  Similarity=0.326  Sum_probs=189.8

Q ss_pred             cCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCE------EEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQ------LLL  313 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~------~~l  313 (511)
                      .+|...++||+|+||.||+|+...+..||+|++......    ..+|+.+++.++||||+++++++.....      .++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            468899999999999999999877777999988654322    2369999999999999999999975433      789


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEc-CCCCeEEeecCCccc
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD-RDLNPKISDFGLAKL  392 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld-~~~~~kl~DfGla~~  392 (511)
                      ||||++++.+...... ......+++..+..++.|+++||+|||+.+   |+||||||+|||++ .++.+||+|||+++.
T Consensus       116 v~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          116 VLEYVPETVYRASRHY-AKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEECCSEEHHHHHHHH-HHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EeeccCccHHHHHHHH-HhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            9999987544433321 112346899999999999999999999987   99999999999999 789999999999986


Q ss_pred             CCCCCceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchh
Q 045835          393 DEGDKTHISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLV  471 (511)
Q Consensus       393 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  471 (511)
                      .......  ....||..|+|||.+.+. .++.++|||||||++|||++|+.||......    ..+....... ......
T Consensus       192 ~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~----~~l~~i~~~~-g~p~~~  264 (394)
T 4e7w_A          192 LIAGEPN--VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI----DQLVEIIKVL-GTPSRE  264 (394)
T ss_dssp             CCTTCCC--CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHHH-CCCCHH
T ss_pred             ccCCCCC--cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHh-CCCCHH
Confidence            5433322  335689999999998765 6999999999999999999999999743211    1111111110 000000


Q ss_pred             H--hhhhhh--------C-----CCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          472 E--LVDERL--------G-----SKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       472 ~--~~d~~l--------~-----~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .  .+++..        .     ..++......+.+|+.+||+.||++|||+.|+
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~  319 (394)
T 4e7w_A          265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEA  319 (394)
T ss_dssp             HHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             HHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHH
Confidence            0  001100        0     00112234578999999999999999998763

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.2e-39  Score=322.11  Aligned_cols=249  Identities=25%  Similarity=0.403  Sum_probs=190.2

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEe----------
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVE----------  307 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----------  307 (511)
                      .++|+..+.||+|+||.||+|+. .+++.||||++... ....+.+.+|+.++++++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            46789999999999999999985 47899999999643 3344678999999999999999999999875          


Q ss_pred             ---CCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEE
Q 045835          308 ---GDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKI  384 (511)
Q Consensus       308 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl  384 (511)
                         .+..++||||+++|+|.+++....   ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl  157 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI  157 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence               356899999999999999997542   35788999999999999999999987   999999999999999999999


Q ss_pred             eecCCcccCCCCC-------------ceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcc
Q 045835          385 SDFGLAKLDEGDK-------------THISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPAL  450 (511)
Q Consensus       385 ~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~  450 (511)
                      +|||+++......             ........||..|+|||.+.+. .++.++|||||||++|||++   |+....  
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--  232 (303)
T 1zy4_A          158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--  232 (303)
T ss_dssp             CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--
T ss_pred             eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--
Confidence            9999998654221             1112334689999999998754 78999999999999999998   443110  


Q ss_pred             cccccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          451 EFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       451 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                        +   ..........       ........++......+.+++.+||+.||++|||+.||
T Consensus       233 --~---~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l  281 (303)
T 1zy4_A          233 --E---RVNILKKLRS-------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL  281 (303)
T ss_dssp             --H---HHHHHHHHHS-------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             --h---HHHHHHhccc-------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHH
Confidence              0   0011111000       01112223344555678999999999999999998764

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=8.3e-39  Score=337.06  Aligned_cols=253  Identities=25%  Similarity=0.290  Sum_probs=196.6

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCCC-CCceeEEEEEEeCCEEEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQH-PNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~E  316 (511)
                      .++|++.++||+|+||.||+|+. .+++.||||++......  .++..|+.+++.++| +++..+..++.+.+..++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            36799999999999999999974 57899999988654332  358899999999987 566667777788889999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEE---cCCCCeEEeecCCcccC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLD  393 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILl---d~~~~~kl~DfGla~~~  393 (511)
                      |+ +++|.+++....   ..+++..++.++.||+.||+|||+.+   |+||||||+||||   +.++.+||+|||+++..
T Consensus        84 ~~-g~sL~~ll~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~  156 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY  156 (483)
T ss_dssp             CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             CC-CCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence            99 999999996432   35999999999999999999999987   9999999999999   68899999999999865


Q ss_pred             CCCCce------eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhcc
Q 045835          394 EGDKTH------ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD  467 (511)
Q Consensus       394 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~  467 (511)
                      ......      ......||..|+|||.+.+..++.++|||||||+||||++|+.||......  ............   
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~i~~~---  231 (483)
T 3sv0_A          157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG--TKKQKYEKISEK---  231 (483)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS--SHHHHHHHHHHH---
T ss_pred             cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccch--hHHHHHHHHhhc---
Confidence            443221      122467999999999999999999999999999999999999999743311  101111111100   


Q ss_pred             CchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          468 GKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       468 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                       .+...+.. +...    ...++.+++..||+.+|++||++.+|
T Consensus       232 -~~~~~~~~-l~~~----~p~~l~~li~~cl~~dP~~RPs~~el  269 (483)
T 3sv0_A          232 -KVATSIEA-LCRG----YPTEFASYFHYCRSLRFDDKPDYSYL  269 (483)
T ss_dssp             -HHHSCHHH-HHTT----SCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred             -cccccHHH-HhcC----CcHHHHHHHHHHhcCChhhCcCHHHH
Confidence             00001111 1112    23578999999999999999999764

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.5e-39  Score=333.63  Aligned_cols=202  Identities=25%  Similarity=0.395  Sum_probs=155.0

Q ss_pred             cCCcc-cCceeccCceeEEecccc---CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEe--CCEEEE
Q 045835          240 NNFDS-AKKIGEGGFGPVYKGQLA---DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVE--GDQLLL  313 (511)
Q Consensus       240 ~~f~~-~~~lG~G~fG~Vy~g~~~---~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~l  313 (511)
                      +.|++ .++||+|+||.||+|+..   +++.||||++....  ....+.+|+.+|++++||||+++++++..  ....++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            34555 458999999999999854   57889999997542  23578899999999999999999999965  668999


Q ss_pred             EEEecCCCCHhHHHhcCC-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEE----cCCCCeEE
Q 045835          314 VYEYMENNSLACALFGRE-----NCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL----DRDLNPKI  384 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILl----d~~~~~kl  384 (511)
                      ||||+.+ +|.+++....     .....+++..++.++.||+.||+|||+.+   |+||||||+|||+    +.++.+||
T Consensus        98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence            9999975 7777775321     11234899999999999999999999987   9999999999999    77889999


Q ss_pred             eecCCcccCCCCCc--eeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 045835          385 SDFGLAKLDEGDKT--HISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYA  447 (511)
Q Consensus       385 ~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~  447 (511)
                      +|||+++.......  .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  239 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  239 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence            99999986543221  222345789999999998874 5999999999999999999999999643

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.3e-39  Score=317.71  Aligned_cols=247  Identities=23%  Similarity=0.341  Sum_probs=197.4

Q ss_pred             HhcCCcccCceeccCceeEEecccc-CCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEE
Q 045835          238 ATNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       238 ~~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  314 (511)
                      ..++|++.+.||+|+||.||+|+.. +++.||||++....  ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            3467999999999999999999864 68899999986542  34456889999999999999999999999999999999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCC---CCeEEeecCCcc
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD---LNPKISDFGLAK  391 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~---~~~kl~DfGla~  391 (511)
                      +||+++++|.+.+....    .+++..+..++.|++.||+|||+.+   ++||||||+||+++.+   +.+||+|||++.
T Consensus       100 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~  172 (287)
T 2wei_A          100 GELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (287)
T ss_dssp             ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred             EEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence            99999999999886543    4899999999999999999999987   9999999999999764   469999999998


Q ss_pred             cCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchh
Q 045835          392 LDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLV  471 (511)
Q Consensus       392 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  471 (511)
                      ........  ....||..|+|||.+.+ .++.++||||||++++||++|+.||.....     .   +.....       
T Consensus       173 ~~~~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~---~~~~~~-------  234 (287)
T 2wei_A          173 CFQQNTKM--KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-----Y---DILKRV-------  234 (287)
T ss_dssp             TBCCCSSC--SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----H---HHHHHH-------
T ss_pred             eecCCCcc--ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH-----H---HHHHHH-------
Confidence            65433221  23357889999998765 589999999999999999999999864321     1   111111       


Q ss_pred             HhhhhhhCCCC--CHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          472 ELVDERLGSKY--KKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       472 ~~~d~~l~~~~--~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                        .........  ....+..+.+++.+||+.+|++|||+.|+
T Consensus       235 --~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el  274 (287)
T 2wei_A          235 --ETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC  274 (287)
T ss_dssp             --HHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             --HcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHH
Confidence              111110000  11234568999999999999999998764

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=6.5e-39  Score=324.84  Aligned_cols=259  Identities=21%  Similarity=0.275  Sum_probs=195.0

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeC-----CEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEG-----DQL  311 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~  311 (511)
                      .++|.+.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            467999999999999999999854 68999999997543 23345788999999999999999999998764     678


Q ss_pred             EEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcc
Q 045835          312 LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK  391 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~  391 (511)
                      ++||||+. ++|.+++...     .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        90 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR  160 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence            99999997 5899988653     4899999999999999999999987   9999999999999999999999999998


Q ss_pred             cCCCCCce---------eecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhh
Q 045835          392 LDEGDKTH---------ISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWA  461 (511)
Q Consensus       392 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~  461 (511)
                      ........         ......||..|+|||.+.. ..++.++|||||||+++||++|+.||......     ......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~  235 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR-----HQLLLI  235 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHH
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH-----HHHHHH
Confidence            65432211         1123468999999998764 68999999999999999999999999743210     000000


Q ss_pred             Hhhh------------ccCchhHhhhhhhC-CC-----CCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          462 CHLQ------------QDGKLVELVDERLG-SK-----YKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       462 ~~~~------------~~~~~~~~~d~~l~-~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ....            ......+.+..... ..     ..+.....+.+++.+||+.||++|||+.||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  303 (353)
T 2b9h_A          236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEA  303 (353)
T ss_dssp             HHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             HHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHH
Confidence            0000            00001111111000 00     011234568899999999999999999764

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.6e-39  Score=331.69  Aligned_cols=255  Identities=22%  Similarity=0.298  Sum_probs=179.1

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeC------C
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEG------D  309 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~  309 (511)
                      .++|+..+.||+|+||.||+|.. .+|+.||||++....  ....+.+.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            36899999999999999999974 568999999996532  23446788999999999999999999999754      5


Q ss_pred             EEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCC
Q 045835          310 QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL  389 (511)
Q Consensus       310 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGl  389 (511)
                      ..++|+|++ +++|.+++..     ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~  178 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL  178 (367)
T ss_dssp             CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred             eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence            679999999 6899888854     24899999999999999999999987   99999999999999999999999999


Q ss_pred             cccCCCCCceeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhcc-
Q 045835          390 AKLDEGDKTHISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD-  467 (511)
Q Consensus       390 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~-  467 (511)
                      ++.....    .....||..|+|||.+.+ ..++.++|||||||+++||++|+.||......     ............ 
T Consensus       179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~l~~i~~~~g~p  249 (367)
T 2fst_X          179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-----DQLKLILRLVGTP  249 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCSC
T ss_pred             ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCCC
Confidence            9864332    233578999999999886 68999999999999999999999999743211     111111110000 


Q ss_pred             ----------CchhHhhhhhhC-CCCC-----HHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          468 ----------GKLVELVDERLG-SKYK-----KEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       468 ----------~~~~~~~d~~l~-~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                                ......+..... ...+     ......+.+|+.+||+.||++|||+.|+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~  309 (367)
T 2fst_X          250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA  309 (367)
T ss_dssp             CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHH
Confidence                      000111111000 0001     1123568899999999999999998763

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.9e-39  Score=325.48  Aligned_cols=253  Identities=27%  Similarity=0.381  Sum_probs=175.6

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccC-ccchHHHHHHHH-HHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS-RQGNREFLNEIA-MISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      ++|+..+.||+|+||.||+|... +|+.||||++.... .....++..|+. +++.++||||+++++++.+.+..++|||
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e  101 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME  101 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence            67889999999999999999864 68999999997643 233345666666 7788899999999999999999999999


Q ss_pred             ecCCCCHhHHHhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          317 YMENNSLACALFGR-ENCELELDWPTRQKICLGIARGLAFLHEE-SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       317 y~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      |+++ +|.+++... ......+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||+++...
T Consensus       102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  177 (327)
T 3aln_A          102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLV  177 (327)
T ss_dssp             CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred             ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence            9985 787776531 11124589999999999999999999997 6   9999999999999999999999999998654


Q ss_pred             CCCceeecccccCCCccccccc----ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCch
Q 045835          395 GDKTHISTRIAGTIGYMAPEYA----LWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKL  470 (511)
Q Consensus       395 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  470 (511)
                      ....  .....||..|+|||.+    .+..++.++||||||+++|||++|+.||.......       +...... .+. 
T Consensus       178 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~-~~~-  246 (327)
T 3aln_A          178 DSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-------DQLTQVV-KGD-  246 (327)
T ss_dssp             ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCC-CSC-
T ss_pred             cccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-------HHHHHHh-cCC-
Confidence            3222  2234689999999998    45678999999999999999999999986432110       0000000 000 


Q ss_pred             hHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          471 VELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       471 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                          .+.+...........+.+++.+||+.+|++|||+.||
T Consensus       247 ----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el  283 (327)
T 3aln_A          247 ----PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKEL  283 (327)
T ss_dssp             ----CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             ----CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHH
Confidence                0111111112334578999999999999999999764

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2e-38  Score=325.33  Aligned_cols=207  Identities=23%  Similarity=0.290  Sum_probs=172.6

Q ss_pred             HHHHHHHhcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCC-CC-----CceeEEEE
Q 045835          232 LKQIKAATNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ-HP-----NLVKIHGC  304 (511)
Q Consensus       232 ~~~l~~~~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~-----niv~l~g~  304 (511)
                      ........++|++.+.||+|+||.||+|... +++.||||+++.. .....++..|+.+++.++ |+     ++++++++
T Consensus        46 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~  124 (382)
T 2vx3_A           46 VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH  124 (382)
T ss_dssp             CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred             eecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence            3333444678999999999999999999754 6889999999743 233456778888888875 44     49999999


Q ss_pred             EEeCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEc--CCCCe
Q 045835          305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD--RDLNP  382 (511)
Q Consensus       305 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld--~~~~~  382 (511)
                      +...+..++||||+. ++|.+++.....  ..+++..+..++.|++.||+|||++ ..+|+||||||+|||++  .++.+
T Consensus       125 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~  200 (382)
T 2vx3_A          125 FMFRNHLCLVFEMLS-YNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAI  200 (382)
T ss_dssp             EEETTEEEEEEECCC-CBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCE
T ss_pred             eccCCceEEEEecCC-CCHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcE
Confidence            999999999999996 599999976532  3489999999999999999999963 13599999999999994  47789


Q ss_pred             EEeecCCcccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 045835          383 KISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYA  447 (511)
Q Consensus       383 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~  447 (511)
                      ||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus       201 kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          201 KIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             EECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999865432    22357899999999999999999999999999999999999999743

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=4e-39  Score=336.18  Aligned_cols=250  Identities=24%  Similarity=0.257  Sum_probs=184.1

Q ss_pred             CCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEEEEEEEecC
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQLLLVYEYME  319 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~  319 (511)
                      .|...+.||+|+||+||.+...+|+.||||++....   .+.+.+|+.+++++ +||||+++++++.+++..++||||+.
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            445568899999999987666679999999986532   35678999999876 89999999999999999999999996


Q ss_pred             CCCHhHHHhcCCCCCCC---CCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCC-------------CCeE
Q 045835          320 NNSLACALFGRENCELE---LDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD-------------LNPK  383 (511)
Q Consensus       320 ~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~-------------~~~k  383 (511)
                       |+|.+++.........   ..+..+..++.||+.||+|||+.+   |+||||||+|||++.+             +.+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence             6999999765432211   133456789999999999999986   9999999999999754             4899


Q ss_pred             EeecCCcccCCCCCce---eecccccCCCccccccccc-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccc
Q 045835          384 ISDFGLAKLDEGDKTH---ISTRIAGTIGYMAPEYALW-------GYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEF  452 (511)
Q Consensus       384 l~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~  452 (511)
                      |+|||+++........   ......||+.|+|||++.+       ..++.++|||||||++|||+| |+.||......  
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--  246 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR--  246 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH--
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh--
Confidence            9999999876543322   1223579999999999865       678999999999999999999 99998632210  


Q ss_pred             cccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          453 DCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       453 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                          ...........        +......+...+..+.+++.+||+.+|++|||+.||
T Consensus       247 ----~~~i~~~~~~~--------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ei  293 (434)
T 2rio_A          247 ----ESNIIRGIFSL--------DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV  293 (434)
T ss_dssp             ----HHHHHHTCCCC--------CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             ----HHHHhcCCCCc--------ccccccccccchHHHHHHHHHHhhCChhhCCCHHHH
Confidence                00000000000        011112245667889999999999999999999764

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=7.3e-40  Score=326.98  Aligned_cols=250  Identities=22%  Similarity=0.376  Sum_probs=191.6

Q ss_pred             HHHhcCCcccCceeccCceeEEeccccCCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEE
Q 045835          236 KAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       236 ~~~~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  313 (511)
                      ....++|++.+.||+|+||.||+|+..+  .+|+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  106 (319)
T 2y4i_B           29 DIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI  106 (319)
T ss_dssp             SSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred             cCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence            3345789999999999999999998753  49999987542  2334567889999999999999999999999999999


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      ||||+++++|.+++....   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++ ++.+||+|||+++..
T Consensus       107 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~  179 (319)
T 2y4i_B          107 ITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSIS  179 (319)
T ss_dssp             ECBCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred             EeecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence            999999999999996532   35899999999999999999999987   99999999999998 679999999998754


Q ss_pred             CCCC----ceeecccccCCCccccccccc---------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhh
Q 045835          394 EGDK----THISTRIAGTIGYMAPEYALW---------GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDW  460 (511)
Q Consensus       394 ~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~  460 (511)
                      ....    ........|+..|+|||.+..         ..++.++||||||+++|||++|+.||......        ..
T Consensus       180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------~~  251 (319)
T 2y4i_B          180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE--------AI  251 (319)
T ss_dssp             --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH--------HH
T ss_pred             ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HH
Confidence            2211    111223458999999999864         45789999999999999999999998643210        01


Q ss_pred             hHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          461 ACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       461 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..... .+     ..+..   .+......+.+++.+||+.+|++|||+.||
T Consensus       252 ~~~~~-~~-----~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l  293 (319)
T 2y4i_B          252 IWQMG-TG-----MKPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKL  293 (319)
T ss_dssp             HHHHH-TT-----CCCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHH
T ss_pred             HHHhc-cC-----CCCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence            10100 00     00101   111233468899999999999999999764

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=7.9e-39  Score=327.11  Aligned_cols=255  Identities=22%  Similarity=0.308  Sum_probs=191.5

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEE----
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQL----  311 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~----  311 (511)
                      .++|...+.||+|+||.||+|.. .+|+.||||++....  ......+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            36788999999999999999974 468999999997542  23346788999999999999999999999876654    


Q ss_pred             --EEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCC
Q 045835          312 --LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL  389 (511)
Q Consensus       312 --~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGl  389 (511)
                        ++||||+. ++|.+.+.      ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       121 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             eEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence              99999998 58887762      23899999999999999999999987   99999999999999999999999999


Q ss_pred             cccCCCCCceeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhh---
Q 045835          390 AKLDEGDKTHISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQ---  465 (511)
Q Consensus       390 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~---  465 (511)
                      ++.....    .....||+.|+|||.+.+ ..++.++|||||||+++||++|+.||.......    .+........   
T Consensus       191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i~~~~~~~~  262 (371)
T 4exu_A          191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD----QLTQILKVTGVPG  262 (371)
T ss_dssp             C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCC
T ss_pred             ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCc
Confidence            9854332    233568999999999887 689999999999999999999999997432110    0100000000   


Q ss_pred             -------ccCchhHhhhhhhCC---C---CCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          466 -------QDGKLVELVDERLGS---K---YKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       466 -------~~~~~~~~~d~~l~~---~---~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                             ...............   .   ........+.+|+.+||+.+|++|||+.|+
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  321 (371)
T 4exu_A          263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQA  321 (371)
T ss_dssp             HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred             HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHH
Confidence                   000000111110000   0   011235678999999999999999998764

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=9e-39  Score=326.12  Aligned_cols=259  Identities=21%  Similarity=0.305  Sum_probs=197.4

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCC-----------CCCceeEEEEEEe
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ-----------HPNLVKIHGCCVE  307 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-----------H~niv~l~g~~~~  307 (511)
                      ++|.+.+.||+|+||.||+|+. .+++.||||++... ......+.+|+.++++++           ||||+++++++..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            5799999999999999999975 57899999999743 233457889999998886           8999999999986


Q ss_pred             CC----EEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEEccCCCCCeEEc-----
Q 045835          308 GD----QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE-SRFKIVHRDIKATNVLLD-----  377 (511)
Q Consensus       308 ~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~iiH~Dlk~~NILld-----  377 (511)
                      .+    ..++||||+ +++|.+++.....  ..+++..+..++.||+.||+|||++ +   |+||||||+|||++     
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence            54    789999999 8899999976432  3489999999999999999999997 6   99999999999994     


Q ss_pred             -CCCCeEEeecCCcccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccc--cc
Q 045835          378 -RDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEF--DC  454 (511)
Q Consensus       378 -~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~--~~  454 (511)
                       ..+.+||+|||+++.....    .....||..|+|||.+.+..++.++|||||||++|||++|+.||........  +.
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  247 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  247 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             cCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence             4457999999999865432    2234689999999999999999999999999999999999999974321110  00


Q ss_pred             cchhhhhHhhhc-------cC----------------------chhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCC
Q 045835          455 TCLLDWACHLQQ-------DG----------------------KLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLR  505 (511)
Q Consensus       455 ~~l~~~~~~~~~-------~~----------------------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~R  505 (511)
                      ..+......+..       .+                      .+.+++..  ...++......+.+|+.+||+.||++|
T Consensus       248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R  325 (373)
T 1q8y_A          248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE--KYKFSKDEAKEISDFLSPMLQLDPRKR  325 (373)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH--TTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred             HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh--cccCCcchHHHHHHHHHHHhccCcccc
Confidence            001110000000       00                      01111111  224567788899999999999999999


Q ss_pred             CCcCCC
Q 045835          506 PTMSEV  511 (511)
Q Consensus       506 Ps~~eV  511 (511)
                      ||+.||
T Consensus       326 pt~~el  331 (373)
T 1q8y_A          326 ADAGGL  331 (373)
T ss_dssp             BCHHHH
T ss_pred             CCHHHH
Confidence            999764

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.8e-38  Score=319.75  Aligned_cols=257  Identities=19%  Similarity=0.236  Sum_probs=195.8

Q ss_pred             hcCCcccCceeccCceeEEecccc-C-CcEEEEEEecccCccchHHHHHHHHHHhcCCCCC------ceeEEEEEEeCCE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-D-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPN------LVKIHGCCVEGDQ  310 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~-g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~n------iv~l~g~~~~~~~  310 (511)
                      .++|++.+.||+|+||.||+|... + ++.||||+++.. ....+.+.+|+.+++.++|++      ++.+.+++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            368999999999999999999753 3 478999999743 233467888999999987766      9999999999999


Q ss_pred             EEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEE--------------
Q 045835          311 LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL--------------  376 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILl--------------  376 (511)
                      .++||||+ +++|.+++.....  ..+++..+..++.||+.||+|||+.+   |+||||||+|||+              
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             EEEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence            99999999 5677777755432  35899999999999999999999986   9999999999999              


Q ss_pred             -----cCCCCeEEeecCCcccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccc
Q 045835          377 -----DRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALE  451 (511)
Q Consensus       377 -----d~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~  451 (511)
                           +.++.+||+|||+++......    ....||..|+|||.+.+..++.++|||||||++|||++|+.||...... 
T Consensus       171 ~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-  245 (355)
T 2eu9_A          171 CEEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR-  245 (355)
T ss_dssp             CCEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-
T ss_pred             ccccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-
Confidence                 667899999999998644322    2357899999999999999999999999999999999999999743211 


Q ss_pred             ccccchhhhhHhhhcc-------------------------CchhHhhhhhh-----CCCCCHHHHHHHHHHHHHcCCCC
Q 045835          452 FDCTCLLDWACHLQQD-------------------------GKLVELVDERL-----GSKYKKEEAERMIKVSLLCTNAS  501 (511)
Q Consensus       452 ~~~~~l~~~~~~~~~~-------------------------~~~~~~~d~~l-----~~~~~~~~~~~l~~l~~~Cl~~~  501 (511)
                          ............                         ......+....     ...........+.+|+.+||+.|
T Consensus       246 ----~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  321 (355)
T 2eu9_A          246 ----EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD  321 (355)
T ss_dssp             ----HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred             ----HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence                001100000000                         00000000000     01122345668999999999999


Q ss_pred             CCCCCCcCCC
Q 045835          502 PSLRPTMSEV  511 (511)
Q Consensus       502 p~~RPs~~eV  511 (511)
                      |++|||+.||
T Consensus       322 P~~Rpt~~e~  331 (355)
T 2eu9_A          322 PAQRITLAEA  331 (355)
T ss_dssp             TTTSCCHHHH
T ss_pred             hhhCcCHHHH
Confidence            9999999764

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.6e-39  Score=320.44  Aligned_cols=241  Identities=23%  Similarity=0.383  Sum_probs=188.0

Q ss_pred             HHHhcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCcc------chHHHHHHHHHHhcC----CCCCceeEEEE
Q 045835          236 KAATNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQ------GNREFLNEIAMISCL----QHPNLVKIHGC  304 (511)
Q Consensus       236 ~~~~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~------~~~~~~~Ei~~l~~l----~H~niv~l~g~  304 (511)
                      ....++|++.+.||+|+||.||+|+. .+++.||||++......      ....+.+|+.++.++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            34457899999999999999999975 46889999999754321      223456789999888    89999999999


Q ss_pred             EEeCCEEEEEEEe-cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEc-CCCCe
Q 045835          305 CVEGDQLLLVYEY-MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD-RDLNP  382 (511)
Q Consensus       305 ~~~~~~~~lV~Ey-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld-~~~~~  382 (511)
                      +.+.+..++|+|+ +.+++|.+++....    .+++..+..++.|++.||+|||+.+   |+||||||+||+++ .++.+
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~  179 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA  179 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence            9999999999999 78999999997543    4899999999999999999999986   99999999999999 88999


Q ss_pred             EEeecCCcccCCCCCceeecccccCCCcccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhh
Q 045835          383 KISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYL-TYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWA  461 (511)
Q Consensus       383 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~  461 (511)
                      ||+|||+++......   .....|+..|+|||.+.+..+ +.++||||||+++|||++|+.||....             
T Consensus       180 kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------------  243 (312)
T 2iwi_A          180 KLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------------  243 (312)
T ss_dssp             EECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------
T ss_pred             EEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------------
Confidence            999999998655432   233568999999999887665 458999999999999999999985211             


Q ss_pred             HhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          462 CHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       462 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                                ++.+..  ...+......+.+++.+||+.+|++|||+.||
T Consensus       244 ----------~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~  281 (312)
T 2iwi_A          244 ----------EILEAE--LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEI  281 (312)
T ss_dssp             ----------HHHHTC--CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             ----------HHhhhc--cCCcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence                      011111  11223344578899999999999999999764

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.1e-39  Score=322.46  Aligned_cols=240  Identities=23%  Similarity=0.373  Sum_probs=195.3

Q ss_pred             HHhcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCcc------chHHHHHHHHHHhcCC--CCCceeEEEEEEe
Q 045835          237 AATNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQ------GNREFLNEIAMISCLQ--HPNLVKIHGCCVE  307 (511)
Q Consensus       237 ~~~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~------~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~  307 (511)
                      ...++|++.+.||+|+||.||+|+. .+++.||||++......      ....+.+|+.++++++  |+||+++++++.+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            3457799999999999999999974 57899999999754321      2245678999999996  5999999999999


Q ss_pred             CCEEEEEEEecCC-CCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEc-CCCCeEEe
Q 045835          308 GDQLLLVYEYMEN-NSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD-RDLNPKIS  385 (511)
Q Consensus       308 ~~~~~lV~Ey~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld-~~~~~kl~  385 (511)
                      .+..++|+|++.+ ++|.+++...    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++ +++.+||+
T Consensus       120 ~~~~~lv~e~~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          120 PDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred             CCcEEEEEEcCCCCccHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence            9999999999986 8999998653    25899999999999999999999987   99999999999999 77899999


Q ss_pred             ecCCcccCCCCCceeecccccCCCcccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhh
Q 045835          386 DFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYL-TYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHL  464 (511)
Q Consensus       386 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~  464 (511)
                      |||+++......   .....||..|+|||.+....+ +.++||||||+++|||++|+.||....                
T Consensus       193 Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----------------  253 (320)
T 3a99_A          193 DFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------------  253 (320)
T ss_dssp             CCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------------
T ss_pred             eCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----------------
Confidence            999998654322   223568999999999887665 788999999999999999999986311                


Q ss_pred             hccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          465 QQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       465 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                             ++....  ...+......+.+++.+||+.+|++|||+.||
T Consensus       254 -------~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l  291 (320)
T 3a99_A          254 -------EIIRGQ--VFFRQRVSSECQHLIRWCLALRPSDRPTFEEI  291 (320)
T ss_dssp             -------HHHHCC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             -------hhhccc--ccccccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence                   000000  01122234568899999999999999999864

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.3e-38  Score=321.00  Aligned_cols=250  Identities=22%  Similarity=0.247  Sum_probs=170.1

Q ss_pred             hcCCcccC-ceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEe----CCEEE
Q 045835          239 TNNFDSAK-KIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVE----GDQLL  312 (511)
Q Consensus       239 ~~~f~~~~-~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~  312 (511)
                      .++|.+.+ .||+|+||.||+|... +++.||||++....    ....+....++.++||||+++++++..    +...+
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            46788855 6999999999999765 68999999986431    122223334667799999999999976    44589


Q ss_pred             EEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcC---CCCeEEeecCC
Q 045835          313 LVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR---DLNPKISDFGL  389 (511)
Q Consensus       313 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~---~~~~kl~DfGl  389 (511)
                      +||||+++|+|.+++.....  ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.   ++.+||+|||+
T Consensus       103 lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence            99999999999999976432  45899999999999999999999987   999999999999986   45599999999


Q ss_pred             cccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCc
Q 045835          390 AKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGK  469 (511)
Q Consensus       390 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  469 (511)
                      ++......   .....||+.|+|||.+....++.++||||||+++|||++|+.||.........    ..... .     
T Consensus       178 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~~~~-~-----  244 (336)
T 3fhr_A          178 AKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS----PGMKR-R-----  244 (336)
T ss_dssp             CEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred             ceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh----hhHHH-h-----
Confidence            98654322   22346899999999998888999999999999999999999999643211000    00000 0     


Q ss_pred             hhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          470 LVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       470 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                       ................+..+.+++.+||+.+|++|||+.|+
T Consensus       245 -~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  285 (336)
T 3fhr_A          245 -IRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQF  285 (336)
T ss_dssp             -------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             -hhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence             00000001111112345678999999999999999999764

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.8e-38  Score=322.03  Aligned_cols=253  Identities=22%  Similarity=0.308  Sum_probs=191.4

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCE------
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQ------  310 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~------  310 (511)
                      ++|...+.||+|+||.||+|.. .+|+.||||++....  ......+.+|+.+++.++||||+++++++.....      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            5788999999999999999975 468999999997542  2334578899999999999999999999987653      


Q ss_pred             EEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCc
Q 045835          311 LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA  390 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla  390 (511)
                      .++||||+. ++|.+++.      ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             EEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence            499999998 58877763      23899999999999999999999987   999999999999999999999999999


Q ss_pred             ccCCCCCceeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhc---
Q 045835          391 KLDEGDKTHISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQ---  466 (511)
Q Consensus       391 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~---  466 (511)
                      +.....    .....+|..|+|||.+.+ ..++.++|||||||+++||++|+.||......     ...........   
T Consensus       174 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~~~~i~~~~~~~~  244 (353)
T 3coi_A          174 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-----DQLTQILKVTGVPG  244 (353)
T ss_dssp             TC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH-----HHHHHHHHHHCBCC
T ss_pred             cCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCCCC
Confidence            864322    223468999999999886 68899999999999999999999999643211     01110000000   


Q ss_pred             --------cCchhHhhhhh---hC---CCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          467 --------DGKLVELVDER---LG---SKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       467 --------~~~~~~~~d~~---l~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                              .......+...   ..   ..........+.+++.+||+.||++|||+.|+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~  303 (353)
T 3coi_A          245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQA  303 (353)
T ss_dssp             HHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred             HHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHH
Confidence                    00000111100   00   11122445678999999999999999998764

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.8e-38  Score=342.69  Aligned_cols=259  Identities=26%  Similarity=0.328  Sum_probs=199.0

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEeccc-CccchHHHHHHHHHHhcCCCCCceeEEEEEEe------CCEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK-SRQGNREFLNEIAMISCLQHPNLVKIHGCCVE------GDQL  311 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------~~~~  311 (511)
                      ++|++.++||+|+||.||+|.. .+|+.||||+++.. .......+.+|+.++++++||||+++++++..      ++..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            6899999999999999999976 46889999998754 33445678999999999999999999999765      6678


Q ss_pred             EEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCC---eEEeecC
Q 045835          312 LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN---PKISDFG  388 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~---~kl~DfG  388 (511)
                      ++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.   +||+|||
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence            999999999999999976443 235889999999999999999999987   999999999999997765   8999999


Q ss_pred             CcccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccC
Q 045835          389 LAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDG  468 (511)
Q Consensus       389 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~  468 (511)
                      +++.......  .....||..|+|||.+.+..++.++||||||+++|||++|+.||....       ....|........
T Consensus       170 ~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~-------~~~~~~~~i~~~~  240 (676)
T 3qa8_A          170 YAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW-------QPVQWHGKVREKS  240 (676)
T ss_dssp             CCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC-------HHHHSSTTCC---
T ss_pred             cccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc-------chhhhhhhhhccc
Confidence            9986544322  234578999999999999999999999999999999999999996321       1122221111111


Q ss_pred             chhHhhhh------------hhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          469 KLVELVDE------------RLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       469 ~~~~~~d~------------~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ........            ..........+..+.+++.+||+.||++|||+.|+
T Consensus       241 ~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el  295 (676)
T 3qa8_A          241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN  295 (676)
T ss_dssp             ---CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred             chhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence            11000000            01122345567889999999999999999999874

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2e-38  Score=330.49  Aligned_cols=247  Identities=23%  Similarity=0.273  Sum_probs=183.7

Q ss_pred             hcCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEEEEEEEe
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      ..+|...++||+|+||+|+.....+++.||||++.....   ..+.+|+.+|+.+ +||||+++++++.+....++||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            356888899999999996655455789999999965432   2356899999999 899999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcC-----CCCeEEeecCCccc
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR-----DLNPKISDFGLAKL  392 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~-----~~~~kl~DfGla~~  392 (511)
                      +. |+|.+++.....   .+.+.....++.||+.||+|||+.+   |+||||||+|||++.     ...+||+|||+++.
T Consensus       100 ~~-g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~  172 (432)
T 3p23_A          100 CA-ATLQEYVEQKDF---AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK  172 (432)
T ss_dssp             CS-EEHHHHHHSSSC---CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred             CC-CCHHHHHHhcCC---CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence            97 599999975432   3455567789999999999999987   999999999999953     34688999999986


Q ss_pred             CCCCCc--eeecccccCCCcccccccc---cCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhc
Q 045835          393 DEGDKT--HISTRIAGTIGYMAPEYAL---WGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQ  466 (511)
Q Consensus       393 ~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~  466 (511)
                      ......  .......||+.|+|||++.   ...++.++|||||||+++||+| |+.||.....         ........
T Consensus       173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~---------~~~~~~~~  243 (432)
T 3p23_A          173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ---------RQANILLG  243 (432)
T ss_dssp             C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT---------HHHHHHTT
T ss_pred             ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH---------HHHHHHhc
Confidence            543321  1223457999999999987   4577889999999999999999 8888853210         00000000


Q ss_pred             cCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          467 DGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       467 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ....     +  ...........+.+++.+||+.+|++|||+.||
T Consensus       244 ~~~~-----~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ev  281 (432)
T 3p23_A          244 ACSL-----D--CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHV  281 (432)
T ss_dssp             CCCC-----T--TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             cCCc-----c--ccCccccccHHHHHHHHHHHhCCHhhCCCHHHH
Confidence            0000     0  001122345568899999999999999999764

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.3e-38  Score=315.77  Aligned_cols=248  Identities=23%  Similarity=0.351  Sum_probs=175.1

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCc-cc-hHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR-QG-NREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~-~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      .++|+..+.||+|+||.||+|+.. +|+.||||++..... .. .+.+.++..+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            357888999999999999999864 689999999975432 22 233445556788899999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE-SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      ||+ ++.+..+....   ...+++..+..++.|++.||+|||+. +   |+||||||+|||++.++.+||+|||++....
T Consensus       104 e~~-~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  176 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLV  176 (318)
T ss_dssp             CCC-SEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             ecc-CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence            999 44555554322   23589999999999999999999985 6   9999999999999999999999999997554


Q ss_pred             CCCceeecccccCCCcccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCc
Q 045835          395 GDKTHISTRIAGTIGYMAPEYAL-----WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGK  469 (511)
Q Consensus       395 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  469 (511)
                      ....  .....||..|+|||.+.     ...++.++||||||+++|||++|+.||......       .+...       
T Consensus       177 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~-------  240 (318)
T 2dyl_A          177 DDKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-------FEVLT-------  240 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-------HHHHH-------
T ss_pred             CCcc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-------HHHHH-------
Confidence            3222  23346899999999984     557899999999999999999999998642210       01100       


Q ss_pred             hhHhhhhhh-CCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          470 LVELVDERL-GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       470 ~~~~~d~~l-~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                        .+..... ...........+.+++.+||+.+|.+|||+.||
T Consensus       241 --~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  281 (318)
T 2dyl_A          241 --KVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKL  281 (318)
T ss_dssp             --HHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred             --HHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence              1111100 000111234568899999999999999998764

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1e-37  Score=343.48  Aligned_cols=230  Identities=21%  Similarity=0.269  Sum_probs=186.3

Q ss_pred             hcCCcccCceeccCceeEEecccc--CCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCE-----
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA--DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQ-----  310 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~--~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-----  310 (511)
                      .++|++.+.||+|+||.||+|...  +++.||||++.... ......+.+|+.++++++||||++++++|...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            368999999999999999999764  68999999986543 3344578899999999999999999999987655     


Q ss_pred             EEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCc
Q 045835          311 LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA  390 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla  390 (511)
                      .++||||+++++|.+++..      .++|..++.++.||+.||+|||+++   |+||||||+|||++.+ .+||+|||++
T Consensus       159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a  228 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAV  228 (681)
T ss_dssp             EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred             eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccc
Confidence            7999999999999887632      4899999999999999999999987   9999999999999986 8999999999


Q ss_pred             ccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCch
Q 045835          391 KLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKL  470 (511)
Q Consensus       391 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  470 (511)
                      +.....     ....||+.|+|||++.++. +.++|||||||+++||++|.+|+.....     ..+.            
T Consensus       229 ~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~-----~~~~------------  285 (681)
T 2pzi_A          229 SRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV-----DGLP------------  285 (681)
T ss_dssp             EETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC-----SSCC------------
T ss_pred             hhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc-----cccc------------
Confidence            865433     3356899999999987654 8999999999999999999887652110     0000            


Q ss_pred             hHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcC
Q 045835          471 VELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMS  509 (511)
Q Consensus       471 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~  509 (511)
                              ...........+.+++.+||+.+|++||+..
T Consensus       286 --------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~  316 (681)
T 2pzi_A          286 --------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTA  316 (681)
T ss_dssp             --------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSH
T ss_pred             --------ccccccccCHHHHHHHhhhccCChhhCCCHH
Confidence                    0000112335688999999999999999754

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.9e-37  Score=319.08  Aligned_cols=240  Identities=15%  Similarity=0.114  Sum_probs=177.4

Q ss_pred             hcCCcccCceeccCceeEEecc-ccCCcEEEEEEecccCc---cchHHHHHHHHHHhcCCC-CCc---------eeEE--
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSR---QGNREFLNEIAMISCLQH-PNL---------VKIH--  302 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H-~ni---------v~l~--  302 (511)
                      +.+|...+.||+|+||.||+|+ ..+|+.||||++.....   ...+.+.+|+.+++.++| +|.         +...  
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            3457778899999999999998 55789999999874322   335779999999999987 221         1111  


Q ss_pred             ----------EEEEe-----CCEEEEEEEecCCCCHhHHHhcC---CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 045835          303 ----------GCCVE-----GDQLLLVYEYMENNSLACALFGR---ENCELELDWPTRQKICLGIARGLAFLHEESRFKI  364 (511)
Q Consensus       303 ----------g~~~~-----~~~~~lV~Ey~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~i  364 (511)
                                .++..     ....+++|+++ +++|.+++...   ......+++..++.++.|++.||+|||+.+   |
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence                      11111     12356677755 67999888421   222345889999999999999999999987   9


Q ss_pred             EEccCCCCCeEEcCCCCeEEeecCCcccCCCCCceeecccccCCCccccccc----------ccCCCCcchhHHHHHHHH
Q 045835          365 VHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYA----------LWGYLTYKADVYSFGIVA  434 (511)
Q Consensus       365 iH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DV~S~Gvvl  434 (511)
                      +||||||+|||++.++.+||+|||+++.....    .....| +.|+|||++          ....++.++|||||||++
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            99999999999999999999999999864322    334567 999999998          555688999999999999


Q ss_pred             HHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCC
Q 045835          435 LEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSE  510 (511)
Q Consensus       435 ~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e  510 (511)
                      |||+||+.||.......     .            ...++..  ...+    +..+.+|+.+||+.+|++|||+.|
T Consensus       308 ~elltg~~Pf~~~~~~~-----~------------~~~~~~~--~~~~----~~~~~~li~~~l~~dP~~Rpt~~~  360 (413)
T 3dzo_A          308 YWIWCADLPNTDDAALG-----G------------SEWIFRS--CKNI----PQPVRALLEGFLRYPKEDRLLPLQ  360 (413)
T ss_dssp             HHHHHSSCCCCTTGGGS-----C------------SGGGGSS--CCCC----CHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHCCCCCCCcchhh-----h------------HHHHHhh--cccC----CHHHHHHHHHHccCChhhCcCHHH
Confidence            99999999996432110     0            0011110  0122    356899999999999999999865

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=7.4e-36  Score=295.75  Aligned_cols=224  Identities=21%  Similarity=0.306  Sum_probs=174.5

Q ss_pred             cCCccc-CceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHH-hcCCCCCceeEEEEEEe----CCEEE
Q 045835          240 NNFDSA-KKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMI-SCLQHPNLVKIHGCCVE----GDQLL  312 (511)
Q Consensus       240 ~~f~~~-~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l-~~l~H~niv~l~g~~~~----~~~~~  312 (511)
                      ++|.+. +.||+|+||.||++.. .+++.||+|++..     ...+.+|+.++ +.++||||+++++++..    ....+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            456666 7799999999999975 4689999999864     24677888887 66699999999999987    66789


Q ss_pred             EEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcC---CCCeEEeecCC
Q 045835          313 LVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR---DLNPKISDFGL  389 (511)
Q Consensus       313 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~---~~~~kl~DfGl  389 (511)
                      +||||+++|+|.+++.....  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.   ++.+||+|||+
T Consensus        92 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~  166 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  166 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence            99999999999999976432  35899999999999999999999987   999999999999998   78899999999


Q ss_pred             cccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCc
Q 045835          390 AKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGK  469 (511)
Q Consensus       390 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  469 (511)
                      +.....                       ..++.++|||||||++|||++|+.||..........              .
T Consensus       167 a~~~~~-----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~--------------~  209 (299)
T 3m2w_A          167 AKETTG-----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--------------G  209 (299)
T ss_dssp             CEECTT-----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C--------------C
T ss_pred             cccccc-----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH--------------H
Confidence            974321                       346779999999999999999999996432111000              0


Q ss_pred             hhHhhhhhhCCCCC----HHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          470 LVELVDERLGSKYK----KEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       470 ~~~~~d~~l~~~~~----~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +...+... ....+    ...+..+.+++.+||+.+|++|||+.|+
T Consensus       210 ~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~  254 (299)
T 3m2w_A          210 MKTRIRMG-QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF  254 (299)
T ss_dssp             SCCSSCTT-CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HHHHHhhc-cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHH
Confidence            00000000 00111    1234578999999999999999999764

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.6e-36  Score=296.42  Aligned_cols=222  Identities=11%  Similarity=0.051  Sum_probs=173.3

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEecccCc---cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR---QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|++.+.||+|+||.||+|+.. +++.||||++.....   ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            57999999999999999999864 589999999976533   23367899999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++++|.+++...      .......+++.|++.||+|||+++   |+||||||+|||++.++.+||++++       
T Consensus       111 e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-------  174 (286)
T ss_dssp             ECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred             EecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence            999999999998432      345578889999999999999987   9999999999999999999997442       


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                                    |++|       ++.++|||||||++|||+||+.||........    +.......  .+....  .
T Consensus       175 --------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~----~~~~~~~~--~~~~~~--~  225 (286)
T 3uqc_A          175 --------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSG----LAPAERDT--AGQPIE--P  225 (286)
T ss_dssp             --------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC----SEECCBCT--TSCBCC--H
T ss_pred             --------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchh----hHHHHHHh--ccCCCC--h
Confidence                          4433       68899999999999999999999975432110    00000000  000000  0


Q ss_pred             hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       476 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....    ..+..+.+++.+||+.||++| |+.|+
T Consensus       226 ~~~~~----~~~~~l~~li~~~l~~dP~~R-s~~el  256 (286)
T 3uqc_A          226 ADIDR----DIPFQISAVAARSVQGDGGIR-SASTL  256 (286)
T ss_dssp             HHHCT----TSCHHHHHHHHHHHCTTSSCC-CHHHH
T ss_pred             hhccc----CCCHHHHHHHHHHcccCCccC-CHHHH
Confidence            01111    233568999999999999999 98764

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=8.3e-36  Score=300.36  Aligned_cols=231  Identities=21%  Similarity=0.239  Sum_probs=179.0

Q ss_pred             hcCCcccCceeccCceeEEeccccCCcEEEEEEecccC--------ccchHHHHHHHHHHhcCC---------CCCceeE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKS--------RQGNREFLNEIAMISCLQ---------HPNLVKI  301 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~--------~~~~~~~~~Ei~~l~~l~---------H~niv~l  301 (511)
                      .++|++.++||+|+||.||+|+. +|+.||||++....        ....+.+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            35688999999999999999987 68999999997542        223367889999998885         8888888


Q ss_pred             EEEEE------------------------------eCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHH
Q 045835          302 HGCCV------------------------------EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIAR  351 (511)
Q Consensus       302 ~g~~~------------------------------~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~  351 (511)
                      .+++.                              +.+..++||||+++|++.+.+..     ..+++..+..++.||+.
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTA  172 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHH
Confidence            88754                              26789999999999977666633     24899999999999999


Q ss_pred             HHHHHh-cCCCCCeEEccCCCCCeEEcCCC--------------------CeEEeecCCcccCCCCCceeecccccCCCc
Q 045835          352 GLAFLH-EESRFKIVHRDIKATNVLLDRDL--------------------NPKISDFGLAKLDEGDKTHISTRIAGTIGY  410 (511)
Q Consensus       352 gl~yLH-~~~~~~iiH~Dlk~~NILld~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y  410 (511)
                      ||+||| +.+   |+||||||+|||++.++                    .+||+|||+++.....      ...||+.|
T Consensus       173 aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y  243 (336)
T 2vuw_A          173 SLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVS  243 (336)
T ss_dssp             HHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCT
T ss_pred             HHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecc
Confidence            999999 776   99999999999999887                    8999999999865432      23689999


Q ss_pred             ccccccccCCCCcchhHHHHHHH-HHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhh-----hhCCCCCH
Q 045835          411 MAPEYALWGYLTYKADVYSFGIV-ALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDE-----RLGSKYKK  484 (511)
Q Consensus       411 ~aPE~~~~~~~~~~~DV~S~Gvv-l~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~-----~l~~~~~~  484 (511)
                      +|||.+.+.. +.++||||+|++ .+++++|..||..           ..|....     ...++..     ......+.
T Consensus       244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~-----------~~~~~~~-----~~~~~~~~~~~~~~~~~~~~  306 (336)
T 2vuw_A          244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN-----------VLWLHYL-----TDKMLKQMTFKTKCNTPAMK  306 (336)
T ss_dssp             TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH-----------HHHHHHH-----HHHHHHTCCCSSCCCSHHHH
T ss_pred             cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc-----------hhhhhHH-----HHhhhhhhccCcccchhhhh
Confidence            9999998766 899999998777 7778888887731           1121111     0111110     01111234


Q ss_pred             HHHHHHHHHHHHcCCCC
Q 045835          485 EEAERMIKVSLLCTNAS  501 (511)
Q Consensus       485 ~~~~~l~~l~~~Cl~~~  501 (511)
                      ..+.++.+|+.+||+.+
T Consensus       307 ~~s~~~~dli~~~L~~d  323 (336)
T 2vuw_A          307 QIKRKIQEFHRTMLNFS  323 (336)
T ss_dssp             HHHHHHHHHHHHGGGSS
T ss_pred             hcCHHHHHHHHHHhccC
Confidence            56788999999999976

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=8.3e-30  Score=273.72  Aligned_cols=183  Identities=18%  Similarity=0.131  Sum_probs=128.2

Q ss_pred             ceeccCceeEEecc-ccCCcEEEEEEecccC----------ccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEEEEE
Q 045835          247 KIGEGGFGPVYKGQ-LADGTIIAVKQLSSKS----------RQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       247 ~lG~G~fG~Vy~g~-~~~g~~vAvK~~~~~~----------~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV  314 (511)
                      ..+.|++|.+..++ ..-|+.+|+|.+....          ....++|.+|+++|+++ .|+||++++++++++...|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            45667777666553 3357889999996542          12335799999999999 799999999999999999999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      |||++|++|.+.|....    .++..   +|+.||+.||+|||+++   ||||||||+||||++++.+||+|||+|+...
T Consensus       321 MEyv~G~~L~d~i~~~~----~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~  390 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGE----EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTP  390 (569)
T ss_dssp             EECCCSEEHHHHHHTTC----CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred             EecCCCCcHHHHHHhCC----CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence            99999999999997543    35543   58999999999999997   9999999999999999999999999998665


Q ss_pred             CCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCC
Q 045835          395 GDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK  441 (511)
Q Consensus       395 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~  441 (511)
                      .... .....+||+.|||||++.+ .+..++|+||+|++++++.++.
T Consensus       391 ~~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          391 QDCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             ---C-CSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred             CCCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhcccc
Confidence            4332 2334679999999998875 4677899999999988775543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=4e-27  Score=251.42  Aligned_cols=184  Identities=15%  Similarity=0.161  Sum_probs=145.8

Q ss_pred             cccCceeccCceeEEeccccCCcEEEEEEecccCcc--------chHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEE
Q 045835          243 DSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQ--------GNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       243 ~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~--------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  314 (511)
                      ...++||+|+||.||+|.. .+..+++|+.......        ..+.+.+|+.++++++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3467899999999999955 4678899986543211        134589999999999999999777777788888999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      |||+++++|.+++..            +..++.|++.||+|||+++   |+||||||+|||++.  .+||+|||+++...
T Consensus       418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~  480 (540)
T 3en9_A          418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISN  480 (540)
T ss_dssp             EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred             EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECC
Confidence            999999999999853            4579999999999999987   999999999999999  99999999999765


Q ss_pred             CCCce------eecccccCCCccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCC
Q 045835          395 GDKTH------ISTRIAGTIGYMAPEYALW--GYLTYKADVYSFGIVALEIVSGKNNM  444 (511)
Q Consensus       395 ~~~~~------~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~Gvvl~elltG~~p~  444 (511)
                      .....      ......||+.|||||++..  ..|+..+|+||..+-.++.+.++.++
T Consensus       481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            43221      1234679999999999986  56788899999999999988887765

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.89  E-value=7.4e-24  Score=207.77  Aligned_cols=153  Identities=18%  Similarity=0.085  Sum_probs=121.1

Q ss_pred             HHHHHHHhcCCcccCceeccCceeEEeccccCCcEEEEEEecccCc------------------cchHHHHHHHHHHhcC
Q 045835          232 LKQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSR------------------QGNREFLNEIAMISCL  293 (511)
Q Consensus       232 ~~~l~~~~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~------------------~~~~~~~~Ei~~l~~l  293 (511)
                      +..+......|.+.+.||+|+||.||+|...+|+.||||.++....                  .....+.+|+.+++++
T Consensus        82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l  161 (282)
T 1zar_A           82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL  161 (282)
T ss_dssp             HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence            3444445566778899999999999999887799999999964321                  1245688999999999


Q ss_pred             CCCCceeEEEEEEeCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCC
Q 045835          294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATN  373 (511)
Q Consensus       294 ~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~N  373 (511)
                      +  | +++.+++.. +..++||||+++++|.+ +..          .....++.|++.||+|||+.+   |+||||||+|
T Consensus       162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~N  223 (282)
T 1zar_A          162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYN  223 (282)
T ss_dssp             T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTS
T ss_pred             c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHH
Confidence            9  4 566665543 45699999999999987 411          123469999999999999987   9999999999


Q ss_pred             eEEcCCCCeEEeecCCcccCCCCCceeecccccCCCcccccccc
Q 045835          374 VLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYAL  417 (511)
Q Consensus       374 ILld~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~  417 (511)
                      ||++ ++.+||+|||+++.              +..++|||++.
T Consensus       224 ILl~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~  252 (282)
T 1zar_A          224 VLVS-EEGIWIIDFPQSVE--------------VGEEGWREILE  252 (282)
T ss_dssp             EEEE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred             EEEE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence            9999 99999999999973              23478899764

>2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A*

Probab=99.83  E-value=3.1e-21  Score=174.67  Aligned_cols=114  Identities=19%  Similarity=0.254  Sum_probs=95.0

Q ss_pred             CchhhhhhhccCCcceeEeecccCCceeEEEeeeeeeeccccceeecccceEEEEEecccccccccchhhhhcCCCccce
Q 045835           50 GLSELYINARIAPLSLTYFGYCLDNGNYTLSLHFAEIQFSNGITFHSLGRRLFDIYIQDNLVERNFDIKAEASGVLKPVA  129 (511)
Q Consensus        50 ~~~~ly~~~r~~~~~~t~~~~~~~~~~y~v~lhfae~~~~~~~~~~~~g~r~fdiyi~~~~~~~~~~i~~~~~g~~~~~~  129 (511)
                      .|+.||+|||.++.++||++||++||+|+|||||||+.++      ++|+|+|||||||+.++++|||.+++++ ..++.
T Consensus        52 ~~~~lY~TaR~~~~~~tY~f~v~~~G~Y~VrLhF~ei~~~------~~~~rvFdV~ing~~~l~~fdi~~~ag~-~~~~~  124 (174)
T 2jwp_A           52 EDQVLYQTERYNEDSFGYDIPIKEEGEYVLVLKFAEVYFA------QSQQKVFDVRVNGHTVVKDLDIFDRVGH-STAHD  124 (174)
T ss_dssp             HHHHTTTCCCCCCSCEEEEEECCSCEEEEEEEEEECCSCC------CSSSSCEEEEETTEEEEEEECHHHHHSS-SSCEE
T ss_pred             CCchhhhhhccCCCCeEEEEEeCCCeEEEEEEEEeccccC------CCCCeEeEEEECCEEeecCcCHHHhhCC-CeeEE
Confidence            5788999999999999999999999999999999999643      4899999999999999999999999987 78999


Q ss_pred             eeeeeeeeceeeEEEEEEC-CCCCccC---CCCCcCCCcccccccC
Q 045835          130 RSYNVTVTNHIIEIRFHWA-GKGTTAL---PKRGIYGPLVSAISLN  171 (511)
Q Consensus       130 ~~f~v~v~~~~~~i~~~~~-g~~~~~~---p~~~~~~p~~~~~~~~  171 (511)
                      ++|.+.|+++.++|+..|+ +.+...+   |. ...+|+++++.+-
T Consensus       125 ~~~~~~v~~~~l~i~~~~~~~~g~L~I~f~p~-~~~~a~inaIEI~  169 (174)
T 2jwp_A          125 EIIPISIKKGKLSVQGEVSTFTGKLSVEFVKG-YYDNPKVCALFIM  169 (174)
T ss_dssp             EEEEEEEETTEEEETTEEEECCSEEEEEEECS-SSCSSSEEEEEEE
T ss_pred             EEEEEEEecCceeeeeeecccCCeEEEEEecc-CCCCcEEEEEEEE
Confidence            9999998877777766664 3333222   22 2467888888764

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.79  E-value=8e-20  Score=176.69  Aligned_cols=137  Identities=17%  Similarity=0.096  Sum_probs=106.1

Q ss_pred             CCcccCceeccCceeEEeccc-cCCcE--EEEEEecccCcc------------------------chHHHHHHHHHHhcC
Q 045835          241 NFDSAKKIGEGGFGPVYKGQL-ADGTI--IAVKQLSSKSRQ------------------------GNREFLNEIAMISCL  293 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~-~~g~~--vAvK~~~~~~~~------------------------~~~~~~~Ei~~l~~l  293 (511)
                      -|++.+.||+|+||.||+|.. .+|+.  ||||+++.....                        ....+.+|+..|.++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            356788999999999999987 68888  999987543111                        113678999999999


Q ss_pred             CCCCc--eeEEEEEEeCCEEEEEEEecCC-C----CHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCeE
Q 045835          294 QHPNL--VKIHGCCVEGDQLLLVYEYMEN-N----SLACALFGRENCELELDWPTRQKICLGIARGLAFLH-EESRFKIV  365 (511)
Q Consensus       294 ~H~ni--v~l~g~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH-~~~~~~ii  365 (511)
                      +|+++  ..++++    +..++||||+.+ |    +|.++...       .++.....++.|++.||.||| +.+   |+
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g---iv  193 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE---LV  193 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence            88764  334432    246899999942 4    66665422       224467789999999999999 876   99


Q ss_pred             EccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          366 HRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       366 H~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      ||||||+|||++.  .++|+|||++...
T Consensus       194 HrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          194 HADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             eCCCCHHHEEEcC--cEEEEECcccccC
Confidence            9999999999998  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.64  E-value=6.2e-17  Score=163.44  Aligned_cols=145  Identities=13%  Similarity=0.151  Sum_probs=102.3

Q ss_pred             HHHHHhcCCcccCceeccCceeEEeccccCCcEEEEEEecccCc--------------cchHH--------HHHHHHHHh
Q 045835          234 QIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSR--------------QGNRE--------FLNEIAMIS  291 (511)
Q Consensus       234 ~l~~~~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~--------------~~~~~--------~~~Ei~~l~  291 (511)
                      .+.....-|.+.++||+|+||.||+|...+|+.||||+++....              .....        ...|...|.
T Consensus        89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~  168 (397)
T 4gyi_A           89 THAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK  168 (397)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence            33333334889999999999999999988899999998753210              00111        234566666


Q ss_pred             cCCCCCceeEEEEEEeCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCC
Q 045835          292 CLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKA  371 (511)
Q Consensus       292 ~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~  371 (511)
                      ++.+.++....-+...  ..++||||+++++|..+..        .  +....++.|++.+|.|||+.+   ||||||||
T Consensus       169 rL~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~--------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp  233 (397)
T 4gyi_A          169 ALYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSS--------V--PDPASLYADLIALILRLAKHG---LIHGDFNE  233 (397)
T ss_dssp             HHHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCC--------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCST
T ss_pred             HHHhcCCCCCeeeecc--CceEEEEecCCccHhhhcc--------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCH
Confidence            6654443222112122  2379999999988865431        1  123568899999999999987   99999999


Q ss_pred             CCeEEcCCC----------CeEEeecCCcccC
Q 045835          372 TNVLLDRDL----------NPKISDFGLAKLD  393 (511)
Q Consensus       372 ~NILld~~~----------~~kl~DfGla~~~  393 (511)
                      .|||+++++          .+.|+||+-+...
T Consensus       234 ~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          234 FNILIREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             TSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             HHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence            999998876          3899999988643

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.33  E-value=5.7e-12  Score=121.32  Aligned_cols=146  Identities=14%  Similarity=0.091  Sum_probs=114.1

Q ss_pred             HHHhcCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCC-CCCceeEEEEEEeCCEEEEE
Q 045835          236 KAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ-HPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       236 ~~~~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV  314 (511)
                      ...-..|.....++.|+.+.||+.... +..+++|+...........+.+|+.+++.+. |.++.++++++.+.+..++|
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            334457887888888889999998754 6789999987532233346889999999884 67788999999999999999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES----------------------------------  360 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~----------------------------------  360 (511)
                      |||+++.+|.+.+..         ......++.+++++|+.||+..                                  
T Consensus        89 ~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T 3tm0_A           89 MSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred             EEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence            999999998876311         1223478889999999999821                                  


Q ss_pred             ----------------------CCCeEEccCCCCCeEEcCCCCeEEeecCCcc
Q 045835          361 ----------------------RFKIVHRDIKATNVLLDRDLNPKISDFGLAK  391 (511)
Q Consensus       361 ----------------------~~~iiH~Dlk~~NILld~~~~~kl~DfGla~  391 (511)
                                            ...++|+|+++.|||++++..+.|.||+.+.
T Consensus       160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                  1348999999999999876667799998775

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.16  E-value=3.4e-11  Score=115.25  Aligned_cols=136  Identities=17%  Similarity=0.147  Sum_probs=100.4

Q ss_pred             CCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCC--ceeEEEEEEeCCEEEEEEEec
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPN--LVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      .+......+.|..+.||+....+|..+++|.....   ....+.+|+.+++.+.+.+  +.+++++...++..++||||+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            44443333456669999998777888999997643   2245778999999886544  456888888878899999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--------------------------------------
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES--------------------------------------  360 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~--------------------------------------  360 (511)
                      ++.+|.  .. .      .+   ...++.++++.|..||+..                                      
T Consensus        98 ~G~~l~--~~-~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (264)
T 1nd4_A           98 PGQDLL--SS-H------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL  165 (264)
T ss_dssp             SSEETT--TS-C------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred             CCcccC--cC-c------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence            998874  21 1      11   2356777888888888643                                      


Q ss_pred             -----------------CCCeEEccCCCCCeEEcCCCCeEEeecCCcc
Q 045835          361 -----------------RFKIVHRDIKATNVLLDRDLNPKISDFGLAK  391 (511)
Q Consensus       361 -----------------~~~iiH~Dlk~~NILld~~~~~kl~DfGla~  391 (511)
                                       ...++|+|++|.|||++++..+.|.||+.+.
T Consensus       166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                             1229999999999999887667899999886

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.99  E-value=7.1e-10  Score=111.83  Aligned_cols=142  Identities=16%  Similarity=0.223  Sum_probs=106.1

Q ss_pred             ccCceeccCceeEEeccccCCcEEEEEEec--ccC-ccchHHHHHHHHHHhcCC--CCCceeEEEEEEeC---CEEEEEE
Q 045835          244 SAKKIGEGGFGPVYKGQLADGTIIAVKQLS--SKS-RQGNREFLNEIAMISCLQ--HPNLVKIHGCCVEG---DQLLLVY  315 (511)
Q Consensus       244 ~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~--~~~-~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~---~~~~lV~  315 (511)
                      ..+.|+.|.++.||+....+ ..+++|+..  ... ......+.+|..+++.+.  +.++.+++.++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            35678999999999988754 567788765  322 122346788999999887  45678899988776   3478999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES-----------------------------------  360 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~-----------------------------------  360 (511)
                      ||+++..+.+..      ...++...+..++.++++.|+.||+..                                   
T Consensus       121 e~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          121 EFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             ECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             EecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            999988774321      123678888899999999999999831                                   


Q ss_pred             --------------------CCCeEEccCCCCCeEEcCCCC--eEEeecCCccc
Q 045835          361 --------------------RFKIVHRDIKATNVLLDRDLN--PKISDFGLAKL  392 (511)
Q Consensus       361 --------------------~~~iiH~Dlk~~NILld~~~~--~kl~DfGla~~  392 (511)
                                          ...++|+|+++.|||++.++.  +.|.||+.+..
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                246999999999999997753  68999999874

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.93  E-value=6.5e-10  Score=109.44  Aligned_cols=184  Identities=17%  Similarity=0.214  Sum_probs=120.4

Q ss_pred             ccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCC-CCC--ceeEEEEEEeCC---EEEEEEEe
Q 045835          244 SAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ-HPN--LVKIHGCCVEGD---QLLLVYEY  317 (511)
Q Consensus       244 ~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~n--iv~l~g~~~~~~---~~~lV~Ey  317 (511)
                      ..+.++.|....||+..    ..+++|+....  .....+.+|..+|+.+. +..  +.+++..+...+   ..++|||+
T Consensus        24 ~i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           24 TIEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eeEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            35678999999999875    34788876432  33457889999998873 333  344555443333   34789999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE--------------------------------------  359 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~--------------------------------------  359 (511)
                      +++.+|......      .++..++..++.++++.|+.||+.                                      
T Consensus        98 i~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (304)
T 3sg8_A           98 IKGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK  171 (304)
T ss_dssp             CCCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred             cCCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence            999888654321      256677777888888888888862                                      


Q ss_pred             -----------------CCCCeEEccCCCCCeEEcC--CCCeEEeecCCcccCCCCCceeecccccCCCc---ccccccc
Q 045835          360 -----------------SRFKIVHRDIKATNVLLDR--DLNPKISDFGLAKLDEGDKTHISTRIAGTIGY---MAPEYAL  417 (511)
Q Consensus       360 -----------------~~~~iiH~Dlk~~NILld~--~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y---~aPE~~~  417 (511)
                                       ..+.++|+|+++.||++++  ...+.|.||+.+....... ..    ......   ..|+...
T Consensus       172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-Dl----~~~~~~~~~~~~~~~~  246 (304)
T 3sg8_A          172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-DF----ISLMEDDEEYGMEFVS  246 (304)
T ss_dssp             HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-HH----HTTCCTTTSCCHHHHH
T ss_pred             HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-HH----HHHHhhccccCHHHHH
Confidence                             1235899999999999998  4567899999987532210 00    000001   1222111


Q ss_pred             -----cCCC---------CcchhHHHHHHHHHHHHhCCCCC
Q 045835          418 -----WGYL---------TYKADVYSFGIVALEIVSGKNNM  444 (511)
Q Consensus       418 -----~~~~---------~~~~DV~S~Gvvl~elltG~~p~  444 (511)
                           .+..         ....+.|+++.+++++.+|+.++
T Consensus       247 ~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          247 KILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence                 0111         12268999999999999998654

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.36  E-value=2.2e-06  Score=84.26  Aligned_cols=137  Identities=18%  Similarity=0.172  Sum_probs=91.8

Q ss_pred             cCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCC---CceeEEEEEE-eCCEEEEEEEecCC
Q 045835          245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHP---NLVKIHGCCV-EGDQLLLVYEYMEN  320 (511)
Q Consensus       245 ~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~---niv~l~g~~~-~~~~~~lV~Ey~~~  320 (511)
                      .+.++.|....||+.    |..+++|+-.  .......+.+|..+|+.+.+.   .+.+++.++. ..+..++|||++++
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            456788888899987    4557788743  223345788999999999753   3566777765 34457899999999


Q ss_pred             CCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 045835          321 NSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE-----------------------------------------  359 (511)
Q Consensus       321 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-----------------------------------------  359 (511)
                      .++......      .++...+..++.++++.|+.||+.                                         
T Consensus        98 ~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           98 QILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             EECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             eECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            888663211      123334444444444444444432                                         


Q ss_pred             ----------------CCCCeEEccCCCCCeEEcC---CCC-eEEeecCCcccC
Q 045835          360 ----------------SRFKIVHRDIKATNVLLDR---DLN-PKISDFGLAKLD  393 (511)
Q Consensus       360 ----------------~~~~iiH~Dlk~~NILld~---~~~-~kl~DfGla~~~  393 (511)
                                      ..+.++|+|+++.|||++.   ++. +.|.||+.+...
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                            2335799999999999998   455 589999988753

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.33  E-value=2.6e-06  Score=81.72  Aligned_cols=134  Identities=16%  Similarity=0.117  Sum_probs=93.7

Q ss_pred             ceeccCce-eEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCC-CCCceeEEEEEEeCCEEEEEEEecCCCCH
Q 045835          247 KIGEGGFG-PVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ-HPNLVKIHGCCVEGDQLLLVYEYMENNSL  323 (511)
Q Consensus       247 ~lG~G~fG-~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gsL  323 (511)
                      .+..|..| .||+.... ++..+++|+-...   ....+.+|...|+.+. +-.+.++++++.+.+..++|||++++.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            45556555 58987544 4567888986543   3356788999988774 33467789999999999999999999887


Q ss_pred             hHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 045835          324 ACALFGRENCELELDWPTRQKICLGIARGLAFLHEE--------------------------------------------  359 (511)
Q Consensus       324 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~--------------------------------------------  359 (511)
                      .+.....        ......++.+++..|.-||..                                            
T Consensus       108 ~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (272)
T 4gkh_A          108 FQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV  179 (272)
T ss_dssp             HHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred             cccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence            7654221        112233445555555555542                                            


Q ss_pred             -----------CCCCeEEccCCCCCeEEcCCCCeEEeecCCcc
Q 045835          360 -----------SRFKIVHRDIKATNVLLDRDLNPKISDFGLAK  391 (511)
Q Consensus       360 -----------~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~  391 (511)
                                 ..+.++|+|+.+.|||++++..+-|.||+.+.
T Consensus       180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                       11237999999999999988777899999886

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.07  E-value=3e-06  Score=84.85  Aligned_cols=80  Identities=6%  Similarity=0.023  Sum_probs=55.0

Q ss_pred             cCce-eccCceeEEecccc-------CCcEEEEEEecccC---ccchHHHHHHHHHHhcCC-C--CCceeEEEEEEeC--
Q 045835          245 AKKI-GEGGFGPVYKGQLA-------DGTIIAVKQLSSKS---RQGNREFLNEIAMISCLQ-H--PNLVKIHGCCVEG--  308 (511)
Q Consensus       245 ~~~l-G~G~fG~Vy~g~~~-------~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~-H--~niv~l~g~~~~~--  308 (511)
                      .+.| +.|....+|+....       ++..+++|+.....   ......+.+|..+++.+. +  ..+.+++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 78888999988754       25678888765432   111245778888888774 2  3567788887655  


Q ss_pred             -CEEEEEEEecCCCCHh
Q 045835          309 -DQLLLVYEYMENNSLA  324 (511)
Q Consensus       309 -~~~~lV~Ey~~~gsL~  324 (511)
                       ...++||||+++.++.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             3468999999987654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.86  E-value=4.2e-05  Score=75.67  Aligned_cols=142  Identities=18%  Similarity=0.252  Sum_probs=80.1

Q ss_pred             CceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcC-----CCCCceeEE-E--EEEeCCEEEEEEEe
Q 045835          246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCL-----QHPNLVKIH-G--CCVEGDQLLLVYEY  317 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-----~H~niv~l~-g--~~~~~~~~~lV~Ey  317 (511)
                      +.|+.|..+.||+....+| .+++|+....    ...+..|..+++.|     ..|.++... |  +....+..+++|||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            3455577889999877555 4889988652    12333455555444     234444310 1  12346778999999


Q ss_pred             cCCCCHh--------------HHHhcCCC----C------CCCCCHHHHH------------------------------
Q 045835          318 MENNSLA--------------CALFGREN----C------ELELDWPTRQ------------------------------  343 (511)
Q Consensus       318 ~~~gsL~--------------~~l~~~~~----~------~~~l~~~~~~------------------------------  343 (511)
                      +++.++.              ..+|....    .      ...-.|....                              
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542              11121100    0      0012343211                              


Q ss_pred             -HHHHHHHHHHHHHhc----------CCCCCeEEccCCCCCeEEcCCCCeEEeecCCccc
Q 045835          344 -KICLGIARGLAFLHE----------ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       344 -~i~~~ia~gl~yLH~----------~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~  392 (511)
                       .+...+..++++|++          .....++|+|+++.|||++.++.+.|.||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence             011123446667763          1234699999999999998888899999998863

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.85  E-value=4.4e-05  Score=77.58  Aligned_cols=75  Identities=16%  Similarity=0.197  Sum_probs=49.6

Q ss_pred             cCceeccCceeEEecccc-CCcEEEEEEecccCc-------cchHHHHHHHHHHhcCCC--CCce-eEEEEEEeCCEEEE
Q 045835          245 AKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSR-------QGNREFLNEIAMISCLQH--PNLV-KIHGCCVEGDQLLL  313 (511)
Q Consensus       245 ~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~-------~~~~~~~~Ei~~l~~l~H--~niv-~l~g~~~~~~~~~l  313 (511)
                      .+.||.|.++.||++... +++.++||.......       .....+..|.++++.+..  +..+ +++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            457899999999999754 467899998654321       123456788888887742  3333 55544  4455689


Q ss_pred             EEEecCCC
Q 045835          314 VYEYMENN  321 (511)
Q Consensus       314 V~Ey~~~g  321 (511)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.67  E-value=0.00017  Score=70.81  Aligned_cols=140  Identities=14%  Similarity=0.118  Sum_probs=92.9

Q ss_pred             ccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCC---CCCceeEEEEEEeCCEEEEEEEecCC
Q 045835          244 SAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ---HPNLVKIHGCCVEGDQLLLVYEYMEN  320 (511)
Q Consensus       244 ~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~Ey~~~  320 (511)
                      ..+.|+.|....+|+... ++..+++|+....   ....+..|...|+.|.   ...+.++++++...+..++||||+++
T Consensus        40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            346789999999999876 4667888987543   2456888988888873   35688899998888899999999998


Q ss_pred             CCHhH-----------HHhcCCC-C-----------------CCCCCHHHHH---HHHH----------------HHHHH
Q 045835          321 NSLAC-----------ALFGREN-C-----------------ELELDWPTRQ---KICL----------------GIARG  352 (511)
Q Consensus       321 gsL~~-----------~l~~~~~-~-----------------~~~l~~~~~~---~i~~----------------~ia~g  352 (511)
                      ..+..           .|+.... .                 ...-+|....   ++..                .++..
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            76521           1222211 0                 0012454321   1111                11111


Q ss_pred             -HHHHhc-CCCCCeEEccCCCCCeEEcCCCCeEEeecC
Q 045835          353 -LAFLHE-ESRFKIVHRDIKATNVLLDRDLNPKISDFG  388 (511)
Q Consensus       353 -l~yLH~-~~~~~iiH~Dlk~~NILld~~~~~kl~DfG  388 (511)
                       ...|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence             223432 2356799999999999999887 8899974

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.65  E-value=0.00016  Score=69.92  Aligned_cols=79  Identities=20%  Similarity=0.274  Sum_probs=58.4

Q ss_pred             CCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCC---CCceeEEEEEEeCCEEEEEEEe
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQH---PNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H---~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      .....+.+|.|..+.||+.++.||+.+.+|+-..........|..|...|+.|.-   -.+.+++++  +.  -++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEEEe
Confidence            4556778999999999999999999999998765544444568889998888742   234445544  22  3789999


Q ss_pred             cCCCCH
Q 045835          318 MENNSL  323 (511)
Q Consensus       318 ~~~gsL  323 (511)
                      ++.+..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987653

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.28  E-value=0.00061  Score=69.73  Aligned_cols=79  Identities=11%  Similarity=0.127  Sum_probs=48.1

Q ss_pred             CCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCceeecccc-cCCCcccccccccC---CCCcchhHHHHHHHHHH
Q 045835          361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIA-GTIGYMAPEYALWG---YLTYKADVYSFGIVALE  436 (511)
Q Consensus       361 ~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~-gt~~y~aPE~~~~~---~~~~~~DV~S~Gvvl~e  436 (511)
                      ...++|+|+++.|||++.+. ++|.||+.+....... ....... -...|.+|+.....   ......+..+....+|+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            34699999999999999876 9999999987533110 0000000 01235666654321   11223556688888888


Q ss_pred             HHhCC
Q 045835          437 IVSGK  441 (511)
Q Consensus       437 lltG~  441 (511)
                      .++++
T Consensus       309 ~y~~~  313 (420)
T 2pyw_A          309 LFNKR  313 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77653

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.05  E-value=0.0099  Score=58.12  Aligned_cols=160  Identities=14%  Similarity=0.059  Sum_probs=88.6

Q ss_pred             cccHHHHHHHhcCCcc-----cCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCC--CceeE
Q 045835          229 SFTLKQIKAATNNFDS-----AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHP--NLVKI  301 (511)
Q Consensus       229 ~~~~~~l~~~~~~f~~-----~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~--niv~l  301 (511)
                      .++.+++...-..|..     ...++ |....||+....+|+.+++|...... .....+..|..++..+...  .+.++
T Consensus        10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~   87 (328)
T 1zyl_A           10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAP   87 (328)
T ss_dssp             CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCC
T ss_pred             CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecce
Confidence            3455555555444432     23466 77789999887777778999986431 2334666787777766321  23333


Q ss_pred             EEE-----EEeCCEEEEEEEecCCCCHh-----H------H---HhcC----C-CCCCCCCHHHH---------------
Q 045835          302 HGC-----CVEGDQLLLVYEYMENNSLA-----C------A---LFGR----E-NCELELDWPTR---------------  342 (511)
Q Consensus       302 ~g~-----~~~~~~~~lV~Ey~~~gsL~-----~------~---l~~~----~-~~~~~l~~~~~---------------  342 (511)
                      +..     ....+..+++||++++.++.     .      .   +|..    . .....+++...               
T Consensus        88 ~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  167 (328)
T 1zyl_A           88 VAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIP  167 (328)
T ss_dssp             CCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSC
T ss_pred             eecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCC
Confidence            332     22355678899999875432     0      0   1110    0 00112232211               


Q ss_pred             -------HHHHHHHHHHHHHHhc-CCCCCeEEccCCCCCeEEcCCCCeEEeecCCccc
Q 045835          343 -------QKICLGIARGLAFLHE-ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       343 -------~~i~~~ia~gl~yLH~-~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~  392 (511)
                             ...+..++..++-+-. .....++|+|+++.|||++ + .+.|.||+.+..
T Consensus       168 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          168 SGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             TTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                   0111112222222211 1234589999999999999 4 899999988764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.99  E-value=0.0013  Score=64.45  Aligned_cols=160  Identities=14%  Similarity=0.128  Sum_probs=87.7

Q ss_pred             ccHHHHHHHhcCCcc-----cCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCC-----CCCce
Q 045835          230 FTLKQIKAATNNFDS-----AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ-----HPNLV  299 (511)
Q Consensus       230 ~~~~~l~~~~~~f~~-----~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-----H~niv  299 (511)
                      ++.+++...-..|..     .+.|+.|....+|+....+| .+++|......  ....+..|+.++..+.     -|.++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            455566665556654     23456687889999877666 57788876521  1234556777766553     23333


Q ss_pred             eEE-E--EEEeCCEEEEEEEecCCCCHhH--------------HHhcC--C--CCC-CC---CCHHHHHH----------
Q 045835          300 KIH-G--CCVEGDQLLLVYEYMENNSLAC--------------ALFGR--E--NCE-LE---LDWPTRQK----------  344 (511)
Q Consensus       300 ~l~-g--~~~~~~~~~lV~Ey~~~gsL~~--------------~l~~~--~--~~~-~~---l~~~~~~~----------  344 (511)
                      ... |  +....+..+++++|+++..+..              .++..  .  ... ..   ..|.....          
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            210 1  1123467789999999865321              01211  0  000 00   12332111          


Q ss_pred             --HHHHHHHHHHHHhcC----CCCCeEEccCCCCCeEEcCCCCeEEeecCCccc
Q 045835          345 --ICLGIARGLAFLHEE----SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       345 --i~~~ia~gl~yLH~~----~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~  392 (511)
                        +...+...++.+++.    ....++|+|+++.|||++++..+.|.||+.+..
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence              011244455555532    234599999999999999876668999998863

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.99  E-value=0.0035  Score=61.66  Aligned_cols=144  Identities=17%  Similarity=0.121  Sum_probs=72.7

Q ss_pred             cCceeccCcee-EEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCC--CCceeEEEEEEeCCEEEEEEEecCCC
Q 045835          245 AKKIGEGGFGP-VYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQH--PNLVKIHGCCVEGDQLLLVYEYMENN  321 (511)
Q Consensus       245 ~~~lG~G~fG~-Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~lV~Ey~~~g  321 (511)
                      .+.|+.|.... +|+....++..+++|.......   ..+..|+.+++.+..  -.+.+++.++.+..  +++||++.+.
T Consensus        23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~   97 (333)
T 3csv_A           23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA   97 (333)
T ss_dssp             ECC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred             eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence            34565554443 6676654466677776543321   223456666655532  23455666643333  6899999776


Q ss_pred             CHhHHHhcCC---------------------CCC-CCCCHHHHH-------H-------------HHHHHHHHHHHHh--
Q 045835          322 SLACALFGRE---------------------NCE-LELDWPTRQ-------K-------------ICLGIARGLAFLH--  357 (511)
Q Consensus       322 sL~~~l~~~~---------------------~~~-~~l~~~~~~-------~-------------i~~~ia~gl~yLH--  357 (511)
                      ++.+++....                     ... ..++.....       .             ....+...++.|.  
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            6654442211                     000 011111100       0             0001112222221  


Q ss_pred             -cCCCCCeEEccCCCCCeEEcCC----CCeEEeecCCcccC
Q 045835          358 -EESRFKIVHRDIKATNVLLDRD----LNPKISDFGLAKLD  393 (511)
Q Consensus       358 -~~~~~~iiH~Dlk~~NILld~~----~~~kl~DfGla~~~  393 (511)
                       ......++|+|+.+.|||++.+    ..+.|.||+.+...
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence             1123469999999999999875    67899999998754

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.88  E-value=0.00079  Score=69.11  Aligned_cols=73  Identities=15%  Similarity=0.232  Sum_probs=49.0

Q ss_pred             cCceeccCceeEEeccccC--------CcEEEEEEecccCccchHHHHHHHHHHhcCCCCCc-eeEEEEEEeCCEEEEEE
Q 045835          245 AKKIGEGGFGPVYKGQLAD--------GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNL-VKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       245 ~~~lG~G~fG~Vy~g~~~~--------g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~  315 (511)
                      .+.|+.|....+|+....+        +..+++|+....  .....+.+|..+++.+...++ .++++.+.  +  .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence            3567788889999987653        467888887432  112466689988888753344 56676553  2  2899


Q ss_pred             EecCCCCH
Q 045835          316 EYMENNSL  323 (511)
Q Consensus       316 Ey~~~gsL  323 (511)
                      ||+++-+|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99986443

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.78  E-value=0.0019  Score=65.00  Aligned_cols=142  Identities=18%  Similarity=0.230  Sum_probs=81.3

Q ss_pred             CceeccCceeEEecccc--------CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCC-ceeEEEEEEeCCEEEEEEE
Q 045835          246 KKIGEGGFGPVYKGQLA--------DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPN-LVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~--------~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E  316 (511)
                      +.|..|-...+|+....        ++..+++|+.... ........+|..+++.|.-.+ ..++++++.+  .  +|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~--g--~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE--G--RLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT--E--EEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC--c--cEEE
Confidence            46666777888998764        2467888886332 234456678999888774222 3556666543  2  8999


Q ss_pred             ecCCCCHhHH-----------------HhcCCC-CCCCCC--HHHHHHHHHHHH-------------------HHHHH--
Q 045835          317 YMENNSLACA-----------------LFGREN-CELELD--WPTRQKICLGIA-------------------RGLAF--  355 (511)
Q Consensus       317 y~~~gsL~~~-----------------l~~~~~-~~~~l~--~~~~~~i~~~ia-------------------~gl~y--  355 (511)
                      |+++.+|..-                 ||.... ......  |.+..++..++.                   ..+..  
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9998655311                 111110 011122  444444443331                   12233  


Q ss_pred             --HhcC-CCCCeEEccCCCCCeEEcCC----CCeEEeecCCccc
Q 045835          356 --LHEE-SRFKIVHRDIKATNVLLDRD----LNPKISDFGLAKL  392 (511)
Q Consensus       356 --LH~~-~~~~iiH~Dlk~~NILld~~----~~~kl~DfGla~~  392 (511)
                        |... ....++|+|+.+.|||++.+    +.+.|.||..+..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence              3222 23468999999999999876    6899999988853

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.77  E-value=0.0029  Score=61.33  Aligned_cols=139  Identities=12%  Similarity=0.115  Sum_probs=74.0

Q ss_pred             cCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCc-eeEEEEEEeCCEEEEEEEec-CCCC
Q 045835          245 AKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNL-VKIHGCCVEGDQLLLVYEYM-ENNS  322 (511)
Q Consensus       245 ~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~-~~gs  322 (511)
                      .+.|+.|....+|+.     ..+++|+........ ....+|..+++.+...++ .+++++  +.+.-++++||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence            577888999999998     447788776432211 123467777766643223 455554  333457899999 5544


Q ss_pred             HhHH------------------HhcCCC-CCCCCCH-HHHHHHHH--------------HHHHHH----HHHhc-CCCCC
Q 045835          323 LACA------------------LFGREN-CELELDW-PTRQKICL--------------GIARGL----AFLHE-ESRFK  363 (511)
Q Consensus       323 L~~~------------------l~~~~~-~~~~l~~-~~~~~i~~--------------~ia~gl----~yLH~-~~~~~  363 (511)
                      +...                  +|.... .....+. ........              .+...+    +.|.. .....
T Consensus        95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~  174 (301)
T 3dxq_A           95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA  174 (301)
T ss_dssp             CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred             CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence            4210                  111110 0000111 11111100              011111    12211 22345


Q ss_pred             eEEccCCCCCeEEcCCCCeEEeecCCccc
Q 045835          364 IVHRDIKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       364 iiH~Dlk~~NILld~~~~~kl~DfGla~~  392 (511)
                      ++|+|+.+.||+ ..++.+.|.||..+..
T Consensus       175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          175 ACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            899999999999 5566789999998864

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.60  E-value=0.0072  Score=62.41  Aligned_cols=74  Identities=16%  Similarity=0.086  Sum_probs=47.1

Q ss_pred             cCceeccCceeEEeccccC-CcEEEEEEecccCccchHHHHHHHHHHhcCCCCCc-eeEEEEEEeCCEEEEEEEecCCCC
Q 045835          245 AKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNL-VKIHGCCVEGDQLLLVYEYMENNS  322 (511)
Q Consensus       245 ~~~lG~G~fG~Vy~g~~~~-g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~gs  322 (511)
                      .+.|+.|-...+|+....+ +..+++|+........ ..-.+|..+++.|...++ .++++++  .+.  +||||+++-+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~--~~G--~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFF--TNG--RIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEE--TTE--EEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEe--CCe--EEEEeeCCcc
Confidence            4567888889999998765 4678888774432211 112578888888865555 4677766  232  4999998754


Q ss_pred             H
Q 045835          323 L  323 (511)
Q Consensus       323 L  323 (511)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=95.72  E-value=0.0085  Score=59.86  Aligned_cols=73  Identities=11%  Similarity=0.156  Sum_probs=42.3

Q ss_pred             CceeccCceeEEeccccC---------CcEEEEEEecccCccchHHHHHHHHHHhcCCCCCc-eeEEEEEEeCCEEEEEE
Q 045835          246 KKIGEGGFGPVYKGQLAD---------GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNL-VKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~~---------g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~  315 (511)
                      +.|+.|....+|+....+         +..+++|+....... ......|..+++.+...++ .++++..  .+  ++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--CC--cEEE
Confidence            456777778899887643         257888876543221 1123567777777743333 4566543  22  6899


Q ss_pred             EecCCCCH
Q 045835          316 EYMENNSL  323 (511)
Q Consensus       316 Ey~~~gsL  323 (511)
                      ||+++.++
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99987543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.71  E-value=0.026  Score=55.74  Aligned_cols=32  Identities=31%  Similarity=0.475  Sum_probs=28.1

Q ss_pred             CCCeEEccCCCCCeEEcCCCCeEEeecCCccc
Q 045835          361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       361 ~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~  392 (511)
                      ...++|+|+.+.||++++++.+.|.||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            34699999999999999888899999988764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=95.49  E-value=0.026  Score=51.64  Aligned_cols=102  Identities=16%  Similarity=0.082  Sum_probs=65.7

Q ss_pred             CCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCce
Q 045835          320 NNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH  399 (511)
Q Consensus       320 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~  399 (511)
                      .-||.++|....   .++++.+.+.+|.|.+.+|.-+-.... + ..+=+.|..|++..+|.+...+ ..+.        
T Consensus        32 ~vSL~eIL~~~~---~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~--------   97 (229)
T 2yle_A           32 ALSLEEILRLYN---QPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD--------   97 (229)
T ss_dssp             EEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred             cccHHHHHHHcC---CCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc--------
Confidence            347999997654   479999999999999999887622110 1 1222346889999999888764 1111        


Q ss_pred             eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCC
Q 045835          400 ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK  441 (511)
Q Consensus       400 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~  441 (511)
                           .....+.|||... ...+.+.=|||+|+++|..+-=.
T Consensus        98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg  133 (229)
T 2yle_A           98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG  133 (229)
T ss_dssp             --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred             -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence                 0122366888653 45678899999999999988633

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=92.27  E-value=0.33  Score=49.28  Aligned_cols=74  Identities=14%  Similarity=0.127  Sum_probs=45.8

Q ss_pred             cCceeccCceeEEeccccC--------CcEEEEEEecccCccchHHHHHHHHHHhcCCCCC-ceeEEEEEEeCCEEEEEE
Q 045835          245 AKKIGEGGFGPVYKGQLAD--------GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPN-LVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       245 ~~~lG~G~fG~Vy~g~~~~--------g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~  315 (511)
                      .+.+..|-...+|+....+        +..+++|+....... ...-.+|..+++.+.-.+ ..++++.+  .+  ++|+
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEE
Confidence            3456667778899887653        577888886443221 122356888777774323 34555433  32  6899


Q ss_pred             EecCCCCH
Q 045835          316 EYMENNSL  323 (511)
Q Consensus       316 Ey~~~gsL  323 (511)
                      ||+++.+|
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=87.79  E-value=1.3  Score=44.32  Aligned_cols=29  Identities=24%  Similarity=0.417  Sum_probs=24.6

Q ss_pred             eEEccCCCCCeEE------cCCCCeEEeecCCccc
Q 045835          364 IVHRDIKATNVLL------DRDLNPKISDFGLAKL  392 (511)
Q Consensus       364 iiH~Dlk~~NILl------d~~~~~kl~DfGla~~  392 (511)
                      ++|+|+.+.|||+      +++..+.+.||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            5799999999999      4566799999988863

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=87.10  E-value=1.5  Score=39.77  Aligned_cols=116  Identities=11%  Similarity=0.127  Sum_probs=80.1

Q ss_pred             CCCCCceeEEEEEEeCCEEEEEEEecCCC-CHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCC
Q 045835          293 LQHPNLVKIHGCCVEGDQLLLVYEYMENN-SLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKA  371 (511)
Q Consensus       293 l~H~niv~l~g~~~~~~~~~lV~Ey~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~  371 (511)
                      ..||++++. .+-.+.+.+.+.|+.-+.+ ++.. +       ..++...+++++.+|+....+++.     -+|--|.|
T Consensus        42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P  107 (215)
T 4ann_A           42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAP  107 (215)
T ss_dssp             SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSG
T ss_pred             ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEec
Confidence            368999877 4666677777767655432 2222 2       236788999999999988866654     47888999


Q ss_pred             CCeEEcCCCCeEEeecCCcccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 045835          372 TNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMS  445 (511)
Q Consensus       372 ~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~  445 (511)
                      +|++++.++.+++.=.|+-...                  +|.     ..++..=.-.+=+++..+++++..|.
T Consensus       108 ~NL~f~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          108 DELFFTRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             GGEEECTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             ceEEEcCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999999999877765322                  121     11222223367888899999988775

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=86.47  E-value=0.13  Score=33.89  Aligned_cols=15  Identities=33%  Similarity=0.676  Sum_probs=7.5

Q ss_pred             cEEehhhHHHHHHHH
Q 045835          184 PIVVGVVAGLSLIIL  198 (511)
Q Consensus       184 ~ivi~~~~~~~~~~~  198 (511)
                      .|+.|++.+++++++
T Consensus        12 ~IA~gVVgGv~~~~i   26 (44)
T 2ks1_B           12 SIATGMVGALLLLLV   26 (44)
T ss_dssp             SSTHHHHHHHHHHHH
T ss_pred             eEEeehhHHHHHHHH
Confidence            455556555544333

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=86.05  E-value=0.091  Score=54.18  Aligned_cols=62  Identities=13%  Similarity=0.151  Sum_probs=19.3

Q ss_pred             cccCceeccCceeEEeccccC-CcEEEE------EEeccc--CccchHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 045835          243 DSAKKIGEGGFGPVYKGQLAD-GTIIAV------KQLSSK--SRQGNREFLNEIAMISCLQHPNLVKIHGCCVE  307 (511)
Q Consensus       243 ~~~~~lG~G~fG~Vy~g~~~~-g~~vAv------K~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~  307 (511)
                      .+.++||   ||.||+|.+.. ..+|||      |..+..  +.+....|.+|..+++.++|||+++.+++...
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            3456776   99999998764 367888      776543  22334578889999999999999999888654

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=81.18  E-value=0.2  Score=32.94  Aligned_cols=13  Identities=38%  Similarity=0.741  Sum_probs=6.3

Q ss_pred             cEEehhhHHHHHH
Q 045835          184 PIVVGVVAGLSLI  196 (511)
Q Consensus       184 ~ivi~~~~~~~~~  196 (511)
                      .|+.|++.+++++
T Consensus        11 aIA~gVVgGv~~v   23 (44)
T 2l2t_A           11 LIAAGVIGGLFIL   23 (44)
T ss_dssp             HHHHHHHHHHHHH
T ss_pred             eEEEeehHHHHHH
Confidence            3445555544443

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	511
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-71
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-68
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-67
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-67
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-65
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-65
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	9e-65
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-64
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-64
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-64
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-62
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	6e-62
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	9e-61
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-60
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-60
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-60
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	6e-60
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	8e-60
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-59
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-59
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-59
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	9e-59
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	6e-58
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-57
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-57
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	6e-57
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-56
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-55
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-55
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-55
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-53
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-52
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-51
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-51
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-48
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	8e-48
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-47
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-46
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-46
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-46
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-45
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-45
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	6e-45
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-44
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-44
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	6e-44
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-43
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-43
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-42
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-41
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-41
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-41
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-41
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	6e-40
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-39
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-39
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-38
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-36
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-35
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	8e-35
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-33
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-28
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-21

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (576), Expect = 4e-71
 Identities = 69/276 (25%), Positives = 125/276 (45%), Gaps = 24/276 (8%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
                 ++IG G FG VYKG+      + +  +++ + Q  + F NE+ ++   +H N++
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
              G      QL +V ++ E +SL   L   E    + +      I    A+G+ +LH +
Sbjct: 68  LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK 123

Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL-DEGDKTHISTRIAGTIGYMAPEYAL- 417
               I+HRD+K+ N+ L  DL  KI DFGLA +      +H   +++G+I +MAPE    
Sbjct: 124 ---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180

Query: 418 --WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD 475
                 ++++DVY+FGIV  E+++G+        L +      D    +   G L   + 
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQ--------LPYSNINNRDQIIFMVGRGYLSPDLS 232

Query: 476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           +      +    + M ++   C       RP   ++
Sbjct: 233 K-----VRSNCPKAMKRLMAECLKKKRDERPLFPQI 263

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (556), Expect = 3e-68
 Identities = 75/272 (27%), Positives = 123/272 (45%), Gaps = 24/272 (8%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
                 +++G G FG V+ G     T +AVK L  +       FL E  ++  LQH  LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
           +++    + + + ++ EYMEN SL   L      +L         +   IA G+AF+ E 
Sbjct: 72  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKL--TINKLLDMAAQIAEGMAFIEER 128

Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWG 419
                +HRD++A N+L+   L+ KI+DFGLA+L E ++          I + APE   +G
Sbjct: 129 ---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185

Query: 420 YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLG 479
             T K+DV+SFGI+  EIV+          + +      +   +L++  ++V        
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGR-------IPYPGMTNPEVIQNLERGYRMV-------- 230

Query: 480 SKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                   E + ++  LC    P  RPT   +
Sbjct: 231 --RPDNCPEELYQLMRLCWKERPEDRPTFDYL 260

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (550), Expect = 2e-67
 Identities = 58/272 (21%), Positives = 113/272 (41%), Gaps = 24/272 (8%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
            +    K++G G FG V  G+      +A+K +  +      EF+ E  ++  L H  LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLV 62

Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
           +++G C +   + ++ EYM N  L   L    +           ++C  +   + +L  +
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLESK 119

Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWG 419
              + +HRD+ A N L++     K+SDFGL++    D+   S      + +  PE  ++ 
Sbjct: 120 ---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176

Query: 420 YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLG 479
             + K+D+++FG++  EI S        P   F              + +  E + + L 
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLG----KMPYERFT-------------NSETAEHIAQGLR 219

Query: 480 SKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                  +E++  +   C +     RPT   +
Sbjct: 220 LYRPHLASEKVYTIMYSCWHEKADERPTFKIL 251

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (548), Expect = 4e-67
 Identities = 64/272 (23%), Positives = 121/272 (44%), Gaps = 24/272 (8%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
           +     ++IG G FG V+ G   +   +A+K +  +      +F+ E  ++  L HP LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
           +++G C+E   + LV+E+ME+  L+  L  +          T   +CL +  G+A+L E 
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF---AAETLLGMCLDVCEGMAYLEEA 120

Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWG 419
               ++HRD+ A N L+  +   K+SDFG+ +    D+   ST     + + +PE   + 
Sbjct: 121 ---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177

Query: 420 YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLG 479
             + K+DV+SFG++  E+ S                         + + ++VE +     
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIP-----------------YENRSNSEVVEDISTGFR 220

Query: 480 SKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
               +  +  + ++   C    P  RP  S +
Sbjct: 221 LYKPRLASTHVYQIMNHCWKERPEDRPAFSRL 252

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (536), Expect = 4e-65
 Identities = 72/272 (26%), Positives = 117/272 (43%), Gaps = 24/272 (8%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
            +     K+G+G FG V+ G     T +A+K L          FL E  ++  L+H  LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLV 75

Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
           +++      + + +V EYM   SL    F +      L  P    +   IA G+A++   
Sbjct: 76  QLYAVV-SEEPIYIVTEYMSKGSLL--DFLKGETGKYLRLPQLVDMAAQIASGMAYVE-- 130

Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWG 419
            R   VHRD++A N+L+  +L  K++DFGLA+L E ++          I + APE AL+G
Sbjct: 131 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 189

Query: 420 YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLG 479
             T K+DV+SFGI+  E+ +                             ++++ V+    
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----------------EVLDQVERGYR 232

Query: 480 SKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                E  E +  +   C    P  RPT   +
Sbjct: 233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYL 264

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (539), Expect = 4e-65
 Identities = 58/304 (19%), Positives = 119/304 (39%), Gaps = 42/304 (13%)

Query: 238 ATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNRE-FLNEIAMISCLQH 295
             ++F+   ++G G  G V+K      G ++A K +  + +   R   + E+ ++     
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           P +V  +G      ++ +  E+M+  SL   L         +      K+ + + +GL +
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTY 119

Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEY 415
           L    + KI+HRD+K +N+L++     K+ DFG++               GT  YM+PE 
Sbjct: 120 LR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPER 174

Query: 416 ALWGYLTYKADVYSFGIVALEIVSGK---------------------NNMSYAPALEFDC 454
               + + ++D++S G+  +E+  G+                     +     P      
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234

Query: 455 TCLLDWACHLQQDGKLVELVDE-------RLGSKYKKEEAERMIKVSLLCTNASPSLRPT 507
             L  +    +    + EL+D        +L S     E +  +    L  N  P+ R  
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN-KCLIKN--PAERAD 291

Query: 508 MSEV 511
           + ++
Sbjct: 292 LKQL 295

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  210 bits (535), Expect = 9e-65
 Identities = 70/300 (23%), Positives = 125/300 (41%), Gaps = 41/300 (13%)

Query: 230 FTLKQIKAATNNFDSA---------KKIGEGGFGPVYKGQLA----DGTIIAVKQL-SSK 275
           FT +    A   F            + IG G FG V  G L         +A+K L S  
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 276 SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL 335
           + +  R+FL+E +++    HPN++ + G   +   ++++ E+MEN SL   L   +    
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 336 ELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG 395
                    +  GIA G+ +L        VHRD+ A N+L++ +L  K+SDFGL++  E 
Sbjct: 126 --TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 396 DKTHISTR----IAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALE 451
           D +  +          I + APE   +   T  +DV+S+GIV  E++S        P  +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG----ERPYWD 236

Query: 452 FDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                          +  ++  +++        +    + ++ L C     + RP   ++
Sbjct: 237 MT-------------NQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQI 283

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  209 bits (533), Expect = 1e-64
 Identities = 65/273 (23%), Positives = 122/273 (44%), Gaps = 24/273 (8%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNL 298
            +     K+G G +G VY+G        +AVK L   + +   EFL E A++  ++HPNL
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNL 75

Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
           V++ G C       ++ E+M   +L   L        E+       +   I+  + +L +
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEK 133

Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALW 418
           +     +HRD+ A N L+  +   K++DFGL++L  GD           I + APE   +
Sbjct: 134 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190

Query: 419 GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERL 478
              + K+DV++FG++  EI +   +      L                  ++ EL+++  
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----------------QVYELLEKDY 233

Query: 479 GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
             +  +   E++ ++   C   +PS RP+ +E+
Sbjct: 234 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 266

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (532), Expect = 3e-64
 Identities = 74/287 (25%), Positives = 121/287 (42%), Gaps = 28/287 (9%)

Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCC 305
           + IG+G FG V++G+   G  +AVK  SS+  + +     EI     L+H N++      
Sbjct: 9   ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAAD 66

Query: 306 VEGD----QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE-- 359
            + +    QL LV +Y E+ SL   L         +      K+ L  A GLA LH E  
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIV 121

Query: 360 ---SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIS---TRIAGTIGYMAP 413
               +  I HRD+K+ N+L+ ++    I+D GLA   +     I        GT  YMAP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

Query: 414 EYAL------WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLL--DWACHLQ 465
           E               +AD+Y+ G+V  EI    +        +     L+  D +    
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241

Query: 466 QDGKLVELVDERLGSKYKKEEAER-MIKVSLLCTNASPSLRPTMSEV 511
           +     + +   + ++++  EA R M K+   C  A+ + R T   +
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  208 bits (531), Expect = 3e-64
 Identities = 75/312 (24%), Positives = 131/312 (41%), Gaps = 48/312 (15%)

Query: 228 ISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQL------ADGTIIAVKQLSSKSRQGNR 281
           ++  L  ++   NN +  + IGEG FG V++ +          T++AVK L  ++    +
Sbjct: 1   LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60

Query: 282 -EFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELE---- 336
            +F  E A+++   +PN+VK+ G C  G  + L++EYM    L   L       +     
Sbjct: 61  ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120

Query: 337 ----------------LDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL 380
                           L    +  I   +A G+A+L E    K VHRD+   N L+  ++
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENM 177

Query: 381 NPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS 439
             KI+DFGL++ +   D        A  I +M PE   +   T ++DV+++G+V  EI S
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237

Query: 440 GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTN 499
                 Y  A E           +  +DG ++   +              +  +  LC +
Sbjct: 238 YGLQPYYGMAHE--------EVIYYVRDGNILACPE---------NCPLELYNLMRLCWS 280

Query: 500 ASPSLRPTMSEV 511
             P+ RP+   +
Sbjct: 281 KLPADRPSFCSI 292

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (521), Expect = 1e-62
 Identities = 73/295 (24%), Positives = 117/295 (39%), Gaps = 42/295 (14%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSKSRQGNRE-FLNEIAMISC 292
           N     K +G G FG V +              +AVK L   +    RE  ++E+ ++S 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 293 L-QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGR--------------ENCELEL 337
           L  H N+V + G C  G   L++ EY     L   L  +              E+ EL L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 338 DWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGD 396
           D          +A+G+AFL  +     +HRD+ A N+LL      KI DFGLA+ +    
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 397 KTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTC 456
              +       + +MAPE       T+++DV+S+GI   E+ S  ++             
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS------------- 246

Query: 457 LLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                  +  D K  +++ E       +     M  +   C +A P  RPT  ++
Sbjct: 247 ---PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 6e-62
 Identities = 65/280 (23%), Positives = 128/280 (45%), Gaps = 31/280 (11%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQLADGT-----IIAVKQLSSKSRQGNR-EFLNEIAMISCL 293
           +     K IG G FG VYKG L   +      +A+K L +   +  R +FL E  ++   
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 294 QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
            H N++++ G   +   ++++ EYMEN +L   L  ++             +  GIA G+
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGIAAGM 123

Query: 354 AFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL--DEGDKTHISTRIAGTIGYM 411
            +L        VHRD+ A N+L++ +L  K+SDFGL+++  D+ + T+ ++     I + 
Sbjct: 124 KYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180

Query: 412 APEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLV 471
           APE   +   T  +DV+SFGIV  E+++                   +       + +++
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYG-----------------ERPYWELSNHEVM 223

Query: 472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           + +++        +    + ++ + C     + RP  +++
Sbjct: 224 KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADI 263

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  200 bits (509), Expect = 9e-61
 Identities = 70/277 (25%), Positives = 115/277 (41%), Gaps = 36/277 (12%)

Query: 242 FDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGN---REFLNEIAMISCLQHPN 297
           F   ++IG G FG VY  + + +  ++A+K++S   +Q N   ++ + E+  +  L+HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH 357
            ++  GC +      LV EY   ++       ++     L       +  G  +GLA+LH
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQGLAYLH 132

Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYAL 417
                 ++HRD+KA N+LL      K+ DFG A +     + +     GT  +MAPE  L
Sbjct: 133 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVIL 184

Query: 418 W---GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV 474
               G    K DV+S GI  +E+   K      P    +    L           + +  
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERK-----PPLFNMNAMSALY---------HIAQNE 230

Query: 475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
              L S +  E     +     C    P  RPT   +
Sbjct: 231 SPALQSGHWSEYFRNFVD---SCLQKIPQDRPTSEVL 264

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 2e-60
 Identities = 78/307 (25%), Positives = 134/307 (43%), Gaps = 34/307 (11%)

Query: 214 HKETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLAD----GTIIAV 269
           H + + +    +Q +   +    +   +F+  + IG G FG VY G L D        AV
Sbjct: 3   HIDLSALNPELVQAVQHVVIGPSSLIVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAV 60

Query: 270 KQLSSKSRQGN-REFLNEIAMISCLQHPNLVKIHGCCVEGD-QLLLVYEYMENNSLACAL 327
           K L+  +  G   +FL E  ++    HPN++ + G C+  +   L+V  YM++  L   +
Sbjct: 61  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 120

Query: 328 FGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDF 387
               +              L +A+G+ FL  +   K VHRD+ A N +LD     K++DF
Sbjct: 121 RNETH---NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADF 174

Query: 388 GLAKL---DEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNM 444
           GLA+     E D  H  T     + +MA E       T K+DV+SFG++  E+++     
Sbjct: 175 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG--- 231

Query: 445 SYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSL 504
               A  +      D   +L Q  +L++           +   + + +V L C +    +
Sbjct: 232 ----APPYPDVNTFDITVYLLQGRRLLQ----------PEYCPDPLYEVMLKCWHPKAEM 277

Query: 505 RPTMSEV 511
           RP+ SE+
Sbjct: 278 RPSFSEL 284

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 6e-60
 Identities = 68/278 (24%), Positives = 117/278 (42%), Gaps = 26/278 (9%)

Query: 241 NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQL--SSKSRQGNREFLNEIAMISCLQHPN 297
           +++    IG G +G   K +  +DG I+  K+L   S +    +  ++E+ ++  L+HPN
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 298 LVKIHGCCVE--GDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           +V+ +   ++     L +V EY E   LA  +         LD     ++   +   L  
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 356 LHEESR--FKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAP 413
            H  S     ++HRD+K  NV LD   N K+ DFGLA++   D T  +    GT  YM+P
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYMSP 183

Query: 414 EYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVEL 473
           E         K+D++S G +  E+ +                         +  GK+ E 
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALM--------------PPFTAFSQKELAGKIREG 229

Query: 474 VDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
              R+  +Y  +E   +I       N     RP++ E+
Sbjct: 230 KFRRIPYRY-SDELNEIIT---RMLNLKDYHRPSVEEI 263

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 6e-60
 Identities = 71/276 (25%), Positives = 114/276 (41%), Gaps = 27/276 (9%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNRE-FLNEIAMISCLQHPN 297
            ++D  + +GEG +G V           +AVK +  K      E    EI +   L H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH 357
           +VK +G   EG+   L  EY     L   +         +  P  Q+    +  G+ +LH
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYLH 120

Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIAGTIGYMAPEYA 416
                 I HRDIK  N+LLD   N KISDFGLA      ++  +  ++ GT+ Y+APE  
Sbjct: 121 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177

Query: 417 LWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD 475
               +     DV+S GIV   +++G+        L +D            ++ K      
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGE--------LPWDQPSDSCQEYSDWKEKKTYLNPW 229

Query: 476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           +++           ++   +L  N  PS R T+ ++
Sbjct: 230 KKID-----SAPLALLH-KILVEN--PSARITIPDI 257

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 6e-60
 Identities = 66/273 (24%), Positives = 109/273 (39%), Gaps = 32/273 (11%)

Query: 246 KKIGEGGFGPVYKGQLAD---GTIIAVKQLSSKSRQGN--REFLNEIAMISCLQHPNLVK 300
           K++G G FG V KG          +AVK L +++       E L E  ++  L +P +V+
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 301 IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES 360
           + G C E +  +LV E  E   L   L    +    +      ++   ++ G+ +L E  
Sbjct: 73  MIGIC-EAESWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEES- 126

Query: 361 RFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR--IAGTIGYMAPEYALW 418
               VHRD+ A NVLL      KISDFGL+K    D+ +   +      + + APE   +
Sbjct: 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184

Query: 419 GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERL 478
              + K+DV+SFG++  E  S        P                    ++  ++++  
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYG----QKPYRGMK-------------GSEVTAMLEKGE 227

Query: 479 GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                      M  +  LC       RP  + V
Sbjct: 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAV 260

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (498), Expect = 8e-60
 Identities = 71/273 (26%), Positives = 111/273 (40%), Gaps = 30/273 (10%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
                 + IG+G FG V  G    G  +AVK + + +    + FL E ++++ L+H NLV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63

Query: 300 KIHGCCVEGD-QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
           ++ G  VE    L +V EYM   SL   L  R    L        K  L +   + +L  
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL--GGDCLLKFSLDVCEAMEYLEG 121

Query: 359 ESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALW 418
                 VHRD+ A NVL+  D   K+SDFGL K     +          + + APE    
Sbjct: 122 N---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKWTAPEALRE 174

Query: 419 GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERL 478
              + K+DV+SFGI+  EI S          L+                  +V  V++  
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----------------DVVPRVEKGY 217

Query: 479 GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                      + +V   C +   ++RP+  ++
Sbjct: 218 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQL 250

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 2e-59
 Identities = 69/300 (23%), Positives = 108/300 (36%), Gaps = 47/300 (15%)

Query: 240 NNFDSAKKIGEGGFGPVYKG------QLADGTIIAVKQLSSKSRQGNRE-FLNEIAMIS- 291
            N +  K +G G FG V         +      +AVK L  K+    RE  ++E+ M++ 
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 292 CLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELE--------------- 336
              H N+V + G C     + L++EY     L   L  +     E               
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 337 ----LDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK- 391
               L +         +A+G+ FL  +     VHRD+ A NVL+      KI DFGLA+ 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 392 LDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALE 451
           +       +       + +MAPE    G  T K+DV+S+GI+  EI S   N        
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP----- 268

Query: 452 FDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                       +  D    +L+             E +  +   C       RP+   +
Sbjct: 269 -----------GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 2e-59
 Identities = 67/274 (24%), Positives = 111/274 (40%), Gaps = 33/274 (12%)

Query: 246 KKIGEGGFGPVYKGQLAD-GTIIAVKQLSSK--SRQGNREFLNEIAMISCLQHPNLVKIH 302
            +IG G F  VYKG   +    +A  +L  +  ++   + F  E  M+  LQHPN+V+ +
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 303 GCCVE----GDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
                       ++LV E M + +L   L   +     +     +  C  I +GL FLH 
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHT 130

Query: 359 ESRFKIVHRDIKATNVLL-DRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYAL 417
            +   I+HRD+K  N+ +     + KI D GLA L           + GT  +MAPE   
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPEMYE 186

Query: 418 WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER 477
             Y     DVY+FG+  LE+ + +   S             +     Q   ++   V   
Sbjct: 187 EKY-DESVDVYAFGMCMLEMATSEYPYS-------------ECQNAAQIYRRVTSGVKPA 232

Query: 478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
              K    E + +I+    C   +   R ++ ++
Sbjct: 233 SFDKVAIPEVKEIIE---GCIRQNKDERYSIKDL 263

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 2e-59
 Identities = 64/286 (22%), Positives = 119/286 (41%), Gaps = 31/286 (10%)

Query: 233 KQIKAATNNFDSAK-KIGEGGFGPVYKGQLA---DGTIIAVKQLSSKSRQGNRE-FLNEI 287
           K++    +N   A  ++G G FG V +G          +A+K L   + + + E  + E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 288 AMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICL 347
            ++  L +P +V++ G C + + L+LV E      L   L G+     E+      ++  
Sbjct: 61  QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLH 116

Query: 348 GIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTR--IA 405
            ++ G+ +L E+     VHRD+ A NVLL      KISDFGL+K    D ++ + R    
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173

Query: 406 GTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQ 465
             + + APE   +   + ++DV+S+G+   E +S        P  +              
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG----QKPYKKMK------------ 217

Query: 466 QDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
              +++  +++    +   E    +  +   C       RP    V
Sbjct: 218 -GPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTV 262

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 9e-59
 Identities = 65/272 (23%), Positives = 113/272 (41%), Gaps = 29/272 (10%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
            ++G+G FG VYK Q      + A K + +KS +   +++ EI +++   HPN+VK+   
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
               + L ++ E+    ++   +   E     L     Q +C      L +LH+    KI
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLELERP---LTESQIQVVCKQTLDALNYLHD---NKI 131

Query: 365 VHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALW-----G 419
           +HRD+KA N+L   D + K++DFG++  +        + I GT  +MAPE  +       
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDR 190

Query: 420 YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLG 479
              YKADV+S GI  +E+   +                +     + +          R  
Sbjct: 191 PYDYKADVWSLGITLIEMAEIE--------PPHHELNPMRVLLKIAKSEPPTLAQPSRW- 241

Query: 480 SKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                   +  +K   L  N     R T S++
Sbjct: 242 ----SSNFKDFLK-KCLEKN--VDARWTTSQL 266

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 6e-58
 Identities = 71/293 (24%), Positives = 127/293 (43%), Gaps = 30/293 (10%)

Query: 223 SDLQTISFTLKQIKAA---TNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQ 278
           SD + +   L+ I +       +   +KIG+G  G VY    +A G  +A++Q++ + + 
Sbjct: 1   SDEEILE-KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP 59

Query: 279 GNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELD 338
                +NEI ++   ++PN+V      + GD+L +V EY+   SL   +          D
Sbjct: 60  KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-----D 114

Query: 339 WPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT 398
                 +C    + L FLH     +++HRDIK+ N+LL  D + K++DFG       +++
Sbjct: 115 EGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171

Query: 399 HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLL 458
             ST + GT  +MAPE         K D++S GI+A+E++ G+          +     L
Sbjct: 172 KRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE--------PPYLNENPL 222

Query: 459 DWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                +  +G       E+L            +     C +     R +  E+
Sbjct: 223 RALYLIATNGTPELQNPEKL-----SAIFRDFLN---RCLDMDVEKRGSAKEL 267

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 2e-57
 Identities = 65/289 (22%), Positives = 116/289 (40%), Gaps = 39/289 (13%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQLADG---TIIAVKQLS-SKSRQGNREFLNEIAMISCL-Q 294
           N+      IGEG FG V K ++         A+K++    S+  +R+F  E+ ++  L  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELE------------LDWPTR 342
           HPN++ + G C     L L  EY  + +L   L      E +            L     
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 343 QKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHIST 402
                 +ARG+ +L ++   + +HRD+ A N+L+  +   KI+DFGL++  E       T
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--T 184

Query: 403 RIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWAC 462
                + +MA E   +   T  +DV+S+G++  EIVS                       
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG--------------- 229

Query: 463 HLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                 +L E + +    +      + +  +   C    P  RP+ +++
Sbjct: 230 --MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 276

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 4e-57
 Identities = 64/287 (22%), Positives = 125/287 (43%), Gaps = 33/287 (11%)

Query: 232 LKQIKAATNNFDSAKKIGEGGFGPVYKGQLAD-----GTIIAVKQLS-SKSRQGNREFLN 285
           L+ +K     F   K +G G FG VYKG            +A+K+L  + S + N+E L+
Sbjct: 3   LRILKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 60

Query: 286 EIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKI 345
           E  +++ + +P++ ++ G C+    + L+ + M    L   +   ++             
Sbjct: 61  EAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNI---GSQYLLNW 116

Query: 346 CLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRI 404
           C+ IA+G+ +L +    ++VHRD+ A NVL+    + KI+DFGLAK L   +K + +   
Sbjct: 117 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 173

Query: 405 AGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHL 464
              I +MA E  L    T+++DV+S+G+   E+++  +                      
Sbjct: 174 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS-----------------KPYDG 216

Query: 465 QQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
               ++  ++++             +  + + C       RP   E+
Sbjct: 217 IPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFREL 263

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 6e-57
 Identities = 62/276 (22%), Positives = 111/276 (40%), Gaps = 33/276 (11%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK---SRQGNREFLNEIAMISCLQH 295
            +F+  + +G+G FG VY  +      I+A+K L            +   E+ + S L+H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           PN+++++G   +  ++ L+ EY    ++   L          D          +A  L++
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSY 121

Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEY 415
            H +   +++HRDIK  N+LL      KI+DFG +      +      + GT+ Y+ PE 
Sbjct: 122 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEM 175

Query: 416 ALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD 475
                   K D++S G++  E + GK         E        +    + +    + V 
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-------YKRISRVEFTFPDFVT 228

Query: 476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                    E A  +I         +PS RP + EV
Sbjct: 229 ---------EGARDLIS---RLLKHNPSQRPMLREV 252

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 5e-56
 Identities = 66/286 (23%), Positives = 120/286 (41%), Gaps = 34/286 (11%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQL------ADGTIIAVKQLS-SKSRQGNREFLNEIAMISC 292
                ++++G+G FG VY+G           T +A+K ++ + S +   EFLNE +++  
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 293 LQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCEL------ELDWPTRQKIC 346
               ++V++ G   +G   L++ E M    L   L                      ++ 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 347 LGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK-LDEGDKTHISTRIA 405
             IA G+A+L+     K VHRD+ A N ++  D   KI DFG+ + + E D      +  
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 406 GTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQ 465
             + +M+PE    G  T  +DV+SFG+V  EI +         + E              
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--------QVLRFV 248

Query: 466 QDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
            +G L++  D            + + ++  +C   +P +RP+  E+
Sbjct: 249 MEGGLLDKPD---------NCPDMLFELMRMCWQYNPKMRPSFLEI 285

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 2e-55
 Identities = 56/281 (19%), Positives = 108/281 (38%), Gaps = 32/281 (11%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQL----ADGTIIAVKQLSSK---SRQGNREFLNEIAMISC 292
            +    +K+G+G FG V +G+          +AVK L        +   +F+ E+  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 293 LQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARG 352
           L H NL++++G  +    + +V E     SL   L   +         T  +  + +A G
Sbjct: 68  LDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEG 123

Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL--DEGDKTHISTRIAGTIGY 410
           + +L  +   + +HRD+ A N+LL      KI DFGL +      D   +         +
Sbjct: 124 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180

Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKL 470
            APE       ++ +D + FG+   E+ +        P   +           + ++G+ 
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYG----QEP---WIGLNGSQILHKIDKEGER 233

Query: 471 VELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           +   +         +  + +  V + C    P  RPT   +
Sbjct: 234 LPRPE---------DCPQDIYNVMVQCWAHKPEDRPTFVAL 265

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  186 bits (473), Expect = 5e-55
 Identities = 60/275 (21%), Positives = 115/275 (41%), Gaps = 26/275 (9%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNL 298
           +++D  +++G G FG V++    A G   A K + +           EI  +S L+HP L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
           V +H    + ++++++YE+M    L   +    N    +      +    + +GL  +HE
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK---MSEDEAVEYMRQVCKGLCHMHE 142

Query: 359 ESRFKIVHRDIKATNVLLDRDLNP--KISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYA 416
                 VH D+K  N++     +   K+ DFGL    +  ++   T   GT  + APE A
Sbjct: 143 N---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVA 197

Query: 417 LWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDE 476
               + Y  D++S G+++  ++SG +        E               D  + +    
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-------LRNVKSCDWNMDDSAFS 250

Query: 477 RLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
            +      E+ +  I+  LL  +  P+ R T+ + 
Sbjct: 251 GIS-----EDGKDFIR-KLLLAD--PNTRMTIHQA 277

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 6e-55
 Identities = 62/277 (22%), Positives = 111/277 (40%), Gaps = 29/277 (10%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQLAD----GTIIAVKQLSSKSRQGNRE-FLNEIAMISCLQ 294
              +  + IGEG FG V++G           +A+K   + +    RE FL E   +    
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HP++VK+ G   E + + ++ E      L       +  +  LD  +       ++  LA
Sbjct: 67  HPHIVKLIGVITE-NPVWIIMELCTLGEL---RSFLQVRKYSLDLASLILYAYQLSTALA 122

Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPE 414
           +L  +   + VHRDI A NVL+  +   K+ DFGL++  E    + +++    I +MAPE
Sbjct: 123 YLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179

Query: 415 YALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV 474
              +   T  +DV+ FG+   EI+         P                 ++  ++  +
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHG----VKP-------------FQGVKNNDVIGRI 222

Query: 475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           +              +  +   C    PS RP  +E+
Sbjct: 223 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 259

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 1e-53
 Identities = 72/294 (24%), Positives = 121/294 (41%), Gaps = 41/294 (13%)

Query: 240 NNFDSAKKIGEGGFGPVYKG------QLADGTIIAVKQLSSKSRQG-NREFLNEIA-MIS 291
           +     K +G G FG V +       + A    +AVK L   +    +R  ++E+  +I 
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 292 CLQHPNLVKIHGCCVE-GDQLLLVYEYMENNSLACALFGRENCELE------------LD 338
              H N+V + G C + G  L+++ E+ +  +L+  L  + N  +             L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 339 WPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT 398
                     +A+G+ FL      K +HRD+ A N+LL      KI DFGLA+    D  
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 399 HI-STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCL 457
           ++        + +MAPE       T ++DV+SFG++  EI S   +        +    +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-------YPGVKI 242

Query: 458 LDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
            +  C   ++G  +   D              M +  L C +  PS RPT SE+
Sbjct: 243 DEEFCRRLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSEL 287

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 4e-52
 Identities = 72/295 (24%), Positives = 122/295 (41%), Gaps = 43/295 (14%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQL--------ADGTIIAVKQLSSKSRQGN-REFLNEIAMI 290
           +     K +GEG FG V   +            T +AVK L S + + +  + ++E+ M+
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 291 SCL-QHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELE------------L 337
             + +H N++ + G C +   L ++ EY    +L   L  R    LE            L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 338 DWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK 397
                      +ARG+ +L  +   K +HRD+ A NVL+  D   KI+DFGLA+      
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 398 THIST-RIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTC 456
            +  T      + +MAPE       T+++DV+SFG++  EI +   +      +E     
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----- 244

Query: 457 LLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                       +L +L+ E             +  +   C +A PS RPT  ++
Sbjct: 245 ------------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 287

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  177 bits (450), Expect = 1e-51
 Identities = 61/275 (22%), Positives = 113/275 (41%), Gaps = 26/275 (9%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNL 298
           + +D  +++G G FG V++    A G +   K +++          NEI++++ L HP L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 299 VKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHE 358
           + +H    +  +++L+ E++    L   +   +    ++              GL  +HE
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY---KMSEAEVINYMRQACEGLKHMHE 145

Query: 359 ESRFKIVHRDIKATNVLLDRDLNP--KISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYA 416
                IVH DIK  N++ +       KI DFGLA     D+    T    T  + APE  
Sbjct: 146 H---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIV 200

Query: 417 LWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDE 476
               + +  D+++ G++   ++SG +  +    LE             + D +  E    
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET-------LQNVKRCDWEFDEDAFS 253

Query: 477 RLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
            +       EA+  IK +LL     P  R T+ + 
Sbjct: 254 SVS-----PEAKDFIK-NLLQKE--PRKRLTVHDA 280

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 3e-51
 Identities = 61/286 (21%), Positives = 111/286 (38%), Gaps = 41/286 (14%)

Query: 236 KAATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSK---SRQGNREFLNEIAMIS 291
           K    +F   K +GEG F  V   + LA     A+K L  +             E  ++S
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63

Query: 292 CLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIAR 351
            L HP  VK++    + ++L     Y +N  L   +    +     D    +     I  
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVS 119

Query: 352 GLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL-DEGDKTHISTRIAGTIGY 410
            L +LH +    I+HRD+K  N+LL+ D++ +I+DFG AK+     K   +    GT  Y
Sbjct: 120 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 176

Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKL 470
           ++PE          +D+++ G +  ++V+G                         + G  
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGL---------------------PPFRAGNE 215

Query: 471 VELVDERLGSKYK-----KEEAERMIKVSLLCTNASPSLRPTMSEV 511
             +  + +  +Y        +A  +++  LL  +   + R    E+
Sbjct: 216 YLIFQKIIKLEYDFPEKFFPKARDLVE-KLLVLD--ATKRLGCEEM 258

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  168 bits (427), Expect = 3e-48
 Identities = 72/279 (25%), Positives = 108/279 (38%), Gaps = 34/279 (12%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSK---SRQGNREFLNEIAMISCLQ- 294
           N+F   + IG GGFG VY  + AD G + A+K L  K    +QG    LNE  M+S +  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 295 --HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARG 352
              P +V +       D+L  + + M    L   L               +     I  G
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF----SEADMRFYAAEIILG 119

Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMA 412
           L  +H      +V+RD+K  N+LLD   + +ISD GLA      K H S    GT GYMA
Sbjct: 120 LEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 173

Query: 413 PEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLV 471
           PE    G      AD +S G +  +++ G +         F      D     +    + 
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP--------FRQHKTKDKHEIDRMTLTMA 225

Query: 472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSE 510
             + +         E   +++  LL  +   + R     
Sbjct: 226 VELPDSFS-----PELRSLLE-GLLQRD--VNRRLGCLG 256

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 8e-48
 Identities = 58/284 (20%), Positives = 118/284 (41%), Gaps = 19/284 (6%)

Query: 241 NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQL--SSKSRQGNREFLNEIAMISCLQHPN 297
           NF   +KIGEG +G VYK +    G ++A+K++   +++       + EI+++  L HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH 357
           +VK+       ++L LV+E++  +      F   +    +  P  +     + +GLAF H
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLK---KFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYAL 417
                +++HRD+K  N+L++ +   K++DFGLA+         +  +             
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176

Query: 418 WGYLTYKADVYSFGIVALEIVSGK---NNMSYAPALEFDCTCLLDWACHLQQDGKLVELV 474
             Y +   D++S G +  E+V+ +      S    L      L      +      +   
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236

Query: 475 DERLGSKYKKEEAERMIKVS-----LL--CTNASPSLRPTMSEV 511
                   +++ ++ +  +      LL    +  P+ R +    
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  164 bits (417), Expect = 2e-47
 Identities = 62/284 (21%), Positives = 118/284 (41%), Gaps = 29/284 (10%)

Query: 233 KQIKAATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNRE-FLNEIAMI 290
           KQ +   + +D    +G G F  V   +      ++A+K ++ K+ +G      NEIA++
Sbjct: 2   KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61

Query: 291 SCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
             ++HPN+V +      G  L L+ + +    L   +  +             ++   + 
Sbjct: 62  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF----YTERDASRLIFQVL 117

Query: 351 RGLAFLHEESRFKIVHRDIKATNVLL---DRDLNPKISDFGLAKLDEGDKTHISTRIAGT 407
             + +LH+     IVHRD+K  N+L    D D    ISDFGL+K++  D   + +   GT
Sbjct: 118 DAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGT 172

Query: 408 IGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD 467
            GY+APE       +   D +S G++A  ++ G          +        +   L+ +
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL-------FEQILKAE 225

Query: 468 GKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
            +      + +      + A+  I+  L+  +  P  R T  + 
Sbjct: 226 YEFDSPYWDDIS-----DSAKDFIR-HLMEKD--PEKRFTCEQA 261

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 1e-46
 Identities = 62/293 (21%), Positives = 112/293 (38%), Gaps = 27/293 (9%)

Query: 239 TNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNRE-FLNEIAMISCLQHP 296
              + +   IGEG +G V       +   +A+K++S    Q   +  L EI ++   +H 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFL 356
           N++ I+          +   Y+  + +   L+     +  L           I RGL ++
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 125

Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL--DEGDKTHISTRIAGTIGYMAPE 414
           H      ++HRD+K +N+LL+   + KI DFGLA++   + D T   T    T  Y APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 415 YALWG-YLTYKADVYSFGIVALEIVSGKN---------------NMSYAPALEFDCTCLL 458
             L     T   D++S G +  E++S +                 +  +P+ E     + 
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 459 DWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
             A +          V           +A  ++   +L  N  P  R  + + 
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD-KMLTFN--PHKRIEVEQA 292

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 1e-46
 Identities = 49/269 (18%), Positives = 95/269 (35%), Gaps = 27/269 (10%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
           + +G G FG V++    +       K +  K          EI++++  +H N++ +H  
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHES 69

Query: 305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKI 364
               ++L++++E++    +   +        EL+          +   L FLH      I
Sbjct: 70  FESMEELVMIFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCEALQFLHS---HNI 123

Query: 365 VHRDIKATNVLLDRDLNP--KISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLT 422
            H DI+  N++     +   KI +FG A+  +               Y APE      ++
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHDVVS 181

Query: 423 YKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKY 482
              D++S G +   ++SG N        +            +  +    E   + +    
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQI-------IENIMNAEYTFDEEAFKEIS--- 231

Query: 483 KKEEAERMIKVSLLCTNASPSLRPTMSEV 511
              EA   +   LL        R T SE 
Sbjct: 232 --IEAMDFVD-RLLVKE--RKSRMTASEA 255

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  160 bits (405), Expect = 5e-46
 Identities = 63/284 (22%), Positives = 116/284 (40%), Gaps = 19/284 (6%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQL--SSKSRQGNREFLNEIAMISCLQHPN 297
             +   +KIGEG +G VYK Q   G   A+K++    +        + EI+++  L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH 357
           +VK++       +L+LV+E+++ +         + CE  L+  T +   L +  G+A+ H
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKL----LDVCEGGLESVTAKSFLLQLLNGIAYCH 117

Query: 358 EESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYAL 417
           +    +++HRD+K  N+L++R+   KI+DFGLA+         +  I             
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174

Query: 418 WGYLTYKADVYSFGIVALEIVSGK---NNMSYAPALEFDCTCLLDWACHLQQDGKLVELV 474
               +   D++S G +  E+V+G      +S A  L      L         +   +   
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234

Query: 475 DERLGSKYKKEEAERMIKVS-----LL--CTNASPSLRPTMSEV 511
           D              +  +      LL       P+ R T  + 
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  159 bits (404), Expect = 2e-45
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 15/206 (7%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSK---SRQGNREFLNEIAMISCLQH 295
            +F   + +G G FG V+  +   +G   A+K L  +     +      +E  M+S + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           P ++++ G   +  Q+ ++ +Y+E       LF           P  +     +   L +
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFYAAEVCLALEY 119

Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEY 415
           LH +    I++RD+K  N+LLD++ + KI+DFG AK            + GT  Y+APE 
Sbjct: 120 LHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEV 172

Query: 416 ALWGYLTYKADVYSFGIVALEIVSGK 441
                     D +SFGI+  E+++G 
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGY 198

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 4e-45
 Identities = 67/285 (23%), Positives = 110/285 (38%), Gaps = 30/285 (10%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQG-----NREFLNEIAMISCLQHPNLV 299
             +GEG F  VYK +      I+A+K++    R       NR  L EI ++  L HPN++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 300 KIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
            +         + LV+++ME           ++  L L     +   L   +GL +LH+ 
Sbjct: 64  GLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119

Query: 360 SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYAL-W 418
               I+HRD+K  N+LLD +   K++DFGLAK   G      T    T  Y APE     
Sbjct: 120 ---WILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNRAYTHQVVTRWYRAPELLFGA 175

Query: 419 GYLTYKADVYSFGIVALEIVSGK------NNMS----YAPALEFDCTCLLDWACHLQQDG 468
                  D+++ G +  E++         +++         L           C L    
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235

Query: 469 KLVELVDERLGSKYKK--EEAERMIKVSLLCTNASPSLRPTMSEV 511
                    L   +    ++   +I+  L   N  P  R T ++ 
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQ-GLFLFN--PCARITATQA 277

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (399), Expect = 6e-45
 Identities = 63/291 (21%), Positives = 117/291 (40%), Gaps = 22/291 (7%)

Query: 238 ATNNFDSAKKIGEGGFGPVYKGQ--LADGTIIAVKQLSSKSRQGN--REFLNEIA---MI 290
           A   ++   +IGEG +G V+K +     G  +A+K++  ++ +       + E+A    +
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 291 SCLQHPNLVKIHGCCVEG--DQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLG 348
              +HPN+V++   C     D+   +    E+       +  +  E  +   T + +   
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTI 408
           + RGL FLH     ++VHRD+K  N+L+      K++DFGLA++         T +  T+
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTL 179

Query: 409 GYMAPEYALWGYLTYKADVYSFGIVALEIVSGK---NNMSYAPALEFDCTCLL-----DW 460
            Y APE  L        D++S G +  E+   K      S    L      +      DW
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239

Query: 461 ACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
              +    +       +   K+  +  E    + L C   +P+ R +    
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  155 bits (393), Expect = 4e-44
 Identities = 56/283 (19%), Positives = 99/283 (34%), Gaps = 31/283 (10%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNL 298
           N +   +KIG G FG +Y G  +A G  +A+K    K++    +   E  +   +Q    
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64

Query: 299 VK-IHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH 357
           +  I  C  EGD  ++V E +  +           C  +    T   +   +   + ++H
Sbjct: 65  IPTIRWCGAEGDYNVMVMELLGPSLE----DLFNFCSRKFSLKTVLLLADQMISRIEYIH 120

Query: 358 EESRFKIVHRDIKATNVL---LDRDLNPKISDFGLAKLDEGDKTHI------STRIAGTI 408
            +     +HRD+K  N L     +     I DFGLAK     +TH       +  + GT 
Sbjct: 121 SK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177

Query: 409 GYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDG 468
            Y +    L    + + D+ S G V +    G         L +            ++  
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGS--------LPWQGLKAATKRQKYERIS 229

Query: 469 KLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           +        +  K    E    +     C +     +P  S +
Sbjct: 230 EKKMSTPIEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYL 269

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 4e-44
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 13/207 (6%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNRE---FLNEIAMIS-CLQ 294
            +F   K +G+G FG V+  +        A+K L       + +    + E  ++S   +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 295 HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLA 354
           HP L  +       + L  V EY+    L   +        + D          I  GL 
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQ 117

Query: 355 FLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPE 414
           FLH +    IV+RD+K  N+LLD+D + KI+DFG+ K +       +T   GT  Y+APE
Sbjct: 118 FLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPE 173

Query: 415 YALWGYLTYKADVYSFGIVALEIVSGK 441
             L     +  D +SFG++  E++ G+
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ 200

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  154 bits (390), Expect = 6e-44
 Identities = 56/288 (19%), Positives = 108/288 (37%), Gaps = 41/288 (14%)

Query: 241 NFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLS---------SKSRQGNREFLNEIAMI 290
           N++  + +G G    V +          AVK +           + ++     L E+ ++
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 291 SCLQ-HPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGI 349
             +  HPN++++           LV++ M+   L   L  +      L     +KI   +
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRAL 119

Query: 350 ARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIG 409
              +  LH+     IVHRD+K  N+LLD D+N K++DFG +   + D       + GT  
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC--QLDPGEKLREVCGTPS 174

Query: 410 YMAPEYALWG------YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACH 463
           Y+APE               + D++S G++   +++G                   W   
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS---------------PPFWHRK 219

Query: 464 LQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                +++   + + GS    + ++ +  +        P  R T  E 
Sbjct: 220 QMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  153 bits (387), Expect = 1e-43
 Identities = 50/213 (23%), Positives = 95/213 (44%), Gaps = 17/213 (7%)

Query: 239 TNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLS---SKSRQGNREFLNEIAMISCLQ 294
           ++ ++  + +G GG   V+  + L     +AVK L    ++       F  E    + L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 295 HPNLVKIHGCCVE----GDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           HP +V ++         G    +V EY++  +L   +         +      ++     
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADAC 121

Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL--DEGDKTHISTRIAGTI 408
           + L F H+     I+HRD+K  N+++      K+ DFG+A+   D G+    +  + GT 
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178

Query: 409 GYMAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
            Y++PE A    +  ++DVYS G V  E+++G+
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 211

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 2e-43
 Identities = 63/283 (22%), Positives = 118/283 (41%), Gaps = 35/283 (12%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNR------EFLNEIAMISC 292
           + +D+ +++G G F  V K +  + G   A K +  +  + +R      +   E++++  
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 293 LQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARG 352
           +QHPN++ +H        ++L+ E +    L   L  +E+    L      +    I  G
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEEATEFLKQILNG 125

Query: 353 LAFLHEESRFKIVHRDIKATNVLLDRDLNP----KISDFGLAKLDEGDKTHISTRIAGTI 408
           + +LH     +I H D+K  N++L     P    KI DFGLA   + D  +    I GT 
Sbjct: 126 VYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIFGTP 180

Query: 409 GYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDG 468
            ++APE   +  L  +AD++S G++   ++SG +        E         A     + 
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANVSAVNY 233

Query: 469 KLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
           +  +              A+  I+  LL  +  P  R T+ + 
Sbjct: 234 EFEDEYFSNTS-----ALAKDFIR-RLLVKD--PKKRMTIQDS 268

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 4e-42
 Identities = 65/303 (21%), Positives = 121/303 (39%), Gaps = 41/303 (13%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGN--REFLNEIAMISCLQHP 296
           + ++   KIG+G FG V+K +    G  +A+K++  ++ +       L EI ++  L+H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 297 NLVKIHGCCVEGD--------QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLG 348
           N+V +   C             + LV+++ E++              +      +++   
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV----KFTLSEIKRVMQM 125

Query: 349 IARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK---LDEGDKTHISTRIA 405
           +  GL ++H     KI+HRD+KA NVL+ RD   K++DFGLA+   L +  + +  T   
Sbjct: 126 LLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182

Query: 406 GTIGYMAPEYAL-WGYLTYKADVYSFGIVALEIVSGK---NNMSYAPALEFDCTCLLDWA 461
            T+ Y  PE  L         D++  G +  E+ +        +    L           
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242

Query: 462 CHLQQDGKLVEL-------------VDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTM 508
             +  +    EL             V +RL +  +   A  +I   LL  +  P+ R   
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID-KLLVLD--PAQRIDS 299

Query: 509 SEV 511
            + 
Sbjct: 300 DDA 302

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (378), Expect = 1e-41
 Identities = 55/275 (20%), Positives = 100/275 (36%), Gaps = 32/275 (11%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEI-AMISCLQHPNLVKIHG 303
           + +G G  G V +          A+K L    +        E+       Q P++V+I  
Sbjct: 18  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVD 72

Query: 304 CC----VEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE 359
                      LL+V E ++   L   +  ++  +         +I   I   + +LH  
Sbjct: 73  VYENLYAGRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLHSI 130

Query: 360 SRFKIVHRDIKATNVLLDRDLNP---KISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYA 416
               I HRD+K  N+L          K++DFG AK      +  +     T  Y+APE  
Sbjct: 131 ---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVL 185

Query: 417 LWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDE 476
                    D++S G++   ++ G           F     L  +  ++   ++ +    
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGY--------PPFYSNHGLAISPGMKTRIRMGQYEFP 237

Query: 477 RLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                   EE + +I+ +LL T   P+ R T++E 
Sbjct: 238 NPEWSEVSEEVKMLIR-NLLKTE--PTQRMTITEF 269

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 1e-41
 Identities = 68/290 (23%), Positives = 113/290 (38%), Gaps = 29/290 (10%)

Query: 241 NFDSAKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLV 299
           ++   K IG G FG VY+ +L D G ++A+K++    R  NRE    + ++  L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 76

Query: 300 KIHGCCVEGDQ------LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGL 353
           ++        +      L LV +Y+       A       +  L     +     + R L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ-TLPVIYVKLYMYQLFRSL 135

Query: 354 AFLHEESRFKIVHRDIKATNVLLDRD-LNPKISDFGLAKLDEGDKTHISTRIAGTIGYMA 412
           A++H      I HRDIK  N+LLD D    K+ DFG AK     + ++S     +  Y A
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYRA 190

Query: 413 PEYALWG-YLTYKADVYSFGIVALEIVSGK-------NNMSYAPALEFDCTCLLDWACHL 464
           PE        T   DV+S G V  E++ G+               ++   T   +    +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250

Query: 465 Q---QDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
                + K  ++        ++       I +       +P+ R T  E 
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  148 bits (374), Expect = 2e-41
 Identities = 51/285 (17%), Positives = 99/285 (34%), Gaps = 33/285 (11%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQH-PN 297
            ++   ++IGEG FG +++G  L +   +A+K    +S     +  +E      L     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62

Query: 298 LVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLH 357
           +  ++    EG   +LV + +  +         + C  +    T       +   +  +H
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDL----LDLCGRKFSVKTVAMAAKQMLARVQSIH 118

Query: 358 EESRFKIVHRDIKATNVLLDRDLNP-----KISDFGLAKLDEGDKTHI------STRIAG 406
           E+    +V+RDIK  N L+ R  +       + DFG+ K      T           ++G
Sbjct: 119 EK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175

Query: 407 TIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQ 466
           T  YM+    L    + + D+ + G V +  + G                 L  A + Q+
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG-----------LKAATNKQK 224

Query: 467 DGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
             ++ E        +      E   K      N +    P    +
Sbjct: 225 YERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYL 269

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 4e-41
 Identities = 46/207 (22%), Positives = 77/207 (37%), Gaps = 20/207 (9%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNRE------FLNEIAMISCLQ--HP 296
             +G GGFG VY G  ++D   +A+K +         E         E+ ++  +     
Sbjct: 10  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69

Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFL 356
            ++++       D  +L+ E  E                 L     +     +   +   
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHC 126

Query: 357 HEESRFKIVHRDIKATNVLLDRD-LNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEY 415
           H      ++HRDIK  N+L+D +    K+ DFG   L +       T   GT  Y  PE+
Sbjct: 127 HNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEW 180

Query: 416 AL-WGYLTYKADVYSFGIVALEIVSGK 441
                Y    A V+S GI+  ++V G 
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGD 207

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 6e-40
 Identities = 53/286 (18%), Positives = 103/286 (36%), Gaps = 21/286 (7%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQL--SSKSRQGNREFLNEIAMISCLQHP 296
             ++  +KIGEG +G V+K +      I+A+K++             L EI ++  L+H 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 297 NLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFL 356
           N+V++H       +L LV+E+ + +          +     D    +     + +GL F 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL----DPEIVKSFLFQLLKGLGFC 117

Query: 357 HEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYA 416
           H      ++HRD+K  N+L++R+   K+++FGLA+         S  +            
Sbjct: 118 H---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174

Query: 417 LWGYLTYKADVYSFGIVALEIVSGK----NNMSYAPALEFDCTCLLDWACHLQQDGKLVE 472
                +   D++S G +  E+ +              L+     L             + 
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234

Query: 473 LVDERLGSKYKKEEAERMIKVS-----LL--CTNASPSLRPTMSEV 511
                            + K++     LL      +P  R +  E 
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 2e-39
 Identities = 57/206 (27%), Positives = 86/206 (41%), Gaps = 12/206 (5%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSK---SRQGNREFLNEIAMISCLQH 295
           N+FD  K +G+G FG V   +  A G   A+K L  +   ++      + E  ++   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           P L  +       D+L  V EY     L   L               +     I   L +
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV----FTEERARFYGAEIVSALEY 120

Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEY 415
           LH      +V+RDIK  N++LD+D + KI+DFGL K    D         GT  Y+APE 
Sbjct: 121 LHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEV 176

Query: 416 ALWGYLTYKADVYSFGIVALEIVSGK 441
                     D +  G+V  E++ G+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 2e-39
 Identities = 60/285 (21%), Positives = 110/285 (38%), Gaps = 29/285 (10%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQL--SSKSRQGNREFLNEIAMISCLQHPNLVKIH 302
           + +G G +G V        G  +A+K+L    +S    +    E+ ++  ++H N++ + 
Sbjct: 24  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83

Query: 303 GCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRF 362
                 + L    ++           G+     +L     Q +   + +GL ++H     
Sbjct: 84  DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA--- 140

Query: 363 KIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYAL-WGYL 421
            I+HRD+K  N+ ++ D   KI DFGLA+  + + T        T  Y APE  L W   
Sbjct: 141 GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG----YVVTRWYRAPEVILNWMRY 196

Query: 422 TYKADVYSFGIVALEIVSGKN---------------NMSYAPALEFDCTCLLDWACHLQQ 466
           T   D++S G +  E+++GK                 ++  P  EF      D A +  +
Sbjct: 197 TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMK 256

Query: 467 DGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
               +E  D           A  +++  +L  +     R T  E 
Sbjct: 257 GLPELEKKDFASILTNASPLAVNLLE-KMLVLD--AEQRVTAGEA 298

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  142 bits (358), Expect = 1e-38
 Identities = 60/262 (22%), Positives = 100/262 (38%), Gaps = 18/262 (6%)

Query: 215 KETAFMKESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLS 273
           KE     + D      T  Q  A  + FD  K +G G FG V   +    G   A+K L 
Sbjct: 16  KEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD 75

Query: 274 SKSRQGNRE---FLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGR 330
            +     ++    LNE  ++  +  P LVK+     +   L +V EY+    +   L   
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 135

Query: 331 ENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA 390
                    P  +     I     +LH      +++RD+K  N+L+D+    +++DFG A
Sbjct: 136 GR----FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFA 188

Query: 391 KLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK---NNMSYA 447
           K  +G    +     GT   +APE  L        D ++ G++  E+ +G          
Sbjct: 189 KRVKGRTWTLC----GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244

Query: 448 PALEFDCTCLLDWACHLQQDGK 469
              E   +  + +  H   D K
Sbjct: 245 QIYEKIVSGKVRFPSHFSSDLK 266

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 3e-36
 Identities = 57/231 (24%), Positives = 104/231 (45%), Gaps = 18/231 (7%)

Query: 222 ESDLQTISFTLKQIKAATNNFDSAKKIGEGGFGPVYKGQLA----DGTIIAVKQLS---- 273
           + +L+T + T    K    NF+  K +G G +G V+  +       G + A+K L     
Sbjct: 6   KHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATI 65

Query: 274 SKSRQGNREFLNEIAMISCLQH-PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGREN 332
            +  +       E  ++  ++  P LV +H       +L L+ +Y+    L   L  R  
Sbjct: 66  VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-- 123

Query: 333 CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL 392
                +  T  ++ + +   +  L    +  I++RDIK  N+LLD + +  ++DFGL+K 
Sbjct: 124 -----ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178

Query: 393 DEGDKTHISTRIAGTIGYMAPEYALWGYLTY--KADVYSFGIVALEIVSGK 441
              D+T  +    GTI YMAP+    G   +    D +S G++  E+++G 
Sbjct: 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 4e-35
 Identities = 65/307 (21%), Positives = 116/307 (37%), Gaps = 50/307 (16%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLS--SKSRQGNREFLNEIAMISCLQHP 296
             + + K IG G  G V           +A+K+LS   +++   +    E+ ++ C+ H 
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 297 NLVKIHGCCV------EGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIA 350
           N++ +           E   + LV E M+ N         +  ++ELD      +   + 
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLC-------QVIQMELDHERMSYLLYQML 129

Query: 351 RGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGY 410
            G+  LH      I+HRD+K +N+++  D   KI DFGLA+      + + T    T  Y
Sbjct: 130 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYY 184

Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSGKN---------------NMSYAPALEFDCT 455
            APE  L        D++S G +  E+V  K                     P  EF   
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244

Query: 456 CLLDWACHLQQDGKLVELVDERL-----------GSKYKKEEAERMIKVSLLCTNASPSL 504
                  +++   K   L   +L            +K K  +A  ++   +L  +  P+ 
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS-KMLVID--PAK 301

Query: 505 RPTMSEV 511
           R ++ + 
Sbjct: 302 RISVDDA 308

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 8e-35
 Identities = 59/292 (20%), Positives = 110/292 (37%), Gaps = 29/292 (9%)

Query: 239 TNNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLS--SKSRQGNREFLNEIAMISCLQH 295
              + +   +G G +G V        G  +AVK+LS   +S    +    E+ ++  ++H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
            N++ +         L    +      L  A         +L     Q +   I RGL +
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEY 415
           +H      I+HRD+K +N+ ++ D   KI DFGLA+  + + T        T  Y APE 
Sbjct: 137 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEI 189

Query: 416 AL-WGYLTYKADVYSFGIVALEIVSGKN---------------NMSYAPALEFDCTCLLD 459
            L W +     D++S G +  E+++G+                 +   P  E       +
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249

Query: 460 WACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV 511
            A +  Q    +  ++           A  +++  +L  +     R T ++ 
Sbjct: 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLE-KMLVLD--SDKRITAAQA 298

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  128 bits (321), Expect = 1e-33
 Identities = 50/300 (16%), Positives = 113/300 (37%), Gaps = 46/300 (15%)

Query: 240 NNFDSAKKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ-HPN 297
           +++   +K+G G +  V++   + +   + VK L    ++   +   EI ++  L+  PN
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPN 91

Query: 298 LVKIHGCCVE--GDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
           ++ +     +       LV+E++ N      L+        L     +     I + L +
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFK-QLYQT------LTDYDIRFYMYEILKALDY 144

Query: 356 LHEESRFKIVHRDIKATNVLLDRD-LNPKISDFGLAKLDEGDKTHISTRIAGTIGYMAPE 414
            H      I+HRD+K  NV++D +    ++ D+GLA+     + +       +  +  PE
Sbjct: 145 CHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPE 199

Query: 415 YAL-WGYLTYKADVYSFGIVALEIVSGKN-----------NMSYAPALEFDCTCLLDWAC 462
             + +    Y  D++S G +   ++  K             +  A  L  +         
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259

Query: 463 HLQQDGKLVELVDERLGSKYKK-----------EEAERMIKVSLLCTNASPSLRPTMSEV 511
           +++ D +  +++      ++++            EA   +   LL  +     R T  E 
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLD-KLLRYD--HQSRLTAREA 316

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  113 bits (283), Expect = 2e-28
 Identities = 40/211 (18%), Positives = 76/211 (36%), Gaps = 18/211 (8%)

Query: 246 KKIGEGGFGPVYKGQ-LADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGC 304
           +K+G G F  V+  + + + T +A+K +    +       +EI ++  +   +  K    
Sbjct: 19  RKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77

Query: 305 CVEGDQLLLVYEY------------MENNSLACALFGRENCELELDWPTRQKICLGIARG 352
                  LL +               E          ++     +     ++I   +  G
Sbjct: 78  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137

Query: 353 LAFLHEESRFKIVHRDIKATNVLLDR-DLNPKISDFGLAKLDEGDKTHISTR-IAGTIGY 410
           L ++H   R  I+H DIK  NVL++  D    +    +A L               T  Y
Sbjct: 138 LDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195

Query: 411 MAPEYALWGYLTYKADVYSFGIVALEIVSGK 441
            +PE  L       AD++S   +  E+++G 
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 89.8 bits (222), Expect = 2e-21
 Identities = 26/156 (16%), Positives = 42/156 (26%), Gaps = 21/156 (13%)

Query: 246 KKIGEGGFGPVYKGQLADGTIIAVKQLSSKSR----------QGNREFLNEIAMISCLQH 295
           K +GEG    V+           VK                  G+  F       +  + 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 296 PNLVKIHGCCVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAF 355
             L K+ G  V          Y    +              +      ++   I   +A 
Sbjct: 66  RALQKLQGLAV-------PKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAK 118

Query: 356 LHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAK 391
            +      IVH D+   NVL+  +    I DF  + 
Sbjct: 119 FY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	511
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.88
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.52
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.87
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.32
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.23
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.55
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.75
d2o14a1	146	Hypothetical protein YxiM {Bacillus subtilis [TaxI	89.96

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=414.11  Aligned_cols=247  Identities=26%  Similarity=0.445  Sum_probs=195.4

Q ss_pred             cCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecC
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYME  319 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~  319 (511)
                      ++|+..++||+|+||.||+|++.+++.||||+++.. ....++|.+|+.++++++|||||+++|+|.+++..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            578889999999999999999888889999999753 3445789999999999999999999999999999999999999


Q ss_pred             CCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCce
Q 045835          320 NNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH  399 (511)
Q Consensus       320 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~  399 (511)
                      +|+|.+++....   ..++|..+..++.|+|.||+|||+.+   |+||||||+|||+++++.+||+|||+++........
T Consensus        84 ~g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~  157 (263)
T d1sm2a_          84 HGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  157 (263)
T ss_dssp             TCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred             CCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce
Confidence            999999986543   35899999999999999999999986   999999999999999999999999999876554444


Q ss_pred             eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhh
Q 045835          400 ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSG-KNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERL  478 (511)
Q Consensus       400 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG-~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  478 (511)
                      ......||..|+|||++.+..++.++|||||||++|||+|+ ++|+....        ..+          +.+.+....
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--------~~~----------~~~~i~~~~  219 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------NSE----------VVEDISTGF  219 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--------HHH----------HHHHHHHTC
T ss_pred             eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC--------HHH----------HHHHHHhcC
Confidence            44456789999999999999999999999999999999995 54443211        111          111222222


Q ss_pred             CCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          479 GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       479 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +...+..++.++.+++.+||+.+|++||||+||
T Consensus       220 ~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~i  252 (263)
T d1sm2a_         220 RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRL  252 (263)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCccccCHHHHHHHHHHccCCHhHCcCHHHH
Confidence            333444556678999999999999999999874

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-53  Score=412.77  Aligned_cols=249  Identities=30%  Similarity=0.457  Sum_probs=204.9

Q ss_pred             hcCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      .++|++.++||+|+||.||+|++++++.||||+++... ...++|.+|+.++++++|||||+++|+|.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            35788899999999999999999888999999997543 445789999999999999999999998865 5678999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      ++|+|.+++....  ...++|..+++|+.||++||+|||+.+   |+||||||+||||++++.+||+|||+++.......
T Consensus        90 ~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~  164 (272)
T d1qpca_          90 ENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (272)
T ss_dssp             TTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             CCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcc
Confidence            9999999875432  235999999999999999999999986   99999999999999999999999999997765555


Q ss_pred             eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhh
Q 045835          399 HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERL  478 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  478 (511)
                      .......||+.|||||++.++.++.++|||||||++|||+||+.|+....    ...             .+.+.+....
T Consensus       165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~----~~~-------------~~~~~i~~~~  227 (272)
T d1qpca_         165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM----TNP-------------EVIQNLERGY  227 (272)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC----CHH-------------HHHHHHHTTC
T ss_pred             ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC----CHH-------------HHHHHHHhcC
Confidence            55555678999999999999999999999999999999999765543221    100             1111122222


Q ss_pred             CCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          479 GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       479 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +...+...+.++.+|+.+||+.+|++||||.||
T Consensus       228 ~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei  260 (272)
T d1qpca_         228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYL  260 (272)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHH
Confidence            233344556679999999999999999999874

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.8e-53  Score=416.12  Aligned_cols=250  Identities=26%  Similarity=0.425  Sum_probs=211.7

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      .++|++.++||+|+||.||+|+.. +++.||||+++... ...++|.+|+.+|++++|||||+++|+|.+++..++||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            467888999999999999999865 58899999997543 3456899999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +++|+|.+++....  ...++|..+..++.|||.||+|||+++   |+||||||+||||++++.+||+|||+++......
T Consensus        95 ~~~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~  169 (287)
T d1opja_          95 MTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  169 (287)
T ss_dssp             CTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred             ccCcchHHHhhhcc--ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence            99999999997543  246899999999999999999999986   9999999999999999999999999999776655


Q ss_pred             ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          398 THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                      ........|++.|+|||++.++.++.++|||||||++|||++|+.|+.....                 ...+.+.+...
T Consensus       170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-----------------~~~~~~~i~~~  232 (287)
T d1opja_         170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----------------LSQVYELLEKD  232 (287)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-----------------HHHHHHHHHTT
T ss_pred             ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-----------------HHHHHHHHhcC
Confidence            5555556789999999999999999999999999999999998776642211                 01123334444


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....+...+.++.+|+.+||+.||++||||.||
T Consensus       233 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei  266 (287)
T d1opja_         233 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI  266 (287)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHH
Confidence            4445555667789999999999999999999874

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-52  Score=402.62  Aligned_cols=247  Identities=24%  Similarity=0.411  Sum_probs=209.0

Q ss_pred             cCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecC
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYME  319 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~  319 (511)
                      ++|+..++||+|+||.||+|++++++.||||+++... ...++|++|+.++++++||||++++|+|.+.+..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            6899999999999999999999888899999997643 345789999999999999999999999999999999999999


Q ss_pred             CCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCce
Q 045835          320 NNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH  399 (511)
Q Consensus       320 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~  399 (511)
                      +|+|..++....   ..+++..+.+++.|+|+||+|||+.+   |+||||||+|||+++++.+||+|||+++........
T Consensus        83 ~g~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~  156 (258)
T d1k2pa_          83 NGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT  156 (258)
T ss_dssp             TEEHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred             CCcHHHhhhccc---cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence            999999976543   35899999999999999999999986   999999999999999999999999999865544443


Q ss_pred             eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhh
Q 045835          400 ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERL  478 (511)
Q Consensus       400 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  478 (511)
                      ......||..|+|||.+....++.++|||||||++|||+| |+.||.....     .             ++...+....
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~-----~-------------~~~~~i~~~~  218 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-----S-------------ETAEHIAQGL  218 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH-----H-------------HHHHHHHTTC
T ss_pred             eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH-----H-------------HHHHHHHhCC
Confidence            3444678999999999999999999999999999999998 8988864321     0             1111122222


Q ss_pred             CCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          479 GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       479 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +...|...+..+.+++.+||+.+|++|||++||
T Consensus       219 ~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei  251 (258)
T d1k2pa_         219 RLYRPHLASEKVYTIMYSCWHEKADERPTFKIL  251 (258)
T ss_dssp             CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred             CCCCcccccHHHHHHHHHHccCCHhHCcCHHHH
Confidence            333445556789999999999999999999874

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-52  Score=413.14  Aligned_cols=247  Identities=27%  Similarity=0.470  Sum_probs=192.1

Q ss_pred             CCcccCceeccCceeEEecccc-CC---cEEEEEEeccc-CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQLA-DG---TIIAVKQLSSK-SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~~-~g---~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      +|++.++||+|+||.||+|+.. ++   ..||||++... .....++|.+|+.+|++++|||||+++|+|.+++..++||
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~  106 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT  106 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence            4566789999999999999864 22   36899998654 3344567999999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      |||++|+|.+++....   ..++|.++.+++.|||+||+|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus       107 Ey~~~g~L~~~~~~~~---~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         107 EFMENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             ECCTTEEHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EecCCCcceeeecccc---CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence            9999999999886543   35899999999999999999999986   99999999999999999999999999986544


Q ss_pred             CCcee----ecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCch
Q 045835          396 DKTHI----STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKL  470 (511)
Q Consensus       396 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  470 (511)
                      .....    .....||+.|||||.+.++.++.++|||||||++|||+| |+.||.....     .             ++
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-----~-------------~~  242 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-----Q-------------DV  242 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----H-------------HH
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-----H-------------HH
Confidence            32211    122457899999999999999999999999999999998 8999864321     1             11


Q ss_pred             hHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          471 VELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       471 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...+....+...+.+.+..+.+|+.+||+.+|++||||.||
T Consensus       243 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei  283 (299)
T d1jpaa_         243 INAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQI  283 (299)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHH
Confidence            12222223334455667789999999999999999999874

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=407.21  Aligned_cols=253  Identities=24%  Similarity=0.368  Sum_probs=193.7

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEe--CCEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVE--GDQLLLV  314 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV  314 (511)
                      ++|++.+.||+|+||.||+|+. .+|+.||||.+....  ....+.+.+|+.+|++++|||||++++++.+  .+.+++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            5799999999999999999975 578999999987543  2334578999999999999999999999975  4568999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEEccCCCCCeEEcCCCCeEEeecCCccc
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES--RFKIVHRDIKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~--~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~  392 (511)
                      |||+++|+|.+++.........+++..++.++.|++.||+|||+.+  ..+|+||||||+|||++.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999998654333456999999999999999999999864  23599999999999999999999999999987


Q ss_pred             CCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhH
Q 045835          393 DEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVE  472 (511)
Q Consensus       393 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  472 (511)
                      ...... ......||+.|||||++.+..++.++|||||||++|||+||+.||.....     ..+..            .
T Consensus       164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-----~~~~~------------~  225 (269)
T d2java1         164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----KELAG------------K  225 (269)
T ss_dssp             C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHH------------H
T ss_pred             cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-----HHHHH------------H
Confidence            654322 23446799999999999999999999999999999999999999963221     11111            1


Q ss_pred             hhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          473 LVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       473 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +.... ....+...+.++.+|+.+||+.||++|||+.||
T Consensus       226 i~~~~-~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~el  263 (269)
T d2java1         226 IREGK-FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI  263 (269)
T ss_dssp             HHHTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHcCC-CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            11111 112334455678999999999999999999874

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-52  Score=402.89  Aligned_cols=249  Identities=27%  Similarity=0.357  Sum_probs=199.6

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      ++|++.++||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+++..++||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            5789999999999999999975 468999999997543 33345789999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +++|+|.+++...    ..+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+|+......
T Consensus        85 ~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          85 CSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             CTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCcHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence            9999999998543    35999999999999999999999987   9999999999999999999999999998654332


Q ss_pred             -ceeecccccCCCcccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          398 -THISTRIAGTIGYMAPEYALWGYL-TYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       398 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                       ....+..+||+.|||||++.+..+ +.++|||||||++|||+||+.||.......   .....             +..
T Consensus       158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~~~~~-------------~~~  221 (271)
T d1nvra_         158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QEYSD-------------WKE  221 (271)
T ss_dssp             EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS---HHHHH-------------HHT
T ss_pred             ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH---HHHHH-------------Hhc
Confidence             223445689999999999987765 678999999999999999999996432110   00000             111


Q ss_pred             hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       476 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...........+..+.+|+.+||+.||++|||+.||
T Consensus       222 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~ei  257 (271)
T d1nvra_         222 KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDI  257 (271)
T ss_dssp             TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             CCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            111111122334567899999999999999999864

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-52  Score=404.21  Aligned_cols=251  Identities=30%  Similarity=0.484  Sum_probs=195.1

Q ss_pred             hcCCcccCceeccCceeEEeccccCCcEEEEEEeccc--CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSK--SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      .++|++.++||+|+||.||+|++++  .||||+++..  .....+.|.+|+.+|++++|||||+++|++.+ +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            4678899999999999999998753  5999999754  34455789999999999999999999999864 56899999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      |+++|+|.+++....   ..++|..+..++.|||+||+|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus        84 y~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          84 WCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             CCCEEEHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred             cCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence            999999999996543   35999999999999999999999986   999999999999999999999999999865432


Q ss_pred             C-ceeecccccCCCccccccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhH
Q 045835          397 K-THISTRIAGTIGYMAPEYALW---GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVE  472 (511)
Q Consensus       397 ~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  472 (511)
                      . ........||+.|||||++.+   +.++.++|||||||++|||+||+.||......        .........+.   
T Consensus       158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~--------~~~~~~~~~~~---  226 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--------DQIIFMVGRGY---  226 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--------HHHHHHHHHTS---
T ss_pred             CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH--------HHHHHHHhcCC---
Confidence            2 223345679999999999864   35899999999999999999999999643211        00001111100   


Q ss_pred             hhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          473 LVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       473 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                       ..+.+ ...+.+++..+.+|+.+||+.+|++||||.||
T Consensus       227 -~~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i  263 (276)
T d1uwha_         227 -LSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQI  263 (276)
T ss_dssp             -CCCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             -CCCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHH
Confidence             00000 12233445679999999999999999999874

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-51  Score=400.87  Aligned_cols=246  Identities=25%  Similarity=0.397  Sum_probs=206.1

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      ++|+..++||+|+||.||+|+. .+|+.||||+++.......+.+.+|+.+|++++|||||++++++.+.+..++||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            4799999999999999999974 579999999998665556678999999999999999999999999999999999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      ++|+|.+++...     .+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus       100 ~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~  171 (293)
T d1yhwa1         100 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (293)
T ss_dssp             TTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence            999999987543     4899999999999999999999987   99999999999999999999999999986644332


Q ss_pred             eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhh-h
Q 045835          399 HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDE-R  477 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~-~  477 (511)
                       ......||+.|+|||++.+..++.++|||||||++|||+||+.||......        +..         ..+... .
T Consensus       172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--------~~~---------~~~~~~~~  233 (293)
T d1yhwa1         172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--------RAL---------YLIATNGT  233 (293)
T ss_dssp             -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHH---------HHHHHHCS
T ss_pred             -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH--------HHH---------HHHHhCCC
Confidence             234457999999999999999999999999999999999999999632210        000         111111 1


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....+...+..+.+++.+||+.||++|||+.|+
T Consensus       234 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ei  267 (293)
T d1yhwa1         234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL  267 (293)
T ss_dssp             CCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             CCCCCcccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence            1122334456678999999999999999998764

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-51  Score=395.89  Aligned_cols=243  Identities=24%  Similarity=0.394  Sum_probs=203.2

Q ss_pred             cCCcccCceeccCceeEEecccc-CCcEEEEEEeccc---CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK---SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++...   .......+.+|+.++++++|||||++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46889999999999999999864 6889999998643   2344567899999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++|+|.+++....    .+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        86 Ey~~~g~L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             eecCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC
Confidence            9999999999996543    4899999999999999999999987   99999999999999999999999999986554


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      ...   ....||+.|||||++.+..++.++|||||||++|||++|+.||.....     ..+..            .+..
T Consensus       159 ~~~---~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~------------~i~~  218 (263)
T d2j4za1         159 SRR---TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-----QETYK------------RISR  218 (263)
T ss_dssp             CCC---EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHH------------HHHT
T ss_pred             Ccc---cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH-----HHHHH------------HHHc
Confidence            332   345799999999999999999999999999999999999999963221     00110            0111


Q ss_pred             hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       476 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .  ...++...+.++.+++.+||+.||++|||+.||
T Consensus       219 ~--~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~ei  252 (263)
T d2j4za1         219 V--EFTFPDFVTEGARDLISRLLKHNPSQRPMLREV  252 (263)
T ss_dssp             T--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             C--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHH
Confidence            1  112333445678999999999999999999874

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-51  Score=402.88  Aligned_cols=247  Identities=25%  Similarity=0.403  Sum_probs=201.0

Q ss_pred             cCCcccC-ceeccCceeEEecccc---CCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEE
Q 045835          240 NNFDSAK-KIGEGGFGPVYKGQLA---DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       240 ~~f~~~~-~lG~G~fG~Vy~g~~~---~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  314 (511)
                      ++|.+.+ +||+|+||.||+|.+.   ++..||||+++... ....++|.+|+.+|++++|||||+++|+|.+ +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            4566666 4999999999999653   35579999997543 3445689999999999999999999999965 568999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      |||+++|+|.+++....   ..+++..+.+++.|+|.||+|||+++   |+||||||+||||+.++.+||+|||+++...
T Consensus        87 mE~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             EECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEeCCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence            99999999999985432   36999999999999999999999986   9999999999999999999999999998765


Q ss_pred             CCCcee--ecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchh
Q 045835          395 GDKTHI--STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLV  471 (511)
Q Consensus       395 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  471 (511)
                      ......  .....||+.|||||++..+.++.++|||||||++|||+| |+.||.....     .             ++.
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-----~-------------~~~  222 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----P-------------EVM  222 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-----H-------------HHH
T ss_pred             ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH-----H-------------HHH
Confidence            433222  223468999999999999999999999999999999998 8999964321     1             111


Q ss_pred             HhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       472 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..+....+.+.+...+.++.+|+.+||+.+|++||||.+|
T Consensus       223 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i  262 (285)
T d1u59a_         223 AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTV  262 (285)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred             HHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence            2222222334455666789999999999999999999764

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-51  Score=400.59  Aligned_cols=240  Identities=28%  Similarity=0.397  Sum_probs=194.8

Q ss_pred             CceeccCceeEEecccc---CCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecCC
Q 045835          246 KKIGEGGFGPVYKGQLA---DGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYMEN  320 (511)
Q Consensus       246 ~~lG~G~fG~Vy~g~~~---~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~  320 (511)
                      ++||+|+||.||+|.+.   .++.||||+++...  ....++|.+|+.+|++++|||||+++|+|.+ +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            47999999999999754   34689999997542  2334679999999999999999999999965 567899999999


Q ss_pred             CCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCcee
Q 045835          321 NSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTHI  400 (511)
Q Consensus       321 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~~  400 (511)
                      |+|.+++....    .++|..++.++.|||.||+|||+.+   |+||||||+||||+.++.+||+|||+++.........
T Consensus        92 g~L~~~l~~~~----~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          92 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CcHHHHHhhcc----CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            99999997543    5999999999999999999999986   9999999999999999999999999998765443322


Q ss_pred             --ecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          401 --STRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       401 --~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                        .....||+.|||||.+.+..++.++|||||||++|||+| |+.||.....     .             ++.+.+...
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-----~-------------~~~~~i~~~  226 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----S-------------EVTAMLEKG  226 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----H-------------HHHHHHHTT
T ss_pred             ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH-----H-------------HHHHHHHcC
Confidence              234568999999999999999999999999999999998 8999864321     1             112222222


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .+...+...+.++.+|+.+||+.+|++||||+||
T Consensus       227 ~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i  260 (277)
T d1xbba_         227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAV  260 (277)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence            3334455566789999999999999999999864

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-51  Score=400.99  Aligned_cols=249  Identities=26%  Similarity=0.441  Sum_probs=197.4

Q ss_pred             cCCcccCceeccCceeEEeccccCC-----cEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLADG-----TIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~g-----~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  313 (511)
                      ..|+..++||+|+||.||+|.+++.     ..||||+++... .....+|.+|+.++++++|||||+++|+|.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4577889999999999999986532     479999997543 3334579999999999999999999999999999999


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      ||||+.+|++.+.+....   ..++|..+..++.|++.||+|||+.+   |+||||||+||||+.++.+||+|||+++..
T Consensus        87 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          87 ITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             EEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEecccCcchhhhhccc---ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence            999999999999886543   35999999999999999999999986   999999999999999999999999999865


Q ss_pred             CCCCc--eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchh
Q 045835          394 EGDKT--HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLV  471 (511)
Q Consensus       394 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  471 (511)
                      .....  .......||+.|||||++.++.++.++|||||||++|||+||+.|+....    ..             ..+.
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~----~~-------------~~~~  223 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL----SN-------------HEVM  223 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----CH-------------HHHH
T ss_pred             cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC----CH-------------HHHH
Confidence            44322  22233568999999999999999999999999999999999766654221    10             1122


Q ss_pred             HhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       472 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +.+....+...+.+.+..+.+|+.+||+.+|++||||.||
T Consensus       224 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ei  263 (283)
T d1mqba_         224 KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADI  263 (283)
T ss_dssp             HHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHH
Confidence            3333344445555667789999999999999999999874

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-51  Score=399.49  Aligned_cols=248  Identities=25%  Similarity=0.400  Sum_probs=203.7

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      +.|++.++||+|+||.||+|+. .+++.||||+++.......+.+.+|+++|++++|||||++++++.+.+..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            4688999999999999999975 468999999998776666778999999999999999999999999999999999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      ++|+|.+++....   ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        92 ~~g~L~~~~~~~~---~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-  164 (288)
T d2jfla1          92 AGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-  164 (288)
T ss_dssp             TTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-
T ss_pred             CCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc-
Confidence            9999999876432   35999999999999999999999987   9999999999999999999999999997543211 


Q ss_pred             eeecccccCCCcccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHh
Q 045835          399 HISTRIAGTIGYMAPEYAL-----WGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVEL  473 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  473 (511)
                      .......||+.|||||++.     ...++.++|||||||++|||+||+.||......     ...            ..+
T Consensus       165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~-----~~~------------~~i  227 (288)
T d2jfla1         165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM-----RVL------------LKI  227 (288)
T ss_dssp             HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG-----GHH------------HHH
T ss_pred             ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH-----HHH------------HHH
Confidence            1223457999999999984     456899999999999999999999999643211     111            111


Q ss_pred             hhhh-hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          474 VDER-LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       474 ~d~~-l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .... .....+...+.++.+|+.+||+.||++|||+.|+
T Consensus       228 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~el  266 (288)
T d2jfla1         228 AKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL  266 (288)
T ss_dssp             HHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             HcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence            1110 1112233455678999999999999999999864

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-51  Score=401.78  Aligned_cols=248  Identities=29%  Similarity=0.443  Sum_probs=198.6

Q ss_pred             cCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEecC
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYME  319 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~  319 (511)
                      ++|++.+.||+|+||.||+|++++++.||||+++.. ....+.|.+|+.++++++|||||+++|+|.+ +..++||||++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence            578899999999999999999988889999999754 3445789999999999999999999999854 56889999999


Q ss_pred             CCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCce
Q 045835          320 NNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKTH  399 (511)
Q Consensus       320 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~~  399 (511)
                      +|+|..++....  ...++|..++.++.|||.||+|||+.+   |+||||||+|||||+++.+||+|||+++........
T Consensus        95 ~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~  169 (285)
T d1fmka3          95 KGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  169 (285)
T ss_dssp             TCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             CCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence            999999886532  235999999999999999999999986   999999999999999999999999999876544444


Q ss_pred             eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhhhC
Q 045835          400 ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLG  479 (511)
Q Consensus       400 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  479 (511)
                      ......||+.|+|||++..+.++.++|||||||++|||+||+.|+.....    ...             +...+....+
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~----~~~-------------~~~~i~~~~~  232 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV----NRE-------------VLDQVERGYR  232 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHH-------------HHHHHHTTCC
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC----HHH-------------HHHHHHhcCC
Confidence            44446789999999999999999999999999999999997666543221    011             1122222233


Q ss_pred             CCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          480 SKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       480 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .+.+...+.++.+++.+||+.+|++||||.+|
T Consensus       233 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i  264 (285)
T d1fmka3         233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYL  264 (285)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCcccCHHHHHHHHHHcccCHhHCcCHHHH
Confidence            34555666789999999999999999999874

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-51  Score=407.23  Aligned_cols=253  Identities=28%  Similarity=0.417  Sum_probs=204.7

Q ss_pred             hcCCcccCceeccCceeEEeccccC------CcEEEEEEeccc-CccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLAD------GTIIAVKQLSSK-SRQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQ  310 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~~------g~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~  310 (511)
                      .++|++.++||+|+||.||+|+...      ...||||.+... .......+.+|+.+|+++ +|||||+++++|.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            4678999999999999999997542      236999998654 334456789999999998 89999999999999999


Q ss_pred             EEEEEEecCCCCHhHHHhcCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCC
Q 045835          311 LLLVYEYMENNSLACALFGREN-------------------CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKA  371 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~  371 (511)
                      .++|||||++|+|.++|.....                   ....++|..++.++.||+.||+|||+++   |+||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence            9999999999999999976432                   1235899999999999999999999986   99999999


Q ss_pred             CCeEEcCCCCeEEeecCCcccCCCCCc-eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 045835          372 TNVLLDRDLNPKISDFGLAKLDEGDKT-HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPA  449 (511)
Q Consensus       372 ~NILld~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~  449 (511)
                      +|||++.++.+||+|||+|+....... .......||+.|||||.+.++.++.++|||||||++|||+| |+.||.....
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999986544332 23344568999999999999999999999999999999998 8999864321


Q ss_pred             ccccccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          450 LEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       450 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .                 ..+.+++....+.+.+...+.++.+|+.+||+.+|++||||+||
T Consensus       273 ~-----------------~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei  317 (325)
T d1rjba_         273 D-----------------ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL  317 (325)
T ss_dssp             S-----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             H-----------------HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            0                 11223333333444555666789999999999999999999875

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-50  Score=395.58  Aligned_cols=246  Identities=22%  Similarity=0.312  Sum_probs=201.8

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEeccc---CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK---SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|++.+.||+|+||.||+|+. .+|+.||||++...   .....+.+.+|+.+|++++||||+++++++.+++..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            5699999999999999999975 47899999998643   2334567899999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++|+|.+++....    .+++.....++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++....
T Consensus        88 Ey~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EccCCCCHHHhhhccC----CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceeccc
Confidence            9999999999886543    5999999999999999999999987   99999999999999999999999999986643


Q ss_pred             CC-ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          396 DK-THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       396 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      .. ........||+.|||||++.+..++.++|||||||++|||+||+.||.....     ..+.            ..+.
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----~~~~------------~~i~  223 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----YLIF------------QKII  223 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHH------------HHHH
T ss_pred             CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH-----HHHH------------HHHH
Confidence            32 2233446799999999999999999999999999999999999999973221     0010            0111


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..  ...++...+.++.+|+.+||+.||++|||+.|+
T Consensus       224 ~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~  258 (288)
T d1uu3a_         224 KL--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM  258 (288)
T ss_dssp             TT--CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGG
T ss_pred             cC--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHH
Confidence            11  112334455678999999999999999999874

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-50  Score=387.92  Aligned_cols=244  Identities=26%  Similarity=0.400  Sum_probs=192.8

Q ss_pred             cccCceeccCceeEEecccc-CCcEEEEEEeccc--CccchHHHHHHHHHHhcCCCCCceeEEEEEEe----CCEEEEEE
Q 045835          243 DSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSK--SRQGNREFLNEIAMISCLQHPNLVKIHGCCVE----GDQLLLVY  315 (511)
Q Consensus       243 ~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~  315 (511)
                      +..++||+|+||.||+|+.. +++.||+|++...  .....+.|.+|+++|++++|||||++++++.+    ...+++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            55668999999999999754 6889999998754  23344678999999999999999999999875    34689999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEc-CCCCeEEeecCCcccCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD-RDLNPKISDFGLAKLDE  394 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld-~~~~~kl~DfGla~~~~  394 (511)
                      ||+++|+|.+++....    .+++..+..++.||+.||+|||+++ ++|+||||||+|||++ +++.+||+|||+++...
T Consensus        92 E~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCcHHHHHhccc----cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            9999999999996543    5899999999999999999999874 4599999999999996 57899999999998654


Q ss_pred             CCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          395 GDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       395 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      ...   .....||+.|||||++.+ .++.++|||||||++|||++|+.||......    ..+..   .. ..+.     
T Consensus       167 ~~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~----~~~~~---~i-~~~~-----  229 (270)
T d1t4ha_         167 ASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA----AQIYR---RV-TSGV-----  229 (270)
T ss_dssp             TTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----HHHHH---HH-TTTC-----
T ss_pred             CCc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH----HHHHH---HH-HcCC-----
Confidence            332   234579999999998765 6999999999999999999999999632210    00111   11 0110     


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                         .....+...+.++.+|+.+||+.||++|||+.|+
T Consensus       230 ---~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~el  263 (270)
T d1t4ha_         230 ---KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL  263 (270)
T ss_dssp             ---CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             ---CCcccCccCCHHHHHHHHHHccCCHhHCcCHHHH
Confidence               0011122233468899999999999999999874

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-50  Score=402.50  Aligned_cols=263  Identities=21%  Similarity=0.352  Sum_probs=202.3

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      .++|++.++||+|+||+||+|+. .+|+.||+|+++... ......+.+|+.+|++++|||||+++++|.+.+..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            56899999999999999999985 478999999997543 3334678999999999999999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEE-SRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      |+++|+|.+++....    .+++..+..++.|++.||+|||+. +   |+||||||+|||+++++.+||+|||+|+....
T Consensus        85 y~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             CCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             cCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence            999999999997543    489999999999999999999974 5   99999999999999999999999999985432


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccccccc-------c------------
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCT-------C------------  456 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~-------~------------  456 (511)
                      .   ..+..+||+.|||||++.+..++.++||||+||+++||++|+.||...........       .            
T Consensus       158 ~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (322)
T d1s9ja_         158 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  234 (322)
T ss_dssp             H---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred             C---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence            1   12345899999999999999999999999999999999999999964321100000       0            


Q ss_pred             --hhhhhHhhhccCchhHhhhhhhCC---CCC-HHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          457 --LLDWACHLQQDGKLVELVDERLGS---KYK-KEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       457 --l~~~~~~~~~~~~~~~~~d~~l~~---~~~-~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                        ...............+..+.....   ..+ ...+.++.+++.+||+.||++|||+.|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~  295 (322)
T d1s9ja_         235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL  295 (322)
T ss_dssp             -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence              000000000011111222221111   011 1224578899999999999999999764

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5e-50  Score=396.57  Aligned_cols=243  Identities=27%  Similarity=0.426  Sum_probs=198.2

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCc---cchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSR---QGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      +.|+..++||+|+||.||+|+. .+++.||||+++....   ...+.+.+|+.+|++++|||||++++++.+++..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            3588999999999999999974 5789999999975432   23356899999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      |||++|+|..++...    ..+++..+..++.||+.||+|||+++   |+||||||+||||++++.+||+|||+++....
T Consensus        95 E~~~~g~l~~~~~~~----~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             ECCSEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence            999999998766543    35999999999999999999999987   99999999999999999999999999986543


Q ss_pred             CCceeecccccCCCccccccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhH
Q 045835          396 DKTHISTRIAGTIGYMAPEYALW---GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVE  472 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  472 (511)
                      .     ....||+.|||||++.+   +.++.++|||||||++|||++|+.||.....       . +.         +..
T Consensus       168 ~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-------~-~~---------~~~  225 (309)
T d1u5ra_         168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------M-SA---------LYH  225 (309)
T ss_dssp             B-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------H-HH---------HHH
T ss_pred             C-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH-------H-HH---------HHH
Confidence            2     23579999999999864   4689999999999999999999999863221       0 00         111


Q ss_pred             hhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          473 LVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       473 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +.........+...+..+.+|+.+||+.||++|||+.|+
T Consensus       226 i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~el  264 (309)
T d1u5ra_         226 IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL  264 (309)
T ss_dssp             HHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence            111111111222345678999999999999999999764

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.1e-50  Score=397.41  Aligned_cols=258  Identities=26%  Similarity=0.413  Sum_probs=205.7

Q ss_pred             HHHHHHhcCCcccCceeccCceeEEecccc------CCcEEEEEEecccCc-cchHHHHHHHHHHhcCCCCCceeEEEEE
Q 045835          233 KQIKAATNNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSKSR-QGNREFLNEIAMISCLQHPNLVKIHGCC  305 (511)
Q Consensus       233 ~~l~~~~~~f~~~~~lG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~  305 (511)
                      .+++..+++|++.+.||+|+||.||+|+..      +++.||||+++.... +..++|.+|+.+|++++||||++++++|
T Consensus         6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            344445678999999999999999999753      457899999975433 3456799999999999999999999999


Q ss_pred             EeCCEEEEEEEecCCCCHhHHHhcCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 045835          306 VEGDQLLLVYEYMENNSLACALFGREN--------------------CELELDWPTRQKICLGIARGLAFLHEESRFKIV  365 (511)
Q Consensus       306 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ii  365 (511)
                      .+.+..+++|||+++|+|.+++.....                    ....++|..++.++.|++.||+|||+.+   |+
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv  162 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV  162 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eE
Confidence            999999999999999999999964321                    1234899999999999999999999986   99


Q ss_pred             EccCCCCCeEEcCCCCeEEeecCCcccCCCCC-ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCC-CC
Q 045835          366 HRDIKATNVLLDRDLNPKISDFGLAKLDEGDK-THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK-NN  443 (511)
Q Consensus       366 H~Dlk~~NILld~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~-~p  443 (511)
                      ||||||+|||||.++.+||+|||+++...... ........||+.|+|||.+.+..++.++|||||||++|||++|. +|
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p  242 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  242 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence            99999999999999999999999998554322 22333457889999999999999999999999999999999996 45


Q ss_pred             CCCCCcccccccchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          444 MSYAPALEFDCTCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       444 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      |.....     ..+..             .+........+...+.++.+|+.+||+.+|++||||.||
T Consensus       243 ~~~~~~-----~e~~~-------------~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev  292 (301)
T d1lufa_         243 YYGMAH-----EEVIY-------------YVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSI  292 (301)
T ss_dssp             TTTSCH-----HHHHH-------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCH-----HHHHH-------------HHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence            653221     11111             111111223344555679999999999999999999875

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.2e-49  Score=391.80  Aligned_cols=247  Identities=23%  Similarity=0.376  Sum_probs=187.1

Q ss_pred             hcCCcccCceeccCceeEEecccc-CCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA-DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~-~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      .+.|++.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.+|++++|||||++++++.+++.+++|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            356999999999999999999754 68999999997543 2334568899999999999999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEc---CCCCeEEeecCCcccC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD---RDLNPKISDFGLAKLD  393 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld---~~~~~kl~DfGla~~~  393 (511)
                      |+++|+|.+++....    .+++.....++.||+.||+|||+.+   |+||||||+|||+.   +++.+||+|||+++..
T Consensus        88 ~~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          88 LVSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             CCCSCBHHHHHHTCS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             ccCCCcHHHhhhccc----CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            999999999996543    5999999999999999999999987   99999999999994   5789999999999865


Q ss_pred             CCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHh
Q 045835          394 EGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVEL  473 (511)
Q Consensus       394 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  473 (511)
                      ....  ......||+.|||||++.+..++.++|||||||++|||++|+.||.....     ..+...            +
T Consensus       161 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----~~~~~~------------i  221 (307)
T d1a06a_         161 DPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND-----AKLFEQ------------I  221 (307)
T ss_dssp             --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHH------------H
T ss_pred             cCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH-----HHHHHH------------H
Confidence            4332  22345799999999999999999999999999999999999999963221     111111            1


Q ss_pred             hhh--hhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          474 VDE--RLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       474 ~d~--~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...  ........+.+..+.+|+.+||+.||++|||+.|+
T Consensus       222 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ei  261 (307)
T d1a06a_         222 LKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA  261 (307)
T ss_dssp             HTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             hccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHH
Confidence            111  11112223445678999999999999999999764

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-49  Score=394.46  Aligned_cols=247  Identities=26%  Similarity=0.453  Sum_probs=198.6

Q ss_pred             cCCcccCceeccCceeEEecccc-CCc----EEEEEEeccc-CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGT----IIAVKQLSSK-SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~----~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  313 (511)
                      .+|+..++||+|+||.||+|+.. +|+    .||||+++.. ..+..++|.+|+.++++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            35889999999999999999754 443    6899998653 345567899999999999999999999999875 5678


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      ++||+.+|+|.+++....   ..+++..+++++.|||.||+|||+++   |+||||||+||||+.++.+||+|||+++..
T Consensus        88 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             EEECCTTCBHHHHHHHTS---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred             EEEeccCCcccccccccc---cCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceec
Confidence            899999999999886543   36899999999999999999999986   999999999999999999999999999876


Q ss_pred             CCCCce-eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchh
Q 045835          394 EGDKTH-ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLV  471 (511)
Q Consensus       394 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  471 (511)
                      ...... ......||+.|+|||.+.++.++.++|||||||++|||+| |++||.....                  ..+.
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~------------------~~~~  223 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA------------------SEIS  223 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG------------------GGHH
T ss_pred             ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH------------------HHHH
Confidence            443322 2334568999999999999999999999999999999999 7888763321                  1223


Q ss_pred             HhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          472 ELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       472 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..+....+...+..++..+.+|+.+||+.+|++|||+.||
T Consensus       224 ~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei  263 (317)
T d1xkka_         224 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFREL  263 (317)
T ss_dssp             HHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHH
Confidence            3333334444555667789999999999999999999874

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=388.09  Aligned_cols=248  Identities=25%  Similarity=0.373  Sum_probs=191.1

Q ss_pred             hcCCcccCceeccCceeEEeccccC----CcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLAD----GTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~~----g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  313 (511)
                      .++|++.+.||+|+||.||+|+...    +..||||.++... ....+.|.+|+.+|++++|||||+++|+|. .+..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            3578899999999999999997542    3568999987543 334567999999999999999999999996 467899


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLD  393 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~  393 (511)
                      ||||+++|+|.+++....   ..+++..++.++.||+.||+|||+.+   |+||||||+||++++++.+||+|||+++..
T Consensus        85 v~E~~~~g~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             EEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEeccCCcHHhhhhccC---CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheec
Confidence            999999999999876543   35899999999999999999999986   999999999999999999999999999876


Q ss_pred             CCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhH
Q 045835          394 EGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVE  472 (511)
Q Consensus       394 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  472 (511)
                      ............||+.|+|||.+....++.++|||||||++|||+| |++|+.....     ..+.             +
T Consensus       159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~-----~~~~-------------~  220 (273)
T d1mp8a_         159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----NDVI-------------G  220 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHH-------------H
T ss_pred             cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH-----HHHH-------------H
Confidence            5544444455678999999999999999999999999999999998 8888864331     1111             1


Q ss_pred             hhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          473 LVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       473 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .+........+...+..+.+|+.+||+.||++|||+.||
T Consensus       221 ~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei  259 (273)
T d1mp8a_         221 RIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL  259 (273)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence            111112223445566789999999999999999999874

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=6.6e-49  Score=395.00  Aligned_cols=247  Identities=22%  Similarity=0.342  Sum_probs=203.9

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      ++|++.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+++.+++|||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            5799999999999999999975 478999999998766556678899999999999999999999999999999999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcC--CCCeEEeecCCcccCCCC
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR--DLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~--~~~~kl~DfGla~~~~~~  396 (511)
                      ++|+|.+++....   ..+++..+..++.||+.||+|||+++   |+||||||+|||++.  ++.+||+|||+++.....
T Consensus       106 ~gg~L~~~l~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         106 SGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CSCBHHHHHTCTT---SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            9999999985432   35999999999999999999999987   999999999999964  578999999999876543


Q ss_pred             CceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhh
Q 045835          397 KTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDE  476 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  476 (511)
                      ...  ....||+.|||||++.+..++.++|||||||++|||+||+.||.....     .   +...         .+...
T Consensus       180 ~~~--~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~---~~~~---------~i~~~  240 (350)
T d1koaa2         180 QSV--KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-----D---ETLR---------NVKSC  240 (350)
T ss_dssp             SCE--EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----H---HHHH---------HHHHT
T ss_pred             ccc--ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-----H---HHHH---------HHHhC
Confidence            332  345799999999999999999999999999999999999999963221     1   1111         11111


Q ss_pred             h--hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          477 R--LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       477 ~--l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .  .........+..+.+|+.+||+.||++|||+.|+
T Consensus       241 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~ei  277 (350)
T d1koaa2         241 DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA  277 (350)
T ss_dssp             CCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence            0  1111112334578999999999999999998764

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-50  Score=385.86  Aligned_cols=242  Identities=29%  Similarity=0.430  Sum_probs=193.0

Q ss_pred             cCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeC-CEEEEEEEec
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEG-DQLLLVYEYM  318 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~Ey~  318 (511)
                      ++|++.++||+|+||.||+|+++ |+.||||+++..  ...++|.+|++++++++||||++++|+|.+. +.+++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            46788899999999999999984 788999999653  3446899999999999999999999999654 5689999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      ++|+|.++|....  ...++|..+++++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        84 ~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-  157 (262)
T d1byga_          84 AKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  157 (262)
T ss_dssp             TTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCC-
Confidence            9999999996542  235899999999999999999999986   9999999999999999999999999998644322 


Q ss_pred             eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCchhHhhhhh
Q 045835          399 HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDER  477 (511)
Q Consensus       399 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  477 (511)
                         ....+|..|+|||++.++.+++++|||||||++|||+| |+.|+....     ...+..+             +...
T Consensus       158 ---~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~-----~~~~~~~-------------i~~~  216 (262)
T d1byga_         158 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVPR-------------VEKG  216 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-----GGGHHHH-------------HTTT
T ss_pred             ---ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC-----HHHHHHH-------------HHcC
Confidence               22457889999999999999999999999999999998 677765322     1112222             2222


Q ss_pred             hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          478 LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       478 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .+.+.+...+.++.+|+.+||+.||++||||.||
T Consensus       217 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l  250 (262)
T d1byga_         217 YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQL  250 (262)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHH
Confidence            3334455556789999999999999999999864

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-48  Score=382.50  Aligned_cols=248  Identities=23%  Similarity=0.332  Sum_probs=200.6

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC------ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS------RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLL  312 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  312 (511)
                      ++|++.+.||+|+||.||+|+. .+|+.||||+++...      ....+.+.+|+.+|++++|||||++++++.+.+.++
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            5799999999999999999985 578999999986432      123567999999999999999999999999999999


Q ss_pred             EEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCC----CeEEeecC
Q 045835          313 LVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL----NPKISDFG  388 (511)
Q Consensus       313 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~----~~kl~DfG  388 (511)
                      +|||||++|+|.+++....    .+++.....++.|++.||+|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        90 iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence            9999999999999996543    5999999999999999999999987   99999999999998876    49999999


Q ss_pred             CcccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccC
Q 045835          389 LAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDG  468 (511)
Q Consensus       389 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~  468 (511)
                      +++.......  .....||+.|+|||.+.+..++.++|||||||++|||+||+.||.....     ....   ...... 
T Consensus       163 ~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----~~~~---~~i~~~-  231 (293)
T d1jksa_         163 LAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----QETL---ANVSAV-  231 (293)
T ss_dssp             TCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHH---HHHHTT-
T ss_pred             hhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH-----HHHH---HHHHhc-
Confidence            9986643322  2345789999999999999999999999999999999999999964321     0011   011000 


Q ss_pred             chhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          469 KLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       469 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .      .......+...+..+.+|+.+||+.||++|||+.|+
T Consensus       232 ~------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ei  268 (293)
T d1jksa_         232 N------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS  268 (293)
T ss_dssp             C------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             C------CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence            0      000000011234568899999999999999999764

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.2e-48  Score=393.36  Aligned_cols=247  Identities=21%  Similarity=0.330  Sum_probs=204.6

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEec
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEYM  318 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~  318 (511)
                      ++|++.+.||+|+||.||+|+. .+|+.||||+++.........+.+|+.+|++++|||||++++++.+++.+++|||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            5799999999999999999975 579999999998765555667889999999999999999999999999999999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEc--CCCCeEEeecCCcccCCCC
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD--RDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld--~~~~~kl~DfGla~~~~~~  396 (511)
                      ++|+|.+++....   ..+++.....++.||+.||+|||+.+   |+||||||+||||+  .++.+||+|||+++.....
T Consensus       109 ~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         109 SGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCChHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence            9999998875432   35899999999999999999999987   99999999999998  5789999999999876543


Q ss_pred             CceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhhh
Q 045835          397 KTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVDE  476 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  476 (511)
                      ..  .....||+.|+|||++.+..++.++|||||||++|||+||+.||.....     ..+..            .+...
T Consensus       183 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~~~~------------~i~~~  243 (352)
T d1koba_         183 EI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-----LETLQ------------NVKRC  243 (352)
T ss_dssp             SC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHH------------HHHHC
T ss_pred             Cc--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----HHHHH------------HHHhC
Confidence            32  2345789999999999999999999999999999999999999964321     11111            11111


Q ss_pred             --hhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          477 --RLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       477 --~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                        ..........+..+.+|+.+||+.||++|||+.|+
T Consensus       244 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ei  280 (352)
T d1koba_         244 DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA  280 (352)
T ss_dssp             CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence              11122223445678999999999999999998764

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-49  Score=384.74  Aligned_cols=248  Identities=23%  Similarity=0.380  Sum_probs=191.1

Q ss_pred             cCCcccCceeccCceeEEecccc--CC--cEEEEEEeccc---CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA--DG--TIIAVKQLSSK---SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLL  312 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~--~g--~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  312 (511)
                      ++|++.+.||+|+||.||+|++.  ++  ..||||++...   ..+..++|.+|+.+|++++|||||+++|+|.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            56889999999999999999753  22  37899998653   23445689999999999999999999999975 4678


Q ss_pred             EEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCccc
Q 045835          313 LVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       313 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~  392 (511)
                      +||||+++|++.+.+..+.   ..+++..+++++.|+|+||+|||+++   |+||||||+||||+.++.+||+|||+++.
T Consensus        87 lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~  160 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  160 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeeeecCcchhhhhhccc---CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence            9999999999998886543   35999999999999999999999986   99999999999999999999999999997


Q ss_pred             CCCCCce--eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccccchhhhhHhhhccCc
Q 045835          393 DEGDKTH--ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDCTCLLDWACHLQQDGK  469 (511)
Q Consensus       393 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  469 (511)
                      .......  ......||..|+|||.+.+..++.++|||||||++|||+| |+.||....     ......          
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~-----~~~~~~----------  225 (273)
T d1u46a_         161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-----GSQILH----------  225 (273)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHH----------
T ss_pred             cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC-----HHHHHH----------
Confidence            6543322  2334567889999999999999999999999999999998 899986322     111111          


Q ss_pred             hhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          470 LVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       470 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                        .+.....+.+.+...+..+.+|+.+||+.+|++||||.||
T Consensus       226 --~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei  265 (273)
T d1u46a_         226 --KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL  265 (273)
T ss_dssp             --HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             --HHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHH
Confidence              1111222223344455679999999999999999999874

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.2e-48  Score=382.85  Aligned_cols=237  Identities=24%  Similarity=0.369  Sum_probs=198.8

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEeccc---CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK---SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|++.+.||+|+||.||+|+. .+|+.||||+++..   .....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            4689999999999999999985 46899999999643   2344567899999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+++|+|..++....    .+++.....++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus        84 E~~~gg~l~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~  156 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD  156 (316)
T ss_dssp             CCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eecCCccccccccccc----cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc
Confidence            9999999999886554    4788999999999999999999987   99999999999999999999999999987654


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      ..    ....||+.|||||++.+..++.++|||||||++|||+||+.||.....        .+..         ..+..
T Consensus       157 ~~----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~---------~~i~~  215 (316)
T d1fota_         157 VT----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--------MKTY---------EKILN  215 (316)
T ss_dssp             CB----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHH---------HHHHH
T ss_pred             cc----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH--------HHHH---------HHHHc
Confidence            32    346799999999999999999999999999999999999999964221        0100         11111


Q ss_pred             hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCC
Q 045835          476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRP  506 (511)
Q Consensus       476 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP  506 (511)
                      .  ...+++..+.++.+++.+||+.+|.+||
T Consensus       216 ~--~~~~p~~~s~~~~~li~~~L~~dp~~R~  244 (316)
T d1fota_         216 A--ELRFPPFFNEDVKDLLSRLITRDLSQRL  244 (316)
T ss_dssp             C--CCCCCTTSCHHHHHHHHHHTCSCTTTCT
T ss_pred             C--CCCCCCCCCHHHHHHHHHHhhhCHHhcc
Confidence            1  1123344456789999999999999997

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-47  Score=383.14  Aligned_cols=241  Identities=25%  Similarity=0.336  Sum_probs=201.9

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEeccc---CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK---SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|++.+.||+|+||.||+|+. .+|+.||||+++..   .....+.+.+|+.+|++++||||+++++++.+.+.+++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            5799999999999999999975 57899999999753   2344567899999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      |||++|+|.+++....    .+++.....++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+|+....
T Consensus        85 ey~~gg~L~~~~~~~~----~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          85 EYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             ECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eccCCCchhhhhhccc----CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            9999999999987643    4889999999999999999999997   99999999999999999999999999986543


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      ... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||....     ...+..            .+..
T Consensus       158 ~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~-----~~~~~~------------~i~~  219 (337)
T d1o6la_         158 DGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HERLFE------------LILM  219 (337)
T ss_dssp             TTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHH------------HHHH
T ss_pred             CCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC-----HHHHHH------------HHhc
Confidence            222 2344689999999999999999999999999999999999999997432     111111            0111


Q ss_pred             hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCC
Q 045835          476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPT  507 (511)
Q Consensus       476 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs  507 (511)
                      .  ...+|...+.++.+|+.+||+.||++||+
T Consensus       220 ~--~~~~p~~~s~~~~dli~~~L~~dP~~R~~  249 (337)
T d1o6la_         220 E--EIRFPRTLSPEAKSLLAGLLKKDPKQRLG  249 (337)
T ss_dssp             C--CCCCCTTSCHHHHHHHHHHTCSSTTTSTT
T ss_pred             C--CCCCCccCCHHHHHHHHhhccCCchhhcc
Confidence            1  12334445567899999999999999996

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-48  Score=383.25  Aligned_cols=244  Identities=27%  Similarity=0.380  Sum_probs=194.8

Q ss_pred             cCceeccCceeEEeccccCC----cEEEEEEeccc-CccchHHHHHHHHHHhcCCCCCceeEEEEEEeC-CEEEEEEEec
Q 045835          245 AKKIGEGGFGPVYKGQLADG----TIIAVKQLSSK-SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEG-DQLLLVYEYM  318 (511)
Q Consensus       245 ~~~lG~G~fG~Vy~g~~~~g----~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~Ey~  318 (511)
                      .++||+|+||+||+|++.++    ..||||+++.. .....++|.+|+++|++++||||++++|+|.+. ...++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46899999999999986432    36899999743 444557899999999999999999999999864 5899999999


Q ss_pred             CCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCCc
Q 045835          319 ENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDKT  398 (511)
Q Consensus       319 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~~  398 (511)
                      ++|+|.+++....   ..+++..+++++.|+|+||.|||+.+   |+||||||+||||++++.+||+|||+++.......
T Consensus       112 ~~g~l~~~~~~~~---~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         112 KHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             TTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             ecCchhhhhcccc---ccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            9999999987543   35788999999999999999999986   99999999999999999999999999986544322


Q ss_pred             e---eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          399 H---ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       399 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      .   ......||..|+|||.+..+.++.++||||||+++|||+||+.|+....    ....+..++.             
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~----~~~~~~~~i~-------------  248 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV----NTFDITVYLL-------------  248 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------CHHHHH-------------
T ss_pred             ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC----CHHHHHHHHH-------------
Confidence            2   2233568999999999999999999999999999999999888775321    1111222211             


Q ss_pred             hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       476 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...+...+......+.+|+.+||+.+|++||||.||
T Consensus       249 ~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei  284 (311)
T d1r0pa_         249 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSEL  284 (311)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             cCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHH
Confidence            111122333445678999999999999999999875

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-48  Score=385.61  Aligned_cols=249  Identities=27%  Similarity=0.436  Sum_probs=198.5

Q ss_pred             cCCcccCceeccCceeEEecccc-CCc--EEEEEEeccc-CccchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLA-DGT--IIAVKQLSSK-SRQGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~-~g~--~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV  314 (511)
                      ++|++.++||+|+||.||+|++. +|.  .||||+++.. .....++|.+|+.+|+++ +|||||+++|+|.+++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            57888899999999999999865 344  5788888643 344556899999999999 799999999999999999999


Q ss_pred             EEecCCCCHhHHHhcCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCe
Q 045835          315 YEYMENNSLACALFGRE------------NCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNP  382 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~  382 (511)
                      |||+++|+|.++|+...            .....++|..+.+++.|||.||+|||+.+   |+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            99999999999997542            23456999999999999999999999986   9999999999999999999


Q ss_pred             EEeecCCcccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCC-CCCCCCcccccccchhhhh
Q 045835          383 KISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKN-NMSYAPALEFDCTCLLDWA  461 (511)
Q Consensus       383 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~-p~~~~~~~~~~~~~l~~~~  461 (511)
                      ||+|||+++.......  .....||..|+|||.+..+.++.++|||||||++|||++|.. |+....     ...+    
T Consensus       167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~-----~~~~----  235 (309)
T d1fvra_         167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----CAEL----  235 (309)
T ss_dssp             EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHH----
T ss_pred             EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC-----HHHH----
Confidence            9999999985432221  123468999999999999999999999999999999999765 554221     1111    


Q ss_pred             HhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          462 CHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       462 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                               .+.+....+.+.+...+.++.+|+.+||+.+|++||||+||
T Consensus       236 ---------~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei  276 (309)
T d1fvra_         236 ---------YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI  276 (309)
T ss_dssp             ---------HHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             ---------HHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence                     11122222334445566789999999999999999999875

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-48  Score=385.63  Aligned_cols=253  Identities=26%  Similarity=0.390  Sum_probs=192.8

Q ss_pred             hcCCcccCceeccCceeEEecccc------CCcEEEEEEecccC-ccchHHHHHHHHHHhcC-CCCCceeEEEEEEeC-C
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSKS-RQGNREFLNEIAMISCL-QHPNLVKIHGCCVEG-D  309 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~  309 (511)
                      .++|++.++||+|+||.||+|+..      +++.||||+++... ....+.+.+|...+.++ +|+||+++++++.+. .
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            467999999999999999999742      35689999997543 33456788888888777 689999999998765 4


Q ss_pred             EEEEEEEecCCCCHhHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEc
Q 045835          310 QLLLVYEYMENNSLACALFGREN------------CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLD  377 (511)
Q Consensus       310 ~~~lV~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld  377 (511)
                      ..++|||||++|+|.+++.....            ....++|..++.++.||++||+|||+++   |+||||||+||||+
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~  168 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS  168 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence            68999999999999999975432            1235899999999999999999999986   99999999999999


Q ss_pred             CCCCeEEeecCCcccCCCCCce-eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCccccccc
Q 045835          378 RDLNPKISDFGLAKLDEGDKTH-ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK-NNMSYAPALEFDCT  455 (511)
Q Consensus       378 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~-~p~~~~~~~~~~~~  455 (511)
                      +++.+||+|||+++........ ......||+.|||||.+.++.++.++|||||||++|||+||. +||......     
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~-----  243 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-----  243 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-----
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH-----
Confidence            9999999999999865443322 233467999999999999999999999999999999999975 566432210     


Q ss_pred             chhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          456 CLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       456 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                         +         .+...+........+...+.++.+++.+||+.||++|||+.||
T Consensus       244 ---~---------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ei  287 (299)
T d1ywna1         244 ---E---------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL  287 (299)
T ss_dssp             ---H---------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             ---H---------HHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence               0         1122222333334444556679999999999999999999874

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-48  Score=382.24  Aligned_cols=261  Identities=28%  Similarity=0.342  Sum_probs=192.5

Q ss_pred             cCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHH--HHHHHHhcCCCCCceeEEEEEEeCC----EEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFL--NEIAMISCLQHPNLVKIHGCCVEGD----QLLL  313 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~--~Ei~~l~~l~H~niv~l~g~~~~~~----~~~l  313 (511)
                      +.|.+.++||+|+||.||+|++ +|+.||||+++...   .+++.  .|+..+++++|||||+++|+|.+.+    .+++
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            3566778999999999999987 58899999996543   23444  4555566889999999999998754    6899


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeEEccCCCCCeEEcCCCCeEEeecC
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES-----RFKIVHRDIKATNVLLDRDLNPKISDFG  388 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~-----~~~iiH~Dlk~~NILld~~~~~kl~DfG  388 (511)
                      |||||++|+|.++|...     .++|..+++++.|+|.||+|||+..     ..+|+||||||+||||+.++.+||+|||
T Consensus        79 v~Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG  153 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence            99999999999999653     4899999999999999999999751     3469999999999999999999999999


Q ss_pred             CcccCCCCCce---eecccccCCCcccccccccC------CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhh
Q 045835          389 LAKLDEGDKTH---ISTRIAGTIGYMAPEYALWG------YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLD  459 (511)
Q Consensus       389 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~  459 (511)
                      +++........   ......||+.|+|||++...      .++.++|||||||+||||+||..|+...............
T Consensus       154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~  233 (303)
T d1vjya_         154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence            99865443322   22346799999999998754      2677999999999999999999887543321111111100


Q ss_pred             hhHhhhccCchhHhhhhhhCCCC-----CHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          460 WACHLQQDGKLVELVDERLGSKY-----KKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       460 ~~~~~~~~~~~~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      +....  ......+.+..++...     +.+....+.+|+.+||+.||++||||.||
T Consensus       234 ~~~~~--~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei  288 (303)
T d1vjya_         234 SDPSV--EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI  288 (303)
T ss_dssp             SSCCH--HHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHH
T ss_pred             ccchH--HHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHH
Confidence            00000  0000111222222222     23456779999999999999999999874

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-48  Score=383.69  Aligned_cols=253  Identities=28%  Similarity=0.468  Sum_probs=207.9

Q ss_pred             hcCCcccCceeccCceeEEeccc------cCCcEEEEEEecccCc-cchHHHHHHHHHHhcC-CCCCceeEEEEEEeCCE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL------ADGTIIAVKQLSSKSR-QGNREFLNEIAMISCL-QHPNLVKIHGCCVEGDQ  310 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~------~~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~  310 (511)
                      .++|++.++||+|+||.||+|++      .+++.||||+++.... ....+|.+|+.+++++ +|||||+++|+|.+++.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            35788899999999999999964      3467899999976433 3445789999999999 69999999999999999


Q ss_pred             EEEEEEecCCCCHhHHHhcCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEE
Q 045835          311 LLLVYEYMENNSLACALFGREN--------------CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL  376 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILl  376 (511)
                      .++|||||++|+|.+++.....              ....+++..+.+++.||++||+|||+++   ++||||||+|||+
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence            9999999999999999975431              2235899999999999999999999987   9999999999999


Q ss_pred             cCCCCeEEeecCCcccCCCCCc-eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCC-CCCCCcccccc
Q 045835          377 DRDLNPKISDFGLAKLDEGDKT-HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNN-MSYAPALEFDC  454 (511)
Q Consensus       377 d~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p-~~~~~~~~~~~  454 (511)
                      +.++.+||+|||+++....... .......||+.|+|||.+..+.++.++|||||||++|||+|++.| +.....     
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~-----  253 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV-----  253 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS-----
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH-----
Confidence            9999999999999997654433 334456789999999999999999999999999999999995444 432221     


Q ss_pred             cchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          455 TCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       455 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                                  .+.+.++++...+...+...+..+.+|+.+||+.||++||||.||
T Consensus       254 ------------~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~i  298 (311)
T d1t46a_         254 ------------DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI  298 (311)
T ss_dssp             ------------SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             ------------HHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHH
Confidence                        112334444545555555566789999999999999999999874

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.8e-47  Score=372.47  Aligned_cols=246  Identities=22%  Similarity=0.323  Sum_probs=200.9

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCcc---------chHHHHHHHHHHhcCC-CCCceeEEEEEEeC
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQ---------GNREFLNEIAMISCLQ-HPNLVKIHGCCVEG  308 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~---------~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~  308 (511)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++.....         ..+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            5799999999999999999975 57899999998754221         2235889999999997 99999999999999


Q ss_pred             CEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecC
Q 045835          309 DQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFG  388 (511)
Q Consensus       309 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfG  388 (511)
                      +..++||||+++|+|.+++..+.    .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             cceEEEEEcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence            99999999999999999996543    5999999999999999999999987   9999999999999999999999999


Q ss_pred             CcccCCCCCceeecccccCCCccccccccc------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhH
Q 045835          389 LAKLDEGDKTHISTRIAGTIGYMAPEYALW------GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWAC  462 (511)
Q Consensus       389 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~  462 (511)
                      +++......  ..+...||..|+|||.+..      ..++.++||||+||+++||++|+.||.....     ....    
T Consensus       156 ~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~-----~~~~----  224 (277)
T d1phka_         156 FSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-----MLML----  224 (277)
T ss_dssp             TCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHH----
T ss_pred             heeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH-----HHHH----
Confidence            998755432  2344679999999998853      3578899999999999999999999974321     0000    


Q ss_pred             hhhccCchhHhhhhh--hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          463 HLQQDGKLVELVDER--LGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       463 ~~~~~~~~~~~~d~~--l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                              ..+....  .........+.++.+++.+||+.+|++|||+.||
T Consensus       225 --------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~ei  267 (277)
T d1phka_         225 --------RMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA  267 (277)
T ss_dssp             --------HHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             --------HHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence                    1111111  1111223455679999999999999999999874

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-48  Score=382.36  Aligned_cols=252  Identities=28%  Similarity=0.424  Sum_probs=200.5

Q ss_pred             hcCCcccCceeccCceeEEecccc--------CCcEEEEEEecccCc-cchHHHHHHHHHHhcC-CCCCceeEEEEEEeC
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA--------DGTIIAVKQLSSKSR-QGNREFLNEIAMISCL-QHPNLVKIHGCCVEG  308 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~--------~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~  308 (511)
                      .++|++.+.||+|+||.||+|+..        ++..||||+++.... ....++.+|...+.++ +|||||+++++|.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            357888999999999999999743        235799999976543 3456788999999888 899999999999999


Q ss_pred             CEEEEEEEecCCCCHhHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEE
Q 045835          309 DQLLLVYEYMENNSLACALFGREN------------CELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLL  376 (511)
Q Consensus       309 ~~~~lV~Ey~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILl  376 (511)
                      +..++||||+++|+|.+++.....            ....+++.++++++.||+.||+|||+.+   |+||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence            999999999999999999975431            2345899999999999999999999987   9999999999999


Q ss_pred             cCCCCeEEeecCCcccCCCCC-ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcccccc
Q 045835          377 DRDLNPKISDFGLAKLDEGDK-THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVS-GKNNMSYAPALEFDC  454 (511)
Q Consensus       377 d~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~ellt-G~~p~~~~~~~~~~~  454 (511)
                      +.++.+||+|||+++...... ........||+.|+|||.+.++.+++++|||||||++|||+| |++||.....     
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~-----  243 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-----  243 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH-----
Confidence            999999999999998654332 222344678999999999999999999999999999999998 6777753221     


Q ss_pred             cchhhhhHhhhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          455 TCLLDWACHLQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       455 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .             .+.+.+........+...+.++.+|+.+||+.+|++|||+.||
T Consensus       244 ~-------------~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~ei  287 (299)
T d1fgka_         244 E-------------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL  287 (299)
T ss_dssp             H-------------HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             H-------------HHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHH
Confidence            1             1122233333334455556789999999999999999999875

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-48  Score=383.45  Aligned_cols=252  Identities=23%  Similarity=0.349  Sum_probs=202.8

Q ss_pred             hcCCcccCceeccCceeEEecccc------CCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQLA------DGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQL  311 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~~------~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~  311 (511)
                      .++|++.++||+|+||.||+|.+.      +++.||||+++... .+....|.+|+.++++++|||||+++|+|..++..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            467888999999999999999753      35789999997543 33445689999999999999999999999999999


Q ss_pred             EEEEEecCCCCHhHHHhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEe
Q 045835          312 LLVYEYMENNSLACALFGRE------NCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKIS  385 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~  385 (511)
                      ++||||+++|+|.+++....      .....+++..+.+++.|+|+||+|||+++   |+||||||+|||+++++.+||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence            99999999999999986432      11234799999999999999999999986   9999999999999999999999


Q ss_pred             ecCCcccCCCCCce-eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCcccccccchhhhhHh
Q 045835          386 DFGLAKLDEGDKTH-ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGK-NNMSYAPALEFDCTCLLDWACH  463 (511)
Q Consensus       386 DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~-~p~~~~~~~~~~~~~l~~~~~~  463 (511)
                      |||+++........ ......||+.|+|||.+.++.++.++||||||+++|||+||+ +|+....        ..++.. 
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~--------~~~~~~-  246 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--------NEQVLR-  246 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--------HHHHHH-
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC--------HHHHHH-
Confidence            99999865433322 233446899999999999999999999999999999999985 5554221        111111 


Q ss_pred             hhccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          464 LQQDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       464 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                              .+.+ ....+.+...+..+.+++.+||+.+|++||||.||
T Consensus       247 --------~i~~-~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~i  285 (308)
T d1p4oa_         247 --------FVME-GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI  285 (308)
T ss_dssp             --------HHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             --------HHHh-CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence                    1111 11223344556789999999999999999999764

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-47  Score=377.09  Aligned_cols=245  Identities=24%  Similarity=0.380  Sum_probs=200.3

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEeccc---CccchHHHHHHHHHHh-cCCCCCceeEEEEEEeCCEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK---SRQGNREFLNEIAMIS-CLQHPNLVKIHGCCVEGDQLLLV  314 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~---~~~~~~~~~~Ei~~l~-~l~H~niv~l~g~~~~~~~~~lV  314 (511)
                      ++|++.+.||+|+||+||+|+. .+++.||||+++..   .....+.+..|..++. .++|||||++++++.+++..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            5789999999999999999975 46899999999743   2334456777777665 68999999999999999999999


Q ss_pred             EEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCC
Q 045835          315 YEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDE  394 (511)
Q Consensus       315 ~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~  394 (511)
                      |||+++|+|.+++....    .+++.....++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++...
T Consensus        82 mEy~~~g~L~~~i~~~~----~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~  154 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM  154 (320)
T ss_dssp             EECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EeecCCCcHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcc
Confidence            99999999999996543    4889999999999999999999987   9999999999999999999999999998654


Q ss_pred             CCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhh
Q 045835          395 GDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELV  474 (511)
Q Consensus       395 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  474 (511)
                      .... ..+...||+.|+|||++.+..++.++|||||||++|||+||+.||.....     ..+..   .         +.
T Consensus       155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~-----~~~~~---~---------i~  216 (320)
T d1xjda_         155 LGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-----EELFH---S---------IR  216 (320)
T ss_dssp             CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH---H---------HH
T ss_pred             cccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH-----HHHHH---H---------HH
Confidence            3322 23346799999999999999999999999999999999999999974321     11110   0         00


Q ss_pred             hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcC-CC
Q 045835          475 DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMS-EV  511 (511)
Q Consensus       475 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~-eV  511 (511)
                      ..  ...++...+.++.+|+.+||+.||++|||+. ||
T Consensus       217 ~~--~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l  252 (320)
T d1xjda_         217 MD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDI  252 (320)
T ss_dssp             HC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCG
T ss_pred             cC--CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHH
Confidence            00  1123334456789999999999999999985 43

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6e-47  Score=380.82  Aligned_cols=241  Identities=22%  Similarity=0.331  Sum_probs=200.8

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEeccc---CccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK---SRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  315 (511)
                      ++|+++++||+|+||.||+|+. .+|+.||||++...   .....+.+.+|+.+|+.++|||||++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            5799999999999999999975 47999999998643   2334567899999999999999999999999999999999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEG  395 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~  395 (511)
                      ||+.+|+|..++....    .+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       121 e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             ccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            9999999999986543    4899999999999999999999987   99999999999999999999999999987643


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      ..    ....||+.|||||++.+..++.++|||||||++|||+||+.||.....     ..+..            .+..
T Consensus       194 ~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~------------~i~~  252 (350)
T d1rdqe_         194 RT----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-----IQIYE------------KIVS  252 (350)
T ss_dssp             CB----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH------------HHHH
T ss_pred             cc----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH-----HHHHH------------HHhc
Confidence            32    235799999999999999999999999999999999999999963221     11111            1111


Q ss_pred             hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCC-----CcCC
Q 045835          476 ERLGSKYKKEEAERMIKVSLLCTNASPSLRP-----TMSE  510 (511)
Q Consensus       476 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~e  510 (511)
                      ..  ...+...+.++.+++.+||+.||.+|+     |++|
T Consensus       253 ~~--~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~e  290 (350)
T d1rdqe_         253 GK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVND  290 (350)
T ss_dssp             CC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHH
T ss_pred             CC--CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHH
Confidence            11  122334456789999999999999995     6654

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.7e-47  Score=371.85  Aligned_cols=250  Identities=22%  Similarity=0.308  Sum_probs=192.5

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCc---cchHHHHHHHHHHhcCCCCCceeEEEEEEeCC----E
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSR---QGNREFLNEIAMISCLQHPNLVKIHGCCVEGD----Q  310 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~  310 (511)
                      .++|++.+.||+|+||.||+|+. .+|+.||||+++....   .....|.+|+.+++.++|||||++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            36799999999999999999974 5799999999975432   33457899999999999999999999998654    4


Q ss_pred             EEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCc
Q 045835          311 LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA  390 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla  390 (511)
                      .++||||+++++|.+++....    .+++.....++.||+.||+|||+.+   |+||||||+|||++.++..+|+|||++
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~  158 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA  158 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred             EEEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhh
Confidence            789999999999999886543    5999999999999999999999987   999999999999999999999999999


Q ss_pred             ccCCCCC--ceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccC
Q 045835          391 KLDEGDK--THISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDG  468 (511)
Q Consensus       391 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~  468 (511)
                      +......  ........||+.|+|||++.+..+++++|||||||++|||+||+.||.....        .+........+
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~~~~~~  230 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--------VSVAYQHVRED  230 (277)
T ss_dssp             EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHCC
T ss_pred             hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH--------HHHHHHHHhcC
Confidence            7543322  2223446799999999999999999999999999999999999999964321        11111111111


Q ss_pred             chhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCC-CcCC
Q 045835          469 KLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRP-TMSE  510 (511)
Q Consensus       469 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-s~~e  510 (511)
                      ..       .......+.+.++.+++.+||+.||++|| |++|
T Consensus       231 ~~-------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~  266 (277)
T d1o6ya_         231 PI-------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAE  266 (277)
T ss_dssp             CC-------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHH
T ss_pred             CC-------CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHH
Confidence            00       00111223345788999999999999999 6654

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=7e-47  Score=382.36  Aligned_cols=241  Identities=25%  Similarity=0.314  Sum_probs=195.1

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC---ccchHHHHH---HHHHHhcCCCCCceeEEEEEEeCCEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS---RQGNREFLN---EIAMISCLQHPNLVKIHGCCVEGDQLL  312 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~---~~~~~~~~~---Ei~~l~~l~H~niv~l~g~~~~~~~~~  312 (511)
                      ++|++.++||+|+||.||+|+. .+|+.||||++....   ......+.+   |+.+++.++|||||++++++.+.+.++
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            5799999999999999999975 468999999986431   222333444   477788889999999999999999999


Q ss_pred             EEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCccc
Q 045835          313 LVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       313 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~  392 (511)
                      +||||+++|+|.+++....    .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+|+.
T Consensus        84 ivmE~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~  156 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD  156 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred             EEEEecCCCcHHHHHHhcc----cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence            9999999999999996543    4889999999999999999999987   99999999999999999999999999986


Q ss_pred             CCCCCceeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchh
Q 045835          393 DEGDKTHISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLV  471 (511)
Q Consensus       393 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  471 (511)
                      .....   .....||+.|+|||++.. ..++.++|||||||++|||+||+.||......     ..             .
T Consensus       157 ~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-----~~-------------~  215 (364)
T d1omwa3         157 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DK-------------H  215 (364)
T ss_dssp             CSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS-----CH-------------H
T ss_pred             cCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH-----HH-------------H
Confidence            55432   234579999999999975 46899999999999999999999999743211     01             1


Q ss_pred             Hhhhhh--hCCCCCHHHHHHHHHHHHHcCCCCCCCCCCc
Q 045835          472 ELVDER--LGSKYKKEEAERMIKVSLLCTNASPSLRPTM  508 (511)
Q Consensus       472 ~~~d~~--l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  508 (511)
                      ++....  .....+...+.++.+|+.+||+.||++|||+
T Consensus       216 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~  254 (364)
T d1omwa3         216 EIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGC  254 (364)
T ss_dssp             HHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTT
T ss_pred             HHHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCC
Confidence            111111  1112233445678999999999999999995

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-46  Score=372.92  Aligned_cols=245  Identities=19%  Similarity=0.272  Sum_probs=200.2

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      .++|++.+.||+|+||.||+|.. .+++.||||+++.... ....+.+|+.+|+.++|||||++++++.+++.+++||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            36789999999999999999975 4688999999976432 335688999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCC--CCeEEeecCCcccCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD--LNPKISDFGLAKLDEG  395 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~--~~~kl~DfGla~~~~~  395 (511)
                      |++|+|.+++....   ..+++.....++.||+.||+|||+.+   |+||||||+|||++.+  ..+||+|||+++....
T Consensus        83 ~~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          83 ISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             CCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence            99999999996432   35899999999999999999999987   9999999999999854  4799999999987654


Q ss_pred             CCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhHhhh
Q 045835          396 DKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVELVD  475 (511)
Q Consensus       396 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  475 (511)
                      ...  .....+|+.|+|||...+..++.++||||+||++|||++|+.||.....     .   +..         ..+..
T Consensus       157 ~~~--~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~-----~---~~~---------~~i~~  217 (321)
T d1tkia_         157 GDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-----Q---QII---------ENIMN  217 (321)
T ss_dssp             TCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-----H---HHH---------HHHHH
T ss_pred             CCc--ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH-----H---HHH---------HHHHh
Confidence            332  2335689999999999999999999999999999999999999964321     0   111         11111


Q ss_pred             hhhCCCCCH----HHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          476 ERLGSKYKK----EEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       476 ~~l~~~~~~----~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...  .++.    ..+.++.+|+.+||+.||++|||+.|+
T Consensus       218 ~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ei  255 (321)
T d1tkia_         218 AEY--TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA  255 (321)
T ss_dssp             TCC--CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             CCC--CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence            111  1111    234568899999999999999998764

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-46  Score=376.26  Aligned_cols=249  Identities=21%  Similarity=0.247  Sum_probs=193.6

Q ss_pred             cCCcccC-ceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhc-CCCCCceeEEEEEEe----CCEEE
Q 045835          240 NNFDSAK-KIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISC-LQHPNLVKIHGCCVE----GDQLL  312 (511)
Q Consensus       240 ~~f~~~~-~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~----~~~~~  312 (511)
                      ++|.+.+ .||+|+||.||+|+. .+++.||||+++..     ..+.+|+.++.+ .+|||||++++++.+    ...++
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            5788775 599999999999974 57899999998642     467789998765 489999999999876    35689


Q ss_pred             EEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcC---CCCeEEeecCC
Q 045835          313 LVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR---DLNPKISDFGL  389 (511)
Q Consensus       313 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~---~~~~kl~DfGl  389 (511)
                      +|||||++|+|.+++..+.  ...+++.....++.||+.||+|||+.+   |+||||||+|||+++   ++.+||+|||+
T Consensus        86 ivmEy~~gg~L~~~i~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCS--CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEECCCCCcHHHHHHhcC--CCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence            9999999999999997543  235899999999999999999999987   999999999999986   45799999999


Q ss_pred             cccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCc
Q 045835          390 AKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGK  469 (511)
Q Consensus       390 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  469 (511)
                      ++.......  .....||+.|||||++.+..++.++|||||||++|||+||+.||......     ............+.
T Consensus       161 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~-----~~~~~~~~~i~~~~  233 (335)
T d2ozaa1         161 AKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-----AISPGMKTRIRMGQ  233 (335)
T ss_dssp             CEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------CCCSCS
T ss_pred             eeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHH-----HHHHHHHHHHhcCC
Confidence            986554332  23457999999999999999999999999999999999999999632211     01110000000000


Q ss_pred             hhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          470 LVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       470 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                            ...........+.++.+|+.+||+.||++|||+.|+
T Consensus       234 ------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ei  269 (335)
T d2ozaa1         234 ------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF  269 (335)
T ss_dssp             ------SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             ------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence                  000111112345679999999999999999999764

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-46  Score=369.09  Aligned_cols=255  Identities=25%  Similarity=0.296  Sum_probs=190.3

Q ss_pred             ccCceeccCceeEEeccc-cCCcEEEEEEecccCcc-----chHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          244 SAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQ-----GNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       244 ~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~-----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      .+++||+|+||+||+|+. .+|+.||||+++.....     ..+.+.+|+.+|++++|||||++++++.+++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            357899999999999985 46899999998654321     234688999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +.++++..+....    ..+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++......
T Consensus        82 ~~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~  154 (299)
T d1ua2a_          82 METDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  154 (299)
T ss_dssp             CSEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             hcchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence            9998777665322    35888999999999999999999987   9999999999999999999999999998654432


Q ss_pred             ceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCchhH----
Q 045835          398 THISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGKLVE----  472 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~----  472 (511)
                      .. .....||+.|+|||.+... .++.++|||||||++|||+||++||......     +...-............    
T Consensus       155 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-----~~l~~i~~~~~~~~~~~~~~~  228 (299)
T d1ua2a_         155 RA-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-----DQLTRIFETLGTPTEEQWPDM  228 (299)
T ss_dssp             CC-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHHHCCCCTTTSSST
T ss_pred             cc-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH-----HHHHHHHHhcCCCChhhccch
Confidence            22 2335789999999998754 6799999999999999999999998643211     11111111000000000    


Q ss_pred             --hhhh---hhCCCCC-----HHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          473 --LVDE---RLGSKYK-----KEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       473 --~~d~---~l~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                        ....   ......+     .....++.+|+.+||+.||++|||++|+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~  277 (299)
T d1ua2a_         229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA  277 (299)
T ss_dssp             TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHH
T ss_pred             hccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence              0000   0000011     1224578999999999999999999864

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-46  Score=368.08  Aligned_cols=261  Identities=25%  Similarity=0.369  Sum_probs=194.4

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      ++|++.++||+|+||.||+|+. .+|+.||||+++...  .....++.+|+.+|++++|||||++++++.+++..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5799999999999999999975 578999999996542  2345689999999999999999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      |+.++.+. .+....  ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        82 ~~~~~~~~-~~~~~~--~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          82 FLHQDLKK-FMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             CCSEEHHH-HHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             ecCCchhh-hhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC
Confidence            99865444 443322  235999999999999999999999987   999999999999999999999999999865433


Q ss_pred             CceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhc-cC----ch
Q 045835          397 KTHISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQ-DG----KL  470 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~-~~----~~  470 (511)
                      .. ......||+.|+|||.+... ..+.++|||||||++|||++|+.||......+    .+..-...... ..    ..
T Consensus       156 ~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~  230 (298)
T d1gz8a_         156 VR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID----QLFRIFRTLGTPDEVVWPGV  230 (298)
T ss_dssp             SB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCCTTTSTTG
T ss_pred             cc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH----HHHHHHHhcCCCchhhcccc
Confidence            22 23345799999999987765 46899999999999999999999997432110    00000000000 00    00


Q ss_pred             hHhhhh--hh----CCC---CCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          471 VELVDE--RL----GSK---YKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       471 ~~~~d~--~l----~~~---~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ....+.  ..    ...   .....+.++.+|+.+||+.||++|||+.|+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~el  280 (298)
T d1gz8a_         231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA  280 (298)
T ss_dssp             GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence            000000  00    000   001224578899999999999999999764

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=9.4e-46  Score=362.61  Aligned_cols=263  Identities=24%  Similarity=0.319  Sum_probs=196.8

Q ss_pred             cCCcccCceeccCceeEEeccccCCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEEe
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYEY  317 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey  317 (511)
                      ++|++.++||+|+||+||+|+.++|+.||||+++...  ....+.+.+|+.+|++++|||||++++++.+.+..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5799999999999999999998889999999996542  33356899999999999999999999999999999999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGDK  397 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~~  397 (511)
                      +.++.+..+....    ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~  154 (286)
T d1ob3a_          82 LDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (286)
T ss_dssp             CSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             ehhhhHHHHHhhc----CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence            9887776665432    35999999999999999999999986   9999999999999999999999999998654332


Q ss_pred             ceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCccccc--------ccchhhhhHhhhccC
Q 045835          398 THISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFD--------CTCLLDWACHLQQDG  468 (511)
Q Consensus       398 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~--------~~~l~~~~~~~~~~~  468 (511)
                      .. .....+++.|+|||.+... .++.++|||||||+++||++|+.||......+.-        ......|.... ...
T Consensus       155 ~~-~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~  232 (286)
T d1ob3a_         155 RK-YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT-ELP  232 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG-GST
T ss_pred             cc-cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchh-hhh
Confidence            22 2234688999999998754 6799999999999999999999999643211000        00000010000 000


Q ss_pred             chhH---hhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          469 KLVE---LVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       469 ~~~~---~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ....   ...+..........+..+.+++.+||+.||++|||++|+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~el  278 (286)
T d1ob3a_         233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA  278 (286)
T ss_dssp             TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence            0000   000000011122234578899999999999999999874

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-46  Score=363.21  Aligned_cols=237  Identities=23%  Similarity=0.378  Sum_probs=192.3

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCc------cchHHHHHHHHHHhcCC--CCCceeEEEEEEeCCE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSR------QGNREFLNEIAMISCLQ--HPNLVKIHGCCVEGDQ  310 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~------~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~  310 (511)
                      ++|++.++||+|+||.||+|+. .+|+.||||++.....      .....+.+|+.+|++++  |||||++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            5799999999999999999975 5789999999864321      11234678999999986  8999999999999999


Q ss_pred             EEEEEEecCC-CCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCC-CCeEEeecC
Q 045835          311 LLLVYEYMEN-NSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRD-LNPKISDFG  388 (511)
Q Consensus       311 ~~lV~Ey~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~-~~~kl~DfG  388 (511)
                      .++||||+.+ +++.+++...    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.+ +.+||+|||
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~----~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEEEeccCcchHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence            9999999986 5777777543    25899999999999999999999987   9999999999999855 789999999


Q ss_pred             CcccCCCCCceeecccccCCCcccccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhcc
Q 045835          389 LAKLDEGDKTHISTRIAGTIGYMAPEYALWGYL-TYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQD  467 (511)
Q Consensus       389 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~  467 (511)
                      +++......   .+...||+.|+|||++.+..+ +.++|||||||++|||+||+.||....                   
T Consensus       157 ~a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------------------  214 (273)
T d1xwsa_         157 SGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------------  214 (273)
T ss_dssp             TCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------------
T ss_pred             cceeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------------------
Confidence            998654322   234679999999999987654 677999999999999999999986311                   


Q ss_pred             CchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          468 GKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       468 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                          ++....  ..++...+.++.+++.+||+.||++|||+.|+
T Consensus       215 ----~i~~~~--~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ei  252 (273)
T d1xwsa_         215 ----EIIRGQ--VFFRQRVSSECQHLIRWCLALRPSDRPTFEEI  252 (273)
T ss_dssp             ----HHHHCC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             ----HHhhcc--cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHH
Confidence                001100  11222334568999999999999999999864

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-45  Score=364.16  Aligned_cols=260  Identities=24%  Similarity=0.359  Sum_probs=192.8

Q ss_pred             hcCCcccCceeccCceeEEeccc-cC-CcEEEEEEecccC--ccchHHHHHHHHHHhcC---CCCCceeEEEEEEe----
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-AD-GTIIAVKQLSSKS--RQGNREFLNEIAMISCL---QHPNLVKIHGCCVE----  307 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~-g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~----  307 (511)
                      .++|++.++||+|+||.||+|+. .+ ++.||||+++...  ......+.+|+.+|+.|   +||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46899999999999999999975 33 6789999986532  22334566787777665   89999999999864    


Q ss_pred             -CCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEee
Q 045835          308 -GDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISD  386 (511)
Q Consensus       308 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~D  386 (511)
                       ....+++|||+.++++.......   ...+++.....++.|++.||+|||+++   |+||||||+|||+++++.+||+|
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCceEEEEEEeccCCchhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecc
Confidence             24689999999988776554332   235899999999999999999999987   99999999999999999999999


Q ss_pred             cCCcccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhc
Q 045835          387 FGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQ  466 (511)
Q Consensus       387 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~  466 (511)
                      ||+++......  ......||+.|+|||++.+..++.++||||+||++|||++|+.||......     ....-......
T Consensus       160 fg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-----~~~~~i~~~~~  232 (305)
T d1blxa_         160 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-----DQLGKILDVIG  232 (305)
T ss_dssp             CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHC
T ss_pred             hhhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH-----HHHHHHHHhhC
Confidence            99998654322  234467999999999999999999999999999999999999999743211     01000000000


Q ss_pred             c---------Cchh-Hhhhh---hhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          467 D---------GKLV-ELVDE---RLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       467 ~---------~~~~-~~~d~---~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .         .... .....   .............+.+|+.+||+.||++|||+.|+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~  290 (305)
T d1blxa_         233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA  290 (305)
T ss_dssp             CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             CCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence            0         0000 00000   00001122234568899999999999999998764

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-43  Score=353.16  Aligned_cols=260  Identities=24%  Similarity=0.313  Sum_probs=190.4

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEeccc--CccchHHHHHHHHHHhcCCCCCceeEEEEEEe--------C
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSK--SRQGNREFLNEIAMISCLQHPNLVKIHGCCVE--------G  308 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--------~  308 (511)
                      ++|++.++||+|+||+||+|+. .+|+.||||++...  .......+.+|+.+|++++|||++++++++..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            6899999999999999999985 57999999998643  23345678999999999999999999999865        3


Q ss_pred             CEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecC
Q 045835          309 DQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFG  388 (511)
Q Consensus       309 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfG  388 (511)
                      ...++||||+.++.+......    ...++......++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred             ceEEEEEeccCCCccchhhhc----ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence            458999999998877655432    235888999999999999999999987   9999999999999999999999999


Q ss_pred             CcccCCCCCc---eeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhh
Q 045835          389 LAKLDEGDKT---HISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHL  464 (511)
Q Consensus       389 la~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~  464 (511)
                      +++.......   .......||+.|+|||.+.+. .+++++|||||||+++||++|+.||......     ....-....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~-----~~~~~i~~~  237 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-----HQLALISQL  237 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHH
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH-----HHHHHHHHh
Confidence            9975543221   112234689999999998765 6899999999999999999999999642211     010000000


Q ss_pred             hc-----------cCchhHhhhhhhCCCCCH-------HHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          465 QQ-----------DGKLVELVDERLGSKYKK-------EEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       465 ~~-----------~~~~~~~~d~~l~~~~~~-------~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..           ................+.       .....+.+|+.+||+.||++|||++|+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~el  302 (318)
T d3blha1         238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA  302 (318)
T ss_dssp             HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             cCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence            00           000000000000001111       113456789999999999999999874

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-43  Score=346.01  Aligned_cols=260  Identities=21%  Similarity=0.297  Sum_probs=199.8

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCCEEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E  316 (511)
                      ++|+++++||+|+||+||+|+. .+++.||||+++...  ......+.+|+.+|+.++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5799999999999999999985 578999999996543  2335688999999999999999999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCcccCCCC
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKLDEGD  396 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~~~~~  396 (511)
                      ++.+++|..++...    ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.++.....
T Consensus        82 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_          82 FCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSEEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             eccccccccccccc----cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCC
Confidence            99999988877544    35889999999999999999999986   999999999999999999999999999875543


Q ss_pred             CceeecccccCCCcccccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccC------c
Q 045835          397 KTHISTRIAGTIGYMAPEYALWGY-LTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDG------K  469 (511)
Q Consensus       397 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~------~  469 (511)
                      ... .....++..|+|||.+.... ++.++|||||||+++||++|+.|+.......    ....-........      .
T Consensus       155 ~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  229 (292)
T d1unla_         155 VRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD----DQLKRIFRLLGTPTEEQWPS  229 (292)
T ss_dssp             CSC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH----HHHHHHHHHHCCCCTTTCTT
T ss_pred             Ccc-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH----HHHHHHHhhcCCCChhhhhh
Confidence            322 22345778899999887664 6999999999999999999999975322111    1111000000000      0


Q ss_pred             hhHhhhh---------hhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          470 LVELVDE---------RLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       470 ~~~~~d~---------~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ..+..+.         .............+.+|+.+||+.||++|||++||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~  280 (292)
T d1unla_         230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA  280 (292)
T ss_dssp             GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence            0000000         00111223345578899999999999999999874

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-43  Score=353.93  Aligned_cols=256  Identities=25%  Similarity=0.331  Sum_probs=188.7

Q ss_pred             CCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeEEEEEEeC------CEEEE
Q 045835          241 NFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKIHGCCVEG------DQLLL  313 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~~l  313 (511)
                      .|+..++||+|+||+||+|+. .+|+.||||++......    +.+|+.+|++++||||+++++++...      ..+++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            477889999999999999986 46899999999754332    34799999999999999999999653      24789


Q ss_pred             EEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCC-CeEEeecCCccc
Q 045835          314 VYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL-NPKISDFGLAKL  392 (511)
Q Consensus       314 V~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~-~~kl~DfGla~~  392 (511)
                      ||||++++.+..+... ......+++..+..++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||+++.
T Consensus        97 v~Ey~~~~~~~~l~~~-~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          97 VLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEECCSEEHHHHHHHH-HHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEeccCCccHHHHHhh-hhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhh
Confidence            9999987654443321 122346999999999999999999999986   99999999999999875 899999999986


Q ss_pred             CCCCCceeecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCc--
Q 045835          393 DEGDKTHISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGK--  469 (511)
Q Consensus       393 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~--  469 (511)
                      .......  ....||..|+|||.+.. ..++.++||||+||++|||++|+.||......    ..+....... ....  
T Consensus       173 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~----~~l~~i~~~~-g~~~~~  245 (350)
T d1q5ka_         173 LVRGEPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV----DQLVEIIKVL-GTPTRE  245 (350)
T ss_dssp             CCTTSCC--CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH----HHHHHHHHHH-CCCCHH
T ss_pred             ccCCccc--ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH----HHHHHHHHHh-CCChHH
Confidence            6543322  33578999999998775 47899999999999999999999999643311    1111110000 0000  


Q ss_pred             -hhHh----hhhhh--------CCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          470 -LVEL----VDERL--------GSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       470 -~~~~----~d~~l--------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                       ....    .+...        ..........++.+|+.+||+.||++|||+.|+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~  300 (350)
T d1q5ka_         246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA  300 (350)
T ss_dssp             HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence             0000    00000        001112234568899999999999999998764

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-43  Score=351.75  Aligned_cols=245  Identities=25%  Similarity=0.351  Sum_probs=198.0

Q ss_pred             cCCcccCceeccCceeEEeccc----cCCcEEEEEEecccC----ccchHHHHHHHHHHhcCCC-CCceeEEEEEEeCCE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL----ADGTIIAVKQLSSKS----RQGNREFLNEIAMISCLQH-PNLVKIHGCCVEGDQ  310 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~----~~g~~vAvK~~~~~~----~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~  310 (511)
                      ++|++.+.||+|+||.||+|+.    .+|+.||||+++...    ....+.+.+|+.++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            5699999999999999999963    247899999986432    2344678899999999976 899999999999999


Q ss_pred             EEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCc
Q 045835          311 LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA  390 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla  390 (511)
                      .+++|||+.+|+|.+++....    .+.......++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~----~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a  176 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS  176 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eeeeeecccccHHHHHHHhcc----cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccch
Confidence            999999999999999986554    3678888999999999999999986   999999999999999999999999999


Q ss_pred             ccCCCCCceeecccccCCCcccccccccC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccC
Q 045835          391 KLDEGDKTHISTRIAGTIGYMAPEYALWG--YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDG  468 (511)
Q Consensus       391 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~  468 (511)
                      +..............|++.|+|||.+...  .++.++|||||||+||||++|+.||.......     .           
T Consensus       177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~-----~-----------  240 (322)
T d1vzoa_         177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-----S-----------  240 (322)
T ss_dssp             EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-----C-----------
T ss_pred             hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-----H-----------
Confidence            86654444334456799999999998754  57889999999999999999999997433111     0           


Q ss_pred             chhHhhhh--hhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCc
Q 045835          469 KLVELVDE--RLGSKYKKEEAERMIKVSLLCTNASPSLRPTM  508 (511)
Q Consensus       469 ~~~~~~d~--~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  508 (511)
                       ...+...  ......+...+.++.+++.+||+.||++|||+
T Consensus       241 -~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~  281 (322)
T d1vzoa_         241 -QAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGC  281 (322)
T ss_dssp             -HHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred             -HHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCC
Confidence             1111111  11223344566789999999999999999974

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-43  Score=355.42  Aligned_cols=260  Identities=22%  Similarity=0.287  Sum_probs=191.2

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC-ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCC----EEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS-RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGD----QLL  312 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~  312 (511)
                      +.+|+++++||+|+||+||+|+. .+|+.||||+++... ....+.+++|+.+|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            35699999999999999999974 579999999997543 334457899999999999999999999997643    334


Q ss_pred             EEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCccc
Q 045835          313 LVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       313 lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~~  392 (511)
                      ++++|+.+|+|.+++...     .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        87 ~l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~  158 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV  158 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence            555677799999999643     4899999999999999999999987   99999999999999999999999999986


Q ss_pred             CCCCCce--eecccccCCCccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccCc
Q 045835          393 DEGDKTH--ISTRIAGTIGYMAPEYALW-GYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDGK  469 (511)
Q Consensus       393 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  469 (511)
                      .......  ......||+.|+|||.+.. ..++.++||||+||+++||++|+.||......+     .............
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~-----~~~~~~~~~~~~~  233 (345)
T d1pmea_         159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-----QLNHILGILGSPS  233 (345)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHHHCSCC
T ss_pred             ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH-----HHHHHhhhccCCC
Confidence            5432221  2234578999999999854 467899999999999999999999996432110     0000000000000


Q ss_pred             -----------hhHhhhhhh-CCCCC-----HHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          470 -----------LVELVDERL-GSKYK-----KEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       470 -----------~~~~~d~~l-~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                                 ......... ....+     +....++.+|+.+||+.||++|||+.|+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~  292 (345)
T d1pmea_         234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA  292 (345)
T ss_dssp             HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             hhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence                       000000000 00011     1123468899999999999999999864

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.6e-43  Score=347.39  Aligned_cols=251  Identities=22%  Similarity=0.242  Sum_probs=188.4

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCceeE-EEEEEeCCEEEEEEEe
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNLVKI-HGCCVEGDQLLLVYEY  317 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l-~g~~~~~~~~~lV~Ey  317 (511)
                      ++|++.++||+|+||.||+|+. .+|+.||||++.....  ..++..|+++++.++|+|++.. .++..+++..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            5799999999999999999975 5689999999875433  2467899999999987776555 4555678889999999


Q ss_pred             cCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcC---CCCeEEeecCCcccCC
Q 045835          318 MENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR---DLNPKISDFGLAKLDE  394 (511)
Q Consensus       318 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~---~~~~kl~DfGla~~~~  394 (511)
                      +. ++|...+....   ..+++..+..++.|++.||+|||+++   |+||||||+|||++.   +..+||+|||+++...
T Consensus        85 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          85 LG-PSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             CC-CBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             cC-Cchhhhhhhcc---CCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            95 56666654332   35899999999999999999999987   999999999999864   5579999999998654


Q ss_pred             CCCce------eecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhccC
Q 045835          395 GDKTH------ISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQDG  468 (511)
Q Consensus       395 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~  468 (511)
                      .....      ......||+.|||||.+.+..++.++|||||||++|||+||+.||......... .....+....    
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~-~~~~~~~~~~----  232 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-QKYERISEKK----  232 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHH----
T ss_pred             ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHH-HHHHHhhccc----
Confidence            33221      233457999999999999999999999999999999999999999754321110 0000110000    


Q ss_pred             chhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCC
Q 045835          469 KLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSE  510 (511)
Q Consensus       469 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e  510 (511)
                        .....+.+...    .+.++.+++..||+.+|++||++++
T Consensus       233 --~~~~~~~~~~~----~p~~~~~li~~cl~~~p~~RP~~~~  268 (299)
T d1ckia_         233 --MSTPIEVLCKG----YPSEFATYLNFCRSLRFDDKPDYSY  268 (299)
T ss_dssp             --HHSCHHHHTTT----SCHHHHHHHHHHHHSCTTCCCCHHH
T ss_pred             --CCCChhHhccC----CCHHHHHHHHHHccCChhHCcCHHH
Confidence              00000111222    3356889999999999999999864

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-43  Score=353.50  Aligned_cols=256  Identities=21%  Similarity=0.299  Sum_probs=188.6

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeCC------
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEGD------  309 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------  309 (511)
                      .++|++.++||+|+||+||+|.. .+|+.||||+++...  ....+.+.+|+.+|+.++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            36799999999999999999975 469999999997532  233457889999999999999999999998654      


Q ss_pred             EEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCC
Q 045835          310 QLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGL  389 (511)
Q Consensus       310 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGl  389 (511)
                      .+++||||+ +.+|..+....     .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecc-cccHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence            579999999 55777776432     4999999999999999999999987   99999999999999999999999999


Q ss_pred             cccCCCCCceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhh---
Q 045835          390 AKLDEGDKTHISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQ---  465 (511)
Q Consensus       390 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~---  465 (511)
                      ++......    +...||+.|+|||.+.+. .++.++||||+||+++||++|+.||.......    .+........   
T Consensus       168 a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~----~~~~~~~~~~~~~  239 (346)
T d1cm8a_         168 ARQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD----QLKEIMKVTGTPP  239 (346)
T ss_dssp             CEECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHCCCC
T ss_pred             eeccCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH----HHHHHHhccCCCc
Confidence            98654332    335789999999998764 67999999999999999999999997432110    1111000000   


Q ss_pred             ----cc--CchhHhhhhhhC-------CCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          466 ----QD--GKLVELVDERLG-------SKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       466 ----~~--~~~~~~~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                          ..  .....-....+.       ..........+.+|+.+||+.||++|||+.|+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~ei  298 (346)
T d1cm8a_         240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA  298 (346)
T ss_dssp             HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             HHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence                00  000000000000       01112234567899999999999999999864

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=7.3e-43  Score=342.97  Aligned_cols=251  Identities=21%  Similarity=0.239  Sum_probs=194.4

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCCC-CCceeEEEEEEeCCEEEEEEE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQH-PNLVKIHGCCVEGDQLLLVYE  316 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~E  316 (511)
                      .++|++.++||+|+||.||+|+. .+|+.||||++.....  ...+.+|++.++.++| +|++.+++++.++...++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            36899999999999999999984 4689999999865432  2457788999999965 899999999999999999999


Q ss_pred             ecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcC-----CCCeEEeecCCcc
Q 045835          317 YMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDR-----DLNPKISDFGLAK  391 (511)
Q Consensus       317 y~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~-----~~~~kl~DfGla~  391 (511)
                      |+ +++|.+++....   ..+++.+...++.|++.||+|||+.+   |+||||||+|||++.     ++.+||+|||+++
T Consensus        82 ~~-~~~l~~~~~~~~---~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~  154 (293)
T d1csna_          82 LL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  154 (293)
T ss_dssp             CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             ec-CCCHHHHHHhhc---cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeE
Confidence            99 689999886543   35899999999999999999999987   999999999999975     5679999999998


Q ss_pred             cCCCCCc------eeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhh
Q 045835          392 LDEGDKT------HISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQ  465 (511)
Q Consensus       392 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~  465 (511)
                      .......      .......||+.|||||.+.+..+++++|||||||++|||+||+.||........  ...........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~--~~~~~~i~~~~  232 (293)
T d1csna_         155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN--KQKYERIGEKK  232 (293)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH--HHHHHHHHHHH
T ss_pred             EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhH--HHHHHHHHhcc
Confidence            6543211      112345799999999999999999999999999999999999999974331110  00000000000


Q ss_pred             ccCchhHhhhhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcC
Q 045835          466 QDGKLVELVDERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMS  509 (511)
Q Consensus       466 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~  509 (511)
                      .....     +.+...+|    .++.+++..|++.+|++||+++
T Consensus       233 ~~~~~-----~~l~~~~p----~~l~~ii~~~~~~~~~~rP~y~  267 (293)
T d1csna_         233 QSTPL-----RELCAGFP----EEFYKYMHYARNLAFDATPDYD  267 (293)
T ss_dssp             HHSCH-----HHHTTTSC----HHHHHHHHHHHHCCTTCCCCHH
T ss_pred             CCCCh-----HHhcCCCC----HHHHHHHHHHhcCCcccCcCHH
Confidence            00001     11222233    4688899999999999999864

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.4e-42  Score=346.54  Aligned_cols=257  Identities=18%  Similarity=0.264  Sum_probs=193.3

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCC-CCCceeEEEEEEeC--CEEEEEE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ-HPNLVKIHGCCVEG--DQLLLVY  315 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~--~~~~lV~  315 (511)
                      ++|++.++||+|+||+||+|+. .+|+.||||+++..   ..+++.+|+.+|+.++ ||||+++++++...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            5799999999999999999975 57899999998753   2457889999999995 99999999999854  4689999


Q ss_pred             EecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCC-CeEEeecCCcccCC
Q 045835          316 EYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDL-NPKISDFGLAKLDE  394 (511)
Q Consensus       316 Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~-~~kl~DfGla~~~~  394 (511)
                      ||+.+++|..+.       ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||+++...
T Consensus       112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             eecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceecc
Confidence            999999987653       24899999999999999999999987   99999999999998765 58999999998655


Q ss_pred             CCCceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCccccccc---------chhhhhHhh
Q 045835          395 GDKTHISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCT---------CLLDWACHL  464 (511)
Q Consensus       395 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~---------~l~~~~~~~  464 (511)
                      ....  .....+|..|+|||.+.+. .++.++||||+||+++||++|+.||...........         ....|....
T Consensus       182 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  259 (328)
T d3bqca1         182 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  259 (328)
T ss_dssp             TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             CCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence            4322  2345789999999998765 579999999999999999999999874432110000         000111000


Q ss_pred             hcc--CchhHhh--------hhhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          465 QQD--GKLVELV--------DERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       465 ~~~--~~~~~~~--------d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      ...  .......        ............+.++.+|+.+||+.||++|||++|+
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~  316 (328)
T d3bqca1         260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA  316 (328)
T ss_dssp             TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence            000  0000000        0001111112234568899999999999999999874

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-42  Score=344.70  Aligned_cols=260  Identities=23%  Similarity=0.284  Sum_probs=186.3

Q ss_pred             cCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEe------CCE
Q 045835          240 NNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVE------GDQ  310 (511)
Q Consensus       240 ~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------~~~  310 (511)
                      ++|++.++||+|+||+||+|+. .+|+.||||++....  ......+.+|+.++++++|||||++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            5799999999999999999975 469999999997543  3334568899999999999999999999964      368


Q ss_pred             EEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCc
Q 045835          311 LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA  390 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla  390 (511)
                      +++||||+.++.+. .+.      ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+|++|||++
T Consensus        97 ~~iv~Ey~~~~l~~-~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~  166 (355)
T d2b1pa1          97 VYLVMELMDANLCQ-VIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_dssp             EEEEEECCSEEHHH-HHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             eEEEEeccchHHHH-hhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence            89999999766554 442      24889999999999999999999997   999999999999999999999999999


Q ss_pred             ccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccc-------cchhhh---
Q 045835          391 KLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDC-------TCLLDW---  460 (511)
Q Consensus       391 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~-------~~l~~~---  460 (511)
                      +......  ..+...+|+.|+|||.+.+..+++++||||+||+++||++|+.||..........       ....++   
T Consensus       167 ~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (355)
T d2b1pa1         167 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_dssp             ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             hcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence            8654322  2344578999999999999999999999999999999999999996432110000       000000   


Q ss_pred             ----hHhhhcc------CchhHhhhhhhCCC---CCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          461 ----ACHLQQD------GKLVELVDERLGSK---YKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       461 ----~~~~~~~------~~~~~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                          .......      ..............   .....+..+.+|+.+||+.||++|||++||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~el  308 (355)
T d2b1pa1         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA  308 (355)
T ss_dssp             SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence                0000000      00111111111111   122346778999999999999999999874

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-41  Score=340.77  Aligned_cols=256  Identities=20%  Similarity=0.276  Sum_probs=189.7

Q ss_pred             hcCCcccCceeccCceeEEeccc-cCCcEEEEEEecccC--ccchHHHHHHHHHHhcCCCCCceeEEEEEEeC-----CE
Q 045835          239 TNNFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKS--RQGNREFLNEIAMISCLQHPNLVKIHGCCVEG-----DQ  310 (511)
Q Consensus       239 ~~~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~  310 (511)
                      +++|++.++||+|+||+||+|+. .+|+.||||+++...  ....+.+.+|+.+|++++|||+|++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            46799999999999999999974 579999999997543  23345788999999999999999999998643     34


Q ss_pred             EEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEEeecCCc
Q 045835          311 LLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKISDFGLA  390 (511)
Q Consensus       311 ~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl~DfGla  390 (511)
                      .+++++|+.+|+|.+++..+     .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+|++|||++
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             eEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchh
Confidence            56778888999999998542     4999999999999999999999987   999999999999999999999999999


Q ss_pred             ccCCCCCceeecccccCCCcccccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCcccccccchhhhhHhhhc---
Q 045835          391 KLDEGDKTHISTRIAGTIGYMAPEYALWG-YLTYKADVYSFGIVALEIVSGKNNMSYAPALEFDCTCLLDWACHLQQ---  466 (511)
Q Consensus       391 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~---  466 (511)
                      ......    .....||..|+|||...+. .++.++|||||||+++||++|+.||......     ...........   
T Consensus       169 ~~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~-----~~~~~i~~~~~~~~  239 (348)
T d2gfsa1         169 RHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-----DQLKLILRLVGTPG  239 (348)
T ss_dssp             -CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCCCC
T ss_pred             cccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH-----HHHHHHHHhcCCCC
Confidence            754322    2335689999999987765 5789999999999999999999999643211     01000000000   


Q ss_pred             --------cCchhHhhhhhhC-CCCC-----HHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          467 --------DGKLVELVDERLG-SKYK-----KEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       467 --------~~~~~~~~d~~l~-~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                              ............. ...+     ......+.+|+.+||+.||++|||+.|+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~el  298 (348)
T d2gfsa1         240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA  298 (348)
T ss_dssp             HHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             hHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHH
Confidence                    0000000000000 0000     1124567899999999999999999864

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.4e-37  Score=310.55  Aligned_cols=263  Identities=19%  Similarity=0.212  Sum_probs=188.3

Q ss_pred             CCcccCceeccCceeEEeccc-cCCcEEEEEEecccCccchHHHHHHHHHHhcCC-----------CCCceeEEEEEEe-
Q 045835          241 NFDSAKKIGEGGFGPVYKGQL-ADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ-----------HPNLVKIHGCCVE-  307 (511)
Q Consensus       241 ~f~~~~~lG~G~fG~Vy~g~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-----------H~niv~l~g~~~~-  307 (511)
                      +|++.++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+.+++.++           |+||+++++++.. 
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            589999999999999999975 579999999997543 23456788999888775           5789999998864 


Q ss_pred             -CCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCC-----
Q 045835          308 -GDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLN-----  381 (511)
Q Consensus       308 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~-----  381 (511)
                       ....+++++++..+......... .....+++..+..++.|++.||+|||+..  +|+||||||+|||++.++.     
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEE
T ss_pred             cccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCcccccc
Confidence             45677788877665543333221 12345888999999999999999999832  4999999999999987653     


Q ss_pred             -eEEeecCCcccCCCCCceeecccccCCCcccccccccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcccc--cccchh
Q 045835          382 -PKISDFGLAKLDEGDKTHISTRIAGTIGYMAPEYALWGYLTYKADVYSFGIVALEIVSGKNNMSYAPALEF--DCTCLL  458 (511)
Q Consensus       382 -~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gvvl~elltG~~p~~~~~~~~~--~~~~l~  458 (511)
                       +|++|||.+.......    ....||+.|+|||.+....++.++||||+||+++||++|+.||........  ....+.
T Consensus       170 ~~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~  245 (362)
T d1q8ya_         170 QIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA  245 (362)
T ss_dssp             EEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred             eeeEeeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence             8999999998543322    335789999999999999999999999999999999999999864321110  001111


Q ss_pred             hhhHhhhcc--------CchhHhhh-------------------hhhCCCCCHHHHHHHHHHHHHcCCCCCCCCCCcCCC
Q 045835          459 DWACHLQQD--------GKLVELVD-------------------ERLGSKYKKEEAERMIKVSLLCTNASPSLRPTMSEV  511 (511)
Q Consensus       459 ~~~~~~~~~--------~~~~~~~d-------------------~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~eV  511 (511)
                      .....+...        .......+                   ...........+..+.+|+.+||+.||.+|||++|+
T Consensus       246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~  325 (362)
T d1q8ya_         246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL  325 (362)
T ss_dssp             HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred             HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence            111110000        00000000                   001223456778899999999999999999998764

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.88  E-value=1.7e-23  Score=190.95  Aligned_cols=164  Identities=20%  Similarity=0.126  Sum_probs=120.5

Q ss_pred             cccCceeccCceeEEeccccCCcEEEEEEecccCc------------------cchHHHHHHHHHHhcCCCCCceeEEEE
Q 045835          243 DSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSR------------------QGNREFLNEIAMISCLQHPNLVKIHGC  304 (511)
Q Consensus       243 ~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~------------------~~~~~~~~Ei~~l~~l~H~niv~l~g~  304 (511)
                      .+.++||+|+||.||+|+..+|+.||||+++....                  .....+..|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            35689999999999999988899999998753211                  011234568889999999999998765


Q ss_pred             EEeCCEEEEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEccCCCCCeEEcCCCCeEE
Q 045835          305 CVEGDQLLLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEESRFKIVHRDIKATNVLLDRDLNPKI  384 (511)
Q Consensus       305 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH~Dlk~~NILld~~~~~kl  384 (511)
                      .  .  .+++|||+++..+..           ++.....+++.|++++|+|||+.+   |+||||||+|||++++ .++|
T Consensus        83 ~--~--~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~l  143 (191)
T d1zara2          83 E--G--NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWI  143 (191)
T ss_dssp             E--T--TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEE
T ss_pred             c--C--CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEE
Confidence            3  2  378999998865432           334455679999999999999987   9999999999999976 4899


Q ss_pred             eecCCcccCCCCCceeecccccCCCcccc------cccccCCCCcchhHHHHHHHHH
Q 045835          385 SDFGLAKLDEGDKTHISTRIAGTIGYMAP------EYALWGYLTYKADVYSFGIVAL  435 (511)
Q Consensus       385 ~DfGla~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~DV~S~Gvvl~  435 (511)
                      +|||+|.........         .|+..      |. ..+.++.++|+||..--++
T Consensus       144 iDFG~a~~~~~~~~~---------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         144 IDFPQSVEVGEEGWR---------EILERDVRNIITY-FSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             CCCTTCEETTSTTHH---------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred             EECCCcccCCCCCcH---------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHHh
Confidence            999999765432211         01111      11 1356788899999865443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.52  E-value=3.5e-07  Score=85.17  Aligned_cols=149  Identities=14%  Similarity=0.114  Sum_probs=100.6

Q ss_pred             HHHHHHhcCCcccCceeccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCC-CCCceeEEEEEEeCCEE
Q 045835          233 KQIKAATNNFDSAKKIGEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ-HPNLVKIHGCCVEGDQL  311 (511)
Q Consensus       233 ~~l~~~~~~f~~~~~lG~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~  311 (511)
                      .+++..-..|.+.+..+.++...||+... ++..+.+|+...........+.+|...+..+. +-.+.+++.++.+++..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            34555556777666555455578998865 45567788876555444556778888877663 43466788888888999


Q ss_pred             EEEEEecCCCCHhHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------
Q 045835          312 LLVYEYMENNSLACALFGRENCELELDWPTRQKICLGIARGLAFLHEES-------------------------------  360 (511)
Q Consensus       312 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~-------------------------------  360 (511)
                      ++||+++++.++.+.....         .....++.++++.++.||+..                               
T Consensus        86 ~lv~~~l~G~~~~~~~~~~---------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDE---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTC---------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred             EEEEEeccccccccccccc---------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence            9999999998876543211         112223444455555555321                               


Q ss_pred             -------------------------CCCeEEccCCCCCeEEcCCCCeEEeecCCcc
Q 045835          361 -------------------------RFKIVHRDIKATNVLLDRDLNPKISDFGLAK  391 (511)
Q Consensus       361 -------------------------~~~iiH~Dlk~~NILld~~~~~kl~DfGla~  391 (511)
                                               ...++|+|+.|.|||++++..+-|.||+.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                     1227999999999999987767799998875

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.87  E-value=2.9e-05  Score=71.22  Aligned_cols=141  Identities=17%  Similarity=0.135  Sum_probs=84.4

Q ss_pred             eeccCc-eeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCC--CCCceeEEEEEEeCCEEEEEEEecCCCCHh
Q 045835          248 IGEGGF-GPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQ--HPNLVKIHGCCVEGDQLLLVYEYMENNSLA  324 (511)
Q Consensus       248 lG~G~f-G~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~  324 (511)
                      +..|.. ..||+...+++..+.+|.......   ..+..|...++.+.  .-.+.++++++.+++..++||+++++-++.
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~   94 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL   94 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence            344443 578999887788888898654432   34667777777663  334667888888888899999999876653


Q ss_pred             HH-----------------HhcCCCCCCCC--CHHHHHHH--------------------HHHHHHHHHHHhcC----CC
Q 045835          325 CA-----------------LFGRENCELEL--DWPTRQKI--------------------CLGIARGLAFLHEE----SR  361 (511)
Q Consensus       325 ~~-----------------l~~~~~~~~~l--~~~~~~~i--------------------~~~ia~gl~yLH~~----~~  361 (511)
                      +.                 |+........+  .+.....-                    .......+..+...    ..
T Consensus        95 ~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  174 (255)
T d1nd4a_          95 SSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGED  174 (255)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCC
T ss_pred             cccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCC
Confidence            21                 11100000001  11100000                    00011223333222    12


Q ss_pred             CCeEEccCCCCCeEEcCCCCeEEeecCCcc
Q 045835          362 FKIVHRDIKATNVLLDRDLNPKISDFGLAK  391 (511)
Q Consensus       362 ~~iiH~Dlk~~NILld~~~~~kl~DfGla~  391 (511)
                      +.++|+|+.|.|||++++..+-|.||+.+.
T Consensus       175 ~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         175 LVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             EEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence            238999999999999988777899998875

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.32  E-value=0.00029  Score=69.00  Aligned_cols=76  Identities=13%  Similarity=0.124  Sum_probs=47.8

Q ss_pred             cCceeccCceeEEeccccC-CcEEEEEEecccC-------ccchHHHHHHHHHHhcCC-C--CCceeEEEEEEeCCEEEE
Q 045835          245 AKKIGEGGFGPVYKGQLAD-GTIIAVKQLSSKS-------RQGNREFLNEIAMISCLQ-H--PNLVKIHGCCVEGDQLLL  313 (511)
Q Consensus       245 ~~~lG~G~fG~Vy~g~~~~-g~~vAvK~~~~~~-------~~~~~~~~~Ei~~l~~l~-H--~niv~l~g~~~~~~~~~l  313 (511)
                      .+.||.|....||+....+ ++.++||.-....       .........|.+.|+.+. +  ..+.+++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            3468999999999997654 6788999754321       112234456777776552 2  334555544  4556689


Q ss_pred             EEEecCCCC
Q 045835          314 VYEYMENNS  322 (511)
Q Consensus       314 V~Ey~~~gs  322 (511)
                      |||++.+..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.23  E-value=0.0099  Score=55.98  Aligned_cols=136  Identities=15%  Similarity=0.133  Sum_probs=77.3

Q ss_pred             eeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCCCCc-----eeEE--EEEEeCCEEEEEEEecCCCCHhH-
Q 045835          254 GPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNL-----VKIH--GCCVEGDQLLLVYEYMENNSLAC-  325 (511)
Q Consensus       254 G~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni-----v~l~--g~~~~~~~~~lV~Ey~~~gsL~~-  325 (511)
                      -.||+.+..+|+.+++|+.+.. .....++..|...+..|....+     +..-  .....+...+.+++++++..+.. 
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            4799999999999999987653 3345667788888776642221     1111  11234667889999987643311 


Q ss_pred             ---HH----------hc----C-CCCCCCCCHHH-------------------HHHHHHHHHHHHHHHhc----CCCCCe
Q 045835          326 ---AL----------FG----R-ENCELELDWPT-------------------RQKICLGIARGLAFLHE----ESRFKI  364 (511)
Q Consensus       326 ---~l----------~~----~-~~~~~~l~~~~-------------------~~~i~~~ia~gl~yLH~----~~~~~i  364 (511)
                         .+          +.    . ......+++..                   +..+...+.+.++.+..    .....+
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence               11          10    0 00111222211                   11111122223333322    223458


Q ss_pred             EEccCCCCCeEEcCCCCeEEeecCCccc
Q 045835          365 VHRDIKATNVLLDRDLNPKISDFGLAKL  392 (511)
Q Consensus       365 iH~Dlk~~NILld~~~~~kl~DfGla~~  392 (511)
                      +|+|+.+.|||++++  ..+.||+-++.
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999754  45889998874

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.55  E-value=0.011  Score=57.18  Aligned_cols=73  Identities=15%  Similarity=0.227  Sum_probs=47.5

Q ss_pred             cCceeccCceeEEeccccC--------CcEEEEEEecccCccchHHHHHHHHHHhcCCCCCc-eeEEEEEEeCCEEEEEE
Q 045835          245 AKKIGEGGFGPVYKGQLAD--------GTIIAVKQLSSKSRQGNREFLNEIAMISCLQHPNL-VKIHGCCVEGDQLLLVY  315 (511)
Q Consensus       245 ~~~lG~G~fG~Vy~g~~~~--------g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~  315 (511)
                      ++.|+.|-.-.+|+....+        ...|.+++...  ........+|..+++.+.-.++ .++++++.+    .+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            3567778888999987543        24566666542  2233455688888887753344 467777642    5789


Q ss_pred             EecCCCCH
Q 045835          316 EYMENNSL  323 (511)
Q Consensus       316 Ey~~~gsL  323 (511)
                      ||+++.+|
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.75  E-value=0.11  Score=47.86  Aligned_cols=159  Identities=12%  Similarity=0.058  Sum_probs=83.4

Q ss_pred             ccHHHHHHHhcCCcccCce-----eccCceeEEeccccCCcEEEEEEecccCccchHHHHHHHHHHhcCCC-----CCce
Q 045835          230 FTLKQIKAATNNFDSAKKI-----GEGGFGPVYKGQLADGTIIAVKQLSSKSRQGNREFLNEIAMISCLQH-----PNLV  299 (511)
Q Consensus       230 ~~~~~l~~~~~~f~~~~~l-----G~G~fG~Vy~g~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H-----~niv  299 (511)
                      ++.+|++....+|.+.+..     ..|---+.|+.+..+|+ +++|+......  ..+...|+.++..|..     |..+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence            4667888888888775544     34555678998876665 78888754322  2344456666665532     2222


Q ss_pred             eEE-E--EEEeCCEEEEEEEecCCCCHhHH--------------Hhc--C----CCCCCCCC-H----------------
Q 045835          300 KIH-G--CCVEGDQLLLVYEYMENNSLACA--------------LFG--R----ENCELELD-W----------------  339 (511)
Q Consensus       300 ~l~-g--~~~~~~~~~lV~Ey~~~gsL~~~--------------l~~--~----~~~~~~l~-~----------------  339 (511)
                      ... |  +.........++.+..+......              ++.  .    ........ |                
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            110 0  11224566777777765433110              000  0    00000000 0                


Q ss_pred             HHHHHHHHHHHHHHHHHhcC-CCCCeEEccCCCCCeEEcCCCCeEEeecCCcc
Q 045835          340 PTRQKICLGIARGLAFLHEE-SRFKIVHRDIKATNVLLDRDLNPKISDFGLAK  391 (511)
Q Consensus       340 ~~~~~i~~~ia~gl~yLH~~-~~~~iiH~Dlk~~NILld~~~~~kl~DfGla~  391 (511)
                      ......+..+...+.-.+.. -+..+||+|+.+.||+++.+...-|.||+.+.
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            01111222222333333222 13359999999999999998877899999886

>d2o14a1 b.18.1.32 (A:14-159) Hypothetical protein YxiM {Bacillus subtilis [TaxId: 1423]}

class: All beta proteins
fold: Galactose-binding domain-like
superfamily: Galactose-binding domain-like
family: YxiM N-terminal domain-like
domain: Hypothetical protein YxiM
species: Bacillus subtilis [TaxId: 1423]

Probab=89.96  E-value=0.37  Score=39.02  Aligned_cols=60  Identities=13%  Similarity=0.195  Sum_probs=42.0

Q ss_pred             eecccCCceeEEEeeeeeeeccccceeecccceEEEEEecccccccccchhhhhcCCCccceeeeeeeeeceeeEEEEEE
Q 045835           68 FGYCLDNGNYTLSLHFAEIQFSNGITFHSLGRRLFDIYIQDNLVERNFDIKAEASGVLKPVARSYNVTVTNHIIEIRFHW  147 (511)
Q Consensus        68 ~~~~~~~~~y~v~lhfae~~~~~~~~~~~~g~r~fdiyi~~~~~~~~~~i~~~~~g~~~~~~~~f~v~v~~~~~~i~~~~  147 (511)
                      |..-++||+|.|++.|.+..             -.++.+.+...+..+        ......+.|.|.|.+..+.|+|.-
T Consensus        67 f~v~vPnG~Y~Vtv~~Gd~~-------------~~~~~~eg~~~~~~~--------~g~~~~~~~~V~VtDG~L~l~ft~  125 (146)
T d2o14a1          67 FNVDLPNGLYEVKVTLGNTA-------------RASVAAEGVFQVINM--------TGDGAEDTFQIPVTDGQLNLLVTE  125 (146)
T ss_dssp             EEEECCSEEEEEEEEESSCS-------------EEEEEETTEEEEEEE--------ESTTCEEEEEEEECSSEEEEEEEE
T ss_pred             EEEECCCCeEEEEEEEecCC-------------CccEEEeeEEecccc--------CCccEEEEEEEEEECCeEEEEEec
Confidence            33446799999999999853             124556665554443        223457889999999999998875


Q ss_pred             C
Q 045835          148 A  148 (511)
Q Consensus       148 ~  148 (511)
                      +
T Consensus       126 ~  126 (146)
T d2o14a1         126 G  126 (146)
T ss_dssp             S
T ss_pred             C
Confidence            5